data_1k3g_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1k3g _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.454 -0.247 0 N-CA-C 104.12 -2.548 . . . . 2.3100000000000001 104.12 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.27 -52.49 33.22 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-O 122.428 1.109 . . . . 1.8799999999999999 109.265 -166.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -55.69 -48.06 75.72 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 114.15 -1.387 . . . . 2.73 111.839 175.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.86 -46.06 82.05 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 119.617 1.099 . . . . 1.74 111.013 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 68.7 t -55.86 -56.76 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.225 0 N-CA-C 108.901 -0.777 . . . . 1.6499999999999999 108.901 176.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 29.9 t -51.93 -49.14 38.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 O-C-N 122.343 -0.223 . . . . 1.53 111.274 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 18.1 mm-40 -57.34 -8.03 0.69 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 127.895 2.478 . . . . 1.22 113.671 176.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 19.6 tp60 -137.44 17.57 2.93 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 119.772 1.169 . . . . 3.9500000000000002 111.522 172.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 50.3 mmtt -138.97 -59.44 0.6 Allowed 'General case' 0 CA--C 1.514 -0.434 0 O-C-N 121.111 -0.993 . . . . 3.6699999999999999 110.435 -177.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 2.8 m -79.45 -47.68 15.24 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 108.698 -0.852 . . . . 0.44 108.698 -173.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.5 pp -52.85 -30.2 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 CA-C-N 115.384 -0.826 . . . . 1.74 111.95 -179.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.8 m -46.01 -30.81 1.97 Allowed 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.132 1.373 . . . . 1.8200000000000001 112.738 176.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 30.1 m -121.93 -44.55 2.3 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.784 0.834 . . . . 0.20999999999999999 111.386 173.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 87.1 m-70 -68.61 -10.13 54.07 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.724 1.21 . . . . 0.38 112.558 -177.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 87.99 148.31 15.19 Favored Glycine 0 C--N 1.339 0.702 0 C-N-CA 125.468 1.509 . . . . 1.48 109.64 179.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -41.83 -36.98 1.92 Allowed Glycine 0 C--N 1.341 0.84 0 C-N-CA 124.653 1.121 . . . . 1.23 112.214 173.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -89.94 -12.4 38.93 Favored 'General case' 0 N--CA 1.444 -0.76 0 C-N-CA 125.876 1.67 . . . . 3.0800000000000001 111.429 -172.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.0 mt 71.24 11.61 6.79 Favored 'General case' 0 C--N 1.349 0.56 0 CA-C-N 119.983 1.265 . . . . 2.2200000000000002 111.249 178.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.6 p -87.2 0.09 55.88 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 127.696 2.398 . . . . 1.6299999999999999 110.018 -175.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.7 126.22 2.32 Favored Glycine 0 N--CA 1.441 -0.977 0 N-CA-C 109.052 -1.619 . . . . 0.81000000000000005 109.052 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -131.27 -77.93 0.52 Allowed 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 124.311 1.044 . . . . 1.5 108.405 178.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 12.6 m -92.59 4.29 53.9 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.393 1.077 . . . . 2.02 110.984 173.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -157.82 166.63 16.16 Favored Pre-proline 0 CA--C 1.537 0.453 0 C-N-CA 125.013 1.325 . . . . 1.5 108.353 -168.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -73.88 153.91 48.01 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 123.136 2.557 . . . . 0.51000000000000001 110.552 -173.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -72.04 125.71 27.94 Favored 'General case' 0 C--N 1.332 -0.171 0 O-C-N 121.107 -0.996 . . . . 1.5900000000000001 110.725 -174.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 18.1 pt -104.43 1.63 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.143 0 C-N-CA 123.351 0.66 . . . . 1.6799999999999999 111.697 176.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -36.79 -44.9 0.51 Allowed 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.416 1.086 . . . . 2.3799999999999999 112.986 170.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 8.4 pttp -113.2 31.89 6.13 Favored 'General case' 0 C--N 1.344 0.332 0 C-N-CA 123.94 0.896 . . . . 4.9299999999999997 111.876 178.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.92 -44.32 96.41 Favored 'General case' 0 N--CA 1.454 -0.242 0 O-C-N 120.836 -1.165 . . . . 1.54 109.297 178.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -54.2 -26.65 36.62 Favored Glycine 0 C--N 1.339 0.746 0 CA-C-N 118.238 0.472 . . . . 0.58999999999999997 113.915 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -83.59 -45.07 13.92 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 117.29 0.545 . . . . 2.1400000000000001 110.031 175.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 35.3 m-80 -58.27 -51.77 68.37 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 122.728 0.411 . . . . 1.6200000000000001 111.333 178.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -134.12 149.99 51.11 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.456 1.503 . . . . 1.3200000000000001 108.485 -166.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.66 164.37 25.37 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 109.856 -0.424 . . . . 2.52 109.856 -179.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -49.39 -42.77 43.27 Favored 'General case' 0 C--O 1.223 -0.331 0 C-N-CA 123.301 0.64 . . . . 3.27 110.779 173.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 70.9 mt-10 -52.98 -44.86 67.5 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.207 0.603 . . . . 2.9199999999999999 110.776 178.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 58.2 mm-40 -75.06 -47.96 26.28 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.172 0.589 . . . . 3.0499999999999998 110.037 -177.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 76.4 mt -62.77 -46.34 96.6 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.111 0 N-CA-C 108.941 -0.763 . . . . 1.5700000000000001 108.941 -175.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 32.4 tp -53.48 -51.72 61.83 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 124.061 0.944 . . . . 1.71 109.281 176.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -53.09 -51.56 61.44 Favored 'General case' 0 N--CA 1.452 -0.368 0 O-C-N 123.374 0.421 . . . . 1.95 110.504 176.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 40.9 mt -56.02 -45.15 80.26 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.378 0 O-C-N 121.451 -0.781 . . . . 1.78 111.184 177.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 43.3 mt -61.98 -45.41 98.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 O-C-N 119.951 -1.718 . . . . 1.7 109.482 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 87.5 mt -69.81 -29.04 66.23 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.118 0.967 . . . . 2.04 113.364 -178.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -128.87 19.54 6.05 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 119.683 1.128 . . . . 1.8 110.338 -166.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 34.87 -146.52 0.04 OUTLIER Glycine 0 CA--C 1.538 1.516 0 C-N-CA 128.975 3.179 . . . . 0.64000000000000001 112.397 -170.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 177.37 135.64 0.07 Allowed 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.173 1.389 . . . . 1.3100000000000001 108.075 -176.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 32.0 -110.67 0.04 OUTLIER Glycine 0 CA--C 1.533 1.171 0 C-N-CA 125.038 1.304 . . . . 0.45000000000000001 114.095 -174.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -71.03 -24.65 76.91 Favored Glycine 0 CA--C 1.534 1.243 0 CA-C-N 118.116 0.958 . . . . 0.57999999999999996 113.053 -178.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 17.6 ttt -69.36 118.35 61.33 Favored Pre-proline 0 CA--C 1.535 0.388 0 C-N-CA 125.06 1.344 . . . . 1.6899999999999999 111.3 -179.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -75.67 127.86 10.54 Favored 'Trans proline' 0 N--CA 1.446 -1.279 0 C-N-CA 122.877 2.385 . . . . 2.1099999999999999 110.671 177.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -66.48 140.35 38.86 Favored Glycine 0 N--CA 1.442 -0.909 0 N-CA-C 115.158 0.823 . . . . 1.6799999999999999 115.158 -177.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 79.53 39.17 18.93 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 110.6 -1.0 . . . . 0.38 110.6 176.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -60.19 -48.95 86.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 124.645 1.178 . . . . 2.1800000000000002 108.863 175.07 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -102.72 149.3 24.59 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 126.031 1.732 . . . . 1.53 108.87 162.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 65.6 mttt -141.42 160.04 40.97 Favored 'General case' 0 C--N 1.339 0.119 0 C-N-CA 124.097 0.959 . . . . 3.5699999999999998 110.036 172.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 74.84 -165.16 54.73 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 109.999 -1.241 . . . . 1.25 109.999 -174.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -54.32 -24.47 19.38 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.451 0.701 . . . . 2.2000000000000002 111.691 -178.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -41.92 -60.14 1.49 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.198 1.399 . . . . 2.3100000000000001 110.511 169.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.6 -45.66 93.16 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 122.537 0.335 . . . . 1.51 110.293 -174.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -51.73 -60.69 2.88 Favored 'General case' 0 C--N 1.339 0.111 0 C-N-CA 124.08 0.952 . . . . 2.73 110.739 174.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -52.77 -48.9 66.49 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-O 119.242 -0.408 . . . . 1.6899999999999999 110.743 -179.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 78.6 t -53.69 -59.75 1.75 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 CA-C-N 117.787 0.267 . . . . 1.72 110.865 176.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -50.33 -51.47 45.28 Favored 'General case' 0 C--O 1.226 -0.138 0 C-N-CA 123.669 0.788 . . . . 1.73 112.159 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.2 -45.43 80.81 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.4 0.68 . . . . 1.55 110.683 -175.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 77.3 t90 -55.23 -47.82 74.83 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 109.041 -0.726 . . . . 0.91000000000000003 109.041 173.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.03 -37.79 80.83 Favored 'General case' 0 C--O 1.22 -0.474 0 CA-C-O 117.977 -1.011 . . . . 3.1400000000000001 112.911 173.04 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -52.95 -40.89 64.02 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 120.381 1.446 . . . . 1.6200000000000001 110.735 175.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -67.54 -38.08 83.66 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-O 118.944 -0.55 . . . . 3.7400000000000002 112.329 170.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 24.2 mtpp -76.37 108.86 9.62 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 119.906 1.23 . . . . 3.6600000000000001 111.092 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 88.9 mttt . . . . . 0 C--O 1.25 1.126 0 C-N-CA 126.013 1.725 . . . . 3.02 107.599 -176.356 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.447 -0.589 0 N-CA-C 108.137 -1.06 . . . . 2.2000000000000002 108.137 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -48.0 -54.14 13.91 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.834 0.854 . . . . 1.5900000000000001 110.786 -179.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -53.34 -46.55 69.53 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 122.73 0.412 . . . . 3.29 111.621 176.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.3 -44.47 97.16 Favored 'General case' 0 CA--C 1.527 0.062 0 C-N-CA 122.877 0.471 . . . . 1.4099999999999999 110.569 -179.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 77.7 t -57.94 -55.4 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 N-CA-C 109.232 -0.655 . . . . 1.74 109.232 175.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 79.0 t -50.99 -47.92 29.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 110.379 -0.23 . . . . 1.72 110.379 -179.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 28.6 mm-40 -54.22 -23.33 14.29 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 126.455 1.902 . . . . 0.64000000000000001 114.72 174.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -142.6 59.23 1.44 Allowed 'General case' 0 N--CA 1.461 0.088 0 CA-C-N 120.54 1.518 . . . . 2.6899999999999999 112.106 173.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.08 -36.39 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 124.435 1.094 . . . . 2.0499999999999998 109.611 171.177 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 3.7 m -101.9 -50.4 3.69 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 118.813 0.733 . . . . 0.28999999999999998 110.931 -177.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.0 pp -56.77 -25.77 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 N-CA-C 112.556 0.576 . . . . 1.8200000000000001 112.556 -174.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.3 m -41.8 -34.89 0.7 Allowed 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.576 1.55 . . . . 1.6699999999999999 112.475 172.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 18.9 m -121.1 -42.97 2.46 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.369 0.668 . . . . 0.20000000000000001 111.385 175.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 84.8 m-70 -71.34 -7.65 48.52 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.422 0.689 . . . . 0.23000000000000001 112.741 -176.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 88.49 149.29 18.67 Favored Glycine 0 C--N 1.338 0.669 0 N-CA-C 109.776 -1.329 . . . . 1.4399999999999999 109.776 178.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -43.17 -36.45 2.84 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 124.615 1.102 . . . . 1.26 112.233 174.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -97.58 -4.39 37.79 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 124.88 1.272 . . . . 2.8999999999999999 111.793 -172.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.5 mt 71.43 12.83 6.58 Favored 'General case' 0 C--N 1.348 0.531 0 CA-C-N 120.238 1.381 . . . . 2.4500000000000002 111.071 176.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.3 p -88.71 1.23 55.5 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 127.866 2.466 . . . . 1.6599999999999999 110.038 -173.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.51 138.0 5.57 Favored Glycine 0 N--CA 1.444 -0.808 0 N-CA-C 109.049 -1.62 . . . . 0.41999999999999998 109.049 -177.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -143.79 -71.56 0.29 Allowed 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.469 -0.567 . . . . 1.6799999999999999 109.469 178.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -99.02 3.92 47.01 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.939 1.696 . . . . 1.75 110.315 172.393 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -158.28 165.43 18.6 Favored Pre-proline 0 CA--C 1.535 0.394 0 C-N-CA 124.907 1.283 . . . . 1.4299999999999999 107.852 -168.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -69.5 157.73 59.84 Favored 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 122.621 2.214 . . . . 0.25 110.53 -175.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.64 121.49 20.79 Favored 'General case' 0 N--CA 1.454 -0.246 0 O-C-N 121.724 -0.61 . . . . 1.6100000000000001 109.934 -178.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 41.7 pt -100.99 1.88 10.56 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.161 0 C-N-CA 123.536 0.735 . . . . 1.52 111.039 178.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.404 ' OD1' ' NZ ' ' A' ' 91' ' ' LYS . 34.2 t70 -44.01 -41.23 5.28 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 113.506 0.928 . . . . 3.1800000000000002 113.506 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 35.0 mttm -109.3 33.19 4.44 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 125.838 1.655 . . . . 6.9100000000000001 111.403 179.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -58.26 -46.02 86.76 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 108.975 -0.75 . . . . 1.4099999999999999 108.975 173.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -54.07 -28.55 41.62 Favored Glycine 0 CA--C 1.527 0.785 0 CA-C-N 118.243 0.474 . . . . 0.51000000000000001 114.158 -179.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -78.62 -42.6 28.46 Favored 'General case' 0 N--CA 1.455 -0.223 0 O-C-N 122.227 -0.573 . . . . 1.6000000000000001 110.049 175.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 15.8 m-80 -65.63 -48.53 71.91 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 122.784 0.434 . . . . 1.5700000000000001 111.197 -178.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -138.79 147.74 42.93 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 125.423 1.489 . . . . 1.29 108.327 -170.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 89.6 p -74.62 168.28 20.11 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.033 0.533 . . . . 3.02 110.973 177.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -46.66 -47.21 20.3 Favored 'General case' 0 C--O 1.224 -0.278 0 C-N-CA 124.311 1.044 . . . . 2.7599999999999998 111.582 174.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -57.7 -41.54 81.91 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.422 0.689 . . . . 4.0300000000000002 110.531 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -76.23 -45.79 31.26 Favored 'General case' 0 N--CA 1.45 -0.428 0 O-C-N 121.437 -0.789 . . . . 3.4399999999999999 109.391 -175.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 80.9 mt -60.76 -44.43 97.37 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.125 0 N-CA-C 109.027 -0.731 . . . . 1.6299999999999999 109.027 178.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 33.5 tp -54.66 -49.02 71.58 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 109.277 -0.638 . . . . 1.49 109.277 176.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -54.1 -46.19 72.04 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 117.891 0.314 . . . . 1.48 111.498 175.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 73.9 mt -59.63 -49.79 82.4 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.261 0 O-C-N 121.115 -0.991 . . . . 1.6799999999999999 110.453 176.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 58.8 mt -56.18 -44.64 79.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 O-C-N 120.386 -1.446 . . . . 1.6299999999999999 110.002 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 69.5 mt -71.04 -28.64 64.52 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 124.309 1.043 . . . . 1.52 113.802 -178.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 51.3 m-80 -125.02 15.54 8.51 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 120.374 1.443 . . . . 1.73 110.629 -169.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 35.84 -144.14 0.09 OUTLIER Glycine 0 CA--C 1.537 1.428 0 C-N-CA 128.082 2.753 . . . . 0.62 111.597 -166.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 173.83 133.56 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 119.465 1.632 . . . . 1.3200000000000001 110.021 -177.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 40.26 -119.36 1.26 Allowed Glycine 0 CA--C 1.532 1.126 0 CA-C-N 119.574 1.079 . . . . 0.46000000000000002 112.789 -173.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -66.14 -21.76 70.22 Favored Glycine 0 CA--C 1.534 1.233 0 CA-C-N 117.498 0.649 . . . . 0.56000000000000005 113.245 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 18.2 ttt -74.04 121.07 84.33 Favored Pre-proline 0 CA--C 1.536 0.41 0 C-N-CA 124.406 1.082 . . . . 1.4099999999999999 111.539 -176.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -79.02 122.71 5.41 Favored 'Trans proline' 0 N--CA 1.449 -1.097 0 C-N-CA 123.262 2.641 . . . . 2.1099999999999999 111.688 -178.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -60.65 138.76 48.21 Favored Glycine 0 N--CA 1.443 -0.89 0 N-CA-C 115.5 0.96 . . . . 1.6100000000000001 115.5 -177.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 81.94 35.63 21.03 Favored Glycine 0 CA--C 1.527 0.783 0 CA-C-N 114.379 -0.911 . . . . 0.33000000000000002 111.612 174.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.2 mt -58.23 -52.16 62.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 124.924 1.29 . . . . 2.2999999999999998 110.059 175.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -111.02 161.68 15.63 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.748 1.619 . . . . 1.6299999999999999 109.036 165.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 18.0 mttm -144.32 164.3 31.18 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 124.931 1.292 . . . . 3.6699999999999999 110.412 176.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 57.2 -144.5 39.51 Favored Glycine 0 CA--C 1.529 0.908 0 N-CA-C 111.185 -0.766 . . . . 0.88 111.185 179.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -52.23 -33.98 43.84 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.203 0.601 . . . . 1.98 111.526 174.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -55.02 -36.64 65.69 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.443 0.697 . . . . 2.2799999999999998 110.515 176.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -88.05 -52.69 5.12 Favored 'General case' 0 CA--C 1.534 0.336 0 O-C-N 121.662 -0.649 . . . . 1.45 111.086 175.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -54.73 -50.9 67.24 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.789 0.836 . . . . 2.48 111.568 -175.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.61 -45.37 92.14 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 109.644 -0.502 . . . . 1.46 109.644 -178.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 64.9 t -57.19 -55.12 22.43 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 C-N-CA 122.831 0.452 . . . . 1.5900000000000001 110.363 176.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -50.28 -53.83 25.69 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 122.973 0.509 . . . . 1.3600000000000001 111.497 177.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.33 -44.78 95.69 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 121.542 0.686 . . . . 1.5700000000000001 111.278 -178.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 81.0 t90 -60.82 -50.08 74.91 Favored 'General case' 0 N--CA 1.452 -0.356 0 O-C-N 121.471 -0.768 . . . . 0.75 110.221 179.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.6 -30.64 70.82 Favored 'General case' 0 C--O 1.222 -0.367 0 O-C-N 121.3 -0.875 . . . . 2.96 111.927 172.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -58.92 -31.48 68.69 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 119.603 1.092 . . . . 1.48 111.21 171.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -76.02 -35.68 59.43 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 118.927 0.785 . . . . 3.4900000000000002 111.784 169.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.404 ' NZ ' ' OD1' ' A' ' 49' ' ' ASP . 0.7 OUTLIER -73.34 110.18 7.44 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 119.522 1.055 . . . . 3.7999999999999998 111.068 -179.64 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 19.7 mttt . . . . . 0 C--O 1.251 1.163 0 C-N-CA 125.507 1.523 . . . . 3.7000000000000002 109.342 -170.817 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 . . . . . 0 N--CA 1.449 -0.517 0 N-CA-C 108.383 -0.969 . . . . 2.6800000000000002 108.383 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -42.69 -56.09 3.3 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.677 1.191 . . . . 1.55 111.088 177.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -47.56 -47.04 28.45 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 123.524 0.73 . . . . 3.0699999999999998 111.73 175.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.98 -46.06 90.91 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-N 118.682 0.674 . . . . 1.52 110.412 -179.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 94.5 t -58.51 -52.22 62.1 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.134 0 N-CA-C 109.691 -0.485 . . . . 1.76 109.691 177.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 72.4 t -52.47 -52.22 27.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 N-CA-C 109.756 -0.461 . . . . 1.6799999999999999 109.756 179.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 35.3 mm-40 -58.12 -7.2 0.75 Allowed 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 127.547 2.339 . . . . 0.65000000000000002 114.022 174.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -142.82 33.1 1.4 Allowed 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 119.81 1.187 . . . . 3.1600000000000001 113.369 172.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -153.92 -55.66 0.11 Allowed 'General case' 0 CA--C 1.517 -0.314 0 O-C-N 121.766 -0.584 . . . . 2.6600000000000001 109.885 170.183 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 3.2 m -76.34 -48.29 20.5 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 109.824 -0.436 . . . . 0.27000000000000002 109.824 -170.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.1 pt -49.93 -30.99 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-N 115.217 -0.901 . . . . 2.1200000000000001 112.517 -179.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.9 m -46.06 -33.02 3.17 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 125.64 1.576 . . . . 1.8799999999999999 112.077 177.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 14.6 m -121.95 -44.84 2.28 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.706 0.802 . . . . 0.19 111.228 175.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 82.0 m-70 -67.43 -11.11 57.0 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.189 0.996 . . . . 0.38 112.319 -178.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 87.82 148.04 14.25 Favored Glycine 0 C--N 1.339 0.712 0 N-CA-C 109.396 -1.481 . . . . 1.4299999999999999 109.396 178.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -43.83 -31.92 2.04 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 124.655 1.121 . . . . 1.3400000000000001 112.969 173.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -92.62 -12.44 31.63 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.596 1.559 . . . . 2.1499999999999999 112.831 -175.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 73.0 9.71 5.37 Favored 'General case' 0 C--N 1.347 0.489 0 CA-C-N 120.326 1.421 . . . . 2.7400000000000002 111.168 178.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.0 p -86.0 -1.66 57.55 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 127.947 2.499 . . . . 1.5 110.222 -174.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.64 132.25 4.64 Favored Glycine 0 N--CA 1.443 -0.86 0 N-CA-C 108.726 -1.75 . . . . 0.52000000000000002 108.726 -179.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -137.45 -75.83 0.4 Allowed 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 108.869 -0.789 . . . . 1.71 108.869 179.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 15.7 m -95.47 4.3 53.4 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.658 1.183 . . . . 2.0299999999999998 110.628 172.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -156.6 167.73 13.84 Favored Pre-proline 0 N--CA 1.45 -0.474 0 C-N-CA 124.842 1.257 . . . . 1.6799999999999999 108.33 -171.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -71.02 156.43 60.04 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 122.951 2.434 . . . . 0.37 110.508 -174.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.37 126.74 30.84 Favored 'General case' 0 N--CA 1.455 -0.199 0 O-C-N 121.513 -0.742 . . . . 1.6000000000000001 110.083 -177.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 36.3 pt -103.2 0.62 10.32 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.191 0 C-N-CA 123.239 0.616 . . . . 1.6699999999999999 111.196 174.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -33.23 -45.73 0.15 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.606 1.562 . . . . 2.29 113.071 168.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.62 39.95 3.2 Favored 'General case' 0 C--N 1.343 0.317 0 C-N-CA 124.184 0.993 . . . . 4.8499999999999996 111.475 177.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.63 -42.99 85.88 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 121.324 -0.86 . . . . 1.7 109.601 174.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -52.4 -32.53 37.89 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-N 118.507 0.594 . . . . 0.66000000000000003 114.387 -175.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -78.22 -49.13 14.33 Favored 'General case' 0 N--CA 1.455 -0.221 0 O-C-N 122.39 -0.477 . . . . 1.8200000000000001 110.172 174.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 33.0 m-80 -56.6 -48.84 76.57 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 122.865 0.466 . . . . 1.53 111.533 -177.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -136.47 140.16 42.88 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.751 1.62 . . . . 1.6499999999999999 107.373 -169.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 90.4 p -73.87 169.01 18.29 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 121.641 -0.662 . . . . 3.2599999999999998 110.716 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -48.17 -52.59 20.1 Favored 'General case' 0 C--N 1.341 0.233 0 O-C-N 121.811 -0.555 . . . . 4.9400000000000004 110.103 174.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -53.97 -27.22 29.94 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 118.69 -0.672 . . . . 2.75 112.51 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -87.87 -46.87 9.04 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 119.325 0.966 . . . . 3.2799999999999998 110.248 177.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 83.4 mt -62.62 -47.73 91.53 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.145 0 O-C-N 121.31 -0.868 . . . . 1.6000000000000001 109.153 -177.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 25.3 tp -53.38 -50.07 65.87 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 109.036 -0.728 . . . . 1.6499999999999999 109.036 176.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -49.43 -55.83 11.75 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 122.701 0.4 . . . . 2.77 110.054 173.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 23.2 mt -56.16 -45.45 80.83 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.366 0 C-N-CA 120.329 -0.548 . . . . 1.6499999999999999 110.69 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 56.0 mt -58.46 -40.34 78.14 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 O-C-N 120.099 -1.626 . . . . 1.6599999999999999 109.926 178.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 71.9 mt -70.73 -40.61 72.65 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.359 1.064 . . . . 1.76 113.439 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 14.8 p30 -124.29 27.16 7.14 Favored 'General case' 0 C--N 1.343 0.312 0 CA-C-N 120.899 1.681 . . . . 3.8999999999999999 110.12 -168.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 34.2 -140.33 0.12 Allowed Glycine 0 CA--C 1.534 1.268 0 C-N-CA 128.344 2.878 . . . . 0.64000000000000001 110.999 -173.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 2.3 tp-100 176.87 140.58 0.07 Allowed 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 107.592 -1.262 . . . . 2.9700000000000002 107.592 -179.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 40.97 -112.17 0.33 Allowed Glycine 0 CA--C 1.536 1.344 0 CA-C-N 119.953 1.251 . . . . 0.48999999999999999 113.782 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -79.78 -20.92 67.2 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 123.87 0.748 . . . . 0.64000000000000001 112.866 178.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 19.8 ttt -68.01 118.48 58.87 Favored Pre-proline 0 CA--C 1.534 0.338 0 C-N-CA 125.041 1.336 . . . . 1.48 110.734 179.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -76.42 122.05 6.34 Favored 'Trans proline' 0 N--CA 1.446 -1.293 0 C-N-CA 122.698 2.265 . . . . 2.0800000000000001 111.166 -179.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -59.06 135.79 51.64 Favored Glycine 0 N--CA 1.442 -0.922 0 CA-C-N 115.364 -0.834 . . . . 1.6399999999999999 114.869 -179.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 88.19 35.92 8.57 Favored Glycine 0 CA--C 1.53 0.97 0 CA-C-N 114.466 -0.867 . . . . 0.34999999999999998 112.368 172.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.3 mt -64.94 -46.88 90.33 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.863 0 C-N-CA 125.76 1.624 . . . . 2.2200000000000002 110.981 178.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -116.36 149.33 39.52 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 126.238 1.815 . . . . 1.5800000000000001 107.561 163.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.3 mtpp -144.03 162.26 36.68 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 125.973 1.709 . . . . 3.1800000000000002 108.293 178.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 63.68 -161.4 35.79 Favored Glycine 0 CA--C 1.529 0.966 0 N-CA-C 110.933 -0.867 . . . . 0.75 110.933 -174.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -51.6 -27.71 12.0 Favored 'General case' 0 C--O 1.225 -0.224 0 C-N-CA 123.949 0.9 . . . . 1.6899999999999999 112.226 -177.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -44.63 -60.68 1.88 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.931 1.293 . . . . 2.0800000000000001 109.766 168.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -69.47 -46.19 67.24 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.838 0.855 . . . . 1.46 110.821 -178.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -56.27 -49.58 73.83 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 121.231 0.539 . . . . 1.97 110.157 -176.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -55.52 -53.5 55.63 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 123.467 0.707 . . . . 1.51 109.678 176.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 89.1 t -51.37 -56.24 5.84 Favored 'Isoleucine or valine' 0 C--N 1.339 0.138 0 CA-C-N 117.826 0.284 . . . . 1.6200000000000001 110.738 178.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -50.66 -54.85 19.7 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 123.833 0.853 . . . . 1.6899999999999999 111.763 179.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -63.04 -45.11 93.84 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 121.338 0.589 . . . . 1.3100000000000001 110.995 -177.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 84.7 t90 -57.69 -52.74 64.2 Favored 'General case' 0 C--N 1.329 -0.286 0 O-C-N 121.701 -0.624 . . . . 0.81999999999999995 109.485 177.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.77 -30.96 71.14 Favored 'General case' 0 C--O 1.222 -0.366 0 CA-C-O 118.028 -0.987 . . . . 2.9300000000000002 112.714 174.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -55.88 -35.67 66.77 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 119.963 1.256 . . . . 1.5600000000000001 109.985 172.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -74.18 -37.51 63.92 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.002 0.521 . . . . 2.8199999999999998 111.392 173.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 3.5 mtpt -73.82 126.6 30.75 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 119.342 0.974 . . . . 3.29 110.988 -178.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 19.6 mtmt . . . . . 0 C--O 1.253 1.244 0 CA-C-O 115.897 -2.001 . . . . 3.0499999999999998 106.187 -174.751 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 20.5 t0 . . . . . 0 N--CA 1.451 -0.404 0 N-CA-C 106.744 -1.576 . . . . 4.0499999999999998 106.744 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -50.27 -44.97 53.98 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 123.682 0.793 . . . . 1.55 111.46 176.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -66.26 -46.94 75.34 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 107.94 -1.133 . . . . 2.75 107.94 -174.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.78 -46.64 77.9 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 122.886 0.474 . . . . 1.6100000000000001 111.175 175.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 75.4 t -56.58 -57.49 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 N-CA-C 109.264 -0.643 . . . . 1.6499999999999999 109.264 176.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 72.2 t -53.31 -47.8 56.81 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 CA-C-N 118.05 0.386 . . . . 1.53 110.865 -177.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -51.38 -23.92 4.26 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 126.326 1.85 . . . . 0.55000000000000004 113.488 174.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -138.19 57.44 1.71 Allowed 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 119.354 0.979 . . . . 2.8799999999999999 110.857 172.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -172.04 -38.58 0.02 OUTLIER 'General case' 0 C--O 1.225 -0.231 0 C-N-CA 123.736 0.815 . . . . 2.2999999999999998 110.524 168.567 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 3.7 m -97.5 -50.85 4.35 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 119.042 0.837 . . . . 0.23000000000000001 110.26 -178.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.6 pp -57.92 -26.05 27.44 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.156 0 CA-C-N 116.202 -0.454 . . . . 1.6599999999999999 112.134 -173.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.9 m -38.92 -36.75 0.3 Allowed 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 125.841 1.656 . . . . 1.75 112.224 170.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 15.0 m -120.27 -44.72 2.47 Favored 'General case' 0 C--N 1.34 0.187 0 C-N-CA 123.356 0.662 . . . . 0.23000000000000001 111.317 174.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 85.7 m-70 -70.46 -7.79 46.06 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.899 0.879 . . . . 0.25 112.946 -175.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 87.92 149.3 17.16 Favored Glycine 0 C--N 1.337 0.622 0 N-CA-C 109.977 -1.249 . . . . 1.48 109.977 176.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -45.89 -38.7 8.17 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 124.197 0.903 . . . . 1.22 111.981 177.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -93.73 -1.13 55.52 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.417 1.087 . . . . 2.3900000000000001 111.563 -174.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.5 mt 70.66 12.26 7.27 Favored 'General case' 0 C--N 1.349 0.58 0 CA-C-N 120.39 1.45 . . . . 2.52 110.828 174.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.5 p -87.81 0.26 56.02 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 128.185 2.594 . . . . 1.48 109.976 -172.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.56 136.25 4.42 Favored Glycine 0 N--CA 1.442 -0.916 0 N-CA-C 108.973 -1.651 . . . . 0.41999999999999998 108.973 -177.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -143.52 -76.9 0.24 Allowed 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 123.967 0.907 . . . . 1.3899999999999999 108.78 -179.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 24.4 t -95.91 4.97 52.32 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.902 1.281 . . . . 2.6499999999999999 110.397 172.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -157.15 165.49 18.69 Favored Pre-proline 0 N--CA 1.451 -0.376 0 C-N-CA 125.339 1.456 . . . . 1.48 107.936 -170.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -70.8 159.02 53.99 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.886 2.391 . . . . 0.28999999999999998 110.71 -174.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.7 119.96 18.65 Favored 'General case' 0 C--N 1.332 -0.186 0 O-C-N 121.362 -0.836 . . . . 1.51 109.941 -178.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 46.5 pt -101.17 2.56 10.63 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.118 0 C-N-CA 124.46 1.104 . . . . 1.52 110.51 177.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.408 ' OD1' ' NZ ' ' A' ' 91' ' ' LYS . 24.6 t70 -43.51 -43.98 5.75 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 112.316 0.487 . . . . 3.0699999999999998 112.316 178.214 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -109.31 40.87 1.76 Allowed 'General case' 0 C--N 1.344 0.345 0 C-N-CA 126.294 1.838 . . . . 4.7699999999999996 110.517 179.3 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.21 -48.54 81.3 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 118.968 -0.539 . . . . 1.5600000000000001 109.763 172.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -50.12 -39.28 34.03 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 123.578 0.609 . . . . 0.84999999999999998 113.578 -177.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.57 -41.62 98.37 Favored 'General case' 0 CA--C 1.528 0.123 0 O-C-N 122.05 -0.677 . . . . 1.8 111.578 174.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 18.2 m-80 -72.21 -51.23 22.09 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 122.71 0.404 . . . . 1.7 110.196 -177.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -140.41 140.1 35.39 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.052 1.341 . . . . 1.1499999999999999 107.832 -167.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.82 170.34 16.64 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 118.699 0.681 . . . . 2.9700000000000002 109.748 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -50.31 -42.94 53.48 Favored 'General case' 0 C--O 1.224 -0.239 0 O-C-N 121.547 -0.721 . . . . 2.96 111.898 179.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -54.51 -40.63 68.76 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 120.981 0.419 . . . . 2.5499999999999998 110.471 179.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -81.09 -45.58 16.26 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.241 1.016 . . . . 2.7599999999999998 109.76 -175.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 74.9 mt -61.63 -45.94 97.59 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.059 0 O-C-N 121.039 -1.038 . . . . 1.5600000000000001 109.057 179.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 31.0 tp -54.2 -46.23 72.38 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 109.212 -0.662 . . . . 1.8700000000000001 109.212 177.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -53.02 -53.24 53.01 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 123.148 0.28 . . . . 1.4099999999999999 110.626 173.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 59.2 mt -56.24 -43.08 75.55 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 O-C-N 121.385 -0.822 . . . . 1.71 111.414 178.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 45.4 mt -62.46 -45.29 99.14 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 O-C-N 120.07 -1.644 . . . . 1.54 109.677 179.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 76.5 mt -72.92 -28.9 62.73 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.425 1.09 . . . . 1.6599999999999999 113.042 -177.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -127.19 17.44 7.16 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 119.614 1.097 . . . . 1.71 110.331 -166.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.403 ' N ' ' HA2' ' A' ' 73' ' ' GLY . . . 36.41 -146.99 0.06 OUTLIER Glycine 0 CA--C 1.539 1.536 0 C-N-CA 128.65 3.024 . . . . 0.66000000000000003 112.216 -170.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 176.31 131.38 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 118.809 1.304 . . . . 1.3700000000000001 108.907 -175.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 39.78 -117.13 0.77 Allowed Glycine 0 CA--C 1.532 1.152 0 CA-C-N 119.938 1.245 . . . . 0.46000000000000002 113.16 -175.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -69.6 -20.64 75.81 Favored Glycine 0 CA--C 1.534 1.236 0 CA-C-N 117.481 0.641 . . . . 0.54000000000000004 113.402 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 20.5 ttt -71.94 120.45 80.2 Favored Pre-proline 0 N--CA 1.452 -0.362 0 C-N-CA 124.536 1.134 . . . . 1.47 110.821 -178.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -76.54 128.25 10.17 Favored 'Trans proline' 0 N--CA 1.444 -1.43 0 C-N-CA 122.241 1.96 . . . . 2.0699999999999998 110.434 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.403 ' HA2' ' N ' ' A' ' 67' ' ' GLY . . . -63.27 135.65 42.66 Favored Glycine 0 N--CA 1.443 -0.884 0 CA-C-N 115.627 -0.715 . . . . 1.71 114.691 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 82.78 41.36 8.88 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.648 -0.981 . . . . 0.44 110.648 176.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -60.34 -51.18 75.96 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 N-CA-C 108.765 -0.828 . . . . 3.1800000000000002 108.765 174.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -105.74 156.82 17.92 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.746 1.618 . . . . 1.51 109.648 166.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.3 mmtm -144.86 157.68 44.07 Favored 'General case' 0 C--O 1.227 -0.104 0 C-N-CA 125.166 1.387 . . . . 4.1799999999999997 108.038 178.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 67.37 -166.31 42.07 Favored Glycine 0 CA--C 1.531 1.046 0 N-CA-C 111.379 -0.688 . . . . 1.24 111.379 -173.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -51.32 -27.55 9.87 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.717 1.207 . . . . 1.6799999999999999 112.27 -179.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -37.69 -59.82 0.77 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.678 1.591 . . . . 1.8899999999999999 111.191 165.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.76 -49.12 69.52 Favored 'General case' 0 CA--C 1.531 0.215 0 O-C-N 121.937 -0.477 . . . . 1.49 111.128 -177.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -52.47 -54.62 30.01 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.568 1.147 . . . . 2.6000000000000001 111.055 -178.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -54.72 -51.56 65.22 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.145 0.978 . . . . 1.6899999999999999 109.82 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 54.7 t -54.12 -56.54 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 CA-C-N 116.933 -0.121 . . . . 1.5900000000000001 111.165 177.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -51.71 -50.48 60.45 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 123.009 0.523 . . . . 1.3500000000000001 111.831 179.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.44 -48.71 80.59 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 121.689 0.756 . . . . 1.45 110.581 -179.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . 0.425 ' CE3' ' CD2' ' A' ' 88' ' ' LEU . 54.4 t90 -58.72 -44.26 90.36 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.08 0.552 . . . . 0.56999999999999995 110.492 178.058 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.425 ' CD2' ' CE3' ' A' ' 87' ' ' TRP . 0.1 OUTLIER -63.11 -38.47 91.29 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.529 1.132 . . . . 2.8700000000000001 110.476 177.26 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -52.34 -49.77 63.63 Favored 'General case' 0 C--O 1.23 0.063 0 N-CA-C 109.468 -0.567 . . . . 1.5900000000000001 109.468 171.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -84.7 35.65 0.57 Allowed 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 116.434 -0.348 . . . . 3.5899999999999999 111.601 175.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.408 ' NZ ' ' OD1' ' A' ' 49' ' ' ASP . 0.5 OUTLIER -130.21 142.12 50.59 Favored 'General case' 0 C--N 1.343 0.311 0 O-C-N 121.171 -0.955 . . . . 3.8999999999999999 110.651 165.09 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 16.9 mtmt . . . . . 0 C--O 1.252 1.219 0 C-N-CA 128.82 2.848 . . . . 3.7200000000000002 105.413 -178.381 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 . . . . . 0 N--CA 1.449 -0.511 0 N-CA-C 109.339 -0.615 . . . . 2.79 109.339 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -44.91 -52.26 8.85 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.124 0.969 . . . . 1.6499999999999999 111.124 174.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -53.92 -44.83 70.92 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 116.632 -0.258 . . . . 3.4399999999999999 111.456 177.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.89 -44.64 92.41 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 123.232 0.613 . . . . 1.45 110.44 -178.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 89.7 t -58.33 -54.66 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 N-CA-C 109.236 -0.653 . . . . 1.74 109.236 175.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.4 ' HA ' ' SG ' ' A' ' 32' ' ' CYS . 53.9 t -52.54 -49.01 46.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 C-N-CA 122.53 0.332 . . . . 1.6399999999999999 110.348 -178.445 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 24.4 mm-40 -52.52 -19.68 2.42 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 126.763 2.025 . . . . 0.75 114.248 174.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.43 48.6 1.18 Allowed 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 119.877 1.217 . . . . 3.6499999999999999 111.994 176.249 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.407 ' NZ ' ' OE2' ' A' ' 80' ' ' GLU . 0.5 OUTLIER -162.46 -39.7 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 124.415 1.086 . . . . 2.5 110.314 169.154 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.4 ' SG ' ' HA ' ' A' ' 28' ' ' VAL . 3.4 m -97.21 -49.05 5.11 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 118.845 0.748 . . . . 0.23999999999999999 110.383 -176.017 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.8 pp -58.01 -26.44 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 CA-C-N 115.819 -0.628 . . . . 1.76 112.148 -173.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 68.0 m -37.38 -39.19 0.27 Allowed 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 125.234 1.414 . . . . 1.6299999999999999 112.451 168.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 9.9 m -120.29 -41.16 2.63 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 122.818 0.447 . . . . 0.22 111.92 176.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 85.4 m-70 -71.63 -10.02 59.14 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.628 0.771 . . . . 0.32000000000000001 112.6 -177.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 86.34 149.5 13.89 Favored Glycine 0 C--N 1.337 0.625 0 N-CA-C 109.783 -1.327 . . . . 1.52 109.783 179.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -44.42 -37.83 4.95 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 124.53 1.062 . . . . 1.1799999999999999 112.103 175.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -93.22 -4.54 51.77 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.193 0.997 . . . . 2.3700000000000001 111.788 -173.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.4 mt 70.3 10.84 7.39 Favored 'General case' 0 C--N 1.349 0.583 0 CA-C-N 120.513 1.506 . . . . 2.23 111.297 176.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.9 p -84.84 -0.66 54.72 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 127.801 2.44 . . . . 1.48 109.957 -175.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.86 137.66 5.09 Favored Glycine 0 N--CA 1.44 -1.057 0 N-CA-C 108.885 -1.686 . . . . 0.44 108.885 -175.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -143.6 -79.77 0.2 Allowed 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 124.332 1.053 . . . . 1.3300000000000001 108.827 176.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -88.6 2.5 52.99 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.377 1.071 . . . . 1.6799999999999999 110.756 171.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -157.14 169.52 10.48 Favored Pre-proline 0 N--CA 1.451 -0.378 0 C-N-CA 124.518 1.127 . . . . 1.52 108.629 -172.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -70.08 158.69 55.71 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.973 2.448 . . . . 0.31 110.506 -174.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.68 124.41 25.93 Favored 'General case' 0 C--N 1.332 -0.177 0 O-C-N 121.512 -0.743 . . . . 1.6000000000000001 110.181 -177.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 45.1 pt -102.02 0.36 10.29 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.158 0 CA-C-O 118.885 -0.579 . . . . 1.7 111.419 175.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.483 ' OD1' ' NZ ' ' A' ' 91' ' ' LYS . 37.9 t70 -44.35 -36.96 3.05 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 113.605 0.965 . . . . 3.2799999999999998 113.605 178.005 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.4 ptpt -108.33 19.01 20.38 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.695 1.598 . . . . 4.6100000000000003 112.015 -178.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -55.54 -45.26 77.22 Favored 'General case' 0 N--CA 1.455 -0.198 0 O-C-N 121.228 -0.92 . . . . 1.75 110.297 -172.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -51.16 -31.66 26.9 Favored Glycine 0 CA--C 1.523 0.582 0 C-N-CA 123.461 0.553 . . . . 0.59999999999999998 114.26 179.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.08 -39.59 49.16 Favored 'General case' 0 N--CA 1.454 -0.273 0 O-C-N 122.036 -0.685 . . . . 1.8200000000000001 110.046 176.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -66.24 -47.84 72.45 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.559 0.743 . . . . 2.2200000000000002 111.22 -178.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -141.34 148.16 39.26 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.743 1.617 . . . . 1.73 107.971 -171.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 88.7 p -74.66 170.96 14.76 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 119.144 0.883 . . . . 3.1400000000000001 110.692 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -49.13 -42.1 38.29 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 123.118 0.567 . . . . 2.7000000000000002 111.187 173.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -62.49 -45.24 93.92 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 123.315 0.646 . . . . 2.77 109.55 -177.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -70.96 -47.15 60.59 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 108.362 -0.977 . . . . 2.79 108.362 -175.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 91.2 mt -59.97 -46.21 94.36 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 O-C-N 121.672 -0.643 . . . . 1.5900000000000001 109.403 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 58.4 tp -55.53 -50.1 70.89 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 109.127 -0.694 . . . . 1.55 109.127 176.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -52.7 -44.85 66.57 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 117.985 0.357 . . . . 1.95 111.341 178.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 79.6 mt -59.5 -56.7 15.44 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.288 0 C-N-CA 120.381 -0.528 . . . . 1.6899999999999999 109.7 174.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 69.9 mt -50.0 -41.65 18.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 O-C-N 120.655 -1.278 . . . . 1.5600000000000001 110.87 -178.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 73.5 mt -70.98 -34.25 71.22 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.276 1.03 . . . . 1.6499999999999999 113.619 178.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 48.1 m-80 -123.36 20.67 9.64 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 120.499 1.5 . . . . 1.78 110.59 -167.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 29.27 -138.77 0.03 OUTLIER Glycine 0 CA--C 1.535 1.338 0 C-N-CA 128.961 3.172 . . . . 0.62 111.722 -164.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 173.98 130.18 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 119.119 1.46 . . . . 1.6799999999999999 109.22 -178.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 43.23 -116.36 1.3 Allowed Glycine 0 CA--C 1.531 1.034 0 CA-C-N 119.719 1.145 . . . . 0.47999999999999998 112.883 -177.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -70.65 -18.61 75.86 Favored Glycine 0 CA--C 1.531 1.079 0 O-C-N 122.374 -0.486 . . . . 0.56000000000000005 113.16 -179.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 22.3 ttt -75.95 118.7 73.06 Favored Pre-proline 0 N--CA 1.45 -0.43 0 C-N-CA 124.52 1.128 . . . . 1.47 110.629 -178.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -75.65 119.41 5.45 Favored 'Trans proline' 0 N--CA 1.445 -1.369 0 C-N-CA 122.446 2.098 . . . . 2.1000000000000001 111.286 -178.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -58.66 138.13 49.59 Favored Glycine 0 N--CA 1.44 -1.083 0 CA-C-N 115.257 -0.883 . . . . 1.6100000000000001 114.594 -179.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 76.06 50.13 7.97 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.19 -1.164 . . . . 0.83999999999999997 110.19 177.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.7 mt -72.61 -62.33 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 124.901 1.28 . . . . 2.02 108.889 168.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -103.45 158.44 16.35 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.919 1.288 . . . . 1.54 109.261 168.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.1 mttt -142.54 171.28 14.27 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 126.175 1.79 . . . . 5.2699999999999996 109.702 177.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 54.55 -149.72 18.6 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 111.698 -0.561 . . . . 0.91000000000000003 111.698 175.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -52.13 -32.21 34.54 Favored 'General case' 0 C--N 1.339 0.149 0 C-N-CA 122.983 0.513 . . . . 1.99 111.435 172.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.407 ' OE2' ' NZ ' ' A' ' 31' ' ' LYS . 6.8 tt0 -53.6 -43.39 68.57 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 110.032 -0.358 . . . . 1.9099999999999999 110.032 176.009 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -84.57 -50.63 7.53 Favored 'General case' 0 CA--C 1.53 0.204 0 O-C-N 121.79 -0.569 . . . . 1.5 111.911 176.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -53.93 -50.9 65.4 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 118.591 0.632 . . . . 2.4300000000000002 111.549 -177.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.63 -46.36 84.25 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 109.361 -0.607 . . . . 1.6100000000000001 109.361 -179.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 53.8 t -57.19 -57.42 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 C-N-CA 122.913 0.485 . . . . 1.6799999999999999 110.955 177.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -48.29 -53.13 18.36 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 123.516 0.727 . . . . 1.3200000000000001 111.638 176.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -64.01 -44.31 93.0 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 121.329 0.585 . . . . 1.5900000000000001 111.548 -178.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 76.9 t90 -58.2 -49.43 77.08 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 121.493 -0.754 . . . . 0.57999999999999996 109.425 177.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.6 -29.01 70.31 Favored 'General case' 0 C--O 1.222 -0.381 0 CA-C-O 118.374 -0.822 . . . . 2.9100000000000001 112.977 173.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.58 -36.45 71.73 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 119.697 1.135 . . . . 1.4399999999999999 110.299 170.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -73.74 -37.33 65.11 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 119.255 -0.402 . . . . 2.8999999999999999 111.51 172.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.483 ' NZ ' ' OD1' ' A' ' 49' ' ' ASP . 8.5 mtpm? -72.81 114.18 10.67 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 119.039 0.836 . . . . 3.0099999999999998 111.478 178.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 75.0 mttt . . . . . 0 C--O 1.252 1.197 0 CA-C-O 116.372 -1.775 . . . . 3.23 108.004 -174.924 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 . . . . . 0 N--CA 1.447 -0.598 0 N-CA-C 109.349 -0.611 . . . . 2.8900000000000001 109.349 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -45.68 -54.37 7.91 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 124.932 1.293 . . . . 1.6499999999999999 111.664 -178.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -51.44 -51.58 53.69 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 122.998 0.519 . . . . 3.48 111.653 175.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.39 -45.59 93.0 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 118.586 0.63 . . . . 1.51 110.84 -177.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 72.1 t -58.14 -55.67 20.68 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 N-CA-C 109.178 -0.675 . . . . 1.75 109.178 177.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 39.4 t -53.21 -48.67 54.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 C-N-CA 124.149 0.979 . . . . 1.76 109.944 -179.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 26.7 mm-40 -50.86 -19.37 0.97 Allowed 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 125.706 1.602 . . . . 0.59999999999999998 112.958 175.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -142.56 44.57 1.62 Allowed 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 119.126 0.875 . . . . 3.04 111.787 173.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -157.36 -39.98 0.07 Allowed 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 124.792 1.237 . . . . 2.1899999999999999 111.428 168.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 4.5 m -96.6 -50.29 4.78 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 119.445 1.021 . . . . 0.27000000000000002 110.657 -177.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.4 pp -59.14 -24.89 28.52 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 CA-C-N 116.067 -0.515 . . . . 1.78 111.889 -174.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 21.7 m -41.47 -35.79 0.76 Allowed 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 125.036 1.334 . . . . 1.5700000000000001 112.455 172.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 24.3 m -119.2 -42.71 2.66 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 122.911 0.484 . . . . 0.25 111.328 175.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 84.2 m-70 -72.88 -9.54 58.81 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 113.074 0.768 . . . . 0.27000000000000002 113.074 -175.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 87.1 149.75 16.25 Favored Glycine 0 C--N 1.337 0.611 0 N-CA-C 109.997 -1.241 . . . . 1.6299999999999999 109.997 178.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -45.35 -39.21 7.21 Favored Glycine 0 C--N 1.34 0.767 0 C-N-CA 124.348 0.975 . . . . 1.1200000000000001 111.936 178.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -94.67 -2.31 51.49 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.595 1.158 . . . . 3.21 111.452 -173.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.4 mt 72.31 11.09 5.86 Favored 'General case' 0 C--N 1.352 0.698 0 O-C-N 120.722 -1.236 . . . . 2.2400000000000002 110.798 174.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 13.6 p -83.51 -0.37 49.93 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 127.865 2.466 . . . . 1.5900000000000001 110.331 -174.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.5 147.84 17.25 Favored Glycine 0 N--CA 1.44 -1.067 0 N-CA-C 108.726 -1.75 . . . . 0.48999999999999999 108.726 -173.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -151.79 -73.1 0.15 Allowed 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.15 0.98 . . . . 1.4199999999999999 109.465 177.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.3 m -100.49 4.37 43.6 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.699 1.6 . . . . 2.0899999999999999 110.756 171.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -155.59 164.88 19.75 Favored Pre-proline 0 N--CA 1.451 -0.405 0 C-N-CA 125.369 1.467 . . . . 1.45 107.636 -170.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -68.88 159.72 52.71 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.837 2.358 . . . . 0.27000000000000002 110.385 -176.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.11 127.15 31.75 Favored 'General case' 0 C--N 1.332 -0.189 0 O-C-N 121.937 -0.477 . . . . 1.49 109.808 -177.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 45.8 pt -107.85 2.02 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 C-N-CA 123.971 0.909 . . . . 1.75 111.488 176.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -35.22 -45.43 0.3 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.597 1.559 . . . . 3.9900000000000002 112.623 168.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -113.16 28.24 8.95 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 125.552 1.541 . . . . 4.2400000000000002 111.721 -178.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.7 -44.58 85.97 Favored 'General case' 0 N--CA 1.451 -0.389 0 O-C-N 121.57 -0.706 . . . . 1.48 109.236 175.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -54.5 -29.61 48.05 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 123.755 0.693 . . . . 0.48999999999999999 114.472 -176.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -76.57 -43.68 37.89 Favored 'General case' 0 N--CA 1.457 -0.102 0 O-C-N 121.786 -0.832 . . . . 1.8500000000000001 110.544 174.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 40.5 m-80 -66.81 -47.63 71.46 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 122.662 0.385 . . . . 1.54 110.665 -177.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -136.84 133.71 36.15 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 126.022 1.729 . . . . 1.3300000000000001 107.089 -168.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.5 p -74.78 171.87 13.18 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 119.179 0.899 . . . . 2.8700000000000001 110.268 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -48.9 -45.24 41.04 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 123.476 0.71 . . . . 2.8300000000000001 111.764 178.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -59.24 -32.32 69.88 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.352 0.661 . . . . 3.02 111.795 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -86.89 -44.33 11.76 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 121.808 -0.557 . . . . 2.8799999999999999 110.266 -178.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 45.3 mt -56.96 -46.49 83.95 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 N-CA-C 109.251 -0.648 . . . . 1.74 109.251 176.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 57.9 tp -54.41 -49.69 69.33 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 109.166 -0.679 . . . . 1.76 109.166 178.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -52.44 -49.26 64.93 Favored 'General case' 0 N--CA 1.451 -0.401 0 O-C-N 123.195 0.309 . . . . 1.46 110.652 178.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 31.5 mt -57.77 -53.1 49.4 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.267 0 O-C-N 121.529 -0.732 . . . . 1.6399999999999999 110.677 175.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 96.8 mt -51.62 -42.64 30.78 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 O-C-N 120.645 -1.284 . . . . 1.55 110.706 179.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 82.8 mt -72.77 -36.13 67.59 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.065 0.946 . . . . 1.54 113.141 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -116.63 15.59 15.5 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 119.82 1.191 . . . . 1.6000000000000001 110.165 -165.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 31.31 -141.74 0.03 OUTLIER Glycine 0 CA--C 1.533 1.187 0 C-N-CA 128.21 2.814 . . . . 0.62 111.389 -162.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 1.7 tp60 176.51 136.28 0.06 Allowed 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 118.621 1.21 . . . . 2.0099999999999998 107.933 -175.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 42.38 -118.19 1.62 Allowed Glycine 0 CA--C 1.536 1.357 0 CA-C-N 120.584 1.538 . . . . 0.56000000000000005 113.384 -179.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -74.51 -18.23 79.93 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 124.038 0.828 . . . . 0.72999999999999998 113.007 178.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 19.3 ttt -71.86 118.19 64.54 Favored Pre-proline 0 N--CA 1.452 -0.374 0 C-N-CA 124.859 1.264 . . . . 1.6299999999999999 110.414 179.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -78.18 122.57 5.76 Favored 'Trans proline' 0 N--CA 1.444 -1.388 0 C-N-CA 122.782 2.322 . . . . 2.1200000000000001 110.925 -178.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -58.84 138.17 49.72 Favored Glycine 0 N--CA 1.442 -0.907 0 CA-C-N 115.27 -0.877 . . . . 1.6200000000000001 114.999 -178.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 83.4 35.44 17.31 Favored Glycine 0 CA--C 1.528 0.856 0 CA-C-N 114.072 -1.064 . . . . 0.32000000000000001 111.758 174.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.2 mt -57.61 -52.96 50.79 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 125.196 1.398 . . . . 2.2000000000000002 109.859 174.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -101.08 151.32 21.96 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.317 1.447 . . . . 1.6000000000000001 108.991 164.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.4 mtpm? -143.43 155.75 44.47 Favored 'General case' 0 C--N 1.34 0.157 0 C-N-CA 124.323 1.049 . . . . 4.2599999999999998 109.317 173.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.29 -170.28 54.79 Favored Glycine 0 CA--C 1.528 0.845 0 N-CA-C 110.108 -1.197 . . . . 1.2 110.108 -175.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -51.38 -25.97 7.01 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.243 1.017 . . . . 2.3999999999999999 112.232 179.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -39.86 -58.85 1.29 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.92 1.288 . . . . 2.1000000000000001 110.634 166.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.23 -47.76 84.6 Favored 'General case' 0 CA--C 1.531 0.247 0 O-C-N 122.071 -0.393 . . . . 1.5700000000000001 110.893 -174.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -50.68 -56.49 11.66 Favored 'General case' 0 C--N 1.338 0.094 0 C-N-CA 123.829 0.852 . . . . 3.0499999999999998 110.852 174.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -54.4 -49.51 69.73 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 123.139 0.575 . . . . 1.6200000000000001 110.132 -178.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 85.6 t -56.94 -54.92 23.74 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-N 117.523 0.147 . . . . 1.6499999999999999 111.176 177.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -51.69 -51.49 55.62 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 123.676 0.79 . . . . 1.3899999999999999 111.733 178.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.4 -46.56 89.53 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 124.175 0.99 . . . . 1.77 110.546 -179.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 46.6 t90 -57.25 -48.31 79.17 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 109.588 -0.523 . . . . 0.55000000000000004 109.588 175.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.49 -33.94 73.33 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.179 0.992 . . . . 2.6899999999999999 111.59 176.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -54.62 -37.44 65.62 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 118.551 0.614 . . . . 1.5600000000000001 110.936 172.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -94.76 22.04 6.8 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.798 0.839 . . . . 2.9500000000000002 111.958 175.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 2.7 mtpm? -113.38 119.62 38.28 Favored 'General case' 0 C--N 1.342 0.24 0 O-C-N 121.122 -0.986 . . . . 2.96 109.094 169.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 89.1 mttt . . . . . 0 C--O 1.257 1.462 0 C-N-CA 129.451 3.1 . . . . 2.9399999999999999 104.116 -178.274 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.446 -0.662 0 N-CA-C 106.968 -1.493 . . . . 2.1499999999999999 106.968 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -41.38 -54.22 3.11 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 124.682 1.193 . . . . 1.6499999999999999 110.9 179.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -58.2 -47.21 84.16 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 115.239 -0.891 . . . . 2.6000000000000001 110.258 -179.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.26 -45.8 92.02 Favored 'General case' 0 C--N 1.339 0.111 0 C-N-CA 122.935 0.494 . . . . 1.4099999999999999 111.135 -179.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 81.9 t -56.58 -54.25 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 N-CA-C 108.766 -0.828 . . . . 1.79 108.766 177.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 22.8 t -53.78 -49.69 56.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 CA-C-N 117.742 0.246 . . . . 1.6499999999999999 111.237 178.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 27.6 mm-40 -54.87 -14.85 1.59 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.1 1.76 . . . . 0.58999999999999997 113.285 174.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 14.1 mt-30 -136.36 44.05 2.44 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 119.795 1.179 . . . . 4.4199999999999999 112.617 169.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.28 -58.61 0.05 Allowed 'General case' 0 CA--C 1.519 -0.244 0 O-C-N 121.782 -0.574 . . . . 2.5899999999999999 109.799 168.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 2.8 m -75.63 -48.14 23.48 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 109.938 -0.393 . . . . 0.29999999999999999 109.938 -171.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.0 pp -50.01 -32.77 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.14 0 C-N-CA 123.449 0.7 . . . . 1.95 112.435 -178.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.4 m -44.08 -35.34 2.1 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 125.076 1.35 . . . . 2.1299999999999999 112.033 178.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 13.1 m -119.36 -41.76 2.7 Favored 'General case' 0 CA--C 1.53 0.207 0 O-C-N 123.522 0.514 . . . . 0.22 111.922 175.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 79.6 m-70 -70.35 -9.01 55.0 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.028 0.931 . . . . 0.28999999999999998 112.481 -178.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 85.56 148.64 10.99 Favored Glycine 0 C--N 1.337 0.621 0 N-CA-C 109.224 -1.55 . . . . 1.45 109.224 -179.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -43.02 -33.25 1.7 Allowed Glycine 0 CA--C 1.53 0.989 0 C-N-CA 124.496 1.046 . . . . 1.28 112.687 173.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -94.98 -10.01 32.25 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.986 1.315 . . . . 2.3300000000000001 111.613 -172.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 70.63 11.75 7.27 Favored 'General case' 0 C--N 1.347 0.467 0 CA-C-N 120.263 1.392 . . . . 2.5600000000000001 111.255 178.357 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 10.4 p -85.43 -2.29 57.95 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 127.808 2.443 . . . . 1.6100000000000001 109.986 -177.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.93 145.3 12.66 Favored Glycine 0 N--CA 1.437 -1.261 0 N-CA-C 108.648 -1.781 . . . . 0.42999999999999999 108.648 -174.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -152.52 -80.34 0.1 Allowed 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 124.758 1.223 . . . . 1.3100000000000001 109.043 177.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 17.0 m -91.46 4.02 53.54 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.457 1.103 . . . . 1.9299999999999999 111.14 170.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -153.4 163.68 22.93 Favored Pre-proline 0 N--CA 1.45 -0.439 0 C-N-CA 126.065 1.746 . . . . 1.6899999999999999 107.554 -172.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -70.51 161.52 45.75 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 123.128 2.552 . . . . 0.37 110.59 -176.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -74.06 124.01 25.45 Favored 'General case' 0 N--CA 1.454 -0.268 0 O-C-N 121.577 -0.702 . . . . 1.49 110.235 -176.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 44.6 pt -104.44 2.45 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 CA-C-O 119.055 -0.498 . . . . 1.71 111.564 176.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -40.33 -52.64 2.68 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 112.985 0.735 . . . . 2.6800000000000002 112.985 176.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.26 21.49 11.87 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 126.3 1.84 . . . . 6.2699999999999996 110.653 -175.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -54.19 -39.5 66.71 Favored 'General case' 0 N--CA 1.453 -0.307 0 O-C-N 121.506 -0.746 . . . . 1.47 110.146 -178.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -54.8 -24.95 35.15 Favored Glycine 0 CA--C 1.53 1.022 0 N-CA-C 114.603 0.601 . . . . 0.52000000000000002 114.603 176.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -78.95 -36.95 40.84 Favored 'General case' 0 C--N 1.338 0.097 0 CA-C-N 118.616 1.208 . . . . 1.8799999999999999 110.278 174.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -73.91 -47.85 34.89 Favored 'General case' 0 N--CA 1.457 -0.078 0 C-N-CA 122.515 0.326 . . . . 1.9199999999999999 110.326 -177.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -139.96 149.04 42.8 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.47 1.108 . . . . 1.77 108.689 -168.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.92 168.32 18.03 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 109.614 -0.514 . . . . 2.9300000000000002 109.614 178.446 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -48.2 -43.52 32.02 Favored 'General case' 0 C--O 1.226 -0.179 0 C-N-CA 124.43 1.092 . . . . 2.7999999999999998 111.553 178.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -53.2 -47.69 68.69 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.654 0.782 . . . . 2.75 110.481 178.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -74.56 -45.69 43.83 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.78 0.832 . . . . 3.25 109.575 -175.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 58.6 mt -59.55 -44.16 92.5 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 N-CA-C 109.194 -0.669 . . . . 1.6000000000000001 109.194 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 31.3 tp -54.77 -54.38 42.82 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 123.468 0.707 . . . . 1.76 109.38 175.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -52.07 -49.48 63.45 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 123.107 0.254 . . . . 1.48 111.2 178.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 57.6 mt -55.16 -55.49 16.16 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.155 0 O-C-N 121.564 -0.71 . . . . 1.8200000000000001 110.558 176.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 57.8 mt -49.15 -46.75 17.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 O-C-N 121.191 -0.943 . . . . 1.5900000000000001 110.199 178.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 91.7 mt -66.11 -33.3 75.46 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 113.932 1.086 . . . . 1.78 113.932 179.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -128.97 24.13 5.65 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 120.37 1.441 . . . . 1.8200000000000001 110.641 -163.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 23.75 -136.97 0.01 OUTLIER Glycine 0 CA--C 1.543 1.791 0 C-N-CA 127.702 2.572 . . . . 0.67000000000000004 112.808 -159.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 170.46 139.13 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 126.483 1.913 . . . . 1.55 107.603 -175.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 23.78 -106.2 0.01 OUTLIER Glycine 0 CA--C 1.535 1.316 0 C-N-CA 126.386 1.945 . . . . 0.68999999999999995 115.029 -170.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.26 -29.05 74.33 Favored Glycine 0 CA--C 1.533 1.187 0 CA-C-N 118.271 1.036 . . . . 0.84999999999999998 113.169 -177.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 4.6 ttt -67.32 126.19 92.18 Favored Pre-proline 0 CA--C 1.542 0.635 0 C-N-CA 125.053 1.341 . . . . 1.5600000000000001 110.688 -179.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -62.66 -57.2 0.47 Allowed 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 123.893 3.062 . . . . 3.0299999999999998 111.144 -174.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 118.14 149.92 8.87 Favored Glycine 0 C--N 1.334 0.471 0 C-N-CA 123.925 0.774 . . . . 2.2599999999999998 113.536 174.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 69.06 23.21 76.14 Favored Glycine 0 CA--C 1.531 1.06 0 CA-C-N 115.156 -0.522 . . . . 0.40000000000000002 111.852 178.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.6 mt -56.32 -49.29 77.41 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.919 0 C-N-CA 126.12 1.768 . . . . 2.1800000000000002 111.267 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -109.71 161.22 15.62 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.133 0.973 . . . . 1.5600000000000001 108.589 160.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -146.42 172.72 13.1 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.082 0.953 . . . . 4.5499999999999998 109.198 173.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 54.18 -147.06 22.78 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 123.336 0.494 . . . . 0.93000000000000005 112.015 176.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -47.47 -41.03 19.77 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.19 0.996 . . . . 1.9299999999999999 111.23 175.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -53.07 -44.43 67.49 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.889 1.276 . . . . 2.7400000000000002 110.799 177.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -79.18 -49.97 11.71 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 121.759 -0.588 . . . . 1.49 111.487 176.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -51.4 -54.39 27.16 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 124.027 0.931 . . . . 2.1899999999999999 111.691 -178.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.24 -47.59 83.06 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.824 -0.435 . . . . 1.5800000000000001 109.824 -177.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 53.8 t -56.72 -53.96 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 C-N-CA 123.442 0.697 . . . . 1.54 110.748 177.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -52.19 -51.86 55.58 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 123.896 0.878 . . . . 1.6000000000000001 111.915 176.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.26 -50.59 73.04 Favored 'General case' 0 C--N 1.333 -0.116 0 C-N-CA 123.192 0.597 . . . . 1.5 110.204 -179.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . 0.417 ' CE3' ' CD2' ' A' ' 88' ' ' LEU . 50.0 t90 -56.59 -46.43 80.83 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.622 0.769 . . . . 0.63 110.49 177.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.417 ' CD2' ' CE3' ' A' ' 87' ' ' TRP . 0.1 OUTLIER -63.15 -38.8 92.6 Favored 'General case' 0 C--O 1.224 -0.282 0 O-C-N 121.416 -0.803 . . . . 2.8599999999999999 109.88 178.269 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -62.26 -42.31 99.22 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 118.723 0.692 . . . . 1.7 110.683 174.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -55.74 -45.46 78.02 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 121.843 -0.535 . . . . 3.6000000000000001 110.61 169.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 4.1 mtmp? -74.93 100.29 4.07 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 118.921 0.782 . . . . 3.8900000000000001 111.553 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 9.7 ptpp? . . . . . 0 C--O 1.25 1.095 0 N-CA-C 106.869 -1.53 . . . . 3.5800000000000001 106.869 174.311 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 N--CA 1.443 -0.789 0 N-CA-C 105.787 -1.931 . . . . 2.75 105.787 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -41.38 -52.84 3.46 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 124.655 1.182 . . . . 1.6200000000000001 110.857 -177.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -57.13 -47.79 80.27 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 115.9 -0.591 . . . . 3.1699999999999999 110.677 -179.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.07 -44.83 94.46 Favored 'General case' 0 C--N 1.339 0.11 0 C-N-CA 122.926 0.49 . . . . 1.6000000000000001 110.691 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 97.7 t -58.5 -57.4 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 N-CA-C 108.934 -0.765 . . . . 1.6499999999999999 108.934 177.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 52.9 t -52.21 -48.34 43.34 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 C-N-CA 122.741 0.416 . . . . 1.5700000000000001 110.875 -179.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -51.03 -24.44 3.79 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 125.503 1.521 . . . . 0.63 113.115 175.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 11.6 mt-30 -137.4 55.75 1.8 Allowed 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 119.514 1.052 . . . . 3.75 112.179 170.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.96 -38.97 0.02 OUTLIER 'General case' 0 C--O 1.226 -0.138 0 C-N-CA 123.566 0.746 . . . . 2.04 110.214 168.24 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 4.0 m -98.21 -50.01 4.51 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 119.004 0.82 . . . . 0.25 110.971 -177.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.9 pp -58.08 -25.86 27.53 Favored 'Isoleucine or valine' 0 C--N 1.338 0.071 0 N-CA-C 112.127 0.417 . . . . 1.6899999999999999 112.127 -174.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 59.7 m -37.92 -38.55 0.31 Allowed 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 125.491 1.516 . . . . 1.5900000000000001 112.646 170.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 18.9 m -120.7 -40.15 2.68 Favored 'General case' 0 C--N 1.34 0.189 0 C-N-CA 122.892 0.477 . . . . 0.17000000000000001 111.901 175.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 81.6 m-70 -73.31 -7.92 53.66 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 112.65 0.611 . . . . 0.26000000000000001 112.65 -176.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 85.59 149.78 12.83 Favored Glycine 0 C--N 1.337 0.627 0 N-CA-C 109.497 -1.441 . . . . 1.51 109.497 179.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -42.35 -34.95 1.73 Allowed Glycine 0 CA--C 1.527 0.826 0 C-N-CA 124.855 1.216 . . . . 1.2 112.176 175.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -99.03 -5.9 29.52 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 124.937 1.295 . . . . 2.3599999999999999 111.402 -168.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 8.8 mt 69.34 13.04 8.47 Favored 'General case' 0 C--N 1.352 0.682 0 CA-C-N 120.712 1.596 . . . . 2.0800000000000001 111.326 178.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.2 p -89.39 -1.37 58.03 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 127.802 2.441 . . . . 1.54 109.815 -176.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.62 130.44 2.81 Favored Glycine 0 N--CA 1.44 -1.085 0 N-CA-C 109.502 -1.439 . . . . 0.54000000000000004 109.502 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -135.39 -78.1 0.44 Allowed 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 124.387 1.075 . . . . 1.6499999999999999 108.641 178.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 50.1 m -93.45 4.01 54.65 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.176 0.991 . . . . 2.04 111.102 171.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -153.6 161.74 28.41 Favored Pre-proline 0 CA--C 1.533 0.314 0 C-N-CA 125.808 1.643 . . . . 1.6699999999999999 107.488 -171.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -71.78 159.58 50.32 Favored 'Trans proline' 0 N--CA 1.459 -0.541 0 C-N-CA 122.977 2.451 . . . . 0.35999999999999999 111.172 -175.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -74.68 117.36 16.43 Favored 'General case' 0 CA--C 1.53 0.211 0 O-C-N 121.727 -0.608 . . . . 1.55 111.768 -172.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 42.2 pt -95.94 0.54 10.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 C-N-CA 123.642 0.777 . . . . 1.76 112.031 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -45.34 -35.74 3.73 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.526 0.936 . . . . 2.6400000000000001 113.526 172.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -112.98 27.94 9.21 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 124.11 0.964 . . . . 5.6699999999999999 110.687 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -58.63 -43.83 89.82 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 108.998 -0.742 . . . . 1.51 108.998 176.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -53.77 -29.55 41.85 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 123.349 0.499 . . . . 0.63 113.692 179.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.13 -32.95 65.23 Favored 'General case' 0 N--CA 1.454 -0.229 0 O-C-N 122.078 -0.66 . . . . 1.9199999999999999 110.356 178.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 -85.31 -44.94 12.4 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.962 0.905 . . . . 1.6699999999999999 109.954 -174.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -138.38 133.28 32.7 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 125.273 1.429 . . . . 1.1699999999999999 108.025 -167.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 13.9 m -73.63 169.97 16.18 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 118.409 0.55 . . . . 2.48 110.095 175.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -47.24 -48.13 24.46 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.277 1.031 . . . . 2.9199999999999999 112.44 -176.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -58.1 -41.77 84.25 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.835 -0.541 . . . . 2.98 111.618 177.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -72.39 -41.96 65.74 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 109.053 -0.721 . . . . 2.9900000000000002 109.053 -176.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 41.3 mt -61.86 -46.71 95.91 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.131 0 O-C-N 121.286 -0.884 . . . . 1.5800000000000001 109.386 175.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 66.8 tp -53.95 -48.41 70.3 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.441 -0.577 . . . . 1.76 109.441 178.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -48.54 -56.02 9.48 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 117.993 0.36 . . . . 2.3700000000000001 110.996 174.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 95.4 mt -55.78 -46.25 79.77 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.298 0 O-C-N 121.6 -0.688 . . . . 1.77 110.778 178.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 73.3 mt -55.8 -44.77 78.64 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 O-C-N 120.45 -1.406 . . . . 1.78 110.164 176.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 90.9 mt -67.81 -36.81 81.06 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 113.903 1.075 . . . . 2.0 113.903 -176.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -128.82 26.32 5.56 Favored 'General case' 0 C--N 1.344 0.338 0 CA-C-N 120.85 1.659 . . . . 3.7799999999999998 110.205 -170.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 37.41 -142.78 0.23 Allowed Glycine 0 CA--C 1.534 1.258 0 C-N-CA 128.247 2.832 . . . . 0.65000000000000002 111.009 -176.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 44.9 tt0 174.3 132.87 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 119.246 1.523 . . . . 1.46 109.658 -178.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 45.14 -118.94 3.04 Favored Glycine 0 CA--C 1.532 1.138 0 O-C-N 121.22 -0.925 . . . . 0.51000000000000001 112.18 -175.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -70.93 -19.63 77.13 Favored Glycine 0 CA--C 1.531 1.082 0 O-C-N 122.495 -0.415 . . . . 0.58999999999999997 113.016 179.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 20.0 ttt -73.4 119.27 74.95 Favored Pre-proline 0 N--CA 1.451 -0.424 0 C-N-CA 124.163 0.985 . . . . 1.6000000000000001 110.604 -178.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -80.22 124.74 5.52 Favored 'Trans proline' 0 N--CA 1.447 -1.221 0 C-N-CA 123.208 2.605 . . . . 2.0699999999999998 111.054 -179.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -63.38 142.6 47.35 Favored Glycine 0 N--CA 1.444 -0.8 0 N-CA-C 115.902 1.121 . . . . 1.6499999999999999 115.902 -174.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 78.2 32.41 43.7 Favored Glycine 0 CA--C 1.526 0.779 0 CA-C-N 114.142 -1.029 . . . . 0.34000000000000002 111.442 174.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -51.37 -53.02 17.28 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 125.692 1.597 . . . . 2.3100000000000001 109.878 174.45 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -105.48 160.05 15.46 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 124.961 1.304 . . . . 1.5 108.652 162.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 81.7 mttt -144.1 168.7 19.4 Favored 'General case' 0 CA--C 1.527 0.086 0 N-CA-C 107.461 -1.311 . . . . 3.2999999999999998 107.461 170.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 65.7 -164.04 39.28 Favored Glycine 0 CA--C 1.528 0.902 0 N-CA-C 111.517 -0.633 . . . . 0.82999999999999996 111.517 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -54.32 -29.6 48.28 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.457 0.703 . . . . 1.74 112.283 -174.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -40.32 -67.63 0.22 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.79 1.236 . . . . 2.9500000000000002 110.457 164.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -59.07 -43.91 91.8 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.25 0.62 . . . . 1.47 110.977 -175.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -59.13 -53.48 57.86 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.411 1.084 . . . . 2.6899999999999999 110.597 -178.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.18 -49.12 78.12 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.008 0.923 . . . . 1.5 109.797 179.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 54.1 t -52.5 -56.49 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 C-N-CA 122.292 0.237 . . . . 1.5800000000000001 110.598 176.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -49.56 -51.38 37.28 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 123.738 0.815 . . . . 1.53 111.764 177.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.38 -50.33 74.38 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 121.673 0.749 . . . . 1.54 111.163 -178.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . 0.408 ' CE3' HD23 ' A' ' 88' ' ' LEU . 51.0 t90 -58.23 -45.34 87.87 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 121.228 0.537 . . . . 0.76000000000000001 110.047 178.543 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.408 HD23 ' CE3' ' A' ' 87' ' ' TRP . 0.1 OUTLIER -62.73 -36.41 82.91 Favored 'General case' 0 CA--C 1.531 0.213 0 O-C-N 121.493 -0.754 . . . . 2.71 110.814 176.571 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -59.74 -39.19 83.92 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 118.758 0.708 . . . . 1.5800000000000001 110.848 173.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -59.74 -41.06 90.11 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 122.28 0.232 . . . . 3.21 110.535 173.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.1 mtpm? -74.04 104.12 4.76 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.806 0.813 . . . . 3.2000000000000002 111.21 179.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 15.5 pttp . . . . . 0 C--O 1.25 1.089 0 C-N-CA 126.619 1.967 . . . . 3.1299999999999999 106.048 176.364 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.451 -0.391 0 N-CA-C 108.726 -0.842 . . . . 2.8599999999999999 108.726 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -46.39 -55.15 7.78 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 123.25 0.62 . . . . 1.51 110.024 176.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -57.36 -46.71 83.07 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 110.233 -0.284 . . . . 2.6899999999999999 110.233 -177.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.24 -48.69 79.63 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 118.262 0.483 . . . . 1.3999999999999999 111.399 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 55.6 t -56.46 -56.18 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 N-CA-C 109.233 -0.654 . . . . 1.6399999999999999 109.233 177.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 61.1 t -53.5 -49.92 52.11 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 C-N-CA 122.888 0.475 . . . . 1.6299999999999999 110.305 -177.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 33.6 mm-40 -51.55 -17.44 0.83 Allowed 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 126.454 1.902 . . . . 0.5 112.964 175.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 16.6 tp60 -141.71 43.67 1.72 Allowed 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 119.519 1.054 . . . . 4.9400000000000004 112.204 171.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.18 -39.73 0.1 Allowed 'General case' 0 C--O 1.227 -0.083 0 C-N-CA 123.659 0.784 . . . . 2.0 111.425 166.377 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 3.6 m -98.12 -49.51 4.71 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 119.124 0.874 . . . . 0.20999999999999999 110.539 -174.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.2 pp -55.51 -29.13 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 CA-C-N 115.766 -0.652 . . . . 1.6299999999999999 111.564 -177.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.1 m -37.75 -37.01 0.21 Allowed 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 125.61 1.564 . . . . 1.8600000000000001 112.713 171.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 28.2 m -119.59 -40.45 2.77 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.298 0.639 . . . . 0.17000000000000001 112.009 174.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 84.7 m-70 -73.37 -8.71 57.03 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.474 0.71 . . . . 0.31 112.711 -175.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 85.55 151.14 15.28 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 109.628 -1.389 . . . . 1.52 109.628 -178.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -40.46 -42.27 2.54 Favored Glycine 0 C--N 1.34 0.802 0 C-N-CA 124.996 1.284 . . . . 1.1899999999999999 112.21 178.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -95.89 -6.34 39.47 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 125.556 1.542 . . . . 2.5699999999999998 110.939 -169.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 69.56 19.1 7.55 Favored 'General case' 0 C--N 1.347 0.469 0 CA-C-N 119.648 1.113 . . . . 2.6699999999999999 111.026 177.456 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 11.2 p -82.18 -4.84 57.83 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 128.462 2.705 . . . . 1.5900000000000001 109.898 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.14 148.26 21.19 Favored Glycine 0 N--CA 1.44 -1.035 0 N-CA-C 108.32 -1.912 . . . . 0.59999999999999998 108.32 -173.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -155.08 -72.98 0.12 Allowed 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 123.91 0.884 . . . . 1.3 109.552 176.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.3 t -98.35 1.17 46.73 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.627 1.171 . . . . 1.79 110.252 172.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -155.62 167.07 14.94 Favored Pre-proline 0 CA--C 1.536 0.432 0 C-N-CA 125.551 1.541 . . . . 1.5700000000000001 107.913 -171.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -70.43 160.98 47.67 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 123.098 2.532 . . . . 0.34000000000000002 111.195 -173.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -74.87 119.99 19.8 Favored 'General case' 0 CA--C 1.531 0.214 0 O-C-N 121.748 -0.595 . . . . 1.6599999999999999 110.638 -177.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 47.4 pt -105.05 0.83 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 C-N-CA 124.157 0.983 . . . . 1.6200000000000001 111.551 179.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -34.17 -46.39 0.24 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.572 1.549 . . . . 2.4199999999999999 112.856 167.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 5.3 pttt -111.44 35.32 3.67 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.798 1.239 . . . . 4.8099999999999996 111.166 -178.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.01 -46.4 87.83 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-O 118.868 -0.587 . . . . 1.75 109.51 174.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -51.73 -32.73 33.34 Favored Glycine 0 CA--C 1.527 0.795 0 CA-C-N 118.566 0.621 . . . . 0.65000000000000002 114.329 -177.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.21 -37.08 66.57 Favored 'General case' 0 N--CA 1.455 -0.196 0 O-C-N 121.898 -0.766 . . . . 1.6599999999999999 110.797 176.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 20.5 m-80 -73.51 -50.77 19.77 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 122.929 0.492 . . . . 1.6799999999999999 110.15 -178.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -137.6 138.07 39.16 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.211 1.404 . . . . 1.9099999999999999 107.382 -169.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 67.3 m -76.19 172.0 13.57 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 119.03 0.832 . . . . 2.2999999999999998 110.389 179.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.0 pm0 -50.5 -43.29 55.61 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 123.78 0.832 . . . . 2.8700000000000001 111.834 -178.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -56.15 -41.37 75.3 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 121.336 0.588 . . . . 2.8100000000000001 110.136 179.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -80.01 -47.38 15.01 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 123.81 0.844 . . . . 3.54 108.995 -173.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 63.9 mt -56.33 -44.99 81.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 N-CA-C 109.113 -0.699 . . . . 1.6799999999999999 109.113 176.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 33.8 tp -54.77 -49.47 70.8 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 109.375 -0.602 . . . . 1.6899999999999999 109.375 177.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -55.11 -46.44 75.56 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 118.576 0.625 . . . . 1.48 111.604 175.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 86.7 mt -61.92 -30.34 48.34 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 O-C-N 121.351 -0.843 . . . . 1.8500000000000001 111.521 178.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 46.4 mt -73.19 -50.24 32.87 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 O-C-N 120.278 -1.514 . . . . 1.5900000000000001 109.128 174.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 77.3 mt -61.88 -28.43 69.5 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 125.232 1.413 . . . . 1.48 113.474 -175.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 11.0 m-80 -130.62 15.37 5.41 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 120.02 1.282 . . . . 1.75 110.386 -169.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 40.01 -141.97 0.69 Allowed Glycine 0 CA--C 1.545 1.906 0 C-N-CA 125.679 1.609 . . . . 0.66000000000000003 111.707 -167.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 167.08 139.63 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 126.386 1.874 . . . . 1.5700000000000001 108.447 -174.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 31.77 -111.45 0.05 OUTLIER Glycine 0 C--N 1.347 1.18 0 C-N-CA 125.465 1.507 . . . . 0.60999999999999999 114.153 -174.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.58 -30.1 76.67 Favored Glycine 0 CA--C 1.534 1.23 0 CA-C-N 117.299 0.549 . . . . 0.81000000000000005 112.834 -179.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 2.3 ttt -65.42 123.74 85.2 Favored Pre-proline 0 CA--C 1.541 0.615 0 C-N-CA 124.576 1.15 . . . . 1.6599999999999999 111.393 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -63.64 -55.38 0.7 Allowed 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 124.223 3.282 . . . . 2.96 111.224 -173.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 115.28 149.08 9.53 Favored Glycine 0 N--CA 1.448 -0.514 0 CA-C-N 115.732 -0.667 . . . . 2.3100000000000001 114.185 171.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 67.45 22.38 73.06 Favored Glycine 0 CA--C 1.531 1.036 0 CA-C-N 114.712 -0.744 . . . . 0.48999999999999999 111.854 -178.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -51.69 -53.01 18.63 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 C-N-CA 126.611 1.964 . . . . 2.2000000000000002 111.127 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -107.76 159.99 16.07 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.164 1.386 . . . . 1.52 108.335 162.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 36.6 mttt -145.84 174.77 10.94 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.554 1.141 . . . . 4.0999999999999996 109.57 171.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 53.11 -149.55 11.66 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 123.826 0.727 . . . . 0.88 112.045 178.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -49.63 -36.61 25.01 Favored 'General case' 0 C--N 1.34 0.163 0 C-N-CA 123.877 0.871 . . . . 1.8600000000000001 111.278 179.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -47.76 -66.41 0.41 Allowed 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.992 1.317 . . . . 1.9099999999999999 109.216 173.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -62.97 -45.48 92.23 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 122.829 0.452 . . . . 1.4399999999999999 112.011 -178.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -54.79 -52.9 61.19 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 122.931 0.492 . . . . 2.1499999999999999 110.488 -178.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.42 -50.17 73.87 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 122.915 0.486 . . . . 1.71 110.233 178.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 70.1 t -50.63 -58.51 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-O 120.613 0.244 . . . . 1.8999999999999999 110.919 177.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -55.26 -49.98 70.67 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.206 1.003 . . . . 1.7 111.684 -179.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.69 -46.01 88.18 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 121.67 0.748 . . . . 1.49 110.584 -179.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . 0.406 ' CE3' ' CD2' ' A' ' 88' ' ' LEU . 48.6 t90 -60.71 -50.48 73.3 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.667 -0.494 . . . . 0.60999999999999999 109.667 176.538 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.406 ' CD2' ' CE3' ' A' ' 87' ' ' TRP . 0.1 OUTLIER -59.92 -32.01 70.38 Favored 'General case' 0 CA--C 1.531 0.247 0 O-C-N 121.487 -0.758 . . . . 2.7200000000000002 111.193 179.152 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.9 -42.85 97.33 Favored 'General case' 0 N--CA 1.457 -0.097 0 CA-C-N 118.671 0.669 . . . . 1.9299999999999999 111.146 171.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -58.59 -40.73 84.02 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 110.347 -0.242 . . . . 3.29 110.347 173.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 21.4 mtpp -73.38 133.98 43.94 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 121.916 -0.49 . . . . 3.2999999999999998 110.984 -178.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 49.8 mtmt . . . . . 0 C--O 1.25 1.084 0 N-CA-C 105.887 -1.894 . . . . 3.3900000000000001 105.887 179.36 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 N--CA 1.448 -0.534 0 N-CA-C 108.639 -0.874 . . . . 2.9199999999999999 108.639 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -89.29 -65.38 1.02 Allowed 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 109.327 -0.619 . . . . 1.6100000000000001 109.327 177.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -47.35 -47.01 26.13 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.578 0.751 . . . . 3.0899999999999999 111.702 -178.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.69 -42.82 79.75 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.057 0.543 . . . . 1.4199999999999999 111.676 178.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 53.4 t -64.45 -54.13 34.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 N-CA-C 108.23 -1.026 . . . . 1.55 108.23 178.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 65.9 t -48.33 -51.49 10.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 C-N-CA 122.486 0.314 . . . . 1.8700000000000001 110.376 179.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 35.7 mm-40 -50.55 -26.82 5.7 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 126.313 1.845 . . . . 0.62 113.416 177.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 -136.6 53.48 1.91 Allowed 'General case' 0 C--N 1.339 0.125 0 CA-C-N 119.756 1.162 . . . . 2.7599999999999998 112.121 173.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.444 ' HZ3' ' CD ' ' A' ' 80' ' ' GLU . 0.1 OUTLIER -166.43 -38.9 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 123.459 0.704 . . . . 2.0600000000000001 110.504 167.834 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 6.5 m -97.69 -51.31 4.15 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 118.913 0.779 . . . . 0.34000000000000002 110.843 -175.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.4 pp -56.41 -27.94 25.56 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.095 0 CA-C-N 116.128 -0.487 . . . . 1.6699999999999999 111.925 -175.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.9 m -36.92 -39.31 0.22 Allowed 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 125.605 1.562 . . . . 1.6100000000000001 112.683 171.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 38.1 m -117.88 -38.86 3.18 Favored 'General case' 0 C--N 1.339 0.122 0 C-N-CA 123.127 0.571 . . . . 0.22 111.652 174.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 83.8 m-70 -77.03 -6.49 52.89 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 113.167 0.803 . . . . 0.38 113.167 -174.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 84.54 151.83 14.5 Favored Glycine 0 C--N 1.338 0.645 0 N-CA-C 109.865 -1.294 . . . . 1.5700000000000001 109.865 -179.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -41.87 -39.53 2.8 Favored Glycine 0 C--N 1.341 0.84 0 C-N-CA 125.015 1.293 . . . . 1.1200000000000001 112.274 178.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -99.84 -0.44 39.72 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 125.249 1.42 . . . . 2.4199999999999999 111.058 -169.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.3 mp 66.12 18.34 10.96 Favored 'General case' 0 C--N 1.347 0.476 0 CA-C-N 119.779 1.172 . . . . 2.7000000000000002 111.351 -179.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.0 p -82.14 -5.24 58.3 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 127.413 2.285 . . . . 1.6899999999999999 110.277 -177.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.58 148.21 18.35 Favored Glycine 0 N--CA 1.437 -1.277 0 N-CA-C 108.129 -1.988 . . . . 0.51000000000000001 108.129 -172.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -156.24 -76.77 0.09 Allowed 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 124.035 0.934 . . . . 1.3 109.09 178.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -95.38 2.37 54.59 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.683 1.193 . . . . 1.96 110.552 172.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -157.58 161.75 28.56 Favored Pre-proline 0 N--CA 1.452 -0.374 0 C-N-CA 126.834 2.054 . . . . 1.5600000000000001 106.577 -170.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -68.1 164.65 31.26 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 123.178 2.585 . . . . 0.48999999999999999 111.807 -175.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -75.52 116.39 16.18 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 123.265 0.626 . . . . 1.49 110.841 -176.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 40.4 pt -98.11 1.0 10.54 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.174 0 C-N-CA 123.162 0.585 . . . . 1.6299999999999999 110.886 176.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -43.13 -37.31 1.99 Allowed 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 114.037 1.125 . . . . 2.4199999999999999 114.037 174.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.13 23.7 13.97 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 124.899 1.28 . . . . 5.0499999999999998 111.681 179.565 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -58.09 -43.4 87.03 Favored 'General case' 0 N--CA 1.45 -0.449 0 O-C-N 121.607 -0.683 . . . . 1.47 109.573 178.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -51.38 -30.16 25.03 Favored Glycine 0 CA--C 1.529 0.913 0 N-CA-C 114.643 0.617 . . . . 0.60999999999999999 114.643 -178.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -87.28 -40.59 14.36 Favored 'General case' 0 C--O 1.227 -0.092 0 CA-C-N 117.965 0.882 . . . . 1.96 110.45 176.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 15.3 m-80 -62.48 -41.82 99.05 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 122.135 0.174 . . . . 1.5700000000000001 111.322 -179.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -140.35 142.74 35.55 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 125.722 1.609 . . . . 1.53 107.649 -170.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 57.9 m -83.06 176.67 9.06 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 121.491 0.663 . . . . 2.6499999999999999 110.504 177.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -58.07 -45.75 86.59 Favored 'General case' 0 N--CA 1.454 -0.228 0 O-C-N 121.505 -0.747 . . . . 3.2000000000000002 110.705 -166.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -61.73 -38.78 89.19 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.228 0.611 . . . . 2.9700000000000002 110.199 -177.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.1 mp0 -70.33 -46.14 64.78 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 124.186 0.994 . . . . 4.21 108.489 -178.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 62.2 mt -62.96 -46.19 96.95 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.109 0 N-CA-C 108.834 -0.802 . . . . 1.53 108.834 178.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 46.4 tp -51.8 -54.06 32.97 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 123.132 0.573 . . . . 1.6000000000000001 109.682 176.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -50.61 -52.48 38.98 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.338 0.655 . . . . 1.6000000000000001 110.586 175.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 76.2 mt -62.6 -25.76 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 O-C-N 121.652 -0.655 . . . . 1.73 112.196 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 51.9 mt -73.26 -49.37 38.16 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 O-C-N 120.213 -1.554 . . . . 1.5800000000000001 108.993 170.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 86.7 mt -62.89 -34.28 77.08 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 125.006 1.322 . . . . 1.5700000000000001 114.238 -173.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -134.49 29.95 3.55 Favored 'General case' 0 C--N 1.342 0.257 0 CA-C-N 120.572 1.533 . . . . 3.2400000000000002 109.68 -172.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 37.95 -140.26 0.47 Allowed Glycine 0 CA--C 1.542 1.72 0 C-N-CA 127.05 2.262 . . . . 0.65000000000000002 111.837 -176.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 167.03 140.72 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 126.052 1.741 . . . . 1.28 109.516 -178.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 44.62 -120.67 3.74 Favored Glycine 0 CA--C 1.531 1.067 0 CA-C-N 119.684 1.129 . . . . 0.60999999999999999 112.551 -177.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -71.36 -19.46 77.58 Favored Glycine 0 CA--C 1.534 1.222 0 O-C-N 122.379 -0.483 . . . . 0.56000000000000005 112.972 178.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 17.1 ttt -72.25 119.94 77.57 Favored Pre-proline 0 CA--C 1.537 0.464 0 C-N-CA 123.762 0.825 . . . . 1.52 109.968 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -63.41 -53.25 1.51 Allowed 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 124.178 3.252 . . . . 2.8900000000000001 111.467 -169.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 114.39 152.07 10.47 Favored Glycine 0 N--CA 1.447 -0.596 0 CA-C-O 121.98 0.767 . . . . 2.3700000000000001 114.555 172.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 66.18 19.47 68.21 Favored Glycine 0 CA--C 1.531 1.04 0 CA-C-N 114.247 -0.976 . . . . 0.56999999999999995 111.74 -177.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 2.5 mt -50.21 -49.85 21.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 126.382 1.873 . . . . 2.1400000000000001 110.793 177.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -111.44 155.36 23.31 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.467 1.107 . . . . 1.49 108.909 159.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.5 mttm -146.13 157.87 43.86 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.276 1.43 . . . . 3.1800000000000002 109.859 178.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 56.49 -149.28 28.56 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 110.414 -1.074 . . . . 1.3 110.414 -176.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -51.18 -32.85 24.91 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 117.548 0.674 . . . . 1.6399999999999999 112.483 -178.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.444 ' CD ' ' HZ3' ' A' ' 31' ' ' LYS . 29.3 tt0 -51.79 -47.4 64.26 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.268 0.627 . . . . 2.3599999999999999 109.619 174.204 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -75.92 -49.23 18.42 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.175 0.59 . . . . 1.6200000000000001 111.304 175.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -57.34 -47.82 80.58 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 118.138 0.427 . . . . 2.0 111.503 -172.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.24 -49.07 77.19 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 109.625 -0.509 . . . . 1.46 109.625 178.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 45.9 t -57.62 -52.62 55.09 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 C-N-CA 122.898 0.479 . . . . 1.72 111.035 178.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -52.04 -55.8 18.32 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 123.467 0.707 . . . . 1.5700000000000001 111.366 176.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.69 -40.49 88.06 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.085 0.554 . . . . 1.52 111.084 -178.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 70.6 t90 -64.36 -52.44 58.32 Favored 'General case' 0 N--CA 1.453 -0.315 0 O-C-N 121.709 -0.619 . . . . 0.77000000000000002 109.727 177.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.52 -28.09 66.77 Favored 'General case' 0 C--O 1.224 -0.246 0 O-C-N 120.374 -1.454 . . . . 3.0 112.436 176.067 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -54.56 -35.34 63.16 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 119.036 0.834 . . . . 1.8200000000000001 111.387 169.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -70.64 -41.21 72.45 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 109.287 -0.634 . . . . 4.8600000000000003 109.287 174.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 4.1 mtpm? -74.33 105.85 5.69 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 120.988 0.423 . . . . 3.4500000000000002 111.459 -174.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.093 0 C-N-CA 126.341 1.856 . . . . 3.0600000000000001 106.736 170.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.2 t0 . . . . . 0 N--CA 1.45 -0.436 0 N-CA-C 103.487 -2.783 . . . . 3.6099999999999999 103.487 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -111.65 -62.07 1.61 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.447 -0.946 . . . . 1.72 108.447 173.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -58.05 -44.54 87.5 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.749 -0.66 . . . . 3.3599999999999999 110.417 -176.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.35 -36.7 83.05 Favored 'General case' 0 C--N 1.339 0.144 0 CA-C-N 118.707 0.685 . . . . 1.6399999999999999 111.21 -179.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 92.8 t -62.87 -55.98 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 N-CA-C 107.891 -1.152 . . . . 1.78 107.891 176.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 74.0 t -52.76 -48.33 49.75 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 CA-C-N 117.547 0.158 . . . . 1.5700000000000001 110.868 -179.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 25.3 mm-40 -50.06 -21.03 1.11 Allowed 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 126.565 1.946 . . . . 0.58999999999999997 113.496 174.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 17.4 tp60 -144.67 55.1 1.25 Allowed 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 119.481 1.037 . . . . 5.21 111.528 172.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.42 ' HZ1' ' CD ' ' A' ' 80' ' ' GLU . 0.5 OUTLIER -167.25 -38.29 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 124.005 0.922 . . . . 2.2400000000000002 110.025 170.623 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 3.7 m -99.58 -50.52 4.04 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 119.0 0.818 . . . . 0.22 110.772 -178.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.2 pp -56.91 -26.26 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.153 0 CA-C-N 116.151 -0.477 . . . . 1.6599999999999999 111.89 -175.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.6 t -42.23 -32.33 0.48 Allowed 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.041 1.336 . . . . 3.0299999999999998 111.848 172.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 12.5 m -123.08 -43.71 2.21 Favored 'General case' 0 C--N 1.341 0.212 0 C-N-CA 123.413 0.685 . . . . 0.17000000000000001 111.593 173.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 84.3 m-70 -70.09 -10.18 57.9 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.745 0.818 . . . . 0.25 112.768 -176.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 88.67 149.09 18.75 Favored Glycine 0 C--N 1.337 0.635 0 N-CA-C 109.747 -1.341 . . . . 1.52 109.747 178.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -43.28 -39.49 4.17 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 124.512 1.053 . . . . 1.1799999999999999 111.485 176.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -94.03 -7.16 43.51 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 125.574 1.549 . . . . 3.1699999999999999 111.027 -170.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.9 mt 71.16 11.54 6.87 Favored 'General case' 0 C--N 1.35 0.589 0 CA-C-N 119.524 1.057 . . . . 2.0299999999999998 111.627 177.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 12.5 p -83.49 0.1 47.86 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 127.128 2.171 . . . . 1.6000000000000001 109.742 -176.049 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.85 129.92 2.78 Favored Glycine 0 N--CA 1.442 -0.917 0 N-CA-C 108.978 -1.649 . . . . 0.56000000000000005 108.978 -178.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -135.95 -79.55 0.42 Allowed 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 124.195 0.998 . . . . 1.49 108.825 178.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.6 t -90.28 4.62 50.16 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.948 0.899 . . . . 2.6299999999999999 110.705 172.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -158.08 168.89 11.55 Favored Pre-proline 0 CA--C 1.535 0.374 0 C-N-CA 124.688 1.195 . . . . 1.5600000000000001 108.387 -172.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -70.01 158.72 55.73 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.927 2.418 . . . . 0.26000000000000001 110.528 -174.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.53 126.74 30.92 Favored 'General case' 0 C--N 1.332 -0.162 0 O-C-N 121.516 -0.74 . . . . 1.47 109.927 -178.098 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 50.6 pt -107.34 1.36 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 C-N-CA 123.716 0.806 . . . . 1.5 111.331 176.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 18.5 p-10 -35.75 -49.56 0.6 Allowed 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 124.894 1.278 . . . . 3.5299999999999998 111.744 171.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.68 32.32 4.62 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 127.232 2.213 . . . . 4.25 113.103 -179.56 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.12 -49.24 78.61 Favored 'General case' 0 CA--C 1.535 0.371 0 O-C-N 120.746 -1.221 . . . . 1.4099999999999999 110.147 177.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -54.11 -17.26 7.33 Favored Glycine 0 C--N 1.343 0.926 0 C-N-CA 124.64 1.114 . . . . 0.67000000000000004 114.886 178.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.7 -40.7 88.58 Favored 'General case' 0 N--CA 1.453 -0.32 0 O-C-N 121.373 -1.075 . . . . 1.8200000000000001 110.978 176.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 -105.5 -52.05 2.9 Favored 'General case' 0 CA--C 1.52 -0.198 0 N-CA-C 109.563 -0.532 . . . . 2.7599999999999998 109.563 -172.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -92.7 147.86 22.53 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.725 -1.213 . . . . 1.4199999999999999 107.725 -176.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -96.29 167.29 11.28 Favored 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 108.383 -0.969 . . . . 2.98 108.383 174.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -45.27 -43.51 10.6 Favored 'General case' 0 C--O 1.225 -0.216 0 C-N-CA 124.797 1.239 . . . . 2.7999999999999998 111.484 177.014 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -55.82 -49.29 73.65 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.842 0.857 . . . . 3.04 110.72 178.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -74.55 -43.25 56.62 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 123.228 0.611 . . . . 3.1699999999999999 109.423 -175.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 61.4 mt -60.57 -45.22 97.54 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 109.173 -0.677 . . . . 1.6799999999999999 109.173 179.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 55.2 tp -55.44 -50.44 69.81 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.274 -0.639 . . . . 1.77 109.274 176.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -53.79 -48.75 69.5 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 121.197 -0.201 . . . . 1.5 110.562 175.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 49.7 mt -63.88 -21.09 27.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 O-C-N 121.421 -0.799 . . . . 1.76 112.48 179.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 66.1 mt -78.63 -44.99 25.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 O-C-N 120.264 -1.522 . . . . 1.5600000000000001 109.207 173.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 80.7 mt -75.64 -31.28 59.76 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 113.43 0.9 . . . . 1.95 113.43 -176.132 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -120.06 19.47 12.28 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 119.641 1.109 . . . . 1.75 109.592 -171.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 36.42 -136.99 0.5 Allowed Glycine 0 CA--C 1.532 1.148 0 C-N-CA 127.689 2.566 . . . . 0.68999999999999995 111.169 -173.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 31.1 tt0 166.73 138.38 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 125.718 1.607 . . . . 1.3400000000000001 109.988 177.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 41.3 -119.95 1.74 Allowed Glycine 0 CA--C 1.531 1.072 0 O-C-N 120.436 -1.415 . . . . 0.46999999999999997 113.157 -173.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -71.66 -18.44 77.27 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 123.374 0.512 . . . . 0.57999999999999996 112.976 179.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 23.3 ttt -71.55 118.69 68.57 Favored Pre-proline 0 N--CA 1.45 -0.426 0 C-N-CA 123.734 0.813 . . . . 1.6399999999999999 110.52 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -75.25 125.03 8.89 Favored 'Trans proline' 0 N--CA 1.442 -1.53 0 C-N-CA 121.845 1.697 . . . . 2.1600000000000001 109.923 179.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -63.56 140.44 44.56 Favored Glycine 0 N--CA 1.44 -1.077 0 CA-C-N 115.077 -0.965 . . . . 1.5800000000000001 114.558 178.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 84.74 33.72 17.98 Favored Glycine 0 CA--C 1.525 0.668 0 CA-C-N 113.95 -1.125 . . . . 0.32000000000000001 111.329 173.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -61.47 -50.76 79.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 124.606 1.162 . . . . 3.5699999999999998 109.247 179.007 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -104.18 154.39 19.81 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.668 1.587 . . . . 1.5700000000000001 109.476 164.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.3 mtmp? -143.74 150.97 39.41 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 124.781 1.232 . . . . 6.1799999999999997 109.556 179.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 68.82 -163.21 50.39 Favored Glycine 0 CA--C 1.528 0.886 0 N-CA-C 110.379 -1.088 . . . . 0.88 110.379 -173.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -48.6 -31.05 6.03 Favored 'General case' 0 C--O 1.226 -0.166 0 C-N-CA 123.967 0.907 . . . . 1.8899999999999999 112.053 -179.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.42 ' CD ' ' HZ1' ' A' ' 31' ' ' LYS . 38.0 tt0 -41.73 -54.85 3.18 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.778 1.231 . . . . 1.96 109.904 174.416 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.17 -45.25 77.56 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 122.822 0.449 . . . . 1.46 110.93 -179.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 57.4 mt-10 -55.98 -51.62 67.05 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.162 0.985 . . . . 1.9199999999999999 110.643 -176.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -53.34 -52.01 60.58 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.027 0.931 . . . . 1.6299999999999999 110.451 176.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 77.0 t -55.02 -52.04 48.0 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 C-N-CA 120.997 -0.281 . . . . 1.6399999999999999 110.395 178.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -53.79 -51.51 63.23 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 123.172 0.589 . . . . 1.48 111.972 179.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.77 -48.43 77.87 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 123.611 0.764 . . . . 1.3999999999999999 110.701 178.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . 0.421 ' CE3' HD21 ' A' ' 88' ' ' LEU . 48.9 t90 -61.61 -45.6 93.41 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 121.916 -0.49 . . . . 0.77000000000000002 110.386 179.065 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.421 HD21 ' CE3' ' A' ' 87' ' ' TRP . 0.1 OUTLIER -64.17 -32.68 74.35 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 124.427 1.091 . . . . 2.6499999999999999 111.184 178.337 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -65.66 -44.63 85.72 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 123.377 0.671 . . . . 1.5600000000000001 110.279 171.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -59.83 -39.45 85.16 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 109.924 -0.398 . . . . 3.6499999999999999 109.924 174.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -73.62 149.88 41.75 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 121.526 0.679 . . . . 3.6099999999999999 110.878 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 18.6 mttt . . . . . 0 C--O 1.251 1.144 0 N-CA-C 105.274 -2.121 . . . . 3.6800000000000002 105.274 177.345 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.446 -0.645 0 N-CA-C 109.088 -0.708 . . . . 3.1099999999999999 109.088 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -105.18 -64.12 1.16 Allowed 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 107.975 -1.12 . . . . 1.5 107.975 174.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -48.92 -48.95 42.19 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 115.65 -0.704 . . . . 2.8599999999999999 111.166 178.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.56 -44.96 93.11 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 118.878 0.763 . . . . 1.55 111.426 -177.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 71.9 t -59.8 -54.19 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 N-CA-C 108.495 -0.928 . . . . 1.74 108.495 177.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 85.5 t -54.39 -50.74 55.12 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-N 117.979 0.354 . . . . 1.5800000000000001 110.595 -178.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 34.8 mm-40 -53.48 -15.68 1.18 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 126.696 1.998 . . . . 0.62 112.931 174.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -135.94 32.75 2.93 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 119.416 1.007 . . . . 2.9399999999999999 113.129 173.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 8.3 mtmt -152.37 -56.67 0.14 Allowed 'General case' 0 CA--C 1.521 -0.145 0 CA-C-N 118.694 0.679 . . . . 2.9300000000000002 109.633 172.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 4.0 m -75.08 -49.78 18.57 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 121.071 0.462 . . . . 0.23999999999999999 110.406 -171.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.4 pp -53.38 -27.16 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.142 0 CA-C-N 115.487 -0.779 . . . . 1.72 111.963 179.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.5 t -46.86 -29.19 1.86 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.27 1.028 . . . . 2.9500000000000002 111.92 176.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 15.9 m -122.45 -42.1 2.36 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.433 0.693 . . . . 0.29999999999999999 111.662 170.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 89.0 m-70 -70.5 -4.44 22.84 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.226 1.01 . . . . 0.47999999999999998 112.722 -177.16 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 116.44 -76.25 0.27 Allowed Glycine 0 C--N 1.339 0.746 0 C-N-CA 125.269 1.414 . . . . 3.1899999999999999 111.927 161.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -178.91 -51.24 0.08 OUTLIER Glycine 0 CA--C 1.519 0.318 0 N-CA-C 108.597 -1.801 . . . . 2.2999999999999998 108.597 -170.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -101.36 3.79 40.9 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 124.086 0.955 . . . . 2.2000000000000002 110.777 -174.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 15.3 mt 75.4 11.61 3.35 Favored 'General case' 0 C--N 1.351 0.661 0 CA-C-N 119.764 1.165 . . . . 2.23 110.384 -178.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.6 p -81.24 -9.3 59.8 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 127.941 2.496 . . . . 1.51 109.913 -175.248 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.41 143.68 9.26 Favored Glycine 0 N--CA 1.441 -0.994 0 N-CA-C 109.142 -1.583 . . . . 0.46999999999999997 109.142 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -152.92 -81.92 0.09 Allowed 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 124.137 0.975 . . . . 1.6499999999999999 108.978 -178.406 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -88.93 3.44 51.44 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.544 1.137 . . . . 1.8400000000000001 110.828 171.142 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -156.05 160.9 30.46 Favored Pre-proline 0 N--CA 1.449 -0.499 0 C-N-CA 125.988 1.715 . . . . 1.5800000000000001 107.266 -169.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -68.17 160.03 50.6 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 123.466 2.778 . . . . 0.46000000000000002 111.069 -174.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.45 125.65 28.39 Favored 'General case' 0 N--CA 1.455 -0.224 0 O-C-N 121.513 -0.742 . . . . 1.71 109.762 -177.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 46.1 pt -105.29 2.54 10.39 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 C-N-CA 123.555 0.742 . . . . 1.6499999999999999 111.482 175.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -33.39 -47.9 0.23 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.528 1.931 . . . . 2.48 112.869 166.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.7 33.68 5.22 Favored 'General case' 0 C--N 1.344 0.35 0 C-N-CA 124.389 1.075 . . . . 5.8300000000000001 110.281 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.22 -46.91 88.14 Favored 'General case' 0 N--CA 1.45 -0.435 0 O-C-N 121.15 -0.969 . . . . 1.6100000000000001 108.923 176.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -56.87 -23.02 43.66 Favored Glycine 0 C--N 1.341 0.813 0 CA-C-N 118.65 0.659 . . . . 0.59999999999999998 114.588 178.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -83.92 -47.38 11.09 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 117.81 0.805 . . . . 1.78 109.558 173.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 13.2 m-80 -59.5 -49.91 75.96 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.016 0.526 . . . . 1.6499999999999999 111.535 -178.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -137.06 154.81 50.25 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.472 1.509 . . . . 1.3700000000000001 108.578 -169.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.6 p -84.57 165.87 17.65 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 123.925 0.89 . . . . 3.1699999999999999 110.226 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -50.53 -39.39 48.88 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 123.723 0.809 . . . . 3.2400000000000002 111.407 178.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -57.29 -50.46 72.84 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 118.457 0.571 . . . . 4.5800000000000001 110.83 177.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 27.5 mm-40 -68.09 -46.2 71.63 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 121.733 0.777 . . . . 3.0899999999999999 108.917 -175.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 48.7 mt -60.19 -47.31 92.6 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 N-CA-C 109.44 -0.578 . . . . 1.74 109.44 -179.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.9 tp -58.45 -49.58 76.8 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 109.117 -0.697 . . . . 1.7 109.117 178.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -50.42 -51.05 49.96 Favored 'General case' 0 N--CA 1.452 -0.355 0 O-C-N 123.409 0.443 . . . . 1.8200000000000001 109.961 176.27 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 55.0 mt -57.62 -52.32 58.92 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 O-C-N 121.868 -0.52 . . . . 1.51 110.957 178.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 60.7 mt -53.4 -44.9 56.45 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 O-C-N 120.561 -1.337 . . . . 1.71 110.404 179.383 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 75.1 mt -72.91 -32.67 65.49 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 113.361 0.874 . . . . 1.8300000000000001 113.361 -178.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -123.04 19.77 9.98 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 119.655 1.116 . . . . 1.74 109.981 -165.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.401 ' N ' ' HA2' ' A' ' 73' ' ' GLY . . . 31.0 -142.98 0.02 OUTLIER Glycine 0 CA--C 1.533 1.207 0 C-N-CA 129.107 3.242 . . . . 0.62 111.492 -167.477 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 173.27 133.41 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 119.005 1.403 . . . . 1.3799999999999999 109.057 -175.147 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 35.39 -113.64 0.14 Allowed Glycine 0 CA--C 1.534 1.224 0 CA-C-N 120.019 1.282 . . . . 0.54000000000000004 113.925 -171.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -71.76 -21.42 78.91 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 123.47 0.557 . . . . 0.69999999999999996 112.936 -178.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 19.6 ttt -71.13 117.98 61.54 Favored Pre-proline 0 N--CA 1.451 -0.409 0 C-N-CA 124.994 1.318 . . . . 1.4299999999999999 110.793 179.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -77.95 123.76 6.42 Favored 'Trans proline' 0 N--CA 1.447 -1.262 0 C-N-CA 122.938 2.425 . . . . 2.1000000000000001 111.015 -178.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.401 ' HA2' ' N ' ' A' ' 67' ' ' GLY . . . -59.48 137.06 50.21 Favored Glycine 0 N--CA 1.444 -0.815 0 N-CA-C 115.688 1.035 . . . . 1.6399999999999999 115.688 -177.262 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 80.49 38.64 16.84 Favored Glycine 0 CA--C 1.525 0.688 0 CA-C-N 114.071 -1.064 . . . . 0.32000000000000001 111.005 174.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.2 mt -58.35 -58.04 8.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 124.892 1.277 . . . . 2.23 109.255 174.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -93.97 151.5 19.5 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 108.31 -0.996 . . . . 1.52 108.31 163.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -143.0 164.81 29.08 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 105.985 -1.857 . . . . 4.3499999999999996 105.985 172.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 75.17 -173.19 53.02 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 110.306 -1.117 . . . . 1.72 110.306 -173.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -51.46 -27.96 11.83 Favored 'General case' 0 C--O 1.225 -0.23 0 C-N-CA 123.877 0.871 . . . . 1.8400000000000001 111.628 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 6.2 mp0 -42.23 -57.85 2.38 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 124.097 0.959 . . . . 4.5899999999999999 111.39 170.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -58.24 -47.98 81.82 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 118.519 0.599 . . . . 1.51 110.782 -175.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -52.37 -60.92 2.65 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 124.507 1.123 . . . . 2.04 111.348 174.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -55.16 -47.34 75.28 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 124.233 1.013 . . . . 1.5700000000000001 109.922 -177.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 62.4 t -55.91 -55.58 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 C-N-CA 123.669 0.788 . . . . 1.6899999999999999 110.339 176.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -51.4 -53.75 33.46 Favored 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 123.178 0.591 . . . . 1.4399999999999999 111.614 176.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -63.34 -42.13 98.92 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.872 0.869 . . . . 1.6599999999999999 110.784 -175.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 62.0 t90 -58.69 -50.8 72.56 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 108.626 -0.879 . . . . 0.5 108.626 174.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.39 -32.1 69.85 Favored 'General case' 0 C--O 1.222 -0.357 0 O-C-N 120.512 -1.367 . . . . 3.0099999999999998 112.585 173.381 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -60.64 -32.02 71.21 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 119.556 1.071 . . . . 1.47 111.925 172.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -77.59 -34.64 53.49 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 119.668 1.122 . . . . 3.8999999999999999 111.643 168.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 21.6 mtpp -73.96 116.32 14.44 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 119.806 1.185 . . . . 3.98 111.029 -175.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 12.3 mttt . . . . . 0 C--O 1.254 1.299 0 C-N-CA 127.787 2.435 . . . . 3.3799999999999999 105.569 -176.747 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 . . . . . 0 N--CA 1.449 -0.477 0 N-CA-C 108.45 -0.945 . . . . 2.23 108.45 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -41.64 -57.38 2.3 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 124.951 1.3 . . . . 1.71 111.371 177.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -55.67 -48.21 75.43 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 116.314 -0.403 . . . . 2.3300000000000001 111.502 179.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.16 -44.7 83.72 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 118.266 0.485 . . . . 1.8300000000000001 110.921 178.256 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 54.6 t -57.53 -55.67 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 N-CA-C 109.332 -0.618 . . . . 1.6000000000000001 109.332 175.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 78.9 t -54.08 -49.61 60.13 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 N-CA-C 110.292 -0.262 . . . . 1.73 110.292 -177.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 30.6 mm-40 -51.83 -15.97 0.61 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.624 1.969 . . . . 0.87 113.588 174.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.43 30.96 2.61 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 119.313 0.961 . . . . 3.2799999999999998 112.314 178.496 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 5.0 mtmt -157.08 -47.31 0.07 Allowed 'General case' 0 CA--C 1.519 -0.214 0 O-C-N 121.85 -0.531 . . . . 2.4300000000000002 111.384 173.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 4.3 m -86.26 -48.13 8.8 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.65 -0.5 . . . . 0.23000000000000001 109.65 -174.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.5 pp -55.22 -27.8 20.51 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 CA-C-N 115.854 -0.612 . . . . 1.6499999999999999 112.332 -177.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.7 m -42.53 -34.42 0.85 Allowed 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.692 1.197 . . . . 1.9199999999999999 112.702 172.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 26.2 m -120.05 -41.37 2.65 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.134 0.574 . . . . 0.17999999999999999 111.763 174.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 84.5 m-70 -73.49 -7.85 53.49 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.712 0.805 . . . . 0.32000000000000001 112.688 -176.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 87.94 149.14 16.85 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 109.825 -1.31 . . . . 1.48 109.825 178.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -42.92 -34.89 2.08 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 124.78 1.181 . . . . 1.21 112.237 173.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -97.84 -6.99 31.35 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 125.737 1.615 . . . . 2.29 111.537 -171.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.2 mt 71.89 10.73 6.22 Favored 'General case' 0 C--N 1.351 0.665 0 CA-C-N 120.604 1.547 . . . . 2.21 111.232 176.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.7 p -88.79 0.43 56.53 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 128.603 2.761 . . . . 1.6899999999999999 109.992 -173.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.84 124.21 1.73 Allowed Glycine 0 N--CA 1.439 -1.106 0 N-CA-C 109.271 -1.532 . . . . 0.75 109.271 178.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -128.5 -78.74 0.57 Allowed 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 124.368 1.067 . . . . 1.29 108.873 177.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 21.4 m -93.67 4.55 53.77 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.387 1.075 . . . . 2.0499999999999998 111.104 172.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -152.16 163.28 24.09 Favored Pre-proline 0 CA--C 1.534 0.358 0 C-N-CA 126.096 1.758 . . . . 1.6100000000000001 107.164 -171.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -70.52 160.59 48.98 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 122.683 2.255 . . . . 0.33000000000000002 110.423 -176.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.52 128.23 34.91 Favored 'General case' 0 C--N 1.332 -0.187 0 O-C-N 121.461 -0.774 . . . . 1.48 110.255 -176.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 26.7 pt -108.21 0.84 9.74 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 C-N-CA 123.904 0.882 . . . . 1.5600000000000001 111.931 177.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 22.8 p-10 -33.08 -50.67 0.29 Allowed 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.812 1.645 . . . . 3.8700000000000001 113.243 169.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 12.6 pttp -111.96 22.46 14.85 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 125.796 1.638 . . . . 5.5300000000000002 112.054 -178.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -54.72 -38.34 66.97 Favored 'General case' 0 C--O 1.224 -0.285 0 O-C-N 121.632 -0.667 . . . . 1.8400000000000001 109.576 177.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -57.96 -17.58 29.91 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 123.862 0.744 . . . . 0.57999999999999996 114.927 176.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -90.0 -39.58 12.87 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 118.295 1.048 . . . . 1.6499999999999999 109.733 172.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -63.17 -48.86 76.63 Favored 'General case' 0 CA--C 1.527 0.084 0 C-N-CA 123.129 0.572 . . . . 3.6800000000000002 111.504 178.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -141.05 148.88 40.91 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 125.695 1.598 . . . . 1.1899999999999999 107.969 -166.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 16.6 m -81.89 167.57 18.83 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 118.39 0.541 . . . . 2.2999999999999998 110.573 179.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -46.9 -43.12 18.57 Favored 'General case' 0 C--O 1.225 -0.225 0 C-N-CA 124.191 0.996 . . . . 3.1000000000000001 111.424 175.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -55.13 -45.62 75.61 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.039 0.936 . . . . 2.6899999999999999 110.568 179.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -73.42 -49.42 27.11 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 123.766 0.826 . . . . 3.1200000000000001 109.75 -178.007 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 72.8 mt -60.05 -42.76 90.9 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 N-CA-C 108.618 -0.882 . . . . 1.55 108.618 -176.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 23.4 tp -55.01 -52.11 64.15 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 123.473 0.709 . . . . 1.8400000000000001 109.739 175.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -52.04 -48.31 64.62 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 118.118 0.417 . . . . 1.5 111.136 176.168 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 95.6 mt -57.81 -54.22 34.56 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 O-C-N 121.348 -0.845 . . . . 1.6599999999999999 110.446 177.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 38.3 mt -50.0 -46.02 23.22 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 O-C-N 121.163 -0.961 . . . . 1.6499999999999999 109.909 178.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 96.5 mt -62.96 -40.02 96.41 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 118.044 -0.979 . . . . 1.99 113.395 177.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -127.85 25.45 5.96 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 120.369 1.44 . . . . 1.8400000000000001 110.442 -159.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 23.57 -134.98 0.01 OUTLIER Glycine 0 CA--C 1.542 1.758 0 C-N-CA 127.615 2.531 . . . . 0.65000000000000002 112.694 -159.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 21.6 tt0 169.25 138.62 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.148 0 CA-C-N 119.799 1.8 . . . . 1.3899999999999999 108.933 -177.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 30.06 -111.15 0.03 OUTLIER Glycine 0 CA--C 1.534 1.247 0 C-N-CA 125.212 1.387 . . . . 0.54000000000000004 114.154 -171.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -66.97 -25.85 73.25 Favored Glycine 0 CA--C 1.534 1.226 0 CA-C-N 118.069 0.935 . . . . 0.64000000000000001 113.415 -178.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 16.7 ttt -70.9 120.67 80.72 Favored Pre-proline 0 CA--C 1.536 0.441 0 C-N-CA 124.747 1.219 . . . . 1.51 110.033 -179.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -61.89 -56.0 0.9 Allowed 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 124.358 3.372 . . . . 2.96 111.237 -169.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 118.25 151.56 9.16 Favored Glycine 0 N--CA 1.447 -0.63 0 CA-C-N 115.58 -0.736 . . . . 2.3199999999999998 113.874 173.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 65.73 22.47 70.05 Favored Glycine 0 CA--C 1.528 0.849 0 CA-C-N 114.313 -0.943 . . . . 0.41999999999999998 111.522 -179.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 2.6 mt -50.13 -57.51 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 C-N-CA 125.282 1.433 . . . . 2.1699999999999999 109.462 176.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -102.62 152.74 20.84 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.36 0.664 . . . . 1.52 109.794 163.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 3.2 mmmp? -145.03 151.82 39.16 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.594 1.158 . . . . 4.71 109.598 177.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 71.99 -156.67 52.61 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 123.518 0.58 . . . . 0.89000000000000001 111.749 177.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -48.22 -35.59 12.18 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 124.941 1.296 . . . . 2.1699999999999999 112.09 -177.007 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -47.45 -63.53 1.03 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.897 1.279 . . . . 2.1800000000000002 110.715 169.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.03 -44.34 94.69 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.979 0.912 . . . . 1.45 110.794 -179.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -54.59 -52.31 62.55 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 121.219 0.533 . . . . 2.5299999999999998 110.047 179.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.13 -51.67 68.76 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.57 0.748 . . . . 1.4399999999999999 109.971 179.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 55.7 t -49.55 -56.71 2.67 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 123.027 0.531 . . . . 1.79 111.012 176.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -53.44 -51.9 61.16 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 124.059 0.944 . . . . 1.6000000000000001 111.855 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.95 -48.61 80.99 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 121.599 0.714 . . . . 1.8 110.434 -179.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 49.9 t90 -56.5 -43.35 79.65 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.165 0.586 . . . . 0.47999999999999998 110.303 177.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.43 -42.31 98.71 Favored 'General case' 0 C--O 1.227 -0.117 0 C-N-CA 123.646 0.778 . . . . 2.7200000000000002 110.862 175.568 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -55.36 -38.15 68.42 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 119.236 0.925 . . . . 1.48 110.716 171.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -84.15 13.09 5.49 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.655 1.182 . . . . 3.5299999999999998 113.655 174.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.46 122.7 43.37 Favored 'General case' 0 C--N 1.34 0.189 0 CA-C-N 119.954 1.252 . . . . 3.2000000000000002 109.733 173.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.255 1.378 0 C-N-CA 127.541 2.336 . . . . 3.7999999999999998 104.959 178.097 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 . . . . . 0 N--CA 1.449 -0.491 0 N-CA-C 107.786 -1.19 . . . . 2.5899999999999999 107.786 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -49.69 -50.22 44.51 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.204 1.002 . . . . 1.8799999999999999 109.805 179.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -60.61 -51.59 68.77 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 116.002 -0.544 . . . . 3.2000000000000002 110.414 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.99 -45.28 79.06 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 118.916 0.78 . . . . 1.75 110.99 -178.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 24.5 t -56.64 -56.43 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 CA-C-N 116.12 -0.491 . . . . 2.0299999999999998 109.713 175.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 52.2 t -55.68 -45.72 79.22 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 N-CA-C 110.005 -0.369 . . . . 1.76 110.005 -178.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 26.0 mm-40 -55.72 -11.31 0.91 Allowed 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 127.355 2.262 . . . . 0.83999999999999997 113.859 173.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -139.05 16.62 2.63 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 119.63 1.104 . . . . 3.8100000000000001 113.514 173.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 23.6 mttm -135.86 -62.79 0.67 Allowed 'General case' 0 CA--C 1.518 -0.257 0 C-N-CA 123.919 0.888 . . . . 3.1800000000000002 109.457 176.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 3.2 m -72.71 -47.93 42.99 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.096 0.474 . . . . 0.29999999999999999 110.43 -173.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.2 pp -58.72 -25.13 27.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 CA-C-N 115.533 -0.758 . . . . 1.6299999999999999 111.688 -174.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.6 m -46.16 -32.93 3.23 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.829 1.251 . . . . 2.1699999999999999 111.768 175.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 21.6 m -120.31 -42.57 2.56 Favored 'General case' 0 C--N 1.341 0.21 0 C-N-CA 123.523 0.729 . . . . 0.19 111.516 175.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -72.56 -8.63 56.15 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.577 0.751 . . . . 0.28999999999999998 112.667 -177.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 86.46 148.81 12.71 Favored Glycine 0 C--N 1.336 0.567 0 N-CA-C 109.442 -1.463 . . . . 1.47 109.442 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -42.05 -33.43 1.23 Allowed Glycine 0 CA--C 1.527 0.821 0 C-N-CA 125.241 1.401 . . . . 1.25 112.914 175.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -100.66 -4.8 27.62 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 125.408 1.483 . . . . 3.1099999999999999 112.089 -170.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 13.0 mt 68.94 12.94 8.77 Favored 'General case' 0 C--N 1.352 0.699 0 CA-C-N 120.212 1.369 . . . . 2.1000000000000001 112.002 177.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 11.0 p -84.32 -3.63 58.37 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 127.329 2.252 . . . . 1.77 110.365 -177.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.72 130.7 3.74 Favored Glycine 0 N--CA 1.441 -0.988 0 N-CA-C 108.943 -1.663 . . . . 0.58999999999999997 108.943 -176.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -134.5 -79.44 0.45 Allowed 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 124.285 1.034 . . . . 1.3200000000000001 108.471 177.175 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 19.5 m -91.61 4.28 53.04 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.208 1.003 . . . . 2.0699999999999998 111.043 173.144 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -155.72 163.95 22.95 Favored Pre-proline 0 CA--C 1.536 0.407 0 C-N-CA 125.388 1.475 . . . . 1.47 107.884 -169.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -70.74 157.97 56.99 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.915 2.41 . . . . 0.32000000000000001 110.582 -174.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.52 123.44 23.93 Favored 'General case' 0 C--N 1.331 -0.208 0 O-C-N 121.492 -0.755 . . . . 1.5800000000000001 110.16 -175.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 44.0 pt -106.78 2.22 10.09 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.135 0 C-N-CA 124.22 1.008 . . . . 1.5900000000000001 111.132 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.439 ' OD1' ' NZ ' ' A' ' 91' ' ' LYS . 24.4 t0 -42.01 -49.59 4.67 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 118.457 0.571 . . . . 2.8999999999999999 112.149 177.643 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 5.3 pttt -101.28 26.32 7.28 Favored 'General case' 0 C--N 1.344 0.331 0 C-N-CA 125.743 1.617 . . . . 5.71 111.698 -178.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -53.74 -43.13 68.88 Favored 'General case' 0 N--CA 1.457 -0.122 0 O-C-N 121.483 -0.761 . . . . 1.4299999999999999 110.302 -178.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -52.05 -23.82 12.92 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 114.682 0.633 . . . . 0.60999999999999999 114.682 175.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -80.99 -35.69 31.67 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 118.061 0.931 . . . . 1.6899999999999999 110.509 175.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 -74.2 -48.36 29.53 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 122.814 0.446 . . . . 2.8100000000000001 109.997 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -140.4 153.67 46.42 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.356 1.062 . . . . 1.8999999999999999 109.274 -170.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 20.0 m -83.83 166.92 17.53 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 118.485 0.584 . . . . 2.46 110.684 178.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.2 pm0 -47.07 -42.41 18.64 Favored 'General case' 0 C--O 1.223 -0.293 0 C-N-CA 124.793 1.237 . . . . 2.79 111.92 178.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -58.44 -45.83 87.73 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.378 0.609 . . . . 2.6600000000000001 110.152 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -74.2 -46.68 40.38 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.599 0.76 . . . . 3.2000000000000002 109.134 -176.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 62.6 mt -59.32 -44.28 91.95 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.132 0 O-C-N 121.475 -0.766 . . . . 1.6000000000000001 109.018 179.263 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 52.8 tp -54.43 -51.17 65.79 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 109.14 -0.689 . . . . 1.6599999999999999 109.14 176.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -52.48 -50.16 63.25 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 123.297 0.373 . . . . 1.5 110.253 174.147 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 76.7 mt -61.65 -24.09 32.88 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 O-C-N 121.323 -0.861 . . . . 1.9099999999999999 112.621 179.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 75.1 mt -82.38 -46.66 19.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 O-C-N 120.059 -1.65 . . . . 1.6299999999999999 109.621 176.129 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 68.7 mt -72.64 -30.29 64.19 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.395 1.078 . . . . 1.97 112.713 -176.146 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -127.39 17.31 7.06 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 119.207 0.912 . . . . 1.96 109.614 -169.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.428 ' N ' ' HA2' ' A' ' 73' ' ' GLY . . . 40.41 -143.87 0.55 Allowed Glycine 0 CA--C 1.539 1.539 0 C-N-CA 127.759 2.6 . . . . 0.70999999999999996 111.814 -177.722 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 31.4 tt0 170.12 138.18 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 126.069 1.748 . . . . 1.3100000000000001 109.731 -179.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 35.76 -116.62 0.28 Allowed Glycine 0 C--N 1.347 1.16 0 CA-C-N 120.46 1.482 . . . . 0.44 114.082 -175.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -67.32 -23.16 73.27 Favored Glycine 0 CA--C 1.531 1.091 0 CA-C-N 117.98 0.89 . . . . 0.55000000000000004 112.555 -179.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 18.6 ttt -72.7 117.96 63.84 Favored Pre-proline 0 CA--C 1.535 0.398 0 C-N-CA 124.45 1.1 . . . . 1.5800000000000001 112.053 179.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -75.57 123.78 7.8 Favored 'Trans proline' 0 N--CA 1.446 -1.277 0 C-N-CA 122.848 2.366 . . . . 2.1099999999999999 111.706 -179.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.428 ' HA2' ' N ' ' A' ' 67' ' ' GLY . . . -58.01 126.67 43.01 Favored Glycine 0 N--CA 1.443 -0.889 0 CA-C-N 115.012 -0.995 . . . . 1.6599999999999999 115.246 179.191 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 86.66 48.01 4.63 Favored Glycine 0 C--N 1.337 0.636 0 N-CA-C 110.648 -0.981 . . . . 0.57999999999999996 110.648 173.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.1 mt -69.11 -50.88 49.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 123.833 0.853 . . . . 2.2799999999999998 109.497 175.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -102.92 153.63 20.02 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 126.002 1.721 . . . . 1.6699999999999999 109.619 164.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 44.9 mttm -143.63 155.36 44.23 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 125.386 1.475 . . . . 3.7599999999999998 108.861 178.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 72.63 -167.77 53.43 Favored Glycine 0 CA--C 1.53 0.981 0 N-CA-C 110.926 -0.869 . . . . 1.1699999999999999 110.926 -175.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -52.04 -25.95 9.76 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.469 1.108 . . . . 2.4300000000000002 112.728 -177.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -42.19 -60.3 1.5 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.723 1.209 . . . . 2.21 110.939 168.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.27 -45.73 92.28 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 122.608 0.363 . . . . 1.7 110.638 -175.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -52.11 -57.12 10.55 Favored 'General case' 0 N--CA 1.461 0.096 0 C-N-CA 123.503 0.721 . . . . 3.04 111.196 174.129 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -53.95 -48.48 70.25 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 123.139 0.576 . . . . 1.75 109.812 -177.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 98.5 t -59.18 -53.32 49.71 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 N-CA-C 111.588 0.218 . . . . 1.6899999999999999 111.588 177.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -51.29 -53.82 31.98 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 124.051 0.941 . . . . 1.71 111.455 178.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.89 -54.42 47.13 Favored 'General case' 0 C--O 1.224 -0.268 0 N-CA-C 109.299 -0.63 . . . . 1.4099999999999999 109.299 179.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . 0.406 ' CE3' ' CD2' ' A' ' 88' ' ' LEU . 50.2 t90 -49.38 -46.61 47.48 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 122.984 0.514 . . . . 0.65000000000000002 111.134 177.066 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.406 ' CD2' ' CE3' ' A' ' 87' ' ' TRP . 0.1 OUTLIER -66.05 -31.82 72.93 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 124.585 1.154 . . . . 2.79 111.908 177.338 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -67.8 -44.85 76.35 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 118.739 0.7 . . . . 2.0600000000000001 110.731 173.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -57.52 -39.76 77.27 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.286 0.634 . . . . 5.2400000000000002 110.196 173.042 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.439 ' NZ ' ' OD1' ' A' ' 49' ' ' ASP . 1.6 mtmp? -73.45 136.22 44.2 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 118.852 0.751 . . . . 3.6400000000000001 110.538 178.074 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 67.8 mttt . . . . . 0 C--O 1.249 1.044 0 CA-C-O 117.189 -1.386 . . . . 3.4900000000000002 108.091 174.704 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 . . . . . 0 N--CA 1.452 -0.326 0 N-CA-C 108.664 -0.865 . . . . 2.5800000000000001 108.664 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -51.84 -58.62 5.92 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.655 0.782 . . . . 1.5900000000000001 110.906 -178.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -50.15 -45.14 52.94 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 118.936 -0.554 . . . . 2.8500000000000001 111.362 176.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.99 -47.66 84.91 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 119.033 0.833 . . . . 1.8700000000000001 110.829 179.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 89.3 t -56.32 -54.49 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.155 0 N-CA-C 108.934 -0.765 . . . . 1.6499999999999999 108.934 176.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 96.4 t -56.02 -48.21 79.11 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 C-N-CA 122.55 0.34 . . . . 1.8500000000000001 111.037 -177.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 36.4 mm-40 -53.67 -15.81 1.37 Allowed 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 126.912 2.085 . . . . 0.48999999999999999 113.036 174.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -144.98 48.21 1.31 Allowed 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 119.286 0.948 . . . . 3.2599999999999998 111.086 174.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 3.8 mttt -162.69 -49.28 0.04 OUTLIER 'General case' 0 C--O 1.227 -0.131 0 C-N-CA 124.483 1.113 . . . . 3.1299999999999999 110.206 167.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 5.2 m -85.2 -50.11 7.66 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 121.443 0.64 . . . . 0.20000000000000001 110.417 -172.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.4 pp -53.48 -28.63 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 CA-C-N 115.063 -0.971 . . . . 1.6499999999999999 111.487 -178.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.9 m -41.61 -35.14 0.69 Allowed 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 125.574 1.549 . . . . 1.8100000000000001 112.377 173.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 34.9 m -119.23 -41.53 2.73 Favored 'General case' 0 C--N 1.34 0.185 0 C-N-CA 123.546 0.739 . . . . 0.19 111.562 174.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 84.4 m-70 -74.18 -7.72 53.66 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.749 0.82 . . . . 0.51000000000000001 112.791 -175.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 84.24 148.72 9.29 Favored Glycine 0 C--N 1.338 0.643 0 C-N-CA 125.511 1.529 . . . . 1.52 109.6 -179.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -44.49 -36.47 4.46 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 124.41 1.005 . . . . 1.22 112.317 174.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -88.61 -10.72 47.68 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 124.842 1.257 . . . . 2.0600000000000001 111.454 -174.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.4 mt 71.78 10.59 6.31 Favored 'General case' 0 C--N 1.349 0.578 0 CA-C-N 120.197 1.362 . . . . 2.1899999999999999 110.818 176.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.4 p -84.06 -0.27 51.13 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 128.415 2.686 . . . . 1.52 110.126 -175.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.4 138.88 5.84 Favored Glycine 0 N--CA 1.44 -1.071 0 N-CA-C 108.599 -1.801 . . . . 0.44 108.599 -176.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -145.35 -78.34 0.19 Allowed 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 123.789 0.836 . . . . 1.3100000000000001 108.932 178.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.5 t -89.07 1.7 55.17 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.824 0.85 . . . . 1.6799999999999999 110.355 174.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -162.43 165.13 15.98 Favored Pre-proline 0 CA--C 1.537 0.467 0 C-N-CA 125.12 1.368 . . . . 1.7 107.434 -167.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -66.81 159.52 51.06 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 123.46 2.773 . . . . 0.41999999999999998 111.54 -173.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.33 132.19 42.78 Favored 'General case' 0 C--N 1.332 -0.177 0 O-C-N 121.67 -0.643 . . . . 1.52 109.867 -178.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 35.3 pt -109.03 1.16 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 C-N-CA 123.242 0.617 . . . . 1.7 112.516 175.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -38.49 -47.4 1.27 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.459 1.104 . . . . 3.5600000000000001 111.811 170.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 10.7 mttt -108.52 35.2 3.28 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 125.553 1.541 . . . . 6.3300000000000001 111.683 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.81 -55.28 35.02 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 108.567 -0.901 . . . . 1.51 108.567 169.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -57.02 -21.28 37.58 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 124.726 1.155 . . . . 0.75 113.551 -179.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.01 -38.91 92.47 Favored 'General case' 0 N--CA 1.451 -0.394 0 O-C-N 121.799 -0.824 . . . . 1.8700000000000001 110.994 177.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 72.0 m-80 -105.23 -53.66 2.62 Favored 'General case' 0 CA--C 1.523 -0.076 0 C-N-CA 123.411 0.684 . . . . 2.98 109.937 -174.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -94.66 142.34 27.57 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 124.848 1.259 . . . . 1.73 108.929 -171.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.5 167.06 17.76 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 118.748 0.704 . . . . 2.8700000000000001 110.167 175.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -48.37 -47.43 37.32 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 124.009 0.924 . . . . 3.04 110.894 174.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -54.72 -34.95 63.14 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.39 0.676 . . . . 4.46 111.598 178.632 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -84.44 -47.05 11.04 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 121.533 0.682 . . . . 3.4399999999999999 109.602 -175.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 87.1 mt -61.48 -41.93 91.93 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 N-CA-C 108.778 -0.823 . . . . 1.6799999999999999 108.778 179.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.4 tp -54.95 -49.46 71.31 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 123.02 0.528 . . . . 1.5900000000000001 109.714 175.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -52.1 -52.09 53.59 Favored 'General case' 0 CA--C 1.533 0.306 0 O-C-N 123.271 0.357 . . . . 1.51 110.152 176.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 75.7 mt -57.76 -50.69 76.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.288 0 O-C-N 121.572 -0.705 . . . . 1.5800000000000001 110.311 178.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 46.3 mt -54.06 -44.39 62.62 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 O-C-N 120.383 -1.448 . . . . 1.51 110.411 179.163 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 84.8 mt -70.5 -32.78 70.42 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 118.33 -0.843 . . . . 1.5600000000000001 112.892 -179.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -124.69 18.84 8.7 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 119.752 1.16 . . . . 1.6899999999999999 110.387 -164.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.428 ' N ' ' HA2' ' A' ' 73' ' ' GLY . . . 30.81 -137.33 0.07 OUTLIER Glycine 0 CA--C 1.532 1.116 0 C-N-CA 128.819 3.104 . . . . 0.63 111.206 -167.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 11.6 tt0 165.7 129.74 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.518 1.527 . . . . 1.9199999999999999 109.81 -178.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 41.04 -118.42 1.26 Allowed Glycine 0 C--N 1.346 1.089 0 CA-C-N 120.865 1.666 . . . . 0.81999999999999995 113.846 -176.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -66.07 -17.36 65.55 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 123.711 0.672 . . . . 0.78000000000000003 112.644 -179.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 19.4 ttt -81.39 117.74 69.41 Favored Pre-proline 0 N--CA 1.448 -0.531 0 C-N-CA 124.879 1.272 . . . . 1.5 111.525 179.063 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -77.93 122.64 5.9 Favored 'Trans proline' 0 N--CA 1.447 -1.237 0 C-N-CA 122.992 2.461 . . . . 2.1099999999999999 111.704 -179.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.428 ' HA2' ' N ' ' A' ' 67' ' ' GLY . . . -57.84 132.93 52.8 Favored Glycine 0 N--CA 1.443 -0.853 0 N-CA-C 115.737 1.055 . . . . 1.6200000000000001 115.737 -179.29 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 82.59 34.4 22.57 Favored Glycine 0 CA--C 1.527 0.803 0 CA-C-N 114.228 -0.986 . . . . 0.34000000000000002 112.06 173.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.4 mt -53.9 -57.24 6.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 125.256 1.422 . . . . 2.0800000000000001 110.038 174.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -101.73 150.06 23.51 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 124.292 1.037 . . . . 1.5800000000000001 108.27 166.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 56.2 mttm -142.26 165.25 27.95 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 106.986 -1.487 . . . . 3.6499999999999999 106.986 172.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 76.8 -170.29 55.04 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 110.022 -1.231 . . . . 1.6200000000000001 110.022 -173.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -52.35 -30.19 27.52 Favored 'General case' 0 C--O 1.225 -0.222 0 C-N-CA 123.865 0.866 . . . . 1.71 111.15 -176.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.5 mp0 -39.5 -62.98 0.61 Allowed 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.147 1.379 . . . . 4.54 111.063 170.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -58.46 -48.92 79.18 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.207 0.458 . . . . 1.49 111.125 -175.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -50.06 -57.63 7.23 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.362 1.065 . . . . 2.0 111.353 175.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.95 -43.63 98.44 Favored 'General case' 0 N--CA 1.449 -0.507 0 O-C-N 121.902 -0.499 . . . . 1.7 110.769 -177.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 71.3 t -53.97 -53.95 23.89 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 C-N-CA 123.332 0.653 . . . . 1.8200000000000001 109.737 176.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -52.73 -53.53 46.55 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 123.401 0.68 . . . . 1.74 112.082 175.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.61 -47.14 82.98 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 122.115 0.96 . . . . 1.3200000000000001 110.976 -179.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 50.9 t90 -59.86 -42.48 93.78 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.315 1.046 . . . . 0.52000000000000002 110.273 178.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.25 -38.92 92.75 Favored 'General case' 0 C--N 1.333 -0.116 0 C-N-CA 123.996 0.918 . . . . 2.7200000000000002 110.818 175.552 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -52.81 -45.5 67.28 Favored 'General case' 0 CA--C 1.528 0.12 0 N-CA-C 109.424 -0.584 . . . . 1.6000000000000001 109.424 173.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -90.28 36.78 0.88 Allowed 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.216 0.606 . . . . 3.0600000000000001 111.896 175.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 4.4 mttm -126.36 136.37 52.62 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.267 1.027 . . . . 3.9500000000000002 108.702 164.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 30.8 mttt . . . . . 0 C--O 1.253 1.256 0 N-CA-C 105.162 -2.162 . . . . 4.4199999999999999 105.162 172.916 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 . . . . . 0 N--CA 1.451 -0.415 0 N-CA-C 109.287 -0.634 . . . . 2.52 109.287 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -40.84 -51.91 3.09 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 125.012 1.325 . . . . 1.8300000000000001 111.8 176.097 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -57.02 -46.09 82.59 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 110.146 -0.316 . . . . 2.9300000000000002 110.146 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.1 -43.75 98.41 Favored 'General case' 0 CA--C 1.528 0.109 0 C-N-CA 123.386 0.674 . . . . 1.51 110.768 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 89.8 t -58.93 -58.76 5.44 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.261 0 N-CA-C 109.062 -0.718 . . . . 1.8799999999999999 109.062 176.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 44.1 t -53.02 -47.03 54.74 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 C-N-CA 123.224 0.609 . . . . 1.6200000000000001 110.431 -177.114 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 24.7 mm-40 -48.9 -25.91 2.17 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 126.119 1.768 . . . . 0.71999999999999997 113.427 173.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -141.01 56.73 1.56 Allowed 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 119.261 0.937 . . . . 4.29 111.624 174.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.44 ' HZ2' ' CD ' ' A' ' 80' ' ' GLU . 0.0 OUTLIER -170.47 -38.12 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 124.145 0.978 . . . . 2.2000000000000002 110.033 170.442 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 3.4 m -101.18 -50.23 3.85 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 119.27 0.941 . . . . 0.26000000000000001 110.86 -177.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.2 pp -56.88 -27.07 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 CA-C-N 116.107 -0.497 . . . . 1.6200000000000001 112.027 -174.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.7 m -38.64 -35.76 0.21 Allowed 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.635 1.574 . . . . 1.72 112.473 170.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 20.9 m -121.02 -44.28 2.41 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.75 0.82 . . . . 0.19 111.371 174.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 86.5 m-70 -70.5 -9.55 56.9 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.753 0.821 . . . . 0.31 112.897 -176.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 88.37 148.08 15.54 Favored Glycine 0 C--N 1.338 0.643 0 N-CA-C 109.816 -1.314 . . . . 1.52 109.816 177.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -44.6 -36.29 4.51 Favored Glycine 0 C--N 1.341 0.807 0 C-N-CA 124.454 1.026 . . . . 1.21 111.852 175.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -93.7 -6.93 45.12 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 124.909 1.283 . . . . 2.5499999999999998 111.758 -172.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 8.9 mt 70.91 11.12 7.07 Favored 'General case' 0 C--N 1.352 0.693 0 CA-C-N 120.237 1.381 . . . . 2.0099999999999998 111.301 177.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 11.0 p -86.28 0.88 52.84 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 127.186 2.194 . . . . 1.5 109.832 -175.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.72 133.19 3.52 Favored Glycine 0 N--CA 1.443 -0.89 0 N-CA-C 108.881 -1.688 . . . . 0.45000000000000001 108.881 -177.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -136.42 -75.82 0.43 Allowed 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 108.431 -0.951 . . . . 1.3799999999999999 108.431 178.344 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 9.3 t -95.85 4.17 53.06 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.09 0.956 . . . . 2.5699999999999998 110.753 173.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -157.92 167.39 14.58 Favored Pre-proline 0 CA--C 1.538 0.488 0 C-N-CA 125.207 1.403 . . . . 1.6499999999999999 108.181 -169.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -71.03 155.63 61.39 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 122.968 2.446 . . . . 0.26000000000000001 110.801 -173.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.67 123.28 23.75 Favored 'General case' 0 C--N 1.332 -0.176 0 O-C-N 121.589 -0.695 . . . . 1.6299999999999999 110.57 -176.119 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 45.4 pt -104.46 0.68 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 C-N-CA 123.526 0.73 . . . . 1.79 111.801 179.1 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -41.13 -39.29 1.24 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.971 0.908 . . . . 3.0699999999999998 112.396 171.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 12.4 mtpt -117.73 34.08 5.32 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 125.187 1.395 . . . . 4.8700000000000001 109.828 -177.339 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.18 -53.59 50.92 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 108.654 -0.869 . . . . 1.49 108.654 171.174 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -56.85 -21.76 38.4 Favored Glycine 0 C--N 1.34 0.765 0 C-N-CA 124.116 0.865 . . . . 0.58999999999999997 114.247 -178.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -60.91 -38.86 87.22 Favored 'General case' 0 N--CA 1.449 -0.49 0 O-C-N 122.01 -0.7 . . . . 1.8700000000000001 110.636 174.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 41.3 m-80 -107.55 -58.9 1.9 Allowed 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 124.356 1.062 . . . . 2.96 110.295 -174.271 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -78.37 149.49 33.37 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.391 1.077 . . . . 2.5099999999999998 110.084 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 29.3 m -94.86 173.94 7.34 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.943 1.297 . . . . 2.6800000000000002 110.13 176.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -56.64 -53.09 61.65 Favored 'General case' 0 N--CA 1.457 -0.098 0 O-C-N 121.761 -0.587 . . . . 3.02 109.825 -176.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 35.3 mm-40 -55.38 -32.17 62.39 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.434 0.693 . . . . 4.4500000000000002 111.816 177.334 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -75.97 -50.9 13.6 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 108.635 -0.876 . . . . 2.5499999999999998 108.635 -177.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 66.4 mt -62.7 -43.47 98.66 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.133 0 O-C-N 121.431 -0.793 . . . . 1.6799999999999999 108.89 -178.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 27.0 tp -55.9 -50.34 70.95 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 109.749 -0.463 . . . . 1.51 109.749 176.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -51.72 -51.91 52.46 Favored 'General case' 0 CA--C 1.53 0.21 0 O-C-N 123.057 0.223 . . . . 2.2200000000000002 110.503 175.295 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 81.2 mt -57.33 -50.47 76.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 O-C-N 121.781 -0.575 . . . . 1.6499999999999999 109.962 179.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 71.9 mt -53.35 -42.56 48.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 O-C-N 120.522 -1.361 . . . . 1.6799999999999999 110.306 178.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 68.9 mt -72.23 -32.61 66.89 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 113.736 1.013 . . . . 1.6200000000000001 113.736 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -122.75 20.06 10.19 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 120.176 1.353 . . . . 1.6100000000000001 110.387 -167.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.411 ' N ' ' HA2' ' A' ' 73' ' ' GLY . . . 31.05 -133.61 0.11 Allowed Glycine 0 CA--C 1.532 1.107 0 C-N-CA 128.621 3.01 . . . . 0.71999999999999997 111.462 -166.729 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 168.52 130.94 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 119.034 1.417 . . . . 1.7 109.465 -179.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 35.41 -111.97 0.1 OUTLIER Glycine 0 CA--C 1.532 1.147 0 CA-C-N 120.116 1.326 . . . . 0.62 113.815 -171.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -70.92 -20.91 78.07 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 123.367 0.508 . . . . 0.65000000000000002 113.029 -178.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 19.0 ttt -74.39 120.24 80.48 Favored Pre-proline 0 N--CA 1.45 -0.466 0 C-N-CA 125.15 1.38 . . . . 1.5600000000000001 110.353 -179.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -79.73 121.41 4.6 Favored 'Trans proline' 0 N--CA 1.446 -1.319 0 C-N-CA 122.888 2.392 . . . . 2.0299999999999998 111.534 -176.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.411 ' HA2' ' N ' ' A' ' 67' ' ' GLY . . . -57.06 134.05 52.44 Favored Glycine 0 N--CA 1.444 -0.792 0 N-CA-C 115.275 0.87 . . . . 1.6799999999999999 115.275 -179.458 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 87.22 38.98 7.54 Favored Glycine 0 CA--C 1.527 0.792 0 CA-C-N 114.353 -0.924 . . . . 0.44 111.709 174.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 2.5 mt -63.79 -59.67 3.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 124.751 1.22 . . . . 2.4300000000000002 110.22 176.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -104.18 161.36 14.09 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.632 1.173 . . . . 1.54 108.233 165.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 21.5 mttm -145.47 175.92 9.97 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.998 0.919 . . . . 4.2000000000000002 109.659 173.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 57.94 -153.66 25.23 Favored Glycine 0 CA--C 1.531 1.093 0 CA-C-O 121.45 0.472 . . . . 0.79000000000000004 112.537 177.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -53.39 -29.93 37.26 Favored 'General case' 0 C--N 1.339 0.13 0 C-N-CA 123.955 0.902 . . . . 1.76 111.681 174.079 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.44 ' CD ' ' HZ2' ' A' ' 31' ' ' LYS . 5.1 tt0 -52.42 -61.2 2.43 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 108.612 -0.885 . . . . 2.3900000000000001 108.612 173.69 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -63.28 -51.09 67.54 Favored 'General case' 0 CA--C 1.53 0.209 0 O-C-N 122.187 -0.32 . . . . 1.74 111.668 179.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -51.34 -52.64 43.65 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 121.034 0.445 . . . . 2.73 111.67 -178.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -56.45 -48.79 76.29 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 109.788 -0.449 . . . . 1.6399999999999999 109.788 -179.096 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 77.6 t -54.81 -49.97 65.06 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 CA-C-O 119.389 -0.339 . . . . 1.6799999999999999 111.127 176.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -51.71 -54.22 30.64 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 122.757 0.423 . . . . 1.51 111.34 176.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.06 -44.85 95.8 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 121.269 0.557 . . . . 1.96 111.376 -177.4 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . 0.453 ' CE3' HD21 ' A' ' 88' ' ' LEU . 47.9 t90 -60.29 -52.24 66.14 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 121.715 -0.615 . . . . 0.77000000000000002 109.566 177.694 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.453 HD21 ' CE3' ' A' ' 87' ' ' TRP . 0.1 OUTLIER -55.59 -35.27 65.62 Favored 'General case' 0 C--O 1.222 -0.363 0 C-N-CA 124.068 0.947 . . . . 2.6899999999999999 110.369 176.602 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -59.07 -44.69 91.9 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 118.559 0.618 . . . . 1.4299999999999999 111.803 176.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -72.37 -27.88 62.67 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 110.248 -0.279 . . . . 4.2699999999999996 110.248 173.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 12.3 tptp -69.51 116.4 9.88 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.788 0.835 . . . . 3.4199999999999999 109.774 -175.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 23.9 mttt . . . . . 0 C--O 1.256 1.444 0 C-N-CA 128.649 2.779 . . . . 2.8900000000000001 104.232 -178.128 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 . . . . . 0 N--CA 1.45 -0.428 0 N-CA-C 109.261 -0.644 . . . . 2.1400000000000001 109.261 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -40.82 -55.07 2.54 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 124.096 0.958 . . . . 1.6599999999999999 110.866 175.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -59.63 -40.37 87.38 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 119.514 -0.279 . . . . 3.0899999999999999 110.814 -177.332 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.5 -44.78 93.35 Favored 'General case' 0 C--N 1.339 0.125 0 CA-C-N 118.532 0.606 . . . . 1.8100000000000001 110.678 178.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 93.8 t -58.58 -53.34 48.23 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.219 0 N-CA-C 109.157 -0.683 . . . . 1.6299999999999999 109.157 176.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 54.2 t -52.28 -48.92 43.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 N-CA-C 110.286 -0.264 . . . . 1.78 110.286 179.099 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 28.8 mm-40 -55.14 -18.45 5.72 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 126.05 1.74 . . . . 0.59999999999999998 114.041 174.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -150.36 50.65 0.89 Allowed 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 120.046 1.294 . . . . 2.8399999999999999 112.628 178.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.453 ' HZ3' ' CD ' ' A' ' 80' ' ' GLU . 0.0 OUTLIER -167.24 -37.34 0.02 OUTLIER 'General case' 0 C--O 1.225 -0.189 0 C-N-CA 126.056 1.742 . . . . 1.95 110.071 170.068 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 4.5 m -98.81 -52.79 3.48 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 119.431 1.014 . . . . 0.27000000000000002 111.423 -176.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.5 pp -54.69 -27.4 18.15 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.077 0 CA-C-N 115.878 -0.601 . . . . 1.79 111.763 -177.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.8 m -40.07 -37.04 0.55 Allowed 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 126.392 1.877 . . . . 1.8200000000000001 112.073 173.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 19.1 m -118.8 -40.08 2.9 Favored 'General case' 0 C--N 1.339 0.15 0 C-N-CA 123.115 0.566 . . . . 0.17999999999999999 111.927 173.1 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 83.3 m-70 -72.65 -7.57 50.99 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 112.852 0.686 . . . . 0.44 112.852 -175.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 86.12 151.35 17.55 Favored Glycine 0 C--N 1.336 0.579 0 N-CA-C 109.324 -1.51 . . . . 1.51 109.324 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -42.41 -36.62 2.26 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 125.019 1.295 . . . . 1.1699999999999999 112.928 178.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 44.5 m-20 -102.99 1.34 33.44 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.734 1.214 . . . . 2.1800000000000002 112.342 -172.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.9 mm? 64.12 21.67 12.64 Favored 'General case' 0 C--N 1.35 0.595 0 CA-C-N 120.482 1.492 . . . . 4.4500000000000002 111.415 179.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.2 p -84.68 -5.13 59.3 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 127.661 2.384 . . . . 1.5 110.016 179.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.27 131.6 3.8 Favored Glycine 0 N--CA 1.439 -1.1 0 N-CA-C 108.954 -1.658 . . . . 0.55000000000000004 108.954 -177.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -138.39 -79.97 0.34 Allowed 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.021 0.928 . . . . 1.6599999999999999 109.44 177.183 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 70.9 m -89.12 4.02 49.88 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.638 0.775 . . . . 2.3799999999999999 111.391 170.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -155.85 161.46 29.43 Favored Pre-proline 0 CA--C 1.535 0.373 0 C-N-CA 125.253 1.421 . . . . 1.45 107.823 -170.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -66.96 159.67 50.76 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 123.185 2.59 . . . . 0.38 111.164 -176.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.69 126.86 31.28 Favored 'General case' 0 C--N 1.331 -0.214 0 O-C-N 121.447 -0.783 . . . . 1.45 110.603 -175.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 25.4 pt -104.94 0.88 10.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 C-N-CA 123.27 0.628 . . . . 1.71 111.581 177.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -34.83 -48.03 0.37 Allowed 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.26 1.424 . . . . 2.46 113.595 172.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 29.5 pttt -106.92 22.76 15.46 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 124.143 0.977 . . . . 4.9699999999999998 112.017 -176.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -54.94 -42.63 72.54 Favored 'General case' 0 N--CA 1.45 -0.43 0 O-C-N 121.548 -0.72 . . . . 1.6000000000000001 110.261 -176.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -55.25 -25.77 41.24 Favored Glycine 0 CA--C 1.529 0.943 0 N-CA-C 114.603 0.601 . . . . 0.51000000000000001 114.603 179.086 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -84.62 -45.28 12.67 Favored 'General case' 0 CA--C 1.522 -0.119 0 CA-C-N 118.287 1.043 . . . . 1.6799999999999999 109.561 172.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -56.36 -46.75 79.85 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 119.555 -0.259 . . . . 2.6000000000000001 111.037 -178.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -145.38 151.41 38.23 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.738 1.615 . . . . 1.3200000000000001 108.71 -170.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 84.1 p -78.75 170.72 16.22 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 119.374 0.988 . . . . 3.0299999999999998 111.422 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -49.69 -44.27 47.95 Favored 'General case' 0 C--O 1.224 -0.274 0 CA-C-O 118.619 -0.705 . . . . 3.0499999999999998 111.491 174.03 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -56.91 -47.97 79.32 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 118.911 0.778 . . . . 2.3999999999999999 110.461 178.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -69.51 -47.23 64.5 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 109.129 -0.693 . . . . 3.27 109.129 -174.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 52.3 mt -59.0 -48.28 87.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 109.249 -0.649 . . . . 1.6399999999999999 109.249 179.587 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 41.3 tp -54.82 -50.32 68.86 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 123.668 0.787 . . . . 1.5600000000000001 109.076 178.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -55.01 -47.86 74.12 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 110.305 -0.258 . . . . 2.2799999999999998 110.305 175.838 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 46.7 mt -61.47 -33.82 58.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 O-C-N 121.018 -1.051 . . . . 1.76 111.812 178.427 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 75.8 mt -68.77 -48.17 72.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 O-C-N 120.157 -1.589 . . . . 1.6399999999999999 108.986 175.082 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 92.9 mt -69.37 -31.24 69.51 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.43 1.092 . . . . 1.6299999999999999 113.177 -176.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 22.3 m-20 -121.51 13.72 10.98 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 119.445 1.02 . . . . 1.77 109.735 -168.073 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 40.14 -146.78 0.27 Allowed Glycine 0 CA--C 1.54 1.654 0 C-N-CA 127.604 2.526 . . . . 0.63 111.325 -169.164 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 10.6 tt0 178.29 135.65 0.08 Allowed 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 125.104 1.362 . . . . 1.25 108.596 -177.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 37.77 -114.6 0.3 Allowed Glycine 0 CA--C 1.533 1.198 0 CA-C-N 119.86 1.209 . . . . 0.46000000000000002 113.361 -172.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -74.77 -20.53 79.46 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 123.289 0.471 . . . . 0.71999999999999997 113.064 -179.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 21.3 ttt -67.42 119.19 63.53 Favored Pre-proline 0 N--CA 1.452 -0.373 0 C-N-CA 124.269 1.028 . . . . 1.6899999999999999 110.662 179.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -76.22 123.93 7.52 Favored 'Trans proline' 0 N--CA 1.446 -1.321 0 C-N-CA 122.698 2.265 . . . . 2.1499999999999999 110.795 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -65.05 141.82 43.94 Favored Glycine 0 N--CA 1.442 -0.958 0 N-CA-C 115.349 0.9 . . . . 1.5900000000000001 115.349 -176.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 78.34 33.42 39.62 Favored Glycine 0 CA--C 1.524 0.649 0 CA-C-N 114.047 -1.077 . . . . 0.34999999999999998 110.84 175.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -56.53 -49.93 75.33 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 C-N-CA 124.407 1.083 . . . . 2.0899999999999999 109.022 173.486 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -111.95 154.02 25.89 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.411 1.485 . . . . 1.5 110.409 165.218 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 4.7 mmmt -139.02 158.71 43.71 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.197 1.799 . . . . 3.9500000000000002 109.896 179.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 56.13 -141.04 41.17 Favored Glycine 0 CA--C 1.528 0.892 0 N-CA-C 111.164 -0.775 . . . . 0.98999999999999999 111.164 178.025 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -51.23 -36.65 42.78 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 117.496 0.648 . . . . 2.0800000000000001 111.542 176.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.453 ' CD ' ' HZ3' ' A' ' 31' ' ' LYS . 18.5 tt0 -57.15 -37.0 71.41 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 122.892 0.477 . . . . 2.4100000000000001 110.023 178.499 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -82.94 -56.6 3.71 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.212 0.605 . . . . 1.5900000000000001 110.522 176.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -51.93 -52.21 51.68 Favored 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 124.543 1.137 . . . . 3.0600000000000001 112.076 -176.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.04 -47.45 83.07 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 109.644 -0.502 . . . . 1.52 109.644 -177.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 78.9 t -59.01 -56.37 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 C-N-CA 122.895 0.478 . . . . 1.6100000000000001 110.532 178.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -47.78 -56.12 8.11 Favored 'General case' 0 C--O 1.226 -0.146 0 C-N-CA 123.369 0.668 . . . . 1.3400000000000001 111.296 177.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.77 -45.75 92.54 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.371 0.669 . . . . 1.45 110.887 -176.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 79.1 t90 -57.04 -52.41 65.39 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 121.713 -0.617 . . . . 0.79000000000000004 109.722 177.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.74 -31.08 71.23 Favored 'General case' 0 C--O 1.223 -0.32 0 CA-C-O 118.603 -0.713 . . . . 2.98 112.654 175.818 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.08 -26.57 60.62 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 119.491 1.041 . . . . 1.49 111.534 172.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -90.81 -29.67 17.45 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 112.938 0.718 . . . . 4.9299999999999997 112.938 171.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 19.7 mtpp -74.64 103.95 5.13 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 119.721 1.146 . . . . 3.8799999999999999 110.633 174.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 20.2 pttt . . . . . 0 C--O 1.25 1.11 0 C-N-CA 126.298 1.839 . . . . 3.5099999999999998 106.354 -175.351 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.9 t70 . . . . . 0 N--CA 1.451 -0.398 0 N-CA-C 109.307 -0.627 . . . . 3.8300000000000001 109.307 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -52.9 -45.03 67.35 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 123.921 0.888 . . . . 1.53 111.608 -178.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -64.48 -48.91 73.43 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 108.195 -1.039 . . . . 3.3300000000000001 108.195 -176.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.97 -47.61 74.33 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 123.44 0.696 . . . . 1.5 111.333 177.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 74.1 t -55.97 -55.64 17.05 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.12 0 N-CA-C 109.525 -0.546 . . . . 1.6000000000000001 109.525 177.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 5.6 t -54.75 -49.4 68.91 Favored 'Isoleucine or valine' 0 C--O 1.239 0.525 0 CA-C-N 117.851 0.296 . . . . 1.8600000000000001 111.265 -178.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 35.8 mm-40 -52.65 -14.86 0.58 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 126.732 2.013 . . . . 0.46999999999999997 112.984 173.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.77 47.76 1.64 Allowed 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 119.469 1.031 . . . . 4.54 111.514 173.17 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.469 ' HZ3' ' CD ' ' A' ' 80' ' ' GLU . 0.0 OUTLIER -166.71 -42.7 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.16 0 O-C-N 121.915 -0.49 . . . . 1.9199999999999999 110.485 169.205 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 3.6 m -93.36 -48.45 6.41 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 118.284 0.493 . . . . 0.20999999999999999 110.026 -173.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.4 pp -51.65 -31.61 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 CA-C-N 115.977 -0.556 . . . . 1.7 111.962 -179.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 20.0 m -38.47 -37.31 0.3 Allowed 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 125.748 1.619 . . . . 1.6200000000000001 112.73 173.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 21.5 m -121.3 -40.01 2.63 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 123.069 0.548 . . . . 0.19 112.009 173.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 82.2 m-70 -71.79 -7.66 49.57 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.616 0.766 . . . . 0.28000000000000003 112.755 -177.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 84.44 148.29 9.16 Favored Glycine 0 C--N 1.337 0.602 0 N-CA-C 109.296 -1.522 . . . . 1.49 109.296 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -41.69 -35.11 1.35 Allowed Glycine 0 CA--C 1.527 0.843 0 C-N-CA 124.73 1.157 . . . . 1.24 112.496 174.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -95.39 -8.48 35.51 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 124.961 1.305 . . . . 2.3799999999999999 111.264 -169.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.3 mt 72.33 6.89 5.6 Favored 'General case' 0 C--N 1.348 0.534 0 CA-C-N 120.136 1.334 . . . . 2.3500000000000001 111.398 178.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 16.0 p -83.92 0.27 48.48 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 127.176 2.19 . . . . 1.54 110.102 -175.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.09 150.03 21.56 Favored Glycine 0 N--CA 1.436 -1.339 0 N-CA-C 108.855 -1.698 . . . . 0.53000000000000003 108.855 -173.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -156.33 -78.03 0.09 Allowed 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 124.609 1.164 . . . . 1.6699999999999999 108.863 177.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.0 m -97.37 2.63 50.77 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.448 1.099 . . . . 2.5800000000000001 111.216 170.063 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -148.14 162.05 32.19 Favored Pre-proline 0 CA--C 1.535 0.372 0 C-N-CA 126.999 2.12 . . . . 1.7 107.159 -176.191 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -71.26 163.15 40.13 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 123.219 2.613 . . . . 0.31 111.203 -176.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -74.93 113.58 12.4 Favored 'General case' 0 C--N 1.332 -0.19 0 O-C-N 121.73 -0.607 . . . . 1.51 111.235 -174.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 48.1 pt -97.07 0.66 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 C-N-CA 123.307 0.643 . . . . 1.5600000000000001 111.797 178.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -48.88 -34.9 13.54 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.154 0.581 . . . . 3.3399999999999999 112.319 176.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.2 pttm -115.43 38.66 3.18 Favored 'General case' 0 C--N 1.343 0.311 0 C-N-CA 124.82 1.248 . . . . 4.1699999999999999 111.216 175.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.73 -55.75 20.87 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 108.076 -1.083 . . . . 1.51 108.076 168.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -54.08 -27.0 36.91 Favored Glycine 0 C--N 1.339 0.717 0 C-N-CA 124.675 1.131 . . . . 0.64000000000000001 113.695 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.95 -38.44 75.97 Favored 'General case' 0 N--CA 1.449 -0.488 0 O-C-N 121.957 -0.731 . . . . 2.1000000000000001 111.446 175.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 47.3 m-80 -107.85 -57.73 2.06 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 124.318 1.047 . . . . 2.8999999999999999 110.819 -174.166 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -89.51 149.47 22.89 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 125.086 1.354 . . . . 1.3400000000000001 109.06 -174.297 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 60.7 m -94.29 164.11 13.16 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 122.961 0.505 . . . . 2.5 110.643 179.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.1 tm-20 -40.9 -64.39 0.54 Allowed 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.023 1.329 . . . . 5.6600000000000001 111.002 178.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -41.12 -47.02 3.14 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.936 1.294 . . . . 4.1100000000000003 112.905 174.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 61.1 mm-40 -69.55 -47.27 64.25 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 122.23 1.014 . . . . 3.3300000000000001 108.573 -174.456 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 61.5 mt -61.46 -44.18 98.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-N 115.948 -0.569 . . . . 1.6000000000000001 109.503 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 35.3 tp -55.31 -53.39 56.77 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 124.366 1.066 . . . . 1.72 109.163 175.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -49.72 -52.31 32.32 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 117.992 0.36 . . . . 1.53 110.389 175.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 87.4 mt -60.31 -37.65 74.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 119.744 -0.783 . . . . 1.55 111.557 179.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 60.5 mt -61.53 -46.81 95.78 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 O-C-N 120.041 -1.662 . . . . 1.79 109.851 173.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 85.6 mt -67.14 -32.17 73.1 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 117.179 -1.391 . . . . 1.75 114.479 -171.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -139.05 30.57 2.22 Favored 'General case' 0 C--N 1.344 0.362 0 CA-C-N 120.191 1.359 . . . . 3.2200000000000002 110.112 -171.119 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 35.08 -141.28 0.13 Allowed Glycine 0 CA--C 1.542 1.754 0 C-N-CA 128.122 2.772 . . . . 0.65000000000000002 112.81 -175.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 172.46 136.45 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.58 1.552 . . . . 1.95 108.022 -175.283 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 28.83 -106.7 0.01 OUTLIER Glycine 0 CA--C 1.534 1.222 0 C-N-CA 125.519 1.533 . . . . 0.59999999999999998 114.785 -176.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -66.07 -27.27 72.75 Favored Glycine 0 CA--C 1.537 1.428 0 CA-C-N 117.769 0.784 . . . . 0.83999999999999997 113.562 -178.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 15.8 ttt -76.47 123.04 87.69 Favored Pre-proline 0 CA--C 1.54 0.567 0 C-N-CA 125.888 1.675 . . . . 1.6399999999999999 110.683 -178.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -62.32 -56.66 0.63 Allowed 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 124.462 3.441 . . . . 3.0 111.781 -168.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 118.24 144.92 7.72 Favored Glycine 0 N--CA 1.449 -0.482 0 CA-C-N 115.795 -0.639 . . . . 2.2999999999999998 114.228 172.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 67.82 26.79 73.76 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.907 -0.877 . . . . 0.35999999999999999 110.907 -174.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 2.0 mm -52.01 -51.88 26.92 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 124.561 1.144 . . . . 3.3900000000000001 110.11 177.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -112.27 159.42 18.64 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.478 1.111 . . . . 1.6399999999999999 108.974 161.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 21.3 mttp -146.01 158.09 43.87 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.35 1.06 . . . . 4.5999999999999996 110.147 175.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 64.67 -153.35 49.66 Favored Glycine 0 CA--C 1.53 0.992 0 N-CA-C 111.343 -0.703 . . . . 1.05 111.343 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -45.61 -38.6 6.75 Favored 'General case' 0 C--N 1.34 0.186 0 C-N-CA 124.855 1.262 . . . . 1.72 112.154 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.469 ' CD ' ' HZ3' ' A' ' 31' ' ' LYS . 27.2 tt0 -50.51 -52.93 34.04 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.423 1.089 . . . . 2.1499999999999999 110.396 175.006 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -71.32 -48.0 53.19 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.649 0.78 . . . . 1.49 110.853 179.261 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -53.97 -50.67 66.02 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.826 0.85 . . . . 2.6699999999999999 110.708 -176.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -55.19 -49.54 71.64 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 123.071 0.548 . . . . 1.5700000000000001 110.286 178.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 53.8 t -58.12 -52.9 52.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 CA-C-O 119.343 -0.36 . . . . 1.74 110.986 178.499 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -49.26 -52.49 27.01 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 123.341 0.656 . . . . 1.6200000000000001 111.452 176.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.75 -51.88 67.45 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 121.46 0.648 . . . . 1.5800000000000001 110.215 -177.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 48.9 t90 -54.84 -43.18 72.82 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 122.757 0.423 . . . . 0.62 110.69 177.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.96 -37.73 86.76 Favored 'General case' 0 C--O 1.227 -0.118 0 C-N-CA 124.504 1.121 . . . . 2.7799999999999998 110.712 178.271 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -52.96 -42.75 65.79 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 119.0 0.818 . . . . 1.79 109.55 171.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -85.79 21.6 1.85 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.439 1.095 . . . . 4.1699999999999999 112.405 175.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 4.7 mtpm? -116.68 139.43 50.56 Favored 'General case' 0 C--N 1.342 0.253 0 CA-C-O 122.256 1.027 . . . . 3.2599999999999998 109.956 167.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 53.2 mttm . . . . . 0 C--O 1.25 1.116 0 C-N-CA 129.206 3.002 . . . . 4.5300000000000002 103.152 177.606 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 . . . . . 0 N--CA 1.449 -0.497 0 N-CA-C 108.475 -0.935 . . . . 2.3799999999999999 108.475 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -41.15 -54.54 2.86 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 124.554 1.141 . . . . 1.6699999999999999 110.708 175.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -58.39 -46.77 85.72 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 115.805 -0.634 . . . . 3.1600000000000001 110.272 -178.128 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.2 -44.51 92.24 Favored 'General case' 0 C--N 1.34 0.159 0 C-N-CA 123.125 0.57 . . . . 1.5700000000000001 111.147 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 77.8 t -57.81 -56.88 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 N-CA-C 109.279 -0.638 . . . . 1.51 109.279 175.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 71.7 t -54.0 -48.65 63.71 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 CA-C-N 117.933 0.333 . . . . 1.6200000000000001 110.494 -176.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 28.0 mm-40 -47.94 -24.69 1.1 Allowed 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 126.261 1.824 . . . . 0.64000000000000001 112.872 174.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -141.26 51.56 1.58 Allowed 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 119.144 0.884 . . . . 3.2200000000000002 111.642 173.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.467 ' HZ3' ' CD ' ' A' ' 80' ' ' GLU . 0.0 OUTLIER -162.68 -36.63 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 124.319 1.048 . . . . 1.96 111.211 166.722 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 3.8 m -101.89 -50.87 3.55 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 119.159 0.89 . . . . 0.27000000000000002 110.954 -174.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.2 pp -54.41 -29.37 19.92 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.082 0 CA-C-N 116.369 -0.378 . . . . 1.6100000000000001 111.949 -176.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 10.0 m -35.26 -41.71 0.17 Allowed 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 125.507 1.523 . . . . 1.6699999999999999 112.81 171.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 22.4 m -114.86 -35.63 4.73 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.294 0.638 . . . . 0.16 111.839 174.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 89.4 m-70 -80.66 2.09 27.28 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.226 1.01 . . . . 0.40000000000000002 113.314 -175.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 107.78 -80.96 0.28 Allowed Glycine 0 CA--C 1.525 0.668 0 C-N-CA 125.747 1.641 . . . . 2.8999999999999999 111.785 165.149 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -175.24 -52.51 0.06 OUTLIER Glycine 0 CA--C 1.519 0.304 0 N-CA-C 108.441 -1.864 . . . . 2.4900000000000002 108.441 -171.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -97.71 4.6 49.94 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 124.452 1.101 . . . . 3.3199999999999998 111.076 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.2 mt 76.15 14.33 2.51 Favored 'General case' 0 C--N 1.351 0.661 0 CA-C-N 119.85 1.205 . . . . 3.1400000000000001 110.007 -179.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.0 p -76.27 -13.37 60.16 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 128.11 2.564 . . . . 1.6399999999999999 109.822 -178.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.98 154.02 30.62 Favored Glycine 0 N--CA 1.442 -0.9 0 N-CA-C 108.449 -1.86 . . . . 0.68000000000000005 108.449 -178.356 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -156.8 -76.89 0.09 Allowed 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.457 -0.572 . . . . 1.28 109.457 177.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 19.6 t -93.55 4.17 54.37 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 122.854 0.462 . . . . 2.5499999999999998 110.483 172.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -157.53 163.01 26.25 Favored Pre-proline 0 N--CA 1.448 -0.56 0 C-N-CA 126.242 1.817 . . . . 1.6899999999999999 107.195 -166.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -67.72 162.85 37.6 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 123.044 2.496 . . . . 0.27000000000000002 111.193 -172.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -76.03 122.32 24.05 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 122.95 0.5 . . . . 1.5700000000000001 109.693 -178.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 47.9 pt -107.95 2.79 9.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 123.739 0.816 . . . . 1.72 112.063 178.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.444 ' OD1' ' NZ ' ' A' ' 91' ' ' LYS . 28.4 t70 -45.25 -45.99 12.24 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 113.125 0.787 . . . . 2.79 113.125 175.475 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.5 mptp? -100.92 26.62 6.74 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.999 1.32 . . . . 7.2599999999999998 109.837 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -52.9 -45.6 67.61 Favored 'General case' 0 N--CA 1.453 -0.277 0 O-C-N 121.345 -0.847 . . . . 1.6100000000000001 109.318 177.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -54.84 -22.26 26.1 Favored Glycine 0 CA--C 1.528 0.883 0 N-CA-C 115.021 0.768 . . . . 0.60999999999999999 115.021 177.047 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -81.54 -36.01 29.64 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 118.387 1.093 . . . . 1.8899999999999999 110.513 174.021 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -76.55 -48.55 18.96 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 123.08 0.552 . . . . 1.95 111.003 -178.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -141.21 143.97 34.47 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.699 1.6 . . . . 1.49 107.756 -167.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 69.7 m -83.91 169.86 14.62 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 119.57 1.077 . . . . 2.7400000000000002 111.096 178.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -51.03 -43.68 60.94 Favored 'General case' 0 C--O 1.222 -0.376 0 CA-C-O 118.602 -0.713 . . . . 2.73 112.681 -175.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -52.66 -45.69 66.84 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 119.057 0.844 . . . . 2.6600000000000001 111.055 176.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -71.17 -51.01 27.3 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 108.96 -0.756 . . . . 3.48 108.96 -176.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 71.5 mt -58.11 -44.9 88.36 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 N-CA-C 108.765 -0.828 . . . . 1.5800000000000001 108.765 -177.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 19.4 tp -56.27 -51.03 69.67 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 124.47 1.108 . . . . 1.95 109.401 177.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -53.92 -48.62 70.0 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 117.832 0.287 . . . . 1.46 111.345 175.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 93.0 mt -55.53 -54.88 20.8 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.211 0 O-C-N 121.526 -0.733 . . . . 1.54 109.443 177.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 52.2 mt -50.68 -46.54 28.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 O-C-N 120.807 -1.183 . . . . 1.6100000000000001 110.154 178.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 61.3 mt -64.17 -31.72 73.02 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 117.685 -1.15 . . . . 2.0899999999999999 113.541 178.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -131.63 20.09 4.69 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 120.278 1.399 . . . . 1.8100000000000001 111.109 -163.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 29.41 -141.0 0.02 OUTLIER Glycine 0 CA--C 1.543 1.809 0 C-N-CA 127.295 2.379 . . . . 0.67000000000000004 113.048 -160.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 37.4 tt0 174.63 141.72 0.05 OUTLIER 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 126.198 1.799 . . . . 1.8500000000000001 106.977 -176.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 22.25 -100.39 0.01 OUTLIER Glycine 0 CA--C 1.535 1.328 0 C-N-CA 126.094 1.807 . . . . 0.76000000000000001 114.822 -173.378 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -68.31 -34.08 79.31 Favored Glycine 0 CA--C 1.539 1.553 0 CA-C-N 118.802 1.301 . . . . 0.91000000000000003 113.485 -178.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -55.55 130.99 71.13 Favored Pre-proline 0 CA--C 1.539 0.538 0 C-N-CA 124.044 0.938 . . . . 1.55 112.282 176.616 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -63.8 -57.23 0.38 Allowed 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 123.895 3.063 . . . . 3.0299999999999998 110.857 178.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 116.74 146.68 8.52 Favored Glycine 0 C--N 1.335 0.497 0 C-N-CA 124.194 0.902 . . . . 2.2400000000000002 113.761 173.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 69.45 24.56 76.07 Favored Glycine 0 CA--C 1.529 0.952 0 N-CA-C 111.558 -0.617 . . . . 0.46000000000000002 111.558 -179.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.7 mt -52.61 -58.49 2.59 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 C-N-CA 126.212 1.805 . . . . 2.1499999999999999 110.982 179.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -103.48 158.33 16.43 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.162 0.985 . . . . 1.53 108.967 162.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 4.9 mmtp -145.12 166.36 25.63 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.574 1.55 . . . . 3.7999999999999998 108.783 179.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 56.94 -147.51 33.75 Favored Glycine 0 CA--C 1.532 1.135 0 O-C-N 121.741 -0.599 . . . . 0.83999999999999997 112.491 176.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -50.23 -36.94 33.09 Favored 'General case' 0 C--N 1.34 0.186 0 C-N-CA 123.809 0.843 . . . . 1.97 111.255 175.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.467 ' CD ' ' HZ3' ' A' ' 31' ' ' LYS . 5.0 tt0 -52.78 -51.55 60.24 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.802 0.841 . . . . 2.02 109.599 176.16 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -69.51 -52.05 30.11 Favored 'General case' 0 CA--C 1.53 0.209 0 O-C-N 122.035 -0.416 . . . . 1.51 111.477 177.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -50.77 -56.23 13.04 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 123.117 0.567 . . . . 2.5899999999999999 111.547 -177.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -55.38 -50.0 70.85 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 109.686 -0.487 . . . . 1.52 109.686 -175.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 54.4 t -55.26 -56.59 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 C-N-CA 123.006 0.522 . . . . 1.5700000000000001 111.395 176.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -52.6 -50.88 62.18 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.343 0.657 . . . . 1.6699999999999999 111.267 -178.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.79 -47.63 85.43 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.111 0.564 . . . . 1.3899999999999999 110.365 -179.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . 0.413 ' CE3' HD23 ' A' ' 88' ' ' LEU . 53.5 t90 -56.73 -50.44 72.21 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 121.991 -0.443 . . . . 0.65000000000000002 110.164 177.31 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.413 HD23 ' CE3' ' A' ' 87' ' ' TRP . 0.1 OUTLIER -60.77 -34.93 75.21 Favored 'General case' 0 C--O 1.226 -0.184 0 C-N-CA 124.31 1.044 . . . . 2.73 110.802 177.548 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -67.09 -40.74 87.02 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 118.187 0.448 . . . . 1.9399999999999999 110.978 176.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -61.39 -40.17 93.36 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 122.856 0.462 . . . . 4.1100000000000003 110.643 171.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.444 ' NZ ' ' OD1' ' A' ' 49' ' ' ASP . 0.0 OUTLIER -73.31 105.66 4.8 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 121.527 -0.733 . . . . 3.0099999999999998 110.169 178.983 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.163 0 CA-C-O 117.578 -1.201 . . . . 3.5 109.559 -177.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.446 -0.66 0 N-CA-C 108.153 -1.055 . . . . 2.2400000000000002 108.153 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -41.07 -55.14 2.66 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.747 1.219 . . . . 1.6100000000000001 111.519 177.197 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -51.87 -46.91 64.67 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 123.157 0.583 . . . . 2.98 111.785 176.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.67 -45.65 89.14 Favored 'General case' 0 N--CA 1.457 -0.104 0 CA-C-N 118.442 0.564 . . . . 1.3999999999999999 110.442 -177.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 72.8 t -57.07 -57.71 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 N-CA-C 109.007 -0.738 . . . . 1.54 109.007 175.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 25.6 t -47.92 -50.83 9.58 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 C-N-CA 124.305 1.042 . . . . 1.79 110.64 -178.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 30.8 mm-40 -53.1 -25.21 12.21 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 125.811 1.645 . . . . 0.56999999999999995 113.398 176.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 11.0 mt-30 -137.69 59.37 1.67 Allowed 'General case' 0 N--CA 1.456 -0.14 0 CA-C-N 119.309 0.959 . . . . 2.75 111.719 172.11 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 5.1 mttt -172.2 -36.46 0.01 OUTLIER 'General case' 0 C--O 1.224 -0.249 0 C-N-CA 124.204 1.002 . . . . 3.3700000000000001 110.322 168.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 4.0 m -101.22 -52.62 3.21 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 119.426 1.012 . . . . 0.22 111.312 -177.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.2 pp -55.83 -26.66 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.095 0 CA-C-N 115.99 -0.55 . . . . 1.6699999999999999 111.614 -177.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.1 t -40.17 -36.03 0.46 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.37 1.468 . . . . 2.8199999999999998 111.83 173.563 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 32.9 m -118.78 -40.06 2.91 Favored 'General case' 0 C--N 1.342 0.259 0 C-N-CA 123.539 0.736 . . . . 0.17000000000000001 111.908 174.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 87.1 m-70 -75.89 -7.11 53.75 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 113.171 0.804 . . . . 0.32000000000000001 113.171 -174.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 86.26 150.26 15.46 Favored Glycine 0 C--N 1.337 0.625 0 N-CA-C 110.034 -1.227 . . . . 1.55 110.034 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -43.56 -39.19 4.41 Favored Glycine 0 C--N 1.34 0.801 0 C-N-CA 124.76 1.172 . . . . 1.1399999999999999 112.338 178.259 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -97.65 -0.83 44.91 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 124.366 1.066 . . . . 2.21 110.959 -171.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.2 mp 67.41 15.8 9.93 Favored 'General case' 0 C--N 1.349 0.558 0 CA-C-N 120.11 1.323 . . . . 2.96 111.432 176.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 6.9 p -83.43 -1.73 54.18 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 128.132 2.573 . . . . 1.6599999999999999 109.906 -178.008 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.98 144.71 9.72 Favored Glycine 0 N--CA 1.438 -1.174 0 N-CA-C 108.552 -1.819 . . . . 0.40999999999999998 108.552 -175.076 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -150.15 -80.38 0.12 Allowed 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 124.406 1.083 . . . . 1.3 108.939 177.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 58.7 m -91.56 3.64 54.52 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.812 0.845 . . . . 2.3599999999999999 111.422 170.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -154.38 163.41 24.27 Favored Pre-proline 0 N--CA 1.45 -0.469 0 C-N-CA 125.88 1.672 . . . . 1.48 107.197 -172.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -68.27 163.89 34.53 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.618 2.212 . . . . 0.5 110.877 -176.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -74.27 122.74 23.33 Favored 'General case' 0 N--CA 1.455 -0.193 0 O-C-N 121.931 -0.481 . . . . 1.49 110.306 -177.047 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 35.3 pt -105.78 0.88 10.16 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.181 0 C-N-CA 123.713 0.805 . . . . 1.5700000000000001 110.917 177.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -39.32 -45.41 1.43 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.059 0.944 . . . . 2.3999999999999999 112.409 169.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.59 15.97 21.81 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.129 0.972 . . . . 5.6699999999999999 111.13 -175.18 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -56.39 -47.28 79.26 Favored 'General case' 0 N--CA 1.452 -0.326 0 O-C-N 121.198 -0.939 . . . . 1.6200000000000001 110.069 -171.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -54.7 -26.62 40.21 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 114.447 0.539 . . . . 0.46999999999999997 114.447 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -80.55 -42.05 23.06 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 117.815 0.808 . . . . 1.79 109.827 175.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 52.8 m-80 -63.5 -52.51 60.93 Favored 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 122.499 0.32 . . . . 1.6599999999999999 110.906 179.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -138.1 145.88 42.21 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 125.956 1.702 . . . . 1.9299999999999999 108.479 -167.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -79.96 170.82 15.94 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.543 0.737 . . . . 2.9100000000000001 110.571 -178.804 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -49.94 -46.53 52.29 Favored 'General case' 0 C--O 1.225 -0.185 0 C-N-CA 124.079 0.952 . . . . 2.6699999999999999 111.615 177.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -58.91 -29.72 67.28 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.237 0.615 . . . . 2.8399999999999999 112.093 179.369 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -86.7 -48.0 8.65 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.0 -0.741 . . . . 3.4100000000000001 109.0 -178.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 98.7 mt -61.36 -43.91 97.52 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 O-C-N 121.714 -0.616 . . . . 1.71 109.461 -179.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 60.0 tp -52.57 -51.06 61.58 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 109.197 -0.668 . . . . 1.6599999999999999 109.197 175.195 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -58.51 -44.52 89.51 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 110.113 -0.329 . . . . 1.6200000000000001 110.113 178.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 78.8 mt -60.2 -36.52 68.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 O-C-N 121.104 -0.997 . . . . 1.6599999999999999 111.498 176.048 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 50.9 mt -67.41 -49.37 72.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 O-C-N 120.03 -1.669 . . . . 1.6000000000000001 109.42 176.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 80.7 mt -66.74 -29.64 69.67 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 124.639 1.175 . . . . 1.6499999999999999 113.154 -175.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 14.3 m-80 -124.1 11.57 8.87 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 119.789 1.177 . . . . 1.77 110.157 -170.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.424 ' N ' ' HA2' ' A' ' 73' ' ' GLY . . . 43.12 -147.4 0.81 Allowed Glycine 0 CA--C 1.539 1.571 0 C-N-CA 126.623 2.059 . . . . 0.63 110.833 -171.465 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 170.45 135.49 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 119.524 1.662 . . . . 1.22 110.82 -178.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 43.63 -122.14 3.83 Favored Glycine 0 CA--C 1.532 1.149 0 O-C-N 120.685 -1.259 . . . . 0.52000000000000002 112.474 -173.088 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -69.08 -17.83 72.26 Favored Glycine 0 CA--C 1.531 1.046 0 O-C-N 122.483 -0.422 . . . . 0.57999999999999996 112.886 179.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 20.8 ttt -73.95 119.73 77.68 Favored Pre-proline 0 N--CA 1.451 -0.42 0 C-N-CA 123.838 0.855 . . . . 1.52 111.486 -178.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -78.08 120.88 5.14 Favored 'Trans proline' 0 N--CA 1.448 -1.172 0 C-N-CA 122.884 2.389 . . . . 2.1299999999999999 112.031 -177.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.424 ' HA2' ' N ' ' A' ' 67' ' ' GLY . . . -57.84 135.5 51.7 Favored Glycine 0 N--CA 1.445 -0.711 0 N-CA-C 116.421 1.328 . . . . 1.5800000000000001 116.421 -177.712 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 81.15 36.91 20.0 Favored Glycine 0 C--N 1.337 0.609 0 CA-C-N 114.124 -1.038 . . . . 0.34000000000000002 111.454 173.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.3 mt -57.96 -57.0 12.39 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 124.876 1.27 . . . . 2.2400000000000002 109.942 175.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -105.7 161.56 14.29 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.06 1.344 . . . . 1.47 109.508 167.16 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.0 mmtp -142.87 161.7 37.42 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.377 1.471 . . . . 3.54 110.466 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 55.55 -146.5 30.13 Favored Glycine 0 CA--C 1.531 1.04 0 O-C-N 121.596 -0.69 . . . . 0.89000000000000001 111.437 179.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -54.55 -28.91 49.04 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 117.157 0.479 . . . . 1.97 111.814 175.006 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -56.54 -39.08 72.78 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 109.827 -0.434 . . . . 2.29 109.827 174.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -82.41 -52.43 6.9 Favored 'General case' 0 CA--C 1.53 0.208 0 O-C-N 121.738 -0.601 . . . . 1.49 110.963 174.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -58.44 -48.67 79.96 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 122.87 0.468 . . . . 2.3199999999999998 112.077 -173.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.74 -48.15 80.43 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 109.363 -0.606 . . . . 1.51 109.363 179.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 49.6 t -55.38 -55.2 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 C-N-CA 123.065 0.546 . . . . 1.5700000000000001 110.952 177.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -52.48 -53.48 45.14 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 123.313 0.645 . . . . 1.3300000000000001 111.483 178.282 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.7 -48.61 81.0 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 121.772 0.796 . . . . 1.3999999999999999 110.934 -178.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 83.6 t90 -57.22 -47.84 80.3 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 123.466 0.707 . . . . 0.70999999999999996 110.084 178.427 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.02 -31.21 72.31 Favored 'General case' 0 C--O 1.221 -0.398 0 CA-C-O 118.167 -0.921 . . . . 2.8799999999999999 112.649 173.359 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -56.39 -43.08 78.92 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 119.76 1.164 . . . . 1.4199999999999999 109.898 171.068 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -68.0 -36.93 80.81 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 118.344 -0.836 . . . . 3.54 112.585 171.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 15.3 mtpp -72.11 113.43 9.13 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 120.35 1.432 . . . . 3.6000000000000001 110.847 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 77.3 mttt . . . . . 0 C--O 1.254 1.337 0 N-CA-C 104.953 -2.24 . . . . 2.8300000000000001 104.953 179.767 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 . . . . . 0 N--CA 1.45 -0.473 0 N-CA-C 108.312 -0.996 . . . . 2.1699999999999999 108.312 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -39.02 -54.26 1.7 Allowed 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 125.387 1.475 . . . . 1.6200000000000001 112.046 175.173 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -54.58 -48.86 71.59 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 116.108 -0.496 . . . . 2.6899999999999999 111.26 177.058 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.1 -36.57 82.14 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 118.96 0.8 . . . . 1.5900000000000001 111.932 -178.748 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 56.2 t -62.78 -58.46 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 N-CA-C 109.032 -0.729 . . . . 1.52 109.032 172.809 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.0 t -53.55 -48.71 58.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 C-N-CA 123.255 0.622 . . . . 1.6599999999999999 110.757 -175.738 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -49.35 -21.92 0.99 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 126.495 1.918 . . . . 0.52000000000000002 112.811 174.49 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -130.75 26.1 5.01 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.727 0.811 . . . . 5.8899999999999997 111.59 -179.807 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.3 mppp? -148.96 -66.85 0.22 Allowed 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 109.151 -0.685 . . . . 2.9300000000000002 109.151 171.718 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 2.0 m -71.76 -47.53 53.0 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.93 -0.396 . . . . 0.40000000000000002 109.93 -168.926 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.0 pp -56.12 -26.37 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.075 0 N-CA-C 111.899 0.333 . . . . 1.5900000000000001 111.899 -178.046 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.3 t -46.32 -36.0 5.89 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.376 1.071 . . . . 2.1299999999999999 110.699 177.727 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 28.9 m -116.82 -44.13 2.84 Favored 'General case' 0 C--N 1.34 0.178 0 C-N-CA 123.286 0.635 . . . . 0.20000000000000001 111.267 175.959 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 85.9 m-70 -71.09 -8.41 53.25 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.906 0.883 . . . . 0.29999999999999999 112.564 -176.194 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 88.25 152.19 24.03 Favored Glycine 0 C--N 1.337 0.606 0 N-CA-C 109.707 -1.357 . . . . 1.51 109.707 178.235 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -39.39 -39.43 1.13 Allowed Glycine 0 CA--C 1.528 0.877 0 C-N-CA 125.366 1.46 . . . . 1.1599999999999999 112.9 179.11 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -105.74 2.21 27.74 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.216 1.406 . . . . 2.23 112.241 -170.822 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.8 mm? 64.88 23.04 12.59 Favored 'General case' 0 C--N 1.348 0.531 0 CA-C-N 120.493 1.497 . . . . 4.54 111.127 -179.731 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.7 p -85.55 -3.73 58.95 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 128.23 2.612 . . . . 1.5700000000000001 109.992 179.277 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.52 139.75 5.68 Favored Glycine 0 N--CA 1.441 -0.969 0 N-CA-C 109.037 -1.625 . . . . 0.45000000000000001 109.037 -174.387 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -145.4 -73.87 0.24 Allowed 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 107.813 -1.18 . . . . 1.72 107.813 176.355 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.1 t -100.16 4.62 44.56 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.307 1.443 . . . . 2.4900000000000002 111.169 173.233 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -156.63 162.81 26.84 Favored Pre-proline 0 CA--C 1.537 0.451 0 C-N-CA 126.289 1.836 . . . . 1.6599999999999999 108.004 -168.773 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.22 153.16 40.54 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 123.271 2.647 . . . . 0.39000000000000001 111.414 -173.928 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -75.16 109.27 8.51 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.864 0.866 . . . . 1.6100000000000001 113.097 -170.136 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 43.7 pt -91.45 1.06 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 C-N-CA 125.8 1.64 . . . . 1.6399999999999999 111.793 -178.683 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -32.34 -48.59 0.18 Allowed 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 127.061 2.144 . . . . 2.79 113.044 164.226 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.51 36.83 3.25 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.955 0.902 . . . . 5.7199999999999998 111.537 176.328 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.11 -52.54 58.66 Favored 'General case' 0 N--CA 1.454 -0.257 0 O-C-N 121.146 -0.971 . . . . 1.74 108.849 176.236 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -52.33 -27.1 23.62 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 124.187 0.899 . . . . 0.54000000000000004 114.021 177.496 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.19 -38.24 88.37 Favored 'General case' 0 N--CA 1.452 -0.355 0 O-C-N 121.461 -1.023 . . . . 1.7 110.548 176.63 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 34.4 m-80 -103.83 -61.78 1.39 Allowed 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.798 1.239 . . . . 2.3500000000000001 109.835 -171.5 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -91.93 136.13 33.4 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.007 1.323 . . . . 1.6399999999999999 109.0 -174.896 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.7 t -80.69 166.91 20.6 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 118.102 0.41 . . . . 2.4399999999999999 110.632 -179.928 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -43.72 -55.85 4.16 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 124.384 1.074 . . . . 4.9000000000000004 109.856 177.352 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -57.01 -35.61 69.44 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.665 0.786 . . . . 3.3399999999999999 111.359 -176.187 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -74.15 -49.05 25.38 Favored 'General case' 0 C--N 1.343 0.302 0 O-C-N 121.243 -0.911 . . . . 2.9100000000000001 110.295 177.002 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 73.3 mt -58.56 -41.05 80.91 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.141 0 N-CA-C 108.375 -0.972 . . . . 1.6299999999999999 108.375 -177.538 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 27.0 tp -55.22 -54.58 41.65 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 123.759 0.823 . . . . 1.72 110.171 174.115 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -50.98 -48.02 61.33 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 118.104 0.411 . . . . 1.72 111.498 176.521 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 93.1 mt -59.01 -55.77 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 O-C-N 121.54 -0.725 . . . . 1.79 109.767 177.197 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 56.5 mt -47.61 -46.08 10.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 O-C-N 121.276 -0.89 . . . . 1.6299999999999999 110.192 178.976 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 69.5 mt -66.31 -36.4 82.84 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 113.503 0.927 . . . . 1.6699999999999999 113.503 178.537 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -127.65 27.35 5.79 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 120.085 1.312 . . . . 1.8400000000000001 110.418 -161.994 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 20.38 -130.47 0.01 OUTLIER Glycine 0 CA--C 1.539 1.585 0 C-N-CA 127.764 2.602 . . . . 0.65000000000000002 112.749 -159.592 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 165.62 136.04 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 126.801 2.04 . . . . 1.26 107.707 -176.768 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 27.57 -108.42 0.01 OUTLIER Glycine 0 CA--C 1.535 1.286 0 C-N-CA 126.053 1.787 . . . . 0.55000000000000004 114.714 -172.603 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -62.93 -28.22 71.59 Favored Glycine 0 CA--C 1.534 1.279 0 CA-C-N 117.694 0.747 . . . . 0.68999999999999995 113.467 -178.443 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 6.5 ttt -70.86 126.0 92.08 Favored Pre-proline 0 CA--C 1.539 0.547 0 C-N-CA 124.887 1.275 . . . . 1.48 110.364 -178.751 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -62.8 -55.03 0.93 Allowed 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 123.686 2.924 . . . . 2.9900000000000002 111.254 -172.71 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 116.94 147.23 8.59 Favored Glycine 0 C--N 1.334 0.457 0 C-N-CA 124.156 0.884 . . . . 2.29 113.19 175.028 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 69.73 24.4 76.32 Favored Glycine 0 CA--C 1.53 1.02 0 N-CA-C 111.524 -0.631 . . . . 0.46000000000000002 111.524 179.76 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.0 mm -55.87 -44.96 79.53 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.843 0 C-N-CA 125.51 1.524 . . . . 3.48 111.597 -178.919 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -113.6 160.51 18.48 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.003 1.321 . . . . 1.5600000000000001 108.843 161.021 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 5.0 ttmt -146.38 167.45 23.57 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 118.423 0.556 . . . . 3.5499999999999998 110.768 170.53 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 55.91 -148.61 27.48 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 111.092 -0.803 . . . . 0.92000000000000004 111.092 -179.595 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -49.53 -37.4 26.72 Favored 'General case' 0 C--N 1.341 0.204 0 C-N-CA 123.755 0.822 . . . . 1.8700000000000001 111.314 -178.709 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -50.69 -49.48 57.3 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 124.994 1.318 . . . . 2.0299999999999998 110.4 175.287 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -78.75 -48.6 14.56 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 123.233 0.613 . . . . 1.6599999999999999 111.375 178.953 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -53.7 -50.75 65.19 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.252 1.021 . . . . 2.23 110.623 -176.319 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.01 -48.9 78.64 Favored 'General case' 0 N--CA 1.455 -0.214 0 O-C-N 122.022 -0.424 . . . . 1.6200000000000001 110.144 177.893 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 56.0 t -55.54 -49.73 71.55 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 C-N-CA 122.783 0.433 . . . . 1.5 110.955 179.467 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -52.52 -53.17 49.66 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 123.331 0.652 . . . . 1.46 111.466 175.928 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.1 -48.26 82.25 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-O 121.417 0.627 . . . . 1.72 111.257 -179.736 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 47.8 t90 -56.05 -50.16 71.74 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.017 0.527 . . . . 0.55000000000000004 109.733 177.848 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.92 -34.61 74.96 Favored 'General case' 0 C--O 1.224 -0.279 0 C-N-CA 124.351 1.06 . . . . 2.7000000000000002 111.449 176.897 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.28 -42.57 98.87 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 119.009 0.822 . . . . 1.6899999999999999 110.095 173.332 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -59.66 -42.13 92.13 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.044 0.538 . . . . 3.0099999999999998 111.093 172.244 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 9.5 mtpp -71.85 130.8 41.94 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 118.545 0.611 . . . . 4.0300000000000002 110.357 -177.547 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 38.6 mttt . . . . . 0 C--O 1.25 1.102 0 N-CA-C 106.469 -1.678 . . . . 4.3200000000000003 106.469 -178.274 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 28.8 t0 . . . . . 0 N--CA 1.451 -0.417 0 N-CA-C 108.306 -0.998 . . . . 3.7200000000000002 108.306 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -47.69 -41.95 23.76 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.239 1.016 . . . . 1.6699999999999999 111.739 176.097 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -66.99 -52.64 40.2 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 107.73 -1.211 . . . . 3.3399999999999999 107.73 -176.75 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.99 -45.88 71.57 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.316 0.646 . . . . 1.78 111.484 178.483 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 64.0 t -56.57 -60.95 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 N-CA-C 109.181 -0.674 . . . . 1.74 109.181 176.148 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 46.2 t -55.81 -45.36 79.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 O-C-N 121.908 -0.495 . . . . 1.7 110.888 -175.969 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 23.2 mm-40 -49.78 -19.39 0.64 Allowed 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 126.968 2.107 . . . . 0.87 112.998 173.509 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 44.3 tt0 -139.69 35.06 2.0 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 119.012 0.823 . . . . 2.8500000000000001 111.367 173.372 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 67.9 mmtt -145.96 -56.92 0.3 Allowed 'General case' 0 CA--C 1.516 -0.358 0 O-C-N 121.211 -0.931 . . . . 3.3100000000000001 109.977 175.08 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 3.2 m -86.36 -49.71 7.45 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 109.213 -0.662 . . . . 0.37 109.213 -172.768 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.8 pp -56.23 -27.88 24.69 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.21 0 CA-C-N 115.739 -0.664 . . . . 1.8799999999999999 110.569 -178.106 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -36.78 -40.46 0.27 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.199 1.399 . . . . 2.1600000000000001 111.654 170.943 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 24.4 m -114.69 -35.72 4.76 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.792 0.837 . . . . 0.37 112.127 172.794 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 92.2 m-70 -80.59 3.56 21.43 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 125.065 1.346 . . . . 0.33000000000000002 113.13 -175.115 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 112.46 -92.58 0.64 Allowed Glycine 0 CA--C 1.528 0.856 0 C-N-CA 126.396 1.951 . . . . 2.98 112.511 164.747 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -162.45 -47.82 0.02 OUTLIER Glycine 0 CA--C 1.522 0.519 0 N-CA-C 108.815 -1.714 . . . . 2.21 108.815 -173.306 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -102.21 7.24 40.89 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 126.099 1.759 . . . . 3.4900000000000002 111.395 176.643 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 76.28 13.34 2.56 Favored 'General case' 0 C--N 1.35 0.597 0 CA-C-N 120.006 1.276 . . . . 3.3199999999999998 111.056 179.562 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 35.5 p -75.41 -10.79 59.77 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 126.953 2.101 . . . . 1.8300000000000001 110.112 -175.777 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.84 147.11 22.14 Favored Glycine 0 N--CA 1.444 -0.817 0 N-CA-C 108.653 -1.779 . . . . 0.58999999999999997 108.653 -177.396 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -154.23 -81.36 0.08 Allowed 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 123.181 0.593 . . . . 1.3300000000000001 109.525 177.264 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 5.4 m -89.31 2.8 53.83 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.752 0.821 . . . . 1.8999999999999999 110.862 171.451 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -152.71 162.73 25.65 Favored Pre-proline 0 N--CA 1.45 -0.459 0 C-N-CA 125.77 1.628 . . . . 1.4299999999999999 107.256 -172.344 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -66.74 163.95 31.2 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 122.545 2.163 . . . . 0.40000000000000002 110.905 -175.378 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.87 123.35 24.05 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 109.33 -0.618 . . . . 1.6599999999999999 109.33 -178.89 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 49.8 pt -107.14 1.95 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 C-N-CA 123.544 0.737 . . . . 1.6100000000000001 111.424 176.85 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 18.4 p-10 -34.08 -49.92 0.37 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.382 1.473 . . . . 3.7599999999999998 112.21 167.739 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 18.1 pttt -109.9 34.7 3.71 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 125.086 1.354 . . . . 5.4299999999999997 112.433 -179.924 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.13 -46.04 91.0 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 109.473 -0.566 . . . . 1.51 109.473 173.242 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -54.88 -32.58 55.73 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 123.154 0.407 . . . . 0.56000000000000005 113.455 -176.829 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.32 -40.01 62.49 Favored 'General case' 0 CA--C 1.529 0.142 0 O-C-N 121.947 -0.737 . . . . 1.6699999999999999 110.908 174.689 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 19.5 m-80 -65.71 -52.86 47.98 Favored 'General case' 0 C--O 1.227 -0.088 0 N-CA-C 110.384 -0.228 . . . . 1.6899999999999999 110.384 -179.788 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -136.07 144.28 45.1 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.035 1.334 . . . . 1.26 108.401 -168.584 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 4.9 m -74.03 167.58 21.24 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 118.268 0.486 . . . . 2.48 110.38 177.626 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.8 pm0 -49.83 -41.68 45.54 Favored 'General case' 0 C--O 1.225 -0.232 0 C-N-CA 123.731 0.813 . . . . 2.6499999999999999 111.354 -179.476 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -56.62 -44.3 81.06 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.775 0.83 . . . . 3.0899999999999999 109.966 179.578 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -78.21 -43.65 27.88 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.07 0.948 . . . . 2.79 109.55 -174.481 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 76.2 mt -59.83 -48.34 88.04 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 O-C-N 121.094 -1.004 . . . . 1.6499999999999999 108.749 176.606 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 33.5 tp -55.7 -45.33 77.88 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 109.193 -0.669 . . . . 1.79 109.193 178.425 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -47.22 -56.71 6.19 Favored 'General case' 0 N--CA 1.453 -0.302 0 O-C-N 124.108 0.88 . . . . 1.6399999999999999 109.328 172.449 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 43.7 mt -61.78 -45.78 97.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 117.827 -1.549 . . . . 2.3100000000000001 111.999 179.851 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 85.9 mt -52.6 -48.66 47.43 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 O-C-N 119.693 -1.879 . . . . 1.75 110.296 -179.023 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 88.3 mt -72.95 -31.94 64.91 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 123.416 0.687 . . . . 2.0 111.886 178.144 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 45.8 m-20 -129.18 46.91 2.55 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 107.699 -1.223 . . . . 1.8 107.699 -163.198 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -40.67 106.25 0.06 OUTLIER Glycine 0 CA--C 1.534 1.244 0 C-N-CA 125.838 1.685 . . . . 3.25 111.476 -171.256 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 -87.86 165.19 15.46 Favored 'General case' 0 N--CA 1.435 -1.212 0 C-N-CA 127.466 2.306 . . . . 3.4399999999999999 109.382 -175.307 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 57.4 -127.81 45.86 Favored Glycine 0 CA--C 1.529 0.943 0 N-CA-C 111.521 -0.631 . . . . 1.1000000000000001 111.521 174.385 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -73.79 -25.55 71.62 Favored Glycine 0 CA--C 1.53 0.979 0 CA-C-N 117.096 0.448 . . . . 1.02 112.131 179.799 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 5.5 ttt -63.44 137.22 97.02 Favored Pre-proline 0 CA--C 1.54 0.566 0 O-C-N 121.914 -0.757 . . . . 1.6299999999999999 109.741 178.849 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -74.35 -54.19 0.1 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.844 2.362 . . . . 2.8599999999999999 111.233 -177.234 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 113.73 149.81 10.31 Favored Glycine 0 C--N 1.335 0.515 0 C-N-CA 123.849 0.738 . . . . 2.3700000000000001 112.785 177.321 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 67.25 24.4 73.46 Favored Glycine 0 CA--C 1.531 1.092 0 CA-C-N 114.906 -0.647 . . . . 0.39000000000000001 112.146 176.727 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -55.5 -51.62 55.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 125.936 1.694 . . . . 2.0499999999999998 110.877 177.784 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -104.99 149.08 26.06 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 125.171 1.389 . . . . 1.6699999999999999 108.101 169.768 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 2.9 mtpm? -146.25 153.13 40.24 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.966 0.907 . . . . 5.1600000000000001 111.441 -178.431 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 71.76 -162.64 54.38 Favored Glycine 0 CA--C 1.532 1.131 0 N-CA-C 110.638 -0.985 . . . . 1.1899999999999999 110.638 -170.311 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -50.83 -26.72 6.09 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.823 1.249 . . . . 2.0699999999999998 112.607 -178.702 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 51.7 tt0 -40.93 -62.34 0.83 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.081 1.352 . . . . 2.1000000000000001 110.508 168.142 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -62.77 -46.85 86.13 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 122.816 0.446 . . . . 1.46 110.666 -174.688 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -51.12 -56.85 10.62 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 123.71 0.804 . . . . 1.9399999999999999 111.06 175.705 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -56.34 -47.57 78.52 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 109.429 -0.582 . . . . 1.54 109.429 -177.682 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 53.3 t -57.93 -53.66 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 N-CA-C 111.774 0.287 . . . . 1.55 111.774 177.49 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -52.38 -52.69 52.23 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 123.214 0.605 . . . . 1.3200000000000001 111.306 179.028 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.76 -49.48 77.49 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 121.415 0.626 . . . . 1.55 110.134 179.189 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . 0.413 ' CE3' HD23 ' A' ' 88' ' ' LEU . 46.3 t90 -53.63 -48.76 69.05 Favored 'General case' 0 N--CA 1.451 -0.413 0 O-C-N 121.69 -0.631 . . . . 0.64000000000000001 110.378 177.473 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.413 HD23 ' CE3' ' A' ' 87' ' ' TRP . 0.1 OUTLIER -61.58 -34.68 76.02 Favored 'General case' 0 C--O 1.227 -0.123 0 C-N-CA 124.394 1.078 . . . . 2.79 111.004 177.206 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -52.58 -47.11 67.07 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 118.889 0.768 . . . . 1.49 109.972 170.989 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -83.22 26.08 0.66 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.404 0.682 . . . . 5.0599999999999996 112.597 173.686 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 8.1 mtpm? -125.69 120.99 32.17 Favored 'General case' 0 C--N 1.341 0.197 0 CA-C-N 119.775 1.171 . . . . 3.0099999999999998 110.017 167.043 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.438 -1.043 0 C-N-CA 127.397 2.279 . . . . 3.23 105.1 173.933 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 N--CA 1.445 -0.697 0 N-CA-C 108.049 -1.093 . . . . 2.1800000000000002 108.049 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -40.41 -55.66 2.2 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 125.087 1.355 . . . . 1.6299999999999999 111.732 177.697 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -52.93 -47.0 68.35 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 123.012 0.525 . . . . 2.75 111.78 177.287 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.07 -46.44 87.46 Favored 'General case' 0 N--CA 1.458 -0.06 0 CA-C-N 118.494 0.588 . . . . 1.6499999999999999 110.468 -178.233 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 69.8 t -55.33 -54.73 21.87 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.252 0 N-CA-C 109.221 -0.659 . . . . 1.6100000000000001 109.221 175.274 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 34.1 t -56.66 -48.41 80.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 C-N-CA 123.375 0.67 . . . . 1.6499999999999999 110.531 -175.14 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 36.4 mm-40 -51.42 -21.63 2.46 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.913 1.685 . . . . 0.48999999999999999 112.78 172.373 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -136.81 49.42 2.06 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 119.151 0.887 . . . . 3.75 111.705 178.104 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -168.5 -59.18 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.183 0 N-CA-C 108.112 -1.07 . . . . 2.4100000000000001 108.112 168.163 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 3.6 m -75.54 -51.55 12.67 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 120.862 0.363 . . . . 0.28999999999999998 110.655 -170.231 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.2 pp -55.01 -26.58 17.88 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.165 0 CA-C-N 115.838 -0.619 . . . . 1.6000000000000001 111.697 -179.225 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.7 t -43.61 -34.72 1.51 Allowed 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.034 0.933 . . . . 2.96 111.867 175.051 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 28.7 m -117.03 -37.34 3.59 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.482 0.713 . . . . 0.22 111.706 172.774 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -78.92 2.31 20.62 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.35 1.06 . . . . 0.27000000000000002 113.0 -175.921 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 112.1 -85.63 0.4 Allowed Glycine 0 C--N 1.34 0.755 0 C-N-CA 125.676 1.607 . . . . 3.0 112.196 162.609 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -171.23 -50.23 0.04 OUTLIER Glycine 0 CA--C 1.518 0.242 0 N-CA-C 108.452 -1.859 . . . . 2.3599999999999999 108.452 -171.906 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -102.0 4.91 40.38 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.711 1.204 . . . . 3.0899999999999999 111.504 179.38 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 5.2 mt 80.16 15.29 0.8 Allowed 'General case' 0 C--N 1.354 0.761 0 CA-C-N 120.392 1.451 . . . . 2.3799999999999999 110.206 -178.903 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.4 p -80.75 -9.4 59.81 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 128.34 2.656 . . . . 1.77 110.002 -175.906 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.56 161.27 36.95 Favored Glycine 0 N--CA 1.442 -0.908 0 N-CA-C 108.995 -1.642 . . . . 0.92000000000000004 108.995 -174.691 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -164.8 -72.94 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 124.503 1.121 . . . . 1.8400000000000001 108.187 174.066 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 30.3 m -101.73 3.14 39.31 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.398 1.079 . . . . 1.96 110.857 174.202 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -152.14 160.87 30.8 Favored Pre-proline 0 CA--C 1.536 0.417 0 C-N-CA 126.456 1.902 . . . . 1.52 107.092 -171.599 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.46 158.8 55.38 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 123.115 2.544 . . . . 0.28999999999999998 110.942 -175.046 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -74.01 120.63 19.85 Favored 'General case' 0 N--CA 1.454 -0.229 0 O-C-N 121.887 -0.508 . . . . 1.54 109.871 -176.749 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 25.3 pt -100.32 2.64 10.6 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 C-N-CA 123.475 0.71 . . . . 1.5600000000000001 111.679 177.728 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -36.28 -44.89 0.43 Allowed 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.215 1.406 . . . . 2.5299999999999998 113.668 171.49 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 8.3 mtpt -111.36 26.23 10.88 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.371 1.068 . . . . 4.5300000000000002 111.324 -177.542 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -58.31 -43.24 88.07 Favored 'General case' 0 N--CA 1.453 -0.317 0 O-C-N 121.631 -0.668 . . . . 1.48 110.205 179.923 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -54.13 -23.58 25.24 Favored Glycine 0 CA--C 1.53 0.98 0 CA-C-N 118.299 0.5 . . . . 0.5 114.344 179.172 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -88.03 -41.56 13.01 Favored 'General case' 0 N--CA 1.457 -0.123 0 CA-C-N 118.123 0.962 . . . . 1.5900000000000001 109.818 175.849 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -56.85 -53.41 58.18 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 122.529 0.331 . . . . 2.02 110.801 176.504 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -139.15 154.61 48.11 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.677 1.191 . . . . 1.3600000000000001 109.229 -170.576 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 2.1 p -80.07 167.37 20.5 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.793 0.837 . . . . 3.2200000000000002 110.927 178.434 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -46.63 -46.22 19.66 Favored 'General case' 0 C--O 1.224 -0.258 0 C-N-CA 124.473 1.109 . . . . 2.7400000000000002 111.319 176.703 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -58.72 -40.83 84.84 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.285 0.634 . . . . 2.8100000000000001 110.638 -177.941 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -76.78 -47.93 20.16 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 108.877 -0.786 . . . . 3.0099999999999998 108.877 -175.393 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 83.1 mt -59.58 -42.96 89.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 N-CA-C 109.087 -0.709 . . . . 1.6599999999999999 109.087 178.666 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.8 tp -54.04 -52.91 59.36 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 109.383 -0.599 . . . . 1.55 109.383 175.954 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -50.51 -51.27 49.09 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 118.064 0.393 . . . . 1.6499999999999999 110.824 175.004 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 60.9 mt -61.72 -30.57 48.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 O-C-N 121.574 -0.704 . . . . 1.5600000000000001 112.307 -179.036 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 49.2 mt -69.99 -49.3 57.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 O-C-N 120.381 -1.449 . . . . 1.52 109.08 173.313 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 86.3 mt -67.39 -34.16 76.7 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 124.437 1.095 . . . . 1.53 113.354 -174.448 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -123.37 20.39 9.65 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 119.717 1.144 . . . . 1.8300000000000001 110.224 -166.644 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 32.24 -141.23 0.05 OUTLIER Glycine 0 CA--C 1.543 1.827 0 C-N-CA 127.039 2.256 . . . . 0.64000000000000001 112.207 -164.642 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 39.5 tt0 170.72 137.45 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 119.588 1.694 . . . . 1.6699999999999999 109.243 -176.736 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 38.1 -114.85 0.34 Allowed Glycine 0 CA--C 1.531 1.067 0 CA-C-N 120.04 1.291 . . . . 0.46999999999999997 113.291 -177.008 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -69.26 -25.04 75.79 Favored Glycine 0 CA--C 1.534 1.25 0 CA-C-N 117.263 0.532 . . . . 0.55000000000000004 113.233 179.566 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 16.8 ttt -70.27 120.21 76.92 Favored Pre-proline 0 CA--C 1.539 0.532 0 C-N-CA 124.492 1.117 . . . . 1.51 110.058 -179.591 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -62.5 -55.89 0.8 Allowed 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 124.249 3.299 . . . . 2.9100000000000001 111.578 -168.965 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 118.2 149.13 8.7 Favored Glycine 0 N--CA 1.449 -0.489 0 CA-C-N 115.857 -0.61 . . . . 2.3500000000000001 114.124 172.429 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 67.41 21.65 72.52 Favored Glycine 0 CA--C 1.532 1.111 0 CA-C-N 114.782 -0.709 . . . . 0.52000000000000002 111.686 -179.845 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 2.0 mt -52.53 -44.54 45.18 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 C-N-CA 126.872 2.069 . . . . 2.0600000000000001 110.98 178.211 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -114.82 159.95 20.03 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.817 1.247 . . . . 1.6200000000000001 110.311 161.775 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 19.3 mmtp -141.92 159.95 41.2 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.972 1.709 . . . . 2.96 110.28 -179.343 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 56.3 -142.94 38.8 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 111.426 -0.669 . . . . 0.98999999999999999 111.426 176.027 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -50.07 -35.98 27.42 Favored 'General case' 0 C--N 1.341 0.22 0 C-N-CA 123.661 0.785 . . . . 1.8300000000000001 111.592 174.753 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -57.9 -33.11 68.4 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.61 0.764 . . . . 2.1000000000000001 110.795 178.782 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -91.97 -53.2 4.37 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.613 0.765 . . . . 1.45 110.882 175.415 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -50.15 -54.49 20.39 Favored 'General case' 0 N--CA 1.461 0.105 0 C-N-CA 124.563 1.145 . . . . 2.1099999999999999 111.544 -179.533 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.25 -44.75 92.36 Favored 'General case' 0 C--O 1.225 -0.236 0 N-CA-C 109.588 -0.523 . . . . 1.54 109.588 -178.522 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 54.7 t -58.16 -53.75 41.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 C-N-CA 122.772 0.429 . . . . 1.6899999999999999 111.1 179.451 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -53.17 -52.33 59.15 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 123.081 0.552 . . . . 1.4099999999999999 111.533 174.921 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.2 -38.62 83.88 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.515 0.726 . . . . 1.6200000000000001 111.155 -178.216 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 73.7 t90 -67.86 -51.08 52.4 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 123.82 0.848 . . . . 0.58999999999999997 109.578 177.637 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.46 -30.33 69.6 Favored 'General case' 0 C--O 1.223 -0.318 0 O-C-N 121.363 -0.836 . . . . 2.9399999999999999 112.143 175.91 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -55.31 -38.91 69.29 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 119.592 1.087 . . . . 1.6000000000000001 110.836 170.9 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -68.54 -41.81 79.32 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 118.588 -0.72 . . . . 3.1000000000000001 110.92 170.908 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.6 mtpm? -72.86 106.34 4.75 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 119.173 0.897 . . . . 2.79 110.384 -174.587 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 4.4 mtmp? . . . . . 0 C--O 1.25 1.084 0 C-N-CA 126.233 1.813 . . . . 3.0499999999999998 106.51 179.374 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 . . . . . 0 N--CA 1.449 -0.514 0 N-CA-C 108.509 -0.923 . . . . 2.5699999999999998 108.509 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -43.3 -52.07 5.95 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 124.335 1.054 . . . . 1.47 111.012 176.101 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -57.91 -47.14 83.7 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 116.287 -0.415 . . . . 2.6800000000000002 110.401 179.938 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.07 -45.1 94.0 Favored 'General case' 0 N--CA 1.461 0.098 0 CA-C-N 118.472 0.578 . . . . 1.73 110.891 -178.874 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 79.5 t -57.49 -57.25 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 108.93 -0.767 . . . . 1.5600000000000001 108.93 176.884 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 35.7 t -55.24 -46.04 77.79 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 C-N-CA 121.213 -0.195 . . . . 1.6100000000000001 111.011 -176.762 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 26.3 mm-40 -49.98 -25.94 3.79 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 125.794 1.638 . . . . 0.5 112.808 173.769 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -140.66 67.23 1.36 Allowed 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 119.06 0.846 . . . . 3.3599999999999999 112.001 171.4 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.418 ' HZ3' ' CD ' ' A' ' 80' ' ' GLU . 0.1 OUTLIER -178.22 -36.11 0.01 OUTLIER 'General case' 0 C--O 1.225 -0.221 0 C-N-CA 124.812 1.245 . . . . 1.97 109.202 169.627 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 2.7 m -103.95 -53.79 2.68 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 119.339 0.972 . . . . 0.31 111.13 -177.649 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.0 pp -55.26 -27.88 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 CA-C-N 115.9 -0.591 . . . . 1.78 111.386 -176.302 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.3 m -35.21 -42.12 0.18 Allowed 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 125.358 1.463 . . . . 1.77 112.633 170.244 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 18.2 m -112.66 -34.74 5.72 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.655 0.782 . . . . 0.23000000000000001 111.706 174.14 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 92.5 m-70 -82.0 5.21 19.99 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.446 1.098 . . . . 0.34999999999999998 113.409 -175.351 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 107.22 -91.05 0.68 Allowed Glycine 0 CA--C 1.525 0.667 0 C-N-CA 126.57 2.033 . . . . 2.8700000000000001 111.961 166.312 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -167.63 -47.37 0.03 OUTLIER Glycine 0 CA--C 1.519 0.316 0 N-CA-C 108.792 -1.723 . . . . 2.3700000000000001 108.792 -172.446 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -102.88 6.42 39.08 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.935 1.294 . . . . 4.0999999999999996 111.158 178.675 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.5 mt 78.49 10.32 1.89 Allowed 'General case' 0 C--N 1.354 0.798 0 CA-C-N 120.075 1.307 . . . . 2.2999999999999998 110.352 177.441 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.1 p -74.81 -10.26 59.34 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 128.62 2.768 . . . . 1.54 109.629 -179.69 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.64 159.11 34.3 Favored Glycine 0 N--CA 1.444 -0.822 0 N-CA-C 109.269 -1.532 . . . . 0.84999999999999998 109.269 -177.017 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -160.67 -79.82 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 124.334 1.054 . . . . 1.3100000000000001 108.653 175.692 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 58.5 m -91.55 2.24 56.58 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.474 0.709 . . . . 1.9399999999999999 110.966 173.437 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -154.35 164.8 19.6 Favored Pre-proline 0 N--CA 1.448 -0.544 0 C-N-CA 125.245 1.418 . . . . 1.6299999999999999 108.038 -169.672 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -67.42 159.75 50.95 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 123.002 2.468 . . . . 0.38 111.243 -173.696 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -74.75 115.56 14.47 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.073 0.549 . . . . 1.49 109.999 -177.593 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 32.2 pt -102.55 2.5 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 C-N-CA 124.342 1.057 . . . . 2.0099999999999998 111.528 179.549 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -34.3 -48.87 0.36 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.28 1.432 . . . . 2.2599999999999998 112.427 167.49 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 10.0 pttt -109.19 26.26 10.83 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.58 0.752 . . . . 4.1299999999999999 111.812 -176.458 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -51.55 -44.3 62.66 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 118.927 -0.559 . . . . 1.45 109.8 178.287 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -52.84 -25.72 23.82 Favored Glycine 0 CA--C 1.529 0.952 0 N-CA-C 114.566 0.586 . . . . 0.46000000000000002 114.566 177.692 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -82.44 -42.36 18.66 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 118.076 0.938 . . . . 1.78 109.49 175.67 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 36.1 m120 -63.69 -48.41 77.22 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 122.574 0.35 . . . . 3.2400000000000002 110.564 -179.471 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -144.2 145.62 32.18 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.547 1.539 . . . . 1.77 108.553 -169.925 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 19.6 m -75.33 169.17 18.57 Favored 'General case' 0 CA--C 1.532 0.284 0 O-C-N 121.542 -0.724 . . . . 2.2799999999999998 111.198 179.132 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -44.17 -56.03 4.38 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 123.337 0.655 . . . . 4.7699999999999996 110.735 174.182 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -53.13 -29.96 34.03 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 112.724 0.638 . . . . 2.96 112.724 -178.406 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 53.6 mm-40 -86.83 -48.85 7.86 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.709 0.804 . . . . 3.0299999999999998 109.789 -178.315 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 84.0 mt -57.6 -46.5 86.33 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.097 0 O-C-N 121.114 -0.991 . . . . 1.6599999999999999 108.73 178.143 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 46.6 tp -52.97 -47.55 68.08 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 123.618 0.767 . . . . 1.55 109.274 176.543 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -55.45 -46.99 76.72 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 118.244 0.474 . . . . 2.21 110.705 175.099 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 47.7 mt -60.51 -36.7 71.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 O-C-N 121.444 -0.785 . . . . 1.5600000000000001 110.996 176.728 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 58.5 mt -69.21 -42.22 81.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 O-C-N 119.864 -1.773 . . . . 1.53 109.939 178.816 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 71.3 mt -76.65 -26.53 54.97 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.815 1.246 . . . . 1.8 112.891 -176.715 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 28.8 m-80 -124.85 14.43 8.59 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 119.584 1.084 . . . . 1.76 109.989 -172.044 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.431 ' N ' ' HA2' ' A' ' 73' ' ' GLY . . . 40.43 -139.99 1.13 Allowed Glycine 0 CA--C 1.537 1.451 0 C-N-CA 126.614 2.054 . . . . 0.64000000000000001 110.994 -171.885 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 168.48 127.1 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.602 1.561 . . . . 1.7 110.41 179.152 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 42.13 -115.87 0.97 Allowed Glycine 0 C--N 1.346 1.092 0 CA-C-N 120.283 1.402 . . . . 0.78000000000000003 113.294 -178.145 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -64.54 -22.06 67.45 Favored Glycine 0 CA--C 1.532 1.097 0 CA-C-N 117.349 0.574 . . . . 0.68000000000000005 112.53 -179.54 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 21.5 ttt -80.32 118.93 74.79 Favored Pre-proline 0 N--CA 1.45 -0.442 0 C-N-CA 124.878 1.271 . . . . 1.48 111.433 -179.35 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -77.83 122.77 6.0 Favored 'Trans proline' 0 N--CA 1.448 -1.193 0 C-N-CA 122.645 2.23 . . . . 2.0499999999999998 112.066 -178.515 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.431 ' HA2' ' N ' ' A' ' 67' ' ' GLY . . . -57.26 131.28 51.97 Favored Glycine 0 N--CA 1.444 -0.817 0 N-CA-C 115.348 0.899 . . . . 1.6699999999999999 115.348 179.376 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 87.55 40.63 6.74 Favored Glycine 0 C--N 1.338 0.678 0 CA-C-N 114.342 -0.929 . . . . 0.48999999999999999 112.008 172.687 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 2.4 mt -66.92 -61.44 1.69 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 124.691 1.196 . . . . 2.2400000000000002 109.925 176.616 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -98.36 161.35 13.73 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.632 1.173 . . . . 1.53 109.705 167.613 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.0 mttm -146.81 164.34 33.14 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 125.085 1.354 . . . . 3.2999999999999998 110.71 176.828 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 52.7 -146.32 17.4 Favored Glycine 0 CA--C 1.529 0.92 0 N-CA-C 111.383 -0.687 . . . . 0.88 111.383 -178.527 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -53.12 -31.49 42.39 Favored 'General case' 0 C--O 1.225 -0.215 0 C-N-CA 122.942 0.497 . . . . 1.8500000000000001 111.295 177.432 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.418 ' CD ' ' HZ3' ' A' ' 31' ' ' LYS . 3.9 tt0 -53.61 -46.1 70.3 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 123.299 0.64 . . . . 2.3199999999999998 110.168 174.398 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -78.69 -52.25 8.68 Favored 'General case' 0 CA--C 1.53 0.191 0 O-C-N 121.552 -0.717 . . . . 1.52 111.098 176.496 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -57.17 -51.6 68.66 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.631 0.773 . . . . 2.6000000000000001 111.331 -173.53 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.18 -45.62 90.56 Favored 'General case' 0 N--CA 1.457 -0.12 0 O-C-N 121.99 -0.444 . . . . 1.48 109.881 -179.265 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 37.9 t -56.25 -53.04 44.4 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 CA-C-O 119.515 -0.279 . . . . 1.6100000000000001 110.94 176.263 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -52.43 -50.53 62.39 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 122.767 0.427 . . . . 1.6899999999999999 111.048 177.831 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.04 -45.07 96.29 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-O 121.263 0.554 . . . . 1.3700000000000001 110.964 -179.189 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . 0.408 ' CE3' HD23 ' A' ' 88' ' ' LEU . 45.6 t90 -59.93 -48.11 83.05 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.863 0.84 . . . . 0.65000000000000002 109.703 176.464 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.408 HD23 ' CE3' ' A' ' 87' ' ' TRP . 0.1 OUTLIER -62.11 -27.6 69.04 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 120.448 -1.407 . . . . 2.79 110.3 177.039 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -65.67 -43.75 88.39 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 123.319 0.648 . . . . 1.54 111.13 172.583 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -62.13 -42.09 98.9 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 118.537 -1.265 . . . . 3.98 109.944 171.807 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 7.8 mtpp -69.38 119.98 14.48 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 121.581 0.705 . . . . 3.1499999999999999 111.501 -171.18 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 8.2 mttp . . . . . 0 C--O 1.25 1.083 0 C-N-CA 128.092 2.557 . . . . 3.4500000000000002 105.456 -176.352 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 . . . . . 0 N--CA 1.448 -0.568 0 N-CA-C 109.228 -0.656 . . . . 2.6299999999999999 109.228 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -38.25 -53.73 1.44 Allowed 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 125.669 1.587 . . . . 1.6699999999999999 112.498 176.461 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -52.69 -49.79 64.6 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 122.844 0.458 . . . . 2.9100000000000001 111.213 176.637 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.28 -43.92 95.82 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 118.429 0.559 . . . . 1.73 110.532 -179.777 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 89.4 t -58.6 -54.26 35.75 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 N-CA-C 109.702 -0.481 . . . . 1.77 109.702 176.649 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 32.7 t -53.4 -50.63 47.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 C-N-CA 122.709 0.404 . . . . 1.77 110.11 179.762 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 31.8 mm-40 -54.74 -14.47 1.39 Allowed 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 126.49 1.916 . . . . 0.67000000000000004 113.953 174.518 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -141.48 34.06 1.65 Allowed 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 119.757 1.162 . . . . 3.7400000000000002 112.583 176.668 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.3 mptt -152.0 -62.62 0.17 Allowed 'General case' 0 CA--C 1.521 -0.159 0 N-CA-C 108.401 -0.963 . . . . 3.9100000000000001 108.401 166.056 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 3.7 m -69.65 -46.84 65.22 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 121.13 0.49 . . . . 0.42999999999999999 110.144 -168.746 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.3 pp -56.15 -23.31 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 CA-C-N 115.462 -0.79 . . . . 1.6899999999999999 112.882 -178.388 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.0 t -48.38 -35.45 12.61 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.981 0.913 . . . . 2.21 110.748 177.794 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 15.9 m -120.04 -40.49 2.72 Favored 'General case' 0 C--N 1.342 0.255 0 C-N-CA 123.564 0.746 . . . . 0.20000000000000001 111.525 177.319 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 86.1 m-70 -72.16 -9.01 57.85 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.581 0.752 . . . . 0.28999999999999998 112.219 -178.59 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 88.61 148.87 18.05 Favored Glycine 0 C--N 1.339 0.714 0 N-CA-C 109.742 -1.343 . . . . 1.4399999999999999 109.742 177.595 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -42.34 -33.41 1.37 Allowed Glycine 0 CA--C 1.529 0.956 0 C-N-CA 125.202 1.382 . . . . 1.3 112.988 175.085 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -101.26 -5.29 25.7 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.076 1.351 . . . . 2.98 112.209 -171.687 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 73.37 8.63 5.18 Favored 'General case' 0 C--N 1.35 0.601 0 O-C-N 120.633 -1.292 . . . . 2.5099999999999998 111.393 175.696 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 17.2 p -82.11 -1.99 50.52 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 127.491 2.316 . . . . 1.55 110.287 -174.523 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.57 145.27 9.84 Favored Glycine 0 N--CA 1.438 -1.19 0 N-CA-C 108.164 -1.975 . . . . 0.40999999999999998 108.164 -171.475 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -150.88 -73.0 0.16 Allowed 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 124.181 0.992 . . . . 1.6399999999999999 108.98 176.7 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.93 3.85 49.57 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.948 1.299 . . . . 1.75 110.441 173.33 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -158.05 163.68 23.79 Favored Pre-proline 0 CA--C 1.536 0.419 0 C-N-CA 125.994 1.718 . . . . 1.45 107.331 -167.523 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -70.16 158.01 57.8 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 123.144 2.563 . . . . 0.34999999999999998 110.768 -174.823 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.39 126.96 31.36 Favored 'General case' 0 C--N 1.333 -0.148 0 O-C-N 121.636 -0.665 . . . . 1.47 110.075 -177.305 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 39.4 pt -106.9 -2.88 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 C-N-CA 123.07 0.548 . . . . 1.6499999999999999 111.887 177.037 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 24.6 p-10 -33.66 -49.95 0.33 Allowed 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.29 1.436 . . . . 3.6099999999999999 112.744 171.834 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.5 pttp -106.17 23.82 13.45 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.261 1.424 . . . . 4.8700000000000001 112.579 -176.859 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.04 -50.02 75.67 Favored 'General case' 0 CA--C 1.527 0.072 0 O-C-N 121.228 -0.92 . . . . 1.78 109.963 179.168 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -60.18 -12.84 25.47 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 123.386 0.517 . . . . 0.93999999999999995 114.157 178.804 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.98 -34.15 68.69 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 118.454 1.127 . . . . 1.8700000000000001 110.664 173.539 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -107.24 -52.09 2.82 Favored 'General case' 0 C--N 1.34 0.174 0 C-N-CA 123.976 0.91 . . . . 3.3399999999999999 111.878 -176.137 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -84.04 170.29 14.07 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.713 0.805 . . . . 1.5 110.184 175.763 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 54.1 m -119.53 169.1 10.35 Favored 'General case' 0 C--O 1.233 0.237 0 C-N-CA 125.647 1.579 . . . . 2.48 108.619 172.899 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.8 pm0 -46.25 -49.86 16.71 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 124.475 1.11 . . . . 2.7400000000000002 112.355 -177.198 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -58.83 -41.71 87.51 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 118.298 0.499 . . . . 2.4100000000000001 111.888 179.172 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.65 -49.07 51.34 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 122.114 0.959 . . . . 3.5299999999999998 108.623 -176.253 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 31.2 mt -60.03 -44.48 94.91 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 O-C-N 121.631 -0.668 . . . . 1.7 109.253 178.545 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 61.7 tp -54.61 -52.45 62.19 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.289 -0.634 . . . . 1.99 109.289 177.119 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -48.28 -53.91 15.55 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.165 0.586 . . . . 1.8899999999999999 109.77 179.264 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 81.4 mt -57.18 -47.87 83.22 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.283 0 O-C-N 121.707 -0.621 . . . . 1.76 111.409 177.37 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 79.5 mt -54.79 -43.0 65.24 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 O-C-N 120.464 -1.398 . . . . 1.6200000000000001 110.216 176.665 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 94.3 mt -70.8 -40.41 72.55 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 113.957 1.095 . . . . 1.74 113.957 -176.171 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -123.3 27.51 7.49 Favored 'General case' 0 C--N 1.344 0.35 0 CA-C-N 120.956 1.707 . . . . 3.7999999999999998 109.787 -171.515 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 36.55 -136.97 0.52 Allowed Glycine 0 CA--C 1.532 1.151 0 C-N-CA 127.786 2.612 . . . . 0.64000000000000001 110.613 -174.969 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 30.9 tt0 167.41 133.36 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 119.237 1.519 . . . . 1.76 109.197 -177.089 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 45.04 -122.5 5.15 Favored Glycine 0 CA--C 1.532 1.102 0 CA-C-N 119.872 1.215 . . . . 0.60999999999999999 112.252 -175.396 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -70.8 -16.97 74.78 Favored Glycine 0 CA--C 1.532 1.131 0 CA-C-N 117.595 0.697 . . . . 0.83999999999999997 113.017 178.448 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 20.5 ttt -71.29 119.03 71.27 Favored Pre-proline 0 N--CA 1.451 -0.385 0 CA-C-N 118.23 1.015 . . . . 1.49 110.434 -178.938 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -78.18 120.55 4.99 Favored 'Trans proline' 0 N--CA 1.446 -1.275 0 C-N-CA 122.847 2.365 . . . . 2.1400000000000001 110.886 -179.431 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -61.3 140.63 47.74 Favored Glycine 0 N--CA 1.443 -0.892 0 CA-C-N 115.047 -0.979 . . . . 1.5800000000000001 115.499 -175.691 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 79.87 35.25 28.51 Favored Glycine 0 CA--C 1.524 0.644 0 CA-C-N 114.05 -1.075 . . . . 0.33000000000000002 110.911 174.161 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -57.41 -52.04 61.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 125.094 1.358 . . . . 2.0099999999999998 109.499 175.465 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -111.5 155.0 23.92 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 125.404 1.481 . . . . 1.51 108.339 163.147 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.2 mtpp -142.64 157.86 44.26 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.868 1.267 . . . . 3.0800000000000001 109.408 175.959 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 62.32 -151.06 46.3 Favored Glycine 0 CA--C 1.529 0.94 0 N-CA-C 111.133 -0.787 . . . . 0.98999999999999999 111.133 -177.38 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -50.79 -35.08 30.15 Favored 'General case' 0 C--N 1.34 0.192 0 C-N-CA 123.865 0.866 . . . . 1.71 111.736 -175.775 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -50.87 -50.96 55.89 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.006 0.922 . . . . 2.1400000000000001 110.621 174.105 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -75.81 -49.59 17.6 Favored 'General case' 0 CA--C 1.528 0.1 0 C-N-CA 123.335 0.654 . . . . 1.74 111.043 179.36 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -55.11 -48.35 73.73 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.724 0.809 . . . . 2.4900000000000002 110.696 -176.397 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.21 -50.67 72.73 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 109.909 -0.404 . . . . 1.5800000000000001 109.909 177.638 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 57.4 t -53.57 -59.14 2.06 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.272 0 CA-C-O 119.508 -0.282 . . . . 1.6200000000000001 110.465 178.591 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -42.87 -56.34 3.29 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 123.831 0.852 . . . . 1.29 112.144 174.299 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.67 -46.97 85.71 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 121.487 0.661 . . . . 1.47 111.923 -176.364 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 74.9 t90 -58.99 -49.9 76.14 Favored 'General case' 0 C--N 1.328 -0.362 0 O-C-N 121.747 -0.596 . . . . 0.62 109.879 178.339 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.05 -32.89 74.37 Favored 'General case' 0 C--O 1.223 -0.329 0 CA-C-O 117.981 -1.009 . . . . 3.1800000000000002 111.995 176.164 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -55.99 -36.16 67.59 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 119.621 1.1 . . . . 1.48 110.097 170.233 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -68.59 -36.06 78.19 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 118.459 -0.781 . . . . 3.3100000000000001 111.51 172.589 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 4.2 mtpt -74.17 134.71 42.8 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 119.736 1.153 . . . . 3.1299999999999999 110.801 -178.338 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 2.6 mptt . . . . . 0 C--O 1.25 1.12 0 N-CA-C 105.738 -1.949 . . . . 3.8799999999999999 105.738 172.458 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 . . . . . 0 N--CA 1.452 -0.331 0 N-CA-C 103.587 -2.746 . . . . 2.73 103.587 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.62 -49.91 71.57 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-O 121.481 0.658 . . . . 1.5 109.905 -171.764 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -58.91 -48.25 82.12 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.116 -0.947 . . . . 3.1699999999999999 109.929 -178.773 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.96 -47.07 87.3 Favored 'General case' 0 CA--C 1.527 0.096 0 C-N-CA 122.938 0.495 . . . . 1.6299999999999999 111.066 -179.933 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 75.6 t -55.72 -55.54 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 N-CA-C 108.913 -0.773 . . . . 1.9199999999999999 108.913 176.727 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 37.3 t -54.6 -47.55 72.13 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 C-N-CA 122.55 0.34 . . . . 1.6499999999999999 111.188 -177.8 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 40.1 mm-40 -52.3 -19.46 2.09 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.098 1.359 . . . . 0.66000000000000003 113.078 174.584 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -135.66 42.31 2.67 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 119.876 1.216 . . . . 3.3799999999999999 111.939 174.903 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -163.5 -34.19 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 118.106 -0.949 . . . . 2.6699999999999999 112.8 172.062 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 3.5 m -100.75 -50.66 3.79 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 119.668 1.122 . . . . 0.25 110.736 -178.619 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 8.6 pt -56.07 -27.19 22.82 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 CA-C-N 116.191 -0.459 . . . . 2.7599999999999998 111.977 -175.627 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.7 m -40.1 -37.35 0.6 Allowed 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.51 1.524 . . . . 1.6899999999999999 112.145 173.966 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 17.6 m -116.56 -36.65 3.89 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.398 0.679 . . . . 0.23000000000000001 111.753 173.955 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 92.5 m-70 -80.63 3.31 22.39 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.018 0.927 . . . . 0.29999999999999999 113.372 -175.628 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 108.43 -78.84 0.24 Allowed Glycine 0 CA--C 1.525 0.681 0 C-N-CA 125.778 1.656 . . . . 2.9900000000000002 111.937 163.991 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -178.14 -53.4 0.07 OUTLIER Glycine 0 C--O 1.229 -0.219 0 N-CA-C 108.306 -1.918 . . . . 2.4500000000000002 108.306 -171.355 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -97.07 3.93 51.58 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 117.948 -1.025 . . . . 2.52 110.919 -178.356 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.5 mt 77.76 13.23 1.8 Allowed 'General case' 0 C--N 1.352 0.702 0 CA-C-N 119.704 1.138 . . . . 2.8799999999999999 110.054 -178.443 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.7 p -78.55 -11.92 59.99 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 128.462 2.705 . . . . 1.49 110.189 -176.166 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.42 156.72 32.41 Favored Glycine 0 N--CA 1.444 -0.829 0 N-CA-C 109.167 -1.573 . . . . 0.65000000000000002 109.167 -178.758 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -163.21 -79.16 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 123.52 0.728 . . . . 1.3200000000000001 109.719 179.222 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.5 m -93.1 2.49 56.71 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.187 0.995 . . . . 1.78 110.676 170.798 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -153.27 160.67 30.67 Favored Pre-proline 0 N--CA 1.447 -0.585 0 C-N-CA 126.219 1.808 . . . . 1.5600000000000001 106.973 -171.455 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -67.15 164.5 29.99 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 123.282 2.655 . . . . 0.33000000000000002 111.191 -174.86 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -74.38 123.87 25.45 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.858 -0.423 . . . . 1.51 109.858 -178.262 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 49.8 pt -109.85 1.35 9.34 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 C-N-CA 124.28 1.032 . . . . 1.7 112.486 177.784 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 22.0 p-10 -34.53 -48.46 0.36 Allowed 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.587 1.555 . . . . 3.5299999999999998 112.574 167.516 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 4.6 tttt -113.68 38.97 2.78 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 126.606 1.962 . . . . 6.6399999999999997 109.326 -177.595 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.36 -47.37 86.18 Favored 'General case' 0 N--CA 1.454 -0.245 0 O-C-N 121.119 -0.988 . . . . 1.54 109.896 170.559 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -51.26 -42.48 49.59 Favored Glycine 0 CA--C 1.526 0.761 0 C-N-CA 123.959 0.79 . . . . 0.77000000000000002 114.448 -171.67 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.37 -21.06 58.6 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 121.684 -0.892 . . . . 2.0099999999999998 112.107 179.285 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -82.55 -46.68 13.05 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 118.531 0.605 . . . . 1.97 109.516 176.027 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -138.05 137.78 38.14 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.858 1.263 . . . . 1.26 108.55 -171.777 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 35.1 t -75.64 167.2 22.34 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.898 0.879 . . . . 3.1000000000000001 109.841 178.951 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -49.51 -43.19 45.32 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.864 0.865 . . . . 2.8100000000000001 111.893 177.53 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -53.54 -37.54 62.94 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 118.991 0.814 . . . . 2.8799999999999999 111.447 176.467 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -83.08 -49.07 9.91 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 123.615 0.766 . . . . 3.48 110.091 -178.352 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 65.2 mt -58.73 -44.93 91.15 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.052 0 O-C-N 121.283 -0.885 . . . . 1.48 108.758 -178.637 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 35.3 tp -54.41 -47.55 72.63 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 124.002 0.921 . . . . 1.72 109.846 176.182 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -56.0 -50.64 70.29 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 109.794 -0.447 . . . . 2.0600000000000001 109.794 174.49 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 74.2 mt -60.22 -30.17 45.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 O-C-N 121.575 -0.703 . . . . 1.54 111.694 178.895 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 46.6 mt -71.64 -50.77 37.07 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 O-C-N 120.151 -1.593 . . . . 1.4099999999999999 109.95 174.559 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 82.8 mt -70.74 -30.39 66.9 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.869 0.868 . . . . 1.75 112.91 -174.336 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -119.3 12.62 12.59 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 119.11 0.868 . . . . 1.6799999999999999 109.974 -170.048 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 39.38 -147.07 0.18 Allowed Glycine 0 CA--C 1.542 1.719 0 C-N-CA 127.722 2.582 . . . . 0.63 111.211 -172.449 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 38.8 tt0 175.34 131.1 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 119.344 1.572 . . . . 2.0 108.93 -177.144 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 40.72 -115.62 0.7 Allowed Glycine 0 CA--C 1.532 1.137 0 CA-C-N 119.957 1.253 . . . . 0.5 113.33 -175.95 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -69.98 -21.65 76.9 Favored Glycine 0 CA--C 1.532 1.142 0 O-C-N 122.335 -0.509 . . . . 0.62 112.992 -179.727 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 22.4 ttt -73.66 119.08 74.16 Favored Pre-proline 0 N--CA 1.452 -0.374 0 C-N-CA 124.363 1.065 . . . . 1.5600000000000001 110.773 -179.817 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -78.85 128.1 8.25 Favored 'Trans proline' 0 N--CA 1.445 -1.376 0 C-N-CA 122.263 1.976 . . . . 2.1600000000000001 110.525 -179.454 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -61.31 134.17 48.28 Favored Glycine 0 N--CA 1.442 -0.921 0 CA-C-N 115.215 -0.902 . . . . 1.6200000000000001 114.703 -179.486 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 84.23 38.56 9.93 Favored Glycine 0 CA--C 1.526 0.781 0 CA-C-N 114.543 -0.828 . . . . 0.32000000000000001 111.676 171.261 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -61.2 -44.31 98.11 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.881 0 C-N-CA 125.43 1.492 . . . . 3.6000000000000001 110.237 177.203 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -111.48 161.76 15.81 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.498 1.919 . . . . 1.6200000000000001 109.565 164.659 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 68.6 mttt -133.12 157.64 44.8 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 124.798 1.239 . . . . 3.9100000000000001 110.837 174.74 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 53.22 -141.74 29.64 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 110.712 -0.955 . . . . 0.93999999999999995 110.712 176.854 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -52.44 -34.83 50.45 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 117.139 0.469 . . . . 1.8899999999999999 111.835 179.254 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -53.77 -35.94 61.86 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.699 0.8 . . . . 2.4700000000000002 109.48 178.39 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -82.18 -52.66 6.76 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.465 0.706 . . . . 1.48 110.805 170.967 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -57.4 -54.52 45.85 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 112.657 0.614 . . . . 1.96 112.657 -172.333 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -55.96 -42.79 76.78 Favored 'General case' 0 N--CA 1.454 -0.253 0 O-C-N 121.88 -0.513 . . . . 1.5700000000000001 110.472 -179.832 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 50.8 t -61.12 -53.67 45.79 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 C-N-CA 122.66 0.384 . . . . 1.6100000000000001 110.666 178.365 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -51.66 -50.46 60.32 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 123.12 0.568 . . . . 1.74 111.514 176.099 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.16 -48.41 81.7 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.452 0.701 . . . . 1.5 110.69 179.412 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 47.6 t90 -56.71 -47.53 79.74 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 121.915 -0.49 . . . . 0.58999999999999997 109.769 177.086 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.22 -36.32 83.69 Favored 'General case' 0 N--CA 1.462 0.139 0 C-N-CA 124.162 0.985 . . . . 2.8100000000000001 111.476 179.305 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -54.55 -41.01 69.25 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 118.987 0.812 . . . . 1.77 110.096 170.988 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -88.4 27.39 1.26 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.722 0.809 . . . . 4.4400000000000004 112.706 173.098 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.6 mtpm? -119.85 130.95 55.12 Favored 'General case' 0 C--N 1.341 0.21 0 O-C-N 120.858 -1.151 . . . . 2.9199999999999999 109.245 165.14 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 9.5 mtmp? . . . . . 0 C--O 1.248 1.022 0 C-N-CA 127.924 2.49 . . . . 4.46 104.607 -177.243 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 . . . . . 0 N--CA 1.451 -0.418 0 N-CA-C 109.61 -0.515 . . . . 2.1299999999999999 109.61 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -97.73 -61.94 1.32 Allowed 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 109.144 -0.687 . . . . 1.6599999999999999 109.144 178.203 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -51.53 -43.74 62.4 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 116.173 -0.467 . . . . 3.1299999999999999 111.116 178.164 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.55 -43.72 89.42 Favored 'General case' 0 CA--C 1.528 0.135 0 CA-C-N 118.579 0.627 . . . . 1.54 111.509 179.731 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 73.6 t -63.39 -53.18 48.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 N-CA-C 108.12 -1.067 . . . . 1.5 108.12 178.438 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 45.1 t -52.34 -48.44 44.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 110.437 -0.209 . . . . 1.55 110.437 -179.623 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 35.6 mm-40 -50.47 -24.5 3.16 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.448 1.899 . . . . 0.65000000000000002 112.937 175.658 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -142.62 59.04 1.44 Allowed 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 119.184 0.902 . . . . 3.23 111.323 178.459 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -179.81 -36.28 0.01 OUTLIER 'General case' 0 C--O 1.225 -0.207 0 C-N-CA 124.648 1.179 . . . . 1.95 109.695 173.356 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 5.0 m -101.1 -53.66 2.98 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 119.28 0.945 . . . . 0.26000000000000001 110.973 -178.632 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.1 pp -57.37 -25.92 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 CA-C-N 115.876 -0.602 . . . . 1.77 112.041 -175.735 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.1 m -38.17 -35.53 0.17 Allowed 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.001 1.72 . . . . 1.75 112.548 170.483 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 18.5 m -120.9 -44.02 2.44 Favored 'General case' 0 C--N 1.34 0.174 0 C-N-CA 123.326 0.651 . . . . 0.25 111.629 172.854 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 82.4 m-70 -70.13 -8.81 52.61 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.413 0.685 . . . . 0.52000000000000002 112.817 -175.2 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 88.48 151.93 23.96 Favored Glycine 0 C--N 1.337 0.589 0 N-CA-C 109.757 -1.337 . . . . 1.51 109.757 177.488 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -44.51 -37.54 4.95 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 124.518 1.056 . . . . 1.1699999999999999 112.31 178.514 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -98.37 0.24 45.03 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.707 1.203 . . . . 2.0899999999999999 111.747 -174.061 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.4 mp 65.28 17.14 10.89 Favored 'General case' 0 C--N 1.347 0.458 0 CA-C-N 120.232 1.378 . . . . 2.8500000000000001 111.543 178.582 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.3 p -84.9 -4.77 59.25 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 128.529 2.731 . . . . 1.46 110.03 -175.707 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.04 127.18 3.65 Favored Glycine 0 N--CA 1.442 -0.903 0 N-CA-C 109.009 -1.636 . . . . 0.55000000000000004 109.009 179.437 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -134.31 -80.13 0.45 Allowed 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 124.229 1.012 . . . . 1.45 108.904 179.552 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 46.1 m -88.85 2.85 52.98 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.757 0.823 . . . . 1.8500000000000001 111.047 172.695 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -158.99 164.86 19.78 Favored Pre-proline 0 CA--C 1.537 0.444 0 C-N-CA 124.529 1.132 . . . . 1.54 108.246 -169.188 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -68.75 157.69 60.84 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 123.157 2.571 . . . . 0.33000000000000002 110.951 -173.389 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.45 128.76 36.41 Favored 'General case' 0 CA--C 1.529 0.146 0 O-C-N 121.584 -0.697 . . . . 1.6399999999999999 110.307 -175.653 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 48.6 pt -106.63 0.21 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 C-N-CA 123.328 0.651 . . . . 1.76 111.626 176.954 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -38.99 -38.29 0.43 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.789 0.836 . . . . 2.27 113.105 170.085 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 4.2 pttt -113.49 30.05 7.52 Favored 'General case' 0 C--N 1.343 0.316 0 C-N-CA 124.507 1.123 . . . . 4.7699999999999996 111.642 -178.689 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -68.36 -41.97 79.86 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 118.652 -0.689 . . . . 1.5800000000000001 109.624 176.766 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -53.38 -29.83 39.35 Favored Glycine 0 CA--C 1.526 0.735 0 CA-C-N 118.614 0.643 . . . . 0.71999999999999997 114.646 -175.419 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -83.41 -47.49 11.36 Favored 'General case' 0 N--CA 1.455 -0.197 0 O-C-N 122.403 -0.469 . . . . 2.0099999999999998 110.366 175.253 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 38.4 m-80 -55.63 -44.27 76.96 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 122.286 0.234 . . . . 1.54 111.158 179.43 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -139.75 134.15 31.46 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.022 1.729 . . . . 1.3200000000000001 107.691 -167.309 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 49.2 m -74.98 170.73 15.4 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 118.348 0.522 . . . . 2.46 110.774 178.059 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 73.3 tt0 -45.54 -59.53 2.67 Favored 'General case' 0 C--N 1.342 0.267 0 C-N-CA 123.178 0.591 . . . . 5.2599999999999998 110.75 177.148 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 31.5 mp0 -51.28 -31.86 22.71 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.656 0.782 . . . . 4.2800000000000002 112.906 179.259 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -80.85 -48.46 12.38 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 119.23 0.923 . . . . 2.6400000000000001 109.315 -179.191 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 84.6 mt -61.77 -47.1 94.85 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.222 0 O-C-N 121.565 -0.709 . . . . 1.5700000000000001 109.256 -179.215 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 31.2 tp -52.2 -50.2 62.38 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 108.956 -0.757 . . . . 1.8400000000000001 108.956 175.789 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -57.02 -43.23 81.65 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 120.72 -0.392 . . . . 1.6699999999999999 110.997 178.157 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 31.6 mt -58.73 -54.0 39.63 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.262 0 O-C-N 120.861 -1.149 . . . . 1.5700000000000001 110.494 173.257 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 58.2 mt -50.75 -41.97 22.04 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 O-C-N 120.655 -1.278 . . . . 1.6200000000000001 110.513 -179.614 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 88.5 mt -69.18 -40.53 78.03 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 113.436 0.902 . . . . 1.7 113.436 176.951 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 -118.31 19.1 13.56 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 120.489 1.495 . . . . 1.77 110.202 -164.706 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.409 ' N ' ' HA2' ' A' ' 73' ' ' GLY . . . 29.47 -136.5 0.05 OUTLIER Glycine 0 CA--C 1.532 1.154 0 C-N-CA 128.511 2.958 . . . . 0.65000000000000002 110.973 -162.458 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 171.66 133.01 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 119.085 1.443 . . . . 2.0800000000000001 108.28 -176.736 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 40.76 -118.85 1.28 Allowed Glycine 0 CA--C 1.533 1.208 0 CA-C-N 120.405 1.457 . . . . 0.42999999999999999 113.294 -178.199 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -68.49 -19.25 72.57 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 123.704 0.669 . . . . 0.53000000000000003 113.23 179.204 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 19.9 ttt -74.41 119.12 74.95 Favored Pre-proline 0 N--CA 1.449 -0.485 0 C-N-CA 124.288 1.035 . . . . 1.46 110.677 179.174 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -74.86 127.34 10.7 Favored 'Trans proline' 0 N--CA 1.442 -1.551 0 C-N-CA 122.01 1.806 . . . . 2.1000000000000001 109.812 177.631 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.409 ' HA2' ' N ' ' A' ' 67' ' ' GLY . . . -63.17 140.76 45.55 Favored Glycine 0 N--CA 1.442 -0.956 0 CA-C-N 115.487 -0.779 . . . . 1.6699999999999999 114.655 176.953 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 84.27 38.0 10.47 Favored Glycine 0 CA--C 1.525 0.692 0 CA-C-N 113.757 -1.221 . . . . 0.56000000000000005 111.507 173.605 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.5 mm -64.3 -58.03 8.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 C-N-CA 123.779 0.831 . . . . 3.1899999999999999 110.002 176.559 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -104.94 152.58 22.5 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.893 1.277 . . . . 1.6100000000000001 108.206 167.807 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 2.1 mmmt -142.28 154.99 45.19 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 124.732 1.213 . . . . 4.0899999999999999 108.995 -178.721 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 63.67 -158.29 40.44 Favored Glycine 0 CA--C 1.531 1.043 0 N-CA-C 111.315 -0.714 . . . . 0.79000000000000004 111.315 -173.814 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -53.14 -26.04 15.42 Favored 'General case' 0 C--N 1.34 0.173 0 C-N-CA 123.873 0.869 . . . . 1.77 112.415 -179.983 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -47.92 -48.81 31.61 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.493 1.117 . . . . 2.1099999999999999 110.577 171.326 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -74.32 -47.68 33.07 Favored 'General case' 0 N--CA 1.455 -0.189 0 O-C-N 121.645 -0.659 . . . . 1.77 111.333 177.285 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -55.92 -51.95 65.82 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.24 0.616 . . . . 2.5899999999999999 110.645 -174.979 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -54.0 -47.5 71.4 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.774 0.829 . . . . 1.6299999999999999 110.308 178.644 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 44.4 t -58.84 -55.46 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 C-N-CA 122.607 0.363 . . . . 1.78 110.832 177.983 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -48.68 -51.9 26.1 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.183 0.593 . . . . 1.3200000000000001 111.252 176.639 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.23 -48.91 79.74 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 121.449 0.642 . . . . 1.4299999999999999 111.138 -179.768 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 75.2 t90 -58.75 -50.23 74.69 Favored 'General case' 0 CA--C 1.532 0.287 0 O-C-N 121.459 -0.776 . . . . 0.57999999999999996 109.975 -179.987 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.71 -32.93 72.15 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 118.283 -0.865 . . . . 3.0800000000000001 111.83 173.631 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -54.99 -31.49 60.95 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 119.85 1.204 . . . . 1.52 110.975 173.332 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -77.93 -38.34 45.7 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 118.342 -0.837 . . . . 3.2799999999999998 112.448 169.534 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 42.6 mtpt -73.04 111.65 8.35 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 119.714 1.143 . . . . 3.2799999999999998 111.162 -177.347 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 2.0 pttt . . . . . 0 C--O 1.251 1.149 0 C-N-CA 126.467 1.907 . . . . 3.3100000000000001 107.175 177.514 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 . . . . . 0 N--CA 1.454 -0.273 0 N-CA-C 109.462 -0.569 . . . . 2.21 109.462 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -48.38 -52.72 20.52 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.94 0.896 . . . . 1.6499999999999999 110.918 -179.325 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -58.78 -44.34 90.67 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 116.269 -0.423 . . . . 2.8399999999999999 110.111 179.607 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.02 -43.27 99.14 Favored 'General case' 0 C--N 1.34 0.163 0 C-N-CA 122.719 0.408 . . . . 1.5800000000000001 111.221 -179.675 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 77.7 t -58.4 -55.73 20.72 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.365 0 N-CA-C 108.923 -0.769 . . . . 1.8700000000000001 108.923 175.432 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 50.9 t -54.6 -45.02 71.64 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 N-CA-C 110.331 -0.248 . . . . 1.49 110.331 -177.227 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 -51.49 -26.28 8.02 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.927 1.691 . . . . 0.56999999999999995 113.611 172.742 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -139.99 58.85 1.59 Allowed 'General case' 0 C--N 1.338 0.103 0 CA-C-N 119.851 1.205 . . . . 2.9199999999999999 112.403 173.073 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -173.82 -36.74 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 123.866 0.867 . . . . 2.1800000000000002 110.143 169.3 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 5.6 m -98.71 -51.67 3.84 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 118.958 0.799 . . . . 0.29999999999999999 110.402 -177.923 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.2 pp -57.09 -26.67 25.57 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.08 0 CA-C-N 116.211 -0.449 . . . . 1.54 112.027 -176.414 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 50.3 m -37.82 -38.45 0.29 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.121 1.369 . . . . 1.8700000000000001 112.194 170.989 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 22.5 m -120.23 -40.96 2.65 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.194 0.597 . . . . 0.17999999999999999 111.549 174.625 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 84.1 m-70 -71.7 -8.93 57.2 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 112.766 0.654 . . . . 0.27000000000000002 112.766 -176.15 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 86.09 150.15 14.8 Favored Glycine 0 C--N 1.338 0.66 0 N-CA-C 109.838 -1.305 . . . . 1.49 109.838 178.958 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -44.47 -36.91 4.63 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 124.558 1.075 . . . . 1.21 112.191 177.277 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -95.96 -3.82 44.43 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 124.691 1.196 . . . . 2.6299999999999999 111.725 -172.831 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 8.7 mt 69.41 13.05 8.41 Favored 'General case' 0 C--N 1.35 0.607 0 CA-C-N 120.463 1.483 . . . . 2.0499999999999998 111.316 176.126 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.4 p -86.03 -2.68 58.54 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 128.318 2.647 . . . . 1.6599999999999999 109.9 -175.867 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.89 129.27 3.02 Favored Glycine 0 N--CA 1.441 -0.997 0 N-CA-C 108.827 -1.709 . . . . 0.53000000000000003 108.827 -178.559 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -134.86 -78.42 0.45 Allowed 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 124.071 0.949 . . . . 1.53 108.773 178.662 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -90.72 3.58 53.89 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.148 0.979 . . . . 2.0 110.7 173.415 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -156.12 168.01 13.16 Favored Pre-proline 0 CA--C 1.537 0.45 0 C-N-CA 125.657 1.583 . . . . 1.4399999999999999 108.078 -170.551 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -67.11 168.79 16.54 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.698 2.266 . . . . 0.58999999999999997 110.816 -178.793 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -85.19 124.46 31.87 Favored 'General case' 0 CA--C 1.53 0.199 0 O-C-N 121.234 -0.917 . . . . 1.5 110.883 -176.494 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 43.6 pt -100.41 0.09 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 C-N-CA 123.769 0.827 . . . . 2.0 111.312 178.942 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -36.87 -46.0 0.59 Allowed 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.807 1.243 . . . . 2.2999999999999998 113.095 171.566 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.5 mttp -114.33 38.83 2.93 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.947 0.88 . . . . 4.5999999999999996 110.573 -179.515 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.06 -50.08 74.76 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 118.641 -0.695 . . . . 1.6799999999999999 109.432 175.106 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -54.3 -26.28 36.07 Favored Glycine 0 CA--C 1.528 0.878 0 CA-C-N 118.721 0.691 . . . . 0.56000000000000005 113.695 -177.257 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -81.32 -44.23 17.95 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 117.507 0.653 . . . . 1.74 110.181 176.582 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 38.6 m-80 -62.08 -48.11 81.68 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 122.446 0.298 . . . . 1.7 110.934 178.12 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 -141.38 145.0 34.82 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.431 1.492 . . . . 1.21 108.731 -168.016 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 64.5 m -78.87 166.81 22.0 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.59 0.756 . . . . 2.4199999999999999 111.118 179.659 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -43.96 -53.8 5.9 Favored 'General case' 0 C--N 1.342 0.266 0 C-N-CA 123.712 0.805 . . . . 4.5499999999999998 110.927 177.52 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -51.1 -41.41 59.98 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 122.868 0.467 . . . . 4.0800000000000001 111.387 -178.858 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -74.62 -48.48 26.19 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 123.32 0.648 . . . . 3.2000000000000002 109.484 -177.484 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 67.0 mt -60.76 -46.73 95.56 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.078 0 N-CA-C 108.935 -0.765 . . . . 1.6200000000000001 108.935 -177.915 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 24.6 tp -52.04 -53.72 38.68 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 124.223 1.009 . . . . 1.5800000000000001 109.367 175.819 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -53.5 -48.47 68.95 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 120.879 0.371 . . . . 1.9399999999999999 110.846 175.471 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 71.3 mt -62.2 -26.58 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 O-C-N 121.385 -0.822 . . . . 1.8300000000000001 112.32 179.842 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 54.8 mt -75.12 -50.7 23.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 O-C-N 120.131 -1.606 . . . . 1.5 108.297 173.048 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 88.4 mt -62.62 -32.65 73.71 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.793 1.237 . . . . 1.74 113.193 -177.376 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -128.08 20.06 6.42 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 119.697 1.135 . . . . 1.8500000000000001 110.213 -166.031 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 33.81 -137.97 0.17 Allowed Glycine 0 CA--C 1.544 1.852 0 C-N-CA 126.638 2.066 . . . . 0.68000000000000005 112.023 -167.282 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 164.68 141.22 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 126.45 1.9 . . . . 1.3 109.191 -177.785 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 29.06 -111.71 0.03 OUTLIER Glycine 0 C--N 1.347 1.177 0 C-N-CA 125.68 1.609 . . . . 0.70999999999999996 114.294 -172.471 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -62.35 -30.34 75.87 Favored Glycine 0 CA--C 1.535 1.344 0 CA-C-N 117.655 0.727 . . . . 0.92000000000000004 113.087 -179.414 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 5.9 ttt -70.41 122.08 85.35 Favored Pre-proline 0 CA--C 1.542 0.652 0 C-N-CA 125.114 1.366 . . . . 1.4199999999999999 111.224 -179.079 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -62.87 -58.27 0.34 Allowed 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 124.275 3.317 . . . . 3.0699999999999998 111.333 -172.32 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 120.8 148.33 7.98 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-O 122.205 0.891 . . . . 2.1899999999999999 114.448 172.82 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 70.91 21.94 78.26 Favored Glycine 0 CA--C 1.526 0.768 0 CA-C-O 118.484 -1.176 . . . . 0.51000000000000001 112.126 177.518 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.5 mt -47.12 -52.4 4.56 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 C-N-CA 129.052 2.941 . . . . 2.2999999999999998 111.158 175.001 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -109.98 156.87 19.92 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.609 1.564 . . . . 1.47 108.903 164.375 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 17.9 mtmm -146.28 159.75 42.92 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 124.559 1.144 . . . . 4.0700000000000003 110.403 171.565 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 61.59 -151.22 43.91 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 110.05 -1.22 . . . . 0.93000000000000005 110.05 -177.586 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -46.76 -37.3 8.35 Favored 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 123.901 0.88 . . . . 1.96 112.01 179.69 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -51.84 -45.68 64.09 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.73 0.812 . . . . 2.0800000000000001 110.691 176.169 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -81.15 -50.22 9.87 Favored 'General case' 0 N--CA 1.455 -0.186 0 O-C-N 121.786 -0.572 . . . . 1.4099999999999999 110.937 177.379 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -53.4 -51.06 63.78 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.461 0.704 . . . . 2.3900000000000001 111.455 -175.781 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.26 -46.13 86.58 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 122.567 0.347 . . . . 1.4299999999999999 110.309 179.791 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 67.2 t -58.25 -54.71 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 CA-C-O 119.385 -0.341 . . . . 1.5700000000000001 110.629 178.12 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -49.99 -50.42 47.12 Favored 'General case' 0 C--O 1.224 -0.266 0 C-N-CA 122.855 0.462 . . . . 1.6299999999999999 111.023 176.397 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.57 -48.12 83.17 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 121.822 0.82 . . . . 1.97 110.723 -177.616 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . 0.416 ' CE3' HD23 ' A' ' 88' ' ' LEU . 50.8 t90 -60.92 -43.79 98.1 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 121.79 0.805 . . . . 0.60999999999999999 110.768 178.197 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.416 HD23 ' CE3' ' A' ' 87' ' ' TRP . 0.1 OUTLIER -64.28 -33.85 76.78 Favored 'General case' 0 C--O 1.223 -0.291 0 O-C-N 121.189 -0.945 . . . . 2.7999999999999998 109.698 175.527 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.8 -42.19 97.75 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 118.54 0.609 . . . . 1.5 109.553 174.292 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -52.45 -50.78 61.96 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 118.108 -0.949 . . . . 3.2400000000000002 110.307 168.151 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 26.5 mttm -70.5 111.96 6.42 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 118.955 0.798 . . . . 4.1399999999999997 111.973 -173.755 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 26.9 mttp . . . . . 0 C--O 1.254 1.303 0 CA-C-O 116.277 -1.821 . . . . 3.5699999999999998 106.485 -178.505 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 . . . . . 0 N--CA 1.449 -0.5 0 N-CA-C 109.22 -0.659 . . . . 2.5899999999999999 109.22 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -40.3 -56.0 2.07 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.896 1.278 . . . . 1.6100000000000001 111.804 179.083 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -48.02 -48.38 32.93 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.451 0.701 . . . . 3.1699999999999999 112.2 176.435 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.62 -42.27 98.2 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 123.025 0.53 . . . . 1.45 110.485 -179.043 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 61.5 t -61.83 -50.07 81.68 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 N-CA-C 109.768 -0.456 . . . . 1.5700000000000001 109.768 176.1 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 79.6 t -52.61 -49.9 43.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 C-N-CA 123.066 0.546 . . . . 1.8400000000000001 109.593 178.379 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 30.3 mm-40 -54.29 -17.51 3.03 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.688 1.595 . . . . 0.57999999999999996 114.298 173.517 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -149.15 58.14 1.02 Allowed 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 119.612 1.096 . . . . 3.8900000000000001 111.853 -179.081 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.1 mttm 178.34 -35.34 0.01 OUTLIER 'General case' 0 C--O 1.225 -0.202 0 C-N-CA 126.233 1.813 . . . . 2.1000000000000001 109.695 172.926 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 6.4 m -100.28 -53.07 3.21 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 118.949 0.795 . . . . 0.32000000000000001 110.639 -177.115 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.0 pp -55.14 -26.96 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.111 0 CA-C-N 115.936 -0.574 . . . . 1.71 112.182 -177.94 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.4 m -38.23 -37.15 0.26 Allowed 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 126.418 1.887 . . . . 1.76 112.434 171.313 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 39.5 m -120.52 -41.34 2.6 Favored 'General case' 0 C--N 1.341 0.201 0 C-N-CA 123.729 0.811 . . . . 0.17999999999999999 111.741 173.519 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 85.1 m-70 -72.23 -6.78 45.37 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.33 0.652 . . . . 0.28999999999999998 112.673 -175.735 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 87.1 148.16 12.85 Favored Glycine 0 C--N 1.337 0.633 0 N-CA-C 109.547 -1.421 . . . . 1.45 109.547 177.971 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -43.98 -33.11 2.56 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 124.71 1.148 . . . . 1.27 112.532 174.939 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -94.42 -9.88 34.23 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.582 1.553 . . . . 2.3999999999999999 112.235 -172.839 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.5 mt 71.17 10.21 6.75 Favored 'General case' 0 C--N 1.348 0.516 0 CA-C-N 120.301 1.409 . . . . 2.5600000000000001 111.395 179.563 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 11.9 p -86.43 0.28 54.46 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 127.206 2.202 . . . . 1.6299999999999999 109.999 -175.753 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.87 132.42 2.95 Favored Glycine 0 N--CA 1.44 -1.083 0 N-CA-C 108.789 -1.724 . . . . 0.59999999999999998 108.789 -177.024 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -136.73 -75.47 0.42 Allowed 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 124.122 0.969 . . . . 1.53 108.396 178.328 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -93.71 3.71 55.05 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.852 0.861 . . . . 2.3599999999999999 110.859 174.615 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -160.53 163.89 20.58 Favored Pre-proline 0 CA--C 1.537 0.474 0 C-N-CA 125.799 1.64 . . . . 1.53 107.564 -166.093 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -69.37 158.87 55.89 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.952 2.435 . . . . 0.38 111.237 -174.124 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -74.5 125.17 28.01 Favored 'General case' 0 C--N 1.332 -0.164 0 O-C-N 121.675 -0.64 . . . . 1.6000000000000001 111.045 -174.761 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 37.3 pt -103.98 -1.09 9.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-O 119.169 -0.443 . . . . 1.6599999999999999 112.073 178.996 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -36.6 -40.32 0.25 Allowed 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.899 1.28 . . . . 2.7400000000000002 113.721 171.548 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.6 mtpm? -119.47 36.62 4.43 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 124.548 1.139 . . . . 4.0 110.759 -178.085 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.53 -46.62 88.32 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 109.317 -0.623 . . . . 1.8200000000000001 109.317 171.98 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -57.79 -14.94 17.39 Favored Glycine 0 CA--C 1.532 1.14 0 N-CA-C 114.76 0.664 . . . . 0.81999999999999995 114.76 179.267 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -89.65 -45.41 9.36 Favored 'General case' 0 C--N 1.338 0.091 0 CA-C-N 119.048 1.424 . . . . 1.53 109.755 168.729 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -56.16 -54.33 46.47 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 122.608 0.363 . . . . 1.8700000000000001 111.616 179.622 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -140.42 158.97 43.21 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.512 1.125 . . . . 1.26 109.563 -168.576 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 22.6 m -84.93 168.26 15.17 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.065 0.546 . . . . 2.3700000000000001 110.825 178.217 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -50.72 -44.5 58.16 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 123.785 0.834 . . . . 3.0 111.908 -179.608 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -54.86 -46.26 74.68 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 119.116 0.871 . . . . 2.9900000000000002 111.394 176.474 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 51.7 mm-40 -71.86 -47.17 54.81 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 121.751 0.786 . . . . 3.0600000000000001 109.064 -173.511 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 64.3 mt -60.51 -46.31 95.63 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 N-CA-C 108.644 -0.873 . . . . 1.52 108.644 178.75 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 38.9 tp -53.95 -51.35 64.12 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 109.087 -0.709 . . . . 1.6299999999999999 109.087 176.626 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -53.57 -47.06 70.43 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 117.969 0.35 . . . . 1.47 111.208 177.561 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 62.0 mt -58.71 -46.86 90.36 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.295 0 O-C-N 121.341 -0.849 . . . . 1.6299999999999999 110.844 175.431 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 57.3 mt -58.6 -43.96 88.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 O-C-N 120.339 -1.476 . . . . 1.6000000000000001 109.89 179.532 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 86.4 mt -71.45 -34.62 70.41 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.496 1.119 . . . . 1.53 113.321 -178.188 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 71.3 m-80 -119.43 16.8 13.0 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 120.069 1.304 . . . . 1.6599999999999999 110.317 -168.532 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 36.11 -142.46 0.15 Allowed Glycine 0 CA--C 1.536 1.404 0 C-N-CA 127.696 2.569 . . . . 0.62 111.106 -167.463 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 173.22 131.85 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 119.076 1.438 . . . . 1.46 109.216 -175.067 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 42.13 -119.14 1.81 Allowed Glycine 0 CA--C 1.534 1.224 0 CA-C-N 120.006 1.276 . . . . 0.59999999999999998 112.687 -174.976 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -70.44 -19.35 76.11 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 123.561 0.6 . . . . 0.78000000000000003 113.016 179.148 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 20.0 ttt -71.21 117.81 60.09 Favored Pre-proline 0 N--CA 1.452 -0.348 0 C-N-CA 124.404 1.081 . . . . 1.49 110.53 -179.584 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -78.26 122.09 5.53 Favored 'Trans proline' 0 N--CA 1.445 -1.349 0 C-N-CA 123.28 2.653 . . . . 2.1699999999999999 110.732 179.986 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -62.58 142.46 47.86 Favored Glycine 0 N--CA 1.442 -0.917 0 N-CA-C 115.503 0.961 . . . . 1.5700000000000001 115.503 -175.285 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 77.95 33.49 41.18 Favored Glycine 0 CA--C 1.525 0.678 0 CA-C-N 114.01 -1.095 . . . . 0.37 111.135 174.889 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -56.49 -49.86 75.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.442 0 C-N-CA 124.899 1.28 . . . . 2.0899999999999999 108.94 172.996 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -109.53 160.06 16.55 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.069 1.748 . . . . 1.7 109.879 164.314 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.1 mmtp -145.91 167.54 23.03 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 126.467 1.907 . . . . 3.04 108.922 177.21 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 50.31 -145.87 9.14 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 110.883 -0.887 . . . . 0.98999999999999999 110.883 176.811 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -51.98 -34.9 44.46 Favored 'General case' 0 C--O 1.225 -0.199 0 CA-C-N 118.148 0.974 . . . . 1.8400000000000001 112.045 176.517 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -57.52 -38.61 74.94 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 118.664 0.666 . . . . 2.1800000000000002 110.118 177.598 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -83.18 -57.68 3.17 Favored 'General case' 0 N--CA 1.461 0.11 0 O-C-N 121.565 -0.71 . . . . 1.51 111.113 174.925 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -51.41 -49.37 61.76 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 124.887 1.275 . . . . 2.4300000000000002 111.803 -176.123 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.22 -47.06 87.57 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 109.568 -0.53 . . . . 1.5700000000000001 109.568 178.415 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 56.0 t -57.48 -52.74 53.24 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.312 0 CA-C-O 119.226 -0.416 . . . . 1.54 110.842 178.961 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -52.28 -57.79 8.65 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.548 0.739 . . . . 1.3 111.519 176.561 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.71 -40.76 89.06 Favored 'General case' 0 C--O 1.226 -0.144 0 C-N-CA 123.032 0.533 . . . . 1.6699999999999999 110.934 -177.062 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 83.6 t90 -63.79 -52.17 61.49 Favored 'General case' 0 N--CA 1.449 -0.513 0 O-C-N 121.721 -0.612 . . . . 0.96999999999999997 109.724 176.34 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.36 -27.41 64.16 Favored 'General case' 0 C--N 1.33 -0.277 0 O-C-N 120.675 -1.266 . . . . 3.0 112.167 176.413 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -56.8 -31.79 65.04 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 118.935 0.789 . . . . 1.7 111.988 170.026 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -74.66 -36.36 62.82 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 118.844 0.747 . . . . 4.9800000000000004 111.052 172.002 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 11.9 mmtm -73.85 102.92 4.2 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 121.428 0.633 . . . . 4.7199999999999998 110.193 -178.484 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.25 1.088 0 C-N-CA 125.339 1.456 . . . . 3.8999999999999999 107.711 173.57 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 N--CA 1.448 -0.549 0 N-CA-C 108.191 -1.04 . . . . 3.8999999999999999 108.191 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -105.78 -62.39 1.37 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.053 -0.721 . . . . 1.6799999999999999 109.053 173.22 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -55.04 -47.97 74.06 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 119.021 -0.514 . . . . 2.7599999999999998 111.251 178.778 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.32 -41.58 93.82 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 118.95 0.796 . . . . 1.5600000000000001 111.106 -176.731 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 73.6 t -59.93 -57.41 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 108.677 -0.86 . . . . 1.78 108.677 175.031 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 49.3 t -53.11 -48.37 53.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 CA-C-N 118.544 0.611 . . . . 1.6799999999999999 110.885 -178.479 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 22.4 mm-40 -51.88 -16.21 0.67 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 127.032 2.133 . . . . 0.77000000000000002 113.244 175.263 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -138.31 30.25 2.42 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 119.139 0.882 . . . . 3.0299999999999998 111.812 173.431 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -146.59 -48.43 0.19 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 118.831 0.741 . . . . 3.4100000000000001 111.103 176.481 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 3.5 m -93.45 -47.95 6.62 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 109.583 -0.525 . . . . 0.29999999999999999 109.583 -174.6 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.3 pp -57.35 -25.74 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 CA-C-N 115.897 -0.592 . . . . 1.6599999999999999 111.62 -178.451 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.1 m -41.89 -34.09 0.62 Allowed 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 126.157 1.783 . . . . 1.95 112.388 172.144 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 37.2 m -121.37 -42.43 2.46 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.454 0.702 . . . . 0.25 111.592 172.939 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 87.0 m-70 -72.93 -8.01 53.67 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.031 0.932 . . . . 0.34999999999999998 113.161 -175.483 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 85.05 150.03 11.99 Favored Glycine 0 C--N 1.337 0.601 0 N-CA-C 110.028 -1.229 . . . . 1.5800000000000001 110.028 178.699 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -43.83 -35.92 3.43 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 124.857 1.217 . . . . 1.1499999999999999 112.558 178.227 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -93.12 -9.0 41.05 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.307 1.443 . . . . 2.0699999999999998 112.41 -173.08 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.3 mt 71.41 9.49 6.49 Favored 'General case' 0 C--N 1.347 0.465 0 CA-C-N 120.254 1.388 . . . . 2.3100000000000001 111.268 179.909 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.6 p -81.95 -2.47 51.53 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 127.764 2.425 . . . . 1.8300000000000001 110.207 -177.205 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.54 150.31 25.18 Favored Glycine 0 N--CA 1.438 -1.169 0 N-CA-C 108.472 -1.851 . . . . 0.5 108.472 -174.597 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -156.77 -79.94 0.08 Allowed 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 124.477 1.111 . . . . 1.3500000000000001 108.712 179.278 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.3 t -92.06 2.71 56.4 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.146 0.978 . . . . 2.1099999999999999 110.379 172.963 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -158.62 163.89 22.86 Favored Pre-proline 0 N--CA 1.45 -0.47 0 C-N-CA 125.704 1.602 . . . . 1.5900000000000001 107.494 -168.227 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -69.01 162.47 41.57 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 123.63 2.887 . . . . 0.41999999999999998 111.265 -174.207 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -74.76 122.49 23.37 Favored 'General case' 0 N--CA 1.455 -0.21 0 O-C-N 121.849 -0.532 . . . . 1.6200000000000001 110.654 -176.072 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 33.8 pt -105.41 1.81 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.117 0 C-N-CA 123.717 0.807 . . . . 1.6000000000000001 111.4 178.096 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -44.95 -45.45 10.48 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 112.982 0.734 . . . . 2.6200000000000001 112.982 176.379 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.04 27.76 5.82 Favored 'General case' 0 C--N 1.343 0.303 0 C-N-CA 123.945 0.898 . . . . 4.8399999999999999 111.582 178.63 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -56.17 -46.04 79.47 Favored 'General case' 0 N--CA 1.452 -0.352 0 O-C-N 121.62 -0.675 . . . . 1.47 109.502 177.07 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -53.47 -30.91 42.74 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 123.448 0.547 . . . . 0.48999999999999999 113.313 -179.126 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -76.94 -42.32 39.77 Favored 'General case' 0 N--CA 1.455 -0.206 0 O-C-N 122.031 -0.687 . . . . 1.73 110.613 176.529 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 48.7 m-20 -66.05 -49.29 68.17 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 122.129 0.172 . . . . 1.8200000000000001 111.034 -179.926 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -139.14 141.67 38.04 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 125.568 1.547 . . . . 1.8500000000000001 107.837 -167.448 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 22.4 m -78.18 168.98 19.02 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 118.45 0.568 . . . . 2.48 110.363 179.65 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -50.82 -44.23 59.18 Favored 'General case' 0 C--O 1.224 -0.258 0 C-N-CA 123.346 0.658 . . . . 3.0499999999999998 111.973 -179.593 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -54.92 -39.26 68.63 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 118.492 0.587 . . . . 2.8999999999999999 111.67 176.98 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -78.67 -45.67 20.86 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 121.495 0.664 . . . . 3.4900000000000002 109.47 -177.262 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 62.4 mt -59.11 -44.5 91.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 O-C-N 121.653 -0.654 . . . . 1.51 109.289 179.189 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 35.4 tp -55.33 -50.1 70.51 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 123.854 0.861 . . . . 1.51 109.453 176.174 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -50.98 -52.68 40.27 Favored 'General case' 0 N--CA 1.454 -0.235 0 O-C-N 123.312 0.382 . . . . 1.51 110.264 176.138 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 86.3 mt -56.8 -51.11 71.46 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.328 0 O-C-N 121.64 -0.663 . . . . 1.49 110.287 177.977 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 71.0 mt -52.65 -44.78 47.16 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 O-C-N 120.47 -1.394 . . . . 1.6399999999999999 110.486 179.247 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 79.4 mt -73.06 -32.57 65.13 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 113.164 0.801 . . . . 1.74 113.164 -179.087 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -121.96 20.6 10.76 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 119.591 1.087 . . . . 1.6399999999999999 110.161 -165.539 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 28.75 -139.43 0.02 OUTLIER Glycine 0 CA--C 1.534 1.268 0 C-N-CA 129.127 3.251 . . . . 0.68000000000000005 111.524 -165.401 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 174.58 133.95 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 118.994 1.397 . . . . 1.4299999999999999 107.935 -178.394 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 31.43 -110.04 0.04 OUTLIER Glycine 0 CA--C 1.535 1.282 0 C-N-CA 124.971 1.272 . . . . 0.44 114.246 -172.515 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -69.61 -24.11 76.37 Favored Glycine 0 CA--C 1.533 1.206 0 CA-C-N 118.114 0.957 . . . . 0.5 113.166 -178.328 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 18.1 ttt -70.99 120.03 76.96 Favored Pre-proline 0 N--CA 1.452 -0.371 0 C-N-CA 125.004 1.321 . . . . 1.46 111.039 -178.605 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -75.62 122.33 6.85 Favored 'Trans proline' 0 N--CA 1.446 -1.304 0 C-N-CA 123.297 2.665 . . . . 2.0499999999999998 111.135 178.933 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -61.06 137.39 48.16 Favored Glycine 0 N--CA 1.442 -0.934 0 CA-C-N 115.271 -0.877 . . . . 1.6799999999999999 114.833 -179.272 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 82.16 42.71 8.53 Favored Glycine 0 CA--C 1.524 0.632 0 CA-C-N 114.225 -0.988 . . . . 0.54000000000000004 110.636 175.829 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -63.66 -57.42 11.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 C-N-CA 124.379 1.072 . . . . 2.1899999999999999 109.283 174.172 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -98.12 155.94 16.9 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.952 1.301 . . . . 1.53 109.383 166.08 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -146.0 151.37 37.67 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 124.322 1.049 . . . . 3.4900000000000002 110.959 178.424 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 72.51 -163.62 54.69 Favored Glycine 0 CA--C 1.53 1.016 0 N-CA-C 110.747 -0.941 . . . . 1.05 110.747 -174.437 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -52.02 -24.13 6.2 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.737 1.215 . . . . 2.1200000000000001 112.718 -179.061 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 47.9 tt0 -43.99 -63.16 0.92 Allowed 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.736 1.215 . . . . 2.6099999999999999 110.283 167.903 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.45 -45.09 94.93 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.189 0.596 . . . . 1.3999999999999999 110.271 -176.275 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -53.81 -54.07 43.58 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.742 0.817 . . . . 1.99 110.979 178.001 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -56.41 -49.51 74.3 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 123.811 0.844 . . . . 1.73 109.764 -179.824 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 69.2 t -54.99 -52.77 40.58 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-N 116.939 -0.119 . . . . 1.5900000000000001 111.26 176.802 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -54.63 -52.02 63.57 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.38 0.672 . . . . 1.3200000000000001 111.919 -179.881 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.99 -48.06 79.33 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 121.553 0.692 . . . . 1.26 110.555 177.226 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 54.6 t90 -57.08 -44.97 83.64 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 121.71 -0.619 . . . . 0.54000000000000004 110.548 177.778 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.89 -37.38 87.17 Favored 'General case' 0 N--CA 1.461 0.088 0 C-N-CA 124.749 1.22 . . . . 2.7799999999999998 111.599 177.203 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -54.69 -38.44 67.01 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 119.216 0.916 . . . . 1.6599999999999999 110.432 169.552 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -88.76 26.2 1.58 Allowed 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 113.473 0.916 . . . . 3.3100000000000001 113.473 171.795 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 2.1 mtpm? -122.05 117.88 27.41 Favored 'General case' 0 C--N 1.341 0.239 0 O-C-N 120.647 -1.283 . . . . 3.1400000000000001 110.218 165.854 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.256 1.405 0 C-N-CA 129.535 3.134 . . . . 3.6600000000000001 104.738 174.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . 2.22 0.5 OUTLIER . . . . . 0 N--CA 1.471 0.623 0 CA-C-O 114.298 -2.763 . . . . 3.7200000000000002 105.977 . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -96.59 89.31 4.94 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 104.12 -2.548 . . . . 2.3100000000000001 104.12 153.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.27 -52.49 33.22 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-O 122.428 1.109 . . . . 1.8799999999999999 109.265 -166.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -55.69 -48.06 75.72 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 114.15 -1.387 . . . . 2.73 111.839 175.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.86 -46.06 82.05 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 119.617 1.099 . . . . 1.74 111.013 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 68.7 t -55.86 -56.76 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.225 0 N-CA-C 108.901 -0.777 . . . . 1.6499999999999999 108.901 176.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 29.9 t -51.93 -49.14 38.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 O-C-N 122.343 -0.223 . . . . 1.53 111.274 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 18.1 mm-40 -57.34 -8.03 0.69 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 127.895 2.478 . . . . 1.22 113.671 176.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 19.6 tp60 -137.44 17.57 2.93 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 119.772 1.169 . . . . 3.9500000000000002 111.522 172.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 50.3 mmtt -138.97 -59.44 0.6 Allowed 'General case' 0 CA--C 1.514 -0.434 0 O-C-N 121.111 -0.993 . . . . 3.6699999999999999 110.435 -177.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 2.8 m -79.45 -47.68 15.24 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 108.698 -0.852 . . . . 0.44 108.698 -173.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.5 pp -52.85 -30.2 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 CA-C-N 115.384 -0.826 . . . . 1.74 111.95 -179.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.8 m -46.01 -30.81 1.97 Allowed 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.132 1.373 . . . . 1.8200000000000001 112.738 176.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 30.1 m -121.93 -44.55 2.3 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.784 0.834 . . . . 0.20999999999999999 111.386 173.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 87.1 m-70 -68.61 -10.13 54.07 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.724 1.21 . . . . 0.38 112.558 -177.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 87.99 148.31 15.19 Favored Glycine 0 C--N 1.339 0.702 0 C-N-CA 125.468 1.509 . . . . 1.48 109.64 179.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -41.83 -36.98 1.92 Allowed Glycine 0 C--N 1.341 0.84 0 C-N-CA 124.653 1.121 . . . . 1.23 112.214 173.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -89.94 -12.4 38.93 Favored 'General case' 0 N--CA 1.444 -0.76 0 C-N-CA 125.876 1.67 . . . . 3.0800000000000001 111.429 -172.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.0 mt 71.24 11.61 6.79 Favored 'General case' 0 C--N 1.349 0.56 0 CA-C-N 119.983 1.265 . . . . 2.2200000000000002 111.249 178.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.6 p -87.2 0.09 55.88 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 127.696 2.398 . . . . 1.6299999999999999 110.018 -175.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.7 126.22 2.32 Favored Glycine 0 N--CA 1.441 -0.977 0 N-CA-C 109.052 -1.619 . . . . 0.81000000000000005 109.052 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -131.27 -77.93 0.52 Allowed 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 124.311 1.044 . . . . 1.5 108.405 178.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 12.6 m -92.59 4.29 53.9 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.393 1.077 . . . . 2.02 110.984 173.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -157.82 166.63 16.16 Favored Pre-proline 0 CA--C 1.537 0.453 0 C-N-CA 125.013 1.325 . . . . 1.5 108.353 -168.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -73.88 153.91 48.01 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 123.136 2.557 . . . . 0.51000000000000001 110.552 -173.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -72.04 125.71 27.94 Favored 'General case' 0 C--N 1.332 -0.171 0 O-C-N 121.107 -0.996 . . . . 1.5900000000000001 110.725 -174.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 18.1 pt -104.43 1.63 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.143 0 C-N-CA 123.351 0.66 . . . . 1.6799999999999999 111.697 176.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -36.79 -44.9 0.51 Allowed 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.416 1.086 . . . . 2.3799999999999999 112.986 170.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 8.4 pttp -113.2 31.89 6.13 Favored 'General case' 0 C--N 1.344 0.332 0 C-N-CA 123.94 0.896 . . . . 4.9299999999999997 111.876 178.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.92 -44.32 96.41 Favored 'General case' 0 N--CA 1.454 -0.242 0 O-C-N 120.836 -1.165 . . . . 1.54 109.297 178.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -54.2 -26.65 36.62 Favored Glycine 0 C--N 1.339 0.746 0 CA-C-N 118.238 0.472 . . . . 0.58999999999999997 113.915 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -83.59 -45.07 13.92 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 117.29 0.545 . . . . 2.1400000000000001 110.031 175.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 35.3 m-80 -58.27 -51.77 68.37 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 122.728 0.411 . . . . 1.6200000000000001 111.333 178.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -134.12 149.99 51.11 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.456 1.503 . . . . 1.3200000000000001 108.485 -166.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.66 164.37 25.37 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 109.856 -0.424 . . . . 2.52 109.856 -179.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -49.39 -42.77 43.27 Favored 'General case' 0 C--O 1.223 -0.331 0 C-N-CA 123.301 0.64 . . . . 3.27 110.779 173.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 70.9 mt-10 -52.98 -44.86 67.5 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.207 0.603 . . . . 2.9199999999999999 110.776 178.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 58.2 mm-40 -75.06 -47.96 26.28 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.172 0.589 . . . . 3.0499999999999998 110.037 -177.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 76.4 mt -62.77 -46.34 96.6 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.111 0 N-CA-C 108.941 -0.763 . . . . 1.5700000000000001 108.941 -175.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 32.4 tp -53.48 -51.72 61.83 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 124.061 0.944 . . . . 1.71 109.281 176.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -53.09 -51.56 61.44 Favored 'General case' 0 N--CA 1.452 -0.368 0 O-C-N 123.374 0.421 . . . . 1.95 110.504 176.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 40.9 mt -56.02 -45.15 80.26 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.378 0 O-C-N 121.451 -0.781 . . . . 1.78 111.184 177.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 43.3 mt -61.98 -45.41 98.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 O-C-N 119.951 -1.718 . . . . 1.7 109.482 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 87.5 mt -69.81 -29.04 66.23 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.118 0.967 . . . . 2.04 113.364 -178.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -128.87 19.54 6.05 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 119.683 1.128 . . . . 1.8 110.338 -166.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 34.87 -146.52 0.04 OUTLIER Glycine 0 CA--C 1.538 1.516 0 C-N-CA 128.975 3.179 . . . . 0.64000000000000001 112.397 -170.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 177.37 135.64 0.07 Allowed 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.173 1.389 . . . . 1.3100000000000001 108.075 -176.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 32.0 -110.67 0.04 OUTLIER Glycine 0 CA--C 1.533 1.171 0 C-N-CA 125.038 1.304 . . . . 0.45000000000000001 114.095 -174.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -71.03 -24.65 76.91 Favored Glycine 0 CA--C 1.534 1.243 0 CA-C-N 118.116 0.958 . . . . 0.57999999999999996 113.053 -178.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 17.6 ttt -69.36 118.35 61.33 Favored Pre-proline 0 CA--C 1.535 0.388 0 C-N-CA 125.06 1.344 . . . . 1.6899999999999999 111.3 -179.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -75.67 127.86 10.54 Favored 'Trans proline' 0 N--CA 1.446 -1.279 0 C-N-CA 122.877 2.385 . . . . 2.1099999999999999 110.671 177.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -66.48 140.35 38.86 Favored Glycine 0 N--CA 1.442 -0.909 0 N-CA-C 115.158 0.823 . . . . 1.6799999999999999 115.158 -177.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 79.53 39.17 18.93 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 110.6 -1.0 . . . . 0.38 110.6 176.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -60.19 -48.95 86.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 124.645 1.178 . . . . 2.1800000000000002 108.863 175.07 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -102.72 149.3 24.59 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 126.031 1.732 . . . . 1.53 108.87 162.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 65.6 mttt -141.42 160.04 40.97 Favored 'General case' 0 C--N 1.339 0.119 0 C-N-CA 124.097 0.959 . . . . 3.5699999999999998 110.036 172.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 74.84 -165.16 54.73 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 109.999 -1.241 . . . . 1.25 109.999 -174.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -54.32 -24.47 19.38 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.451 0.701 . . . . 2.2000000000000002 111.691 -178.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -41.92 -60.14 1.49 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.198 1.399 . . . . 2.3100000000000001 110.511 169.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.6 -45.66 93.16 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 122.537 0.335 . . . . 1.51 110.293 -174.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -51.73 -60.69 2.88 Favored 'General case' 0 C--N 1.339 0.111 0 C-N-CA 124.08 0.952 . . . . 2.73 110.739 174.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -52.77 -48.9 66.49 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-O 119.242 -0.408 . . . . 1.6899999999999999 110.743 -179.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 78.6 t -53.69 -59.75 1.75 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 CA-C-N 117.787 0.267 . . . . 1.72 110.865 176.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -50.33 -51.47 45.28 Favored 'General case' 0 C--O 1.226 -0.138 0 C-N-CA 123.669 0.788 . . . . 1.73 112.159 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.2 -45.43 80.81 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.4 0.68 . . . . 1.55 110.683 -175.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 77.3 t90 -55.23 -47.82 74.83 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 109.041 -0.726 . . . . 0.91000000000000003 109.041 173.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.03 -37.79 80.83 Favored 'General case' 0 C--O 1.22 -0.474 0 CA-C-O 117.977 -1.011 . . . . 3.1400000000000001 112.911 173.04 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -52.95 -40.89 64.02 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 120.381 1.446 . . . . 1.6200000000000001 110.735 175.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -67.54 -38.08 83.66 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-O 118.944 -0.55 . . . . 3.7400000000000002 112.329 170.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 24.2 mtpp -76.37 108.86 9.62 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 119.906 1.23 . . . . 3.6600000000000001 111.092 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 88.9 mttt . . . . . 0 C--O 1.25 1.126 0 C-N-CA 126.013 1.725 . . . . 3.02 107.599 -176.356 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 24.9 t . . . . . 0 N--CA 1.471 0.593 0 N-CA-C 106.994 -1.484 . . . . 2.1299999999999999 106.994 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -83.04 106.36 14.79 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 108.137 -1.06 . . . . 2.2000000000000002 108.137 -173.508 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -48.0 -54.14 13.91 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.834 0.854 . . . . 1.5900000000000001 110.786 -179.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -53.34 -46.55 69.53 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 122.73 0.412 . . . . 3.29 111.621 176.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.3 -44.47 97.16 Favored 'General case' 0 CA--C 1.527 0.062 0 C-N-CA 122.877 0.471 . . . . 1.4099999999999999 110.569 -179.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 77.7 t -57.94 -55.4 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 N-CA-C 109.232 -0.655 . . . . 1.74 109.232 175.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 79.0 t -50.99 -47.92 29.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 110.379 -0.23 . . . . 1.72 110.379 -179.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 28.6 mm-40 -54.22 -23.33 14.29 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 126.455 1.902 . . . . 0.64000000000000001 114.72 174.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -142.6 59.23 1.44 Allowed 'General case' 0 N--CA 1.461 0.088 0 CA-C-N 120.54 1.518 . . . . 2.6899999999999999 112.106 173.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.08 -36.39 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 124.435 1.094 . . . . 2.0499999999999998 109.611 171.177 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 3.7 m -101.9 -50.4 3.69 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 118.813 0.733 . . . . 0.28999999999999998 110.931 -177.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.0 pp -56.77 -25.77 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 N-CA-C 112.556 0.576 . . . . 1.8200000000000001 112.556 -174.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.3 m -41.8 -34.89 0.7 Allowed 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.576 1.55 . . . . 1.6699999999999999 112.475 172.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 18.9 m -121.1 -42.97 2.46 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.369 0.668 . . . . 0.20000000000000001 111.385 175.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 84.8 m-70 -71.34 -7.65 48.52 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.422 0.689 . . . . 0.23000000000000001 112.741 -176.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 88.49 149.29 18.67 Favored Glycine 0 C--N 1.338 0.669 0 N-CA-C 109.776 -1.329 . . . . 1.4399999999999999 109.776 178.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -43.17 -36.45 2.84 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 124.615 1.102 . . . . 1.26 112.233 174.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -97.58 -4.39 37.79 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 124.88 1.272 . . . . 2.8999999999999999 111.793 -172.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.5 mt 71.43 12.83 6.58 Favored 'General case' 0 C--N 1.348 0.531 0 CA-C-N 120.238 1.381 . . . . 2.4500000000000002 111.071 176.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.3 p -88.71 1.23 55.5 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 127.866 2.466 . . . . 1.6599999999999999 110.038 -173.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.51 138.0 5.57 Favored Glycine 0 N--CA 1.444 -0.808 0 N-CA-C 109.049 -1.62 . . . . 0.41999999999999998 109.049 -177.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -143.79 -71.56 0.29 Allowed 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.469 -0.567 . . . . 1.6799999999999999 109.469 178.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -99.02 3.92 47.01 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.939 1.696 . . . . 1.75 110.315 172.393 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -158.28 165.43 18.6 Favored Pre-proline 0 CA--C 1.535 0.394 0 C-N-CA 124.907 1.283 . . . . 1.4299999999999999 107.852 -168.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -69.5 157.73 59.84 Favored 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 122.621 2.214 . . . . 0.25 110.53 -175.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.64 121.49 20.79 Favored 'General case' 0 N--CA 1.454 -0.246 0 O-C-N 121.724 -0.61 . . . . 1.6100000000000001 109.934 -178.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 41.7 pt -100.99 1.88 10.56 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.161 0 C-N-CA 123.536 0.735 . . . . 1.52 111.039 178.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.404 ' OD1' ' NZ ' ' A' ' 91' ' ' LYS . 34.2 t70 -44.01 -41.23 5.28 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 113.506 0.928 . . . . 3.1800000000000002 113.506 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 35.0 mttm -109.3 33.19 4.44 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 125.838 1.655 . . . . 6.9100000000000001 111.403 179.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -58.26 -46.02 86.76 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 108.975 -0.75 . . . . 1.4099999999999999 108.975 173.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -54.07 -28.55 41.62 Favored Glycine 0 CA--C 1.527 0.785 0 CA-C-N 118.243 0.474 . . . . 0.51000000000000001 114.158 -179.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -78.62 -42.6 28.46 Favored 'General case' 0 N--CA 1.455 -0.223 0 O-C-N 122.227 -0.573 . . . . 1.6000000000000001 110.049 175.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 15.8 m-80 -65.63 -48.53 71.91 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 122.784 0.434 . . . . 1.5700000000000001 111.197 -178.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -138.79 147.74 42.93 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 125.423 1.489 . . . . 1.29 108.327 -170.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 89.6 p -74.62 168.28 20.11 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.033 0.533 . . . . 3.02 110.973 177.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -46.66 -47.21 20.3 Favored 'General case' 0 C--O 1.224 -0.278 0 C-N-CA 124.311 1.044 . . . . 2.7599999999999998 111.582 174.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -57.7 -41.54 81.91 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.422 0.689 . . . . 4.0300000000000002 110.531 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -76.23 -45.79 31.26 Favored 'General case' 0 N--CA 1.45 -0.428 0 O-C-N 121.437 -0.789 . . . . 3.4399999999999999 109.391 -175.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 80.9 mt -60.76 -44.43 97.37 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.125 0 N-CA-C 109.027 -0.731 . . . . 1.6299999999999999 109.027 178.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 33.5 tp -54.66 -49.02 71.58 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 109.277 -0.638 . . . . 1.49 109.277 176.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -54.1 -46.19 72.04 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 117.891 0.314 . . . . 1.48 111.498 175.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 73.9 mt -59.63 -49.79 82.4 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.261 0 O-C-N 121.115 -0.991 . . . . 1.6799999999999999 110.453 176.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 58.8 mt -56.18 -44.64 79.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 O-C-N 120.386 -1.446 . . . . 1.6299999999999999 110.002 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 69.5 mt -71.04 -28.64 64.52 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 124.309 1.043 . . . . 1.52 113.802 -178.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 51.3 m-80 -125.02 15.54 8.51 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 120.374 1.443 . . . . 1.73 110.629 -169.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 35.84 -144.14 0.09 OUTLIER Glycine 0 CA--C 1.537 1.428 0 C-N-CA 128.082 2.753 . . . . 0.62 111.597 -166.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 173.83 133.56 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 119.465 1.632 . . . . 1.3200000000000001 110.021 -177.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 40.26 -119.36 1.26 Allowed Glycine 0 CA--C 1.532 1.126 0 CA-C-N 119.574 1.079 . . . . 0.46000000000000002 112.789 -173.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -66.14 -21.76 70.22 Favored Glycine 0 CA--C 1.534 1.233 0 CA-C-N 117.498 0.649 . . . . 0.56000000000000005 113.245 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 18.2 ttt -74.04 121.07 84.33 Favored Pre-proline 0 CA--C 1.536 0.41 0 C-N-CA 124.406 1.082 . . . . 1.4099999999999999 111.539 -176.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -79.02 122.71 5.41 Favored 'Trans proline' 0 N--CA 1.449 -1.097 0 C-N-CA 123.262 2.641 . . . . 2.1099999999999999 111.688 -178.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -60.65 138.76 48.21 Favored Glycine 0 N--CA 1.443 -0.89 0 N-CA-C 115.5 0.96 . . . . 1.6100000000000001 115.5 -177.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 81.94 35.63 21.03 Favored Glycine 0 CA--C 1.527 0.783 0 CA-C-N 114.379 -0.911 . . . . 0.33000000000000002 111.612 174.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.2 mt -58.23 -52.16 62.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 124.924 1.29 . . . . 2.2999999999999998 110.059 175.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -111.02 161.68 15.63 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.748 1.619 . . . . 1.6299999999999999 109.036 165.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 18.0 mttm -144.32 164.3 31.18 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 124.931 1.292 . . . . 3.6699999999999999 110.412 176.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 57.2 -144.5 39.51 Favored Glycine 0 CA--C 1.529 0.908 0 N-CA-C 111.185 -0.766 . . . . 0.88 111.185 179.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -52.23 -33.98 43.84 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.203 0.601 . . . . 1.98 111.526 174.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -55.02 -36.64 65.69 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.443 0.697 . . . . 2.2799999999999998 110.515 176.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -88.05 -52.69 5.12 Favored 'General case' 0 CA--C 1.534 0.336 0 O-C-N 121.662 -0.649 . . . . 1.45 111.086 175.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -54.73 -50.9 67.24 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.789 0.836 . . . . 2.48 111.568 -175.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.61 -45.37 92.14 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 109.644 -0.502 . . . . 1.46 109.644 -178.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 64.9 t -57.19 -55.12 22.43 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 C-N-CA 122.831 0.452 . . . . 1.5900000000000001 110.363 176.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -50.28 -53.83 25.69 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 122.973 0.509 . . . . 1.3600000000000001 111.497 177.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.33 -44.78 95.69 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 121.542 0.686 . . . . 1.5700000000000001 111.278 -178.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 81.0 t90 -60.82 -50.08 74.91 Favored 'General case' 0 N--CA 1.452 -0.356 0 O-C-N 121.471 -0.768 . . . . 0.75 110.221 179.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.6 -30.64 70.82 Favored 'General case' 0 C--O 1.222 -0.367 0 O-C-N 121.3 -0.875 . . . . 2.96 111.927 172.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -58.92 -31.48 68.69 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 119.603 1.092 . . . . 1.48 111.21 171.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -76.02 -35.68 59.43 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 118.927 0.785 . . . . 3.4900000000000002 111.784 169.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.404 ' NZ ' ' OD1' ' A' ' 49' ' ' ASP . 0.7 OUTLIER -73.34 110.18 7.44 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 119.522 1.055 . . . . 3.7999999999999998 111.068 -179.64 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 19.7 mttt . . . . . 0 C--O 1.251 1.163 0 C-N-CA 125.507 1.523 . . . . 3.7000000000000002 109.342 -170.817 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.0 t . . . . . 0 N--CA 1.472 0.625 0 N-CA-C 106.566 -1.642 . . . . 2.25 106.566 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -74.1 103.83 4.7 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 108.383 -0.969 . . . . 2.6800000000000002 108.383 -177.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -42.69 -56.09 3.3 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.677 1.191 . . . . 1.55 111.088 177.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -47.56 -47.04 28.45 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 123.524 0.73 . . . . 3.0699999999999998 111.73 175.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.98 -46.06 90.91 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-N 118.682 0.674 . . . . 1.52 110.412 -179.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 94.5 t -58.51 -52.22 62.1 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.134 0 N-CA-C 109.691 -0.485 . . . . 1.76 109.691 177.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 72.4 t -52.47 -52.22 27.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 N-CA-C 109.756 -0.461 . . . . 1.6799999999999999 109.756 179.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 35.3 mm-40 -58.12 -7.2 0.75 Allowed 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 127.547 2.339 . . . . 0.65000000000000002 114.022 174.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -142.82 33.1 1.4 Allowed 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 119.81 1.187 . . . . 3.1600000000000001 113.369 172.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -153.92 -55.66 0.11 Allowed 'General case' 0 CA--C 1.517 -0.314 0 O-C-N 121.766 -0.584 . . . . 2.6600000000000001 109.885 170.183 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 3.2 m -76.34 -48.29 20.5 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 109.824 -0.436 . . . . 0.27000000000000002 109.824 -170.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.1 pt -49.93 -30.99 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-N 115.217 -0.901 . . . . 2.1200000000000001 112.517 -179.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.9 m -46.06 -33.02 3.17 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 125.64 1.576 . . . . 1.8799999999999999 112.077 177.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 14.6 m -121.95 -44.84 2.28 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.706 0.802 . . . . 0.19 111.228 175.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 82.0 m-70 -67.43 -11.11 57.0 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.189 0.996 . . . . 0.38 112.319 -178.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 87.82 148.04 14.25 Favored Glycine 0 C--N 1.339 0.712 0 N-CA-C 109.396 -1.481 . . . . 1.4299999999999999 109.396 178.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -43.83 -31.92 2.04 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 124.655 1.121 . . . . 1.3400000000000001 112.969 173.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -92.62 -12.44 31.63 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.596 1.559 . . . . 2.1499999999999999 112.831 -175.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 73.0 9.71 5.37 Favored 'General case' 0 C--N 1.347 0.489 0 CA-C-N 120.326 1.421 . . . . 2.7400000000000002 111.168 178.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.0 p -86.0 -1.66 57.55 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 127.947 2.499 . . . . 1.5 110.222 -174.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.64 132.25 4.64 Favored Glycine 0 N--CA 1.443 -0.86 0 N-CA-C 108.726 -1.75 . . . . 0.52000000000000002 108.726 -179.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -137.45 -75.83 0.4 Allowed 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 108.869 -0.789 . . . . 1.71 108.869 179.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 15.7 m -95.47 4.3 53.4 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.658 1.183 . . . . 2.0299999999999998 110.628 172.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -156.6 167.73 13.84 Favored Pre-proline 0 N--CA 1.45 -0.474 0 C-N-CA 124.842 1.257 . . . . 1.6799999999999999 108.33 -171.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -71.02 156.43 60.04 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 122.951 2.434 . . . . 0.37 110.508 -174.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.37 126.74 30.84 Favored 'General case' 0 N--CA 1.455 -0.199 0 O-C-N 121.513 -0.742 . . . . 1.6000000000000001 110.083 -177.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 36.3 pt -103.2 0.62 10.32 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.191 0 C-N-CA 123.239 0.616 . . . . 1.6699999999999999 111.196 174.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -33.23 -45.73 0.15 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.606 1.562 . . . . 2.29 113.071 168.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.62 39.95 3.2 Favored 'General case' 0 C--N 1.343 0.317 0 C-N-CA 124.184 0.993 . . . . 4.8499999999999996 111.475 177.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.63 -42.99 85.88 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 121.324 -0.86 . . . . 1.7 109.601 174.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -52.4 -32.53 37.89 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-N 118.507 0.594 . . . . 0.66000000000000003 114.387 -175.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -78.22 -49.13 14.33 Favored 'General case' 0 N--CA 1.455 -0.221 0 O-C-N 122.39 -0.477 . . . . 1.8200000000000001 110.172 174.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 33.0 m-80 -56.6 -48.84 76.57 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 122.865 0.466 . . . . 1.53 111.533 -177.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -136.47 140.16 42.88 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.751 1.62 . . . . 1.6499999999999999 107.373 -169.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 90.4 p -73.87 169.01 18.29 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 121.641 -0.662 . . . . 3.2599999999999998 110.716 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -48.17 -52.59 20.1 Favored 'General case' 0 C--N 1.341 0.233 0 O-C-N 121.811 -0.555 . . . . 4.9400000000000004 110.103 174.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -53.97 -27.22 29.94 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 118.69 -0.672 . . . . 2.75 112.51 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -87.87 -46.87 9.04 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 119.325 0.966 . . . . 3.2799999999999998 110.248 177.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 83.4 mt -62.62 -47.73 91.53 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.145 0 O-C-N 121.31 -0.868 . . . . 1.6000000000000001 109.153 -177.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 25.3 tp -53.38 -50.07 65.87 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 109.036 -0.728 . . . . 1.6499999999999999 109.036 176.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -49.43 -55.83 11.75 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 122.701 0.4 . . . . 2.77 110.054 173.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 23.2 mt -56.16 -45.45 80.83 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.366 0 C-N-CA 120.329 -0.548 . . . . 1.6499999999999999 110.69 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 56.0 mt -58.46 -40.34 78.14 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 O-C-N 120.099 -1.626 . . . . 1.6599999999999999 109.926 178.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 71.9 mt -70.73 -40.61 72.65 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.359 1.064 . . . . 1.76 113.439 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 14.8 p30 -124.29 27.16 7.14 Favored 'General case' 0 C--N 1.343 0.312 0 CA-C-N 120.899 1.681 . . . . 3.8999999999999999 110.12 -168.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 34.2 -140.33 0.12 Allowed Glycine 0 CA--C 1.534 1.268 0 C-N-CA 128.344 2.878 . . . . 0.64000000000000001 110.999 -173.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 2.3 tp-100 176.87 140.58 0.07 Allowed 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 107.592 -1.262 . . . . 2.9700000000000002 107.592 -179.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 40.97 -112.17 0.33 Allowed Glycine 0 CA--C 1.536 1.344 0 CA-C-N 119.953 1.251 . . . . 0.48999999999999999 113.782 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -79.78 -20.92 67.2 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 123.87 0.748 . . . . 0.64000000000000001 112.866 178.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.411 ' HB2' ' C1D' ' A' ' 93' ' ' HEC . 19.8 ttt -68.01 118.48 58.87 Favored Pre-proline 0 CA--C 1.534 0.338 0 C-N-CA 125.041 1.336 . . . . 1.48 110.734 179.18 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -76.42 122.05 6.34 Favored 'Trans proline' 0 N--CA 1.446 -1.293 0 C-N-CA 122.698 2.265 . . . . 2.0800000000000001 111.166 -179.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -59.06 135.79 51.64 Favored Glycine 0 N--CA 1.442 -0.922 0 CA-C-N 115.364 -0.834 . . . . 1.6399999999999999 114.869 -179.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 88.19 35.92 8.57 Favored Glycine 0 CA--C 1.53 0.97 0 CA-C-N 114.466 -0.867 . . . . 0.34999999999999998 112.368 172.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.3 mt -64.94 -46.88 90.33 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.863 0 C-N-CA 125.76 1.624 . . . . 2.2200000000000002 110.981 178.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -116.36 149.33 39.52 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 126.238 1.815 . . . . 1.5800000000000001 107.561 163.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.3 mtpp -144.03 162.26 36.68 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 125.973 1.709 . . . . 3.1800000000000002 108.293 178.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 63.68 -161.4 35.79 Favored Glycine 0 CA--C 1.529 0.966 0 N-CA-C 110.933 -0.867 . . . . 0.75 110.933 -174.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -51.6 -27.71 12.0 Favored 'General case' 0 C--O 1.225 -0.224 0 C-N-CA 123.949 0.9 . . . . 1.6899999999999999 112.226 -177.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -44.63 -60.68 1.88 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.931 1.293 . . . . 2.0800000000000001 109.766 168.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -69.47 -46.19 67.24 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.838 0.855 . . . . 1.46 110.821 -178.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -56.27 -49.58 73.83 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 121.231 0.539 . . . . 1.97 110.157 -176.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -55.52 -53.5 55.63 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 123.467 0.707 . . . . 1.51 109.678 176.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 89.1 t -51.37 -56.24 5.84 Favored 'Isoleucine or valine' 0 C--N 1.339 0.138 0 CA-C-N 117.826 0.284 . . . . 1.6200000000000001 110.738 178.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -50.66 -54.85 19.7 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 123.833 0.853 . . . . 1.6899999999999999 111.763 179.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -63.04 -45.11 93.84 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 121.338 0.589 . . . . 1.3100000000000001 110.995 -177.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 84.7 t90 -57.69 -52.74 64.2 Favored 'General case' 0 C--N 1.329 -0.286 0 O-C-N 121.701 -0.624 . . . . 0.81999999999999995 109.485 177.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.77 -30.96 71.14 Favored 'General case' 0 C--O 1.222 -0.366 0 CA-C-O 118.028 -0.987 . . . . 2.9300000000000002 112.714 174.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -55.88 -35.67 66.77 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 119.963 1.256 . . . . 1.5600000000000001 109.985 172.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -74.18 -37.51 63.92 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.002 0.521 . . . . 2.8199999999999998 111.392 173.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 3.5 mtpt -73.82 126.6 30.75 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 119.342 0.974 . . . . 3.29 110.988 -178.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 19.6 mtmt . . . . . 0 C--O 1.253 1.244 0 CA-C-O 115.897 -2.001 . . . . 3.0499999999999998 106.187 -174.751 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' HEC . . . . . 0.411 ' C1D' ' HB2' ' A' ' 71' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.1 t . . . . . 0 N--CA 1.472 0.67 0 N-CA-C 106.638 -1.616 . . . . 2.4300000000000002 106.638 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -116.97 107.25 14.33 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 106.744 -1.576 . . . . 4.0499999999999998 106.744 178.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -50.27 -44.97 53.98 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 123.682 0.793 . . . . 1.55 111.46 176.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -66.26 -46.94 75.34 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 107.94 -1.133 . . . . 2.75 107.94 -174.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.78 -46.64 77.9 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 122.886 0.474 . . . . 1.6100000000000001 111.175 175.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 75.4 t -56.58 -57.49 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 N-CA-C 109.264 -0.643 . . . . 1.6499999999999999 109.264 176.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 72.2 t -53.31 -47.8 56.81 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 CA-C-N 118.05 0.386 . . . . 1.53 110.865 -177.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -51.38 -23.92 4.26 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 126.326 1.85 . . . . 0.55000000000000004 113.488 174.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -138.19 57.44 1.71 Allowed 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 119.354 0.979 . . . . 2.8799999999999999 110.857 172.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -172.04 -38.58 0.02 OUTLIER 'General case' 0 C--O 1.225 -0.231 0 C-N-CA 123.736 0.815 . . . . 2.2999999999999998 110.524 168.567 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 3.7 m -97.5 -50.85 4.35 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 119.042 0.837 . . . . 0.23000000000000001 110.26 -178.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.6 pp -57.92 -26.05 27.44 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.156 0 CA-C-N 116.202 -0.454 . . . . 1.6599999999999999 112.134 -173.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.9 m -38.92 -36.75 0.3 Allowed 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 125.841 1.656 . . . . 1.75 112.224 170.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 15.0 m -120.27 -44.72 2.47 Favored 'General case' 0 C--N 1.34 0.187 0 C-N-CA 123.356 0.662 . . . . 0.23000000000000001 111.317 174.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 85.7 m-70 -70.46 -7.79 46.06 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.899 0.879 . . . . 0.25 112.946 -175.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 87.92 149.3 17.16 Favored Glycine 0 C--N 1.337 0.622 0 N-CA-C 109.977 -1.249 . . . . 1.48 109.977 176.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -45.89 -38.7 8.17 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 124.197 0.903 . . . . 1.22 111.981 177.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -93.73 -1.13 55.52 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.417 1.087 . . . . 2.3900000000000001 111.563 -174.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.5 mt 70.66 12.26 7.27 Favored 'General case' 0 C--N 1.349 0.58 0 CA-C-N 120.39 1.45 . . . . 2.52 110.828 174.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.5 p -87.81 0.26 56.02 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 128.185 2.594 . . . . 1.48 109.976 -172.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.56 136.25 4.42 Favored Glycine 0 N--CA 1.442 -0.916 0 N-CA-C 108.973 -1.651 . . . . 0.41999999999999998 108.973 -177.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -143.52 -76.9 0.24 Allowed 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 123.967 0.907 . . . . 1.3899999999999999 108.78 -179.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 24.4 t -95.91 4.97 52.32 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.902 1.281 . . . . 2.6499999999999999 110.397 172.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -157.15 165.49 18.69 Favored Pre-proline 0 N--CA 1.451 -0.376 0 C-N-CA 125.339 1.456 . . . . 1.48 107.936 -170.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -70.8 159.02 53.99 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.886 2.391 . . . . 0.28999999999999998 110.71 -174.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.7 119.96 18.65 Favored 'General case' 0 C--N 1.332 -0.186 0 O-C-N 121.362 -0.836 . . . . 1.51 109.941 -178.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 46.5 pt -101.17 2.56 10.63 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.118 0 C-N-CA 124.46 1.104 . . . . 1.52 110.51 177.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.408 ' OD1' ' NZ ' ' A' ' 91' ' ' LYS . 24.6 t70 -43.51 -43.98 5.75 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 112.316 0.487 . . . . 3.0699999999999998 112.316 178.214 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -109.31 40.87 1.76 Allowed 'General case' 0 C--N 1.344 0.345 0 C-N-CA 126.294 1.838 . . . . 4.7699999999999996 110.517 179.3 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.21 -48.54 81.3 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 118.968 -0.539 . . . . 1.5600000000000001 109.763 172.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -50.12 -39.28 34.03 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 123.578 0.609 . . . . 0.84999999999999998 113.578 -177.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.57 -41.62 98.37 Favored 'General case' 0 CA--C 1.528 0.123 0 O-C-N 122.05 -0.677 . . . . 1.8 111.578 174.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 18.2 m-80 -72.21 -51.23 22.09 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 122.71 0.404 . . . . 1.7 110.196 -177.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -140.41 140.1 35.39 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.052 1.341 . . . . 1.1499999999999999 107.832 -167.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.82 170.34 16.64 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 118.699 0.681 . . . . 2.9700000000000002 109.748 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -50.31 -42.94 53.48 Favored 'General case' 0 C--O 1.224 -0.239 0 O-C-N 121.547 -0.721 . . . . 2.96 111.898 179.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -54.51 -40.63 68.76 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 120.981 0.419 . . . . 2.5499999999999998 110.471 179.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -81.09 -45.58 16.26 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.241 1.016 . . . . 2.7599999999999998 109.76 -175.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 74.9 mt -61.63 -45.94 97.59 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.059 0 O-C-N 121.039 -1.038 . . . . 1.5600000000000001 109.057 179.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 31.0 tp -54.2 -46.23 72.38 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 109.212 -0.662 . . . . 1.8700000000000001 109.212 177.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -53.02 -53.24 53.01 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 123.148 0.28 . . . . 1.4099999999999999 110.626 173.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 59.2 mt -56.24 -43.08 75.55 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 O-C-N 121.385 -0.822 . . . . 1.71 111.414 178.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 45.4 mt -62.46 -45.29 99.14 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 O-C-N 120.07 -1.644 . . . . 1.54 109.677 179.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 76.5 mt -72.92 -28.9 62.73 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.425 1.09 . . . . 1.6599999999999999 113.042 -177.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -127.19 17.44 7.16 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 119.614 1.097 . . . . 1.71 110.331 -166.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.403 ' N ' ' HA2' ' A' ' 73' ' ' GLY . . . 36.41 -146.99 0.06 OUTLIER Glycine 0 CA--C 1.539 1.536 0 C-N-CA 128.65 3.024 . . . . 0.66000000000000003 112.216 -170.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 176.31 131.38 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 118.809 1.304 . . . . 1.3700000000000001 108.907 -175.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 39.78 -117.13 0.77 Allowed Glycine 0 CA--C 1.532 1.152 0 CA-C-N 119.938 1.245 . . . . 0.46000000000000002 113.16 -175.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -69.6 -20.64 75.81 Favored Glycine 0 CA--C 1.534 1.236 0 CA-C-N 117.481 0.641 . . . . 0.54000000000000004 113.402 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 20.5 ttt -71.94 120.45 80.2 Favored Pre-proline 0 N--CA 1.452 -0.362 0 C-N-CA 124.536 1.134 . . . . 1.47 110.821 -178.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -76.54 128.25 10.17 Favored 'Trans proline' 0 N--CA 1.444 -1.43 0 C-N-CA 122.241 1.96 . . . . 2.0699999999999998 110.434 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.403 ' HA2' ' N ' ' A' ' 67' ' ' GLY . . . -63.27 135.65 42.66 Favored Glycine 0 N--CA 1.443 -0.884 0 CA-C-N 115.627 -0.715 . . . . 1.71 114.691 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 82.78 41.36 8.88 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.648 -0.981 . . . . 0.44 110.648 176.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -60.34 -51.18 75.96 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 N-CA-C 108.765 -0.828 . . . . 3.1800000000000002 108.765 174.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -105.74 156.82 17.92 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.746 1.618 . . . . 1.51 109.648 166.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.3 mmtm -144.86 157.68 44.07 Favored 'General case' 0 C--O 1.227 -0.104 0 C-N-CA 125.166 1.387 . . . . 4.1799999999999997 108.038 178.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 67.37 -166.31 42.07 Favored Glycine 0 CA--C 1.531 1.046 0 N-CA-C 111.379 -0.688 . . . . 1.24 111.379 -173.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -51.32 -27.55 9.87 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.717 1.207 . . . . 1.6799999999999999 112.27 -179.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -37.69 -59.82 0.77 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.678 1.591 . . . . 1.8899999999999999 111.191 165.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.76 -49.12 69.52 Favored 'General case' 0 CA--C 1.531 0.215 0 O-C-N 121.937 -0.477 . . . . 1.49 111.128 -177.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -52.47 -54.62 30.01 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.568 1.147 . . . . 2.6000000000000001 111.055 -178.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -54.72 -51.56 65.22 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.145 0.978 . . . . 1.6899999999999999 109.82 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 54.7 t -54.12 -56.54 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 CA-C-N 116.933 -0.121 . . . . 1.5900000000000001 111.165 177.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -51.71 -50.48 60.45 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 123.009 0.523 . . . . 1.3500000000000001 111.831 179.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.44 -48.71 80.59 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 121.689 0.756 . . . . 1.45 110.581 -179.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . 0.425 ' CE3' ' CD2' ' A' ' 88' ' ' LEU . 54.4 t90 -58.72 -44.26 90.36 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.08 0.552 . . . . 0.56999999999999995 110.492 178.058 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.425 ' CD2' ' CE3' ' A' ' 87' ' ' TRP . 0.1 OUTLIER -63.11 -38.47 91.29 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.529 1.132 . . . . 2.8700000000000001 110.476 177.26 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -52.34 -49.77 63.63 Favored 'General case' 0 C--O 1.23 0.063 0 N-CA-C 109.468 -0.567 . . . . 1.5900000000000001 109.468 171.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -84.7 35.65 0.57 Allowed 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 116.434 -0.348 . . . . 3.5899999999999999 111.601 175.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.408 ' NZ ' ' OD1' ' A' ' 49' ' ' ASP . 0.5 OUTLIER -130.21 142.12 50.59 Favored 'General case' 0 C--N 1.343 0.311 0 O-C-N 121.171 -0.955 . . . . 3.8999999999999999 110.651 165.09 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 16.9 mtmt . . . . . 0 C--O 1.252 1.219 0 C-N-CA 128.82 2.848 . . . . 3.7200000000000002 105.413 -178.381 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.5 t . . . . . 0 N--CA 1.471 0.593 0 N-CA-C 107.446 -1.316 . . . . 2.3399999999999999 107.446 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -76.8 106.63 8.58 Favored 'General case' 0 N--CA 1.449 -0.511 0 O-C-N 124.053 0.845 . . . . 2.79 109.339 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -44.91 -52.26 8.85 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.124 0.969 . . . . 1.6499999999999999 111.124 174.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -53.92 -44.83 70.92 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 116.632 -0.258 . . . . 3.4399999999999999 111.456 177.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.89 -44.64 92.41 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 123.232 0.613 . . . . 1.45 110.44 -178.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 89.7 t -58.33 -54.66 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 N-CA-C 109.236 -0.653 . . . . 1.74 109.236 175.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.4 ' HA ' ' SG ' ' A' ' 32' ' ' CYS . 53.9 t -52.54 -49.01 46.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 C-N-CA 122.53 0.332 . . . . 1.6399999999999999 110.348 -178.445 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 24.4 mm-40 -52.52 -19.68 2.42 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 126.763 2.025 . . . . 0.75 114.248 174.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.43 48.6 1.18 Allowed 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 119.877 1.217 . . . . 3.6499999999999999 111.994 176.249 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.407 ' NZ ' ' OE2' ' A' ' 80' ' ' GLU . 0.5 OUTLIER -162.46 -39.7 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 124.415 1.086 . . . . 2.5 110.314 169.154 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.4 ' SG ' ' HA ' ' A' ' 28' ' ' VAL . 3.4 m -97.21 -49.05 5.11 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 118.845 0.748 . . . . 0.23999999999999999 110.383 -176.017 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.8 pp -58.01 -26.44 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 CA-C-N 115.819 -0.628 . . . . 1.76 112.148 -173.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 68.0 m -37.38 -39.19 0.27 Allowed 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 125.234 1.414 . . . . 1.6299999999999999 112.451 168.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 9.9 m -120.29 -41.16 2.63 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 122.818 0.447 . . . . 0.22 111.92 176.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 85.4 m-70 -71.63 -10.02 59.14 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.628 0.771 . . . . 0.32000000000000001 112.6 -177.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 86.34 149.5 13.89 Favored Glycine 0 C--N 1.337 0.625 0 N-CA-C 109.783 -1.327 . . . . 1.52 109.783 179.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -44.42 -37.83 4.95 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 124.53 1.062 . . . . 1.1799999999999999 112.103 175.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -93.22 -4.54 51.77 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.193 0.997 . . . . 2.3700000000000001 111.788 -173.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.4 mt 70.3 10.84 7.39 Favored 'General case' 0 C--N 1.349 0.583 0 CA-C-N 120.513 1.506 . . . . 2.23 111.297 176.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.9 p -84.84 -0.66 54.72 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 127.801 2.44 . . . . 1.48 109.957 -175.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.86 137.66 5.09 Favored Glycine 0 N--CA 1.44 -1.057 0 N-CA-C 108.885 -1.686 . . . . 0.44 108.885 -175.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -143.6 -79.77 0.2 Allowed 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 124.332 1.053 . . . . 1.3300000000000001 108.827 176.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -88.6 2.5 52.99 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.377 1.071 . . . . 1.6799999999999999 110.756 171.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -157.14 169.52 10.48 Favored Pre-proline 0 N--CA 1.451 -0.378 0 C-N-CA 124.518 1.127 . . . . 1.52 108.629 -172.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -70.08 158.69 55.71 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.973 2.448 . . . . 0.31 110.506 -174.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.68 124.41 25.93 Favored 'General case' 0 C--N 1.332 -0.177 0 O-C-N 121.512 -0.743 . . . . 1.6000000000000001 110.181 -177.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 45.1 pt -102.02 0.36 10.29 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.158 0 CA-C-O 118.885 -0.579 . . . . 1.7 111.419 175.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.483 ' OD1' ' NZ ' ' A' ' 91' ' ' LYS . 37.9 t70 -44.35 -36.96 3.05 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 113.605 0.965 . . . . 3.2799999999999998 113.605 178.005 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.4 ptpt -108.33 19.01 20.38 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.695 1.598 . . . . 4.6100000000000003 112.015 -178.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -55.54 -45.26 77.22 Favored 'General case' 0 N--CA 1.455 -0.198 0 O-C-N 121.228 -0.92 . . . . 1.75 110.297 -172.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -51.16 -31.66 26.9 Favored Glycine 0 CA--C 1.523 0.582 0 C-N-CA 123.461 0.553 . . . . 0.59999999999999998 114.26 179.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.08 -39.59 49.16 Favored 'General case' 0 N--CA 1.454 -0.273 0 O-C-N 122.036 -0.685 . . . . 1.8200000000000001 110.046 176.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -66.24 -47.84 72.45 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.559 0.743 . . . . 2.2200000000000002 111.22 -178.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -141.34 148.16 39.26 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.743 1.617 . . . . 1.73 107.971 -171.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 88.7 p -74.66 170.96 14.76 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 119.144 0.883 . . . . 3.1400000000000001 110.692 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -49.13 -42.1 38.29 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 123.118 0.567 . . . . 2.7000000000000002 111.187 173.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -62.49 -45.24 93.92 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 123.315 0.646 . . . . 2.77 109.55 -177.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -70.96 -47.15 60.59 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 108.362 -0.977 . . . . 2.79 108.362 -175.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 91.2 mt -59.97 -46.21 94.36 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 O-C-N 121.672 -0.643 . . . . 1.5900000000000001 109.403 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 58.4 tp -55.53 -50.1 70.89 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 109.127 -0.694 . . . . 1.55 109.127 176.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -52.7 -44.85 66.57 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 117.985 0.357 . . . . 1.95 111.341 178.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 79.6 mt -59.5 -56.7 15.44 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.288 0 C-N-CA 120.381 -0.528 . . . . 1.6899999999999999 109.7 174.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 69.9 mt -50.0 -41.65 18.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 O-C-N 120.655 -1.278 . . . . 1.5600000000000001 110.87 -178.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 73.5 mt -70.98 -34.25 71.22 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.276 1.03 . . . . 1.6499999999999999 113.619 178.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 48.1 m-80 -123.36 20.67 9.64 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 120.499 1.5 . . . . 1.78 110.59 -167.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 29.27 -138.77 0.03 OUTLIER Glycine 0 CA--C 1.535 1.338 0 C-N-CA 128.961 3.172 . . . . 0.62 111.722 -164.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 173.98 130.18 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 119.119 1.46 . . . . 1.6799999999999999 109.22 -178.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 43.23 -116.36 1.3 Allowed Glycine 0 CA--C 1.531 1.034 0 CA-C-N 119.719 1.145 . . . . 0.47999999999999998 112.883 -177.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -70.65 -18.61 75.86 Favored Glycine 0 CA--C 1.531 1.079 0 O-C-N 122.374 -0.486 . . . . 0.56000000000000005 113.16 -179.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 22.3 ttt -75.95 118.7 73.06 Favored Pre-proline 0 N--CA 1.45 -0.43 0 C-N-CA 124.52 1.128 . . . . 1.47 110.629 -178.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -75.65 119.41 5.45 Favored 'Trans proline' 0 N--CA 1.445 -1.369 0 C-N-CA 122.446 2.098 . . . . 2.1000000000000001 111.286 -178.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -58.66 138.13 49.59 Favored Glycine 0 N--CA 1.44 -1.083 0 CA-C-N 115.257 -0.883 . . . . 1.6100000000000001 114.594 -179.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 76.06 50.13 7.97 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.19 -1.164 . . . . 0.83999999999999997 110.19 177.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.7 mt -72.61 -62.33 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 124.901 1.28 . . . . 2.02 108.889 168.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -103.45 158.44 16.35 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.919 1.288 . . . . 1.54 109.261 168.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.1 mttt -142.54 171.28 14.27 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 126.175 1.79 . . . . 5.2699999999999996 109.702 177.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 54.55 -149.72 18.6 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 111.698 -0.561 . . . . 0.91000000000000003 111.698 175.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -52.13 -32.21 34.54 Favored 'General case' 0 C--N 1.339 0.149 0 C-N-CA 122.983 0.513 . . . . 1.99 111.435 172.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.407 ' OE2' ' NZ ' ' A' ' 31' ' ' LYS . 6.8 tt0 -53.6 -43.39 68.57 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 110.032 -0.358 . . . . 1.9099999999999999 110.032 176.009 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -84.57 -50.63 7.53 Favored 'General case' 0 CA--C 1.53 0.204 0 O-C-N 121.79 -0.569 . . . . 1.5 111.911 176.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -53.93 -50.9 65.4 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 118.591 0.632 . . . . 2.4300000000000002 111.549 -177.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.63 -46.36 84.25 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 109.361 -0.607 . . . . 1.6100000000000001 109.361 -179.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 53.8 t -57.19 -57.42 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 C-N-CA 122.913 0.485 . . . . 1.6799999999999999 110.955 177.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -48.29 -53.13 18.36 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 123.516 0.727 . . . . 1.3200000000000001 111.638 176.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -64.01 -44.31 93.0 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 121.329 0.585 . . . . 1.5900000000000001 111.548 -178.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 76.9 t90 -58.2 -49.43 77.08 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 121.493 -0.754 . . . . 0.57999999999999996 109.425 177.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.6 -29.01 70.31 Favored 'General case' 0 C--O 1.222 -0.381 0 CA-C-O 118.374 -0.822 . . . . 2.9100000000000001 112.977 173.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.58 -36.45 71.73 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 119.697 1.135 . . . . 1.4399999999999999 110.299 170.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -73.74 -37.33 65.11 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 119.255 -0.402 . . . . 2.8999999999999999 111.51 172.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.483 ' NZ ' ' OD1' ' A' ' 49' ' ' ASP . 8.5 mtpm? -72.81 114.18 10.67 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 119.039 0.836 . . . . 3.0099999999999998 111.478 178.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 75.0 mttt . . . . . 0 C--O 1.252 1.197 0 CA-C-O 116.372 -1.775 . . . . 3.23 108.004 -174.924 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.8 t . . . . . 0 N--CA 1.468 0.441 0 N-CA-C 106.762 -1.57 . . . . 1.97 106.762 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -74.71 97.25 3.18 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 123.937 0.895 . . . . 2.8900000000000001 109.349 -169.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -45.68 -54.37 7.91 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 124.932 1.293 . . . . 1.6499999999999999 111.664 -178.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -51.44 -51.58 53.69 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 122.998 0.519 . . . . 3.48 111.653 175.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.39 -45.59 93.0 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 118.586 0.63 . . . . 1.51 110.84 -177.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 72.1 t -58.14 -55.67 20.68 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 N-CA-C 109.178 -0.675 . . . . 1.75 109.178 177.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 39.4 t -53.21 -48.67 54.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 C-N-CA 124.149 0.979 . . . . 1.76 109.944 -179.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 26.7 mm-40 -50.86 -19.37 0.97 Allowed 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 125.706 1.602 . . . . 0.59999999999999998 112.958 175.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -142.56 44.57 1.62 Allowed 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 119.126 0.875 . . . . 3.04 111.787 173.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -157.36 -39.98 0.07 Allowed 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 124.792 1.237 . . . . 2.1899999999999999 111.428 168.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 4.5 m -96.6 -50.29 4.78 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 119.445 1.021 . . . . 0.27000000000000002 110.657 -177.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.4 pp -59.14 -24.89 28.52 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 CA-C-N 116.067 -0.515 . . . . 1.78 111.889 -174.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 21.7 m -41.47 -35.79 0.76 Allowed 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 125.036 1.334 . . . . 1.5700000000000001 112.455 172.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 24.3 m -119.2 -42.71 2.66 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 122.911 0.484 . . . . 0.25 111.328 175.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 84.2 m-70 -72.88 -9.54 58.81 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 113.074 0.768 . . . . 0.27000000000000002 113.074 -175.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 87.1 149.75 16.25 Favored Glycine 0 C--N 1.337 0.611 0 N-CA-C 109.997 -1.241 . . . . 1.6299999999999999 109.997 178.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -45.35 -39.21 7.21 Favored Glycine 0 C--N 1.34 0.767 0 C-N-CA 124.348 0.975 . . . . 1.1200000000000001 111.936 178.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -94.67 -2.31 51.49 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.595 1.158 . . . . 3.21 111.452 -173.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.4 mt 72.31 11.09 5.86 Favored 'General case' 0 C--N 1.352 0.698 0 O-C-N 120.722 -1.236 . . . . 2.2400000000000002 110.798 174.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 13.6 p -83.51 -0.37 49.93 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 127.865 2.466 . . . . 1.5900000000000001 110.331 -174.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.5 147.84 17.25 Favored Glycine 0 N--CA 1.44 -1.067 0 N-CA-C 108.726 -1.75 . . . . 0.48999999999999999 108.726 -173.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -151.79 -73.1 0.15 Allowed 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.15 0.98 . . . . 1.4199999999999999 109.465 177.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.3 m -100.49 4.37 43.6 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.699 1.6 . . . . 2.0899999999999999 110.756 171.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -155.59 164.88 19.75 Favored Pre-proline 0 N--CA 1.451 -0.405 0 C-N-CA 125.369 1.467 . . . . 1.45 107.636 -170.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -68.88 159.72 52.71 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.837 2.358 . . . . 0.27000000000000002 110.385 -176.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.11 127.15 31.75 Favored 'General case' 0 C--N 1.332 -0.189 0 O-C-N 121.937 -0.477 . . . . 1.49 109.808 -177.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 45.8 pt -107.85 2.02 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 C-N-CA 123.971 0.909 . . . . 1.75 111.488 176.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -35.22 -45.43 0.3 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.597 1.559 . . . . 3.9900000000000002 112.623 168.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -113.16 28.24 8.95 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 125.552 1.541 . . . . 4.2400000000000002 111.721 -178.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.7 -44.58 85.97 Favored 'General case' 0 N--CA 1.451 -0.389 0 O-C-N 121.57 -0.706 . . . . 1.48 109.236 175.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -54.5 -29.61 48.05 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 123.755 0.693 . . . . 0.48999999999999999 114.472 -176.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -76.57 -43.68 37.89 Favored 'General case' 0 N--CA 1.457 -0.102 0 O-C-N 121.786 -0.832 . . . . 1.8500000000000001 110.544 174.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 40.5 m-80 -66.81 -47.63 71.46 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 122.662 0.385 . . . . 1.54 110.665 -177.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -136.84 133.71 36.15 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 126.022 1.729 . . . . 1.3300000000000001 107.089 -168.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.5 p -74.78 171.87 13.18 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 119.179 0.899 . . . . 2.8700000000000001 110.268 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -48.9 -45.24 41.04 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 123.476 0.71 . . . . 2.8300000000000001 111.764 178.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -59.24 -32.32 69.88 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.352 0.661 . . . . 3.02 111.795 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -86.89 -44.33 11.76 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 121.808 -0.557 . . . . 2.8799999999999999 110.266 -178.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 45.3 mt -56.96 -46.49 83.95 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 N-CA-C 109.251 -0.648 . . . . 1.74 109.251 176.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 57.9 tp -54.41 -49.69 69.33 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 109.166 -0.679 . . . . 1.76 109.166 178.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -52.44 -49.26 64.93 Favored 'General case' 0 N--CA 1.451 -0.401 0 O-C-N 123.195 0.309 . . . . 1.46 110.652 178.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 31.5 mt -57.77 -53.1 49.4 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.267 0 O-C-N 121.529 -0.732 . . . . 1.6399999999999999 110.677 175.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 96.8 mt -51.62 -42.64 30.78 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 O-C-N 120.645 -1.284 . . . . 1.55 110.706 179.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 82.8 mt -72.77 -36.13 67.59 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.065 0.946 . . . . 1.54 113.141 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -116.63 15.59 15.5 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 119.82 1.191 . . . . 1.6000000000000001 110.165 -165.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 31.31 -141.74 0.03 OUTLIER Glycine 0 CA--C 1.533 1.187 0 C-N-CA 128.21 2.814 . . . . 0.62 111.389 -162.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 1.7 tp60 176.51 136.28 0.06 Allowed 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 118.621 1.21 . . . . 2.0099999999999998 107.933 -175.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 42.38 -118.19 1.62 Allowed Glycine 0 CA--C 1.536 1.357 0 CA-C-N 120.584 1.538 . . . . 0.56000000000000005 113.384 -179.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -74.51 -18.23 79.93 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 124.038 0.828 . . . . 0.72999999999999998 113.007 178.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.409 ' HB2' ' C1D' ' A' ' 93' ' ' HEC . 19.3 ttt -71.86 118.19 64.54 Favored Pre-proline 0 N--CA 1.452 -0.374 0 C-N-CA 124.859 1.264 . . . . 1.6299999999999999 110.414 179.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -78.18 122.57 5.76 Favored 'Trans proline' 0 N--CA 1.444 -1.388 0 C-N-CA 122.782 2.322 . . . . 2.1200000000000001 110.925 -178.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -58.84 138.17 49.72 Favored Glycine 0 N--CA 1.442 -0.907 0 CA-C-N 115.27 -0.877 . . . . 1.6200000000000001 114.999 -178.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 83.4 35.44 17.31 Favored Glycine 0 CA--C 1.528 0.856 0 CA-C-N 114.072 -1.064 . . . . 0.32000000000000001 111.758 174.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.2 mt -57.61 -52.96 50.79 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 125.196 1.398 . . . . 2.2000000000000002 109.859 174.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -101.08 151.32 21.96 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.317 1.447 . . . . 1.6000000000000001 108.991 164.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.4 mtpm? -143.43 155.75 44.47 Favored 'General case' 0 C--N 1.34 0.157 0 C-N-CA 124.323 1.049 . . . . 4.2599999999999998 109.317 173.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.29 -170.28 54.79 Favored Glycine 0 CA--C 1.528 0.845 0 N-CA-C 110.108 -1.197 . . . . 1.2 110.108 -175.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -51.38 -25.97 7.01 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.243 1.017 . . . . 2.3999999999999999 112.232 179.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -39.86 -58.85 1.29 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.92 1.288 . . . . 2.1000000000000001 110.634 166.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.23 -47.76 84.6 Favored 'General case' 0 CA--C 1.531 0.247 0 O-C-N 122.071 -0.393 . . . . 1.5700000000000001 110.893 -174.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -50.68 -56.49 11.66 Favored 'General case' 0 C--N 1.338 0.094 0 C-N-CA 123.829 0.852 . . . . 3.0499999999999998 110.852 174.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -54.4 -49.51 69.73 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 123.139 0.575 . . . . 1.6200000000000001 110.132 -178.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 85.6 t -56.94 -54.92 23.74 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-N 117.523 0.147 . . . . 1.6499999999999999 111.176 177.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -51.69 -51.49 55.62 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 123.676 0.79 . . . . 1.3899999999999999 111.733 178.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.4 -46.56 89.53 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 124.175 0.99 . . . . 1.77 110.546 -179.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 46.6 t90 -57.25 -48.31 79.17 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 109.588 -0.523 . . . . 0.55000000000000004 109.588 175.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.49 -33.94 73.33 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.179 0.992 . . . . 2.6899999999999999 111.59 176.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -54.62 -37.44 65.62 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 118.551 0.614 . . . . 1.5600000000000001 110.936 172.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -94.76 22.04 6.8 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.798 0.839 . . . . 2.9500000000000002 111.958 175.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 2.7 mtpm? -113.38 119.62 38.28 Favored 'General case' 0 C--N 1.342 0.24 0 O-C-N 121.122 -0.986 . . . . 2.96 109.094 169.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 89.1 mttt . . . . . 0 C--O 1.257 1.462 0 C-N-CA 129.451 3.1 . . . . 2.9399999999999999 104.116 -178.274 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' HEC . . . . . 0.409 ' C1D' ' HB2' ' A' ' 71' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.1 t . . . . . 0 N--CA 1.469 0.524 0 N-CA-C 106.473 -1.677 . . . . 2.52 106.473 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -107.95 100.03 9.42 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 106.968 -1.493 . . . . 2.1499999999999999 106.968 -168.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -41.38 -54.22 3.11 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 124.682 1.193 . . . . 1.6499999999999999 110.9 179.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -58.2 -47.21 84.16 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 115.239 -0.891 . . . . 2.6000000000000001 110.258 -179.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.26 -45.8 92.02 Favored 'General case' 0 C--N 1.339 0.111 0 C-N-CA 122.935 0.494 . . . . 1.4099999999999999 111.135 -179.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 81.9 t -56.58 -54.25 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 N-CA-C 108.766 -0.828 . . . . 1.79 108.766 177.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 22.8 t -53.78 -49.69 56.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 CA-C-N 117.742 0.246 . . . . 1.6499999999999999 111.237 178.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 27.6 mm-40 -54.87 -14.85 1.59 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.1 1.76 . . . . 0.58999999999999997 113.285 174.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 14.1 mt-30 -136.36 44.05 2.44 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 119.795 1.179 . . . . 4.4199999999999999 112.617 169.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.28 -58.61 0.05 Allowed 'General case' 0 CA--C 1.519 -0.244 0 O-C-N 121.782 -0.574 . . . . 2.5899999999999999 109.799 168.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 2.8 m -75.63 -48.14 23.48 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 109.938 -0.393 . . . . 0.29999999999999999 109.938 -171.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.0 pp -50.01 -32.77 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.14 0 C-N-CA 123.449 0.7 . . . . 1.95 112.435 -178.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.4 m -44.08 -35.34 2.1 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 125.076 1.35 . . . . 2.1299999999999999 112.033 178.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 13.1 m -119.36 -41.76 2.7 Favored 'General case' 0 CA--C 1.53 0.207 0 O-C-N 123.522 0.514 . . . . 0.22 111.922 175.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 79.6 m-70 -70.35 -9.01 55.0 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.028 0.931 . . . . 0.28999999999999998 112.481 -178.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 85.56 148.64 10.99 Favored Glycine 0 C--N 1.337 0.621 0 N-CA-C 109.224 -1.55 . . . . 1.45 109.224 -179.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -43.02 -33.25 1.7 Allowed Glycine 0 CA--C 1.53 0.989 0 C-N-CA 124.496 1.046 . . . . 1.28 112.687 173.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -94.98 -10.01 32.25 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.986 1.315 . . . . 2.3300000000000001 111.613 -172.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 70.63 11.75 7.27 Favored 'General case' 0 C--N 1.347 0.467 0 CA-C-N 120.263 1.392 . . . . 2.5600000000000001 111.255 178.357 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 10.4 p -85.43 -2.29 57.95 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 127.808 2.443 . . . . 1.6100000000000001 109.986 -177.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.93 145.3 12.66 Favored Glycine 0 N--CA 1.437 -1.261 0 N-CA-C 108.648 -1.781 . . . . 0.42999999999999999 108.648 -174.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -152.52 -80.34 0.1 Allowed 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 124.758 1.223 . . . . 1.3100000000000001 109.043 177.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 17.0 m -91.46 4.02 53.54 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.457 1.103 . . . . 1.9299999999999999 111.14 170.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -153.4 163.68 22.93 Favored Pre-proline 0 N--CA 1.45 -0.439 0 C-N-CA 126.065 1.746 . . . . 1.6899999999999999 107.554 -172.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -70.51 161.52 45.75 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 123.128 2.552 . . . . 0.37 110.59 -176.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -74.06 124.01 25.45 Favored 'General case' 0 N--CA 1.454 -0.268 0 O-C-N 121.577 -0.702 . . . . 1.49 110.235 -176.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 44.6 pt -104.44 2.45 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 CA-C-O 119.055 -0.498 . . . . 1.71 111.564 176.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -40.33 -52.64 2.68 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 112.985 0.735 . . . . 2.6800000000000002 112.985 176.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.26 21.49 11.87 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 126.3 1.84 . . . . 6.2699999999999996 110.653 -175.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -54.19 -39.5 66.71 Favored 'General case' 0 N--CA 1.453 -0.307 0 O-C-N 121.506 -0.746 . . . . 1.47 110.146 -178.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -54.8 -24.95 35.15 Favored Glycine 0 CA--C 1.53 1.022 0 N-CA-C 114.603 0.601 . . . . 0.52000000000000002 114.603 176.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -78.95 -36.95 40.84 Favored 'General case' 0 C--N 1.338 0.097 0 CA-C-N 118.616 1.208 . . . . 1.8799999999999999 110.278 174.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -73.91 -47.85 34.89 Favored 'General case' 0 N--CA 1.457 -0.078 0 C-N-CA 122.515 0.326 . . . . 1.9199999999999999 110.326 -177.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -139.96 149.04 42.8 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.47 1.108 . . . . 1.77 108.689 -168.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.92 168.32 18.03 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 109.614 -0.514 . . . . 2.9300000000000002 109.614 178.446 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -48.2 -43.52 32.02 Favored 'General case' 0 C--O 1.226 -0.179 0 C-N-CA 124.43 1.092 . . . . 2.7999999999999998 111.553 178.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -53.2 -47.69 68.69 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.654 0.782 . . . . 2.75 110.481 178.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -74.56 -45.69 43.83 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.78 0.832 . . . . 3.25 109.575 -175.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 58.6 mt -59.55 -44.16 92.5 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 N-CA-C 109.194 -0.669 . . . . 1.6000000000000001 109.194 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 31.3 tp -54.77 -54.38 42.82 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 123.468 0.707 . . . . 1.76 109.38 175.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -52.07 -49.48 63.45 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 123.107 0.254 . . . . 1.48 111.2 178.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 57.6 mt -55.16 -55.49 16.16 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.155 0 O-C-N 121.564 -0.71 . . . . 1.8200000000000001 110.558 176.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 57.8 mt -49.15 -46.75 17.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 O-C-N 121.191 -0.943 . . . . 1.5900000000000001 110.199 178.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 91.7 mt -66.11 -33.3 75.46 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 113.932 1.086 . . . . 1.78 113.932 179.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -128.97 24.13 5.65 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 120.37 1.441 . . . . 1.8200000000000001 110.641 -163.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 23.75 -136.97 0.01 OUTLIER Glycine 0 CA--C 1.543 1.791 0 C-N-CA 127.702 2.572 . . . . 0.67000000000000004 112.808 -159.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 170.46 139.13 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 126.483 1.913 . . . . 1.55 107.603 -175.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 23.78 -106.2 0.01 OUTLIER Glycine 0 CA--C 1.535 1.316 0 C-N-CA 126.386 1.945 . . . . 0.68999999999999995 115.029 -170.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.26 -29.05 74.33 Favored Glycine 0 CA--C 1.533 1.187 0 CA-C-N 118.271 1.036 . . . . 0.84999999999999998 113.169 -177.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 4.6 ttt -67.32 126.19 92.18 Favored Pre-proline 0 CA--C 1.542 0.635 0 C-N-CA 125.053 1.341 . . . . 1.5600000000000001 110.688 -179.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -62.66 -57.2 0.47 Allowed 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 123.893 3.062 . . . . 3.0299999999999998 111.144 -174.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 118.14 149.92 8.87 Favored Glycine 0 C--N 1.334 0.471 0 C-N-CA 123.925 0.774 . . . . 2.2599999999999998 113.536 174.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 69.06 23.21 76.14 Favored Glycine 0 CA--C 1.531 1.06 0 CA-C-N 115.156 -0.522 . . . . 0.40000000000000002 111.852 178.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.6 mt -56.32 -49.29 77.41 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.919 0 C-N-CA 126.12 1.768 . . . . 2.1800000000000002 111.267 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -109.71 161.22 15.62 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.133 0.973 . . . . 1.5600000000000001 108.589 160.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -146.42 172.72 13.1 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.082 0.953 . . . . 4.5499999999999998 109.198 173.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 54.18 -147.06 22.78 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 123.336 0.494 . . . . 0.93000000000000005 112.015 176.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -47.47 -41.03 19.77 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.19 0.996 . . . . 1.9299999999999999 111.23 175.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -53.07 -44.43 67.49 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.889 1.276 . . . . 2.7400000000000002 110.799 177.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -79.18 -49.97 11.71 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 121.759 -0.588 . . . . 1.49 111.487 176.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -51.4 -54.39 27.16 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 124.027 0.931 . . . . 2.1899999999999999 111.691 -178.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.24 -47.59 83.06 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.824 -0.435 . . . . 1.5800000000000001 109.824 -177.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 53.8 t -56.72 -53.96 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 C-N-CA 123.442 0.697 . . . . 1.54 110.748 177.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -52.19 -51.86 55.58 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 123.896 0.878 . . . . 1.6000000000000001 111.915 176.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.26 -50.59 73.04 Favored 'General case' 0 C--N 1.333 -0.116 0 C-N-CA 123.192 0.597 . . . . 1.5 110.204 -179.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . 0.417 ' CE3' ' CD2' ' A' ' 88' ' ' LEU . 50.0 t90 -56.59 -46.43 80.83 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.622 0.769 . . . . 0.63 110.49 177.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.417 ' CD2' ' CE3' ' A' ' 87' ' ' TRP . 0.1 OUTLIER -63.15 -38.8 92.6 Favored 'General case' 0 C--O 1.224 -0.282 0 O-C-N 121.416 -0.803 . . . . 2.8599999999999999 109.88 178.269 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -62.26 -42.31 99.22 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 118.723 0.692 . . . . 1.7 110.683 174.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -55.74 -45.46 78.02 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 121.843 -0.535 . . . . 3.6000000000000001 110.61 169.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 4.1 mtmp? -74.93 100.29 4.07 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 118.921 0.782 . . . . 3.8900000000000001 111.553 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 9.7 ptpp? . . . . . 0 C--O 1.25 1.095 0 N-CA-C 106.869 -1.53 . . . . 3.5800000000000001 106.869 174.311 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 10.5 t . . . . . 0 N--CA 1.469 0.514 0 N-CA-C 105.873 -1.899 . . . . 2.6200000000000001 105.873 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -125.04 97.38 5.23 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 105.787 -1.931 . . . . 2.75 105.787 -166.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -41.38 -52.84 3.46 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 124.655 1.182 . . . . 1.6200000000000001 110.857 -177.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -57.13 -47.79 80.27 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 115.9 -0.591 . . . . 3.1699999999999999 110.677 -179.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.07 -44.83 94.46 Favored 'General case' 0 C--N 1.339 0.11 0 C-N-CA 122.926 0.49 . . . . 1.6000000000000001 110.691 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 97.7 t -58.5 -57.4 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 N-CA-C 108.934 -0.765 . . . . 1.6499999999999999 108.934 177.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 52.9 t -52.21 -48.34 43.34 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 C-N-CA 122.741 0.416 . . . . 1.5700000000000001 110.875 -179.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -51.03 -24.44 3.79 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 125.503 1.521 . . . . 0.63 113.115 175.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 11.6 mt-30 -137.4 55.75 1.8 Allowed 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 119.514 1.052 . . . . 3.75 112.179 170.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.96 -38.97 0.02 OUTLIER 'General case' 0 C--O 1.226 -0.138 0 C-N-CA 123.566 0.746 . . . . 2.04 110.214 168.24 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 4.0 m -98.21 -50.01 4.51 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 119.004 0.82 . . . . 0.25 110.971 -177.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.9 pp -58.08 -25.86 27.53 Favored 'Isoleucine or valine' 0 C--N 1.338 0.071 0 N-CA-C 112.127 0.417 . . . . 1.6899999999999999 112.127 -174.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 59.7 m -37.92 -38.55 0.31 Allowed 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 125.491 1.516 . . . . 1.5900000000000001 112.646 170.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 18.9 m -120.7 -40.15 2.68 Favored 'General case' 0 C--N 1.34 0.189 0 C-N-CA 122.892 0.477 . . . . 0.17000000000000001 111.901 175.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 81.6 m-70 -73.31 -7.92 53.66 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 112.65 0.611 . . . . 0.26000000000000001 112.65 -176.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 85.59 149.78 12.83 Favored Glycine 0 C--N 1.337 0.627 0 N-CA-C 109.497 -1.441 . . . . 1.51 109.497 179.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -42.35 -34.95 1.73 Allowed Glycine 0 CA--C 1.527 0.826 0 C-N-CA 124.855 1.216 . . . . 1.2 112.176 175.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -99.03 -5.9 29.52 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 124.937 1.295 . . . . 2.3599999999999999 111.402 -168.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 8.8 mt 69.34 13.04 8.47 Favored 'General case' 0 C--N 1.352 0.682 0 CA-C-N 120.712 1.596 . . . . 2.0800000000000001 111.326 178.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.2 p -89.39 -1.37 58.03 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 127.802 2.441 . . . . 1.54 109.815 -176.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.62 130.44 2.81 Favored Glycine 0 N--CA 1.44 -1.085 0 N-CA-C 109.502 -1.439 . . . . 0.54000000000000004 109.502 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -135.39 -78.1 0.44 Allowed 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 124.387 1.075 . . . . 1.6499999999999999 108.641 178.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 50.1 m -93.45 4.01 54.65 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.176 0.991 . . . . 2.04 111.102 171.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -153.6 161.74 28.41 Favored Pre-proline 0 CA--C 1.533 0.314 0 C-N-CA 125.808 1.643 . . . . 1.6699999999999999 107.488 -171.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -71.78 159.58 50.32 Favored 'Trans proline' 0 N--CA 1.459 -0.541 0 C-N-CA 122.977 2.451 . . . . 0.35999999999999999 111.172 -175.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -74.68 117.36 16.43 Favored 'General case' 0 CA--C 1.53 0.211 0 O-C-N 121.727 -0.608 . . . . 1.55 111.768 -172.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 42.2 pt -95.94 0.54 10.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 C-N-CA 123.642 0.777 . . . . 1.76 112.031 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -45.34 -35.74 3.73 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.526 0.936 . . . . 2.6400000000000001 113.526 172.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -112.98 27.94 9.21 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 124.11 0.964 . . . . 5.6699999999999999 110.687 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -58.63 -43.83 89.82 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 108.998 -0.742 . . . . 1.51 108.998 176.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -53.77 -29.55 41.85 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 123.349 0.499 . . . . 0.63 113.692 179.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.13 -32.95 65.23 Favored 'General case' 0 N--CA 1.454 -0.229 0 O-C-N 122.078 -0.66 . . . . 1.9199999999999999 110.356 178.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 -85.31 -44.94 12.4 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.962 0.905 . . . . 1.6699999999999999 109.954 -174.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -138.38 133.28 32.7 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 125.273 1.429 . . . . 1.1699999999999999 108.025 -167.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 13.9 m -73.63 169.97 16.18 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 118.409 0.55 . . . . 2.48 110.095 175.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -47.24 -48.13 24.46 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.277 1.031 . . . . 2.9199999999999999 112.44 -176.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -58.1 -41.77 84.25 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.835 -0.541 . . . . 2.98 111.618 177.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -72.39 -41.96 65.74 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 109.053 -0.721 . . . . 2.9900000000000002 109.053 -176.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 41.3 mt -61.86 -46.71 95.91 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.131 0 O-C-N 121.286 -0.884 . . . . 1.5800000000000001 109.386 175.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 66.8 tp -53.95 -48.41 70.3 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.441 -0.577 . . . . 1.76 109.441 178.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -48.54 -56.02 9.48 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 117.993 0.36 . . . . 2.3700000000000001 110.996 174.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 95.4 mt -55.78 -46.25 79.77 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.298 0 O-C-N 121.6 -0.688 . . . . 1.77 110.778 178.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 73.3 mt -55.8 -44.77 78.64 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 O-C-N 120.45 -1.406 . . . . 1.78 110.164 176.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 90.9 mt -67.81 -36.81 81.06 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 113.903 1.075 . . . . 2.0 113.903 -176.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -128.82 26.32 5.56 Favored 'General case' 0 C--N 1.344 0.338 0 CA-C-N 120.85 1.659 . . . . 3.7799999999999998 110.205 -170.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 37.41 -142.78 0.23 Allowed Glycine 0 CA--C 1.534 1.258 0 C-N-CA 128.247 2.832 . . . . 0.65000000000000002 111.009 -176.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 44.9 tt0 174.3 132.87 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 119.246 1.523 . . . . 1.46 109.658 -178.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 45.14 -118.94 3.04 Favored Glycine 0 CA--C 1.532 1.138 0 O-C-N 121.22 -0.925 . . . . 0.51000000000000001 112.18 -175.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -70.93 -19.63 77.13 Favored Glycine 0 CA--C 1.531 1.082 0 O-C-N 122.495 -0.415 . . . . 0.58999999999999997 113.016 179.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 20.0 ttt -73.4 119.27 74.95 Favored Pre-proline 0 N--CA 1.451 -0.424 0 C-N-CA 124.163 0.985 . . . . 1.6000000000000001 110.604 -178.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -80.22 124.74 5.52 Favored 'Trans proline' 0 N--CA 1.447 -1.221 0 C-N-CA 123.208 2.605 . . . . 2.0699999999999998 111.054 -179.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -63.38 142.6 47.35 Favored Glycine 0 N--CA 1.444 -0.8 0 N-CA-C 115.902 1.121 . . . . 1.6499999999999999 115.902 -174.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 78.2 32.41 43.7 Favored Glycine 0 CA--C 1.526 0.779 0 CA-C-N 114.142 -1.029 . . . . 0.34000000000000002 111.442 174.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -51.37 -53.02 17.28 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 125.692 1.597 . . . . 2.3100000000000001 109.878 174.45 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -105.48 160.05 15.46 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 124.961 1.304 . . . . 1.5 108.652 162.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 81.7 mttt -144.1 168.7 19.4 Favored 'General case' 0 CA--C 1.527 0.086 0 N-CA-C 107.461 -1.311 . . . . 3.2999999999999998 107.461 170.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 65.7 -164.04 39.28 Favored Glycine 0 CA--C 1.528 0.902 0 N-CA-C 111.517 -0.633 . . . . 0.82999999999999996 111.517 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -54.32 -29.6 48.28 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.457 0.703 . . . . 1.74 112.283 -174.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -40.32 -67.63 0.22 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.79 1.236 . . . . 2.9500000000000002 110.457 164.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -59.07 -43.91 91.8 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.25 0.62 . . . . 1.47 110.977 -175.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -59.13 -53.48 57.86 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.411 1.084 . . . . 2.6899999999999999 110.597 -178.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.18 -49.12 78.12 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.008 0.923 . . . . 1.5 109.797 179.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 54.1 t -52.5 -56.49 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 C-N-CA 122.292 0.237 . . . . 1.5800000000000001 110.598 176.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -49.56 -51.38 37.28 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 123.738 0.815 . . . . 1.53 111.764 177.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.38 -50.33 74.38 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 121.673 0.749 . . . . 1.54 111.163 -178.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . 0.408 ' CE3' HD23 ' A' ' 88' ' ' LEU . 51.0 t90 -58.23 -45.34 87.87 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 121.228 0.537 . . . . 0.76000000000000001 110.047 178.543 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.408 HD23 ' CE3' ' A' ' 87' ' ' TRP . 0.1 OUTLIER -62.73 -36.41 82.91 Favored 'General case' 0 CA--C 1.531 0.213 0 O-C-N 121.493 -0.754 . . . . 2.71 110.814 176.571 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -59.74 -39.19 83.92 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 118.758 0.708 . . . . 1.5800000000000001 110.848 173.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -59.74 -41.06 90.11 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 122.28 0.232 . . . . 3.21 110.535 173.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.1 mtpm? -74.04 104.12 4.76 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.806 0.813 . . . . 3.2000000000000002 111.21 179.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 15.5 pttp . . . . . 0 C--O 1.25 1.089 0 C-N-CA 126.619 1.967 . . . . 3.1299999999999999 106.048 176.364 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.4 t . . . . . 0 N--CA 1.471 0.624 0 N-CA-C 105.831 -1.915 . . . . 2.3900000000000001 105.831 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -83.81 108.56 16.91 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.726 -0.842 . . . . 2.8599999999999999 108.726 -173.567 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -46.39 -55.15 7.78 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 123.25 0.62 . . . . 1.51 110.024 176.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -57.36 -46.71 83.07 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 110.233 -0.284 . . . . 2.6899999999999999 110.233 -177.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.24 -48.69 79.63 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 118.262 0.483 . . . . 1.3999999999999999 111.399 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 55.6 t -56.46 -56.18 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 N-CA-C 109.233 -0.654 . . . . 1.6399999999999999 109.233 177.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 61.1 t -53.5 -49.92 52.11 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 C-N-CA 122.888 0.475 . . . . 1.6299999999999999 110.305 -177.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 33.6 mm-40 -51.55 -17.44 0.83 Allowed 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 126.454 1.902 . . . . 0.5 112.964 175.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 16.6 tp60 -141.71 43.67 1.72 Allowed 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 119.519 1.054 . . . . 4.9400000000000004 112.204 171.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.18 -39.73 0.1 Allowed 'General case' 0 C--O 1.227 -0.083 0 C-N-CA 123.659 0.784 . . . . 2.0 111.425 166.377 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 3.6 m -98.12 -49.51 4.71 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 119.124 0.874 . . . . 0.20999999999999999 110.539 -174.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.2 pp -55.51 -29.13 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 CA-C-N 115.766 -0.652 . . . . 1.6299999999999999 111.564 -177.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.1 m -37.75 -37.01 0.21 Allowed 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 125.61 1.564 . . . . 1.8600000000000001 112.713 171.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 28.2 m -119.59 -40.45 2.77 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.298 0.639 . . . . 0.17000000000000001 112.009 174.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 84.7 m-70 -73.37 -8.71 57.03 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.474 0.71 . . . . 0.31 112.711 -175.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 85.55 151.14 15.28 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 109.628 -1.389 . . . . 1.52 109.628 -178.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -40.46 -42.27 2.54 Favored Glycine 0 C--N 1.34 0.802 0 C-N-CA 124.996 1.284 . . . . 1.1899999999999999 112.21 178.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -95.89 -6.34 39.47 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 125.556 1.542 . . . . 2.5699999999999998 110.939 -169.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 69.56 19.1 7.55 Favored 'General case' 0 C--N 1.347 0.469 0 CA-C-N 119.648 1.113 . . . . 2.6699999999999999 111.026 177.456 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 11.2 p -82.18 -4.84 57.83 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 128.462 2.705 . . . . 1.5900000000000001 109.898 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.14 148.26 21.19 Favored Glycine 0 N--CA 1.44 -1.035 0 N-CA-C 108.32 -1.912 . . . . 0.59999999999999998 108.32 -173.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -155.08 -72.98 0.12 Allowed 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 123.91 0.884 . . . . 1.3 109.552 176.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.3 t -98.35 1.17 46.73 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.627 1.171 . . . . 1.79 110.252 172.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -155.62 167.07 14.94 Favored Pre-proline 0 CA--C 1.536 0.432 0 C-N-CA 125.551 1.541 . . . . 1.5700000000000001 107.913 -171.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -70.43 160.98 47.67 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 123.098 2.532 . . . . 0.34000000000000002 111.195 -173.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -74.87 119.99 19.8 Favored 'General case' 0 CA--C 1.531 0.214 0 O-C-N 121.748 -0.595 . . . . 1.6599999999999999 110.638 -177.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 47.4 pt -105.05 0.83 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 C-N-CA 124.157 0.983 . . . . 1.6200000000000001 111.551 179.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -34.17 -46.39 0.24 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.572 1.549 . . . . 2.4199999999999999 112.856 167.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 5.3 pttt -111.44 35.32 3.67 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.798 1.239 . . . . 4.8099999999999996 111.166 -178.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.01 -46.4 87.83 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-O 118.868 -0.587 . . . . 1.75 109.51 174.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -51.73 -32.73 33.34 Favored Glycine 0 CA--C 1.527 0.795 0 CA-C-N 118.566 0.621 . . . . 0.65000000000000002 114.329 -177.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.21 -37.08 66.57 Favored 'General case' 0 N--CA 1.455 -0.196 0 O-C-N 121.898 -0.766 . . . . 1.6599999999999999 110.797 176.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 20.5 m-80 -73.51 -50.77 19.77 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 122.929 0.492 . . . . 1.6799999999999999 110.15 -178.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -137.6 138.07 39.16 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.211 1.404 . . . . 1.9099999999999999 107.382 -169.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 67.3 m -76.19 172.0 13.57 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 119.03 0.832 . . . . 2.2999999999999998 110.389 179.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.0 pm0 -50.5 -43.29 55.61 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 123.78 0.832 . . . . 2.8700000000000001 111.834 -178.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -56.15 -41.37 75.3 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 121.336 0.588 . . . . 2.8100000000000001 110.136 179.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -80.01 -47.38 15.01 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 123.81 0.844 . . . . 3.54 108.995 -173.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 63.9 mt -56.33 -44.99 81.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 N-CA-C 109.113 -0.699 . . . . 1.6799999999999999 109.113 176.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 33.8 tp -54.77 -49.47 70.8 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 109.375 -0.602 . . . . 1.6899999999999999 109.375 177.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -55.11 -46.44 75.56 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 118.576 0.625 . . . . 1.48 111.604 175.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 86.7 mt -61.92 -30.34 48.34 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 O-C-N 121.351 -0.843 . . . . 1.8500000000000001 111.521 178.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 46.4 mt -73.19 -50.24 32.87 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 O-C-N 120.278 -1.514 . . . . 1.5900000000000001 109.128 174.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 77.3 mt -61.88 -28.43 69.5 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 125.232 1.413 . . . . 1.48 113.474 -175.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 11.0 m-80 -130.62 15.37 5.41 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 120.02 1.282 . . . . 1.75 110.386 -169.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 40.01 -141.97 0.69 Allowed Glycine 0 CA--C 1.545 1.906 0 C-N-CA 125.679 1.609 . . . . 0.66000000000000003 111.707 -167.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 167.08 139.63 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 126.386 1.874 . . . . 1.5700000000000001 108.447 -174.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 31.77 -111.45 0.05 OUTLIER Glycine 0 C--N 1.347 1.18 0 C-N-CA 125.465 1.507 . . . . 0.60999999999999999 114.153 -174.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.58 -30.1 76.67 Favored Glycine 0 CA--C 1.534 1.23 0 CA-C-N 117.299 0.549 . . . . 0.81000000000000005 112.834 -179.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 2.3 ttt -65.42 123.74 85.2 Favored Pre-proline 0 CA--C 1.541 0.615 0 C-N-CA 124.576 1.15 . . . . 1.6599999999999999 111.393 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -63.64 -55.38 0.7 Allowed 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 124.223 3.282 . . . . 2.96 111.224 -173.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 115.28 149.08 9.53 Favored Glycine 0 N--CA 1.448 -0.514 0 CA-C-N 115.732 -0.667 . . . . 2.3100000000000001 114.185 171.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 67.45 22.38 73.06 Favored Glycine 0 CA--C 1.531 1.036 0 CA-C-N 114.712 -0.744 . . . . 0.48999999999999999 111.854 -178.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -51.69 -53.01 18.63 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 C-N-CA 126.611 1.964 . . . . 2.2000000000000002 111.127 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -107.76 159.99 16.07 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.164 1.386 . . . . 1.52 108.335 162.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 36.6 mttt -145.84 174.77 10.94 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.554 1.141 . . . . 4.0999999999999996 109.57 171.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 53.11 -149.55 11.66 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 123.826 0.727 . . . . 0.88 112.045 178.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -49.63 -36.61 25.01 Favored 'General case' 0 C--N 1.34 0.163 0 C-N-CA 123.877 0.871 . . . . 1.8600000000000001 111.278 179.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -47.76 -66.41 0.41 Allowed 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.992 1.317 . . . . 1.9099999999999999 109.216 173.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -62.97 -45.48 92.23 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 122.829 0.452 . . . . 1.4399999999999999 112.011 -178.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -54.79 -52.9 61.19 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 122.931 0.492 . . . . 2.1499999999999999 110.488 -178.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.42 -50.17 73.87 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 122.915 0.486 . . . . 1.71 110.233 178.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 70.1 t -50.63 -58.51 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-O 120.613 0.244 . . . . 1.8999999999999999 110.919 177.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -55.26 -49.98 70.67 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.206 1.003 . . . . 1.7 111.684 -179.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.69 -46.01 88.18 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 121.67 0.748 . . . . 1.49 110.584 -179.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . 0.406 ' CE3' ' CD2' ' A' ' 88' ' ' LEU . 48.6 t90 -60.71 -50.48 73.3 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.667 -0.494 . . . . 0.60999999999999999 109.667 176.538 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.406 ' CD2' ' CE3' ' A' ' 87' ' ' TRP . 0.1 OUTLIER -59.92 -32.01 70.38 Favored 'General case' 0 CA--C 1.531 0.247 0 O-C-N 121.487 -0.758 . . . . 2.7200000000000002 111.193 179.152 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.9 -42.85 97.33 Favored 'General case' 0 N--CA 1.457 -0.097 0 CA-C-N 118.671 0.669 . . . . 1.9299999999999999 111.146 171.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -58.59 -40.73 84.02 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 110.347 -0.242 . . . . 3.29 110.347 173.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 21.4 mtpp -73.38 133.98 43.94 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 121.916 -0.49 . . . . 3.2999999999999998 110.984 -178.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 49.8 mtmt . . . . . 0 C--O 1.25 1.084 0 N-CA-C 105.887 -1.894 . . . . 3.3900000000000001 105.887 179.36 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.47 0.554 0 N-CA-C 106.542 -1.651 . . . . 2.3900000000000001 106.542 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -74.21 144.83 44.56 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.311 1.044 . . . . 2.9199999999999999 108.639 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -89.29 -65.38 1.02 Allowed 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 109.327 -0.619 . . . . 1.6100000000000001 109.327 177.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -47.35 -47.01 26.13 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.578 0.751 . . . . 3.0899999999999999 111.702 -178.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.69 -42.82 79.75 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.057 0.543 . . . . 1.4199999999999999 111.676 178.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 53.4 t -64.45 -54.13 34.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 N-CA-C 108.23 -1.026 . . . . 1.55 108.23 178.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 65.9 t -48.33 -51.49 10.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 C-N-CA 122.486 0.314 . . . . 1.8700000000000001 110.376 179.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 35.7 mm-40 -50.55 -26.82 5.7 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 126.313 1.845 . . . . 0.62 113.416 177.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 -136.6 53.48 1.91 Allowed 'General case' 0 C--N 1.339 0.125 0 CA-C-N 119.756 1.162 . . . . 2.7599999999999998 112.121 173.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.444 ' HZ3' ' CD ' ' A' ' 80' ' ' GLU . 0.1 OUTLIER -166.43 -38.9 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 123.459 0.704 . . . . 2.0600000000000001 110.504 167.834 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 6.5 m -97.69 -51.31 4.15 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 118.913 0.779 . . . . 0.34000000000000002 110.843 -175.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.4 pp -56.41 -27.94 25.56 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.095 0 CA-C-N 116.128 -0.487 . . . . 1.6699999999999999 111.925 -175.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.9 m -36.92 -39.31 0.22 Allowed 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 125.605 1.562 . . . . 1.6100000000000001 112.683 171.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 38.1 m -117.88 -38.86 3.18 Favored 'General case' 0 C--N 1.339 0.122 0 C-N-CA 123.127 0.571 . . . . 0.22 111.652 174.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 83.8 m-70 -77.03 -6.49 52.89 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 113.167 0.803 . . . . 0.38 113.167 -174.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 84.54 151.83 14.5 Favored Glycine 0 C--N 1.338 0.645 0 N-CA-C 109.865 -1.294 . . . . 1.5700000000000001 109.865 -179.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -41.87 -39.53 2.8 Favored Glycine 0 C--N 1.341 0.84 0 C-N-CA 125.015 1.293 . . . . 1.1200000000000001 112.274 178.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -99.84 -0.44 39.72 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 125.249 1.42 . . . . 2.4199999999999999 111.058 -169.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.3 mp 66.12 18.34 10.96 Favored 'General case' 0 C--N 1.347 0.476 0 CA-C-N 119.779 1.172 . . . . 2.7000000000000002 111.351 -179.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.0 p -82.14 -5.24 58.3 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 127.413 2.285 . . . . 1.6899999999999999 110.277 -177.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.58 148.21 18.35 Favored Glycine 0 N--CA 1.437 -1.277 0 N-CA-C 108.129 -1.988 . . . . 0.51000000000000001 108.129 -172.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -156.24 -76.77 0.09 Allowed 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 124.035 0.934 . . . . 1.3 109.09 178.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -95.38 2.37 54.59 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.683 1.193 . . . . 1.96 110.552 172.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -157.58 161.75 28.56 Favored Pre-proline 0 N--CA 1.452 -0.374 0 C-N-CA 126.834 2.054 . . . . 1.5600000000000001 106.577 -170.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -68.1 164.65 31.26 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 123.178 2.585 . . . . 0.48999999999999999 111.807 -175.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -75.52 116.39 16.18 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 123.265 0.626 . . . . 1.49 110.841 -176.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 40.4 pt -98.11 1.0 10.54 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.174 0 C-N-CA 123.162 0.585 . . . . 1.6299999999999999 110.886 176.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -43.13 -37.31 1.99 Allowed 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 114.037 1.125 . . . . 2.4199999999999999 114.037 174.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.13 23.7 13.97 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 124.899 1.28 . . . . 5.0499999999999998 111.681 179.565 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -58.09 -43.4 87.03 Favored 'General case' 0 N--CA 1.45 -0.449 0 O-C-N 121.607 -0.683 . . . . 1.47 109.573 178.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -51.38 -30.16 25.03 Favored Glycine 0 CA--C 1.529 0.913 0 N-CA-C 114.643 0.617 . . . . 0.60999999999999999 114.643 -178.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -87.28 -40.59 14.36 Favored 'General case' 0 C--O 1.227 -0.092 0 CA-C-N 117.965 0.882 . . . . 1.96 110.45 176.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 15.3 m-80 -62.48 -41.82 99.05 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 122.135 0.174 . . . . 1.5700000000000001 111.322 -179.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -140.35 142.74 35.55 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 125.722 1.609 . . . . 1.53 107.649 -170.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 57.9 m -83.06 176.67 9.06 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 121.491 0.663 . . . . 2.6499999999999999 110.504 177.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -58.07 -45.75 86.59 Favored 'General case' 0 N--CA 1.454 -0.228 0 O-C-N 121.505 -0.747 . . . . 3.2000000000000002 110.705 -166.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -61.73 -38.78 89.19 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.228 0.611 . . . . 2.9700000000000002 110.199 -177.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.1 mp0 -70.33 -46.14 64.78 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 124.186 0.994 . . . . 4.21 108.489 -178.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 62.2 mt -62.96 -46.19 96.95 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.109 0 N-CA-C 108.834 -0.802 . . . . 1.53 108.834 178.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 46.4 tp -51.8 -54.06 32.97 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 123.132 0.573 . . . . 1.6000000000000001 109.682 176.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -50.61 -52.48 38.98 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.338 0.655 . . . . 1.6000000000000001 110.586 175.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 76.2 mt -62.6 -25.76 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 O-C-N 121.652 -0.655 . . . . 1.73 112.196 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 51.9 mt -73.26 -49.37 38.16 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 O-C-N 120.213 -1.554 . . . . 1.5800000000000001 108.993 170.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 86.7 mt -62.89 -34.28 77.08 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 125.006 1.322 . . . . 1.5700000000000001 114.238 -173.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -134.49 29.95 3.55 Favored 'General case' 0 C--N 1.342 0.257 0 CA-C-N 120.572 1.533 . . . . 3.2400000000000002 109.68 -172.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 37.95 -140.26 0.47 Allowed Glycine 0 CA--C 1.542 1.72 0 C-N-CA 127.05 2.262 . . . . 0.65000000000000002 111.837 -176.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 167.03 140.72 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 126.052 1.741 . . . . 1.28 109.516 -178.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 44.62 -120.67 3.74 Favored Glycine 0 CA--C 1.531 1.067 0 CA-C-N 119.684 1.129 . . . . 0.60999999999999999 112.551 -177.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -71.36 -19.46 77.58 Favored Glycine 0 CA--C 1.534 1.222 0 O-C-N 122.379 -0.483 . . . . 0.56000000000000005 112.972 178.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 17.1 ttt -72.25 119.94 77.57 Favored Pre-proline 0 CA--C 1.537 0.464 0 C-N-CA 123.762 0.825 . . . . 1.52 109.968 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -63.41 -53.25 1.51 Allowed 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 124.178 3.252 . . . . 2.8900000000000001 111.467 -169.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 114.39 152.07 10.47 Favored Glycine 0 N--CA 1.447 -0.596 0 CA-C-O 121.98 0.767 . . . . 2.3700000000000001 114.555 172.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 66.18 19.47 68.21 Favored Glycine 0 CA--C 1.531 1.04 0 CA-C-N 114.247 -0.976 . . . . 0.56999999999999995 111.74 -177.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 2.5 mt -50.21 -49.85 21.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 126.382 1.873 . . . . 2.1400000000000001 110.793 177.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -111.44 155.36 23.31 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.467 1.107 . . . . 1.49 108.909 159.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.5 mttm -146.13 157.87 43.86 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.276 1.43 . . . . 3.1800000000000002 109.859 178.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 56.49 -149.28 28.56 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 110.414 -1.074 . . . . 1.3 110.414 -176.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -51.18 -32.85 24.91 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 117.548 0.674 . . . . 1.6399999999999999 112.483 -178.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.444 ' CD ' ' HZ3' ' A' ' 31' ' ' LYS . 29.3 tt0 -51.79 -47.4 64.26 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.268 0.627 . . . . 2.3599999999999999 109.619 174.204 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -75.92 -49.23 18.42 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.175 0.59 . . . . 1.6200000000000001 111.304 175.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -57.34 -47.82 80.58 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 118.138 0.427 . . . . 2.0 111.503 -172.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.24 -49.07 77.19 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 109.625 -0.509 . . . . 1.46 109.625 178.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 45.9 t -57.62 -52.62 55.09 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 C-N-CA 122.898 0.479 . . . . 1.72 111.035 178.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -52.04 -55.8 18.32 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 123.467 0.707 . . . . 1.5700000000000001 111.366 176.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.69 -40.49 88.06 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.085 0.554 . . . . 1.52 111.084 -178.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 70.6 t90 -64.36 -52.44 58.32 Favored 'General case' 0 N--CA 1.453 -0.315 0 O-C-N 121.709 -0.619 . . . . 0.77000000000000002 109.727 177.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.52 -28.09 66.77 Favored 'General case' 0 C--O 1.224 -0.246 0 O-C-N 120.374 -1.454 . . . . 3.0 112.436 176.067 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -54.56 -35.34 63.16 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 119.036 0.834 . . . . 1.8200000000000001 111.387 169.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -70.64 -41.21 72.45 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 109.287 -0.634 . . . . 4.8600000000000003 109.287 174.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 4.1 mtpm? -74.33 105.85 5.69 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 120.988 0.423 . . . . 3.4500000000000002 111.459 -174.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.093 0 C-N-CA 126.341 1.856 . . . . 3.0600000000000001 106.736 170.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . 2.303 1.1 t . . . . . 0 N--CA 1.47 0.554 0 CA-C-O 116.56 -1.686 . . . . 3.8300000000000001 106.586 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -101.81 153.68 19.6 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 103.487 -2.783 . . . . 3.6099999999999999 103.487 133.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -111.65 -62.07 1.61 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.447 -0.946 . . . . 1.72 108.447 173.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -58.05 -44.54 87.5 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.749 -0.66 . . . . 3.3599999999999999 110.417 -176.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.35 -36.7 83.05 Favored 'General case' 0 C--N 1.339 0.144 0 CA-C-N 118.707 0.685 . . . . 1.6399999999999999 111.21 -179.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 92.8 t -62.87 -55.98 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 N-CA-C 107.891 -1.152 . . . . 1.78 107.891 176.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 74.0 t -52.76 -48.33 49.75 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 CA-C-N 117.547 0.158 . . . . 1.5700000000000001 110.868 -179.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 25.3 mm-40 -50.06 -21.03 1.11 Allowed 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 126.565 1.946 . . . . 0.58999999999999997 113.496 174.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 17.4 tp60 -144.67 55.1 1.25 Allowed 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 119.481 1.037 . . . . 5.21 111.528 172.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.42 ' HZ1' ' CD ' ' A' ' 80' ' ' GLU . 0.5 OUTLIER -167.25 -38.29 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 124.005 0.922 . . . . 2.2400000000000002 110.025 170.623 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 3.7 m -99.58 -50.52 4.04 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 119.0 0.818 . . . . 0.22 110.772 -178.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.2 pp -56.91 -26.26 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.153 0 CA-C-N 116.151 -0.477 . . . . 1.6599999999999999 111.89 -175.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.6 t -42.23 -32.33 0.48 Allowed 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.041 1.336 . . . . 3.0299999999999998 111.848 172.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 12.5 m -123.08 -43.71 2.21 Favored 'General case' 0 C--N 1.341 0.212 0 C-N-CA 123.413 0.685 . . . . 0.17000000000000001 111.593 173.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 84.3 m-70 -70.09 -10.18 57.9 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.745 0.818 . . . . 0.25 112.768 -176.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 88.67 149.09 18.75 Favored Glycine 0 C--N 1.337 0.635 0 N-CA-C 109.747 -1.341 . . . . 1.52 109.747 178.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -43.28 -39.49 4.17 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 124.512 1.053 . . . . 1.1799999999999999 111.485 176.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -94.03 -7.16 43.51 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 125.574 1.549 . . . . 3.1699999999999999 111.027 -170.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.9 mt 71.16 11.54 6.87 Favored 'General case' 0 C--N 1.35 0.589 0 CA-C-N 119.524 1.057 . . . . 2.0299999999999998 111.627 177.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 12.5 p -83.49 0.1 47.86 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 127.128 2.171 . . . . 1.6000000000000001 109.742 -176.049 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.85 129.92 2.78 Favored Glycine 0 N--CA 1.442 -0.917 0 N-CA-C 108.978 -1.649 . . . . 0.56000000000000005 108.978 -178.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -135.95 -79.55 0.42 Allowed 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 124.195 0.998 . . . . 1.49 108.825 178.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.6 t -90.28 4.62 50.16 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.948 0.899 . . . . 2.6299999999999999 110.705 172.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -158.08 168.89 11.55 Favored Pre-proline 0 CA--C 1.535 0.374 0 C-N-CA 124.688 1.195 . . . . 1.5600000000000001 108.387 -172.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -70.01 158.72 55.73 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.927 2.418 . . . . 0.26000000000000001 110.528 -174.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.53 126.74 30.92 Favored 'General case' 0 C--N 1.332 -0.162 0 O-C-N 121.516 -0.74 . . . . 1.47 109.927 -178.098 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 50.6 pt -107.34 1.36 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 C-N-CA 123.716 0.806 . . . . 1.5 111.331 176.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 18.5 p-10 -35.75 -49.56 0.6 Allowed 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 124.894 1.278 . . . . 3.5299999999999998 111.744 171.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.68 32.32 4.62 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 127.232 2.213 . . . . 4.25 113.103 -179.56 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.12 -49.24 78.61 Favored 'General case' 0 CA--C 1.535 0.371 0 O-C-N 120.746 -1.221 . . . . 1.4099999999999999 110.147 177.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -54.11 -17.26 7.33 Favored Glycine 0 C--N 1.343 0.926 0 C-N-CA 124.64 1.114 . . . . 0.67000000000000004 114.886 178.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.7 -40.7 88.58 Favored 'General case' 0 N--CA 1.453 -0.32 0 O-C-N 121.373 -1.075 . . . . 1.8200000000000001 110.978 176.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 -105.5 -52.05 2.9 Favored 'General case' 0 CA--C 1.52 -0.198 0 N-CA-C 109.563 -0.532 . . . . 2.7599999999999998 109.563 -172.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -92.7 147.86 22.53 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.725 -1.213 . . . . 1.4199999999999999 107.725 -176.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -96.29 167.29 11.28 Favored 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 108.383 -0.969 . . . . 2.98 108.383 174.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -45.27 -43.51 10.6 Favored 'General case' 0 C--O 1.225 -0.216 0 C-N-CA 124.797 1.239 . . . . 2.7999999999999998 111.484 177.014 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -55.82 -49.29 73.65 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.842 0.857 . . . . 3.04 110.72 178.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -74.55 -43.25 56.62 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 123.228 0.611 . . . . 3.1699999999999999 109.423 -175.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 61.4 mt -60.57 -45.22 97.54 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 109.173 -0.677 . . . . 1.6799999999999999 109.173 179.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 55.2 tp -55.44 -50.44 69.81 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.274 -0.639 . . . . 1.77 109.274 176.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -53.79 -48.75 69.5 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 121.197 -0.201 . . . . 1.5 110.562 175.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 49.7 mt -63.88 -21.09 27.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 O-C-N 121.421 -0.799 . . . . 1.76 112.48 179.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 66.1 mt -78.63 -44.99 25.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 O-C-N 120.264 -1.522 . . . . 1.5600000000000001 109.207 173.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 80.7 mt -75.64 -31.28 59.76 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 113.43 0.9 . . . . 1.95 113.43 -176.132 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -120.06 19.47 12.28 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 119.641 1.109 . . . . 1.75 109.592 -171.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 36.42 -136.99 0.5 Allowed Glycine 0 CA--C 1.532 1.148 0 C-N-CA 127.689 2.566 . . . . 0.68999999999999995 111.169 -173.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 31.1 tt0 166.73 138.38 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 125.718 1.607 . . . . 1.3400000000000001 109.988 177.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 41.3 -119.95 1.74 Allowed Glycine 0 CA--C 1.531 1.072 0 O-C-N 120.436 -1.415 . . . . 0.46999999999999997 113.157 -173.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -71.66 -18.44 77.27 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 123.374 0.512 . . . . 0.57999999999999996 112.976 179.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.41 ' HB2' ' C1D' ' A' ' 93' ' ' HEC . 23.3 ttt -71.55 118.69 68.57 Favored Pre-proline 0 N--CA 1.45 -0.426 0 C-N-CA 123.734 0.813 . . . . 1.6399999999999999 110.52 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -75.25 125.03 8.89 Favored 'Trans proline' 0 N--CA 1.442 -1.53 0 C-N-CA 121.845 1.697 . . . . 2.1600000000000001 109.923 179.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -63.56 140.44 44.56 Favored Glycine 0 N--CA 1.44 -1.077 0 CA-C-N 115.077 -0.965 . . . . 1.5800000000000001 114.558 178.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 84.74 33.72 17.98 Favored Glycine 0 CA--C 1.525 0.668 0 CA-C-N 113.95 -1.125 . . . . 0.32000000000000001 111.329 173.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -61.47 -50.76 79.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 124.606 1.162 . . . . 3.5699999999999998 109.247 179.007 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -104.18 154.39 19.81 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.668 1.587 . . . . 1.5700000000000001 109.476 164.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.3 mtmp? -143.74 150.97 39.41 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 124.781 1.232 . . . . 6.1799999999999997 109.556 179.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 68.82 -163.21 50.39 Favored Glycine 0 CA--C 1.528 0.886 0 N-CA-C 110.379 -1.088 . . . . 0.88 110.379 -173.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -48.6 -31.05 6.03 Favored 'General case' 0 C--O 1.226 -0.166 0 C-N-CA 123.967 0.907 . . . . 1.8899999999999999 112.053 -179.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.42 ' CD ' ' HZ1' ' A' ' 31' ' ' LYS . 38.0 tt0 -41.73 -54.85 3.18 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.778 1.231 . . . . 1.96 109.904 174.416 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.17 -45.25 77.56 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 122.822 0.449 . . . . 1.46 110.93 -179.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 57.4 mt-10 -55.98 -51.62 67.05 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.162 0.985 . . . . 1.9199999999999999 110.643 -176.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -53.34 -52.01 60.58 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.027 0.931 . . . . 1.6299999999999999 110.451 176.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 77.0 t -55.02 -52.04 48.0 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 C-N-CA 120.997 -0.281 . . . . 1.6399999999999999 110.395 178.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -53.79 -51.51 63.23 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 123.172 0.589 . . . . 1.48 111.972 179.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.77 -48.43 77.87 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 123.611 0.764 . . . . 1.3999999999999999 110.701 178.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . 0.421 ' CE3' HD21 ' A' ' 88' ' ' LEU . 48.9 t90 -61.61 -45.6 93.41 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 121.916 -0.49 . . . . 0.77000000000000002 110.386 179.065 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.421 HD21 ' CE3' ' A' ' 87' ' ' TRP . 0.1 OUTLIER -64.17 -32.68 74.35 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 124.427 1.091 . . . . 2.6499999999999999 111.184 178.337 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -65.66 -44.63 85.72 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 123.377 0.671 . . . . 1.5600000000000001 110.279 171.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -59.83 -39.45 85.16 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 109.924 -0.398 . . . . 3.6499999999999999 109.924 174.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -73.62 149.88 41.75 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 121.526 0.679 . . . . 3.6099999999999999 110.878 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 18.6 mttt . . . . . 0 C--O 1.251 1.144 0 N-CA-C 105.274 -2.121 . . . . 3.6800000000000002 105.274 177.345 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' HEC . . . . . 0.41 ' C1D' ' HB2' ' A' ' 71' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.473 0.694 0 N-CA-C 106.505 -1.665 . . . . 3.0800000000000001 106.505 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -113.78 158.76 20.56 Favored 'General case' 0 N--CA 1.446 -0.645 0 O-C-N 124.597 1.186 . . . . 3.1099999999999999 109.088 173.547 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -105.18 -64.12 1.16 Allowed 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 107.975 -1.12 . . . . 1.5 107.975 174.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -48.92 -48.95 42.19 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 115.65 -0.704 . . . . 2.8599999999999999 111.166 178.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.56 -44.96 93.11 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 118.878 0.763 . . . . 1.55 111.426 -177.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 71.9 t -59.8 -54.19 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 N-CA-C 108.495 -0.928 . . . . 1.74 108.495 177.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 85.5 t -54.39 -50.74 55.12 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-N 117.979 0.354 . . . . 1.5800000000000001 110.595 -178.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 34.8 mm-40 -53.48 -15.68 1.18 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 126.696 1.998 . . . . 0.62 112.931 174.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -135.94 32.75 2.93 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 119.416 1.007 . . . . 2.9399999999999999 113.129 173.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 8.3 mtmt -152.37 -56.67 0.14 Allowed 'General case' 0 CA--C 1.521 -0.145 0 CA-C-N 118.694 0.679 . . . . 2.9300000000000002 109.633 172.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 4.0 m -75.08 -49.78 18.57 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 121.071 0.462 . . . . 0.23999999999999999 110.406 -171.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.4 pp -53.38 -27.16 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.142 0 CA-C-N 115.487 -0.779 . . . . 1.72 111.963 179.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.5 t -46.86 -29.19 1.86 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.27 1.028 . . . . 2.9500000000000002 111.92 176.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 15.9 m -122.45 -42.1 2.36 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.433 0.693 . . . . 0.29999999999999999 111.662 170.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 89.0 m-70 -70.5 -4.44 22.84 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.226 1.01 . . . . 0.47999999999999998 112.722 -177.16 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 116.44 -76.25 0.27 Allowed Glycine 0 C--N 1.339 0.746 0 C-N-CA 125.269 1.414 . . . . 3.1899999999999999 111.927 161.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -178.91 -51.24 0.08 OUTLIER Glycine 0 CA--C 1.519 0.318 0 N-CA-C 108.597 -1.801 . . . . 2.2999999999999998 108.597 -170.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -101.36 3.79 40.9 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 124.086 0.955 . . . . 2.2000000000000002 110.777 -174.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 15.3 mt 75.4 11.61 3.35 Favored 'General case' 0 C--N 1.351 0.661 0 CA-C-N 119.764 1.165 . . . . 2.23 110.384 -178.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.6 p -81.24 -9.3 59.8 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 127.941 2.496 . . . . 1.51 109.913 -175.248 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.41 143.68 9.26 Favored Glycine 0 N--CA 1.441 -0.994 0 N-CA-C 109.142 -1.583 . . . . 0.46999999999999997 109.142 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -152.92 -81.92 0.09 Allowed 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 124.137 0.975 . . . . 1.6499999999999999 108.978 -178.406 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -88.93 3.44 51.44 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.544 1.137 . . . . 1.8400000000000001 110.828 171.142 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -156.05 160.9 30.46 Favored Pre-proline 0 N--CA 1.449 -0.499 0 C-N-CA 125.988 1.715 . . . . 1.5800000000000001 107.266 -169.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -68.17 160.03 50.6 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 123.466 2.778 . . . . 0.46000000000000002 111.069 -174.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.45 125.65 28.39 Favored 'General case' 0 N--CA 1.455 -0.224 0 O-C-N 121.513 -0.742 . . . . 1.71 109.762 -177.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 46.1 pt -105.29 2.54 10.39 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 C-N-CA 123.555 0.742 . . . . 1.6499999999999999 111.482 175.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -33.39 -47.9 0.23 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.528 1.931 . . . . 2.48 112.869 166.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.7 33.68 5.22 Favored 'General case' 0 C--N 1.344 0.35 0 C-N-CA 124.389 1.075 . . . . 5.8300000000000001 110.281 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.22 -46.91 88.14 Favored 'General case' 0 N--CA 1.45 -0.435 0 O-C-N 121.15 -0.969 . . . . 1.6100000000000001 108.923 176.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -56.87 -23.02 43.66 Favored Glycine 0 C--N 1.341 0.813 0 CA-C-N 118.65 0.659 . . . . 0.59999999999999998 114.588 178.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -83.92 -47.38 11.09 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 117.81 0.805 . . . . 1.78 109.558 173.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 13.2 m-80 -59.5 -49.91 75.96 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.016 0.526 . . . . 1.6499999999999999 111.535 -178.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -137.06 154.81 50.25 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.472 1.509 . . . . 1.3700000000000001 108.578 -169.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.6 p -84.57 165.87 17.65 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 123.925 0.89 . . . . 3.1699999999999999 110.226 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -50.53 -39.39 48.88 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 123.723 0.809 . . . . 3.2400000000000002 111.407 178.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -57.29 -50.46 72.84 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 118.457 0.571 . . . . 4.5800000000000001 110.83 177.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 27.5 mm-40 -68.09 -46.2 71.63 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 121.733 0.777 . . . . 3.0899999999999999 108.917 -175.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 48.7 mt -60.19 -47.31 92.6 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 N-CA-C 109.44 -0.578 . . . . 1.74 109.44 -179.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.9 tp -58.45 -49.58 76.8 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 109.117 -0.697 . . . . 1.7 109.117 178.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -50.42 -51.05 49.96 Favored 'General case' 0 N--CA 1.452 -0.355 0 O-C-N 123.409 0.443 . . . . 1.8200000000000001 109.961 176.27 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 55.0 mt -57.62 -52.32 58.92 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 O-C-N 121.868 -0.52 . . . . 1.51 110.957 178.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 60.7 mt -53.4 -44.9 56.45 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 O-C-N 120.561 -1.337 . . . . 1.71 110.404 179.383 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 75.1 mt -72.91 -32.67 65.49 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 113.361 0.874 . . . . 1.8300000000000001 113.361 -178.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -123.04 19.77 9.98 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 119.655 1.116 . . . . 1.74 109.981 -165.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.401 ' N ' ' HA2' ' A' ' 73' ' ' GLY . . . 31.0 -142.98 0.02 OUTLIER Glycine 0 CA--C 1.533 1.207 0 C-N-CA 129.107 3.242 . . . . 0.62 111.492 -167.477 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 173.27 133.41 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 119.005 1.403 . . . . 1.3799999999999999 109.057 -175.147 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 35.39 -113.64 0.14 Allowed Glycine 0 CA--C 1.534 1.224 0 CA-C-N 120.019 1.282 . . . . 0.54000000000000004 113.925 -171.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -71.76 -21.42 78.91 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 123.47 0.557 . . . . 0.69999999999999996 112.936 -178.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.402 ' HB2' ' C1D' ' A' ' 93' ' ' HEC . 19.6 ttt -71.13 117.98 61.54 Favored Pre-proline 0 N--CA 1.451 -0.409 0 C-N-CA 124.994 1.318 . . . . 1.4299999999999999 110.793 179.507 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -77.95 123.76 6.42 Favored 'Trans proline' 0 N--CA 1.447 -1.262 0 C-N-CA 122.938 2.425 . . . . 2.1000000000000001 111.015 -178.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.401 ' HA2' ' N ' ' A' ' 67' ' ' GLY . . . -59.48 137.06 50.21 Favored Glycine 0 N--CA 1.444 -0.815 0 N-CA-C 115.688 1.035 . . . . 1.6399999999999999 115.688 -177.262 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 80.49 38.64 16.84 Favored Glycine 0 CA--C 1.525 0.688 0 CA-C-N 114.071 -1.064 . . . . 0.32000000000000001 111.005 174.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.2 mt -58.35 -58.04 8.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 124.892 1.277 . . . . 2.23 109.255 174.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -93.97 151.5 19.5 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 108.31 -0.996 . . . . 1.52 108.31 163.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -143.0 164.81 29.08 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 105.985 -1.857 . . . . 4.3499999999999996 105.985 172.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 75.17 -173.19 53.02 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 110.306 -1.117 . . . . 1.72 110.306 -173.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -51.46 -27.96 11.83 Favored 'General case' 0 C--O 1.225 -0.23 0 C-N-CA 123.877 0.871 . . . . 1.8400000000000001 111.628 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 6.2 mp0 -42.23 -57.85 2.38 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 124.097 0.959 . . . . 4.5899999999999999 111.39 170.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -58.24 -47.98 81.82 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 118.519 0.599 . . . . 1.51 110.782 -175.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -52.37 -60.92 2.65 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 124.507 1.123 . . . . 2.04 111.348 174.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -55.16 -47.34 75.28 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 124.233 1.013 . . . . 1.5700000000000001 109.922 -177.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 62.4 t -55.91 -55.58 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 C-N-CA 123.669 0.788 . . . . 1.6899999999999999 110.339 176.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -51.4 -53.75 33.46 Favored 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 123.178 0.591 . . . . 1.4399999999999999 111.614 176.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -63.34 -42.13 98.92 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.872 0.869 . . . . 1.6599999999999999 110.784 -175.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 62.0 t90 -58.69 -50.8 72.56 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 108.626 -0.879 . . . . 0.5 108.626 174.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.39 -32.1 69.85 Favored 'General case' 0 C--O 1.222 -0.357 0 O-C-N 120.512 -1.367 . . . . 3.0099999999999998 112.585 173.381 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -60.64 -32.02 71.21 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 119.556 1.071 . . . . 1.47 111.925 172.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -77.59 -34.64 53.49 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 119.668 1.122 . . . . 3.8999999999999999 111.643 168.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 21.6 mtpp -73.96 116.32 14.44 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 119.806 1.185 . . . . 3.98 111.029 -175.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 12.3 mttt . . . . . 0 C--O 1.254 1.299 0 C-N-CA 127.787 2.435 . . . . 3.3799999999999999 105.569 -176.747 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' HEC . . . . . 0.402 ' C1D' ' HB2' ' A' ' 71' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 91.2 t . . . . . 0 N--CA 1.472 0.652 0 N-CA-C 106.697 -1.594 . . . . 2.75 106.697 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -74.47 99.44 3.56 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 108.45 -0.945 . . . . 2.23 108.45 -174.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -41.64 -57.38 2.3 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 124.951 1.3 . . . . 1.71 111.371 177.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -55.67 -48.21 75.43 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 116.314 -0.403 . . . . 2.3300000000000001 111.502 179.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.16 -44.7 83.72 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 118.266 0.485 . . . . 1.8300000000000001 110.921 178.256 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 54.6 t -57.53 -55.67 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 N-CA-C 109.332 -0.618 . . . . 1.6000000000000001 109.332 175.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 78.9 t -54.08 -49.61 60.13 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 N-CA-C 110.292 -0.262 . . . . 1.73 110.292 -177.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 30.6 mm-40 -51.83 -15.97 0.61 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.624 1.969 . . . . 0.87 113.588 174.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.43 30.96 2.61 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 119.313 0.961 . . . . 3.2799999999999998 112.314 178.496 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 5.0 mtmt -157.08 -47.31 0.07 Allowed 'General case' 0 CA--C 1.519 -0.214 0 O-C-N 121.85 -0.531 . . . . 2.4300000000000002 111.384 173.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 4.3 m -86.26 -48.13 8.8 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.65 -0.5 . . . . 0.23000000000000001 109.65 -174.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.5 pp -55.22 -27.8 20.51 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 CA-C-N 115.854 -0.612 . . . . 1.6499999999999999 112.332 -177.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.7 m -42.53 -34.42 0.85 Allowed 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.692 1.197 . . . . 1.9199999999999999 112.702 172.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 26.2 m -120.05 -41.37 2.65 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.134 0.574 . . . . 0.17999999999999999 111.763 174.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 84.5 m-70 -73.49 -7.85 53.49 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.712 0.805 . . . . 0.32000000000000001 112.688 -176.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 87.94 149.14 16.85 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 109.825 -1.31 . . . . 1.48 109.825 178.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -42.92 -34.89 2.08 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 124.78 1.181 . . . . 1.21 112.237 173.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -97.84 -6.99 31.35 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 125.737 1.615 . . . . 2.29 111.537 -171.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.2 mt 71.89 10.73 6.22 Favored 'General case' 0 C--N 1.351 0.665 0 CA-C-N 120.604 1.547 . . . . 2.21 111.232 176.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.7 p -88.79 0.43 56.53 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 128.603 2.761 . . . . 1.6899999999999999 109.992 -173.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.84 124.21 1.73 Allowed Glycine 0 N--CA 1.439 -1.106 0 N-CA-C 109.271 -1.532 . . . . 0.75 109.271 178.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -128.5 -78.74 0.57 Allowed 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 124.368 1.067 . . . . 1.29 108.873 177.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 21.4 m -93.67 4.55 53.77 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.387 1.075 . . . . 2.0499999999999998 111.104 172.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -152.16 163.28 24.09 Favored Pre-proline 0 CA--C 1.534 0.358 0 C-N-CA 126.096 1.758 . . . . 1.6100000000000001 107.164 -171.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -70.52 160.59 48.98 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 122.683 2.255 . . . . 0.33000000000000002 110.423 -176.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.52 128.23 34.91 Favored 'General case' 0 C--N 1.332 -0.187 0 O-C-N 121.461 -0.774 . . . . 1.48 110.255 -176.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 26.7 pt -108.21 0.84 9.74 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 C-N-CA 123.904 0.882 . . . . 1.5600000000000001 111.931 177.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 22.8 p-10 -33.08 -50.67 0.29 Allowed 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.812 1.645 . . . . 3.8700000000000001 113.243 169.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 12.6 pttp -111.96 22.46 14.85 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 125.796 1.638 . . . . 5.5300000000000002 112.054 -178.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -54.72 -38.34 66.97 Favored 'General case' 0 C--O 1.224 -0.285 0 O-C-N 121.632 -0.667 . . . . 1.8400000000000001 109.576 177.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -57.96 -17.58 29.91 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 123.862 0.744 . . . . 0.57999999999999996 114.927 176.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -90.0 -39.58 12.87 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 118.295 1.048 . . . . 1.6499999999999999 109.733 172.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -63.17 -48.86 76.63 Favored 'General case' 0 CA--C 1.527 0.084 0 C-N-CA 123.129 0.572 . . . . 3.6800000000000002 111.504 178.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -141.05 148.88 40.91 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 125.695 1.598 . . . . 1.1899999999999999 107.969 -166.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 16.6 m -81.89 167.57 18.83 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 118.39 0.541 . . . . 2.2999999999999998 110.573 179.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -46.9 -43.12 18.57 Favored 'General case' 0 C--O 1.225 -0.225 0 C-N-CA 124.191 0.996 . . . . 3.1000000000000001 111.424 175.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -55.13 -45.62 75.61 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.039 0.936 . . . . 2.6899999999999999 110.568 179.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -73.42 -49.42 27.11 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 123.766 0.826 . . . . 3.1200000000000001 109.75 -178.007 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 72.8 mt -60.05 -42.76 90.9 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 N-CA-C 108.618 -0.882 . . . . 1.55 108.618 -176.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 23.4 tp -55.01 -52.11 64.15 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 123.473 0.709 . . . . 1.8400000000000001 109.739 175.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -52.04 -48.31 64.62 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 118.118 0.417 . . . . 1.5 111.136 176.168 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 95.6 mt -57.81 -54.22 34.56 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 O-C-N 121.348 -0.845 . . . . 1.6599999999999999 110.446 177.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 38.3 mt -50.0 -46.02 23.22 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 O-C-N 121.163 -0.961 . . . . 1.6499999999999999 109.909 178.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 96.5 mt -62.96 -40.02 96.41 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 118.044 -0.979 . . . . 1.99 113.395 177.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -127.85 25.45 5.96 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 120.369 1.44 . . . . 1.8400000000000001 110.442 -159.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 23.57 -134.98 0.01 OUTLIER Glycine 0 CA--C 1.542 1.758 0 C-N-CA 127.615 2.531 . . . . 0.65000000000000002 112.694 -159.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 21.6 tt0 169.25 138.62 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.148 0 CA-C-N 119.799 1.8 . . . . 1.3899999999999999 108.933 -177.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 30.06 -111.15 0.03 OUTLIER Glycine 0 CA--C 1.534 1.247 0 C-N-CA 125.212 1.387 . . . . 0.54000000000000004 114.154 -171.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -66.97 -25.85 73.25 Favored Glycine 0 CA--C 1.534 1.226 0 CA-C-N 118.069 0.935 . . . . 0.64000000000000001 113.415 -178.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 16.7 ttt -70.9 120.67 80.72 Favored Pre-proline 0 CA--C 1.536 0.441 0 C-N-CA 124.747 1.219 . . . . 1.51 110.033 -179.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -61.89 -56.0 0.9 Allowed 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 124.358 3.372 . . . . 2.96 111.237 -169.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 118.25 151.56 9.16 Favored Glycine 0 N--CA 1.447 -0.63 0 CA-C-N 115.58 -0.736 . . . . 2.3199999999999998 113.874 173.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 65.73 22.47 70.05 Favored Glycine 0 CA--C 1.528 0.849 0 CA-C-N 114.313 -0.943 . . . . 0.41999999999999998 111.522 -179.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 2.6 mt -50.13 -57.51 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 C-N-CA 125.282 1.433 . . . . 2.1699999999999999 109.462 176.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -102.62 152.74 20.84 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.36 0.664 . . . . 1.52 109.794 163.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 3.2 mmmp? -145.03 151.82 39.16 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.594 1.158 . . . . 4.71 109.598 177.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 71.99 -156.67 52.61 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 123.518 0.58 . . . . 0.89000000000000001 111.749 177.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -48.22 -35.59 12.18 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 124.941 1.296 . . . . 2.1699999999999999 112.09 -177.007 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -47.45 -63.53 1.03 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.897 1.279 . . . . 2.1800000000000002 110.715 169.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.03 -44.34 94.69 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.979 0.912 . . . . 1.45 110.794 -179.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -54.59 -52.31 62.55 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 121.219 0.533 . . . . 2.5299999999999998 110.047 179.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.13 -51.67 68.76 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.57 0.748 . . . . 1.4399999999999999 109.971 179.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 55.7 t -49.55 -56.71 2.67 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 123.027 0.531 . . . . 1.79 111.012 176.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -53.44 -51.9 61.16 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 124.059 0.944 . . . . 1.6000000000000001 111.855 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.95 -48.61 80.99 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 121.599 0.714 . . . . 1.8 110.434 -179.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 49.9 t90 -56.5 -43.35 79.65 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.165 0.586 . . . . 0.47999999999999998 110.303 177.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.43 -42.31 98.71 Favored 'General case' 0 C--O 1.227 -0.117 0 C-N-CA 123.646 0.778 . . . . 2.7200000000000002 110.862 175.568 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -55.36 -38.15 68.42 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 119.236 0.925 . . . . 1.48 110.716 171.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -84.15 13.09 5.49 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.655 1.182 . . . . 3.5299999999999998 113.655 174.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.46 122.7 43.37 Favored 'General case' 0 C--N 1.34 0.189 0 CA-C-N 119.954 1.252 . . . . 3.2000000000000002 109.733 173.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.255 1.378 0 C-N-CA 127.541 2.336 . . . . 3.7999999999999998 104.959 178.097 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 84.8 t . . . . . 0 N--CA 1.472 0.63 0 N-CA-C 106.853 -1.536 . . . . 2.7000000000000002 106.853 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -74.87 95.91 3.03 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 107.786 -1.19 . . . . 2.5899999999999999 107.786 -175.14 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -49.69 -50.22 44.51 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.204 1.002 . . . . 1.8799999999999999 109.805 179.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -60.61 -51.59 68.77 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 116.002 -0.544 . . . . 3.2000000000000002 110.414 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.99 -45.28 79.06 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 118.916 0.78 . . . . 1.75 110.99 -178.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 24.5 t -56.64 -56.43 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 CA-C-N 116.12 -0.491 . . . . 2.0299999999999998 109.713 175.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 52.2 t -55.68 -45.72 79.22 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 N-CA-C 110.005 -0.369 . . . . 1.76 110.005 -178.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 26.0 mm-40 -55.72 -11.31 0.91 Allowed 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 127.355 2.262 . . . . 0.83999999999999997 113.859 173.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -139.05 16.62 2.63 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 119.63 1.104 . . . . 3.8100000000000001 113.514 173.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 23.6 mttm -135.86 -62.79 0.67 Allowed 'General case' 0 CA--C 1.518 -0.257 0 C-N-CA 123.919 0.888 . . . . 3.1800000000000002 109.457 176.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 3.2 m -72.71 -47.93 42.99 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.096 0.474 . . . . 0.29999999999999999 110.43 -173.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.2 pp -58.72 -25.13 27.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 CA-C-N 115.533 -0.758 . . . . 1.6299999999999999 111.688 -174.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.6 m -46.16 -32.93 3.23 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.829 1.251 . . . . 2.1699999999999999 111.768 175.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 21.6 m -120.31 -42.57 2.56 Favored 'General case' 0 C--N 1.341 0.21 0 C-N-CA 123.523 0.729 . . . . 0.19 111.516 175.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -72.56 -8.63 56.15 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.577 0.751 . . . . 0.28999999999999998 112.667 -177.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 86.46 148.81 12.71 Favored Glycine 0 C--N 1.336 0.567 0 N-CA-C 109.442 -1.463 . . . . 1.47 109.442 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -42.05 -33.43 1.23 Allowed Glycine 0 CA--C 1.527 0.821 0 C-N-CA 125.241 1.401 . . . . 1.25 112.914 175.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -100.66 -4.8 27.62 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 125.408 1.483 . . . . 3.1099999999999999 112.089 -170.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 13.0 mt 68.94 12.94 8.77 Favored 'General case' 0 C--N 1.352 0.699 0 CA-C-N 120.212 1.369 . . . . 2.1000000000000001 112.002 177.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 11.0 p -84.32 -3.63 58.37 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 127.329 2.252 . . . . 1.77 110.365 -177.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.72 130.7 3.74 Favored Glycine 0 N--CA 1.441 -0.988 0 N-CA-C 108.943 -1.663 . . . . 0.58999999999999997 108.943 -176.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -134.5 -79.44 0.45 Allowed 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 124.285 1.034 . . . . 1.3200000000000001 108.471 177.175 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 19.5 m -91.61 4.28 53.04 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.208 1.003 . . . . 2.0699999999999998 111.043 173.144 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -155.72 163.95 22.95 Favored Pre-proline 0 CA--C 1.536 0.407 0 C-N-CA 125.388 1.475 . . . . 1.47 107.884 -169.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -70.74 157.97 56.99 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.915 2.41 . . . . 0.32000000000000001 110.582 -174.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.52 123.44 23.93 Favored 'General case' 0 C--N 1.331 -0.208 0 O-C-N 121.492 -0.755 . . . . 1.5800000000000001 110.16 -175.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 44.0 pt -106.78 2.22 10.09 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.135 0 C-N-CA 124.22 1.008 . . . . 1.5900000000000001 111.132 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.439 ' OD1' ' NZ ' ' A' ' 91' ' ' LYS . 24.4 t0 -42.01 -49.59 4.67 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 118.457 0.571 . . . . 2.8999999999999999 112.149 177.643 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 5.3 pttt -101.28 26.32 7.28 Favored 'General case' 0 C--N 1.344 0.331 0 C-N-CA 125.743 1.617 . . . . 5.71 111.698 -178.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -53.74 -43.13 68.88 Favored 'General case' 0 N--CA 1.457 -0.122 0 O-C-N 121.483 -0.761 . . . . 1.4299999999999999 110.302 -178.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -52.05 -23.82 12.92 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 114.682 0.633 . . . . 0.60999999999999999 114.682 175.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -80.99 -35.69 31.67 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 118.061 0.931 . . . . 1.6899999999999999 110.509 175.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 -74.2 -48.36 29.53 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 122.814 0.446 . . . . 2.8100000000000001 109.997 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -140.4 153.67 46.42 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.356 1.062 . . . . 1.8999999999999999 109.274 -170.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 20.0 m -83.83 166.92 17.53 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 118.485 0.584 . . . . 2.46 110.684 178.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.2 pm0 -47.07 -42.41 18.64 Favored 'General case' 0 C--O 1.223 -0.293 0 C-N-CA 124.793 1.237 . . . . 2.79 111.92 178.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -58.44 -45.83 87.73 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.378 0.609 . . . . 2.6600000000000001 110.152 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -74.2 -46.68 40.38 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.599 0.76 . . . . 3.2000000000000002 109.134 -176.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 62.6 mt -59.32 -44.28 91.95 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.132 0 O-C-N 121.475 -0.766 . . . . 1.6000000000000001 109.018 179.263 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 52.8 tp -54.43 -51.17 65.79 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 109.14 -0.689 . . . . 1.6599999999999999 109.14 176.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -52.48 -50.16 63.25 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 123.297 0.373 . . . . 1.5 110.253 174.147 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 76.7 mt -61.65 -24.09 32.88 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 O-C-N 121.323 -0.861 . . . . 1.9099999999999999 112.621 179.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 75.1 mt -82.38 -46.66 19.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 O-C-N 120.059 -1.65 . . . . 1.6299999999999999 109.621 176.129 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 68.7 mt -72.64 -30.29 64.19 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.395 1.078 . . . . 1.97 112.713 -176.146 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -127.39 17.31 7.06 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 119.207 0.912 . . . . 1.96 109.614 -169.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.428 ' N ' ' HA2' ' A' ' 73' ' ' GLY . . . 40.41 -143.87 0.55 Allowed Glycine 0 CA--C 1.539 1.539 0 C-N-CA 127.759 2.6 . . . . 0.70999999999999996 111.814 -177.722 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 31.4 tt0 170.12 138.18 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 126.069 1.748 . . . . 1.3100000000000001 109.731 -179.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 35.76 -116.62 0.28 Allowed Glycine 0 C--N 1.347 1.16 0 CA-C-N 120.46 1.482 . . . . 0.44 114.082 -175.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -67.32 -23.16 73.27 Favored Glycine 0 CA--C 1.531 1.091 0 CA-C-N 117.98 0.89 . . . . 0.55000000000000004 112.555 -179.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 18.6 ttt -72.7 117.96 63.84 Favored Pre-proline 0 CA--C 1.535 0.398 0 C-N-CA 124.45 1.1 . . . . 1.5800000000000001 112.053 179.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -75.57 123.78 7.8 Favored 'Trans proline' 0 N--CA 1.446 -1.277 0 C-N-CA 122.848 2.366 . . . . 2.1099999999999999 111.706 -179.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.428 ' HA2' ' N ' ' A' ' 67' ' ' GLY . . . -58.01 126.67 43.01 Favored Glycine 0 N--CA 1.443 -0.889 0 CA-C-N 115.012 -0.995 . . . . 1.6599999999999999 115.246 179.191 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 86.66 48.01 4.63 Favored Glycine 0 C--N 1.337 0.636 0 N-CA-C 110.648 -0.981 . . . . 0.57999999999999996 110.648 173.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.1 mt -69.11 -50.88 49.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 123.833 0.853 . . . . 2.2799999999999998 109.497 175.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -102.92 153.63 20.02 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 126.002 1.721 . . . . 1.6699999999999999 109.619 164.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 44.9 mttm -143.63 155.36 44.23 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 125.386 1.475 . . . . 3.7599999999999998 108.861 178.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 72.63 -167.77 53.43 Favored Glycine 0 CA--C 1.53 0.981 0 N-CA-C 110.926 -0.869 . . . . 1.1699999999999999 110.926 -175.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -52.04 -25.95 9.76 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.469 1.108 . . . . 2.4300000000000002 112.728 -177.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -42.19 -60.3 1.5 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.723 1.209 . . . . 2.21 110.939 168.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.27 -45.73 92.28 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 122.608 0.363 . . . . 1.7 110.638 -175.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -52.11 -57.12 10.55 Favored 'General case' 0 N--CA 1.461 0.096 0 C-N-CA 123.503 0.721 . . . . 3.04 111.196 174.129 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -53.95 -48.48 70.25 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 123.139 0.576 . . . . 1.75 109.812 -177.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 98.5 t -59.18 -53.32 49.71 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 N-CA-C 111.588 0.218 . . . . 1.6899999999999999 111.588 177.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -51.29 -53.82 31.98 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 124.051 0.941 . . . . 1.71 111.455 178.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.89 -54.42 47.13 Favored 'General case' 0 C--O 1.224 -0.268 0 N-CA-C 109.299 -0.63 . . . . 1.4099999999999999 109.299 179.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . 0.406 ' CE3' ' CD2' ' A' ' 88' ' ' LEU . 50.2 t90 -49.38 -46.61 47.48 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 122.984 0.514 . . . . 0.65000000000000002 111.134 177.066 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.406 ' CD2' ' CE3' ' A' ' 87' ' ' TRP . 0.1 OUTLIER -66.05 -31.82 72.93 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 124.585 1.154 . . . . 2.79 111.908 177.338 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -67.8 -44.85 76.35 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 118.739 0.7 . . . . 2.0600000000000001 110.731 173.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -57.52 -39.76 77.27 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.286 0.634 . . . . 5.2400000000000002 110.196 173.042 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.439 ' NZ ' ' OD1' ' A' ' 49' ' ' ASP . 1.6 mtmp? -73.45 136.22 44.2 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 118.852 0.751 . . . . 3.6400000000000001 110.538 178.074 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 67.8 mttt . . . . . 0 C--O 1.249 1.044 0 CA-C-O 117.189 -1.386 . . . . 3.4900000000000002 108.091 174.704 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.1 p . . . . . 0 N--CA 1.475 0.794 0 N-CA-C 105.384 -2.08 . . . . 3.4100000000000001 105.384 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -91.88 95.29 9.75 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 119.439 1.018 . . . . 2.5800000000000001 108.664 -173.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -51.84 -58.62 5.92 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.655 0.782 . . . . 1.5900000000000001 110.906 -178.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -50.15 -45.14 52.94 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 118.936 -0.554 . . . . 2.8500000000000001 111.362 176.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.99 -47.66 84.91 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 119.033 0.833 . . . . 1.8700000000000001 110.829 179.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 89.3 t -56.32 -54.49 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.155 0 N-CA-C 108.934 -0.765 . . . . 1.6499999999999999 108.934 176.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 96.4 t -56.02 -48.21 79.11 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 C-N-CA 122.55 0.34 . . . . 1.8500000000000001 111.037 -177.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 36.4 mm-40 -53.67 -15.81 1.37 Allowed 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 126.912 2.085 . . . . 0.48999999999999999 113.036 174.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -144.98 48.21 1.31 Allowed 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 119.286 0.948 . . . . 3.2599999999999998 111.086 174.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 3.8 mttt -162.69 -49.28 0.04 OUTLIER 'General case' 0 C--O 1.227 -0.131 0 C-N-CA 124.483 1.113 . . . . 3.1299999999999999 110.206 167.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 5.2 m -85.2 -50.11 7.66 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 121.443 0.64 . . . . 0.20000000000000001 110.417 -172.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.4 pp -53.48 -28.63 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 CA-C-N 115.063 -0.971 . . . . 1.6499999999999999 111.487 -178.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.9 m -41.61 -35.14 0.69 Allowed 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 125.574 1.549 . . . . 1.8100000000000001 112.377 173.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 34.9 m -119.23 -41.53 2.73 Favored 'General case' 0 C--N 1.34 0.185 0 C-N-CA 123.546 0.739 . . . . 0.19 111.562 174.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 84.4 m-70 -74.18 -7.72 53.66 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.749 0.82 . . . . 0.51000000000000001 112.791 -175.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 84.24 148.72 9.29 Favored Glycine 0 C--N 1.338 0.643 0 C-N-CA 125.511 1.529 . . . . 1.52 109.6 -179.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -44.49 -36.47 4.46 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 124.41 1.005 . . . . 1.22 112.317 174.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -88.61 -10.72 47.68 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 124.842 1.257 . . . . 2.0600000000000001 111.454 -174.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.4 mt 71.78 10.59 6.31 Favored 'General case' 0 C--N 1.349 0.578 0 CA-C-N 120.197 1.362 . . . . 2.1899999999999999 110.818 176.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.4 p -84.06 -0.27 51.13 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 128.415 2.686 . . . . 1.52 110.126 -175.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.4 138.88 5.84 Favored Glycine 0 N--CA 1.44 -1.071 0 N-CA-C 108.599 -1.801 . . . . 0.44 108.599 -176.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -145.35 -78.34 0.19 Allowed 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 123.789 0.836 . . . . 1.3100000000000001 108.932 178.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.5 t -89.07 1.7 55.17 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.824 0.85 . . . . 1.6799999999999999 110.355 174.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -162.43 165.13 15.98 Favored Pre-proline 0 CA--C 1.537 0.467 0 C-N-CA 125.12 1.368 . . . . 1.7 107.434 -167.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -66.81 159.52 51.06 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 123.46 2.773 . . . . 0.41999999999999998 111.54 -173.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.33 132.19 42.78 Favored 'General case' 0 C--N 1.332 -0.177 0 O-C-N 121.67 -0.643 . . . . 1.52 109.867 -178.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 35.3 pt -109.03 1.16 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 C-N-CA 123.242 0.617 . . . . 1.7 112.516 175.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -38.49 -47.4 1.27 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.459 1.104 . . . . 3.5600000000000001 111.811 170.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 10.7 mttt -108.52 35.2 3.28 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 125.553 1.541 . . . . 6.3300000000000001 111.683 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.81 -55.28 35.02 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 108.567 -0.901 . . . . 1.51 108.567 169.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -57.02 -21.28 37.58 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 124.726 1.155 . . . . 0.75 113.551 -179.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.01 -38.91 92.47 Favored 'General case' 0 N--CA 1.451 -0.394 0 O-C-N 121.799 -0.824 . . . . 1.8700000000000001 110.994 177.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 72.0 m-80 -105.23 -53.66 2.62 Favored 'General case' 0 CA--C 1.523 -0.076 0 C-N-CA 123.411 0.684 . . . . 2.98 109.937 -174.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -94.66 142.34 27.57 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 124.848 1.259 . . . . 1.73 108.929 -171.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.5 167.06 17.76 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 118.748 0.704 . . . . 2.8700000000000001 110.167 175.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -48.37 -47.43 37.32 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 124.009 0.924 . . . . 3.04 110.894 174.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -54.72 -34.95 63.14 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.39 0.676 . . . . 4.46 111.598 178.632 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -84.44 -47.05 11.04 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 121.533 0.682 . . . . 3.4399999999999999 109.602 -175.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 87.1 mt -61.48 -41.93 91.93 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 N-CA-C 108.778 -0.823 . . . . 1.6799999999999999 108.778 179.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.4 tp -54.95 -49.46 71.31 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 123.02 0.528 . . . . 1.5900000000000001 109.714 175.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -52.1 -52.09 53.59 Favored 'General case' 0 CA--C 1.533 0.306 0 O-C-N 123.271 0.357 . . . . 1.51 110.152 176.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 75.7 mt -57.76 -50.69 76.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.288 0 O-C-N 121.572 -0.705 . . . . 1.5800000000000001 110.311 178.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 46.3 mt -54.06 -44.39 62.62 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 O-C-N 120.383 -1.448 . . . . 1.51 110.411 179.163 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 84.8 mt -70.5 -32.78 70.42 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 118.33 -0.843 . . . . 1.5600000000000001 112.892 -179.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -124.69 18.84 8.7 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 119.752 1.16 . . . . 1.6899999999999999 110.387 -164.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.428 ' N ' ' HA2' ' A' ' 73' ' ' GLY . . . 30.81 -137.33 0.07 OUTLIER Glycine 0 CA--C 1.532 1.116 0 C-N-CA 128.819 3.104 . . . . 0.63 111.206 -167.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 11.6 tt0 165.7 129.74 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.518 1.527 . . . . 1.9199999999999999 109.81 -178.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 41.04 -118.42 1.26 Allowed Glycine 0 C--N 1.346 1.089 0 CA-C-N 120.865 1.666 . . . . 0.81999999999999995 113.846 -176.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -66.07 -17.36 65.55 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 123.711 0.672 . . . . 0.78000000000000003 112.644 -179.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 19.4 ttt -81.39 117.74 69.41 Favored Pre-proline 0 N--CA 1.448 -0.531 0 C-N-CA 124.879 1.272 . . . . 1.5 111.525 179.063 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -77.93 122.64 5.9 Favored 'Trans proline' 0 N--CA 1.447 -1.237 0 C-N-CA 122.992 2.461 . . . . 2.1099999999999999 111.704 -179.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.428 ' HA2' ' N ' ' A' ' 67' ' ' GLY . . . -57.84 132.93 52.8 Favored Glycine 0 N--CA 1.443 -0.853 0 N-CA-C 115.737 1.055 . . . . 1.6200000000000001 115.737 -179.29 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 82.59 34.4 22.57 Favored Glycine 0 CA--C 1.527 0.803 0 CA-C-N 114.228 -0.986 . . . . 0.34000000000000002 112.06 173.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.4 mt -53.9 -57.24 6.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 125.256 1.422 . . . . 2.0800000000000001 110.038 174.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -101.73 150.06 23.51 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 124.292 1.037 . . . . 1.5800000000000001 108.27 166.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 56.2 mttm -142.26 165.25 27.95 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 106.986 -1.487 . . . . 3.6499999999999999 106.986 172.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 76.8 -170.29 55.04 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 110.022 -1.231 . . . . 1.6200000000000001 110.022 -173.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -52.35 -30.19 27.52 Favored 'General case' 0 C--O 1.225 -0.222 0 C-N-CA 123.865 0.866 . . . . 1.71 111.15 -176.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.5 mp0 -39.5 -62.98 0.61 Allowed 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.147 1.379 . . . . 4.54 111.063 170.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -58.46 -48.92 79.18 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.207 0.458 . . . . 1.49 111.125 -175.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -50.06 -57.63 7.23 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.362 1.065 . . . . 2.0 111.353 175.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.95 -43.63 98.44 Favored 'General case' 0 N--CA 1.449 -0.507 0 O-C-N 121.902 -0.499 . . . . 1.7 110.769 -177.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 71.3 t -53.97 -53.95 23.89 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 C-N-CA 123.332 0.653 . . . . 1.8200000000000001 109.737 176.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -52.73 -53.53 46.55 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 123.401 0.68 . . . . 1.74 112.082 175.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.61 -47.14 82.98 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 122.115 0.96 . . . . 1.3200000000000001 110.976 -179.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 50.9 t90 -59.86 -42.48 93.78 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.315 1.046 . . . . 0.52000000000000002 110.273 178.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.25 -38.92 92.75 Favored 'General case' 0 C--N 1.333 -0.116 0 C-N-CA 123.996 0.918 . . . . 2.7200000000000002 110.818 175.552 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -52.81 -45.5 67.28 Favored 'General case' 0 CA--C 1.528 0.12 0 N-CA-C 109.424 -0.584 . . . . 1.6000000000000001 109.424 173.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -90.28 36.78 0.88 Allowed 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.216 0.606 . . . . 3.0600000000000001 111.896 175.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 4.4 mttm -126.36 136.37 52.62 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.267 1.027 . . . . 3.9500000000000002 108.702 164.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 30.8 mttt . . . . . 0 C--O 1.253 1.256 0 N-CA-C 105.162 -2.162 . . . . 4.4199999999999999 105.162 172.916 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 53.7 t . . . . . 0 N--CA 1.473 0.712 0 N-CA-C 106.965 -1.494 . . . . 2.4900000000000002 106.965 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -73.8 97.73 2.8 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 118.655 0.661 . . . . 2.52 109.287 -175.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -40.84 -51.91 3.09 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 125.012 1.325 . . . . 1.8300000000000001 111.8 176.097 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -57.02 -46.09 82.59 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 110.146 -0.316 . . . . 2.9300000000000002 110.146 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.1 -43.75 98.41 Favored 'General case' 0 CA--C 1.528 0.109 0 C-N-CA 123.386 0.674 . . . . 1.51 110.768 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 89.8 t -58.93 -58.76 5.44 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.261 0 N-CA-C 109.062 -0.718 . . . . 1.8799999999999999 109.062 176.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 44.1 t -53.02 -47.03 54.74 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 C-N-CA 123.224 0.609 . . . . 1.6200000000000001 110.431 -177.114 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 24.7 mm-40 -48.9 -25.91 2.17 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 126.119 1.768 . . . . 0.71999999999999997 113.427 173.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -141.01 56.73 1.56 Allowed 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 119.261 0.937 . . . . 4.29 111.624 174.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.44 ' HZ2' ' CD ' ' A' ' 80' ' ' GLU . 0.0 OUTLIER -170.47 -38.12 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 124.145 0.978 . . . . 2.2000000000000002 110.033 170.442 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 3.4 m -101.18 -50.23 3.85 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 119.27 0.941 . . . . 0.26000000000000001 110.86 -177.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.2 pp -56.88 -27.07 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 CA-C-N 116.107 -0.497 . . . . 1.6200000000000001 112.027 -174.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.7 m -38.64 -35.76 0.21 Allowed 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.635 1.574 . . . . 1.72 112.473 170.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 20.9 m -121.02 -44.28 2.41 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.75 0.82 . . . . 0.19 111.371 174.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 86.5 m-70 -70.5 -9.55 56.9 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.753 0.821 . . . . 0.31 112.897 -176.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 88.37 148.08 15.54 Favored Glycine 0 C--N 1.338 0.643 0 N-CA-C 109.816 -1.314 . . . . 1.52 109.816 177.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -44.6 -36.29 4.51 Favored Glycine 0 C--N 1.341 0.807 0 C-N-CA 124.454 1.026 . . . . 1.21 111.852 175.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -93.7 -6.93 45.12 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 124.909 1.283 . . . . 2.5499999999999998 111.758 -172.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 8.9 mt 70.91 11.12 7.07 Favored 'General case' 0 C--N 1.352 0.693 0 CA-C-N 120.237 1.381 . . . . 2.0099999999999998 111.301 177.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 11.0 p -86.28 0.88 52.84 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 127.186 2.194 . . . . 1.5 109.832 -175.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.72 133.19 3.52 Favored Glycine 0 N--CA 1.443 -0.89 0 N-CA-C 108.881 -1.688 . . . . 0.45000000000000001 108.881 -177.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -136.42 -75.82 0.43 Allowed 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 108.431 -0.951 . . . . 1.3799999999999999 108.431 178.344 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 9.3 t -95.85 4.17 53.06 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.09 0.956 . . . . 2.5699999999999998 110.753 173.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -157.92 167.39 14.58 Favored Pre-proline 0 CA--C 1.538 0.488 0 C-N-CA 125.207 1.403 . . . . 1.6499999999999999 108.181 -169.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -71.03 155.63 61.39 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 122.968 2.446 . . . . 0.26000000000000001 110.801 -173.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.67 123.28 23.75 Favored 'General case' 0 C--N 1.332 -0.176 0 O-C-N 121.589 -0.695 . . . . 1.6299999999999999 110.57 -176.119 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 45.4 pt -104.46 0.68 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 C-N-CA 123.526 0.73 . . . . 1.79 111.801 179.1 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -41.13 -39.29 1.24 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.971 0.908 . . . . 3.0699999999999998 112.396 171.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 12.4 mtpt -117.73 34.08 5.32 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 125.187 1.395 . . . . 4.8700000000000001 109.828 -177.339 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.18 -53.59 50.92 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 108.654 -0.869 . . . . 1.49 108.654 171.174 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -56.85 -21.76 38.4 Favored Glycine 0 C--N 1.34 0.765 0 C-N-CA 124.116 0.865 . . . . 0.58999999999999997 114.247 -178.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -60.91 -38.86 87.22 Favored 'General case' 0 N--CA 1.449 -0.49 0 O-C-N 122.01 -0.7 . . . . 1.8700000000000001 110.636 174.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 41.3 m-80 -107.55 -58.9 1.9 Allowed 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 124.356 1.062 . . . . 2.96 110.295 -174.271 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -78.37 149.49 33.37 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.391 1.077 . . . . 2.5099999999999998 110.084 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 29.3 m -94.86 173.94 7.34 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.943 1.297 . . . . 2.6800000000000002 110.13 176.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -56.64 -53.09 61.65 Favored 'General case' 0 N--CA 1.457 -0.098 0 O-C-N 121.761 -0.587 . . . . 3.02 109.825 -176.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 35.3 mm-40 -55.38 -32.17 62.39 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.434 0.693 . . . . 4.4500000000000002 111.816 177.334 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -75.97 -50.9 13.6 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 108.635 -0.876 . . . . 2.5499999999999998 108.635 -177.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 66.4 mt -62.7 -43.47 98.66 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.133 0 O-C-N 121.431 -0.793 . . . . 1.6799999999999999 108.89 -178.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 27.0 tp -55.9 -50.34 70.95 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 109.749 -0.463 . . . . 1.51 109.749 176.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -51.72 -51.91 52.46 Favored 'General case' 0 CA--C 1.53 0.21 0 O-C-N 123.057 0.223 . . . . 2.2200000000000002 110.503 175.295 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 81.2 mt -57.33 -50.47 76.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 O-C-N 121.781 -0.575 . . . . 1.6499999999999999 109.962 179.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 71.9 mt -53.35 -42.56 48.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 O-C-N 120.522 -1.361 . . . . 1.6799999999999999 110.306 178.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 68.9 mt -72.23 -32.61 66.89 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 113.736 1.013 . . . . 1.6200000000000001 113.736 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -122.75 20.06 10.19 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 120.176 1.353 . . . . 1.6100000000000001 110.387 -167.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.411 ' N ' ' HA2' ' A' ' 73' ' ' GLY . . . 31.05 -133.61 0.11 Allowed Glycine 0 CA--C 1.532 1.107 0 C-N-CA 128.621 3.01 . . . . 0.71999999999999997 111.462 -166.729 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 168.52 130.94 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 119.034 1.417 . . . . 1.7 109.465 -179.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 35.41 -111.97 0.1 OUTLIER Glycine 0 CA--C 1.532 1.147 0 CA-C-N 120.116 1.326 . . . . 0.62 113.815 -171.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -70.92 -20.91 78.07 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 123.367 0.508 . . . . 0.65000000000000002 113.029 -178.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.404 ' HB2' ' C1D' ' A' ' 93' ' ' HEC . 19.0 ttt -74.39 120.24 80.48 Favored Pre-proline 0 N--CA 1.45 -0.466 0 C-N-CA 125.15 1.38 . . . . 1.5600000000000001 110.353 -179.403 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -79.73 121.41 4.6 Favored 'Trans proline' 0 N--CA 1.446 -1.319 0 C-N-CA 122.888 2.392 . . . . 2.0299999999999998 111.534 -176.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.411 ' HA2' ' N ' ' A' ' 67' ' ' GLY . . . -57.06 134.05 52.44 Favored Glycine 0 N--CA 1.444 -0.792 0 N-CA-C 115.275 0.87 . . . . 1.6799999999999999 115.275 -179.458 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 87.22 38.98 7.54 Favored Glycine 0 CA--C 1.527 0.792 0 CA-C-N 114.353 -0.924 . . . . 0.44 111.709 174.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 2.5 mt -63.79 -59.67 3.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 124.751 1.22 . . . . 2.4300000000000002 110.22 176.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -104.18 161.36 14.09 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.632 1.173 . . . . 1.54 108.233 165.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 21.5 mttm -145.47 175.92 9.97 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.998 0.919 . . . . 4.2000000000000002 109.659 173.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 57.94 -153.66 25.23 Favored Glycine 0 CA--C 1.531 1.093 0 CA-C-O 121.45 0.472 . . . . 0.79000000000000004 112.537 177.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -53.39 -29.93 37.26 Favored 'General case' 0 C--N 1.339 0.13 0 C-N-CA 123.955 0.902 . . . . 1.76 111.681 174.079 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.44 ' CD ' ' HZ2' ' A' ' 31' ' ' LYS . 5.1 tt0 -52.42 -61.2 2.43 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 108.612 -0.885 . . . . 2.3900000000000001 108.612 173.69 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -63.28 -51.09 67.54 Favored 'General case' 0 CA--C 1.53 0.209 0 O-C-N 122.187 -0.32 . . . . 1.74 111.668 179.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -51.34 -52.64 43.65 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 121.034 0.445 . . . . 2.73 111.67 -178.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -56.45 -48.79 76.29 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 109.788 -0.449 . . . . 1.6399999999999999 109.788 -179.096 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 77.6 t -54.81 -49.97 65.06 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 CA-C-O 119.389 -0.339 . . . . 1.6799999999999999 111.127 176.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -51.71 -54.22 30.64 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 122.757 0.423 . . . . 1.51 111.34 176.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.06 -44.85 95.8 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 121.269 0.557 . . . . 1.96 111.376 -177.4 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . 0.453 ' CE3' HD21 ' A' ' 88' ' ' LEU . 47.9 t90 -60.29 -52.24 66.14 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 121.715 -0.615 . . . . 0.77000000000000002 109.566 177.694 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.453 HD21 ' CE3' ' A' ' 87' ' ' TRP . 0.1 OUTLIER -55.59 -35.27 65.62 Favored 'General case' 0 C--O 1.222 -0.363 0 C-N-CA 124.068 0.947 . . . . 2.6899999999999999 110.369 176.602 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -59.07 -44.69 91.9 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 118.559 0.618 . . . . 1.4299999999999999 111.803 176.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -72.37 -27.88 62.67 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 110.248 -0.279 . . . . 4.2699999999999996 110.248 173.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 12.3 tptp -69.51 116.4 9.88 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.788 0.835 . . . . 3.4199999999999999 109.774 -175.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 23.9 mttt . . . . . 0 C--O 1.256 1.444 0 C-N-CA 128.649 2.779 . . . . 2.8900000000000001 104.232 -178.128 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' HEC . . . . . 0.404 ' C1D' ' HB2' ' A' ' 71' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 39.5 t . . . . . 0 N--CA 1.471 0.606 0 N-CA-C 107.322 -1.362 . . . . 2.3900000000000001 107.322 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -74.47 104.29 5.14 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 123.585 0.754 . . . . 2.1400000000000001 109.261 -178.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -40.82 -55.07 2.54 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 124.096 0.958 . . . . 1.6599999999999999 110.866 175.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -59.63 -40.37 87.38 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 119.514 -0.279 . . . . 3.0899999999999999 110.814 -177.332 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.5 -44.78 93.35 Favored 'General case' 0 C--N 1.339 0.125 0 CA-C-N 118.532 0.606 . . . . 1.8100000000000001 110.678 178.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 93.8 t -58.58 -53.34 48.23 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.219 0 N-CA-C 109.157 -0.683 . . . . 1.6299999999999999 109.157 176.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 54.2 t -52.28 -48.92 43.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 N-CA-C 110.286 -0.264 . . . . 1.78 110.286 179.099 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 28.8 mm-40 -55.14 -18.45 5.72 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 126.05 1.74 . . . . 0.59999999999999998 114.041 174.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -150.36 50.65 0.89 Allowed 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 120.046 1.294 . . . . 2.8399999999999999 112.628 178.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.453 ' HZ3' ' CD ' ' A' ' 80' ' ' GLU . 0.0 OUTLIER -167.24 -37.34 0.02 OUTLIER 'General case' 0 C--O 1.225 -0.189 0 C-N-CA 126.056 1.742 . . . . 1.95 110.071 170.068 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 4.5 m -98.81 -52.79 3.48 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 119.431 1.014 . . . . 0.27000000000000002 111.423 -176.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.5 pp -54.69 -27.4 18.15 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.077 0 CA-C-N 115.878 -0.601 . . . . 1.79 111.763 -177.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.8 m -40.07 -37.04 0.55 Allowed 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 126.392 1.877 . . . . 1.8200000000000001 112.073 173.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 19.1 m -118.8 -40.08 2.9 Favored 'General case' 0 C--N 1.339 0.15 0 C-N-CA 123.115 0.566 . . . . 0.17999999999999999 111.927 173.1 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 83.3 m-70 -72.65 -7.57 50.99 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 112.852 0.686 . . . . 0.44 112.852 -175.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 86.12 151.35 17.55 Favored Glycine 0 C--N 1.336 0.579 0 N-CA-C 109.324 -1.51 . . . . 1.51 109.324 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -42.41 -36.62 2.26 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 125.019 1.295 . . . . 1.1699999999999999 112.928 178.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 44.5 m-20 -102.99 1.34 33.44 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.734 1.214 . . . . 2.1800000000000002 112.342 -172.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.9 mm? 64.12 21.67 12.64 Favored 'General case' 0 C--N 1.35 0.595 0 CA-C-N 120.482 1.492 . . . . 4.4500000000000002 111.415 179.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.2 p -84.68 -5.13 59.3 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 127.661 2.384 . . . . 1.5 110.016 179.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.27 131.6 3.8 Favored Glycine 0 N--CA 1.439 -1.1 0 N-CA-C 108.954 -1.658 . . . . 0.55000000000000004 108.954 -177.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -138.39 -79.97 0.34 Allowed 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.021 0.928 . . . . 1.6599999999999999 109.44 177.183 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 70.9 m -89.12 4.02 49.88 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.638 0.775 . . . . 2.3799999999999999 111.391 170.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -155.85 161.46 29.43 Favored Pre-proline 0 CA--C 1.535 0.373 0 C-N-CA 125.253 1.421 . . . . 1.45 107.823 -170.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -66.96 159.67 50.76 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 123.185 2.59 . . . . 0.38 111.164 -176.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.69 126.86 31.28 Favored 'General case' 0 C--N 1.331 -0.214 0 O-C-N 121.447 -0.783 . . . . 1.45 110.603 -175.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 25.4 pt -104.94 0.88 10.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 C-N-CA 123.27 0.628 . . . . 1.71 111.581 177.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -34.83 -48.03 0.37 Allowed 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.26 1.424 . . . . 2.46 113.595 172.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 29.5 pttt -106.92 22.76 15.46 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 124.143 0.977 . . . . 4.9699999999999998 112.017 -176.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -54.94 -42.63 72.54 Favored 'General case' 0 N--CA 1.45 -0.43 0 O-C-N 121.548 -0.72 . . . . 1.6000000000000001 110.261 -176.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -55.25 -25.77 41.24 Favored Glycine 0 CA--C 1.529 0.943 0 N-CA-C 114.603 0.601 . . . . 0.51000000000000001 114.603 179.086 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -84.62 -45.28 12.67 Favored 'General case' 0 CA--C 1.522 -0.119 0 CA-C-N 118.287 1.043 . . . . 1.6799999999999999 109.561 172.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -56.36 -46.75 79.85 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 119.555 -0.259 . . . . 2.6000000000000001 111.037 -178.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -145.38 151.41 38.23 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.738 1.615 . . . . 1.3200000000000001 108.71 -170.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 84.1 p -78.75 170.72 16.22 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 119.374 0.988 . . . . 3.0299999999999998 111.422 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -49.69 -44.27 47.95 Favored 'General case' 0 C--O 1.224 -0.274 0 CA-C-O 118.619 -0.705 . . . . 3.0499999999999998 111.491 174.03 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -56.91 -47.97 79.32 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 118.911 0.778 . . . . 2.3999999999999999 110.461 178.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -69.51 -47.23 64.5 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 109.129 -0.693 . . . . 3.27 109.129 -174.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 52.3 mt -59.0 -48.28 87.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 109.249 -0.649 . . . . 1.6399999999999999 109.249 179.587 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 41.3 tp -54.82 -50.32 68.86 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 123.668 0.787 . . . . 1.5600000000000001 109.076 178.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -55.01 -47.86 74.12 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 110.305 -0.258 . . . . 2.2799999999999998 110.305 175.838 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 46.7 mt -61.47 -33.82 58.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 O-C-N 121.018 -1.051 . . . . 1.76 111.812 178.427 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 75.8 mt -68.77 -48.17 72.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 O-C-N 120.157 -1.589 . . . . 1.6399999999999999 108.986 175.082 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 92.9 mt -69.37 -31.24 69.51 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.43 1.092 . . . . 1.6299999999999999 113.177 -176.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 22.3 m-20 -121.51 13.72 10.98 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 119.445 1.02 . . . . 1.77 109.735 -168.073 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 40.14 -146.78 0.27 Allowed Glycine 0 CA--C 1.54 1.654 0 C-N-CA 127.604 2.526 . . . . 0.63 111.325 -169.164 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 10.6 tt0 178.29 135.65 0.08 Allowed 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 125.104 1.362 . . . . 1.25 108.596 -177.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 37.77 -114.6 0.3 Allowed Glycine 0 CA--C 1.533 1.198 0 CA-C-N 119.86 1.209 . . . . 0.46000000000000002 113.361 -172.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -74.77 -20.53 79.46 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 123.289 0.471 . . . . 0.71999999999999997 113.064 -179.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 21.3 ttt -67.42 119.19 63.53 Favored Pre-proline 0 N--CA 1.452 -0.373 0 C-N-CA 124.269 1.028 . . . . 1.6899999999999999 110.662 179.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -76.22 123.93 7.52 Favored 'Trans proline' 0 N--CA 1.446 -1.321 0 C-N-CA 122.698 2.265 . . . . 2.1499999999999999 110.795 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -65.05 141.82 43.94 Favored Glycine 0 N--CA 1.442 -0.958 0 N-CA-C 115.349 0.9 . . . . 1.5900000000000001 115.349 -176.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 78.34 33.42 39.62 Favored Glycine 0 CA--C 1.524 0.649 0 CA-C-N 114.047 -1.077 . . . . 0.34999999999999998 110.84 175.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -56.53 -49.93 75.33 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 C-N-CA 124.407 1.083 . . . . 2.0899999999999999 109.022 173.486 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -111.95 154.02 25.89 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.411 1.485 . . . . 1.5 110.409 165.218 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 4.7 mmmt -139.02 158.71 43.71 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.197 1.799 . . . . 3.9500000000000002 109.896 179.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 56.13 -141.04 41.17 Favored Glycine 0 CA--C 1.528 0.892 0 N-CA-C 111.164 -0.775 . . . . 0.98999999999999999 111.164 178.025 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -51.23 -36.65 42.78 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 117.496 0.648 . . . . 2.0800000000000001 111.542 176.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.453 ' CD ' ' HZ3' ' A' ' 31' ' ' LYS . 18.5 tt0 -57.15 -37.0 71.41 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 122.892 0.477 . . . . 2.4100000000000001 110.023 178.499 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -82.94 -56.6 3.71 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.212 0.605 . . . . 1.5900000000000001 110.522 176.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -51.93 -52.21 51.68 Favored 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 124.543 1.137 . . . . 3.0600000000000001 112.076 -176.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.04 -47.45 83.07 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 109.644 -0.502 . . . . 1.52 109.644 -177.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 78.9 t -59.01 -56.37 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 C-N-CA 122.895 0.478 . . . . 1.6100000000000001 110.532 178.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -47.78 -56.12 8.11 Favored 'General case' 0 C--O 1.226 -0.146 0 C-N-CA 123.369 0.668 . . . . 1.3400000000000001 111.296 177.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.77 -45.75 92.54 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.371 0.669 . . . . 1.45 110.887 -176.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 79.1 t90 -57.04 -52.41 65.39 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 121.713 -0.617 . . . . 0.79000000000000004 109.722 177.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.74 -31.08 71.23 Favored 'General case' 0 C--O 1.223 -0.32 0 CA-C-O 118.603 -0.713 . . . . 2.98 112.654 175.818 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.08 -26.57 60.62 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 119.491 1.041 . . . . 1.49 111.534 172.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -90.81 -29.67 17.45 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 112.938 0.718 . . . . 4.9299999999999997 112.938 171.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 19.7 mtpp -74.64 103.95 5.13 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 119.721 1.146 . . . . 3.8799999999999999 110.633 174.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 20.2 pttt . . . . . 0 C--O 1.25 1.11 0 C-N-CA 126.298 1.839 . . . . 3.5099999999999998 106.354 -175.351 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 25.1 t . . . . . 0 N--CA 1.471 0.587 0 N-CA-C 106.456 -1.683 . . . . 2.4199999999999999 106.456 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -78.5 111.4 14.5 Favored 'General case' 0 N--CA 1.451 -0.398 0 O-C-N 123.79 0.681 . . . . 3.8300000000000001 109.307 -176.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -52.9 -45.03 67.35 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 123.921 0.888 . . . . 1.53 111.608 -178.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -64.48 -48.91 73.43 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 108.195 -1.039 . . . . 3.3300000000000001 108.195 -176.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.97 -47.61 74.33 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 123.44 0.696 . . . . 1.5 111.333 177.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 74.1 t -55.97 -55.64 17.05 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.12 0 N-CA-C 109.525 -0.546 . . . . 1.6000000000000001 109.525 177.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 5.6 t -54.75 -49.4 68.91 Favored 'Isoleucine or valine' 0 C--O 1.239 0.525 0 CA-C-N 117.851 0.296 . . . . 1.8600000000000001 111.265 -178.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 35.8 mm-40 -52.65 -14.86 0.58 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 126.732 2.013 . . . . 0.46999999999999997 112.984 173.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.77 47.76 1.64 Allowed 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 119.469 1.031 . . . . 4.54 111.514 173.17 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.469 ' HZ3' ' CD ' ' A' ' 80' ' ' GLU . 0.0 OUTLIER -166.71 -42.7 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.16 0 O-C-N 121.915 -0.49 . . . . 1.9199999999999999 110.485 169.205 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 3.6 m -93.36 -48.45 6.41 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 118.284 0.493 . . . . 0.20999999999999999 110.026 -173.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.4 pp -51.65 -31.61 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 CA-C-N 115.977 -0.556 . . . . 1.7 111.962 -179.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 20.0 m -38.47 -37.31 0.3 Allowed 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 125.748 1.619 . . . . 1.6200000000000001 112.73 173.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 21.5 m -121.3 -40.01 2.63 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 123.069 0.548 . . . . 0.19 112.009 173.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 82.2 m-70 -71.79 -7.66 49.57 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.616 0.766 . . . . 0.28000000000000003 112.755 -177.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 84.44 148.29 9.16 Favored Glycine 0 C--N 1.337 0.602 0 N-CA-C 109.296 -1.522 . . . . 1.49 109.296 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -41.69 -35.11 1.35 Allowed Glycine 0 CA--C 1.527 0.843 0 C-N-CA 124.73 1.157 . . . . 1.24 112.496 174.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -95.39 -8.48 35.51 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 124.961 1.305 . . . . 2.3799999999999999 111.264 -169.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.3 mt 72.33 6.89 5.6 Favored 'General case' 0 C--N 1.348 0.534 0 CA-C-N 120.136 1.334 . . . . 2.3500000000000001 111.398 178.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 16.0 p -83.92 0.27 48.48 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 127.176 2.19 . . . . 1.54 110.102 -175.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.09 150.03 21.56 Favored Glycine 0 N--CA 1.436 -1.339 0 N-CA-C 108.855 -1.698 . . . . 0.53000000000000003 108.855 -173.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -156.33 -78.03 0.09 Allowed 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 124.609 1.164 . . . . 1.6699999999999999 108.863 177.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.0 m -97.37 2.63 50.77 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.448 1.099 . . . . 2.5800000000000001 111.216 170.063 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -148.14 162.05 32.19 Favored Pre-proline 0 CA--C 1.535 0.372 0 C-N-CA 126.999 2.12 . . . . 1.7 107.159 -176.191 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -71.26 163.15 40.13 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 123.219 2.613 . . . . 0.31 111.203 -176.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -74.93 113.58 12.4 Favored 'General case' 0 C--N 1.332 -0.19 0 O-C-N 121.73 -0.607 . . . . 1.51 111.235 -174.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 48.1 pt -97.07 0.66 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 C-N-CA 123.307 0.643 . . . . 1.5600000000000001 111.797 178.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -48.88 -34.9 13.54 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.154 0.581 . . . . 3.3399999999999999 112.319 176.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.2 pttm -115.43 38.66 3.18 Favored 'General case' 0 C--N 1.343 0.311 0 C-N-CA 124.82 1.248 . . . . 4.1699999999999999 111.216 175.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.73 -55.75 20.87 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 108.076 -1.083 . . . . 1.51 108.076 168.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -54.08 -27.0 36.91 Favored Glycine 0 C--N 1.339 0.717 0 C-N-CA 124.675 1.131 . . . . 0.64000000000000001 113.695 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.95 -38.44 75.97 Favored 'General case' 0 N--CA 1.449 -0.488 0 O-C-N 121.957 -0.731 . . . . 2.1000000000000001 111.446 175.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 47.3 m-80 -107.85 -57.73 2.06 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 124.318 1.047 . . . . 2.8999999999999999 110.819 -174.166 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -89.51 149.47 22.89 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 125.086 1.354 . . . . 1.3400000000000001 109.06 -174.297 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 60.7 m -94.29 164.11 13.16 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 122.961 0.505 . . . . 2.5 110.643 179.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.1 tm-20 -40.9 -64.39 0.54 Allowed 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.023 1.329 . . . . 5.6600000000000001 111.002 178.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -41.12 -47.02 3.14 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.936 1.294 . . . . 4.1100000000000003 112.905 174.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 61.1 mm-40 -69.55 -47.27 64.25 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 122.23 1.014 . . . . 3.3300000000000001 108.573 -174.456 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 61.5 mt -61.46 -44.18 98.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-N 115.948 -0.569 . . . . 1.6000000000000001 109.503 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 35.3 tp -55.31 -53.39 56.77 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 124.366 1.066 . . . . 1.72 109.163 175.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -49.72 -52.31 32.32 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 117.992 0.36 . . . . 1.53 110.389 175.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 87.4 mt -60.31 -37.65 74.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 119.744 -0.783 . . . . 1.55 111.557 179.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 60.5 mt -61.53 -46.81 95.78 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 O-C-N 120.041 -1.662 . . . . 1.79 109.851 173.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 85.6 mt -67.14 -32.17 73.1 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 117.179 -1.391 . . . . 1.75 114.479 -171.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -139.05 30.57 2.22 Favored 'General case' 0 C--N 1.344 0.362 0 CA-C-N 120.191 1.359 . . . . 3.2200000000000002 110.112 -171.119 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 35.08 -141.28 0.13 Allowed Glycine 0 CA--C 1.542 1.754 0 C-N-CA 128.122 2.772 . . . . 0.65000000000000002 112.81 -175.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 172.46 136.45 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.58 1.552 . . . . 1.95 108.022 -175.283 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 28.83 -106.7 0.01 OUTLIER Glycine 0 CA--C 1.534 1.222 0 C-N-CA 125.519 1.533 . . . . 0.59999999999999998 114.785 -176.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -66.07 -27.27 72.75 Favored Glycine 0 CA--C 1.537 1.428 0 CA-C-N 117.769 0.784 . . . . 0.83999999999999997 113.562 -178.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 15.8 ttt -76.47 123.04 87.69 Favored Pre-proline 0 CA--C 1.54 0.567 0 C-N-CA 125.888 1.675 . . . . 1.6399999999999999 110.683 -178.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -62.32 -56.66 0.63 Allowed 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 124.462 3.441 . . . . 3.0 111.781 -168.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 118.24 144.92 7.72 Favored Glycine 0 N--CA 1.449 -0.482 0 CA-C-N 115.795 -0.639 . . . . 2.2999999999999998 114.228 172.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 67.82 26.79 73.76 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.907 -0.877 . . . . 0.35999999999999999 110.907 -174.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 2.0 mm -52.01 -51.88 26.92 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 124.561 1.144 . . . . 3.3900000000000001 110.11 177.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -112.27 159.42 18.64 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.478 1.111 . . . . 1.6399999999999999 108.974 161.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 21.3 mttp -146.01 158.09 43.87 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.35 1.06 . . . . 4.5999999999999996 110.147 175.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 64.67 -153.35 49.66 Favored Glycine 0 CA--C 1.53 0.992 0 N-CA-C 111.343 -0.703 . . . . 1.05 111.343 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -45.61 -38.6 6.75 Favored 'General case' 0 C--N 1.34 0.186 0 C-N-CA 124.855 1.262 . . . . 1.72 112.154 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.469 ' CD ' ' HZ3' ' A' ' 31' ' ' LYS . 27.2 tt0 -50.51 -52.93 34.04 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.423 1.089 . . . . 2.1499999999999999 110.396 175.006 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -71.32 -48.0 53.19 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.649 0.78 . . . . 1.49 110.853 179.261 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -53.97 -50.67 66.02 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.826 0.85 . . . . 2.6699999999999999 110.708 -176.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -55.19 -49.54 71.64 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 123.071 0.548 . . . . 1.5700000000000001 110.286 178.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 53.8 t -58.12 -52.9 52.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 CA-C-O 119.343 -0.36 . . . . 1.74 110.986 178.499 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -49.26 -52.49 27.01 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 123.341 0.656 . . . . 1.6200000000000001 111.452 176.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.75 -51.88 67.45 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 121.46 0.648 . . . . 1.5800000000000001 110.215 -177.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 48.9 t90 -54.84 -43.18 72.82 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 122.757 0.423 . . . . 0.62 110.69 177.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.96 -37.73 86.76 Favored 'General case' 0 C--O 1.227 -0.118 0 C-N-CA 124.504 1.121 . . . . 2.7799999999999998 110.712 178.271 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -52.96 -42.75 65.79 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 119.0 0.818 . . . . 1.79 109.55 171.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -85.79 21.6 1.85 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.439 1.095 . . . . 4.1699999999999999 112.405 175.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 4.7 mtpm? -116.68 139.43 50.56 Favored 'General case' 0 C--N 1.342 0.253 0 CA-C-O 122.256 1.027 . . . . 3.2599999999999998 109.956 167.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 53.2 mttm . . . . . 0 C--O 1.25 1.116 0 C-N-CA 129.206 3.002 . . . . 4.5300000000000002 103.152 177.606 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.5 t . . . . . 0 N--CA 1.471 0.588 0 N-CA-C 106.882 -1.525 . . . . 2.2400000000000002 106.882 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -75.94 104.43 6.47 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 108.475 -0.935 . . . . 2.3799999999999999 108.475 -176.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -41.15 -54.54 2.86 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 124.554 1.141 . . . . 1.6699999999999999 110.708 175.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -58.39 -46.77 85.72 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 115.805 -0.634 . . . . 3.1600000000000001 110.272 -178.128 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.2 -44.51 92.24 Favored 'General case' 0 C--N 1.34 0.159 0 C-N-CA 123.125 0.57 . . . . 1.5700000000000001 111.147 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 77.8 t -57.81 -56.88 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 N-CA-C 109.279 -0.638 . . . . 1.51 109.279 175.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 71.7 t -54.0 -48.65 63.71 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 CA-C-N 117.933 0.333 . . . . 1.6200000000000001 110.494 -176.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 28.0 mm-40 -47.94 -24.69 1.1 Allowed 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 126.261 1.824 . . . . 0.64000000000000001 112.872 174.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -141.26 51.56 1.58 Allowed 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 119.144 0.884 . . . . 3.2200000000000002 111.642 173.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.467 ' HZ3' ' CD ' ' A' ' 80' ' ' GLU . 0.0 OUTLIER -162.68 -36.63 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 124.319 1.048 . . . . 1.96 111.211 166.722 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 3.8 m -101.89 -50.87 3.55 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 119.159 0.89 . . . . 0.27000000000000002 110.954 -174.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.2 pp -54.41 -29.37 19.92 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.082 0 CA-C-N 116.369 -0.378 . . . . 1.6100000000000001 111.949 -176.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 10.0 m -35.26 -41.71 0.17 Allowed 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 125.507 1.523 . . . . 1.6699999999999999 112.81 171.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 22.4 m -114.86 -35.63 4.73 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.294 0.638 . . . . 0.16 111.839 174.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 89.4 m-70 -80.66 2.09 27.28 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.226 1.01 . . . . 0.40000000000000002 113.314 -175.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 107.78 -80.96 0.28 Allowed Glycine 0 CA--C 1.525 0.668 0 C-N-CA 125.747 1.641 . . . . 2.8999999999999999 111.785 165.149 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -175.24 -52.51 0.06 OUTLIER Glycine 0 CA--C 1.519 0.304 0 N-CA-C 108.441 -1.864 . . . . 2.4900000000000002 108.441 -171.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -97.71 4.6 49.94 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 124.452 1.101 . . . . 3.3199999999999998 111.076 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.2 mt 76.15 14.33 2.51 Favored 'General case' 0 C--N 1.351 0.661 0 CA-C-N 119.85 1.205 . . . . 3.1400000000000001 110.007 -179.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.0 p -76.27 -13.37 60.16 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 128.11 2.564 . . . . 1.6399999999999999 109.822 -178.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.98 154.02 30.62 Favored Glycine 0 N--CA 1.442 -0.9 0 N-CA-C 108.449 -1.86 . . . . 0.68000000000000005 108.449 -178.356 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -156.8 -76.89 0.09 Allowed 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.457 -0.572 . . . . 1.28 109.457 177.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 19.6 t -93.55 4.17 54.37 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 122.854 0.462 . . . . 2.5499999999999998 110.483 172.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -157.53 163.01 26.25 Favored Pre-proline 0 N--CA 1.448 -0.56 0 C-N-CA 126.242 1.817 . . . . 1.6899999999999999 107.195 -166.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -67.72 162.85 37.6 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 123.044 2.496 . . . . 0.27000000000000002 111.193 -172.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -76.03 122.32 24.05 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 122.95 0.5 . . . . 1.5700000000000001 109.693 -178.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 47.9 pt -107.95 2.79 9.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 123.739 0.816 . . . . 1.72 112.063 178.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.444 ' OD1' ' NZ ' ' A' ' 91' ' ' LYS . 28.4 t70 -45.25 -45.99 12.24 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 113.125 0.787 . . . . 2.79 113.125 175.475 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.5 mptp? -100.92 26.62 6.74 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.999 1.32 . . . . 7.2599999999999998 109.837 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -52.9 -45.6 67.61 Favored 'General case' 0 N--CA 1.453 -0.277 0 O-C-N 121.345 -0.847 . . . . 1.6100000000000001 109.318 177.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -54.84 -22.26 26.1 Favored Glycine 0 CA--C 1.528 0.883 0 N-CA-C 115.021 0.768 . . . . 0.60999999999999999 115.021 177.047 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -81.54 -36.01 29.64 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 118.387 1.093 . . . . 1.8899999999999999 110.513 174.021 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -76.55 -48.55 18.96 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 123.08 0.552 . . . . 1.95 111.003 -178.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -141.21 143.97 34.47 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.699 1.6 . . . . 1.49 107.756 -167.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 69.7 m -83.91 169.86 14.62 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 119.57 1.077 . . . . 2.7400000000000002 111.096 178.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -51.03 -43.68 60.94 Favored 'General case' 0 C--O 1.222 -0.376 0 CA-C-O 118.602 -0.713 . . . . 2.73 112.681 -175.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -52.66 -45.69 66.84 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 119.057 0.844 . . . . 2.6600000000000001 111.055 176.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -71.17 -51.01 27.3 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 108.96 -0.756 . . . . 3.48 108.96 -176.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 71.5 mt -58.11 -44.9 88.36 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 N-CA-C 108.765 -0.828 . . . . 1.5800000000000001 108.765 -177.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 19.4 tp -56.27 -51.03 69.67 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 124.47 1.108 . . . . 1.95 109.401 177.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -53.92 -48.62 70.0 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 117.832 0.287 . . . . 1.46 111.345 175.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 93.0 mt -55.53 -54.88 20.8 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.211 0 O-C-N 121.526 -0.733 . . . . 1.54 109.443 177.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 52.2 mt -50.68 -46.54 28.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 O-C-N 120.807 -1.183 . . . . 1.6100000000000001 110.154 178.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 61.3 mt -64.17 -31.72 73.02 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 117.685 -1.15 . . . . 2.0899999999999999 113.541 178.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -131.63 20.09 4.69 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 120.278 1.399 . . . . 1.8100000000000001 111.109 -163.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 29.41 -141.0 0.02 OUTLIER Glycine 0 CA--C 1.543 1.809 0 C-N-CA 127.295 2.379 . . . . 0.67000000000000004 113.048 -160.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 37.4 tt0 174.63 141.72 0.05 OUTLIER 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 126.198 1.799 . . . . 1.8500000000000001 106.977 -176.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 22.25 -100.39 0.01 OUTLIER Glycine 0 CA--C 1.535 1.328 0 C-N-CA 126.094 1.807 . . . . 0.76000000000000001 114.822 -173.378 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -68.31 -34.08 79.31 Favored Glycine 0 CA--C 1.539 1.553 0 CA-C-N 118.802 1.301 . . . . 0.91000000000000003 113.485 -178.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -55.55 130.99 71.13 Favored Pre-proline 0 CA--C 1.539 0.538 0 C-N-CA 124.044 0.938 . . . . 1.55 112.282 176.616 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -63.8 -57.23 0.38 Allowed 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 123.895 3.063 . . . . 3.0299999999999998 110.857 178.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 116.74 146.68 8.52 Favored Glycine 0 C--N 1.335 0.497 0 C-N-CA 124.194 0.902 . . . . 2.2400000000000002 113.761 173.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 69.45 24.56 76.07 Favored Glycine 0 CA--C 1.529 0.952 0 N-CA-C 111.558 -0.617 . . . . 0.46000000000000002 111.558 -179.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.7 mt -52.61 -58.49 2.59 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 C-N-CA 126.212 1.805 . . . . 2.1499999999999999 110.982 179.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -103.48 158.33 16.43 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.162 0.985 . . . . 1.53 108.967 162.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 4.9 mmtp -145.12 166.36 25.63 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.574 1.55 . . . . 3.7999999999999998 108.783 179.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 56.94 -147.51 33.75 Favored Glycine 0 CA--C 1.532 1.135 0 O-C-N 121.741 -0.599 . . . . 0.83999999999999997 112.491 176.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -50.23 -36.94 33.09 Favored 'General case' 0 C--N 1.34 0.186 0 C-N-CA 123.809 0.843 . . . . 1.97 111.255 175.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.467 ' CD ' ' HZ3' ' A' ' 31' ' ' LYS . 5.0 tt0 -52.78 -51.55 60.24 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.802 0.841 . . . . 2.02 109.599 176.16 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -69.51 -52.05 30.11 Favored 'General case' 0 CA--C 1.53 0.209 0 O-C-N 122.035 -0.416 . . . . 1.51 111.477 177.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -50.77 -56.23 13.04 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 123.117 0.567 . . . . 2.5899999999999999 111.547 -177.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -55.38 -50.0 70.85 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 109.686 -0.487 . . . . 1.52 109.686 -175.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 54.4 t -55.26 -56.59 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 C-N-CA 123.006 0.522 . . . . 1.5700000000000001 111.395 176.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -52.6 -50.88 62.18 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.343 0.657 . . . . 1.6699999999999999 111.267 -178.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.79 -47.63 85.43 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.111 0.564 . . . . 1.3899999999999999 110.365 -179.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . 0.413 ' CE3' HD23 ' A' ' 88' ' ' LEU . 53.5 t90 -56.73 -50.44 72.21 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 121.991 -0.443 . . . . 0.65000000000000002 110.164 177.31 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.413 HD23 ' CE3' ' A' ' 87' ' ' TRP . 0.1 OUTLIER -60.77 -34.93 75.21 Favored 'General case' 0 C--O 1.226 -0.184 0 C-N-CA 124.31 1.044 . . . . 2.73 110.802 177.548 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -67.09 -40.74 87.02 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 118.187 0.448 . . . . 1.9399999999999999 110.978 176.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -61.39 -40.17 93.36 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 122.856 0.462 . . . . 4.1100000000000003 110.643 171.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.444 ' NZ ' ' OD1' ' A' ' 49' ' ' ASP . 0.0 OUTLIER -73.31 105.66 4.8 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 121.527 -0.733 . . . . 3.0099999999999998 110.169 178.983 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.163 0 CA-C-O 117.578 -1.201 . . . . 3.5 109.559 -177.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 18.7 t . . . . . 0 N--CA 1.469 0.486 0 N-CA-C 107.284 -1.376 . . . . 2.0499999999999998 107.284 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -78.38 101.26 7.15 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 108.153 -1.055 . . . . 2.2400000000000002 108.153 -173.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -41.07 -55.14 2.66 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.747 1.219 . . . . 1.6100000000000001 111.519 177.197 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -51.87 -46.91 64.67 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 123.157 0.583 . . . . 2.98 111.785 176.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.67 -45.65 89.14 Favored 'General case' 0 N--CA 1.457 -0.104 0 CA-C-N 118.442 0.564 . . . . 1.3999999999999999 110.442 -177.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 72.8 t -57.07 -57.71 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 N-CA-C 109.007 -0.738 . . . . 1.54 109.007 175.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 25.6 t -47.92 -50.83 9.58 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 C-N-CA 124.305 1.042 . . . . 1.79 110.64 -178.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 30.8 mm-40 -53.1 -25.21 12.21 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 125.811 1.645 . . . . 0.56999999999999995 113.398 176.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 11.0 mt-30 -137.69 59.37 1.67 Allowed 'General case' 0 N--CA 1.456 -0.14 0 CA-C-N 119.309 0.959 . . . . 2.75 111.719 172.11 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 5.1 mttt -172.2 -36.46 0.01 OUTLIER 'General case' 0 C--O 1.224 -0.249 0 C-N-CA 124.204 1.002 . . . . 3.3700000000000001 110.322 168.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 4.0 m -101.22 -52.62 3.21 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 119.426 1.012 . . . . 0.22 111.312 -177.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.2 pp -55.83 -26.66 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.095 0 CA-C-N 115.99 -0.55 . . . . 1.6699999999999999 111.614 -177.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.1 t -40.17 -36.03 0.46 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.37 1.468 . . . . 2.8199999999999998 111.83 173.563 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 32.9 m -118.78 -40.06 2.91 Favored 'General case' 0 C--N 1.342 0.259 0 C-N-CA 123.539 0.736 . . . . 0.17000000000000001 111.908 174.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 87.1 m-70 -75.89 -7.11 53.75 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 113.171 0.804 . . . . 0.32000000000000001 113.171 -174.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 86.26 150.26 15.46 Favored Glycine 0 C--N 1.337 0.625 0 N-CA-C 110.034 -1.227 . . . . 1.55 110.034 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -43.56 -39.19 4.41 Favored Glycine 0 C--N 1.34 0.801 0 C-N-CA 124.76 1.172 . . . . 1.1399999999999999 112.338 178.259 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -97.65 -0.83 44.91 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 124.366 1.066 . . . . 2.21 110.959 -171.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.2 mp 67.41 15.8 9.93 Favored 'General case' 0 C--N 1.349 0.558 0 CA-C-N 120.11 1.323 . . . . 2.96 111.432 176.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 6.9 p -83.43 -1.73 54.18 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 128.132 2.573 . . . . 1.6599999999999999 109.906 -178.008 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.98 144.71 9.72 Favored Glycine 0 N--CA 1.438 -1.174 0 N-CA-C 108.552 -1.819 . . . . 0.40999999999999998 108.552 -175.076 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -150.15 -80.38 0.12 Allowed 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 124.406 1.083 . . . . 1.3 108.939 177.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 58.7 m -91.56 3.64 54.52 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.812 0.845 . . . . 2.3599999999999999 111.422 170.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -154.38 163.41 24.27 Favored Pre-proline 0 N--CA 1.45 -0.469 0 C-N-CA 125.88 1.672 . . . . 1.48 107.197 -172.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -68.27 163.89 34.53 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.618 2.212 . . . . 0.5 110.877 -176.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -74.27 122.74 23.33 Favored 'General case' 0 N--CA 1.455 -0.193 0 O-C-N 121.931 -0.481 . . . . 1.49 110.306 -177.047 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 35.3 pt -105.78 0.88 10.16 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.181 0 C-N-CA 123.713 0.805 . . . . 1.5700000000000001 110.917 177.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -39.32 -45.41 1.43 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.059 0.944 . . . . 2.3999999999999999 112.409 169.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.59 15.97 21.81 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.129 0.972 . . . . 5.6699999999999999 111.13 -175.18 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -56.39 -47.28 79.26 Favored 'General case' 0 N--CA 1.452 -0.326 0 O-C-N 121.198 -0.939 . . . . 1.6200000000000001 110.069 -171.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -54.7 -26.62 40.21 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 114.447 0.539 . . . . 0.46999999999999997 114.447 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -80.55 -42.05 23.06 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 117.815 0.808 . . . . 1.79 109.827 175.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 52.8 m-80 -63.5 -52.51 60.93 Favored 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 122.499 0.32 . . . . 1.6599999999999999 110.906 179.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -138.1 145.88 42.21 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 125.956 1.702 . . . . 1.9299999999999999 108.479 -167.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -79.96 170.82 15.94 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.543 0.737 . . . . 2.9100000000000001 110.571 -178.804 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -49.94 -46.53 52.29 Favored 'General case' 0 C--O 1.225 -0.185 0 C-N-CA 124.079 0.952 . . . . 2.6699999999999999 111.615 177.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -58.91 -29.72 67.28 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.237 0.615 . . . . 2.8399999999999999 112.093 179.369 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -86.7 -48.0 8.65 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.0 -0.741 . . . . 3.4100000000000001 109.0 -178.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 98.7 mt -61.36 -43.91 97.52 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 O-C-N 121.714 -0.616 . . . . 1.71 109.461 -179.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 60.0 tp -52.57 -51.06 61.58 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 109.197 -0.668 . . . . 1.6599999999999999 109.197 175.195 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -58.51 -44.52 89.51 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 110.113 -0.329 . . . . 1.6200000000000001 110.113 178.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 78.8 mt -60.2 -36.52 68.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 O-C-N 121.104 -0.997 . . . . 1.6599999999999999 111.498 176.048 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 50.9 mt -67.41 -49.37 72.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 O-C-N 120.03 -1.669 . . . . 1.6000000000000001 109.42 176.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 80.7 mt -66.74 -29.64 69.67 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 124.639 1.175 . . . . 1.6499999999999999 113.154 -175.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 14.3 m-80 -124.1 11.57 8.87 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 119.789 1.177 . . . . 1.77 110.157 -170.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.424 ' N ' ' HA2' ' A' ' 73' ' ' GLY . . . 43.12 -147.4 0.81 Allowed Glycine 0 CA--C 1.539 1.571 0 C-N-CA 126.623 2.059 . . . . 0.63 110.833 -171.465 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 170.45 135.49 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 119.524 1.662 . . . . 1.22 110.82 -178.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 43.63 -122.14 3.83 Favored Glycine 0 CA--C 1.532 1.149 0 O-C-N 120.685 -1.259 . . . . 0.52000000000000002 112.474 -173.088 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -69.08 -17.83 72.26 Favored Glycine 0 CA--C 1.531 1.046 0 O-C-N 122.483 -0.422 . . . . 0.57999999999999996 112.886 179.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 20.8 ttt -73.95 119.73 77.68 Favored Pre-proline 0 N--CA 1.451 -0.42 0 C-N-CA 123.838 0.855 . . . . 1.52 111.486 -178.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -78.08 120.88 5.14 Favored 'Trans proline' 0 N--CA 1.448 -1.172 0 C-N-CA 122.884 2.389 . . . . 2.1299999999999999 112.031 -177.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.424 ' HA2' ' N ' ' A' ' 67' ' ' GLY . . . -57.84 135.5 51.7 Favored Glycine 0 N--CA 1.445 -0.711 0 N-CA-C 116.421 1.328 . . . . 1.5800000000000001 116.421 -177.712 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 81.15 36.91 20.0 Favored Glycine 0 C--N 1.337 0.609 0 CA-C-N 114.124 -1.038 . . . . 0.34000000000000002 111.454 173.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.3 mt -57.96 -57.0 12.39 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 124.876 1.27 . . . . 2.2400000000000002 109.942 175.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -105.7 161.56 14.29 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.06 1.344 . . . . 1.47 109.508 167.16 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.0 mmtp -142.87 161.7 37.42 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.377 1.471 . . . . 3.54 110.466 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 55.55 -146.5 30.13 Favored Glycine 0 CA--C 1.531 1.04 0 O-C-N 121.596 -0.69 . . . . 0.89000000000000001 111.437 179.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -54.55 -28.91 49.04 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 117.157 0.479 . . . . 1.97 111.814 175.006 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -56.54 -39.08 72.78 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 109.827 -0.434 . . . . 2.29 109.827 174.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -82.41 -52.43 6.9 Favored 'General case' 0 CA--C 1.53 0.208 0 O-C-N 121.738 -0.601 . . . . 1.49 110.963 174.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -58.44 -48.67 79.96 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 122.87 0.468 . . . . 2.3199999999999998 112.077 -173.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.74 -48.15 80.43 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 109.363 -0.606 . . . . 1.51 109.363 179.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 49.6 t -55.38 -55.2 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 C-N-CA 123.065 0.546 . . . . 1.5700000000000001 110.952 177.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -52.48 -53.48 45.14 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 123.313 0.645 . . . . 1.3300000000000001 111.483 178.282 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.7 -48.61 81.0 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 121.772 0.796 . . . . 1.3999999999999999 110.934 -178.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 83.6 t90 -57.22 -47.84 80.3 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 123.466 0.707 . . . . 0.70999999999999996 110.084 178.427 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.02 -31.21 72.31 Favored 'General case' 0 C--O 1.221 -0.398 0 CA-C-O 118.167 -0.921 . . . . 2.8799999999999999 112.649 173.359 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -56.39 -43.08 78.92 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 119.76 1.164 . . . . 1.4199999999999999 109.898 171.068 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -68.0 -36.93 80.81 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 118.344 -0.836 . . . . 3.54 112.585 171.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 15.3 mtpp -72.11 113.43 9.13 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 120.35 1.432 . . . . 3.6000000000000001 110.847 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 77.3 mttt . . . . . 0 C--O 1.254 1.337 0 N-CA-C 104.953 -2.24 . . . . 2.8300000000000001 104.953 179.767 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 29.5 t . . . . . 0 N--CA 1.471 0.608 0 N-CA-C 106.899 -1.519 . . . . 2.3399999999999999 106.899 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 -76.1 100.38 4.95 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 108.312 -0.996 . . . . 2.1699999999999999 108.312 -177.104 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -39.02 -54.26 1.7 Allowed 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 125.387 1.475 . . . . 1.6200000000000001 112.046 175.173 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -54.58 -48.86 71.59 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 116.108 -0.496 . . . . 2.6899999999999999 111.26 177.058 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.1 -36.57 82.14 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 118.96 0.8 . . . . 1.5900000000000001 111.932 -178.748 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 56.2 t -62.78 -58.46 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 N-CA-C 109.032 -0.729 . . . . 1.52 109.032 172.809 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.0 t -53.55 -48.71 58.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 C-N-CA 123.255 0.622 . . . . 1.6599999999999999 110.757 -175.738 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -49.35 -21.92 0.99 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 126.495 1.918 . . . . 0.52000000000000002 112.811 174.49 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -130.75 26.1 5.01 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.727 0.811 . . . . 5.8899999999999997 111.59 -179.807 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.3 mppp? -148.96 -66.85 0.22 Allowed 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 109.151 -0.685 . . . . 2.9300000000000002 109.151 171.718 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 2.0 m -71.76 -47.53 53.0 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.93 -0.396 . . . . 0.40000000000000002 109.93 -168.926 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.0 pp -56.12 -26.37 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.075 0 N-CA-C 111.899 0.333 . . . . 1.5900000000000001 111.899 -178.046 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.3 t -46.32 -36.0 5.89 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.376 1.071 . . . . 2.1299999999999999 110.699 177.727 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 28.9 m -116.82 -44.13 2.84 Favored 'General case' 0 C--N 1.34 0.178 0 C-N-CA 123.286 0.635 . . . . 0.20000000000000001 111.267 175.959 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 85.9 m-70 -71.09 -8.41 53.25 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.906 0.883 . . . . 0.29999999999999999 112.564 -176.194 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 88.25 152.19 24.03 Favored Glycine 0 C--N 1.337 0.606 0 N-CA-C 109.707 -1.357 . . . . 1.51 109.707 178.235 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -39.39 -39.43 1.13 Allowed Glycine 0 CA--C 1.528 0.877 0 C-N-CA 125.366 1.46 . . . . 1.1599999999999999 112.9 179.11 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -105.74 2.21 27.74 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.216 1.406 . . . . 2.23 112.241 -170.822 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.8 mm? 64.88 23.04 12.59 Favored 'General case' 0 C--N 1.348 0.531 0 CA-C-N 120.493 1.497 . . . . 4.54 111.127 -179.731 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.7 p -85.55 -3.73 58.95 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 128.23 2.612 . . . . 1.5700000000000001 109.992 179.277 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.52 139.75 5.68 Favored Glycine 0 N--CA 1.441 -0.969 0 N-CA-C 109.037 -1.625 . . . . 0.45000000000000001 109.037 -174.387 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -145.4 -73.87 0.24 Allowed 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 107.813 -1.18 . . . . 1.72 107.813 176.355 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.1 t -100.16 4.62 44.56 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.307 1.443 . . . . 2.4900000000000002 111.169 173.233 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -156.63 162.81 26.84 Favored Pre-proline 0 CA--C 1.537 0.451 0 C-N-CA 126.289 1.836 . . . . 1.6599999999999999 108.004 -168.773 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.22 153.16 40.54 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 123.271 2.647 . . . . 0.39000000000000001 111.414 -173.928 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -75.16 109.27 8.51 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.864 0.866 . . . . 1.6100000000000001 113.097 -170.136 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 43.7 pt -91.45 1.06 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 C-N-CA 125.8 1.64 . . . . 1.6399999999999999 111.793 -178.683 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -32.34 -48.59 0.18 Allowed 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 127.061 2.144 . . . . 2.79 113.044 164.226 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.51 36.83 3.25 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.955 0.902 . . . . 5.7199999999999998 111.537 176.328 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.11 -52.54 58.66 Favored 'General case' 0 N--CA 1.454 -0.257 0 O-C-N 121.146 -0.971 . . . . 1.74 108.849 176.236 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -52.33 -27.1 23.62 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 124.187 0.899 . . . . 0.54000000000000004 114.021 177.496 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.19 -38.24 88.37 Favored 'General case' 0 N--CA 1.452 -0.355 0 O-C-N 121.461 -1.023 . . . . 1.7 110.548 176.63 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 34.4 m-80 -103.83 -61.78 1.39 Allowed 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.798 1.239 . . . . 2.3500000000000001 109.835 -171.5 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -91.93 136.13 33.4 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.007 1.323 . . . . 1.6399999999999999 109.0 -174.896 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.7 t -80.69 166.91 20.6 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 118.102 0.41 . . . . 2.4399999999999999 110.632 -179.928 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -43.72 -55.85 4.16 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 124.384 1.074 . . . . 4.9000000000000004 109.856 177.352 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -57.01 -35.61 69.44 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.665 0.786 . . . . 3.3399999999999999 111.359 -176.187 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -74.15 -49.05 25.38 Favored 'General case' 0 C--N 1.343 0.302 0 O-C-N 121.243 -0.911 . . . . 2.9100000000000001 110.295 177.002 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 73.3 mt -58.56 -41.05 80.91 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.141 0 N-CA-C 108.375 -0.972 . . . . 1.6299999999999999 108.375 -177.538 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 27.0 tp -55.22 -54.58 41.65 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 123.759 0.823 . . . . 1.72 110.171 174.115 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -50.98 -48.02 61.33 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 118.104 0.411 . . . . 1.72 111.498 176.521 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 93.1 mt -59.01 -55.77 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 O-C-N 121.54 -0.725 . . . . 1.79 109.767 177.197 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 56.5 mt -47.61 -46.08 10.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 O-C-N 121.276 -0.89 . . . . 1.6299999999999999 110.192 178.976 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 69.5 mt -66.31 -36.4 82.84 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 113.503 0.927 . . . . 1.6699999999999999 113.503 178.537 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -127.65 27.35 5.79 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 120.085 1.312 . . . . 1.8400000000000001 110.418 -161.994 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 20.38 -130.47 0.01 OUTLIER Glycine 0 CA--C 1.539 1.585 0 C-N-CA 127.764 2.602 . . . . 0.65000000000000002 112.749 -159.592 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 165.62 136.04 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 126.801 2.04 . . . . 1.26 107.707 -176.768 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 27.57 -108.42 0.01 OUTLIER Glycine 0 CA--C 1.535 1.286 0 C-N-CA 126.053 1.787 . . . . 0.55000000000000004 114.714 -172.603 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -62.93 -28.22 71.59 Favored Glycine 0 CA--C 1.534 1.279 0 CA-C-N 117.694 0.747 . . . . 0.68999999999999995 113.467 -178.443 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 6.5 ttt -70.86 126.0 92.08 Favored Pre-proline 0 CA--C 1.539 0.547 0 C-N-CA 124.887 1.275 . . . . 1.48 110.364 -178.751 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -62.8 -55.03 0.93 Allowed 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 123.686 2.924 . . . . 2.9900000000000002 111.254 -172.71 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 116.94 147.23 8.59 Favored Glycine 0 C--N 1.334 0.457 0 C-N-CA 124.156 0.884 . . . . 2.29 113.19 175.028 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 69.73 24.4 76.32 Favored Glycine 0 CA--C 1.53 1.02 0 N-CA-C 111.524 -0.631 . . . . 0.46000000000000002 111.524 179.76 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.0 mm -55.87 -44.96 79.53 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.843 0 C-N-CA 125.51 1.524 . . . . 3.48 111.597 -178.919 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -113.6 160.51 18.48 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.003 1.321 . . . . 1.5600000000000001 108.843 161.021 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 5.0 ttmt -146.38 167.45 23.57 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 118.423 0.556 . . . . 3.5499999999999998 110.768 170.53 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 55.91 -148.61 27.48 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 111.092 -0.803 . . . . 0.92000000000000004 111.092 -179.595 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -49.53 -37.4 26.72 Favored 'General case' 0 C--N 1.341 0.204 0 C-N-CA 123.755 0.822 . . . . 1.8700000000000001 111.314 -178.709 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -50.69 -49.48 57.3 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 124.994 1.318 . . . . 2.0299999999999998 110.4 175.287 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -78.75 -48.6 14.56 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 123.233 0.613 . . . . 1.6599999999999999 111.375 178.953 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -53.7 -50.75 65.19 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.252 1.021 . . . . 2.23 110.623 -176.319 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.01 -48.9 78.64 Favored 'General case' 0 N--CA 1.455 -0.214 0 O-C-N 122.022 -0.424 . . . . 1.6200000000000001 110.144 177.893 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 56.0 t -55.54 -49.73 71.55 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 C-N-CA 122.783 0.433 . . . . 1.5 110.955 179.467 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -52.52 -53.17 49.66 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 123.331 0.652 . . . . 1.46 111.466 175.928 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.1 -48.26 82.25 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-O 121.417 0.627 . . . . 1.72 111.257 -179.736 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 47.8 t90 -56.05 -50.16 71.74 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.017 0.527 . . . . 0.55000000000000004 109.733 177.848 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.92 -34.61 74.96 Favored 'General case' 0 C--O 1.224 -0.279 0 C-N-CA 124.351 1.06 . . . . 2.7000000000000002 111.449 176.897 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.28 -42.57 98.87 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 119.009 0.822 . . . . 1.6899999999999999 110.095 173.332 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -59.66 -42.13 92.13 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.044 0.538 . . . . 3.0099999999999998 111.093 172.244 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 9.5 mtpp -71.85 130.8 41.94 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 118.545 0.611 . . . . 4.0300000000000002 110.357 -177.547 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 38.6 mttt . . . . . 0 C--O 1.25 1.102 0 N-CA-C 106.469 -1.678 . . . . 4.3200000000000003 106.469 -178.274 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.4 t . . . . . 0 N--CA 1.471 0.619 0 N-CA-C 106.178 -1.786 . . . . 2.25 106.178 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -74.35 99.27 3.45 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 108.306 -0.998 . . . . 3.7200000000000002 108.306 -175.971 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -47.69 -41.95 23.76 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.239 1.016 . . . . 1.6699999999999999 111.739 176.097 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -66.99 -52.64 40.2 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 107.73 -1.211 . . . . 3.3399999999999999 107.73 -176.75 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.99 -45.88 71.57 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.316 0.646 . . . . 1.78 111.484 178.483 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 64.0 t -56.57 -60.95 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 N-CA-C 109.181 -0.674 . . . . 1.74 109.181 176.148 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 46.2 t -55.81 -45.36 79.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 O-C-N 121.908 -0.495 . . . . 1.7 110.888 -175.969 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 23.2 mm-40 -49.78 -19.39 0.64 Allowed 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 126.968 2.107 . . . . 0.87 112.998 173.509 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 44.3 tt0 -139.69 35.06 2.0 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 119.012 0.823 . . . . 2.8500000000000001 111.367 173.372 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 67.9 mmtt -145.96 -56.92 0.3 Allowed 'General case' 0 CA--C 1.516 -0.358 0 O-C-N 121.211 -0.931 . . . . 3.3100000000000001 109.977 175.08 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 3.2 m -86.36 -49.71 7.45 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 109.213 -0.662 . . . . 0.37 109.213 -172.768 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.8 pp -56.23 -27.88 24.69 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.21 0 CA-C-N 115.739 -0.664 . . . . 1.8799999999999999 110.569 -178.106 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -36.78 -40.46 0.27 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.199 1.399 . . . . 2.1600000000000001 111.654 170.943 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 24.4 m -114.69 -35.72 4.76 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.792 0.837 . . . . 0.37 112.127 172.794 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 92.2 m-70 -80.59 3.56 21.43 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 125.065 1.346 . . . . 0.33000000000000002 113.13 -175.115 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 112.46 -92.58 0.64 Allowed Glycine 0 CA--C 1.528 0.856 0 C-N-CA 126.396 1.951 . . . . 2.98 112.511 164.747 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -162.45 -47.82 0.02 OUTLIER Glycine 0 CA--C 1.522 0.519 0 N-CA-C 108.815 -1.714 . . . . 2.21 108.815 -173.306 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -102.21 7.24 40.89 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 126.099 1.759 . . . . 3.4900000000000002 111.395 176.643 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 76.28 13.34 2.56 Favored 'General case' 0 C--N 1.35 0.597 0 CA-C-N 120.006 1.276 . . . . 3.3199999999999998 111.056 179.562 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 35.5 p -75.41 -10.79 59.77 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 126.953 2.101 . . . . 1.8300000000000001 110.112 -175.777 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.84 147.11 22.14 Favored Glycine 0 N--CA 1.444 -0.817 0 N-CA-C 108.653 -1.779 . . . . 0.58999999999999997 108.653 -177.396 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -154.23 -81.36 0.08 Allowed 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 123.181 0.593 . . . . 1.3300000000000001 109.525 177.264 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 5.4 m -89.31 2.8 53.83 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.752 0.821 . . . . 1.8999999999999999 110.862 171.451 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -152.71 162.73 25.65 Favored Pre-proline 0 N--CA 1.45 -0.459 0 C-N-CA 125.77 1.628 . . . . 1.4299999999999999 107.256 -172.344 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -66.74 163.95 31.2 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 122.545 2.163 . . . . 0.40000000000000002 110.905 -175.378 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.87 123.35 24.05 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 109.33 -0.618 . . . . 1.6599999999999999 109.33 -178.89 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 49.8 pt -107.14 1.95 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 C-N-CA 123.544 0.737 . . . . 1.6100000000000001 111.424 176.85 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 18.4 p-10 -34.08 -49.92 0.37 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.382 1.473 . . . . 3.7599999999999998 112.21 167.739 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 18.1 pttt -109.9 34.7 3.71 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 125.086 1.354 . . . . 5.4299999999999997 112.433 -179.924 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.13 -46.04 91.0 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 109.473 -0.566 . . . . 1.51 109.473 173.242 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -54.88 -32.58 55.73 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 123.154 0.407 . . . . 0.56000000000000005 113.455 -176.829 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.32 -40.01 62.49 Favored 'General case' 0 CA--C 1.529 0.142 0 O-C-N 121.947 -0.737 . . . . 1.6699999999999999 110.908 174.689 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 19.5 m-80 -65.71 -52.86 47.98 Favored 'General case' 0 C--O 1.227 -0.088 0 N-CA-C 110.384 -0.228 . . . . 1.6899999999999999 110.384 -179.788 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -136.07 144.28 45.1 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.035 1.334 . . . . 1.26 108.401 -168.584 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 4.9 m -74.03 167.58 21.24 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 118.268 0.486 . . . . 2.48 110.38 177.626 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.8 pm0 -49.83 -41.68 45.54 Favored 'General case' 0 C--O 1.225 -0.232 0 C-N-CA 123.731 0.813 . . . . 2.6499999999999999 111.354 -179.476 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -56.62 -44.3 81.06 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.775 0.83 . . . . 3.0899999999999999 109.966 179.578 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -78.21 -43.65 27.88 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.07 0.948 . . . . 2.79 109.55 -174.481 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 76.2 mt -59.83 -48.34 88.04 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 O-C-N 121.094 -1.004 . . . . 1.6499999999999999 108.749 176.606 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 33.5 tp -55.7 -45.33 77.88 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 109.193 -0.669 . . . . 1.79 109.193 178.425 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -47.22 -56.71 6.19 Favored 'General case' 0 N--CA 1.453 -0.302 0 O-C-N 124.108 0.88 . . . . 1.6399999999999999 109.328 172.449 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 43.7 mt -61.78 -45.78 97.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 117.827 -1.549 . . . . 2.3100000000000001 111.999 179.851 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 85.9 mt -52.6 -48.66 47.43 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 O-C-N 119.693 -1.879 . . . . 1.75 110.296 -179.023 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 88.3 mt -72.95 -31.94 64.91 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 123.416 0.687 . . . . 2.0 111.886 178.144 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 45.8 m-20 -129.18 46.91 2.55 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 107.699 -1.223 . . . . 1.8 107.699 -163.198 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -40.67 106.25 0.06 OUTLIER Glycine 0 CA--C 1.534 1.244 0 C-N-CA 125.838 1.685 . . . . 3.25 111.476 -171.256 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 -87.86 165.19 15.46 Favored 'General case' 0 N--CA 1.435 -1.212 0 C-N-CA 127.466 2.306 . . . . 3.4399999999999999 109.382 -175.307 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 57.4 -127.81 45.86 Favored Glycine 0 CA--C 1.529 0.943 0 N-CA-C 111.521 -0.631 . . . . 1.1000000000000001 111.521 174.385 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -73.79 -25.55 71.62 Favored Glycine 0 CA--C 1.53 0.979 0 CA-C-N 117.096 0.448 . . . . 1.02 112.131 179.799 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 5.5 ttt -63.44 137.22 97.02 Favored Pre-proline 0 CA--C 1.54 0.566 0 O-C-N 121.914 -0.757 . . . . 1.6299999999999999 109.741 178.849 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -74.35 -54.19 0.1 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.844 2.362 . . . . 2.8599999999999999 111.233 -177.234 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 113.73 149.81 10.31 Favored Glycine 0 C--N 1.335 0.515 0 C-N-CA 123.849 0.738 . . . . 2.3700000000000001 112.785 177.321 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 67.25 24.4 73.46 Favored Glycine 0 CA--C 1.531 1.092 0 CA-C-N 114.906 -0.647 . . . . 0.39000000000000001 112.146 176.727 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -55.5 -51.62 55.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 125.936 1.694 . . . . 2.0499999999999998 110.877 177.784 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -104.99 149.08 26.06 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 125.171 1.389 . . . . 1.6699999999999999 108.101 169.768 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 2.9 mtpm? -146.25 153.13 40.24 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.966 0.907 . . . . 5.1600000000000001 111.441 -178.431 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 71.76 -162.64 54.38 Favored Glycine 0 CA--C 1.532 1.131 0 N-CA-C 110.638 -0.985 . . . . 1.1899999999999999 110.638 -170.311 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -50.83 -26.72 6.09 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.823 1.249 . . . . 2.0699999999999998 112.607 -178.702 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 51.7 tt0 -40.93 -62.34 0.83 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.081 1.352 . . . . 2.1000000000000001 110.508 168.142 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -62.77 -46.85 86.13 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 122.816 0.446 . . . . 1.46 110.666 -174.688 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -51.12 -56.85 10.62 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 123.71 0.804 . . . . 1.9399999999999999 111.06 175.705 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -56.34 -47.57 78.52 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 109.429 -0.582 . . . . 1.54 109.429 -177.682 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 53.3 t -57.93 -53.66 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 N-CA-C 111.774 0.287 . . . . 1.55 111.774 177.49 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -52.38 -52.69 52.23 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 123.214 0.605 . . . . 1.3200000000000001 111.306 179.028 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.76 -49.48 77.49 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 121.415 0.626 . . . . 1.55 110.134 179.189 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . 0.413 ' CE3' HD23 ' A' ' 88' ' ' LEU . 46.3 t90 -53.63 -48.76 69.05 Favored 'General case' 0 N--CA 1.451 -0.413 0 O-C-N 121.69 -0.631 . . . . 0.64000000000000001 110.378 177.473 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.413 HD23 ' CE3' ' A' ' 87' ' ' TRP . 0.1 OUTLIER -61.58 -34.68 76.02 Favored 'General case' 0 C--O 1.227 -0.123 0 C-N-CA 124.394 1.078 . . . . 2.79 111.004 177.206 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -52.58 -47.11 67.07 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 118.889 0.768 . . . . 1.49 109.972 170.989 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -83.22 26.08 0.66 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.404 0.682 . . . . 5.0599999999999996 112.597 173.686 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 8.1 mtpm? -125.69 120.99 32.17 Favored 'General case' 0 C--N 1.341 0.197 0 CA-C-N 119.775 1.171 . . . . 3.0099999999999998 110.017 167.043 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.438 -1.043 0 C-N-CA 127.397 2.279 . . . . 3.23 105.1 173.933 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 93' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 23.3 t . . . . . 0 N--CA 1.469 0.495 0 N-CA-C 107.204 -1.406 . . . . 2.1899999999999999 107.204 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -78.28 99.35 6.26 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 108.049 -1.093 . . . . 2.1800000000000002 108.049 -173.496 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -40.41 -55.66 2.2 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 125.087 1.355 . . . . 1.6299999999999999 111.732 177.697 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -52.93 -47.0 68.35 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 123.012 0.525 . . . . 2.75 111.78 177.287 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.07 -46.44 87.46 Favored 'General case' 0 N--CA 1.458 -0.06 0 CA-C-N 118.494 0.588 . . . . 1.6499999999999999 110.468 -178.233 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 69.8 t -55.33 -54.73 21.87 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.252 0 N-CA-C 109.221 -0.659 . . . . 1.6100000000000001 109.221 175.274 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 34.1 t -56.66 -48.41 80.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 C-N-CA 123.375 0.67 . . . . 1.6499999999999999 110.531 -175.14 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 36.4 mm-40 -51.42 -21.63 2.46 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.913 1.685 . . . . 0.48999999999999999 112.78 172.373 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -136.81 49.42 2.06 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 119.151 0.887 . . . . 3.75 111.705 178.104 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -168.5 -59.18 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.183 0 N-CA-C 108.112 -1.07 . . . . 2.4100000000000001 108.112 168.163 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 3.6 m -75.54 -51.55 12.67 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 120.862 0.363 . . . . 0.28999999999999998 110.655 -170.231 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.2 pp -55.01 -26.58 17.88 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.165 0 CA-C-N 115.838 -0.619 . . . . 1.6000000000000001 111.697 -179.225 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.7 t -43.61 -34.72 1.51 Allowed 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.034 0.933 . . . . 2.96 111.867 175.051 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 28.7 m -117.03 -37.34 3.59 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.482 0.713 . . . . 0.22 111.706 172.774 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -78.92 2.31 20.62 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.35 1.06 . . . . 0.27000000000000002 113.0 -175.921 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 112.1 -85.63 0.4 Allowed Glycine 0 C--N 1.34 0.755 0 C-N-CA 125.676 1.607 . . . . 3.0 112.196 162.609 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -171.23 -50.23 0.04 OUTLIER Glycine 0 CA--C 1.518 0.242 0 N-CA-C 108.452 -1.859 . . . . 2.3599999999999999 108.452 -171.906 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -102.0 4.91 40.38 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.711 1.204 . . . . 3.0899999999999999 111.504 179.38 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 5.2 mt 80.16 15.29 0.8 Allowed 'General case' 0 C--N 1.354 0.761 0 CA-C-N 120.392 1.451 . . . . 2.3799999999999999 110.206 -178.903 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.4 p -80.75 -9.4 59.81 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 128.34 2.656 . . . . 1.77 110.002 -175.906 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.56 161.27 36.95 Favored Glycine 0 N--CA 1.442 -0.908 0 N-CA-C 108.995 -1.642 . . . . 0.92000000000000004 108.995 -174.691 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -164.8 -72.94 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 124.503 1.121 . . . . 1.8400000000000001 108.187 174.066 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 30.3 m -101.73 3.14 39.31 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.398 1.079 . . . . 1.96 110.857 174.202 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -152.14 160.87 30.8 Favored Pre-proline 0 CA--C 1.536 0.417 0 C-N-CA 126.456 1.902 . . . . 1.52 107.092 -171.599 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.46 158.8 55.38 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 123.115 2.544 . . . . 0.28999999999999998 110.942 -175.046 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -74.01 120.63 19.85 Favored 'General case' 0 N--CA 1.454 -0.229 0 O-C-N 121.887 -0.508 . . . . 1.54 109.871 -176.749 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 25.3 pt -100.32 2.64 10.6 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 C-N-CA 123.475 0.71 . . . . 1.5600000000000001 111.679 177.728 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -36.28 -44.89 0.43 Allowed 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.215 1.406 . . . . 2.5299999999999998 113.668 171.49 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 8.3 mtpt -111.36 26.23 10.88 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.371 1.068 . . . . 4.5300000000000002 111.324 -177.542 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -58.31 -43.24 88.07 Favored 'General case' 0 N--CA 1.453 -0.317 0 O-C-N 121.631 -0.668 . . . . 1.48 110.205 179.923 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -54.13 -23.58 25.24 Favored Glycine 0 CA--C 1.53 0.98 0 CA-C-N 118.299 0.5 . . . . 0.5 114.344 179.172 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -88.03 -41.56 13.01 Favored 'General case' 0 N--CA 1.457 -0.123 0 CA-C-N 118.123 0.962 . . . . 1.5900000000000001 109.818 175.849 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -56.85 -53.41 58.18 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 122.529 0.331 . . . . 2.02 110.801 176.504 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -139.15 154.61 48.11 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.677 1.191 . . . . 1.3600000000000001 109.229 -170.576 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 2.1 p -80.07 167.37 20.5 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.793 0.837 . . . . 3.2200000000000002 110.927 178.434 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -46.63 -46.22 19.66 Favored 'General case' 0 C--O 1.224 -0.258 0 C-N-CA 124.473 1.109 . . . . 2.7400000000000002 111.319 176.703 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -58.72 -40.83 84.84 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.285 0.634 . . . . 2.8100000000000001 110.638 -177.941 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -76.78 -47.93 20.16 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 108.877 -0.786 . . . . 3.0099999999999998 108.877 -175.393 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 83.1 mt -59.58 -42.96 89.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 N-CA-C 109.087 -0.709 . . . . 1.6599999999999999 109.087 178.666 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.8 tp -54.04 -52.91 59.36 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 109.383 -0.599 . . . . 1.55 109.383 175.954 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -50.51 -51.27 49.09 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 118.064 0.393 . . . . 1.6499999999999999 110.824 175.004 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 60.9 mt -61.72 -30.57 48.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 O-C-N 121.574 -0.704 . . . . 1.5600000000000001 112.307 -179.036 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 49.2 mt -69.99 -49.3 57.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 O-C-N 120.381 -1.449 . . . . 1.52 109.08 173.313 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 86.3 mt -67.39 -34.16 76.7 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 124.437 1.095 . . . . 1.53 113.354 -174.448 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -123.37 20.39 9.65 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 119.717 1.144 . . . . 1.8300000000000001 110.224 -166.644 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 32.24 -141.23 0.05 OUTLIER Glycine 0 CA--C 1.543 1.827 0 C-N-CA 127.039 2.256 . . . . 0.64000000000000001 112.207 -164.642 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 39.5 tt0 170.72 137.45 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 119.588 1.694 . . . . 1.6699999999999999 109.243 -176.736 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 38.1 -114.85 0.34 Allowed Glycine 0 CA--C 1.531 1.067 0 CA-C-N 120.04 1.291 . . . . 0.46999999999999997 113.291 -177.008 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -69.26 -25.04 75.79 Favored Glycine 0 CA--C 1.534 1.25 0 CA-C-N 117.263 0.532 . . . . 0.55000000000000004 113.233 179.566 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 16.8 ttt -70.27 120.21 76.92 Favored Pre-proline 0 CA--C 1.539 0.532 0 C-N-CA 124.492 1.117 . . . . 1.51 110.058 -179.591 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -62.5 -55.89 0.8 Allowed 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 124.249 3.299 . . . . 2.9100000000000001 111.578 -168.965 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 118.2 149.13 8.7 Favored Glycine 0 N--CA 1.449 -0.489 0 CA-C-N 115.857 -0.61 . . . . 2.3500000000000001 114.124 172.429 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 67.41 21.65 72.52 Favored Glycine 0 CA--C 1.532 1.111 0 CA-C-N 114.782 -0.709 . . . . 0.52000000000000002 111.686 -179.845 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 2.0 mt -52.53 -44.54 45.18 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 C-N-CA 126.872 2.069 . . . . 2.0600000000000001 110.98 178.211 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -114.82 159.95 20.03 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.817 1.247 . . . . 1.6200000000000001 110.311 161.775 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 19.3 mmtp -141.92 159.95 41.2 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.972 1.709 . . . . 2.96 110.28 -179.343 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 56.3 -142.94 38.8 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 111.426 -0.669 . . . . 0.98999999999999999 111.426 176.027 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -50.07 -35.98 27.42 Favored 'General case' 0 C--N 1.341 0.22 0 C-N-CA 123.661 0.785 . . . . 1.8300000000000001 111.592 174.753 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -57.9 -33.11 68.4 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.61 0.764 . . . . 2.1000000000000001 110.795 178.782 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -91.97 -53.2 4.37 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.613 0.765 . . . . 1.45 110.882 175.415 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -50.15 -54.49 20.39 Favored 'General case' 0 N--CA 1.461 0.105 0 C-N-CA 124.563 1.145 . . . . 2.1099999999999999 111.544 -179.533 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.25 -44.75 92.36 Favored 'General case' 0 C--O 1.225 -0.236 0 N-CA-C 109.588 -0.523 . . . . 1.54 109.588 -178.522 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 54.7 t -58.16 -53.75 41.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 C-N-CA 122.772 0.429 . . . . 1.6899999999999999 111.1 179.451 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -53.17 -52.33 59.15 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 123.081 0.552 . . . . 1.4099999999999999 111.533 174.921 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.2 -38.62 83.88 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.515 0.726 . . . . 1.6200000000000001 111.155 -178.216 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 73.7 t90 -67.86 -51.08 52.4 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 123.82 0.848 . . . . 0.58999999999999997 109.578 177.637 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.46 -30.33 69.6 Favored 'General case' 0 C--O 1.223 -0.318 0 O-C-N 121.363 -0.836 . . . . 2.9399999999999999 112.143 175.91 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -55.31 -38.91 69.29 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 119.592 1.087 . . . . 1.6000000000000001 110.836 170.9 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -68.54 -41.81 79.32 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 118.588 -0.72 . . . . 3.1000000000000001 110.92 170.908 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.6 mtpm? -72.86 106.34 4.75 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 119.173 0.897 . . . . 2.79 110.384 -174.587 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 4.4 mtmp? . . . . . 0 C--O 1.25 1.084 0 C-N-CA 126.233 1.813 . . . . 3.0499999999999998 106.51 179.374 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 93' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 12.4 t . . . . . 0 N--CA 1.471 0.587 0 N-CA-C 107.687 -1.227 . . . . 2.2400000000000002 107.687 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -75.0 97.8 3.46 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 108.509 -0.923 . . . . 2.5699999999999998 108.509 -178.305 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -43.3 -52.07 5.95 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 124.335 1.054 . . . . 1.47 111.012 176.101 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -57.91 -47.14 83.7 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 116.287 -0.415 . . . . 2.6800000000000002 110.401 179.938 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.07 -45.1 94.0 Favored 'General case' 0 N--CA 1.461 0.098 0 CA-C-N 118.472 0.578 . . . . 1.73 110.891 -178.874 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 79.5 t -57.49 -57.25 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 108.93 -0.767 . . . . 1.5600000000000001 108.93 176.884 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 35.7 t -55.24 -46.04 77.79 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 C-N-CA 121.213 -0.195 . . . . 1.6100000000000001 111.011 -176.762 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 26.3 mm-40 -49.98 -25.94 3.79 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 125.794 1.638 . . . . 0.5 112.808 173.769 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -140.66 67.23 1.36 Allowed 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 119.06 0.846 . . . . 3.3599999999999999 112.001 171.4 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.418 ' HZ3' ' CD ' ' A' ' 80' ' ' GLU . 0.1 OUTLIER -178.22 -36.11 0.01 OUTLIER 'General case' 0 C--O 1.225 -0.221 0 C-N-CA 124.812 1.245 . . . . 1.97 109.202 169.627 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 2.7 m -103.95 -53.79 2.68 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 119.339 0.972 . . . . 0.31 111.13 -177.649 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.0 pp -55.26 -27.88 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 CA-C-N 115.9 -0.591 . . . . 1.78 111.386 -176.302 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.3 m -35.21 -42.12 0.18 Allowed 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 125.358 1.463 . . . . 1.77 112.633 170.244 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 18.2 m -112.66 -34.74 5.72 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.655 0.782 . . . . 0.23000000000000001 111.706 174.14 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 92.5 m-70 -82.0 5.21 19.99 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.446 1.098 . . . . 0.34999999999999998 113.409 -175.351 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 107.22 -91.05 0.68 Allowed Glycine 0 CA--C 1.525 0.667 0 C-N-CA 126.57 2.033 . . . . 2.8700000000000001 111.961 166.312 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -167.63 -47.37 0.03 OUTLIER Glycine 0 CA--C 1.519 0.316 0 N-CA-C 108.792 -1.723 . . . . 2.3700000000000001 108.792 -172.446 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -102.88 6.42 39.08 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.935 1.294 . . . . 4.0999999999999996 111.158 178.675 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.5 mt 78.49 10.32 1.89 Allowed 'General case' 0 C--N 1.354 0.798 0 CA-C-N 120.075 1.307 . . . . 2.2999999999999998 110.352 177.441 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.1 p -74.81 -10.26 59.34 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 128.62 2.768 . . . . 1.54 109.629 -179.69 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.64 159.11 34.3 Favored Glycine 0 N--CA 1.444 -0.822 0 N-CA-C 109.269 -1.532 . . . . 0.84999999999999998 109.269 -177.017 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -160.67 -79.82 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 124.334 1.054 . . . . 1.3100000000000001 108.653 175.692 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 58.5 m -91.55 2.24 56.58 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.474 0.709 . . . . 1.9399999999999999 110.966 173.437 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -154.35 164.8 19.6 Favored Pre-proline 0 N--CA 1.448 -0.544 0 C-N-CA 125.245 1.418 . . . . 1.6299999999999999 108.038 -169.672 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -67.42 159.75 50.95 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 123.002 2.468 . . . . 0.38 111.243 -173.696 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -74.75 115.56 14.47 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.073 0.549 . . . . 1.49 109.999 -177.593 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 32.2 pt -102.55 2.5 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 C-N-CA 124.342 1.057 . . . . 2.0099999999999998 111.528 179.549 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -34.3 -48.87 0.36 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.28 1.432 . . . . 2.2599999999999998 112.427 167.49 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 10.0 pttt -109.19 26.26 10.83 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.58 0.752 . . . . 4.1299999999999999 111.812 -176.458 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -51.55 -44.3 62.66 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 118.927 -0.559 . . . . 1.45 109.8 178.287 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -52.84 -25.72 23.82 Favored Glycine 0 CA--C 1.529 0.952 0 N-CA-C 114.566 0.586 . . . . 0.46000000000000002 114.566 177.692 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -82.44 -42.36 18.66 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 118.076 0.938 . . . . 1.78 109.49 175.67 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 36.1 m120 -63.69 -48.41 77.22 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 122.574 0.35 . . . . 3.2400000000000002 110.564 -179.471 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -144.2 145.62 32.18 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.547 1.539 . . . . 1.77 108.553 -169.925 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 19.6 m -75.33 169.17 18.57 Favored 'General case' 0 CA--C 1.532 0.284 0 O-C-N 121.542 -0.724 . . . . 2.2799999999999998 111.198 179.132 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -44.17 -56.03 4.38 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 123.337 0.655 . . . . 4.7699999999999996 110.735 174.182 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -53.13 -29.96 34.03 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 112.724 0.638 . . . . 2.96 112.724 -178.406 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 53.6 mm-40 -86.83 -48.85 7.86 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.709 0.804 . . . . 3.0299999999999998 109.789 -178.315 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 84.0 mt -57.6 -46.5 86.33 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.097 0 O-C-N 121.114 -0.991 . . . . 1.6599999999999999 108.73 178.143 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 46.6 tp -52.97 -47.55 68.08 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 123.618 0.767 . . . . 1.55 109.274 176.543 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -55.45 -46.99 76.72 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 118.244 0.474 . . . . 2.21 110.705 175.099 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 47.7 mt -60.51 -36.7 71.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 O-C-N 121.444 -0.785 . . . . 1.5600000000000001 110.996 176.728 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 58.5 mt -69.21 -42.22 81.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 O-C-N 119.864 -1.773 . . . . 1.53 109.939 178.816 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 71.3 mt -76.65 -26.53 54.97 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.815 1.246 . . . . 1.8 112.891 -176.715 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 28.8 m-80 -124.85 14.43 8.59 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 119.584 1.084 . . . . 1.76 109.989 -172.044 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.431 ' N ' ' HA2' ' A' ' 73' ' ' GLY . . . 40.43 -139.99 1.13 Allowed Glycine 0 CA--C 1.537 1.451 0 C-N-CA 126.614 2.054 . . . . 0.64000000000000001 110.994 -171.885 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 168.48 127.1 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.602 1.561 . . . . 1.7 110.41 179.152 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 42.13 -115.87 0.97 Allowed Glycine 0 C--N 1.346 1.092 0 CA-C-N 120.283 1.402 . . . . 0.78000000000000003 113.294 -178.145 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -64.54 -22.06 67.45 Favored Glycine 0 CA--C 1.532 1.097 0 CA-C-N 117.349 0.574 . . . . 0.68000000000000005 112.53 -179.54 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 21.5 ttt -80.32 118.93 74.79 Favored Pre-proline 0 N--CA 1.45 -0.442 0 C-N-CA 124.878 1.271 . . . . 1.48 111.433 -179.35 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -77.83 122.77 6.0 Favored 'Trans proline' 0 N--CA 1.448 -1.193 0 C-N-CA 122.645 2.23 . . . . 2.0499999999999998 112.066 -178.515 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.431 ' HA2' ' N ' ' A' ' 67' ' ' GLY . . . -57.26 131.28 51.97 Favored Glycine 0 N--CA 1.444 -0.817 0 N-CA-C 115.348 0.899 . . . . 1.6699999999999999 115.348 179.376 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 87.55 40.63 6.74 Favored Glycine 0 C--N 1.338 0.678 0 CA-C-N 114.342 -0.929 . . . . 0.48999999999999999 112.008 172.687 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 2.4 mt -66.92 -61.44 1.69 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 124.691 1.196 . . . . 2.2400000000000002 109.925 176.616 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -98.36 161.35 13.73 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.632 1.173 . . . . 1.53 109.705 167.613 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.0 mttm -146.81 164.34 33.14 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 125.085 1.354 . . . . 3.2999999999999998 110.71 176.828 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 52.7 -146.32 17.4 Favored Glycine 0 CA--C 1.529 0.92 0 N-CA-C 111.383 -0.687 . . . . 0.88 111.383 -178.527 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -53.12 -31.49 42.39 Favored 'General case' 0 C--O 1.225 -0.215 0 C-N-CA 122.942 0.497 . . . . 1.8500000000000001 111.295 177.432 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.418 ' CD ' ' HZ3' ' A' ' 31' ' ' LYS . 3.9 tt0 -53.61 -46.1 70.3 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 123.299 0.64 . . . . 2.3199999999999998 110.168 174.398 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -78.69 -52.25 8.68 Favored 'General case' 0 CA--C 1.53 0.191 0 O-C-N 121.552 -0.717 . . . . 1.52 111.098 176.496 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -57.17 -51.6 68.66 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.631 0.773 . . . . 2.6000000000000001 111.331 -173.53 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.18 -45.62 90.56 Favored 'General case' 0 N--CA 1.457 -0.12 0 O-C-N 121.99 -0.444 . . . . 1.48 109.881 -179.265 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 37.9 t -56.25 -53.04 44.4 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 CA-C-O 119.515 -0.279 . . . . 1.6100000000000001 110.94 176.263 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -52.43 -50.53 62.39 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 122.767 0.427 . . . . 1.6899999999999999 111.048 177.831 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.04 -45.07 96.29 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-O 121.263 0.554 . . . . 1.3700000000000001 110.964 -179.189 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . 0.408 ' CE3' HD23 ' A' ' 88' ' ' LEU . 45.6 t90 -59.93 -48.11 83.05 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.863 0.84 . . . . 0.65000000000000002 109.703 176.464 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.408 HD23 ' CE3' ' A' ' 87' ' ' TRP . 0.1 OUTLIER -62.11 -27.6 69.04 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 120.448 -1.407 . . . . 2.79 110.3 177.039 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -65.67 -43.75 88.39 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 123.319 0.648 . . . . 1.54 111.13 172.583 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -62.13 -42.09 98.9 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 118.537 -1.265 . . . . 3.98 109.944 171.807 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 7.8 mtpp -69.38 119.98 14.48 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 121.581 0.705 . . . . 3.1499999999999999 111.501 -171.18 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 8.2 mttp . . . . . 0 C--O 1.25 1.083 0 C-N-CA 128.092 2.557 . . . . 3.4500000000000002 105.456 -176.352 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 93' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 29.6 t . . . . . 0 N--CA 1.47 0.538 0 N-CA-C 106.696 -1.594 . . . . 2.3700000000000001 106.696 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -73.64 99.8 3.19 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 123.907 0.883 . . . . 2.6299999999999999 109.228 -171.932 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -38.25 -53.73 1.44 Allowed 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 125.669 1.587 . . . . 1.6699999999999999 112.498 176.461 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -52.69 -49.79 64.6 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 122.844 0.458 . . . . 2.9100000000000001 111.213 176.637 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.28 -43.92 95.82 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 118.429 0.559 . . . . 1.73 110.532 -179.777 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 89.4 t -58.6 -54.26 35.75 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 N-CA-C 109.702 -0.481 . . . . 1.77 109.702 176.649 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 32.7 t -53.4 -50.63 47.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 C-N-CA 122.709 0.404 . . . . 1.77 110.11 179.762 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 31.8 mm-40 -54.74 -14.47 1.39 Allowed 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 126.49 1.916 . . . . 0.67000000000000004 113.953 174.518 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -141.48 34.06 1.65 Allowed 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 119.757 1.162 . . . . 3.7400000000000002 112.583 176.668 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.3 mptt -152.0 -62.62 0.17 Allowed 'General case' 0 CA--C 1.521 -0.159 0 N-CA-C 108.401 -0.963 . . . . 3.9100000000000001 108.401 166.056 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 3.7 m -69.65 -46.84 65.22 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 121.13 0.49 . . . . 0.42999999999999999 110.144 -168.746 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.3 pp -56.15 -23.31 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 CA-C-N 115.462 -0.79 . . . . 1.6899999999999999 112.882 -178.388 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.0 t -48.38 -35.45 12.61 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.981 0.913 . . . . 2.21 110.748 177.794 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 15.9 m -120.04 -40.49 2.72 Favored 'General case' 0 C--N 1.342 0.255 0 C-N-CA 123.564 0.746 . . . . 0.20000000000000001 111.525 177.319 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 86.1 m-70 -72.16 -9.01 57.85 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.581 0.752 . . . . 0.28999999999999998 112.219 -178.59 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 88.61 148.87 18.05 Favored Glycine 0 C--N 1.339 0.714 0 N-CA-C 109.742 -1.343 . . . . 1.4399999999999999 109.742 177.595 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -42.34 -33.41 1.37 Allowed Glycine 0 CA--C 1.529 0.956 0 C-N-CA 125.202 1.382 . . . . 1.3 112.988 175.085 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -101.26 -5.29 25.7 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.076 1.351 . . . . 2.98 112.209 -171.687 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 73.37 8.63 5.18 Favored 'General case' 0 C--N 1.35 0.601 0 O-C-N 120.633 -1.292 . . . . 2.5099999999999998 111.393 175.696 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 17.2 p -82.11 -1.99 50.52 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 127.491 2.316 . . . . 1.55 110.287 -174.523 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.57 145.27 9.84 Favored Glycine 0 N--CA 1.438 -1.19 0 N-CA-C 108.164 -1.975 . . . . 0.40999999999999998 108.164 -171.475 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -150.88 -73.0 0.16 Allowed 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 124.181 0.992 . . . . 1.6399999999999999 108.98 176.7 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.93 3.85 49.57 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.948 1.299 . . . . 1.75 110.441 173.33 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -158.05 163.68 23.79 Favored Pre-proline 0 CA--C 1.536 0.419 0 C-N-CA 125.994 1.718 . . . . 1.45 107.331 -167.523 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -70.16 158.01 57.8 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 123.144 2.563 . . . . 0.34999999999999998 110.768 -174.823 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.39 126.96 31.36 Favored 'General case' 0 C--N 1.333 -0.148 0 O-C-N 121.636 -0.665 . . . . 1.47 110.075 -177.305 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 39.4 pt -106.9 -2.88 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 C-N-CA 123.07 0.548 . . . . 1.6499999999999999 111.887 177.037 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 24.6 p-10 -33.66 -49.95 0.33 Allowed 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.29 1.436 . . . . 3.6099999999999999 112.744 171.834 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.5 pttp -106.17 23.82 13.45 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.261 1.424 . . . . 4.8700000000000001 112.579 -176.859 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.04 -50.02 75.67 Favored 'General case' 0 CA--C 1.527 0.072 0 O-C-N 121.228 -0.92 . . . . 1.78 109.963 179.168 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -60.18 -12.84 25.47 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 123.386 0.517 . . . . 0.93999999999999995 114.157 178.804 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.98 -34.15 68.69 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 118.454 1.127 . . . . 1.8700000000000001 110.664 173.539 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -107.24 -52.09 2.82 Favored 'General case' 0 C--N 1.34 0.174 0 C-N-CA 123.976 0.91 . . . . 3.3399999999999999 111.878 -176.137 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -84.04 170.29 14.07 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.713 0.805 . . . . 1.5 110.184 175.763 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 54.1 m -119.53 169.1 10.35 Favored 'General case' 0 C--O 1.233 0.237 0 C-N-CA 125.647 1.579 . . . . 2.48 108.619 172.899 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.8 pm0 -46.25 -49.86 16.71 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 124.475 1.11 . . . . 2.7400000000000002 112.355 -177.198 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -58.83 -41.71 87.51 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 118.298 0.499 . . . . 2.4100000000000001 111.888 179.172 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.65 -49.07 51.34 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 122.114 0.959 . . . . 3.5299999999999998 108.623 -176.253 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 31.2 mt -60.03 -44.48 94.91 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 O-C-N 121.631 -0.668 . . . . 1.7 109.253 178.545 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 61.7 tp -54.61 -52.45 62.19 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.289 -0.634 . . . . 1.99 109.289 177.119 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -48.28 -53.91 15.55 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.165 0.586 . . . . 1.8899999999999999 109.77 179.264 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 81.4 mt -57.18 -47.87 83.22 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.283 0 O-C-N 121.707 -0.621 . . . . 1.76 111.409 177.37 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 79.5 mt -54.79 -43.0 65.24 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 O-C-N 120.464 -1.398 . . . . 1.6200000000000001 110.216 176.665 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 94.3 mt -70.8 -40.41 72.55 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 113.957 1.095 . . . . 1.74 113.957 -176.171 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -123.3 27.51 7.49 Favored 'General case' 0 C--N 1.344 0.35 0 CA-C-N 120.956 1.707 . . . . 3.7999999999999998 109.787 -171.515 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 36.55 -136.97 0.52 Allowed Glycine 0 CA--C 1.532 1.151 0 C-N-CA 127.786 2.612 . . . . 0.64000000000000001 110.613 -174.969 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 30.9 tt0 167.41 133.36 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 119.237 1.519 . . . . 1.76 109.197 -177.089 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 45.04 -122.5 5.15 Favored Glycine 0 CA--C 1.532 1.102 0 CA-C-N 119.872 1.215 . . . . 0.60999999999999999 112.252 -175.396 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -70.8 -16.97 74.78 Favored Glycine 0 CA--C 1.532 1.131 0 CA-C-N 117.595 0.697 . . . . 0.83999999999999997 113.017 178.448 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 20.5 ttt -71.29 119.03 71.27 Favored Pre-proline 0 N--CA 1.451 -0.385 0 CA-C-N 118.23 1.015 . . . . 1.49 110.434 -178.938 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -78.18 120.55 4.99 Favored 'Trans proline' 0 N--CA 1.446 -1.275 0 C-N-CA 122.847 2.365 . . . . 2.1400000000000001 110.886 -179.431 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -61.3 140.63 47.74 Favored Glycine 0 N--CA 1.443 -0.892 0 CA-C-N 115.047 -0.979 . . . . 1.5800000000000001 115.499 -175.691 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 79.87 35.25 28.51 Favored Glycine 0 CA--C 1.524 0.644 0 CA-C-N 114.05 -1.075 . . . . 0.33000000000000002 110.911 174.161 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -57.41 -52.04 61.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 125.094 1.358 . . . . 2.0099999999999998 109.499 175.465 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -111.5 155.0 23.92 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 125.404 1.481 . . . . 1.51 108.339 163.147 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.2 mtpp -142.64 157.86 44.26 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.868 1.267 . . . . 3.0800000000000001 109.408 175.959 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 62.32 -151.06 46.3 Favored Glycine 0 CA--C 1.529 0.94 0 N-CA-C 111.133 -0.787 . . . . 0.98999999999999999 111.133 -177.38 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -50.79 -35.08 30.15 Favored 'General case' 0 C--N 1.34 0.192 0 C-N-CA 123.865 0.866 . . . . 1.71 111.736 -175.775 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -50.87 -50.96 55.89 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.006 0.922 . . . . 2.1400000000000001 110.621 174.105 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -75.81 -49.59 17.6 Favored 'General case' 0 CA--C 1.528 0.1 0 C-N-CA 123.335 0.654 . . . . 1.74 111.043 179.36 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -55.11 -48.35 73.73 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.724 0.809 . . . . 2.4900000000000002 110.696 -176.397 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.21 -50.67 72.73 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 109.909 -0.404 . . . . 1.5800000000000001 109.909 177.638 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 57.4 t -53.57 -59.14 2.06 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.272 0 CA-C-O 119.508 -0.282 . . . . 1.6200000000000001 110.465 178.591 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -42.87 -56.34 3.29 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 123.831 0.852 . . . . 1.29 112.144 174.299 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.67 -46.97 85.71 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 121.487 0.661 . . . . 1.47 111.923 -176.364 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 74.9 t90 -58.99 -49.9 76.14 Favored 'General case' 0 C--N 1.328 -0.362 0 O-C-N 121.747 -0.596 . . . . 0.62 109.879 178.339 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.05 -32.89 74.37 Favored 'General case' 0 C--O 1.223 -0.329 0 CA-C-O 117.981 -1.009 . . . . 3.1800000000000002 111.995 176.164 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -55.99 -36.16 67.59 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 119.621 1.1 . . . . 1.48 110.097 170.233 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -68.59 -36.06 78.19 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 118.459 -0.781 . . . . 3.3100000000000001 111.51 172.589 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 4.2 mtpt -74.17 134.71 42.8 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 119.736 1.153 . . . . 3.1299999999999999 110.801 -178.338 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 2.6 mptt . . . . . 0 C--O 1.25 1.12 0 N-CA-C 105.738 -1.949 . . . . 3.8799999999999999 105.738 172.458 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 93' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.448 ' CG2' ' H ' ' A' ' 23' ' ' ASP 2.191 0.7 OUTLIER . . . . . 0 N--CA 1.469 0.507 0 CA-C-O 113.97 -2.919 . . . . 3.4900000000000002 106.474 . . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.448 ' H ' ' CG2' ' A' ' 22' ' ' VAL . 83.9 m-20 -91.11 91.78 8.41 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 103.587 -2.746 . . . . 2.73 103.587 156.534 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.62 -49.91 71.57 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-O 121.481 0.658 . . . . 1.5 109.905 -171.764 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -58.91 -48.25 82.12 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.116 -0.947 . . . . 3.1699999999999999 109.929 -178.773 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.96 -47.07 87.3 Favored 'General case' 0 CA--C 1.527 0.096 0 C-N-CA 122.938 0.495 . . . . 1.6299999999999999 111.066 -179.933 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 75.6 t -55.72 -55.54 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 N-CA-C 108.913 -0.773 . . . . 1.9199999999999999 108.913 176.727 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 37.3 t -54.6 -47.55 72.13 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 C-N-CA 122.55 0.34 . . . . 1.6499999999999999 111.188 -177.8 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 40.1 mm-40 -52.3 -19.46 2.09 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.098 1.359 . . . . 0.66000000000000003 113.078 174.584 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -135.66 42.31 2.67 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 119.876 1.216 . . . . 3.3799999999999999 111.939 174.903 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -163.5 -34.19 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 118.106 -0.949 . . . . 2.6699999999999999 112.8 172.062 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 3.5 m -100.75 -50.66 3.79 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 119.668 1.122 . . . . 0.25 110.736 -178.619 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 8.6 pt -56.07 -27.19 22.82 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 CA-C-N 116.191 -0.459 . . . . 2.7599999999999998 111.977 -175.627 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.7 m -40.1 -37.35 0.6 Allowed 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.51 1.524 . . . . 1.6899999999999999 112.145 173.966 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 17.6 m -116.56 -36.65 3.89 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.398 0.679 . . . . 0.23000000000000001 111.753 173.955 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 92.5 m-70 -80.63 3.31 22.39 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.018 0.927 . . . . 0.29999999999999999 113.372 -175.628 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 108.43 -78.84 0.24 Allowed Glycine 0 CA--C 1.525 0.681 0 C-N-CA 125.778 1.656 . . . . 2.9900000000000002 111.937 163.991 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -178.14 -53.4 0.07 OUTLIER Glycine 0 C--O 1.229 -0.219 0 N-CA-C 108.306 -1.918 . . . . 2.4500000000000002 108.306 -171.355 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -97.07 3.93 51.58 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 117.948 -1.025 . . . . 2.52 110.919 -178.356 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.5 mt 77.76 13.23 1.8 Allowed 'General case' 0 C--N 1.352 0.702 0 CA-C-N 119.704 1.138 . . . . 2.8799999999999999 110.054 -178.443 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.7 p -78.55 -11.92 59.99 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 128.462 2.705 . . . . 1.49 110.189 -176.166 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.42 156.72 32.41 Favored Glycine 0 N--CA 1.444 -0.829 0 N-CA-C 109.167 -1.573 . . . . 0.65000000000000002 109.167 -178.758 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -163.21 -79.16 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 123.52 0.728 . . . . 1.3200000000000001 109.719 179.222 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.5 m -93.1 2.49 56.71 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.187 0.995 . . . . 1.78 110.676 170.798 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -153.27 160.67 30.67 Favored Pre-proline 0 N--CA 1.447 -0.585 0 C-N-CA 126.219 1.808 . . . . 1.5600000000000001 106.973 -171.455 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -67.15 164.5 29.99 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 123.282 2.655 . . . . 0.33000000000000002 111.191 -174.86 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -74.38 123.87 25.45 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.858 -0.423 . . . . 1.51 109.858 -178.262 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 49.8 pt -109.85 1.35 9.34 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 C-N-CA 124.28 1.032 . . . . 1.7 112.486 177.784 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 22.0 p-10 -34.53 -48.46 0.36 Allowed 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.587 1.555 . . . . 3.5299999999999998 112.574 167.516 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 4.6 tttt -113.68 38.97 2.78 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 126.606 1.962 . . . . 6.6399999999999997 109.326 -177.595 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.36 -47.37 86.18 Favored 'General case' 0 N--CA 1.454 -0.245 0 O-C-N 121.119 -0.988 . . . . 1.54 109.896 170.559 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -51.26 -42.48 49.59 Favored Glycine 0 CA--C 1.526 0.761 0 C-N-CA 123.959 0.79 . . . . 0.77000000000000002 114.448 -171.67 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.37 -21.06 58.6 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 121.684 -0.892 . . . . 2.0099999999999998 112.107 179.285 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -82.55 -46.68 13.05 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 118.531 0.605 . . . . 1.97 109.516 176.027 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -138.05 137.78 38.14 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.858 1.263 . . . . 1.26 108.55 -171.777 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 35.1 t -75.64 167.2 22.34 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.898 0.879 . . . . 3.1000000000000001 109.841 178.951 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -49.51 -43.19 45.32 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.864 0.865 . . . . 2.8100000000000001 111.893 177.53 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -53.54 -37.54 62.94 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 118.991 0.814 . . . . 2.8799999999999999 111.447 176.467 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -83.08 -49.07 9.91 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 123.615 0.766 . . . . 3.48 110.091 -178.352 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 65.2 mt -58.73 -44.93 91.15 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.052 0 O-C-N 121.283 -0.885 . . . . 1.48 108.758 -178.637 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 35.3 tp -54.41 -47.55 72.63 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 124.002 0.921 . . . . 1.72 109.846 176.182 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -56.0 -50.64 70.29 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 109.794 -0.447 . . . . 2.0600000000000001 109.794 174.49 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 74.2 mt -60.22 -30.17 45.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 O-C-N 121.575 -0.703 . . . . 1.54 111.694 178.895 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 46.6 mt -71.64 -50.77 37.07 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 O-C-N 120.151 -1.593 . . . . 1.4099999999999999 109.95 174.559 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 82.8 mt -70.74 -30.39 66.9 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.869 0.868 . . . . 1.75 112.91 -174.336 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -119.3 12.62 12.59 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 119.11 0.868 . . . . 1.6799999999999999 109.974 -170.048 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 39.38 -147.07 0.18 Allowed Glycine 0 CA--C 1.542 1.719 0 C-N-CA 127.722 2.582 . . . . 0.63 111.211 -172.449 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 38.8 tt0 175.34 131.1 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 119.344 1.572 . . . . 2.0 108.93 -177.144 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 40.72 -115.62 0.7 Allowed Glycine 0 CA--C 1.532 1.137 0 CA-C-N 119.957 1.253 . . . . 0.5 113.33 -175.95 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -69.98 -21.65 76.9 Favored Glycine 0 CA--C 1.532 1.142 0 O-C-N 122.335 -0.509 . . . . 0.62 112.992 -179.727 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.402 ' HB2' ' C1D' ' A' ' 93' ' ' HEC . 22.4 ttt -73.66 119.08 74.16 Favored Pre-proline 0 N--CA 1.452 -0.374 0 C-N-CA 124.363 1.065 . . . . 1.5600000000000001 110.773 -179.817 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -78.85 128.1 8.25 Favored 'Trans proline' 0 N--CA 1.445 -1.376 0 C-N-CA 122.263 1.976 . . . . 2.1600000000000001 110.525 -179.454 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -61.31 134.17 48.28 Favored Glycine 0 N--CA 1.442 -0.921 0 CA-C-N 115.215 -0.902 . . . . 1.6200000000000001 114.703 -179.486 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 84.23 38.56 9.93 Favored Glycine 0 CA--C 1.526 0.781 0 CA-C-N 114.543 -0.828 . . . . 0.32000000000000001 111.676 171.261 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -61.2 -44.31 98.11 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.881 0 C-N-CA 125.43 1.492 . . . . 3.6000000000000001 110.237 177.203 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -111.48 161.76 15.81 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.498 1.919 . . . . 1.6200000000000001 109.565 164.659 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 68.6 mttt -133.12 157.64 44.8 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 124.798 1.239 . . . . 3.9100000000000001 110.837 174.74 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 53.22 -141.74 29.64 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 110.712 -0.955 . . . . 0.93999999999999995 110.712 176.854 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -52.44 -34.83 50.45 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 117.139 0.469 . . . . 1.8899999999999999 111.835 179.254 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -53.77 -35.94 61.86 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.699 0.8 . . . . 2.4700000000000002 109.48 178.39 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -82.18 -52.66 6.76 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.465 0.706 . . . . 1.48 110.805 170.967 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -57.4 -54.52 45.85 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 112.657 0.614 . . . . 1.96 112.657 -172.333 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -55.96 -42.79 76.78 Favored 'General case' 0 N--CA 1.454 -0.253 0 O-C-N 121.88 -0.513 . . . . 1.5700000000000001 110.472 -179.832 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 50.8 t -61.12 -53.67 45.79 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 C-N-CA 122.66 0.384 . . . . 1.6100000000000001 110.666 178.365 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -51.66 -50.46 60.32 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 123.12 0.568 . . . . 1.74 111.514 176.099 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.16 -48.41 81.7 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.452 0.701 . . . . 1.5 110.69 179.412 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 47.6 t90 -56.71 -47.53 79.74 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 121.915 -0.49 . . . . 0.58999999999999997 109.769 177.086 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.22 -36.32 83.69 Favored 'General case' 0 N--CA 1.462 0.139 0 C-N-CA 124.162 0.985 . . . . 2.8100000000000001 111.476 179.305 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -54.55 -41.01 69.25 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 118.987 0.812 . . . . 1.77 110.096 170.988 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -88.4 27.39 1.26 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.722 0.809 . . . . 4.4400000000000004 112.706 173.098 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.6 mtpm? -119.85 130.95 55.12 Favored 'General case' 0 C--N 1.341 0.21 0 O-C-N 120.858 -1.151 . . . . 2.9199999999999999 109.245 165.14 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 9.5 mtmp? . . . . . 0 C--O 1.248 1.022 0 C-N-CA 127.924 2.49 . . . . 4.46 104.607 -177.243 . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 93' ' ' HEC . . . . . 0.402 ' C1D' ' HB2' ' A' ' 71' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 43.0 t . . . . . 0 N--CA 1.47 0.551 0 N-CA-C 107.289 -1.375 . . . . 2.0600000000000001 107.289 . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -74.08 156.92 36.92 Favored 'General case' 0 N--CA 1.451 -0.418 0 O-C-N 124.049 0.843 . . . . 2.1299999999999999 109.61 178.266 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -97.73 -61.94 1.32 Allowed 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 109.144 -0.687 . . . . 1.6599999999999999 109.144 178.203 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -51.53 -43.74 62.4 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 116.173 -0.467 . . . . 3.1299999999999999 111.116 178.164 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.55 -43.72 89.42 Favored 'General case' 0 CA--C 1.528 0.135 0 CA-C-N 118.579 0.627 . . . . 1.54 111.509 179.731 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 73.6 t -63.39 -53.18 48.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 N-CA-C 108.12 -1.067 . . . . 1.5 108.12 178.438 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 45.1 t -52.34 -48.44 44.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 110.437 -0.209 . . . . 1.55 110.437 -179.623 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 35.6 mm-40 -50.47 -24.5 3.16 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.448 1.899 . . . . 0.65000000000000002 112.937 175.658 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -142.62 59.04 1.44 Allowed 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 119.184 0.902 . . . . 3.23 111.323 178.459 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -179.81 -36.28 0.01 OUTLIER 'General case' 0 C--O 1.225 -0.207 0 C-N-CA 124.648 1.179 . . . . 1.95 109.695 173.356 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 5.0 m -101.1 -53.66 2.98 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 119.28 0.945 . . . . 0.26000000000000001 110.973 -178.632 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.1 pp -57.37 -25.92 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 CA-C-N 115.876 -0.602 . . . . 1.77 112.041 -175.735 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.1 m -38.17 -35.53 0.17 Allowed 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.001 1.72 . . . . 1.75 112.548 170.483 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 18.5 m -120.9 -44.02 2.44 Favored 'General case' 0 C--N 1.34 0.174 0 C-N-CA 123.326 0.651 . . . . 0.25 111.629 172.854 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 82.4 m-70 -70.13 -8.81 52.61 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.413 0.685 . . . . 0.52000000000000002 112.817 -175.2 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 88.48 151.93 23.96 Favored Glycine 0 C--N 1.337 0.589 0 N-CA-C 109.757 -1.337 . . . . 1.51 109.757 177.488 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -44.51 -37.54 4.95 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 124.518 1.056 . . . . 1.1699999999999999 112.31 178.514 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -98.37 0.24 45.03 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.707 1.203 . . . . 2.0899999999999999 111.747 -174.061 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.4 mp 65.28 17.14 10.89 Favored 'General case' 0 C--N 1.347 0.458 0 CA-C-N 120.232 1.378 . . . . 2.8500000000000001 111.543 178.582 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.3 p -84.9 -4.77 59.25 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 128.529 2.731 . . . . 1.46 110.03 -175.707 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.04 127.18 3.65 Favored Glycine 0 N--CA 1.442 -0.903 0 N-CA-C 109.009 -1.636 . . . . 0.55000000000000004 109.009 179.437 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -134.31 -80.13 0.45 Allowed 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 124.229 1.012 . . . . 1.45 108.904 179.552 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 46.1 m -88.85 2.85 52.98 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.757 0.823 . . . . 1.8500000000000001 111.047 172.695 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -158.99 164.86 19.78 Favored Pre-proline 0 CA--C 1.537 0.444 0 C-N-CA 124.529 1.132 . . . . 1.54 108.246 -169.188 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -68.75 157.69 60.84 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 123.157 2.571 . . . . 0.33000000000000002 110.951 -173.389 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.45 128.76 36.41 Favored 'General case' 0 CA--C 1.529 0.146 0 O-C-N 121.584 -0.697 . . . . 1.6399999999999999 110.307 -175.653 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 48.6 pt -106.63 0.21 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 C-N-CA 123.328 0.651 . . . . 1.76 111.626 176.954 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -38.99 -38.29 0.43 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.789 0.836 . . . . 2.27 113.105 170.085 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 4.2 pttt -113.49 30.05 7.52 Favored 'General case' 0 C--N 1.343 0.316 0 C-N-CA 124.507 1.123 . . . . 4.7699999999999996 111.642 -178.689 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -68.36 -41.97 79.86 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 118.652 -0.689 . . . . 1.5800000000000001 109.624 176.766 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -53.38 -29.83 39.35 Favored Glycine 0 CA--C 1.526 0.735 0 CA-C-N 118.614 0.643 . . . . 0.71999999999999997 114.646 -175.419 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -83.41 -47.49 11.36 Favored 'General case' 0 N--CA 1.455 -0.197 0 O-C-N 122.403 -0.469 . . . . 2.0099999999999998 110.366 175.253 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 38.4 m-80 -55.63 -44.27 76.96 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 122.286 0.234 . . . . 1.54 111.158 179.43 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -139.75 134.15 31.46 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.022 1.729 . . . . 1.3200000000000001 107.691 -167.309 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 49.2 m -74.98 170.73 15.4 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 118.348 0.522 . . . . 2.46 110.774 178.059 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 73.3 tt0 -45.54 -59.53 2.67 Favored 'General case' 0 C--N 1.342 0.267 0 C-N-CA 123.178 0.591 . . . . 5.2599999999999998 110.75 177.148 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 31.5 mp0 -51.28 -31.86 22.71 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.656 0.782 . . . . 4.2800000000000002 112.906 179.259 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -80.85 -48.46 12.38 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 119.23 0.923 . . . . 2.6400000000000001 109.315 -179.191 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 84.6 mt -61.77 -47.1 94.85 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.222 0 O-C-N 121.565 -0.709 . . . . 1.5700000000000001 109.256 -179.215 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 31.2 tp -52.2 -50.2 62.38 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 108.956 -0.757 . . . . 1.8400000000000001 108.956 175.789 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -57.02 -43.23 81.65 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 120.72 -0.392 . . . . 1.6699999999999999 110.997 178.157 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 31.6 mt -58.73 -54.0 39.63 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.262 0 O-C-N 120.861 -1.149 . . . . 1.5700000000000001 110.494 173.257 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 58.2 mt -50.75 -41.97 22.04 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 O-C-N 120.655 -1.278 . . . . 1.6200000000000001 110.513 -179.614 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 88.5 mt -69.18 -40.53 78.03 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 113.436 0.902 . . . . 1.7 113.436 176.951 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 -118.31 19.1 13.56 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 120.489 1.495 . . . . 1.77 110.202 -164.706 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.409 ' N ' ' HA2' ' A' ' 73' ' ' GLY . . . 29.47 -136.5 0.05 OUTLIER Glycine 0 CA--C 1.532 1.154 0 C-N-CA 128.511 2.958 . . . . 0.65000000000000002 110.973 -162.458 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 171.66 133.01 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 119.085 1.443 . . . . 2.0800000000000001 108.28 -176.736 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 40.76 -118.85 1.28 Allowed Glycine 0 CA--C 1.533 1.208 0 CA-C-N 120.405 1.457 . . . . 0.42999999999999999 113.294 -178.199 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -68.49 -19.25 72.57 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 123.704 0.669 . . . . 0.53000000000000003 113.23 179.204 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 19.9 ttt -74.41 119.12 74.95 Favored Pre-proline 0 N--CA 1.449 -0.485 0 C-N-CA 124.288 1.035 . . . . 1.46 110.677 179.174 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -74.86 127.34 10.7 Favored 'Trans proline' 0 N--CA 1.442 -1.551 0 C-N-CA 122.01 1.806 . . . . 2.1000000000000001 109.812 177.631 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.409 ' HA2' ' N ' ' A' ' 67' ' ' GLY . . . -63.17 140.76 45.55 Favored Glycine 0 N--CA 1.442 -0.956 0 CA-C-N 115.487 -0.779 . . . . 1.6699999999999999 114.655 176.953 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 84.27 38.0 10.47 Favored Glycine 0 CA--C 1.525 0.692 0 CA-C-N 113.757 -1.221 . . . . 0.56000000000000005 111.507 173.605 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.5 mm -64.3 -58.03 8.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 C-N-CA 123.779 0.831 . . . . 3.1899999999999999 110.002 176.559 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -104.94 152.58 22.5 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.893 1.277 . . . . 1.6100000000000001 108.206 167.807 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 2.1 mmmt -142.28 154.99 45.19 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 124.732 1.213 . . . . 4.0899999999999999 108.995 -178.721 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 63.67 -158.29 40.44 Favored Glycine 0 CA--C 1.531 1.043 0 N-CA-C 111.315 -0.714 . . . . 0.79000000000000004 111.315 -173.814 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -53.14 -26.04 15.42 Favored 'General case' 0 C--N 1.34 0.173 0 C-N-CA 123.873 0.869 . . . . 1.77 112.415 -179.983 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -47.92 -48.81 31.61 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.493 1.117 . . . . 2.1099999999999999 110.577 171.326 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -74.32 -47.68 33.07 Favored 'General case' 0 N--CA 1.455 -0.189 0 O-C-N 121.645 -0.659 . . . . 1.77 111.333 177.285 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -55.92 -51.95 65.82 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.24 0.616 . . . . 2.5899999999999999 110.645 -174.979 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -54.0 -47.5 71.4 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.774 0.829 . . . . 1.6299999999999999 110.308 178.644 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 44.4 t -58.84 -55.46 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 C-N-CA 122.607 0.363 . . . . 1.78 110.832 177.983 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -48.68 -51.9 26.1 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.183 0.593 . . . . 1.3200000000000001 111.252 176.639 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.23 -48.91 79.74 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 121.449 0.642 . . . . 1.4299999999999999 111.138 -179.768 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 75.2 t90 -58.75 -50.23 74.69 Favored 'General case' 0 CA--C 1.532 0.287 0 O-C-N 121.459 -0.776 . . . . 0.57999999999999996 109.975 -179.987 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.71 -32.93 72.15 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 118.283 -0.865 . . . . 3.0800000000000001 111.83 173.631 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -54.99 -31.49 60.95 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 119.85 1.204 . . . . 1.52 110.975 173.332 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -77.93 -38.34 45.7 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 118.342 -0.837 . . . . 3.2799999999999998 112.448 169.534 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 42.6 mtpt -73.04 111.65 8.35 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 119.714 1.143 . . . . 3.2799999999999998 111.162 -177.347 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 2.0 pttt . . . . . 0 C--O 1.251 1.149 0 C-N-CA 126.467 1.907 . . . . 3.3100000000000001 107.175 177.514 . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 93' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 42.1 t . . . . . 0 N--CA 1.469 0.507 0 N-CA-C 106.986 -1.487 . . . . 2.6000000000000001 106.986 . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -74.54 110.9 9.2 Favored 'General case' 0 N--CA 1.454 -0.273 0 O-C-N 123.755 0.66 . . . . 2.21 109.462 -176.073 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -48.38 -52.72 20.52 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.94 0.896 . . . . 1.6499999999999999 110.918 -179.325 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -58.78 -44.34 90.67 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 116.269 -0.423 . . . . 2.8399999999999999 110.111 179.607 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.02 -43.27 99.14 Favored 'General case' 0 C--N 1.34 0.163 0 C-N-CA 122.719 0.408 . . . . 1.5800000000000001 111.221 -179.675 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 77.7 t -58.4 -55.73 20.72 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.365 0 N-CA-C 108.923 -0.769 . . . . 1.8700000000000001 108.923 175.432 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 50.9 t -54.6 -45.02 71.64 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 N-CA-C 110.331 -0.248 . . . . 1.49 110.331 -177.227 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 -51.49 -26.28 8.02 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.927 1.691 . . . . 0.56999999999999995 113.611 172.742 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -139.99 58.85 1.59 Allowed 'General case' 0 C--N 1.338 0.103 0 CA-C-N 119.851 1.205 . . . . 2.9199999999999999 112.403 173.073 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -173.82 -36.74 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 123.866 0.867 . . . . 2.1800000000000002 110.143 169.3 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 5.6 m -98.71 -51.67 3.84 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 118.958 0.799 . . . . 0.29999999999999999 110.402 -177.923 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.2 pp -57.09 -26.67 25.57 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.08 0 CA-C-N 116.211 -0.449 . . . . 1.54 112.027 -176.414 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 50.3 m -37.82 -38.45 0.29 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.121 1.369 . . . . 1.8700000000000001 112.194 170.989 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 22.5 m -120.23 -40.96 2.65 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.194 0.597 . . . . 0.17999999999999999 111.549 174.625 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 84.1 m-70 -71.7 -8.93 57.2 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 112.766 0.654 . . . . 0.27000000000000002 112.766 -176.15 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 86.09 150.15 14.8 Favored Glycine 0 C--N 1.338 0.66 0 N-CA-C 109.838 -1.305 . . . . 1.49 109.838 178.958 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -44.47 -36.91 4.63 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 124.558 1.075 . . . . 1.21 112.191 177.277 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -95.96 -3.82 44.43 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 124.691 1.196 . . . . 2.6299999999999999 111.725 -172.831 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 8.7 mt 69.41 13.05 8.41 Favored 'General case' 0 C--N 1.35 0.607 0 CA-C-N 120.463 1.483 . . . . 2.0499999999999998 111.316 176.126 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.4 p -86.03 -2.68 58.54 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 128.318 2.647 . . . . 1.6599999999999999 109.9 -175.867 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.89 129.27 3.02 Favored Glycine 0 N--CA 1.441 -0.997 0 N-CA-C 108.827 -1.709 . . . . 0.53000000000000003 108.827 -178.559 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -134.86 -78.42 0.45 Allowed 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 124.071 0.949 . . . . 1.53 108.773 178.662 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -90.72 3.58 53.89 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.148 0.979 . . . . 2.0 110.7 173.415 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -156.12 168.01 13.16 Favored Pre-proline 0 CA--C 1.537 0.45 0 C-N-CA 125.657 1.583 . . . . 1.4399999999999999 108.078 -170.551 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -67.11 168.79 16.54 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.698 2.266 . . . . 0.58999999999999997 110.816 -178.793 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -85.19 124.46 31.87 Favored 'General case' 0 CA--C 1.53 0.199 0 O-C-N 121.234 -0.917 . . . . 1.5 110.883 -176.494 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 43.6 pt -100.41 0.09 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 C-N-CA 123.769 0.827 . . . . 2.0 111.312 178.942 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -36.87 -46.0 0.59 Allowed 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.807 1.243 . . . . 2.2999999999999998 113.095 171.566 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.5 mttp -114.33 38.83 2.93 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.947 0.88 . . . . 4.5999999999999996 110.573 -179.515 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.06 -50.08 74.76 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 118.641 -0.695 . . . . 1.6799999999999999 109.432 175.106 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -54.3 -26.28 36.07 Favored Glycine 0 CA--C 1.528 0.878 0 CA-C-N 118.721 0.691 . . . . 0.56000000000000005 113.695 -177.257 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -81.32 -44.23 17.95 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 117.507 0.653 . . . . 1.74 110.181 176.582 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 38.6 m-80 -62.08 -48.11 81.68 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 122.446 0.298 . . . . 1.7 110.934 178.12 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 -141.38 145.0 34.82 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.431 1.492 . . . . 1.21 108.731 -168.016 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 64.5 m -78.87 166.81 22.0 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.59 0.756 . . . . 2.4199999999999999 111.118 179.659 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -43.96 -53.8 5.9 Favored 'General case' 0 C--N 1.342 0.266 0 C-N-CA 123.712 0.805 . . . . 4.5499999999999998 110.927 177.52 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -51.1 -41.41 59.98 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 122.868 0.467 . . . . 4.0800000000000001 111.387 -178.858 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -74.62 -48.48 26.19 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 123.32 0.648 . . . . 3.2000000000000002 109.484 -177.484 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 67.0 mt -60.76 -46.73 95.56 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.078 0 N-CA-C 108.935 -0.765 . . . . 1.6200000000000001 108.935 -177.915 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 24.6 tp -52.04 -53.72 38.68 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 124.223 1.009 . . . . 1.5800000000000001 109.367 175.819 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -53.5 -48.47 68.95 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 120.879 0.371 . . . . 1.9399999999999999 110.846 175.471 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 71.3 mt -62.2 -26.58 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 O-C-N 121.385 -0.822 . . . . 1.8300000000000001 112.32 179.842 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 54.8 mt -75.12 -50.7 23.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 O-C-N 120.131 -1.606 . . . . 1.5 108.297 173.048 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 88.4 mt -62.62 -32.65 73.71 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.793 1.237 . . . . 1.74 113.193 -177.376 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -128.08 20.06 6.42 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 119.697 1.135 . . . . 1.8500000000000001 110.213 -166.031 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 33.81 -137.97 0.17 Allowed Glycine 0 CA--C 1.544 1.852 0 C-N-CA 126.638 2.066 . . . . 0.68000000000000005 112.023 -167.282 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 164.68 141.22 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 126.45 1.9 . . . . 1.3 109.191 -177.785 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 29.06 -111.71 0.03 OUTLIER Glycine 0 C--N 1.347 1.177 0 C-N-CA 125.68 1.609 . . . . 0.70999999999999996 114.294 -172.471 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -62.35 -30.34 75.87 Favored Glycine 0 CA--C 1.535 1.344 0 CA-C-N 117.655 0.727 . . . . 0.92000000000000004 113.087 -179.414 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 5.9 ttt -70.41 122.08 85.35 Favored Pre-proline 0 CA--C 1.542 0.652 0 C-N-CA 125.114 1.366 . . . . 1.4199999999999999 111.224 -179.079 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -62.87 -58.27 0.34 Allowed 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 124.275 3.317 . . . . 3.0699999999999998 111.333 -172.32 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 120.8 148.33 7.98 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-O 122.205 0.891 . . . . 2.1899999999999999 114.448 172.82 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 70.91 21.94 78.26 Favored Glycine 0 CA--C 1.526 0.768 0 CA-C-O 118.484 -1.176 . . . . 0.51000000000000001 112.126 177.518 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.5 mt -47.12 -52.4 4.56 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 C-N-CA 129.052 2.941 . . . . 2.2999999999999998 111.158 175.001 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -109.98 156.87 19.92 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.609 1.564 . . . . 1.47 108.903 164.375 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 17.9 mtmm -146.28 159.75 42.92 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 124.559 1.144 . . . . 4.0700000000000003 110.403 171.565 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 61.59 -151.22 43.91 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 110.05 -1.22 . . . . 0.93000000000000005 110.05 -177.586 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -46.76 -37.3 8.35 Favored 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 123.901 0.88 . . . . 1.96 112.01 179.69 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -51.84 -45.68 64.09 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.73 0.812 . . . . 2.0800000000000001 110.691 176.169 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -81.15 -50.22 9.87 Favored 'General case' 0 N--CA 1.455 -0.186 0 O-C-N 121.786 -0.572 . . . . 1.4099999999999999 110.937 177.379 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -53.4 -51.06 63.78 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.461 0.704 . . . . 2.3900000000000001 111.455 -175.781 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.26 -46.13 86.58 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 122.567 0.347 . . . . 1.4299999999999999 110.309 179.791 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 67.2 t -58.25 -54.71 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 CA-C-O 119.385 -0.341 . . . . 1.5700000000000001 110.629 178.12 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -49.99 -50.42 47.12 Favored 'General case' 0 C--O 1.224 -0.266 0 C-N-CA 122.855 0.462 . . . . 1.6299999999999999 111.023 176.397 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.57 -48.12 83.17 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 121.822 0.82 . . . . 1.97 110.723 -177.616 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . 0.416 ' CE3' HD23 ' A' ' 88' ' ' LEU . 50.8 t90 -60.92 -43.79 98.1 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 121.79 0.805 . . . . 0.60999999999999999 110.768 178.197 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.416 HD23 ' CE3' ' A' ' 87' ' ' TRP . 0.1 OUTLIER -64.28 -33.85 76.78 Favored 'General case' 0 C--O 1.223 -0.291 0 O-C-N 121.189 -0.945 . . . . 2.7999999999999998 109.698 175.527 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.8 -42.19 97.75 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 118.54 0.609 . . . . 1.5 109.553 174.292 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -52.45 -50.78 61.96 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 118.108 -0.949 . . . . 3.2400000000000002 110.307 168.151 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 26.5 mttm -70.5 111.96 6.42 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 118.955 0.798 . . . . 4.1399999999999997 111.973 -173.755 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 26.9 mttp . . . . . 0 C--O 1.254 1.303 0 CA-C-O 116.277 -1.821 . . . . 3.5699999999999998 106.485 -178.505 . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 93' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 5.4 t . . . . . 0 N--CA 1.469 0.51 0 N-CA-C 106.605 -1.628 . . . . 2.3100000000000001 106.605 . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -75.68 98.06 3.97 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 123.794 0.684 . . . . 2.5899999999999999 109.22 -173.204 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -40.3 -56.0 2.07 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.896 1.278 . . . . 1.6100000000000001 111.804 179.083 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -48.02 -48.38 32.93 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.451 0.701 . . . . 3.1699999999999999 112.2 176.435 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.62 -42.27 98.2 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 123.025 0.53 . . . . 1.45 110.485 -179.043 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 61.5 t -61.83 -50.07 81.68 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 N-CA-C 109.768 -0.456 . . . . 1.5700000000000001 109.768 176.1 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 79.6 t -52.61 -49.9 43.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 C-N-CA 123.066 0.546 . . . . 1.8400000000000001 109.593 178.379 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 30.3 mm-40 -54.29 -17.51 3.03 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.688 1.595 . . . . 0.57999999999999996 114.298 173.517 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -149.15 58.14 1.02 Allowed 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 119.612 1.096 . . . . 3.8900000000000001 111.853 -179.081 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.1 mttm 178.34 -35.34 0.01 OUTLIER 'General case' 0 C--O 1.225 -0.202 0 C-N-CA 126.233 1.813 . . . . 2.1000000000000001 109.695 172.926 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 6.4 m -100.28 -53.07 3.21 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 118.949 0.795 . . . . 0.32000000000000001 110.639 -177.115 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.0 pp -55.14 -26.96 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.111 0 CA-C-N 115.936 -0.574 . . . . 1.71 112.182 -177.94 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.4 m -38.23 -37.15 0.26 Allowed 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 126.418 1.887 . . . . 1.76 112.434 171.313 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 39.5 m -120.52 -41.34 2.6 Favored 'General case' 0 C--N 1.341 0.201 0 C-N-CA 123.729 0.811 . . . . 0.17999999999999999 111.741 173.519 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 85.1 m-70 -72.23 -6.78 45.37 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.33 0.652 . . . . 0.28999999999999998 112.673 -175.735 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 87.1 148.16 12.85 Favored Glycine 0 C--N 1.337 0.633 0 N-CA-C 109.547 -1.421 . . . . 1.45 109.547 177.971 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -43.98 -33.11 2.56 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 124.71 1.148 . . . . 1.27 112.532 174.939 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -94.42 -9.88 34.23 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.582 1.553 . . . . 2.3999999999999999 112.235 -172.839 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.5 mt 71.17 10.21 6.75 Favored 'General case' 0 C--N 1.348 0.516 0 CA-C-N 120.301 1.409 . . . . 2.5600000000000001 111.395 179.563 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 11.9 p -86.43 0.28 54.46 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 127.206 2.202 . . . . 1.6299999999999999 109.999 -175.753 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.87 132.42 2.95 Favored Glycine 0 N--CA 1.44 -1.083 0 N-CA-C 108.789 -1.724 . . . . 0.59999999999999998 108.789 -177.024 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -136.73 -75.47 0.42 Allowed 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 124.122 0.969 . . . . 1.53 108.396 178.328 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -93.71 3.71 55.05 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.852 0.861 . . . . 2.3599999999999999 110.859 174.615 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -160.53 163.89 20.58 Favored Pre-proline 0 CA--C 1.537 0.474 0 C-N-CA 125.799 1.64 . . . . 1.53 107.564 -166.093 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -69.37 158.87 55.89 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.952 2.435 . . . . 0.38 111.237 -174.124 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -74.5 125.17 28.01 Favored 'General case' 0 C--N 1.332 -0.164 0 O-C-N 121.675 -0.64 . . . . 1.6000000000000001 111.045 -174.761 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 37.3 pt -103.98 -1.09 9.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-O 119.169 -0.443 . . . . 1.6599999999999999 112.073 178.996 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -36.6 -40.32 0.25 Allowed 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.899 1.28 . . . . 2.7400000000000002 113.721 171.548 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.6 mtpm? -119.47 36.62 4.43 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 124.548 1.139 . . . . 4.0 110.759 -178.085 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.53 -46.62 88.32 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 109.317 -0.623 . . . . 1.8200000000000001 109.317 171.98 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -57.79 -14.94 17.39 Favored Glycine 0 CA--C 1.532 1.14 0 N-CA-C 114.76 0.664 . . . . 0.81999999999999995 114.76 179.267 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -89.65 -45.41 9.36 Favored 'General case' 0 C--N 1.338 0.091 0 CA-C-N 119.048 1.424 . . . . 1.53 109.755 168.729 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -56.16 -54.33 46.47 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 122.608 0.363 . . . . 1.8700000000000001 111.616 179.622 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -140.42 158.97 43.21 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.512 1.125 . . . . 1.26 109.563 -168.576 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 22.6 m -84.93 168.26 15.17 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.065 0.546 . . . . 2.3700000000000001 110.825 178.217 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -50.72 -44.5 58.16 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 123.785 0.834 . . . . 3.0 111.908 -179.608 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -54.86 -46.26 74.68 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 119.116 0.871 . . . . 2.9900000000000002 111.394 176.474 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 51.7 mm-40 -71.86 -47.17 54.81 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 121.751 0.786 . . . . 3.0600000000000001 109.064 -173.511 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 64.3 mt -60.51 -46.31 95.63 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 N-CA-C 108.644 -0.873 . . . . 1.52 108.644 178.75 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 38.9 tp -53.95 -51.35 64.12 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 109.087 -0.709 . . . . 1.6299999999999999 109.087 176.626 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -53.57 -47.06 70.43 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 117.969 0.35 . . . . 1.47 111.208 177.561 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 62.0 mt -58.71 -46.86 90.36 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.295 0 O-C-N 121.341 -0.849 . . . . 1.6299999999999999 110.844 175.431 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 57.3 mt -58.6 -43.96 88.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 O-C-N 120.339 -1.476 . . . . 1.6000000000000001 109.89 179.532 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 86.4 mt -71.45 -34.62 70.41 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.496 1.119 . . . . 1.53 113.321 -178.188 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 71.3 m-80 -119.43 16.8 13.0 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 120.069 1.304 . . . . 1.6599999999999999 110.317 -168.532 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 36.11 -142.46 0.15 Allowed Glycine 0 CA--C 1.536 1.404 0 C-N-CA 127.696 2.569 . . . . 0.62 111.106 -167.463 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 173.22 131.85 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 119.076 1.438 . . . . 1.46 109.216 -175.067 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 42.13 -119.14 1.81 Allowed Glycine 0 CA--C 1.534 1.224 0 CA-C-N 120.006 1.276 . . . . 0.59999999999999998 112.687 -174.976 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -70.44 -19.35 76.11 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 123.561 0.6 . . . . 0.78000000000000003 113.016 179.148 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.407 ' HB2' ' C1D' ' A' ' 93' ' ' HEC . 20.0 ttt -71.21 117.81 60.09 Favored Pre-proline 0 N--CA 1.452 -0.348 0 C-N-CA 124.404 1.081 . . . . 1.49 110.53 -179.584 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -78.26 122.09 5.53 Favored 'Trans proline' 0 N--CA 1.445 -1.349 0 C-N-CA 123.28 2.653 . . . . 2.1699999999999999 110.732 179.986 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -62.58 142.46 47.86 Favored Glycine 0 N--CA 1.442 -0.917 0 N-CA-C 115.503 0.961 . . . . 1.5700000000000001 115.503 -175.285 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 77.95 33.49 41.18 Favored Glycine 0 CA--C 1.525 0.678 0 CA-C-N 114.01 -1.095 . . . . 0.37 111.135 174.889 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -56.49 -49.86 75.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.442 0 C-N-CA 124.899 1.28 . . . . 2.0899999999999999 108.94 172.996 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -109.53 160.06 16.55 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.069 1.748 . . . . 1.7 109.879 164.314 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.1 mmtp -145.91 167.54 23.03 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 126.467 1.907 . . . . 3.04 108.922 177.21 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 50.31 -145.87 9.14 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 110.883 -0.887 . . . . 0.98999999999999999 110.883 176.811 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -51.98 -34.9 44.46 Favored 'General case' 0 C--O 1.225 -0.199 0 CA-C-N 118.148 0.974 . . . . 1.8400000000000001 112.045 176.517 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -57.52 -38.61 74.94 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 118.664 0.666 . . . . 2.1800000000000002 110.118 177.598 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -83.18 -57.68 3.17 Favored 'General case' 0 N--CA 1.461 0.11 0 O-C-N 121.565 -0.71 . . . . 1.51 111.113 174.925 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -51.41 -49.37 61.76 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 124.887 1.275 . . . . 2.4300000000000002 111.803 -176.123 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.22 -47.06 87.57 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 109.568 -0.53 . . . . 1.5700000000000001 109.568 178.415 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 56.0 t -57.48 -52.74 53.24 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.312 0 CA-C-O 119.226 -0.416 . . . . 1.54 110.842 178.961 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -52.28 -57.79 8.65 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.548 0.739 . . . . 1.3 111.519 176.561 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.71 -40.76 89.06 Favored 'General case' 0 C--O 1.226 -0.144 0 C-N-CA 123.032 0.533 . . . . 1.6699999999999999 110.934 -177.062 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 83.6 t90 -63.79 -52.17 61.49 Favored 'General case' 0 N--CA 1.449 -0.513 0 O-C-N 121.721 -0.612 . . . . 0.96999999999999997 109.724 176.34 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.36 -27.41 64.16 Favored 'General case' 0 C--N 1.33 -0.277 0 O-C-N 120.675 -1.266 . . . . 3.0 112.167 176.413 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -56.8 -31.79 65.04 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 118.935 0.789 . . . . 1.7 111.988 170.026 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -74.66 -36.36 62.82 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 118.844 0.747 . . . . 4.9800000000000004 111.052 172.002 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 11.9 mmtm -73.85 102.92 4.2 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 121.428 0.633 . . . . 4.7199999999999998 110.193 -178.484 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.25 1.088 0 C-N-CA 125.339 1.456 . . . . 3.8999999999999999 107.711 173.57 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 93' ' ' HEC . . . . . 0.407 ' C1D' ' HB2' ' A' ' 71' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 69.1 t . . . . . 0 N--CA 1.471 0.607 0 N-CA-C 106.924 -1.51 . . . . 2.3799999999999999 106.924 . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -71.42 161.66 30.69 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 124.466 1.106 . . . . 3.8999999999999999 108.191 -177.746 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -105.78 -62.39 1.37 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.053 -0.721 . . . . 1.6799999999999999 109.053 173.22 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -55.04 -47.97 74.06 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 119.021 -0.514 . . . . 2.7599999999999998 111.251 178.778 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.32 -41.58 93.82 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 118.95 0.796 . . . . 1.5600000000000001 111.106 -176.731 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 73.6 t -59.93 -57.41 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 108.677 -0.86 . . . . 1.78 108.677 175.031 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 49.3 t -53.11 -48.37 53.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 CA-C-N 118.544 0.611 . . . . 1.6799999999999999 110.885 -178.479 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 22.4 mm-40 -51.88 -16.21 0.67 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 127.032 2.133 . . . . 0.77000000000000002 113.244 175.263 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -138.31 30.25 2.42 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 119.139 0.882 . . . . 3.0299999999999998 111.812 173.431 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -146.59 -48.43 0.19 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 118.831 0.741 . . . . 3.4100000000000001 111.103 176.481 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 3.5 m -93.45 -47.95 6.62 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 109.583 -0.525 . . . . 0.29999999999999999 109.583 -174.6 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.3 pp -57.35 -25.74 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 CA-C-N 115.897 -0.592 . . . . 1.6599999999999999 111.62 -178.451 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.1 m -41.89 -34.09 0.62 Allowed 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 126.157 1.783 . . . . 1.95 112.388 172.144 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 37.2 m -121.37 -42.43 2.46 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.454 0.702 . . . . 0.25 111.592 172.939 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 87.0 m-70 -72.93 -8.01 53.67 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.031 0.932 . . . . 0.34999999999999998 113.161 -175.483 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 85.05 150.03 11.99 Favored Glycine 0 C--N 1.337 0.601 0 N-CA-C 110.028 -1.229 . . . . 1.5800000000000001 110.028 178.699 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -43.83 -35.92 3.43 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 124.857 1.217 . . . . 1.1499999999999999 112.558 178.227 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -93.12 -9.0 41.05 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.307 1.443 . . . . 2.0699999999999998 112.41 -173.08 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.3 mt 71.41 9.49 6.49 Favored 'General case' 0 C--N 1.347 0.465 0 CA-C-N 120.254 1.388 . . . . 2.3100000000000001 111.268 179.909 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.6 p -81.95 -2.47 51.53 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 127.764 2.425 . . . . 1.8300000000000001 110.207 -177.205 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.54 150.31 25.18 Favored Glycine 0 N--CA 1.438 -1.169 0 N-CA-C 108.472 -1.851 . . . . 0.5 108.472 -174.597 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -156.77 -79.94 0.08 Allowed 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 124.477 1.111 . . . . 1.3500000000000001 108.712 179.278 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.3 t -92.06 2.71 56.4 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.146 0.978 . . . . 2.1099999999999999 110.379 172.963 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -158.62 163.89 22.86 Favored Pre-proline 0 N--CA 1.45 -0.47 0 C-N-CA 125.704 1.602 . . . . 1.5900000000000001 107.494 -168.227 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -69.01 162.47 41.57 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 123.63 2.887 . . . . 0.41999999999999998 111.265 -174.207 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -74.76 122.49 23.37 Favored 'General case' 0 N--CA 1.455 -0.21 0 O-C-N 121.849 -0.532 . . . . 1.6200000000000001 110.654 -176.072 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 33.8 pt -105.41 1.81 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.117 0 C-N-CA 123.717 0.807 . . . . 1.6000000000000001 111.4 178.096 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -44.95 -45.45 10.48 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 112.982 0.734 . . . . 2.6200000000000001 112.982 176.379 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.04 27.76 5.82 Favored 'General case' 0 C--N 1.343 0.303 0 C-N-CA 123.945 0.898 . . . . 4.8399999999999999 111.582 178.63 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -56.17 -46.04 79.47 Favored 'General case' 0 N--CA 1.452 -0.352 0 O-C-N 121.62 -0.675 . . . . 1.47 109.502 177.07 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -53.47 -30.91 42.74 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 123.448 0.547 . . . . 0.48999999999999999 113.313 -179.126 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -76.94 -42.32 39.77 Favored 'General case' 0 N--CA 1.455 -0.206 0 O-C-N 122.031 -0.687 . . . . 1.73 110.613 176.529 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 48.7 m-20 -66.05 -49.29 68.17 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 122.129 0.172 . . . . 1.8200000000000001 111.034 -179.926 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -139.14 141.67 38.04 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 125.568 1.547 . . . . 1.8500000000000001 107.837 -167.448 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 22.4 m -78.18 168.98 19.02 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 118.45 0.568 . . . . 2.48 110.363 179.65 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -50.82 -44.23 59.18 Favored 'General case' 0 C--O 1.224 -0.258 0 C-N-CA 123.346 0.658 . . . . 3.0499999999999998 111.973 -179.593 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -54.92 -39.26 68.63 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 118.492 0.587 . . . . 2.8999999999999999 111.67 176.98 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -78.67 -45.67 20.86 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 121.495 0.664 . . . . 3.4900000000000002 109.47 -177.262 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 62.4 mt -59.11 -44.5 91.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 O-C-N 121.653 -0.654 . . . . 1.51 109.289 179.189 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 35.4 tp -55.33 -50.1 70.51 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 123.854 0.861 . . . . 1.51 109.453 176.174 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -50.98 -52.68 40.27 Favored 'General case' 0 N--CA 1.454 -0.235 0 O-C-N 123.312 0.382 . . . . 1.51 110.264 176.138 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 86.3 mt -56.8 -51.11 71.46 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.328 0 O-C-N 121.64 -0.663 . . . . 1.49 110.287 177.977 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 71.0 mt -52.65 -44.78 47.16 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 O-C-N 120.47 -1.394 . . . . 1.6399999999999999 110.486 179.247 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 79.4 mt -73.06 -32.57 65.13 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 113.164 0.801 . . . . 1.74 113.164 -179.087 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -121.96 20.6 10.76 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 119.591 1.087 . . . . 1.6399999999999999 110.161 -165.539 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 28.75 -139.43 0.02 OUTLIER Glycine 0 CA--C 1.534 1.268 0 C-N-CA 129.127 3.251 . . . . 0.68000000000000005 111.524 -165.401 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 174.58 133.95 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 118.994 1.397 . . . . 1.4299999999999999 107.935 -178.394 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 31.43 -110.04 0.04 OUTLIER Glycine 0 CA--C 1.535 1.282 0 C-N-CA 124.971 1.272 . . . . 0.44 114.246 -172.515 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -69.61 -24.11 76.37 Favored Glycine 0 CA--C 1.533 1.206 0 CA-C-N 118.114 0.957 . . . . 0.5 113.166 -178.328 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 18.1 ttt -70.99 120.03 76.96 Favored Pre-proline 0 N--CA 1.452 -0.371 0 C-N-CA 125.004 1.321 . . . . 1.46 111.039 -178.605 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -75.62 122.33 6.85 Favored 'Trans proline' 0 N--CA 1.446 -1.304 0 C-N-CA 123.297 2.665 . . . . 2.0499999999999998 111.135 178.933 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -61.06 137.39 48.16 Favored Glycine 0 N--CA 1.442 -0.934 0 CA-C-N 115.271 -0.877 . . . . 1.6799999999999999 114.833 -179.272 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 82.16 42.71 8.53 Favored Glycine 0 CA--C 1.524 0.632 0 CA-C-N 114.225 -0.988 . . . . 0.54000000000000004 110.636 175.829 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -63.66 -57.42 11.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 C-N-CA 124.379 1.072 . . . . 2.1899999999999999 109.283 174.172 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -98.12 155.94 16.9 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.952 1.301 . . . . 1.53 109.383 166.08 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -146.0 151.37 37.67 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 124.322 1.049 . . . . 3.4900000000000002 110.959 178.424 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 72.51 -163.62 54.69 Favored Glycine 0 CA--C 1.53 1.016 0 N-CA-C 110.747 -0.941 . . . . 1.05 110.747 -174.437 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -52.02 -24.13 6.2 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.737 1.215 . . . . 2.1200000000000001 112.718 -179.061 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 47.9 tt0 -43.99 -63.16 0.92 Allowed 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.736 1.215 . . . . 2.6099999999999999 110.283 167.903 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.45 -45.09 94.93 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.189 0.596 . . . . 1.3999999999999999 110.271 -176.275 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -53.81 -54.07 43.58 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.742 0.817 . . . . 1.99 110.979 178.001 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -56.41 -49.51 74.3 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 123.811 0.844 . . . . 1.73 109.764 -179.824 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 69.2 t -54.99 -52.77 40.58 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-N 116.939 -0.119 . . . . 1.5900000000000001 111.26 176.802 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -54.63 -52.02 63.57 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.38 0.672 . . . . 1.3200000000000001 111.919 -179.881 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.99 -48.06 79.33 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 121.553 0.692 . . . . 1.26 110.555 177.226 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 54.6 t90 -57.08 -44.97 83.64 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 121.71 -0.619 . . . . 0.54000000000000004 110.548 177.778 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.89 -37.38 87.17 Favored 'General case' 0 N--CA 1.461 0.088 0 C-N-CA 124.749 1.22 . . . . 2.7799999999999998 111.599 177.203 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -54.69 -38.44 67.01 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 119.216 0.916 . . . . 1.6599999999999999 110.432 169.552 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -88.76 26.2 1.58 Allowed 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 113.473 0.916 . . . . 3.3100000000000001 113.473 171.795 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 2.1 mtpm? -122.05 117.88 27.41 Favored 'General case' 0 C--N 1.341 0.239 0 O-C-N 120.647 -1.283 . . . . 3.1400000000000001 110.218 165.854 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.256 1.405 0 C-N-CA 129.535 3.134 . . . . 3.6600000000000001 104.738 174.483 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 93' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.462 ' HB3' ' HB3' ' A' ' 26' ' ' ALA . 0.1 OUTLIER . . . . . 0 N--CA 1.454 -0.247 0 N-CA-C 104.12 -2.548 . . . . 2.3100000000000001 104.12 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.27 -52.49 33.22 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-O 122.428 1.109 . . . . 0.47999999999999998 109.265 -166.366 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.434 ' HB3' ' CZ2' ' A' ' 87' ' ' TRP . 5.5 pt-20 -55.69 -48.06 75.72 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 114.15 -1.387 . . . . 2.73 111.839 175.751 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.462 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . . . -56.86 -46.06 82.05 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 119.617 1.099 . . . . 0.37 111.013 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.576 HG21 ' HG3' ' A' ' 80' ' ' GLU . 68.7 t -55.86 -56.76 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.225 0 N-CA-C 108.901 -0.777 . . . . 0.47999999999999998 108.901 176.543 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.589 HG22 ' SG ' ' A' ' 32' ' ' CYS . 29.9 t -51.93 -49.14 38.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 O-C-N 122.343 -0.223 . . . . 0.28999999999999998 111.274 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.414 ' HA ' HG12 ' A' ' 33' ' ' ILE . 18.1 mm-40 -57.34 -8.03 0.69 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 127.895 2.478 . . . . 1.22 113.671 176.513 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 19.6 tp60 -137.44 17.57 2.93 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 119.772 1.169 . . . . 2.9399999999999999 111.522 172.533 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 50.3 mmtt -138.97 -59.44 0.6 Allowed 'General case' 0 CA--C 1.514 -0.434 0 O-C-N 121.111 -0.993 . . . . 2.54 110.435 -177.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.589 ' SG ' HG22 ' A' ' 28' ' ' VAL . 2.8 m -79.45 -47.68 15.24 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 108.698 -0.852 . . . . 0.34000000000000002 108.698 -173.331 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.414 HG12 ' HA ' ' A' ' 29' ' ' GLN . 2.5 pp -52.85 -30.2 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 CA-C-N 115.384 -0.826 . . . . 0.39000000000000001 111.95 -179.265 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.8 m -46.01 -30.81 1.97 Allowed 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.132 1.373 . . . . 1.23 112.738 176.202 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 30.1 m -121.93 -44.55 2.3 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.784 0.834 . . . . 0.17000000000000001 111.386 173.144 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 87.1 m-70 -68.61 -10.13 54.07 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.724 1.21 . . . . 0.26000000000000001 112.558 -177.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 87.99 148.31 15.19 Favored Glycine 0 C--N 1.339 0.702 0 C-N-CA 125.468 1.509 . . . . 1.48 109.64 179.148 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -41.83 -36.98 1.92 Allowed Glycine 0 C--N 1.341 0.84 0 C-N-CA 124.653 1.121 . . . . 0.46999999999999997 112.214 173.237 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -89.94 -12.4 38.93 Favored 'General case' 0 N--CA 1.444 -0.76 0 C-N-CA 125.876 1.67 . . . . 3.0800000000000001 111.429 -172.2 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.0 mt 71.24 11.61 6.79 Favored 'General case' 0 C--N 1.349 0.56 0 CA-C-N 119.983 1.265 . . . . 1.1499999999999999 111.249 178.522 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.6 p -87.2 0.09 55.88 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 127.696 2.398 . . . . 0.5 110.018 -175.062 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.7 126.22 2.32 Favored Glycine 0 N--CA 1.441 -0.977 0 N-CA-C 109.052 -1.619 . . . . 0.81000000000000005 109.052 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -131.27 -77.93 0.52 Allowed 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 124.311 1.044 . . . . 0.29999999999999999 108.405 178.82 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 12.6 m -92.59 4.29 53.9 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.393 1.077 . . . . 1.3500000000000001 110.984 173.19 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.468 ' HB1' ' HD2' ' A' ' 46' ' ' PRO . . . -157.82 166.63 16.16 Favored Pre-proline 0 CA--C 1.537 0.453 0 C-N-CA 125.013 1.325 . . . . 0.23000000000000001 108.353 -168.637 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.468 ' HD2' ' HB1' ' A' ' 45' ' ' ALA . 69.7 Cg_endo -73.88 153.91 48.01 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 123.136 2.557 . . . . 0.39000000000000001 110.552 -173.63 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -72.04 125.71 27.94 Favored 'General case' 0 C--N 1.332 -0.171 0 O-C-N 121.107 -0.996 . . . . 0.28000000000000003 110.725 -174.194 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 18.1 pt -104.43 1.63 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.143 0 C-N-CA 123.351 0.66 . . . . 0.48999999999999999 111.697 176.031 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -36.79 -44.9 0.51 Allowed 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.416 1.086 . . . . 2.3799999999999999 112.986 170.317 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 8.4 pttp -113.2 31.89 6.13 Favored 'General case' 0 C--N 1.344 0.332 0 C-N-CA 123.94 0.896 . . . . 4.2599999999999998 111.876 178.263 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.92 -44.32 96.41 Favored 'General case' 0 N--CA 1.454 -0.242 0 O-C-N 120.836 -1.165 . . . . 0.31 109.297 178.404 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -54.2 -26.65 36.62 Favored Glycine 0 C--N 1.339 0.746 0 CA-C-N 118.238 0.472 . . . . 0.58999999999999997 113.915 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -83.59 -45.07 13.92 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 117.29 0.545 . . . . 0.77000000000000002 110.031 175.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 35.3 m-80 -58.27 -51.77 68.37 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 122.728 0.411 . . . . 1.6200000000000001 111.333 178.813 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -134.12 149.99 51.11 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.456 1.503 . . . . 0.87 108.485 -166.675 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.66 164.37 25.37 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 109.856 -0.424 . . . . 1.55 109.856 -179.64 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -49.39 -42.77 43.27 Favored 'General case' 0 C--O 1.223 -0.331 0 C-N-CA 123.301 0.64 . . . . 3.27 110.779 173.645 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 70.9 mt-10 -52.98 -44.86 67.5 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.207 0.603 . . . . 2.9199999999999999 110.776 178.106 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 58.2 mm-40 -75.06 -47.96 26.28 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.172 0.589 . . . . 3.0499999999999998 110.037 -177.844 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 76.4 mt -62.77 -46.34 96.6 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.111 0 N-CA-C 108.941 -0.763 . . . . 0.31 108.941 -175.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 32.4 tp -53.48 -51.72 61.83 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 124.061 0.944 . . . . 0.56000000000000005 109.281 176.333 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -53.09 -51.56 61.44 Favored 'General case' 0 N--CA 1.452 -0.368 0 O-C-N 123.374 0.421 . . . . 1.95 110.504 176.167 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 40.9 mt -56.02 -45.15 80.26 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.378 0 O-C-N 121.451 -0.781 . . . . 0.45000000000000001 111.184 177.726 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 43.3 mt -61.98 -45.41 98.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 O-C-N 119.951 -1.718 . . . . 0.34000000000000002 109.482 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 87.5 mt -69.81 -29.04 66.23 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.118 0.967 . . . . 0.56999999999999995 113.364 -178.524 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -128.87 19.54 6.05 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 119.683 1.128 . . . . 1.8 110.338 -166.651 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.525 ' N ' ' HA2' ' A' ' 73' ' ' GLY . . . 34.87 -146.52 0.04 OUTLIER Glycine 0 CA--C 1.538 1.516 0 C-N-CA 128.975 3.179 . . . . 0.64000000000000001 112.397 -170.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 177.37 135.64 0.07 Allowed 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.173 1.389 . . . . 1.23 108.075 -176.762 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 32.0 -110.67 0.04 OUTLIER Glycine 0 CA--C 1.533 1.171 0 C-N-CA 125.038 1.304 . . . . 0.38 114.095 -174.023 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -71.03 -24.65 76.91 Favored Glycine 0 CA--C 1.534 1.243 0 CA-C-N 118.116 0.958 . . . . 0.53000000000000003 113.053 -178.665 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 17.6 ttt -69.36 118.35 61.33 Favored Pre-proline 0 CA--C 1.535 0.388 0 C-N-CA 125.06 1.344 . . . . 0.40000000000000002 111.3 -179.003 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -75.67 127.86 10.54 Favored 'Trans proline' 0 N--CA 1.446 -1.279 0 C-N-CA 122.877 2.385 . . . . 2.1099999999999999 110.671 177.625 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.525 ' HA2' ' N ' ' A' ' 67' ' ' GLY . . . -66.48 140.35 38.86 Favored Glycine 0 N--CA 1.442 -0.909 0 N-CA-C 115.158 0.823 . . . . 0.69999999999999996 115.158 -177.064 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 79.53 39.17 18.93 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 110.6 -1.0 . . . . 0.32000000000000001 110.6 176.296 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -60.19 -48.95 86.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 124.645 1.178 . . . . 1.0900000000000001 108.863 175.07 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -102.72 149.3 24.59 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 126.031 1.732 . . . . 0.32000000000000001 108.87 162.766 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 65.6 mttt -141.42 160.04 40.97 Favored 'General case' 0 C--N 1.339 0.119 0 C-N-CA 124.097 0.959 . . . . 2.7400000000000002 110.036 172.635 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 74.84 -165.16 54.73 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 109.999 -1.241 . . . . 0.96999999999999997 109.999 -174.184 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -54.32 -24.47 19.38 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.451 0.701 . . . . 0.93999999999999995 111.691 -178.076 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.576 ' HG3' HG21 ' A' ' 27' ' ' VAL . 30.8 tt0 -41.92 -60.14 1.49 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.198 1.399 . . . . 2.3100000000000001 110.511 169.771 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.6 -45.66 93.16 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 122.537 0.335 . . . . 0.33000000000000002 110.293 -174.395 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -51.73 -60.69 2.88 Favored 'General case' 0 C--N 1.339 0.111 0 C-N-CA 124.08 0.952 . . . . 2.73 110.739 174.764 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -52.77 -48.9 66.49 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-O 119.242 -0.408 . . . . 0.28000000000000003 110.743 -179.221 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.461 HG13 ' CG2' ' A' ' 28' ' ' VAL . 78.6 t -53.69 -59.75 1.75 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 CA-C-N 117.787 0.267 . . . . 0.40000000000000002 110.865 176.674 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -50.33 -51.47 45.28 Favored 'General case' 0 C--O 1.226 -0.138 0 C-N-CA 123.669 0.788 . . . . 0.22 112.159 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.2 -45.43 80.81 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.4 0.68 . . . . 0.38 110.683 -175.526 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.465 ' CZ3' HG21 ' A' ' 28' ' ' VAL . 77.3 t90 -55.23 -47.82 74.83 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 109.041 -0.726 . . . . 0.70999999999999996 109.041 173.631 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.03 -37.79 80.83 Favored 'General case' 0 C--O 1.22 -0.474 0 CA-C-O 117.977 -1.011 . . . . 2.0 112.911 173.04 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -52.95 -40.89 64.02 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 120.381 1.446 . . . . 0.38 110.735 175.364 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -67.54 -38.08 83.66 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-O 118.944 -0.55 . . . . 3.7400000000000002 112.329 170.586 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 24.2 mtpp -76.37 108.86 9.62 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 119.906 1.23 . . . . 2.79 111.092 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 88.9 mttt . . . . . 0 C--O 1.25 1.126 0 C-N-CA 126.013 1.725 . . . . 2.1400000000000001 107.599 -176.356 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.447 -0.589 0 N-CA-C 108.137 -1.06 . . . . 2.2000000000000002 108.137 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -48.0 -54.14 13.91 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.834 0.854 . . . . 0.27000000000000002 110.786 -179.215 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -53.34 -46.55 69.53 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 122.73 0.412 . . . . 3.29 111.621 176.7 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.3 -44.47 97.16 Favored 'General case' 0 CA--C 1.527 0.062 0 C-N-CA 122.877 0.471 . . . . 0.29999999999999999 110.569 -179.177 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 77.7 t -57.94 -55.4 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 N-CA-C 109.232 -0.655 . . . . 0.44 109.232 175.304 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.423 ' HA ' ' SG ' ' A' ' 32' ' ' CYS . 79.0 t -50.99 -47.92 29.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 110.379 -0.23 . . . . 0.40999999999999998 110.379 -179.288 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 28.6 mm-40 -54.22 -23.33 14.29 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 126.455 1.902 . . . . 0.64000000000000001 114.72 174.623 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -142.6 59.23 1.44 Allowed 'General case' 0 N--CA 1.461 0.088 0 CA-C-N 120.54 1.518 . . . . 2.4199999999999999 112.106 173.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.08 -36.39 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 124.435 1.094 . . . . 1.2 109.611 171.177 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.423 ' SG ' ' HA ' ' A' ' 28' ' ' VAL . 3.7 m -101.9 -50.4 3.69 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 118.813 0.733 . . . . 0.20000000000000001 110.931 -177.623 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.536 HG22 HD23 ' A' ' 40' ' ' LEU . 2.0 pp -56.77 -25.77 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 N-CA-C 112.556 0.576 . . . . 0.5 112.556 -174.678 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.451 ' N ' HD12 ' A' ' 33' ' ' ILE . 8.3 m -41.8 -34.89 0.7 Allowed 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.576 1.55 . . . . 1.01 112.475 172.146 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 18.9 m -121.1 -42.97 2.46 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.369 0.668 . . . . 0.19 111.385 175.029 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 84.8 m-70 -71.34 -7.65 48.52 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.422 0.689 . . . . 0.17000000000000001 112.741 -176.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 88.49 149.29 18.67 Favored Glycine 0 C--N 1.338 0.669 0 N-CA-C 109.776 -1.329 . . . . 1.4399999999999999 109.776 178.064 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -43.17 -36.45 2.84 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 124.615 1.102 . . . . 0.52000000000000002 112.233 174.74 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -97.58 -4.39 37.79 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 124.88 1.272 . . . . 2.8999999999999999 111.793 -172.341 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.536 HD23 HG22 ' A' ' 33' ' ' ILE . 1.5 mt 71.43 12.83 6.58 Favored 'General case' 0 C--N 1.348 0.531 0 CA-C-N 120.238 1.381 . . . . 1.4199999999999999 111.071 176.006 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.3 p -88.71 1.23 55.5 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 127.866 2.466 . . . . 0.31 110.038 -173.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.51 138.0 5.57 Favored Glycine 0 N--CA 1.444 -0.808 0 N-CA-C 109.049 -1.62 . . . . 0.41999999999999998 109.049 -177.048 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -143.79 -71.56 0.29 Allowed 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.469 -0.567 . . . . 0.34999999999999998 109.469 178.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -99.02 3.92 47.01 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.939 1.696 . . . . 0.97999999999999998 110.315 172.393 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.428 ' HB1' ' HD2' ' A' ' 46' ' ' PRO . . . -158.28 165.43 18.6 Favored Pre-proline 0 CA--C 1.535 0.394 0 C-N-CA 124.907 1.283 . . . . 0.23999999999999999 107.852 -168.868 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.428 ' HD2' ' HB1' ' A' ' 45' ' ' ALA . 46.3 Cg_endo -69.5 157.73 59.84 Favored 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 122.621 2.214 . . . . 0.20000000000000001 110.53 -175.162 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.64 121.49 20.79 Favored 'General case' 0 N--CA 1.454 -0.246 0 O-C-N 121.724 -0.61 . . . . 0.23999999999999999 109.934 -178.089 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 41.7 pt -100.99 1.88 10.56 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.161 0 C-N-CA 123.536 0.735 . . . . 0.26000000000000001 111.039 178.295 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.434 ' OD1' ' NZ ' ' A' ' 91' ' ' LYS . 34.2 t70 -44.01 -41.23 5.28 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 113.506 0.928 . . . . 3.1800000000000002 113.506 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 35.0 mttm -109.3 33.19 4.44 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 125.838 1.655 . . . . 6.1200000000000001 111.403 179.237 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -58.26 -46.02 86.76 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 108.975 -0.75 . . . . 0.34000000000000002 108.975 173.513 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -54.07 -28.55 41.62 Favored Glycine 0 CA--C 1.527 0.785 0 CA-C-N 118.243 0.474 . . . . 0.51000000000000001 114.158 -179.316 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -78.62 -42.6 28.46 Favored 'General case' 0 N--CA 1.455 -0.223 0 O-C-N 122.227 -0.573 . . . . 0.71999999999999997 110.049 175.368 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 15.8 m-80 -65.63 -48.53 71.91 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 122.784 0.434 . . . . 1.5700000000000001 111.197 -178.492 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -138.79 147.74 42.93 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 125.423 1.489 . . . . 0.60999999999999999 108.327 -170.639 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 89.6 p -74.62 168.28 20.11 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.033 0.533 . . . . 2.3500000000000001 110.973 177.797 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -46.66 -47.21 20.3 Favored 'General case' 0 C--O 1.224 -0.278 0 C-N-CA 124.311 1.044 . . . . 2.7599999999999998 111.582 174.564 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -57.7 -41.54 81.91 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.422 0.689 . . . . 4.0300000000000002 110.531 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -76.23 -45.79 31.26 Favored 'General case' 0 N--CA 1.45 -0.428 0 O-C-N 121.437 -0.789 . . . . 3.4399999999999999 109.391 -175.52 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 80.9 mt -60.76 -44.43 97.37 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.125 0 N-CA-C 109.027 -0.731 . . . . 0.29999999999999999 109.027 178.493 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 33.5 tp -54.66 -49.02 71.58 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 109.277 -0.638 . . . . 0.32000000000000001 109.277 176.722 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -54.1 -46.19 72.04 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 117.891 0.314 . . . . 1.48 111.498 175.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 73.9 mt -59.63 -49.79 82.4 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.261 0 O-C-N 121.115 -0.991 . . . . 0.54000000000000004 110.453 176.302 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 58.8 mt -56.18 -44.64 79.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 O-C-N 120.386 -1.446 . . . . 0.22 110.002 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 69.5 mt -71.04 -28.64 64.52 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 124.309 1.043 . . . . 0.35999999999999999 113.802 -178.513 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 51.3 m-80 -125.02 15.54 8.51 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 120.374 1.443 . . . . 1.73 110.629 -169.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.554 ' N ' ' HA2' ' A' ' 73' ' ' GLY . . . 35.84 -144.14 0.09 OUTLIER Glycine 0 CA--C 1.537 1.428 0 C-N-CA 128.082 2.753 . . . . 0.62 111.597 -166.689 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 173.83 133.56 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 119.465 1.632 . . . . 1.22 110.021 -177.391 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 40.26 -119.36 1.26 Allowed Glycine 0 CA--C 1.532 1.126 0 CA-C-N 119.574 1.079 . . . . 0.38 112.789 -173.578 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -66.14 -21.76 70.22 Favored Glycine 0 CA--C 1.534 1.233 0 CA-C-N 117.498 0.649 . . . . 0.47999999999999998 113.245 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 18.2 ttt -74.04 121.07 84.33 Favored Pre-proline 0 CA--C 1.536 0.41 0 C-N-CA 124.406 1.082 . . . . 0.34999999999999998 111.539 -176.586 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.455 ' HD2' HD11 ' A' ' 75' ' ' ILE . 53.3 Cg_endo -79.02 122.71 5.41 Favored 'Trans proline' 0 N--CA 1.449 -1.097 0 C-N-CA 123.262 2.641 . . . . 2.1099999999999999 111.688 -178.423 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.554 ' HA2' ' N ' ' A' ' 67' ' ' GLY . . . -60.65 138.76 48.21 Favored Glycine 0 N--CA 1.443 -0.89 0 N-CA-C 115.5 0.96 . . . . 0.60999999999999999 115.5 -177.212 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 81.94 35.63 21.03 Favored Glycine 0 CA--C 1.527 0.783 0 CA-C-N 114.379 -0.911 . . . . 0.33000000000000002 111.612 174.672 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.455 HD11 ' HD2' ' A' ' 72' ' ' PRO . 1.2 mt -58.23 -52.16 62.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 124.924 1.29 . . . . 1.22 110.059 175.246 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -111.02 161.68 15.63 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.748 1.619 . . . . 0.26000000000000001 109.036 165.651 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 18.0 mttm -144.32 164.3 31.18 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 124.931 1.292 . . . . 2.9399999999999999 110.412 176.827 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 57.2 -144.5 39.51 Favored Glycine 0 CA--C 1.529 0.908 0 N-CA-C 111.185 -0.766 . . . . 0.70999999999999996 111.185 179.083 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -52.23 -33.98 43.84 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.203 0.601 . . . . 0.80000000000000004 111.526 174.255 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -55.02 -36.64 65.69 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.443 0.697 . . . . 2.2799999999999998 110.515 176.28 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -88.05 -52.69 5.12 Favored 'General case' 0 CA--C 1.534 0.336 0 O-C-N 121.662 -0.649 . . . . 0.20999999999999999 111.086 175.578 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -54.73 -50.9 67.24 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.789 0.836 . . . . 2.48 111.568 -175.779 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.61 -45.37 92.14 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 109.644 -0.502 . . . . 0.23999999999999999 109.644 -178.229 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 64.9 t -57.19 -55.12 22.43 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 C-N-CA 122.831 0.452 . . . . 0.28999999999999998 110.363 176.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -50.28 -53.83 25.69 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 122.973 0.509 . . . . 0.20000000000000001 111.497 177.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.33 -44.78 95.69 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 121.542 0.686 . . . . 0.33000000000000002 111.278 -178.083 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 81.0 t90 -60.82 -50.08 74.91 Favored 'General case' 0 N--CA 1.452 -0.356 0 O-C-N 121.471 -0.768 . . . . 0.63 110.221 179.291 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.6 -30.64 70.82 Favored 'General case' 0 C--O 1.222 -0.367 0 O-C-N 121.3 -0.875 . . . . 1.97 111.927 172.755 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -58.92 -31.48 68.69 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 119.603 1.092 . . . . 0.53000000000000003 111.21 171.348 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -76.02 -35.68 59.43 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 118.927 0.785 . . . . 3.4900000000000002 111.784 169.322 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.517 ' HB3' ' HZ2' ' A' ' 91' ' ' LYS . 0.7 OUTLIER -73.34 110.18 7.44 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 119.522 1.055 . . . . 2.7599999999999998 111.068 -179.64 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 19.7 mttt . . . . . 0 C--O 1.251 1.163 0 C-N-CA 125.507 1.523 . . . . 2.8399999999999999 109.342 -170.817 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 . . . . . 0 N--CA 1.449 -0.517 0 N-CA-C 108.383 -0.969 . . . . 2.6800000000000002 108.383 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -42.69 -56.09 3.3 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.677 1.191 . . . . 0.29999999999999999 111.088 177.534 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -47.56 -47.04 28.45 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 123.524 0.73 . . . . 3.0699999999999998 111.73 175.586 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.98 -46.06 90.91 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-N 118.682 0.674 . . . . 0.34999999999999998 110.412 -179.196 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 94.5 t -58.51 -52.22 62.1 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.134 0 N-CA-C 109.691 -0.485 . . . . 0.41999999999999998 109.691 177.053 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.406 ' HA ' ' SG ' ' A' ' 32' ' ' CYS . 72.4 t -52.47 -52.22 27.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 N-CA-C 109.756 -0.461 . . . . 0.40000000000000002 109.756 179.033 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 35.3 mm-40 -58.12 -7.2 0.75 Allowed 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 127.547 2.339 . . . . 0.65000000000000002 114.022 174.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -142.82 33.1 1.4 Allowed 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 119.81 1.187 . . . . 3.1000000000000001 113.369 172.605 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -153.92 -55.66 0.11 Allowed 'General case' 0 CA--C 1.517 -0.314 0 O-C-N 121.766 -0.584 . . . . 1.5700000000000001 109.885 170.183 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.406 ' SG ' ' HA ' ' A' ' 28' ' ' VAL . 3.2 m -76.34 -48.29 20.5 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 109.824 -0.436 . . . . 0.20000000000000001 109.824 -170.756 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.1 pt -49.93 -30.99 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-N 115.217 -0.901 . . . . 0.79000000000000004 112.517 -179.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.9 m -46.06 -33.02 3.17 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 125.64 1.576 . . . . 1.02 112.077 177.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 14.6 m -121.95 -44.84 2.28 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.706 0.802 . . . . 0.17999999999999999 111.228 175.72 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 82.0 m-70 -67.43 -11.11 57.0 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.189 0.996 . . . . 0.29999999999999999 112.319 -178.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 87.82 148.04 14.25 Favored Glycine 0 C--N 1.339 0.712 0 N-CA-C 109.396 -1.481 . . . . 1.4299999999999999 109.396 178.501 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -43.83 -31.92 2.04 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 124.655 1.121 . . . . 0.58999999999999997 112.969 173.514 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -92.62 -12.44 31.63 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.596 1.559 . . . . 2.1499999999999999 112.831 -175.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 73.0 9.71 5.37 Favored 'General case' 0 C--N 1.347 0.489 0 CA-C-N 120.326 1.421 . . . . 1.6000000000000001 111.168 178.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.0 p -86.0 -1.66 57.55 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 127.947 2.499 . . . . 0.29999999999999999 110.222 -174.799 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.64 132.25 4.64 Favored Glycine 0 N--CA 1.443 -0.86 0 N-CA-C 108.726 -1.75 . . . . 0.52000000000000002 108.726 -179.219 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -137.45 -75.83 0.4 Allowed 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 108.869 -0.789 . . . . 0.25 108.869 179.363 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 15.7 m -95.47 4.3 53.4 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.658 1.183 . . . . 1.3100000000000001 110.628 172.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.528 ' HB1' ' HD2' ' A' ' 46' ' ' PRO . . . -156.6 167.73 13.84 Favored Pre-proline 0 N--CA 1.45 -0.474 0 C-N-CA 124.842 1.257 . . . . 0.25 108.33 -171.651 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.528 ' HD2' ' HB1' ' A' ' 45' ' ' ALA . 36.7 Cg_endo -71.02 156.43 60.04 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 122.951 2.434 . . . . 0.28999999999999998 110.508 -174.638 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.37 126.74 30.84 Favored 'General case' 0 N--CA 1.455 -0.199 0 O-C-N 121.513 -0.742 . . . . 0.28999999999999998 110.083 -177.137 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 36.3 pt -103.2 0.62 10.32 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.191 0 C-N-CA 123.239 0.616 . . . . 0.47999999999999998 111.196 174.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -33.23 -45.73 0.15 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.606 1.562 . . . . 2.29 113.071 168.722 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.62 39.95 3.2 Favored 'General case' 0 C--N 1.343 0.317 0 C-N-CA 124.184 0.993 . . . . 4.0199999999999996 111.475 177.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.63 -42.99 85.88 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 121.324 -0.86 . . . . 0.28999999999999998 109.601 174.578 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -52.4 -32.53 37.89 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-N 118.507 0.594 . . . . 0.66000000000000003 114.387 -175.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -78.22 -49.13 14.33 Favored 'General case' 0 N--CA 1.455 -0.221 0 O-C-N 122.39 -0.477 . . . . 0.93999999999999995 110.172 174.731 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 33.0 m-80 -56.6 -48.84 76.57 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 122.865 0.466 . . . . 1.53 111.533 -177.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -136.47 140.16 42.88 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.751 1.62 . . . . 1.0700000000000001 107.373 -169.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 90.4 p -73.87 169.01 18.29 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 121.641 -0.662 . . . . 2.46 110.716 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -48.17 -52.59 20.1 Favored 'General case' 0 C--N 1.341 0.233 0 O-C-N 121.811 -0.555 . . . . 4.9400000000000004 110.103 174.069 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -53.97 -27.22 29.94 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 118.69 -0.672 . . . . 2.75 112.51 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -87.87 -46.87 9.04 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 119.325 0.966 . . . . 3.2799999999999998 110.248 177.735 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 83.4 mt -62.62 -47.73 91.53 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.145 0 O-C-N 121.31 -0.868 . . . . 0.22 109.153 -177.565 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 25.3 tp -53.38 -50.07 65.87 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 109.036 -0.728 . . . . 0.41999999999999998 109.036 176.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -49.43 -55.83 11.75 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 122.701 0.4 . . . . 2.77 110.054 173.88 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 23.2 mt -56.16 -45.45 80.83 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.366 0 C-N-CA 120.329 -0.548 . . . . 0.46999999999999997 110.69 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 56.0 mt -58.46 -40.34 78.14 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 O-C-N 120.099 -1.626 . . . . 0.23000000000000001 109.926 178.464 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 71.9 mt -70.73 -40.61 72.65 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.359 1.064 . . . . 0.54000000000000004 113.439 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 14.8 p30 -124.29 27.16 7.14 Favored 'General case' 0 C--N 1.343 0.312 0 CA-C-N 120.899 1.681 . . . . 3.8999999999999999 110.12 -168.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.538 ' N ' ' HA2' ' A' ' 73' ' ' GLY . . . 34.2 -140.33 0.12 Allowed Glycine 0 CA--C 1.534 1.268 0 C-N-CA 128.344 2.878 . . . . 0.64000000000000001 110.999 -173.23 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 2.3 tp-100 176.87 140.58 0.07 Allowed 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 107.592 -1.262 . . . . 2.5 107.592 -179.598 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 40.97 -112.17 0.33 Allowed Glycine 0 CA--C 1.536 1.344 0 CA-C-N 119.953 1.251 . . . . 0.48999999999999999 113.782 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -79.78 -20.92 67.2 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 123.87 0.748 . . . . 0.53000000000000003 112.866 178.359 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 19.8 ttt -68.01 118.48 58.87 Favored Pre-proline 0 CA--C 1.534 0.338 0 C-N-CA 125.041 1.336 . . . . 0.34999999999999998 110.734 179.18 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.403 ' HD2' HD11 ' A' ' 75' ' ' ILE . 37.4 Cg_endo -76.42 122.05 6.34 Favored 'Trans proline' 0 N--CA 1.446 -1.293 0 C-N-CA 122.698 2.265 . . . . 2.0800000000000001 111.166 -179.393 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.538 ' HA2' ' N ' ' A' ' 67' ' ' GLY . . . -59.06 135.79 51.64 Favored Glycine 0 N--CA 1.442 -0.922 0 CA-C-N 115.364 -0.834 . . . . 0.63 114.869 -179.075 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 88.19 35.92 8.57 Favored Glycine 0 CA--C 1.53 0.97 0 CA-C-N 114.466 -0.867 . . . . 0.34999999999999998 112.368 172.114 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.403 HD11 ' HD2' ' A' ' 72' ' ' PRO . 1.3 mt -64.94 -46.88 90.33 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.863 0 C-N-CA 125.76 1.624 . . . . 1.1100000000000001 110.981 178.675 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -116.36 149.33 39.52 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 126.238 1.815 . . . . 0.46999999999999997 107.561 163.319 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.3 mtpp -144.03 162.26 36.68 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 125.973 1.709 . . . . 2.3100000000000001 108.293 178.398 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 63.68 -161.4 35.79 Favored Glycine 0 CA--C 1.529 0.966 0 N-CA-C 110.933 -0.867 . . . . 0.58999999999999997 110.933 -174.775 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -51.6 -27.71 12.0 Favored 'General case' 0 C--O 1.225 -0.224 0 C-N-CA 123.949 0.9 . . . . 0.56000000000000005 112.226 -177.818 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.498 ' O ' HG23 ' A' ' 84' ' ' VAL . 8.5 tt0 -44.63 -60.68 1.88 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.931 1.293 . . . . 2.0800000000000001 109.766 168.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -69.47 -46.19 67.24 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.838 0.855 . . . . 0.28000000000000003 110.821 -178.211 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -56.27 -49.58 73.83 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 121.231 0.539 . . . . 1.97 110.157 -176.76 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -55.52 -53.5 55.63 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 123.467 0.707 . . . . 0.29999999999999999 109.678 176.276 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 80' ' ' GLU . 89.1 t -51.37 -56.24 5.84 Favored 'Isoleucine or valine' 0 C--N 1.339 0.138 0 CA-C-N 117.826 0.284 . . . . 0.34999999999999998 110.738 178.665 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -50.66 -54.85 19.7 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 123.833 0.853 . . . . 0.20000000000000001 111.763 179.145 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -63.04 -45.11 93.84 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 121.338 0.589 . . . . 0.33000000000000002 110.995 -177.118 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 84.7 t90 -57.69 -52.74 64.2 Favored 'General case' 0 C--N 1.329 -0.286 0 O-C-N 121.701 -0.624 . . . . 0.63 109.485 177.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.77 -30.96 71.14 Favored 'General case' 0 C--O 1.222 -0.366 0 CA-C-O 118.028 -0.987 . . . . 1.97 112.714 174.853 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -55.88 -35.67 66.77 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 119.963 1.256 . . . . 0.40999999999999998 109.985 172.033 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -74.18 -37.51 63.92 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.002 0.521 . . . . 2.8199999999999998 111.392 173.681 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 3.5 mtpt -73.82 126.6 30.75 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 119.342 0.974 . . . . 2.1800000000000002 110.988 -178.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 19.6 mtmt . . . . . 0 C--O 1.253 1.244 0 CA-C-O 115.897 -2.001 . . . . 2.21 106.187 -174.751 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 20.5 t0 . . . . . 0 N--CA 1.451 -0.404 0 N-CA-C 106.744 -1.576 . . . . 4.0499999999999998 106.744 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -50.27 -44.97 53.98 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 123.682 0.793 . . . . 0.32000000000000001 111.46 176.724 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -66.26 -46.94 75.34 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 107.94 -1.133 . . . . 2.75 107.94 -174.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.78 -46.64 77.9 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 122.886 0.474 . . . . 0.26000000000000001 111.175 175.711 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 75.4 t -56.58 -57.49 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 N-CA-C 109.264 -0.643 . . . . 0.37 109.264 176.554 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.556 HG13 ' HB2' ' A' ' 32' ' ' CYS . 72.2 t -53.31 -47.8 56.81 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 CA-C-N 118.05 0.386 . . . . 0.31 110.865 -177.291 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -51.38 -23.92 4.26 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 126.326 1.85 . . . . 0.55000000000000004 113.488 174.872 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -138.19 57.44 1.71 Allowed 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 119.354 0.979 . . . . 2.7999999999999998 110.857 172.603 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -172.04 -38.58 0.02 OUTLIER 'General case' 0 C--O 1.225 -0.231 0 C-N-CA 123.736 0.815 . . . . 1.3 110.524 168.567 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.556 ' HB2' HG13 ' A' ' 28' ' ' VAL . 3.7 m -97.5 -50.85 4.35 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 119.042 0.837 . . . . 0.22 110.26 -178.392 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.495 HG22 HD23 ' A' ' 40' ' ' LEU . 1.6 pp -57.92 -26.05 27.44 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.156 0 CA-C-N 116.202 -0.454 . . . . 0.42999999999999999 112.134 -173.587 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.422 ' N ' HD12 ' A' ' 33' ' ' ILE . 5.9 m -38.92 -36.75 0.3 Allowed 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 125.841 1.656 . . . . 1.0900000000000001 112.224 170.451 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 15.0 m -120.27 -44.72 2.47 Favored 'General case' 0 C--N 1.34 0.187 0 C-N-CA 123.356 0.662 . . . . 0.23000000000000001 111.317 174.491 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 85.7 m-70 -70.46 -7.79 46.06 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.899 0.879 . . . . 0.17000000000000001 112.946 -175.369 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 87.92 149.3 17.16 Favored Glycine 0 C--N 1.337 0.622 0 N-CA-C 109.977 -1.249 . . . . 1.48 109.977 176.348 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -45.89 -38.7 8.17 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 124.197 0.903 . . . . 0.46999999999999997 111.981 177.779 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -93.73 -1.13 55.52 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.417 1.087 . . . . 2.3900000000000001 111.563 -174.425 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.495 HD23 HG22 ' A' ' 33' ' ' ILE . 4.5 mt 70.66 12.26 7.27 Favored 'General case' 0 C--N 1.349 0.58 0 CA-C-N 120.39 1.45 . . . . 1.3 110.828 174.875 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.5 p -87.81 0.26 56.02 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 128.185 2.594 . . . . 0.34999999999999998 109.976 -172.499 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.56 136.25 4.42 Favored Glycine 0 N--CA 1.442 -0.916 0 N-CA-C 108.973 -1.651 . . . . 0.41999999999999998 108.973 -177.289 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -143.52 -76.9 0.24 Allowed 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 123.967 0.907 . . . . 0.25 108.78 -179.324 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 24.4 t -95.91 4.97 52.32 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.902 1.281 . . . . 1.6000000000000001 110.397 172.159 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.441 ' HB1' ' HD2' ' A' ' 46' ' ' PRO . . . -157.15 165.49 18.69 Favored Pre-proline 0 N--CA 1.451 -0.376 0 C-N-CA 125.339 1.456 . . . . 0.20999999999999999 107.936 -170.751 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.441 ' HD2' ' HB1' ' A' ' 45' ' ' ALA . 45.5 Cg_endo -70.8 159.02 53.99 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.886 2.391 . . . . 0.23000000000000001 110.71 -174.339 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.7 119.96 18.65 Favored 'General case' 0 C--N 1.332 -0.186 0 O-C-N 121.362 -0.836 . . . . 0.26000000000000001 109.941 -178.379 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 46.5 pt -101.17 2.56 10.63 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.118 0 C-N-CA 124.46 1.104 . . . . 0.28000000000000003 110.51 177.585 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.408 ' OD1' ' NZ ' ' A' ' 91' ' ' LYS . 24.6 t70 -43.51 -43.98 5.75 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 112.316 0.487 . . . . 3.0699999999999998 112.316 178.214 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -109.31 40.87 1.76 Allowed 'General case' 0 C--N 1.344 0.345 0 C-N-CA 126.294 1.838 . . . . 4.04 110.517 179.3 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.21 -48.54 81.3 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 118.968 -0.539 . . . . 0.34999999999999998 109.763 172.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -50.12 -39.28 34.03 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 123.578 0.609 . . . . 0.84999999999999998 113.578 -177.059 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.468 ' HB2' ' HG2' ' A' ' 92' ' ' LYS . . . -63.57 -41.62 98.37 Favored 'General case' 0 CA--C 1.528 0.123 0 O-C-N 122.05 -0.677 . . . . 0.81999999999999995 111.578 174.723 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 18.2 m-80 -72.21 -51.23 22.09 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 122.71 0.404 . . . . 1.7 110.196 -177.005 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -140.41 140.1 35.39 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.052 1.341 . . . . 0.70999999999999996 107.832 -167.73 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.82 170.34 16.64 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 118.699 0.681 . . . . 2.02 109.748 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -50.31 -42.94 53.48 Favored 'General case' 0 C--O 1.224 -0.239 0 O-C-N 121.547 -0.721 . . . . 2.96 111.898 179.208 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -54.51 -40.63 68.76 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 120.981 0.419 . . . . 2.5499999999999998 110.471 179.276 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -81.09 -45.58 16.26 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.241 1.016 . . . . 2.7599999999999998 109.76 -175.212 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 74.9 mt -61.63 -45.94 97.59 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.059 0 O-C-N 121.039 -1.038 . . . . 0.28000000000000003 109.057 179.483 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 31.0 tp -54.2 -46.23 72.38 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 109.212 -0.662 . . . . 0.40000000000000002 109.212 177.569 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -53.02 -53.24 53.01 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 123.148 0.28 . . . . 1.4099999999999999 110.626 173.788 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 59.2 mt -56.24 -43.08 75.55 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 O-C-N 121.385 -0.822 . . . . 0.45000000000000001 111.414 178.095 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 45.4 mt -62.46 -45.29 99.14 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 O-C-N 120.07 -1.644 . . . . 0.28999999999999998 109.677 179.072 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 76.5 mt -72.92 -28.9 62.73 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.425 1.09 . . . . 0.44 113.042 -177.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -127.19 17.44 7.16 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 119.614 1.097 . . . . 1.71 110.331 -166.096 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.56 ' N ' ' HA2' ' A' ' 73' ' ' GLY . . . 36.41 -146.99 0.06 OUTLIER Glycine 0 CA--C 1.539 1.536 0 C-N-CA 128.65 3.024 . . . . 0.66000000000000003 112.216 -170.609 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 176.31 131.38 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 118.809 1.304 . . . . 1.21 108.907 -175.851 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 39.78 -117.13 0.77 Allowed Glycine 0 CA--C 1.532 1.152 0 CA-C-N 119.938 1.245 . . . . 0.37 113.16 -175.745 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -69.6 -20.64 75.81 Favored Glycine 0 CA--C 1.534 1.236 0 CA-C-N 117.481 0.641 . . . . 0.45000000000000001 113.402 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 20.5 ttt -71.94 120.45 80.2 Favored Pre-proline 0 N--CA 1.452 -0.362 0 C-N-CA 124.536 1.134 . . . . 0.38 110.821 -178.443 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -76.54 128.25 10.17 Favored 'Trans proline' 0 N--CA 1.444 -1.43 0 C-N-CA 122.241 1.96 . . . . 2.0699999999999998 110.434 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.56 ' HA2' ' N ' ' A' ' 67' ' ' GLY . . . -63.27 135.65 42.66 Favored Glycine 0 N--CA 1.443 -0.884 0 CA-C-N 115.627 -0.715 . . . . 0.71999999999999997 114.691 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 82.78 41.36 8.88 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.648 -0.981 . . . . 0.44 110.648 176.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -60.34 -51.18 75.96 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 N-CA-C 108.765 -0.828 . . . . 2.02 108.765 174.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -105.74 156.82 17.92 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.746 1.618 . . . . 0.39000000000000001 109.648 166.732 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.3 mmtm -144.86 157.68 44.07 Favored 'General case' 0 C--O 1.227 -0.104 0 C-N-CA 125.166 1.387 . . . . 3.3300000000000001 108.038 178.669 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 67.37 -166.31 42.07 Favored Glycine 0 CA--C 1.531 1.046 0 N-CA-C 111.379 -0.688 . . . . 1.0 111.379 -173.465 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -51.32 -27.55 9.87 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.717 1.207 . . . . 0.56999999999999995 112.27 -179.435 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -37.69 -59.82 0.77 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.678 1.591 . . . . 1.8899999999999999 111.191 165.586 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.76 -49.12 69.52 Favored 'General case' 0 CA--C 1.531 0.215 0 O-C-N 121.937 -0.477 . . . . 0.22 111.128 -177.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -52.47 -54.62 30.01 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.568 1.147 . . . . 2.6000000000000001 111.055 -178.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -54.72 -51.56 65.22 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.145 0.978 . . . . 0.23999999999999999 109.82 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.518 HG22 HG23 ' A' ' 28' ' ' VAL . 54.7 t -54.12 -56.54 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 CA-C-N 116.933 -0.121 . . . . 0.28999999999999998 111.165 177.478 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -51.71 -50.48 60.45 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 123.009 0.523 . . . . 0.20000000000000001 111.831 179.485 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.437 ' O ' ' HB3' ' A' ' 89' ' ' ALA . . . -59.44 -48.71 80.59 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 121.689 0.756 . . . . 0.29999999999999999 110.581 -179.45 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.495 ' HZ3' HG21 ' A' ' 28' ' ' VAL . 54.4 t90 -58.72 -44.26 90.36 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.08 0.552 . . . . 0.53000000000000003 110.492 178.058 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.487 HD23 ' CE3' ' A' ' 87' ' ' TRP . 0.1 OUTLIER -63.11 -38.47 91.29 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.529 1.132 . . . . 1.6799999999999999 110.476 177.26 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.437 ' HB3' ' O ' ' A' ' 86' ' ' ALA . . . -52.34 -49.77 63.63 Favored 'General case' 0 C--O 1.23 0.063 0 N-CA-C 109.468 -0.567 . . . . 0.44 109.468 171.073 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -84.7 35.65 0.57 Allowed 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 116.434 -0.348 . . . . 3.5899999999999999 111.601 175.87 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.408 ' NZ ' ' OD1' ' A' ' 49' ' ' ASP . 0.5 OUTLIER -130.21 142.12 50.59 Favored 'General case' 0 C--N 1.343 0.311 0 O-C-N 121.171 -0.955 . . . . 2.9300000000000002 110.651 165.09 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.468 ' HG2' ' HB2' ' A' ' 53' ' ' ALA . 16.9 mtmt . . . . . 0 C--O 1.252 1.219 0 C-N-CA 128.82 2.848 . . . . 2.71 105.413 -178.381 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 . . . . . 0 N--CA 1.449 -0.511 0 N-CA-C 109.339 -0.615 . . . . 2.79 109.339 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -44.91 -52.26 8.85 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.124 0.969 . . . . 0.31 111.124 174.238 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -53.92 -44.83 70.92 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 116.632 -0.258 . . . . 3.4399999999999999 111.456 177.069 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.89 -44.64 92.41 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 123.232 0.613 . . . . 0.31 110.44 -178.158 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 89.7 t -58.33 -54.66 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 N-CA-C 109.236 -0.653 . . . . 0.40999999999999998 109.236 175.622 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.462 HG21 ' CZ3' ' A' ' 87' ' ' TRP . 53.9 t -52.54 -49.01 46.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 C-N-CA 122.53 0.332 . . . . 0.32000000000000001 110.348 -178.445 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 24.4 mm-40 -52.52 -19.68 2.42 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 126.763 2.025 . . . . 0.63 114.248 174.127 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.43 48.6 1.18 Allowed 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 119.877 1.217 . . . . 3.2000000000000002 111.994 176.249 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.407 ' NZ ' ' OE2' ' A' ' 80' ' ' GLU . 0.5 OUTLIER -162.46 -39.7 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 124.415 1.086 . . . . 1.5 110.314 169.154 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.433 ' SG ' ' HA ' ' A' ' 28' ' ' VAL . 3.4 m -97.21 -49.05 5.11 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 118.845 0.748 . . . . 0.20000000000000001 110.383 -176.017 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.461 HD12 ' N ' ' A' ' 34' ' ' SER . 1.8 pp -58.01 -26.44 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 CA-C-N 115.819 -0.628 . . . . 0.5 112.148 -173.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.461 ' N ' HD12 ' A' ' 33' ' ' ILE . 68.0 m -37.38 -39.19 0.27 Allowed 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 125.234 1.414 . . . . 0.96999999999999997 112.451 168.757 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 9.9 m -120.29 -41.16 2.63 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 122.818 0.447 . . . . 0.20999999999999999 111.92 176.717 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 85.4 m-70 -71.63 -10.02 59.14 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.628 0.771 . . . . 0.23999999999999999 112.6 -177.536 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 86.34 149.5 13.89 Favored Glycine 0 C--N 1.337 0.625 0 N-CA-C 109.783 -1.327 . . . . 1.52 109.783 179.26 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -44.42 -37.83 4.95 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 124.53 1.062 . . . . 0.42999999999999999 112.103 175.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -93.22 -4.54 51.77 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.193 0.997 . . . . 2.3700000000000001 111.788 -173.61 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.4 mt 70.3 10.84 7.39 Favored 'General case' 0 C--N 1.349 0.583 0 CA-C-N 120.513 1.506 . . . . 1.0900000000000001 111.297 176.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.9 p -84.84 -0.66 54.72 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 127.801 2.44 . . . . 0.32000000000000001 109.957 -175.81 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.86 137.66 5.09 Favored Glycine 0 N--CA 1.44 -1.057 0 N-CA-C 108.885 -1.686 . . . . 0.44 108.885 -175.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -143.6 -79.77 0.2 Allowed 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 124.332 1.053 . . . . 0.28999999999999998 108.827 176.692 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -88.6 2.5 52.99 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.377 1.071 . . . . 0.95999999999999996 110.756 171.707 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.583 ' HB1' ' HD2' ' A' ' 46' ' ' PRO . . . -157.14 169.52 10.48 Favored Pre-proline 0 N--CA 1.451 -0.378 0 C-N-CA 124.518 1.127 . . . . 0.23000000000000001 108.629 -172.603 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.583 ' HD2' ' HB1' ' A' ' 45' ' ' ALA . 38.0 Cg_endo -70.08 158.69 55.71 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.973 2.448 . . . . 0.25 110.506 -174.704 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.68 124.41 25.93 Favored 'General case' 0 C--N 1.332 -0.177 0 O-C-N 121.512 -0.743 . . . . 0.31 110.181 -177.198 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 45.1 pt -102.02 0.36 10.29 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.158 0 CA-C-O 118.885 -0.579 . . . . 0.39000000000000001 111.419 175.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.483 ' OD1' ' NZ ' ' A' ' 91' ' ' LYS . 37.9 t70 -44.35 -36.96 3.05 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 113.605 0.965 . . . . 3.2799999999999998 113.605 178.005 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.4 ptpt -108.33 19.01 20.38 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.695 1.598 . . . . 3.7599999999999998 112.015 -178.558 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -55.54 -45.26 77.22 Favored 'General case' 0 N--CA 1.455 -0.198 0 O-C-N 121.228 -0.92 . . . . 0.35999999999999999 110.297 -172.48 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -51.16 -31.66 26.9 Favored Glycine 0 CA--C 1.523 0.582 0 C-N-CA 123.461 0.553 . . . . 0.59999999999999998 114.26 179.567 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.08 -39.59 49.16 Favored 'General case' 0 N--CA 1.454 -0.273 0 O-C-N 122.036 -0.685 . . . . 0.72999999999999998 110.046 176.304 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -66.24 -47.84 72.45 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.559 0.743 . . . . 2.2200000000000002 111.22 -178.842 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -141.34 148.16 39.26 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.743 1.617 . . . . 0.95999999999999996 107.971 -171.068 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 88.7 p -74.66 170.96 14.76 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 119.144 0.883 . . . . 2.4900000000000002 110.692 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -49.13 -42.1 38.29 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 123.118 0.567 . . . . 2.7000000000000002 111.187 173.514 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -62.49 -45.24 93.92 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 123.315 0.646 . . . . 2.77 109.55 -177.271 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -70.96 -47.15 60.59 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 108.362 -0.977 . . . . 2.79 108.362 -175.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 91.2 mt -59.97 -46.21 94.36 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 O-C-N 121.672 -0.643 . . . . 0.28999999999999998 109.403 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 58.4 tp -55.53 -50.1 70.89 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 109.127 -0.694 . . . . 0.44 109.127 176.754 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -52.7 -44.85 66.57 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 117.985 0.357 . . . . 1.95 111.341 178.023 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 79.6 mt -59.5 -56.7 15.44 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.288 0 C-N-CA 120.381 -0.528 . . . . 0.76000000000000001 109.7 174.753 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 69.9 mt -50.0 -41.65 18.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 O-C-N 120.655 -1.278 . . . . 0.23999999999999999 110.87 -178.417 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 73.5 mt -70.98 -34.25 71.22 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.276 1.03 . . . . 0.44 113.619 178.449 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 48.1 m-80 -123.36 20.67 9.64 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 120.499 1.5 . . . . 1.78 110.59 -167.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.565 ' N ' ' HA2' ' A' ' 73' ' ' GLY . . . 29.27 -138.77 0.03 OUTLIER Glycine 0 CA--C 1.535 1.338 0 C-N-CA 128.961 3.172 . . . . 0.62 111.722 -164.031 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 173.98 130.18 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 119.119 1.46 . . . . 1.5700000000000001 109.22 -178.599 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 43.23 -116.36 1.3 Allowed Glycine 0 CA--C 1.531 1.034 0 CA-C-N 119.719 1.145 . . . . 0.41999999999999998 112.883 -177.123 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -70.65 -18.61 75.86 Favored Glycine 0 CA--C 1.531 1.079 0 O-C-N 122.374 -0.486 . . . . 0.47999999999999998 113.16 -179.635 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 22.3 ttt -75.95 118.7 73.06 Favored Pre-proline 0 N--CA 1.45 -0.43 0 C-N-CA 124.52 1.128 . . . . 0.39000000000000001 110.629 -178.234 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -75.65 119.41 5.45 Favored 'Trans proline' 0 N--CA 1.445 -1.369 0 C-N-CA 122.446 2.098 . . . . 2.1000000000000001 111.286 -178.674 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.565 ' HA2' ' N ' ' A' ' 67' ' ' GLY . . . -58.66 138.13 49.59 Favored Glycine 0 N--CA 1.44 -1.083 0 CA-C-N 115.257 -0.883 . . . . 0.60999999999999999 114.594 -179.299 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 76.06 50.13 7.97 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.19 -1.164 . . . . 0.83999999999999997 110.19 177.288 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.7 mt -72.61 -62.33 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 124.901 1.28 . . . . 1.02 108.889 168.716 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -103.45 158.44 16.35 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.919 1.288 . . . . 0.31 109.261 168.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.1 mttt -142.54 171.28 14.27 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 126.175 1.79 . . . . 4.3200000000000003 109.702 177.774 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 54.55 -149.72 18.6 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 111.698 -0.561 . . . . 0.76000000000000001 111.698 175.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -52.13 -32.21 34.54 Favored 'General case' 0 C--N 1.339 0.149 0 C-N-CA 122.983 0.513 . . . . 0.82999999999999996 111.435 172.239 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.407 ' OE2' ' NZ ' ' A' ' 31' ' ' LYS . 6.8 tt0 -53.6 -43.39 68.57 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 110.032 -0.358 . . . . 1.9099999999999999 110.032 176.009 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -84.57 -50.63 7.53 Favored 'General case' 0 CA--C 1.53 0.204 0 O-C-N 121.79 -0.569 . . . . 0.26000000000000001 111.911 176.486 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -53.93 -50.9 65.4 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 118.591 0.632 . . . . 2.4300000000000002 111.549 -177.169 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.63 -46.36 84.25 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 109.361 -0.607 . . . . 0.26000000000000001 109.361 -179.307 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.407 HG22 HG23 ' A' ' 28' ' ' VAL . 53.8 t -57.19 -57.42 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 C-N-CA 122.913 0.485 . . . . 0.34000000000000002 110.955 177.841 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -48.29 -53.13 18.36 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 123.516 0.727 . . . . 0.17000000000000001 111.638 176.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -64.01 -44.31 93.0 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 121.329 0.585 . . . . 0.31 111.548 -178.143 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.462 ' CZ3' HG21 ' A' ' 28' ' ' VAL . 76.9 t90 -58.2 -49.43 77.08 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 121.493 -0.754 . . . . 0.52000000000000002 109.425 177.286 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.6 -29.01 70.31 Favored 'General case' 0 C--O 1.222 -0.381 0 CA-C-O 118.374 -0.822 . . . . 1.8500000000000001 112.977 173.654 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.58 -36.45 71.73 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 119.697 1.135 . . . . 0.35999999999999999 110.299 170.487 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -73.74 -37.33 65.11 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 119.255 -0.402 . . . . 2.8999999999999999 111.51 172.752 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.483 ' NZ ' ' OD1' ' A' ' 49' ' ' ASP . 8.5 mtpm? -72.81 114.18 10.67 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 119.039 0.836 . . . . 2.1800000000000002 111.478 178.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 75.0 mttt . . . . . 0 C--O 1.252 1.197 0 CA-C-O 116.372 -1.775 . . . . 2.5800000000000001 108.004 -174.924 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 . . . . . 0 N--CA 1.447 -0.598 0 N-CA-C 109.349 -0.611 . . . . 2.8900000000000001 109.349 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -45.68 -54.37 7.91 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 124.932 1.293 . . . . 0.38 111.664 -178.093 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -51.44 -51.58 53.69 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 122.998 0.519 . . . . 3.48 111.653 175.915 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.39 -45.59 93.0 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 118.586 0.63 . . . . 0.39000000000000001 110.84 -177.601 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 72.1 t -58.14 -55.67 20.68 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 N-CA-C 109.178 -0.675 . . . . 0.60999999999999999 109.178 177.13 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.607 HG13 ' HB2' ' A' ' 32' ' ' CYS . 39.4 t -53.21 -48.67 54.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 C-N-CA 124.149 0.979 . . . . 0.41999999999999998 109.944 -179.051 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 10.4 mm100 -50.86 -19.37 0.97 Allowed 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 125.706 1.602 . . . . 0.59999999999999998 112.958 175.345 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -142.56 44.57 1.62 Allowed 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 119.126 0.875 . . . . 2.4199999999999999 111.787 173.55 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -157.36 -39.98 0.07 Allowed 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 124.792 1.237 . . . . 1.23 111.428 168.501 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.607 ' HB2' HG13 ' A' ' 28' ' ' VAL . 4.5 m -96.6 -50.29 4.78 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 119.445 1.021 . . . . 0.20000000000000001 110.657 -177.81 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.4 pp -59.14 -24.89 28.52 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 CA-C-N 116.067 -0.515 . . . . 0.47999999999999998 111.889 -174.13 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 21.7 m -41.47 -35.79 0.76 Allowed 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 125.036 1.334 . . . . 1.04 112.455 172.83 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 24.3 m -119.2 -42.71 2.66 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 122.911 0.484 . . . . 0.25 111.328 175.331 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 84.2 m-70 -72.88 -9.54 58.81 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 113.074 0.768 . . . . 0.27000000000000002 113.074 -175.551 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 87.1 149.75 16.25 Favored Glycine 0 C--N 1.337 0.611 0 N-CA-C 109.997 -1.241 . . . . 1.6299999999999999 109.997 178.51 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -45.35 -39.21 7.21 Favored Glycine 0 C--N 1.34 0.767 0 C-N-CA 124.348 0.975 . . . . 0.46999999999999997 111.936 178.236 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -94.67 -2.31 51.49 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.595 1.158 . . . . 3.21 111.452 -173.432 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.4 mt 72.31 11.09 5.86 Favored 'General case' 0 C--N 1.352 0.698 0 O-C-N 120.722 -1.236 . . . . 1.22 110.798 174.802 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 13.6 p -83.51 -0.37 49.93 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 127.865 2.466 . . . . 0.39000000000000001 110.331 -174.216 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.5 147.84 17.25 Favored Glycine 0 N--CA 1.44 -1.067 0 N-CA-C 108.726 -1.75 . . . . 0.48999999999999999 108.726 -173.354 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -151.79 -73.1 0.15 Allowed 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.15 0.98 . . . . 0.34999999999999998 109.465 177.142 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.3 m -100.49 4.37 43.6 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.699 1.6 . . . . 1.0 110.756 171.266 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.426 ' HB1' ' HD2' ' A' ' 46' ' ' PRO . . . -155.59 164.88 19.75 Favored Pre-proline 0 N--CA 1.451 -0.405 0 C-N-CA 125.369 1.467 . . . . 0.22 107.636 -170.53 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.426 ' HD2' ' HB1' ' A' ' 45' ' ' ALA . 51.7 Cg_endo -68.88 159.72 52.71 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.837 2.358 . . . . 0.22 110.385 -176.063 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.11 127.15 31.75 Favored 'General case' 0 C--N 1.332 -0.189 0 O-C-N 121.937 -0.477 . . . . 0.32000000000000001 109.808 -177.573 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 45.8 pt -107.85 2.02 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 C-N-CA 123.971 0.909 . . . . 0.29999999999999999 111.488 176.256 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -35.22 -45.43 0.3 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.597 1.559 . . . . 3.9900000000000002 112.623 168.028 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -113.16 28.24 8.95 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 125.552 1.541 . . . . 3.5600000000000001 111.721 -178.351 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.7 -44.58 85.97 Favored 'General case' 0 N--CA 1.451 -0.389 0 O-C-N 121.57 -0.706 . . . . 0.26000000000000001 109.236 175.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -54.5 -29.61 48.05 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 123.755 0.693 . . . . 0.48999999999999999 114.472 -176.369 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -76.57 -43.68 37.89 Favored 'General case' 0 N--CA 1.457 -0.102 0 O-C-N 121.786 -0.832 . . . . 0.79000000000000004 110.544 174.862 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 40.5 m-80 -66.81 -47.63 71.46 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 122.662 0.385 . . . . 1.54 110.665 -177.2 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -136.84 133.71 36.15 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 126.022 1.729 . . . . 0.69999999999999996 107.089 -168.156 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.5 p -74.78 171.87 13.18 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 119.179 0.899 . . . . 1.8 110.268 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -48.9 -45.24 41.04 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 123.476 0.71 . . . . 2.8300000000000001 111.764 178.707 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -59.24 -32.32 69.88 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.352 0.661 . . . . 3.02 111.795 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -86.89 -44.33 11.76 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 121.808 -0.557 . . . . 2.8799999999999999 110.266 -178.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 45.3 mt -56.96 -46.49 83.95 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 N-CA-C 109.251 -0.648 . . . . 0.31 109.251 176.014 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 57.9 tp -54.41 -49.69 69.33 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 109.166 -0.679 . . . . 0.40999999999999998 109.166 178.585 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -52.44 -49.26 64.93 Favored 'General case' 0 N--CA 1.451 -0.401 0 O-C-N 123.195 0.309 . . . . 1.46 110.652 178.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 31.5 mt -57.77 -53.1 49.4 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.267 0 O-C-N 121.529 -0.732 . . . . 0.55000000000000004 110.677 175.086 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 96.8 mt -51.62 -42.64 30.78 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 O-C-N 120.645 -1.284 . . . . 0.28000000000000003 110.706 179.398 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 82.8 mt -72.77 -36.13 67.59 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.065 0.946 . . . . 0.40000000000000002 113.141 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -116.63 15.59 15.5 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 119.82 1.191 . . . . 1.6000000000000001 110.165 -165.427 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.553 ' N ' ' HA2' ' A' ' 73' ' ' GLY . . . 31.31 -141.74 0.03 OUTLIER Glycine 0 CA--C 1.533 1.187 0 C-N-CA 128.21 2.814 . . . . 0.62 111.389 -162.506 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 1.7 tp60 176.51 136.28 0.06 Allowed 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 118.621 1.21 . . . . 1.5800000000000001 107.933 -175.634 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 42.38 -118.19 1.62 Allowed Glycine 0 CA--C 1.536 1.357 0 CA-C-N 120.584 1.538 . . . . 0.41999999999999998 113.384 -179.336 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -74.51 -18.23 79.93 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 124.038 0.828 . . . . 0.60999999999999999 113.007 178.459 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 19.3 ttt -71.86 118.19 64.54 Favored Pre-proline 0 N--CA 1.452 -0.374 0 C-N-CA 124.859 1.264 . . . . 0.40999999999999998 110.414 179.694 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.46 ' HD2' HD11 ' A' ' 75' ' ' ILE . 43.9 Cg_endo -78.18 122.57 5.76 Favored 'Trans proline' 0 N--CA 1.444 -1.388 0 C-N-CA 122.782 2.322 . . . . 2.1200000000000001 110.925 -178.187 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.553 ' HA2' ' N ' ' A' ' 67' ' ' GLY . . . -58.84 138.17 49.72 Favored Glycine 0 N--CA 1.442 -0.907 0 CA-C-N 115.27 -0.877 . . . . 0.63 114.999 -178.48 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 83.4 35.44 17.31 Favored Glycine 0 CA--C 1.528 0.856 0 CA-C-N 114.072 -1.064 . . . . 0.32000000000000001 111.758 174.345 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.46 HD11 ' HD2' ' A' ' 72' ' ' PRO . 1.2 mt -57.61 -52.96 50.79 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 125.196 1.398 . . . . 1.25 109.859 174.78 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -101.08 151.32 21.96 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.317 1.447 . . . . 0.35999999999999999 108.991 164.411 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.4 mtpm? -143.43 155.75 44.47 Favored 'General case' 0 C--N 1.34 0.157 0 C-N-CA 124.323 1.049 . . . . 3.5099999999999998 109.317 173.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.29 -170.28 54.79 Favored Glycine 0 CA--C 1.528 0.845 0 N-CA-C 110.108 -1.197 . . . . 0.89000000000000001 110.108 -175.036 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -51.38 -25.97 7.01 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.243 1.017 . . . . 1.24 112.232 179.391 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -39.86 -58.85 1.29 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.92 1.288 . . . . 2.1000000000000001 110.634 166.821 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.23 -47.76 84.6 Favored 'General case' 0 CA--C 1.531 0.247 0 O-C-N 122.071 -0.393 . . . . 0.46999999999999997 110.893 -174.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -50.68 -56.49 11.66 Favored 'General case' 0 C--N 1.338 0.094 0 C-N-CA 123.829 0.852 . . . . 3.0499999999999998 110.852 174.018 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -54.4 -49.51 69.73 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 123.139 0.575 . . . . 0.31 110.132 -178.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.442 HG13 ' CG2' ' A' ' 28' ' ' VAL . 85.6 t -56.94 -54.92 23.74 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-N 117.523 0.147 . . . . 0.40000000000000002 111.176 177.735 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -51.69 -51.49 55.62 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 123.676 0.79 . . . . 0.25 111.733 178.817 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.4 -46.56 89.53 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 124.175 0.99 . . . . 0.32000000000000001 110.546 -179.376 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.531 ' CE3' HD23 ' A' ' 88' ' ' LEU . 46.6 t90 -57.25 -48.31 79.17 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 109.588 -0.523 . . . . 0.46000000000000002 109.588 175.808 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.531 HD23 ' CE3' ' A' ' 87' ' ' TRP . 0.1 OUTLIER -60.49 -33.94 73.33 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.179 0.992 . . . . 1.6200000000000001 111.59 176.905 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -54.62 -37.44 65.62 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 118.551 0.614 . . . . 0.47999999999999998 110.936 172.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -94.76 22.04 6.8 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.798 0.839 . . . . 2.9500000000000002 111.958 175.55 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 2.7 mtpm? -113.38 119.62 38.28 Favored 'General case' 0 C--N 1.342 0.24 0 O-C-N 121.122 -0.986 . . . . 2.1600000000000001 109.094 169.57 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 89.1 mttt . . . . . 0 C--O 1.257 1.462 0 C-N-CA 129.451 3.1 . . . . 2.7799999999999998 104.116 -178.274 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.446 -0.662 0 N-CA-C 106.968 -1.493 . . . . 2.1499999999999999 106.968 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -41.38 -54.22 3.11 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 124.682 1.193 . . . . 0.32000000000000001 110.9 179.425 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -58.2 -47.21 84.16 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 115.239 -0.891 . . . . 2.6000000000000001 110.258 -179.311 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.26 -45.8 92.02 Favored 'General case' 0 C--N 1.339 0.111 0 C-N-CA 122.935 0.494 . . . . 0.26000000000000001 111.135 -179.55 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 81.9 t -56.58 -54.25 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 N-CA-C 108.766 -0.828 . . . . 0.34000000000000002 108.766 177.593 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.627 HG22 ' SG ' ' A' ' 32' ' ' CYS . 22.8 t -53.78 -49.69 56.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 CA-C-N 117.742 0.246 . . . . 0.35999999999999999 111.237 178.858 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 27.6 mm-40 -54.87 -14.85 1.59 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.1 1.76 . . . . 0.58999999999999997 113.285 174.753 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 14.1 mt-30 -136.36 44.05 2.44 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 119.795 1.179 . . . . 3.48 112.617 169.594 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.28 -58.61 0.05 Allowed 'General case' 0 CA--C 1.519 -0.244 0 O-C-N 121.782 -0.574 . . . . 1.5700000000000001 109.799 168.613 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.627 ' SG ' HG22 ' A' ' 28' ' ' VAL . 2.8 m -75.63 -48.14 23.48 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 109.938 -0.393 . . . . 0.17000000000000001 109.938 -171.766 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.0 pp -50.01 -32.77 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.14 0 C-N-CA 123.449 0.7 . . . . 0.67000000000000004 112.435 -178.581 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.4 m -44.08 -35.34 2.1 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 125.076 1.35 . . . . 1.05 112.033 178.191 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 13.1 m -119.36 -41.76 2.7 Favored 'General case' 0 CA--C 1.53 0.207 0 O-C-N 123.522 0.514 . . . . 0.17999999999999999 111.922 175.319 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 79.6 m-70 -70.35 -9.01 55.0 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.028 0.931 . . . . 0.22 112.481 -178.02 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 85.56 148.64 10.99 Favored Glycine 0 C--N 1.337 0.621 0 N-CA-C 109.224 -1.55 . . . . 1.45 109.224 -179.432 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -43.02 -33.25 1.7 Allowed Glycine 0 CA--C 1.53 0.989 0 C-N-CA 124.496 1.046 . . . . 0.52000000000000002 112.687 173.718 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -94.98 -10.01 32.25 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.986 1.315 . . . . 2.3300000000000001 111.613 -172.12 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 70.63 11.75 7.27 Favored 'General case' 0 C--N 1.347 0.467 0 CA-C-N 120.263 1.392 . . . . 1.4399999999999999 111.255 178.357 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 10.4 p -85.43 -2.29 57.95 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 127.808 2.443 . . . . 0.33000000000000002 109.986 -177.38 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.93 145.3 12.66 Favored Glycine 0 N--CA 1.437 -1.261 0 N-CA-C 108.648 -1.781 . . . . 0.42999999999999999 108.648 -174.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -152.52 -80.34 0.1 Allowed 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 124.758 1.223 . . . . 0.25 109.043 177.333 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 17.0 m -91.46 4.02 53.54 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.457 1.103 . . . . 1.1399999999999999 111.14 170.438 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -153.4 163.68 22.93 Favored Pre-proline 0 N--CA 1.45 -0.439 0 C-N-CA 126.065 1.746 . . . . 0.31 107.554 -172.628 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -70.51 161.52 45.75 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 123.128 2.552 . . . . 0.27000000000000002 110.59 -176.276 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -74.06 124.01 25.45 Favored 'General case' 0 N--CA 1.454 -0.268 0 O-C-N 121.577 -0.702 . . . . 0.26000000000000001 110.235 -176.425 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 44.6 pt -104.44 2.45 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 CA-C-O 119.055 -0.498 . . . . 0.28000000000000003 111.564 176.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -40.33 -52.64 2.68 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 112.985 0.735 . . . . 2.6800000000000002 112.985 176.777 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.26 21.49 11.87 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 126.3 1.84 . . . . 5.3499999999999996 110.653 -175.826 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -54.19 -39.5 66.71 Favored 'General case' 0 N--CA 1.453 -0.307 0 O-C-N 121.506 -0.746 . . . . 0.27000000000000002 110.146 -178.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -54.8 -24.95 35.15 Favored Glycine 0 CA--C 1.53 1.022 0 N-CA-C 114.603 0.601 . . . . 0.52000000000000002 114.603 176.314 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -78.95 -36.95 40.84 Favored 'General case' 0 C--N 1.338 0.097 0 CA-C-N 118.616 1.208 . . . . 0.83999999999999997 110.278 174.516 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -73.91 -47.85 34.89 Favored 'General case' 0 N--CA 1.457 -0.078 0 C-N-CA 122.515 0.326 . . . . 1.9199999999999999 110.326 -177.368 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -139.96 149.04 42.8 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.47 1.108 . . . . 0.68000000000000005 108.689 -168.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.92 168.32 18.03 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 109.614 -0.514 . . . . 1.9299999999999999 109.614 178.446 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -48.2 -43.52 32.02 Favored 'General case' 0 C--O 1.226 -0.179 0 C-N-CA 124.43 1.092 . . . . 2.7999999999999998 111.553 178.558 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -53.2 -47.69 68.69 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.654 0.782 . . . . 2.75 110.481 178.581 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -74.56 -45.69 43.83 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.78 0.832 . . . . 3.25 109.575 -175.399 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 58.6 mt -59.55 -44.16 92.5 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 N-CA-C 109.194 -0.669 . . . . 0.28000000000000003 109.194 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 31.3 tp -54.77 -54.38 42.82 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 123.468 0.707 . . . . 0.37 109.38 175.217 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -52.07 -49.48 63.45 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 123.107 0.254 . . . . 1.48 111.2 178.668 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 57.6 mt -55.16 -55.49 16.16 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.155 0 O-C-N 121.564 -0.71 . . . . 0.65000000000000002 110.558 176.437 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 57.8 mt -49.15 -46.75 17.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 O-C-N 121.191 -0.943 . . . . 0.26000000000000001 110.199 178.179 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 91.7 mt -66.11 -33.3 75.46 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 113.932 1.086 . . . . 0.39000000000000001 113.932 179.496 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -128.97 24.13 5.65 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 120.37 1.441 . . . . 1.8200000000000001 110.641 -163.087 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 23.75 -136.97 0.01 OUTLIER Glycine 0 CA--C 1.543 1.791 0 C-N-CA 127.702 2.572 . . . . 0.67000000000000004 112.808 -159.484 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 170.46 139.13 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 126.483 1.913 . . . . 1.3 107.603 -175.19 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 23.78 -106.2 0.01 OUTLIER Glycine 0 CA--C 1.535 1.316 0 C-N-CA 126.386 1.945 . . . . 0.56999999999999995 115.029 -170.128 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.26 -29.05 74.33 Favored Glycine 0 CA--C 1.533 1.187 0 CA-C-N 118.271 1.036 . . . . 0.70999999999999996 113.169 -177.625 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 4.6 ttt -67.32 126.19 92.18 Favored Pre-proline 0 CA--C 1.542 0.635 0 C-N-CA 125.053 1.341 . . . . 0.57999999999999996 110.688 -179.109 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -62.66 -57.2 0.47 Allowed 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 123.893 3.062 . . . . 3.0299999999999998 111.144 -174.181 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 118.14 149.92 8.87 Favored Glycine 0 C--N 1.334 0.471 0 C-N-CA 123.925 0.774 . . . . 0.87 113.536 174.681 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 69.06 23.21 76.14 Favored Glycine 0 CA--C 1.531 1.06 0 CA-C-N 115.156 -0.522 . . . . 0.40000000000000002 111.852 178.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.6 mt -56.32 -49.29 77.41 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.919 0 C-N-CA 126.12 1.768 . . . . 1.0700000000000001 111.267 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -109.71 161.22 15.62 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.133 0.973 . . . . 0.38 108.589 160.331 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -146.42 172.72 13.1 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.082 0.953 . . . . 3.46 109.198 173.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 54.18 -147.06 22.78 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 123.336 0.494 . . . . 0.76000000000000001 112.015 176.252 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -47.47 -41.03 19.77 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.19 0.996 . . . . 0.73999999999999999 111.23 175.601 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -53.07 -44.43 67.49 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.889 1.276 . . . . 2.7400000000000002 110.799 177.284 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -79.18 -49.97 11.71 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 121.759 -0.588 . . . . 0.20999999999999999 111.487 176.188 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -51.4 -54.39 27.16 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 124.027 0.931 . . . . 2.1899999999999999 111.691 -178.105 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.24 -47.59 83.06 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.824 -0.435 . . . . 0.25 109.824 -177.155 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.412 HG22 HG23 ' A' ' 28' ' ' VAL . 53.8 t -56.72 -53.96 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 C-N-CA 123.442 0.697 . . . . 0.28999999999999998 110.748 177.538 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -52.19 -51.86 55.58 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 123.896 0.878 . . . . 0.17999999999999999 111.915 176.417 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.26 -50.59 73.04 Favored 'General case' 0 C--N 1.333 -0.116 0 C-N-CA 123.192 0.597 . . . . 0.32000000000000001 110.204 -179.589 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.506 ' CE3' HD23 ' A' ' 88' ' ' LEU . 50.0 t90 -56.59 -46.43 80.83 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.622 0.769 . . . . 0.53000000000000003 110.49 177.782 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.506 HD23 ' CE3' ' A' ' 87' ' ' TRP . 0.1 OUTLIER -63.15 -38.8 92.6 Favored 'General case' 0 C--O 1.224 -0.282 0 O-C-N 121.416 -0.803 . . . . 1.6499999999999999 109.88 178.269 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -62.26 -42.31 99.22 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 118.723 0.692 . . . . 0.5 110.683 174.038 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -55.74 -45.46 78.02 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 121.843 -0.535 . . . . 3.6000000000000001 110.61 169.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 4.1 mtmp? -74.93 100.29 4.07 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 118.921 0.782 . . . . 2.8900000000000001 111.553 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 9.7 ptpp? . . . . . 0 C--O 1.25 1.095 0 N-CA-C 106.869 -1.53 . . . . 2.7799999999999998 106.869 174.311 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 N--CA 1.443 -0.789 0 N-CA-C 105.787 -1.931 . . . . 2.75 105.787 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -41.38 -52.84 3.46 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 124.655 1.182 . . . . 0.33000000000000002 110.857 -177.595 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -57.13 -47.79 80.27 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 115.9 -0.591 . . . . 3.1699999999999999 110.677 -179.319 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.07 -44.83 94.46 Favored 'General case' 0 C--N 1.339 0.11 0 C-N-CA 122.926 0.49 . . . . 0.32000000000000001 110.691 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 97.7 t -58.5 -57.4 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 N-CA-C 108.934 -0.765 . . . . 0.42999999999999999 108.934 177.494 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.681 HG13 ' HB2' ' A' ' 32' ' ' CYS . 52.9 t -52.21 -48.34 43.34 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 C-N-CA 122.741 0.416 . . . . 0.32000000000000001 110.875 -179.479 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -51.03 -24.44 3.79 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 125.503 1.521 . . . . 0.63 113.115 175.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 11.6 mt-30 -137.4 55.75 1.8 Allowed 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 119.514 1.052 . . . . 2.6600000000000001 112.179 170.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.96 -38.97 0.02 OUTLIER 'General case' 0 C--O 1.226 -0.138 0 C-N-CA 123.566 0.746 . . . . 1.25 110.214 168.24 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.681 ' HB2' HG13 ' A' ' 28' ' ' VAL . 4.0 m -98.21 -50.01 4.51 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 119.004 0.82 . . . . 0.17999999999999999 110.971 -177.322 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.9 pp -58.08 -25.86 27.53 Favored 'Isoleucine or valine' 0 C--N 1.338 0.071 0 N-CA-C 112.127 0.417 . . . . 0.40000000000000002 112.127 -174.291 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 59.7 m -37.92 -38.55 0.31 Allowed 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 125.491 1.516 . . . . 0.98999999999999999 112.646 170.638 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 18.9 m -120.7 -40.15 2.68 Favored 'General case' 0 C--N 1.34 0.189 0 C-N-CA 122.892 0.477 . . . . 0.16 111.901 175.858 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 81.6 m-70 -73.31 -7.92 53.66 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 112.65 0.611 . . . . 0.19 112.65 -176.42 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 85.59 149.78 12.83 Favored Glycine 0 C--N 1.337 0.627 0 N-CA-C 109.497 -1.441 . . . . 1.51 109.497 179.064 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -42.35 -34.95 1.73 Allowed Glycine 0 CA--C 1.527 0.826 0 C-N-CA 124.855 1.216 . . . . 0.46000000000000002 112.176 175.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -99.03 -5.9 29.52 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 124.937 1.295 . . . . 2.3599999999999999 111.402 -168.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 8.8 mt 69.34 13.04 8.47 Favored 'General case' 0 C--N 1.352 0.682 0 CA-C-N 120.712 1.596 . . . . 1.1100000000000001 111.326 178.104 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.2 p -89.39 -1.37 58.03 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 127.802 2.441 . . . . 0.34000000000000002 109.815 -176.159 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.62 130.44 2.81 Favored Glycine 0 N--CA 1.44 -1.085 0 N-CA-C 109.502 -1.439 . . . . 0.54000000000000004 109.502 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -135.39 -78.1 0.44 Allowed 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 124.387 1.075 . . . . 0.28000000000000003 108.641 178.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 50.1 m -93.45 4.01 54.65 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.176 0.991 . . . . 1.3600000000000001 111.102 171.637 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -153.6 161.74 28.41 Favored Pre-proline 0 CA--C 1.533 0.314 0 C-N-CA 125.808 1.643 . . . . 0.31 107.488 -171.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -71.78 159.58 50.32 Favored 'Trans proline' 0 N--CA 1.459 -0.541 0 C-N-CA 122.977 2.451 . . . . 0.28000000000000003 111.172 -175.553 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -74.68 117.36 16.43 Favored 'General case' 0 CA--C 1.53 0.211 0 O-C-N 121.727 -0.608 . . . . 0.45000000000000001 111.768 -172.353 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 42.2 pt -95.94 0.54 10.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 C-N-CA 123.642 0.777 . . . . 0.29999999999999999 112.031 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -45.34 -35.74 3.73 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.526 0.936 . . . . 2.6400000000000001 113.526 172.808 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -112.98 27.94 9.21 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 124.11 0.964 . . . . 4.9400000000000004 110.687 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -58.63 -43.83 89.82 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 108.998 -0.742 . . . . 0.33000000000000002 108.998 176.618 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -53.77 -29.55 41.85 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 123.349 0.499 . . . . 0.63 113.692 179.108 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.13 -32.95 65.23 Favored 'General case' 0 N--CA 1.454 -0.229 0 O-C-N 122.078 -0.66 . . . . 0.82999999999999996 110.356 178.543 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 -85.31 -44.94 12.4 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.962 0.905 . . . . 1.6699999999999999 109.954 -174.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -138.38 133.28 32.7 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 125.273 1.429 . . . . 1.0 108.025 -167.244 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 13.9 m -73.63 169.97 16.18 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 118.409 0.55 . . . . 1.51 110.095 175.532 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -47.24 -48.13 24.46 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.277 1.031 . . . . 2.9199999999999999 112.44 -176.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -58.1 -41.77 84.25 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.835 -0.541 . . . . 2.98 111.618 177.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -72.39 -41.96 65.74 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 109.053 -0.721 . . . . 2.9900000000000002 109.053 -176.14 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 41.3 mt -61.86 -46.71 95.91 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.131 0 O-C-N 121.286 -0.884 . . . . 0.29999999999999999 109.386 175.536 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 66.8 tp -53.95 -48.41 70.3 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.441 -0.577 . . . . 0.46999999999999997 109.441 178.602 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -48.54 -56.02 9.48 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 117.993 0.36 . . . . 2.3700000000000001 110.996 174.848 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 95.4 mt -55.78 -46.25 79.77 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.298 0 O-C-N 121.6 -0.688 . . . . 0.47999999999999998 110.778 178.236 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 73.3 mt -55.8 -44.77 78.64 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 O-C-N 120.45 -1.406 . . . . 0.28000000000000003 110.164 176.675 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 90.9 mt -67.81 -36.81 81.06 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 113.903 1.075 . . . . 0.67000000000000004 113.903 -176.644 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -128.82 26.32 5.56 Favored 'General case' 0 C--N 1.344 0.338 0 CA-C-N 120.85 1.659 . . . . 3.7799999999999998 110.205 -170.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.511 ' N ' ' HA2' ' A' ' 73' ' ' GLY . . . 37.41 -142.78 0.23 Allowed Glycine 0 CA--C 1.534 1.258 0 C-N-CA 128.247 2.832 . . . . 0.65000000000000002 111.009 -176.226 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 44.9 tt0 174.3 132.87 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 119.246 1.523 . . . . 1.46 109.658 -178.217 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 45.14 -118.94 3.04 Favored Glycine 0 CA--C 1.532 1.138 0 O-C-N 121.22 -0.925 . . . . 0.40000000000000002 112.18 -175.445 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -70.93 -19.63 77.13 Favored Glycine 0 CA--C 1.531 1.082 0 O-C-N 122.495 -0.415 . . . . 0.47999999999999998 113.016 179.357 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 20.0 ttt -73.4 119.27 74.95 Favored Pre-proline 0 N--CA 1.451 -0.424 0 C-N-CA 124.163 0.985 . . . . 0.34000000000000002 110.604 -178.442 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.448 ' HD2' HD11 ' A' ' 75' ' ' ILE . 58.0 Cg_endo -80.22 124.74 5.52 Favored 'Trans proline' 0 N--CA 1.447 -1.221 0 C-N-CA 123.208 2.605 . . . . 2.0699999999999998 111.054 -179.075 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.511 ' HA2' ' N ' ' A' ' 67' ' ' GLY . . . -63.38 142.6 47.35 Favored Glycine 0 N--CA 1.444 -0.8 0 N-CA-C 115.902 1.121 . . . . 0.64000000000000001 115.902 -174.317 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 78.2 32.41 43.7 Favored Glycine 0 CA--C 1.526 0.779 0 CA-C-N 114.142 -1.029 . . . . 0.34000000000000002 111.442 174.33 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.448 HD11 ' HD2' ' A' ' 72' ' ' PRO . 0.8 OUTLIER -51.37 -53.02 17.28 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 125.692 1.597 . . . . 1.1799999999999999 109.878 174.45 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -105.48 160.05 15.46 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 124.961 1.304 . . . . 0.34000000000000002 108.652 162.443 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 81.7 mttt -144.1 168.7 19.4 Favored 'General case' 0 CA--C 1.527 0.086 0 N-CA-C 107.461 -1.311 . . . . 2.5600000000000001 107.461 170.312 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 65.7 -164.04 39.28 Favored Glycine 0 CA--C 1.528 0.902 0 N-CA-C 111.517 -0.633 . . . . 0.66000000000000003 111.517 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -54.32 -29.6 48.28 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.457 0.703 . . . . 0.58999999999999997 112.283 -174.227 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -40.32 -67.63 0.22 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.79 1.236 . . . . 2.9500000000000002 110.457 164.068 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -59.07 -43.91 91.8 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.25 0.62 . . . . 0.28000000000000003 110.977 -175.023 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -59.13 -53.48 57.86 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.411 1.084 . . . . 2.6899999999999999 110.597 -178.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.18 -49.12 78.12 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.008 0.923 . . . . 0.27000000000000002 109.797 179.373 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.557 HG22 HG23 ' A' ' 28' ' ' VAL . 54.1 t -52.5 -56.49 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 C-N-CA 122.292 0.237 . . . . 0.27000000000000002 110.598 176.223 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -49.56 -51.38 37.28 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 123.738 0.815 . . . . 0.20000000000000001 111.764 177.26 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.38 -50.33 74.38 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 121.673 0.749 . . . . 0.42999999999999999 111.163 -178.757 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.552 ' CE3' HD23 ' A' ' 88' ' ' LEU . 51.0 t90 -58.23 -45.34 87.87 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 121.228 0.537 . . . . 0.63 110.047 178.543 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.552 HD23 ' CE3' ' A' ' 87' ' ' TRP . 0.1 OUTLIER -62.73 -36.41 82.91 Favored 'General case' 0 CA--C 1.531 0.213 0 O-C-N 121.493 -0.754 . . . . 1.6100000000000001 110.814 176.571 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -59.74 -39.19 83.92 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 118.758 0.708 . . . . 0.44 110.848 173.257 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -59.74 -41.06 90.11 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 122.28 0.232 . . . . 3.21 110.535 173.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.1 mtpm? -74.04 104.12 4.76 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.806 0.813 . . . . 2.2999999999999998 111.21 179.087 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 15.5 pttp . . . . . 0 C--O 1.25 1.089 0 C-N-CA 126.619 1.967 . . . . 3.1299999999999999 106.048 176.364 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.451 -0.391 0 N-CA-C 108.726 -0.842 . . . . 2.8599999999999999 108.726 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -46.39 -55.15 7.78 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 123.25 0.62 . . . . 0.31 110.024 176.474 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -57.36 -46.71 83.07 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 110.233 -0.284 . . . . 2.6899999999999999 110.233 -177.207 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.24 -48.69 79.63 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 118.262 0.483 . . . . 0.28999999999999998 111.399 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 55.6 t -56.46 -56.18 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 N-CA-C 109.233 -0.654 . . . . 0.40999999999999998 109.233 177.071 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.562 HG23 HG22 ' A' ' 84' ' ' VAL . 61.1 t -53.5 -49.92 52.11 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 C-N-CA 122.888 0.475 . . . . 0.40000000000000002 110.305 -177.201 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.458 ' HA ' HG12 ' A' ' 33' ' ' ILE . 33.6 mm-40 -51.55 -17.44 0.83 Allowed 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 126.454 1.902 . . . . 0.5 112.964 175.818 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 16.6 tp60 -141.71 43.67 1.72 Allowed 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 119.519 1.054 . . . . 3.6699999999999999 112.204 171.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.18 -39.73 0.1 Allowed 'General case' 0 C--O 1.227 -0.083 0 C-N-CA 123.659 0.784 . . . . 1.1799999999999999 111.425 166.377 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.485 ' HB2' HG13 ' A' ' 28' ' ' VAL . 3.6 m -98.12 -49.51 4.71 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 119.124 0.874 . . . . 0.17000000000000001 110.539 -174.106 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.458 HG12 ' HA ' ' A' ' 29' ' ' GLN . 2.2 pp -55.51 -29.13 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 CA-C-N 115.766 -0.652 . . . . 0.40000000000000002 111.564 -177.127 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.1 m -37.75 -37.01 0.21 Allowed 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 125.61 1.564 . . . . 1.1399999999999999 112.713 171.646 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 28.2 m -119.59 -40.45 2.77 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.298 0.639 . . . . 0.17000000000000001 112.009 174.125 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 84.7 m-70 -73.37 -8.71 57.03 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.474 0.71 . . . . 0.22 112.711 -175.778 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 85.55 151.14 15.28 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 109.628 -1.389 . . . . 1.52 109.628 -178.413 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -40.46 -42.27 2.54 Favored Glycine 0 C--N 1.34 0.802 0 C-N-CA 124.996 1.284 . . . . 0.48999999999999999 112.21 178.088 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -95.89 -6.34 39.47 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 125.556 1.542 . . . . 2.5699999999999998 110.939 -169.641 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.537 HD21 ' CG1' ' A' ' 28' ' ' VAL . 0.6 OUTLIER 69.56 19.1 7.55 Favored 'General case' 0 C--N 1.347 0.469 0 CA-C-N 119.648 1.113 . . . . 1.48 111.026 177.456 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 11.2 p -82.18 -4.84 57.83 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 128.462 2.705 . . . . 0.34999999999999998 109.898 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.14 148.26 21.19 Favored Glycine 0 N--CA 1.44 -1.035 0 N-CA-C 108.32 -1.912 . . . . 0.59999999999999998 108.32 -173.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -155.08 -72.98 0.12 Allowed 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 123.91 0.884 . . . . 0.48999999999999999 109.552 176.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.3 t -98.35 1.17 46.73 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.627 1.171 . . . . 1.3400000000000001 110.252 172.622 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.495 ' HB1' ' HD2' ' A' ' 46' ' ' PRO . . . -155.62 167.07 14.94 Favored Pre-proline 0 CA--C 1.536 0.432 0 C-N-CA 125.551 1.541 . . . . 0.26000000000000001 107.913 -171.503 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.495 ' HD2' ' HB1' ' A' ' 45' ' ' ALA . 54.9 Cg_endo -70.43 160.98 47.67 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 123.098 2.532 . . . . 0.29999999999999999 111.195 -173.485 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -74.87 119.99 19.8 Favored 'General case' 0 CA--C 1.531 0.214 0 O-C-N 121.748 -0.595 . . . . 0.31 110.638 -177.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 47.4 pt -105.05 0.83 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 C-N-CA 124.157 0.983 . . . . 0.40000000000000002 111.551 179.327 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -34.17 -46.39 0.24 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.572 1.549 . . . . 2.4199999999999999 112.856 167.244 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 5.3 pttt -111.44 35.32 3.67 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.798 1.239 . . . . 3.9300000000000002 111.166 -178.254 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.01 -46.4 87.83 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-O 118.868 -0.587 . . . . 0.29999999999999999 109.51 174.497 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -51.73 -32.73 33.34 Favored Glycine 0 CA--C 1.527 0.795 0 CA-C-N 118.566 0.621 . . . . 0.65000000000000002 114.329 -177.055 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.21 -37.08 66.57 Favored 'General case' 0 N--CA 1.455 -0.196 0 O-C-N 121.898 -0.766 . . . . 0.79000000000000004 110.797 176.696 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 20.5 m-80 -73.51 -50.77 19.77 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 122.929 0.492 . . . . 1.6799999999999999 110.15 -178.576 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -137.6 138.07 39.16 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.211 1.404 . . . . 0.71999999999999997 107.382 -169.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 67.3 m -76.19 172.0 13.57 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 119.03 0.832 . . . . 1.6000000000000001 110.389 179.546 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.0 pm0 -50.5 -43.29 55.61 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 123.78 0.832 . . . . 2.8700000000000001 111.834 -178.471 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -56.15 -41.37 75.3 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 121.336 0.588 . . . . 2.8100000000000001 110.136 179.389 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -80.01 -47.38 15.01 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 123.81 0.844 . . . . 3.54 108.995 -173.278 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 63.9 mt -56.33 -44.99 81.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 N-CA-C 109.113 -0.699 . . . . 0.23999999999999999 109.113 176.69 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 33.8 tp -54.77 -49.47 70.8 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 109.375 -0.602 . . . . 0.46000000000000002 109.375 177.764 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -55.11 -46.44 75.56 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 118.576 0.625 . . . . 1.48 111.604 175.816 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 86.7 mt -61.92 -30.34 48.34 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 O-C-N 121.351 -0.843 . . . . 0.66000000000000003 111.521 178.106 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 46.4 mt -73.19 -50.24 32.87 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 O-C-N 120.278 -1.514 . . . . 0.34000000000000002 109.128 174.253 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 77.3 mt -61.88 -28.43 69.5 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 125.232 1.413 . . . . 0.38 113.474 -175.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 11.0 m-80 -130.62 15.37 5.41 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 120.02 1.282 . . . . 1.75 110.386 -169.545 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 40.01 -141.97 0.69 Allowed Glycine 0 CA--C 1.545 1.906 0 C-N-CA 125.679 1.609 . . . . 0.66000000000000003 111.707 -167.05 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 167.08 139.63 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 126.386 1.874 . . . . 1.54 108.447 -174.773 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 31.77 -111.45 0.05 OUTLIER Glycine 0 C--N 1.347 1.18 0 C-N-CA 125.465 1.507 . . . . 0.52000000000000002 114.153 -174.581 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.58 -30.1 76.67 Favored Glycine 0 CA--C 1.534 1.23 0 CA-C-N 117.299 0.549 . . . . 0.69999999999999996 112.834 -179.083 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 2.3 ttt -65.42 123.74 85.2 Favored Pre-proline 0 CA--C 1.541 0.615 0 C-N-CA 124.576 1.15 . . . . 0.51000000000000001 111.393 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -63.64 -55.38 0.7 Allowed 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 124.223 3.282 . . . . 2.96 111.224 -173.117 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 115.28 149.08 9.53 Favored Glycine 0 N--CA 1.448 -0.514 0 CA-C-N 115.732 -0.667 . . . . 0.90000000000000002 114.185 171.791 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 67.45 22.38 73.06 Favored Glycine 0 CA--C 1.531 1.036 0 CA-C-N 114.712 -0.744 . . . . 0.48999999999999999 111.854 -178.439 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -51.69 -53.01 18.63 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 C-N-CA 126.611 1.964 . . . . 1.0800000000000001 111.127 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -107.76 159.99 16.07 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.164 1.386 . . . . 0.34000000000000002 108.335 162.446 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 36.6 mttt -145.84 174.77 10.94 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.554 1.141 . . . . 3.3100000000000001 109.57 171.683 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 53.11 -149.55 11.66 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 123.826 0.727 . . . . 0.69999999999999996 112.045 178.084 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -49.63 -36.61 25.01 Favored 'General case' 0 C--N 1.34 0.163 0 C-N-CA 123.877 0.871 . . . . 0.68999999999999995 111.278 179.182 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.531 ' O ' HG23 ' A' ' 84' ' ' VAL . 3.9 tt0 -47.76 -66.41 0.41 Allowed 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.992 1.317 . . . . 1.9099999999999999 109.216 173.047 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -62.97 -45.48 92.23 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 122.829 0.452 . . . . 0.26000000000000001 112.011 -178.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -54.79 -52.9 61.19 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 122.931 0.492 . . . . 2.1499999999999999 110.488 -178.644 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.42 -50.17 73.87 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 122.915 0.486 . . . . 0.39000000000000001 110.233 178.131 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.562 HG22 HG23 ' A' ' 28' ' ' VAL . 70.1 t -50.63 -58.51 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-O 120.613 0.244 . . . . 0.56000000000000005 110.919 177.293 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -55.26 -49.98 70.67 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.206 1.003 . . . . 0.28999999999999998 111.684 -179.123 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.69 -46.01 88.18 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 121.67 0.748 . . . . 0.34999999999999998 110.584 -179.336 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.532 ' CE3' HD23 ' A' ' 88' ' ' LEU . 48.6 t90 -60.71 -50.48 73.3 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.667 -0.494 . . . . 0.56000000000000005 109.667 176.538 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.532 HD23 ' CE3' ' A' ' 87' ' ' TRP . 0.1 OUTLIER -59.92 -32.01 70.38 Favored 'General case' 0 CA--C 1.531 0.247 0 O-C-N 121.487 -0.758 . . . . 1.6000000000000001 111.193 179.152 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.9 -42.85 97.33 Favored 'General case' 0 N--CA 1.457 -0.097 0 CA-C-N 118.671 0.669 . . . . 0.40999999999999998 111.146 171.754 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -58.59 -40.73 84.02 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 110.347 -0.242 . . . . 3.29 110.347 173.433 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 21.4 mtpp -73.38 133.98 43.94 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 121.916 -0.49 . . . . 2.4199999999999999 110.984 -178.037 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 49.8 mtmt . . . . . 0 C--O 1.25 1.084 0 N-CA-C 105.887 -1.894 . . . . 2.5499999999999998 105.887 179.36 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 N--CA 1.448 -0.534 0 N-CA-C 108.639 -0.874 . . . . 2.9199999999999999 108.639 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -89.29 -65.38 1.02 Allowed 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 109.327 -0.619 . . . . 0.5 109.327 177.386 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -47.35 -47.01 26.13 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.578 0.751 . . . . 3.0899999999999999 111.702 -178.645 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.69 -42.82 79.75 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.057 0.543 . . . . 0.33000000000000002 111.676 178.789 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 53.4 t -64.45 -54.13 34.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 N-CA-C 108.23 -1.026 . . . . 0.34999999999999998 108.23 178.05 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.606 HG11 HD21 ' A' ' 40' ' ' LEU . 65.9 t -48.33 -51.49 10.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 C-N-CA 122.486 0.314 . . . . 0.57999999999999996 110.376 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.414 ' HA ' HG12 ' A' ' 33' ' ' ILE . 35.7 mm-40 -50.55 -26.82 5.7 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 126.313 1.845 . . . . 0.62 113.416 177.672 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 -136.6 53.48 1.91 Allowed 'General case' 0 C--N 1.339 0.125 0 CA-C-N 119.756 1.162 . . . . 2.3999999999999999 112.121 173.586 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -166.43 -38.9 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 123.459 0.704 . . . . 1.26 110.504 167.834 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.484 ' HB2' HG13 ' A' ' 28' ' ' VAL . 6.5 m -97.69 -51.31 4.15 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 118.913 0.779 . . . . 0.23000000000000001 110.843 -175.463 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.414 HG12 ' HA ' ' A' ' 29' ' ' GLN . 2.4 pp -56.41 -27.94 25.56 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.095 0 CA-C-N 116.128 -0.487 . . . . 0.39000000000000001 111.925 -175.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.9 m -36.92 -39.31 0.22 Allowed 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 125.605 1.562 . . . . 1.05 112.683 171.754 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 38.1 m -117.88 -38.86 3.18 Favored 'General case' 0 C--N 1.339 0.122 0 C-N-CA 123.127 0.571 . . . . 0.20999999999999999 111.652 174.724 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 83.8 m-70 -77.03 -6.49 52.89 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 113.167 0.803 . . . . 0.23999999999999999 113.167 -174.416 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 84.54 151.83 14.5 Favored Glycine 0 C--N 1.338 0.645 0 N-CA-C 109.865 -1.294 . . . . 1.5700000000000001 109.865 -179.315 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -41.87 -39.53 2.8 Favored Glycine 0 C--N 1.341 0.84 0 C-N-CA 125.015 1.293 . . . . 0.45000000000000001 112.274 178.623 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -99.84 -0.44 39.72 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 125.249 1.42 . . . . 2.4199999999999999 111.058 -169.211 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.606 HD21 HG11 ' A' ' 28' ' ' VAL . 1.3 mp 66.12 18.34 10.96 Favored 'General case' 0 C--N 1.347 0.476 0 CA-C-N 119.779 1.172 . . . . 1.8500000000000001 111.351 -179.395 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.0 p -82.14 -5.24 58.3 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 127.413 2.285 . . . . 0.35999999999999999 110.277 -177.224 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.58 148.21 18.35 Favored Glycine 0 N--CA 1.437 -1.277 0 N-CA-C 108.129 -1.988 . . . . 0.51000000000000001 108.129 -172.625 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -156.24 -76.77 0.09 Allowed 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 124.035 0.934 . . . . 0.26000000000000001 109.09 178.359 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -95.38 2.37 54.59 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.683 1.193 . . . . 1.1499999999999999 110.552 172.814 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -157.58 161.75 28.56 Favored Pre-proline 0 N--CA 1.452 -0.374 0 C-N-CA 126.834 2.054 . . . . 0.20999999999999999 106.577 -170.5 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -68.1 164.65 31.26 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 123.178 2.585 . . . . 0.34000000000000002 111.807 -175.004 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -75.52 116.39 16.18 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 123.265 0.626 . . . . 0.26000000000000001 110.841 -176.064 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 40.4 pt -98.11 1.0 10.54 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.174 0 C-N-CA 123.162 0.585 . . . . 0.32000000000000001 110.886 176.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -43.13 -37.31 1.99 Allowed 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 114.037 1.125 . . . . 2.4199999999999999 114.037 174.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.13 23.7 13.97 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 124.899 1.28 . . . . 4.21 111.681 179.565 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -58.09 -43.4 87.03 Favored 'General case' 0 N--CA 1.45 -0.449 0 O-C-N 121.607 -0.683 . . . . 0.34000000000000002 109.573 178.877 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -51.38 -30.16 25.03 Favored Glycine 0 CA--C 1.529 0.913 0 N-CA-C 114.643 0.617 . . . . 0.60999999999999999 114.643 -178.714 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -87.28 -40.59 14.36 Favored 'General case' 0 C--O 1.227 -0.092 0 CA-C-N 117.965 0.882 . . . . 0.87 110.45 176.42 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 15.3 m-80 -62.48 -41.82 99.05 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 122.135 0.174 . . . . 1.5700000000000001 111.322 -179.529 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -140.35 142.74 35.55 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 125.722 1.609 . . . . 0.67000000000000004 107.649 -170.475 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 57.9 m -83.06 176.67 9.06 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 121.491 0.663 . . . . 1.72 110.504 177.78 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.468 ' HG3' ' HB2' ' A' ' 89' ' ' ALA . 2.8 mp0 -58.07 -45.75 86.59 Favored 'General case' 0 N--CA 1.454 -0.228 0 O-C-N 121.505 -0.747 . . . . 2.8100000000000001 110.705 -166.138 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -61.73 -38.78 89.19 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.228 0.611 . . . . 2.9700000000000002 110.199 -177.676 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.1 mp0 -70.33 -46.14 64.78 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 124.186 0.994 . . . . 4.21 108.489 -178.015 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 62.2 mt -62.96 -46.19 96.95 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.109 0 N-CA-C 108.834 -0.802 . . . . 0.23999999999999999 108.834 178.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 46.4 tp -51.8 -54.06 32.97 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 123.132 0.573 . . . . 0.35999999999999999 109.682 176.259 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -50.61 -52.48 38.98 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.338 0.655 . . . . 1.6000000000000001 110.586 175.615 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 76.2 mt -62.6 -25.76 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 O-C-N 121.652 -0.655 . . . . 0.72999999999999998 112.196 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 51.9 mt -73.26 -49.37 38.16 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 O-C-N 120.213 -1.554 . . . . 0.28000000000000003 108.993 170.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 86.7 mt -62.89 -34.28 77.08 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 125.006 1.322 . . . . 0.41999999999999998 114.238 -173.012 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -134.49 29.95 3.55 Favored 'General case' 0 C--N 1.342 0.257 0 CA-C-N 120.572 1.533 . . . . 3.2400000000000002 109.68 -172.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 37.95 -140.26 0.47 Allowed Glycine 0 CA--C 1.542 1.72 0 C-N-CA 127.05 2.262 . . . . 0.65000000000000002 111.837 -176.379 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 167.03 140.72 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 126.052 1.741 . . . . 1.27 109.516 -178.33 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 44.62 -120.67 3.74 Favored Glycine 0 CA--C 1.531 1.067 0 CA-C-N 119.684 1.129 . . . . 0.46000000000000002 112.551 -177.547 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -71.36 -19.46 77.58 Favored Glycine 0 CA--C 1.534 1.222 0 O-C-N 122.379 -0.483 . . . . 0.47999999999999998 112.972 178.675 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 17.1 ttt -72.25 119.94 77.57 Favored Pre-proline 0 CA--C 1.537 0.464 0 C-N-CA 123.762 0.825 . . . . 0.37 109.968 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -63.41 -53.25 1.51 Allowed 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 124.178 3.252 . . . . 2.8900000000000001 111.467 -169.273 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 114.39 152.07 10.47 Favored Glycine 0 N--CA 1.447 -0.596 0 CA-C-O 121.98 0.767 . . . . 0.94999999999999996 114.555 172.197 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 66.18 19.47 68.21 Favored Glycine 0 CA--C 1.531 1.04 0 CA-C-N 114.247 -0.976 . . . . 0.56999999999999995 111.74 -177.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 2.5 mt -50.21 -49.85 21.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 126.382 1.873 . . . . 1.05 110.793 177.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -111.44 155.36 23.31 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.467 1.107 . . . . 0.51000000000000001 108.909 159.817 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.5 mttm -146.13 157.87 43.86 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.276 1.43 . . . . 2.4399999999999999 109.859 178.439 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 56.49 -149.28 28.56 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 110.414 -1.074 . . . . 1.02 110.414 -176.746 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -51.18 -32.85 24.91 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 117.548 0.674 . . . . 0.58999999999999997 112.483 -178.217 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -51.79 -47.4 64.26 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.268 0.627 . . . . 2.3599999999999999 109.619 174.204 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -75.92 -49.23 18.42 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.175 0.59 . . . . 0.34999999999999998 111.304 175.807 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -57.34 -47.82 80.58 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 118.138 0.427 . . . . 2.0 111.503 -172.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.24 -49.07 77.19 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 109.625 -0.509 . . . . 0.28000000000000003 109.625 178.5 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.46 HG22 HG23 ' A' ' 28' ' ' VAL . 45.9 t -57.62 -52.62 55.09 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 C-N-CA 122.898 0.479 . . . . 0.38 111.035 178.827 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -52.04 -55.8 18.32 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 123.467 0.707 . . . . 0.35999999999999999 111.366 176.24 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.453 ' O ' ' HB3' ' A' ' 89' ' ' ALA . . . -59.69 -40.49 88.06 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.085 0.554 . . . . 0.46999999999999997 111.084 -178.16 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.406 ' CZ3' HG21 ' A' ' 28' ' ' VAL . 70.6 t90 -64.36 -52.44 58.32 Favored 'General case' 0 N--CA 1.453 -0.315 0 O-C-N 121.709 -0.619 . . . . 0.60999999999999999 109.727 177.032 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.52 -28.09 66.77 Favored 'General case' 0 C--O 1.224 -0.246 0 O-C-N 120.374 -1.454 . . . . 2.04 112.436 176.067 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.468 ' HB2' ' HG3' ' A' ' 57' ' ' GLU . . . -54.56 -35.34 63.16 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 119.036 0.834 . . . . 0.64000000000000001 111.387 169.871 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -70.64 -41.21 72.45 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 109.287 -0.634 . . . . 4.8600000000000003 109.287 174.368 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 4.1 mtpm? -74.33 105.85 5.69 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 120.988 0.423 . . . . 2.6400000000000001 111.459 -174.491 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.093 0 C-N-CA 126.341 1.856 . . . . 2.2799999999999998 106.736 170.643 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.2 t0 . . . . . 0 N--CA 1.45 -0.436 0 N-CA-C 103.487 -2.783 . . . . 3.6099999999999999 103.487 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -111.65 -62.07 1.61 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.447 -0.946 . . . . 0.38 108.447 173.798 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -58.05 -44.54 87.5 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.749 -0.66 . . . . 3.3599999999999999 110.417 -176.404 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.35 -36.7 83.05 Favored 'General case' 0 C--N 1.339 0.144 0 CA-C-N 118.707 0.685 . . . . 0.29999999999999999 111.21 -179.778 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 92.8 t -62.87 -55.98 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 N-CA-C 107.891 -1.152 . . . . 0.46000000000000002 107.891 176.748 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.548 HG13 ' HB2' ' A' ' 32' ' ' CYS . 74.0 t -52.76 -48.33 49.75 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 CA-C-N 117.547 0.158 . . . . 0.33000000000000002 110.868 -179.598 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.434 ' HA ' HG12 ' A' ' 33' ' ' ILE . 25.3 mm-40 -50.06 -21.03 1.11 Allowed 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 126.565 1.946 . . . . 0.56000000000000005 113.496 174.592 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 17.4 tp60 -144.67 55.1 1.25 Allowed 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 119.481 1.037 . . . . 3.9700000000000002 111.528 172.353 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -167.25 -38.29 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 124.005 0.922 . . . . 1.3500000000000001 110.025 170.623 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.548 ' HB2' HG13 ' A' ' 28' ' ' VAL . 3.7 m -99.58 -50.52 4.04 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 119.0 0.818 . . . . 0.20999999999999999 110.772 -178.662 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.434 HG12 ' HA ' ' A' ' 29' ' ' GLN . 2.2 pp -56.91 -26.26 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.153 0 CA-C-N 116.151 -0.477 . . . . 0.39000000000000001 111.89 -175.021 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.6 t -42.23 -32.33 0.48 Allowed 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.041 1.336 . . . . 2.1099999999999999 111.848 172.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 12.5 m -123.08 -43.71 2.21 Favored 'General case' 0 C--N 1.341 0.212 0 C-N-CA 123.413 0.685 . . . . 0.17000000000000001 111.593 173.912 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 84.3 m-70 -70.09 -10.18 57.9 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.745 0.818 . . . . 0.17999999999999999 112.768 -176.343 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 88.67 149.09 18.75 Favored Glycine 0 C--N 1.337 0.635 0 N-CA-C 109.747 -1.341 . . . . 1.52 109.747 178.593 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -43.28 -39.49 4.17 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 124.512 1.053 . . . . 0.44 111.485 176.264 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -94.03 -7.16 43.51 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 125.574 1.549 . . . . 3.1699999999999999 111.027 -170.68 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.9 mt 71.16 11.54 6.87 Favored 'General case' 0 C--N 1.35 0.589 0 CA-C-N 119.524 1.057 . . . . 1.0700000000000001 111.627 177.018 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 12.5 p -83.49 0.1 47.86 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 127.128 2.171 . . . . 0.37 109.742 -176.049 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.85 129.92 2.78 Favored Glycine 0 N--CA 1.442 -0.917 0 N-CA-C 108.978 -1.649 . . . . 0.56000000000000005 108.978 -178.747 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -135.95 -79.55 0.42 Allowed 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 124.195 0.998 . . . . 0.23000000000000001 108.825 178.873 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.6 t -90.28 4.62 50.16 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.948 0.899 . . . . 1.5900000000000001 110.705 172.783 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.566 ' HB1' ' HD2' ' A' ' 46' ' ' PRO . . . -158.08 168.89 11.55 Favored Pre-proline 0 CA--C 1.535 0.374 0 C-N-CA 124.688 1.195 . . . . 0.23999999999999999 108.387 -172.315 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.566 ' HD2' ' HB1' ' A' ' 45' ' ' ALA . 38.1 Cg_endo -70.01 158.72 55.73 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.927 2.418 . . . . 0.19 110.528 -174.44 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.53 126.74 30.92 Favored 'General case' 0 C--N 1.332 -0.162 0 O-C-N 121.516 -0.74 . . . . 0.26000000000000001 109.927 -178.098 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 50.6 pt -107.34 1.36 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 C-N-CA 123.716 0.806 . . . . 0.27000000000000002 111.331 176.729 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 18.5 p-10 -35.75 -49.56 0.6 Allowed 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 124.894 1.278 . . . . 3.5299999999999998 111.744 171.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.68 32.32 4.62 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 127.232 2.213 . . . . 3.5899999999999999 113.103 -179.56 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.12 -49.24 78.61 Favored 'General case' 0 CA--C 1.535 0.371 0 O-C-N 120.746 -1.221 . . . . 0.44 110.147 177.462 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -54.11 -17.26 7.33 Favored Glycine 0 C--N 1.343 0.926 0 C-N-CA 124.64 1.114 . . . . 0.67000000000000004 114.886 178.654 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.7 -40.7 88.58 Favored 'General case' 0 N--CA 1.453 -0.32 0 O-C-N 121.373 -1.075 . . . . 1.03 110.978 176.84 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 -105.5 -52.05 2.9 Favored 'General case' 0 CA--C 1.52 -0.198 0 N-CA-C 109.563 -0.532 . . . . 2.7599999999999998 109.563 -172.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -92.7 147.86 22.53 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.725 -1.213 . . . . 0.81000000000000005 107.725 -176.187 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -96.29 167.29 11.28 Favored 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 108.383 -0.969 . . . . 1.96 108.383 174.918 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -45.27 -43.51 10.6 Favored 'General case' 0 C--O 1.225 -0.216 0 C-N-CA 124.797 1.239 . . . . 2.7999999999999998 111.484 177.014 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -55.82 -49.29 73.65 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.842 0.857 . . . . 3.04 110.72 178.67 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -74.55 -43.25 56.62 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 123.228 0.611 . . . . 3.1699999999999999 109.423 -175.231 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 61.4 mt -60.57 -45.22 97.54 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 109.173 -0.677 . . . . 0.32000000000000001 109.173 179.537 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 55.2 tp -55.44 -50.44 69.81 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.274 -0.639 . . . . 0.34999999999999998 109.274 176.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -53.79 -48.75 69.5 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 121.197 -0.201 . . . . 1.5 110.562 175.642 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 49.7 mt -63.88 -21.09 27.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 O-C-N 121.421 -0.799 . . . . 0.94999999999999996 112.48 179.499 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 66.1 mt -78.63 -44.99 25.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 O-C-N 120.264 -1.522 . . . . 0.26000000000000001 109.207 173.641 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 80.7 mt -75.64 -31.28 59.76 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 113.43 0.9 . . . . 0.75 113.43 -176.132 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -120.06 19.47 12.28 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 119.641 1.109 . . . . 1.75 109.592 -171.828 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.536 ' N ' ' HA2' ' A' ' 73' ' ' GLY . . . 36.42 -136.99 0.5 Allowed Glycine 0 CA--C 1.532 1.148 0 C-N-CA 127.689 2.566 . . . . 0.68999999999999995 111.169 -173.12 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 31.1 tt0 166.73 138.38 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 125.718 1.607 . . . . 1.1299999999999999 109.988 177.183 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 41.3 -119.95 1.74 Allowed Glycine 0 CA--C 1.531 1.072 0 O-C-N 120.436 -1.415 . . . . 0.35999999999999999 113.157 -173.309 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -71.66 -18.44 77.27 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 123.374 0.512 . . . . 0.47999999999999998 112.976 179.549 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 23.3 ttt -71.55 118.69 68.57 Favored Pre-proline 0 N--CA 1.45 -0.426 0 C-N-CA 123.734 0.813 . . . . 0.39000000000000001 110.52 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -75.25 125.03 8.89 Favored 'Trans proline' 0 N--CA 1.442 -1.53 0 C-N-CA 121.845 1.697 . . . . 2.1600000000000001 109.923 179.302 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.536 ' HA2' ' N ' ' A' ' 67' ' ' GLY . . . -63.56 140.44 44.56 Favored Glycine 0 N--CA 1.44 -1.077 0 CA-C-N 115.077 -0.965 . . . . 0.57999999999999996 114.558 178.91 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 84.74 33.72 17.98 Favored Glycine 0 CA--C 1.525 0.668 0 CA-C-N 113.95 -1.125 . . . . 0.32000000000000001 111.329 173.242 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -61.47 -50.76 79.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 124.606 1.162 . . . . 2.2799999999999998 109.247 179.007 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -104.18 154.39 19.81 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.668 1.587 . . . . 0.37 109.476 164.197 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.3 mtmp? -143.74 150.97 39.41 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 124.781 1.232 . . . . 5.0599999999999996 109.556 179.003 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 68.82 -163.21 50.39 Favored Glycine 0 CA--C 1.528 0.886 0 N-CA-C 110.379 -1.088 . . . . 0.70999999999999996 110.379 -173.719 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -48.6 -31.05 6.03 Favored 'General case' 0 C--O 1.226 -0.166 0 C-N-CA 123.967 0.907 . . . . 0.79000000000000004 112.053 -179.303 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -41.73 -54.85 3.18 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.778 1.231 . . . . 1.96 109.904 174.416 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.17 -45.25 77.56 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 122.822 0.449 . . . . 0.22 110.93 -179.454 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 57.4 mt-10 -55.98 -51.62 67.05 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.162 0.985 . . . . 1.9199999999999999 110.643 -176.706 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -53.34 -52.01 60.58 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.027 0.931 . . . . 0.28000000000000003 110.451 176.583 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.527 HG22 HG23 ' A' ' 28' ' ' VAL . 77.0 t -55.02 -52.04 48.0 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 C-N-CA 120.997 -0.281 . . . . 0.34999999999999998 110.395 178.226 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -53.79 -51.51 63.23 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 123.172 0.589 . . . . 0.17999999999999999 111.972 179.569 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.77 -48.43 77.87 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 123.611 0.764 . . . . 0.31 110.701 178.18 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.565 ' CE3' HD23 ' A' ' 88' ' ' LEU . 48.9 t90 -61.61 -45.6 93.41 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 121.916 -0.49 . . . . 0.69999999999999996 110.386 179.065 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.565 HD23 ' CE3' ' A' ' 87' ' ' TRP . 0.1 OUTLIER -64.17 -32.68 74.35 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 124.427 1.091 . . . . 1.54 111.184 178.337 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -65.66 -44.63 85.72 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 123.377 0.671 . . . . 0.41999999999999998 110.279 171.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -59.83 -39.45 85.16 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 109.924 -0.398 . . . . 3.6499999999999999 109.924 174.299 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -73.62 149.88 41.75 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 121.526 0.679 . . . . 2.7000000000000002 110.878 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 18.6 mttt . . . . . 0 C--O 1.251 1.144 0 N-CA-C 105.274 -2.121 . . . . 2.7200000000000002 105.274 177.345 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.444 ' HB3' ' HB3' ' A' ' 26' ' ' ALA . 0.7 OUTLIER . . . . . 0 N--CA 1.446 -0.645 0 N-CA-C 109.088 -0.708 . . . . 3.1099999999999999 109.088 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -105.18 -64.12 1.16 Allowed 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 107.975 -1.12 . . . . 0.37 107.975 174.672 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -48.92 -48.95 42.19 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 115.65 -0.704 . . . . 2.8599999999999999 111.166 178.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.444 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . . . -59.56 -44.96 93.11 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 118.878 0.763 . . . . 0.28000000000000003 111.426 -177.937 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 71.9 t -59.8 -54.19 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 N-CA-C 108.495 -0.928 . . . . 0.44 108.495 177.749 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.538 HG13 ' HB2' ' A' ' 32' ' ' CYS . 85.5 t -54.39 -50.74 55.12 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-N 117.979 0.354 . . . . 0.32000000000000001 110.595 -178.391 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 34.8 mm-40 -53.48 -15.68 1.18 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 126.696 1.998 . . . . 0.62 112.931 174.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -135.94 32.75 2.93 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 119.416 1.007 . . . . 2.8500000000000001 113.129 173.26 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 8.3 mtmt -152.37 -56.67 0.14 Allowed 'General case' 0 CA--C 1.521 -0.145 0 CA-C-N 118.694 0.679 . . . . 1.76 109.633 172.272 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.538 ' HB2' HG13 ' A' ' 28' ' ' VAL . 4.0 m -75.08 -49.78 18.57 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 121.071 0.462 . . . . 0.20000000000000001 110.406 -171.415 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.4 pp -53.38 -27.16 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.142 0 CA-C-N 115.487 -0.779 . . . . 0.40999999999999998 111.963 179.031 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.5 t -46.86 -29.19 1.86 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.27 1.028 . . . . 2.1000000000000001 111.92 176.589 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 15.9 m -122.45 -42.1 2.36 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.433 0.693 . . . . 0.29999999999999999 111.662 170.368 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 89.0 m-70 -70.5 -4.44 22.84 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.226 1.01 . . . . 0.32000000000000001 112.722 -177.16 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 116.44 -76.25 0.27 Allowed Glycine 0 C--N 1.339 0.746 0 C-N-CA 125.269 1.414 . . . . 3.1899999999999999 111.927 161.183 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -178.91 -51.24 0.08 OUTLIER Glycine 0 CA--C 1.519 0.318 0 N-CA-C 108.597 -1.801 . . . . 0.81000000000000005 108.597 -170.576 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -101.36 3.79 40.9 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 124.086 0.955 . . . . 2.2000000000000002 110.777 -174.555 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.495 HD21 ' CG1' ' A' ' 28' ' ' VAL . 15.3 mt 75.4 11.61 3.35 Favored 'General case' 0 C--N 1.351 0.661 0 CA-C-N 119.764 1.165 . . . . 1.3100000000000001 110.384 -178.609 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.6 p -81.24 -9.3 59.8 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 127.941 2.496 . . . . 0.48999999999999999 109.913 -175.248 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.41 143.68 9.26 Favored Glycine 0 N--CA 1.441 -0.994 0 N-CA-C 109.142 -1.583 . . . . 0.46999999999999997 109.142 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -152.92 -81.92 0.09 Allowed 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 124.137 0.975 . . . . 0.57999999999999996 108.978 -178.406 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -88.93 3.44 51.44 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.544 1.137 . . . . 0.98999999999999999 110.828 171.142 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -156.05 160.9 30.46 Favored Pre-proline 0 N--CA 1.449 -0.499 0 C-N-CA 125.988 1.715 . . . . 0.33000000000000002 107.266 -169.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -68.17 160.03 50.6 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 123.466 2.778 . . . . 0.40000000000000002 111.069 -174.539 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.45 125.65 28.39 Favored 'General case' 0 N--CA 1.455 -0.224 0 O-C-N 121.513 -0.742 . . . . 0.28999999999999998 109.762 -177.397 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 46.1 pt -105.29 2.54 10.39 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 C-N-CA 123.555 0.742 . . . . 0.39000000000000001 111.482 175.647 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -33.39 -47.9 0.23 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.528 1.931 . . . . 2.48 112.869 166.788 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.7 33.68 5.22 Favored 'General case' 0 C--N 1.344 0.35 0 C-N-CA 124.389 1.075 . . . . 4.6600000000000001 110.281 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.22 -46.91 88.14 Favored 'General case' 0 N--CA 1.45 -0.435 0 O-C-N 121.15 -0.969 . . . . 0.37 108.923 176.081 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -56.87 -23.02 43.66 Favored Glycine 0 C--N 1.341 0.813 0 CA-C-N 118.65 0.659 . . . . 0.59999999999999998 114.588 178.898 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -83.92 -47.38 11.09 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 117.81 0.805 . . . . 0.70999999999999996 109.558 173.602 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 13.2 m-80 -59.5 -49.91 75.96 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.016 0.526 . . . . 1.6499999999999999 111.535 -178.515 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -137.06 154.81 50.25 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.472 1.509 . . . . 0.87 108.578 -169.164 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.6 p -84.57 165.87 17.65 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 123.925 0.89 . . . . 2.3500000000000001 110.226 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -50.53 -39.39 48.88 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 123.723 0.809 . . . . 3.2400000000000002 111.407 178.737 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -57.29 -50.46 72.84 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 118.457 0.571 . . . . 4.5199999999999996 110.83 177.21 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 27.5 mm-40 -68.09 -46.2 71.63 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 121.733 0.777 . . . . 3.0899999999999999 108.917 -175.474 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 48.7 mt -60.19 -47.31 92.6 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 N-CA-C 109.44 -0.578 . . . . 0.39000000000000001 109.44 -179.431 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.9 tp -58.45 -49.58 76.8 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 109.117 -0.697 . . . . 0.35999999999999999 109.117 178.845 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -50.42 -51.05 49.96 Favored 'General case' 0 N--CA 1.452 -0.355 0 O-C-N 123.409 0.443 . . . . 1.8200000000000001 109.961 176.27 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 55.0 mt -57.62 -52.32 58.92 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 O-C-N 121.868 -0.52 . . . . 0.51000000000000001 110.957 178.226 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 60.7 mt -53.4 -44.9 56.45 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 O-C-N 120.561 -1.337 . . . . 0.26000000000000001 110.404 179.383 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 75.1 mt -72.91 -32.67 65.49 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 113.361 0.874 . . . . 0.55000000000000004 113.361 -178.386 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -123.04 19.77 9.98 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 119.655 1.116 . . . . 1.74 109.981 -165.4 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.562 ' N ' ' HA2' ' A' ' 73' ' ' GLY . . . 31.0 -142.98 0.02 OUTLIER Glycine 0 CA--C 1.533 1.207 0 C-N-CA 129.107 3.242 . . . . 0.62 111.492 -167.477 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 173.27 133.41 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 119.005 1.403 . . . . 1.3799999999999999 109.057 -175.147 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 35.39 -113.64 0.14 Allowed Glycine 0 CA--C 1.534 1.224 0 CA-C-N 120.019 1.282 . . . . 0.46999999999999997 113.925 -171.694 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -71.76 -21.42 78.91 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 123.47 0.557 . . . . 0.60999999999999999 112.936 -178.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 19.6 ttt -71.13 117.98 61.54 Favored Pre-proline 0 N--CA 1.451 -0.409 0 C-N-CA 124.994 1.318 . . . . 0.42999999999999999 110.793 179.507 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.548 ' HD2' HD11 ' A' ' 75' ' ' ILE . 41.3 Cg_endo -77.95 123.76 6.42 Favored 'Trans proline' 0 N--CA 1.447 -1.262 0 C-N-CA 122.938 2.425 . . . . 2.1000000000000001 111.015 -178.913 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.562 ' HA2' ' N ' ' A' ' 67' ' ' GLY . . . -59.48 137.06 50.21 Favored Glycine 0 N--CA 1.444 -0.815 0 N-CA-C 115.688 1.035 . . . . 0.68000000000000005 115.688 -177.262 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 80.49 38.64 16.84 Favored Glycine 0 CA--C 1.525 0.688 0 CA-C-N 114.071 -1.064 . . . . 0.32000000000000001 111.005 174.53 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.548 HD11 ' HD2' ' A' ' 72' ' ' PRO . 1.2 mt -58.35 -58.04 8.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 124.892 1.277 . . . . 1.1299999999999999 109.255 174.4 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -93.97 151.5 19.5 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 108.31 -0.996 . . . . 0.39000000000000001 108.31 163.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -143.0 164.81 29.08 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 105.985 -1.857 . . . . 3.3999999999999999 105.985 172.899 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 75.17 -173.19 53.02 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 110.306 -1.117 . . . . 1.3100000000000001 110.306 -173.661 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -51.46 -27.96 11.83 Favored 'General case' 0 C--O 1.225 -0.23 0 C-N-CA 123.877 0.871 . . . . 0.82999999999999996 111.628 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 6.2 mp0 -42.23 -57.85 2.38 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 124.097 0.959 . . . . 4.5899999999999999 111.39 170.671 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -58.24 -47.98 81.82 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 118.519 0.599 . . . . 0.40999999999999998 110.782 -175.625 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -52.37 -60.92 2.65 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 124.507 1.123 . . . . 2.04 111.348 174.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -55.16 -47.34 75.28 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 124.233 1.013 . . . . 0.34999999999999998 109.922 -177.418 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 62.4 t -55.91 -55.58 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 C-N-CA 123.669 0.788 . . . . 0.35999999999999999 110.339 176.883 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -51.4 -53.75 33.46 Favored 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 123.178 0.591 . . . . 0.23999999999999999 111.614 176.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -63.34 -42.13 98.92 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.872 0.869 . . . . 0.35999999999999999 110.784 -175.779 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.495 ' CZ3' HG21 ' A' ' 28' ' ' VAL . 62.0 t90 -58.69 -50.8 72.56 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 108.626 -0.879 . . . . 0.47999999999999998 108.626 174.507 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.39 -32.1 69.85 Favored 'General case' 0 C--O 1.222 -0.357 0 O-C-N 120.512 -1.367 . . . . 1.98 112.585 173.381 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -60.64 -32.02 71.21 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 119.556 1.071 . . . . 0.67000000000000004 111.925 172.78 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -77.59 -34.64 53.49 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 119.668 1.122 . . . . 3.8999999999999999 111.643 168.454 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 21.6 mtpp -73.96 116.32 14.44 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 119.806 1.185 . . . . 2.9500000000000002 111.029 -175.69 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 12.3 mttt . . . . . 0 C--O 1.254 1.299 0 C-N-CA 127.787 2.435 . . . . 2.6499999999999999 105.569 -176.747 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 . . . . . 0 N--CA 1.449 -0.477 0 N-CA-C 108.45 -0.945 . . . . 2.23 108.45 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -41.64 -57.38 2.3 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 124.951 1.3 . . . . 0.34999999999999998 111.371 177.175 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -55.67 -48.21 75.43 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 116.314 -0.403 . . . . 2.3300000000000001 111.502 179.451 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.16 -44.7 83.72 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 118.266 0.485 . . . . 0.38 110.921 178.256 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.439 HG21 ' HG3' ' A' ' 80' ' ' GLU . 54.6 t -57.53 -55.67 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 N-CA-C 109.332 -0.618 . . . . 0.33000000000000002 109.332 175.946 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.666 HG13 ' HB2' ' A' ' 32' ' ' CYS . 78.9 t -54.08 -49.61 60.13 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 N-CA-C 110.292 -0.262 . . . . 0.39000000000000001 110.292 -177.316 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.421 ' HA ' HG12 ' A' ' 33' ' ' ILE . 30.6 mm-40 -51.83 -15.97 0.61 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.624 1.969 . . . . 0.87 113.588 174.266 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.43 30.96 2.61 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 119.313 0.961 . . . . 2.3900000000000001 112.314 178.496 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 5.0 mtmt -157.08 -47.31 0.07 Allowed 'General case' 0 CA--C 1.519 -0.214 0 O-C-N 121.85 -0.531 . . . . 1.49 111.384 173.749 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.666 ' HB2' HG13 ' A' ' 28' ' ' VAL . 4.3 m -86.26 -48.13 8.8 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.65 -0.5 . . . . 0.20000000000000001 109.65 -174.556 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.421 HG12 ' HA ' ' A' ' 29' ' ' GLN . 2.5 pp -55.22 -27.8 20.51 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 CA-C-N 115.854 -0.612 . . . . 0.38 112.332 -177.314 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.7 m -42.53 -34.42 0.85 Allowed 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.692 1.197 . . . . 1.0800000000000001 112.702 172.63 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 26.2 m -120.05 -41.37 2.65 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.134 0.574 . . . . 0.17999999999999999 111.763 174.292 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 84.5 m-70 -73.49 -7.85 53.49 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.712 0.805 . . . . 0.23999999999999999 112.688 -176.881 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 87.94 149.14 16.85 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 109.825 -1.31 . . . . 1.48 109.825 178.58 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -42.92 -34.89 2.08 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 124.78 1.181 . . . . 0.45000000000000001 112.237 173.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -97.84 -6.99 31.35 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 125.737 1.615 . . . . 2.29 111.537 -171.493 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.2 mt 71.89 10.73 6.22 Favored 'General case' 0 C--N 1.351 0.665 0 CA-C-N 120.604 1.547 . . . . 1.1599999999999999 111.232 176.248 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.7 p -88.79 0.43 56.53 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 128.603 2.761 . . . . 0.35999999999999999 109.992 -173.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.84 124.21 1.73 Allowed Glycine 0 N--CA 1.439 -1.106 0 N-CA-C 109.271 -1.532 . . . . 0.75 109.271 178.832 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -128.5 -78.74 0.57 Allowed 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 124.368 1.067 . . . . 0.28999999999999998 108.873 177.237 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 21.4 m -93.67 4.55 53.77 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.387 1.075 . . . . 1.28 111.104 172.734 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -152.16 163.28 24.09 Favored Pre-proline 0 CA--C 1.534 0.358 0 C-N-CA 126.096 1.758 . . . . 0.31 107.164 -171.873 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -70.52 160.59 48.98 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 122.683 2.255 . . . . 0.26000000000000001 110.423 -176.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.52 128.23 34.91 Favored 'General case' 0 C--N 1.332 -0.187 0 O-C-N 121.461 -0.774 . . . . 0.31 110.255 -176.48 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.425 HD12 HD11 ' A' ' 88' ' ' LEU . 26.7 pt -108.21 0.84 9.74 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 C-N-CA 123.904 0.882 . . . . 0.34999999999999998 111.931 177.309 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 22.8 p-10 -33.08 -50.67 0.29 Allowed 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.812 1.645 . . . . 3.8700000000000001 113.243 169.342 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 12.6 pttp -111.96 22.46 14.85 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 125.796 1.638 . . . . 4.8600000000000003 112.054 -178.375 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -54.72 -38.34 66.97 Favored 'General case' 0 C--O 1.224 -0.285 0 O-C-N 121.632 -0.667 . . . . 0.35999999999999999 109.576 177.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -57.96 -17.58 29.91 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 123.862 0.744 . . . . 0.57999999999999996 114.927 176.881 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -90.0 -39.58 12.87 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 118.295 1.048 . . . . 0.69999999999999996 109.733 172.247 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -63.17 -48.86 76.63 Favored 'General case' 0 CA--C 1.527 0.084 0 C-N-CA 123.129 0.572 . . . . 2.5800000000000001 111.504 178.622 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -141.05 148.88 40.91 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 125.695 1.598 . . . . 0.65000000000000002 107.969 -166.68 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 16.6 m -81.89 167.57 18.83 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 118.39 0.541 . . . . 1.54 110.573 179.194 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -46.9 -43.12 18.57 Favored 'General case' 0 C--O 1.225 -0.225 0 C-N-CA 124.191 0.996 . . . . 3.1000000000000001 111.424 175.896 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -55.13 -45.62 75.61 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.039 0.936 . . . . 2.6899999999999999 110.568 179.473 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -73.42 -49.42 27.11 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 123.766 0.826 . . . . 3.1200000000000001 109.75 -178.007 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 72.8 mt -60.05 -42.76 90.9 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 N-CA-C 108.618 -0.882 . . . . 0.22 108.618 -176.887 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 23.4 tp -55.01 -52.11 64.15 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 123.473 0.709 . . . . 0.40000000000000002 109.739 175.199 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -52.04 -48.31 64.62 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 118.118 0.417 . . . . 1.5 111.136 176.168 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 95.6 mt -57.81 -54.22 34.56 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 O-C-N 121.348 -0.845 . . . . 0.67000000000000004 110.446 177.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 38.3 mt -50.0 -46.02 23.22 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 O-C-N 121.163 -0.961 . . . . 0.34000000000000002 109.909 178.483 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 96.5 mt -62.96 -40.02 96.41 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 118.044 -0.979 . . . . 0.60999999999999999 113.395 177.514 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -127.85 25.45 5.96 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 120.369 1.44 . . . . 1.8400000000000001 110.442 -159.59 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 23.57 -134.98 0.01 OUTLIER Glycine 0 CA--C 1.542 1.758 0 C-N-CA 127.615 2.531 . . . . 0.65000000000000002 112.694 -159.608 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 21.6 tt0 169.25 138.62 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.148 0 CA-C-N 119.799 1.8 . . . . 1.22 108.933 -177.476 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 30.06 -111.15 0.03 OUTLIER Glycine 0 CA--C 1.534 1.247 0 C-N-CA 125.212 1.387 . . . . 0.44 114.154 -171.791 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -66.97 -25.85 73.25 Favored Glycine 0 CA--C 1.534 1.226 0 CA-C-N 118.069 0.935 . . . . 0.55000000000000004 113.415 -178.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 16.7 ttt -70.9 120.67 80.72 Favored Pre-proline 0 CA--C 1.536 0.441 0 C-N-CA 124.747 1.219 . . . . 0.39000000000000001 110.033 -179.448 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -61.89 -56.0 0.9 Allowed 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 124.358 3.372 . . . . 2.96 111.237 -169.139 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 118.25 151.56 9.16 Favored Glycine 0 N--CA 1.447 -0.63 0 CA-C-N 115.58 -0.736 . . . . 0.91000000000000003 113.874 173.33 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 65.73 22.47 70.05 Favored Glycine 0 CA--C 1.528 0.849 0 CA-C-N 114.313 -0.943 . . . . 0.41999999999999998 111.522 -179.165 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 2.6 mt -50.13 -57.51 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 C-N-CA 125.282 1.433 . . . . 1.0600000000000001 109.462 176.107 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -102.62 152.74 20.84 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.36 0.664 . . . . 0.37 109.794 163.538 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 3.2 mmmp? -145.03 151.82 39.16 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.594 1.158 . . . . 3.79 109.598 177.043 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 71.99 -156.67 52.61 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 123.518 0.58 . . . . 0.70999999999999996 111.749 177.887 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -48.22 -35.59 12.18 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 124.941 1.296 . . . . 0.81999999999999995 112.09 -177.007 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.439 ' HG3' HG21 ' A' ' 27' ' ' VAL . 43.5 tt0 -47.45 -63.53 1.03 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.897 1.279 . . . . 2.1800000000000002 110.715 169.406 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.03 -44.34 94.69 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.979 0.912 . . . . 0.28999999999999998 110.794 -179.275 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -54.59 -52.31 62.55 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 121.219 0.533 . . . . 2.5299999999999998 110.047 179.106 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.13 -51.67 68.76 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.57 0.748 . . . . 0.20999999999999999 109.971 179.329 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 55.7 t -49.55 -56.71 2.67 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 123.027 0.531 . . . . 0.45000000000000001 111.012 176.312 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -53.44 -51.9 61.16 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 124.059 0.944 . . . . 0.19 111.855 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.95 -48.61 80.99 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 121.599 0.714 . . . . 0.28999999999999998 110.434 -179.428 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.529 ' CE3' HD23 ' A' ' 88' ' ' LEU . 49.9 t90 -56.5 -43.35 79.65 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.165 0.586 . . . . 0.40000000000000002 110.303 177.931 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.529 HD23 ' CE3' ' A' ' 87' ' ' TRP . 0.1 OUTLIER -63.43 -42.31 98.71 Favored 'General case' 0 C--O 1.227 -0.117 0 C-N-CA 123.646 0.778 . . . . 1.5800000000000001 110.862 175.568 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -55.36 -38.15 68.42 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 119.236 0.925 . . . . 0.40999999999999998 110.716 171.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -84.15 13.09 5.49 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.655 1.182 . . . . 3.5299999999999998 113.655 174.063 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.46 122.7 43.37 Favored 'General case' 0 C--N 1.34 0.189 0 CA-C-N 119.954 1.252 . . . . 2.2799999999999998 109.733 173.907 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.255 1.378 0 C-N-CA 127.541 2.336 . . . . 2.8100000000000001 104.959 178.097 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 . . . . . 0 N--CA 1.449 -0.491 0 N-CA-C 107.786 -1.19 . . . . 2.5899999999999999 107.786 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -49.69 -50.22 44.51 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.204 1.002 . . . . 0.58999999999999997 109.805 179.675 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -60.61 -51.59 68.77 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 116.002 -0.544 . . . . 3.2000000000000002 110.414 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.99 -45.28 79.06 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 118.916 0.78 . . . . 0.58999999999999997 110.99 -178.767 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.545 HG21 ' HG3' ' A' ' 80' ' ' GLU . 24.5 t -56.64 -56.43 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 CA-C-N 116.12 -0.491 . . . . 0.81000000000000005 109.713 175.92 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.639 HG22 ' SG ' ' A' ' 32' ' ' CYS . 52.2 t -55.68 -45.72 79.22 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 N-CA-C 110.005 -0.369 . . . . 0.40000000000000002 110.005 -178.384 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.439 ' HA ' HG12 ' A' ' 33' ' ' ILE . 26.0 mm-40 -55.72 -11.31 0.91 Allowed 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 127.355 2.262 . . . . 0.83999999999999997 113.859 173.699 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -139.05 16.62 2.63 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 119.63 1.104 . . . . 2.9199999999999999 113.514 173.847 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 23.6 mttm -135.86 -62.79 0.67 Allowed 'General case' 0 CA--C 1.518 -0.257 0 C-N-CA 123.919 0.888 . . . . 2.2799999999999998 109.457 176.807 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.639 ' SG ' HG22 ' A' ' 28' ' ' VAL . 3.2 m -72.71 -47.93 42.99 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.096 0.474 . . . . 0.27000000000000002 110.43 -173.704 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.439 HG12 ' HA ' ' A' ' 29' ' ' GLN . 2.2 pp -58.72 -25.13 27.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 CA-C-N 115.533 -0.758 . . . . 0.38 111.688 -174.483 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.6 m -46.16 -32.93 3.23 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.829 1.251 . . . . 1.1100000000000001 111.768 175.552 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 21.6 m -120.31 -42.57 2.56 Favored 'General case' 0 C--N 1.341 0.21 0 C-N-CA 123.523 0.729 . . . . 0.19 111.516 175.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -72.56 -8.63 56.15 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.577 0.751 . . . . 0.20999999999999999 112.667 -177.321 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 86.46 148.81 12.71 Favored Glycine 0 C--N 1.336 0.567 0 N-CA-C 109.442 -1.463 . . . . 1.47 109.442 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -42.05 -33.43 1.23 Allowed Glycine 0 CA--C 1.527 0.821 0 C-N-CA 125.241 1.401 . . . . 0.47999999999999998 112.914 175.814 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -100.66 -4.8 27.62 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 125.408 1.483 . . . . 3.1099999999999999 112.089 -170.935 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 13.0 mt 68.94 12.94 8.77 Favored 'General case' 0 C--N 1.352 0.699 0 CA-C-N 120.212 1.369 . . . . 1.0900000000000001 112.002 177.313 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 11.0 p -84.32 -3.63 58.37 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 127.329 2.252 . . . . 0.41999999999999998 110.365 -177.078 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.72 130.7 3.74 Favored Glycine 0 N--CA 1.441 -0.988 0 N-CA-C 108.943 -1.663 . . . . 0.58999999999999997 108.943 -176.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -134.5 -79.44 0.45 Allowed 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 124.285 1.034 . . . . 0.28999999999999998 108.471 177.175 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 19.5 m -91.61 4.28 53.04 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.208 1.003 . . . . 1.3 111.043 173.144 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -155.72 163.95 22.95 Favored Pre-proline 0 CA--C 1.536 0.407 0 C-N-CA 125.388 1.475 . . . . 0.22 107.884 -169.4 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -70.74 157.97 56.99 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.915 2.41 . . . . 0.23999999999999999 110.582 -174.715 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.52 123.44 23.93 Favored 'General case' 0 C--N 1.331 -0.208 0 O-C-N 121.492 -0.755 . . . . 0.23000000000000001 110.16 -175.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 44.0 pt -106.78 2.22 10.09 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.135 0 C-N-CA 124.22 1.008 . . . . 0.29999999999999999 111.132 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.439 ' OD1' ' NZ ' ' A' ' 91' ' ' LYS . 24.4 t0 -42.01 -49.59 4.67 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 118.457 0.571 . . . . 2.8999999999999999 112.149 177.643 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 5.3 pttt -101.28 26.32 7.28 Favored 'General case' 0 C--N 1.344 0.331 0 C-N-CA 125.743 1.617 . . . . 4.7999999999999998 111.698 -178.721 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -53.74 -43.13 68.88 Favored 'General case' 0 N--CA 1.457 -0.122 0 O-C-N 121.483 -0.761 . . . . 0.29999999999999999 110.302 -178.301 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -52.05 -23.82 12.92 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 114.682 0.633 . . . . 0.60999999999999999 114.682 175.438 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -80.99 -35.69 31.67 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 118.061 0.931 . . . . 0.98999999999999999 110.509 175.42 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 -74.2 -48.36 29.53 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 122.814 0.446 . . . . 2.0299999999999998 109.997 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -140.4 153.67 46.42 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.356 1.062 . . . . 0.80000000000000004 109.274 -170.073 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 20.0 m -83.83 166.92 17.53 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 118.485 0.584 . . . . 1.6399999999999999 110.684 178.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.2 pm0 -47.07 -42.41 18.64 Favored 'General case' 0 C--O 1.223 -0.293 0 C-N-CA 124.793 1.237 . . . . 2.79 111.92 178.694 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -58.44 -45.83 87.73 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.378 0.609 . . . . 2.6600000000000001 110.152 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -74.2 -46.68 40.38 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.599 0.76 . . . . 3.2000000000000002 109.134 -176.185 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 62.6 mt -59.32 -44.28 91.95 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.132 0 O-C-N 121.475 -0.766 . . . . 0.38 109.018 179.263 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 52.8 tp -54.43 -51.17 65.79 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 109.14 -0.689 . . . . 0.44 109.14 176.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -52.48 -50.16 63.25 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 123.297 0.373 . . . . 1.5 110.253 174.147 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 76.7 mt -61.65 -24.09 32.88 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 O-C-N 121.323 -0.861 . . . . 1.01 112.621 179.527 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 75.1 mt -82.38 -46.66 19.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 O-C-N 120.059 -1.65 . . . . 0.35999999999999999 109.621 176.129 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 68.7 mt -72.64 -30.29 64.19 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.395 1.078 . . . . 0.77000000000000002 112.713 -176.146 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -127.39 17.31 7.06 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 119.207 0.912 . . . . 1.96 109.614 -169.335 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.585 ' N ' ' HA2' ' A' ' 73' ' ' GLY . . . 40.41 -143.87 0.55 Allowed Glycine 0 CA--C 1.539 1.539 0 C-N-CA 127.759 2.6 . . . . 0.70999999999999996 111.814 -177.722 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 31.4 tt0 170.12 138.18 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 126.069 1.748 . . . . 1.2 109.731 -179.734 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 35.76 -116.62 0.28 Allowed Glycine 0 C--N 1.347 1.16 0 CA-C-N 120.46 1.482 . . . . 0.42999999999999999 114.082 -175.778 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -67.32 -23.16 73.27 Favored Glycine 0 CA--C 1.531 1.091 0 CA-C-N 117.98 0.89 . . . . 0.53000000000000003 112.555 -179.297 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 18.6 ttt -72.7 117.96 63.84 Favored Pre-proline 0 CA--C 1.535 0.398 0 C-N-CA 124.45 1.1 . . . . 0.51000000000000001 112.053 179.654 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.417 ' HD2' HD11 ' A' ' 75' ' ' ILE . 37.2 Cg_endo -75.57 123.78 7.8 Favored 'Trans proline' 0 N--CA 1.446 -1.277 0 C-N-CA 122.848 2.366 . . . . 2.1099999999999999 111.706 -179.763 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.585 ' HA2' ' N ' ' A' ' 67' ' ' GLY . . . -58.01 126.67 43.01 Favored Glycine 0 N--CA 1.443 -0.889 0 CA-C-N 115.012 -0.995 . . . . 0.69999999999999996 115.246 179.191 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 86.66 48.01 4.63 Favored Glycine 0 C--N 1.337 0.636 0 N-CA-C 110.648 -0.981 . . . . 0.57999999999999996 110.648 173.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.417 HD11 ' HD2' ' A' ' 72' ' ' PRO . 1.1 mt -69.11 -50.88 49.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 123.833 0.853 . . . . 1.1799999999999999 109.497 175.168 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -102.92 153.63 20.02 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 126.002 1.721 . . . . 0.38 109.619 164.585 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 44.9 mttm -143.63 155.36 44.23 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 125.386 1.475 . . . . 2.79 108.861 178.916 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 72.63 -167.77 53.43 Favored Glycine 0 CA--C 1.53 0.981 0 N-CA-C 110.926 -0.869 . . . . 0.91000000000000003 110.926 -175.183 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -52.04 -25.95 9.76 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.469 1.108 . . . . 1.0600000000000001 112.728 -177.624 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.545 ' HG3' HG21 ' A' ' 27' ' ' VAL . 34.8 tt0 -42.19 -60.3 1.5 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.723 1.209 . . . . 2.21 110.939 168.778 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.27 -45.73 92.28 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 122.608 0.363 . . . . 0.34000000000000002 110.638 -175.643 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -52.11 -57.12 10.55 Favored 'General case' 0 N--CA 1.461 0.096 0 C-N-CA 123.503 0.721 . . . . 3.04 111.196 174.129 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -53.95 -48.48 70.25 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 123.139 0.576 . . . . 0.29999999999999999 109.812 -177.599 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.402 HG13 ' CG2' ' A' ' 28' ' ' VAL . 98.5 t -59.18 -53.32 49.71 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 N-CA-C 111.588 0.218 . . . . 0.32000000000000001 111.588 177.32 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -51.29 -53.82 31.98 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 124.051 0.941 . . . . 0.28999999999999998 111.455 178.733 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.89 -54.42 47.13 Favored 'General case' 0 C--O 1.224 -0.268 0 N-CA-C 109.299 -0.63 . . . . 0.59999999999999998 109.299 179.332 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.551 ' CE3' HD23 ' A' ' 88' ' ' LEU . 50.2 t90 -49.38 -46.61 47.48 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 122.984 0.514 . . . . 0.51000000000000001 111.134 177.066 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.551 HD23 ' CE3' ' A' ' 87' ' ' TRP . 0.1 OUTLIER -66.05 -31.82 72.93 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 124.585 1.154 . . . . 1.6599999999999999 111.908 177.338 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -67.8 -44.85 76.35 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 118.739 0.7 . . . . 0.57999999999999996 110.731 173.512 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -57.52 -39.76 77.27 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.286 0.634 . . . . 5.2400000000000002 110.196 173.042 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.439 ' NZ ' ' OD1' ' A' ' 49' ' ' ASP . 1.6 mtmp? -73.45 136.22 44.2 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 118.852 0.751 . . . . 2.7799999999999998 110.538 178.074 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 67.8 mttt . . . . . 0 C--O 1.249 1.044 0 CA-C-O 117.189 -1.386 . . . . 2.5899999999999999 108.091 174.704 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 . . . . . 0 N--CA 1.452 -0.326 0 N-CA-C 108.664 -0.865 . . . . 2.5800000000000001 108.664 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -51.84 -58.62 5.92 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.655 0.782 . . . . 0.38 110.906 -178.685 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -50.15 -45.14 52.94 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 118.936 -0.554 . . . . 2.8500000000000001 111.362 176.854 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.99 -47.66 84.91 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 119.033 0.833 . . . . 0.39000000000000001 110.829 179.454 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 89.3 t -56.32 -54.49 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.155 0 N-CA-C 108.934 -0.765 . . . . 0.40000000000000002 108.934 176.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.614 HG13 ' HB2' ' A' ' 32' ' ' CYS . 96.4 t -56.02 -48.21 79.11 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 C-N-CA 122.55 0.34 . . . . 0.40999999999999998 111.037 -177.738 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 36.4 mm-40 -53.67 -15.81 1.37 Allowed 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 126.912 2.085 . . . . 0.48999999999999999 113.036 174.558 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -144.98 48.21 1.31 Allowed 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 119.286 0.948 . . . . 2.46 111.086 174.048 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 3.8 mttt -162.69 -49.28 0.04 OUTLIER 'General case' 0 C--O 1.227 -0.131 0 C-N-CA 124.483 1.113 . . . . 1.9399999999999999 110.206 167.489 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.614 ' HB2' HG13 ' A' ' 28' ' ' VAL . 5.2 m -85.2 -50.11 7.66 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 121.443 0.64 . . . . 0.16 110.417 -172.682 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.4 pp -53.48 -28.63 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 CA-C-N 115.063 -0.971 . . . . 0.40999999999999998 111.487 -178.9 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.9 m -41.61 -35.14 0.69 Allowed 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 125.574 1.549 . . . . 1.1000000000000001 112.377 173.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 34.9 m -119.23 -41.53 2.73 Favored 'General case' 0 C--N 1.34 0.185 0 C-N-CA 123.546 0.739 . . . . 0.16 111.562 174.417 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 84.4 m-70 -74.18 -7.72 53.66 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.749 0.82 . . . . 0.34999999999999998 112.791 -175.838 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 84.24 148.72 9.29 Favored Glycine 0 C--N 1.338 0.643 0 C-N-CA 125.511 1.529 . . . . 1.52 109.6 -179.516 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -44.49 -36.47 4.46 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 124.41 1.005 . . . . 0.46000000000000002 112.317 174.798 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -88.61 -10.72 47.68 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 124.842 1.257 . . . . 2.0600000000000001 111.454 -174.586 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.4 mt 71.78 10.59 6.31 Favored 'General case' 0 C--N 1.349 0.578 0 CA-C-N 120.197 1.362 . . . . 1.1499999999999999 110.818 176.572 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.4 p -84.06 -0.27 51.13 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 128.415 2.686 . . . . 0.32000000000000001 110.126 -175.456 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.4 138.88 5.84 Favored Glycine 0 N--CA 1.44 -1.071 0 N-CA-C 108.599 -1.801 . . . . 0.44 108.599 -176.554 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -145.35 -78.34 0.19 Allowed 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 123.789 0.836 . . . . 0.23999999999999999 108.932 178.248 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.5 t -89.07 1.7 55.17 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.824 0.85 . . . . 1.25 110.355 174.195 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.457 ' HB1' ' HD2' ' A' ' 46' ' ' PRO . . . -162.43 165.13 15.98 Favored Pre-proline 0 CA--C 1.537 0.467 0 C-N-CA 125.12 1.368 . . . . 0.40000000000000002 107.434 -167.372 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.457 ' HD2' ' HB1' ' A' ' 45' ' ' ALA . 33.3 Cg_endo -66.81 159.52 51.06 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 123.46 2.773 . . . . 0.32000000000000001 111.54 -173.224 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.33 132.19 42.78 Favored 'General case' 0 C--N 1.332 -0.177 0 O-C-N 121.67 -0.643 . . . . 0.39000000000000001 109.867 -178.671 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 35.3 pt -109.03 1.16 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 C-N-CA 123.242 0.617 . . . . 0.28999999999999998 112.516 175.732 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -38.49 -47.4 1.27 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.459 1.104 . . . . 3.5600000000000001 111.811 170.49 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 10.7 mttt -108.52 35.2 3.28 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 125.553 1.541 . . . . 5.6399999999999997 111.683 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.81 -55.28 35.02 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 108.567 -0.901 . . . . 0.44 108.567 169.794 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -57.02 -21.28 37.58 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 124.726 1.155 . . . . 0.75 113.551 -179.246 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.01 -38.91 92.47 Favored 'General case' 0 N--CA 1.451 -0.394 0 O-C-N 121.799 -0.824 . . . . 1.3999999999999999 110.994 177.138 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 72.0 m-80 -105.23 -53.66 2.62 Favored 'General case' 0 CA--C 1.523 -0.076 0 C-N-CA 123.411 0.684 . . . . 2.98 109.937 -174.41 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -94.66 142.34 27.57 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 124.848 1.259 . . . . 1.49 108.929 -171.77 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.5 167.06 17.76 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 118.748 0.704 . . . . 1.8799999999999999 110.167 175.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -48.37 -47.43 37.32 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 124.009 0.924 . . . . 3.04 110.894 174.437 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -54.72 -34.95 63.14 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.39 0.676 . . . . 4.46 111.598 178.632 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -84.44 -47.05 11.04 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 121.533 0.682 . . . . 3.4399999999999999 109.602 -175.365 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 87.1 mt -61.48 -41.93 91.93 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 N-CA-C 108.778 -0.823 . . . . 0.31 108.778 179.68 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.4 tp -54.95 -49.46 71.31 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 123.02 0.528 . . . . 0.34999999999999998 109.714 175.638 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -52.1 -52.09 53.59 Favored 'General case' 0 CA--C 1.533 0.306 0 O-C-N 123.271 0.357 . . . . 1.51 110.152 176.919 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 75.7 mt -57.76 -50.69 76.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.288 0 O-C-N 121.572 -0.705 . . . . 0.54000000000000004 110.311 178.784 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 46.3 mt -54.06 -44.39 62.62 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 O-C-N 120.383 -1.448 . . . . 0.29999999999999999 110.411 179.163 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 84.8 mt -70.5 -32.78 70.42 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 118.33 -0.843 . . . . 0.40000000000000002 112.892 -179.593 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -124.69 18.84 8.7 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 119.752 1.16 . . . . 1.6899999999999999 110.387 -164.581 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.604 ' N ' ' HA2' ' A' ' 73' ' ' GLY . . . 30.81 -137.33 0.07 OUTLIER Glycine 0 CA--C 1.532 1.116 0 C-N-CA 128.819 3.104 . . . . 0.63 111.206 -167.959 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 11.6 tt0 165.7 129.74 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.518 1.527 . . . . 1.6000000000000001 109.81 -178.192 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 41.04 -118.42 1.26 Allowed Glycine 0 C--N 1.346 1.089 0 CA-C-N 120.865 1.666 . . . . 0.72999999999999998 113.846 -176.764 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -66.07 -17.36 65.55 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 123.711 0.672 . . . . 0.75 112.644 -179.608 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 19.4 ttt -81.39 117.74 69.41 Favored Pre-proline 0 N--CA 1.448 -0.531 0 C-N-CA 124.879 1.272 . . . . 0.39000000000000001 111.525 179.063 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.563 ' HD2' HD11 ' A' ' 75' ' ' ILE . 37.5 Cg_endo -77.93 122.64 5.9 Favored 'Trans proline' 0 N--CA 1.447 -1.237 0 C-N-CA 122.992 2.461 . . . . 2.1099999999999999 111.704 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.604 ' HA2' ' N ' ' A' ' 67' ' ' GLY . . . -57.84 132.93 52.8 Favored Glycine 0 N--CA 1.443 -0.853 0 N-CA-C 115.737 1.055 . . . . 0.65000000000000002 115.737 -179.29 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 82.59 34.4 22.57 Favored Glycine 0 CA--C 1.527 0.803 0 CA-C-N 114.228 -0.986 . . . . 0.34000000000000002 112.06 173.893 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.563 HD11 ' HD2' ' A' ' 72' ' ' PRO . 1.4 mt -53.9 -57.24 6.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 125.256 1.422 . . . . 1.1299999999999999 110.038 174.389 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -101.73 150.06 23.51 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 124.292 1.037 . . . . 0.40999999999999998 108.27 166.429 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 56.2 mttm -142.26 165.25 27.95 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 106.986 -1.487 . . . . 2.7999999999999998 106.986 172.737 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 76.8 -170.29 55.04 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 110.022 -1.231 . . . . 1.26 110.022 -173.457 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -52.35 -30.19 27.52 Favored 'General case' 0 C--O 1.225 -0.222 0 C-N-CA 123.865 0.866 . . . . 0.75 111.15 -176.812 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.556 ' O ' HG23 ' A' ' 84' ' ' VAL . 11.5 mp0 -39.5 -62.98 0.61 Allowed 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.147 1.379 . . . . 4.54 111.063 170.03 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -58.46 -48.92 79.18 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.207 0.458 . . . . 0.37 111.125 -175.104 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -50.06 -57.63 7.23 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.362 1.065 . . . . 2.0 111.353 175.56 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.95 -43.63 98.44 Favored 'General case' 0 N--CA 1.449 -0.507 0 O-C-N 121.902 -0.499 . . . . 0.44 110.769 -177.757 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.556 HG23 ' O ' ' A' ' 80' ' ' GLU . 71.3 t -53.97 -53.95 23.89 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 C-N-CA 123.332 0.653 . . . . 0.53000000000000003 109.737 176.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -52.73 -53.53 46.55 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 123.401 0.68 . . . . 0.20999999999999999 112.082 175.426 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.61 -47.14 82.98 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 122.115 0.96 . . . . 0.27000000000000002 110.976 -179.181 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.522 ' CE3' HD23 ' A' ' 88' ' ' LEU . 50.9 t90 -59.86 -42.48 93.78 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.315 1.046 . . . . 0.44 110.273 178.286 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.522 HD23 ' CE3' ' A' ' 87' ' ' TRP . 0.1 OUTLIER -64.25 -38.92 92.75 Favored 'General case' 0 C--N 1.333 -0.116 0 C-N-CA 123.996 0.918 . . . . 1.5900000000000001 110.818 175.552 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -52.81 -45.5 67.28 Favored 'General case' 0 CA--C 1.528 0.12 0 N-CA-C 109.424 -0.584 . . . . 0.52000000000000002 109.424 173.345 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -90.28 36.78 0.88 Allowed 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.216 0.606 . . . . 3.0600000000000001 111.896 175.433 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 4.4 mttm -126.36 136.37 52.62 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.267 1.027 . . . . 2.96 108.702 164.615 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 30.8 mttt . . . . . 0 C--O 1.253 1.256 0 N-CA-C 105.162 -2.162 . . . . 3.4700000000000002 105.162 172.916 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 . . . . . 0 N--CA 1.451 -0.415 0 N-CA-C 109.287 -0.634 . . . . 2.52 109.287 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -40.84 -51.91 3.09 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 125.012 1.325 . . . . 0.5 111.8 176.097 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -57.02 -46.09 82.59 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 110.146 -0.316 . . . . 2.9300000000000002 110.146 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.1 -43.75 98.41 Favored 'General case' 0 CA--C 1.528 0.109 0 C-N-CA 123.386 0.674 . . . . 0.34000000000000002 110.768 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 89.8 t -58.93 -58.76 5.44 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.261 0 N-CA-C 109.062 -0.718 . . . . 0.55000000000000004 109.062 176.678 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.554 HG21 ' HZ3' ' A' ' 87' ' ' TRP . 44.1 t -53.02 -47.03 54.74 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 C-N-CA 123.224 0.609 . . . . 0.35999999999999999 110.431 -177.114 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.448 ' HA ' HG12 ' A' ' 33' ' ' ILE . 24.7 mm-40 -48.9 -25.91 2.17 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 126.119 1.768 . . . . 0.68000000000000005 113.427 173.784 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -141.01 56.73 1.56 Allowed 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 119.261 0.937 . . . . 3.2599999999999998 111.624 174.537 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.47 -38.12 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 124.145 0.978 . . . . 1.27 110.033 170.442 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.525 ' SG ' HG22 ' A' ' 28' ' ' VAL . 3.4 m -101.18 -50.23 3.85 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 119.27 0.941 . . . . 0.23000000000000001 110.86 -177.868 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.448 HG12 ' HA ' ' A' ' 29' ' ' GLN . 2.2 pp -56.88 -27.07 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 CA-C-N 116.107 -0.497 . . . . 0.40000000000000002 112.027 -174.453 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.7 m -38.64 -35.76 0.21 Allowed 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.635 1.574 . . . . 1.0600000000000001 112.473 170.867 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 20.9 m -121.02 -44.28 2.41 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.75 0.82 . . . . 0.19 111.371 174.715 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 86.5 m-70 -70.5 -9.55 56.9 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.753 0.821 . . . . 0.20999999999999999 112.897 -176.091 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 88.37 148.08 15.54 Favored Glycine 0 C--N 1.338 0.643 0 N-CA-C 109.816 -1.314 . . . . 1.52 109.816 177.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -44.6 -36.29 4.51 Favored Glycine 0 C--N 1.341 0.807 0 C-N-CA 124.454 1.026 . . . . 0.46999999999999997 111.852 175.579 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -93.7 -6.93 45.12 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 124.909 1.283 . . . . 2.5499999999999998 111.758 -172.9 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 8.9 mt 70.91 11.12 7.07 Favored 'General case' 0 C--N 1.352 0.693 0 CA-C-N 120.237 1.381 . . . . 1.1100000000000001 111.301 177.364 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 11.0 p -86.28 0.88 52.84 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 127.186 2.194 . . . . 0.34999999999999998 109.832 -175.585 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.72 133.19 3.52 Favored Glycine 0 N--CA 1.443 -0.89 0 N-CA-C 108.881 -1.688 . . . . 0.45000000000000001 108.881 -177.566 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -136.42 -75.82 0.43 Allowed 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 108.431 -0.951 . . . . 0.32000000000000001 108.431 178.344 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 9.3 t -95.85 4.17 53.06 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.09 0.956 . . . . 1.53 110.753 173.736 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.508 ' HB1' ' HD2' ' A' ' 46' ' ' PRO . . . -157.92 167.39 14.58 Favored Pre-proline 0 CA--C 1.538 0.488 0 C-N-CA 125.207 1.403 . . . . 0.28000000000000003 108.181 -169.583 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.508 ' HD2' ' HB1' ' A' ' 45' ' ' ALA . 49.3 Cg_endo -71.03 155.63 61.39 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 122.968 2.446 . . . . 0.23000000000000001 110.801 -173.623 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.67 123.28 23.75 Favored 'General case' 0 C--N 1.332 -0.176 0 O-C-N 121.589 -0.695 . . . . 0.28000000000000003 110.57 -176.119 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 45.4 pt -104.46 0.68 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 C-N-CA 123.526 0.73 . . . . 0.32000000000000001 111.801 179.1 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -41.13 -39.29 1.24 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.971 0.908 . . . . 3.0699999999999998 112.396 171.414 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 12.4 mtpt -117.73 34.08 5.32 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 125.187 1.395 . . . . 4.1200000000000001 109.828 -177.339 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.18 -53.59 50.92 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 108.654 -0.869 . . . . 0.45000000000000001 108.654 171.174 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -56.85 -21.76 38.4 Favored Glycine 0 C--N 1.34 0.765 0 C-N-CA 124.116 0.865 . . . . 0.58999999999999997 114.247 -178.614 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -60.91 -38.86 87.22 Favored 'General case' 0 N--CA 1.449 -0.49 0 O-C-N 122.01 -0.7 . . . . 1.3799999999999999 110.636 174.539 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 41.3 m-80 -107.55 -58.9 1.9 Allowed 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 124.356 1.062 . . . . 2.96 110.295 -174.271 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -78.37 149.49 33.37 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.391 1.077 . . . . 1.9099999999999999 110.084 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 29.3 m -94.86 173.94 7.34 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.943 1.297 . . . . 1.6399999999999999 110.13 176.699 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.481 ' HG3' ' HB2' ' A' ' 89' ' ' ALA . 3.5 mp0 -56.64 -53.09 61.65 Favored 'General case' 0 N--CA 1.457 -0.098 0 O-C-N 121.761 -0.587 . . . . 2.8599999999999999 109.825 -176.31 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 35.3 mm-40 -55.38 -32.17 62.39 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.434 0.693 . . . . 4.4500000000000002 111.816 177.334 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -75.97 -50.9 13.6 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 108.635 -0.876 . . . . 2.5499999999999998 108.635 -177.729 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 66.4 mt -62.7 -43.47 98.66 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.133 0 O-C-N 121.431 -0.793 . . . . 0.37 108.89 -178.854 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 27.0 tp -55.9 -50.34 70.95 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 109.749 -0.463 . . . . 0.33000000000000002 109.749 176.846 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -51.72 -51.91 52.46 Favored 'General case' 0 CA--C 1.53 0.21 0 O-C-N 123.057 0.223 . . . . 2.2200000000000002 110.503 175.295 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 81.2 mt -57.33 -50.47 76.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 O-C-N 121.781 -0.575 . . . . 0.56000000000000005 109.962 179.673 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 71.9 mt -53.35 -42.56 48.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 O-C-N 120.522 -1.361 . . . . 0.38 110.306 178.936 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 68.9 mt -72.23 -32.61 66.89 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 113.736 1.013 . . . . 0.57999999999999996 113.736 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -122.75 20.06 10.19 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 120.176 1.353 . . . . 1.6100000000000001 110.387 -167.255 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.591 ' N ' ' HA2' ' A' ' 73' ' ' GLY . . . 31.05 -133.61 0.11 Allowed Glycine 0 CA--C 1.532 1.107 0 C-N-CA 128.621 3.01 . . . . 0.71999999999999997 111.462 -166.729 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 168.52 130.94 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 119.034 1.417 . . . . 1.54 109.465 -179.308 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 35.41 -111.97 0.1 OUTLIER Glycine 0 CA--C 1.532 1.147 0 CA-C-N 120.116 1.326 . . . . 0.48999999999999999 113.815 -171.392 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -70.92 -20.91 78.07 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 123.367 0.508 . . . . 0.56999999999999995 113.029 -178.472 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 19.0 ttt -74.39 120.24 80.48 Favored Pre-proline 0 N--CA 1.45 -0.466 0 C-N-CA 125.15 1.38 . . . . 0.37 110.353 -179.403 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.616 ' HD2' HD11 ' A' ' 75' ' ' ILE . 34.6 Cg_endo -79.73 121.41 4.6 Favored 'Trans proline' 0 N--CA 1.446 -1.319 0 C-N-CA 122.888 2.392 . . . . 2.0299999999999998 111.534 -176.364 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.591 ' HA2' ' N ' ' A' ' 67' ' ' GLY . . . -57.06 134.05 52.44 Favored Glycine 0 N--CA 1.444 -0.792 0 N-CA-C 115.275 0.87 . . . . 0.68999999999999995 115.275 -179.458 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 87.22 38.98 7.54 Favored Glycine 0 CA--C 1.527 0.792 0 CA-C-N 114.353 -0.924 . . . . 0.44 111.709 174.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.616 HD11 ' HD2' ' A' ' 72' ' ' PRO . 2.5 mt -63.79 -59.67 3.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 124.751 1.22 . . . . 1.3100000000000001 110.22 176.777 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -104.18 161.36 14.09 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.632 1.173 . . . . 0.27000000000000002 108.233 165.906 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 21.5 mttm -145.47 175.92 9.97 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.998 0.919 . . . . 3.5099999999999998 109.659 173.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 57.94 -153.66 25.23 Favored Glycine 0 CA--C 1.531 1.093 0 CA-C-O 121.45 0.472 . . . . 0.64000000000000001 112.537 177.167 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -53.39 -29.93 37.26 Favored 'General case' 0 C--N 1.339 0.13 0 C-N-CA 123.955 0.902 . . . . 0.64000000000000001 111.681 174.079 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -52.42 -61.2 2.43 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 108.612 -0.885 . . . . 2.3900000000000001 108.612 173.69 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -63.28 -51.09 67.54 Favored 'General case' 0 CA--C 1.53 0.209 0 O-C-N 122.187 -0.32 . . . . 0.27000000000000002 111.668 179.725 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -51.34 -52.64 43.65 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 121.034 0.445 . . . . 2.73 111.67 -178.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -56.45 -48.79 76.29 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 109.788 -0.449 . . . . 0.27000000000000002 109.788 -179.096 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.514 HG22 HG23 ' A' ' 28' ' ' VAL . 77.6 t -54.81 -49.97 65.06 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 CA-C-O 119.389 -0.339 . . . . 0.34999999999999998 111.127 176.844 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -51.71 -54.22 30.64 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 122.757 0.423 . . . . 0.34999999999999998 111.34 176.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.06 -44.85 95.8 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 121.269 0.557 . . . . 0.35999999999999999 111.376 -177.4 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.586 ' CE3' HD23 ' A' ' 88' ' ' LEU . 47.9 t90 -60.29 -52.24 66.14 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 121.715 -0.615 . . . . 0.68000000000000005 109.566 177.694 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.586 HD23 ' CE3' ' A' ' 87' ' ' TRP . 0.1 OUTLIER -55.59 -35.27 65.62 Favored 'General case' 0 C--O 1.222 -0.363 0 C-N-CA 124.068 0.947 . . . . 1.5800000000000001 110.369 176.602 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.481 ' HB2' ' HG3' ' A' ' 57' ' ' GLU . . . -59.07 -44.69 91.9 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 118.559 0.618 . . . . 0.5 111.803 176.345 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -72.37 -27.88 62.67 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 110.248 -0.279 . . . . 4.2699999999999996 110.248 173.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 12.3 tptp -69.51 116.4 9.88 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.788 0.835 . . . . 2.4100000000000001 109.774 -175.613 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 23.9 mttt . . . . . 0 C--O 1.256 1.444 0 C-N-CA 128.649 2.779 . . . . 2.75 104.232 -178.128 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 . . . . . 0 N--CA 1.45 -0.428 0 N-CA-C 109.261 -0.644 . . . . 2.1400000000000001 109.261 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -40.82 -55.07 2.54 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 124.096 0.958 . . . . 0.33000000000000002 110.866 175.121 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -59.63 -40.37 87.38 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 119.514 -0.279 . . . . 3.0899999999999999 110.814 -177.332 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.5 -44.78 93.35 Favored 'General case' 0 C--N 1.339 0.125 0 CA-C-N 118.532 0.606 . . . . 0.41999999999999998 110.678 178.664 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 93.8 t -58.58 -53.34 48.23 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.219 0 N-CA-C 109.157 -0.683 . . . . 0.44 109.157 176.084 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 54.2 t -52.28 -48.92 43.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 N-CA-C 110.286 -0.264 . . . . 0.52000000000000002 110.286 179.099 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 28.8 mm-40 -55.14 -18.45 5.72 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 126.05 1.74 . . . . 0.59999999999999998 114.041 174.77 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -150.36 50.65 0.89 Allowed 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 120.046 1.294 . . . . 2.2400000000000002 112.628 178.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.24 -37.34 0.02 OUTLIER 'General case' 0 C--O 1.225 -0.189 0 C-N-CA 126.056 1.742 . . . . 1.21 110.071 170.068 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 4.5 m -98.81 -52.79 3.48 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 119.431 1.014 . . . . 0.17999999999999999 111.423 -176.531 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.5 pp -54.69 -27.4 18.15 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.077 0 CA-C-N 115.878 -0.601 . . . . 0.47999999999999998 111.763 -177.121 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.8 m -40.07 -37.04 0.55 Allowed 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 126.392 1.877 . . . . 1.1899999999999999 112.073 173.77 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 19.1 m -118.8 -40.08 2.9 Favored 'General case' 0 C--N 1.339 0.15 0 C-N-CA 123.115 0.566 . . . . 0.17000000000000001 111.927 173.1 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 83.3 m-70 -72.65 -7.57 50.99 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 112.852 0.686 . . . . 0.29999999999999999 112.852 -175.48 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 86.12 151.35 17.55 Favored Glycine 0 C--N 1.336 0.579 0 N-CA-C 109.324 -1.51 . . . . 1.51 109.324 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -42.41 -36.62 2.26 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 125.019 1.295 . . . . 0.42999999999999999 112.928 178.649 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 44.5 m-20 -102.99 1.34 33.44 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.734 1.214 . . . . 2.1800000000000002 112.342 -172.648 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.422 HD22 ' N ' ' A' ' 40' ' ' LEU . 1.9 mm? 64.12 21.67 12.64 Favored 'General case' 0 C--N 1.35 0.595 0 CA-C-N 120.482 1.492 . . . . 3.4300000000000002 111.415 179.617 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.2 p -84.68 -5.13 59.3 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 127.661 2.384 . . . . 0.32000000000000001 110.016 179.463 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.27 131.6 3.8 Favored Glycine 0 N--CA 1.439 -1.1 0 N-CA-C 108.954 -1.658 . . . . 0.55000000000000004 108.954 -177.917 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -138.39 -79.97 0.34 Allowed 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.021 0.928 . . . . 0.25 109.44 177.183 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 70.9 m -89.12 4.02 49.88 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.638 0.775 . . . . 1.1799999999999999 111.391 170.228 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -155.85 161.46 29.43 Favored Pre-proline 0 CA--C 1.535 0.373 0 C-N-CA 125.253 1.421 . . . . 0.20999999999999999 107.823 -170.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -66.96 159.67 50.76 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 123.185 2.59 . . . . 0.23000000000000001 111.164 -176.154 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.69 126.86 31.28 Favored 'General case' 0 C--N 1.331 -0.214 0 O-C-N 121.447 -0.783 . . . . 0.25 110.603 -175.808 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 25.4 pt -104.94 0.88 10.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 C-N-CA 123.27 0.628 . . . . 0.48999999999999999 111.581 177.069 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -34.83 -48.03 0.37 Allowed 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.26 1.424 . . . . 2.46 113.595 172.193 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 29.5 pttt -106.92 22.76 15.46 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 124.143 0.977 . . . . 4.1699999999999999 112.017 -176.745 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -54.94 -42.63 72.54 Favored 'General case' 0 N--CA 1.45 -0.43 0 O-C-N 121.548 -0.72 . . . . 0.38 110.261 -176.76 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -55.25 -25.77 41.24 Favored Glycine 0 CA--C 1.529 0.943 0 N-CA-C 114.603 0.601 . . . . 0.51000000000000001 114.603 179.086 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.415 ' HB2' ' HB2' ' A' ' 92' ' ' LYS . . . -84.62 -45.28 12.67 Favored 'General case' 0 CA--C 1.522 -0.119 0 CA-C-N 118.287 1.043 . . . . 0.84999999999999998 109.561 172.161 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -56.36 -46.75 79.85 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 119.555 -0.259 . . . . 2.2400000000000002 111.037 -178.062 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -145.38 151.41 38.23 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.738 1.615 . . . . 0.67000000000000004 108.71 -170.888 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 84.1 p -78.75 170.72 16.22 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 119.374 0.988 . . . . 2.4500000000000002 111.422 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -49.69 -44.27 47.95 Favored 'General case' 0 C--O 1.224 -0.274 0 CA-C-O 118.619 -0.705 . . . . 3.0499999999999998 111.491 174.03 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -56.91 -47.97 79.32 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 118.911 0.778 . . . . 2.3999999999999999 110.461 178.659 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -69.51 -47.23 64.5 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 109.129 -0.693 . . . . 3.27 109.129 -174.613 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 52.3 mt -59.0 -48.28 87.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 109.249 -0.649 . . . . 0.33000000000000002 109.249 179.587 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 41.3 tp -54.82 -50.32 68.86 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 123.668 0.787 . . . . 0.35999999999999999 109.076 178.735 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -55.01 -47.86 74.12 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 110.305 -0.258 . . . . 2.2799999999999998 110.305 175.838 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 46.7 mt -61.47 -33.82 58.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 O-C-N 121.018 -1.051 . . . . 0.60999999999999999 111.812 178.427 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 75.8 mt -68.77 -48.17 72.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 O-C-N 120.157 -1.589 . . . . 0.23000000000000001 108.986 175.082 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 92.9 mt -69.37 -31.24 69.51 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.43 1.092 . . . . 0.37 113.177 -176.053 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 22.3 m-20 -121.51 13.72 10.98 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 119.445 1.02 . . . . 1.77 109.735 -168.073 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.528 ' N ' ' HA2' ' A' ' 73' ' ' GLY . . . 40.14 -146.78 0.27 Allowed Glycine 0 CA--C 1.54 1.654 0 C-N-CA 127.604 2.526 . . . . 0.63 111.325 -169.164 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 10.6 tt0 178.29 135.65 0.08 Allowed 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 125.104 1.362 . . . . 1.1299999999999999 108.596 -177.518 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 37.77 -114.6 0.3 Allowed Glycine 0 CA--C 1.533 1.198 0 CA-C-N 119.86 1.209 . . . . 0.40000000000000002 113.361 -172.747 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -74.77 -20.53 79.46 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 123.289 0.471 . . . . 0.58999999999999997 113.064 -179.681 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 21.3 ttt -67.42 119.19 63.53 Favored Pre-proline 0 N--CA 1.452 -0.373 0 C-N-CA 124.269 1.028 . . . . 0.41999999999999998 110.662 179.509 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -76.22 123.93 7.52 Favored 'Trans proline' 0 N--CA 1.446 -1.321 0 C-N-CA 122.698 2.265 . . . . 2.1499999999999999 110.795 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.528 ' HA2' ' N ' ' A' ' 67' ' ' GLY . . . -65.05 141.82 43.94 Favored Glycine 0 N--CA 1.442 -0.958 0 N-CA-C 115.349 0.9 . . . . 0.60999999999999999 115.349 -176.333 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 78.34 33.42 39.62 Favored Glycine 0 CA--C 1.524 0.649 0 CA-C-N 114.047 -1.077 . . . . 0.34999999999999998 110.84 175.746 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -56.53 -49.93 75.33 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 C-N-CA 124.407 1.083 . . . . 1.02 109.022 173.486 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -111.95 154.02 25.89 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.411 1.485 . . . . 0.39000000000000001 110.409 165.218 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 4.7 mmmt -139.02 158.71 43.71 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.197 1.799 . . . . 3.0499999999999998 109.896 179.609 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 56.13 -141.04 41.17 Favored Glycine 0 CA--C 1.528 0.892 0 N-CA-C 111.164 -0.775 . . . . 0.75 111.164 178.025 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -51.23 -36.65 42.78 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 117.496 0.648 . . . . 0.93000000000000005 111.542 176.87 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -57.15 -37.0 71.41 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 122.892 0.477 . . . . 2.4100000000000001 110.023 178.499 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -82.94 -56.6 3.71 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.212 0.605 . . . . 0.34999999999999998 110.522 176.681 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -51.93 -52.21 51.68 Favored 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 124.543 1.137 . . . . 3.0600000000000001 112.076 -176.331 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.04 -47.45 83.07 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 109.644 -0.502 . . . . 0.31 109.644 -177.109 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 78.9 t -59.01 -56.37 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 C-N-CA 122.895 0.478 . . . . 0.27000000000000002 110.532 178.387 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -47.78 -56.12 8.11 Favored 'General case' 0 C--O 1.226 -0.146 0 C-N-CA 123.369 0.668 . . . . 0.17999999999999999 111.296 177.151 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.77 -45.75 92.54 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.371 0.669 . . . . 0.35999999999999999 110.887 -176.621 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 79.1 t90 -57.04 -52.41 65.39 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 121.713 -0.617 . . . . 0.59999999999999998 109.722 177.295 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.74 -31.08 71.23 Favored 'General case' 0 C--O 1.223 -0.32 0 CA-C-O 118.603 -0.713 . . . . 1.8899999999999999 112.654 175.818 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.08 -26.57 60.62 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 119.491 1.041 . . . . 0.75 111.534 172.706 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -90.81 -29.67 17.45 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 112.938 0.718 . . . . 4.9299999999999997 112.938 171.487 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 19.7 mtpp -74.64 103.95 5.13 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 119.721 1.146 . . . . 3.04 110.633 174.227 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.415 ' HB2' ' HB2' ' A' ' 53' ' ' ALA . 20.2 pttt . . . . . 0 C--O 1.25 1.11 0 C-N-CA 126.298 1.839 . . . . 2.75 106.354 -175.351 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.9 t70 . . . . . 0 N--CA 1.451 -0.398 0 N-CA-C 109.307 -0.627 . . . . 3.8300000000000001 109.307 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -52.9 -45.03 67.35 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 123.921 0.888 . . . . 0.41999999999999998 111.608 -178.902 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -64.48 -48.91 73.43 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 108.195 -1.039 . . . . 3.3300000000000001 108.195 -176.691 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.97 -47.61 74.33 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 123.44 0.696 . . . . 0.31 111.333 177.249 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 74.1 t -55.97 -55.64 17.05 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.12 0 N-CA-C 109.525 -0.546 . . . . 0.40999999999999998 109.525 177.148 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.574 HG22 ' SG ' ' A' ' 32' ' ' CYS . 5.6 t -54.75 -49.4 68.91 Favored 'Isoleucine or valine' 0 C--O 1.239 0.525 0 CA-C-N 117.851 0.296 . . . . 0.38 111.265 -178.33 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.402 ' HA ' HG12 ' A' ' 33' ' ' ILE . 35.8 mm-40 -52.65 -14.86 0.58 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 126.732 2.013 . . . . 0.46999999999999997 112.984 173.554 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.77 47.76 1.64 Allowed 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 119.469 1.031 . . . . 3.7200000000000002 111.514 173.17 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.71 -42.7 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.16 0 O-C-N 121.915 -0.49 . . . . 1.1799999999999999 110.485 169.205 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.574 ' SG ' HG22 ' A' ' 28' ' ' VAL . 3.6 m -93.36 -48.45 6.41 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 118.284 0.493 . . . . 0.16 110.026 -173.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.402 HG12 ' HA ' ' A' ' 29' ' ' GLN . 2.4 pp -51.65 -31.61 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 CA-C-N 115.977 -0.556 . . . . 0.54000000000000004 111.962 -179.302 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 20.0 m -38.47 -37.31 0.3 Allowed 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 125.748 1.619 . . . . 1.0600000000000001 112.73 173.234 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 21.5 m -121.3 -40.01 2.63 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 123.069 0.548 . . . . 0.19 112.009 173.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 82.2 m-70 -71.79 -7.66 49.57 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.616 0.766 . . . . 0.22 112.755 -177.197 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 84.44 148.29 9.16 Favored Glycine 0 C--N 1.337 0.602 0 N-CA-C 109.296 -1.522 . . . . 1.49 109.296 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -41.69 -35.11 1.35 Allowed Glycine 0 CA--C 1.527 0.843 0 C-N-CA 124.73 1.157 . . . . 0.48999999999999999 112.496 174.003 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -95.39 -8.48 35.51 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 124.961 1.305 . . . . 2.3799999999999999 111.264 -169.522 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.3 mt 72.33 6.89 5.6 Favored 'General case' 0 C--N 1.348 0.534 0 CA-C-N 120.136 1.334 . . . . 1.28 111.398 178.493 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 16.0 p -83.92 0.27 48.48 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 127.176 2.19 . . . . 0.39000000000000001 110.102 -175.579 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.09 150.03 21.56 Favored Glycine 0 N--CA 1.436 -1.339 0 N-CA-C 108.855 -1.698 . . . . 0.53000000000000003 108.855 -173.564 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -156.33 -78.03 0.09 Allowed 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 124.609 1.164 . . . . 0.26000000000000001 108.863 177.603 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.0 m -97.37 2.63 50.77 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.448 1.099 . . . . 1.3300000000000001 111.216 170.063 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -148.14 162.05 32.19 Favored Pre-proline 0 CA--C 1.535 0.372 0 C-N-CA 126.999 2.12 . . . . 0.42999999999999999 107.159 -176.191 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -71.26 163.15 40.13 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 123.219 2.613 . . . . 0.25 111.203 -176.135 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -74.93 113.58 12.4 Favored 'General case' 0 C--N 1.332 -0.19 0 O-C-N 121.73 -0.607 . . . . 0.29999999999999999 111.235 -174.618 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 48.1 pt -97.07 0.66 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 C-N-CA 123.307 0.643 . . . . 0.28999999999999998 111.797 178.73 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -48.88 -34.9 13.54 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.154 0.581 . . . . 3.3399999999999999 112.319 176.622 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.2 pttm -115.43 38.66 3.18 Favored 'General case' 0 C--N 1.343 0.311 0 C-N-CA 124.82 1.248 . . . . 3.4300000000000002 111.216 175.4 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.73 -55.75 20.87 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 108.076 -1.083 . . . . 0.47999999999999998 108.076 168.208 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -54.08 -27.0 36.91 Favored Glycine 0 C--N 1.339 0.717 0 C-N-CA 124.675 1.131 . . . . 0.64000000000000001 113.695 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.95 -38.44 75.97 Favored 'General case' 0 N--CA 1.449 -0.488 0 O-C-N 121.957 -0.731 . . . . 1.45 111.446 175.545 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 47.3 m-80 -107.85 -57.73 2.06 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 124.318 1.047 . . . . 2.8999999999999999 110.819 -174.166 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -89.51 149.47 22.89 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 125.086 1.354 . . . . 0.80000000000000004 109.06 -174.297 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 60.7 m -94.29 164.11 13.16 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 122.961 0.505 . . . . 1.49 110.643 179.433 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.1 tm-20 -40.9 -64.39 0.54 Allowed 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.023 1.329 . . . . 5.6600000000000001 111.002 178.74 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -41.12 -47.02 3.14 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.936 1.294 . . . . 4.1100000000000003 112.905 174.671 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 61.1 mm-40 -69.55 -47.27 64.25 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 122.23 1.014 . . . . 3.3300000000000001 108.573 -174.456 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 61.5 mt -61.46 -44.18 98.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-N 115.948 -0.569 . . . . 0.27000000000000002 109.503 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 35.3 tp -55.31 -53.39 56.77 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 124.366 1.066 . . . . 0.38 109.163 175.738 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -49.72 -52.31 32.32 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 117.992 0.36 . . . . 1.53 110.389 175.574 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 87.4 mt -60.31 -37.65 74.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 119.744 -0.783 . . . . 0.47999999999999998 111.557 179.671 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 60.5 mt -61.53 -46.81 95.78 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 O-C-N 120.041 -1.662 . . . . 0.32000000000000001 109.851 173.722 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 85.6 mt -67.14 -32.17 73.1 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 117.179 -1.391 . . . . 0.47999999999999998 114.479 -171.205 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -139.05 30.57 2.22 Favored 'General case' 0 C--N 1.344 0.362 0 CA-C-N 120.191 1.359 . . . . 3.2200000000000002 110.112 -171.119 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 35.08 -141.28 0.13 Allowed Glycine 0 CA--C 1.542 1.754 0 C-N-CA 128.122 2.772 . . . . 0.65000000000000002 112.81 -175.916 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 172.46 136.45 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.58 1.552 . . . . 1.8200000000000001 108.022 -175.283 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 28.83 -106.7 0.01 OUTLIER Glycine 0 CA--C 1.534 1.222 0 C-N-CA 125.519 1.533 . . . . 0.44 114.785 -176.455 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -66.07 -27.27 72.75 Favored Glycine 0 CA--C 1.537 1.428 0 CA-C-N 117.769 0.784 . . . . 0.68000000000000005 113.562 -178.479 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 15.8 ttt -76.47 123.04 87.69 Favored Pre-proline 0 CA--C 1.54 0.567 0 C-N-CA 125.888 1.675 . . . . 0.42999999999999999 110.683 -178.126 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -62.32 -56.66 0.63 Allowed 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 124.462 3.441 . . . . 3.0 111.781 -168.926 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 118.24 144.92 7.72 Favored Glycine 0 N--CA 1.449 -0.482 0 CA-C-N 115.795 -0.639 . . . . 0.90000000000000002 114.228 172.453 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 67.82 26.79 73.76 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.907 -0.877 . . . . 0.35999999999999999 110.907 -174.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 2.0 mm -52.01 -51.88 26.92 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 124.561 1.144 . . . . 2.1299999999999999 110.11 177.338 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -112.27 159.42 18.64 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.478 1.111 . . . . 0.41999999999999998 108.974 161.465 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 21.3 mttp -146.01 158.09 43.87 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.35 1.06 . . . . 3.6600000000000001 110.147 175.057 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 64.67 -153.35 49.66 Favored Glycine 0 CA--C 1.53 0.992 0 N-CA-C 111.343 -0.703 . . . . 0.83999999999999997 111.343 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -45.61 -38.6 6.75 Favored 'General case' 0 C--N 1.34 0.186 0 C-N-CA 124.855 1.262 . . . . 0.63 112.154 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -50.51 -52.93 34.04 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.423 1.089 . . . . 2.1499999999999999 110.396 175.006 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -71.32 -48.0 53.19 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.649 0.78 . . . . 0.25 110.853 179.261 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -53.97 -50.67 66.02 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.826 0.85 . . . . 2.6699999999999999 110.708 -176.623 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -55.19 -49.54 71.64 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 123.071 0.548 . . . . 0.26000000000000001 110.286 178.776 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.495 HG22 HG23 ' A' ' 28' ' ' VAL . 53.8 t -58.12 -52.9 52.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 CA-C-O 119.343 -0.36 . . . . 0.39000000000000001 110.986 178.499 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -49.26 -52.49 27.01 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 123.341 0.656 . . . . 0.20000000000000001 111.452 176.55 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.75 -51.88 67.45 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 121.46 0.648 . . . . 0.33000000000000002 110.215 -177.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.535 ' CE3' HD23 ' A' ' 88' ' ' LEU . 48.9 t90 -54.84 -43.18 72.82 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 122.757 0.423 . . . . 0.52000000000000002 110.69 177.872 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.535 HD23 ' CE3' ' A' ' 87' ' ' TRP . 0.1 OUTLIER -65.96 -37.73 86.76 Favored 'General case' 0 C--O 1.227 -0.118 0 C-N-CA 124.504 1.121 . . . . 1.6399999999999999 110.712 178.271 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -52.96 -42.75 65.79 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 119.0 0.818 . . . . 0.47999999999999998 109.55 171.388 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -85.79 21.6 1.85 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.439 1.095 . . . . 4.1699999999999999 112.405 175.915 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 4.7 mtpm? -116.68 139.43 50.56 Favored 'General case' 0 C--N 1.342 0.253 0 CA-C-O 122.256 1.027 . . . . 2.4100000000000001 109.956 167.724 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 53.2 mttm . . . . . 0 C--O 1.25 1.116 0 C-N-CA 129.206 3.002 . . . . 3.4199999999999999 103.152 177.606 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 . . . . . 0 N--CA 1.449 -0.497 0 N-CA-C 108.475 -0.935 . . . . 2.3799999999999999 108.475 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -41.15 -54.54 2.86 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 124.554 1.141 . . . . 0.31 110.708 175.542 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -58.39 -46.77 85.72 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 115.805 -0.634 . . . . 3.1600000000000001 110.272 -178.128 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.2 -44.51 92.24 Favored 'General case' 0 C--N 1.34 0.159 0 C-N-CA 123.125 0.57 . . . . 0.31 111.147 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 77.8 t -57.81 -56.88 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 N-CA-C 109.279 -0.638 . . . . 0.33000000000000002 109.279 175.559 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.724 HG11 HD21 ' A' ' 40' ' ' LEU . 71.7 t -54.0 -48.65 63.71 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 CA-C-N 117.933 0.333 . . . . 0.34999999999999998 110.494 -176.862 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.404 ' HA ' HG12 ' A' ' 33' ' ' ILE . 28.0 mm-40 -47.94 -24.69 1.1 Allowed 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 126.261 1.824 . . . . 0.64000000000000001 112.872 174.532 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -141.26 51.56 1.58 Allowed 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 119.144 0.884 . . . . 2.6000000000000001 111.642 173.903 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.68 -36.63 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 124.319 1.048 . . . . 1.22 111.211 166.722 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.699 ' HB2' HG13 ' A' ' 28' ' ' VAL . 3.8 m -101.89 -50.87 3.55 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 119.159 0.89 . . . . 0.23000000000000001 110.954 -174.81 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.404 HG12 ' HA ' ' A' ' 29' ' ' GLN . 2.2 pp -54.41 -29.37 19.92 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.082 0 CA-C-N 116.369 -0.378 . . . . 0.40999999999999998 111.949 -176.96 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 10.0 m -35.26 -41.71 0.17 Allowed 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 125.507 1.523 . . . . 1.0800000000000001 112.81 171.179 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 22.4 m -114.86 -35.63 4.73 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.294 0.638 . . . . 0.14999999999999999 111.839 174.681 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 89.4 m-70 -80.66 2.09 27.28 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.226 1.01 . . . . 0.40000000000000002 113.314 -175.314 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 107.78 -80.96 0.28 Allowed Glycine 0 CA--C 1.525 0.668 0 C-N-CA 125.747 1.641 . . . . 2.8999999999999999 111.785 165.149 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -175.24 -52.51 0.06 OUTLIER Glycine 0 CA--C 1.519 0.304 0 N-CA-C 108.441 -1.864 . . . . 0.90000000000000002 108.441 -171.604 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -97.71 4.6 49.94 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 124.452 1.101 . . . . 3.3199999999999998 111.076 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.724 HD21 HG11 ' A' ' 28' ' ' VAL . 1.2 mt 76.15 14.33 2.51 Favored 'General case' 0 C--N 1.351 0.661 0 CA-C-N 119.85 1.205 . . . . 1.75 110.007 -179.618 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.0 p -76.27 -13.37 60.16 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 128.11 2.564 . . . . 0.60999999999999999 109.822 -178.631 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.98 154.02 30.62 Favored Glycine 0 N--CA 1.442 -0.9 0 N-CA-C 108.449 -1.86 . . . . 0.68000000000000005 108.449 -178.356 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -156.8 -76.89 0.09 Allowed 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.457 -0.572 . . . . 0.28999999999999998 109.457 177.61 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 19.6 t -93.55 4.17 54.37 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 122.854 0.462 . . . . 1.54 110.483 172.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -157.53 163.01 26.25 Favored Pre-proline 0 N--CA 1.448 -0.56 0 C-N-CA 126.242 1.817 . . . . 0.29999999999999999 107.195 -166.232 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -67.72 162.85 37.6 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 123.044 2.496 . . . . 0.27000000000000002 111.193 -172.874 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -76.03 122.32 24.05 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 122.95 0.5 . . . . 0.27000000000000002 109.693 -178.587 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 47.9 pt -107.95 2.79 9.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 123.739 0.816 . . . . 0.47999999999999998 112.063 178.596 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.444 ' OD1' ' NZ ' ' A' ' 91' ' ' LYS . 28.4 t70 -45.25 -45.99 12.24 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 113.125 0.787 . . . . 2.79 113.125 175.475 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.5 mptp? -100.92 26.62 6.74 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.999 1.32 . . . . 6.21 109.837 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -52.9 -45.6 67.61 Favored 'General case' 0 N--CA 1.453 -0.277 0 O-C-N 121.345 -0.847 . . . . 0.28000000000000003 109.318 177.301 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -54.84 -22.26 26.1 Favored Glycine 0 CA--C 1.528 0.883 0 N-CA-C 115.021 0.768 . . . . 0.60999999999999999 115.021 177.047 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -81.54 -36.01 29.64 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 118.387 1.093 . . . . 0.96999999999999997 110.513 174.021 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -76.55 -48.55 18.96 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 123.08 0.552 . . . . 1.95 111.003 -178.721 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -141.21 143.97 34.47 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.699 1.6 . . . . 0.76000000000000001 107.756 -167.407 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 69.7 m -83.91 169.86 14.62 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 119.57 1.077 . . . . 1.74 111.096 178.824 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -51.03 -43.68 60.94 Favored 'General case' 0 C--O 1.222 -0.376 0 CA-C-O 118.602 -0.713 . . . . 2.73 112.681 -175.927 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -52.66 -45.69 66.84 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 119.057 0.844 . . . . 2.6600000000000001 111.055 176.079 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -71.17 -51.01 27.3 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 108.96 -0.756 . . . . 3.48 108.96 -176.38 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 71.5 mt -58.11 -44.9 88.36 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 N-CA-C 108.765 -0.828 . . . . 0.20999999999999999 108.765 -177.724 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 19.4 tp -56.27 -51.03 69.67 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 124.47 1.108 . . . . 0.67000000000000004 109.401 177.542 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -53.92 -48.62 70.0 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 117.832 0.287 . . . . 1.46 111.345 175.277 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 93.0 mt -55.53 -54.88 20.8 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.211 0 O-C-N 121.526 -0.733 . . . . 0.69999999999999996 109.443 177.262 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 52.2 mt -50.68 -46.54 28.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 O-C-N 120.807 -1.183 . . . . 0.20000000000000001 110.154 178.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 61.3 mt -64.17 -31.72 73.02 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 117.685 -1.15 . . . . 0.59999999999999998 113.541 178.616 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -131.63 20.09 4.69 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 120.278 1.399 . . . . 1.8100000000000001 111.109 -163.308 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 29.41 -141.0 0.02 OUTLIER Glycine 0 CA--C 1.543 1.809 0 C-N-CA 127.295 2.379 . . . . 0.67000000000000004 113.048 -160.959 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 37.4 tt0 174.63 141.72 0.05 OUTLIER 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 126.198 1.799 . . . . 1.8500000000000001 106.977 -176.537 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 22.25 -100.39 0.01 OUTLIER Glycine 0 CA--C 1.535 1.328 0 C-N-CA 126.094 1.807 . . . . 0.60999999999999999 114.822 -173.378 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -68.31 -34.08 79.31 Favored Glycine 0 CA--C 1.539 1.553 0 CA-C-N 118.802 1.301 . . . . 0.78000000000000003 113.485 -178.167 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -55.55 130.99 71.13 Favored Pre-proline 0 CA--C 1.539 0.538 0 C-N-CA 124.044 0.938 . . . . 0.75 112.282 176.616 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -63.8 -57.23 0.38 Allowed 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 123.895 3.063 . . . . 3.0299999999999998 110.857 178.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 116.74 146.68 8.52 Favored Glycine 0 C--N 1.335 0.497 0 C-N-CA 124.194 0.902 . . . . 0.82999999999999996 113.761 173.64 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 69.45 24.56 76.07 Favored Glycine 0 CA--C 1.529 0.952 0 N-CA-C 111.558 -0.617 . . . . 0.46000000000000002 111.558 -179.671 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.7 mt -52.61 -58.49 2.59 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 C-N-CA 126.212 1.805 . . . . 1.1299999999999999 110.982 179.172 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -103.48 158.33 16.43 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.162 0.985 . . . . 0.39000000000000001 108.967 162.786 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 4.9 mmtp -145.12 166.36 25.63 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.574 1.55 . . . . 2.96 108.783 179.505 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 56.94 -147.51 33.75 Favored Glycine 0 CA--C 1.532 1.135 0 O-C-N 121.741 -0.599 . . . . 0.67000000000000004 112.491 176.662 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -50.23 -36.94 33.09 Favored 'General case' 0 C--N 1.34 0.186 0 C-N-CA 123.809 0.843 . . . . 0.73999999999999999 111.255 175.635 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -52.78 -51.55 60.24 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.802 0.841 . . . . 2.02 109.599 176.16 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -69.51 -52.05 30.11 Favored 'General case' 0 CA--C 1.53 0.209 0 O-C-N 122.035 -0.416 . . . . 0.28000000000000003 111.477 177.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -50.77 -56.23 13.04 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 123.117 0.567 . . . . 2.5899999999999999 111.547 -177.617 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -55.38 -50.0 70.85 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 109.686 -0.487 . . . . 0.39000000000000001 109.686 -175.866 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.582 HG22 HG23 ' A' ' 28' ' ' VAL . 54.4 t -55.26 -56.59 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 C-N-CA 123.006 0.522 . . . . 0.32000000000000001 111.395 176.745 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -52.6 -50.88 62.18 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.343 0.657 . . . . 0.29999999999999999 111.267 -178.98 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.79 -47.63 85.43 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.111 0.564 . . . . 0.39000000000000001 110.365 -179.408 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.55 ' CE3' HD23 ' A' ' 88' ' ' LEU . 53.5 t90 -56.73 -50.44 72.21 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 121.991 -0.443 . . . . 0.51000000000000001 110.164 177.31 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.55 HD23 ' CE3' ' A' ' 87' ' ' TRP . 0.1 OUTLIER -60.77 -34.93 75.21 Favored 'General case' 0 C--O 1.226 -0.184 0 C-N-CA 124.31 1.044 . . . . 1.6499999999999999 110.802 177.548 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -67.09 -40.74 87.02 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 118.187 0.448 . . . . 0.72999999999999998 110.978 176.011 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -61.39 -40.17 93.36 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 122.856 0.462 . . . . 4.1100000000000003 110.643 171.855 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.444 ' NZ ' ' OD1' ' A' ' 49' ' ' ASP . 0.0 OUTLIER -73.31 105.66 4.8 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 121.527 -0.733 . . . . 2.1000000000000001 110.169 178.983 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.163 0 CA-C-O 117.578 -1.201 . . . . 2.8199999999999998 109.559 -177.5 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.446 -0.66 0 N-CA-C 108.153 -1.055 . . . . 2.2400000000000002 108.153 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -41.07 -55.14 2.66 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.747 1.219 . . . . 0.28000000000000003 111.519 177.197 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -51.87 -46.91 64.67 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 123.157 0.583 . . . . 2.98 111.785 176.779 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.67 -45.65 89.14 Favored 'General case' 0 N--CA 1.457 -0.104 0 CA-C-N 118.442 0.564 . . . . 0.26000000000000001 110.442 -177.924 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 72.8 t -57.07 -57.71 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 N-CA-C 109.007 -0.738 . . . . 0.34000000000000002 109.007 175.514 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.518 HG23 HG22 ' A' ' 84' ' ' VAL . 25.6 t -47.92 -50.83 9.58 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 C-N-CA 124.305 1.042 . . . . 0.41999999999999998 110.64 -178.976 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.434 ' HA ' HG12 ' A' ' 33' ' ' ILE . 30.8 mm-40 -53.1 -25.21 12.21 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 125.811 1.645 . . . . 0.56999999999999995 113.398 176.979 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 11.0 mt-30 -137.69 59.37 1.67 Allowed 'General case' 0 N--CA 1.456 -0.14 0 CA-C-N 119.309 0.959 . . . . 2.25 111.719 172.11 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 5.1 mttt -172.2 -36.46 0.01 OUTLIER 'General case' 0 C--O 1.224 -0.249 0 C-N-CA 124.204 1.002 . . . . 2.1499999999999999 110.322 168.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 4.0 m -101.22 -52.62 3.21 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 119.426 1.012 . . . . 0.16 111.312 -177.502 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.434 HG12 ' HA ' ' A' ' 29' ' ' GLN . 2.2 pp -55.83 -26.66 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.095 0 CA-C-N 115.99 -0.55 . . . . 0.44 111.614 -177.376 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.1 t -40.17 -36.03 0.46 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.37 1.468 . . . . 1.8799999999999999 111.83 173.563 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 32.9 m -118.78 -40.06 2.91 Favored 'General case' 0 C--N 1.342 0.259 0 C-N-CA 123.539 0.736 . . . . 0.17000000000000001 111.908 174.425 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 87.1 m-70 -75.89 -7.11 53.75 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 113.171 0.804 . . . . 0.26000000000000001 113.171 -174.789 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 86.26 150.26 15.46 Favored Glycine 0 C--N 1.337 0.625 0 N-CA-C 110.034 -1.227 . . . . 1.55 110.034 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -43.56 -39.19 4.41 Favored Glycine 0 C--N 1.34 0.801 0 C-N-CA 124.76 1.172 . . . . 0.41999999999999998 112.338 178.259 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -97.65 -0.83 44.91 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 124.366 1.066 . . . . 2.21 110.959 -171.672 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.2 mp 67.41 15.8 9.93 Favored 'General case' 0 C--N 1.349 0.558 0 CA-C-N 120.11 1.323 . . . . 1.5 111.432 176.538 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 6.9 p -83.43 -1.73 54.18 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 128.132 2.573 . . . . 0.33000000000000002 109.906 -178.008 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.98 144.71 9.72 Favored Glycine 0 N--CA 1.438 -1.174 0 N-CA-C 108.552 -1.819 . . . . 0.40999999999999998 108.552 -175.076 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -150.15 -80.38 0.12 Allowed 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 124.406 1.083 . . . . 0.25 108.939 177.616 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 58.7 m -91.56 3.64 54.52 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.812 0.845 . . . . 1.1599999999999999 111.422 170.6 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -154.38 163.41 24.27 Favored Pre-proline 0 N--CA 1.45 -0.469 0 C-N-CA 125.88 1.672 . . . . 0.25 107.197 -172.472 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -68.27 163.89 34.53 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.618 2.212 . . . . 0.40000000000000002 110.877 -176.257 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -74.27 122.74 23.33 Favored 'General case' 0 N--CA 1.455 -0.193 0 O-C-N 121.931 -0.481 . . . . 0.23999999999999999 110.306 -177.047 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 35.3 pt -105.78 0.88 10.16 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.181 0 C-N-CA 123.713 0.805 . . . . 0.32000000000000001 110.917 177.733 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -39.32 -45.41 1.43 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.059 0.944 . . . . 2.3999999999999999 112.409 169.758 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.59 15.97 21.81 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.129 0.972 . . . . 4.7400000000000002 111.13 -175.18 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -56.39 -47.28 79.26 Favored 'General case' 0 N--CA 1.452 -0.326 0 O-C-N 121.198 -0.939 . . . . 0.33000000000000002 110.069 -171.81 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -54.7 -26.62 40.21 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 114.447 0.539 . . . . 0.46999999999999997 114.447 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -80.55 -42.05 23.06 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 117.815 0.808 . . . . 0.68999999999999995 109.827 175.933 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 52.8 m-80 -63.5 -52.51 60.93 Favored 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 122.499 0.32 . . . . 1.53 110.906 179.273 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -138.1 145.88 42.21 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 125.956 1.702 . . . . 0.71999999999999997 108.479 -167.558 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -79.96 170.82 15.94 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.543 0.737 . . . . 1.8999999999999999 110.571 -178.804 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -49.94 -46.53 52.29 Favored 'General case' 0 C--O 1.225 -0.185 0 C-N-CA 124.079 0.952 . . . . 2.6699999999999999 111.615 177.209 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -58.91 -29.72 67.28 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.237 0.615 . . . . 2.8399999999999999 112.093 179.369 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -86.7 -48.0 8.65 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.0 -0.741 . . . . 3.4100000000000001 109.0 -178.604 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 98.7 mt -61.36 -43.91 97.52 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 O-C-N 121.714 -0.616 . . . . 0.31 109.461 -179.632 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 60.0 tp -52.57 -51.06 61.58 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 109.197 -0.668 . . . . 0.46999999999999997 109.197 175.195 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -58.51 -44.52 89.51 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 110.113 -0.329 . . . . 1.6200000000000001 110.113 178.9 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 78.8 mt -60.2 -36.52 68.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 O-C-N 121.104 -0.997 . . . . 0.5 111.498 176.048 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 50.9 mt -67.41 -49.37 72.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 O-C-N 120.03 -1.669 . . . . 0.28000000000000003 109.42 176.738 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 80.7 mt -66.74 -29.64 69.67 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 124.639 1.175 . . . . 0.37 113.154 -175.904 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 14.3 m-80 -124.1 11.57 8.87 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 119.789 1.177 . . . . 1.77 110.157 -170.643 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.597 ' N ' ' HA2' ' A' ' 73' ' ' GLY . . . 43.12 -147.4 0.81 Allowed Glycine 0 CA--C 1.539 1.571 0 C-N-CA 126.623 2.059 . . . . 0.63 110.833 -171.465 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 170.45 135.49 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 119.524 1.662 . . . . 1.1799999999999999 110.82 -178.648 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 43.63 -122.14 3.83 Favored Glycine 0 CA--C 1.532 1.149 0 O-C-N 120.685 -1.259 . . . . 0.40999999999999998 112.474 -173.088 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -69.08 -17.83 72.26 Favored Glycine 0 CA--C 1.531 1.046 0 O-C-N 122.483 -0.422 . . . . 0.5 112.886 179.34 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 20.8 ttt -73.95 119.73 77.68 Favored Pre-proline 0 N--CA 1.451 -0.42 0 C-N-CA 123.838 0.855 . . . . 0.40000000000000002 111.486 -178.771 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.438 ' HD2' HD11 ' A' ' 75' ' ' ILE . 41.8 Cg_endo -78.08 120.88 5.14 Favored 'Trans proline' 0 N--CA 1.448 -1.172 0 C-N-CA 122.884 2.389 . . . . 2.1299999999999999 112.031 -177.95 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.597 ' HA2' ' N ' ' A' ' 67' ' ' GLY . . . -57.84 135.5 51.7 Favored Glycine 0 N--CA 1.445 -0.711 0 N-CA-C 116.421 1.328 . . . . 0.59999999999999998 116.421 -177.712 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 81.15 36.91 20.0 Favored Glycine 0 C--N 1.337 0.609 0 CA-C-N 114.124 -1.038 . . . . 0.34000000000000002 111.454 173.514 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.438 HD11 ' HD2' ' A' ' 72' ' ' PRO . 1.3 mt -57.96 -57.0 12.39 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 124.876 1.27 . . . . 1.1100000000000001 109.942 175.417 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -105.7 161.56 14.29 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.06 1.344 . . . . 0.31 109.508 167.16 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.0 mmtp -142.87 161.7 37.42 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.377 1.471 . . . . 2.4500000000000002 110.466 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 55.55 -146.5 30.13 Favored Glycine 0 CA--C 1.531 1.04 0 O-C-N 121.596 -0.69 . . . . 0.71999999999999997 111.437 179.145 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -54.55 -28.91 49.04 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 117.157 0.479 . . . . 0.71999999999999997 111.814 175.006 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -56.54 -39.08 72.78 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 109.827 -0.434 . . . . 2.29 109.827 174.871 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -82.41 -52.43 6.9 Favored 'General case' 0 CA--C 1.53 0.208 0 O-C-N 121.738 -0.601 . . . . 0.23999999999999999 110.963 174.496 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -58.44 -48.67 79.96 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 122.87 0.468 . . . . 2.3199999999999998 112.077 -173.637 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.74 -48.15 80.43 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 109.363 -0.606 . . . . 0.22 109.363 179.31 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.518 HG22 HG23 ' A' ' 28' ' ' VAL . 49.6 t -55.38 -55.2 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 C-N-CA 123.065 0.546 . . . . 0.28000000000000003 110.952 177.582 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -52.48 -53.48 45.14 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 123.313 0.645 . . . . 0.17999999999999999 111.483 178.282 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.7 -48.61 81.0 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 121.772 0.796 . . . . 0.27000000000000002 110.934 -178.826 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 83.6 t90 -57.22 -47.84 80.3 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 123.466 0.707 . . . . 0.58999999999999997 110.084 178.427 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.02 -31.21 72.31 Favored 'General case' 0 C--O 1.221 -0.398 0 CA-C-O 118.167 -0.921 . . . . 1.8999999999999999 112.649 173.359 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -56.39 -43.08 78.92 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 119.76 1.164 . . . . 0.34000000000000002 109.898 171.068 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -68.0 -36.93 80.81 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 118.344 -0.836 . . . . 3.54 112.585 171.482 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 15.3 mtpp -72.11 113.43 9.13 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 120.35 1.432 . . . . 2.8100000000000001 110.847 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 77.3 mttt . . . . . 0 C--O 1.254 1.337 0 N-CA-C 104.953 -2.24 . . . . 2.5 104.953 179.767 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 . . . . . 0 N--CA 1.45 -0.473 0 N-CA-C 108.312 -0.996 . . . . 2.1699999999999999 108.312 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -39.02 -54.26 1.7 Allowed 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 125.387 1.475 . . . . 0.34999999999999998 112.046 175.173 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -54.58 -48.86 71.59 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 116.108 -0.496 . . . . 2.6899999999999999 111.26 177.058 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.1 -36.57 82.14 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 118.96 0.8 . . . . 0.51000000000000001 111.932 -178.748 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 56.2 t -62.78 -58.46 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 N-CA-C 109.032 -0.729 . . . . 0.34000000000000002 109.032 172.809 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.693 HG22 ' SG ' ' A' ' 32' ' ' CYS . 21.0 t -53.55 -48.71 58.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 C-N-CA 123.255 0.622 . . . . 0.37 110.757 -175.738 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.462 ' HA ' HG12 ' A' ' 33' ' ' ILE . 28.3 mm-40 -49.35 -21.92 0.99 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 126.495 1.918 . . . . 0.52000000000000002 112.811 174.49 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -130.75 26.1 5.01 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.727 0.811 . . . . 4.96 111.59 -179.807 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.3 mppp? -148.96 -66.85 0.22 Allowed 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 109.151 -0.685 . . . . 1.76 109.151 171.718 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.693 ' SG ' HG22 ' A' ' 28' ' ' VAL . 2.0 m -71.76 -47.53 53.0 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.93 -0.396 . . . . 0.22 109.93 -168.926 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.462 HG12 ' HA ' ' A' ' 29' ' ' GLN . 2.0 pp -56.12 -26.37 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.075 0 N-CA-C 111.899 0.333 . . . . 0.37 111.899 -178.046 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.3 t -46.32 -36.0 5.89 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.376 1.071 . . . . 1.9199999999999999 110.699 177.727 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 28.9 m -116.82 -44.13 2.84 Favored 'General case' 0 C--N 1.34 0.178 0 C-N-CA 123.286 0.635 . . . . 0.20000000000000001 111.267 175.959 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 85.9 m-70 -71.09 -8.41 53.25 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.906 0.883 . . . . 0.22 112.564 -176.194 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 88.25 152.19 24.03 Favored Glycine 0 C--N 1.337 0.606 0 N-CA-C 109.707 -1.357 . . . . 1.51 109.707 178.235 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -39.39 -39.43 1.13 Allowed Glycine 0 CA--C 1.528 0.877 0 C-N-CA 125.366 1.46 . . . . 0.41999999999999998 112.9 179.11 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -105.74 2.21 27.74 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.216 1.406 . . . . 2.23 112.241 -170.822 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.411 HD22 ' N ' ' A' ' 40' ' ' LEU . 1.8 mm? 64.88 23.04 12.59 Favored 'General case' 0 C--N 1.348 0.531 0 CA-C-N 120.493 1.497 . . . . 3.5299999999999998 111.127 -179.731 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.7 p -85.55 -3.73 58.95 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 128.23 2.612 . . . . 0.39000000000000001 109.992 179.277 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.52 139.75 5.68 Favored Glycine 0 N--CA 1.441 -0.969 0 N-CA-C 109.037 -1.625 . . . . 0.45000000000000001 109.037 -174.387 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -145.4 -73.87 0.24 Allowed 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 107.813 -1.18 . . . . 0.39000000000000001 107.813 176.355 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.1 t -100.16 4.62 44.56 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.307 1.443 . . . . 1.48 111.169 173.233 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -156.63 162.81 26.84 Favored Pre-proline 0 CA--C 1.537 0.451 0 C-N-CA 126.289 1.836 . . . . 0.31 108.004 -168.773 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.22 153.16 40.54 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 123.271 2.647 . . . . 0.39000000000000001 111.414 -173.928 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -75.16 109.27 8.51 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.864 0.866 . . . . 0.59999999999999998 113.097 -170.136 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 43.7 pt -91.45 1.06 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 C-N-CA 125.8 1.64 . . . . 0.34000000000000002 111.793 -178.683 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -32.34 -48.59 0.18 Allowed 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 127.061 2.144 . . . . 2.79 113.044 164.226 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.51 36.83 3.25 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.955 0.902 . . . . 4.96 111.537 176.328 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.11 -52.54 58.66 Favored 'General case' 0 N--CA 1.454 -0.257 0 O-C-N 121.146 -0.971 . . . . 0.40999999999999998 108.849 176.236 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -52.33 -27.1 23.62 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 124.187 0.899 . . . . 0.54000000000000004 114.021 177.496 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.19 -38.24 88.37 Favored 'General case' 0 N--CA 1.452 -0.355 0 O-C-N 121.461 -1.023 . . . . 1.1299999999999999 110.548 176.63 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 34.4 m-80 -103.83 -61.78 1.39 Allowed 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.798 1.239 . . . . 2.3500000000000001 109.835 -171.5 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -91.93 136.13 33.4 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.007 1.323 . . . . 0.62 109.0 -174.896 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.7 t -80.69 166.91 20.6 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 118.102 0.41 . . . . 1.8500000000000001 110.632 -179.928 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -43.72 -55.85 4.16 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 124.384 1.074 . . . . 4.9000000000000004 109.856 177.352 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -57.01 -35.61 69.44 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.665 0.786 . . . . 3.3399999999999999 111.359 -176.187 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -74.15 -49.05 25.38 Favored 'General case' 0 C--N 1.343 0.302 0 O-C-N 121.243 -0.911 . . . . 2.9100000000000001 110.295 177.002 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 73.3 mt -58.56 -41.05 80.91 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.141 0 N-CA-C 108.375 -0.972 . . . . 0.28999999999999998 108.375 -177.538 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 27.0 tp -55.22 -54.58 41.65 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 123.759 0.823 . . . . 0.33000000000000002 110.171 174.115 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -50.98 -48.02 61.33 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 118.104 0.411 . . . . 1.72 111.498 176.521 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 93.1 mt -59.01 -55.77 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 O-C-N 121.54 -0.725 . . . . 0.71999999999999997 109.767 177.197 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 56.5 mt -47.61 -46.08 10.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 O-C-N 121.276 -0.89 . . . . 0.22 110.192 178.976 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 69.5 mt -66.31 -36.4 82.84 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 113.503 0.927 . . . . 0.52000000000000002 113.503 178.537 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -127.65 27.35 5.79 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 120.085 1.312 . . . . 1.8400000000000001 110.418 -161.994 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 20.38 -130.47 0.01 OUTLIER Glycine 0 CA--C 1.539 1.585 0 C-N-CA 127.764 2.602 . . . . 0.65000000000000002 112.749 -159.592 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 165.62 136.04 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 126.801 2.04 . . . . 1.1699999999999999 107.707 -176.768 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 27.57 -108.42 0.01 OUTLIER Glycine 0 CA--C 1.535 1.286 0 C-N-CA 126.053 1.787 . . . . 0.39000000000000001 114.714 -172.603 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -62.93 -28.22 71.59 Favored Glycine 0 CA--C 1.534 1.279 0 CA-C-N 117.694 0.747 . . . . 0.55000000000000004 113.467 -178.443 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 6.5 ttt -70.86 126.0 92.08 Favored Pre-proline 0 CA--C 1.539 0.547 0 C-N-CA 124.887 1.275 . . . . 0.55000000000000004 110.364 -178.751 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -62.8 -55.03 0.93 Allowed 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 123.686 2.924 . . . . 2.9900000000000002 111.254 -172.71 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 116.94 147.23 8.59 Favored Glycine 0 C--N 1.334 0.457 0 C-N-CA 124.156 0.884 . . . . 0.88 113.19 175.028 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 69.73 24.4 76.32 Favored Glycine 0 CA--C 1.53 1.02 0 N-CA-C 111.524 -0.631 . . . . 0.46000000000000002 111.524 179.76 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.0 mm -55.87 -44.96 79.53 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.843 0 C-N-CA 125.51 1.524 . . . . 2.1899999999999999 111.597 -178.919 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -113.6 160.51 18.48 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.003 1.321 . . . . 0.29999999999999999 108.843 161.021 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 5.0 ttmt -146.38 167.45 23.57 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 118.423 0.556 . . . . 2.6899999999999999 110.768 170.53 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 55.91 -148.61 27.48 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 111.092 -0.803 . . . . 0.70999999999999996 111.092 -179.595 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -49.53 -37.4 26.72 Favored 'General case' 0 C--N 1.341 0.204 0 C-N-CA 123.755 0.822 . . . . 0.68000000000000005 111.314 -178.709 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -50.69 -49.48 57.3 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 124.994 1.318 . . . . 2.0299999999999998 110.4 175.287 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -78.75 -48.6 14.56 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 123.233 0.613 . . . . 0.23000000000000001 111.375 178.953 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -53.7 -50.75 65.19 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.252 1.021 . . . . 2.23 110.623 -176.319 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.01 -48.9 78.64 Favored 'General case' 0 N--CA 1.455 -0.214 0 O-C-N 122.022 -0.424 . . . . 0.20999999999999999 110.144 177.893 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.436 HG22 HG23 ' A' ' 28' ' ' VAL . 56.0 t -55.54 -49.73 71.55 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 C-N-CA 122.783 0.433 . . . . 0.26000000000000001 110.955 179.467 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -52.52 -53.17 49.66 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 123.331 0.652 . . . . 0.31 111.466 175.928 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.1 -48.26 82.25 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-O 121.417 0.627 . . . . 0.39000000000000001 111.257 -179.736 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.533 ' CE3' HD23 ' A' ' 88' ' ' LEU . 47.8 t90 -56.05 -50.16 71.74 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.017 0.527 . . . . 0.47999999999999998 109.733 177.848 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.533 HD23 ' CE3' ' A' ' 87' ' ' TRP . 0.1 OUTLIER -60.92 -34.61 74.96 Favored 'General case' 0 C--O 1.224 -0.279 0 C-N-CA 124.351 1.06 . . . . 1.55 111.449 176.897 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.28 -42.57 98.87 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 119.009 0.822 . . . . 0.38 110.095 173.332 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -59.66 -42.13 92.13 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.044 0.538 . . . . 3.0099999999999998 111.093 172.244 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 9.5 mtpp -71.85 130.8 41.94 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 118.545 0.611 . . . . 2.9300000000000002 110.357 -177.547 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 38.6 mttt . . . . . 0 C--O 1.25 1.102 0 N-CA-C 106.469 -1.678 . . . . 3.25 106.469 -178.274 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 28.8 t0 . . . . . 0 N--CA 1.451 -0.417 0 N-CA-C 108.306 -0.998 . . . . 3.7200000000000002 108.306 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -47.69 -41.95 23.76 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.239 1.016 . . . . 0.34999999999999998 111.739 176.097 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -66.99 -52.64 40.2 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 107.73 -1.211 . . . . 3.3399999999999999 107.73 -176.75 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.99 -45.88 71.57 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.316 0.646 . . . . 0.46999999999999997 111.484 178.483 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 64.0 t -56.57 -60.95 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 N-CA-C 109.181 -0.674 . . . . 0.52000000000000002 109.181 176.148 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.682 HG22 ' SG ' ' A' ' 32' ' ' CYS . 46.2 t -55.81 -45.36 79.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 O-C-N 121.908 -0.495 . . . . 0.37 110.888 -175.969 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.447 ' HA ' HG12 ' A' ' 33' ' ' ILE . 23.2 mm-40 -49.78 -19.39 0.64 Allowed 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 126.968 2.107 . . . . 0.87 112.998 173.509 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 44.3 tt0 -139.69 35.06 2.0 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 119.012 0.823 . . . . 2.3300000000000001 111.367 173.372 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 67.9 mmtt -145.96 -56.92 0.3 Allowed 'General case' 0 CA--C 1.516 -0.358 0 O-C-N 121.211 -0.931 . . . . 2.2000000000000002 109.977 175.08 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.682 ' SG ' HG22 ' A' ' 28' ' ' VAL . 3.2 m -86.36 -49.71 7.45 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 109.213 -0.662 . . . . 0.28000000000000003 109.213 -172.768 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.447 HG12 ' HA ' ' A' ' 29' ' ' GLN . 1.8 pp -56.23 -27.88 24.69 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.21 0 CA-C-N 115.739 -0.664 . . . . 0.55000000000000004 110.569 -178.106 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -36.78 -40.46 0.27 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.199 1.399 . . . . 1.3600000000000001 111.654 170.943 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 24.4 m -114.69 -35.72 4.76 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.792 0.837 . . . . 0.37 112.127 172.794 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 92.2 m-70 -80.59 3.56 21.43 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 125.065 1.346 . . . . 0.33000000000000002 113.13 -175.115 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 112.46 -92.58 0.64 Allowed Glycine 0 CA--C 1.528 0.856 0 C-N-CA 126.396 1.951 . . . . 2.98 112.511 164.747 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -162.45 -47.82 0.02 OUTLIER Glycine 0 CA--C 1.522 0.519 0 N-CA-C 108.815 -1.714 . . . . 0.69999999999999996 108.815 -173.306 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -102.21 7.24 40.89 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 126.099 1.759 . . . . 3.4900000000000002 111.395 176.643 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.682 HD21 HG11 ' A' ' 28' ' ' VAL . 0.5 OUTLIER 76.28 13.34 2.56 Favored 'General case' 0 C--N 1.35 0.597 0 CA-C-N 120.006 1.276 . . . . 1.8700000000000001 111.056 179.562 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 35.5 p -75.41 -10.79 59.77 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 126.953 2.101 . . . . 0.59999999999999998 110.112 -175.777 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.84 147.11 22.14 Favored Glycine 0 N--CA 1.444 -0.817 0 N-CA-C 108.653 -1.779 . . . . 0.58999999999999997 108.653 -177.396 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -154.23 -81.36 0.08 Allowed 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 123.181 0.593 . . . . 0.34000000000000002 109.525 177.264 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 5.4 m -89.31 2.8 53.83 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.752 0.821 . . . . 1.02 110.862 171.451 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -152.71 162.73 25.65 Favored Pre-proline 0 N--CA 1.45 -0.459 0 C-N-CA 125.77 1.628 . . . . 0.28999999999999998 107.256 -172.344 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -66.74 163.95 31.2 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 122.545 2.163 . . . . 0.27000000000000002 110.905 -175.378 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.87 123.35 24.05 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 109.33 -0.618 . . . . 0.34999999999999998 109.33 -178.89 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 49.8 pt -107.14 1.95 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 C-N-CA 123.544 0.737 . . . . 0.33000000000000002 111.424 176.85 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 18.4 p-10 -34.08 -49.92 0.37 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.382 1.473 . . . . 3.7599999999999998 112.21 167.739 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 18.1 pttt -109.9 34.7 3.71 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 125.086 1.354 . . . . 4.5999999999999996 112.433 -179.924 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.13 -46.04 91.0 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 109.473 -0.566 . . . . 0.31 109.473 173.242 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -54.88 -32.58 55.73 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 123.154 0.407 . . . . 0.56000000000000005 113.455 -176.829 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.32 -40.01 62.49 Favored 'General case' 0 CA--C 1.529 0.142 0 O-C-N 121.947 -0.737 . . . . 0.72999999999999998 110.908 174.689 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 19.5 m-80 -65.71 -52.86 47.98 Favored 'General case' 0 C--O 1.227 -0.088 0 N-CA-C 110.384 -0.228 . . . . 1.6899999999999999 110.384 -179.788 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -136.07 144.28 45.1 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.035 1.334 . . . . 0.66000000000000003 108.401 -168.584 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 4.9 m -74.03 167.58 21.24 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 118.268 0.486 . . . . 1.5800000000000001 110.38 177.626 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.8 pm0 -49.83 -41.68 45.54 Favored 'General case' 0 C--O 1.225 -0.232 0 C-N-CA 123.731 0.813 . . . . 2.6499999999999999 111.354 -179.476 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -56.62 -44.3 81.06 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.775 0.83 . . . . 3.0899999999999999 109.966 179.578 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -78.21 -43.65 27.88 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.07 0.948 . . . . 2.79 109.55 -174.481 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 76.2 mt -59.83 -48.34 88.04 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 O-C-N 121.094 -1.004 . . . . 0.39000000000000001 108.749 176.606 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 33.5 tp -55.7 -45.33 77.88 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 109.193 -0.669 . . . . 0.54000000000000004 109.193 178.425 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -47.22 -56.71 6.19 Favored 'General case' 0 N--CA 1.453 -0.302 0 O-C-N 124.108 0.88 . . . . 1.6399999999999999 109.328 172.449 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 43.7 mt -61.78 -45.78 97.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 117.827 -1.549 . . . . 0.80000000000000004 111.999 179.851 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 85.9 mt -52.6 -48.66 47.43 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 O-C-N 119.693 -1.879 . . . . 0.31 110.296 -179.023 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 88.3 mt -72.95 -31.94 64.91 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 123.416 0.687 . . . . 0.64000000000000001 111.886 178.144 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 45.8 m-20 -129.18 46.91 2.55 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 107.699 -1.223 . . . . 1.8 107.699 -163.198 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -40.67 106.25 0.06 OUTLIER Glycine 0 CA--C 1.534 1.244 0 C-N-CA 125.838 1.685 . . . . 3.25 111.476 -171.256 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 -87.86 165.19 15.46 Favored 'General case' 0 N--CA 1.435 -1.212 0 C-N-CA 127.466 2.306 . . . . 3.4399999999999999 109.382 -175.307 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 57.4 -127.81 45.86 Favored Glycine 0 CA--C 1.529 0.943 0 N-CA-C 111.521 -0.631 . . . . 0.82999999999999996 111.521 174.385 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -73.79 -25.55 71.62 Favored Glycine 0 CA--C 1.53 0.979 0 CA-C-N 117.096 0.448 . . . . 0.92000000000000004 112.131 179.799 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 5.5 ttt -63.44 137.22 97.02 Favored Pre-proline 0 CA--C 1.54 0.566 0 O-C-N 121.914 -0.757 . . . . 0.78000000000000003 109.741 178.849 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -74.35 -54.19 0.1 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.844 2.362 . . . . 2.8599999999999999 111.233 -177.234 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 113.73 149.81 10.31 Favored Glycine 0 C--N 1.335 0.515 0 C-N-CA 123.849 0.738 . . . . 0.95999999999999996 112.785 177.321 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 67.25 24.4 73.46 Favored Glycine 0 CA--C 1.531 1.092 0 CA-C-N 114.906 -0.647 . . . . 0.39000000000000001 112.146 176.727 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -55.5 -51.62 55.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 125.936 1.694 . . . . 1.05 110.877 177.784 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -104.99 149.08 26.06 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 125.171 1.389 . . . . 0.5 108.101 169.768 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 2.9 mtpm? -146.25 153.13 40.24 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.966 0.907 . . . . 4.3499999999999996 111.441 -178.431 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 71.76 -162.64 54.38 Favored Glycine 0 CA--C 1.532 1.131 0 N-CA-C 110.638 -0.985 . . . . 0.98999999999999999 110.638 -170.311 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -50.83 -26.72 6.09 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.823 1.249 . . . . 0.72999999999999998 112.607 -178.702 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 51.7 tt0 -40.93 -62.34 0.83 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.081 1.352 . . . . 2.1000000000000001 110.508 168.142 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -62.77 -46.85 86.13 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 122.816 0.446 . . . . 0.27000000000000002 110.666 -174.688 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -51.12 -56.85 10.62 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 123.71 0.804 . . . . 1.9399999999999999 111.06 175.705 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -56.34 -47.57 78.52 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 109.429 -0.582 . . . . 0.27000000000000002 109.429 -177.682 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.486 HG22 HG23 ' A' ' 28' ' ' VAL . 53.3 t -57.93 -53.66 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 N-CA-C 111.774 0.287 . . . . 0.29999999999999999 111.774 177.49 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -52.38 -52.69 52.23 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 123.214 0.605 . . . . 0.19 111.306 179.028 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.444 ' O ' ' HB3' ' A' ' 89' ' ' ALA . . . -58.76 -49.48 77.49 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 121.415 0.626 . . . . 0.34999999999999998 110.134 179.189 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.564 ' CE3' HD23 ' A' ' 88' ' ' LEU . 46.3 t90 -53.63 -48.76 69.05 Favored 'General case' 0 N--CA 1.451 -0.413 0 O-C-N 121.69 -0.631 . . . . 0.5 110.378 177.473 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.564 HD23 ' CE3' ' A' ' 87' ' ' TRP . 0.1 OUTLIER -61.58 -34.68 76.02 Favored 'General case' 0 C--O 1.227 -0.123 0 C-N-CA 124.394 1.078 . . . . 1.6499999999999999 111.004 177.206 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.444 ' HB3' ' O ' ' A' ' 86' ' ' ALA . . . -52.58 -47.11 67.07 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 118.889 0.768 . . . . 0.58999999999999997 109.972 170.989 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -83.22 26.08 0.66 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.404 0.682 . . . . 5.0599999999999996 112.597 173.686 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 8.1 mtpm? -125.69 120.99 32.17 Favored 'General case' 0 C--N 1.341 0.197 0 CA-C-N 119.775 1.171 . . . . 2.0600000000000001 110.017 167.043 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.438 -1.043 0 C-N-CA 127.397 2.279 . . . . 2.3599999999999999 105.1 173.933 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 N--CA 1.445 -0.697 0 N-CA-C 108.049 -1.093 . . . . 2.1800000000000002 108.049 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -40.41 -55.66 2.2 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 125.087 1.355 . . . . 0.33000000000000002 111.732 177.697 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -52.93 -47.0 68.35 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 123.012 0.525 . . . . 2.75 111.78 177.287 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.07 -46.44 87.46 Favored 'General case' 0 N--CA 1.458 -0.06 0 CA-C-N 118.494 0.588 . . . . 0.26000000000000001 110.468 -178.233 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 69.8 t -55.33 -54.73 21.87 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.252 0 N-CA-C 109.221 -0.659 . . . . 0.34000000000000002 109.221 175.274 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.473 HG22 ' SG ' ' A' ' 32' ' ' CYS . 34.1 t -56.66 -48.41 80.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 C-N-CA 123.375 0.67 . . . . 0.33000000000000002 110.531 -175.14 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.416 ' HA ' HG12 ' A' ' 33' ' ' ILE . 36.4 mm-40 -51.42 -21.63 2.46 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.913 1.685 . . . . 0.48999999999999999 112.78 172.373 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -136.81 49.42 2.06 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 119.151 0.887 . . . . 3.75 111.705 178.104 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -168.5 -59.18 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.183 0 N-CA-C 108.112 -1.07 . . . . 1.52 108.112 168.163 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.473 ' SG ' HG22 ' A' ' 28' ' ' VAL . 3.6 m -75.54 -51.55 12.67 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 120.862 0.363 . . . . 0.17999999999999999 110.655 -170.231 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.416 HG12 ' HA ' ' A' ' 29' ' ' GLN . 2.2 pp -55.01 -26.58 17.88 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.165 0 CA-C-N 115.838 -0.619 . . . . 0.41999999999999998 111.697 -179.225 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.7 t -43.61 -34.72 1.51 Allowed 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.034 0.933 . . . . 2.0600000000000001 111.867 175.051 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 28.7 m -117.03 -37.34 3.59 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.482 0.713 . . . . 0.22 111.706 172.774 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -78.92 2.31 20.62 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.35 1.06 . . . . 0.27000000000000002 113.0 -175.921 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 112.1 -85.63 0.4 Allowed Glycine 0 C--N 1.34 0.755 0 C-N-CA 125.676 1.607 . . . . 3.0 112.196 162.609 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -171.23 -50.23 0.04 OUTLIER Glycine 0 CA--C 1.518 0.242 0 N-CA-C 108.452 -1.859 . . . . 0.82999999999999996 108.452 -171.906 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -102.0 4.91 40.38 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.711 1.204 . . . . 3.0899999999999999 111.504 179.38 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 5.2 mt 80.16 15.29 0.8 Allowed 'General case' 0 C--N 1.354 0.761 0 CA-C-N 120.392 1.451 . . . . 1.53 110.206 -178.903 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.4 p -80.75 -9.4 59.81 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 128.34 2.656 . . . . 0.57999999999999996 110.002 -175.906 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.56 161.27 36.95 Favored Glycine 0 N--CA 1.442 -0.908 0 N-CA-C 108.995 -1.642 . . . . 0.92000000000000004 108.995 -174.691 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -164.8 -72.94 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 124.503 1.121 . . . . 0.31 108.187 174.066 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 30.3 m -101.73 3.14 39.31 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.398 1.079 . . . . 1.1899999999999999 110.857 174.202 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -152.14 160.87 30.8 Favored Pre-proline 0 CA--C 1.536 0.417 0 C-N-CA 126.456 1.902 . . . . 0.23999999999999999 107.092 -171.599 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.46 158.8 55.38 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 123.115 2.544 . . . . 0.22 110.942 -175.046 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -74.01 120.63 19.85 Favored 'General case' 0 N--CA 1.454 -0.229 0 O-C-N 121.887 -0.508 . . . . 0.27000000000000002 109.871 -176.749 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 25.3 pt -100.32 2.64 10.6 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 C-N-CA 123.475 0.71 . . . . 0.31 111.679 177.728 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -36.28 -44.89 0.43 Allowed 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.215 1.406 . . . . 2.5299999999999998 113.668 171.49 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 8.3 mtpt -111.36 26.23 10.88 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.371 1.068 . . . . 3.71 111.324 -177.542 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -58.31 -43.24 88.07 Favored 'General case' 0 N--CA 1.453 -0.317 0 O-C-N 121.631 -0.668 . . . . 0.31 110.205 179.923 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -54.13 -23.58 25.24 Favored Glycine 0 CA--C 1.53 0.98 0 CA-C-N 118.299 0.5 . . . . 0.5 114.344 179.172 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -88.03 -41.56 13.01 Favored 'General case' 0 N--CA 1.457 -0.123 0 CA-C-N 118.123 0.962 . . . . 0.75 109.818 175.849 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -56.85 -53.41 58.18 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 122.529 0.331 . . . . 2.02 110.801 176.504 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -139.15 154.61 48.11 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.677 1.191 . . . . 0.64000000000000001 109.229 -170.576 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 2.1 p -80.07 167.37 20.5 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.793 0.837 . . . . 2.1800000000000002 110.927 178.434 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -46.63 -46.22 19.66 Favored 'General case' 0 C--O 1.224 -0.258 0 C-N-CA 124.473 1.109 . . . . 2.7400000000000002 111.319 176.703 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -58.72 -40.83 84.84 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.285 0.634 . . . . 2.8100000000000001 110.638 -177.941 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -76.78 -47.93 20.16 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 108.877 -0.786 . . . . 3.0099999999999998 108.877 -175.393 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 83.1 mt -59.58 -42.96 89.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 N-CA-C 109.087 -0.709 . . . . 0.22 109.087 178.666 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.8 tp -54.04 -52.91 59.36 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 109.383 -0.599 . . . . 0.29999999999999999 109.383 175.954 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -50.51 -51.27 49.09 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 118.064 0.393 . . . . 1.6499999999999999 110.824 175.004 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 60.9 mt -61.72 -30.57 48.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 O-C-N 121.574 -0.704 . . . . 0.72999999999999998 112.307 -179.036 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 49.2 mt -69.99 -49.3 57.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 O-C-N 120.381 -1.449 . . . . 0.20999999999999999 109.08 173.313 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 86.3 mt -67.39 -34.16 76.7 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 124.437 1.095 . . . . 0.48999999999999999 113.354 -174.448 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -123.37 20.39 9.65 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 119.717 1.144 . . . . 1.8300000000000001 110.224 -166.644 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 32.24 -141.23 0.05 OUTLIER Glycine 0 CA--C 1.543 1.827 0 C-N-CA 127.039 2.256 . . . . 0.64000000000000001 112.207 -164.642 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 39.5 tt0 170.72 137.45 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 119.588 1.694 . . . . 1.6699999999999999 109.243 -176.736 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 38.1 -114.85 0.34 Allowed Glycine 0 CA--C 1.531 1.067 0 CA-C-N 120.04 1.291 . . . . 0.39000000000000001 113.291 -177.008 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -69.26 -25.04 75.79 Favored Glycine 0 CA--C 1.534 1.25 0 CA-C-N 117.263 0.532 . . . . 0.46999999999999997 113.233 179.566 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 16.8 ttt -70.27 120.21 76.92 Favored Pre-proline 0 CA--C 1.539 0.532 0 C-N-CA 124.492 1.117 . . . . 0.37 110.058 -179.591 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -62.5 -55.89 0.8 Allowed 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 124.249 3.299 . . . . 2.9100000000000001 111.578 -168.965 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 118.2 149.13 8.7 Favored Glycine 0 N--CA 1.449 -0.489 0 CA-C-N 115.857 -0.61 . . . . 0.91000000000000003 114.124 172.429 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 67.41 21.65 72.52 Favored Glycine 0 CA--C 1.532 1.111 0 CA-C-N 114.782 -0.709 . . . . 0.52000000000000002 111.686 -179.845 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 2.0 mt -52.53 -44.54 45.18 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 C-N-CA 126.872 2.069 . . . . 1.03 110.98 178.211 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -114.82 159.95 20.03 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.817 1.247 . . . . 0.27000000000000002 110.311 161.775 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 19.3 mmtp -141.92 159.95 41.2 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.972 1.709 . . . . 2.27 110.28 -179.343 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 56.3 -142.94 38.8 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 111.426 -0.669 . . . . 0.78000000000000003 111.426 176.027 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -50.07 -35.98 27.42 Favored 'General case' 0 C--N 1.341 0.22 0 C-N-CA 123.661 0.785 . . . . 0.70999999999999996 111.592 174.753 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -57.9 -33.11 68.4 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.61 0.764 . . . . 2.1000000000000001 110.795 178.782 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -91.97 -53.2 4.37 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.613 0.765 . . . . 0.23000000000000001 110.882 175.415 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -50.15 -54.49 20.39 Favored 'General case' 0 N--CA 1.461 0.105 0 C-N-CA 124.563 1.145 . . . . 2.1099999999999999 111.544 -179.533 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.25 -44.75 92.36 Favored 'General case' 0 C--O 1.225 -0.236 0 N-CA-C 109.588 -0.523 . . . . 0.31 109.588 -178.522 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 54.7 t -58.16 -53.75 41.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 C-N-CA 122.772 0.429 . . . . 0.32000000000000001 111.1 179.451 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -53.17 -52.33 59.15 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 123.081 0.552 . . . . 0.23000000000000001 111.533 174.921 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.2 -38.62 83.88 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.515 0.726 . . . . 0.58999999999999997 111.155 -178.216 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 73.7 t90 -67.86 -51.08 52.4 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 123.82 0.848 . . . . 0.5 109.578 177.637 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.46 -30.33 69.6 Favored 'General case' 0 C--O 1.223 -0.318 0 O-C-N 121.363 -0.836 . . . . 1.99 112.143 175.91 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -55.31 -38.91 69.29 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 119.592 1.087 . . . . 0.40999999999999998 110.836 170.9 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -68.54 -41.81 79.32 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 118.588 -0.72 . . . . 3.1000000000000001 110.92 170.908 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.6 mtpm? -72.86 106.34 4.75 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 119.173 0.897 . . . . 1.98 110.384 -174.587 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 4.4 mtmp? . . . . . 0 C--O 1.25 1.084 0 C-N-CA 126.233 1.813 . . . . 2.0600000000000001 106.51 179.374 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 . . . . . 0 N--CA 1.449 -0.514 0 N-CA-C 108.509 -0.923 . . . . 2.5699999999999998 108.509 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -43.3 -52.07 5.95 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 124.335 1.054 . . . . 0.27000000000000002 111.012 176.101 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -57.91 -47.14 83.7 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 116.287 -0.415 . . . . 2.6800000000000002 110.401 179.938 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.07 -45.1 94.0 Favored 'General case' 0 N--CA 1.461 0.098 0 CA-C-N 118.472 0.578 . . . . 0.34999999999999998 110.891 -178.874 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 79.5 t -57.49 -57.25 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 108.93 -0.767 . . . . 0.33000000000000002 108.93 176.884 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.619 HG11 HD21 ' A' ' 40' ' ' LEU . 35.7 t -55.24 -46.04 77.79 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 C-N-CA 121.213 -0.195 . . . . 0.35999999999999999 111.011 -176.762 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.429 ' HA ' HG12 ' A' ' 33' ' ' ILE . 26.3 mm-40 -49.98 -25.94 3.79 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 125.794 1.638 . . . . 0.5 112.808 173.769 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -140.66 67.23 1.36 Allowed 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 119.06 0.846 . . . . 2.7000000000000002 112.001 171.4 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -178.22 -36.11 0.01 OUTLIER 'General case' 0 C--O 1.225 -0.221 0 C-N-CA 124.812 1.245 . . . . 1.2 109.202 169.627 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.492 ' SG ' HG22 ' A' ' 28' ' ' VAL . 2.7 m -103.95 -53.79 2.68 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 119.339 0.972 . . . . 0.25 111.13 -177.649 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.429 HG12 ' HA ' ' A' ' 29' ' ' GLN . 2.0 pp -55.26 -27.88 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 CA-C-N 115.9 -0.591 . . . . 0.54000000000000004 111.386 -176.302 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.3 m -35.21 -42.12 0.18 Allowed 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 125.358 1.463 . . . . 1.1799999999999999 112.633 170.244 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 18.2 m -112.66 -34.74 5.72 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.655 0.782 . . . . 0.23000000000000001 111.706 174.14 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 92.5 m-70 -82.0 5.21 19.99 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.446 1.098 . . . . 0.34999999999999998 113.409 -175.351 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 107.22 -91.05 0.68 Allowed Glycine 0 CA--C 1.525 0.667 0 C-N-CA 126.57 2.033 . . . . 2.8700000000000001 111.961 166.312 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -167.63 -47.37 0.03 OUTLIER Glycine 0 CA--C 1.519 0.316 0 N-CA-C 108.792 -1.723 . . . . 0.83999999999999997 108.792 -172.446 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -102.88 6.42 39.08 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.935 1.294 . . . . 4.0999999999999996 111.158 178.675 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.619 HD21 HG11 ' A' ' 28' ' ' VAL . 2.5 mt 78.49 10.32 1.89 Allowed 'General case' 0 C--N 1.354 0.798 0 CA-C-N 120.075 1.307 . . . . 1.4299999999999999 110.352 177.441 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.1 p -74.81 -10.26 59.34 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 128.62 2.768 . . . . 0.58999999999999997 109.629 -179.69 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.64 159.11 34.3 Favored Glycine 0 N--CA 1.444 -0.822 0 N-CA-C 109.269 -1.532 . . . . 0.84999999999999998 109.269 -177.017 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -160.67 -79.82 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 124.334 1.054 . . . . 0.34999999999999998 108.653 175.692 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 58.5 m -91.55 2.24 56.58 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.474 0.709 . . . . 1.21 110.966 173.437 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.446 ' HB1' ' HD2' ' A' ' 46' ' ' PRO . . . -154.35 164.8 19.6 Favored Pre-proline 0 N--CA 1.448 -0.544 0 C-N-CA 125.245 1.418 . . . . 0.31 108.038 -169.672 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.446 ' HD2' ' HB1' ' A' ' 45' ' ' ALA . 27.9 Cg_endo -67.42 159.75 50.95 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 123.002 2.468 . . . . 0.27000000000000002 111.243 -173.696 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -74.75 115.56 14.47 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.073 0.549 . . . . 0.38 109.999 -177.593 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 32.2 pt -102.55 2.5 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 C-N-CA 124.342 1.057 . . . . 0.55000000000000004 111.528 179.549 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -34.3 -48.87 0.36 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.28 1.432 . . . . 2.2599999999999998 112.427 167.49 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 10.0 pttt -109.19 26.26 10.83 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.58 0.752 . . . . 3.4100000000000001 111.812 -176.458 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -51.55 -44.3 62.66 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 118.927 -0.559 . . . . 0.34000000000000002 109.8 178.287 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -52.84 -25.72 23.82 Favored Glycine 0 CA--C 1.529 0.952 0 N-CA-C 114.566 0.586 . . . . 0.46000000000000002 114.566 177.692 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -82.44 -42.36 18.66 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 118.076 0.938 . . . . 0.83999999999999997 109.49 175.67 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 36.1 m120 -63.69 -48.41 77.22 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 122.574 0.35 . . . . 3.2400000000000002 110.564 -179.471 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -144.2 145.62 32.18 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.547 1.539 . . . . 0.64000000000000001 108.553 -169.925 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 19.6 m -75.33 169.17 18.57 Favored 'General case' 0 CA--C 1.532 0.284 0 O-C-N 121.542 -0.724 . . . . 1.52 111.198 179.132 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -44.17 -56.03 4.38 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 123.337 0.655 . . . . 4.7699999999999996 110.735 174.182 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -53.13 -29.96 34.03 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 112.724 0.638 . . . . 2.96 112.724 -178.406 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 53.6 mm-40 -86.83 -48.85 7.86 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.709 0.804 . . . . 3.0299999999999998 109.789 -178.315 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 84.0 mt -57.6 -46.5 86.33 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.097 0 O-C-N 121.114 -0.991 . . . . 0.26000000000000001 108.73 178.143 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 46.6 tp -52.97 -47.55 68.08 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 123.618 0.767 . . . . 0.33000000000000002 109.274 176.543 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -55.45 -46.99 76.72 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 118.244 0.474 . . . . 2.21 110.705 175.099 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 47.7 mt -60.51 -36.7 71.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 O-C-N 121.444 -0.785 . . . . 0.51000000000000001 110.996 176.728 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 58.5 mt -69.21 -42.22 81.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 O-C-N 119.864 -1.773 . . . . 0.23999999999999999 109.939 178.816 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 71.3 mt -76.65 -26.53 54.97 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.815 1.246 . . . . 0.44 112.891 -176.715 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 28.8 m-80 -124.85 14.43 8.59 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 119.584 1.084 . . . . 1.76 109.989 -172.044 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.586 ' N ' ' HA2' ' A' ' 73' ' ' GLY . . . 40.43 -139.99 1.13 Allowed Glycine 0 CA--C 1.537 1.451 0 C-N-CA 126.614 2.054 . . . . 0.64000000000000001 110.994 -171.885 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 168.48 127.1 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.602 1.561 . . . . 1.3899999999999999 110.41 179.152 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 42.13 -115.87 0.97 Allowed Glycine 0 C--N 1.346 1.092 0 CA-C-N 120.283 1.402 . . . . 0.66000000000000003 113.294 -178.145 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -64.54 -22.06 67.45 Favored Glycine 0 CA--C 1.532 1.097 0 CA-C-N 117.349 0.574 . . . . 0.63 112.53 -179.54 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 21.5 ttt -80.32 118.93 74.79 Favored Pre-proline 0 N--CA 1.45 -0.442 0 C-N-CA 124.878 1.271 . . . . 0.37 111.433 -179.35 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.445 ' HD2' HD11 ' A' ' 75' ' ' ILE . 36.2 Cg_endo -77.83 122.77 6.0 Favored 'Trans proline' 0 N--CA 1.448 -1.193 0 C-N-CA 122.645 2.23 . . . . 2.0499999999999998 112.066 -178.515 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.586 ' HA2' ' N ' ' A' ' 67' ' ' GLY . . . -57.26 131.28 51.97 Favored Glycine 0 N--CA 1.444 -0.817 0 N-CA-C 115.348 0.899 . . . . 0.71999999999999997 115.348 179.376 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 87.55 40.63 6.74 Favored Glycine 0 C--N 1.338 0.678 0 CA-C-N 114.342 -0.929 . . . . 0.48999999999999999 112.008 172.687 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.445 HD11 ' HD2' ' A' ' 72' ' ' PRO . 2.4 mt -66.92 -61.44 1.69 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 124.691 1.196 . . . . 1.0800000000000001 109.925 176.616 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -98.36 161.35 13.73 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.632 1.173 . . . . 0.32000000000000001 109.705 167.613 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.0 mttm -146.81 164.34 33.14 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 125.085 1.354 . . . . 2.4900000000000002 110.71 176.828 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 52.7 -146.32 17.4 Favored Glycine 0 CA--C 1.529 0.92 0 N-CA-C 111.383 -0.687 . . . . 0.70999999999999996 111.383 -178.527 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -53.12 -31.49 42.39 Favored 'General case' 0 C--O 1.225 -0.215 0 C-N-CA 122.942 0.497 . . . . 0.81999999999999995 111.295 177.432 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -53.61 -46.1 70.3 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 123.299 0.64 . . . . 2.3199999999999998 110.168 174.398 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -78.69 -52.25 8.68 Favored 'General case' 0 CA--C 1.53 0.191 0 O-C-N 121.552 -0.717 . . . . 0.22 111.098 176.496 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -57.17 -51.6 68.66 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.631 0.773 . . . . 2.6000000000000001 111.331 -173.53 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.18 -45.62 90.56 Favored 'General case' 0 N--CA 1.457 -0.12 0 O-C-N 121.99 -0.444 . . . . 0.26000000000000001 109.881 -179.265 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.588 HG22 HG23 ' A' ' 28' ' ' VAL . 37.9 t -56.25 -53.04 44.4 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 CA-C-O 119.515 -0.279 . . . . 0.29999999999999999 110.94 176.263 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -52.43 -50.53 62.39 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 122.767 0.427 . . . . 0.17000000000000001 111.048 177.831 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.04 -45.07 96.29 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-O 121.263 0.554 . . . . 0.29999999999999999 110.964 -179.189 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.534 ' CE3' HD23 ' A' ' 88' ' ' LEU . 45.6 t90 -59.93 -48.11 83.05 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.863 0.84 . . . . 0.5 109.703 176.464 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.534 HD23 ' CE3' ' A' ' 87' ' ' TRP . 0.1 OUTLIER -62.11 -27.6 69.04 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 120.448 -1.407 . . . . 1.6699999999999999 110.3 177.039 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -65.67 -43.75 88.39 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 123.319 0.648 . . . . 0.34999999999999998 111.13 172.583 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -62.13 -42.09 98.9 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 118.537 -1.265 . . . . 3.7599999999999998 109.944 171.807 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 7.8 mtpp -69.38 119.98 14.48 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 121.581 0.705 . . . . 2.1800000000000002 111.501 -171.18 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 8.2 mttp . . . . . 0 C--O 1.25 1.083 0 C-N-CA 128.092 2.557 . . . . 2.3799999999999999 105.456 -176.352 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 . . . . . 0 N--CA 1.448 -0.568 0 N-CA-C 109.228 -0.656 . . . . 2.6299999999999999 109.228 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -38.25 -53.73 1.44 Allowed 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 125.669 1.587 . . . . 0.41999999999999998 112.498 176.461 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -52.69 -49.79 64.6 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 122.844 0.458 . . . . 2.9100000000000001 111.213 176.637 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.28 -43.92 95.82 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 118.429 0.559 . . . . 0.37 110.532 -179.777 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 89.4 t -58.6 -54.26 35.75 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 N-CA-C 109.702 -0.481 . . . . 0.46000000000000002 109.702 176.649 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.447 HG23 HG22 ' A' ' 84' ' ' VAL . 32.7 t -53.4 -50.63 47.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 C-N-CA 122.709 0.404 . . . . 0.44 110.11 179.762 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 31.8 mm-40 -54.74 -14.47 1.39 Allowed 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 126.49 1.916 . . . . 0.67000000000000004 113.953 174.518 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -141.48 34.06 1.65 Allowed 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 119.757 1.162 . . . . 2.9399999999999999 112.583 176.668 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.3 mptt -152.0 -62.62 0.17 Allowed 'General case' 0 CA--C 1.521 -0.159 0 N-CA-C 108.401 -0.963 . . . . 2.6099999999999999 108.401 166.056 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.438 ' SG ' HG22 ' A' ' 28' ' ' VAL . 3.7 m -69.65 -46.84 65.22 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 121.13 0.49 . . . . 0.19 110.144 -168.746 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.3 pp -56.15 -23.31 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 CA-C-N 115.462 -0.79 . . . . 0.51000000000000001 112.882 -178.388 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.0 t -48.38 -35.45 12.61 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.981 0.913 . . . . 2.0299999999999998 110.748 177.794 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 15.9 m -120.04 -40.49 2.72 Favored 'General case' 0 C--N 1.342 0.255 0 C-N-CA 123.564 0.746 . . . . 0.19 111.525 177.319 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 86.1 m-70 -72.16 -9.01 57.85 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.581 0.752 . . . . 0.23000000000000001 112.219 -178.59 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 88.61 148.87 18.05 Favored Glycine 0 C--N 1.339 0.714 0 N-CA-C 109.742 -1.343 . . . . 1.4399999999999999 109.742 177.595 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -42.34 -33.41 1.37 Allowed Glycine 0 CA--C 1.529 0.956 0 C-N-CA 125.202 1.382 . . . . 0.54000000000000004 112.988 175.085 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -101.26 -5.29 25.7 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.076 1.351 . . . . 2.98 112.209 -171.687 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 73.37 8.63 5.18 Favored 'General case' 0 C--N 1.35 0.601 0 O-C-N 120.633 -1.292 . . . . 1.4299999999999999 111.393 175.696 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 17.2 p -82.11 -1.99 50.52 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 127.491 2.316 . . . . 0.5 110.287 -174.523 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.57 145.27 9.84 Favored Glycine 0 N--CA 1.438 -1.19 0 N-CA-C 108.164 -1.975 . . . . 0.40999999999999998 108.164 -171.475 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -150.88 -73.0 0.16 Allowed 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 124.181 0.992 . . . . 0.26000000000000001 108.98 176.7 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.93 3.85 49.57 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.948 1.299 . . . . 1.1299999999999999 110.441 173.33 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -158.05 163.68 23.79 Favored Pre-proline 0 CA--C 1.536 0.419 0 C-N-CA 125.994 1.718 . . . . 0.20999999999999999 107.331 -167.523 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -70.16 158.01 57.8 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 123.144 2.563 . . . . 0.26000000000000001 110.768 -174.823 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.39 126.96 31.36 Favored 'General case' 0 C--N 1.333 -0.148 0 O-C-N 121.636 -0.665 . . . . 0.31 110.075 -177.305 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 39.4 pt -106.9 -2.88 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 C-N-CA 123.07 0.548 . . . . 0.35999999999999999 111.887 177.037 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 24.6 p-10 -33.66 -49.95 0.33 Allowed 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.29 1.436 . . . . 3.6099999999999999 112.744 171.834 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.5 pttp -106.17 23.82 13.45 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.261 1.424 . . . . 3.9500000000000002 112.579 -176.859 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.04 -50.02 75.67 Favored 'General case' 0 CA--C 1.527 0.072 0 O-C-N 121.228 -0.92 . . . . 0.51000000000000001 109.963 179.168 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -60.18 -12.84 25.47 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 123.386 0.517 . . . . 0.93999999999999995 114.157 178.804 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.98 -34.15 68.69 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 118.454 1.127 . . . . 1.53 110.664 173.539 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -107.24 -52.09 2.82 Favored 'General case' 0 C--N 1.34 0.174 0 C-N-CA 123.976 0.91 . . . . 3.0499999999999998 111.878 -176.137 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -84.04 170.29 14.07 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.713 0.805 . . . . 1.3200000000000001 110.184 175.763 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 54.1 m -119.53 169.1 10.35 Favored 'General case' 0 C--O 1.233 0.237 0 C-N-CA 125.647 1.579 . . . . 1.5 108.619 172.899 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.8 pm0 -46.25 -49.86 16.71 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 124.475 1.11 . . . . 2.7400000000000002 112.355 -177.198 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -58.83 -41.71 87.51 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 118.298 0.499 . . . . 2.4100000000000001 111.888 179.172 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.65 -49.07 51.34 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 122.114 0.959 . . . . 3.5299999999999998 108.623 -176.253 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 31.2 mt -60.03 -44.48 94.91 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 O-C-N 121.631 -0.668 . . . . 0.31 109.253 178.545 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 61.7 tp -54.61 -52.45 62.19 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.289 -0.634 . . . . 0.71999999999999997 109.289 177.119 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -48.28 -53.91 15.55 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.165 0.586 . . . . 1.8899999999999999 109.77 179.264 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 81.4 mt -57.18 -47.87 83.22 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.283 0 O-C-N 121.707 -0.621 . . . . 0.47999999999999998 111.409 177.37 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 79.5 mt -54.79 -43.0 65.24 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 O-C-N 120.464 -1.398 . . . . 0.29999999999999999 110.216 176.665 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 94.3 mt -70.8 -40.41 72.55 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 113.957 1.095 . . . . 0.60999999999999999 113.957 -176.171 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -123.3 27.51 7.49 Favored 'General case' 0 C--N 1.344 0.35 0 CA-C-N 120.956 1.707 . . . . 3.7999999999999998 109.787 -171.515 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.532 ' N ' ' HA2' ' A' ' 73' ' ' GLY . . . 36.55 -136.97 0.52 Allowed Glycine 0 CA--C 1.532 1.151 0 C-N-CA 127.786 2.612 . . . . 0.64000000000000001 110.613 -174.969 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 30.9 tt0 167.41 133.36 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 119.237 1.519 . . . . 1.76 109.197 -177.089 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 45.04 -122.5 5.15 Favored Glycine 0 CA--C 1.532 1.102 0 CA-C-N 119.872 1.215 . . . . 0.48999999999999999 112.252 -175.396 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -70.8 -16.97 74.78 Favored Glycine 0 CA--C 1.532 1.131 0 CA-C-N 117.595 0.697 . . . . 0.69999999999999996 113.017 178.448 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 20.5 ttt -71.29 119.03 71.27 Favored Pre-proline 0 N--CA 1.451 -0.385 0 CA-C-N 118.23 1.015 . . . . 0.42999999999999999 110.434 -178.938 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -78.18 120.55 4.99 Favored 'Trans proline' 0 N--CA 1.446 -1.275 0 C-N-CA 122.847 2.365 . . . . 2.1400000000000001 110.886 -179.431 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.532 ' HA2' ' N ' ' A' ' 67' ' ' GLY . . . -61.3 140.63 47.74 Favored Glycine 0 N--CA 1.443 -0.892 0 CA-C-N 115.047 -0.979 . . . . 0.60999999999999999 115.499 -175.691 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 79.87 35.25 28.51 Favored Glycine 0 CA--C 1.524 0.644 0 CA-C-N 114.05 -1.075 . . . . 0.33000000000000002 110.911 174.161 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -57.41 -52.04 61.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 125.094 1.358 . . . . 1.03 109.499 175.465 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -111.5 155.0 23.92 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 125.404 1.481 . . . . 0.33000000000000002 108.339 163.147 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.2 mtpp -142.64 157.86 44.26 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.868 1.267 . . . . 2.3799999999999999 109.408 175.959 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 62.32 -151.06 46.3 Favored Glycine 0 CA--C 1.529 0.94 0 N-CA-C 111.133 -0.787 . . . . 0.76000000000000001 111.133 -177.38 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -50.79 -35.08 30.15 Favored 'General case' 0 C--N 1.34 0.192 0 C-N-CA 123.865 0.866 . . . . 0.56000000000000005 111.736 -175.775 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -50.87 -50.96 55.89 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.006 0.922 . . . . 2.1400000000000001 110.621 174.105 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -75.81 -49.59 17.6 Favored 'General case' 0 CA--C 1.528 0.1 0 C-N-CA 123.335 0.654 . . . . 0.23999999999999999 111.043 179.36 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -55.11 -48.35 73.73 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.724 0.809 . . . . 2.4900000000000002 110.696 -176.397 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.21 -50.67 72.73 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 109.909 -0.404 . . . . 0.26000000000000001 109.909 177.638 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.447 HG22 HG23 ' A' ' 28' ' ' VAL . 57.4 t -53.57 -59.14 2.06 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.272 0 CA-C-O 119.508 -0.282 . . . . 0.34999999999999998 110.465 178.591 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -42.87 -56.34 3.29 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 123.831 0.852 . . . . 0.20000000000000001 112.144 174.299 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.67 -46.97 85.71 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 121.487 0.661 . . . . 0.31 111.923 -176.364 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.439 ' CZ3' HG21 ' A' ' 28' ' ' VAL . 74.9 t90 -58.99 -49.9 76.14 Favored 'General case' 0 C--N 1.328 -0.362 0 O-C-N 121.747 -0.596 . . . . 0.51000000000000001 109.879 178.339 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.05 -32.89 74.37 Favored 'General case' 0 C--O 1.223 -0.329 0 CA-C-O 117.981 -1.009 . . . . 2.1299999999999999 111.995 176.164 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -55.99 -36.16 67.59 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 119.621 1.1 . . . . 0.37 110.097 170.233 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -68.59 -36.06 78.19 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 118.459 -0.781 . . . . 3.3100000000000001 111.51 172.589 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 4.2 mtpt -74.17 134.71 42.8 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 119.736 1.153 . . . . 2.1499999999999999 110.801 -178.338 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 2.6 mptt . . . . . 0 C--O 1.25 1.12 0 N-CA-C 105.738 -1.949 . . . . 2.9100000000000001 105.738 172.458 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 . . . . . 0 N--CA 1.452 -0.331 0 N-CA-C 103.587 -2.746 . . . . 2.73 103.587 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.62 -49.91 71.57 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-O 121.481 0.658 . . . . 0.35999999999999999 109.905 -171.764 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -58.91 -48.25 82.12 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.116 -0.947 . . . . 3.1699999999999999 109.929 -178.773 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.96 -47.07 87.3 Favored 'General case' 0 CA--C 1.527 0.096 0 C-N-CA 122.938 0.495 . . . . 0.32000000000000001 111.066 -179.933 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 75.6 t -55.72 -55.54 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 N-CA-C 108.913 -0.773 . . . . 0.46999999999999997 108.913 176.727 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.516 HG13 ' HB2' ' A' ' 32' ' ' CYS . 37.3 t -54.6 -47.55 72.13 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 C-N-CA 122.55 0.34 . . . . 0.37 111.188 -177.8 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 40.1 mm-40 -52.3 -19.46 2.09 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.098 1.359 . . . . 0.66000000000000003 113.078 174.584 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -135.66 42.31 2.67 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 119.876 1.216 . . . . 2.6699999999999999 111.939 174.903 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -163.5 -34.19 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 118.106 -0.949 . . . . 1.6499999999999999 112.8 172.062 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.516 ' HB2' HG13 ' A' ' 28' ' ' VAL . 3.5 m -100.75 -50.66 3.79 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 119.668 1.122 . . . . 0.16 110.736 -178.619 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 8.6 pt -56.07 -27.19 22.82 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 CA-C-N 116.191 -0.459 . . . . 1.3500000000000001 111.977 -175.627 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.7 m -40.1 -37.35 0.6 Allowed 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.51 1.524 . . . . 1.1100000000000001 112.145 173.966 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 17.6 m -116.56 -36.65 3.89 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.398 0.679 . . . . 0.23000000000000001 111.753 173.955 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 92.5 m-70 -80.63 3.31 22.39 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.018 0.927 . . . . 0.29999999999999999 113.372 -175.628 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 108.43 -78.84 0.24 Allowed Glycine 0 CA--C 1.525 0.681 0 C-N-CA 125.778 1.656 . . . . 2.9900000000000002 111.937 163.991 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -178.14 -53.4 0.07 OUTLIER Glycine 0 C--O 1.229 -0.219 0 N-CA-C 108.306 -1.918 . . . . 0.89000000000000001 108.306 -171.355 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -97.07 3.93 51.58 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 117.948 -1.025 . . . . 2.52 110.919 -178.356 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.5 mt 77.76 13.23 1.8 Allowed 'General case' 0 C--N 1.352 0.702 0 CA-C-N 119.704 1.138 . . . . 1.46 110.054 -178.443 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.7 p -78.55 -11.92 59.99 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 128.462 2.705 . . . . 0.55000000000000004 110.189 -176.166 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.42 156.72 32.41 Favored Glycine 0 N--CA 1.444 -0.829 0 N-CA-C 109.167 -1.573 . . . . 0.65000000000000002 109.167 -178.758 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -163.21 -79.16 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 123.52 0.728 . . . . 0.28000000000000003 109.719 179.222 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.5 m -93.1 2.49 56.71 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.187 0.995 . . . . 0.98999999999999999 110.676 170.798 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -153.27 160.67 30.67 Favored Pre-proline 0 N--CA 1.447 -0.585 0 C-N-CA 126.219 1.808 . . . . 0.20999999999999999 106.973 -171.455 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -67.15 164.5 29.99 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 123.282 2.655 . . . . 0.28999999999999998 111.191 -174.86 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -74.38 123.87 25.45 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.858 -0.423 . . . . 0.27000000000000002 109.858 -178.262 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 49.8 pt -109.85 1.35 9.34 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 C-N-CA 124.28 1.032 . . . . 0.46000000000000002 112.486 177.784 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 22.0 p-10 -34.53 -48.46 0.36 Allowed 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.587 1.555 . . . . 3.5299999999999998 112.574 167.516 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 4.6 tttt -113.68 38.97 2.78 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 126.606 1.962 . . . . 5.5700000000000003 109.326 -177.595 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.36 -47.37 86.18 Favored 'General case' 0 N--CA 1.454 -0.245 0 O-C-N 121.119 -0.988 . . . . 0.32000000000000001 109.896 170.559 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -51.26 -42.48 49.59 Favored Glycine 0 CA--C 1.526 0.761 0 C-N-CA 123.959 0.79 . . . . 0.77000000000000002 114.448 -171.67 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.37 -21.06 58.6 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 121.684 -0.892 . . . . 0.92000000000000004 112.107 179.285 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -82.55 -46.68 13.05 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 118.531 0.605 . . . . 1.97 109.516 176.027 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -138.05 137.78 38.14 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.858 1.263 . . . . 0.60999999999999999 108.55 -171.777 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 35.1 t -75.64 167.2 22.34 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.898 0.879 . . . . 2.2599999999999998 109.841 178.951 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -49.51 -43.19 45.32 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.864 0.865 . . . . 2.8100000000000001 111.893 177.53 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -53.54 -37.54 62.94 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 118.991 0.814 . . . . 2.8799999999999999 111.447 176.467 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -83.08 -49.07 9.91 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 123.615 0.766 . . . . 3.48 110.091 -178.352 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 65.2 mt -58.73 -44.93 91.15 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.052 0 O-C-N 121.283 -0.885 . . . . 0.25 108.758 -178.637 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 35.3 tp -54.41 -47.55 72.63 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 124.002 0.921 . . . . 0.32000000000000001 109.846 176.182 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -56.0 -50.64 70.29 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 109.794 -0.447 . . . . 2.0600000000000001 109.794 174.49 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 74.2 mt -60.22 -30.17 45.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 O-C-N 121.575 -0.703 . . . . 0.78000000000000003 111.694 178.895 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 46.6 mt -71.64 -50.77 37.07 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 O-C-N 120.151 -1.593 . . . . 0.28000000000000003 109.95 174.559 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 82.8 mt -70.74 -30.39 66.9 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.869 0.868 . . . . 0.54000000000000004 112.91 -174.336 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -119.3 12.62 12.59 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 119.11 0.868 . . . . 1.6799999999999999 109.974 -170.048 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.534 ' N ' ' HA2' ' A' ' 73' ' ' GLY . . . 39.38 -147.07 0.18 Allowed Glycine 0 CA--C 1.542 1.719 0 C-N-CA 127.722 2.582 . . . . 0.63 111.211 -172.449 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 38.8 tt0 175.34 131.1 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 119.344 1.572 . . . . 1.8700000000000001 108.93 -177.144 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 40.72 -115.62 0.7 Allowed Glycine 0 CA--C 1.532 1.137 0 CA-C-N 119.957 1.253 . . . . 0.46000000000000002 113.33 -175.95 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -69.98 -21.65 76.9 Favored Glycine 0 CA--C 1.532 1.142 0 O-C-N 122.335 -0.509 . . . . 0.53000000000000003 112.992 -179.727 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 22.4 ttt -73.66 119.08 74.16 Favored Pre-proline 0 N--CA 1.452 -0.374 0 C-N-CA 124.363 1.065 . . . . 0.42999999999999999 110.773 -179.817 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -78.85 128.1 8.25 Favored 'Trans proline' 0 N--CA 1.445 -1.376 0 C-N-CA 122.263 1.976 . . . . 2.1600000000000001 110.525 -179.454 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.534 ' HA2' ' N ' ' A' ' 67' ' ' GLY . . . -61.31 134.17 48.28 Favored Glycine 0 N--CA 1.442 -0.921 0 CA-C-N 115.215 -0.902 . . . . 0.66000000000000003 114.703 -179.486 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 84.23 38.56 9.93 Favored Glycine 0 CA--C 1.526 0.781 0 CA-C-N 114.543 -0.828 . . . . 0.32000000000000001 111.676 171.261 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -61.2 -44.31 98.11 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.881 0 C-N-CA 125.43 1.492 . . . . 2.3199999999999998 110.237 177.203 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -111.48 161.76 15.81 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.498 1.919 . . . . 0.52000000000000002 109.565 164.659 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 68.6 mttt -133.12 157.64 44.8 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 124.798 1.239 . . . . 3.21 110.837 174.74 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 53.22 -141.74 29.64 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 110.712 -0.955 . . . . 0.70999999999999996 110.712 176.854 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -52.44 -34.83 50.45 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 117.139 0.469 . . . . 0.71999999999999997 111.835 179.254 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -53.77 -35.94 61.86 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.699 0.8 . . . . 2.4700000000000002 109.48 178.39 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -82.18 -52.66 6.76 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.465 0.706 . . . . 0.29999999999999999 110.805 170.967 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -57.4 -54.52 45.85 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 112.657 0.614 . . . . 1.96 112.657 -172.333 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -55.96 -42.79 76.78 Favored 'General case' 0 N--CA 1.454 -0.253 0 O-C-N 121.88 -0.513 . . . . 0.26000000000000001 110.472 -179.832 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.481 HG22 HG23 ' A' ' 28' ' ' VAL . 50.8 t -61.12 -53.67 45.79 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 C-N-CA 122.66 0.384 . . . . 0.34999999999999998 110.666 178.365 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -51.66 -50.46 60.32 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 123.12 0.568 . . . . 0.19 111.514 176.099 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.16 -48.41 81.7 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.452 0.701 . . . . 0.27000000000000002 110.69 179.412 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.525 ' CE3' HD23 ' A' ' 88' ' ' LEU . 47.6 t90 -56.71 -47.53 79.74 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 121.915 -0.49 . . . . 0.44 109.769 177.086 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.525 HD23 ' CE3' ' A' ' 87' ' ' TRP . 0.1 OUTLIER -64.22 -36.32 83.69 Favored 'General case' 0 N--CA 1.462 0.139 0 C-N-CA 124.162 0.985 . . . . 1.6399999999999999 111.476 179.305 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -54.55 -41.01 69.25 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 118.987 0.812 . . . . 0.41999999999999998 110.096 170.988 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -88.4 27.39 1.26 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.722 0.809 . . . . 4.4400000000000004 112.706 173.098 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.6 mtpm? -119.85 130.95 55.12 Favored 'General case' 0 C--N 1.341 0.21 0 O-C-N 120.858 -1.151 . . . . 2.1099999999999999 109.245 165.14 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 9.5 mtmp? . . . . . 0 C--O 1.248 1.022 0 C-N-CA 127.924 2.49 . . . . 3.6000000000000001 104.607 -177.243 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 . . . . . 0 N--CA 1.451 -0.418 0 N-CA-C 109.61 -0.515 . . . . 2.1299999999999999 109.61 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -97.73 -61.94 1.32 Allowed 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 109.144 -0.687 . . . . 0.42999999999999999 109.144 178.203 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -51.53 -43.74 62.4 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 116.173 -0.467 . . . . 3.1299999999999999 111.116 178.164 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.55 -43.72 89.42 Favored 'General case' 0 CA--C 1.528 0.135 0 CA-C-N 118.579 0.627 . . . . 0.37 111.509 179.731 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 73.6 t -63.39 -53.18 48.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 N-CA-C 108.12 -1.067 . . . . 0.34000000000000002 108.12 178.438 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.656 HG11 HD21 ' A' ' 40' ' ' LEU . 45.1 t -52.34 -48.44 44.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 110.437 -0.209 . . . . 0.32000000000000001 110.437 -179.623 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.468 ' HA ' HG12 ' A' ' 33' ' ' ILE . 35.6 mm-40 -50.47 -24.5 3.16 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.448 1.899 . . . . 0.65000000000000002 112.937 175.658 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -142.62 59.04 1.44 Allowed 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 119.184 0.902 . . . . 2.54 111.323 178.459 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -179.81 -36.28 0.01 OUTLIER 'General case' 0 C--O 1.225 -0.207 0 C-N-CA 124.648 1.179 . . . . 1.1899999999999999 109.695 173.356 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.464 ' HB2' HG13 ' A' ' 28' ' ' VAL . 5.0 m -101.1 -53.66 2.98 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 119.28 0.945 . . . . 0.17999999999999999 110.973 -178.632 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.468 HG12 ' HA ' ' A' ' 29' ' ' GLN . 2.1 pp -57.37 -25.92 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 CA-C-N 115.876 -0.602 . . . . 0.41999999999999998 112.041 -175.735 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.1 m -38.17 -35.53 0.17 Allowed 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.001 1.72 . . . . 1.23 112.548 170.483 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 18.5 m -120.9 -44.02 2.44 Favored 'General case' 0 C--N 1.34 0.174 0 C-N-CA 123.326 0.651 . . . . 0.25 111.629 172.854 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 82.4 m-70 -70.13 -8.81 52.61 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.413 0.685 . . . . 0.34000000000000002 112.817 -175.2 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 88.48 151.93 23.96 Favored Glycine 0 C--N 1.337 0.589 0 N-CA-C 109.757 -1.337 . . . . 1.51 109.757 177.488 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -44.51 -37.54 4.95 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 124.518 1.056 . . . . 0.44 112.31 178.514 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.482 ' C ' HD12 ' A' ' 40' ' ' LEU . 0.8 OUTLIER -98.37 0.24 45.03 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.707 1.203 . . . . 2.0899999999999999 111.747 -174.061 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.656 HD21 HG11 ' A' ' 28' ' ' VAL . 2.4 mp 65.28 17.14 10.89 Favored 'General case' 0 C--N 1.347 0.458 0 CA-C-N 120.232 1.378 . . . . 1.8400000000000001 111.543 178.582 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.3 p -84.9 -4.77 59.25 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 128.529 2.731 . . . . 0.40000000000000002 110.03 -175.707 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.04 127.18 3.65 Favored Glycine 0 N--CA 1.442 -0.903 0 N-CA-C 109.009 -1.636 . . . . 0.55000000000000004 109.009 179.437 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -134.31 -80.13 0.45 Allowed 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 124.229 1.012 . . . . 0.28999999999999998 108.904 179.552 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 46.1 m -88.85 2.85 52.98 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.757 0.823 . . . . 1.4199999999999999 111.047 172.695 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.445 ' HB1' ' HD2' ' A' ' 46' ' ' PRO . . . -158.99 164.86 19.78 Favored Pre-proline 0 CA--C 1.537 0.444 0 C-N-CA 124.529 1.132 . . . . 0.28000000000000003 108.246 -169.188 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.445 ' HD2' ' HB1' ' A' ' 45' ' ' ALA . 55.2 Cg_endo -68.75 157.69 60.84 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 123.157 2.571 . . . . 0.27000000000000002 110.951 -173.389 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.45 128.76 36.41 Favored 'General case' 0 CA--C 1.529 0.146 0 O-C-N 121.584 -0.697 . . . . 0.32000000000000001 110.307 -175.653 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 48.6 pt -106.63 0.21 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 C-N-CA 123.328 0.651 . . . . 0.31 111.626 176.954 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -38.99 -38.29 0.43 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.789 0.836 . . . . 2.27 113.105 170.085 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 4.2 pttt -113.49 30.05 7.52 Favored 'General case' 0 C--N 1.343 0.316 0 C-N-CA 124.507 1.123 . . . . 4.0800000000000001 111.642 -178.689 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -68.36 -41.97 79.86 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 118.652 -0.689 . . . . 0.34999999999999998 109.624 176.766 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -53.38 -29.83 39.35 Favored Glycine 0 CA--C 1.526 0.735 0 CA-C-N 118.614 0.643 . . . . 0.71999999999999997 114.646 -175.419 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -83.41 -47.49 11.36 Favored 'General case' 0 N--CA 1.455 -0.197 0 O-C-N 122.403 -0.469 . . . . 1.1399999999999999 110.366 175.253 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 38.4 m-80 -55.63 -44.27 76.96 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 122.286 0.234 . . . . 1.54 111.158 179.43 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -139.75 134.15 31.46 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.022 1.729 . . . . 0.62 107.691 -167.309 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 49.2 m -74.98 170.73 15.4 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 118.348 0.522 . . . . 1.49 110.774 178.059 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 73.3 tt0 -45.54 -59.53 2.67 Favored 'General case' 0 C--N 1.342 0.267 0 C-N-CA 123.178 0.591 . . . . 5.2599999999999998 110.75 177.148 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 31.5 mp0 -51.28 -31.86 22.71 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.656 0.782 . . . . 4.2800000000000002 112.906 179.259 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -80.85 -48.46 12.38 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 119.23 0.923 . . . . 2.6400000000000001 109.315 -179.191 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 84.6 mt -61.77 -47.1 94.85 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.222 0 O-C-N 121.565 -0.709 . . . . 0.26000000000000001 109.256 -179.215 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 31.2 tp -52.2 -50.2 62.38 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 108.956 -0.757 . . . . 0.38 108.956 175.789 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -57.02 -43.23 81.65 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 120.72 -0.392 . . . . 1.6699999999999999 110.997 178.157 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 31.6 mt -58.73 -54.0 39.63 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.262 0 O-C-N 120.861 -1.149 . . . . 0.67000000000000004 110.494 173.257 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 58.2 mt -50.75 -41.97 22.04 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 O-C-N 120.655 -1.278 . . . . 0.19 110.513 -179.614 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 88.5 mt -69.18 -40.53 78.03 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 113.436 0.902 . . . . 0.57999999999999996 113.436 176.951 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 -118.31 19.1 13.56 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 120.489 1.495 . . . . 1.77 110.202 -164.706 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.573 ' N ' ' HA2' ' A' ' 73' ' ' GLY . . . 29.47 -136.5 0.05 OUTLIER Glycine 0 CA--C 1.532 1.154 0 C-N-CA 128.511 2.958 . . . . 0.65000000000000002 110.973 -162.458 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 171.66 133.01 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 119.085 1.443 . . . . 1.55 108.28 -176.736 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 40.76 -118.85 1.28 Allowed Glycine 0 CA--C 1.533 1.208 0 CA-C-N 120.405 1.457 . . . . 0.35999999999999999 113.294 -178.199 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -68.49 -19.25 72.57 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 123.704 0.669 . . . . 0.51000000000000001 113.23 179.204 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 19.9 ttt -74.41 119.12 74.95 Favored Pre-proline 0 N--CA 1.449 -0.485 0 C-N-CA 124.288 1.035 . . . . 0.38 110.677 179.174 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -74.86 127.34 10.7 Favored 'Trans proline' 0 N--CA 1.442 -1.551 0 C-N-CA 122.01 1.806 . . . . 2.1000000000000001 109.812 177.631 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.573 ' HA2' ' N ' ' A' ' 67' ' ' GLY . . . -63.17 140.76 45.55 Favored Glycine 0 N--CA 1.442 -0.956 0 CA-C-N 115.487 -0.779 . . . . 0.65000000000000002 114.655 176.953 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 84.27 38.0 10.47 Favored Glycine 0 CA--C 1.525 0.692 0 CA-C-N 113.757 -1.221 . . . . 0.56000000000000005 111.507 173.605 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.5 mm -64.3 -58.03 8.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 C-N-CA 123.779 0.831 . . . . 1.99 110.002 176.559 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -104.94 152.58 22.5 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.893 1.277 . . . . 0.28999999999999998 108.206 167.807 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 2.1 mmmt -142.28 154.99 45.19 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 124.732 1.213 . . . . 3.2000000000000002 108.995 -178.721 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 63.67 -158.29 40.44 Favored Glycine 0 CA--C 1.531 1.043 0 N-CA-C 111.315 -0.714 . . . . 0.63 111.315 -173.814 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -53.14 -26.04 15.42 Favored 'General case' 0 C--N 1.34 0.173 0 C-N-CA 123.873 0.869 . . . . 0.62 112.415 -179.983 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -47.92 -48.81 31.61 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.493 1.117 . . . . 2.1099999999999999 110.577 171.326 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -74.32 -47.68 33.07 Favored 'General case' 0 N--CA 1.455 -0.189 0 O-C-N 121.645 -0.659 . . . . 0.31 111.333 177.285 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -55.92 -51.95 65.82 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.24 0.616 . . . . 2.5899999999999999 110.645 -174.979 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -54.0 -47.5 71.4 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.774 0.829 . . . . 0.27000000000000002 110.308 178.644 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.516 HG22 HG23 ' A' ' 28' ' ' VAL . 44.4 t -58.84 -55.46 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 C-N-CA 122.607 0.363 . . . . 0.42999999999999999 110.832 177.983 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -48.68 -51.9 26.1 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.183 0.593 . . . . 0.20999999999999999 111.252 176.639 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.23 -48.91 79.74 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 121.449 0.642 . . . . 0.34000000000000002 111.138 -179.768 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 75.2 t90 -58.75 -50.23 74.69 Favored 'General case' 0 CA--C 1.532 0.287 0 O-C-N 121.459 -0.776 . . . . 0.48999999999999999 109.975 -179.987 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.71 -32.93 72.15 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 118.283 -0.865 . . . . 2.0800000000000001 111.83 173.631 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -54.99 -31.49 60.95 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 119.85 1.204 . . . . 0.40999999999999998 110.975 173.332 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -77.93 -38.34 45.7 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 118.342 -0.837 . . . . 3.2799999999999998 112.448 169.534 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 42.6 mtpt -73.04 111.65 8.35 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 119.714 1.143 . . . . 2.4900000000000002 111.162 -177.347 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 2.0 pttt . . . . . 0 C--O 1.251 1.149 0 C-N-CA 126.467 1.907 . . . . 2.3300000000000001 107.175 177.514 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 . . . . . 0 N--CA 1.454 -0.273 0 N-CA-C 109.462 -0.569 . . . . 2.21 109.462 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -48.38 -52.72 20.52 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.94 0.896 . . . . 0.33000000000000002 110.918 -179.325 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -58.78 -44.34 90.67 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 116.269 -0.423 . . . . 2.8399999999999999 110.111 179.607 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.02 -43.27 99.14 Favored 'General case' 0 C--N 1.34 0.163 0 C-N-CA 122.719 0.408 . . . . 0.26000000000000001 111.221 -179.675 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 77.7 t -58.4 -55.73 20.72 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.365 0 N-CA-C 108.923 -0.769 . . . . 0.38 108.923 175.432 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.553 HG13 ' HB2' ' A' ' 32' ' ' CYS . 50.9 t -54.6 -45.02 71.64 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 N-CA-C 110.331 -0.248 . . . . 0.27000000000000002 110.331 -177.227 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.445 ' HA ' HG12 ' A' ' 33' ' ' ILE . 29.9 mm-40 -51.49 -26.28 8.02 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.927 1.691 . . . . 0.56999999999999995 113.611 172.742 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -139.99 58.85 1.59 Allowed 'General case' 0 C--N 1.338 0.103 0 CA-C-N 119.851 1.205 . . . . 2.3199999999999998 112.403 173.073 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -173.82 -36.74 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 123.866 0.867 . . . . 1.28 110.143 169.3 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.553 ' HB2' HG13 ' A' ' 28' ' ' VAL . 5.6 m -98.71 -51.67 3.84 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 118.958 0.799 . . . . 0.20999999999999999 110.402 -177.923 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.445 HG12 ' HA ' ' A' ' 29' ' ' GLN . 2.2 pp -57.09 -26.67 25.57 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.08 0 CA-C-N 116.211 -0.449 . . . . 0.38 112.027 -176.414 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 50.3 m -37.82 -38.45 0.29 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.121 1.369 . . . . 1.0600000000000001 112.194 170.989 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 22.5 m -120.23 -40.96 2.65 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.194 0.597 . . . . 0.17999999999999999 111.549 174.625 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 84.1 m-70 -71.7 -8.93 57.2 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 112.766 0.654 . . . . 0.20000000000000001 112.766 -176.15 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 86.09 150.15 14.8 Favored Glycine 0 C--N 1.338 0.66 0 N-CA-C 109.838 -1.305 . . . . 1.49 109.838 178.958 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -44.47 -36.91 4.63 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 124.558 1.075 . . . . 0.46000000000000002 112.191 177.277 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -95.96 -3.82 44.43 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 124.691 1.196 . . . . 2.6299999999999999 111.725 -172.831 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 8.7 mt 69.41 13.05 8.41 Favored 'General case' 0 C--N 1.35 0.607 0 CA-C-N 120.463 1.483 . . . . 1.1000000000000001 111.316 176.126 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.4 p -86.03 -2.68 58.54 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 128.318 2.647 . . . . 0.29999999999999999 109.9 -175.867 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.89 129.27 3.02 Favored Glycine 0 N--CA 1.441 -0.997 0 N-CA-C 108.827 -1.709 . . . . 0.53000000000000003 108.827 -178.559 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -134.86 -78.42 0.45 Allowed 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 124.071 0.949 . . . . 0.28999999999999998 108.773 178.662 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -90.72 3.58 53.89 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.148 0.979 . . . . 1.0900000000000001 110.7 173.415 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.429 ' HB1' ' HD2' ' A' ' 46' ' ' PRO . . . -156.12 168.01 13.16 Favored Pre-proline 0 CA--C 1.537 0.45 0 C-N-CA 125.657 1.583 . . . . 0.23000000000000001 108.078 -170.551 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.429 ' HD2' ' HB1' ' A' ' 45' ' ' ALA . 11.7 Cg_endo -67.11 168.79 16.54 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.698 2.266 . . . . 0.45000000000000001 110.816 -178.793 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -85.19 124.46 31.87 Favored 'General case' 0 CA--C 1.53 0.199 0 O-C-N 121.234 -0.917 . . . . 0.26000000000000001 110.883 -176.494 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 43.6 pt -100.41 0.09 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 C-N-CA 123.769 0.827 . . . . 0.47999999999999998 111.312 178.942 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -36.87 -46.0 0.59 Allowed 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.807 1.243 . . . . 2.2999999999999998 113.095 171.566 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.5 mttp -114.33 38.83 2.93 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.947 0.88 . . . . 3.5600000000000001 110.573 -179.515 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.06 -50.08 74.76 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 118.641 -0.695 . . . . 0.31 109.432 175.106 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -54.3 -26.28 36.07 Favored Glycine 0 CA--C 1.528 0.878 0 CA-C-N 118.721 0.691 . . . . 0.56000000000000005 113.695 -177.257 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -81.32 -44.23 17.95 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 117.507 0.653 . . . . 0.85999999999999999 110.181 176.582 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 38.6 m-80 -62.08 -48.11 81.68 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 122.446 0.298 . . . . 1.7 110.934 178.12 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 -141.38 145.0 34.82 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.431 1.492 . . . . 0.65000000000000002 108.731 -168.016 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 64.5 m -78.87 166.81 22.0 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.59 0.756 . . . . 1.5900000000000001 111.118 179.659 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -43.96 -53.8 5.9 Favored 'General case' 0 C--N 1.342 0.266 0 C-N-CA 123.712 0.805 . . . . 4.5499999999999998 110.927 177.52 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -51.1 -41.41 59.98 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 122.868 0.467 . . . . 4.0800000000000001 111.387 -178.858 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -74.62 -48.48 26.19 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 123.32 0.648 . . . . 3.2000000000000002 109.484 -177.484 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 67.0 mt -60.76 -46.73 95.56 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.078 0 N-CA-C 108.935 -0.765 . . . . 0.22 108.935 -177.915 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 24.6 tp -52.04 -53.72 38.68 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 124.223 1.009 . . . . 0.39000000000000001 109.367 175.819 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -53.5 -48.47 68.95 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 120.879 0.371 . . . . 1.9399999999999999 110.846 175.471 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 71.3 mt -62.2 -26.58 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 O-C-N 121.385 -0.822 . . . . 0.76000000000000001 112.32 179.842 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 54.8 mt -75.12 -50.7 23.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 O-C-N 120.131 -1.606 . . . . 0.20000000000000001 108.297 173.048 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 88.4 mt -62.62 -32.65 73.71 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.793 1.237 . . . . 0.41999999999999998 113.193 -177.376 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -128.08 20.06 6.42 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 119.697 1.135 . . . . 1.8500000000000001 110.213 -166.031 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.411 ' CA ' ' HA2' ' A' ' 73' ' ' GLY . . . 33.81 -137.97 0.17 Allowed Glycine 0 CA--C 1.544 1.852 0 C-N-CA 126.638 2.066 . . . . 0.68000000000000005 112.023 -167.282 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 164.68 141.22 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 126.45 1.9 . . . . 1.27 109.191 -177.785 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 29.06 -111.71 0.03 OUTLIER Glycine 0 C--N 1.347 1.177 0 C-N-CA 125.68 1.609 . . . . 0.59999999999999998 114.294 -172.471 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -62.35 -30.34 75.87 Favored Glycine 0 CA--C 1.535 1.344 0 CA-C-N 117.655 0.727 . . . . 0.78000000000000003 113.087 -179.414 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 5.9 ttt -70.41 122.08 85.35 Favored Pre-proline 0 CA--C 1.542 0.652 0 C-N-CA 125.114 1.366 . . . . 0.54000000000000004 111.224 -179.079 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -62.87 -58.27 0.34 Allowed 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 124.275 3.317 . . . . 3.0699999999999998 111.333 -172.32 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.411 ' HA2' ' CA ' ' A' ' 67' ' ' GLY . . . 120.8 148.33 7.98 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-O 122.205 0.891 . . . . 0.79000000000000004 114.448 172.82 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 70.91 21.94 78.26 Favored Glycine 0 CA--C 1.526 0.768 0 CA-C-O 118.484 -1.176 . . . . 0.51000000000000001 112.126 177.518 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.5 mt -47.12 -52.4 4.56 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 C-N-CA 129.052 2.941 . . . . 1.1399999999999999 111.158 175.001 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -109.98 156.87 19.92 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.609 1.564 . . . . 0.28000000000000003 108.903 164.375 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 17.9 mtmm -146.28 159.75 42.92 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 124.559 1.144 . . . . 3.2200000000000002 110.403 171.565 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 61.59 -151.22 43.91 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 110.05 -1.22 . . . . 0.68999999999999995 110.05 -177.586 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -46.76 -37.3 8.35 Favored 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 123.901 0.88 . . . . 0.80000000000000004 112.01 179.69 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -51.84 -45.68 64.09 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.73 0.812 . . . . 2.0800000000000001 110.691 176.169 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -81.15 -50.22 9.87 Favored 'General case' 0 N--CA 1.455 -0.186 0 O-C-N 121.786 -0.572 . . . . 0.26000000000000001 110.937 177.379 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -53.4 -51.06 63.78 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.461 0.704 . . . . 2.3900000000000001 111.455 -175.781 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.26 -46.13 86.58 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 122.567 0.347 . . . . 0.26000000000000001 110.309 179.791 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.483 HG22 HG23 ' A' ' 28' ' ' VAL . 67.2 t -58.25 -54.71 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 CA-C-O 119.385 -0.341 . . . . 0.28000000000000003 110.629 178.12 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -49.99 -50.42 47.12 Favored 'General case' 0 C--O 1.224 -0.266 0 C-N-CA 122.855 0.462 . . . . 0.25 111.023 176.397 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.57 -48.12 83.17 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 121.822 0.82 . . . . 0.39000000000000001 110.723 -177.616 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.565 ' CE3' HD23 ' A' ' 88' ' ' LEU . 50.8 t90 -60.92 -43.79 98.1 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 121.79 0.805 . . . . 0.54000000000000004 110.768 178.197 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.565 HD23 ' CE3' ' A' ' 87' ' ' TRP . 0.1 OUTLIER -64.28 -33.85 76.78 Favored 'General case' 0 C--O 1.223 -0.291 0 O-C-N 121.189 -0.945 . . . . 1.6100000000000001 109.698 175.527 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.8 -42.19 97.75 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 118.54 0.609 . . . . 0.5 109.553 174.292 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -52.45 -50.78 61.96 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 118.108 -0.949 . . . . 3.2400000000000002 110.307 168.151 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 26.5 mttm -70.5 111.96 6.42 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 118.955 0.798 . . . . 3.0600000000000001 111.973 -173.755 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 26.9 mttp . . . . . 0 C--O 1.254 1.303 0 CA-C-O 116.277 -1.821 . . . . 3.04 106.485 -178.505 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 . . . . . 0 N--CA 1.449 -0.5 0 N-CA-C 109.22 -0.659 . . . . 2.5899999999999999 109.22 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -40.3 -56.0 2.07 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.896 1.278 . . . . 0.34999999999999998 111.804 179.083 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -48.02 -48.38 32.93 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.451 0.701 . . . . 3.1699999999999999 112.2 176.435 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.62 -42.27 98.2 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 123.025 0.53 . . . . 0.34999999999999998 110.485 -179.043 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 61.5 t -61.83 -50.07 81.68 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 N-CA-C 109.768 -0.456 . . . . 0.44 109.768 176.1 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.453 HG21 ' CZ3' ' A' ' 87' ' ' TRP . 79.6 t -52.61 -49.9 43.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 C-N-CA 123.066 0.546 . . . . 0.53000000000000003 109.593 178.379 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 30.3 mm-40 -54.29 -17.51 3.03 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.688 1.595 . . . . 0.57999999999999996 114.298 173.517 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -149.15 58.14 1.02 Allowed 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 119.612 1.096 . . . . 3.8900000000000001 111.853 -179.081 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.1 mttm 178.34 -35.34 0.01 OUTLIER 'General case' 0 C--O 1.225 -0.202 0 C-N-CA 126.233 1.813 . . . . 1.2 109.695 172.926 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 6.4 m -100.28 -53.07 3.21 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 118.949 0.795 . . . . 0.20999999999999999 110.639 -177.115 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.471 HD12 ' N ' ' A' ' 34' ' ' SER . 2.0 pp -55.14 -26.96 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.111 0 CA-C-N 115.936 -0.574 . . . . 0.45000000000000001 112.182 -177.94 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.471 ' N ' HD12 ' A' ' 33' ' ' ILE . 1.4 m -38.23 -37.15 0.26 Allowed 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 126.418 1.887 . . . . 1.24 112.434 171.313 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 39.5 m -120.52 -41.34 2.6 Favored 'General case' 0 C--N 1.341 0.201 0 C-N-CA 123.729 0.811 . . . . 0.17999999999999999 111.741 173.519 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 85.1 m-70 -72.23 -6.78 45.37 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.33 0.652 . . . . 0.20999999999999999 112.673 -175.735 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 87.1 148.16 12.85 Favored Glycine 0 C--N 1.337 0.633 0 N-CA-C 109.547 -1.421 . . . . 1.45 109.547 177.971 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -43.98 -33.11 2.56 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 124.71 1.148 . . . . 0.54000000000000004 112.532 174.939 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -94.42 -9.88 34.23 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.582 1.553 . . . . 2.3999999999999999 112.235 -172.839 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.434 ' CD2' HG22 ' A' ' 33' ' ' ILE . 1.5 mt 71.17 10.21 6.75 Favored 'General case' 0 C--N 1.348 0.516 0 CA-C-N 120.301 1.409 . . . . 1.46 111.395 179.563 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 11.9 p -86.43 0.28 54.46 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 127.206 2.202 . . . . 0.47999999999999998 109.999 -175.753 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.87 132.42 2.95 Favored Glycine 0 N--CA 1.44 -1.083 0 N-CA-C 108.789 -1.724 . . . . 0.59999999999999998 108.789 -177.024 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -136.73 -75.47 0.42 Allowed 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 124.122 0.969 . . . . 0.27000000000000002 108.396 178.328 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -93.71 3.71 55.05 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.852 0.861 . . . . 1.3500000000000001 110.859 174.615 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -160.53 163.89 20.58 Favored Pre-proline 0 CA--C 1.537 0.474 0 C-N-CA 125.799 1.64 . . . . 0.28000000000000003 107.564 -166.093 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -69.37 158.87 55.89 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.952 2.435 . . . . 0.26000000000000001 111.237 -174.124 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -74.5 125.17 28.01 Favored 'General case' 0 C--N 1.332 -0.164 0 O-C-N 121.675 -0.64 . . . . 0.28999999999999998 111.045 -174.761 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 37.3 pt -103.98 -1.09 9.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-O 119.169 -0.443 . . . . 0.40999999999999998 112.073 178.996 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -36.6 -40.32 0.25 Allowed 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.899 1.28 . . . . 2.7400000000000002 113.721 171.548 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.6 mtpm? -119.47 36.62 4.43 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 124.548 1.139 . . . . 3.2000000000000002 110.759 -178.085 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.53 -46.62 88.32 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 109.317 -0.623 . . . . 0.44 109.317 171.98 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -57.79 -14.94 17.39 Favored Glycine 0 CA--C 1.532 1.14 0 N-CA-C 114.76 0.664 . . . . 0.81999999999999995 114.76 179.267 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -89.65 -45.41 9.36 Favored 'General case' 0 C--N 1.338 0.091 0 CA-C-N 119.048 1.424 . . . . 0.70999999999999996 109.755 168.729 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -56.16 -54.33 46.47 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 122.608 0.363 . . . . 1.8700000000000001 111.616 179.622 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -140.42 158.97 43.21 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.512 1.125 . . . . 0.64000000000000001 109.563 -168.576 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 22.6 m -84.93 168.26 15.17 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.065 0.546 . . . . 1.53 110.825 178.217 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -50.72 -44.5 58.16 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 123.785 0.834 . . . . 3.0 111.908 -179.608 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -54.86 -46.26 74.68 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 119.116 0.871 . . . . 2.9900000000000002 111.394 176.474 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 51.7 mm-40 -71.86 -47.17 54.81 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 121.751 0.786 . . . . 3.0600000000000001 109.064 -173.511 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 64.3 mt -60.51 -46.31 95.63 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 N-CA-C 108.644 -0.873 . . . . 0.26000000000000001 108.644 178.75 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 38.9 tp -53.95 -51.35 64.12 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 109.087 -0.709 . . . . 0.34999999999999998 109.087 176.626 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -53.57 -47.06 70.43 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 117.969 0.35 . . . . 1.47 111.208 177.561 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 62.0 mt -58.71 -46.86 90.36 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.295 0 O-C-N 121.341 -0.849 . . . . 0.46000000000000002 110.844 175.431 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 57.3 mt -58.6 -43.96 88.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 O-C-N 120.339 -1.476 . . . . 0.27000000000000002 109.89 179.532 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 86.4 mt -71.45 -34.62 70.41 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.496 1.119 . . . . 0.40999999999999998 113.321 -178.188 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 71.3 m-80 -119.43 16.8 13.0 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 120.069 1.304 . . . . 1.6599999999999999 110.317 -168.532 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.519 ' N ' ' HA2' ' A' ' 73' ' ' GLY . . . 36.11 -142.46 0.15 Allowed Glycine 0 CA--C 1.536 1.404 0 C-N-CA 127.696 2.569 . . . . 0.62 111.106 -167.463 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 173.22 131.85 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 119.076 1.438 . . . . 1.29 109.216 -175.067 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 42.13 -119.14 1.81 Allowed Glycine 0 CA--C 1.534 1.224 0 CA-C-N 120.006 1.276 . . . . 0.48999999999999999 112.687 -174.976 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -70.44 -19.35 76.11 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 123.561 0.6 . . . . 0.67000000000000004 113.016 179.148 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 20.0 ttt -71.21 117.81 60.09 Favored Pre-proline 0 N--CA 1.452 -0.348 0 C-N-CA 124.404 1.081 . . . . 0.42999999999999999 110.53 -179.584 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -78.26 122.09 5.53 Favored 'Trans proline' 0 N--CA 1.445 -1.349 0 C-N-CA 123.28 2.653 . . . . 2.1699999999999999 110.732 179.986 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.519 ' HA2' ' N ' ' A' ' 67' ' ' GLY . . . -62.58 142.46 47.86 Favored Glycine 0 N--CA 1.442 -0.917 0 N-CA-C 115.503 0.961 . . . . 0.60999999999999999 115.503 -175.285 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 77.95 33.49 41.18 Favored Glycine 0 CA--C 1.525 0.678 0 CA-C-N 114.01 -1.095 . . . . 0.37 111.135 174.889 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -56.49 -49.86 75.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.442 0 C-N-CA 124.899 1.28 . . . . 1.0 108.94 172.996 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -109.53 160.06 16.55 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.069 1.748 . . . . 0.34999999999999998 109.879 164.314 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.1 mmtp -145.91 167.54 23.03 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 126.467 1.907 . . . . 2.3700000000000001 108.922 177.21 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 50.31 -145.87 9.14 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 110.883 -0.887 . . . . 0.78000000000000003 110.883 176.811 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -51.98 -34.9 44.46 Favored 'General case' 0 C--O 1.225 -0.199 0 CA-C-N 118.148 0.974 . . . . 0.77000000000000002 112.045 176.517 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -57.52 -38.61 74.94 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 118.664 0.666 . . . . 2.1800000000000002 110.118 177.598 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -83.18 -57.68 3.17 Favored 'General case' 0 N--CA 1.461 0.11 0 O-C-N 121.565 -0.71 . . . . 0.28000000000000003 111.113 174.925 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -51.41 -49.37 61.76 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 124.887 1.275 . . . . 2.4300000000000002 111.803 -176.123 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.22 -47.06 87.57 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 109.568 -0.53 . . . . 0.31 109.568 178.415 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 56.0 t -57.48 -52.74 53.24 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.312 0 CA-C-O 119.226 -0.416 . . . . 0.27000000000000002 110.842 178.961 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -52.28 -57.79 8.65 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.548 0.739 . . . . 0.22 111.519 176.561 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.71 -40.76 89.06 Favored 'General case' 0 C--O 1.226 -0.144 0 C-N-CA 123.032 0.533 . . . . 0.60999999999999999 110.934 -177.062 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.453 ' CZ3' HG21 ' A' ' 28' ' ' VAL . 83.6 t90 -63.79 -52.17 61.49 Favored 'General case' 0 N--CA 1.449 -0.513 0 O-C-N 121.721 -0.612 . . . . 0.73999999999999999 109.724 176.34 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.36 -27.41 64.16 Favored 'General case' 0 C--N 1.33 -0.277 0 O-C-N 120.675 -1.266 . . . . 1.96 112.167 176.413 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -56.8 -31.79 65.04 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 118.935 0.789 . . . . 0.53000000000000003 111.988 170.026 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -74.66 -36.36 62.82 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 118.844 0.747 . . . . 4.9800000000000004 111.052 172.002 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 11.9 mmtm -73.85 102.92 4.2 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 121.428 0.633 . . . . 3.7200000000000002 110.193 -178.484 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.25 1.088 0 C-N-CA 125.339 1.456 . . . . 2.8500000000000001 107.711 173.57 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 N--CA 1.448 -0.549 0 N-CA-C 108.191 -1.04 . . . . 3.8999999999999999 108.191 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -105.78 -62.39 1.37 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.053 -0.721 . . . . 0.40000000000000002 109.053 173.22 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -55.04 -47.97 74.06 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 119.021 -0.514 . . . . 2.7599999999999998 111.251 178.778 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.32 -41.58 93.82 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 118.95 0.796 . . . . 0.41999999999999998 111.106 -176.731 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 73.6 t -59.93 -57.41 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 108.677 -0.86 . . . . 0.46999999999999997 108.677 175.031 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.67 HG13 ' HB2' ' A' ' 32' ' ' CYS . 49.3 t -53.11 -48.37 53.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 CA-C-N 118.544 0.611 . . . . 0.33000000000000002 110.885 -178.479 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 22.4 mm-40 -51.88 -16.21 0.67 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 127.032 2.133 . . . . 0.77000000000000002 113.244 175.263 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -138.31 30.25 2.42 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 119.139 0.882 . . . . 2.6200000000000001 111.812 173.431 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -146.59 -48.43 0.19 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 118.831 0.741 . . . . 2.1699999999999999 111.103 176.481 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.67 ' HB2' HG13 ' A' ' 28' ' ' VAL . 3.5 m -93.45 -47.95 6.62 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 109.583 -0.525 . . . . 0.23999999999999999 109.583 -174.6 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.3 pp -57.35 -25.74 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 CA-C-N 115.897 -0.592 . . . . 0.42999999999999999 111.62 -178.451 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.1 m -41.89 -34.09 0.62 Allowed 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 126.157 1.783 . . . . 1.3999999999999999 112.388 172.144 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 37.2 m -121.37 -42.43 2.46 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.454 0.702 . . . . 0.23000000000000001 111.592 172.939 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 87.0 m-70 -72.93 -8.01 53.67 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.031 0.932 . . . . 0.23999999999999999 113.161 -175.483 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 85.05 150.03 11.99 Favored Glycine 0 C--N 1.337 0.601 0 N-CA-C 110.028 -1.229 . . . . 1.5800000000000001 110.028 178.699 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -43.83 -35.92 3.43 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 124.857 1.217 . . . . 0.47999999999999998 112.558 178.227 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -93.12 -9.0 41.05 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.307 1.443 . . . . 2.0699999999999998 112.41 -173.08 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.3 mt 71.41 9.49 6.49 Favored 'General case' 0 C--N 1.347 0.465 0 CA-C-N 120.254 1.388 . . . . 1.29 111.268 179.909 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.6 p -81.95 -2.47 51.53 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 127.764 2.425 . . . . 0.5 110.207 -177.205 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.54 150.31 25.18 Favored Glycine 0 N--CA 1.438 -1.169 0 N-CA-C 108.472 -1.851 . . . . 0.5 108.472 -174.597 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -156.77 -79.94 0.08 Allowed 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 124.477 1.111 . . . . 0.32000000000000001 108.712 179.278 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.3 t -92.06 2.71 56.4 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.146 0.978 . . . . 1.26 110.379 172.963 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.437 ' HB1' ' HD2' ' A' ' 46' ' ' PRO . . . -158.62 163.89 22.86 Favored Pre-proline 0 N--CA 1.45 -0.47 0 C-N-CA 125.704 1.602 . . . . 0.27000000000000002 107.494 -168.227 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.437 ' HD2' ' HB1' ' A' ' 45' ' ' ALA . 48.1 Cg_endo -69.01 162.47 41.57 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 123.63 2.887 . . . . 0.37 111.265 -174.207 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -74.76 122.49 23.37 Favored 'General case' 0 N--CA 1.455 -0.21 0 O-C-N 121.849 -0.532 . . . . 0.38 110.654 -176.072 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 33.8 pt -105.41 1.81 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.117 0 C-N-CA 123.717 0.807 . . . . 0.39000000000000001 111.4 178.096 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -44.95 -45.45 10.48 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 112.982 0.734 . . . . 2.6200000000000001 112.982 176.379 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.04 27.76 5.82 Favored 'General case' 0 C--N 1.343 0.303 0 C-N-CA 123.945 0.898 . . . . 4.04 111.582 178.63 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -56.17 -46.04 79.47 Favored 'General case' 0 N--CA 1.452 -0.352 0 O-C-N 121.62 -0.675 . . . . 0.27000000000000002 109.502 177.07 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -53.47 -30.91 42.74 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 123.448 0.547 . . . . 0.48999999999999999 113.313 -179.126 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -76.94 -42.32 39.77 Favored 'General case' 0 N--CA 1.455 -0.206 0 O-C-N 122.031 -0.687 . . . . 0.71999999999999997 110.613 176.529 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 48.7 m-20 -66.05 -49.29 68.17 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 122.129 0.172 . . . . 1.53 111.034 -179.926 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -139.14 141.67 38.04 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 125.568 1.547 . . . . 0.68000000000000005 107.837 -167.448 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 22.4 m -78.18 168.98 19.02 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 118.45 0.568 . . . . 1.5900000000000001 110.363 179.65 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -50.82 -44.23 59.18 Favored 'General case' 0 C--O 1.224 -0.258 0 C-N-CA 123.346 0.658 . . . . 3.0499999999999998 111.973 -179.593 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -54.92 -39.26 68.63 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 118.492 0.587 . . . . 2.8999999999999999 111.67 176.98 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -78.67 -45.67 20.86 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 121.495 0.664 . . . . 3.4900000000000002 109.47 -177.262 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 62.4 mt -59.11 -44.5 91.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 O-C-N 121.653 -0.654 . . . . 0.26000000000000001 109.289 179.189 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 35.4 tp -55.33 -50.1 70.51 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 123.854 0.861 . . . . 0.32000000000000001 109.453 176.174 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -50.98 -52.68 40.27 Favored 'General case' 0 N--CA 1.454 -0.235 0 O-C-N 123.312 0.382 . . . . 1.51 110.264 176.138 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 86.3 mt -56.8 -51.11 71.46 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.328 0 O-C-N 121.64 -0.663 . . . . 0.53000000000000003 110.287 177.977 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 71.0 mt -52.65 -44.78 47.16 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 O-C-N 120.47 -1.394 . . . . 0.22 110.486 179.247 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 79.4 mt -73.06 -32.57 65.13 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 113.164 0.801 . . . . 0.39000000000000001 113.164 -179.087 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -121.96 20.6 10.76 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 119.591 1.087 . . . . 1.6399999999999999 110.161 -165.539 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.54 ' N ' ' HA2' ' A' ' 73' ' ' GLY . . . 28.75 -139.43 0.02 OUTLIER Glycine 0 CA--C 1.534 1.268 0 C-N-CA 129.127 3.251 . . . . 0.68000000000000005 111.524 -165.401 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 174.58 133.95 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 118.994 1.397 . . . . 1.2 107.935 -178.394 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 31.43 -110.04 0.04 OUTLIER Glycine 0 CA--C 1.535 1.282 0 C-N-CA 124.971 1.272 . . . . 0.34000000000000002 114.246 -172.515 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -69.61 -24.11 76.37 Favored Glycine 0 CA--C 1.533 1.206 0 CA-C-N 118.114 0.957 . . . . 0.41999999999999998 113.166 -178.328 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 18.1 ttt -70.99 120.03 76.96 Favored Pre-proline 0 N--CA 1.452 -0.371 0 C-N-CA 125.004 1.321 . . . . 0.34999999999999998 111.039 -178.605 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.431 ' HD2' HD11 ' A' ' 75' ' ' ILE . 37.4 Cg_endo -75.62 122.33 6.85 Favored 'Trans proline' 0 N--CA 1.446 -1.304 0 C-N-CA 123.297 2.665 . . . . 2.0499999999999998 111.135 178.933 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.54 ' HA2' ' N ' ' A' ' 67' ' ' GLY . . . -61.06 137.39 48.16 Favored Glycine 0 N--CA 1.442 -0.934 0 CA-C-N 115.271 -0.877 . . . . 0.67000000000000004 114.833 -179.272 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 82.16 42.71 8.53 Favored Glycine 0 CA--C 1.524 0.632 0 CA-C-N 114.225 -0.988 . . . . 0.54000000000000004 110.636 175.829 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.431 HD11 ' HD2' ' A' ' 72' ' ' PRO . 0.9 OUTLIER -63.66 -57.42 11.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 C-N-CA 124.379 1.072 . . . . 1.23 109.283 174.172 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -98.12 155.94 16.9 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.952 1.301 . . . . 0.40000000000000002 109.383 166.08 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -146.0 151.37 37.67 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 124.322 1.049 . . . . 2.75 110.959 178.424 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 72.51 -163.62 54.69 Favored Glycine 0 CA--C 1.53 1.016 0 N-CA-C 110.747 -0.941 . . . . 0.82999999999999996 110.747 -174.437 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -52.02 -24.13 6.2 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.737 1.215 . . . . 0.94999999999999996 112.718 -179.061 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 47.9 tt0 -43.99 -63.16 0.92 Allowed 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.736 1.215 . . . . 2.6099999999999999 110.283 167.903 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.45 -45.09 94.93 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.189 0.596 . . . . 0.23000000000000001 110.271 -176.275 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -53.81 -54.07 43.58 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.742 0.817 . . . . 1.99 110.979 178.001 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -56.41 -49.51 74.3 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 123.811 0.844 . . . . 0.31 109.764 -179.824 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.456 HG22 HG23 ' A' ' 28' ' ' VAL . 69.2 t -54.99 -52.77 40.58 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-N 116.939 -0.119 . . . . 0.29999999999999999 111.26 176.802 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -54.63 -52.02 63.57 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.38 0.672 . . . . 0.17999999999999999 111.919 -179.881 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.99 -48.06 79.33 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 121.553 0.692 . . . . 0.29999999999999999 110.555 177.226 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.539 ' CE3' HD23 ' A' ' 88' ' ' LEU . 54.6 t90 -57.08 -44.97 83.64 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 121.71 -0.619 . . . . 0.5 110.548 177.778 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.539 HD23 ' CE3' ' A' ' 87' ' ' TRP . 0.1 OUTLIER -63.89 -37.38 87.17 Favored 'General case' 0 N--CA 1.461 0.088 0 C-N-CA 124.749 1.22 . . . . 1.6000000000000001 111.599 177.203 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -54.69 -38.44 67.01 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 119.216 0.916 . . . . 0.55000000000000004 110.432 169.552 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -88.76 26.2 1.58 Allowed 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 113.473 0.916 . . . . 3.3100000000000001 113.473 171.795 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 2.1 mtpm? -122.05 117.88 27.41 Favored 'General case' 0 C--N 1.341 0.239 0 O-C-N 120.647 -1.283 . . . . 2.2599999999999998 110.218 165.854 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.256 1.405 0 C-N-CA 129.535 3.134 . . . . 2.8300000000000001 104.738 174.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.535 HG22 ' H ' ' A' ' 23' ' ' ASP 2.22 0.5 OUTLIER . . . . . 0 N--CA 1.471 0.623 0 CA-C-O 114.298 -2.763 . . . . 2.3399999999999999 105.977 . . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.535 ' H ' HG22 ' A' ' 22' ' ' VAL . 0.1 OUTLIER -96.59 89.31 4.94 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 104.12 -2.548 . . . . 2.3100000000000001 104.12 153.772 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.27 -52.49 33.22 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-O 122.428 1.109 . . . . 0.47999999999999998 109.265 -166.366 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.434 ' HB3' ' CZ2' ' A' ' 87' ' ' TRP . 5.5 pt-20 -55.69 -48.06 75.72 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 114.15 -1.387 . . . . 2.73 111.839 175.751 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.462 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . . . -56.86 -46.06 82.05 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 119.617 1.099 . . . . 0.37 111.013 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.576 HG21 ' HG3' ' A' ' 80' ' ' GLU . 68.7 t -55.86 -56.76 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.225 0 N-CA-C 108.901 -0.777 . . . . 0.47999999999999998 108.901 176.543 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.589 HG22 ' SG ' ' A' ' 32' ' ' CYS . 29.9 t -51.93 -49.14 38.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 O-C-N 122.343 -0.223 . . . . 0.28999999999999998 111.274 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.414 ' HA ' HG12 ' A' ' 33' ' ' ILE . 18.1 mm-40 -57.34 -8.03 0.69 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 127.895 2.478 . . . . 1.22 113.671 176.513 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 19.6 tp60 -137.44 17.57 2.93 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 119.772 1.169 . . . . 2.9399999999999999 111.522 172.533 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.476 ' O ' HMC3 ' A' ' 93' ' ' HEC . 50.3 mmtt -138.97 -59.44 0.6 Allowed 'General case' 0 CA--C 1.514 -0.434 0 O-C-N 121.111 -0.993 . . . . 2.54 110.435 -177.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.589 ' SG ' HG22 ' A' ' 28' ' ' VAL . 2.8 m -79.45 -47.68 15.24 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 108.698 -0.852 . . . . 0.34000000000000002 108.698 -173.331 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.414 HG12 ' HA ' ' A' ' 29' ' ' GLN . 2.5 pp -52.85 -30.2 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 CA-C-N 115.384 -0.826 . . . . 0.39000000000000001 111.95 -179.265 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.8 m -46.01 -30.81 1.97 Allowed 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.132 1.373 . . . . 1.23 112.738 176.202 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 30.1 m -121.93 -44.55 2.3 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.784 0.834 . . . . 0.17000000000000001 111.386 173.144 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 87.1 m-70 -68.61 -10.13 54.07 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.724 1.21 . . . . 0.26000000000000001 112.558 -177.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 87.99 148.31 15.19 Favored Glycine 0 C--N 1.339 0.702 0 C-N-CA 125.468 1.509 . . . . 1.48 109.64 179.148 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -41.83 -36.98 1.92 Allowed Glycine 0 C--N 1.341 0.84 0 C-N-CA 124.653 1.121 . . . . 0.46999999999999997 112.214 173.237 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -89.94 -12.4 38.93 Favored 'General case' 0 N--CA 1.444 -0.76 0 C-N-CA 125.876 1.67 . . . . 3.0800000000000001 111.429 -172.2 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.0 mt 71.24 11.61 6.79 Favored 'General case' 0 C--N 1.349 0.56 0 CA-C-N 119.983 1.265 . . . . 1.1499999999999999 111.249 178.522 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.6 p -87.2 0.09 55.88 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 127.696 2.398 . . . . 0.5 110.018 -175.062 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.7 126.22 2.32 Favored Glycine 0 N--CA 1.441 -0.977 0 N-CA-C 109.052 -1.619 . . . . 0.81000000000000005 109.052 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -131.27 -77.93 0.52 Allowed 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 124.311 1.044 . . . . 0.29999999999999999 108.405 178.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 12.6 m -92.59 4.29 53.9 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.393 1.077 . . . . 1.3500000000000001 110.984 173.19 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.468 ' HB1' ' HD2' ' A' ' 46' ' ' PRO . . . -157.82 166.63 16.16 Favored Pre-proline 0 CA--C 1.537 0.453 0 C-N-CA 125.013 1.325 . . . . 0.23000000000000001 108.353 -168.637 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.468 ' HD2' ' HB1' ' A' ' 45' ' ' ALA . 69.7 Cg_endo -73.88 153.91 48.01 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 123.136 2.557 . . . . 0.39000000000000001 110.552 -173.63 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -72.04 125.71 27.94 Favored 'General case' 0 C--N 1.332 -0.171 0 O-C-N 121.107 -0.996 . . . . 0.28000000000000003 110.725 -174.194 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 18.1 pt -104.43 1.63 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.143 0 C-N-CA 123.351 0.66 . . . . 0.48999999999999999 111.697 176.031 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -36.79 -44.9 0.51 Allowed 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.416 1.086 . . . . 2.3799999999999999 112.986 170.317 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 8.4 pttp -113.2 31.89 6.13 Favored 'General case' 0 C--N 1.344 0.332 0 C-N-CA 123.94 0.896 . . . . 4.2599999999999998 111.876 178.263 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.92 -44.32 96.41 Favored 'General case' 0 N--CA 1.454 -0.242 0 O-C-N 120.836 -1.165 . . . . 0.31 109.297 178.404 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -54.2 -26.65 36.62 Favored Glycine 0 C--N 1.339 0.746 0 CA-C-N 118.238 0.472 . . . . 0.58999999999999997 113.915 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -83.59 -45.07 13.92 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 117.29 0.545 . . . . 0.77000000000000002 110.031 175.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 35.3 m-80 -58.27 -51.77 68.37 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 122.728 0.411 . . . . 1.6200000000000001 111.333 178.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -134.12 149.99 51.11 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.456 1.503 . . . . 0.87 108.485 -166.675 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.66 164.37 25.37 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 109.856 -0.424 . . . . 1.55 109.856 -179.64 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -49.39 -42.77 43.27 Favored 'General case' 0 C--O 1.223 -0.331 0 C-N-CA 123.301 0.64 . . . . 3.27 110.779 173.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 70.9 mt-10 -52.98 -44.86 67.5 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.207 0.603 . . . . 2.9199999999999999 110.776 178.106 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 58.2 mm-40 -75.06 -47.96 26.28 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.172 0.589 . . . . 3.0499999999999998 110.037 -177.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.532 HG23 HMA1 ' A' ' 93' ' ' HEC . 76.4 mt -62.77 -46.34 96.6 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.111 0 N-CA-C 108.941 -0.763 . . . . 0.31 108.941 -175.821 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 32.4 tp -53.48 -51.72 61.83 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 124.061 0.944 . . . . 0.56000000000000005 109.281 176.333 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -53.09 -51.56 61.44 Favored 'General case' 0 N--CA 1.452 -0.368 0 O-C-N 123.374 0.421 . . . . 1.95 110.504 176.167 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 40.9 mt -56.02 -45.15 80.26 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.378 0 O-C-N 121.451 -0.781 . . . . 0.45000000000000001 111.184 177.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.512 HD11 HMB2 ' A' ' 93' ' ' HEC . 43.3 mt -61.98 -45.41 98.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 O-C-N 119.951 -1.718 . . . . 0.34000000000000002 109.482 179.661 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 87.5 mt -69.81 -29.04 66.23 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.118 0.967 . . . . 0.56999999999999995 113.364 -178.524 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -128.87 19.54 6.05 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 119.683 1.128 . . . . 1.8 110.338 -166.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.525 ' N ' ' HA2' ' A' ' 73' ' ' GLY . . . 34.87 -146.52 0.04 OUTLIER Glycine 0 CA--C 1.538 1.516 0 C-N-CA 128.975 3.179 . . . . 0.64000000000000001 112.397 -170.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 177.37 135.64 0.07 Allowed 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.173 1.389 . . . . 1.23 108.075 -176.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 32.0 -110.67 0.04 OUTLIER Glycine 0 CA--C 1.533 1.171 0 C-N-CA 125.038 1.304 . . . . 0.38 114.095 -174.023 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -71.03 -24.65 76.91 Favored Glycine 0 CA--C 1.534 1.243 0 CA-C-N 118.116 0.958 . . . . 0.53000000000000003 113.053 -178.665 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.431 ' HB2' ' C1D' ' A' ' 93' ' ' HEC . 17.6 ttt -69.36 118.35 61.33 Favored Pre-proline 0 CA--C 1.535 0.388 0 C-N-CA 125.06 1.344 . . . . 0.40000000000000002 111.3 -179.003 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -75.67 127.86 10.54 Favored 'Trans proline' 0 N--CA 1.446 -1.279 0 C-N-CA 122.877 2.385 . . . . 2.1099999999999999 110.671 177.625 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.525 ' HA2' ' N ' ' A' ' 67' ' ' GLY . . . -66.48 140.35 38.86 Favored Glycine 0 N--CA 1.442 -0.909 0 N-CA-C 115.158 0.823 . . . . 0.69999999999999996 115.158 -177.064 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 79.53 39.17 18.93 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 110.6 -1.0 . . . . 0.32000000000000001 110.6 176.296 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -60.19 -48.95 86.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 124.645 1.178 . . . . 1.0900000000000001 108.863 175.07 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -102.72 149.3 24.59 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 126.031 1.732 . . . . 0.32000000000000001 108.87 162.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 65.6 mttt -141.42 160.04 40.97 Favored 'General case' 0 C--N 1.339 0.119 0 C-N-CA 124.097 0.959 . . . . 2.7400000000000002 110.036 172.635 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 74.84 -165.16 54.73 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 109.999 -1.241 . . . . 0.96999999999999997 109.999 -174.184 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -54.32 -24.47 19.38 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.451 0.701 . . . . 0.93999999999999995 111.691 -178.076 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.576 ' HG3' HG21 ' A' ' 27' ' ' VAL . 30.8 tt0 -41.92 -60.14 1.49 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.198 1.399 . . . . 2.3100000000000001 110.511 169.771 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.6 -45.66 93.16 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 122.537 0.335 . . . . 0.33000000000000002 110.293 -174.395 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -51.73 -60.69 2.88 Favored 'General case' 0 C--N 1.339 0.111 0 C-N-CA 124.08 0.952 . . . . 2.73 110.739 174.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -52.77 -48.9 66.49 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-O 119.242 -0.408 . . . . 0.28000000000000003 110.743 -179.221 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.461 HG13 ' CG2' ' A' ' 28' ' ' VAL . 78.6 t -53.69 -59.75 1.75 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 CA-C-N 117.787 0.267 . . . . 0.40000000000000002 110.865 176.674 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -50.33 -51.47 45.28 Favored 'General case' 0 C--O 1.226 -0.138 0 C-N-CA 123.669 0.788 . . . . 0.22 112.159 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.2 -45.43 80.81 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.4 0.68 . . . . 0.38 110.683 -175.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.465 ' CZ3' HG21 ' A' ' 28' ' ' VAL . 77.3 t90 -55.23 -47.82 74.83 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 109.041 -0.726 . . . . 0.70999999999999996 109.041 173.631 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.03 -37.79 80.83 Favored 'General case' 0 C--O 1.22 -0.474 0 CA-C-O 117.977 -1.011 . . . . 2.0 112.911 173.04 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -52.95 -40.89 64.02 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 120.381 1.446 . . . . 0.38 110.735 175.364 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -67.54 -38.08 83.66 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-O 118.944 -0.55 . . . . 3.7400000000000002 112.329 170.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 24.2 mtpp -76.37 108.86 9.62 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 119.906 1.23 . . . . 2.79 111.092 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 88.9 mttt . . . . . 0 C--O 1.25 1.126 0 C-N-CA 126.013 1.725 . . . . 2.1400000000000001 107.599 -176.356 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 93' ' ' HEC . . . . . 0.532 HMA1 HG23 ' A' ' 60' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.491 HG11 ' HA ' ' A' ' 80' ' ' GLU . 24.9 t . . . . . 0 N--CA 1.471 0.593 0 N-CA-C 106.994 -1.484 . . . . 1.1699999999999999 106.994 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -83.04 106.36 14.79 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 108.137 -1.06 . . . . 2.2000000000000002 108.137 -173.508 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -48.0 -54.14 13.91 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.834 0.854 . . . . 0.27000000000000002 110.786 -179.215 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -53.34 -46.55 69.53 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 122.73 0.412 . . . . 3.29 111.621 176.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.3 -44.47 97.16 Favored 'General case' 0 CA--C 1.527 0.062 0 C-N-CA 122.877 0.471 . . . . 0.29999999999999999 110.569 -179.177 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 77.7 t -57.94 -55.4 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 N-CA-C 109.232 -0.655 . . . . 0.44 109.232 175.304 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.423 ' HA ' ' SG ' ' A' ' 32' ' ' CYS . 79.0 t -50.99 -47.92 29.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 110.379 -0.23 . . . . 0.40999999999999998 110.379 -179.288 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 28.6 mm-40 -54.22 -23.33 14.29 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 126.455 1.902 . . . . 0.64000000000000001 114.72 174.623 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -142.6 59.23 1.44 Allowed 'General case' 0 N--CA 1.461 0.088 0 CA-C-N 120.54 1.518 . . . . 2.4199999999999999 112.106 173.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.08 -36.39 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 124.435 1.094 . . . . 1.2 109.611 171.177 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.423 ' SG ' ' HA ' ' A' ' 28' ' ' VAL . 3.7 m -101.9 -50.4 3.69 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 118.813 0.733 . . . . 0.20000000000000001 110.931 -177.623 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.536 HG22 HD23 ' A' ' 40' ' ' LEU . 2.0 pp -56.77 -25.77 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 N-CA-C 112.556 0.576 . . . . 0.5 112.556 -174.678 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.451 ' N ' HD12 ' A' ' 33' ' ' ILE . 8.3 m -41.8 -34.89 0.7 Allowed 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.576 1.55 . . . . 1.01 112.475 172.146 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 18.9 m -121.1 -42.97 2.46 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.369 0.668 . . . . 0.19 111.385 175.029 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 84.8 m-70 -71.34 -7.65 48.52 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.422 0.689 . . . . 0.17000000000000001 112.741 -176.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 88.49 149.29 18.67 Favored Glycine 0 C--N 1.338 0.669 0 N-CA-C 109.776 -1.329 . . . . 1.4399999999999999 109.776 178.064 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -43.17 -36.45 2.84 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 124.615 1.102 . . . . 0.52000000000000002 112.233 174.74 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -97.58 -4.39 37.79 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 124.88 1.272 . . . . 2.8999999999999999 111.793 -172.341 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.536 HD23 HG22 ' A' ' 33' ' ' ILE . 1.5 mt 71.43 12.83 6.58 Favored 'General case' 0 C--N 1.348 0.531 0 CA-C-N 120.238 1.381 . . . . 1.4199999999999999 111.071 176.006 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.3 p -88.71 1.23 55.5 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 127.866 2.466 . . . . 0.31 110.038 -173.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.51 138.0 5.57 Favored Glycine 0 N--CA 1.444 -0.808 0 N-CA-C 109.049 -1.62 . . . . 0.41999999999999998 109.049 -177.048 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -143.79 -71.56 0.29 Allowed 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.469 -0.567 . . . . 0.34999999999999998 109.469 178.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -99.02 3.92 47.01 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.939 1.696 . . . . 0.97999999999999998 110.315 172.393 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.428 ' HB1' ' HD2' ' A' ' 46' ' ' PRO . . . -158.28 165.43 18.6 Favored Pre-proline 0 CA--C 1.535 0.394 0 C-N-CA 124.907 1.283 . . . . 0.23999999999999999 107.852 -168.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.428 ' HD2' ' HB1' ' A' ' 45' ' ' ALA . 46.3 Cg_endo -69.5 157.73 59.84 Favored 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 122.621 2.214 . . . . 0.20000000000000001 110.53 -175.162 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.64 121.49 20.79 Favored 'General case' 0 N--CA 1.454 -0.246 0 O-C-N 121.724 -0.61 . . . . 0.23999999999999999 109.934 -178.089 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 41.7 pt -100.99 1.88 10.56 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.161 0 C-N-CA 123.536 0.735 . . . . 0.26000000000000001 111.039 178.295 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.434 ' OD1' ' NZ ' ' A' ' 91' ' ' LYS . 34.2 t70 -44.01 -41.23 5.28 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 113.506 0.928 . . . . 3.1800000000000002 113.506 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 35.0 mttm -109.3 33.19 4.44 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 125.838 1.655 . . . . 6.1200000000000001 111.403 179.237 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -58.26 -46.02 86.76 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 108.975 -0.75 . . . . 0.34000000000000002 108.975 173.513 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -54.07 -28.55 41.62 Favored Glycine 0 CA--C 1.527 0.785 0 CA-C-N 118.243 0.474 . . . . 0.51000000000000001 114.158 -179.316 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -78.62 -42.6 28.46 Favored 'General case' 0 N--CA 1.455 -0.223 0 O-C-N 122.227 -0.573 . . . . 0.71999999999999997 110.049 175.368 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 15.8 m-80 -65.63 -48.53 71.91 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 122.784 0.434 . . . . 1.5700000000000001 111.197 -178.492 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -138.79 147.74 42.93 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 125.423 1.489 . . . . 0.60999999999999999 108.327 -170.639 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 89.6 p -74.62 168.28 20.11 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.033 0.533 . . . . 2.3500000000000001 110.973 177.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -46.66 -47.21 20.3 Favored 'General case' 0 C--O 1.224 -0.278 0 C-N-CA 124.311 1.044 . . . . 2.7599999999999998 111.582 174.564 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -57.7 -41.54 81.91 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.422 0.689 . . . . 4.0300000000000002 110.531 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -76.23 -45.79 31.26 Favored 'General case' 0 N--CA 1.45 -0.428 0 O-C-N 121.437 -0.789 . . . . 3.4399999999999999 109.391 -175.52 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.481 HG23 HMA1 ' A' ' 93' ' ' HEC . 80.9 mt -60.76 -44.43 97.37 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.125 0 N-CA-C 109.027 -0.731 . . . . 0.29999999999999999 109.027 178.493 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 33.5 tp -54.66 -49.02 71.58 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 109.277 -0.638 . . . . 0.32000000000000001 109.277 176.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -54.1 -46.19 72.04 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 117.891 0.314 . . . . 1.48 111.498 175.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 73.9 mt -59.63 -49.79 82.4 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.261 0 O-C-N 121.115 -0.991 . . . . 0.54000000000000004 110.453 176.302 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.46 HD11 HMB2 ' A' ' 93' ' ' HEC . 58.8 mt -56.18 -44.64 79.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 O-C-N 120.386 -1.446 . . . . 0.22 110.002 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 69.5 mt -71.04 -28.64 64.52 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 124.309 1.043 . . . . 0.35999999999999999 113.802 -178.513 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 51.3 m-80 -125.02 15.54 8.51 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 120.374 1.443 . . . . 1.73 110.629 -169.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.554 ' N ' ' HA2' ' A' ' 73' ' ' GLY . . . 35.84 -144.14 0.09 OUTLIER Glycine 0 CA--C 1.537 1.428 0 C-N-CA 128.082 2.753 . . . . 0.62 111.597 -166.689 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 173.83 133.56 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 119.465 1.632 . . . . 1.22 110.021 -177.391 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 40.26 -119.36 1.26 Allowed Glycine 0 CA--C 1.532 1.126 0 CA-C-N 119.574 1.079 . . . . 0.38 112.789 -173.578 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -66.14 -21.76 70.22 Favored Glycine 0 CA--C 1.534 1.233 0 CA-C-N 117.498 0.649 . . . . 0.47999999999999998 113.245 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.42 ' HB2' ' C1D' ' A' ' 93' ' ' HEC . 18.2 ttt -74.04 121.07 84.33 Favored Pre-proline 0 CA--C 1.536 0.41 0 C-N-CA 124.406 1.082 . . . . 0.34999999999999998 111.539 -176.586 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.455 ' HD2' HD11 ' A' ' 75' ' ' ILE . 53.3 Cg_endo -79.02 122.71 5.41 Favored 'Trans proline' 0 N--CA 1.449 -1.097 0 C-N-CA 123.262 2.641 . . . . 2.1099999999999999 111.688 -178.423 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.554 ' HA2' ' N ' ' A' ' 67' ' ' GLY . . . -60.65 138.76 48.21 Favored Glycine 0 N--CA 1.443 -0.89 0 N-CA-C 115.5 0.96 . . . . 0.60999999999999999 115.5 -177.212 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 81.94 35.63 21.03 Favored Glycine 0 CA--C 1.527 0.783 0 CA-C-N 114.379 -0.911 . . . . 0.33000000000000002 111.612 174.672 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.455 HD11 ' HD2' ' A' ' 72' ' ' PRO . 1.2 mt -58.23 -52.16 62.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 124.924 1.29 . . . . 1.22 110.059 175.246 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -111.02 161.68 15.63 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.748 1.619 . . . . 0.26000000000000001 109.036 165.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 18.0 mttm -144.32 164.3 31.18 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 124.931 1.292 . . . . 2.9399999999999999 110.412 176.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 57.2 -144.5 39.51 Favored Glycine 0 CA--C 1.529 0.908 0 N-CA-C 111.185 -0.766 . . . . 0.70999999999999996 111.185 179.083 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -52.23 -33.98 43.84 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.203 0.601 . . . . 0.80000000000000004 111.526 174.255 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.491 ' HA ' HG11 ' A' ' 22' ' ' VAL . 7.2 tt0 -55.02 -36.64 65.69 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.443 0.697 . . . . 2.2799999999999998 110.515 176.28 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -88.05 -52.69 5.12 Favored 'General case' 0 CA--C 1.534 0.336 0 O-C-N 121.662 -0.649 . . . . 0.20999999999999999 111.086 175.578 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -54.73 -50.9 67.24 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.789 0.836 . . . . 2.48 111.568 -175.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.61 -45.37 92.14 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 109.644 -0.502 . . . . 0.23999999999999999 109.644 -178.229 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 64.9 t -57.19 -55.12 22.43 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 C-N-CA 122.831 0.452 . . . . 0.28999999999999998 110.363 176.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -50.28 -53.83 25.69 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 122.973 0.509 . . . . 0.20000000000000001 111.497 177.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.33 -44.78 95.69 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 121.542 0.686 . . . . 0.33000000000000002 111.278 -178.083 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 81.0 t90 -60.82 -50.08 74.91 Favored 'General case' 0 N--CA 1.452 -0.356 0 O-C-N 121.471 -0.768 . . . . 0.63 110.221 179.291 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.6 -30.64 70.82 Favored 'General case' 0 C--O 1.222 -0.367 0 O-C-N 121.3 -0.875 . . . . 1.97 111.927 172.755 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -58.92 -31.48 68.69 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 119.603 1.092 . . . . 0.53000000000000003 111.21 171.348 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -76.02 -35.68 59.43 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 118.927 0.785 . . . . 3.4900000000000002 111.784 169.322 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.517 ' HB3' ' HZ2' ' A' ' 91' ' ' LYS . 0.7 OUTLIER -73.34 110.18 7.44 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 119.522 1.055 . . . . 2.7599999999999998 111.068 -179.64 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 19.7 mttt . . . . . 0 C--O 1.251 1.163 0 C-N-CA 125.507 1.523 . . . . 2.8399999999999999 109.342 -170.817 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 93' ' ' HEC . . . . . 0.481 HMA1 HG23 ' A' ' 60' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.0 t . . . . . 0 N--CA 1.472 0.625 0 N-CA-C 106.566 -1.642 . . . . 1.3300000000000001 106.566 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -74.1 103.83 4.7 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 108.383 -0.969 . . . . 2.6800000000000002 108.383 -177.533 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -42.69 -56.09 3.3 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.677 1.191 . . . . 0.29999999999999999 111.088 177.534 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -47.56 -47.04 28.45 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 123.524 0.73 . . . . 3.0699999999999998 111.73 175.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.98 -46.06 90.91 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-N 118.682 0.674 . . . . 0.34999999999999998 110.412 -179.196 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 94.5 t -58.51 -52.22 62.1 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.134 0 N-CA-C 109.691 -0.485 . . . . 0.41999999999999998 109.691 177.053 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.406 ' HA ' ' SG ' ' A' ' 32' ' ' CYS . 72.4 t -52.47 -52.22 27.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 N-CA-C 109.756 -0.461 . . . . 0.40000000000000002 109.756 179.033 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 35.3 mm-40 -58.12 -7.2 0.75 Allowed 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 127.547 2.339 . . . . 0.65000000000000002 114.022 174.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -142.82 33.1 1.4 Allowed 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 119.81 1.187 . . . . 3.1000000000000001 113.369 172.605 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.41 ' O ' HMC3 ' A' ' 93' ' ' HEC . 0.1 OUTLIER -153.92 -55.66 0.11 Allowed 'General case' 0 CA--C 1.517 -0.314 0 O-C-N 121.766 -0.584 . . . . 1.5700000000000001 109.885 170.183 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.406 ' SG ' ' HA ' ' A' ' 28' ' ' VAL . 3.2 m -76.34 -48.29 20.5 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 109.824 -0.436 . . . . 0.20000000000000001 109.824 -170.756 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.1 pt -49.93 -30.99 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-N 115.217 -0.901 . . . . 0.79000000000000004 112.517 -179.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.9 m -46.06 -33.02 3.17 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 125.64 1.576 . . . . 1.02 112.077 177.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 14.6 m -121.95 -44.84 2.28 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.706 0.802 . . . . 0.17999999999999999 111.228 175.72 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 82.0 m-70 -67.43 -11.11 57.0 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.189 0.996 . . . . 0.29999999999999999 112.319 -178.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 87.82 148.04 14.25 Favored Glycine 0 C--N 1.339 0.712 0 N-CA-C 109.396 -1.481 . . . . 1.4299999999999999 109.396 178.501 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -43.83 -31.92 2.04 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 124.655 1.121 . . . . 0.58999999999999997 112.969 173.514 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -92.62 -12.44 31.63 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.596 1.559 . . . . 2.1499999999999999 112.831 -175.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 73.0 9.71 5.37 Favored 'General case' 0 C--N 1.347 0.489 0 CA-C-N 120.326 1.421 . . . . 1.6000000000000001 111.168 178.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.0 p -86.0 -1.66 57.55 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 127.947 2.499 . . . . 0.29999999999999999 110.222 -174.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.64 132.25 4.64 Favored Glycine 0 N--CA 1.443 -0.86 0 N-CA-C 108.726 -1.75 . . . . 0.52000000000000002 108.726 -179.219 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -137.45 -75.83 0.4 Allowed 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 108.869 -0.789 . . . . 0.25 108.869 179.363 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 15.7 m -95.47 4.3 53.4 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.658 1.183 . . . . 1.3100000000000001 110.628 172.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.528 ' HB1' ' HD2' ' A' ' 46' ' ' PRO . . . -156.6 167.73 13.84 Favored Pre-proline 0 N--CA 1.45 -0.474 0 C-N-CA 124.842 1.257 . . . . 0.25 108.33 -171.651 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.528 ' HD2' ' HB1' ' A' ' 45' ' ' ALA . 36.7 Cg_endo -71.02 156.43 60.04 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 122.951 2.434 . . . . 0.28999999999999998 110.508 -174.638 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.37 126.74 30.84 Favored 'General case' 0 N--CA 1.455 -0.199 0 O-C-N 121.513 -0.742 . . . . 0.28999999999999998 110.083 -177.137 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 36.3 pt -103.2 0.62 10.32 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.191 0 C-N-CA 123.239 0.616 . . . . 0.47999999999999998 111.196 174.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -33.23 -45.73 0.15 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.606 1.562 . . . . 2.29 113.071 168.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.62 39.95 3.2 Favored 'General case' 0 C--N 1.343 0.317 0 C-N-CA 124.184 0.993 . . . . 4.0199999999999996 111.475 177.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.63 -42.99 85.88 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 121.324 -0.86 . . . . 0.28999999999999998 109.601 174.578 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -52.4 -32.53 37.89 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-N 118.507 0.594 . . . . 0.66000000000000003 114.387 -175.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -78.22 -49.13 14.33 Favored 'General case' 0 N--CA 1.455 -0.221 0 O-C-N 122.39 -0.477 . . . . 0.93999999999999995 110.172 174.731 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 33.0 m-80 -56.6 -48.84 76.57 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 122.865 0.466 . . . . 1.53 111.533 -177.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -136.47 140.16 42.88 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.751 1.62 . . . . 1.0700000000000001 107.373 -169.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 90.4 p -73.87 169.01 18.29 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 121.641 -0.662 . . . . 2.46 110.716 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -48.17 -52.59 20.1 Favored 'General case' 0 C--N 1.341 0.233 0 O-C-N 121.811 -0.555 . . . . 4.9400000000000004 110.103 174.069 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -53.97 -27.22 29.94 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 118.69 -0.672 . . . . 2.75 112.51 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -87.87 -46.87 9.04 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 119.325 0.966 . . . . 3.2799999999999998 110.248 177.735 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.606 HG23 HMA1 ' A' ' 93' ' ' HEC . 83.4 mt -62.62 -47.73 91.53 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.145 0 O-C-N 121.31 -0.868 . . . . 0.22 109.153 -177.565 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 25.3 tp -53.38 -50.07 65.87 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 109.036 -0.728 . . . . 0.41999999999999998 109.036 176.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -49.43 -55.83 11.75 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 122.701 0.4 . . . . 2.77 110.054 173.88 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.412 HD13 HBA1 ' A' ' 93' ' ' HEC . 23.2 mt -56.16 -45.45 80.83 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.366 0 C-N-CA 120.329 -0.548 . . . . 0.46999999999999997 110.69 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.554 HD11 HMB2 ' A' ' 93' ' ' HEC . 56.0 mt -58.46 -40.34 78.14 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 O-C-N 120.099 -1.626 . . . . 0.23000000000000001 109.926 178.464 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 71.9 mt -70.73 -40.61 72.65 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.359 1.064 . . . . 0.54000000000000004 113.439 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 14.8 p30 -124.29 27.16 7.14 Favored 'General case' 0 C--N 1.343 0.312 0 CA-C-N 120.899 1.681 . . . . 3.8999999999999999 110.12 -168.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.538 ' N ' ' HA2' ' A' ' 73' ' ' GLY . . . 34.2 -140.33 0.12 Allowed Glycine 0 CA--C 1.534 1.268 0 C-N-CA 128.344 2.878 . . . . 0.64000000000000001 110.999 -173.23 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 2.3 tp-100 176.87 140.58 0.07 Allowed 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 107.592 -1.262 . . . . 2.5 107.592 -179.598 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 40.97 -112.17 0.33 Allowed Glycine 0 CA--C 1.536 1.344 0 CA-C-N 119.953 1.251 . . . . 0.48999999999999999 113.782 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -79.78 -20.92 67.2 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 123.87 0.748 . . . . 0.53000000000000003 112.866 178.359 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.461 ' HB2' ' C1D' ' A' ' 93' ' ' HEC . 19.8 ttt -68.01 118.48 58.87 Favored Pre-proline 0 CA--C 1.534 0.338 0 C-N-CA 125.041 1.336 . . . . 0.34999999999999998 110.734 179.18 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.403 ' HD2' HD11 ' A' ' 75' ' ' ILE . 37.4 Cg_endo -76.42 122.05 6.34 Favored 'Trans proline' 0 N--CA 1.446 -1.293 0 C-N-CA 122.698 2.265 . . . . 2.0800000000000001 111.166 -179.393 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.538 ' HA2' ' N ' ' A' ' 67' ' ' GLY . . . -59.06 135.79 51.64 Favored Glycine 0 N--CA 1.442 -0.922 0 CA-C-N 115.364 -0.834 . . . . 0.63 114.869 -179.075 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 88.19 35.92 8.57 Favored Glycine 0 CA--C 1.53 0.97 0 CA-C-N 114.466 -0.867 . . . . 0.34999999999999998 112.368 172.114 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.403 HD11 ' HD2' ' A' ' 72' ' ' PRO . 1.3 mt -64.94 -46.88 90.33 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.863 0 C-N-CA 125.76 1.624 . . . . 1.1100000000000001 110.981 178.675 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -116.36 149.33 39.52 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 126.238 1.815 . . . . 0.46999999999999997 107.561 163.319 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.3 mtpp -144.03 162.26 36.68 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 125.973 1.709 . . . . 2.3100000000000001 108.293 178.398 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 63.68 -161.4 35.79 Favored Glycine 0 CA--C 1.529 0.966 0 N-CA-C 110.933 -0.867 . . . . 0.58999999999999997 110.933 -174.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -51.6 -27.71 12.0 Favored 'General case' 0 C--O 1.225 -0.224 0 C-N-CA 123.949 0.9 . . . . 0.56000000000000005 112.226 -177.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.498 ' O ' HG23 ' A' ' 84' ' ' VAL . 8.5 tt0 -44.63 -60.68 1.88 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.931 1.293 . . . . 2.0800000000000001 109.766 168.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -69.47 -46.19 67.24 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.838 0.855 . . . . 0.28000000000000003 110.821 -178.211 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -56.27 -49.58 73.83 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 121.231 0.539 . . . . 1.97 110.157 -176.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -55.52 -53.5 55.63 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 123.467 0.707 . . . . 0.29999999999999999 109.678 176.276 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.571 HG11 HMB1 ' A' ' 93' ' ' HEC . 89.1 t -51.37 -56.24 5.84 Favored 'Isoleucine or valine' 0 C--N 1.339 0.138 0 CA-C-N 117.826 0.284 . . . . 0.34999999999999998 110.738 178.665 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -50.66 -54.85 19.7 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 123.833 0.853 . . . . 0.20000000000000001 111.763 179.145 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -63.04 -45.11 93.84 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 121.338 0.589 . . . . 0.33000000000000002 110.995 -177.118 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 84.7 t90 -57.69 -52.74 64.2 Favored 'General case' 0 C--N 1.329 -0.286 0 O-C-N 121.701 -0.624 . . . . 0.63 109.485 177.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.77 -30.96 71.14 Favored 'General case' 0 C--O 1.222 -0.366 0 CA-C-O 118.028 -0.987 . . . . 1.97 112.714 174.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -55.88 -35.67 66.77 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 119.963 1.256 . . . . 0.40999999999999998 109.985 172.033 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -74.18 -37.51 63.92 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.002 0.521 . . . . 2.8199999999999998 111.392 173.681 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 3.5 mtpt -73.82 126.6 30.75 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 119.342 0.974 . . . . 2.1800000000000002 110.988 -178.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 19.6 mtmt . . . . . 0 C--O 1.253 1.244 0 CA-C-O 115.897 -2.001 . . . . 2.21 106.187 -174.751 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 93' ' ' HEC . . . . . 0.606 HMA1 HG23 ' A' ' 60' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.1 t . . . . . 0 N--CA 1.472 0.67 0 N-CA-C 106.638 -1.616 . . . . 1.6499999999999999 106.638 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -116.97 107.25 14.33 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 106.744 -1.576 . . . . 4.0499999999999998 106.744 178.068 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -50.27 -44.97 53.98 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 123.682 0.793 . . . . 0.32000000000000001 111.46 176.724 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -66.26 -46.94 75.34 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 107.94 -1.133 . . . . 2.75 107.94 -174.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.78 -46.64 77.9 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 122.886 0.474 . . . . 0.26000000000000001 111.175 175.711 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 75.4 t -56.58 -57.49 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 N-CA-C 109.264 -0.643 . . . . 0.37 109.264 176.554 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.556 HG13 ' HB2' ' A' ' 32' ' ' CYS . 72.2 t -53.31 -47.8 56.81 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 CA-C-N 118.05 0.386 . . . . 0.31 110.865 -177.291 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -51.38 -23.92 4.26 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 126.326 1.85 . . . . 0.55000000000000004 113.488 174.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -138.19 57.44 1.71 Allowed 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 119.354 0.979 . . . . 2.7999999999999998 110.857 172.603 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -172.04 -38.58 0.02 OUTLIER 'General case' 0 C--O 1.225 -0.231 0 C-N-CA 123.736 0.815 . . . . 1.3 110.524 168.567 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.556 ' HB2' HG13 ' A' ' 28' ' ' VAL . 3.7 m -97.5 -50.85 4.35 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 119.042 0.837 . . . . 0.22 110.26 -178.392 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.495 HG22 HD23 ' A' ' 40' ' ' LEU . 1.6 pp -57.92 -26.05 27.44 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.156 0 CA-C-N 116.202 -0.454 . . . . 0.42999999999999999 112.134 -173.587 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.422 ' N ' HD12 ' A' ' 33' ' ' ILE . 5.9 m -38.92 -36.75 0.3 Allowed 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 125.841 1.656 . . . . 1.0900000000000001 112.224 170.451 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 15.0 m -120.27 -44.72 2.47 Favored 'General case' 0 C--N 1.34 0.187 0 C-N-CA 123.356 0.662 . . . . 0.23000000000000001 111.317 174.491 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 85.7 m-70 -70.46 -7.79 46.06 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.899 0.879 . . . . 0.17000000000000001 112.946 -175.369 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 87.92 149.3 17.16 Favored Glycine 0 C--N 1.337 0.622 0 N-CA-C 109.977 -1.249 . . . . 1.48 109.977 176.348 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -45.89 -38.7 8.17 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 124.197 0.903 . . . . 0.46999999999999997 111.981 177.779 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -93.73 -1.13 55.52 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.417 1.087 . . . . 2.3900000000000001 111.563 -174.425 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.495 HD23 HG22 ' A' ' 33' ' ' ILE . 4.5 mt 70.66 12.26 7.27 Favored 'General case' 0 C--N 1.349 0.58 0 CA-C-N 120.39 1.45 . . . . 1.3 110.828 174.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.5 p -87.81 0.26 56.02 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 128.185 2.594 . . . . 0.34999999999999998 109.976 -172.499 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.56 136.25 4.42 Favored Glycine 0 N--CA 1.442 -0.916 0 N-CA-C 108.973 -1.651 . . . . 0.41999999999999998 108.973 -177.289 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -143.52 -76.9 0.24 Allowed 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 123.967 0.907 . . . . 0.25 108.78 -179.324 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 24.4 t -95.91 4.97 52.32 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.902 1.281 . . . . 1.6000000000000001 110.397 172.159 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.441 ' HB1' ' HD2' ' A' ' 46' ' ' PRO . . . -157.15 165.49 18.69 Favored Pre-proline 0 N--CA 1.451 -0.376 0 C-N-CA 125.339 1.456 . . . . 0.20999999999999999 107.936 -170.751 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.441 ' HD2' ' HB1' ' A' ' 45' ' ' ALA . 45.5 Cg_endo -70.8 159.02 53.99 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.886 2.391 . . . . 0.23000000000000001 110.71 -174.339 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.7 119.96 18.65 Favored 'General case' 0 C--N 1.332 -0.186 0 O-C-N 121.362 -0.836 . . . . 0.26000000000000001 109.941 -178.379 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 46.5 pt -101.17 2.56 10.63 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.118 0 C-N-CA 124.46 1.104 . . . . 0.28000000000000003 110.51 177.585 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.408 ' OD1' ' NZ ' ' A' ' 91' ' ' LYS . 24.6 t70 -43.51 -43.98 5.75 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 112.316 0.487 . . . . 3.0699999999999998 112.316 178.214 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -109.31 40.87 1.76 Allowed 'General case' 0 C--N 1.344 0.345 0 C-N-CA 126.294 1.838 . . . . 4.04 110.517 179.3 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.21 -48.54 81.3 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 118.968 -0.539 . . . . 0.34999999999999998 109.763 172.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -50.12 -39.28 34.03 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 123.578 0.609 . . . . 0.84999999999999998 113.578 -177.059 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.468 ' HB2' ' HG2' ' A' ' 92' ' ' LYS . . . -63.57 -41.62 98.37 Favored 'General case' 0 CA--C 1.528 0.123 0 O-C-N 122.05 -0.677 . . . . 0.81999999999999995 111.578 174.723 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 18.2 m-80 -72.21 -51.23 22.09 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 122.71 0.404 . . . . 1.7 110.196 -177.005 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -140.41 140.1 35.39 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.052 1.341 . . . . 0.70999999999999996 107.832 -167.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.82 170.34 16.64 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 118.699 0.681 . . . . 2.02 109.748 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -50.31 -42.94 53.48 Favored 'General case' 0 C--O 1.224 -0.239 0 O-C-N 121.547 -0.721 . . . . 2.96 111.898 179.208 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -54.51 -40.63 68.76 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 120.981 0.419 . . . . 2.5499999999999998 110.471 179.276 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -81.09 -45.58 16.26 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.241 1.016 . . . . 2.7599999999999998 109.76 -175.212 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.467 HG23 HMA1 ' A' ' 93' ' ' HEC . 74.9 mt -61.63 -45.94 97.59 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.059 0 O-C-N 121.039 -1.038 . . . . 0.28000000000000003 109.057 179.483 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 31.0 tp -54.2 -46.23 72.38 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 109.212 -0.662 . . . . 0.40000000000000002 109.212 177.569 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -53.02 -53.24 53.01 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 123.148 0.28 . . . . 1.4099999999999999 110.626 173.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 59.2 mt -56.24 -43.08 75.55 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 O-C-N 121.385 -0.822 . . . . 0.45000000000000001 111.414 178.095 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.415 HD11 HMB2 ' A' ' 93' ' ' HEC . 45.4 mt -62.46 -45.29 99.14 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 O-C-N 120.07 -1.644 . . . . 0.28999999999999998 109.677 179.072 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 76.5 mt -72.92 -28.9 62.73 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.425 1.09 . . . . 0.44 113.042 -177.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -127.19 17.44 7.16 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 119.614 1.097 . . . . 1.71 110.331 -166.096 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.56 ' N ' ' HA2' ' A' ' 73' ' ' GLY . . . 36.41 -146.99 0.06 OUTLIER Glycine 0 CA--C 1.539 1.536 0 C-N-CA 128.65 3.024 . . . . 0.66000000000000003 112.216 -170.609 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 176.31 131.38 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 118.809 1.304 . . . . 1.21 108.907 -175.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 39.78 -117.13 0.77 Allowed Glycine 0 CA--C 1.532 1.152 0 CA-C-N 119.938 1.245 . . . . 0.37 113.16 -175.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -69.6 -20.64 75.81 Favored Glycine 0 CA--C 1.534 1.236 0 CA-C-N 117.481 0.641 . . . . 0.45000000000000001 113.402 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.44 ' HB2' ' C1D' ' A' ' 93' ' ' HEC . 20.5 ttt -71.94 120.45 80.2 Favored Pre-proline 0 N--CA 1.452 -0.362 0 C-N-CA 124.536 1.134 . . . . 0.38 110.821 -178.443 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -76.54 128.25 10.17 Favored 'Trans proline' 0 N--CA 1.444 -1.43 0 C-N-CA 122.241 1.96 . . . . 2.0699999999999998 110.434 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.56 ' HA2' ' N ' ' A' ' 67' ' ' GLY . . . -63.27 135.65 42.66 Favored Glycine 0 N--CA 1.443 -0.884 0 CA-C-N 115.627 -0.715 . . . . 0.71999999999999997 114.691 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 82.78 41.36 8.88 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.648 -0.981 . . . . 0.44 110.648 176.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -60.34 -51.18 75.96 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 N-CA-C 108.765 -0.828 . . . . 2.02 108.765 174.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -105.74 156.82 17.92 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.746 1.618 . . . . 0.39000000000000001 109.648 166.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.3 mmtm -144.86 157.68 44.07 Favored 'General case' 0 C--O 1.227 -0.104 0 C-N-CA 125.166 1.387 . . . . 3.3300000000000001 108.038 178.669 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 67.37 -166.31 42.07 Favored Glycine 0 CA--C 1.531 1.046 0 N-CA-C 111.379 -0.688 . . . . 1.0 111.379 -173.465 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -51.32 -27.55 9.87 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.717 1.207 . . . . 0.56999999999999995 112.27 -179.435 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -37.69 -59.82 0.77 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.678 1.591 . . . . 1.8899999999999999 111.191 165.586 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.76 -49.12 69.52 Favored 'General case' 0 CA--C 1.531 0.215 0 O-C-N 121.937 -0.477 . . . . 0.22 111.128 -177.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -52.47 -54.62 30.01 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.568 1.147 . . . . 2.6000000000000001 111.055 -178.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -54.72 -51.56 65.22 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.145 0.978 . . . . 0.23999999999999999 109.82 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.518 HG22 HG23 ' A' ' 28' ' ' VAL . 54.7 t -54.12 -56.54 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 CA-C-N 116.933 -0.121 . . . . 0.28999999999999998 111.165 177.478 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -51.71 -50.48 60.45 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 123.009 0.523 . . . . 0.20000000000000001 111.831 179.485 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.437 ' O ' ' HB3' ' A' ' 89' ' ' ALA . . . -59.44 -48.71 80.59 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 121.689 0.756 . . . . 0.29999999999999999 110.581 -179.45 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.495 ' HZ3' HG21 ' A' ' 28' ' ' VAL . 54.4 t90 -58.72 -44.26 90.36 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.08 0.552 . . . . 0.53000000000000003 110.492 178.058 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.487 HD23 ' CE3' ' A' ' 87' ' ' TRP . 0.1 OUTLIER -63.11 -38.47 91.29 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.529 1.132 . . . . 1.6799999999999999 110.476 177.26 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.437 ' HB3' ' O ' ' A' ' 86' ' ' ALA . . . -52.34 -49.77 63.63 Favored 'General case' 0 C--O 1.23 0.063 0 N-CA-C 109.468 -0.567 . . . . 0.44 109.468 171.073 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -84.7 35.65 0.57 Allowed 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 116.434 -0.348 . . . . 3.5899999999999999 111.601 175.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.408 ' NZ ' ' OD1' ' A' ' 49' ' ' ASP . 0.5 OUTLIER -130.21 142.12 50.59 Favored 'General case' 0 C--N 1.343 0.311 0 O-C-N 121.171 -0.955 . . . . 2.9300000000000002 110.651 165.09 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.468 ' HG2' ' HB2' ' A' ' 53' ' ' ALA . 16.9 mtmt . . . . . 0 C--O 1.252 1.219 0 C-N-CA 128.82 2.848 . . . . 2.71 105.413 -178.381 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' HEC . . . . . 0.467 HMA1 HG23 ' A' ' 60' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.5 t . . . . . 0 N--CA 1.471 0.593 0 N-CA-C 107.446 -1.316 . . . . 1.3100000000000001 107.446 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -76.8 106.63 8.58 Favored 'General case' 0 N--CA 1.449 -0.511 0 O-C-N 124.053 0.845 . . . . 2.79 109.339 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -44.91 -52.26 8.85 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.124 0.969 . . . . 0.31 111.124 174.238 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -53.92 -44.83 70.92 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 116.632 -0.258 . . . . 3.4399999999999999 111.456 177.069 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.89 -44.64 92.41 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 123.232 0.613 . . . . 0.31 110.44 -178.158 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 89.7 t -58.33 -54.66 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 N-CA-C 109.236 -0.653 . . . . 0.40999999999999998 109.236 175.622 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.462 HG21 ' CZ3' ' A' ' 87' ' ' TRP . 53.9 t -52.54 -49.01 46.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 C-N-CA 122.53 0.332 . . . . 0.32000000000000001 110.348 -178.445 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 24.4 mm-40 -52.52 -19.68 2.42 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 126.763 2.025 . . . . 0.63 114.248 174.127 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.43 48.6 1.18 Allowed 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 119.877 1.217 . . . . 3.2000000000000002 111.994 176.249 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.407 ' NZ ' ' OE2' ' A' ' 80' ' ' GLU . 0.5 OUTLIER -162.46 -39.7 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 124.415 1.086 . . . . 1.5 110.314 169.154 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.433 ' SG ' ' HA ' ' A' ' 28' ' ' VAL . 3.4 m -97.21 -49.05 5.11 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 118.845 0.748 . . . . 0.20000000000000001 110.383 -176.017 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.461 HD12 ' N ' ' A' ' 34' ' ' SER . 1.8 pp -58.01 -26.44 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 CA-C-N 115.819 -0.628 . . . . 0.5 112.148 -173.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.461 ' N ' HD12 ' A' ' 33' ' ' ILE . 68.0 m -37.38 -39.19 0.27 Allowed 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 125.234 1.414 . . . . 0.96999999999999997 112.451 168.757 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 9.9 m -120.29 -41.16 2.63 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 122.818 0.447 . . . . 0.20999999999999999 111.92 176.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 85.4 m-70 -71.63 -10.02 59.14 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.628 0.771 . . . . 0.23999999999999999 112.6 -177.536 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 86.34 149.5 13.89 Favored Glycine 0 C--N 1.337 0.625 0 N-CA-C 109.783 -1.327 . . . . 1.52 109.783 179.26 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -44.42 -37.83 4.95 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 124.53 1.062 . . . . 0.42999999999999999 112.103 175.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -93.22 -4.54 51.77 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.193 0.997 . . . . 2.3700000000000001 111.788 -173.61 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.4 mt 70.3 10.84 7.39 Favored 'General case' 0 C--N 1.349 0.583 0 CA-C-N 120.513 1.506 . . . . 1.0900000000000001 111.297 176.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.9 p -84.84 -0.66 54.72 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 127.801 2.44 . . . . 0.32000000000000001 109.957 -175.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.86 137.66 5.09 Favored Glycine 0 N--CA 1.44 -1.057 0 N-CA-C 108.885 -1.686 . . . . 0.44 108.885 -175.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -143.6 -79.77 0.2 Allowed 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 124.332 1.053 . . . . 0.28999999999999998 108.827 176.692 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -88.6 2.5 52.99 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.377 1.071 . . . . 0.95999999999999996 110.756 171.707 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.583 ' HB1' ' HD2' ' A' ' 46' ' ' PRO . . . -157.14 169.52 10.48 Favored Pre-proline 0 N--CA 1.451 -0.378 0 C-N-CA 124.518 1.127 . . . . 0.23000000000000001 108.629 -172.603 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.583 ' HD2' ' HB1' ' A' ' 45' ' ' ALA . 38.0 Cg_endo -70.08 158.69 55.71 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.973 2.448 . . . . 0.25 110.506 -174.704 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.68 124.41 25.93 Favored 'General case' 0 C--N 1.332 -0.177 0 O-C-N 121.512 -0.743 . . . . 0.31 110.181 -177.198 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 45.1 pt -102.02 0.36 10.29 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.158 0 CA-C-O 118.885 -0.579 . . . . 0.39000000000000001 111.419 175.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.483 ' OD1' ' NZ ' ' A' ' 91' ' ' LYS . 37.9 t70 -44.35 -36.96 3.05 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 113.605 0.965 . . . . 3.2799999999999998 113.605 178.005 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.4 ptpt -108.33 19.01 20.38 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.695 1.598 . . . . 3.7599999999999998 112.015 -178.558 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -55.54 -45.26 77.22 Favored 'General case' 0 N--CA 1.455 -0.198 0 O-C-N 121.228 -0.92 . . . . 0.35999999999999999 110.297 -172.48 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -51.16 -31.66 26.9 Favored Glycine 0 CA--C 1.523 0.582 0 C-N-CA 123.461 0.553 . . . . 0.59999999999999998 114.26 179.567 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.08 -39.59 49.16 Favored 'General case' 0 N--CA 1.454 -0.273 0 O-C-N 122.036 -0.685 . . . . 0.72999999999999998 110.046 176.304 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -66.24 -47.84 72.45 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.559 0.743 . . . . 2.2200000000000002 111.22 -178.842 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -141.34 148.16 39.26 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.743 1.617 . . . . 0.95999999999999996 107.971 -171.068 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 88.7 p -74.66 170.96 14.76 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 119.144 0.883 . . . . 2.4900000000000002 110.692 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -49.13 -42.1 38.29 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 123.118 0.567 . . . . 2.7000000000000002 111.187 173.514 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -62.49 -45.24 93.92 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 123.315 0.646 . . . . 2.77 109.55 -177.271 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -70.96 -47.15 60.59 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 108.362 -0.977 . . . . 2.79 108.362 -175.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.537 HG23 HMA1 ' A' ' 93' ' ' HEC . 91.2 mt -59.97 -46.21 94.36 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 O-C-N 121.672 -0.643 . . . . 0.28999999999999998 109.403 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 58.4 tp -55.53 -50.1 70.89 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 109.127 -0.694 . . . . 0.44 109.127 176.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -52.7 -44.85 66.57 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 117.985 0.357 . . . . 1.95 111.341 178.023 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 79.6 mt -59.5 -56.7 15.44 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.288 0 C-N-CA 120.381 -0.528 . . . . 0.76000000000000001 109.7 174.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.602 HD11 HMB2 ' A' ' 93' ' ' HEC . 69.9 mt -50.0 -41.65 18.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 O-C-N 120.655 -1.278 . . . . 0.23999999999999999 110.87 -178.417 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 73.5 mt -70.98 -34.25 71.22 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.276 1.03 . . . . 0.44 113.619 178.449 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 48.1 m-80 -123.36 20.67 9.64 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 120.499 1.5 . . . . 1.78 110.59 -167.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.565 ' N ' ' HA2' ' A' ' 73' ' ' GLY . . . 29.27 -138.77 0.03 OUTLIER Glycine 0 CA--C 1.535 1.338 0 C-N-CA 128.961 3.172 . . . . 0.62 111.722 -164.031 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 173.98 130.18 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 119.119 1.46 . . . . 1.5700000000000001 109.22 -178.599 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 43.23 -116.36 1.3 Allowed Glycine 0 CA--C 1.531 1.034 0 CA-C-N 119.719 1.145 . . . . 0.41999999999999998 112.883 -177.123 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -70.65 -18.61 75.86 Favored Glycine 0 CA--C 1.531 1.079 0 O-C-N 122.374 -0.486 . . . . 0.47999999999999998 113.16 -179.635 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.44 ' HB2' ' C1D' ' A' ' 93' ' ' HEC . 22.3 ttt -75.95 118.7 73.06 Favored Pre-proline 0 N--CA 1.45 -0.43 0 C-N-CA 124.52 1.128 . . . . 0.39000000000000001 110.629 -178.234 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -75.65 119.41 5.45 Favored 'Trans proline' 0 N--CA 1.445 -1.369 0 C-N-CA 122.446 2.098 . . . . 2.1000000000000001 111.286 -178.674 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.565 ' HA2' ' N ' ' A' ' 67' ' ' GLY . . . -58.66 138.13 49.59 Favored Glycine 0 N--CA 1.44 -1.083 0 CA-C-N 115.257 -0.883 . . . . 0.60999999999999999 114.594 -179.299 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 76.06 50.13 7.97 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.19 -1.164 . . . . 0.83999999999999997 110.19 177.288 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.418 HD13 HMC2 ' A' ' 93' ' ' HEC . 1.7 mt -72.61 -62.33 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 124.901 1.28 . . . . 1.02 108.889 168.716 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -103.45 158.44 16.35 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.919 1.288 . . . . 0.31 109.261 168.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.1 mttt -142.54 171.28 14.27 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 126.175 1.79 . . . . 4.3200000000000003 109.702 177.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 54.55 -149.72 18.6 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 111.698 -0.561 . . . . 0.76000000000000001 111.698 175.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -52.13 -32.21 34.54 Favored 'General case' 0 C--N 1.339 0.149 0 C-N-CA 122.983 0.513 . . . . 0.82999999999999996 111.435 172.239 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.407 ' OE2' ' NZ ' ' A' ' 31' ' ' LYS . 6.8 tt0 -53.6 -43.39 68.57 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 110.032 -0.358 . . . . 1.9099999999999999 110.032 176.009 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -84.57 -50.63 7.53 Favored 'General case' 0 CA--C 1.53 0.204 0 O-C-N 121.79 -0.569 . . . . 0.26000000000000001 111.911 176.486 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -53.93 -50.9 65.4 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 118.591 0.632 . . . . 2.4300000000000002 111.549 -177.169 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.63 -46.36 84.25 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 109.361 -0.607 . . . . 0.26000000000000001 109.361 -179.307 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.407 HG22 HG23 ' A' ' 28' ' ' VAL . 53.8 t -57.19 -57.42 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 C-N-CA 122.913 0.485 . . . . 0.34000000000000002 110.955 177.841 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -48.29 -53.13 18.36 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 123.516 0.727 . . . . 0.17000000000000001 111.638 176.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -64.01 -44.31 93.0 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 121.329 0.585 . . . . 0.31 111.548 -178.143 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.462 ' CZ3' HG21 ' A' ' 28' ' ' VAL . 76.9 t90 -58.2 -49.43 77.08 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 121.493 -0.754 . . . . 0.52000000000000002 109.425 177.286 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.6 -29.01 70.31 Favored 'General case' 0 C--O 1.222 -0.381 0 CA-C-O 118.374 -0.822 . . . . 1.8500000000000001 112.977 173.654 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.58 -36.45 71.73 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 119.697 1.135 . . . . 0.35999999999999999 110.299 170.487 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -73.74 -37.33 65.11 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 119.255 -0.402 . . . . 2.8999999999999999 111.51 172.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.483 ' NZ ' ' OD1' ' A' ' 49' ' ' ASP . 8.5 mtpm? -72.81 114.18 10.67 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 119.039 0.836 . . . . 2.1800000000000002 111.478 178.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 75.0 mttt . . . . . 0 C--O 1.252 1.197 0 CA-C-O 116.372 -1.775 . . . . 2.5800000000000001 108.004 -174.924 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 93' ' ' HEC . . . . . 0.602 HMB2 HD11 ' A' ' 64' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.8 t . . . . . 0 N--CA 1.468 0.441 0 N-CA-C 106.762 -1.57 . . . . 1.1499999999999999 106.762 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -74.71 97.25 3.18 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 123.937 0.895 . . . . 2.8900000000000001 109.349 -169.013 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -45.68 -54.37 7.91 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 124.932 1.293 . . . . 0.38 111.664 -178.093 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -51.44 -51.58 53.69 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 122.998 0.519 . . . . 3.48 111.653 175.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.39 -45.59 93.0 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 118.586 0.63 . . . . 0.39000000000000001 110.84 -177.601 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 72.1 t -58.14 -55.67 20.68 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 N-CA-C 109.178 -0.675 . . . . 0.60999999999999999 109.178 177.13 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.607 HG13 ' HB2' ' A' ' 32' ' ' CYS . 39.4 t -53.21 -48.67 54.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 C-N-CA 124.149 0.979 . . . . 0.41999999999999998 109.944 -179.051 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 10.4 mm100 -50.86 -19.37 0.97 Allowed 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 125.706 1.602 . . . . 0.59999999999999998 112.958 175.345 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -142.56 44.57 1.62 Allowed 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 119.126 0.875 . . . . 2.4199999999999999 111.787 173.55 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -157.36 -39.98 0.07 Allowed 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 124.792 1.237 . . . . 1.23 111.428 168.501 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.607 ' HB2' HG13 ' A' ' 28' ' ' VAL . 4.5 m -96.6 -50.29 4.78 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 119.445 1.021 . . . . 0.20000000000000001 110.657 -177.81 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.4 pp -59.14 -24.89 28.52 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 CA-C-N 116.067 -0.515 . . . . 0.47999999999999998 111.889 -174.13 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 21.7 m -41.47 -35.79 0.76 Allowed 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 125.036 1.334 . . . . 1.04 112.455 172.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 24.3 m -119.2 -42.71 2.66 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 122.911 0.484 . . . . 0.25 111.328 175.331 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 84.2 m-70 -72.88 -9.54 58.81 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 113.074 0.768 . . . . 0.27000000000000002 113.074 -175.551 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 87.1 149.75 16.25 Favored Glycine 0 C--N 1.337 0.611 0 N-CA-C 109.997 -1.241 . . . . 1.6299999999999999 109.997 178.51 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -45.35 -39.21 7.21 Favored Glycine 0 C--N 1.34 0.767 0 C-N-CA 124.348 0.975 . . . . 0.46999999999999997 111.936 178.236 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -94.67 -2.31 51.49 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.595 1.158 . . . . 3.21 111.452 -173.432 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.4 mt 72.31 11.09 5.86 Favored 'General case' 0 C--N 1.352 0.698 0 O-C-N 120.722 -1.236 . . . . 1.22 110.798 174.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 13.6 p -83.51 -0.37 49.93 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 127.865 2.466 . . . . 0.39000000000000001 110.331 -174.216 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.5 147.84 17.25 Favored Glycine 0 N--CA 1.44 -1.067 0 N-CA-C 108.726 -1.75 . . . . 0.48999999999999999 108.726 -173.354 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -151.79 -73.1 0.15 Allowed 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.15 0.98 . . . . 0.34999999999999998 109.465 177.142 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.3 m -100.49 4.37 43.6 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.699 1.6 . . . . 1.0 110.756 171.266 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.426 ' HB1' ' HD2' ' A' ' 46' ' ' PRO . . . -155.59 164.88 19.75 Favored Pre-proline 0 N--CA 1.451 -0.405 0 C-N-CA 125.369 1.467 . . . . 0.22 107.636 -170.53 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.426 ' HD2' ' HB1' ' A' ' 45' ' ' ALA . 51.7 Cg_endo -68.88 159.72 52.71 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.837 2.358 . . . . 0.22 110.385 -176.063 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.11 127.15 31.75 Favored 'General case' 0 C--N 1.332 -0.189 0 O-C-N 121.937 -0.477 . . . . 0.32000000000000001 109.808 -177.573 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 45.8 pt -107.85 2.02 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 C-N-CA 123.971 0.909 . . . . 0.29999999999999999 111.488 176.256 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -35.22 -45.43 0.3 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.597 1.559 . . . . 3.9900000000000002 112.623 168.028 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -113.16 28.24 8.95 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 125.552 1.541 . . . . 3.5600000000000001 111.721 -178.351 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.7 -44.58 85.97 Favored 'General case' 0 N--CA 1.451 -0.389 0 O-C-N 121.57 -0.706 . . . . 0.26000000000000001 109.236 175.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -54.5 -29.61 48.05 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 123.755 0.693 . . . . 0.48999999999999999 114.472 -176.369 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -76.57 -43.68 37.89 Favored 'General case' 0 N--CA 1.457 -0.102 0 O-C-N 121.786 -0.832 . . . . 0.79000000000000004 110.544 174.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 40.5 m-80 -66.81 -47.63 71.46 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 122.662 0.385 . . . . 1.54 110.665 -177.2 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -136.84 133.71 36.15 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 126.022 1.729 . . . . 0.69999999999999996 107.089 -168.156 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.5 p -74.78 171.87 13.18 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 119.179 0.899 . . . . 1.8 110.268 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -48.9 -45.24 41.04 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 123.476 0.71 . . . . 2.8300000000000001 111.764 178.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -59.24 -32.32 69.88 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.352 0.661 . . . . 3.02 111.795 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -86.89 -44.33 11.76 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 121.808 -0.557 . . . . 2.8799999999999999 110.266 -178.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 45.3 mt -56.96 -46.49 83.95 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 N-CA-C 109.251 -0.648 . . . . 0.31 109.251 176.014 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 57.9 tp -54.41 -49.69 69.33 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 109.166 -0.679 . . . . 0.40999999999999998 109.166 178.585 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -52.44 -49.26 64.93 Favored 'General case' 0 N--CA 1.451 -0.401 0 O-C-N 123.195 0.309 . . . . 1.46 110.652 178.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 31.5 mt -57.77 -53.1 49.4 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.267 0 O-C-N 121.529 -0.732 . . . . 0.55000000000000004 110.677 175.086 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.642 HD11 HMB2 ' A' ' 93' ' ' HEC . 96.8 mt -51.62 -42.64 30.78 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 O-C-N 120.645 -1.284 . . . . 0.28000000000000003 110.706 179.398 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 82.8 mt -72.77 -36.13 67.59 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.065 0.946 . . . . 0.40000000000000002 113.141 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -116.63 15.59 15.5 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 119.82 1.191 . . . . 1.6000000000000001 110.165 -165.427 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.553 ' N ' ' HA2' ' A' ' 73' ' ' GLY . . . 31.31 -141.74 0.03 OUTLIER Glycine 0 CA--C 1.533 1.187 0 C-N-CA 128.21 2.814 . . . . 0.62 111.389 -162.506 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 1.7 tp60 176.51 136.28 0.06 Allowed 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 118.621 1.21 . . . . 1.5800000000000001 107.933 -175.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 42.38 -118.19 1.62 Allowed Glycine 0 CA--C 1.536 1.357 0 CA-C-N 120.584 1.538 . . . . 0.41999999999999998 113.384 -179.336 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -74.51 -18.23 79.93 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 124.038 0.828 . . . . 0.60999999999999999 113.007 178.459 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.455 ' HB2' ' C1D' ' A' ' 93' ' ' HEC . 19.3 ttt -71.86 118.19 64.54 Favored Pre-proline 0 N--CA 1.452 -0.374 0 C-N-CA 124.859 1.264 . . . . 0.40999999999999998 110.414 179.694 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.46 ' HD2' HD11 ' A' ' 75' ' ' ILE . 43.9 Cg_endo -78.18 122.57 5.76 Favored 'Trans proline' 0 N--CA 1.444 -1.388 0 C-N-CA 122.782 2.322 . . . . 2.1200000000000001 110.925 -178.187 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.553 ' HA2' ' N ' ' A' ' 67' ' ' GLY . . . -58.84 138.17 49.72 Favored Glycine 0 N--CA 1.442 -0.907 0 CA-C-N 115.27 -0.877 . . . . 0.63 114.999 -178.48 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 83.4 35.44 17.31 Favored Glycine 0 CA--C 1.528 0.856 0 CA-C-N 114.072 -1.064 . . . . 0.32000000000000001 111.758 174.345 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.46 HD11 ' HD2' ' A' ' 72' ' ' PRO . 1.2 mt -57.61 -52.96 50.79 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 125.196 1.398 . . . . 1.25 109.859 174.78 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -101.08 151.32 21.96 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.317 1.447 . . . . 0.35999999999999999 108.991 164.411 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.4 mtpm? -143.43 155.75 44.47 Favored 'General case' 0 C--N 1.34 0.157 0 C-N-CA 124.323 1.049 . . . . 3.5099999999999998 109.317 173.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.29 -170.28 54.79 Favored Glycine 0 CA--C 1.528 0.845 0 N-CA-C 110.108 -1.197 . . . . 0.89000000000000001 110.108 -175.036 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -51.38 -25.97 7.01 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.243 1.017 . . . . 1.24 112.232 179.391 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -39.86 -58.85 1.29 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.92 1.288 . . . . 2.1000000000000001 110.634 166.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.23 -47.76 84.6 Favored 'General case' 0 CA--C 1.531 0.247 0 O-C-N 122.071 -0.393 . . . . 0.46999999999999997 110.893 -174.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -50.68 -56.49 11.66 Favored 'General case' 0 C--N 1.338 0.094 0 C-N-CA 123.829 0.852 . . . . 3.0499999999999998 110.852 174.018 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -54.4 -49.51 69.73 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 123.139 0.575 . . . . 0.31 110.132 -178.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.442 HG13 ' CG2' ' A' ' 28' ' ' VAL . 85.6 t -56.94 -54.92 23.74 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-N 117.523 0.147 . . . . 0.40000000000000002 111.176 177.735 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -51.69 -51.49 55.62 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 123.676 0.79 . . . . 0.25 111.733 178.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.4 -46.56 89.53 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 124.175 0.99 . . . . 0.32000000000000001 110.546 -179.376 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.531 ' CE3' HD23 ' A' ' 88' ' ' LEU . 46.6 t90 -57.25 -48.31 79.17 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 109.588 -0.523 . . . . 0.46000000000000002 109.588 175.808 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.531 HD23 ' CE3' ' A' ' 87' ' ' TRP . 0.1 OUTLIER -60.49 -33.94 73.33 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.179 0.992 . . . . 1.6200000000000001 111.59 176.905 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -54.62 -37.44 65.62 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 118.551 0.614 . . . . 0.47999999999999998 110.936 172.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -94.76 22.04 6.8 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.798 0.839 . . . . 2.9500000000000002 111.958 175.55 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 2.7 mtpm? -113.38 119.62 38.28 Favored 'General case' 0 C--N 1.342 0.24 0 O-C-N 121.122 -0.986 . . . . 2.1600000000000001 109.094 169.57 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 89.1 mttt . . . . . 0 C--O 1.257 1.462 0 C-N-CA 129.451 3.1 . . . . 2.7799999999999998 104.116 -178.274 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 93' ' ' HEC . . . . . 0.642 HMB2 HD11 ' A' ' 64' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.1 t . . . . . 0 N--CA 1.469 0.524 0 N-CA-C 106.473 -1.677 . . . . 1.3899999999999999 106.473 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -107.95 100.03 9.42 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 106.968 -1.493 . . . . 2.1499999999999999 106.968 -168.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -41.38 -54.22 3.11 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 124.682 1.193 . . . . 0.32000000000000001 110.9 179.425 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -58.2 -47.21 84.16 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 115.239 -0.891 . . . . 2.6000000000000001 110.258 -179.311 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.26 -45.8 92.02 Favored 'General case' 0 C--N 1.339 0.111 0 C-N-CA 122.935 0.494 . . . . 0.26000000000000001 111.135 -179.55 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 81.9 t -56.58 -54.25 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 N-CA-C 108.766 -0.828 . . . . 0.34000000000000002 108.766 177.593 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.627 HG22 ' SG ' ' A' ' 32' ' ' CYS . 22.8 t -53.78 -49.69 56.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 CA-C-N 117.742 0.246 . . . . 0.35999999999999999 111.237 178.858 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 27.6 mm-40 -54.87 -14.85 1.59 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.1 1.76 . . . . 0.58999999999999997 113.285 174.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 14.1 mt-30 -136.36 44.05 2.44 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 119.795 1.179 . . . . 3.48 112.617 169.594 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.28 -58.61 0.05 Allowed 'General case' 0 CA--C 1.519 -0.244 0 O-C-N 121.782 -0.574 . . . . 1.5700000000000001 109.799 168.613 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.627 ' SG ' HG22 ' A' ' 28' ' ' VAL . 2.8 m -75.63 -48.14 23.48 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 109.938 -0.393 . . . . 0.17000000000000001 109.938 -171.766 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.0 pp -50.01 -32.77 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.14 0 C-N-CA 123.449 0.7 . . . . 0.67000000000000004 112.435 -178.581 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.4 m -44.08 -35.34 2.1 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 125.076 1.35 . . . . 1.05 112.033 178.191 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.4 ' SG ' HMC1 ' A' ' 93' ' ' HEC . 13.1 m -119.36 -41.76 2.7 Favored 'General case' 0 CA--C 1.53 0.207 0 O-C-N 123.522 0.514 . . . . 0.17999999999999999 111.922 175.319 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 79.6 m-70 -70.35 -9.01 55.0 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.028 0.931 . . . . 0.22 112.481 -178.02 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 85.56 148.64 10.99 Favored Glycine 0 C--N 1.337 0.621 0 N-CA-C 109.224 -1.55 . . . . 1.45 109.224 -179.432 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -43.02 -33.25 1.7 Allowed Glycine 0 CA--C 1.53 0.989 0 C-N-CA 124.496 1.046 . . . . 0.52000000000000002 112.687 173.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -94.98 -10.01 32.25 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.986 1.315 . . . . 2.3300000000000001 111.613 -172.12 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 70.63 11.75 7.27 Favored 'General case' 0 C--N 1.347 0.467 0 CA-C-N 120.263 1.392 . . . . 1.4399999999999999 111.255 178.357 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 10.4 p -85.43 -2.29 57.95 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 127.808 2.443 . . . . 0.33000000000000002 109.986 -177.38 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.93 145.3 12.66 Favored Glycine 0 N--CA 1.437 -1.261 0 N-CA-C 108.648 -1.781 . . . . 0.42999999999999999 108.648 -174.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -152.52 -80.34 0.1 Allowed 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 124.758 1.223 . . . . 0.25 109.043 177.333 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 17.0 m -91.46 4.02 53.54 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.457 1.103 . . . . 1.1399999999999999 111.14 170.438 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -153.4 163.68 22.93 Favored Pre-proline 0 N--CA 1.45 -0.439 0 C-N-CA 126.065 1.746 . . . . 0.31 107.554 -172.628 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -70.51 161.52 45.75 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 123.128 2.552 . . . . 0.27000000000000002 110.59 -176.276 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -74.06 124.01 25.45 Favored 'General case' 0 N--CA 1.454 -0.268 0 O-C-N 121.577 -0.702 . . . . 0.26000000000000001 110.235 -176.425 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 44.6 pt -104.44 2.45 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 CA-C-O 119.055 -0.498 . . . . 0.28000000000000003 111.564 176.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -40.33 -52.64 2.68 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 112.985 0.735 . . . . 2.6800000000000002 112.985 176.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.26 21.49 11.87 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 126.3 1.84 . . . . 5.3499999999999996 110.653 -175.826 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -54.19 -39.5 66.71 Favored 'General case' 0 N--CA 1.453 -0.307 0 O-C-N 121.506 -0.746 . . . . 0.27000000000000002 110.146 -178.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -54.8 -24.95 35.15 Favored Glycine 0 CA--C 1.53 1.022 0 N-CA-C 114.603 0.601 . . . . 0.52000000000000002 114.603 176.314 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -78.95 -36.95 40.84 Favored 'General case' 0 C--N 1.338 0.097 0 CA-C-N 118.616 1.208 . . . . 0.83999999999999997 110.278 174.516 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -73.91 -47.85 34.89 Favored 'General case' 0 N--CA 1.457 -0.078 0 C-N-CA 122.515 0.326 . . . . 1.9199999999999999 110.326 -177.368 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -139.96 149.04 42.8 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.47 1.108 . . . . 0.68000000000000005 108.689 -168.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.92 168.32 18.03 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 109.614 -0.514 . . . . 1.9299999999999999 109.614 178.446 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -48.2 -43.52 32.02 Favored 'General case' 0 C--O 1.226 -0.179 0 C-N-CA 124.43 1.092 . . . . 2.7999999999999998 111.553 178.558 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -53.2 -47.69 68.69 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.654 0.782 . . . . 2.75 110.481 178.581 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -74.56 -45.69 43.83 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.78 0.832 . . . . 3.25 109.575 -175.399 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 58.6 mt -59.55 -44.16 92.5 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 N-CA-C 109.194 -0.669 . . . . 0.28000000000000003 109.194 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 31.3 tp -54.77 -54.38 42.82 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 123.468 0.707 . . . . 0.37 109.38 175.217 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -52.07 -49.48 63.45 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 123.107 0.254 . . . . 1.48 111.2 178.668 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 57.6 mt -55.16 -55.49 16.16 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.155 0 O-C-N 121.564 -0.71 . . . . 0.65000000000000002 110.558 176.437 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 57.8 mt -49.15 -46.75 17.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 O-C-N 121.191 -0.943 . . . . 0.26000000000000001 110.199 178.179 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 91.7 mt -66.11 -33.3 75.46 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 113.932 1.086 . . . . 0.39000000000000001 113.932 179.496 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -128.97 24.13 5.65 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 120.37 1.441 . . . . 1.8200000000000001 110.641 -163.087 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 23.75 -136.97 0.01 OUTLIER Glycine 0 CA--C 1.543 1.791 0 C-N-CA 127.702 2.572 . . . . 0.67000000000000004 112.808 -159.484 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 170.46 139.13 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 126.483 1.913 . . . . 1.3 107.603 -175.19 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 23.78 -106.2 0.01 OUTLIER Glycine 0 CA--C 1.535 1.316 0 C-N-CA 126.386 1.945 . . . . 0.56999999999999995 115.029 -170.128 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.26 -29.05 74.33 Favored Glycine 0 CA--C 1.533 1.187 0 CA-C-N 118.271 1.036 . . . . 0.70999999999999996 113.169 -177.625 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 4.6 ttt -67.32 126.19 92.18 Favored Pre-proline 0 CA--C 1.542 0.635 0 C-N-CA 125.053 1.341 . . . . 0.57999999999999996 110.688 -179.109 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -62.66 -57.2 0.47 Allowed 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 123.893 3.062 . . . . 3.0299999999999998 111.144 -174.181 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 118.14 149.92 8.87 Favored Glycine 0 C--N 1.334 0.471 0 C-N-CA 123.925 0.774 . . . . 0.87 113.536 174.681 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 69.06 23.21 76.14 Favored Glycine 0 CA--C 1.531 1.06 0 CA-C-N 115.156 -0.522 . . . . 0.40000000000000002 111.852 178.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.6 mt -56.32 -49.29 77.41 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.919 0 C-N-CA 126.12 1.768 . . . . 1.0700000000000001 111.267 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -109.71 161.22 15.62 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.133 0.973 . . . . 0.38 108.589 160.331 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -146.42 172.72 13.1 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.082 0.953 . . . . 3.46 109.198 173.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 54.18 -147.06 22.78 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 123.336 0.494 . . . . 0.76000000000000001 112.015 176.252 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -47.47 -41.03 19.77 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.19 0.996 . . . . 0.73999999999999999 111.23 175.601 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -53.07 -44.43 67.49 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.889 1.276 . . . . 2.7400000000000002 110.799 177.284 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -79.18 -49.97 11.71 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 121.759 -0.588 . . . . 0.20999999999999999 111.487 176.188 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -51.4 -54.39 27.16 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 124.027 0.931 . . . . 2.1899999999999999 111.691 -178.105 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.24 -47.59 83.06 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.824 -0.435 . . . . 0.25 109.824 -177.155 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.412 HG22 HG23 ' A' ' 28' ' ' VAL . 53.8 t -56.72 -53.96 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 C-N-CA 123.442 0.697 . . . . 0.28999999999999998 110.748 177.538 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -52.19 -51.86 55.58 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 123.896 0.878 . . . . 0.17999999999999999 111.915 176.417 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.26 -50.59 73.04 Favored 'General case' 0 C--N 1.333 -0.116 0 C-N-CA 123.192 0.597 . . . . 0.32000000000000001 110.204 -179.589 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.506 ' CE3' HD23 ' A' ' 88' ' ' LEU . 50.0 t90 -56.59 -46.43 80.83 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.622 0.769 . . . . 0.53000000000000003 110.49 177.782 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.506 HD23 ' CE3' ' A' ' 87' ' ' TRP . 0.1 OUTLIER -63.15 -38.8 92.6 Favored 'General case' 0 C--O 1.224 -0.282 0 O-C-N 121.416 -0.803 . . . . 1.6499999999999999 109.88 178.269 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -62.26 -42.31 99.22 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 118.723 0.692 . . . . 0.5 110.683 174.038 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -55.74 -45.46 78.02 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 121.843 -0.535 . . . . 3.6000000000000001 110.61 169.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 4.1 mtmp? -74.93 100.29 4.07 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 118.921 0.782 . . . . 2.8900000000000001 111.553 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 9.7 ptpp? . . . . . 0 C--O 1.25 1.095 0 N-CA-C 106.869 -1.53 . . . . 2.7799999999999998 106.869 174.311 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 93' ' ' HEC . . . . . 0.434 HMB1 ' SG ' ' A' ' 32' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 10.5 t . . . . . 0 N--CA 1.469 0.514 0 N-CA-C 105.873 -1.899 . . . . 1.6299999999999999 105.873 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -125.04 97.38 5.23 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 105.787 -1.931 . . . . 2.75 105.787 -166.385 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -41.38 -52.84 3.46 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 124.655 1.182 . . . . 0.33000000000000002 110.857 -177.595 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -57.13 -47.79 80.27 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 115.9 -0.591 . . . . 3.1699999999999999 110.677 -179.319 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.07 -44.83 94.46 Favored 'General case' 0 C--N 1.339 0.11 0 C-N-CA 122.926 0.49 . . . . 0.32000000000000001 110.691 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 97.7 t -58.5 -57.4 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 N-CA-C 108.934 -0.765 . . . . 0.42999999999999999 108.934 177.494 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.681 HG13 ' HB2' ' A' ' 32' ' ' CYS . 52.9 t -52.21 -48.34 43.34 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 C-N-CA 122.741 0.416 . . . . 0.32000000000000001 110.875 -179.479 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -51.03 -24.44 3.79 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 125.503 1.521 . . . . 0.63 113.115 175.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 11.6 mt-30 -137.4 55.75 1.8 Allowed 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 119.514 1.052 . . . . 2.6600000000000001 112.179 170.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.96 -38.97 0.02 OUTLIER 'General case' 0 C--O 1.226 -0.138 0 C-N-CA 123.566 0.746 . . . . 1.25 110.214 168.24 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.681 ' HB2' HG13 ' A' ' 28' ' ' VAL . 4.0 m -98.21 -50.01 4.51 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 119.004 0.82 . . . . 0.17999999999999999 110.971 -177.322 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.9 pp -58.08 -25.86 27.53 Favored 'Isoleucine or valine' 0 C--N 1.338 0.071 0 N-CA-C 112.127 0.417 . . . . 0.40000000000000002 112.127 -174.291 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 59.7 m -37.92 -38.55 0.31 Allowed 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 125.491 1.516 . . . . 0.98999999999999999 112.646 170.638 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 18.9 m -120.7 -40.15 2.68 Favored 'General case' 0 C--N 1.34 0.189 0 C-N-CA 122.892 0.477 . . . . 0.16 111.901 175.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 81.6 m-70 -73.31 -7.92 53.66 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 112.65 0.611 . . . . 0.19 112.65 -176.42 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 85.59 149.78 12.83 Favored Glycine 0 C--N 1.337 0.627 0 N-CA-C 109.497 -1.441 . . . . 1.51 109.497 179.064 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -42.35 -34.95 1.73 Allowed Glycine 0 CA--C 1.527 0.826 0 C-N-CA 124.855 1.216 . . . . 0.46000000000000002 112.176 175.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -99.03 -5.9 29.52 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 124.937 1.295 . . . . 2.3599999999999999 111.402 -168.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 8.8 mt 69.34 13.04 8.47 Favored 'General case' 0 C--N 1.352 0.682 0 CA-C-N 120.712 1.596 . . . . 1.1100000000000001 111.326 178.104 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.2 p -89.39 -1.37 58.03 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 127.802 2.441 . . . . 0.34000000000000002 109.815 -176.159 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.62 130.44 2.81 Favored Glycine 0 N--CA 1.44 -1.085 0 N-CA-C 109.502 -1.439 . . . . 0.54000000000000004 109.502 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -135.39 -78.1 0.44 Allowed 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 124.387 1.075 . . . . 0.28000000000000003 108.641 178.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 50.1 m -93.45 4.01 54.65 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.176 0.991 . . . . 1.3600000000000001 111.102 171.637 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -153.6 161.74 28.41 Favored Pre-proline 0 CA--C 1.533 0.314 0 C-N-CA 125.808 1.643 . . . . 0.31 107.488 -171.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -71.78 159.58 50.32 Favored 'Trans proline' 0 N--CA 1.459 -0.541 0 C-N-CA 122.977 2.451 . . . . 0.28000000000000003 111.172 -175.553 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -74.68 117.36 16.43 Favored 'General case' 0 CA--C 1.53 0.211 0 O-C-N 121.727 -0.608 . . . . 0.45000000000000001 111.768 -172.353 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 42.2 pt -95.94 0.54 10.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 C-N-CA 123.642 0.777 . . . . 0.29999999999999999 112.031 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -45.34 -35.74 3.73 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.526 0.936 . . . . 2.6400000000000001 113.526 172.808 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -112.98 27.94 9.21 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 124.11 0.964 . . . . 4.9400000000000004 110.687 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -58.63 -43.83 89.82 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 108.998 -0.742 . . . . 0.33000000000000002 108.998 176.618 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -53.77 -29.55 41.85 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 123.349 0.499 . . . . 0.63 113.692 179.108 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.13 -32.95 65.23 Favored 'General case' 0 N--CA 1.454 -0.229 0 O-C-N 122.078 -0.66 . . . . 0.82999999999999996 110.356 178.543 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 -85.31 -44.94 12.4 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.962 0.905 . . . . 1.6699999999999999 109.954 -174.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -138.38 133.28 32.7 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 125.273 1.429 . . . . 1.0 108.025 -167.244 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 13.9 m -73.63 169.97 16.18 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 118.409 0.55 . . . . 1.51 110.095 175.532 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -47.24 -48.13 24.46 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.277 1.031 . . . . 2.9199999999999999 112.44 -176.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -58.1 -41.77 84.25 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.835 -0.541 . . . . 2.98 111.618 177.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -72.39 -41.96 65.74 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 109.053 -0.721 . . . . 2.9900000000000002 109.053 -176.14 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 41.3 mt -61.86 -46.71 95.91 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.131 0 O-C-N 121.286 -0.884 . . . . 0.29999999999999999 109.386 175.536 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 66.8 tp -53.95 -48.41 70.3 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.441 -0.577 . . . . 0.46999999999999997 109.441 178.602 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -48.54 -56.02 9.48 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 117.993 0.36 . . . . 2.3700000000000001 110.996 174.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 95.4 mt -55.78 -46.25 79.77 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.298 0 O-C-N 121.6 -0.688 . . . . 0.47999999999999998 110.778 178.236 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.468 HD11 HMB2 ' A' ' 93' ' ' HEC . 73.3 mt -55.8 -44.77 78.64 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 O-C-N 120.45 -1.406 . . . . 0.28000000000000003 110.164 176.675 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 90.9 mt -67.81 -36.81 81.06 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 113.903 1.075 . . . . 0.67000000000000004 113.903 -176.644 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -128.82 26.32 5.56 Favored 'General case' 0 C--N 1.344 0.338 0 CA-C-N 120.85 1.659 . . . . 3.7799999999999998 110.205 -170.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.511 ' N ' ' HA2' ' A' ' 73' ' ' GLY . . . 37.41 -142.78 0.23 Allowed Glycine 0 CA--C 1.534 1.258 0 C-N-CA 128.247 2.832 . . . . 0.65000000000000002 111.009 -176.226 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 44.9 tt0 174.3 132.87 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 119.246 1.523 . . . . 1.46 109.658 -178.217 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 45.14 -118.94 3.04 Favored Glycine 0 CA--C 1.532 1.138 0 O-C-N 121.22 -0.925 . . . . 0.40000000000000002 112.18 -175.445 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -70.93 -19.63 77.13 Favored Glycine 0 CA--C 1.531 1.082 0 O-C-N 122.495 -0.415 . . . . 0.47999999999999998 113.016 179.357 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.417 ' HB2' ' C1D' ' A' ' 93' ' ' HEC . 20.0 ttt -73.4 119.27 74.95 Favored Pre-proline 0 N--CA 1.451 -0.424 0 C-N-CA 124.163 0.985 . . . . 0.34000000000000002 110.604 -178.442 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.448 ' HD2' HD11 ' A' ' 75' ' ' ILE . 58.0 Cg_endo -80.22 124.74 5.52 Favored 'Trans proline' 0 N--CA 1.447 -1.221 0 C-N-CA 123.208 2.605 . . . . 2.0699999999999998 111.054 -179.075 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.511 ' HA2' ' N ' ' A' ' 67' ' ' GLY . . . -63.38 142.6 47.35 Favored Glycine 0 N--CA 1.444 -0.8 0 N-CA-C 115.902 1.121 . . . . 0.64000000000000001 115.902 -174.317 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 78.2 32.41 43.7 Favored Glycine 0 CA--C 1.526 0.779 0 CA-C-N 114.142 -1.029 . . . . 0.34000000000000002 111.442 174.33 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.448 HD11 ' HD2' ' A' ' 72' ' ' PRO . 0.8 OUTLIER -51.37 -53.02 17.28 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 125.692 1.597 . . . . 1.1799999999999999 109.878 174.45 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -105.48 160.05 15.46 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 124.961 1.304 . . . . 0.34000000000000002 108.652 162.443 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 81.7 mttt -144.1 168.7 19.4 Favored 'General case' 0 CA--C 1.527 0.086 0 N-CA-C 107.461 -1.311 . . . . 2.5600000000000001 107.461 170.312 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 65.7 -164.04 39.28 Favored Glycine 0 CA--C 1.528 0.902 0 N-CA-C 111.517 -0.633 . . . . 0.66000000000000003 111.517 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -54.32 -29.6 48.28 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.457 0.703 . . . . 0.58999999999999997 112.283 -174.227 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -40.32 -67.63 0.22 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.79 1.236 . . . . 2.9500000000000002 110.457 164.068 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -59.07 -43.91 91.8 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.25 0.62 . . . . 0.28000000000000003 110.977 -175.023 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -59.13 -53.48 57.86 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.411 1.084 . . . . 2.6899999999999999 110.597 -178.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.18 -49.12 78.12 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.008 0.923 . . . . 0.27000000000000002 109.797 179.373 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.557 HG22 HG23 ' A' ' 28' ' ' VAL . 54.1 t -52.5 -56.49 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 C-N-CA 122.292 0.237 . . . . 0.27000000000000002 110.598 176.223 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -49.56 -51.38 37.28 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 123.738 0.815 . . . . 0.20000000000000001 111.764 177.26 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.38 -50.33 74.38 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 121.673 0.749 . . . . 0.42999999999999999 111.163 -178.757 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.552 ' CE3' HD23 ' A' ' 88' ' ' LEU . 51.0 t90 -58.23 -45.34 87.87 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 121.228 0.537 . . . . 0.63 110.047 178.543 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.552 HD23 ' CE3' ' A' ' 87' ' ' TRP . 0.1 OUTLIER -62.73 -36.41 82.91 Favored 'General case' 0 CA--C 1.531 0.213 0 O-C-N 121.493 -0.754 . . . . 1.6100000000000001 110.814 176.571 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -59.74 -39.19 83.92 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 118.758 0.708 . . . . 0.44 110.848 173.257 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -59.74 -41.06 90.11 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 122.28 0.232 . . . . 3.21 110.535 173.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.1 mtpm? -74.04 104.12 4.76 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.806 0.813 . . . . 2.2999999999999998 111.21 179.087 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 15.5 pttp . . . . . 0 C--O 1.25 1.089 0 C-N-CA 126.619 1.967 . . . . 3.1299999999999999 106.048 176.364 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 93' ' ' HEC . . . . . 0.468 HMB2 HD11 ' A' ' 64' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.4 t . . . . . 0 N--CA 1.471 0.624 0 N-CA-C 105.831 -1.915 . . . . 1.26 105.831 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -83.81 108.56 16.91 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.726 -0.842 . . . . 2.8599999999999999 108.726 -173.567 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -46.39 -55.15 7.78 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 123.25 0.62 . . . . 0.31 110.024 176.474 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -57.36 -46.71 83.07 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 110.233 -0.284 . . . . 2.6899999999999999 110.233 -177.207 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.24 -48.69 79.63 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 118.262 0.483 . . . . 0.28999999999999998 111.399 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 55.6 t -56.46 -56.18 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 N-CA-C 109.233 -0.654 . . . . 0.40999999999999998 109.233 177.071 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.562 HG23 HG22 ' A' ' 84' ' ' VAL . 61.1 t -53.5 -49.92 52.11 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 C-N-CA 122.888 0.475 . . . . 0.40000000000000002 110.305 -177.201 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.458 ' HA ' HG12 ' A' ' 33' ' ' ILE . 33.6 mm-40 -51.55 -17.44 0.83 Allowed 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 126.454 1.902 . . . . 0.5 112.964 175.818 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 16.6 tp60 -141.71 43.67 1.72 Allowed 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 119.519 1.054 . . . . 3.6699999999999999 112.204 171.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.18 -39.73 0.1 Allowed 'General case' 0 C--O 1.227 -0.083 0 C-N-CA 123.659 0.784 . . . . 1.1799999999999999 111.425 166.377 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.485 ' HB2' HG13 ' A' ' 28' ' ' VAL . 3.6 m -98.12 -49.51 4.71 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 119.124 0.874 . . . . 0.17000000000000001 110.539 -174.106 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.458 HG12 ' HA ' ' A' ' 29' ' ' GLN . 2.2 pp -55.51 -29.13 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 CA-C-N 115.766 -0.652 . . . . 0.40000000000000002 111.564 -177.127 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.1 m -37.75 -37.01 0.21 Allowed 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 125.61 1.564 . . . . 1.1399999999999999 112.713 171.646 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 28.2 m -119.59 -40.45 2.77 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.298 0.639 . . . . 0.17000000000000001 112.009 174.125 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 84.7 m-70 -73.37 -8.71 57.03 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.474 0.71 . . . . 0.22 112.711 -175.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 85.55 151.14 15.28 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 109.628 -1.389 . . . . 1.52 109.628 -178.413 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -40.46 -42.27 2.54 Favored Glycine 0 C--N 1.34 0.802 0 C-N-CA 124.996 1.284 . . . . 0.48999999999999999 112.21 178.088 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -95.89 -6.34 39.47 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 125.556 1.542 . . . . 2.5699999999999998 110.939 -169.641 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.537 HD21 ' CG1' ' A' ' 28' ' ' VAL . 0.6 OUTLIER 69.56 19.1 7.55 Favored 'General case' 0 C--N 1.347 0.469 0 CA-C-N 119.648 1.113 . . . . 1.48 111.026 177.456 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 11.2 p -82.18 -4.84 57.83 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 128.462 2.705 . . . . 0.34999999999999998 109.898 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.14 148.26 21.19 Favored Glycine 0 N--CA 1.44 -1.035 0 N-CA-C 108.32 -1.912 . . . . 0.59999999999999998 108.32 -173.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -155.08 -72.98 0.12 Allowed 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 123.91 0.884 . . . . 0.48999999999999999 109.552 176.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.3 t -98.35 1.17 46.73 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.627 1.171 . . . . 1.3400000000000001 110.252 172.622 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.495 ' HB1' ' HD2' ' A' ' 46' ' ' PRO . . . -155.62 167.07 14.94 Favored Pre-proline 0 CA--C 1.536 0.432 0 C-N-CA 125.551 1.541 . . . . 0.26000000000000001 107.913 -171.503 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.495 ' HD2' ' HB1' ' A' ' 45' ' ' ALA . 54.9 Cg_endo -70.43 160.98 47.67 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 123.098 2.532 . . . . 0.29999999999999999 111.195 -173.485 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -74.87 119.99 19.8 Favored 'General case' 0 CA--C 1.531 0.214 0 O-C-N 121.748 -0.595 . . . . 0.31 110.638 -177.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 47.4 pt -105.05 0.83 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 C-N-CA 124.157 0.983 . . . . 0.40000000000000002 111.551 179.327 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -34.17 -46.39 0.24 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.572 1.549 . . . . 2.4199999999999999 112.856 167.244 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 5.3 pttt -111.44 35.32 3.67 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.798 1.239 . . . . 3.9300000000000002 111.166 -178.254 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.01 -46.4 87.83 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-O 118.868 -0.587 . . . . 0.29999999999999999 109.51 174.497 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -51.73 -32.73 33.34 Favored Glycine 0 CA--C 1.527 0.795 0 CA-C-N 118.566 0.621 . . . . 0.65000000000000002 114.329 -177.055 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.21 -37.08 66.57 Favored 'General case' 0 N--CA 1.455 -0.196 0 O-C-N 121.898 -0.766 . . . . 0.79000000000000004 110.797 176.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 20.5 m-80 -73.51 -50.77 19.77 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 122.929 0.492 . . . . 1.6799999999999999 110.15 -178.576 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -137.6 138.07 39.16 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.211 1.404 . . . . 0.71999999999999997 107.382 -169.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 67.3 m -76.19 172.0 13.57 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 119.03 0.832 . . . . 1.6000000000000001 110.389 179.546 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.0 pm0 -50.5 -43.29 55.61 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 123.78 0.832 . . . . 2.8700000000000001 111.834 -178.471 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -56.15 -41.37 75.3 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 121.336 0.588 . . . . 2.8100000000000001 110.136 179.389 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -80.01 -47.38 15.01 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 123.81 0.844 . . . . 3.54 108.995 -173.278 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 63.9 mt -56.33 -44.99 81.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 N-CA-C 109.113 -0.699 . . . . 0.23999999999999999 109.113 176.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 33.8 tp -54.77 -49.47 70.8 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 109.375 -0.602 . . . . 0.46000000000000002 109.375 177.764 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -55.11 -46.44 75.56 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 118.576 0.625 . . . . 1.48 111.604 175.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 86.7 mt -61.92 -30.34 48.34 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 O-C-N 121.351 -0.843 . . . . 0.66000000000000003 111.521 178.106 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.565 HD11 HMB2 ' A' ' 93' ' ' HEC . 46.4 mt -73.19 -50.24 32.87 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 O-C-N 120.278 -1.514 . . . . 0.34000000000000002 109.128 174.253 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 77.3 mt -61.88 -28.43 69.5 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 125.232 1.413 . . . . 0.38 113.474 -175.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 11.0 m-80 -130.62 15.37 5.41 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 120.02 1.282 . . . . 1.75 110.386 -169.545 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 40.01 -141.97 0.69 Allowed Glycine 0 CA--C 1.545 1.906 0 C-N-CA 125.679 1.609 . . . . 0.66000000000000003 111.707 -167.05 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 167.08 139.63 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 126.386 1.874 . . . . 1.54 108.447 -174.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 31.77 -111.45 0.05 OUTLIER Glycine 0 C--N 1.347 1.18 0 C-N-CA 125.465 1.507 . . . . 0.52000000000000002 114.153 -174.581 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.58 -30.1 76.67 Favored Glycine 0 CA--C 1.534 1.23 0 CA-C-N 117.299 0.549 . . . . 0.69999999999999996 112.834 -179.083 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 2.3 ttt -65.42 123.74 85.2 Favored Pre-proline 0 CA--C 1.541 0.615 0 C-N-CA 124.576 1.15 . . . . 0.51000000000000001 111.393 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -63.64 -55.38 0.7 Allowed 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 124.223 3.282 . . . . 2.96 111.224 -173.117 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 115.28 149.08 9.53 Favored Glycine 0 N--CA 1.448 -0.514 0 CA-C-N 115.732 -0.667 . . . . 0.90000000000000002 114.185 171.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 67.45 22.38 73.06 Favored Glycine 0 CA--C 1.531 1.036 0 CA-C-N 114.712 -0.744 . . . . 0.48999999999999999 111.854 -178.439 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -51.69 -53.01 18.63 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 C-N-CA 126.611 1.964 . . . . 1.0800000000000001 111.127 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -107.76 159.99 16.07 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.164 1.386 . . . . 0.34000000000000002 108.335 162.446 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 36.6 mttt -145.84 174.77 10.94 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.554 1.141 . . . . 3.3100000000000001 109.57 171.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 53.11 -149.55 11.66 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 123.826 0.727 . . . . 0.69999999999999996 112.045 178.084 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -49.63 -36.61 25.01 Favored 'General case' 0 C--N 1.34 0.163 0 C-N-CA 123.877 0.871 . . . . 0.68999999999999995 111.278 179.182 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.531 ' O ' HG23 ' A' ' 84' ' ' VAL . 3.9 tt0 -47.76 -66.41 0.41 Allowed 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.992 1.317 . . . . 1.9099999999999999 109.216 173.047 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -62.97 -45.48 92.23 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 122.829 0.452 . . . . 0.26000000000000001 112.011 -178.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -54.79 -52.9 61.19 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 122.931 0.492 . . . . 2.1499999999999999 110.488 -178.644 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.42 -50.17 73.87 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 122.915 0.486 . . . . 0.39000000000000001 110.233 178.131 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.571 HG11 HMB1 ' A' ' 93' ' ' HEC . 70.1 t -50.63 -58.51 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-O 120.613 0.244 . . . . 0.56000000000000005 110.919 177.293 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -55.26 -49.98 70.67 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.206 1.003 . . . . 0.28999999999999998 111.684 -179.123 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.69 -46.01 88.18 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 121.67 0.748 . . . . 0.34999999999999998 110.584 -179.336 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.532 ' CE3' HD23 ' A' ' 88' ' ' LEU . 48.6 t90 -60.71 -50.48 73.3 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.667 -0.494 . . . . 0.56000000000000005 109.667 176.538 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.532 HD23 ' CE3' ' A' ' 87' ' ' TRP . 0.1 OUTLIER -59.92 -32.01 70.38 Favored 'General case' 0 CA--C 1.531 0.247 0 O-C-N 121.487 -0.758 . . . . 1.6000000000000001 111.193 179.152 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.9 -42.85 97.33 Favored 'General case' 0 N--CA 1.457 -0.097 0 CA-C-N 118.671 0.669 . . . . 0.40999999999999998 111.146 171.754 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -58.59 -40.73 84.02 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 110.347 -0.242 . . . . 3.29 110.347 173.433 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 21.4 mtpp -73.38 133.98 43.94 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 121.916 -0.49 . . . . 2.4199999999999999 110.984 -178.037 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 49.8 mtmt . . . . . 0 C--O 1.25 1.084 0 N-CA-C 105.887 -1.894 . . . . 2.5499999999999998 105.887 179.36 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 93' ' ' HEC . . . . . 0.571 HMB1 HG11 ' A' ' 84' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.47 0.554 0 N-CA-C 106.542 -1.651 . . . . 1.4199999999999999 106.542 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -74.21 144.83 44.56 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.311 1.044 . . . . 2.9199999999999999 108.639 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -89.29 -65.38 1.02 Allowed 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 109.327 -0.619 . . . . 0.5 109.327 177.386 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -47.35 -47.01 26.13 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.578 0.751 . . . . 3.0899999999999999 111.702 -178.645 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.69 -42.82 79.75 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.057 0.543 . . . . 0.33000000000000002 111.676 178.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 53.4 t -64.45 -54.13 34.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 N-CA-C 108.23 -1.026 . . . . 0.34999999999999998 108.23 178.05 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.606 HG11 HD21 ' A' ' 40' ' ' LEU . 65.9 t -48.33 -51.49 10.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 C-N-CA 122.486 0.314 . . . . 0.57999999999999996 110.376 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.414 ' HA ' HG12 ' A' ' 33' ' ' ILE . 35.7 mm-40 -50.55 -26.82 5.7 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 126.313 1.845 . . . . 0.62 113.416 177.672 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 -136.6 53.48 1.91 Allowed 'General case' 0 C--N 1.339 0.125 0 CA-C-N 119.756 1.162 . . . . 2.3999999999999999 112.121 173.586 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -166.43 -38.9 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 123.459 0.704 . . . . 1.26 110.504 167.834 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.484 ' HB2' HG13 ' A' ' 28' ' ' VAL . 6.5 m -97.69 -51.31 4.15 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 118.913 0.779 . . . . 0.23000000000000001 110.843 -175.463 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.414 HG12 ' HA ' ' A' ' 29' ' ' GLN . 2.4 pp -56.41 -27.94 25.56 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.095 0 CA-C-N 116.128 -0.487 . . . . 0.39000000000000001 111.925 -175.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.9 m -36.92 -39.31 0.22 Allowed 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 125.605 1.562 . . . . 1.05 112.683 171.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 38.1 m -117.88 -38.86 3.18 Favored 'General case' 0 C--N 1.339 0.122 0 C-N-CA 123.127 0.571 . . . . 0.20999999999999999 111.652 174.724 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 83.8 m-70 -77.03 -6.49 52.89 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 113.167 0.803 . . . . 0.23999999999999999 113.167 -174.416 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 84.54 151.83 14.5 Favored Glycine 0 C--N 1.338 0.645 0 N-CA-C 109.865 -1.294 . . . . 1.5700000000000001 109.865 -179.315 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -41.87 -39.53 2.8 Favored Glycine 0 C--N 1.341 0.84 0 C-N-CA 125.015 1.293 . . . . 0.45000000000000001 112.274 178.623 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -99.84 -0.44 39.72 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 125.249 1.42 . . . . 2.4199999999999999 111.058 -169.211 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.606 HD21 HG11 ' A' ' 28' ' ' VAL . 1.3 mp 66.12 18.34 10.96 Favored 'General case' 0 C--N 1.347 0.476 0 CA-C-N 119.779 1.172 . . . . 1.8500000000000001 111.351 -179.395 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.0 p -82.14 -5.24 58.3 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 127.413 2.285 . . . . 0.35999999999999999 110.277 -177.224 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.58 148.21 18.35 Favored Glycine 0 N--CA 1.437 -1.277 0 N-CA-C 108.129 -1.988 . . . . 0.51000000000000001 108.129 -172.625 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -156.24 -76.77 0.09 Allowed 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 124.035 0.934 . . . . 0.26000000000000001 109.09 178.359 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -95.38 2.37 54.59 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.683 1.193 . . . . 1.1499999999999999 110.552 172.814 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -157.58 161.75 28.56 Favored Pre-proline 0 N--CA 1.452 -0.374 0 C-N-CA 126.834 2.054 . . . . 0.20999999999999999 106.577 -170.5 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -68.1 164.65 31.26 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 123.178 2.585 . . . . 0.34000000000000002 111.807 -175.004 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -75.52 116.39 16.18 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 123.265 0.626 . . . . 0.26000000000000001 110.841 -176.064 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 40.4 pt -98.11 1.0 10.54 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.174 0 C-N-CA 123.162 0.585 . . . . 0.32000000000000001 110.886 176.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -43.13 -37.31 1.99 Allowed 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 114.037 1.125 . . . . 2.4199999999999999 114.037 174.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.13 23.7 13.97 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 124.899 1.28 . . . . 4.21 111.681 179.565 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -58.09 -43.4 87.03 Favored 'General case' 0 N--CA 1.45 -0.449 0 O-C-N 121.607 -0.683 . . . . 0.34000000000000002 109.573 178.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -51.38 -30.16 25.03 Favored Glycine 0 CA--C 1.529 0.913 0 N-CA-C 114.643 0.617 . . . . 0.60999999999999999 114.643 -178.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -87.28 -40.59 14.36 Favored 'General case' 0 C--O 1.227 -0.092 0 CA-C-N 117.965 0.882 . . . . 0.87 110.45 176.42 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 15.3 m-80 -62.48 -41.82 99.05 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 122.135 0.174 . . . . 1.5700000000000001 111.322 -179.529 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -140.35 142.74 35.55 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 125.722 1.609 . . . . 0.67000000000000004 107.649 -170.475 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 57.9 m -83.06 176.67 9.06 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 121.491 0.663 . . . . 1.72 110.504 177.78 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.468 ' HG3' ' HB2' ' A' ' 89' ' ' ALA . 2.8 mp0 -58.07 -45.75 86.59 Favored 'General case' 0 N--CA 1.454 -0.228 0 O-C-N 121.505 -0.747 . . . . 2.8100000000000001 110.705 -166.138 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -61.73 -38.78 89.19 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.228 0.611 . . . . 2.9700000000000002 110.199 -177.676 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.1 mp0 -70.33 -46.14 64.78 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 124.186 0.994 . . . . 4.21 108.489 -178.015 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.594 HG23 HMA1 ' A' ' 93' ' ' HEC . 62.2 mt -62.96 -46.19 96.95 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.109 0 N-CA-C 108.834 -0.802 . . . . 0.23999999999999999 108.834 178.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 46.4 tp -51.8 -54.06 32.97 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 123.132 0.573 . . . . 0.35999999999999999 109.682 176.259 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -50.61 -52.48 38.98 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.338 0.655 . . . . 1.6000000000000001 110.586 175.615 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 76.2 mt -62.6 -25.76 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 O-C-N 121.652 -0.655 . . . . 0.72999999999999998 112.196 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.521 HD11 HMB2 ' A' ' 93' ' ' HEC . 51.9 mt -73.26 -49.37 38.16 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 O-C-N 120.213 -1.554 . . . . 0.28000000000000003 108.993 170.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 86.7 mt -62.89 -34.28 77.08 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 125.006 1.322 . . . . 0.41999999999999998 114.238 -173.012 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -134.49 29.95 3.55 Favored 'General case' 0 C--N 1.342 0.257 0 CA-C-N 120.572 1.533 . . . . 3.2400000000000002 109.68 -172.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 37.95 -140.26 0.47 Allowed Glycine 0 CA--C 1.542 1.72 0 C-N-CA 127.05 2.262 . . . . 0.65000000000000002 111.837 -176.379 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 167.03 140.72 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 126.052 1.741 . . . . 1.27 109.516 -178.33 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 44.62 -120.67 3.74 Favored Glycine 0 CA--C 1.531 1.067 0 CA-C-N 119.684 1.129 . . . . 0.46000000000000002 112.551 -177.547 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -71.36 -19.46 77.58 Favored Glycine 0 CA--C 1.534 1.222 0 O-C-N 122.379 -0.483 . . . . 0.47999999999999998 112.972 178.675 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 17.1 ttt -72.25 119.94 77.57 Favored Pre-proline 0 CA--C 1.537 0.464 0 C-N-CA 123.762 0.825 . . . . 0.37 109.968 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -63.41 -53.25 1.51 Allowed 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 124.178 3.252 . . . . 2.8900000000000001 111.467 -169.273 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 114.39 152.07 10.47 Favored Glycine 0 N--CA 1.447 -0.596 0 CA-C-O 121.98 0.767 . . . . 0.94999999999999996 114.555 172.197 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 66.18 19.47 68.21 Favored Glycine 0 CA--C 1.531 1.04 0 CA-C-N 114.247 -0.976 . . . . 0.56999999999999995 111.74 -177.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 2.5 mt -50.21 -49.85 21.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 126.382 1.873 . . . . 1.05 110.793 177.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -111.44 155.36 23.31 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.467 1.107 . . . . 0.51000000000000001 108.909 159.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.5 mttm -146.13 157.87 43.86 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.276 1.43 . . . . 2.4399999999999999 109.859 178.439 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 56.49 -149.28 28.56 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 110.414 -1.074 . . . . 1.02 110.414 -176.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -51.18 -32.85 24.91 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 117.548 0.674 . . . . 0.58999999999999997 112.483 -178.217 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -51.79 -47.4 64.26 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.268 0.627 . . . . 2.3599999999999999 109.619 174.204 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -75.92 -49.23 18.42 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.175 0.59 . . . . 0.34999999999999998 111.304 175.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -57.34 -47.82 80.58 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 118.138 0.427 . . . . 2.0 111.503 -172.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.24 -49.07 77.19 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 109.625 -0.509 . . . . 0.28000000000000003 109.625 178.5 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.46 HG22 HG23 ' A' ' 28' ' ' VAL . 45.9 t -57.62 -52.62 55.09 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 C-N-CA 122.898 0.479 . . . . 0.38 111.035 178.827 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -52.04 -55.8 18.32 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 123.467 0.707 . . . . 0.35999999999999999 111.366 176.24 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.453 ' O ' ' HB3' ' A' ' 89' ' ' ALA . . . -59.69 -40.49 88.06 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.085 0.554 . . . . 0.46999999999999997 111.084 -178.16 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.406 ' CZ3' HG21 ' A' ' 28' ' ' VAL . 70.6 t90 -64.36 -52.44 58.32 Favored 'General case' 0 N--CA 1.453 -0.315 0 O-C-N 121.709 -0.619 . . . . 0.60999999999999999 109.727 177.032 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.52 -28.09 66.77 Favored 'General case' 0 C--O 1.224 -0.246 0 O-C-N 120.374 -1.454 . . . . 2.04 112.436 176.067 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.468 ' HB2' ' HG3' ' A' ' 57' ' ' GLU . . . -54.56 -35.34 63.16 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 119.036 0.834 . . . . 0.64000000000000001 111.387 169.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -70.64 -41.21 72.45 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 109.287 -0.634 . . . . 4.8600000000000003 109.287 174.368 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 4.1 mtpm? -74.33 105.85 5.69 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 120.988 0.423 . . . . 2.6400000000000001 111.459 -174.491 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.093 0 C-N-CA 126.341 1.856 . . . . 2.2799999999999998 106.736 170.643 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' HEC . . . . . 0.594 HMA1 HG23 ' A' ' 60' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.596 HG22 ' H ' ' A' ' 23' ' ' ASP 2.303 1.1 t . . . . . 0 N--CA 1.47 0.554 0 CA-C-O 116.56 -1.686 . . . . 2.46 106.586 . . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.596 ' H ' HG22 ' A' ' 22' ' ' VAL . 9.2 t0 -101.81 153.68 19.6 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 103.487 -2.783 . . . . 3.6099999999999999 103.487 133.18 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -111.65 -62.07 1.61 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.447 -0.946 . . . . 0.38 108.447 173.798 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -58.05 -44.54 87.5 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.749 -0.66 . . . . 3.3599999999999999 110.417 -176.404 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.35 -36.7 83.05 Favored 'General case' 0 C--N 1.339 0.144 0 CA-C-N 118.707 0.685 . . . . 0.29999999999999999 111.21 -179.778 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 92.8 t -62.87 -55.98 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 N-CA-C 107.891 -1.152 . . . . 0.46000000000000002 107.891 176.748 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.548 HG13 ' HB2' ' A' ' 32' ' ' CYS . 74.0 t -52.76 -48.33 49.75 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 CA-C-N 117.547 0.158 . . . . 0.33000000000000002 110.868 -179.598 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.434 ' HA ' HG12 ' A' ' 33' ' ' ILE . 25.3 mm-40 -50.06 -21.03 1.11 Allowed 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 126.565 1.946 . . . . 0.56000000000000005 113.496 174.592 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 17.4 tp60 -144.67 55.1 1.25 Allowed 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 119.481 1.037 . . . . 3.9700000000000002 111.528 172.353 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -167.25 -38.29 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 124.005 0.922 . . . . 1.3500000000000001 110.025 170.623 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.548 ' HB2' HG13 ' A' ' 28' ' ' VAL . 3.7 m -99.58 -50.52 4.04 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 119.0 0.818 . . . . 0.20999999999999999 110.772 -178.662 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.434 HG12 ' HA ' ' A' ' 29' ' ' GLN . 2.2 pp -56.91 -26.26 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.153 0 CA-C-N 116.151 -0.477 . . . . 0.39000000000000001 111.89 -175.021 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.6 t -42.23 -32.33 0.48 Allowed 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.041 1.336 . . . . 2.1099999999999999 111.848 172.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 12.5 m -123.08 -43.71 2.21 Favored 'General case' 0 C--N 1.341 0.212 0 C-N-CA 123.413 0.685 . . . . 0.17000000000000001 111.593 173.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 84.3 m-70 -70.09 -10.18 57.9 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.745 0.818 . . . . 0.17999999999999999 112.768 -176.343 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 88.67 149.09 18.75 Favored Glycine 0 C--N 1.337 0.635 0 N-CA-C 109.747 -1.341 . . . . 1.52 109.747 178.593 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -43.28 -39.49 4.17 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 124.512 1.053 . . . . 0.44 111.485 176.264 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -94.03 -7.16 43.51 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 125.574 1.549 . . . . 3.1699999999999999 111.027 -170.68 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.9 mt 71.16 11.54 6.87 Favored 'General case' 0 C--N 1.35 0.589 0 CA-C-N 119.524 1.057 . . . . 1.0700000000000001 111.627 177.018 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 12.5 p -83.49 0.1 47.86 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 127.128 2.171 . . . . 0.37 109.742 -176.049 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.85 129.92 2.78 Favored Glycine 0 N--CA 1.442 -0.917 0 N-CA-C 108.978 -1.649 . . . . 0.56000000000000005 108.978 -178.747 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -135.95 -79.55 0.42 Allowed 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 124.195 0.998 . . . . 0.23000000000000001 108.825 178.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.6 t -90.28 4.62 50.16 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.948 0.899 . . . . 1.5900000000000001 110.705 172.783 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.566 ' HB1' ' HD2' ' A' ' 46' ' ' PRO . . . -158.08 168.89 11.55 Favored Pre-proline 0 CA--C 1.535 0.374 0 C-N-CA 124.688 1.195 . . . . 0.23999999999999999 108.387 -172.315 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.566 ' HD2' ' HB1' ' A' ' 45' ' ' ALA . 38.1 Cg_endo -70.01 158.72 55.73 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.927 2.418 . . . . 0.19 110.528 -174.44 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.53 126.74 30.92 Favored 'General case' 0 C--N 1.332 -0.162 0 O-C-N 121.516 -0.74 . . . . 0.26000000000000001 109.927 -178.098 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 50.6 pt -107.34 1.36 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 C-N-CA 123.716 0.806 . . . . 0.27000000000000002 111.331 176.729 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 18.5 p-10 -35.75 -49.56 0.6 Allowed 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 124.894 1.278 . . . . 3.5299999999999998 111.744 171.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.68 32.32 4.62 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 127.232 2.213 . . . . 3.5899999999999999 113.103 -179.56 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.12 -49.24 78.61 Favored 'General case' 0 CA--C 1.535 0.371 0 O-C-N 120.746 -1.221 . . . . 0.44 110.147 177.462 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -54.11 -17.26 7.33 Favored Glycine 0 C--N 1.343 0.926 0 C-N-CA 124.64 1.114 . . . . 0.67000000000000004 114.886 178.654 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.7 -40.7 88.58 Favored 'General case' 0 N--CA 1.453 -0.32 0 O-C-N 121.373 -1.075 . . . . 1.03 110.978 176.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 -105.5 -52.05 2.9 Favored 'General case' 0 CA--C 1.52 -0.198 0 N-CA-C 109.563 -0.532 . . . . 2.7599999999999998 109.563 -172.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -92.7 147.86 22.53 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.725 -1.213 . . . . 0.81000000000000005 107.725 -176.187 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -96.29 167.29 11.28 Favored 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 108.383 -0.969 . . . . 1.96 108.383 174.918 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -45.27 -43.51 10.6 Favored 'General case' 0 C--O 1.225 -0.216 0 C-N-CA 124.797 1.239 . . . . 2.7999999999999998 111.484 177.014 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -55.82 -49.29 73.65 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.842 0.857 . . . . 3.04 110.72 178.67 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -74.55 -43.25 56.62 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 123.228 0.611 . . . . 3.1699999999999999 109.423 -175.231 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 61.4 mt -60.57 -45.22 97.54 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 109.173 -0.677 . . . . 0.32000000000000001 109.173 179.537 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 55.2 tp -55.44 -50.44 69.81 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.274 -0.639 . . . . 0.34999999999999998 109.274 176.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -53.79 -48.75 69.5 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 121.197 -0.201 . . . . 1.5 110.562 175.642 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 49.7 mt -63.88 -21.09 27.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 O-C-N 121.421 -0.799 . . . . 0.94999999999999996 112.48 179.499 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.573 HD11 HMB2 ' A' ' 93' ' ' HEC . 66.1 mt -78.63 -44.99 25.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 O-C-N 120.264 -1.522 . . . . 0.26000000000000001 109.207 173.641 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 80.7 mt -75.64 -31.28 59.76 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 113.43 0.9 . . . . 0.75 113.43 -176.132 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -120.06 19.47 12.28 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 119.641 1.109 . . . . 1.75 109.592 -171.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.536 ' N ' ' HA2' ' A' ' 73' ' ' GLY . . . 36.42 -136.99 0.5 Allowed Glycine 0 CA--C 1.532 1.148 0 C-N-CA 127.689 2.566 . . . . 0.68999999999999995 111.169 -173.12 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 31.1 tt0 166.73 138.38 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 125.718 1.607 . . . . 1.1299999999999999 109.988 177.183 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 41.3 -119.95 1.74 Allowed Glycine 0 CA--C 1.531 1.072 0 O-C-N 120.436 -1.415 . . . . 0.35999999999999999 113.157 -173.309 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -71.66 -18.44 77.27 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 123.374 0.512 . . . . 0.47999999999999998 112.976 179.549 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.457 ' HB2' ' C1D' ' A' ' 93' ' ' HEC . 23.3 ttt -71.55 118.69 68.57 Favored Pre-proline 0 N--CA 1.45 -0.426 0 C-N-CA 123.734 0.813 . . . . 0.39000000000000001 110.52 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -75.25 125.03 8.89 Favored 'Trans proline' 0 N--CA 1.442 -1.53 0 C-N-CA 121.845 1.697 . . . . 2.1600000000000001 109.923 179.302 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.536 ' HA2' ' N ' ' A' ' 67' ' ' GLY . . . -63.56 140.44 44.56 Favored Glycine 0 N--CA 1.44 -1.077 0 CA-C-N 115.077 -0.965 . . . . 0.57999999999999996 114.558 178.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 84.74 33.72 17.98 Favored Glycine 0 CA--C 1.525 0.668 0 CA-C-N 113.95 -1.125 . . . . 0.32000000000000001 111.329 173.242 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -61.47 -50.76 79.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 124.606 1.162 . . . . 2.2799999999999998 109.247 179.007 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -104.18 154.39 19.81 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.668 1.587 . . . . 0.37 109.476 164.197 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.3 mtmp? -143.74 150.97 39.41 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 124.781 1.232 . . . . 5.0599999999999996 109.556 179.003 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 68.82 -163.21 50.39 Favored Glycine 0 CA--C 1.528 0.886 0 N-CA-C 110.379 -1.088 . . . . 0.70999999999999996 110.379 -173.719 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -48.6 -31.05 6.03 Favored 'General case' 0 C--O 1.226 -0.166 0 C-N-CA 123.967 0.907 . . . . 0.79000000000000004 112.053 -179.303 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -41.73 -54.85 3.18 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.778 1.231 . . . . 1.96 109.904 174.416 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.17 -45.25 77.56 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 122.822 0.449 . . . . 0.22 110.93 -179.454 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 57.4 mt-10 -55.98 -51.62 67.05 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.162 0.985 . . . . 1.9199999999999999 110.643 -176.706 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -53.34 -52.01 60.58 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.027 0.931 . . . . 0.28000000000000003 110.451 176.583 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.544 HG11 HMB1 ' A' ' 93' ' ' HEC . 77.0 t -55.02 -52.04 48.0 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 C-N-CA 120.997 -0.281 . . . . 0.34999999999999998 110.395 178.226 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -53.79 -51.51 63.23 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 123.172 0.589 . . . . 0.17999999999999999 111.972 179.569 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.77 -48.43 77.87 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 123.611 0.764 . . . . 0.31 110.701 178.18 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.565 ' CE3' HD23 ' A' ' 88' ' ' LEU . 48.9 t90 -61.61 -45.6 93.41 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 121.916 -0.49 . . . . 0.69999999999999996 110.386 179.065 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.565 HD23 ' CE3' ' A' ' 87' ' ' TRP . 0.1 OUTLIER -64.17 -32.68 74.35 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 124.427 1.091 . . . . 1.54 111.184 178.337 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -65.66 -44.63 85.72 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 123.377 0.671 . . . . 0.41999999999999998 110.279 171.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -59.83 -39.45 85.16 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 109.924 -0.398 . . . . 3.6499999999999999 109.924 174.299 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -73.62 149.88 41.75 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 121.526 0.679 . . . . 2.7000000000000002 110.878 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 18.6 mttt . . . . . 0 C--O 1.251 1.144 0 N-CA-C 105.274 -2.121 . . . . 2.7200000000000002 105.274 177.345 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 93' ' ' HEC . . . . . 0.573 HMB2 HD11 ' A' ' 64' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.473 0.694 0 N-CA-C 106.505 -1.665 . . . . 2.1499999999999999 106.505 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.444 ' HB3' ' HB3' ' A' ' 26' ' ' ALA . 0.7 OUTLIER -113.78 158.76 20.56 Favored 'General case' 0 N--CA 1.446 -0.645 0 O-C-N 124.597 1.186 . . . . 3.1099999999999999 109.088 173.547 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -105.18 -64.12 1.16 Allowed 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 107.975 -1.12 . . . . 0.37 107.975 174.672 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -48.92 -48.95 42.19 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 115.65 -0.704 . . . . 2.8599999999999999 111.166 178.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.444 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . . . -59.56 -44.96 93.11 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 118.878 0.763 . . . . 0.28000000000000003 111.426 -177.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 71.9 t -59.8 -54.19 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 N-CA-C 108.495 -0.928 . . . . 0.44 108.495 177.749 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.538 HG13 ' HB2' ' A' ' 32' ' ' CYS . 85.5 t -54.39 -50.74 55.12 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-N 117.979 0.354 . . . . 0.32000000000000001 110.595 -178.391 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 34.8 mm-40 -53.48 -15.68 1.18 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 126.696 1.998 . . . . 0.62 112.931 174.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -135.94 32.75 2.93 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 119.416 1.007 . . . . 2.8500000000000001 113.129 173.26 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 8.3 mtmt -152.37 -56.67 0.14 Allowed 'General case' 0 CA--C 1.521 -0.145 0 CA-C-N 118.694 0.679 . . . . 1.76 109.633 172.272 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.538 ' HB2' HG13 ' A' ' 28' ' ' VAL . 4.0 m -75.08 -49.78 18.57 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 121.071 0.462 . . . . 0.20000000000000001 110.406 -171.415 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.4 pp -53.38 -27.16 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.142 0 CA-C-N 115.487 -0.779 . . . . 0.40999999999999998 111.963 179.031 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.5 t -46.86 -29.19 1.86 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.27 1.028 . . . . 2.1000000000000001 111.92 176.589 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.421 ' SG ' HMC1 ' A' ' 93' ' ' HEC . 15.9 m -122.45 -42.1 2.36 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.433 0.693 . . . . 0.29999999999999999 111.662 170.368 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 89.0 m-70 -70.5 -4.44 22.84 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.226 1.01 . . . . 0.32000000000000001 112.722 -177.16 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 116.44 -76.25 0.27 Allowed Glycine 0 C--N 1.339 0.746 0 C-N-CA 125.269 1.414 . . . . 3.1899999999999999 111.927 161.183 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -178.91 -51.24 0.08 OUTLIER Glycine 0 CA--C 1.519 0.318 0 N-CA-C 108.597 -1.801 . . . . 0.81000000000000005 108.597 -170.576 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -101.36 3.79 40.9 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 124.086 0.955 . . . . 2.2000000000000002 110.777 -174.555 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.495 HD21 ' CG1' ' A' ' 28' ' ' VAL . 15.3 mt 75.4 11.61 3.35 Favored 'General case' 0 C--N 1.351 0.661 0 CA-C-N 119.764 1.165 . . . . 1.3100000000000001 110.384 -178.609 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.6 p -81.24 -9.3 59.8 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 127.941 2.496 . . . . 0.48999999999999999 109.913 -175.248 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.41 143.68 9.26 Favored Glycine 0 N--CA 1.441 -0.994 0 N-CA-C 109.142 -1.583 . . . . 0.46999999999999997 109.142 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -152.92 -81.92 0.09 Allowed 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 124.137 0.975 . . . . 0.57999999999999996 108.978 -178.406 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -88.93 3.44 51.44 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.544 1.137 . . . . 0.98999999999999999 110.828 171.142 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -156.05 160.9 30.46 Favored Pre-proline 0 N--CA 1.449 -0.499 0 C-N-CA 125.988 1.715 . . . . 0.33000000000000002 107.266 -169.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -68.17 160.03 50.6 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 123.466 2.778 . . . . 0.40000000000000002 111.069 -174.539 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.45 125.65 28.39 Favored 'General case' 0 N--CA 1.455 -0.224 0 O-C-N 121.513 -0.742 . . . . 0.28999999999999998 109.762 -177.397 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 46.1 pt -105.29 2.54 10.39 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 C-N-CA 123.555 0.742 . . . . 0.39000000000000001 111.482 175.647 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -33.39 -47.9 0.23 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.528 1.931 . . . . 2.48 112.869 166.788 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.7 33.68 5.22 Favored 'General case' 0 C--N 1.344 0.35 0 C-N-CA 124.389 1.075 . . . . 4.6600000000000001 110.281 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.22 -46.91 88.14 Favored 'General case' 0 N--CA 1.45 -0.435 0 O-C-N 121.15 -0.969 . . . . 0.37 108.923 176.081 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -56.87 -23.02 43.66 Favored Glycine 0 C--N 1.341 0.813 0 CA-C-N 118.65 0.659 . . . . 0.59999999999999998 114.588 178.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -83.92 -47.38 11.09 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 117.81 0.805 . . . . 0.70999999999999996 109.558 173.602 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 13.2 m-80 -59.5 -49.91 75.96 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.016 0.526 . . . . 1.6499999999999999 111.535 -178.515 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -137.06 154.81 50.25 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.472 1.509 . . . . 0.87 108.578 -169.164 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.6 p -84.57 165.87 17.65 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 123.925 0.89 . . . . 2.3500000000000001 110.226 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -50.53 -39.39 48.88 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 123.723 0.809 . . . . 3.2400000000000002 111.407 178.737 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -57.29 -50.46 72.84 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 118.457 0.571 . . . . 4.5199999999999996 110.83 177.21 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 27.5 mm-40 -68.09 -46.2 71.63 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 121.733 0.777 . . . . 3.0899999999999999 108.917 -175.474 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 48.7 mt -60.19 -47.31 92.6 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 N-CA-C 109.44 -0.578 . . . . 0.39000000000000001 109.44 -179.431 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.9 tp -58.45 -49.58 76.8 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 109.117 -0.697 . . . . 0.35999999999999999 109.117 178.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -50.42 -51.05 49.96 Favored 'General case' 0 N--CA 1.452 -0.355 0 O-C-N 123.409 0.443 . . . . 1.8200000000000001 109.961 176.27 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 55.0 mt -57.62 -52.32 58.92 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 O-C-N 121.868 -0.52 . . . . 0.51000000000000001 110.957 178.226 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 60.7 mt -53.4 -44.9 56.45 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 O-C-N 120.561 -1.337 . . . . 0.26000000000000001 110.404 179.383 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 75.1 mt -72.91 -32.67 65.49 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 113.361 0.874 . . . . 0.55000000000000004 113.361 -178.386 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -123.04 19.77 9.98 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 119.655 1.116 . . . . 1.74 109.981 -165.4 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.562 ' N ' ' HA2' ' A' ' 73' ' ' GLY . . . 31.0 -142.98 0.02 OUTLIER Glycine 0 CA--C 1.533 1.207 0 C-N-CA 129.107 3.242 . . . . 0.62 111.492 -167.477 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 173.27 133.41 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 119.005 1.403 . . . . 1.3799999999999999 109.057 -175.147 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 35.39 -113.64 0.14 Allowed Glycine 0 CA--C 1.534 1.224 0 CA-C-N 120.019 1.282 . . . . 0.46999999999999997 113.925 -171.694 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -71.76 -21.42 78.91 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 123.47 0.557 . . . . 0.60999999999999999 112.936 -178.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.441 ' HB2' ' C1D' ' A' ' 93' ' ' HEC . 19.6 ttt -71.13 117.98 61.54 Favored Pre-proline 0 N--CA 1.451 -0.409 0 C-N-CA 124.994 1.318 . . . . 0.42999999999999999 110.793 179.507 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.548 ' HD2' HD11 ' A' ' 75' ' ' ILE . 41.3 Cg_endo -77.95 123.76 6.42 Favored 'Trans proline' 0 N--CA 1.447 -1.262 0 C-N-CA 122.938 2.425 . . . . 2.1000000000000001 111.015 -178.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.562 ' HA2' ' N ' ' A' ' 67' ' ' GLY . . . -59.48 137.06 50.21 Favored Glycine 0 N--CA 1.444 -0.815 0 N-CA-C 115.688 1.035 . . . . 0.68000000000000005 115.688 -177.262 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 80.49 38.64 16.84 Favored Glycine 0 CA--C 1.525 0.688 0 CA-C-N 114.071 -1.064 . . . . 0.32000000000000001 111.005 174.53 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.548 HD11 ' HD2' ' A' ' 72' ' ' PRO . 1.2 mt -58.35 -58.04 8.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 124.892 1.277 . . . . 1.1299999999999999 109.255 174.4 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -93.97 151.5 19.5 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 108.31 -0.996 . . . . 0.39000000000000001 108.31 163.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -143.0 164.81 29.08 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 105.985 -1.857 . . . . 3.3999999999999999 105.985 172.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 75.17 -173.19 53.02 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 110.306 -1.117 . . . . 1.3100000000000001 110.306 -173.661 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -51.46 -27.96 11.83 Favored 'General case' 0 C--O 1.225 -0.23 0 C-N-CA 123.877 0.871 . . . . 0.82999999999999996 111.628 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 6.2 mp0 -42.23 -57.85 2.38 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 124.097 0.959 . . . . 4.5899999999999999 111.39 170.671 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -58.24 -47.98 81.82 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 118.519 0.599 . . . . 0.40999999999999998 110.782 -175.625 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -52.37 -60.92 2.65 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 124.507 1.123 . . . . 2.04 111.348 174.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -55.16 -47.34 75.28 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 124.233 1.013 . . . . 0.34999999999999998 109.922 -177.418 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 62.4 t -55.91 -55.58 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 C-N-CA 123.669 0.788 . . . . 0.35999999999999999 110.339 176.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -51.4 -53.75 33.46 Favored 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 123.178 0.591 . . . . 0.23999999999999999 111.614 176.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -63.34 -42.13 98.92 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.872 0.869 . . . . 0.35999999999999999 110.784 -175.779 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.495 ' CZ3' HG21 ' A' ' 28' ' ' VAL . 62.0 t90 -58.69 -50.8 72.56 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 108.626 -0.879 . . . . 0.47999999999999998 108.626 174.507 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.39 -32.1 69.85 Favored 'General case' 0 C--O 1.222 -0.357 0 O-C-N 120.512 -1.367 . . . . 1.98 112.585 173.381 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -60.64 -32.02 71.21 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 119.556 1.071 . . . . 0.67000000000000004 111.925 172.78 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -77.59 -34.64 53.49 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 119.668 1.122 . . . . 3.8999999999999999 111.643 168.454 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 21.6 mtpp -73.96 116.32 14.44 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 119.806 1.185 . . . . 2.9500000000000002 111.029 -175.69 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 12.3 mttt . . . . . 0 C--O 1.254 1.299 0 C-N-CA 127.787 2.435 . . . . 2.6499999999999999 105.569 -176.747 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 93' ' ' HEC . . . . . 0.446 HMB1 ' SG ' ' A' ' 32' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 91.2 t . . . . . 0 N--CA 1.472 0.652 0 N-CA-C 106.697 -1.594 . . . . 1.55 106.697 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -74.47 99.44 3.56 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 108.45 -0.945 . . . . 2.23 108.45 -174.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -41.64 -57.38 2.3 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 124.951 1.3 . . . . 0.34999999999999998 111.371 177.175 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -55.67 -48.21 75.43 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 116.314 -0.403 . . . . 2.3300000000000001 111.502 179.451 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.16 -44.7 83.72 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 118.266 0.485 . . . . 0.38 110.921 178.256 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.439 HG21 ' HG3' ' A' ' 80' ' ' GLU . 54.6 t -57.53 -55.67 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 N-CA-C 109.332 -0.618 . . . . 0.33000000000000002 109.332 175.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.666 HG13 ' HB2' ' A' ' 32' ' ' CYS . 78.9 t -54.08 -49.61 60.13 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 N-CA-C 110.292 -0.262 . . . . 0.39000000000000001 110.292 -177.316 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.421 ' HA ' HG12 ' A' ' 33' ' ' ILE . 30.6 mm-40 -51.83 -15.97 0.61 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.624 1.969 . . . . 0.87 113.588 174.266 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.43 30.96 2.61 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 119.313 0.961 . . . . 2.3900000000000001 112.314 178.496 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 5.0 mtmt -157.08 -47.31 0.07 Allowed 'General case' 0 CA--C 1.519 -0.214 0 O-C-N 121.85 -0.531 . . . . 1.49 111.384 173.749 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.666 ' HB2' HG13 ' A' ' 28' ' ' VAL . 4.3 m -86.26 -48.13 8.8 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.65 -0.5 . . . . 0.20000000000000001 109.65 -174.556 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.421 HG12 ' HA ' ' A' ' 29' ' ' GLN . 2.5 pp -55.22 -27.8 20.51 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 CA-C-N 115.854 -0.612 . . . . 0.38 112.332 -177.314 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.7 m -42.53 -34.42 0.85 Allowed 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.692 1.197 . . . . 1.0800000000000001 112.702 172.63 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 26.2 m -120.05 -41.37 2.65 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.134 0.574 . . . . 0.17999999999999999 111.763 174.292 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 84.5 m-70 -73.49 -7.85 53.49 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.712 0.805 . . . . 0.23999999999999999 112.688 -176.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 87.94 149.14 16.85 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 109.825 -1.31 . . . . 1.48 109.825 178.58 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -42.92 -34.89 2.08 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 124.78 1.181 . . . . 0.45000000000000001 112.237 173.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -97.84 -6.99 31.35 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 125.737 1.615 . . . . 2.29 111.537 -171.493 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.2 mt 71.89 10.73 6.22 Favored 'General case' 0 C--N 1.351 0.665 0 CA-C-N 120.604 1.547 . . . . 1.1599999999999999 111.232 176.248 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.7 p -88.79 0.43 56.53 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 128.603 2.761 . . . . 0.35999999999999999 109.992 -173.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.84 124.21 1.73 Allowed Glycine 0 N--CA 1.439 -1.106 0 N-CA-C 109.271 -1.532 . . . . 0.75 109.271 178.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -128.5 -78.74 0.57 Allowed 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 124.368 1.067 . . . . 0.28999999999999998 108.873 177.237 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 21.4 m -93.67 4.55 53.77 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.387 1.075 . . . . 1.28 111.104 172.734 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -152.16 163.28 24.09 Favored Pre-proline 0 CA--C 1.534 0.358 0 C-N-CA 126.096 1.758 . . . . 0.31 107.164 -171.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -70.52 160.59 48.98 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 122.683 2.255 . . . . 0.26000000000000001 110.423 -176.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.52 128.23 34.91 Favored 'General case' 0 C--N 1.332 -0.187 0 O-C-N 121.461 -0.774 . . . . 0.31 110.255 -176.48 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.425 HD12 HD11 ' A' ' 88' ' ' LEU . 26.7 pt -108.21 0.84 9.74 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 C-N-CA 123.904 0.882 . . . . 0.34999999999999998 111.931 177.309 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 22.8 p-10 -33.08 -50.67 0.29 Allowed 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.812 1.645 . . . . 3.8700000000000001 113.243 169.342 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 12.6 pttp -111.96 22.46 14.85 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 125.796 1.638 . . . . 4.8600000000000003 112.054 -178.375 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -54.72 -38.34 66.97 Favored 'General case' 0 C--O 1.224 -0.285 0 O-C-N 121.632 -0.667 . . . . 0.35999999999999999 109.576 177.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -57.96 -17.58 29.91 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 123.862 0.744 . . . . 0.57999999999999996 114.927 176.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -90.0 -39.58 12.87 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 118.295 1.048 . . . . 0.69999999999999996 109.733 172.247 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -63.17 -48.86 76.63 Favored 'General case' 0 CA--C 1.527 0.084 0 C-N-CA 123.129 0.572 . . . . 2.5800000000000001 111.504 178.622 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -141.05 148.88 40.91 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 125.695 1.598 . . . . 0.65000000000000002 107.969 -166.68 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 16.6 m -81.89 167.57 18.83 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 118.39 0.541 . . . . 1.54 110.573 179.194 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -46.9 -43.12 18.57 Favored 'General case' 0 C--O 1.225 -0.225 0 C-N-CA 124.191 0.996 . . . . 3.1000000000000001 111.424 175.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -55.13 -45.62 75.61 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.039 0.936 . . . . 2.6899999999999999 110.568 179.473 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -73.42 -49.42 27.11 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 123.766 0.826 . . . . 3.1200000000000001 109.75 -178.007 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.503 HG23 HMA1 ' A' ' 93' ' ' HEC . 72.8 mt -60.05 -42.76 90.9 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 N-CA-C 108.618 -0.882 . . . . 0.22 108.618 -176.887 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 23.4 tp -55.01 -52.11 64.15 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 123.473 0.709 . . . . 0.40000000000000002 109.739 175.199 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -52.04 -48.31 64.62 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 118.118 0.417 . . . . 1.5 111.136 176.168 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 95.6 mt -57.81 -54.22 34.56 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 O-C-N 121.348 -0.845 . . . . 0.67000000000000004 110.446 177.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 38.3 mt -50.0 -46.02 23.22 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 O-C-N 121.163 -0.961 . . . . 0.34000000000000002 109.909 178.483 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 96.5 mt -62.96 -40.02 96.41 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 118.044 -0.979 . . . . 0.60999999999999999 113.395 177.514 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -127.85 25.45 5.96 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 120.369 1.44 . . . . 1.8400000000000001 110.442 -159.59 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 23.57 -134.98 0.01 OUTLIER Glycine 0 CA--C 1.542 1.758 0 C-N-CA 127.615 2.531 . . . . 0.65000000000000002 112.694 -159.608 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 21.6 tt0 169.25 138.62 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.148 0 CA-C-N 119.799 1.8 . . . . 1.22 108.933 -177.476 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 30.06 -111.15 0.03 OUTLIER Glycine 0 CA--C 1.534 1.247 0 C-N-CA 125.212 1.387 . . . . 0.44 114.154 -171.791 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -66.97 -25.85 73.25 Favored Glycine 0 CA--C 1.534 1.226 0 CA-C-N 118.069 0.935 . . . . 0.55000000000000004 113.415 -178.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 16.7 ttt -70.9 120.67 80.72 Favored Pre-proline 0 CA--C 1.536 0.441 0 C-N-CA 124.747 1.219 . . . . 0.39000000000000001 110.033 -179.448 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -61.89 -56.0 0.9 Allowed 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 124.358 3.372 . . . . 2.96 111.237 -169.139 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 118.25 151.56 9.16 Favored Glycine 0 N--CA 1.447 -0.63 0 CA-C-N 115.58 -0.736 . . . . 0.91000000000000003 113.874 173.33 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 65.73 22.47 70.05 Favored Glycine 0 CA--C 1.528 0.849 0 CA-C-N 114.313 -0.943 . . . . 0.41999999999999998 111.522 -179.165 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 2.6 mt -50.13 -57.51 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 C-N-CA 125.282 1.433 . . . . 1.0600000000000001 109.462 176.107 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -102.62 152.74 20.84 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.36 0.664 . . . . 0.37 109.794 163.538 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 3.2 mmmp? -145.03 151.82 39.16 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.594 1.158 . . . . 3.79 109.598 177.043 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 71.99 -156.67 52.61 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 123.518 0.58 . . . . 0.70999999999999996 111.749 177.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -48.22 -35.59 12.18 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 124.941 1.296 . . . . 0.81999999999999995 112.09 -177.007 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.439 ' HG3' HG21 ' A' ' 27' ' ' VAL . 43.5 tt0 -47.45 -63.53 1.03 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.897 1.279 . . . . 2.1800000000000002 110.715 169.406 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.03 -44.34 94.69 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.979 0.912 . . . . 0.28999999999999998 110.794 -179.275 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -54.59 -52.31 62.55 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 121.219 0.533 . . . . 2.5299999999999998 110.047 179.106 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.13 -51.67 68.76 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.57 0.748 . . . . 0.20999999999999999 109.971 179.329 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 55.7 t -49.55 -56.71 2.67 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 123.027 0.531 . . . . 0.45000000000000001 111.012 176.312 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -53.44 -51.9 61.16 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 124.059 0.944 . . . . 0.19 111.855 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.95 -48.61 80.99 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 121.599 0.714 . . . . 0.28999999999999998 110.434 -179.428 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.529 ' CE3' HD23 ' A' ' 88' ' ' LEU . 49.9 t90 -56.5 -43.35 79.65 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.165 0.586 . . . . 0.40000000000000002 110.303 177.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.529 HD23 ' CE3' ' A' ' 87' ' ' TRP . 0.1 OUTLIER -63.43 -42.31 98.71 Favored 'General case' 0 C--O 1.227 -0.117 0 C-N-CA 123.646 0.778 . . . . 1.5800000000000001 110.862 175.568 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -55.36 -38.15 68.42 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 119.236 0.925 . . . . 0.40999999999999998 110.716 171.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -84.15 13.09 5.49 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.655 1.182 . . . . 3.5299999999999998 113.655 174.063 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.46 122.7 43.37 Favored 'General case' 0 C--N 1.34 0.189 0 CA-C-N 119.954 1.252 . . . . 2.2799999999999998 109.733 173.907 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.255 1.378 0 C-N-CA 127.541 2.336 . . . . 2.8100000000000001 104.959 178.097 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' HEC . . . . . 0.503 HMA1 HG23 ' A' ' 60' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 84.8 t . . . . . 0 N--CA 1.472 0.63 0 N-CA-C 106.853 -1.536 . . . . 1.51 106.853 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -74.87 95.91 3.03 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 107.786 -1.19 . . . . 2.5899999999999999 107.786 -175.14 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -49.69 -50.22 44.51 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.204 1.002 . . . . 0.58999999999999997 109.805 179.675 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -60.61 -51.59 68.77 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 116.002 -0.544 . . . . 3.2000000000000002 110.414 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.99 -45.28 79.06 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 118.916 0.78 . . . . 0.58999999999999997 110.99 -178.767 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.545 HG21 ' HG3' ' A' ' 80' ' ' GLU . 24.5 t -56.64 -56.43 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 CA-C-N 116.12 -0.491 . . . . 0.81000000000000005 109.713 175.92 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.639 HG22 ' SG ' ' A' ' 32' ' ' CYS . 52.2 t -55.68 -45.72 79.22 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 N-CA-C 110.005 -0.369 . . . . 0.40000000000000002 110.005 -178.384 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.439 ' HA ' HG12 ' A' ' 33' ' ' ILE . 26.0 mm-40 -55.72 -11.31 0.91 Allowed 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 127.355 2.262 . . . . 0.83999999999999997 113.859 173.699 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -139.05 16.62 2.63 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 119.63 1.104 . . . . 2.9199999999999999 113.514 173.847 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.431 ' O ' HMC3 ' A' ' 93' ' ' HEC . 23.6 mttm -135.86 -62.79 0.67 Allowed 'General case' 0 CA--C 1.518 -0.257 0 C-N-CA 123.919 0.888 . . . . 2.2799999999999998 109.457 176.807 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.639 ' SG ' HG22 ' A' ' 28' ' ' VAL . 3.2 m -72.71 -47.93 42.99 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.096 0.474 . . . . 0.27000000000000002 110.43 -173.704 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.439 HG12 ' HA ' ' A' ' 29' ' ' GLN . 2.2 pp -58.72 -25.13 27.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 CA-C-N 115.533 -0.758 . . . . 0.38 111.688 -174.483 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.6 m -46.16 -32.93 3.23 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.829 1.251 . . . . 1.1100000000000001 111.768 175.552 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 21.6 m -120.31 -42.57 2.56 Favored 'General case' 0 C--N 1.341 0.21 0 C-N-CA 123.523 0.729 . . . . 0.19 111.516 175.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -72.56 -8.63 56.15 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.577 0.751 . . . . 0.20999999999999999 112.667 -177.321 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 86.46 148.81 12.71 Favored Glycine 0 C--N 1.336 0.567 0 N-CA-C 109.442 -1.463 . . . . 1.47 109.442 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -42.05 -33.43 1.23 Allowed Glycine 0 CA--C 1.527 0.821 0 C-N-CA 125.241 1.401 . . . . 0.47999999999999998 112.914 175.814 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -100.66 -4.8 27.62 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 125.408 1.483 . . . . 3.1099999999999999 112.089 -170.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 13.0 mt 68.94 12.94 8.77 Favored 'General case' 0 C--N 1.352 0.699 0 CA-C-N 120.212 1.369 . . . . 1.0900000000000001 112.002 177.313 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 11.0 p -84.32 -3.63 58.37 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 127.329 2.252 . . . . 0.41999999999999998 110.365 -177.078 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.72 130.7 3.74 Favored Glycine 0 N--CA 1.441 -0.988 0 N-CA-C 108.943 -1.663 . . . . 0.58999999999999997 108.943 -176.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -134.5 -79.44 0.45 Allowed 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 124.285 1.034 . . . . 0.28999999999999998 108.471 177.175 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 19.5 m -91.61 4.28 53.04 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.208 1.003 . . . . 1.3 111.043 173.144 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -155.72 163.95 22.95 Favored Pre-proline 0 CA--C 1.536 0.407 0 C-N-CA 125.388 1.475 . . . . 0.22 107.884 -169.4 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -70.74 157.97 56.99 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.915 2.41 . . . . 0.23999999999999999 110.582 -174.715 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.52 123.44 23.93 Favored 'General case' 0 C--N 1.331 -0.208 0 O-C-N 121.492 -0.755 . . . . 0.23000000000000001 110.16 -175.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 44.0 pt -106.78 2.22 10.09 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.135 0 C-N-CA 124.22 1.008 . . . . 0.29999999999999999 111.132 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.439 ' OD1' ' NZ ' ' A' ' 91' ' ' LYS . 24.4 t0 -42.01 -49.59 4.67 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 118.457 0.571 . . . . 2.8999999999999999 112.149 177.643 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 5.3 pttt -101.28 26.32 7.28 Favored 'General case' 0 C--N 1.344 0.331 0 C-N-CA 125.743 1.617 . . . . 4.7999999999999998 111.698 -178.721 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -53.74 -43.13 68.88 Favored 'General case' 0 N--CA 1.457 -0.122 0 O-C-N 121.483 -0.761 . . . . 0.29999999999999999 110.302 -178.301 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -52.05 -23.82 12.92 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 114.682 0.633 . . . . 0.60999999999999999 114.682 175.438 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -80.99 -35.69 31.67 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 118.061 0.931 . . . . 0.98999999999999999 110.509 175.42 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 -74.2 -48.36 29.53 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 122.814 0.446 . . . . 2.0299999999999998 109.997 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -140.4 153.67 46.42 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.356 1.062 . . . . 0.80000000000000004 109.274 -170.073 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 20.0 m -83.83 166.92 17.53 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 118.485 0.584 . . . . 1.6399999999999999 110.684 178.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.2 pm0 -47.07 -42.41 18.64 Favored 'General case' 0 C--O 1.223 -0.293 0 C-N-CA 124.793 1.237 . . . . 2.79 111.92 178.694 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -58.44 -45.83 87.73 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.378 0.609 . . . . 2.6600000000000001 110.152 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -74.2 -46.68 40.38 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.599 0.76 . . . . 3.2000000000000002 109.134 -176.185 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 62.6 mt -59.32 -44.28 91.95 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.132 0 O-C-N 121.475 -0.766 . . . . 0.38 109.018 179.263 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 52.8 tp -54.43 -51.17 65.79 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 109.14 -0.689 . . . . 0.44 109.14 176.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -52.48 -50.16 63.25 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 123.297 0.373 . . . . 1.5 110.253 174.147 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 76.7 mt -61.65 -24.09 32.88 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 O-C-N 121.323 -0.861 . . . . 1.01 112.621 179.527 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.572 HD11 HMB2 ' A' ' 93' ' ' HEC . 75.1 mt -82.38 -46.66 19.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 O-C-N 120.059 -1.65 . . . . 0.35999999999999999 109.621 176.129 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 68.7 mt -72.64 -30.29 64.19 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.395 1.078 . . . . 0.77000000000000002 112.713 -176.146 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -127.39 17.31 7.06 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 119.207 0.912 . . . . 1.96 109.614 -169.335 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.585 ' N ' ' HA2' ' A' ' 73' ' ' GLY . . . 40.41 -143.87 0.55 Allowed Glycine 0 CA--C 1.539 1.539 0 C-N-CA 127.759 2.6 . . . . 0.70999999999999996 111.814 -177.722 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 31.4 tt0 170.12 138.18 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 126.069 1.748 . . . . 1.2 109.731 -179.734 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 35.76 -116.62 0.28 Allowed Glycine 0 C--N 1.347 1.16 0 CA-C-N 120.46 1.482 . . . . 0.42999999999999999 114.082 -175.778 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -67.32 -23.16 73.27 Favored Glycine 0 CA--C 1.531 1.091 0 CA-C-N 117.98 0.89 . . . . 0.53000000000000003 112.555 -179.297 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 18.6 ttt -72.7 117.96 63.84 Favored Pre-proline 0 CA--C 1.535 0.398 0 C-N-CA 124.45 1.1 . . . . 0.51000000000000001 112.053 179.654 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.417 ' HD2' HD11 ' A' ' 75' ' ' ILE . 37.2 Cg_endo -75.57 123.78 7.8 Favored 'Trans proline' 0 N--CA 1.446 -1.277 0 C-N-CA 122.848 2.366 . . . . 2.1099999999999999 111.706 -179.763 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.585 ' HA2' ' N ' ' A' ' 67' ' ' GLY . . . -58.01 126.67 43.01 Favored Glycine 0 N--CA 1.443 -0.889 0 CA-C-N 115.012 -0.995 . . . . 0.69999999999999996 115.246 179.191 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 86.66 48.01 4.63 Favored Glycine 0 C--N 1.337 0.636 0 N-CA-C 110.648 -0.981 . . . . 0.57999999999999996 110.648 173.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.417 HD11 ' HD2' ' A' ' 72' ' ' PRO . 1.1 mt -69.11 -50.88 49.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 123.833 0.853 . . . . 1.1799999999999999 109.497 175.168 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -102.92 153.63 20.02 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 126.002 1.721 . . . . 0.38 109.619 164.585 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 44.9 mttm -143.63 155.36 44.23 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 125.386 1.475 . . . . 2.79 108.861 178.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 72.63 -167.77 53.43 Favored Glycine 0 CA--C 1.53 0.981 0 N-CA-C 110.926 -0.869 . . . . 0.91000000000000003 110.926 -175.183 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -52.04 -25.95 9.76 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.469 1.108 . . . . 1.0600000000000001 112.728 -177.624 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.545 ' HG3' HG21 ' A' ' 27' ' ' VAL . 34.8 tt0 -42.19 -60.3 1.5 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.723 1.209 . . . . 2.21 110.939 168.778 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.27 -45.73 92.28 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 122.608 0.363 . . . . 0.34000000000000002 110.638 -175.643 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -52.11 -57.12 10.55 Favored 'General case' 0 N--CA 1.461 0.096 0 C-N-CA 123.503 0.721 . . . . 3.04 111.196 174.129 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -53.95 -48.48 70.25 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 123.139 0.576 . . . . 0.29999999999999999 109.812 -177.599 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.402 HG13 ' CG2' ' A' ' 28' ' ' VAL . 98.5 t -59.18 -53.32 49.71 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 N-CA-C 111.588 0.218 . . . . 0.32000000000000001 111.588 177.32 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -51.29 -53.82 31.98 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 124.051 0.941 . . . . 0.28999999999999998 111.455 178.733 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.89 -54.42 47.13 Favored 'General case' 0 C--O 1.224 -0.268 0 N-CA-C 109.299 -0.63 . . . . 0.59999999999999998 109.299 179.332 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.551 ' CE3' HD23 ' A' ' 88' ' ' LEU . 50.2 t90 -49.38 -46.61 47.48 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 122.984 0.514 . . . . 0.51000000000000001 111.134 177.066 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.551 HD23 ' CE3' ' A' ' 87' ' ' TRP . 0.1 OUTLIER -66.05 -31.82 72.93 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 124.585 1.154 . . . . 1.6599999999999999 111.908 177.338 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -67.8 -44.85 76.35 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 118.739 0.7 . . . . 0.57999999999999996 110.731 173.512 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -57.52 -39.76 77.27 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.286 0.634 . . . . 5.2400000000000002 110.196 173.042 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.439 ' NZ ' ' OD1' ' A' ' 49' ' ' ASP . 1.6 mtmp? -73.45 136.22 44.2 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 118.852 0.751 . . . . 2.7799999999999998 110.538 178.074 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 67.8 mttt . . . . . 0 C--O 1.249 1.044 0 CA-C-O 117.189 -1.386 . . . . 2.5899999999999999 108.091 174.704 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 93' ' ' HEC . . . . . 0.572 HMB2 HD11 ' A' ' 64' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.518 HG11 ' HA ' ' A' ' 80' ' ' GLU . 4.1 p . . . . . 0 N--CA 1.475 0.794 0 N-CA-C 105.384 -2.08 . . . . 2.1800000000000002 105.384 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -91.88 95.29 9.75 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 119.439 1.018 . . . . 2.5800000000000001 108.664 -173.21 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -51.84 -58.62 5.92 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.655 0.782 . . . . 0.38 110.906 -178.685 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -50.15 -45.14 52.94 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 118.936 -0.554 . . . . 2.8500000000000001 111.362 176.854 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.99 -47.66 84.91 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 119.033 0.833 . . . . 0.39000000000000001 110.829 179.454 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 89.3 t -56.32 -54.49 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.155 0 N-CA-C 108.934 -0.765 . . . . 0.40000000000000002 108.934 176.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.614 HG13 ' HB2' ' A' ' 32' ' ' CYS . 96.4 t -56.02 -48.21 79.11 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 C-N-CA 122.55 0.34 . . . . 0.40999999999999998 111.037 -177.738 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 36.4 mm-40 -53.67 -15.81 1.37 Allowed 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 126.912 2.085 . . . . 0.48999999999999999 113.036 174.558 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -144.98 48.21 1.31 Allowed 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 119.286 0.948 . . . . 2.46 111.086 174.048 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 3.8 mttt -162.69 -49.28 0.04 OUTLIER 'General case' 0 C--O 1.227 -0.131 0 C-N-CA 124.483 1.113 . . . . 1.9399999999999999 110.206 167.489 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.614 ' HB2' HG13 ' A' ' 28' ' ' VAL . 5.2 m -85.2 -50.11 7.66 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 121.443 0.64 . . . . 0.16 110.417 -172.682 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.4 pp -53.48 -28.63 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 CA-C-N 115.063 -0.971 . . . . 0.40999999999999998 111.487 -178.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.9 m -41.61 -35.14 0.69 Allowed 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 125.574 1.549 . . . . 1.1000000000000001 112.377 173.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 34.9 m -119.23 -41.53 2.73 Favored 'General case' 0 C--N 1.34 0.185 0 C-N-CA 123.546 0.739 . . . . 0.16 111.562 174.417 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 84.4 m-70 -74.18 -7.72 53.66 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.749 0.82 . . . . 0.34999999999999998 112.791 -175.838 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 84.24 148.72 9.29 Favored Glycine 0 C--N 1.338 0.643 0 C-N-CA 125.511 1.529 . . . . 1.52 109.6 -179.516 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -44.49 -36.47 4.46 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 124.41 1.005 . . . . 0.46000000000000002 112.317 174.798 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -88.61 -10.72 47.68 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 124.842 1.257 . . . . 2.0600000000000001 111.454 -174.586 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.4 mt 71.78 10.59 6.31 Favored 'General case' 0 C--N 1.349 0.578 0 CA-C-N 120.197 1.362 . . . . 1.1499999999999999 110.818 176.572 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.4 p -84.06 -0.27 51.13 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 128.415 2.686 . . . . 0.32000000000000001 110.126 -175.456 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.4 138.88 5.84 Favored Glycine 0 N--CA 1.44 -1.071 0 N-CA-C 108.599 -1.801 . . . . 0.44 108.599 -176.554 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -145.35 -78.34 0.19 Allowed 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 123.789 0.836 . . . . 0.23999999999999999 108.932 178.248 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.5 t -89.07 1.7 55.17 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.824 0.85 . . . . 1.25 110.355 174.195 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.457 ' HB1' ' HD2' ' A' ' 46' ' ' PRO . . . -162.43 165.13 15.98 Favored Pre-proline 0 CA--C 1.537 0.467 0 C-N-CA 125.12 1.368 . . . . 0.40000000000000002 107.434 -167.372 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.457 ' HD2' ' HB1' ' A' ' 45' ' ' ALA . 33.3 Cg_endo -66.81 159.52 51.06 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 123.46 2.773 . . . . 0.32000000000000001 111.54 -173.224 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.33 132.19 42.78 Favored 'General case' 0 C--N 1.332 -0.177 0 O-C-N 121.67 -0.643 . . . . 0.39000000000000001 109.867 -178.671 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 35.3 pt -109.03 1.16 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 C-N-CA 123.242 0.617 . . . . 0.28999999999999998 112.516 175.732 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -38.49 -47.4 1.27 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.459 1.104 . . . . 3.5600000000000001 111.811 170.49 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 10.7 mttt -108.52 35.2 3.28 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 125.553 1.541 . . . . 5.6399999999999997 111.683 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.81 -55.28 35.02 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 108.567 -0.901 . . . . 0.44 108.567 169.794 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -57.02 -21.28 37.58 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 124.726 1.155 . . . . 0.75 113.551 -179.246 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.01 -38.91 92.47 Favored 'General case' 0 N--CA 1.451 -0.394 0 O-C-N 121.799 -0.824 . . . . 1.3999999999999999 110.994 177.138 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 72.0 m-80 -105.23 -53.66 2.62 Favored 'General case' 0 CA--C 1.523 -0.076 0 C-N-CA 123.411 0.684 . . . . 2.98 109.937 -174.41 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -94.66 142.34 27.57 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 124.848 1.259 . . . . 1.49 108.929 -171.77 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.5 167.06 17.76 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 118.748 0.704 . . . . 1.8799999999999999 110.167 175.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -48.37 -47.43 37.32 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 124.009 0.924 . . . . 3.04 110.894 174.437 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -54.72 -34.95 63.14 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.39 0.676 . . . . 4.46 111.598 178.632 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -84.44 -47.05 11.04 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 121.533 0.682 . . . . 3.4399999999999999 109.602 -175.365 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.592 HG23 HMA1 ' A' ' 93' ' ' HEC . 87.1 mt -61.48 -41.93 91.93 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 N-CA-C 108.778 -0.823 . . . . 0.31 108.778 179.68 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.4 tp -54.95 -49.46 71.31 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 123.02 0.528 . . . . 0.34999999999999998 109.714 175.638 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -52.1 -52.09 53.59 Favored 'General case' 0 CA--C 1.533 0.306 0 O-C-N 123.271 0.357 . . . . 1.51 110.152 176.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 75.7 mt -57.76 -50.69 76.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.288 0 O-C-N 121.572 -0.705 . . . . 0.54000000000000004 110.311 178.784 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 46.3 mt -54.06 -44.39 62.62 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 O-C-N 120.383 -1.448 . . . . 0.29999999999999999 110.411 179.163 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 84.8 mt -70.5 -32.78 70.42 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 118.33 -0.843 . . . . 0.40000000000000002 112.892 -179.593 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -124.69 18.84 8.7 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 119.752 1.16 . . . . 1.6899999999999999 110.387 -164.581 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.604 ' N ' ' HA2' ' A' ' 73' ' ' GLY . . . 30.81 -137.33 0.07 OUTLIER Glycine 0 CA--C 1.532 1.116 0 C-N-CA 128.819 3.104 . . . . 0.63 111.206 -167.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 11.6 tt0 165.7 129.74 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.518 1.527 . . . . 1.6000000000000001 109.81 -178.192 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 41.04 -118.42 1.26 Allowed Glycine 0 C--N 1.346 1.089 0 CA-C-N 120.865 1.666 . . . . 0.72999999999999998 113.846 -176.764 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -66.07 -17.36 65.55 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 123.711 0.672 . . . . 0.75 112.644 -179.608 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.427 ' HB2' ' C1D' ' A' ' 93' ' ' HEC . 19.4 ttt -81.39 117.74 69.41 Favored Pre-proline 0 N--CA 1.448 -0.531 0 C-N-CA 124.879 1.272 . . . . 0.39000000000000001 111.525 179.063 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.563 ' HD2' HD11 ' A' ' 75' ' ' ILE . 37.5 Cg_endo -77.93 122.64 5.9 Favored 'Trans proline' 0 N--CA 1.447 -1.237 0 C-N-CA 122.992 2.461 . . . . 2.1099999999999999 111.704 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.604 ' HA2' ' N ' ' A' ' 67' ' ' GLY . . . -57.84 132.93 52.8 Favored Glycine 0 N--CA 1.443 -0.853 0 N-CA-C 115.737 1.055 . . . . 0.65000000000000002 115.737 -179.29 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 82.59 34.4 22.57 Favored Glycine 0 CA--C 1.527 0.803 0 CA-C-N 114.228 -0.986 . . . . 0.34000000000000002 112.06 173.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.563 HD11 ' HD2' ' A' ' 72' ' ' PRO . 1.4 mt -53.9 -57.24 6.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 125.256 1.422 . . . . 1.1299999999999999 110.038 174.389 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -101.73 150.06 23.51 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 124.292 1.037 . . . . 0.40999999999999998 108.27 166.429 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 56.2 mttm -142.26 165.25 27.95 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 106.986 -1.487 . . . . 2.7999999999999998 106.986 172.737 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 76.8 -170.29 55.04 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 110.022 -1.231 . . . . 1.26 110.022 -173.457 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -52.35 -30.19 27.52 Favored 'General case' 0 C--O 1.225 -0.222 0 C-N-CA 123.865 0.866 . . . . 0.75 111.15 -176.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.556 ' O ' HG23 ' A' ' 84' ' ' VAL . 11.5 mp0 -39.5 -62.98 0.61 Allowed 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.147 1.379 . . . . 4.54 111.063 170.03 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -58.46 -48.92 79.18 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.207 0.458 . . . . 0.37 111.125 -175.104 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -50.06 -57.63 7.23 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.362 1.065 . . . . 2.0 111.353 175.56 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.95 -43.63 98.44 Favored 'General case' 0 N--CA 1.449 -0.507 0 O-C-N 121.902 -0.499 . . . . 0.44 110.769 -177.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.556 HG23 ' O ' ' A' ' 80' ' ' GLU . 71.3 t -53.97 -53.95 23.89 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 C-N-CA 123.332 0.653 . . . . 0.53000000000000003 109.737 176.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -52.73 -53.53 46.55 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 123.401 0.68 . . . . 0.20999999999999999 112.082 175.426 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.61 -47.14 82.98 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 122.115 0.96 . . . . 0.27000000000000002 110.976 -179.181 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.522 ' CE3' HD23 ' A' ' 88' ' ' LEU . 50.9 t90 -59.86 -42.48 93.78 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.315 1.046 . . . . 0.44 110.273 178.286 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.522 HD23 ' CE3' ' A' ' 87' ' ' TRP . 0.1 OUTLIER -64.25 -38.92 92.75 Favored 'General case' 0 C--N 1.333 -0.116 0 C-N-CA 123.996 0.918 . . . . 1.5900000000000001 110.818 175.552 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -52.81 -45.5 67.28 Favored 'General case' 0 CA--C 1.528 0.12 0 N-CA-C 109.424 -0.584 . . . . 0.52000000000000002 109.424 173.345 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -90.28 36.78 0.88 Allowed 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.216 0.606 . . . . 3.0600000000000001 111.896 175.433 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 4.4 mttm -126.36 136.37 52.62 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.267 1.027 . . . . 2.96 108.702 164.615 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 30.8 mttt . . . . . 0 C--O 1.253 1.256 0 N-CA-C 105.162 -2.162 . . . . 3.4700000000000002 105.162 172.916 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 93' ' ' HEC . . . . . 0.592 HMA1 HG23 ' A' ' 60' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 53.7 t . . . . . 0 N--CA 1.473 0.712 0 N-CA-C 106.965 -1.494 . . . . 1.48 106.965 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -73.8 97.73 2.8 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 118.655 0.661 . . . . 2.52 109.287 -175.022 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -40.84 -51.91 3.09 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 125.012 1.325 . . . . 0.5 111.8 176.097 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -57.02 -46.09 82.59 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 110.146 -0.316 . . . . 2.9300000000000002 110.146 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.1 -43.75 98.41 Favored 'General case' 0 CA--C 1.528 0.109 0 C-N-CA 123.386 0.674 . . . . 0.34000000000000002 110.768 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 89.8 t -58.93 -58.76 5.44 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.261 0 N-CA-C 109.062 -0.718 . . . . 0.55000000000000004 109.062 176.678 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.554 HG21 ' HZ3' ' A' ' 87' ' ' TRP . 44.1 t -53.02 -47.03 54.74 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 C-N-CA 123.224 0.609 . . . . 0.35999999999999999 110.431 -177.114 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.448 ' HA ' HG12 ' A' ' 33' ' ' ILE . 24.7 mm-40 -48.9 -25.91 2.17 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 126.119 1.768 . . . . 0.68000000000000005 113.427 173.784 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -141.01 56.73 1.56 Allowed 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 119.261 0.937 . . . . 3.2599999999999998 111.624 174.537 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.47 -38.12 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 124.145 0.978 . . . . 1.27 110.033 170.442 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.525 ' SG ' HG22 ' A' ' 28' ' ' VAL . 3.4 m -101.18 -50.23 3.85 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 119.27 0.941 . . . . 0.23000000000000001 110.86 -177.868 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.448 HG12 ' HA ' ' A' ' 29' ' ' GLN . 2.2 pp -56.88 -27.07 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 CA-C-N 116.107 -0.497 . . . . 0.40000000000000002 112.027 -174.453 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.7 m -38.64 -35.76 0.21 Allowed 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.635 1.574 . . . . 1.0600000000000001 112.473 170.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 20.9 m -121.02 -44.28 2.41 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.75 0.82 . . . . 0.19 111.371 174.715 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 86.5 m-70 -70.5 -9.55 56.9 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.753 0.821 . . . . 0.20999999999999999 112.897 -176.091 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 88.37 148.08 15.54 Favored Glycine 0 C--N 1.338 0.643 0 N-CA-C 109.816 -1.314 . . . . 1.52 109.816 177.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -44.6 -36.29 4.51 Favored Glycine 0 C--N 1.341 0.807 0 C-N-CA 124.454 1.026 . . . . 0.46999999999999997 111.852 175.579 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -93.7 -6.93 45.12 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 124.909 1.283 . . . . 2.5499999999999998 111.758 -172.9 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 8.9 mt 70.91 11.12 7.07 Favored 'General case' 0 C--N 1.352 0.693 0 CA-C-N 120.237 1.381 . . . . 1.1100000000000001 111.301 177.364 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 11.0 p -86.28 0.88 52.84 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 127.186 2.194 . . . . 0.34999999999999998 109.832 -175.585 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.72 133.19 3.52 Favored Glycine 0 N--CA 1.443 -0.89 0 N-CA-C 108.881 -1.688 . . . . 0.45000000000000001 108.881 -177.566 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -136.42 -75.82 0.43 Allowed 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 108.431 -0.951 . . . . 0.32000000000000001 108.431 178.344 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 9.3 t -95.85 4.17 53.06 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.09 0.956 . . . . 1.53 110.753 173.736 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.508 ' HB1' ' HD2' ' A' ' 46' ' ' PRO . . . -157.92 167.39 14.58 Favored Pre-proline 0 CA--C 1.538 0.488 0 C-N-CA 125.207 1.403 . . . . 0.28000000000000003 108.181 -169.583 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.508 ' HD2' ' HB1' ' A' ' 45' ' ' ALA . 49.3 Cg_endo -71.03 155.63 61.39 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 122.968 2.446 . . . . 0.23000000000000001 110.801 -173.623 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.67 123.28 23.75 Favored 'General case' 0 C--N 1.332 -0.176 0 O-C-N 121.589 -0.695 . . . . 0.28000000000000003 110.57 -176.119 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 45.4 pt -104.46 0.68 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 C-N-CA 123.526 0.73 . . . . 0.32000000000000001 111.801 179.1 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -41.13 -39.29 1.24 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.971 0.908 . . . . 3.0699999999999998 112.396 171.414 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 12.4 mtpt -117.73 34.08 5.32 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 125.187 1.395 . . . . 4.1200000000000001 109.828 -177.339 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.18 -53.59 50.92 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 108.654 -0.869 . . . . 0.45000000000000001 108.654 171.174 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -56.85 -21.76 38.4 Favored Glycine 0 C--N 1.34 0.765 0 C-N-CA 124.116 0.865 . . . . 0.58999999999999997 114.247 -178.614 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -60.91 -38.86 87.22 Favored 'General case' 0 N--CA 1.449 -0.49 0 O-C-N 122.01 -0.7 . . . . 1.3799999999999999 110.636 174.539 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 41.3 m-80 -107.55 -58.9 1.9 Allowed 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 124.356 1.062 . . . . 2.96 110.295 -174.271 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -78.37 149.49 33.37 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.391 1.077 . . . . 1.9099999999999999 110.084 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 29.3 m -94.86 173.94 7.34 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.943 1.297 . . . . 1.6399999999999999 110.13 176.699 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.481 ' HG3' ' HB2' ' A' ' 89' ' ' ALA . 3.5 mp0 -56.64 -53.09 61.65 Favored 'General case' 0 N--CA 1.457 -0.098 0 O-C-N 121.761 -0.587 . . . . 2.8599999999999999 109.825 -176.31 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 35.3 mm-40 -55.38 -32.17 62.39 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.434 0.693 . . . . 4.4500000000000002 111.816 177.334 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -75.97 -50.9 13.6 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 108.635 -0.876 . . . . 2.5499999999999998 108.635 -177.729 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.495 HG23 HMA1 ' A' ' 93' ' ' HEC . 66.4 mt -62.7 -43.47 98.66 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.133 0 O-C-N 121.431 -0.793 . . . . 0.37 108.89 -178.854 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 27.0 tp -55.9 -50.34 70.95 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 109.749 -0.463 . . . . 0.33000000000000002 109.749 176.846 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -51.72 -51.91 52.46 Favored 'General case' 0 CA--C 1.53 0.21 0 O-C-N 123.057 0.223 . . . . 2.2200000000000002 110.503 175.295 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 81.2 mt -57.33 -50.47 76.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 O-C-N 121.781 -0.575 . . . . 0.56000000000000005 109.962 179.673 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.487 HD11 HMB2 ' A' ' 93' ' ' HEC . 71.9 mt -53.35 -42.56 48.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 O-C-N 120.522 -1.361 . . . . 0.38 110.306 178.936 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 68.9 mt -72.23 -32.61 66.89 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 113.736 1.013 . . . . 0.57999999999999996 113.736 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -122.75 20.06 10.19 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 120.176 1.353 . . . . 1.6100000000000001 110.387 -167.255 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.591 ' N ' ' HA2' ' A' ' 73' ' ' GLY . . . 31.05 -133.61 0.11 Allowed Glycine 0 CA--C 1.532 1.107 0 C-N-CA 128.621 3.01 . . . . 0.71999999999999997 111.462 -166.729 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 168.52 130.94 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 119.034 1.417 . . . . 1.54 109.465 -179.308 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 35.41 -111.97 0.1 OUTLIER Glycine 0 CA--C 1.532 1.147 0 CA-C-N 120.116 1.326 . . . . 0.48999999999999999 113.815 -171.392 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -70.92 -20.91 78.07 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 123.367 0.508 . . . . 0.56999999999999995 113.029 -178.472 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.444 ' HB2' ' C1D' ' A' ' 93' ' ' HEC . 19.0 ttt -74.39 120.24 80.48 Favored Pre-proline 0 N--CA 1.45 -0.466 0 C-N-CA 125.15 1.38 . . . . 0.37 110.353 -179.403 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.616 ' HD2' HD11 ' A' ' 75' ' ' ILE . 34.6 Cg_endo -79.73 121.41 4.6 Favored 'Trans proline' 0 N--CA 1.446 -1.319 0 C-N-CA 122.888 2.392 . . . . 2.0299999999999998 111.534 -176.364 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.591 ' HA2' ' N ' ' A' ' 67' ' ' GLY . . . -57.06 134.05 52.44 Favored Glycine 0 N--CA 1.444 -0.792 0 N-CA-C 115.275 0.87 . . . . 0.68999999999999995 115.275 -179.458 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 87.22 38.98 7.54 Favored Glycine 0 CA--C 1.527 0.792 0 CA-C-N 114.353 -0.924 . . . . 0.44 111.709 174.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.616 HD11 ' HD2' ' A' ' 72' ' ' PRO . 2.5 mt -63.79 -59.67 3.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 124.751 1.22 . . . . 1.3100000000000001 110.22 176.777 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -104.18 161.36 14.09 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.632 1.173 . . . . 0.27000000000000002 108.233 165.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 21.5 mttm -145.47 175.92 9.97 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.998 0.919 . . . . 3.5099999999999998 109.659 173.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 57.94 -153.66 25.23 Favored Glycine 0 CA--C 1.531 1.093 0 CA-C-O 121.45 0.472 . . . . 0.64000000000000001 112.537 177.167 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -53.39 -29.93 37.26 Favored 'General case' 0 C--N 1.339 0.13 0 C-N-CA 123.955 0.902 . . . . 0.64000000000000001 111.681 174.079 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -52.42 -61.2 2.43 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 108.612 -0.885 . . . . 2.3900000000000001 108.612 173.69 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -63.28 -51.09 67.54 Favored 'General case' 0 CA--C 1.53 0.209 0 O-C-N 122.187 -0.32 . . . . 0.27000000000000002 111.668 179.725 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -51.34 -52.64 43.65 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 121.034 0.445 . . . . 2.73 111.67 -178.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -56.45 -48.79 76.29 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 109.788 -0.449 . . . . 0.27000000000000002 109.788 -179.096 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.514 HG22 HG23 ' A' ' 28' ' ' VAL . 77.6 t -54.81 -49.97 65.06 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 CA-C-O 119.389 -0.339 . . . . 0.34999999999999998 111.127 176.844 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -51.71 -54.22 30.64 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 122.757 0.423 . . . . 0.34999999999999998 111.34 176.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.06 -44.85 95.8 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 121.269 0.557 . . . . 0.35999999999999999 111.376 -177.4 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.586 ' CE3' HD23 ' A' ' 88' ' ' LEU . 47.9 t90 -60.29 -52.24 66.14 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 121.715 -0.615 . . . . 0.68000000000000005 109.566 177.694 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.586 HD23 ' CE3' ' A' ' 87' ' ' TRP . 0.1 OUTLIER -55.59 -35.27 65.62 Favored 'General case' 0 C--O 1.222 -0.363 0 C-N-CA 124.068 0.947 . . . . 1.5800000000000001 110.369 176.602 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.481 ' HB2' ' HG3' ' A' ' 57' ' ' GLU . . . -59.07 -44.69 91.9 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 118.559 0.618 . . . . 0.5 111.803 176.345 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -72.37 -27.88 62.67 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 110.248 -0.279 . . . . 4.2699999999999996 110.248 173.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 12.3 tptp -69.51 116.4 9.88 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.788 0.835 . . . . 2.4100000000000001 109.774 -175.613 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 23.9 mttt . . . . . 0 C--O 1.256 1.444 0 C-N-CA 128.649 2.779 . . . . 2.75 104.232 -178.128 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 93' ' ' HEC . . . . . 0.495 HMA1 HG23 ' A' ' 60' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 39.5 t . . . . . 0 N--CA 1.471 0.606 0 N-CA-C 107.322 -1.362 . . . . 1.5700000000000001 107.322 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -74.47 104.29 5.14 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 123.585 0.754 . . . . 2.1400000000000001 109.261 -178.285 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -40.82 -55.07 2.54 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 124.096 0.958 . . . . 0.33000000000000002 110.866 175.121 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -59.63 -40.37 87.38 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 119.514 -0.279 . . . . 3.0899999999999999 110.814 -177.332 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.5 -44.78 93.35 Favored 'General case' 0 C--N 1.339 0.125 0 CA-C-N 118.532 0.606 . . . . 0.41999999999999998 110.678 178.664 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 93.8 t -58.58 -53.34 48.23 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.219 0 N-CA-C 109.157 -0.683 . . . . 0.44 109.157 176.084 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 54.2 t -52.28 -48.92 43.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 N-CA-C 110.286 -0.264 . . . . 0.52000000000000002 110.286 179.099 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 28.8 mm-40 -55.14 -18.45 5.72 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 126.05 1.74 . . . . 0.59999999999999998 114.041 174.77 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -150.36 50.65 0.89 Allowed 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 120.046 1.294 . . . . 2.2400000000000002 112.628 178.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.24 -37.34 0.02 OUTLIER 'General case' 0 C--O 1.225 -0.189 0 C-N-CA 126.056 1.742 . . . . 1.21 110.071 170.068 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 4.5 m -98.81 -52.79 3.48 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 119.431 1.014 . . . . 0.17999999999999999 111.423 -176.531 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.5 pp -54.69 -27.4 18.15 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.077 0 CA-C-N 115.878 -0.601 . . . . 0.47999999999999998 111.763 -177.121 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.8 m -40.07 -37.04 0.55 Allowed 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 126.392 1.877 . . . . 1.1899999999999999 112.073 173.77 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 19.1 m -118.8 -40.08 2.9 Favored 'General case' 0 C--N 1.339 0.15 0 C-N-CA 123.115 0.566 . . . . 0.17000000000000001 111.927 173.1 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 83.3 m-70 -72.65 -7.57 50.99 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 112.852 0.686 . . . . 0.29999999999999999 112.852 -175.48 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 86.12 151.35 17.55 Favored Glycine 0 C--N 1.336 0.579 0 N-CA-C 109.324 -1.51 . . . . 1.51 109.324 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -42.41 -36.62 2.26 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 125.019 1.295 . . . . 0.42999999999999999 112.928 178.649 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 44.5 m-20 -102.99 1.34 33.44 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.734 1.214 . . . . 2.1800000000000002 112.342 -172.648 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.422 HD22 ' N ' ' A' ' 40' ' ' LEU . 1.9 mm? 64.12 21.67 12.64 Favored 'General case' 0 C--N 1.35 0.595 0 CA-C-N 120.482 1.492 . . . . 3.4300000000000002 111.415 179.617 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.2 p -84.68 -5.13 59.3 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 127.661 2.384 . . . . 0.32000000000000001 110.016 179.463 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.27 131.6 3.8 Favored Glycine 0 N--CA 1.439 -1.1 0 N-CA-C 108.954 -1.658 . . . . 0.55000000000000004 108.954 -177.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -138.39 -79.97 0.34 Allowed 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.021 0.928 . . . . 0.25 109.44 177.183 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 70.9 m -89.12 4.02 49.88 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.638 0.775 . . . . 1.1799999999999999 111.391 170.228 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -155.85 161.46 29.43 Favored Pre-proline 0 CA--C 1.535 0.373 0 C-N-CA 125.253 1.421 . . . . 0.20999999999999999 107.823 -170.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -66.96 159.67 50.76 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 123.185 2.59 . . . . 0.23000000000000001 111.164 -176.154 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.69 126.86 31.28 Favored 'General case' 0 C--N 1.331 -0.214 0 O-C-N 121.447 -0.783 . . . . 0.25 110.603 -175.808 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 25.4 pt -104.94 0.88 10.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 C-N-CA 123.27 0.628 . . . . 0.48999999999999999 111.581 177.069 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -34.83 -48.03 0.37 Allowed 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.26 1.424 . . . . 2.46 113.595 172.193 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 29.5 pttt -106.92 22.76 15.46 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 124.143 0.977 . . . . 4.1699999999999999 112.017 -176.745 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -54.94 -42.63 72.54 Favored 'General case' 0 N--CA 1.45 -0.43 0 O-C-N 121.548 -0.72 . . . . 0.38 110.261 -176.76 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -55.25 -25.77 41.24 Favored Glycine 0 CA--C 1.529 0.943 0 N-CA-C 114.603 0.601 . . . . 0.51000000000000001 114.603 179.086 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.415 ' HB2' ' HB2' ' A' ' 92' ' ' LYS . . . -84.62 -45.28 12.67 Favored 'General case' 0 CA--C 1.522 -0.119 0 CA-C-N 118.287 1.043 . . . . 0.84999999999999998 109.561 172.161 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -56.36 -46.75 79.85 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 119.555 -0.259 . . . . 2.2400000000000002 111.037 -178.062 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -145.38 151.41 38.23 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.738 1.615 . . . . 0.67000000000000004 108.71 -170.888 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 84.1 p -78.75 170.72 16.22 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 119.374 0.988 . . . . 2.4500000000000002 111.422 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -49.69 -44.27 47.95 Favored 'General case' 0 C--O 1.224 -0.274 0 CA-C-O 118.619 -0.705 . . . . 3.0499999999999998 111.491 174.03 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -56.91 -47.97 79.32 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 118.911 0.778 . . . . 2.3999999999999999 110.461 178.659 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -69.51 -47.23 64.5 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 109.129 -0.693 . . . . 3.27 109.129 -174.613 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 52.3 mt -59.0 -48.28 87.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 109.249 -0.649 . . . . 0.33000000000000002 109.249 179.587 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 41.3 tp -54.82 -50.32 68.86 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 123.668 0.787 . . . . 0.35999999999999999 109.076 178.735 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -55.01 -47.86 74.12 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 110.305 -0.258 . . . . 2.2799999999999998 110.305 175.838 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 46.7 mt -61.47 -33.82 58.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 O-C-N 121.018 -1.051 . . . . 0.60999999999999999 111.812 178.427 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.501 HD11 HMB2 ' A' ' 93' ' ' HEC . 75.8 mt -68.77 -48.17 72.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 O-C-N 120.157 -1.589 . . . . 0.23000000000000001 108.986 175.082 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 92.9 mt -69.37 -31.24 69.51 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.43 1.092 . . . . 0.37 113.177 -176.053 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 22.3 m-20 -121.51 13.72 10.98 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 119.445 1.02 . . . . 1.77 109.735 -168.073 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.528 ' N ' ' HA2' ' A' ' 73' ' ' GLY . . . 40.14 -146.78 0.27 Allowed Glycine 0 CA--C 1.54 1.654 0 C-N-CA 127.604 2.526 . . . . 0.63 111.325 -169.164 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 10.6 tt0 178.29 135.65 0.08 Allowed 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 125.104 1.362 . . . . 1.1299999999999999 108.596 -177.518 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 37.77 -114.6 0.3 Allowed Glycine 0 CA--C 1.533 1.198 0 CA-C-N 119.86 1.209 . . . . 0.40000000000000002 113.361 -172.747 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -74.77 -20.53 79.46 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 123.289 0.471 . . . . 0.58999999999999997 113.064 -179.681 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.447 ' HB2' ' C1D' ' A' ' 93' ' ' HEC . 21.3 ttt -67.42 119.19 63.53 Favored Pre-proline 0 N--CA 1.452 -0.373 0 C-N-CA 124.269 1.028 . . . . 0.41999999999999998 110.662 179.509 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -76.22 123.93 7.52 Favored 'Trans proline' 0 N--CA 1.446 -1.321 0 C-N-CA 122.698 2.265 . . . . 2.1499999999999999 110.795 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.528 ' HA2' ' N ' ' A' ' 67' ' ' GLY . . . -65.05 141.82 43.94 Favored Glycine 0 N--CA 1.442 -0.958 0 N-CA-C 115.349 0.9 . . . . 0.60999999999999999 115.349 -176.333 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 78.34 33.42 39.62 Favored Glycine 0 CA--C 1.524 0.649 0 CA-C-N 114.047 -1.077 . . . . 0.34999999999999998 110.84 175.746 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -56.53 -49.93 75.33 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 C-N-CA 124.407 1.083 . . . . 1.02 109.022 173.486 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -111.95 154.02 25.89 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.411 1.485 . . . . 0.39000000000000001 110.409 165.218 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 4.7 mmmt -139.02 158.71 43.71 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.197 1.799 . . . . 3.0499999999999998 109.896 179.609 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 56.13 -141.04 41.17 Favored Glycine 0 CA--C 1.528 0.892 0 N-CA-C 111.164 -0.775 . . . . 0.75 111.164 178.025 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -51.23 -36.65 42.78 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 117.496 0.648 . . . . 0.93000000000000005 111.542 176.87 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -57.15 -37.0 71.41 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 122.892 0.477 . . . . 2.4100000000000001 110.023 178.499 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -82.94 -56.6 3.71 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.212 0.605 . . . . 0.34999999999999998 110.522 176.681 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -51.93 -52.21 51.68 Favored 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 124.543 1.137 . . . . 3.0600000000000001 112.076 -176.331 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.04 -47.45 83.07 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 109.644 -0.502 . . . . 0.31 109.644 -177.109 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.446 HG11 HMB1 ' A' ' 93' ' ' HEC . 78.9 t -59.01 -56.37 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 C-N-CA 122.895 0.478 . . . . 0.27000000000000002 110.532 178.387 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -47.78 -56.12 8.11 Favored 'General case' 0 C--O 1.226 -0.146 0 C-N-CA 123.369 0.668 . . . . 0.17999999999999999 111.296 177.151 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.77 -45.75 92.54 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.371 0.669 . . . . 0.35999999999999999 110.887 -176.621 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 79.1 t90 -57.04 -52.41 65.39 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 121.713 -0.617 . . . . 0.59999999999999998 109.722 177.295 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.74 -31.08 71.23 Favored 'General case' 0 C--O 1.223 -0.32 0 CA-C-O 118.603 -0.713 . . . . 1.8899999999999999 112.654 175.818 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.08 -26.57 60.62 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 119.491 1.041 . . . . 0.75 111.534 172.706 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -90.81 -29.67 17.45 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 112.938 0.718 . . . . 4.9299999999999997 112.938 171.487 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 19.7 mtpp -74.64 103.95 5.13 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 119.721 1.146 . . . . 3.04 110.633 174.227 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.415 ' HB2' ' HB2' ' A' ' 53' ' ' ALA . 20.2 pttt . . . . . 0 C--O 1.25 1.11 0 C-N-CA 126.298 1.839 . . . . 2.75 106.354 -175.351 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' HEC . . . . . 0.501 HMB2 HD11 ' A' ' 64' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 25.1 t . . . . . 0 N--CA 1.471 0.587 0 N-CA-C 106.456 -1.683 . . . . 1.25 106.456 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -78.5 111.4 14.5 Favored 'General case' 0 N--CA 1.451 -0.398 0 O-C-N 123.79 0.681 . . . . 3.8300000000000001 109.307 -176.837 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -52.9 -45.03 67.35 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 123.921 0.888 . . . . 0.41999999999999998 111.608 -178.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -64.48 -48.91 73.43 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 108.195 -1.039 . . . . 3.3300000000000001 108.195 -176.691 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.97 -47.61 74.33 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 123.44 0.696 . . . . 0.31 111.333 177.249 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 74.1 t -55.97 -55.64 17.05 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.12 0 N-CA-C 109.525 -0.546 . . . . 0.40999999999999998 109.525 177.148 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.574 HG22 ' SG ' ' A' ' 32' ' ' CYS . 5.6 t -54.75 -49.4 68.91 Favored 'Isoleucine or valine' 0 C--O 1.239 0.525 0 CA-C-N 117.851 0.296 . . . . 0.38 111.265 -178.33 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.402 ' HA ' HG12 ' A' ' 33' ' ' ILE . 35.8 mm-40 -52.65 -14.86 0.58 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 126.732 2.013 . . . . 0.46999999999999997 112.984 173.554 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.77 47.76 1.64 Allowed 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 119.469 1.031 . . . . 3.7200000000000002 111.514 173.17 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.71 -42.7 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.16 0 O-C-N 121.915 -0.49 . . . . 1.1799999999999999 110.485 169.205 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.574 ' SG ' HG22 ' A' ' 28' ' ' VAL . 3.6 m -93.36 -48.45 6.41 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 118.284 0.493 . . . . 0.16 110.026 -173.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.402 HG12 ' HA ' ' A' ' 29' ' ' GLN . 2.4 pp -51.65 -31.61 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 CA-C-N 115.977 -0.556 . . . . 0.54000000000000004 111.962 -179.302 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 20.0 m -38.47 -37.31 0.3 Allowed 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 125.748 1.619 . . . . 1.0600000000000001 112.73 173.234 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 21.5 m -121.3 -40.01 2.63 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 123.069 0.548 . . . . 0.19 112.009 173.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 82.2 m-70 -71.79 -7.66 49.57 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.616 0.766 . . . . 0.22 112.755 -177.197 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 84.44 148.29 9.16 Favored Glycine 0 C--N 1.337 0.602 0 N-CA-C 109.296 -1.522 . . . . 1.49 109.296 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -41.69 -35.11 1.35 Allowed Glycine 0 CA--C 1.527 0.843 0 C-N-CA 124.73 1.157 . . . . 0.48999999999999999 112.496 174.003 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -95.39 -8.48 35.51 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 124.961 1.305 . . . . 2.3799999999999999 111.264 -169.522 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.3 mt 72.33 6.89 5.6 Favored 'General case' 0 C--N 1.348 0.534 0 CA-C-N 120.136 1.334 . . . . 1.28 111.398 178.493 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 16.0 p -83.92 0.27 48.48 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 127.176 2.19 . . . . 0.39000000000000001 110.102 -175.579 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.09 150.03 21.56 Favored Glycine 0 N--CA 1.436 -1.339 0 N-CA-C 108.855 -1.698 . . . . 0.53000000000000003 108.855 -173.564 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -156.33 -78.03 0.09 Allowed 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 124.609 1.164 . . . . 0.26000000000000001 108.863 177.603 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.0 m -97.37 2.63 50.77 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.448 1.099 . . . . 1.3300000000000001 111.216 170.063 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -148.14 162.05 32.19 Favored Pre-proline 0 CA--C 1.535 0.372 0 C-N-CA 126.999 2.12 . . . . 0.42999999999999999 107.159 -176.191 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -71.26 163.15 40.13 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 123.219 2.613 . . . . 0.25 111.203 -176.135 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -74.93 113.58 12.4 Favored 'General case' 0 C--N 1.332 -0.19 0 O-C-N 121.73 -0.607 . . . . 0.29999999999999999 111.235 -174.618 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 48.1 pt -97.07 0.66 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 C-N-CA 123.307 0.643 . . . . 0.28999999999999998 111.797 178.73 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -48.88 -34.9 13.54 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.154 0.581 . . . . 3.3399999999999999 112.319 176.622 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.2 pttm -115.43 38.66 3.18 Favored 'General case' 0 C--N 1.343 0.311 0 C-N-CA 124.82 1.248 . . . . 3.4300000000000002 111.216 175.4 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.73 -55.75 20.87 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 108.076 -1.083 . . . . 0.47999999999999998 108.076 168.208 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -54.08 -27.0 36.91 Favored Glycine 0 C--N 1.339 0.717 0 C-N-CA 124.675 1.131 . . . . 0.64000000000000001 113.695 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.95 -38.44 75.97 Favored 'General case' 0 N--CA 1.449 -0.488 0 O-C-N 121.957 -0.731 . . . . 1.45 111.446 175.545 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 47.3 m-80 -107.85 -57.73 2.06 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 124.318 1.047 . . . . 2.8999999999999999 110.819 -174.166 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -89.51 149.47 22.89 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 125.086 1.354 . . . . 0.80000000000000004 109.06 -174.297 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 60.7 m -94.29 164.11 13.16 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 122.961 0.505 . . . . 1.49 110.643 179.433 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.1 tm-20 -40.9 -64.39 0.54 Allowed 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.023 1.329 . . . . 5.6600000000000001 111.002 178.74 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -41.12 -47.02 3.14 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.936 1.294 . . . . 4.1100000000000003 112.905 174.671 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 61.1 mm-40 -69.55 -47.27 64.25 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 122.23 1.014 . . . . 3.3300000000000001 108.573 -174.456 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 61.5 mt -61.46 -44.18 98.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-N 115.948 -0.569 . . . . 0.27000000000000002 109.503 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 35.3 tp -55.31 -53.39 56.77 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 124.366 1.066 . . . . 0.38 109.163 175.738 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -49.72 -52.31 32.32 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 117.992 0.36 . . . . 1.53 110.389 175.574 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 87.4 mt -60.31 -37.65 74.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 119.744 -0.783 . . . . 0.47999999999999998 111.557 179.671 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.545 HD11 HMB2 ' A' ' 93' ' ' HEC . 60.5 mt -61.53 -46.81 95.78 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 O-C-N 120.041 -1.662 . . . . 0.32000000000000001 109.851 173.722 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 85.6 mt -67.14 -32.17 73.1 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 117.179 -1.391 . . . . 0.47999999999999998 114.479 -171.205 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -139.05 30.57 2.22 Favored 'General case' 0 C--N 1.344 0.362 0 CA-C-N 120.191 1.359 . . . . 3.2200000000000002 110.112 -171.119 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 35.08 -141.28 0.13 Allowed Glycine 0 CA--C 1.542 1.754 0 C-N-CA 128.122 2.772 . . . . 0.65000000000000002 112.81 -175.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 172.46 136.45 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.58 1.552 . . . . 1.8200000000000001 108.022 -175.283 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 28.83 -106.7 0.01 OUTLIER Glycine 0 CA--C 1.534 1.222 0 C-N-CA 125.519 1.533 . . . . 0.44 114.785 -176.455 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -66.07 -27.27 72.75 Favored Glycine 0 CA--C 1.537 1.428 0 CA-C-N 117.769 0.784 . . . . 0.68000000000000005 113.562 -178.479 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 15.8 ttt -76.47 123.04 87.69 Favored Pre-proline 0 CA--C 1.54 0.567 0 C-N-CA 125.888 1.675 . . . . 0.42999999999999999 110.683 -178.126 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -62.32 -56.66 0.63 Allowed 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 124.462 3.441 . . . . 3.0 111.781 -168.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 118.24 144.92 7.72 Favored Glycine 0 N--CA 1.449 -0.482 0 CA-C-N 115.795 -0.639 . . . . 0.90000000000000002 114.228 172.453 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 67.82 26.79 73.76 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.907 -0.877 . . . . 0.35999999999999999 110.907 -174.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 2.0 mm -52.01 -51.88 26.92 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 124.561 1.144 . . . . 2.1299999999999999 110.11 177.338 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -112.27 159.42 18.64 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.478 1.111 . . . . 0.41999999999999998 108.974 161.465 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 21.3 mttp -146.01 158.09 43.87 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.35 1.06 . . . . 3.6600000000000001 110.147 175.057 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 64.67 -153.35 49.66 Favored Glycine 0 CA--C 1.53 0.992 0 N-CA-C 111.343 -0.703 . . . . 0.83999999999999997 111.343 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -45.61 -38.6 6.75 Favored 'General case' 0 C--N 1.34 0.186 0 C-N-CA 124.855 1.262 . . . . 0.63 112.154 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -50.51 -52.93 34.04 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.423 1.089 . . . . 2.1499999999999999 110.396 175.006 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -71.32 -48.0 53.19 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.649 0.78 . . . . 0.25 110.853 179.261 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -53.97 -50.67 66.02 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.826 0.85 . . . . 2.6699999999999999 110.708 -176.623 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -55.19 -49.54 71.64 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 123.071 0.548 . . . . 0.26000000000000001 110.286 178.776 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.495 HG22 HG23 ' A' ' 28' ' ' VAL . 53.8 t -58.12 -52.9 52.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 CA-C-O 119.343 -0.36 . . . . 0.39000000000000001 110.986 178.499 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -49.26 -52.49 27.01 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 123.341 0.656 . . . . 0.20000000000000001 111.452 176.55 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.75 -51.88 67.45 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 121.46 0.648 . . . . 0.33000000000000002 110.215 -177.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.535 ' CE3' HD23 ' A' ' 88' ' ' LEU . 48.9 t90 -54.84 -43.18 72.82 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 122.757 0.423 . . . . 0.52000000000000002 110.69 177.872 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.535 HD23 ' CE3' ' A' ' 87' ' ' TRP . 0.1 OUTLIER -65.96 -37.73 86.76 Favored 'General case' 0 C--O 1.227 -0.118 0 C-N-CA 124.504 1.121 . . . . 1.6399999999999999 110.712 178.271 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -52.96 -42.75 65.79 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 119.0 0.818 . . . . 0.47999999999999998 109.55 171.388 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -85.79 21.6 1.85 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.439 1.095 . . . . 4.1699999999999999 112.405 175.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 4.7 mtpm? -116.68 139.43 50.56 Favored 'General case' 0 C--N 1.342 0.253 0 CA-C-O 122.256 1.027 . . . . 2.4100000000000001 109.956 167.724 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 53.2 mttm . . . . . 0 C--O 1.25 1.116 0 C-N-CA 129.206 3.002 . . . . 3.4199999999999999 103.152 177.606 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 93' ' ' HEC . . . . . 0.545 HMB2 HD11 ' A' ' 64' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.5 t . . . . . 0 N--CA 1.471 0.588 0 N-CA-C 106.882 -1.525 . . . . 1.1899999999999999 106.882 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -75.94 104.43 6.47 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 108.475 -0.935 . . . . 2.3799999999999999 108.475 -176.591 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -41.15 -54.54 2.86 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 124.554 1.141 . . . . 0.31 110.708 175.542 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -58.39 -46.77 85.72 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 115.805 -0.634 . . . . 3.1600000000000001 110.272 -178.128 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.2 -44.51 92.24 Favored 'General case' 0 C--N 1.34 0.159 0 C-N-CA 123.125 0.57 . . . . 0.31 111.147 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 77.8 t -57.81 -56.88 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 N-CA-C 109.279 -0.638 . . . . 0.33000000000000002 109.279 175.559 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.724 HG11 HD21 ' A' ' 40' ' ' LEU . 71.7 t -54.0 -48.65 63.71 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 CA-C-N 117.933 0.333 . . . . 0.34999999999999998 110.494 -176.862 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.404 ' HA ' HG12 ' A' ' 33' ' ' ILE . 28.0 mm-40 -47.94 -24.69 1.1 Allowed 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 126.261 1.824 . . . . 0.64000000000000001 112.872 174.532 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -141.26 51.56 1.58 Allowed 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 119.144 0.884 . . . . 2.6000000000000001 111.642 173.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.68 -36.63 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 124.319 1.048 . . . . 1.22 111.211 166.722 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.699 ' HB2' HG13 ' A' ' 28' ' ' VAL . 3.8 m -101.89 -50.87 3.55 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 119.159 0.89 . . . . 0.23000000000000001 110.954 -174.81 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.404 HG12 ' HA ' ' A' ' 29' ' ' GLN . 2.2 pp -54.41 -29.37 19.92 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.082 0 CA-C-N 116.369 -0.378 . . . . 0.40999999999999998 111.949 -176.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 10.0 m -35.26 -41.71 0.17 Allowed 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 125.507 1.523 . . . . 1.0800000000000001 112.81 171.179 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 22.4 m -114.86 -35.63 4.73 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.294 0.638 . . . . 0.14999999999999999 111.839 174.681 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 89.4 m-70 -80.66 2.09 27.28 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.226 1.01 . . . . 0.40000000000000002 113.314 -175.314 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 107.78 -80.96 0.28 Allowed Glycine 0 CA--C 1.525 0.668 0 C-N-CA 125.747 1.641 . . . . 2.8999999999999999 111.785 165.149 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -175.24 -52.51 0.06 OUTLIER Glycine 0 CA--C 1.519 0.304 0 N-CA-C 108.441 -1.864 . . . . 0.90000000000000002 108.441 -171.604 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -97.71 4.6 49.94 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 124.452 1.101 . . . . 3.3199999999999998 111.076 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.724 HD21 HG11 ' A' ' 28' ' ' VAL . 1.2 mt 76.15 14.33 2.51 Favored 'General case' 0 C--N 1.351 0.661 0 CA-C-N 119.85 1.205 . . . . 1.75 110.007 -179.618 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.0 p -76.27 -13.37 60.16 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 128.11 2.564 . . . . 0.60999999999999999 109.822 -178.631 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.98 154.02 30.62 Favored Glycine 0 N--CA 1.442 -0.9 0 N-CA-C 108.449 -1.86 . . . . 0.68000000000000005 108.449 -178.356 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -156.8 -76.89 0.09 Allowed 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.457 -0.572 . . . . 0.28999999999999998 109.457 177.61 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 19.6 t -93.55 4.17 54.37 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 122.854 0.462 . . . . 1.54 110.483 172.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -157.53 163.01 26.25 Favored Pre-proline 0 N--CA 1.448 -0.56 0 C-N-CA 126.242 1.817 . . . . 0.29999999999999999 107.195 -166.232 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -67.72 162.85 37.6 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 123.044 2.496 . . . . 0.27000000000000002 111.193 -172.874 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -76.03 122.32 24.05 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 122.95 0.5 . . . . 0.27000000000000002 109.693 -178.587 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 47.9 pt -107.95 2.79 9.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 123.739 0.816 . . . . 0.47999999999999998 112.063 178.596 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.444 ' OD1' ' NZ ' ' A' ' 91' ' ' LYS . 28.4 t70 -45.25 -45.99 12.24 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 113.125 0.787 . . . . 2.79 113.125 175.475 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.5 mptp? -100.92 26.62 6.74 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.999 1.32 . . . . 6.21 109.837 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -52.9 -45.6 67.61 Favored 'General case' 0 N--CA 1.453 -0.277 0 O-C-N 121.345 -0.847 . . . . 0.28000000000000003 109.318 177.301 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -54.84 -22.26 26.1 Favored Glycine 0 CA--C 1.528 0.883 0 N-CA-C 115.021 0.768 . . . . 0.60999999999999999 115.021 177.047 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -81.54 -36.01 29.64 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 118.387 1.093 . . . . 0.96999999999999997 110.513 174.021 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -76.55 -48.55 18.96 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 123.08 0.552 . . . . 1.95 111.003 -178.721 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -141.21 143.97 34.47 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.699 1.6 . . . . 0.76000000000000001 107.756 -167.407 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 69.7 m -83.91 169.86 14.62 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 119.57 1.077 . . . . 1.74 111.096 178.824 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -51.03 -43.68 60.94 Favored 'General case' 0 C--O 1.222 -0.376 0 CA-C-O 118.602 -0.713 . . . . 2.73 112.681 -175.927 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -52.66 -45.69 66.84 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 119.057 0.844 . . . . 2.6600000000000001 111.055 176.079 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -71.17 -51.01 27.3 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 108.96 -0.756 . . . . 3.48 108.96 -176.38 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.586 HG23 HMA1 ' A' ' 93' ' ' HEC . 71.5 mt -58.11 -44.9 88.36 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 N-CA-C 108.765 -0.828 . . . . 0.20999999999999999 108.765 -177.724 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 19.4 tp -56.27 -51.03 69.67 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 124.47 1.108 . . . . 0.67000000000000004 109.401 177.542 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -53.92 -48.62 70.0 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 117.832 0.287 . . . . 1.46 111.345 175.277 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 93.0 mt -55.53 -54.88 20.8 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.211 0 O-C-N 121.526 -0.733 . . . . 0.69999999999999996 109.443 177.262 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.527 HD11 HMB2 ' A' ' 93' ' ' HEC . 52.2 mt -50.68 -46.54 28.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 O-C-N 120.807 -1.183 . . . . 0.20000000000000001 110.154 178.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 61.3 mt -64.17 -31.72 73.02 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 117.685 -1.15 . . . . 0.59999999999999998 113.541 178.616 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -131.63 20.09 4.69 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 120.278 1.399 . . . . 1.8100000000000001 111.109 -163.308 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 29.41 -141.0 0.02 OUTLIER Glycine 0 CA--C 1.543 1.809 0 C-N-CA 127.295 2.379 . . . . 0.67000000000000004 113.048 -160.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 37.4 tt0 174.63 141.72 0.05 OUTLIER 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 126.198 1.799 . . . . 1.8500000000000001 106.977 -176.537 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 22.25 -100.39 0.01 OUTLIER Glycine 0 CA--C 1.535 1.328 0 C-N-CA 126.094 1.807 . . . . 0.60999999999999999 114.822 -173.378 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -68.31 -34.08 79.31 Favored Glycine 0 CA--C 1.539 1.553 0 CA-C-N 118.802 1.301 . . . . 0.78000000000000003 113.485 -178.167 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.453 ' HG3' ' C4C' ' A' ' 93' ' ' HEC . 0.1 OUTLIER -55.55 130.99 71.13 Favored Pre-proline 0 CA--C 1.539 0.538 0 C-N-CA 124.044 0.938 . . . . 0.75 112.282 176.616 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -63.8 -57.23 0.38 Allowed 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 123.895 3.063 . . . . 3.0299999999999998 110.857 178.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 116.74 146.68 8.52 Favored Glycine 0 C--N 1.335 0.497 0 C-N-CA 124.194 0.902 . . . . 0.82999999999999996 113.761 173.64 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 69.45 24.56 76.07 Favored Glycine 0 CA--C 1.529 0.952 0 N-CA-C 111.558 -0.617 . . . . 0.46000000000000002 111.558 -179.671 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.7 mt -52.61 -58.49 2.59 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 C-N-CA 126.212 1.805 . . . . 1.1299999999999999 110.982 179.172 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -103.48 158.33 16.43 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.162 0.985 . . . . 0.39000000000000001 108.967 162.786 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 4.9 mmtp -145.12 166.36 25.63 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.574 1.55 . . . . 2.96 108.783 179.505 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 56.94 -147.51 33.75 Favored Glycine 0 CA--C 1.532 1.135 0 O-C-N 121.741 -0.599 . . . . 0.67000000000000004 112.491 176.662 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -50.23 -36.94 33.09 Favored 'General case' 0 C--N 1.34 0.186 0 C-N-CA 123.809 0.843 . . . . 0.73999999999999999 111.255 175.635 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -52.78 -51.55 60.24 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.802 0.841 . . . . 2.02 109.599 176.16 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -69.51 -52.05 30.11 Favored 'General case' 0 CA--C 1.53 0.209 0 O-C-N 122.035 -0.416 . . . . 0.28000000000000003 111.477 177.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -50.77 -56.23 13.04 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 123.117 0.567 . . . . 2.5899999999999999 111.547 -177.617 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -55.38 -50.0 70.85 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 109.686 -0.487 . . . . 0.39000000000000001 109.686 -175.866 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.582 HG22 HG23 ' A' ' 28' ' ' VAL . 54.4 t -55.26 -56.59 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 C-N-CA 123.006 0.522 . . . . 0.32000000000000001 111.395 176.745 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -52.6 -50.88 62.18 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.343 0.657 . . . . 0.29999999999999999 111.267 -178.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.79 -47.63 85.43 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.111 0.564 . . . . 0.39000000000000001 110.365 -179.408 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.55 ' CE3' HD23 ' A' ' 88' ' ' LEU . 53.5 t90 -56.73 -50.44 72.21 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 121.991 -0.443 . . . . 0.51000000000000001 110.164 177.31 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.55 HD23 ' CE3' ' A' ' 87' ' ' TRP . 0.1 OUTLIER -60.77 -34.93 75.21 Favored 'General case' 0 C--O 1.226 -0.184 0 C-N-CA 124.31 1.044 . . . . 1.6499999999999999 110.802 177.548 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -67.09 -40.74 87.02 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 118.187 0.448 . . . . 0.72999999999999998 110.978 176.011 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -61.39 -40.17 93.36 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 122.856 0.462 . . . . 4.1100000000000003 110.643 171.855 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.444 ' NZ ' ' OD1' ' A' ' 49' ' ' ASP . 0.0 OUTLIER -73.31 105.66 4.8 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 121.527 -0.733 . . . . 2.1000000000000001 110.169 178.983 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.163 0 CA-C-O 117.578 -1.201 . . . . 2.8199999999999998 109.559 -177.5 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' HEC . . . . . 0.586 HMA1 HG23 ' A' ' 60' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 18.7 t . . . . . 0 N--CA 1.469 0.486 0 N-CA-C 107.284 -1.376 . . . . 1.1899999999999999 107.284 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -78.38 101.26 7.15 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 108.153 -1.055 . . . . 2.2400000000000002 108.153 -173.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -41.07 -55.14 2.66 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.747 1.219 . . . . 0.28000000000000003 111.519 177.197 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -51.87 -46.91 64.67 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 123.157 0.583 . . . . 2.98 111.785 176.779 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.67 -45.65 89.14 Favored 'General case' 0 N--CA 1.457 -0.104 0 CA-C-N 118.442 0.564 . . . . 0.26000000000000001 110.442 -177.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 72.8 t -57.07 -57.71 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 N-CA-C 109.007 -0.738 . . . . 0.34000000000000002 109.007 175.514 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.518 HG23 HG22 ' A' ' 84' ' ' VAL . 25.6 t -47.92 -50.83 9.58 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 C-N-CA 124.305 1.042 . . . . 0.41999999999999998 110.64 -178.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.434 ' HA ' HG12 ' A' ' 33' ' ' ILE . 30.8 mm-40 -53.1 -25.21 12.21 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 125.811 1.645 . . . . 0.56999999999999995 113.398 176.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 11.0 mt-30 -137.69 59.37 1.67 Allowed 'General case' 0 N--CA 1.456 -0.14 0 CA-C-N 119.309 0.959 . . . . 2.25 111.719 172.11 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 5.1 mttt -172.2 -36.46 0.01 OUTLIER 'General case' 0 C--O 1.224 -0.249 0 C-N-CA 124.204 1.002 . . . . 2.1499999999999999 110.322 168.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.427 ' SG ' HMB1 ' A' ' 93' ' ' HEC . 4.0 m -101.22 -52.62 3.21 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 119.426 1.012 . . . . 0.16 111.312 -177.502 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.434 HG12 ' HA ' ' A' ' 29' ' ' GLN . 2.2 pp -55.83 -26.66 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.095 0 CA-C-N 115.99 -0.55 . . . . 0.44 111.614 -177.376 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.1 t -40.17 -36.03 0.46 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.37 1.468 . . . . 1.8799999999999999 111.83 173.563 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 32.9 m -118.78 -40.06 2.91 Favored 'General case' 0 C--N 1.342 0.259 0 C-N-CA 123.539 0.736 . . . . 0.17000000000000001 111.908 174.425 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 87.1 m-70 -75.89 -7.11 53.75 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 113.171 0.804 . . . . 0.26000000000000001 113.171 -174.789 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 86.26 150.26 15.46 Favored Glycine 0 C--N 1.337 0.625 0 N-CA-C 110.034 -1.227 . . . . 1.55 110.034 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -43.56 -39.19 4.41 Favored Glycine 0 C--N 1.34 0.801 0 C-N-CA 124.76 1.172 . . . . 0.41999999999999998 112.338 178.259 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -97.65 -0.83 44.91 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 124.366 1.066 . . . . 2.21 110.959 -171.672 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.2 mp 67.41 15.8 9.93 Favored 'General case' 0 C--N 1.349 0.558 0 CA-C-N 120.11 1.323 . . . . 1.5 111.432 176.538 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 6.9 p -83.43 -1.73 54.18 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 128.132 2.573 . . . . 0.33000000000000002 109.906 -178.008 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.98 144.71 9.72 Favored Glycine 0 N--CA 1.438 -1.174 0 N-CA-C 108.552 -1.819 . . . . 0.40999999999999998 108.552 -175.076 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -150.15 -80.38 0.12 Allowed 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 124.406 1.083 . . . . 0.25 108.939 177.616 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 58.7 m -91.56 3.64 54.52 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.812 0.845 . . . . 1.1599999999999999 111.422 170.6 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -154.38 163.41 24.27 Favored Pre-proline 0 N--CA 1.45 -0.469 0 C-N-CA 125.88 1.672 . . . . 0.25 107.197 -172.472 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -68.27 163.89 34.53 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.618 2.212 . . . . 0.40000000000000002 110.877 -176.257 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -74.27 122.74 23.33 Favored 'General case' 0 N--CA 1.455 -0.193 0 O-C-N 121.931 -0.481 . . . . 0.23999999999999999 110.306 -177.047 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 35.3 pt -105.78 0.88 10.16 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.181 0 C-N-CA 123.713 0.805 . . . . 0.32000000000000001 110.917 177.733 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -39.32 -45.41 1.43 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.059 0.944 . . . . 2.3999999999999999 112.409 169.758 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.59 15.97 21.81 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.129 0.972 . . . . 4.7400000000000002 111.13 -175.18 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -56.39 -47.28 79.26 Favored 'General case' 0 N--CA 1.452 -0.326 0 O-C-N 121.198 -0.939 . . . . 0.33000000000000002 110.069 -171.81 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -54.7 -26.62 40.21 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 114.447 0.539 . . . . 0.46999999999999997 114.447 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -80.55 -42.05 23.06 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 117.815 0.808 . . . . 0.68999999999999995 109.827 175.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 52.8 m-80 -63.5 -52.51 60.93 Favored 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 122.499 0.32 . . . . 1.53 110.906 179.273 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -138.1 145.88 42.21 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 125.956 1.702 . . . . 0.71999999999999997 108.479 -167.558 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -79.96 170.82 15.94 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.543 0.737 . . . . 1.8999999999999999 110.571 -178.804 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -49.94 -46.53 52.29 Favored 'General case' 0 C--O 1.225 -0.185 0 C-N-CA 124.079 0.952 . . . . 2.6699999999999999 111.615 177.209 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -58.91 -29.72 67.28 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.237 0.615 . . . . 2.8399999999999999 112.093 179.369 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -86.7 -48.0 8.65 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.0 -0.741 . . . . 3.4100000000000001 109.0 -178.604 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.441 HG23 HMA1 ' A' ' 93' ' ' HEC . 98.7 mt -61.36 -43.91 97.52 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 O-C-N 121.714 -0.616 . . . . 0.31 109.461 -179.632 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 60.0 tp -52.57 -51.06 61.58 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 109.197 -0.668 . . . . 0.46999999999999997 109.197 175.195 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -58.51 -44.52 89.51 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 110.113 -0.329 . . . . 1.6200000000000001 110.113 178.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 78.8 mt -60.2 -36.52 68.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 O-C-N 121.104 -0.997 . . . . 0.5 111.498 176.048 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.503 HD11 HMB2 ' A' ' 93' ' ' HEC . 50.9 mt -67.41 -49.37 72.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 O-C-N 120.03 -1.669 . . . . 0.28000000000000003 109.42 176.738 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 80.7 mt -66.74 -29.64 69.67 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 124.639 1.175 . . . . 0.37 113.154 -175.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 14.3 m-80 -124.1 11.57 8.87 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 119.789 1.177 . . . . 1.77 110.157 -170.643 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.597 ' N ' ' HA2' ' A' ' 73' ' ' GLY . . . 43.12 -147.4 0.81 Allowed Glycine 0 CA--C 1.539 1.571 0 C-N-CA 126.623 2.059 . . . . 0.63 110.833 -171.465 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 170.45 135.49 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 119.524 1.662 . . . . 1.1799999999999999 110.82 -178.648 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 43.63 -122.14 3.83 Favored Glycine 0 CA--C 1.532 1.149 0 O-C-N 120.685 -1.259 . . . . 0.40999999999999998 112.474 -173.088 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -69.08 -17.83 72.26 Favored Glycine 0 CA--C 1.531 1.046 0 O-C-N 122.483 -0.422 . . . . 0.5 112.886 179.34 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.4 ' HB2' ' C1D' ' A' ' 93' ' ' HEC . 20.8 ttt -73.95 119.73 77.68 Favored Pre-proline 0 N--CA 1.451 -0.42 0 C-N-CA 123.838 0.855 . . . . 0.40000000000000002 111.486 -178.771 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.438 ' HD2' HD11 ' A' ' 75' ' ' ILE . 41.8 Cg_endo -78.08 120.88 5.14 Favored 'Trans proline' 0 N--CA 1.448 -1.172 0 C-N-CA 122.884 2.389 . . . . 2.1299999999999999 112.031 -177.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.597 ' HA2' ' N ' ' A' ' 67' ' ' GLY . . . -57.84 135.5 51.7 Favored Glycine 0 N--CA 1.445 -0.711 0 N-CA-C 116.421 1.328 . . . . 0.59999999999999998 116.421 -177.712 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 81.15 36.91 20.0 Favored Glycine 0 C--N 1.337 0.609 0 CA-C-N 114.124 -1.038 . . . . 0.34000000000000002 111.454 173.514 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.438 HD11 ' HD2' ' A' ' 72' ' ' PRO . 1.3 mt -57.96 -57.0 12.39 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 124.876 1.27 . . . . 1.1100000000000001 109.942 175.417 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -105.7 161.56 14.29 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.06 1.344 . . . . 0.31 109.508 167.16 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.0 mmtp -142.87 161.7 37.42 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.377 1.471 . . . . 2.4500000000000002 110.466 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 55.55 -146.5 30.13 Favored Glycine 0 CA--C 1.531 1.04 0 O-C-N 121.596 -0.69 . . . . 0.71999999999999997 111.437 179.145 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -54.55 -28.91 49.04 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 117.157 0.479 . . . . 0.71999999999999997 111.814 175.006 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -56.54 -39.08 72.78 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 109.827 -0.434 . . . . 2.29 109.827 174.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -82.41 -52.43 6.9 Favored 'General case' 0 CA--C 1.53 0.208 0 O-C-N 121.738 -0.601 . . . . 0.23999999999999999 110.963 174.496 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -58.44 -48.67 79.96 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 122.87 0.468 . . . . 2.3199999999999998 112.077 -173.637 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.74 -48.15 80.43 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 109.363 -0.606 . . . . 0.22 109.363 179.31 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.518 HG22 HG23 ' A' ' 28' ' ' VAL . 49.6 t -55.38 -55.2 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 C-N-CA 123.065 0.546 . . . . 0.28000000000000003 110.952 177.582 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -52.48 -53.48 45.14 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 123.313 0.645 . . . . 0.17999999999999999 111.483 178.282 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.7 -48.61 81.0 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 121.772 0.796 . . . . 0.27000000000000002 110.934 -178.826 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 83.6 t90 -57.22 -47.84 80.3 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 123.466 0.707 . . . . 0.58999999999999997 110.084 178.427 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.02 -31.21 72.31 Favored 'General case' 0 C--O 1.221 -0.398 0 CA-C-O 118.167 -0.921 . . . . 1.8999999999999999 112.649 173.359 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -56.39 -43.08 78.92 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 119.76 1.164 . . . . 0.34000000000000002 109.898 171.068 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -68.0 -36.93 80.81 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 118.344 -0.836 . . . . 3.54 112.585 171.482 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 15.3 mtpp -72.11 113.43 9.13 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 120.35 1.432 . . . . 2.8100000000000001 110.847 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 77.3 mttt . . . . . 0 C--O 1.254 1.337 0 N-CA-C 104.953 -2.24 . . . . 2.5 104.953 179.767 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 93' ' ' HEC . . . . . 0.503 HMB2 HD11 ' A' ' 64' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 29.5 t . . . . . 0 N--CA 1.471 0.608 0 N-CA-C 106.899 -1.519 . . . . 1.3500000000000001 106.899 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 -76.1 100.38 4.95 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 108.312 -0.996 . . . . 2.1699999999999999 108.312 -177.104 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -39.02 -54.26 1.7 Allowed 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 125.387 1.475 . . . . 0.34999999999999998 112.046 175.173 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -54.58 -48.86 71.59 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 116.108 -0.496 . . . . 2.6899999999999999 111.26 177.058 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.1 -36.57 82.14 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 118.96 0.8 . . . . 0.51000000000000001 111.932 -178.748 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 56.2 t -62.78 -58.46 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 N-CA-C 109.032 -0.729 . . . . 0.34000000000000002 109.032 172.809 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.693 HG22 ' SG ' ' A' ' 32' ' ' CYS . 21.0 t -53.55 -48.71 58.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 C-N-CA 123.255 0.622 . . . . 0.37 110.757 -175.738 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.462 ' HA ' HG12 ' A' ' 33' ' ' ILE . 28.3 mm-40 -49.35 -21.92 0.99 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 126.495 1.918 . . . . 0.52000000000000002 112.811 174.49 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -130.75 26.1 5.01 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.727 0.811 . . . . 4.96 111.59 -179.807 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.3 mppp? -148.96 -66.85 0.22 Allowed 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 109.151 -0.685 . . . . 1.76 109.151 171.718 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.693 ' SG ' HG22 ' A' ' 28' ' ' VAL . 2.0 m -71.76 -47.53 53.0 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.93 -0.396 . . . . 0.22 109.93 -168.926 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.462 HG12 ' HA ' ' A' ' 29' ' ' GLN . 2.0 pp -56.12 -26.37 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.075 0 N-CA-C 111.899 0.333 . . . . 0.37 111.899 -178.046 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.3 t -46.32 -36.0 5.89 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.376 1.071 . . . . 1.9199999999999999 110.699 177.727 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 28.9 m -116.82 -44.13 2.84 Favored 'General case' 0 C--N 1.34 0.178 0 C-N-CA 123.286 0.635 . . . . 0.20000000000000001 111.267 175.959 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 85.9 m-70 -71.09 -8.41 53.25 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.906 0.883 . . . . 0.22 112.564 -176.194 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 88.25 152.19 24.03 Favored Glycine 0 C--N 1.337 0.606 0 N-CA-C 109.707 -1.357 . . . . 1.51 109.707 178.235 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -39.39 -39.43 1.13 Allowed Glycine 0 CA--C 1.528 0.877 0 C-N-CA 125.366 1.46 . . . . 0.41999999999999998 112.9 179.11 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -105.74 2.21 27.74 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.216 1.406 . . . . 2.23 112.241 -170.822 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.411 HD22 ' N ' ' A' ' 40' ' ' LEU . 1.8 mm? 64.88 23.04 12.59 Favored 'General case' 0 C--N 1.348 0.531 0 CA-C-N 120.493 1.497 . . . . 3.5299999999999998 111.127 -179.731 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.7 p -85.55 -3.73 58.95 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 128.23 2.612 . . . . 0.39000000000000001 109.992 179.277 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.52 139.75 5.68 Favored Glycine 0 N--CA 1.441 -0.969 0 N-CA-C 109.037 -1.625 . . . . 0.45000000000000001 109.037 -174.387 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -145.4 -73.87 0.24 Allowed 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 107.813 -1.18 . . . . 0.39000000000000001 107.813 176.355 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.1 t -100.16 4.62 44.56 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.307 1.443 . . . . 1.48 111.169 173.233 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -156.63 162.81 26.84 Favored Pre-proline 0 CA--C 1.537 0.451 0 C-N-CA 126.289 1.836 . . . . 0.31 108.004 -168.773 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.22 153.16 40.54 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 123.271 2.647 . . . . 0.39000000000000001 111.414 -173.928 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -75.16 109.27 8.51 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.864 0.866 . . . . 0.59999999999999998 113.097 -170.136 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 43.7 pt -91.45 1.06 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 C-N-CA 125.8 1.64 . . . . 0.34000000000000002 111.793 -178.683 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -32.34 -48.59 0.18 Allowed 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 127.061 2.144 . . . . 2.79 113.044 164.226 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.51 36.83 3.25 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.955 0.902 . . . . 4.96 111.537 176.328 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.11 -52.54 58.66 Favored 'General case' 0 N--CA 1.454 -0.257 0 O-C-N 121.146 -0.971 . . . . 0.40999999999999998 108.849 176.236 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -52.33 -27.1 23.62 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 124.187 0.899 . . . . 0.54000000000000004 114.021 177.496 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.19 -38.24 88.37 Favored 'General case' 0 N--CA 1.452 -0.355 0 O-C-N 121.461 -1.023 . . . . 1.1299999999999999 110.548 176.63 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 34.4 m-80 -103.83 -61.78 1.39 Allowed 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.798 1.239 . . . . 2.3500000000000001 109.835 -171.5 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -91.93 136.13 33.4 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.007 1.323 . . . . 0.62 109.0 -174.896 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.7 t -80.69 166.91 20.6 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 118.102 0.41 . . . . 1.8500000000000001 110.632 -179.928 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -43.72 -55.85 4.16 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 124.384 1.074 . . . . 4.9000000000000004 109.856 177.352 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -57.01 -35.61 69.44 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.665 0.786 . . . . 3.3399999999999999 111.359 -176.187 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -74.15 -49.05 25.38 Favored 'General case' 0 C--N 1.343 0.302 0 O-C-N 121.243 -0.911 . . . . 2.9100000000000001 110.295 177.002 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.553 HG23 HMA1 ' A' ' 93' ' ' HEC . 73.3 mt -58.56 -41.05 80.91 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.141 0 N-CA-C 108.375 -0.972 . . . . 0.28999999999999998 108.375 -177.538 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 27.0 tp -55.22 -54.58 41.65 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 123.759 0.823 . . . . 0.33000000000000002 110.171 174.115 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -50.98 -48.02 61.33 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 118.104 0.411 . . . . 1.72 111.498 176.521 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 93.1 mt -59.01 -55.77 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 O-C-N 121.54 -0.725 . . . . 0.71999999999999997 109.767 177.197 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.476 HD11 HMB2 ' A' ' 93' ' ' HEC . 56.5 mt -47.61 -46.08 10.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 O-C-N 121.276 -0.89 . . . . 0.22 110.192 178.976 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 69.5 mt -66.31 -36.4 82.84 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 113.503 0.927 . . . . 0.52000000000000002 113.503 178.537 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -127.65 27.35 5.79 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 120.085 1.312 . . . . 1.8400000000000001 110.418 -161.994 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 20.38 -130.47 0.01 OUTLIER Glycine 0 CA--C 1.539 1.585 0 C-N-CA 127.764 2.602 . . . . 0.65000000000000002 112.749 -159.592 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 165.62 136.04 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 126.801 2.04 . . . . 1.1699999999999999 107.707 -176.768 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 27.57 -108.42 0.01 OUTLIER Glycine 0 CA--C 1.535 1.286 0 C-N-CA 126.053 1.787 . . . . 0.39000000000000001 114.714 -172.603 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -62.93 -28.22 71.59 Favored Glycine 0 CA--C 1.534 1.279 0 CA-C-N 117.694 0.747 . . . . 0.55000000000000004 113.467 -178.443 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 6.5 ttt -70.86 126.0 92.08 Favored Pre-proline 0 CA--C 1.539 0.547 0 C-N-CA 124.887 1.275 . . . . 0.55000000000000004 110.364 -178.751 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -62.8 -55.03 0.93 Allowed 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 123.686 2.924 . . . . 2.9900000000000002 111.254 -172.71 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 116.94 147.23 8.59 Favored Glycine 0 C--N 1.334 0.457 0 C-N-CA 124.156 0.884 . . . . 0.88 113.19 175.028 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 69.73 24.4 76.32 Favored Glycine 0 CA--C 1.53 1.02 0 N-CA-C 111.524 -0.631 . . . . 0.46000000000000002 111.524 179.76 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.0 mm -55.87 -44.96 79.53 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.843 0 C-N-CA 125.51 1.524 . . . . 2.1899999999999999 111.597 -178.919 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -113.6 160.51 18.48 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.003 1.321 . . . . 0.29999999999999999 108.843 161.021 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 5.0 ttmt -146.38 167.45 23.57 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 118.423 0.556 . . . . 2.6899999999999999 110.768 170.53 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 55.91 -148.61 27.48 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 111.092 -0.803 . . . . 0.70999999999999996 111.092 -179.595 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -49.53 -37.4 26.72 Favored 'General case' 0 C--N 1.341 0.204 0 C-N-CA 123.755 0.822 . . . . 0.68000000000000005 111.314 -178.709 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -50.69 -49.48 57.3 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 124.994 1.318 . . . . 2.0299999999999998 110.4 175.287 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -78.75 -48.6 14.56 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 123.233 0.613 . . . . 0.23000000000000001 111.375 178.953 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -53.7 -50.75 65.19 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.252 1.021 . . . . 2.23 110.623 -176.319 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.01 -48.9 78.64 Favored 'General case' 0 N--CA 1.455 -0.214 0 O-C-N 122.022 -0.424 . . . . 0.20999999999999999 110.144 177.893 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.436 HG22 HG23 ' A' ' 28' ' ' VAL . 56.0 t -55.54 -49.73 71.55 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 C-N-CA 122.783 0.433 . . . . 0.26000000000000001 110.955 179.467 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -52.52 -53.17 49.66 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 123.331 0.652 . . . . 0.31 111.466 175.928 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.1 -48.26 82.25 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-O 121.417 0.627 . . . . 0.39000000000000001 111.257 -179.736 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.533 ' CE3' HD23 ' A' ' 88' ' ' LEU . 47.8 t90 -56.05 -50.16 71.74 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.017 0.527 . . . . 0.47999999999999998 109.733 177.848 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.533 HD23 ' CE3' ' A' ' 87' ' ' TRP . 0.1 OUTLIER -60.92 -34.61 74.96 Favored 'General case' 0 C--O 1.224 -0.279 0 C-N-CA 124.351 1.06 . . . . 1.55 111.449 176.897 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.28 -42.57 98.87 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 119.009 0.822 . . . . 0.38 110.095 173.332 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -59.66 -42.13 92.13 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.044 0.538 . . . . 3.0099999999999998 111.093 172.244 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 9.5 mtpp -71.85 130.8 41.94 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 118.545 0.611 . . . . 2.9300000000000002 110.357 -177.547 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 38.6 mttt . . . . . 0 C--O 1.25 1.102 0 N-CA-C 106.469 -1.678 . . . . 3.25 106.469 -178.274 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 93' ' ' HEC . . . . . 0.553 HMA1 HG23 ' A' ' 60' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.4 t . . . . . 0 N--CA 1.471 0.619 0 N-CA-C 106.178 -1.786 . . . . 1.2 106.178 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -74.35 99.27 3.45 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 108.306 -0.998 . . . . 3.7200000000000002 108.306 -175.971 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -47.69 -41.95 23.76 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.239 1.016 . . . . 0.34999999999999998 111.739 176.097 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -66.99 -52.64 40.2 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 107.73 -1.211 . . . . 3.3399999999999999 107.73 -176.75 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.99 -45.88 71.57 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.316 0.646 . . . . 0.46999999999999997 111.484 178.483 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 64.0 t -56.57 -60.95 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 N-CA-C 109.181 -0.674 . . . . 0.52000000000000002 109.181 176.148 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.682 HG22 ' SG ' ' A' ' 32' ' ' CYS . 46.2 t -55.81 -45.36 79.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 O-C-N 121.908 -0.495 . . . . 0.37 110.888 -175.969 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.447 ' HA ' HG12 ' A' ' 33' ' ' ILE . 23.2 mm-40 -49.78 -19.39 0.64 Allowed 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 126.968 2.107 . . . . 0.87 112.998 173.509 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 44.3 tt0 -139.69 35.06 2.0 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 119.012 0.823 . . . . 2.3300000000000001 111.367 173.372 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.417 ' O ' HMC3 ' A' ' 93' ' ' HEC . 67.9 mmtt -145.96 -56.92 0.3 Allowed 'General case' 0 CA--C 1.516 -0.358 0 O-C-N 121.211 -0.931 . . . . 2.2000000000000002 109.977 175.08 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.682 ' SG ' HG22 ' A' ' 28' ' ' VAL . 3.2 m -86.36 -49.71 7.45 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 109.213 -0.662 . . . . 0.28000000000000003 109.213 -172.768 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.447 HG12 ' HA ' ' A' ' 29' ' ' GLN . 1.8 pp -56.23 -27.88 24.69 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.21 0 CA-C-N 115.739 -0.664 . . . . 0.55000000000000004 110.569 -178.106 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -36.78 -40.46 0.27 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.199 1.399 . . . . 1.3600000000000001 111.654 170.943 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 24.4 m -114.69 -35.72 4.76 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.792 0.837 . . . . 0.37 112.127 172.794 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 92.2 m-70 -80.59 3.56 21.43 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 125.065 1.346 . . . . 0.33000000000000002 113.13 -175.115 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 112.46 -92.58 0.64 Allowed Glycine 0 CA--C 1.528 0.856 0 C-N-CA 126.396 1.951 . . . . 2.98 112.511 164.747 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -162.45 -47.82 0.02 OUTLIER Glycine 0 CA--C 1.522 0.519 0 N-CA-C 108.815 -1.714 . . . . 0.69999999999999996 108.815 -173.306 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -102.21 7.24 40.89 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 126.099 1.759 . . . . 3.4900000000000002 111.395 176.643 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.682 HD21 HG11 ' A' ' 28' ' ' VAL . 0.5 OUTLIER 76.28 13.34 2.56 Favored 'General case' 0 C--N 1.35 0.597 0 CA-C-N 120.006 1.276 . . . . 1.8700000000000001 111.056 179.562 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 35.5 p -75.41 -10.79 59.77 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 126.953 2.101 . . . . 0.59999999999999998 110.112 -175.777 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.84 147.11 22.14 Favored Glycine 0 N--CA 1.444 -0.817 0 N-CA-C 108.653 -1.779 . . . . 0.58999999999999997 108.653 -177.396 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -154.23 -81.36 0.08 Allowed 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 123.181 0.593 . . . . 0.34000000000000002 109.525 177.264 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 5.4 m -89.31 2.8 53.83 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.752 0.821 . . . . 1.02 110.862 171.451 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -152.71 162.73 25.65 Favored Pre-proline 0 N--CA 1.45 -0.459 0 C-N-CA 125.77 1.628 . . . . 0.28999999999999998 107.256 -172.344 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -66.74 163.95 31.2 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 122.545 2.163 . . . . 0.27000000000000002 110.905 -175.378 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.87 123.35 24.05 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 109.33 -0.618 . . . . 0.34999999999999998 109.33 -178.89 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 49.8 pt -107.14 1.95 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 C-N-CA 123.544 0.737 . . . . 0.33000000000000002 111.424 176.85 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 18.4 p-10 -34.08 -49.92 0.37 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.382 1.473 . . . . 3.7599999999999998 112.21 167.739 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 18.1 pttt -109.9 34.7 3.71 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 125.086 1.354 . . . . 4.5999999999999996 112.433 -179.924 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.13 -46.04 91.0 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 109.473 -0.566 . . . . 0.31 109.473 173.242 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -54.88 -32.58 55.73 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 123.154 0.407 . . . . 0.56000000000000005 113.455 -176.829 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.32 -40.01 62.49 Favored 'General case' 0 CA--C 1.529 0.142 0 O-C-N 121.947 -0.737 . . . . 0.72999999999999998 110.908 174.689 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 19.5 m-80 -65.71 -52.86 47.98 Favored 'General case' 0 C--O 1.227 -0.088 0 N-CA-C 110.384 -0.228 . . . . 1.6899999999999999 110.384 -179.788 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -136.07 144.28 45.1 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.035 1.334 . . . . 0.66000000000000003 108.401 -168.584 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 4.9 m -74.03 167.58 21.24 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 118.268 0.486 . . . . 1.5800000000000001 110.38 177.626 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.8 pm0 -49.83 -41.68 45.54 Favored 'General case' 0 C--O 1.225 -0.232 0 C-N-CA 123.731 0.813 . . . . 2.6499999999999999 111.354 -179.476 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -56.62 -44.3 81.06 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.775 0.83 . . . . 3.0899999999999999 109.966 179.578 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -78.21 -43.65 27.88 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.07 0.948 . . . . 2.79 109.55 -174.481 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.558 HG23 HMA1 ' A' ' 93' ' ' HEC . 76.2 mt -59.83 -48.34 88.04 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 O-C-N 121.094 -1.004 . . . . 0.39000000000000001 108.749 176.606 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 33.5 tp -55.7 -45.33 77.88 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 109.193 -0.669 . . . . 0.54000000000000004 109.193 178.425 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -47.22 -56.71 6.19 Favored 'General case' 0 N--CA 1.453 -0.302 0 O-C-N 124.108 0.88 . . . . 1.6399999999999999 109.328 172.449 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 43.7 mt -61.78 -45.78 97.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 117.827 -1.549 . . . . 0.80000000000000004 111.999 179.851 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.565 HD11 HMB2 ' A' ' 93' ' ' HEC . 85.9 mt -52.6 -48.66 47.43 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 O-C-N 119.693 -1.879 . . . . 0.31 110.296 -179.023 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 88.3 mt -72.95 -31.94 64.91 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 123.416 0.687 . . . . 0.64000000000000001 111.886 178.144 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 45.8 m-20 -129.18 46.91 2.55 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 107.699 -1.223 . . . . 1.8 107.699 -163.198 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -40.67 106.25 0.06 OUTLIER Glycine 0 CA--C 1.534 1.244 0 C-N-CA 125.838 1.685 . . . . 3.25 111.476 -171.256 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 -87.86 165.19 15.46 Favored 'General case' 0 N--CA 1.435 -1.212 0 C-N-CA 127.466 2.306 . . . . 3.4399999999999999 109.382 -175.307 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 57.4 -127.81 45.86 Favored Glycine 0 CA--C 1.529 0.943 0 N-CA-C 111.521 -0.631 . . . . 0.82999999999999996 111.521 174.385 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -73.79 -25.55 71.62 Favored Glycine 0 CA--C 1.53 0.979 0 CA-C-N 117.096 0.448 . . . . 0.92000000000000004 112.131 179.799 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 5.5 ttt -63.44 137.22 97.02 Favored Pre-proline 0 CA--C 1.54 0.566 0 O-C-N 121.914 -0.757 . . . . 0.78000000000000003 109.741 178.849 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -74.35 -54.19 0.1 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.844 2.362 . . . . 2.8599999999999999 111.233 -177.234 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 113.73 149.81 10.31 Favored Glycine 0 C--N 1.335 0.515 0 C-N-CA 123.849 0.738 . . . . 0.95999999999999996 112.785 177.321 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 67.25 24.4 73.46 Favored Glycine 0 CA--C 1.531 1.092 0 CA-C-N 114.906 -0.647 . . . . 0.39000000000000001 112.146 176.727 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -55.5 -51.62 55.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 125.936 1.694 . . . . 1.05 110.877 177.784 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -104.99 149.08 26.06 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 125.171 1.389 . . . . 0.5 108.101 169.768 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 2.9 mtpm? -146.25 153.13 40.24 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.966 0.907 . . . . 4.3499999999999996 111.441 -178.431 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 71.76 -162.64 54.38 Favored Glycine 0 CA--C 1.532 1.131 0 N-CA-C 110.638 -0.985 . . . . 0.98999999999999999 110.638 -170.311 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -50.83 -26.72 6.09 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.823 1.249 . . . . 0.72999999999999998 112.607 -178.702 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 51.7 tt0 -40.93 -62.34 0.83 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.081 1.352 . . . . 2.1000000000000001 110.508 168.142 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -62.77 -46.85 86.13 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 122.816 0.446 . . . . 0.27000000000000002 110.666 -174.688 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -51.12 -56.85 10.62 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 123.71 0.804 . . . . 1.9399999999999999 111.06 175.705 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -56.34 -47.57 78.52 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 109.429 -0.582 . . . . 0.27000000000000002 109.429 -177.682 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.486 HG22 HG23 ' A' ' 28' ' ' VAL . 53.3 t -57.93 -53.66 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 N-CA-C 111.774 0.287 . . . . 0.29999999999999999 111.774 177.49 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -52.38 -52.69 52.23 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 123.214 0.605 . . . . 0.19 111.306 179.028 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.444 ' O ' ' HB3' ' A' ' 89' ' ' ALA . . . -58.76 -49.48 77.49 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 121.415 0.626 . . . . 0.34999999999999998 110.134 179.189 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.564 ' CE3' HD23 ' A' ' 88' ' ' LEU . 46.3 t90 -53.63 -48.76 69.05 Favored 'General case' 0 N--CA 1.451 -0.413 0 O-C-N 121.69 -0.631 . . . . 0.5 110.378 177.473 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.564 HD23 ' CE3' ' A' ' 87' ' ' TRP . 0.1 OUTLIER -61.58 -34.68 76.02 Favored 'General case' 0 C--O 1.227 -0.123 0 C-N-CA 124.394 1.078 . . . . 1.6499999999999999 111.004 177.206 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.444 ' HB3' ' O ' ' A' ' 86' ' ' ALA . . . -52.58 -47.11 67.07 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 118.889 0.768 . . . . 0.58999999999999997 109.972 170.989 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -83.22 26.08 0.66 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.404 0.682 . . . . 5.0599999999999996 112.597 173.686 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 8.1 mtpm? -125.69 120.99 32.17 Favored 'General case' 0 C--N 1.341 0.197 0 CA-C-N 119.775 1.171 . . . . 2.0600000000000001 110.017 167.043 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.438 -1.043 0 C-N-CA 127.397 2.279 . . . . 2.3599999999999999 105.1 173.933 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 93' ' ' HEC . . . . . 0.565 HMB2 HD11 ' A' ' 64' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 23.3 t . . . . . 0 N--CA 1.469 0.495 0 N-CA-C 107.204 -1.406 . . . . 1.1899999999999999 107.204 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -78.28 99.35 6.26 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 108.049 -1.093 . . . . 2.1800000000000002 108.049 -173.496 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -40.41 -55.66 2.2 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 125.087 1.355 . . . . 0.33000000000000002 111.732 177.697 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -52.93 -47.0 68.35 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 123.012 0.525 . . . . 2.75 111.78 177.287 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.07 -46.44 87.46 Favored 'General case' 0 N--CA 1.458 -0.06 0 CA-C-N 118.494 0.588 . . . . 0.26000000000000001 110.468 -178.233 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 69.8 t -55.33 -54.73 21.87 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.252 0 N-CA-C 109.221 -0.659 . . . . 0.34000000000000002 109.221 175.274 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.473 HG22 ' SG ' ' A' ' 32' ' ' CYS . 34.1 t -56.66 -48.41 80.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 C-N-CA 123.375 0.67 . . . . 0.33000000000000002 110.531 -175.14 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.416 ' HA ' HG12 ' A' ' 33' ' ' ILE . 36.4 mm-40 -51.42 -21.63 2.46 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.913 1.685 . . . . 0.48999999999999999 112.78 172.373 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -136.81 49.42 2.06 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 119.151 0.887 . . . . 3.75 111.705 178.104 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -168.5 -59.18 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.183 0 N-CA-C 108.112 -1.07 . . . . 1.52 108.112 168.163 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.473 ' SG ' HG22 ' A' ' 28' ' ' VAL . 3.6 m -75.54 -51.55 12.67 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 120.862 0.363 . . . . 0.17999999999999999 110.655 -170.231 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.416 HG12 ' HA ' ' A' ' 29' ' ' GLN . 2.2 pp -55.01 -26.58 17.88 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.165 0 CA-C-N 115.838 -0.619 . . . . 0.41999999999999998 111.697 -179.225 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.7 t -43.61 -34.72 1.51 Allowed 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.034 0.933 . . . . 2.0600000000000001 111.867 175.051 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 28.7 m -117.03 -37.34 3.59 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.482 0.713 . . . . 0.22 111.706 172.774 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -78.92 2.31 20.62 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.35 1.06 . . . . 0.27000000000000002 113.0 -175.921 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 112.1 -85.63 0.4 Allowed Glycine 0 C--N 1.34 0.755 0 C-N-CA 125.676 1.607 . . . . 3.0 112.196 162.609 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -171.23 -50.23 0.04 OUTLIER Glycine 0 CA--C 1.518 0.242 0 N-CA-C 108.452 -1.859 . . . . 0.82999999999999996 108.452 -171.906 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -102.0 4.91 40.38 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.711 1.204 . . . . 3.0899999999999999 111.504 179.38 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 5.2 mt 80.16 15.29 0.8 Allowed 'General case' 0 C--N 1.354 0.761 0 CA-C-N 120.392 1.451 . . . . 1.53 110.206 -178.903 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.4 p -80.75 -9.4 59.81 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 128.34 2.656 . . . . 0.57999999999999996 110.002 -175.906 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.56 161.27 36.95 Favored Glycine 0 N--CA 1.442 -0.908 0 N-CA-C 108.995 -1.642 . . . . 0.92000000000000004 108.995 -174.691 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -164.8 -72.94 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 124.503 1.121 . . . . 0.31 108.187 174.066 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 30.3 m -101.73 3.14 39.31 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.398 1.079 . . . . 1.1899999999999999 110.857 174.202 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -152.14 160.87 30.8 Favored Pre-proline 0 CA--C 1.536 0.417 0 C-N-CA 126.456 1.902 . . . . 0.23999999999999999 107.092 -171.599 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.46 158.8 55.38 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 123.115 2.544 . . . . 0.22 110.942 -175.046 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -74.01 120.63 19.85 Favored 'General case' 0 N--CA 1.454 -0.229 0 O-C-N 121.887 -0.508 . . . . 0.27000000000000002 109.871 -176.749 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 25.3 pt -100.32 2.64 10.6 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 C-N-CA 123.475 0.71 . . . . 0.31 111.679 177.728 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -36.28 -44.89 0.43 Allowed 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.215 1.406 . . . . 2.5299999999999998 113.668 171.49 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 8.3 mtpt -111.36 26.23 10.88 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.371 1.068 . . . . 3.71 111.324 -177.542 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -58.31 -43.24 88.07 Favored 'General case' 0 N--CA 1.453 -0.317 0 O-C-N 121.631 -0.668 . . . . 0.31 110.205 179.923 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -54.13 -23.58 25.24 Favored Glycine 0 CA--C 1.53 0.98 0 CA-C-N 118.299 0.5 . . . . 0.5 114.344 179.172 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -88.03 -41.56 13.01 Favored 'General case' 0 N--CA 1.457 -0.123 0 CA-C-N 118.123 0.962 . . . . 0.75 109.818 175.849 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -56.85 -53.41 58.18 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 122.529 0.331 . . . . 2.02 110.801 176.504 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -139.15 154.61 48.11 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.677 1.191 . . . . 0.64000000000000001 109.229 -170.576 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 2.1 p -80.07 167.37 20.5 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.793 0.837 . . . . 2.1800000000000002 110.927 178.434 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -46.63 -46.22 19.66 Favored 'General case' 0 C--O 1.224 -0.258 0 C-N-CA 124.473 1.109 . . . . 2.7400000000000002 111.319 176.703 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -58.72 -40.83 84.84 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.285 0.634 . . . . 2.8100000000000001 110.638 -177.941 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -76.78 -47.93 20.16 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 108.877 -0.786 . . . . 3.0099999999999998 108.877 -175.393 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.527 HG23 HMA1 ' A' ' 93' ' ' HEC . 83.1 mt -59.58 -42.96 89.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 N-CA-C 109.087 -0.709 . . . . 0.22 109.087 178.666 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.8 tp -54.04 -52.91 59.36 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 109.383 -0.599 . . . . 0.29999999999999999 109.383 175.954 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -50.51 -51.27 49.09 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 118.064 0.393 . . . . 1.6499999999999999 110.824 175.004 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 60.9 mt -61.72 -30.57 48.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 O-C-N 121.574 -0.704 . . . . 0.72999999999999998 112.307 -179.036 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 49.2 mt -69.99 -49.3 57.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 O-C-N 120.381 -1.449 . . . . 0.20999999999999999 109.08 173.313 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 86.3 mt -67.39 -34.16 76.7 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 124.437 1.095 . . . . 0.48999999999999999 113.354 -174.448 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -123.37 20.39 9.65 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 119.717 1.144 . . . . 1.8300000000000001 110.224 -166.644 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 32.24 -141.23 0.05 OUTLIER Glycine 0 CA--C 1.543 1.827 0 C-N-CA 127.039 2.256 . . . . 0.64000000000000001 112.207 -164.642 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 39.5 tt0 170.72 137.45 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 119.588 1.694 . . . . 1.6699999999999999 109.243 -176.736 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 38.1 -114.85 0.34 Allowed Glycine 0 CA--C 1.531 1.067 0 CA-C-N 120.04 1.291 . . . . 0.39000000000000001 113.291 -177.008 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -69.26 -25.04 75.79 Favored Glycine 0 CA--C 1.534 1.25 0 CA-C-N 117.263 0.532 . . . . 0.46999999999999997 113.233 179.566 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 16.8 ttt -70.27 120.21 76.92 Favored Pre-proline 0 CA--C 1.539 0.532 0 C-N-CA 124.492 1.117 . . . . 0.37 110.058 -179.591 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -62.5 -55.89 0.8 Allowed 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 124.249 3.299 . . . . 2.9100000000000001 111.578 -168.965 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 118.2 149.13 8.7 Favored Glycine 0 N--CA 1.449 -0.489 0 CA-C-N 115.857 -0.61 . . . . 0.91000000000000003 114.124 172.429 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 67.41 21.65 72.52 Favored Glycine 0 CA--C 1.532 1.111 0 CA-C-N 114.782 -0.709 . . . . 0.52000000000000002 111.686 -179.845 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 2.0 mt -52.53 -44.54 45.18 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 C-N-CA 126.872 2.069 . . . . 1.03 110.98 178.211 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -114.82 159.95 20.03 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.817 1.247 . . . . 0.27000000000000002 110.311 161.775 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 19.3 mmtp -141.92 159.95 41.2 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.972 1.709 . . . . 2.27 110.28 -179.343 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 56.3 -142.94 38.8 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 111.426 -0.669 . . . . 0.78000000000000003 111.426 176.027 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -50.07 -35.98 27.42 Favored 'General case' 0 C--N 1.341 0.22 0 C-N-CA 123.661 0.785 . . . . 0.70999999999999996 111.592 174.753 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -57.9 -33.11 68.4 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.61 0.764 . . . . 2.1000000000000001 110.795 178.782 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -91.97 -53.2 4.37 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.613 0.765 . . . . 0.23000000000000001 110.882 175.415 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -50.15 -54.49 20.39 Favored 'General case' 0 N--CA 1.461 0.105 0 C-N-CA 124.563 1.145 . . . . 2.1099999999999999 111.544 -179.533 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.25 -44.75 92.36 Favored 'General case' 0 C--O 1.225 -0.236 0 N-CA-C 109.588 -0.523 . . . . 0.31 109.588 -178.522 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 54.7 t -58.16 -53.75 41.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 C-N-CA 122.772 0.429 . . . . 0.32000000000000001 111.1 179.451 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -53.17 -52.33 59.15 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 123.081 0.552 . . . . 0.23000000000000001 111.533 174.921 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.2 -38.62 83.88 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.515 0.726 . . . . 0.58999999999999997 111.155 -178.216 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 73.7 t90 -67.86 -51.08 52.4 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 123.82 0.848 . . . . 0.5 109.578 177.637 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.46 -30.33 69.6 Favored 'General case' 0 C--O 1.223 -0.318 0 O-C-N 121.363 -0.836 . . . . 1.99 112.143 175.91 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -55.31 -38.91 69.29 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 119.592 1.087 . . . . 0.40999999999999998 110.836 170.9 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -68.54 -41.81 79.32 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 118.588 -0.72 . . . . 3.1000000000000001 110.92 170.908 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.6 mtpm? -72.86 106.34 4.75 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 119.173 0.897 . . . . 1.98 110.384 -174.587 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 4.4 mtmp? . . . . . 0 C--O 1.25 1.084 0 C-N-CA 126.233 1.813 . . . . 2.0600000000000001 106.51 179.374 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 93' ' ' HEC . . . . . 0.527 HMA1 HG23 ' A' ' 60' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 12.4 t . . . . . 0 N--CA 1.471 0.587 0 N-CA-C 107.687 -1.227 . . . . 1.1799999999999999 107.687 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -75.0 97.8 3.46 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 108.509 -0.923 . . . . 2.5699999999999998 108.509 -178.305 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -43.3 -52.07 5.95 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 124.335 1.054 . . . . 0.27000000000000002 111.012 176.101 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -57.91 -47.14 83.7 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 116.287 -0.415 . . . . 2.6800000000000002 110.401 179.938 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.07 -45.1 94.0 Favored 'General case' 0 N--CA 1.461 0.098 0 CA-C-N 118.472 0.578 . . . . 0.34999999999999998 110.891 -178.874 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 79.5 t -57.49 -57.25 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 108.93 -0.767 . . . . 0.33000000000000002 108.93 176.884 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.619 HG11 HD21 ' A' ' 40' ' ' LEU . 35.7 t -55.24 -46.04 77.79 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 C-N-CA 121.213 -0.195 . . . . 0.35999999999999999 111.011 -176.762 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.429 ' HA ' HG12 ' A' ' 33' ' ' ILE . 26.3 mm-40 -49.98 -25.94 3.79 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 125.794 1.638 . . . . 0.5 112.808 173.769 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -140.66 67.23 1.36 Allowed 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 119.06 0.846 . . . . 2.7000000000000002 112.001 171.4 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -178.22 -36.11 0.01 OUTLIER 'General case' 0 C--O 1.225 -0.221 0 C-N-CA 124.812 1.245 . . . . 1.2 109.202 169.627 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.492 ' SG ' HG22 ' A' ' 28' ' ' VAL . 2.7 m -103.95 -53.79 2.68 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 119.339 0.972 . . . . 0.25 111.13 -177.649 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.429 HG12 ' HA ' ' A' ' 29' ' ' GLN . 2.0 pp -55.26 -27.88 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 CA-C-N 115.9 -0.591 . . . . 0.54000000000000004 111.386 -176.302 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.3 m -35.21 -42.12 0.18 Allowed 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 125.358 1.463 . . . . 1.1799999999999999 112.633 170.244 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 18.2 m -112.66 -34.74 5.72 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.655 0.782 . . . . 0.23000000000000001 111.706 174.14 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 92.5 m-70 -82.0 5.21 19.99 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.446 1.098 . . . . 0.34999999999999998 113.409 -175.351 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 107.22 -91.05 0.68 Allowed Glycine 0 CA--C 1.525 0.667 0 C-N-CA 126.57 2.033 . . . . 2.8700000000000001 111.961 166.312 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -167.63 -47.37 0.03 OUTLIER Glycine 0 CA--C 1.519 0.316 0 N-CA-C 108.792 -1.723 . . . . 0.83999999999999997 108.792 -172.446 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -102.88 6.42 39.08 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.935 1.294 . . . . 4.0999999999999996 111.158 178.675 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.619 HD21 HG11 ' A' ' 28' ' ' VAL . 2.5 mt 78.49 10.32 1.89 Allowed 'General case' 0 C--N 1.354 0.798 0 CA-C-N 120.075 1.307 . . . . 1.4299999999999999 110.352 177.441 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.1 p -74.81 -10.26 59.34 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 128.62 2.768 . . . . 0.58999999999999997 109.629 -179.69 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.64 159.11 34.3 Favored Glycine 0 N--CA 1.444 -0.822 0 N-CA-C 109.269 -1.532 . . . . 0.84999999999999998 109.269 -177.017 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -160.67 -79.82 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 124.334 1.054 . . . . 0.34999999999999998 108.653 175.692 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 58.5 m -91.55 2.24 56.58 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.474 0.709 . . . . 1.21 110.966 173.437 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.446 ' HB1' ' HD2' ' A' ' 46' ' ' PRO . . . -154.35 164.8 19.6 Favored Pre-proline 0 N--CA 1.448 -0.544 0 C-N-CA 125.245 1.418 . . . . 0.31 108.038 -169.672 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.446 ' HD2' ' HB1' ' A' ' 45' ' ' ALA . 27.9 Cg_endo -67.42 159.75 50.95 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 123.002 2.468 . . . . 0.27000000000000002 111.243 -173.696 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -74.75 115.56 14.47 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.073 0.549 . . . . 0.38 109.999 -177.593 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 32.2 pt -102.55 2.5 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 C-N-CA 124.342 1.057 . . . . 0.55000000000000004 111.528 179.549 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -34.3 -48.87 0.36 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.28 1.432 . . . . 2.2599999999999998 112.427 167.49 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 10.0 pttt -109.19 26.26 10.83 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.58 0.752 . . . . 3.4100000000000001 111.812 -176.458 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -51.55 -44.3 62.66 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 118.927 -0.559 . . . . 0.34000000000000002 109.8 178.287 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -52.84 -25.72 23.82 Favored Glycine 0 CA--C 1.529 0.952 0 N-CA-C 114.566 0.586 . . . . 0.46000000000000002 114.566 177.692 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -82.44 -42.36 18.66 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 118.076 0.938 . . . . 0.83999999999999997 109.49 175.67 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 36.1 m120 -63.69 -48.41 77.22 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 122.574 0.35 . . . . 3.2400000000000002 110.564 -179.471 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -144.2 145.62 32.18 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.547 1.539 . . . . 0.64000000000000001 108.553 -169.925 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 19.6 m -75.33 169.17 18.57 Favored 'General case' 0 CA--C 1.532 0.284 0 O-C-N 121.542 -0.724 . . . . 1.52 111.198 179.132 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -44.17 -56.03 4.38 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 123.337 0.655 . . . . 4.7699999999999996 110.735 174.182 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -53.13 -29.96 34.03 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 112.724 0.638 . . . . 2.96 112.724 -178.406 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 53.6 mm-40 -86.83 -48.85 7.86 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.709 0.804 . . . . 3.0299999999999998 109.789 -178.315 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.553 HG23 HMA1 ' A' ' 93' ' ' HEC . 84.0 mt -57.6 -46.5 86.33 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.097 0 O-C-N 121.114 -0.991 . . . . 0.26000000000000001 108.73 178.143 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 46.6 tp -52.97 -47.55 68.08 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 123.618 0.767 . . . . 0.33000000000000002 109.274 176.543 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -55.45 -46.99 76.72 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 118.244 0.474 . . . . 2.21 110.705 175.099 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 47.7 mt -60.51 -36.7 71.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 O-C-N 121.444 -0.785 . . . . 0.51000000000000001 110.996 176.728 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.527 HD11 HMB2 ' A' ' 93' ' ' HEC . 58.5 mt -69.21 -42.22 81.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 O-C-N 119.864 -1.773 . . . . 0.23999999999999999 109.939 178.816 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 71.3 mt -76.65 -26.53 54.97 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.815 1.246 . . . . 0.44 112.891 -176.715 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 28.8 m-80 -124.85 14.43 8.59 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 119.584 1.084 . . . . 1.76 109.989 -172.044 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.586 ' N ' ' HA2' ' A' ' 73' ' ' GLY . . . 40.43 -139.99 1.13 Allowed Glycine 0 CA--C 1.537 1.451 0 C-N-CA 126.614 2.054 . . . . 0.64000000000000001 110.994 -171.885 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 168.48 127.1 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.602 1.561 . . . . 1.3899999999999999 110.41 179.152 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 42.13 -115.87 0.97 Allowed Glycine 0 C--N 1.346 1.092 0 CA-C-N 120.283 1.402 . . . . 0.66000000000000003 113.294 -178.145 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -64.54 -22.06 67.45 Favored Glycine 0 CA--C 1.532 1.097 0 CA-C-N 117.349 0.574 . . . . 0.63 112.53 -179.54 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.421 ' HB2' ' C1D' ' A' ' 93' ' ' HEC . 21.5 ttt -80.32 118.93 74.79 Favored Pre-proline 0 N--CA 1.45 -0.442 0 C-N-CA 124.878 1.271 . . . . 0.37 111.433 -179.35 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.445 ' HD2' HD11 ' A' ' 75' ' ' ILE . 36.2 Cg_endo -77.83 122.77 6.0 Favored 'Trans proline' 0 N--CA 1.448 -1.193 0 C-N-CA 122.645 2.23 . . . . 2.0499999999999998 112.066 -178.515 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.586 ' HA2' ' N ' ' A' ' 67' ' ' GLY . . . -57.26 131.28 51.97 Favored Glycine 0 N--CA 1.444 -0.817 0 N-CA-C 115.348 0.899 . . . . 0.71999999999999997 115.348 179.376 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 87.55 40.63 6.74 Favored Glycine 0 C--N 1.338 0.678 0 CA-C-N 114.342 -0.929 . . . . 0.48999999999999999 112.008 172.687 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.445 HD11 ' HD2' ' A' ' 72' ' ' PRO . 2.4 mt -66.92 -61.44 1.69 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 124.691 1.196 . . . . 1.0800000000000001 109.925 176.616 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -98.36 161.35 13.73 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.632 1.173 . . . . 0.32000000000000001 109.705 167.613 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.0 mttm -146.81 164.34 33.14 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 125.085 1.354 . . . . 2.4900000000000002 110.71 176.828 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 52.7 -146.32 17.4 Favored Glycine 0 CA--C 1.529 0.92 0 N-CA-C 111.383 -0.687 . . . . 0.70999999999999996 111.383 -178.527 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -53.12 -31.49 42.39 Favored 'General case' 0 C--O 1.225 -0.215 0 C-N-CA 122.942 0.497 . . . . 0.81999999999999995 111.295 177.432 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -53.61 -46.1 70.3 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 123.299 0.64 . . . . 2.3199999999999998 110.168 174.398 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -78.69 -52.25 8.68 Favored 'General case' 0 CA--C 1.53 0.191 0 O-C-N 121.552 -0.717 . . . . 0.22 111.098 176.496 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -57.17 -51.6 68.66 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.631 0.773 . . . . 2.6000000000000001 111.331 -173.53 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.18 -45.62 90.56 Favored 'General case' 0 N--CA 1.457 -0.12 0 O-C-N 121.99 -0.444 . . . . 0.26000000000000001 109.881 -179.265 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.588 HG22 HG23 ' A' ' 28' ' ' VAL . 37.9 t -56.25 -53.04 44.4 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 CA-C-O 119.515 -0.279 . . . . 0.29999999999999999 110.94 176.263 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -52.43 -50.53 62.39 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 122.767 0.427 . . . . 0.17000000000000001 111.048 177.831 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.04 -45.07 96.29 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-O 121.263 0.554 . . . . 0.29999999999999999 110.964 -179.189 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.534 ' CE3' HD23 ' A' ' 88' ' ' LEU . 45.6 t90 -59.93 -48.11 83.05 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.863 0.84 . . . . 0.5 109.703 176.464 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.534 HD23 ' CE3' ' A' ' 87' ' ' TRP . 0.1 OUTLIER -62.11 -27.6 69.04 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 120.448 -1.407 . . . . 1.6699999999999999 110.3 177.039 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -65.67 -43.75 88.39 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 123.319 0.648 . . . . 0.34999999999999998 111.13 172.583 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -62.13 -42.09 98.9 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 118.537 -1.265 . . . . 3.7599999999999998 109.944 171.807 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 7.8 mtpp -69.38 119.98 14.48 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 121.581 0.705 . . . . 2.1800000000000002 111.501 -171.18 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 8.2 mttp . . . . . 0 C--O 1.25 1.083 0 C-N-CA 128.092 2.557 . . . . 2.3799999999999999 105.456 -176.352 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 93' ' ' HEC . . . . . 0.553 HMA1 HG23 ' A' ' 60' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 29.6 t . . . . . 0 N--CA 1.47 0.538 0 N-CA-C 106.696 -1.594 . . . . 1.3200000000000001 106.696 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -73.64 99.8 3.19 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 123.907 0.883 . . . . 2.6299999999999999 109.228 -171.932 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -38.25 -53.73 1.44 Allowed 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 125.669 1.587 . . . . 0.41999999999999998 112.498 176.461 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -52.69 -49.79 64.6 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 122.844 0.458 . . . . 2.9100000000000001 111.213 176.637 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.28 -43.92 95.82 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 118.429 0.559 . . . . 0.37 110.532 -179.777 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 89.4 t -58.6 -54.26 35.75 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 N-CA-C 109.702 -0.481 . . . . 0.46000000000000002 109.702 176.649 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.447 HG23 HG22 ' A' ' 84' ' ' VAL . 32.7 t -53.4 -50.63 47.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 C-N-CA 122.709 0.404 . . . . 0.44 110.11 179.762 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 31.8 mm-40 -54.74 -14.47 1.39 Allowed 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 126.49 1.916 . . . . 0.67000000000000004 113.953 174.518 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -141.48 34.06 1.65 Allowed 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 119.757 1.162 . . . . 2.9399999999999999 112.583 176.668 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.3 mptt -152.0 -62.62 0.17 Allowed 'General case' 0 CA--C 1.521 -0.159 0 N-CA-C 108.401 -0.963 . . . . 2.6099999999999999 108.401 166.056 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.438 ' SG ' HG22 ' A' ' 28' ' ' VAL . 3.7 m -69.65 -46.84 65.22 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 121.13 0.49 . . . . 0.19 110.144 -168.746 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.3 pp -56.15 -23.31 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 CA-C-N 115.462 -0.79 . . . . 0.51000000000000001 112.882 -178.388 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.0 t -48.38 -35.45 12.61 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.981 0.913 . . . . 2.0299999999999998 110.748 177.794 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 15.9 m -120.04 -40.49 2.72 Favored 'General case' 0 C--N 1.342 0.255 0 C-N-CA 123.564 0.746 . . . . 0.19 111.525 177.319 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 86.1 m-70 -72.16 -9.01 57.85 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.581 0.752 . . . . 0.23000000000000001 112.219 -178.59 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 88.61 148.87 18.05 Favored Glycine 0 C--N 1.339 0.714 0 N-CA-C 109.742 -1.343 . . . . 1.4399999999999999 109.742 177.595 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -42.34 -33.41 1.37 Allowed Glycine 0 CA--C 1.529 0.956 0 C-N-CA 125.202 1.382 . . . . 0.54000000000000004 112.988 175.085 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -101.26 -5.29 25.7 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.076 1.351 . . . . 2.98 112.209 -171.687 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 73.37 8.63 5.18 Favored 'General case' 0 C--N 1.35 0.601 0 O-C-N 120.633 -1.292 . . . . 1.4299999999999999 111.393 175.696 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 17.2 p -82.11 -1.99 50.52 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 127.491 2.316 . . . . 0.5 110.287 -174.523 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.57 145.27 9.84 Favored Glycine 0 N--CA 1.438 -1.19 0 N-CA-C 108.164 -1.975 . . . . 0.40999999999999998 108.164 -171.475 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -150.88 -73.0 0.16 Allowed 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 124.181 0.992 . . . . 0.26000000000000001 108.98 176.7 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.93 3.85 49.57 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.948 1.299 . . . . 1.1299999999999999 110.441 173.33 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -158.05 163.68 23.79 Favored Pre-proline 0 CA--C 1.536 0.419 0 C-N-CA 125.994 1.718 . . . . 0.20999999999999999 107.331 -167.523 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -70.16 158.01 57.8 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 123.144 2.563 . . . . 0.26000000000000001 110.768 -174.823 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.39 126.96 31.36 Favored 'General case' 0 C--N 1.333 -0.148 0 O-C-N 121.636 -0.665 . . . . 0.31 110.075 -177.305 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 39.4 pt -106.9 -2.88 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 C-N-CA 123.07 0.548 . . . . 0.35999999999999999 111.887 177.037 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 24.6 p-10 -33.66 -49.95 0.33 Allowed 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.29 1.436 . . . . 3.6099999999999999 112.744 171.834 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.5 pttp -106.17 23.82 13.45 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.261 1.424 . . . . 3.9500000000000002 112.579 -176.859 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.04 -50.02 75.67 Favored 'General case' 0 CA--C 1.527 0.072 0 O-C-N 121.228 -0.92 . . . . 0.51000000000000001 109.963 179.168 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -60.18 -12.84 25.47 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 123.386 0.517 . . . . 0.93999999999999995 114.157 178.804 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.98 -34.15 68.69 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 118.454 1.127 . . . . 1.53 110.664 173.539 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -107.24 -52.09 2.82 Favored 'General case' 0 C--N 1.34 0.174 0 C-N-CA 123.976 0.91 . . . . 3.0499999999999998 111.878 -176.137 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -84.04 170.29 14.07 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.713 0.805 . . . . 1.3200000000000001 110.184 175.763 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 54.1 m -119.53 169.1 10.35 Favored 'General case' 0 C--O 1.233 0.237 0 C-N-CA 125.647 1.579 . . . . 1.5 108.619 172.899 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.8 pm0 -46.25 -49.86 16.71 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 124.475 1.11 . . . . 2.7400000000000002 112.355 -177.198 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -58.83 -41.71 87.51 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 118.298 0.499 . . . . 2.4100000000000001 111.888 179.172 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.65 -49.07 51.34 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 122.114 0.959 . . . . 3.5299999999999998 108.623 -176.253 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 31.2 mt -60.03 -44.48 94.91 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 O-C-N 121.631 -0.668 . . . . 0.31 109.253 178.545 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 61.7 tp -54.61 -52.45 62.19 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.289 -0.634 . . . . 0.71999999999999997 109.289 177.119 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -48.28 -53.91 15.55 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.165 0.586 . . . . 1.8899999999999999 109.77 179.264 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 81.4 mt -57.18 -47.87 83.22 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.283 0 O-C-N 121.707 -0.621 . . . . 0.47999999999999998 111.409 177.37 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.48 HD11 HMB2 ' A' ' 93' ' ' HEC . 79.5 mt -54.79 -43.0 65.24 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 O-C-N 120.464 -1.398 . . . . 0.29999999999999999 110.216 176.665 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 94.3 mt -70.8 -40.41 72.55 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 113.957 1.095 . . . . 0.60999999999999999 113.957 -176.171 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -123.3 27.51 7.49 Favored 'General case' 0 C--N 1.344 0.35 0 CA-C-N 120.956 1.707 . . . . 3.7999999999999998 109.787 -171.515 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.532 ' N ' ' HA2' ' A' ' 73' ' ' GLY . . . 36.55 -136.97 0.52 Allowed Glycine 0 CA--C 1.532 1.151 0 C-N-CA 127.786 2.612 . . . . 0.64000000000000001 110.613 -174.969 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 30.9 tt0 167.41 133.36 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 119.237 1.519 . . . . 1.76 109.197 -177.089 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 45.04 -122.5 5.15 Favored Glycine 0 CA--C 1.532 1.102 0 CA-C-N 119.872 1.215 . . . . 0.48999999999999999 112.252 -175.396 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -70.8 -16.97 74.78 Favored Glycine 0 CA--C 1.532 1.131 0 CA-C-N 117.595 0.697 . . . . 0.69999999999999996 113.017 178.448 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.421 ' HB2' ' C1D' ' A' ' 93' ' ' HEC . 20.5 ttt -71.29 119.03 71.27 Favored Pre-proline 0 N--CA 1.451 -0.385 0 CA-C-N 118.23 1.015 . . . . 0.42999999999999999 110.434 -178.938 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -78.18 120.55 4.99 Favored 'Trans proline' 0 N--CA 1.446 -1.275 0 C-N-CA 122.847 2.365 . . . . 2.1400000000000001 110.886 -179.431 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.532 ' HA2' ' N ' ' A' ' 67' ' ' GLY . . . -61.3 140.63 47.74 Favored Glycine 0 N--CA 1.443 -0.892 0 CA-C-N 115.047 -0.979 . . . . 0.60999999999999999 115.499 -175.691 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 79.87 35.25 28.51 Favored Glycine 0 CA--C 1.524 0.644 0 CA-C-N 114.05 -1.075 . . . . 0.33000000000000002 110.911 174.161 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -57.41 -52.04 61.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 125.094 1.358 . . . . 1.03 109.499 175.465 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -111.5 155.0 23.92 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 125.404 1.481 . . . . 0.33000000000000002 108.339 163.147 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.2 mtpp -142.64 157.86 44.26 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.868 1.267 . . . . 2.3799999999999999 109.408 175.959 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 62.32 -151.06 46.3 Favored Glycine 0 CA--C 1.529 0.94 0 N-CA-C 111.133 -0.787 . . . . 0.76000000000000001 111.133 -177.38 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -50.79 -35.08 30.15 Favored 'General case' 0 C--N 1.34 0.192 0 C-N-CA 123.865 0.866 . . . . 0.56000000000000005 111.736 -175.775 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -50.87 -50.96 55.89 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.006 0.922 . . . . 2.1400000000000001 110.621 174.105 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -75.81 -49.59 17.6 Favored 'General case' 0 CA--C 1.528 0.1 0 C-N-CA 123.335 0.654 . . . . 0.23999999999999999 111.043 179.36 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -55.11 -48.35 73.73 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.724 0.809 . . . . 2.4900000000000002 110.696 -176.397 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.21 -50.67 72.73 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 109.909 -0.404 . . . . 0.26000000000000001 109.909 177.638 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.492 HG11 HMB1 ' A' ' 93' ' ' HEC . 57.4 t -53.57 -59.14 2.06 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.272 0 CA-C-O 119.508 -0.282 . . . . 0.34999999999999998 110.465 178.591 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -42.87 -56.34 3.29 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 123.831 0.852 . . . . 0.20000000000000001 112.144 174.299 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.67 -46.97 85.71 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 121.487 0.661 . . . . 0.31 111.923 -176.364 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.439 ' CZ3' HG21 ' A' ' 28' ' ' VAL . 74.9 t90 -58.99 -49.9 76.14 Favored 'General case' 0 C--N 1.328 -0.362 0 O-C-N 121.747 -0.596 . . . . 0.51000000000000001 109.879 178.339 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.05 -32.89 74.37 Favored 'General case' 0 C--O 1.223 -0.329 0 CA-C-O 117.981 -1.009 . . . . 2.1299999999999999 111.995 176.164 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -55.99 -36.16 67.59 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 119.621 1.1 . . . . 0.37 110.097 170.233 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -68.59 -36.06 78.19 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 118.459 -0.781 . . . . 3.3100000000000001 111.51 172.589 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 4.2 mtpt -74.17 134.71 42.8 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 119.736 1.153 . . . . 2.1499999999999999 110.801 -178.338 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 2.6 mptt . . . . . 0 C--O 1.25 1.12 0 N-CA-C 105.738 -1.949 . . . . 2.9100000000000001 105.738 172.458 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 93' ' ' HEC . . . . . 0.492 HMB1 HG11 ' A' ' 84' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.47 HG22 ' H ' ' A' ' 23' ' ' ASP 2.191 0.7 OUTLIER . . . . . 0 N--CA 1.469 0.507 0 CA-C-O 113.97 -2.919 . . . . 1.72 106.474 . . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.47 ' H ' HG22 ' A' ' 22' ' ' VAL . 83.9 m-20 -91.11 91.78 8.41 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 103.587 -2.746 . . . . 2.73 103.587 156.534 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.62 -49.91 71.57 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-O 121.481 0.658 . . . . 0.35999999999999999 109.905 -171.764 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -58.91 -48.25 82.12 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.116 -0.947 . . . . 3.1699999999999999 109.929 -178.773 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.96 -47.07 87.3 Favored 'General case' 0 CA--C 1.527 0.096 0 C-N-CA 122.938 0.495 . . . . 0.32000000000000001 111.066 -179.933 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 75.6 t -55.72 -55.54 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 N-CA-C 108.913 -0.773 . . . . 0.46999999999999997 108.913 176.727 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.516 HG13 ' HB2' ' A' ' 32' ' ' CYS . 37.3 t -54.6 -47.55 72.13 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 C-N-CA 122.55 0.34 . . . . 0.37 111.188 -177.8 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 40.1 mm-40 -52.3 -19.46 2.09 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.098 1.359 . . . . 0.66000000000000003 113.078 174.584 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -135.66 42.31 2.67 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 119.876 1.216 . . . . 2.6699999999999999 111.939 174.903 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -163.5 -34.19 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 118.106 -0.949 . . . . 1.6499999999999999 112.8 172.062 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.516 ' HB2' HG13 ' A' ' 28' ' ' VAL . 3.5 m -100.75 -50.66 3.79 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 119.668 1.122 . . . . 0.16 110.736 -178.619 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 8.6 pt -56.07 -27.19 22.82 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 CA-C-N 116.191 -0.459 . . . . 1.3500000000000001 111.977 -175.627 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.7 m -40.1 -37.35 0.6 Allowed 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.51 1.524 . . . . 1.1100000000000001 112.145 173.966 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 17.6 m -116.56 -36.65 3.89 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.398 0.679 . . . . 0.23000000000000001 111.753 173.955 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 92.5 m-70 -80.63 3.31 22.39 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.018 0.927 . . . . 0.29999999999999999 113.372 -175.628 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 108.43 -78.84 0.24 Allowed Glycine 0 CA--C 1.525 0.681 0 C-N-CA 125.778 1.656 . . . . 2.9900000000000002 111.937 163.991 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -178.14 -53.4 0.07 OUTLIER Glycine 0 C--O 1.229 -0.219 0 N-CA-C 108.306 -1.918 . . . . 0.89000000000000001 108.306 -171.355 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -97.07 3.93 51.58 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 117.948 -1.025 . . . . 2.52 110.919 -178.356 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.5 mt 77.76 13.23 1.8 Allowed 'General case' 0 C--N 1.352 0.702 0 CA-C-N 119.704 1.138 . . . . 1.46 110.054 -178.443 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.7 p -78.55 -11.92 59.99 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 128.462 2.705 . . . . 0.55000000000000004 110.189 -176.166 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.42 156.72 32.41 Favored Glycine 0 N--CA 1.444 -0.829 0 N-CA-C 109.167 -1.573 . . . . 0.65000000000000002 109.167 -178.758 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -163.21 -79.16 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 123.52 0.728 . . . . 0.28000000000000003 109.719 179.222 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.5 m -93.1 2.49 56.71 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.187 0.995 . . . . 0.98999999999999999 110.676 170.798 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -153.27 160.67 30.67 Favored Pre-proline 0 N--CA 1.447 -0.585 0 C-N-CA 126.219 1.808 . . . . 0.20999999999999999 106.973 -171.455 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -67.15 164.5 29.99 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 123.282 2.655 . . . . 0.28999999999999998 111.191 -174.86 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -74.38 123.87 25.45 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.858 -0.423 . . . . 0.27000000000000002 109.858 -178.262 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 49.8 pt -109.85 1.35 9.34 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 C-N-CA 124.28 1.032 . . . . 0.46000000000000002 112.486 177.784 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 22.0 p-10 -34.53 -48.46 0.36 Allowed 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.587 1.555 . . . . 3.5299999999999998 112.574 167.516 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 4.6 tttt -113.68 38.97 2.78 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 126.606 1.962 . . . . 5.5700000000000003 109.326 -177.595 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.36 -47.37 86.18 Favored 'General case' 0 N--CA 1.454 -0.245 0 O-C-N 121.119 -0.988 . . . . 0.32000000000000001 109.896 170.559 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -51.26 -42.48 49.59 Favored Glycine 0 CA--C 1.526 0.761 0 C-N-CA 123.959 0.79 . . . . 0.77000000000000002 114.448 -171.67 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.37 -21.06 58.6 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 121.684 -0.892 . . . . 0.92000000000000004 112.107 179.285 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -82.55 -46.68 13.05 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 118.531 0.605 . . . . 1.97 109.516 176.027 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -138.05 137.78 38.14 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.858 1.263 . . . . 0.60999999999999999 108.55 -171.777 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 35.1 t -75.64 167.2 22.34 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.898 0.879 . . . . 2.2599999999999998 109.841 178.951 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -49.51 -43.19 45.32 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.864 0.865 . . . . 2.8100000000000001 111.893 177.53 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -53.54 -37.54 62.94 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 118.991 0.814 . . . . 2.8799999999999999 111.447 176.467 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -83.08 -49.07 9.91 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 123.615 0.766 . . . . 3.48 110.091 -178.352 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.445 HG23 HMA1 ' A' ' 93' ' ' HEC . 65.2 mt -58.73 -44.93 91.15 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.052 0 O-C-N 121.283 -0.885 . . . . 0.25 108.758 -178.637 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 35.3 tp -54.41 -47.55 72.63 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 124.002 0.921 . . . . 0.32000000000000001 109.846 176.182 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -56.0 -50.64 70.29 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 109.794 -0.447 . . . . 2.0600000000000001 109.794 174.49 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 74.2 mt -60.22 -30.17 45.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 O-C-N 121.575 -0.703 . . . . 0.78000000000000003 111.694 178.895 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.511 HD11 HMB2 ' A' ' 93' ' ' HEC . 46.6 mt -71.64 -50.77 37.07 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 O-C-N 120.151 -1.593 . . . . 0.28000000000000003 109.95 174.559 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 82.8 mt -70.74 -30.39 66.9 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.869 0.868 . . . . 0.54000000000000004 112.91 -174.336 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -119.3 12.62 12.59 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 119.11 0.868 . . . . 1.6799999999999999 109.974 -170.048 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.534 ' N ' ' HA2' ' A' ' 73' ' ' GLY . . . 39.38 -147.07 0.18 Allowed Glycine 0 CA--C 1.542 1.719 0 C-N-CA 127.722 2.582 . . . . 0.63 111.211 -172.449 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 38.8 tt0 175.34 131.1 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 119.344 1.572 . . . . 1.8700000000000001 108.93 -177.144 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 40.72 -115.62 0.7 Allowed Glycine 0 CA--C 1.532 1.137 0 CA-C-N 119.957 1.253 . . . . 0.46000000000000002 113.33 -175.95 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -69.98 -21.65 76.9 Favored Glycine 0 CA--C 1.532 1.142 0 O-C-N 122.335 -0.509 . . . . 0.53000000000000003 112.992 -179.727 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.444 ' HB2' ' C1D' ' A' ' 93' ' ' HEC . 22.4 ttt -73.66 119.08 74.16 Favored Pre-proline 0 N--CA 1.452 -0.374 0 C-N-CA 124.363 1.065 . . . . 0.42999999999999999 110.773 -179.817 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -78.85 128.1 8.25 Favored 'Trans proline' 0 N--CA 1.445 -1.376 0 C-N-CA 122.263 1.976 . . . . 2.1600000000000001 110.525 -179.454 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.534 ' HA2' ' N ' ' A' ' 67' ' ' GLY . . . -61.31 134.17 48.28 Favored Glycine 0 N--CA 1.442 -0.921 0 CA-C-N 115.215 -0.902 . . . . 0.66000000000000003 114.703 -179.486 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 84.23 38.56 9.93 Favored Glycine 0 CA--C 1.526 0.781 0 CA-C-N 114.543 -0.828 . . . . 0.32000000000000001 111.676 171.261 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -61.2 -44.31 98.11 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.881 0 C-N-CA 125.43 1.492 . . . . 2.3199999999999998 110.237 177.203 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -111.48 161.76 15.81 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.498 1.919 . . . . 0.52000000000000002 109.565 164.659 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 68.6 mttt -133.12 157.64 44.8 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 124.798 1.239 . . . . 3.21 110.837 174.74 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 53.22 -141.74 29.64 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 110.712 -0.955 . . . . 0.70999999999999996 110.712 176.854 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -52.44 -34.83 50.45 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 117.139 0.469 . . . . 0.71999999999999997 111.835 179.254 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -53.77 -35.94 61.86 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.699 0.8 . . . . 2.4700000000000002 109.48 178.39 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -82.18 -52.66 6.76 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.465 0.706 . . . . 0.29999999999999999 110.805 170.967 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -57.4 -54.52 45.85 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 112.657 0.614 . . . . 1.96 112.657 -172.333 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -55.96 -42.79 76.78 Favored 'General case' 0 N--CA 1.454 -0.253 0 O-C-N 121.88 -0.513 . . . . 0.26000000000000001 110.472 -179.832 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.481 HG22 HG23 ' A' ' 28' ' ' VAL . 50.8 t -61.12 -53.67 45.79 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 C-N-CA 122.66 0.384 . . . . 0.34999999999999998 110.666 178.365 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -51.66 -50.46 60.32 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 123.12 0.568 . . . . 0.19 111.514 176.099 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.16 -48.41 81.7 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.452 0.701 . . . . 0.27000000000000002 110.69 179.412 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.525 ' CE3' HD23 ' A' ' 88' ' ' LEU . 47.6 t90 -56.71 -47.53 79.74 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 121.915 -0.49 . . . . 0.44 109.769 177.086 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.525 HD23 ' CE3' ' A' ' 87' ' ' TRP . 0.1 OUTLIER -64.22 -36.32 83.69 Favored 'General case' 0 N--CA 1.462 0.139 0 C-N-CA 124.162 0.985 . . . . 1.6399999999999999 111.476 179.305 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -54.55 -41.01 69.25 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 118.987 0.812 . . . . 0.41999999999999998 110.096 170.988 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -88.4 27.39 1.26 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.722 0.809 . . . . 4.4400000000000004 112.706 173.098 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.6 mtpm? -119.85 130.95 55.12 Favored 'General case' 0 C--N 1.341 0.21 0 O-C-N 120.858 -1.151 . . . . 2.1099999999999999 109.245 165.14 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 9.5 mtmp? . . . . . 0 C--O 1.248 1.022 0 C-N-CA 127.924 2.49 . . . . 3.6000000000000001 104.607 -177.243 . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 93' ' ' HEC . . . . . 0.511 HMB2 HD11 ' A' ' 64' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.467 HG11 ' HA ' ' A' ' 80' ' ' GLU . 43.0 t . . . . . 0 N--CA 1.47 0.551 0 N-CA-C 107.289 -1.375 . . . . 1.1399999999999999 107.289 . . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -74.08 156.92 36.92 Favored 'General case' 0 N--CA 1.451 -0.418 0 O-C-N 124.049 0.843 . . . . 2.1299999999999999 109.61 178.266 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -97.73 -61.94 1.32 Allowed 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 109.144 -0.687 . . . . 0.42999999999999999 109.144 178.203 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -51.53 -43.74 62.4 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 116.173 -0.467 . . . . 3.1299999999999999 111.116 178.164 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.55 -43.72 89.42 Favored 'General case' 0 CA--C 1.528 0.135 0 CA-C-N 118.579 0.627 . . . . 0.37 111.509 179.731 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 73.6 t -63.39 -53.18 48.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 N-CA-C 108.12 -1.067 . . . . 0.34000000000000002 108.12 178.438 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.656 HG11 HD21 ' A' ' 40' ' ' LEU . 45.1 t -52.34 -48.44 44.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 110.437 -0.209 . . . . 0.32000000000000001 110.437 -179.623 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.468 ' HA ' HG12 ' A' ' 33' ' ' ILE . 35.6 mm-40 -50.47 -24.5 3.16 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.448 1.899 . . . . 0.65000000000000002 112.937 175.658 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -142.62 59.04 1.44 Allowed 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 119.184 0.902 . . . . 2.54 111.323 178.459 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -179.81 -36.28 0.01 OUTLIER 'General case' 0 C--O 1.225 -0.207 0 C-N-CA 124.648 1.179 . . . . 1.1899999999999999 109.695 173.356 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.464 ' HB2' HG13 ' A' ' 28' ' ' VAL . 5.0 m -101.1 -53.66 2.98 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 119.28 0.945 . . . . 0.17999999999999999 110.973 -178.632 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.468 HG12 ' HA ' ' A' ' 29' ' ' GLN . 2.1 pp -57.37 -25.92 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 CA-C-N 115.876 -0.602 . . . . 0.41999999999999998 112.041 -175.735 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.1 m -38.17 -35.53 0.17 Allowed 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.001 1.72 . . . . 1.23 112.548 170.483 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 18.5 m -120.9 -44.02 2.44 Favored 'General case' 0 C--N 1.34 0.174 0 C-N-CA 123.326 0.651 . . . . 0.25 111.629 172.854 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 82.4 m-70 -70.13 -8.81 52.61 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.413 0.685 . . . . 0.34000000000000002 112.817 -175.2 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 88.48 151.93 23.96 Favored Glycine 0 C--N 1.337 0.589 0 N-CA-C 109.757 -1.337 . . . . 1.51 109.757 177.488 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -44.51 -37.54 4.95 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 124.518 1.056 . . . . 0.44 112.31 178.514 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.482 ' C ' HD12 ' A' ' 40' ' ' LEU . 0.8 OUTLIER -98.37 0.24 45.03 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.707 1.203 . . . . 2.0899999999999999 111.747 -174.061 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.656 HD21 HG11 ' A' ' 28' ' ' VAL . 2.4 mp 65.28 17.14 10.89 Favored 'General case' 0 C--N 1.347 0.458 0 CA-C-N 120.232 1.378 . . . . 1.8400000000000001 111.543 178.582 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.3 p -84.9 -4.77 59.25 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 128.529 2.731 . . . . 0.40000000000000002 110.03 -175.707 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.04 127.18 3.65 Favored Glycine 0 N--CA 1.442 -0.903 0 N-CA-C 109.009 -1.636 . . . . 0.55000000000000004 109.009 179.437 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -134.31 -80.13 0.45 Allowed 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 124.229 1.012 . . . . 0.28999999999999998 108.904 179.552 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 46.1 m -88.85 2.85 52.98 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.757 0.823 . . . . 1.4199999999999999 111.047 172.695 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.445 ' HB1' ' HD2' ' A' ' 46' ' ' PRO . . . -158.99 164.86 19.78 Favored Pre-proline 0 CA--C 1.537 0.444 0 C-N-CA 124.529 1.132 . . . . 0.28000000000000003 108.246 -169.188 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.445 ' HD2' ' HB1' ' A' ' 45' ' ' ALA . 55.2 Cg_endo -68.75 157.69 60.84 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 123.157 2.571 . . . . 0.27000000000000002 110.951 -173.389 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.45 128.76 36.41 Favored 'General case' 0 CA--C 1.529 0.146 0 O-C-N 121.584 -0.697 . . . . 0.32000000000000001 110.307 -175.653 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 48.6 pt -106.63 0.21 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 C-N-CA 123.328 0.651 . . . . 0.31 111.626 176.954 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -38.99 -38.29 0.43 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.789 0.836 . . . . 2.27 113.105 170.085 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 4.2 pttt -113.49 30.05 7.52 Favored 'General case' 0 C--N 1.343 0.316 0 C-N-CA 124.507 1.123 . . . . 4.0800000000000001 111.642 -178.689 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -68.36 -41.97 79.86 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 118.652 -0.689 . . . . 0.34999999999999998 109.624 176.766 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -53.38 -29.83 39.35 Favored Glycine 0 CA--C 1.526 0.735 0 CA-C-N 118.614 0.643 . . . . 0.71999999999999997 114.646 -175.419 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -83.41 -47.49 11.36 Favored 'General case' 0 N--CA 1.455 -0.197 0 O-C-N 122.403 -0.469 . . . . 1.1399999999999999 110.366 175.253 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 38.4 m-80 -55.63 -44.27 76.96 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 122.286 0.234 . . . . 1.54 111.158 179.43 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -139.75 134.15 31.46 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.022 1.729 . . . . 0.62 107.691 -167.309 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 49.2 m -74.98 170.73 15.4 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 118.348 0.522 . . . . 1.49 110.774 178.059 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 73.3 tt0 -45.54 -59.53 2.67 Favored 'General case' 0 C--N 1.342 0.267 0 C-N-CA 123.178 0.591 . . . . 5.2599999999999998 110.75 177.148 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 31.5 mp0 -51.28 -31.86 22.71 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.656 0.782 . . . . 4.2800000000000002 112.906 179.259 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -80.85 -48.46 12.38 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 119.23 0.923 . . . . 2.6400000000000001 109.315 -179.191 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.569 HG23 HMA1 ' A' ' 93' ' ' HEC . 84.6 mt -61.77 -47.1 94.85 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.222 0 O-C-N 121.565 -0.709 . . . . 0.26000000000000001 109.256 -179.215 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 31.2 tp -52.2 -50.2 62.38 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 108.956 -0.757 . . . . 0.38 108.956 175.789 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -57.02 -43.23 81.65 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 120.72 -0.392 . . . . 1.6699999999999999 110.997 178.157 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 31.6 mt -58.73 -54.0 39.63 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.262 0 O-C-N 120.861 -1.149 . . . . 0.67000000000000004 110.494 173.257 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.536 HD11 HMB2 ' A' ' 93' ' ' HEC . 58.2 mt -50.75 -41.97 22.04 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 O-C-N 120.655 -1.278 . . . . 0.19 110.513 -179.614 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 88.5 mt -69.18 -40.53 78.03 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 113.436 0.902 . . . . 0.57999999999999996 113.436 176.951 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 -118.31 19.1 13.56 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 120.489 1.495 . . . . 1.77 110.202 -164.706 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.573 ' N ' ' HA2' ' A' ' 73' ' ' GLY . . . 29.47 -136.5 0.05 OUTLIER Glycine 0 CA--C 1.532 1.154 0 C-N-CA 128.511 2.958 . . . . 0.65000000000000002 110.973 -162.458 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 171.66 133.01 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 119.085 1.443 . . . . 1.55 108.28 -176.736 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 40.76 -118.85 1.28 Allowed Glycine 0 CA--C 1.533 1.208 0 CA-C-N 120.405 1.457 . . . . 0.35999999999999999 113.294 -178.199 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -68.49 -19.25 72.57 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 123.704 0.669 . . . . 0.51000000000000001 113.23 179.204 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.429 ' HB2' ' C1D' ' A' ' 93' ' ' HEC . 19.9 ttt -74.41 119.12 74.95 Favored Pre-proline 0 N--CA 1.449 -0.485 0 C-N-CA 124.288 1.035 . . . . 0.38 110.677 179.174 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -74.86 127.34 10.7 Favored 'Trans proline' 0 N--CA 1.442 -1.551 0 C-N-CA 122.01 1.806 . . . . 2.1000000000000001 109.812 177.631 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.573 ' HA2' ' N ' ' A' ' 67' ' ' GLY . . . -63.17 140.76 45.55 Favored Glycine 0 N--CA 1.442 -0.956 0 CA-C-N 115.487 -0.779 . . . . 0.65000000000000002 114.655 176.953 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 84.27 38.0 10.47 Favored Glycine 0 CA--C 1.525 0.692 0 CA-C-N 113.757 -1.221 . . . . 0.56000000000000005 111.507 173.605 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.5 mm -64.3 -58.03 8.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 C-N-CA 123.779 0.831 . . . . 1.99 110.002 176.559 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -104.94 152.58 22.5 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.893 1.277 . . . . 0.28999999999999998 108.206 167.807 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 2.1 mmmt -142.28 154.99 45.19 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 124.732 1.213 . . . . 3.2000000000000002 108.995 -178.721 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 63.67 -158.29 40.44 Favored Glycine 0 CA--C 1.531 1.043 0 N-CA-C 111.315 -0.714 . . . . 0.63 111.315 -173.814 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -53.14 -26.04 15.42 Favored 'General case' 0 C--N 1.34 0.173 0 C-N-CA 123.873 0.869 . . . . 0.62 112.415 -179.983 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.467 ' HA ' HG11 ' A' ' 22' ' ' VAL . 6.1 tt0 -47.92 -48.81 31.61 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.493 1.117 . . . . 2.1099999999999999 110.577 171.326 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -74.32 -47.68 33.07 Favored 'General case' 0 N--CA 1.455 -0.189 0 O-C-N 121.645 -0.659 . . . . 0.31 111.333 177.285 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -55.92 -51.95 65.82 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.24 0.616 . . . . 2.5899999999999999 110.645 -174.979 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -54.0 -47.5 71.4 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.774 0.829 . . . . 0.27000000000000002 110.308 178.644 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.516 HG22 HG23 ' A' ' 28' ' ' VAL . 44.4 t -58.84 -55.46 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 C-N-CA 122.607 0.363 . . . . 0.42999999999999999 110.832 177.983 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -48.68 -51.9 26.1 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.183 0.593 . . . . 0.20999999999999999 111.252 176.639 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.23 -48.91 79.74 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 121.449 0.642 . . . . 0.34000000000000002 111.138 -179.768 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 75.2 t90 -58.75 -50.23 74.69 Favored 'General case' 0 CA--C 1.532 0.287 0 O-C-N 121.459 -0.776 . . . . 0.48999999999999999 109.975 -179.987 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.71 -32.93 72.15 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 118.283 -0.865 . . . . 2.0800000000000001 111.83 173.631 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -54.99 -31.49 60.95 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 119.85 1.204 . . . . 0.40999999999999998 110.975 173.332 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -77.93 -38.34 45.7 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 118.342 -0.837 . . . . 3.2799999999999998 112.448 169.534 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 42.6 mtpt -73.04 111.65 8.35 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 119.714 1.143 . . . . 2.4900000000000002 111.162 -177.347 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 2.0 pttt . . . . . 0 C--O 1.251 1.149 0 C-N-CA 126.467 1.907 . . . . 2.3300000000000001 107.175 177.514 . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 93' ' ' HEC . . . . . 0.569 HMA1 HG23 ' A' ' 60' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 42.1 t . . . . . 0 N--CA 1.469 0.507 0 N-CA-C 106.986 -1.487 . . . . 1.51 106.986 . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -74.54 110.9 9.2 Favored 'General case' 0 N--CA 1.454 -0.273 0 O-C-N 123.755 0.66 . . . . 2.21 109.462 -176.073 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -48.38 -52.72 20.52 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.94 0.896 . . . . 0.33000000000000002 110.918 -179.325 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -58.78 -44.34 90.67 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 116.269 -0.423 . . . . 2.8399999999999999 110.111 179.607 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.02 -43.27 99.14 Favored 'General case' 0 C--N 1.34 0.163 0 C-N-CA 122.719 0.408 . . . . 0.26000000000000001 111.221 -179.675 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 77.7 t -58.4 -55.73 20.72 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.365 0 N-CA-C 108.923 -0.769 . . . . 0.38 108.923 175.432 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.553 HG13 ' HB2' ' A' ' 32' ' ' CYS . 50.9 t -54.6 -45.02 71.64 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 N-CA-C 110.331 -0.248 . . . . 0.27000000000000002 110.331 -177.227 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.445 ' HA ' HG12 ' A' ' 33' ' ' ILE . 29.9 mm-40 -51.49 -26.28 8.02 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.927 1.691 . . . . 0.56999999999999995 113.611 172.742 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -139.99 58.85 1.59 Allowed 'General case' 0 C--N 1.338 0.103 0 CA-C-N 119.851 1.205 . . . . 2.3199999999999998 112.403 173.073 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -173.82 -36.74 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 123.866 0.867 . . . . 1.28 110.143 169.3 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.553 ' HB2' HG13 ' A' ' 28' ' ' VAL . 5.6 m -98.71 -51.67 3.84 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 118.958 0.799 . . . . 0.20999999999999999 110.402 -177.923 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.445 HG12 ' HA ' ' A' ' 29' ' ' GLN . 2.2 pp -57.09 -26.67 25.57 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.08 0 CA-C-N 116.211 -0.449 . . . . 0.38 112.027 -176.414 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 50.3 m -37.82 -38.45 0.29 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.121 1.369 . . . . 1.0600000000000001 112.194 170.989 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 22.5 m -120.23 -40.96 2.65 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.194 0.597 . . . . 0.17999999999999999 111.549 174.625 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 84.1 m-70 -71.7 -8.93 57.2 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 112.766 0.654 . . . . 0.20000000000000001 112.766 -176.15 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 86.09 150.15 14.8 Favored Glycine 0 C--N 1.338 0.66 0 N-CA-C 109.838 -1.305 . . . . 1.49 109.838 178.958 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -44.47 -36.91 4.63 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 124.558 1.075 . . . . 0.46000000000000002 112.191 177.277 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -95.96 -3.82 44.43 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 124.691 1.196 . . . . 2.6299999999999999 111.725 -172.831 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 8.7 mt 69.41 13.05 8.41 Favored 'General case' 0 C--N 1.35 0.607 0 CA-C-N 120.463 1.483 . . . . 1.1000000000000001 111.316 176.126 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.4 p -86.03 -2.68 58.54 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 128.318 2.647 . . . . 0.29999999999999999 109.9 -175.867 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.89 129.27 3.02 Favored Glycine 0 N--CA 1.441 -0.997 0 N-CA-C 108.827 -1.709 . . . . 0.53000000000000003 108.827 -178.559 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -134.86 -78.42 0.45 Allowed 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 124.071 0.949 . . . . 0.28999999999999998 108.773 178.662 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -90.72 3.58 53.89 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.148 0.979 . . . . 1.0900000000000001 110.7 173.415 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.429 ' HB1' ' HD2' ' A' ' 46' ' ' PRO . . . -156.12 168.01 13.16 Favored Pre-proline 0 CA--C 1.537 0.45 0 C-N-CA 125.657 1.583 . . . . 0.23000000000000001 108.078 -170.551 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.429 ' HD2' ' HB1' ' A' ' 45' ' ' ALA . 11.7 Cg_endo -67.11 168.79 16.54 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.698 2.266 . . . . 0.45000000000000001 110.816 -178.793 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -85.19 124.46 31.87 Favored 'General case' 0 CA--C 1.53 0.199 0 O-C-N 121.234 -0.917 . . . . 0.26000000000000001 110.883 -176.494 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 43.6 pt -100.41 0.09 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 C-N-CA 123.769 0.827 . . . . 0.47999999999999998 111.312 178.942 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -36.87 -46.0 0.59 Allowed 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.807 1.243 . . . . 2.2999999999999998 113.095 171.566 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.5 mttp -114.33 38.83 2.93 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.947 0.88 . . . . 3.5600000000000001 110.573 -179.515 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.06 -50.08 74.76 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 118.641 -0.695 . . . . 0.31 109.432 175.106 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -54.3 -26.28 36.07 Favored Glycine 0 CA--C 1.528 0.878 0 CA-C-N 118.721 0.691 . . . . 0.56000000000000005 113.695 -177.257 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -81.32 -44.23 17.95 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 117.507 0.653 . . . . 0.85999999999999999 110.181 176.582 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 38.6 m-80 -62.08 -48.11 81.68 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 122.446 0.298 . . . . 1.7 110.934 178.12 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 -141.38 145.0 34.82 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.431 1.492 . . . . 0.65000000000000002 108.731 -168.016 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 64.5 m -78.87 166.81 22.0 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.59 0.756 . . . . 1.5900000000000001 111.118 179.659 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -43.96 -53.8 5.9 Favored 'General case' 0 C--N 1.342 0.266 0 C-N-CA 123.712 0.805 . . . . 4.5499999999999998 110.927 177.52 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -51.1 -41.41 59.98 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 122.868 0.467 . . . . 4.0800000000000001 111.387 -178.858 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -74.62 -48.48 26.19 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 123.32 0.648 . . . . 3.2000000000000002 109.484 -177.484 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.483 HG23 HMA1 ' A' ' 93' ' ' HEC . 67.0 mt -60.76 -46.73 95.56 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.078 0 N-CA-C 108.935 -0.765 . . . . 0.22 108.935 -177.915 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 24.6 tp -52.04 -53.72 38.68 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 124.223 1.009 . . . . 0.39000000000000001 109.367 175.819 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -53.5 -48.47 68.95 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 120.879 0.371 . . . . 1.9399999999999999 110.846 175.471 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 71.3 mt -62.2 -26.58 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 O-C-N 121.385 -0.822 . . . . 0.76000000000000001 112.32 179.842 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.493 HD11 HMB2 ' A' ' 93' ' ' HEC . 54.8 mt -75.12 -50.7 23.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 O-C-N 120.131 -1.606 . . . . 0.20000000000000001 108.297 173.048 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 88.4 mt -62.62 -32.65 73.71 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.793 1.237 . . . . 0.41999999999999998 113.193 -177.376 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -128.08 20.06 6.42 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 119.697 1.135 . . . . 1.8500000000000001 110.213 -166.031 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.411 ' CA ' ' HA2' ' A' ' 73' ' ' GLY . . . 33.81 -137.97 0.17 Allowed Glycine 0 CA--C 1.544 1.852 0 C-N-CA 126.638 2.066 . . . . 0.68000000000000005 112.023 -167.282 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 164.68 141.22 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 126.45 1.9 . . . . 1.27 109.191 -177.785 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 29.06 -111.71 0.03 OUTLIER Glycine 0 C--N 1.347 1.177 0 C-N-CA 125.68 1.609 . . . . 0.59999999999999998 114.294 -172.471 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -62.35 -30.34 75.87 Favored Glycine 0 CA--C 1.535 1.344 0 CA-C-N 117.655 0.727 . . . . 0.78000000000000003 113.087 -179.414 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 5.9 ttt -70.41 122.08 85.35 Favored Pre-proline 0 CA--C 1.542 0.652 0 C-N-CA 125.114 1.366 . . . . 0.54000000000000004 111.224 -179.079 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -62.87 -58.27 0.34 Allowed 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 124.275 3.317 . . . . 3.0699999999999998 111.333 -172.32 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.411 ' HA2' ' CA ' ' A' ' 67' ' ' GLY . . . 120.8 148.33 7.98 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-O 122.205 0.891 . . . . 0.79000000000000004 114.448 172.82 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 70.91 21.94 78.26 Favored Glycine 0 CA--C 1.526 0.768 0 CA-C-O 118.484 -1.176 . . . . 0.51000000000000001 112.126 177.518 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.5 mt -47.12 -52.4 4.56 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 C-N-CA 129.052 2.941 . . . . 1.1399999999999999 111.158 175.001 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -109.98 156.87 19.92 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.609 1.564 . . . . 0.28000000000000003 108.903 164.375 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 17.9 mtmm -146.28 159.75 42.92 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 124.559 1.144 . . . . 3.2200000000000002 110.403 171.565 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 61.59 -151.22 43.91 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 110.05 -1.22 . . . . 0.68999999999999995 110.05 -177.586 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -46.76 -37.3 8.35 Favored 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 123.901 0.88 . . . . 0.80000000000000004 112.01 179.69 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -51.84 -45.68 64.09 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.73 0.812 . . . . 2.0800000000000001 110.691 176.169 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -81.15 -50.22 9.87 Favored 'General case' 0 N--CA 1.455 -0.186 0 O-C-N 121.786 -0.572 . . . . 0.26000000000000001 110.937 177.379 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -53.4 -51.06 63.78 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.461 0.704 . . . . 2.3900000000000001 111.455 -175.781 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.26 -46.13 86.58 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 122.567 0.347 . . . . 0.26000000000000001 110.309 179.791 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.483 HG22 HG23 ' A' ' 28' ' ' VAL . 67.2 t -58.25 -54.71 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 CA-C-O 119.385 -0.341 . . . . 0.28000000000000003 110.629 178.12 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -49.99 -50.42 47.12 Favored 'General case' 0 C--O 1.224 -0.266 0 C-N-CA 122.855 0.462 . . . . 0.25 111.023 176.397 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.57 -48.12 83.17 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 121.822 0.82 . . . . 0.39000000000000001 110.723 -177.616 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.565 ' CE3' HD23 ' A' ' 88' ' ' LEU . 50.8 t90 -60.92 -43.79 98.1 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 121.79 0.805 . . . . 0.54000000000000004 110.768 178.197 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.565 HD23 ' CE3' ' A' ' 87' ' ' TRP . 0.1 OUTLIER -64.28 -33.85 76.78 Favored 'General case' 0 C--O 1.223 -0.291 0 O-C-N 121.189 -0.945 . . . . 1.6100000000000001 109.698 175.527 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.8 -42.19 97.75 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 118.54 0.609 . . . . 0.5 109.553 174.292 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -52.45 -50.78 61.96 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 118.108 -0.949 . . . . 3.2400000000000002 110.307 168.151 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 26.5 mttm -70.5 111.96 6.42 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 118.955 0.798 . . . . 3.0600000000000001 111.973 -173.755 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 26.9 mttp . . . . . 0 C--O 1.254 1.303 0 CA-C-O 116.277 -1.821 . . . . 3.04 106.485 -178.505 . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 93' ' ' HEC . . . . . 0.493 HMB2 HD11 ' A' ' 64' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 5.4 t . . . . . 0 N--CA 1.469 0.51 0 N-CA-C 106.605 -1.628 . . . . 1.3300000000000001 106.605 . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -75.68 98.06 3.97 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 123.794 0.684 . . . . 2.5899999999999999 109.22 -173.204 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -40.3 -56.0 2.07 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.896 1.278 . . . . 0.34999999999999998 111.804 179.083 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -48.02 -48.38 32.93 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.451 0.701 . . . . 3.1699999999999999 112.2 176.435 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.62 -42.27 98.2 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 123.025 0.53 . . . . 0.34999999999999998 110.485 -179.043 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 61.5 t -61.83 -50.07 81.68 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 N-CA-C 109.768 -0.456 . . . . 0.44 109.768 176.1 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.453 HG21 ' CZ3' ' A' ' 87' ' ' TRP . 79.6 t -52.61 -49.9 43.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 C-N-CA 123.066 0.546 . . . . 0.53000000000000003 109.593 178.379 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 30.3 mm-40 -54.29 -17.51 3.03 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.688 1.595 . . . . 0.57999999999999996 114.298 173.517 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -149.15 58.14 1.02 Allowed 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 119.612 1.096 . . . . 3.8900000000000001 111.853 -179.081 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.1 mttm 178.34 -35.34 0.01 OUTLIER 'General case' 0 C--O 1.225 -0.202 0 C-N-CA 126.233 1.813 . . . . 1.2 109.695 172.926 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 6.4 m -100.28 -53.07 3.21 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 118.949 0.795 . . . . 0.20999999999999999 110.639 -177.115 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.471 HD12 ' N ' ' A' ' 34' ' ' SER . 2.0 pp -55.14 -26.96 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.111 0 CA-C-N 115.936 -0.574 . . . . 0.45000000000000001 112.182 -177.94 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.471 ' N ' HD12 ' A' ' 33' ' ' ILE . 1.4 m -38.23 -37.15 0.26 Allowed 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 126.418 1.887 . . . . 1.24 112.434 171.313 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 39.5 m -120.52 -41.34 2.6 Favored 'General case' 0 C--N 1.341 0.201 0 C-N-CA 123.729 0.811 . . . . 0.17999999999999999 111.741 173.519 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 85.1 m-70 -72.23 -6.78 45.37 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.33 0.652 . . . . 0.20999999999999999 112.673 -175.735 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 87.1 148.16 12.85 Favored Glycine 0 C--N 1.337 0.633 0 N-CA-C 109.547 -1.421 . . . . 1.45 109.547 177.971 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -43.98 -33.11 2.56 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 124.71 1.148 . . . . 0.54000000000000004 112.532 174.939 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -94.42 -9.88 34.23 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.582 1.553 . . . . 2.3999999999999999 112.235 -172.839 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.434 ' CD2' HG22 ' A' ' 33' ' ' ILE . 1.5 mt 71.17 10.21 6.75 Favored 'General case' 0 C--N 1.348 0.516 0 CA-C-N 120.301 1.409 . . . . 1.46 111.395 179.563 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 11.9 p -86.43 0.28 54.46 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 127.206 2.202 . . . . 0.47999999999999998 109.999 -175.753 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.87 132.42 2.95 Favored Glycine 0 N--CA 1.44 -1.083 0 N-CA-C 108.789 -1.724 . . . . 0.59999999999999998 108.789 -177.024 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -136.73 -75.47 0.42 Allowed 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 124.122 0.969 . . . . 0.27000000000000002 108.396 178.328 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -93.71 3.71 55.05 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.852 0.861 . . . . 1.3500000000000001 110.859 174.615 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -160.53 163.89 20.58 Favored Pre-proline 0 CA--C 1.537 0.474 0 C-N-CA 125.799 1.64 . . . . 0.28000000000000003 107.564 -166.093 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -69.37 158.87 55.89 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.952 2.435 . . . . 0.26000000000000001 111.237 -174.124 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -74.5 125.17 28.01 Favored 'General case' 0 C--N 1.332 -0.164 0 O-C-N 121.675 -0.64 . . . . 0.28999999999999998 111.045 -174.761 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 37.3 pt -103.98 -1.09 9.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-O 119.169 -0.443 . . . . 0.40999999999999998 112.073 178.996 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -36.6 -40.32 0.25 Allowed 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.899 1.28 . . . . 2.7400000000000002 113.721 171.548 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.6 mtpm? -119.47 36.62 4.43 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 124.548 1.139 . . . . 3.2000000000000002 110.759 -178.085 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.53 -46.62 88.32 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 109.317 -0.623 . . . . 0.44 109.317 171.98 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -57.79 -14.94 17.39 Favored Glycine 0 CA--C 1.532 1.14 0 N-CA-C 114.76 0.664 . . . . 0.81999999999999995 114.76 179.267 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -89.65 -45.41 9.36 Favored 'General case' 0 C--N 1.338 0.091 0 CA-C-N 119.048 1.424 . . . . 0.70999999999999996 109.755 168.729 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -56.16 -54.33 46.47 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 122.608 0.363 . . . . 1.8700000000000001 111.616 179.622 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -140.42 158.97 43.21 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.512 1.125 . . . . 0.64000000000000001 109.563 -168.576 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 22.6 m -84.93 168.26 15.17 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.065 0.546 . . . . 1.53 110.825 178.217 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -50.72 -44.5 58.16 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 123.785 0.834 . . . . 3.0 111.908 -179.608 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -54.86 -46.26 74.68 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 119.116 0.871 . . . . 2.9900000000000002 111.394 176.474 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 51.7 mm-40 -71.86 -47.17 54.81 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 121.751 0.786 . . . . 3.0600000000000001 109.064 -173.511 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.502 HG23 HMA1 ' A' ' 93' ' ' HEC . 64.3 mt -60.51 -46.31 95.63 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 N-CA-C 108.644 -0.873 . . . . 0.26000000000000001 108.644 178.75 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 38.9 tp -53.95 -51.35 64.12 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 109.087 -0.709 . . . . 0.34999999999999998 109.087 176.626 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -53.57 -47.06 70.43 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 117.969 0.35 . . . . 1.47 111.208 177.561 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 62.0 mt -58.71 -46.86 90.36 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.295 0 O-C-N 121.341 -0.849 . . . . 0.46000000000000002 110.844 175.431 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.429 HD11 HMB2 ' A' ' 93' ' ' HEC . 57.3 mt -58.6 -43.96 88.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 O-C-N 120.339 -1.476 . . . . 0.27000000000000002 109.89 179.532 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 86.4 mt -71.45 -34.62 70.41 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.496 1.119 . . . . 0.40999999999999998 113.321 -178.188 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 71.3 m-80 -119.43 16.8 13.0 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 120.069 1.304 . . . . 1.6599999999999999 110.317 -168.532 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.519 ' N ' ' HA2' ' A' ' 73' ' ' GLY . . . 36.11 -142.46 0.15 Allowed Glycine 0 CA--C 1.536 1.404 0 C-N-CA 127.696 2.569 . . . . 0.62 111.106 -167.463 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 173.22 131.85 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 119.076 1.438 . . . . 1.29 109.216 -175.067 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 42.13 -119.14 1.81 Allowed Glycine 0 CA--C 1.534 1.224 0 CA-C-N 120.006 1.276 . . . . 0.48999999999999999 112.687 -174.976 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -70.44 -19.35 76.11 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 123.561 0.6 . . . . 0.67000000000000004 113.016 179.148 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.449 ' HB2' ' C1D' ' A' ' 93' ' ' HEC . 20.0 ttt -71.21 117.81 60.09 Favored Pre-proline 0 N--CA 1.452 -0.348 0 C-N-CA 124.404 1.081 . . . . 0.42999999999999999 110.53 -179.584 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -78.26 122.09 5.53 Favored 'Trans proline' 0 N--CA 1.445 -1.349 0 C-N-CA 123.28 2.653 . . . . 2.1699999999999999 110.732 179.986 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.519 ' HA2' ' N ' ' A' ' 67' ' ' GLY . . . -62.58 142.46 47.86 Favored Glycine 0 N--CA 1.442 -0.917 0 N-CA-C 115.503 0.961 . . . . 0.60999999999999999 115.503 -175.285 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 77.95 33.49 41.18 Favored Glycine 0 CA--C 1.525 0.678 0 CA-C-N 114.01 -1.095 . . . . 0.37 111.135 174.889 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -56.49 -49.86 75.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.442 0 C-N-CA 124.899 1.28 . . . . 1.0 108.94 172.996 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -109.53 160.06 16.55 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.069 1.748 . . . . 0.34999999999999998 109.879 164.314 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.1 mmtp -145.91 167.54 23.03 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 126.467 1.907 . . . . 2.3700000000000001 108.922 177.21 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 50.31 -145.87 9.14 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 110.883 -0.887 . . . . 0.78000000000000003 110.883 176.811 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -51.98 -34.9 44.46 Favored 'General case' 0 C--O 1.225 -0.199 0 CA-C-N 118.148 0.974 . . . . 0.77000000000000002 112.045 176.517 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -57.52 -38.61 74.94 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 118.664 0.666 . . . . 2.1800000000000002 110.118 177.598 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -83.18 -57.68 3.17 Favored 'General case' 0 N--CA 1.461 0.11 0 O-C-N 121.565 -0.71 . . . . 0.28000000000000003 111.113 174.925 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -51.41 -49.37 61.76 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 124.887 1.275 . . . . 2.4300000000000002 111.803 -176.123 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.22 -47.06 87.57 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 109.568 -0.53 . . . . 0.31 109.568 178.415 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.435 HG11 HMB1 ' A' ' 93' ' ' HEC . 56.0 t -57.48 -52.74 53.24 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.312 0 CA-C-O 119.226 -0.416 . . . . 0.27000000000000002 110.842 178.961 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -52.28 -57.79 8.65 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.548 0.739 . . . . 0.22 111.519 176.561 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.71 -40.76 89.06 Favored 'General case' 0 C--O 1.226 -0.144 0 C-N-CA 123.032 0.533 . . . . 0.60999999999999999 110.934 -177.062 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.453 ' CZ3' HG21 ' A' ' 28' ' ' VAL . 83.6 t90 -63.79 -52.17 61.49 Favored 'General case' 0 N--CA 1.449 -0.513 0 O-C-N 121.721 -0.612 . . . . 0.73999999999999999 109.724 176.34 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.36 -27.41 64.16 Favored 'General case' 0 C--N 1.33 -0.277 0 O-C-N 120.675 -1.266 . . . . 1.96 112.167 176.413 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -56.8 -31.79 65.04 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 118.935 0.789 . . . . 0.53000000000000003 111.988 170.026 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -74.66 -36.36 62.82 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 118.844 0.747 . . . . 4.9800000000000004 111.052 172.002 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 11.9 mmtm -73.85 102.92 4.2 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 121.428 0.633 . . . . 3.7200000000000002 110.193 -178.484 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.25 1.088 0 C-N-CA 125.339 1.456 . . . . 2.8500000000000001 107.711 173.57 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 93' ' ' HEC . . . . . 0.502 HMA1 HG23 ' A' ' 60' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 69.1 t . . . . . 0 N--CA 1.471 0.607 0 N-CA-C 106.924 -1.51 . . . . 1.45 106.924 . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -71.42 161.66 30.69 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 124.466 1.106 . . . . 3.8999999999999999 108.191 -177.746 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -105.78 -62.39 1.37 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.053 -0.721 . . . . 0.40000000000000002 109.053 173.22 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -55.04 -47.97 74.06 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 119.021 -0.514 . . . . 2.7599999999999998 111.251 178.778 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.32 -41.58 93.82 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 118.95 0.796 . . . . 0.41999999999999998 111.106 -176.731 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 73.6 t -59.93 -57.41 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 108.677 -0.86 . . . . 0.46999999999999997 108.677 175.031 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.67 HG13 ' HB2' ' A' ' 32' ' ' CYS . 49.3 t -53.11 -48.37 53.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 CA-C-N 118.544 0.611 . . . . 0.33000000000000002 110.885 -178.479 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 22.4 mm-40 -51.88 -16.21 0.67 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 127.032 2.133 . . . . 0.77000000000000002 113.244 175.263 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -138.31 30.25 2.42 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 119.139 0.882 . . . . 2.6200000000000001 111.812 173.431 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -146.59 -48.43 0.19 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 118.831 0.741 . . . . 2.1699999999999999 111.103 176.481 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.67 ' HB2' HG13 ' A' ' 28' ' ' VAL . 3.5 m -93.45 -47.95 6.62 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 109.583 -0.525 . . . . 0.23999999999999999 109.583 -174.6 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.3 pp -57.35 -25.74 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 CA-C-N 115.897 -0.592 . . . . 0.42999999999999999 111.62 -178.451 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.1 m -41.89 -34.09 0.62 Allowed 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 126.157 1.783 . . . . 1.3999999999999999 112.388 172.144 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 37.2 m -121.37 -42.43 2.46 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.454 0.702 . . . . 0.23000000000000001 111.592 172.939 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 87.0 m-70 -72.93 -8.01 53.67 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.031 0.932 . . . . 0.23999999999999999 113.161 -175.483 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 85.05 150.03 11.99 Favored Glycine 0 C--N 1.337 0.601 0 N-CA-C 110.028 -1.229 . . . . 1.5800000000000001 110.028 178.699 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -43.83 -35.92 3.43 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 124.857 1.217 . . . . 0.47999999999999998 112.558 178.227 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -93.12 -9.0 41.05 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.307 1.443 . . . . 2.0699999999999998 112.41 -173.08 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.3 mt 71.41 9.49 6.49 Favored 'General case' 0 C--N 1.347 0.465 0 CA-C-N 120.254 1.388 . . . . 1.29 111.268 179.909 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.6 p -81.95 -2.47 51.53 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 127.764 2.425 . . . . 0.5 110.207 -177.205 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.54 150.31 25.18 Favored Glycine 0 N--CA 1.438 -1.169 0 N-CA-C 108.472 -1.851 . . . . 0.5 108.472 -174.597 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -156.77 -79.94 0.08 Allowed 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 124.477 1.111 . . . . 0.32000000000000001 108.712 179.278 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.3 t -92.06 2.71 56.4 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.146 0.978 . . . . 1.26 110.379 172.963 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.437 ' HB1' ' HD2' ' A' ' 46' ' ' PRO . . . -158.62 163.89 22.86 Favored Pre-proline 0 N--CA 1.45 -0.47 0 C-N-CA 125.704 1.602 . . . . 0.27000000000000002 107.494 -168.227 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.437 ' HD2' ' HB1' ' A' ' 45' ' ' ALA . 48.1 Cg_endo -69.01 162.47 41.57 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 123.63 2.887 . . . . 0.37 111.265 -174.207 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -74.76 122.49 23.37 Favored 'General case' 0 N--CA 1.455 -0.21 0 O-C-N 121.849 -0.532 . . . . 0.38 110.654 -176.072 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 33.8 pt -105.41 1.81 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.117 0 C-N-CA 123.717 0.807 . . . . 0.39000000000000001 111.4 178.096 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -44.95 -45.45 10.48 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 112.982 0.734 . . . . 2.6200000000000001 112.982 176.379 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.04 27.76 5.82 Favored 'General case' 0 C--N 1.343 0.303 0 C-N-CA 123.945 0.898 . . . . 4.04 111.582 178.63 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -56.17 -46.04 79.47 Favored 'General case' 0 N--CA 1.452 -0.352 0 O-C-N 121.62 -0.675 . . . . 0.27000000000000002 109.502 177.07 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -53.47 -30.91 42.74 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 123.448 0.547 . . . . 0.48999999999999999 113.313 -179.126 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -76.94 -42.32 39.77 Favored 'General case' 0 N--CA 1.455 -0.206 0 O-C-N 122.031 -0.687 . . . . 0.71999999999999997 110.613 176.529 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 48.7 m-20 -66.05 -49.29 68.17 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 122.129 0.172 . . . . 1.53 111.034 -179.926 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -139.14 141.67 38.04 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 125.568 1.547 . . . . 0.68000000000000005 107.837 -167.448 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 22.4 m -78.18 168.98 19.02 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 118.45 0.568 . . . . 1.5900000000000001 110.363 179.65 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -50.82 -44.23 59.18 Favored 'General case' 0 C--O 1.224 -0.258 0 C-N-CA 123.346 0.658 . . . . 3.0499999999999998 111.973 -179.593 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -54.92 -39.26 68.63 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 118.492 0.587 . . . . 2.8999999999999999 111.67 176.98 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -78.67 -45.67 20.86 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 121.495 0.664 . . . . 3.4900000000000002 109.47 -177.262 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 62.4 mt -59.11 -44.5 91.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 O-C-N 121.653 -0.654 . . . . 0.26000000000000001 109.289 179.189 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 35.4 tp -55.33 -50.1 70.51 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 123.854 0.861 . . . . 0.32000000000000001 109.453 176.174 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -50.98 -52.68 40.27 Favored 'General case' 0 N--CA 1.454 -0.235 0 O-C-N 123.312 0.382 . . . . 1.51 110.264 176.138 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 86.3 mt -56.8 -51.11 71.46 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.328 0 O-C-N 121.64 -0.663 . . . . 0.53000000000000003 110.287 177.977 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.526 HD11 HMB2 ' A' ' 93' ' ' HEC . 71.0 mt -52.65 -44.78 47.16 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 O-C-N 120.47 -1.394 . . . . 0.22 110.486 179.247 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 79.4 mt -73.06 -32.57 65.13 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 113.164 0.801 . . . . 0.39000000000000001 113.164 -179.087 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -121.96 20.6 10.76 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 119.591 1.087 . . . . 1.6399999999999999 110.161 -165.539 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.54 ' N ' ' HA2' ' A' ' 73' ' ' GLY . . . 28.75 -139.43 0.02 OUTLIER Glycine 0 CA--C 1.534 1.268 0 C-N-CA 129.127 3.251 . . . . 0.68000000000000005 111.524 -165.401 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 174.58 133.95 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 118.994 1.397 . . . . 1.2 107.935 -178.394 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 31.43 -110.04 0.04 OUTLIER Glycine 0 CA--C 1.535 1.282 0 C-N-CA 124.971 1.272 . . . . 0.34000000000000002 114.246 -172.515 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -69.61 -24.11 76.37 Favored Glycine 0 CA--C 1.533 1.206 0 CA-C-N 118.114 0.957 . . . . 0.41999999999999998 113.166 -178.328 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.405 ' HB2' ' C1D' ' A' ' 93' ' ' HEC . 18.1 ttt -70.99 120.03 76.96 Favored Pre-proline 0 N--CA 1.452 -0.371 0 C-N-CA 125.004 1.321 . . . . 0.34999999999999998 111.039 -178.605 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.431 ' HD2' HD11 ' A' ' 75' ' ' ILE . 37.4 Cg_endo -75.62 122.33 6.85 Favored 'Trans proline' 0 N--CA 1.446 -1.304 0 C-N-CA 123.297 2.665 . . . . 2.0499999999999998 111.135 178.933 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.54 ' HA2' ' N ' ' A' ' 67' ' ' GLY . . . -61.06 137.39 48.16 Favored Glycine 0 N--CA 1.442 -0.934 0 CA-C-N 115.271 -0.877 . . . . 0.67000000000000004 114.833 -179.272 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 82.16 42.71 8.53 Favored Glycine 0 CA--C 1.524 0.632 0 CA-C-N 114.225 -0.988 . . . . 0.54000000000000004 110.636 175.829 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.431 HD11 ' HD2' ' A' ' 72' ' ' PRO . 0.9 OUTLIER -63.66 -57.42 11.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 C-N-CA 124.379 1.072 . . . . 1.23 109.283 174.172 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -98.12 155.94 16.9 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.952 1.301 . . . . 0.40000000000000002 109.383 166.08 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -146.0 151.37 37.67 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 124.322 1.049 . . . . 2.75 110.959 178.424 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 72.51 -163.62 54.69 Favored Glycine 0 CA--C 1.53 1.016 0 N-CA-C 110.747 -0.941 . . . . 0.82999999999999996 110.747 -174.437 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -52.02 -24.13 6.2 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.737 1.215 . . . . 0.94999999999999996 112.718 -179.061 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 47.9 tt0 -43.99 -63.16 0.92 Allowed 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.736 1.215 . . . . 2.6099999999999999 110.283 167.903 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.45 -45.09 94.93 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.189 0.596 . . . . 0.23000000000000001 110.271 -176.275 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -53.81 -54.07 43.58 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.742 0.817 . . . . 1.99 110.979 178.001 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -56.41 -49.51 74.3 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 123.811 0.844 . . . . 0.31 109.764 -179.824 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.456 HG22 HG23 ' A' ' 28' ' ' VAL . 69.2 t -54.99 -52.77 40.58 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-N 116.939 -0.119 . . . . 0.29999999999999999 111.26 176.802 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -54.63 -52.02 63.57 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.38 0.672 . . . . 0.17999999999999999 111.919 -179.881 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.99 -48.06 79.33 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 121.553 0.692 . . . . 0.29999999999999999 110.555 177.226 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.539 ' CE3' HD23 ' A' ' 88' ' ' LEU . 54.6 t90 -57.08 -44.97 83.64 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 121.71 -0.619 . . . . 0.5 110.548 177.778 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.539 HD23 ' CE3' ' A' ' 87' ' ' TRP . 0.1 OUTLIER -63.89 -37.38 87.17 Favored 'General case' 0 N--CA 1.461 0.088 0 C-N-CA 124.749 1.22 . . . . 1.6000000000000001 111.599 177.203 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -54.69 -38.44 67.01 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 119.216 0.916 . . . . 0.55000000000000004 110.432 169.552 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -88.76 26.2 1.58 Allowed 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 113.473 0.916 . . . . 3.3100000000000001 113.473 171.795 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 2.1 mtpm? -122.05 117.88 27.41 Favored 'General case' 0 C--N 1.341 0.239 0 O-C-N 120.647 -1.283 . . . . 2.2599999999999998 110.218 165.854 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.256 1.405 0 C-N-CA 129.535 3.134 . . . . 2.8300000000000001 104.738 174.483 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 93' ' ' HEC . . . . . 0.526 HMB2 HD11 ' A' ' 64' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.462 ' HB3' ' HB3' ' A' ' 26' ' ' ALA . 0.1 OUTLIER . . . . . 0 N--CA 1.454 -0.247 0 N-CA-C 104.12 -2.548 . . . . 2.31 104.12 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.27 -52.49 33.22 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-O 122.428 1.109 . . . . 0.48 109.265 -166.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.434 ' HB3' ' CZ2' ' A' ' 87' ' ' TRP . 5.5 pt-20 -55.69 -48.06 75.72 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 114.15 -1.387 . . . . 2.73 111.839 175.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.462 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . . . -56.86 -46.06 82.05 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 119.617 1.099 . . . . 0.37 111.013 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.576 HG21 ' HG3' ' A' ' 80' ' ' GLU . 68.7 t -55.86 -56.76 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.225 0 N-CA-C 108.901 -0.777 . . . . 0.48 108.901 176.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.589 HG22 ' SG ' ' A' ' 32' ' ' CYS . 29.9 t -51.93 -49.14 38.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 O-C-N 122.343 -0.223 . . . . 0.29 111.274 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.414 ' HA ' HG12 ' A' ' 33' ' ' ILE . 18.1 mm-40 -57.34 -8.03 0.69 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 127.895 2.478 . . . . 1.22 113.671 176.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 19.6 tp60 -137.44 17.57 2.93 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 119.772 1.169 . . . . 2.94 111.522 172.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 50.3 mmtt -138.97 -59.44 0.6 Allowed 'General case' 0 CA--C 1.514 -0.434 0 O-C-N 121.111 -0.993 . . . . 2.54 110.435 -177.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.589 ' SG ' HG22 ' A' ' 28' ' ' VAL . 2.8 m -79.45 -47.68 15.24 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 108.698 -0.852 . . . . 0.34 108.698 -173.331 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.414 HG12 ' HA ' ' A' ' 29' ' ' GLN . 2.5 pp -52.85 -30.2 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 CA-C-N 115.384 -0.826 . . . . 0.39 111.95 -179.265 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.8 m -46.01 -30.81 1.97 Allowed 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.132 1.373 . . . . 1.23 112.738 176.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 30.1 m -121.93 -44.55 2.3 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.784 0.834 . . . . 0.17 111.386 173.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 87.1 m-70 -68.61 -10.13 54.07 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.724 1.21 . . . . 0.26 112.558 -177.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 87.99 148.31 15.19 Favored Glycine 0 C--N 1.339 0.702 0 C-N-CA 125.468 1.509 . . . . 1.48 109.64 179.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -41.83 -36.98 1.92 Allowed Glycine 0 C--N 1.341 0.84 0 C-N-CA 124.653 1.121 . . . . 0.47 112.214 173.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -89.94 -12.4 38.93 Favored 'General case' 0 N--CA 1.444 -0.76 0 C-N-CA 125.876 1.67 . . . . 3.08 111.429 -172.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.0 mt 71.24 11.61 6.79 Favored 'General case' 0 C--N 1.349 0.56 0 CA-C-N 119.983 1.265 . . . . 1.15 111.249 178.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.6 p -87.2 0.09 55.88 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 127.696 2.398 . . . . 0.5 110.018 -175.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.7 126.22 2.32 Favored Glycine 0 N--CA 1.441 -0.977 0 N-CA-C 109.052 -1.619 . . . . 0.81 109.052 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -131.27 -77.93 0.52 Allowed 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 124.311 1.044 . . . . 0.3 108.405 178.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 12.6 m -92.59 4.29 53.9 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.393 1.077 . . . . 1.35 110.984 173.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.468 ' HB1' ' HD2' ' A' ' 46' ' ' PRO . . . -157.82 166.63 16.16 Favored Pre-proline 0 CA--C 1.537 0.453 0 C-N-CA 125.013 1.325 . . . . 0.23 108.353 -168.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.468 ' HD2' ' HB1' ' A' ' 45' ' ' ALA . 69.7 Cg_endo -73.88 153.91 48.01 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 123.136 2.557 . . . . 0.39 110.552 -173.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -72.04 125.71 27.94 Favored 'General case' 0 C--N 1.332 -0.171 0 O-C-N 121.107 -0.996 . . . . 0.28 110.725 -174.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 18.1 pt -104.43 1.63 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.143 0 C-N-CA 123.351 0.66 . . . . 0.49 111.697 176.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -36.79 -44.9 0.51 Allowed 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.416 1.086 . . . . 2.38 112.986 170.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 8.4 pttp -113.2 31.89 6.13 Favored 'General case' 0 C--N 1.344 0.332 0 C-N-CA 123.94 0.896 . . . . 4.26 111.876 178.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.92 -44.32 96.41 Favored 'General case' 0 N--CA 1.454 -0.242 0 O-C-N 120.836 -1.165 . . . . 0.31 109.297 178.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -54.2 -26.65 36.62 Favored Glycine 0 C--N 1.339 0.746 0 CA-C-N 118.238 0.472 . . . . 0.59 113.915 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -83.59 -45.07 13.92 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 117.29 0.545 . . . . 0.77 110.031 175.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 35.3 m-80 -58.27 -51.77 68.37 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 122.728 0.411 . . . . 1.62 111.333 178.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -134.12 149.99 51.11 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.456 1.503 . . . . 0.87 108.485 -166.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.66 164.37 25.37 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 109.856 -0.424 . . . . 1.55 109.856 -179.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -49.39 -42.77 43.27 Favored 'General case' 0 C--O 1.223 -0.331 0 C-N-CA 123.301 0.64 . . . . 3.27 110.779 173.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 70.9 mt-10 -52.98 -44.86 67.5 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.207 0.603 . . . . 2.92 110.776 178.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 58.2 mm-40 -75.06 -47.96 26.28 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.172 0.589 . . . . 3.05 110.037 -177.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 76.4 mt -62.77 -46.34 96.6 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.111 0 N-CA-C 108.941 -0.763 . . . . 0.31 108.941 -175.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 32.4 tp -53.48 -51.72 61.83 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 124.061 0.944 . . . . 0.56 109.281 176.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -53.09 -51.56 61.44 Favored 'General case' 0 N--CA 1.452 -0.368 0 O-C-N 123.374 0.421 . . . . 1.95 110.504 176.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 40.9 mt -56.02 -45.15 80.26 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.378 0 O-C-N 121.451 -0.781 . . . . 0.45 111.184 177.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 43.3 mt -61.98 -45.41 98.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 O-C-N 119.951 -1.718 . . . . 0.34 109.482 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 87.5 mt -69.81 -29.04 66.23 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.118 0.967 . . . . 0.57 113.364 -178.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -128.87 19.54 6.05 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 119.683 1.128 . . . . 1.8 110.338 -166.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.525 ' N ' ' HA2' ' A' ' 73' ' ' GLY . . . 34.87 -146.52 0.04 OUTLIER Glycine 0 CA--C 1.538 1.516 0 C-N-CA 128.975 3.179 . . . . 0.64 112.397 -170.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 177.37 135.64 0.07 Allowed 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.173 1.389 . . . . 1.23 108.075 -176.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 32.0 -110.67 0.04 OUTLIER Glycine 0 CA--C 1.533 1.171 0 C-N-CA 125.038 1.304 . . . . 0.38 114.095 -174.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -71.03 -24.65 76.91 Favored Glycine 0 CA--C 1.534 1.243 0 CA-C-N 118.116 0.958 . . . . 0.53 113.053 -178.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 17.6 ttt -69.36 118.35 61.33 Favored Pre-proline 0 CA--C 1.535 0.388 0 C-N-CA 125.06 1.344 . . . . 0.4 111.3 -179.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -75.67 127.86 10.54 Favored 'Trans proline' 0 N--CA 1.446 -1.279 0 C-N-CA 122.877 2.385 . . . . 2.11 110.671 177.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.525 ' HA2' ' N ' ' A' ' 67' ' ' GLY . . . -66.48 140.35 38.86 Favored Glycine 0 N--CA 1.442 -0.909 0 N-CA-C 115.158 0.823 . . . . 0.7 115.158 -177.064 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 79.53 39.17 18.93 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 110.6 -1.0 . . . . 0.32 110.6 176.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -60.19 -48.95 86.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 124.645 1.178 . . . . 1.09 108.863 175.07 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -102.72 149.3 24.59 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 126.031 1.732 . . . . 0.32 108.87 162.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 65.6 mttt -141.42 160.04 40.97 Favored 'General case' 0 C--N 1.339 0.119 0 C-N-CA 124.097 0.959 . . . . 2.74 110.036 172.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 74.84 -165.16 54.73 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 109.999 -1.241 . . . . 0.97 109.999 -174.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -54.32 -24.47 19.38 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.451 0.701 . . . . 0.94 111.691 -178.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.576 ' HG3' HG21 ' A' ' 27' ' ' VAL . 30.8 tt0 -41.92 -60.14 1.49 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.198 1.399 . . . . 2.31 110.511 169.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.6 -45.66 93.16 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 122.537 0.335 . . . . 0.33 110.293 -174.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -51.73 -60.69 2.88 Favored 'General case' 0 C--N 1.339 0.111 0 C-N-CA 124.08 0.952 . . . . 2.73 110.739 174.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -52.77 -48.9 66.49 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-O 119.242 -0.408 . . . . 0.28 110.743 -179.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.461 HG13 ' CG2' ' A' ' 28' ' ' VAL . 78.6 t -53.69 -59.75 1.75 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 CA-C-N 117.787 0.267 . . . . 0.4 110.865 176.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -50.33 -51.47 45.28 Favored 'General case' 0 C--O 1.226 -0.138 0 C-N-CA 123.669 0.788 . . . . 0.22 112.159 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.2 -45.43 80.81 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.4 0.68 . . . . 0.38 110.683 -175.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.465 ' CZ3' HG21 ' A' ' 28' ' ' VAL . 77.3 t90 -55.23 -47.82 74.83 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 109.041 -0.726 . . . . 0.71 109.041 173.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.03 -37.79 80.83 Favored 'General case' 0 C--O 1.22 -0.474 0 CA-C-O 117.977 -1.011 . . . . 2.0 112.911 173.04 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -52.95 -40.89 64.02 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 120.381 1.446 . . . . 0.38 110.735 175.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -67.54 -38.08 83.66 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-O 118.944 -0.55 . . . . 3.74 112.329 170.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 24.2 mtpp -76.37 108.86 9.62 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 119.906 1.23 . . . . 2.79 111.092 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 88.9 mttt . . . . . 0 C--O 1.25 1.126 0 C-N-CA 126.013 1.725 . . . . 2.14 107.599 -176.356 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.447 -0.589 0 N-CA-C 108.137 -1.06 . . . . 2.2 108.137 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -48.0 -54.14 13.91 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.834 0.854 . . . . 0.27 110.786 -179.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -53.34 -46.55 69.53 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 122.73 0.412 . . . . 3.29 111.621 176.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.3 -44.47 97.16 Favored 'General case' 0 CA--C 1.527 0.062 0 C-N-CA 122.877 0.471 . . . . 0.3 110.569 -179.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 77.7 t -57.94 -55.4 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 N-CA-C 109.232 -0.655 . . . . 0.44 109.232 175.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.423 ' HA ' ' SG ' ' A' ' 32' ' ' CYS . 79.0 t -50.99 -47.92 29.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 110.379 -0.23 . . . . 0.41 110.379 -179.288 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 28.6 mm-40 -54.22 -23.33 14.29 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 126.455 1.902 . . . . 0.64 114.72 174.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -142.6 59.23 1.44 Allowed 'General case' 0 N--CA 1.461 0.088 0 CA-C-N 120.54 1.518 . . . . 2.42 112.106 173.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.08 -36.39 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 124.435 1.094 . . . . 1.2 109.611 171.177 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.423 ' SG ' ' HA ' ' A' ' 28' ' ' VAL . 3.7 m -101.9 -50.4 3.69 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 118.813 0.733 . . . . 0.2 110.931 -177.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.536 HG22 HD23 ' A' ' 40' ' ' LEU . 2.0 pp -56.77 -25.77 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 N-CA-C 112.556 0.576 . . . . 0.5 112.556 -174.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.451 ' N ' HD12 ' A' ' 33' ' ' ILE . 8.3 m -41.8 -34.89 0.7 Allowed 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.576 1.55 . . . . 1.01 112.475 172.146 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 18.9 m -121.1 -42.97 2.46 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.369 0.668 . . . . 0.19 111.385 175.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 84.8 m-70 -71.34 -7.65 48.52 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.422 0.689 . . . . 0.17 112.741 -176.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 88.49 149.29 18.67 Favored Glycine 0 C--N 1.338 0.669 0 N-CA-C 109.776 -1.329 . . . . 1.44 109.776 178.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -43.17 -36.45 2.84 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 124.615 1.102 . . . . 0.52 112.233 174.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -97.58 -4.39 37.79 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 124.88 1.272 . . . . 2.9 111.793 -172.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.536 HD23 HG22 ' A' ' 33' ' ' ILE . 1.5 mt 71.43 12.83 6.58 Favored 'General case' 0 C--N 1.348 0.531 0 CA-C-N 120.238 1.381 . . . . 1.42 111.071 176.006 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.3 p -88.71 1.23 55.5 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 127.866 2.466 . . . . 0.31 110.038 -173.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.51 138.0 5.57 Favored Glycine 0 N--CA 1.444 -0.808 0 N-CA-C 109.049 -1.62 . . . . 0.42 109.049 -177.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -143.79 -71.56 0.29 Allowed 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.469 -0.567 . . . . 0.35 109.469 178.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -99.02 3.92 47.01 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.939 1.696 . . . . 0.98 110.315 172.393 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.428 ' HB1' ' HD2' ' A' ' 46' ' ' PRO . . . -158.28 165.43 18.6 Favored Pre-proline 0 CA--C 1.535 0.394 0 C-N-CA 124.907 1.283 . . . . 0.24 107.852 -168.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.428 ' HD2' ' HB1' ' A' ' 45' ' ' ALA . 46.3 Cg_endo -69.5 157.73 59.84 Favored 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 122.621 2.214 . . . . 0.2 110.53 -175.162 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.64 121.49 20.79 Favored 'General case' 0 N--CA 1.454 -0.246 0 O-C-N 121.724 -0.61 . . . . 0.24 109.934 -178.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 41.7 pt -100.99 1.88 10.56 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.161 0 C-N-CA 123.536 0.735 . . . . 0.26 111.039 178.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.434 ' OD1' ' NZ ' ' A' ' 91' ' ' LYS . 34.2 t70 -44.01 -41.23 5.28 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 113.506 0.928 . . . . 3.18 113.506 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 35.0 mttm -109.3 33.19 4.44 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 125.838 1.655 . . . . 6.12 111.403 179.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -58.26 -46.02 86.76 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 108.975 -0.75 . . . . 0.34 108.975 173.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -54.07 -28.55 41.62 Favored Glycine 0 CA--C 1.527 0.785 0 CA-C-N 118.243 0.474 . . . . 0.51 114.158 -179.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -78.62 -42.6 28.46 Favored 'General case' 0 N--CA 1.455 -0.223 0 O-C-N 122.227 -0.573 . . . . 0.72 110.049 175.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 15.8 m-80 -65.63 -48.53 71.91 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 122.784 0.434 . . . . 1.57 111.197 -178.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -138.79 147.74 42.93 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 125.423 1.489 . . . . 0.61 108.327 -170.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 89.6 p -74.62 168.28 20.11 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.033 0.533 . . . . 2.35 110.973 177.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -46.66 -47.21 20.3 Favored 'General case' 0 C--O 1.224 -0.278 0 C-N-CA 124.311 1.044 . . . . 2.76 111.582 174.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -57.7 -41.54 81.91 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.422 0.689 . . . . 4.03 110.531 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -76.23 -45.79 31.26 Favored 'General case' 0 N--CA 1.45 -0.428 0 O-C-N 121.437 -0.789 . . . . 3.44 109.391 -175.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 80.9 mt -60.76 -44.43 97.37 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.125 0 N-CA-C 109.027 -0.731 . . . . 0.3 109.027 178.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 33.5 tp -54.66 -49.02 71.58 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 109.277 -0.638 . . . . 0.32 109.277 176.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -54.1 -46.19 72.04 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 117.891 0.314 . . . . 1.48 111.498 175.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 73.9 mt -59.63 -49.79 82.4 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.261 0 O-C-N 121.115 -0.991 . . . . 0.54 110.453 176.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 58.8 mt -56.18 -44.64 79.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 O-C-N 120.386 -1.446 . . . . 0.22 110.002 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 69.5 mt -71.04 -28.64 64.52 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 124.309 1.043 . . . . 0.36 113.802 -178.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 51.3 m-80 -125.02 15.54 8.51 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 120.374 1.443 . . . . 1.73 110.629 -169.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.554 ' N ' ' HA2' ' A' ' 73' ' ' GLY . . . 35.84 -144.14 0.09 OUTLIER Glycine 0 CA--C 1.537 1.428 0 C-N-CA 128.082 2.753 . . . . 0.62 111.597 -166.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 173.83 133.56 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 119.465 1.632 . . . . 1.22 110.021 -177.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 40.26 -119.36 1.26 Allowed Glycine 0 CA--C 1.532 1.126 0 CA-C-N 119.574 1.079 . . . . 0.38 112.789 -173.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -66.14 -21.76 70.22 Favored Glycine 0 CA--C 1.534 1.233 0 CA-C-N 117.498 0.649 . . . . 0.48 113.245 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 18.2 ttt -74.04 121.07 84.33 Favored Pre-proline 0 CA--C 1.536 0.41 0 C-N-CA 124.406 1.082 . . . . 0.35 111.539 -176.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.455 ' HD2' HD11 ' A' ' 75' ' ' ILE . 53.3 Cg_endo -79.02 122.71 5.41 Favored 'Trans proline' 0 N--CA 1.449 -1.097 0 C-N-CA 123.262 2.641 . . . . 2.11 111.688 -178.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.554 ' HA2' ' N ' ' A' ' 67' ' ' GLY . . . -60.65 138.76 48.21 Favored Glycine 0 N--CA 1.443 -0.89 0 N-CA-C 115.5 0.96 . . . . 0.61 115.5 -177.212 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 81.94 35.63 21.03 Favored Glycine 0 CA--C 1.527 0.783 0 CA-C-N 114.379 -0.911 . . . . 0.33 111.612 174.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.455 HD11 ' HD2' ' A' ' 72' ' ' PRO . 1.2 mt -58.23 -52.16 62.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 124.924 1.29 . . . . 1.22 110.059 175.246 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -111.02 161.68 15.63 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.748 1.619 . . . . 0.26 109.036 165.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 18.0 mttm -144.32 164.3 31.18 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 124.931 1.292 . . . . 2.94 110.412 176.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 57.2 -144.5 39.51 Favored Glycine 0 CA--C 1.529 0.908 0 N-CA-C 111.185 -0.766 . . . . 0.71 111.185 179.083 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -52.23 -33.98 43.84 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.203 0.601 . . . . 0.8 111.526 174.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -55.02 -36.64 65.69 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.443 0.697 . . . . 2.28 110.515 176.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -88.05 -52.69 5.12 Favored 'General case' 0 CA--C 1.534 0.336 0 O-C-N 121.662 -0.649 . . . . 0.21 111.086 175.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -54.73 -50.9 67.24 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.789 0.836 . . . . 2.48 111.568 -175.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.61 -45.37 92.14 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 109.644 -0.502 . . . . 0.24 109.644 -178.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 64.9 t -57.19 -55.12 22.43 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 C-N-CA 122.831 0.452 . . . . 0.29 110.363 176.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -50.28 -53.83 25.69 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 122.973 0.509 . . . . 0.2 111.497 177.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.33 -44.78 95.69 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 121.542 0.686 . . . . 0.33 111.278 -178.083 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 81.0 t90 -60.82 -50.08 74.91 Favored 'General case' 0 N--CA 1.452 -0.356 0 O-C-N 121.471 -0.768 . . . . 0.63 110.221 179.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.6 -30.64 70.82 Favored 'General case' 0 C--O 1.222 -0.367 0 O-C-N 121.3 -0.875 . . . . 1.97 111.927 172.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -58.92 -31.48 68.69 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 119.603 1.092 . . . . 0.53 111.21 171.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -76.02 -35.68 59.43 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 118.927 0.785 . . . . 3.49 111.784 169.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.517 ' HZ2' ' HB3' ' A' ' 91' ' ' LYS . 0.7 OUTLIER -73.34 110.18 7.44 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 119.522 1.055 . . . . 2.76 111.068 -179.64 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 19.7 mttt . . . . . 0 C--O 1.251 1.163 0 C-N-CA 125.507 1.523 . . . . 2.84 109.342 -170.817 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 . . . . . 0 N--CA 1.449 -0.517 0 N-CA-C 108.383 -0.969 . . . . 2.68 108.383 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -42.69 -56.09 3.3 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.677 1.191 . . . . 0.3 111.088 177.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -47.56 -47.04 28.45 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 123.524 0.73 . . . . 3.07 111.73 175.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.98 -46.06 90.91 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-N 118.682 0.674 . . . . 0.35 110.412 -179.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 94.5 t -58.51 -52.22 62.1 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.134 0 N-CA-C 109.691 -0.485 . . . . 0.42 109.691 177.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.406 ' HA ' ' SG ' ' A' ' 32' ' ' CYS . 72.4 t -52.47 -52.22 27.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 N-CA-C 109.756 -0.461 . . . . 0.4 109.756 179.033 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 35.3 mm-40 -58.12 -7.2 0.75 Allowed 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 127.547 2.339 . . . . 0.65 114.022 174.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -142.82 33.1 1.4 Allowed 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 119.81 1.187 . . . . 3.1 113.369 172.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -153.92 -55.66 0.11 Allowed 'General case' 0 CA--C 1.517 -0.314 0 O-C-N 121.766 -0.584 . . . . 1.57 109.885 170.183 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.406 ' SG ' ' HA ' ' A' ' 28' ' ' VAL . 3.2 m -76.34 -48.29 20.5 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 109.824 -0.436 . . . . 0.2 109.824 -170.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.1 pt -49.93 -30.99 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-N 115.217 -0.901 . . . . 0.79 112.517 -179.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.9 m -46.06 -33.02 3.17 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 125.64 1.576 . . . . 1.02 112.077 177.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 14.6 m -121.95 -44.84 2.28 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.706 0.802 . . . . 0.18 111.228 175.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 82.0 m-70 -67.43 -11.11 57.0 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.189 0.996 . . . . 0.3 112.319 -178.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 87.82 148.04 14.25 Favored Glycine 0 C--N 1.339 0.712 0 N-CA-C 109.396 -1.481 . . . . 1.43 109.396 178.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -43.83 -31.92 2.04 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 124.655 1.121 . . . . 0.59 112.969 173.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -92.62 -12.44 31.63 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.596 1.559 . . . . 2.15 112.831 -175.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 73.0 9.71 5.37 Favored 'General case' 0 C--N 1.347 0.489 0 CA-C-N 120.326 1.421 . . . . 1.6 111.168 178.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.0 p -86.0 -1.66 57.55 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 127.947 2.499 . . . . 0.3 110.222 -174.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.64 132.25 4.64 Favored Glycine 0 N--CA 1.443 -0.86 0 N-CA-C 108.726 -1.75 . . . . 0.52 108.726 -179.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -137.45 -75.83 0.4 Allowed 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 108.869 -0.789 . . . . 0.25 108.869 179.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 15.7 m -95.47 4.3 53.4 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.658 1.183 . . . . 1.31 110.628 172.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.528 ' HB1' ' HD2' ' A' ' 46' ' ' PRO . . . -156.6 167.73 13.84 Favored Pre-proline 0 N--CA 1.45 -0.474 0 C-N-CA 124.842 1.257 . . . . 0.25 108.33 -171.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.528 ' HD2' ' HB1' ' A' ' 45' ' ' ALA . 36.7 Cg_endo -71.02 156.43 60.04 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 122.951 2.434 . . . . 0.29 110.508 -174.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.37 126.74 30.84 Favored 'General case' 0 N--CA 1.455 -0.199 0 O-C-N 121.513 -0.742 . . . . 0.29 110.083 -177.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 36.3 pt -103.2 0.62 10.32 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.191 0 C-N-CA 123.239 0.616 . . . . 0.48 111.196 174.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -33.23 -45.73 0.15 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.606 1.562 . . . . 2.29 113.071 168.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.62 39.95 3.2 Favored 'General case' 0 C--N 1.343 0.317 0 C-N-CA 124.184 0.993 . . . . 4.02 111.475 177.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.63 -42.99 85.88 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 121.324 -0.86 . . . . 0.29 109.601 174.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -52.4 -32.53 37.89 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-N 118.507 0.594 . . . . 0.66 114.387 -175.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -78.22 -49.13 14.33 Favored 'General case' 0 N--CA 1.455 -0.221 0 O-C-N 122.39 -0.477 . . . . 0.94 110.172 174.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 33.0 m-80 -56.6 -48.84 76.57 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 122.865 0.466 . . . . 1.53 111.533 -177.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -136.47 140.16 42.88 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.751 1.62 . . . . 1.07 107.373 -169.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 90.4 p -73.87 169.01 18.29 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 121.641 -0.662 . . . . 2.46 110.716 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -48.17 -52.59 20.1 Favored 'General case' 0 C--N 1.341 0.233 0 O-C-N 121.811 -0.555 . . . . 4.94 110.103 174.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -53.97 -27.22 29.94 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 118.69 -0.672 . . . . 2.75 112.51 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -87.87 -46.87 9.04 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 119.325 0.966 . . . . 3.28 110.248 177.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 83.4 mt -62.62 -47.73 91.53 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.145 0 O-C-N 121.31 -0.868 . . . . 0.22 109.153 -177.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 25.3 tp -53.38 -50.07 65.87 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 109.036 -0.728 . . . . 0.42 109.036 176.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -49.43 -55.83 11.75 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 122.701 0.4 . . . . 2.77 110.054 173.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 23.2 mt -56.16 -45.45 80.83 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.366 0 C-N-CA 120.329 -0.548 . . . . 0.47 110.69 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 56.0 mt -58.46 -40.34 78.14 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 O-C-N 120.099 -1.626 . . . . 0.23 109.926 178.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 71.9 mt -70.73 -40.61 72.65 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.359 1.064 . . . . 0.54 113.439 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 14.8 p30 -124.29 27.16 7.14 Favored 'General case' 0 C--N 1.343 0.312 0 CA-C-N 120.899 1.681 . . . . 3.9 110.12 -168.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.538 ' N ' ' HA2' ' A' ' 73' ' ' GLY . . . 34.2 -140.33 0.12 Allowed Glycine 0 CA--C 1.534 1.268 0 C-N-CA 128.344 2.878 . . . . 0.64 110.999 -173.23 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 2.3 tp-100 176.87 140.58 0.07 Allowed 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 107.592 -1.262 . . . . 2.5 107.592 -179.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 40.97 -112.17 0.33 Allowed Glycine 0 CA--C 1.536 1.344 0 CA-C-N 119.953 1.251 . . . . 0.49 113.782 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -79.78 -20.92 67.2 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 123.87 0.748 . . . . 0.53 112.866 178.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 19.8 ttt -68.01 118.48 58.87 Favored Pre-proline 0 CA--C 1.534 0.338 0 C-N-CA 125.041 1.336 . . . . 0.35 110.734 179.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.403 ' HD2' HD11 ' A' ' 75' ' ' ILE . 37.4 Cg_endo -76.42 122.05 6.34 Favored 'Trans proline' 0 N--CA 1.446 -1.293 0 C-N-CA 122.698 2.265 . . . . 2.08 111.166 -179.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.538 ' HA2' ' N ' ' A' ' 67' ' ' GLY . . . -59.06 135.79 51.64 Favored Glycine 0 N--CA 1.442 -0.922 0 CA-C-N 115.364 -0.834 . . . . 0.63 114.869 -179.075 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 88.19 35.92 8.57 Favored Glycine 0 CA--C 1.53 0.97 0 CA-C-N 114.466 -0.867 . . . . 0.35 112.368 172.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.403 HD11 ' HD2' ' A' ' 72' ' ' PRO . 1.3 mt -64.94 -46.88 90.33 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.863 0 C-N-CA 125.76 1.624 . . . . 1.11 110.981 178.675 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -116.36 149.33 39.52 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 126.238 1.815 . . . . 0.47 107.561 163.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.3 mtpp -144.03 162.26 36.68 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 125.973 1.709 . . . . 2.31 108.293 178.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 63.68 -161.4 35.79 Favored Glycine 0 CA--C 1.529 0.966 0 N-CA-C 110.933 -0.867 . . . . 0.59 110.933 -174.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -51.6 -27.71 12.0 Favored 'General case' 0 C--O 1.225 -0.224 0 C-N-CA 123.949 0.9 . . . . 0.56 112.226 -177.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.498 ' O ' HG23 ' A' ' 84' ' ' VAL . 8.5 tt0 -44.63 -60.68 1.88 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.931 1.293 . . . . 2.08 109.766 168.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -69.47 -46.19 67.24 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.838 0.855 . . . . 0.28 110.821 -178.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -56.27 -49.58 73.83 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 121.231 0.539 . . . . 1.97 110.157 -176.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -55.52 -53.5 55.63 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 123.467 0.707 . . . . 0.3 109.678 176.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 80' ' ' GLU . 89.1 t -51.37 -56.24 5.84 Favored 'Isoleucine or valine' 0 C--N 1.339 0.138 0 CA-C-N 117.826 0.284 . . . . 0.35 110.738 178.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -50.66 -54.85 19.7 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 123.833 0.853 . . . . 0.2 111.763 179.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -63.04 -45.11 93.84 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 121.338 0.589 . . . . 0.33 110.995 -177.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 84.7 t90 -57.69 -52.74 64.2 Favored 'General case' 0 C--N 1.329 -0.286 0 O-C-N 121.701 -0.624 . . . . 0.63 109.485 177.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.77 -30.96 71.14 Favored 'General case' 0 C--O 1.222 -0.366 0 CA-C-O 118.028 -0.987 . . . . 1.97 112.714 174.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -55.88 -35.67 66.77 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 119.963 1.256 . . . . 0.41 109.985 172.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -74.18 -37.51 63.92 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.002 0.521 . . . . 2.82 111.392 173.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 3.5 mtpt -73.82 126.6 30.75 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 119.342 0.974 . . . . 2.18 110.988 -178.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 19.6 mtmt . . . . . 0 C--O 1.253 1.244 0 CA-C-O 115.897 -2.001 . . . . 2.21 106.187 -174.751 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 20.5 t0 . . . . . 0 N--CA 1.451 -0.404 0 N-CA-C 106.744 -1.576 . . . . 4.05 106.744 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -50.27 -44.97 53.98 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 123.682 0.793 . . . . 0.32 111.46 176.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -66.26 -46.94 75.34 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 107.94 -1.133 . . . . 2.75 107.94 -174.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.78 -46.64 77.9 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 122.886 0.474 . . . . 0.26 111.175 175.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 75.4 t -56.58 -57.49 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 N-CA-C 109.264 -0.643 . . . . 0.37 109.264 176.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.556 HG13 ' HB2' ' A' ' 32' ' ' CYS . 72.2 t -53.31 -47.8 56.81 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 CA-C-N 118.05 0.386 . . . . 0.31 110.865 -177.291 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -51.38 -23.92 4.26 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 126.326 1.85 . . . . 0.55 113.488 174.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -138.19 57.44 1.71 Allowed 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 119.354 0.979 . . . . 2.8 110.857 172.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -172.04 -38.58 0.02 OUTLIER 'General case' 0 C--O 1.225 -0.231 0 C-N-CA 123.736 0.815 . . . . 1.3 110.524 168.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.556 ' HB2' HG13 ' A' ' 28' ' ' VAL . 3.7 m -97.5 -50.85 4.35 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 119.042 0.837 . . . . 0.22 110.26 -178.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.495 HG22 HD23 ' A' ' 40' ' ' LEU . 1.6 pp -57.92 -26.05 27.44 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.156 0 CA-C-N 116.202 -0.454 . . . . 0.43 112.134 -173.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.422 ' N ' HD12 ' A' ' 33' ' ' ILE . 5.9 m -38.92 -36.75 0.3 Allowed 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 125.841 1.656 . . . . 1.09 112.224 170.451 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 15.0 m -120.27 -44.72 2.47 Favored 'General case' 0 C--N 1.34 0.187 0 C-N-CA 123.356 0.662 . . . . 0.23 111.317 174.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 85.7 m-70 -70.46 -7.79 46.06 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.899 0.879 . . . . 0.17 112.946 -175.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 87.92 149.3 17.16 Favored Glycine 0 C--N 1.337 0.622 0 N-CA-C 109.977 -1.249 . . . . 1.48 109.977 176.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -45.89 -38.7 8.17 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 124.197 0.903 . . . . 0.47 111.981 177.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -93.73 -1.13 55.52 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.417 1.087 . . . . 2.39 111.563 -174.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.495 HD23 HG22 ' A' ' 33' ' ' ILE . 4.5 mt 70.66 12.26 7.27 Favored 'General case' 0 C--N 1.349 0.58 0 CA-C-N 120.39 1.45 . . . . 1.3 110.828 174.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.5 p -87.81 0.26 56.02 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 128.185 2.594 . . . . 0.35 109.976 -172.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.56 136.25 4.42 Favored Glycine 0 N--CA 1.442 -0.916 0 N-CA-C 108.973 -1.651 . . . . 0.42 108.973 -177.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -143.52 -76.9 0.24 Allowed 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 123.967 0.907 . . . . 0.25 108.78 -179.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 24.4 t -95.91 4.97 52.32 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.902 1.281 . . . . 1.6 110.397 172.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.441 ' HB1' ' HD2' ' A' ' 46' ' ' PRO . . . -157.15 165.49 18.69 Favored Pre-proline 0 N--CA 1.451 -0.376 0 C-N-CA 125.339 1.456 . . . . 0.21 107.936 -170.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.441 ' HD2' ' HB1' ' A' ' 45' ' ' ALA . 45.5 Cg_endo -70.8 159.02 53.99 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.886 2.391 . . . . 0.23 110.71 -174.339 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.7 119.96 18.65 Favored 'General case' 0 C--N 1.332 -0.186 0 O-C-N 121.362 -0.836 . . . . 0.26 109.941 -178.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 46.5 pt -101.17 2.56 10.63 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.118 0 C-N-CA 124.46 1.104 . . . . 0.28 110.51 177.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.408 ' OD1' ' NZ ' ' A' ' 91' ' ' LYS . 24.6 t70 -43.51 -43.98 5.75 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 112.316 0.487 . . . . 3.07 112.316 178.214 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -109.31 40.87 1.76 Allowed 'General case' 0 C--N 1.344 0.345 0 C-N-CA 126.294 1.838 . . . . 4.04 110.517 179.3 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.21 -48.54 81.3 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 118.968 -0.539 . . . . 0.35 109.763 172.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -50.12 -39.28 34.03 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 123.578 0.609 . . . . 0.85 113.578 -177.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.468 ' HB2' ' HG2' ' A' ' 92' ' ' LYS . . . -63.57 -41.62 98.37 Favored 'General case' 0 CA--C 1.528 0.123 0 O-C-N 122.05 -0.677 . . . . 0.82 111.578 174.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 18.2 m-80 -72.21 -51.23 22.09 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 122.71 0.404 . . . . 1.7 110.196 -177.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -140.41 140.1 35.39 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.052 1.341 . . . . 0.71 107.832 -167.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.82 170.34 16.64 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 118.699 0.681 . . . . 2.02 109.748 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -50.31 -42.94 53.48 Favored 'General case' 0 C--O 1.224 -0.239 0 O-C-N 121.547 -0.721 . . . . 2.96 111.898 179.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -54.51 -40.63 68.76 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 120.981 0.419 . . . . 2.55 110.471 179.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -81.09 -45.58 16.26 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.241 1.016 . . . . 2.76 109.76 -175.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 74.9 mt -61.63 -45.94 97.59 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.059 0 O-C-N 121.039 -1.038 . . . . 0.28 109.057 179.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 31.0 tp -54.2 -46.23 72.38 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 109.212 -0.662 . . . . 0.4 109.212 177.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -53.02 -53.24 53.01 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 123.148 0.28 . . . . 1.41 110.626 173.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 59.2 mt -56.24 -43.08 75.55 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 O-C-N 121.385 -0.822 . . . . 0.45 111.414 178.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 45.4 mt -62.46 -45.29 99.14 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 O-C-N 120.07 -1.644 . . . . 0.29 109.677 179.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 76.5 mt -72.92 -28.9 62.73 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.425 1.09 . . . . 0.44 113.042 -177.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -127.19 17.44 7.16 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 119.614 1.097 . . . . 1.71 110.331 -166.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.56 ' N ' ' HA2' ' A' ' 73' ' ' GLY . . . 36.41 -146.99 0.06 OUTLIER Glycine 0 CA--C 1.539 1.536 0 C-N-CA 128.65 3.024 . . . . 0.66 112.216 -170.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 176.31 131.38 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 118.809 1.304 . . . . 1.21 108.907 -175.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 39.78 -117.13 0.77 Allowed Glycine 0 CA--C 1.532 1.152 0 CA-C-N 119.938 1.245 . . . . 0.37 113.16 -175.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -69.6 -20.64 75.81 Favored Glycine 0 CA--C 1.534 1.236 0 CA-C-N 117.481 0.641 . . . . 0.45 113.402 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 20.5 ttt -71.94 120.45 80.2 Favored Pre-proline 0 N--CA 1.452 -0.362 0 C-N-CA 124.536 1.134 . . . . 0.38 110.821 -178.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -76.54 128.25 10.17 Favored 'Trans proline' 0 N--CA 1.444 -1.43 0 C-N-CA 122.241 1.96 . . . . 2.07 110.434 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.56 ' HA2' ' N ' ' A' ' 67' ' ' GLY . . . -63.27 135.65 42.66 Favored Glycine 0 N--CA 1.443 -0.884 0 CA-C-N 115.627 -0.715 . . . . 0.72 114.691 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 82.78 41.36 8.88 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.648 -0.981 . . . . 0.44 110.648 176.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -60.34 -51.18 75.96 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 N-CA-C 108.765 -0.828 . . . . 2.02 108.765 174.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -105.74 156.82 17.92 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.746 1.618 . . . . 0.39 109.648 166.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.3 mmtm -144.86 157.68 44.07 Favored 'General case' 0 C--O 1.227 -0.104 0 C-N-CA 125.166 1.387 . . . . 3.33 108.038 178.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 67.37 -166.31 42.07 Favored Glycine 0 CA--C 1.531 1.046 0 N-CA-C 111.379 -0.688 . . . . 1.0 111.379 -173.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -51.32 -27.55 9.87 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.717 1.207 . . . . 0.57 112.27 -179.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -37.69 -59.82 0.77 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.678 1.591 . . . . 1.89 111.191 165.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.76 -49.12 69.52 Favored 'General case' 0 CA--C 1.531 0.215 0 O-C-N 121.937 -0.477 . . . . 0.22 111.128 -177.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -52.47 -54.62 30.01 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.568 1.147 . . . . 2.6 111.055 -178.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -54.72 -51.56 65.22 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.145 0.978 . . . . 0.24 109.82 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.518 HG22 HG23 ' A' ' 28' ' ' VAL . 54.7 t -54.12 -56.54 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 CA-C-N 116.933 -0.121 . . . . 0.29 111.165 177.478 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -51.71 -50.48 60.45 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 123.009 0.523 . . . . 0.2 111.831 179.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.437 ' O ' ' HB3' ' A' ' 89' ' ' ALA . . . -59.44 -48.71 80.59 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 121.689 0.756 . . . . 0.3 110.581 -179.45 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.495 ' HZ3' HG21 ' A' ' 28' ' ' VAL . 54.4 t90 -58.72 -44.26 90.36 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.08 0.552 . . . . 0.53 110.492 178.058 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.487 HD23 ' CE3' ' A' ' 87' ' ' TRP . 0.1 OUTLIER -63.11 -38.47 91.29 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.529 1.132 . . . . 1.68 110.476 177.26 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.437 ' HB3' ' O ' ' A' ' 86' ' ' ALA . . . -52.34 -49.77 63.63 Favored 'General case' 0 C--O 1.23 0.063 0 N-CA-C 109.468 -0.567 . . . . 0.44 109.468 171.073 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -84.7 35.65 0.57 Allowed 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 116.434 -0.348 . . . . 3.59 111.601 175.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.408 ' NZ ' ' OD1' ' A' ' 49' ' ' ASP . 0.5 OUTLIER -130.21 142.12 50.59 Favored 'General case' 0 C--N 1.343 0.311 0 O-C-N 121.171 -0.955 . . . . 2.93 110.651 165.09 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.468 ' HG2' ' HB2' ' A' ' 53' ' ' ALA . 16.9 mtmt . . . . . 0 C--O 1.252 1.219 0 C-N-CA 128.82 2.848 . . . . 2.71 105.413 -178.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 . . . . . 0 N--CA 1.449 -0.511 0 N-CA-C 109.339 -0.615 . . . . 2.79 109.339 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -44.91 -52.26 8.85 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.124 0.969 . . . . 0.31 111.124 174.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -53.92 -44.83 70.92 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 116.632 -0.258 . . . . 3.44 111.456 177.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.89 -44.64 92.41 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 123.232 0.613 . . . . 0.31 110.44 -178.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 89.7 t -58.33 -54.66 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 N-CA-C 109.236 -0.653 . . . . 0.41 109.236 175.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.462 HG21 ' CZ3' ' A' ' 87' ' ' TRP . 53.9 t -52.54 -49.01 46.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 C-N-CA 122.53 0.332 . . . . 0.32 110.348 -178.445 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 24.4 mm-40 -52.52 -19.68 2.42 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 126.763 2.025 . . . . 0.63 114.248 174.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.43 48.6 1.18 Allowed 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 119.877 1.217 . . . . 3.2 111.994 176.249 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.407 ' NZ ' ' OE2' ' A' ' 80' ' ' GLU . 0.5 OUTLIER -162.46 -39.7 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 124.415 1.086 . . . . 1.5 110.314 169.154 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.433 ' SG ' ' HA ' ' A' ' 28' ' ' VAL . 3.4 m -97.21 -49.05 5.11 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 118.845 0.748 . . . . 0.2 110.383 -176.017 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.461 HD12 ' N ' ' A' ' 34' ' ' SER . 1.8 pp -58.01 -26.44 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 CA-C-N 115.819 -0.628 . . . . 0.5 112.148 -173.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.461 ' N ' HD12 ' A' ' 33' ' ' ILE . 68.0 m -37.38 -39.19 0.27 Allowed 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 125.234 1.414 . . . . 0.97 112.451 168.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 9.9 m -120.29 -41.16 2.63 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 122.818 0.447 . . . . 0.21 111.92 176.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 85.4 m-70 -71.63 -10.02 59.14 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.628 0.771 . . . . 0.24 112.6 -177.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 86.34 149.5 13.89 Favored Glycine 0 C--N 1.337 0.625 0 N-CA-C 109.783 -1.327 . . . . 1.52 109.783 179.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -44.42 -37.83 4.95 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 124.53 1.062 . . . . 0.43 112.103 175.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -93.22 -4.54 51.77 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.193 0.997 . . . . 2.37 111.788 -173.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.4 mt 70.3 10.84 7.39 Favored 'General case' 0 C--N 1.349 0.583 0 CA-C-N 120.513 1.506 . . . . 1.09 111.297 176.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.9 p -84.84 -0.66 54.72 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 127.801 2.44 . . . . 0.32 109.957 -175.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.86 137.66 5.09 Favored Glycine 0 N--CA 1.44 -1.057 0 N-CA-C 108.885 -1.686 . . . . 0.44 108.885 -175.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -143.6 -79.77 0.2 Allowed 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 124.332 1.053 . . . . 0.29 108.827 176.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -88.6 2.5 52.99 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.377 1.071 . . . . 0.96 110.756 171.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.583 ' HB1' ' HD2' ' A' ' 46' ' ' PRO . . . -157.14 169.52 10.48 Favored Pre-proline 0 N--CA 1.451 -0.378 0 C-N-CA 124.518 1.127 . . . . 0.23 108.629 -172.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.583 ' HD2' ' HB1' ' A' ' 45' ' ' ALA . 38.0 Cg_endo -70.08 158.69 55.71 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.973 2.448 . . . . 0.25 110.506 -174.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.68 124.41 25.93 Favored 'General case' 0 C--N 1.332 -0.177 0 O-C-N 121.512 -0.743 . . . . 0.31 110.181 -177.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 45.1 pt -102.02 0.36 10.29 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.158 0 CA-C-O 118.885 -0.579 . . . . 0.39 111.419 175.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.483 ' OD1' ' NZ ' ' A' ' 91' ' ' LYS . 37.9 t70 -44.35 -36.96 3.05 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 113.605 0.965 . . . . 3.28 113.605 178.005 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.4 ptpt -108.33 19.01 20.38 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.695 1.598 . . . . 3.76 112.015 -178.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -55.54 -45.26 77.22 Favored 'General case' 0 N--CA 1.455 -0.198 0 O-C-N 121.228 -0.92 . . . . 0.36 110.297 -172.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -51.16 -31.66 26.9 Favored Glycine 0 CA--C 1.523 0.582 0 C-N-CA 123.461 0.553 . . . . 0.6 114.26 179.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.08 -39.59 49.16 Favored 'General case' 0 N--CA 1.454 -0.273 0 O-C-N 122.036 -0.685 . . . . 0.73 110.046 176.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -66.24 -47.84 72.45 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.559 0.743 . . . . 2.22 111.22 -178.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -141.34 148.16 39.26 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.743 1.617 . . . . 0.96 107.971 -171.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 88.7 p -74.66 170.96 14.76 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 119.144 0.883 . . . . 2.49 110.692 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -49.13 -42.1 38.29 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 123.118 0.567 . . . . 2.7 111.187 173.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -62.49 -45.24 93.92 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 123.315 0.646 . . . . 2.77 109.55 -177.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -70.96 -47.15 60.59 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 108.362 -0.977 . . . . 2.79 108.362 -175.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 91.2 mt -59.97 -46.21 94.36 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 O-C-N 121.672 -0.643 . . . . 0.29 109.403 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 58.4 tp -55.53 -50.1 70.89 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 109.127 -0.694 . . . . 0.44 109.127 176.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -52.7 -44.85 66.57 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 117.985 0.357 . . . . 1.95 111.341 178.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 79.6 mt -59.5 -56.7 15.44 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.288 0 C-N-CA 120.381 -0.528 . . . . 0.76 109.7 174.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 69.9 mt -50.0 -41.65 18.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 O-C-N 120.655 -1.278 . . . . 0.24 110.87 -178.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 73.5 mt -70.98 -34.25 71.22 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.276 1.03 . . . . 0.44 113.619 178.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 48.1 m-80 -123.36 20.67 9.64 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 120.499 1.5 . . . . 1.78 110.59 -167.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.565 ' N ' ' HA2' ' A' ' 73' ' ' GLY . . . 29.27 -138.77 0.03 OUTLIER Glycine 0 CA--C 1.535 1.338 0 C-N-CA 128.961 3.172 . . . . 0.62 111.722 -164.031 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 173.98 130.18 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 119.119 1.46 . . . . 1.57 109.22 -178.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 43.23 -116.36 1.3 Allowed Glycine 0 CA--C 1.531 1.034 0 CA-C-N 119.719 1.145 . . . . 0.42 112.883 -177.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -70.65 -18.61 75.86 Favored Glycine 0 CA--C 1.531 1.079 0 O-C-N 122.374 -0.486 . . . . 0.48 113.16 -179.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 22.3 ttt -75.95 118.7 73.06 Favored Pre-proline 0 N--CA 1.45 -0.43 0 C-N-CA 124.52 1.128 . . . . 0.39 110.629 -178.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -75.65 119.41 5.45 Favored 'Trans proline' 0 N--CA 1.445 -1.369 0 C-N-CA 122.446 2.098 . . . . 2.1 111.286 -178.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.565 ' HA2' ' N ' ' A' ' 67' ' ' GLY . . . -58.66 138.13 49.59 Favored Glycine 0 N--CA 1.44 -1.083 0 CA-C-N 115.257 -0.883 . . . . 0.61 114.594 -179.299 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 76.06 50.13 7.97 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.19 -1.164 . . . . 0.84 110.19 177.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.7 mt -72.61 -62.33 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 124.901 1.28 . . . . 1.02 108.889 168.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -103.45 158.44 16.35 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.919 1.288 . . . . 0.31 109.261 168.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.1 mttt -142.54 171.28 14.27 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 126.175 1.79 . . . . 4.32 109.702 177.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 54.55 -149.72 18.6 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 111.698 -0.561 . . . . 0.76 111.698 175.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -52.13 -32.21 34.54 Favored 'General case' 0 C--N 1.339 0.149 0 C-N-CA 122.983 0.513 . . . . 0.83 111.435 172.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.407 ' OE2' ' NZ ' ' A' ' 31' ' ' LYS . 6.8 tt0 -53.6 -43.39 68.57 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 110.032 -0.358 . . . . 1.91 110.032 176.009 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -84.57 -50.63 7.53 Favored 'General case' 0 CA--C 1.53 0.204 0 O-C-N 121.79 -0.569 . . . . 0.26 111.911 176.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -53.93 -50.9 65.4 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 118.591 0.632 . . . . 2.43 111.549 -177.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.63 -46.36 84.25 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 109.361 -0.607 . . . . 0.26 109.361 -179.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.407 HG22 HG23 ' A' ' 28' ' ' VAL . 53.8 t -57.19 -57.42 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 C-N-CA 122.913 0.485 . . . . 0.34 110.955 177.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -48.29 -53.13 18.36 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 123.516 0.727 . . . . 0.17 111.638 176.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -64.01 -44.31 93.0 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 121.329 0.585 . . . . 0.31 111.548 -178.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.462 ' CZ3' HG21 ' A' ' 28' ' ' VAL . 76.9 t90 -58.2 -49.43 77.08 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 121.493 -0.754 . . . . 0.52 109.425 177.286 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.6 -29.01 70.31 Favored 'General case' 0 C--O 1.222 -0.381 0 CA-C-O 118.374 -0.822 . . . . 1.85 112.977 173.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.58 -36.45 71.73 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 119.697 1.135 . . . . 0.36 110.299 170.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -73.74 -37.33 65.11 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 119.255 -0.402 . . . . 2.9 111.51 172.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.483 ' NZ ' ' OD1' ' A' ' 49' ' ' ASP . 8.5 mtpm? -72.81 114.18 10.67 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 119.039 0.836 . . . . 2.18 111.478 178.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 75.0 mttt . . . . . 0 C--O 1.252 1.197 0 CA-C-O 116.372 -1.775 . . . . 2.58 108.004 -174.924 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 . . . . . 0 N--CA 1.447 -0.598 0 N-CA-C 109.349 -0.611 . . . . 2.89 109.349 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -45.68 -54.37 7.91 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 124.932 1.293 . . . . 0.38 111.664 -178.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -51.44 -51.58 53.69 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 122.998 0.519 . . . . 3.48 111.653 175.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.39 -45.59 93.0 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 118.586 0.63 . . . . 0.39 110.84 -177.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 72.1 t -58.14 -55.67 20.68 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 N-CA-C 109.178 -0.675 . . . . 0.61 109.178 177.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.607 HG13 ' HB2' ' A' ' 32' ' ' CYS . 39.4 t -53.21 -48.67 54.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 C-N-CA 124.149 0.979 . . . . 0.42 109.944 -179.051 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 26.7 mm-40 -50.86 -19.37 0.97 Allowed 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 125.706 1.602 . . . . 0.6 112.958 175.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -142.56 44.57 1.62 Allowed 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 119.126 0.875 . . . . 2.42 111.787 173.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -157.36 -39.98 0.07 Allowed 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 124.792 1.237 . . . . 1.23 111.428 168.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.607 ' HB2' HG13 ' A' ' 28' ' ' VAL . 4.5 m -96.6 -50.29 4.78 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 119.445 1.021 . . . . 0.2 110.657 -177.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.4 pp -59.14 -24.89 28.52 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 CA-C-N 116.067 -0.515 . . . . 0.48 111.889 -174.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 21.7 m -41.47 -35.79 0.76 Allowed 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 125.036 1.334 . . . . 1.04 112.455 172.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 24.3 m -119.2 -42.71 2.66 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 122.911 0.484 . . . . 0.25 111.328 175.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 84.2 m-70 -72.88 -9.54 58.81 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 113.074 0.768 . . . . 0.27 113.074 -175.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 87.1 149.75 16.25 Favored Glycine 0 C--N 1.337 0.611 0 N-CA-C 109.997 -1.241 . . . . 1.63 109.997 178.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -45.35 -39.21 7.21 Favored Glycine 0 C--N 1.34 0.767 0 C-N-CA 124.348 0.975 . . . . 0.47 111.936 178.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -94.67 -2.31 51.49 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.595 1.158 . . . . 3.21 111.452 -173.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.4 mt 72.31 11.09 5.86 Favored 'General case' 0 C--N 1.352 0.698 0 O-C-N 120.722 -1.236 . . . . 1.22 110.798 174.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 13.6 p -83.51 -0.37 49.93 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 127.865 2.466 . . . . 0.39 110.331 -174.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.5 147.84 17.25 Favored Glycine 0 N--CA 1.44 -1.067 0 N-CA-C 108.726 -1.75 . . . . 0.49 108.726 -173.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -151.79 -73.1 0.15 Allowed 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.15 0.98 . . . . 0.35 109.465 177.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.3 m -100.49 4.37 43.6 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.699 1.6 . . . . 1.0 110.756 171.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.426 ' HB1' ' HD2' ' A' ' 46' ' ' PRO . . . -155.59 164.88 19.75 Favored Pre-proline 0 N--CA 1.451 -0.405 0 C-N-CA 125.369 1.467 . . . . 0.22 107.636 -170.53 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.426 ' HD2' ' HB1' ' A' ' 45' ' ' ALA . 51.7 Cg_endo -68.88 159.72 52.71 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.837 2.358 . . . . 0.22 110.385 -176.063 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.11 127.15 31.75 Favored 'General case' 0 C--N 1.332 -0.189 0 O-C-N 121.937 -0.477 . . . . 0.32 109.808 -177.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 45.8 pt -107.85 2.02 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 C-N-CA 123.971 0.909 . . . . 0.3 111.488 176.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -35.22 -45.43 0.3 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.597 1.559 . . . . 3.99 112.623 168.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -113.16 28.24 8.95 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 125.552 1.541 . . . . 3.56 111.721 -178.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.7 -44.58 85.97 Favored 'General case' 0 N--CA 1.451 -0.389 0 O-C-N 121.57 -0.706 . . . . 0.26 109.236 175.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -54.5 -29.61 48.05 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 123.755 0.693 . . . . 0.49 114.472 -176.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -76.57 -43.68 37.89 Favored 'General case' 0 N--CA 1.457 -0.102 0 O-C-N 121.786 -0.832 . . . . 0.79 110.544 174.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 40.5 m-80 -66.81 -47.63 71.46 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 122.662 0.385 . . . . 1.54 110.665 -177.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -136.84 133.71 36.15 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 126.022 1.729 . . . . 0.7 107.089 -168.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.5 p -74.78 171.87 13.18 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 119.179 0.899 . . . . 1.8 110.268 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -48.9 -45.24 41.04 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 123.476 0.71 . . . . 2.83 111.764 178.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -59.24 -32.32 69.88 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.352 0.661 . . . . 3.02 111.795 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -86.89 -44.33 11.76 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 121.808 -0.557 . . . . 2.88 110.266 -178.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 45.3 mt -56.96 -46.49 83.95 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 N-CA-C 109.251 -0.648 . . . . 0.31 109.251 176.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 57.9 tp -54.41 -49.69 69.33 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 109.166 -0.679 . . . . 0.41 109.166 178.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -52.44 -49.26 64.93 Favored 'General case' 0 N--CA 1.451 -0.401 0 O-C-N 123.195 0.309 . . . . 1.46 110.652 178.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 31.5 mt -57.77 -53.1 49.4 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.267 0 O-C-N 121.529 -0.732 . . . . 0.55 110.677 175.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 96.8 mt -51.62 -42.64 30.78 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 O-C-N 120.645 -1.284 . . . . 0.28 110.706 179.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 82.8 mt -72.77 -36.13 67.59 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.065 0.946 . . . . 0.4 113.141 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -116.63 15.59 15.5 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 119.82 1.191 . . . . 1.6 110.165 -165.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.553 ' N ' ' HA2' ' A' ' 73' ' ' GLY . . . 31.31 -141.74 0.03 OUTLIER Glycine 0 CA--C 1.533 1.187 0 C-N-CA 128.21 2.814 . . . . 0.62 111.389 -162.506 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 1.7 tp60 176.51 136.28 0.06 Allowed 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 118.621 1.21 . . . . 1.58 107.933 -175.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 42.38 -118.19 1.62 Allowed Glycine 0 CA--C 1.536 1.357 0 CA-C-N 120.584 1.538 . . . . 0.42 113.384 -179.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -74.51 -18.23 79.93 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 124.038 0.828 . . . . 0.61 113.007 178.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 19.3 ttt -71.86 118.19 64.54 Favored Pre-proline 0 N--CA 1.452 -0.374 0 C-N-CA 124.859 1.264 . . . . 0.41 110.414 179.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.46 ' HD2' HD11 ' A' ' 75' ' ' ILE . 43.9 Cg_endo -78.18 122.57 5.76 Favored 'Trans proline' 0 N--CA 1.444 -1.388 0 C-N-CA 122.782 2.322 . . . . 2.12 110.925 -178.187 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.553 ' HA2' ' N ' ' A' ' 67' ' ' GLY . . . -58.84 138.17 49.72 Favored Glycine 0 N--CA 1.442 -0.907 0 CA-C-N 115.27 -0.877 . . . . 0.63 114.999 -178.48 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 83.4 35.44 17.31 Favored Glycine 0 CA--C 1.528 0.856 0 CA-C-N 114.072 -1.064 . . . . 0.32 111.758 174.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.46 HD11 ' HD2' ' A' ' 72' ' ' PRO . 1.2 mt -57.61 -52.96 50.79 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 125.196 1.398 . . . . 1.25 109.859 174.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -101.08 151.32 21.96 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.317 1.447 . . . . 0.36 108.991 164.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.4 mtpm? -143.43 155.75 44.47 Favored 'General case' 0 C--N 1.34 0.157 0 C-N-CA 124.323 1.049 . . . . 3.51 109.317 173.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.29 -170.28 54.79 Favored Glycine 0 CA--C 1.528 0.845 0 N-CA-C 110.108 -1.197 . . . . 0.89 110.108 -175.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -51.38 -25.97 7.01 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.243 1.017 . . . . 1.24 112.232 179.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -39.86 -58.85 1.29 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.92 1.288 . . . . 2.1 110.634 166.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.23 -47.76 84.6 Favored 'General case' 0 CA--C 1.531 0.247 0 O-C-N 122.071 -0.393 . . . . 0.47 110.893 -174.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -50.68 -56.49 11.66 Favored 'General case' 0 C--N 1.338 0.094 0 C-N-CA 123.829 0.852 . . . . 3.05 110.852 174.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -54.4 -49.51 69.73 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 123.139 0.575 . . . . 0.31 110.132 -178.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.442 HG13 ' CG2' ' A' ' 28' ' ' VAL . 85.6 t -56.94 -54.92 23.74 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-N 117.523 0.147 . . . . 0.4 111.176 177.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -51.69 -51.49 55.62 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 123.676 0.79 . . . . 0.25 111.733 178.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.4 -46.56 89.53 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 124.175 0.99 . . . . 0.32 110.546 -179.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.531 ' CE3' HD23 ' A' ' 88' ' ' LEU . 46.6 t90 -57.25 -48.31 79.17 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 109.588 -0.523 . . . . 0.46 109.588 175.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.531 HD23 ' CE3' ' A' ' 87' ' ' TRP . 0.1 OUTLIER -60.49 -33.94 73.33 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.179 0.992 . . . . 1.62 111.59 176.905 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -54.62 -37.44 65.62 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 118.551 0.614 . . . . 0.48 110.936 172.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -94.76 22.04 6.8 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.798 0.839 . . . . 2.95 111.958 175.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 2.7 mtpm? -113.38 119.62 38.28 Favored 'General case' 0 C--N 1.342 0.24 0 O-C-N 121.122 -0.986 . . . . 2.16 109.094 169.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 89.1 mttt . . . . . 0 C--O 1.257 1.462 0 C-N-CA 129.451 3.1 . . . . 2.78 104.116 -178.274 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.446 -0.662 0 N-CA-C 106.968 -1.493 . . . . 2.15 106.968 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -41.38 -54.22 3.11 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 124.682 1.193 . . . . 0.32 110.9 179.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -58.2 -47.21 84.16 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 115.239 -0.891 . . . . 2.6 110.258 -179.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.26 -45.8 92.02 Favored 'General case' 0 C--N 1.339 0.111 0 C-N-CA 122.935 0.494 . . . . 0.26 111.135 -179.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 81.9 t -56.58 -54.25 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 N-CA-C 108.766 -0.828 . . . . 0.34 108.766 177.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.627 HG22 ' SG ' ' A' ' 32' ' ' CYS . 22.8 t -53.78 -49.69 56.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 CA-C-N 117.742 0.246 . . . . 0.36 111.237 178.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 27.6 mm-40 -54.87 -14.85 1.59 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.1 1.76 . . . . 0.59 113.285 174.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 14.1 mt-30 -136.36 44.05 2.44 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 119.795 1.179 . . . . 3.48 112.617 169.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.28 -58.61 0.05 Allowed 'General case' 0 CA--C 1.519 -0.244 0 O-C-N 121.782 -0.574 . . . . 1.57 109.799 168.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.627 ' SG ' HG22 ' A' ' 28' ' ' VAL . 2.8 m -75.63 -48.14 23.48 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 109.938 -0.393 . . . . 0.17 109.938 -171.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.0 pp -50.01 -32.77 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.14 0 C-N-CA 123.449 0.7 . . . . 0.67 112.435 -178.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.4 m -44.08 -35.34 2.1 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 125.076 1.35 . . . . 1.05 112.033 178.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 13.1 m -119.36 -41.76 2.7 Favored 'General case' 0 CA--C 1.53 0.207 0 O-C-N 123.522 0.514 . . . . 0.18 111.922 175.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 79.6 m-70 -70.35 -9.01 55.0 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.028 0.931 . . . . 0.22 112.481 -178.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 85.56 148.64 10.99 Favored Glycine 0 C--N 1.337 0.621 0 N-CA-C 109.224 -1.55 . . . . 1.45 109.224 -179.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -43.02 -33.25 1.7 Allowed Glycine 0 CA--C 1.53 0.989 0 C-N-CA 124.496 1.046 . . . . 0.52 112.687 173.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -94.98 -10.01 32.25 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.986 1.315 . . . . 2.33 111.613 -172.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 70.63 11.75 7.27 Favored 'General case' 0 C--N 1.347 0.467 0 CA-C-N 120.263 1.392 . . . . 1.44 111.255 178.357 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 10.4 p -85.43 -2.29 57.95 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 127.808 2.443 . . . . 0.33 109.986 -177.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.93 145.3 12.66 Favored Glycine 0 N--CA 1.437 -1.261 0 N-CA-C 108.648 -1.781 . . . . 0.43 108.648 -174.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -152.52 -80.34 0.1 Allowed 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 124.758 1.223 . . . . 0.25 109.043 177.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 17.0 m -91.46 4.02 53.54 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.457 1.103 . . . . 1.14 111.14 170.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -153.4 163.68 22.93 Favored Pre-proline 0 N--CA 1.45 -0.439 0 C-N-CA 126.065 1.746 . . . . 0.31 107.554 -172.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -70.51 161.52 45.75 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 123.128 2.552 . . . . 0.27 110.59 -176.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -74.06 124.01 25.45 Favored 'General case' 0 N--CA 1.454 -0.268 0 O-C-N 121.577 -0.702 . . . . 0.26 110.235 -176.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 44.6 pt -104.44 2.45 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 CA-C-O 119.055 -0.498 . . . . 0.28 111.564 176.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -40.33 -52.64 2.68 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 112.985 0.735 . . . . 2.68 112.985 176.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.26 21.49 11.87 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 126.3 1.84 . . . . 5.35 110.653 -175.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -54.19 -39.5 66.71 Favored 'General case' 0 N--CA 1.453 -0.307 0 O-C-N 121.506 -0.746 . . . . 0.27 110.146 -178.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -54.8 -24.95 35.15 Favored Glycine 0 CA--C 1.53 1.022 0 N-CA-C 114.603 0.601 . . . . 0.52 114.603 176.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -78.95 -36.95 40.84 Favored 'General case' 0 C--N 1.338 0.097 0 CA-C-N 118.616 1.208 . . . . 0.84 110.278 174.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -73.91 -47.85 34.89 Favored 'General case' 0 N--CA 1.457 -0.078 0 C-N-CA 122.515 0.326 . . . . 1.92 110.326 -177.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -139.96 149.04 42.8 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.47 1.108 . . . . 0.68 108.689 -168.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.92 168.32 18.03 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 109.614 -0.514 . . . . 1.93 109.614 178.446 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -48.2 -43.52 32.02 Favored 'General case' 0 C--O 1.226 -0.179 0 C-N-CA 124.43 1.092 . . . . 2.8 111.553 178.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -53.2 -47.69 68.69 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.654 0.782 . . . . 2.75 110.481 178.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -74.56 -45.69 43.83 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.78 0.832 . . . . 3.25 109.575 -175.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 58.6 mt -59.55 -44.16 92.5 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 N-CA-C 109.194 -0.669 . . . . 0.28 109.194 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 31.3 tp -54.77 -54.38 42.82 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 123.468 0.707 . . . . 0.37 109.38 175.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -52.07 -49.48 63.45 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 123.107 0.254 . . . . 1.48 111.2 178.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 57.6 mt -55.16 -55.49 16.16 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.155 0 O-C-N 121.564 -0.71 . . . . 0.65 110.558 176.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 57.8 mt -49.15 -46.75 17.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 O-C-N 121.191 -0.943 . . . . 0.26 110.199 178.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 91.7 mt -66.11 -33.3 75.46 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 113.932 1.086 . . . . 0.39 113.932 179.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -128.97 24.13 5.65 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 120.37 1.441 . . . . 1.82 110.641 -163.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 23.75 -136.97 0.01 OUTLIER Glycine 0 CA--C 1.543 1.791 0 C-N-CA 127.702 2.572 . . . . 0.67 112.808 -159.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 170.46 139.13 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 126.483 1.913 . . . . 1.3 107.603 -175.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 23.78 -106.2 0.01 OUTLIER Glycine 0 CA--C 1.535 1.316 0 C-N-CA 126.386 1.945 . . . . 0.57 115.029 -170.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.26 -29.05 74.33 Favored Glycine 0 CA--C 1.533 1.187 0 CA-C-N 118.271 1.036 . . . . 0.71 113.169 -177.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 4.6 ttt -67.32 126.19 92.18 Favored Pre-proline 0 CA--C 1.542 0.635 0 C-N-CA 125.053 1.341 . . . . 0.58 110.688 -179.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -62.66 -57.2 0.47 Allowed 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 123.893 3.062 . . . . 3.03 111.144 -174.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 118.14 149.92 8.87 Favored Glycine 0 C--N 1.334 0.471 0 C-N-CA 123.925 0.774 . . . . 0.87 113.536 174.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 69.06 23.21 76.14 Favored Glycine 0 CA--C 1.531 1.06 0 CA-C-N 115.156 -0.522 . . . . 0.4 111.852 178.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.6 mt -56.32 -49.29 77.41 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.919 0 C-N-CA 126.12 1.768 . . . . 1.07 111.267 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -109.71 161.22 15.62 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.133 0.973 . . . . 0.38 108.589 160.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -146.42 172.72 13.1 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.082 0.953 . . . . 3.46 109.198 173.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 54.18 -147.06 22.78 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 123.336 0.494 . . . . 0.76 112.015 176.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -47.47 -41.03 19.77 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.19 0.996 . . . . 0.74 111.23 175.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -53.07 -44.43 67.49 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.889 1.276 . . . . 2.74 110.799 177.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -79.18 -49.97 11.71 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 121.759 -0.588 . . . . 0.21 111.487 176.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -51.4 -54.39 27.16 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 124.027 0.931 . . . . 2.19 111.691 -178.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.24 -47.59 83.06 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.824 -0.435 . . . . 0.25 109.824 -177.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.412 HG22 HG23 ' A' ' 28' ' ' VAL . 53.8 t -56.72 -53.96 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 C-N-CA 123.442 0.697 . . . . 0.29 110.748 177.538 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -52.19 -51.86 55.58 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 123.896 0.878 . . . . 0.18 111.915 176.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.26 -50.59 73.04 Favored 'General case' 0 C--N 1.333 -0.116 0 C-N-CA 123.192 0.597 . . . . 0.32 110.204 -179.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.506 ' CE3' HD23 ' A' ' 88' ' ' LEU . 50.0 t90 -56.59 -46.43 80.83 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.622 0.769 . . . . 0.53 110.49 177.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.506 HD23 ' CE3' ' A' ' 87' ' ' TRP . 0.1 OUTLIER -63.15 -38.8 92.6 Favored 'General case' 0 C--O 1.224 -0.282 0 O-C-N 121.416 -0.803 . . . . 1.65 109.88 178.269 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -62.26 -42.31 99.22 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 118.723 0.692 . . . . 0.5 110.683 174.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -55.74 -45.46 78.02 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 121.843 -0.535 . . . . 3.6 110.61 169.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 4.1 mtmp? -74.93 100.29 4.07 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 118.921 0.782 . . . . 2.89 111.553 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 9.7 ptpp? . . . . . 0 C--O 1.25 1.095 0 N-CA-C 106.869 -1.53 . . . . 2.78 106.869 174.311 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 N--CA 1.443 -0.789 0 N-CA-C 105.787 -1.931 . . . . 2.75 105.787 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -41.38 -52.84 3.46 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 124.655 1.182 . . . . 0.33 110.857 -177.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -57.13 -47.79 80.27 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 115.9 -0.591 . . . . 3.17 110.677 -179.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.07 -44.83 94.46 Favored 'General case' 0 C--N 1.339 0.11 0 C-N-CA 122.926 0.49 . . . . 0.32 110.691 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 97.7 t -58.5 -57.4 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 N-CA-C 108.934 -0.765 . . . . 0.43 108.934 177.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.681 HG13 ' HB2' ' A' ' 32' ' ' CYS . 52.9 t -52.21 -48.34 43.34 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 C-N-CA 122.741 0.416 . . . . 0.32 110.875 -179.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -51.03 -24.44 3.79 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 125.503 1.521 . . . . 0.63 113.115 175.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 11.6 mt-30 -137.4 55.75 1.8 Allowed 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 119.514 1.052 . . . . 2.66 112.179 170.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.96 -38.97 0.02 OUTLIER 'General case' 0 C--O 1.226 -0.138 0 C-N-CA 123.566 0.746 . . . . 1.25 110.214 168.24 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.681 ' HB2' HG13 ' A' ' 28' ' ' VAL . 4.0 m -98.21 -50.01 4.51 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 119.004 0.82 . . . . 0.18 110.971 -177.322 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.9 pp -58.08 -25.86 27.53 Favored 'Isoleucine or valine' 0 C--N 1.338 0.071 0 N-CA-C 112.127 0.417 . . . . 0.4 112.127 -174.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 59.7 m -37.92 -38.55 0.31 Allowed 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 125.491 1.516 . . . . 0.99 112.646 170.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 18.9 m -120.7 -40.15 2.68 Favored 'General case' 0 C--N 1.34 0.189 0 C-N-CA 122.892 0.477 . . . . 0.16 111.901 175.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 81.6 m-70 -73.31 -7.92 53.66 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 112.65 0.611 . . . . 0.19 112.65 -176.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 85.59 149.78 12.83 Favored Glycine 0 C--N 1.337 0.627 0 N-CA-C 109.497 -1.441 . . . . 1.51 109.497 179.064 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -42.35 -34.95 1.73 Allowed Glycine 0 CA--C 1.527 0.826 0 C-N-CA 124.855 1.216 . . . . 0.46 112.176 175.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -99.03 -5.9 29.52 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 124.937 1.295 . . . . 2.36 111.402 -168.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 8.8 mt 69.34 13.04 8.47 Favored 'General case' 0 C--N 1.352 0.682 0 CA-C-N 120.712 1.596 . . . . 1.11 111.326 178.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.2 p -89.39 -1.37 58.03 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 127.802 2.441 . . . . 0.34 109.815 -176.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.62 130.44 2.81 Favored Glycine 0 N--CA 1.44 -1.085 0 N-CA-C 109.502 -1.439 . . . . 0.54 109.502 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -135.39 -78.1 0.44 Allowed 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 124.387 1.075 . . . . 0.28 108.641 178.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 50.1 m -93.45 4.01 54.65 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.176 0.991 . . . . 1.36 111.102 171.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -153.6 161.74 28.41 Favored Pre-proline 0 CA--C 1.533 0.314 0 C-N-CA 125.808 1.643 . . . . 0.31 107.488 -171.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -71.78 159.58 50.32 Favored 'Trans proline' 0 N--CA 1.459 -0.541 0 C-N-CA 122.977 2.451 . . . . 0.28 111.172 -175.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -74.68 117.36 16.43 Favored 'General case' 0 CA--C 1.53 0.211 0 O-C-N 121.727 -0.608 . . . . 0.45 111.768 -172.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 42.2 pt -95.94 0.54 10.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 C-N-CA 123.642 0.777 . . . . 0.3 112.031 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -45.34 -35.74 3.73 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.526 0.936 . . . . 2.64 113.526 172.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -112.98 27.94 9.21 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 124.11 0.964 . . . . 4.94 110.687 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -58.63 -43.83 89.82 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 108.998 -0.742 . . . . 0.33 108.998 176.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -53.77 -29.55 41.85 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 123.349 0.499 . . . . 0.63 113.692 179.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.13 -32.95 65.23 Favored 'General case' 0 N--CA 1.454 -0.229 0 O-C-N 122.078 -0.66 . . . . 0.83 110.356 178.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 -85.31 -44.94 12.4 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.962 0.905 . . . . 1.67 109.954 -174.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -138.38 133.28 32.7 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 125.273 1.429 . . . . 1.0 108.025 -167.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 13.9 m -73.63 169.97 16.18 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 118.409 0.55 . . . . 1.51 110.095 175.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -47.24 -48.13 24.46 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.277 1.031 . . . . 2.92 112.44 -176.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -58.1 -41.77 84.25 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.835 -0.541 . . . . 2.98 111.618 177.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -72.39 -41.96 65.74 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 109.053 -0.721 . . . . 2.99 109.053 -176.14 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 41.3 mt -61.86 -46.71 95.91 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.131 0 O-C-N 121.286 -0.884 . . . . 0.3 109.386 175.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 66.8 tp -53.95 -48.41 70.3 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.441 -0.577 . . . . 0.47 109.441 178.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -48.54 -56.02 9.48 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 117.993 0.36 . . . . 2.37 110.996 174.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 95.4 mt -55.78 -46.25 79.77 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.298 0 O-C-N 121.6 -0.688 . . . . 0.48 110.778 178.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 73.3 mt -55.8 -44.77 78.64 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 O-C-N 120.45 -1.406 . . . . 0.28 110.164 176.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 90.9 mt -67.81 -36.81 81.06 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 113.903 1.075 . . . . 0.67 113.903 -176.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -128.82 26.32 5.56 Favored 'General case' 0 C--N 1.344 0.338 0 CA-C-N 120.85 1.659 . . . . 3.78 110.205 -170.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.511 ' N ' ' HA2' ' A' ' 73' ' ' GLY . . . 37.41 -142.78 0.23 Allowed Glycine 0 CA--C 1.534 1.258 0 C-N-CA 128.247 2.832 . . . . 0.65 111.009 -176.226 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 44.9 tt0 174.3 132.87 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 119.246 1.523 . . . . 1.46 109.658 -178.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 45.14 -118.94 3.04 Favored Glycine 0 CA--C 1.532 1.138 0 O-C-N 121.22 -0.925 . . . . 0.4 112.18 -175.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -70.93 -19.63 77.13 Favored Glycine 0 CA--C 1.531 1.082 0 O-C-N 122.495 -0.415 . . . . 0.48 113.016 179.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 20.0 ttt -73.4 119.27 74.95 Favored Pre-proline 0 N--CA 1.451 -0.424 0 C-N-CA 124.163 0.985 . . . . 0.34 110.604 -178.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.448 ' HD2' HD11 ' A' ' 75' ' ' ILE . 58.0 Cg_endo -80.22 124.74 5.52 Favored 'Trans proline' 0 N--CA 1.447 -1.221 0 C-N-CA 123.208 2.605 . . . . 2.07 111.054 -179.075 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.511 ' HA2' ' N ' ' A' ' 67' ' ' GLY . . . -63.38 142.6 47.35 Favored Glycine 0 N--CA 1.444 -0.8 0 N-CA-C 115.902 1.121 . . . . 0.64 115.902 -174.317 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 78.2 32.41 43.7 Favored Glycine 0 CA--C 1.526 0.779 0 CA-C-N 114.142 -1.029 . . . . 0.34 111.442 174.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.448 HD11 ' HD2' ' A' ' 72' ' ' PRO . 0.8 OUTLIER -51.37 -53.02 17.28 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 125.692 1.597 . . . . 1.18 109.878 174.45 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -105.48 160.05 15.46 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 124.961 1.304 . . . . 0.34 108.652 162.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 81.7 mttt -144.1 168.7 19.4 Favored 'General case' 0 CA--C 1.527 0.086 0 N-CA-C 107.461 -1.311 . . . . 2.56 107.461 170.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 65.7 -164.04 39.28 Favored Glycine 0 CA--C 1.528 0.902 0 N-CA-C 111.517 -0.633 . . . . 0.66 111.517 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -54.32 -29.6 48.28 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.457 0.703 . . . . 0.59 112.283 -174.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -40.32 -67.63 0.22 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.79 1.236 . . . . 2.95 110.457 164.068 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -59.07 -43.91 91.8 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.25 0.62 . . . . 0.28 110.977 -175.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -59.13 -53.48 57.86 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.411 1.084 . . . . 2.69 110.597 -178.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.18 -49.12 78.12 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.008 0.923 . . . . 0.27 109.797 179.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.557 HG22 HG23 ' A' ' 28' ' ' VAL . 54.1 t -52.5 -56.49 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 C-N-CA 122.292 0.237 . . . . 0.27 110.598 176.223 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -49.56 -51.38 37.28 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 123.738 0.815 . . . . 0.2 111.764 177.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.38 -50.33 74.38 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 121.673 0.749 . . . . 0.43 111.163 -178.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.552 ' CE3' HD23 ' A' ' 88' ' ' LEU . 51.0 t90 -58.23 -45.34 87.87 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 121.228 0.537 . . . . 0.63 110.047 178.543 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.552 HD23 ' CE3' ' A' ' 87' ' ' TRP . 0.1 OUTLIER -62.73 -36.41 82.91 Favored 'General case' 0 CA--C 1.531 0.213 0 O-C-N 121.493 -0.754 . . . . 1.61 110.814 176.571 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -59.74 -39.19 83.92 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 118.758 0.708 . . . . 0.44 110.848 173.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -59.74 -41.06 90.11 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 122.28 0.232 . . . . 3.21 110.535 173.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.1 mtpm? -74.04 104.12 4.76 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.806 0.813 . . . . 2.3 111.21 179.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 15.5 pttp . . . . . 0 C--O 1.25 1.089 0 C-N-CA 126.619 1.967 . . . . 3.13 106.048 176.364 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.451 -0.391 0 N-CA-C 108.726 -0.842 . . . . 2.86 108.726 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -46.39 -55.15 7.78 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 123.25 0.62 . . . . 0.31 110.024 176.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -57.36 -46.71 83.07 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 110.233 -0.284 . . . . 2.69 110.233 -177.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.24 -48.69 79.63 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 118.262 0.483 . . . . 0.29 111.399 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 55.6 t -56.46 -56.18 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 N-CA-C 109.233 -0.654 . . . . 0.41 109.233 177.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.562 HG23 HG22 ' A' ' 84' ' ' VAL . 61.1 t -53.5 -49.92 52.11 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 C-N-CA 122.888 0.475 . . . . 0.4 110.305 -177.201 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.458 ' HA ' HG12 ' A' ' 33' ' ' ILE . 33.6 mm-40 -51.55 -17.44 0.83 Allowed 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 126.454 1.902 . . . . 0.5 112.964 175.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 16.6 tp60 -141.71 43.67 1.72 Allowed 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 119.519 1.054 . . . . 3.67 112.204 171.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.18 -39.73 0.1 Allowed 'General case' 0 C--O 1.227 -0.083 0 C-N-CA 123.659 0.784 . . . . 1.18 111.425 166.377 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.485 ' HB2' HG13 ' A' ' 28' ' ' VAL . 3.6 m -98.12 -49.51 4.71 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 119.124 0.874 . . . . 0.17 110.539 -174.106 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.458 HG12 ' HA ' ' A' ' 29' ' ' GLN . 2.2 pp -55.51 -29.13 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 CA-C-N 115.766 -0.652 . . . . 0.4 111.564 -177.127 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.1 m -37.75 -37.01 0.21 Allowed 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 125.61 1.564 . . . . 1.14 112.713 171.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 28.2 m -119.59 -40.45 2.77 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.298 0.639 . . . . 0.17 112.009 174.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 84.7 m-70 -73.37 -8.71 57.03 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.474 0.71 . . . . 0.22 112.711 -175.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 85.55 151.14 15.28 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 109.628 -1.389 . . . . 1.52 109.628 -178.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -40.46 -42.27 2.54 Favored Glycine 0 C--N 1.34 0.802 0 C-N-CA 124.996 1.284 . . . . 0.49 112.21 178.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -95.89 -6.34 39.47 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 125.556 1.542 . . . . 2.57 110.939 -169.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.537 HD21 ' CG1' ' A' ' 28' ' ' VAL . 0.6 OUTLIER 69.56 19.1 7.55 Favored 'General case' 0 C--N 1.347 0.469 0 CA-C-N 119.648 1.113 . . . . 1.48 111.026 177.456 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 11.2 p -82.18 -4.84 57.83 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 128.462 2.705 . . . . 0.35 109.898 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.14 148.26 21.19 Favored Glycine 0 N--CA 1.44 -1.035 0 N-CA-C 108.32 -1.912 . . . . 0.6 108.32 -173.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -155.08 -72.98 0.12 Allowed 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 123.91 0.884 . . . . 0.49 109.552 176.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.3 t -98.35 1.17 46.73 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.627 1.171 . . . . 1.34 110.252 172.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.495 ' HB1' ' HD2' ' A' ' 46' ' ' PRO . . . -155.62 167.07 14.94 Favored Pre-proline 0 CA--C 1.536 0.432 0 C-N-CA 125.551 1.541 . . . . 0.26 107.913 -171.503 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.495 ' HD2' ' HB1' ' A' ' 45' ' ' ALA . 54.9 Cg_endo -70.43 160.98 47.67 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 123.098 2.532 . . . . 0.3 111.195 -173.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -74.87 119.99 19.8 Favored 'General case' 0 CA--C 1.531 0.214 0 O-C-N 121.748 -0.595 . . . . 0.31 110.638 -177.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 47.4 pt -105.05 0.83 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 C-N-CA 124.157 0.983 . . . . 0.4 111.551 179.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -34.17 -46.39 0.24 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.572 1.549 . . . . 2.42 112.856 167.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 5.3 pttt -111.44 35.32 3.67 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.798 1.239 . . . . 3.93 111.166 -178.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.01 -46.4 87.83 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-O 118.868 -0.587 . . . . 0.3 109.51 174.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -51.73 -32.73 33.34 Favored Glycine 0 CA--C 1.527 0.795 0 CA-C-N 118.566 0.621 . . . . 0.65 114.329 -177.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.21 -37.08 66.57 Favored 'General case' 0 N--CA 1.455 -0.196 0 O-C-N 121.898 -0.766 . . . . 0.79 110.797 176.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 20.5 m-80 -73.51 -50.77 19.77 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 122.929 0.492 . . . . 1.68 110.15 -178.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -137.6 138.07 39.16 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.211 1.404 . . . . 0.72 107.382 -169.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 67.3 m -76.19 172.0 13.57 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 119.03 0.832 . . . . 1.6 110.389 179.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.0 pm0 -50.5 -43.29 55.61 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 123.78 0.832 . . . . 2.87 111.834 -178.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -56.15 -41.37 75.3 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 121.336 0.588 . . . . 2.81 110.136 179.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -80.01 -47.38 15.01 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 123.81 0.844 . . . . 3.54 108.995 -173.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 63.9 mt -56.33 -44.99 81.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 N-CA-C 109.113 -0.699 . . . . 0.24 109.113 176.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 33.8 tp -54.77 -49.47 70.8 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 109.375 -0.602 . . . . 0.46 109.375 177.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -55.11 -46.44 75.56 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 118.576 0.625 . . . . 1.48 111.604 175.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 86.7 mt -61.92 -30.34 48.34 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 O-C-N 121.351 -0.843 . . . . 0.66 111.521 178.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 46.4 mt -73.19 -50.24 32.87 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 O-C-N 120.278 -1.514 . . . . 0.34 109.128 174.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 77.3 mt -61.88 -28.43 69.5 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 125.232 1.413 . . . . 0.38 113.474 -175.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 11.0 m-80 -130.62 15.37 5.41 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 120.02 1.282 . . . . 1.75 110.386 -169.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 40.01 -141.97 0.69 Allowed Glycine 0 CA--C 1.545 1.906 0 C-N-CA 125.679 1.609 . . . . 0.66 111.707 -167.05 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 167.08 139.63 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 126.386 1.874 . . . . 1.54 108.447 -174.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 31.77 -111.45 0.05 OUTLIER Glycine 0 C--N 1.347 1.18 0 C-N-CA 125.465 1.507 . . . . 0.52 114.153 -174.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.58 -30.1 76.67 Favored Glycine 0 CA--C 1.534 1.23 0 CA-C-N 117.299 0.549 . . . . 0.7 112.834 -179.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 2.3 ttt -65.42 123.74 85.2 Favored Pre-proline 0 CA--C 1.541 0.615 0 C-N-CA 124.576 1.15 . . . . 0.51 111.393 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -63.64 -55.38 0.7 Allowed 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 124.223 3.282 . . . . 2.96 111.224 -173.117 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 115.28 149.08 9.53 Favored Glycine 0 N--CA 1.448 -0.514 0 CA-C-N 115.732 -0.667 . . . . 0.9 114.185 171.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 67.45 22.38 73.06 Favored Glycine 0 CA--C 1.531 1.036 0 CA-C-N 114.712 -0.744 . . . . 0.49 111.854 -178.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -51.69 -53.01 18.63 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 C-N-CA 126.611 1.964 . . . . 1.08 111.127 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -107.76 159.99 16.07 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.164 1.386 . . . . 0.34 108.335 162.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 36.6 mttt -145.84 174.77 10.94 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.554 1.141 . . . . 3.31 109.57 171.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 53.11 -149.55 11.66 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 123.826 0.727 . . . . 0.7 112.045 178.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -49.63 -36.61 25.01 Favored 'General case' 0 C--N 1.34 0.163 0 C-N-CA 123.877 0.871 . . . . 0.69 111.278 179.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.531 ' O ' HG23 ' A' ' 84' ' ' VAL . 3.9 tt0 -47.76 -66.41 0.41 Allowed 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.992 1.317 . . . . 1.91 109.216 173.047 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -62.97 -45.48 92.23 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 122.829 0.452 . . . . 0.26 112.011 -178.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -54.79 -52.9 61.19 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 122.931 0.492 . . . . 2.15 110.488 -178.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.42 -50.17 73.87 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 122.915 0.486 . . . . 0.39 110.233 178.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.562 HG22 HG23 ' A' ' 28' ' ' VAL . 70.1 t -50.63 -58.51 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-O 120.613 0.244 . . . . 0.56 110.919 177.293 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -55.26 -49.98 70.67 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.206 1.003 . . . . 0.29 111.684 -179.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.69 -46.01 88.18 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 121.67 0.748 . . . . 0.35 110.584 -179.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.532 ' CE3' HD23 ' A' ' 88' ' ' LEU . 48.6 t90 -60.71 -50.48 73.3 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.667 -0.494 . . . . 0.56 109.667 176.538 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.532 HD23 ' CE3' ' A' ' 87' ' ' TRP . 0.1 OUTLIER -59.92 -32.01 70.38 Favored 'General case' 0 CA--C 1.531 0.247 0 O-C-N 121.487 -0.758 . . . . 1.6 111.193 179.152 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.9 -42.85 97.33 Favored 'General case' 0 N--CA 1.457 -0.097 0 CA-C-N 118.671 0.669 . . . . 0.41 111.146 171.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -58.59 -40.73 84.02 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 110.347 -0.242 . . . . 3.29 110.347 173.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 21.4 mtpp -73.38 133.98 43.94 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 121.916 -0.49 . . . . 2.42 110.984 -178.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 49.8 mtmt . . . . . 0 C--O 1.25 1.084 0 N-CA-C 105.887 -1.894 . . . . 2.55 105.887 179.36 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 N--CA 1.448 -0.534 0 N-CA-C 108.639 -0.874 . . . . 2.92 108.639 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -89.29 -65.38 1.02 Allowed 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 109.327 -0.619 . . . . 0.5 109.327 177.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -47.35 -47.01 26.13 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.578 0.751 . . . . 3.09 111.702 -178.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.69 -42.82 79.75 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.057 0.543 . . . . 0.33 111.676 178.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 53.4 t -64.45 -54.13 34.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 N-CA-C 108.23 -1.026 . . . . 0.35 108.23 178.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.606 HG11 HD21 ' A' ' 40' ' ' LEU . 65.9 t -48.33 -51.49 10.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 C-N-CA 122.486 0.314 . . . . 0.58 110.376 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.414 ' HA ' HG12 ' A' ' 33' ' ' ILE . 35.7 mm-40 -50.55 -26.82 5.7 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 126.313 1.845 . . . . 0.62 113.416 177.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 -136.6 53.48 1.91 Allowed 'General case' 0 C--N 1.339 0.125 0 CA-C-N 119.756 1.162 . . . . 2.4 112.121 173.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -166.43 -38.9 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 123.459 0.704 . . . . 1.26 110.504 167.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.484 ' HB2' HG13 ' A' ' 28' ' ' VAL . 6.5 m -97.69 -51.31 4.15 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 118.913 0.779 . . . . 0.23 110.843 -175.463 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.414 HG12 ' HA ' ' A' ' 29' ' ' GLN . 2.4 pp -56.41 -27.94 25.56 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.095 0 CA-C-N 116.128 -0.487 . . . . 0.39 111.925 -175.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.9 m -36.92 -39.31 0.22 Allowed 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 125.605 1.562 . . . . 1.05 112.683 171.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 38.1 m -117.88 -38.86 3.18 Favored 'General case' 0 C--N 1.339 0.122 0 C-N-CA 123.127 0.571 . . . . 0.21 111.652 174.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 83.8 m-70 -77.03 -6.49 52.89 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 113.167 0.803 . . . . 0.24 113.167 -174.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 84.54 151.83 14.5 Favored Glycine 0 C--N 1.338 0.645 0 N-CA-C 109.865 -1.294 . . . . 1.57 109.865 -179.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -41.87 -39.53 2.8 Favored Glycine 0 C--N 1.341 0.84 0 C-N-CA 125.015 1.293 . . . . 0.45 112.274 178.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -99.84 -0.44 39.72 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 125.249 1.42 . . . . 2.42 111.058 -169.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.606 HD21 HG11 ' A' ' 28' ' ' VAL . 1.3 mp 66.12 18.34 10.96 Favored 'General case' 0 C--N 1.347 0.476 0 CA-C-N 119.779 1.172 . . . . 1.85 111.351 -179.395 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.0 p -82.14 -5.24 58.3 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 127.413 2.285 . . . . 0.36 110.277 -177.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.58 148.21 18.35 Favored Glycine 0 N--CA 1.437 -1.277 0 N-CA-C 108.129 -1.988 . . . . 0.51 108.129 -172.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -156.24 -76.77 0.09 Allowed 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 124.035 0.934 . . . . 0.26 109.09 178.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -95.38 2.37 54.59 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.683 1.193 . . . . 1.15 110.552 172.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -157.58 161.75 28.56 Favored Pre-proline 0 N--CA 1.452 -0.374 0 C-N-CA 126.834 2.054 . . . . 0.21 106.577 -170.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -68.1 164.65 31.26 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 123.178 2.585 . . . . 0.34 111.807 -175.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -75.52 116.39 16.18 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 123.265 0.626 . . . . 0.26 110.841 -176.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 40.4 pt -98.11 1.0 10.54 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.174 0 C-N-CA 123.162 0.585 . . . . 0.32 110.886 176.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -43.13 -37.31 1.99 Allowed 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 114.037 1.125 . . . . 2.42 114.037 174.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.13 23.7 13.97 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 124.899 1.28 . . . . 4.21 111.681 179.565 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -58.09 -43.4 87.03 Favored 'General case' 0 N--CA 1.45 -0.449 0 O-C-N 121.607 -0.683 . . . . 0.34 109.573 178.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -51.38 -30.16 25.03 Favored Glycine 0 CA--C 1.529 0.913 0 N-CA-C 114.643 0.617 . . . . 0.61 114.643 -178.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -87.28 -40.59 14.36 Favored 'General case' 0 C--O 1.227 -0.092 0 CA-C-N 117.965 0.882 . . . . 0.87 110.45 176.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 15.3 m-80 -62.48 -41.82 99.05 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 122.135 0.174 . . . . 1.57 111.322 -179.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -140.35 142.74 35.55 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 125.722 1.609 . . . . 0.67 107.649 -170.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 57.9 m -83.06 176.67 9.06 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 121.491 0.663 . . . . 1.72 110.504 177.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.468 ' HG3' ' HB2' ' A' ' 89' ' ' ALA . 2.8 mp0 -58.07 -45.75 86.59 Favored 'General case' 0 N--CA 1.454 -0.228 0 O-C-N 121.505 -0.747 . . . . 2.81 110.705 -166.138 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -61.73 -38.78 89.19 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.228 0.611 . . . . 2.97 110.199 -177.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.1 mp0 -70.33 -46.14 64.78 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 124.186 0.994 . . . . 4.21 108.489 -178.015 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 62.2 mt -62.96 -46.19 96.95 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.109 0 N-CA-C 108.834 -0.802 . . . . 0.24 108.834 178.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 46.4 tp -51.8 -54.06 32.97 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 123.132 0.573 . . . . 0.36 109.682 176.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -50.61 -52.48 38.98 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.338 0.655 . . . . 1.6 110.586 175.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 76.2 mt -62.6 -25.76 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 O-C-N 121.652 -0.655 . . . . 0.73 112.196 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 51.9 mt -73.26 -49.37 38.16 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 O-C-N 120.213 -1.554 . . . . 0.28 108.993 170.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 86.7 mt -62.89 -34.28 77.08 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 125.006 1.322 . . . . 0.42 114.238 -173.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -134.49 29.95 3.55 Favored 'General case' 0 C--N 1.342 0.257 0 CA-C-N 120.572 1.533 . . . . 3.24 109.68 -172.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 37.95 -140.26 0.47 Allowed Glycine 0 CA--C 1.542 1.72 0 C-N-CA 127.05 2.262 . . . . 0.65 111.837 -176.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 167.03 140.72 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 126.052 1.741 . . . . 1.27 109.516 -178.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 44.62 -120.67 3.74 Favored Glycine 0 CA--C 1.531 1.067 0 CA-C-N 119.684 1.129 . . . . 0.46 112.551 -177.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -71.36 -19.46 77.58 Favored Glycine 0 CA--C 1.534 1.222 0 O-C-N 122.379 -0.483 . . . . 0.48 112.972 178.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 17.1 ttt -72.25 119.94 77.57 Favored Pre-proline 0 CA--C 1.537 0.464 0 C-N-CA 123.762 0.825 . . . . 0.37 109.968 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -63.41 -53.25 1.51 Allowed 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 124.178 3.252 . . . . 2.89 111.467 -169.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 114.39 152.07 10.47 Favored Glycine 0 N--CA 1.447 -0.596 0 CA-C-O 121.98 0.767 . . . . 0.95 114.555 172.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 66.18 19.47 68.21 Favored Glycine 0 CA--C 1.531 1.04 0 CA-C-N 114.247 -0.976 . . . . 0.57 111.74 -177.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 2.5 mt -50.21 -49.85 21.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 126.382 1.873 . . . . 1.05 110.793 177.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -111.44 155.36 23.31 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.467 1.107 . . . . 0.51 108.909 159.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.5 mttm -146.13 157.87 43.86 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.276 1.43 . . . . 2.44 109.859 178.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 56.49 -149.28 28.56 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 110.414 -1.074 . . . . 1.02 110.414 -176.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -51.18 -32.85 24.91 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 117.548 0.674 . . . . 0.59 112.483 -178.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -51.79 -47.4 64.26 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.268 0.627 . . . . 2.36 109.619 174.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -75.92 -49.23 18.42 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.175 0.59 . . . . 0.35 111.304 175.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -57.34 -47.82 80.58 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 118.138 0.427 . . . . 2.0 111.503 -172.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.24 -49.07 77.19 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 109.625 -0.509 . . . . 0.28 109.625 178.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.46 HG22 HG23 ' A' ' 28' ' ' VAL . 45.9 t -57.62 -52.62 55.09 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 C-N-CA 122.898 0.479 . . . . 0.38 111.035 178.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -52.04 -55.8 18.32 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 123.467 0.707 . . . . 0.36 111.366 176.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.453 ' O ' ' HB3' ' A' ' 89' ' ' ALA . . . -59.69 -40.49 88.06 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.085 0.554 . . . . 0.47 111.084 -178.16 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.406 ' CZ3' HG21 ' A' ' 28' ' ' VAL . 70.6 t90 -64.36 -52.44 58.32 Favored 'General case' 0 N--CA 1.453 -0.315 0 O-C-N 121.709 -0.619 . . . . 0.61 109.727 177.032 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.52 -28.09 66.77 Favored 'General case' 0 C--O 1.224 -0.246 0 O-C-N 120.374 -1.454 . . . . 2.04 112.436 176.067 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.468 ' HB2' ' HG3' ' A' ' 57' ' ' GLU . . . -54.56 -35.34 63.16 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 119.036 0.834 . . . . 0.64 111.387 169.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -70.64 -41.21 72.45 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 109.287 -0.634 . . . . 4.86 109.287 174.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 4.1 mtpm? -74.33 105.85 5.69 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 120.988 0.423 . . . . 2.64 111.459 -174.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.093 0 C-N-CA 126.341 1.856 . . . . 2.28 106.736 170.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.2 t0 . . . . . 0 N--CA 1.45 -0.436 0 N-CA-C 103.487 -2.783 . . . . 3.61 103.487 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -111.65 -62.07 1.61 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.447 -0.946 . . . . 0.38 108.447 173.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -58.05 -44.54 87.5 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.749 -0.66 . . . . 3.36 110.417 -176.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.35 -36.7 83.05 Favored 'General case' 0 C--N 1.339 0.144 0 CA-C-N 118.707 0.685 . . . . 0.3 111.21 -179.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 92.8 t -62.87 -55.98 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 N-CA-C 107.891 -1.152 . . . . 0.46 107.891 176.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.548 HG13 ' HB2' ' A' ' 32' ' ' CYS . 74.0 t -52.76 -48.33 49.75 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 CA-C-N 117.547 0.158 . . . . 0.33 110.868 -179.598 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.434 ' HA ' HG12 ' A' ' 33' ' ' ILE . 25.3 mm-40 -50.06 -21.03 1.11 Allowed 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 126.565 1.946 . . . . 0.56 113.496 174.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 17.4 tp60 -144.67 55.1 1.25 Allowed 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 119.481 1.037 . . . . 3.97 111.528 172.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -167.25 -38.29 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 124.005 0.922 . . . . 1.35 110.025 170.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.548 ' HB2' HG13 ' A' ' 28' ' ' VAL . 3.7 m -99.58 -50.52 4.04 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 119.0 0.818 . . . . 0.21 110.772 -178.662 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.434 HG12 ' HA ' ' A' ' 29' ' ' GLN . 2.2 pp -56.91 -26.26 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.153 0 CA-C-N 116.151 -0.477 . . . . 0.39 111.89 -175.021 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.6 t -42.23 -32.33 0.48 Allowed 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.041 1.336 . . . . 2.11 111.848 172.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 12.5 m -123.08 -43.71 2.21 Favored 'General case' 0 C--N 1.341 0.212 0 C-N-CA 123.413 0.685 . . . . 0.17 111.593 173.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 84.3 m-70 -70.09 -10.18 57.9 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.745 0.818 . . . . 0.18 112.768 -176.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 88.67 149.09 18.75 Favored Glycine 0 C--N 1.337 0.635 0 N-CA-C 109.747 -1.341 . . . . 1.52 109.747 178.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -43.28 -39.49 4.17 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 124.512 1.053 . . . . 0.44 111.485 176.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -94.03 -7.16 43.51 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 125.574 1.549 . . . . 3.17 111.027 -170.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.9 mt 71.16 11.54 6.87 Favored 'General case' 0 C--N 1.35 0.589 0 CA-C-N 119.524 1.057 . . . . 1.07 111.627 177.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 12.5 p -83.49 0.1 47.86 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 127.128 2.171 . . . . 0.37 109.742 -176.049 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.85 129.92 2.78 Favored Glycine 0 N--CA 1.442 -0.917 0 N-CA-C 108.978 -1.649 . . . . 0.56 108.978 -178.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -135.95 -79.55 0.42 Allowed 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 124.195 0.998 . . . . 0.23 108.825 178.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.6 t -90.28 4.62 50.16 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.948 0.899 . . . . 1.59 110.705 172.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.566 ' HB1' ' HD2' ' A' ' 46' ' ' PRO . . . -158.08 168.89 11.55 Favored Pre-proline 0 CA--C 1.535 0.374 0 C-N-CA 124.688 1.195 . . . . 0.24 108.387 -172.315 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.566 ' HD2' ' HB1' ' A' ' 45' ' ' ALA . 38.1 Cg_endo -70.01 158.72 55.73 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.927 2.418 . . . . 0.19 110.528 -174.44 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.53 126.74 30.92 Favored 'General case' 0 C--N 1.332 -0.162 0 O-C-N 121.516 -0.74 . . . . 0.26 109.927 -178.098 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 50.6 pt -107.34 1.36 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 C-N-CA 123.716 0.806 . . . . 0.27 111.331 176.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 18.5 p-10 -35.75 -49.56 0.6 Allowed 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 124.894 1.278 . . . . 3.53 111.744 171.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.68 32.32 4.62 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 127.232 2.213 . . . . 3.59 113.103 -179.56 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.12 -49.24 78.61 Favored 'General case' 0 CA--C 1.535 0.371 0 O-C-N 120.746 -1.221 . . . . 0.44 110.147 177.462 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -54.11 -17.26 7.33 Favored Glycine 0 C--N 1.343 0.926 0 C-N-CA 124.64 1.114 . . . . 0.67 114.886 178.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.7 -40.7 88.58 Favored 'General case' 0 N--CA 1.453 -0.32 0 O-C-N 121.373 -1.075 . . . . 1.03 110.978 176.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 -105.5 -52.05 2.9 Favored 'General case' 0 CA--C 1.52 -0.198 0 N-CA-C 109.563 -0.532 . . . . 2.76 109.563 -172.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -92.7 147.86 22.53 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.725 -1.213 . . . . 0.81 107.725 -176.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -96.29 167.29 11.28 Favored 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 108.383 -0.969 . . . . 1.96 108.383 174.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -45.27 -43.51 10.6 Favored 'General case' 0 C--O 1.225 -0.216 0 C-N-CA 124.797 1.239 . . . . 2.8 111.484 177.014 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -55.82 -49.29 73.65 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.842 0.857 . . . . 3.04 110.72 178.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -74.55 -43.25 56.62 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 123.228 0.611 . . . . 3.17 109.423 -175.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 61.4 mt -60.57 -45.22 97.54 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 109.173 -0.677 . . . . 0.32 109.173 179.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 55.2 tp -55.44 -50.44 69.81 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.274 -0.639 . . . . 0.35 109.274 176.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -53.79 -48.75 69.5 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 121.197 -0.201 . . . . 1.5 110.562 175.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 49.7 mt -63.88 -21.09 27.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 O-C-N 121.421 -0.799 . . . . 0.95 112.48 179.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 66.1 mt -78.63 -44.99 25.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 O-C-N 120.264 -1.522 . . . . 0.26 109.207 173.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 80.7 mt -75.64 -31.28 59.76 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 113.43 0.9 . . . . 0.75 113.43 -176.132 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -120.06 19.47 12.28 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 119.641 1.109 . . . . 1.75 109.592 -171.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.536 ' N ' ' HA2' ' A' ' 73' ' ' GLY . . . 36.42 -136.99 0.5 Allowed Glycine 0 CA--C 1.532 1.148 0 C-N-CA 127.689 2.566 . . . . 0.69 111.169 -173.12 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 31.1 tt0 166.73 138.38 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 125.718 1.607 . . . . 1.13 109.988 177.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 41.3 -119.95 1.74 Allowed Glycine 0 CA--C 1.531 1.072 0 O-C-N 120.436 -1.415 . . . . 0.36 113.157 -173.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -71.66 -18.44 77.27 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 123.374 0.512 . . . . 0.48 112.976 179.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 23.3 ttt -71.55 118.69 68.57 Favored Pre-proline 0 N--CA 1.45 -0.426 0 C-N-CA 123.734 0.813 . . . . 0.39 110.52 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -75.25 125.03 8.89 Favored 'Trans proline' 0 N--CA 1.442 -1.53 0 C-N-CA 121.845 1.697 . . . . 2.16 109.923 179.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.536 ' HA2' ' N ' ' A' ' 67' ' ' GLY . . . -63.56 140.44 44.56 Favored Glycine 0 N--CA 1.44 -1.077 0 CA-C-N 115.077 -0.965 . . . . 0.58 114.558 178.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 84.74 33.72 17.98 Favored Glycine 0 CA--C 1.525 0.668 0 CA-C-N 113.95 -1.125 . . . . 0.32 111.329 173.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -61.47 -50.76 79.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 124.606 1.162 . . . . 2.28 109.247 179.007 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -104.18 154.39 19.81 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.668 1.587 . . . . 0.37 109.476 164.197 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.3 mtmp? -143.74 150.97 39.41 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 124.781 1.232 . . . . 5.06 109.556 179.003 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 68.82 -163.21 50.39 Favored Glycine 0 CA--C 1.528 0.886 0 N-CA-C 110.379 -1.088 . . . . 0.71 110.379 -173.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -48.6 -31.05 6.03 Favored 'General case' 0 C--O 1.226 -0.166 0 C-N-CA 123.967 0.907 . . . . 0.79 112.053 -179.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -41.73 -54.85 3.18 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.778 1.231 . . . . 1.96 109.904 174.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.17 -45.25 77.56 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 122.822 0.449 . . . . 0.22 110.93 -179.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 57.4 mt-10 -55.98 -51.62 67.05 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.162 0.985 . . . . 1.92 110.643 -176.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -53.34 -52.01 60.58 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.027 0.931 . . . . 0.28 110.451 176.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.527 HG22 HG23 ' A' ' 28' ' ' VAL . 77.0 t -55.02 -52.04 48.0 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 C-N-CA 120.997 -0.281 . . . . 0.35 110.395 178.226 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -53.79 -51.51 63.23 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 123.172 0.589 . . . . 0.18 111.972 179.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.77 -48.43 77.87 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 123.611 0.764 . . . . 0.31 110.701 178.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.565 ' CE3' HD23 ' A' ' 88' ' ' LEU . 48.9 t90 -61.61 -45.6 93.41 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 121.916 -0.49 . . . . 0.7 110.386 179.065 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.565 HD23 ' CE3' ' A' ' 87' ' ' TRP . 0.1 OUTLIER -64.17 -32.68 74.35 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 124.427 1.091 . . . . 1.54 111.184 178.337 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -65.66 -44.63 85.72 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 123.377 0.671 . . . . 0.42 110.279 171.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -59.83 -39.45 85.16 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 109.924 -0.398 . . . . 3.65 109.924 174.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -73.62 149.88 41.75 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 121.526 0.679 . . . . 2.7 110.878 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 18.6 mttt . . . . . 0 C--O 1.251 1.144 0 N-CA-C 105.274 -2.121 . . . . 2.72 105.274 177.345 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.444 ' HB3' ' HB3' ' A' ' 26' ' ' ALA . 0.7 OUTLIER . . . . . 0 N--CA 1.446 -0.645 0 N-CA-C 109.088 -0.708 . . . . 3.11 109.088 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -105.18 -64.12 1.16 Allowed 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 107.975 -1.12 . . . . 0.37 107.975 174.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -48.92 -48.95 42.19 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 115.65 -0.704 . . . . 2.86 111.166 178.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.444 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . . . -59.56 -44.96 93.11 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 118.878 0.763 . . . . 0.28 111.426 -177.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 71.9 t -59.8 -54.19 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 N-CA-C 108.495 -0.928 . . . . 0.44 108.495 177.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.538 HG13 ' HB2' ' A' ' 32' ' ' CYS . 85.5 t -54.39 -50.74 55.12 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-N 117.979 0.354 . . . . 0.32 110.595 -178.391 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 34.8 mm-40 -53.48 -15.68 1.18 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 126.696 1.998 . . . . 0.62 112.931 174.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -135.94 32.75 2.93 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 119.416 1.007 . . . . 2.85 113.129 173.26 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 8.3 mtmt -152.37 -56.67 0.14 Allowed 'General case' 0 CA--C 1.521 -0.145 0 CA-C-N 118.694 0.679 . . . . 1.76 109.633 172.272 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.538 ' HB2' HG13 ' A' ' 28' ' ' VAL . 4.0 m -75.08 -49.78 18.57 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 121.071 0.462 . . . . 0.2 110.406 -171.415 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.4 pp -53.38 -27.16 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.142 0 CA-C-N 115.487 -0.779 . . . . 0.41 111.963 179.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.5 t -46.86 -29.19 1.86 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.27 1.028 . . . . 2.1 111.92 176.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 15.9 m -122.45 -42.1 2.36 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.433 0.693 . . . . 0.3 111.662 170.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 89.0 m-70 -70.5 -4.44 22.84 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.226 1.01 . . . . 0.32 112.722 -177.16 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 116.44 -76.25 0.27 Allowed Glycine 0 C--N 1.339 0.746 0 C-N-CA 125.269 1.414 . . . . 3.19 111.927 161.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -178.91 -51.24 0.08 OUTLIER Glycine 0 CA--C 1.519 0.318 0 N-CA-C 108.597 -1.801 . . . . 0.81 108.597 -170.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -101.36 3.79 40.9 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 124.086 0.955 . . . . 2.2 110.777 -174.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.495 HD21 ' CG1' ' A' ' 28' ' ' VAL . 15.3 mt 75.4 11.61 3.35 Favored 'General case' 0 C--N 1.351 0.661 0 CA-C-N 119.764 1.165 . . . . 1.31 110.384 -178.609 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.6 p -81.24 -9.3 59.8 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 127.941 2.496 . . . . 0.49 109.913 -175.248 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.41 143.68 9.26 Favored Glycine 0 N--CA 1.441 -0.994 0 N-CA-C 109.142 -1.583 . . . . 0.47 109.142 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -152.92 -81.92 0.09 Allowed 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 124.137 0.975 . . . . 0.58 108.978 -178.406 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -88.93 3.44 51.44 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.544 1.137 . . . . 0.99 110.828 171.142 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -156.05 160.9 30.46 Favored Pre-proline 0 N--CA 1.449 -0.499 0 C-N-CA 125.988 1.715 . . . . 0.33 107.266 -169.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -68.17 160.03 50.6 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 123.466 2.778 . . . . 0.4 111.069 -174.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.45 125.65 28.39 Favored 'General case' 0 N--CA 1.455 -0.224 0 O-C-N 121.513 -0.742 . . . . 0.29 109.762 -177.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 46.1 pt -105.29 2.54 10.39 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 C-N-CA 123.555 0.742 . . . . 0.39 111.482 175.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -33.39 -47.9 0.23 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.528 1.931 . . . . 2.48 112.869 166.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.7 33.68 5.22 Favored 'General case' 0 C--N 1.344 0.35 0 C-N-CA 124.389 1.075 . . . . 4.66 110.281 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.22 -46.91 88.14 Favored 'General case' 0 N--CA 1.45 -0.435 0 O-C-N 121.15 -0.969 . . . . 0.37 108.923 176.081 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -56.87 -23.02 43.66 Favored Glycine 0 C--N 1.341 0.813 0 CA-C-N 118.65 0.659 . . . . 0.6 114.588 178.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -83.92 -47.38 11.09 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 117.81 0.805 . . . . 0.71 109.558 173.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 13.2 m-80 -59.5 -49.91 75.96 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.016 0.526 . . . . 1.65 111.535 -178.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -137.06 154.81 50.25 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.472 1.509 . . . . 0.87 108.578 -169.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.6 p -84.57 165.87 17.65 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 123.925 0.89 . . . . 2.35 110.226 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -50.53 -39.39 48.88 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 123.723 0.809 . . . . 3.24 111.407 178.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -57.29 -50.46 72.84 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 118.457 0.571 . . . . 4.52 110.83 177.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 27.5 mm-40 -68.09 -46.2 71.63 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 121.733 0.777 . . . . 3.09 108.917 -175.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 48.7 mt -60.19 -47.31 92.6 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 N-CA-C 109.44 -0.578 . . . . 0.39 109.44 -179.431 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.9 tp -58.45 -49.58 76.8 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 109.117 -0.697 . . . . 0.36 109.117 178.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -50.42 -51.05 49.96 Favored 'General case' 0 N--CA 1.452 -0.355 0 O-C-N 123.409 0.443 . . . . 1.82 109.961 176.27 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 55.0 mt -57.62 -52.32 58.92 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 O-C-N 121.868 -0.52 . . . . 0.51 110.957 178.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 60.7 mt -53.4 -44.9 56.45 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 O-C-N 120.561 -1.337 . . . . 0.26 110.404 179.383 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 75.1 mt -72.91 -32.67 65.49 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 113.361 0.874 . . . . 0.55 113.361 -178.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -123.04 19.77 9.98 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 119.655 1.116 . . . . 1.74 109.981 -165.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.562 ' N ' ' HA2' ' A' ' 73' ' ' GLY . . . 31.0 -142.98 0.02 OUTLIER Glycine 0 CA--C 1.533 1.207 0 C-N-CA 129.107 3.242 . . . . 0.62 111.492 -167.477 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 173.27 133.41 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 119.005 1.403 . . . . 1.38 109.057 -175.147 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 35.39 -113.64 0.14 Allowed Glycine 0 CA--C 1.534 1.224 0 CA-C-N 120.019 1.282 . . . . 0.47 113.925 -171.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -71.76 -21.42 78.91 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 123.47 0.557 . . . . 0.61 112.936 -178.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 19.6 ttt -71.13 117.98 61.54 Favored Pre-proline 0 N--CA 1.451 -0.409 0 C-N-CA 124.994 1.318 . . . . 0.43 110.793 179.507 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.548 ' HD2' HD11 ' A' ' 75' ' ' ILE . 41.3 Cg_endo -77.95 123.76 6.42 Favored 'Trans proline' 0 N--CA 1.447 -1.262 0 C-N-CA 122.938 2.425 . . . . 2.1 111.015 -178.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.562 ' HA2' ' N ' ' A' ' 67' ' ' GLY . . . -59.48 137.06 50.21 Favored Glycine 0 N--CA 1.444 -0.815 0 N-CA-C 115.688 1.035 . . . . 0.68 115.688 -177.262 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 80.49 38.64 16.84 Favored Glycine 0 CA--C 1.525 0.688 0 CA-C-N 114.071 -1.064 . . . . 0.32 111.005 174.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.548 HD11 ' HD2' ' A' ' 72' ' ' PRO . 1.2 mt -58.35 -58.04 8.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 124.892 1.277 . . . . 1.13 109.255 174.4 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -93.97 151.5 19.5 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 108.31 -0.996 . . . . 0.39 108.31 163.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -143.0 164.81 29.08 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 105.985 -1.857 . . . . 3.4 105.985 172.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 75.17 -173.19 53.02 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 110.306 -1.117 . . . . 1.31 110.306 -173.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -51.46 -27.96 11.83 Favored 'General case' 0 C--O 1.225 -0.23 0 C-N-CA 123.877 0.871 . . . . 0.83 111.628 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 6.2 mp0 -42.23 -57.85 2.38 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 124.097 0.959 . . . . 4.59 111.39 170.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -58.24 -47.98 81.82 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 118.519 0.599 . . . . 0.41 110.782 -175.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -52.37 -60.92 2.65 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 124.507 1.123 . . . . 2.04 111.348 174.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -55.16 -47.34 75.28 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 124.233 1.013 . . . . 0.35 109.922 -177.418 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 62.4 t -55.91 -55.58 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 C-N-CA 123.669 0.788 . . . . 0.36 110.339 176.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -51.4 -53.75 33.46 Favored 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 123.178 0.591 . . . . 0.24 111.614 176.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -63.34 -42.13 98.92 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.872 0.869 . . . . 0.36 110.784 -175.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.495 ' CZ3' HG21 ' A' ' 28' ' ' VAL . 62.0 t90 -58.69 -50.8 72.56 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 108.626 -0.879 . . . . 0.48 108.626 174.507 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.39 -32.1 69.85 Favored 'General case' 0 C--O 1.222 -0.357 0 O-C-N 120.512 -1.367 . . . . 1.98 112.585 173.381 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -60.64 -32.02 71.21 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 119.556 1.071 . . . . 0.67 111.925 172.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -77.59 -34.64 53.49 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 119.668 1.122 . . . . 3.9 111.643 168.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 21.6 mtpp -73.96 116.32 14.44 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 119.806 1.185 . . . . 2.95 111.029 -175.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 12.3 mttt . . . . . 0 C--O 1.254 1.299 0 C-N-CA 127.787 2.435 . . . . 2.65 105.569 -176.747 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 . . . . . 0 N--CA 1.449 -0.477 0 N-CA-C 108.45 -0.945 . . . . 2.23 108.45 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -41.64 -57.38 2.3 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 124.951 1.3 . . . . 0.35 111.371 177.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -55.67 -48.21 75.43 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 116.314 -0.403 . . . . 2.33 111.502 179.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.16 -44.7 83.72 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 118.266 0.485 . . . . 0.38 110.921 178.256 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.439 HG21 ' HG3' ' A' ' 80' ' ' GLU . 54.6 t -57.53 -55.67 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 N-CA-C 109.332 -0.618 . . . . 0.33 109.332 175.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.666 HG13 ' HB2' ' A' ' 32' ' ' CYS . 78.9 t -54.08 -49.61 60.13 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 N-CA-C 110.292 -0.262 . . . . 0.39 110.292 -177.316 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.421 ' HA ' HG12 ' A' ' 33' ' ' ILE . 30.6 mm-40 -51.83 -15.97 0.61 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.624 1.969 . . . . 0.87 113.588 174.266 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.43 30.96 2.61 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 119.313 0.961 . . . . 2.39 112.314 178.496 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 5.0 mtmt -157.08 -47.31 0.07 Allowed 'General case' 0 CA--C 1.519 -0.214 0 O-C-N 121.85 -0.531 . . . . 1.49 111.384 173.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.666 ' HB2' HG13 ' A' ' 28' ' ' VAL . 4.3 m -86.26 -48.13 8.8 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.65 -0.5 . . . . 0.2 109.65 -174.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.421 HG12 ' HA ' ' A' ' 29' ' ' GLN . 2.5 pp -55.22 -27.8 20.51 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 CA-C-N 115.854 -0.612 . . . . 0.38 112.332 -177.314 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.7 m -42.53 -34.42 0.85 Allowed 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.692 1.197 . . . . 1.08 112.702 172.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 26.2 m -120.05 -41.37 2.65 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.134 0.574 . . . . 0.18 111.763 174.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 84.5 m-70 -73.49 -7.85 53.49 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.712 0.805 . . . . 0.24 112.688 -176.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 87.94 149.14 16.85 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 109.825 -1.31 . . . . 1.48 109.825 178.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -42.92 -34.89 2.08 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 124.78 1.181 . . . . 0.45 112.237 173.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -97.84 -6.99 31.35 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 125.737 1.615 . . . . 2.29 111.537 -171.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.2 mt 71.89 10.73 6.22 Favored 'General case' 0 C--N 1.351 0.665 0 CA-C-N 120.604 1.547 . . . . 1.16 111.232 176.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.7 p -88.79 0.43 56.53 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 128.603 2.761 . . . . 0.36 109.992 -173.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.84 124.21 1.73 Allowed Glycine 0 N--CA 1.439 -1.106 0 N-CA-C 109.271 -1.532 . . . . 0.75 109.271 178.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -128.5 -78.74 0.57 Allowed 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 124.368 1.067 . . . . 0.29 108.873 177.237 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 21.4 m -93.67 4.55 53.77 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.387 1.075 . . . . 1.28 111.104 172.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -152.16 163.28 24.09 Favored Pre-proline 0 CA--C 1.534 0.358 0 C-N-CA 126.096 1.758 . . . . 0.31 107.164 -171.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -70.52 160.59 48.98 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 122.683 2.255 . . . . 0.26 110.423 -176.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.52 128.23 34.91 Favored 'General case' 0 C--N 1.332 -0.187 0 O-C-N 121.461 -0.774 . . . . 0.31 110.255 -176.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.425 HD12 HD11 ' A' ' 88' ' ' LEU . 26.7 pt -108.21 0.84 9.74 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 C-N-CA 123.904 0.882 . . . . 0.35 111.931 177.309 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 22.8 p-10 -33.08 -50.67 0.29 Allowed 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.812 1.645 . . . . 3.87 113.243 169.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 12.6 pttp -111.96 22.46 14.85 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 125.796 1.638 . . . . 4.86 112.054 -178.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -54.72 -38.34 66.97 Favored 'General case' 0 C--O 1.224 -0.285 0 O-C-N 121.632 -0.667 . . . . 0.36 109.576 177.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -57.96 -17.58 29.91 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 123.862 0.744 . . . . 0.58 114.927 176.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -90.0 -39.58 12.87 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 118.295 1.048 . . . . 0.7 109.733 172.247 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -63.17 -48.86 76.63 Favored 'General case' 0 CA--C 1.527 0.084 0 C-N-CA 123.129 0.572 . . . . 2.58 111.504 178.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -141.05 148.88 40.91 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 125.695 1.598 . . . . 0.65 107.969 -166.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 16.6 m -81.89 167.57 18.83 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 118.39 0.541 . . . . 1.54 110.573 179.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -46.9 -43.12 18.57 Favored 'General case' 0 C--O 1.225 -0.225 0 C-N-CA 124.191 0.996 . . . . 3.1 111.424 175.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -55.13 -45.62 75.61 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.039 0.936 . . . . 2.69 110.568 179.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -73.42 -49.42 27.11 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 123.766 0.826 . . . . 3.12 109.75 -178.007 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 72.8 mt -60.05 -42.76 90.9 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 N-CA-C 108.618 -0.882 . . . . 0.22 108.618 -176.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 23.4 tp -55.01 -52.11 64.15 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 123.473 0.709 . . . . 0.4 109.739 175.199 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -52.04 -48.31 64.62 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 118.118 0.417 . . . . 1.5 111.136 176.168 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 95.6 mt -57.81 -54.22 34.56 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 O-C-N 121.348 -0.845 . . . . 0.67 110.446 177.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 38.3 mt -50.0 -46.02 23.22 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 O-C-N 121.163 -0.961 . . . . 0.34 109.909 178.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 96.5 mt -62.96 -40.02 96.41 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 118.044 -0.979 . . . . 0.61 113.395 177.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -127.85 25.45 5.96 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 120.369 1.44 . . . . 1.84 110.442 -159.59 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 23.57 -134.98 0.01 OUTLIER Glycine 0 CA--C 1.542 1.758 0 C-N-CA 127.615 2.531 . . . . 0.65 112.694 -159.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 21.6 tt0 169.25 138.62 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.148 0 CA-C-N 119.799 1.8 . . . . 1.22 108.933 -177.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 30.06 -111.15 0.03 OUTLIER Glycine 0 CA--C 1.534 1.247 0 C-N-CA 125.212 1.387 . . . . 0.44 114.154 -171.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -66.97 -25.85 73.25 Favored Glycine 0 CA--C 1.534 1.226 0 CA-C-N 118.069 0.935 . . . . 0.55 113.415 -178.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 16.7 ttt -70.9 120.67 80.72 Favored Pre-proline 0 CA--C 1.536 0.441 0 C-N-CA 124.747 1.219 . . . . 0.39 110.033 -179.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -61.89 -56.0 0.9 Allowed 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 124.358 3.372 . . . . 2.96 111.237 -169.139 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 118.25 151.56 9.16 Favored Glycine 0 N--CA 1.447 -0.63 0 CA-C-N 115.58 -0.736 . . . . 0.91 113.874 173.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 65.73 22.47 70.05 Favored Glycine 0 CA--C 1.528 0.849 0 CA-C-N 114.313 -0.943 . . . . 0.42 111.522 -179.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 2.6 mt -50.13 -57.51 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 C-N-CA 125.282 1.433 . . . . 1.06 109.462 176.107 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -102.62 152.74 20.84 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.36 0.664 . . . . 0.37 109.794 163.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 3.2 mmmp? -145.03 151.82 39.16 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.594 1.158 . . . . 3.79 109.598 177.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 71.99 -156.67 52.61 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 123.518 0.58 . . . . 0.71 111.749 177.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -48.22 -35.59 12.18 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 124.941 1.296 . . . . 0.82 112.09 -177.007 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.439 ' HG3' HG21 ' A' ' 27' ' ' VAL . 43.5 tt0 -47.45 -63.53 1.03 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.897 1.279 . . . . 2.18 110.715 169.406 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.03 -44.34 94.69 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.979 0.912 . . . . 0.29 110.794 -179.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -54.59 -52.31 62.55 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 121.219 0.533 . . . . 2.53 110.047 179.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.13 -51.67 68.76 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.57 0.748 . . . . 0.21 109.971 179.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 55.7 t -49.55 -56.71 2.67 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 123.027 0.531 . . . . 0.45 111.012 176.312 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -53.44 -51.9 61.16 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 124.059 0.944 . . . . 0.19 111.855 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.95 -48.61 80.99 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 121.599 0.714 . . . . 0.29 110.434 -179.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.529 ' CE3' HD23 ' A' ' 88' ' ' LEU . 49.9 t90 -56.5 -43.35 79.65 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.165 0.586 . . . . 0.4 110.303 177.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.529 HD23 ' CE3' ' A' ' 87' ' ' TRP . 0.1 OUTLIER -63.43 -42.31 98.71 Favored 'General case' 0 C--O 1.227 -0.117 0 C-N-CA 123.646 0.778 . . . . 1.58 110.862 175.568 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -55.36 -38.15 68.42 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 119.236 0.925 . . . . 0.41 110.716 171.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -84.15 13.09 5.49 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.655 1.182 . . . . 3.53 113.655 174.063 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.46 122.7 43.37 Favored 'General case' 0 C--N 1.34 0.189 0 CA-C-N 119.954 1.252 . . . . 2.28 109.733 173.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.255 1.378 0 C-N-CA 127.541 2.336 . . . . 2.81 104.959 178.097 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 . . . . . 0 N--CA 1.449 -0.491 0 N-CA-C 107.786 -1.19 . . . . 2.59 107.786 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -49.69 -50.22 44.51 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.204 1.002 . . . . 0.59 109.805 179.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -60.61 -51.59 68.77 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 116.002 -0.544 . . . . 3.2 110.414 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.99 -45.28 79.06 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 118.916 0.78 . . . . 0.59 110.99 -178.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.545 HG21 ' HG3' ' A' ' 80' ' ' GLU . 24.5 t -56.64 -56.43 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 CA-C-N 116.12 -0.491 . . . . 0.81 109.713 175.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.639 HG22 ' SG ' ' A' ' 32' ' ' CYS . 52.2 t -55.68 -45.72 79.22 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 N-CA-C 110.005 -0.369 . . . . 0.4 110.005 -178.384 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.439 ' HA ' HG12 ' A' ' 33' ' ' ILE . 26.0 mm-40 -55.72 -11.31 0.91 Allowed 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 127.355 2.262 . . . . 0.84 113.859 173.699 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -139.05 16.62 2.63 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 119.63 1.104 . . . . 2.92 113.514 173.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 23.6 mttm -135.86 -62.79 0.67 Allowed 'General case' 0 CA--C 1.518 -0.257 0 C-N-CA 123.919 0.888 . . . . 2.28 109.457 176.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.639 ' SG ' HG22 ' A' ' 28' ' ' VAL . 3.2 m -72.71 -47.93 42.99 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.096 0.474 . . . . 0.27 110.43 -173.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.439 HG12 ' HA ' ' A' ' 29' ' ' GLN . 2.2 pp -58.72 -25.13 27.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 CA-C-N 115.533 -0.758 . . . . 0.38 111.688 -174.483 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.6 m -46.16 -32.93 3.23 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.829 1.251 . . . . 1.11 111.768 175.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 21.6 m -120.31 -42.57 2.56 Favored 'General case' 0 C--N 1.341 0.21 0 C-N-CA 123.523 0.729 . . . . 0.19 111.516 175.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -72.56 -8.63 56.15 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.577 0.751 . . . . 0.21 112.667 -177.321 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 86.46 148.81 12.71 Favored Glycine 0 C--N 1.336 0.567 0 N-CA-C 109.442 -1.463 . . . . 1.47 109.442 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -42.05 -33.43 1.23 Allowed Glycine 0 CA--C 1.527 0.821 0 C-N-CA 125.241 1.401 . . . . 0.48 112.914 175.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -100.66 -4.8 27.62 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 125.408 1.483 . . . . 3.11 112.089 -170.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 13.0 mt 68.94 12.94 8.77 Favored 'General case' 0 C--N 1.352 0.699 0 CA-C-N 120.212 1.369 . . . . 1.09 112.002 177.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 11.0 p -84.32 -3.63 58.37 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 127.329 2.252 . . . . 0.42 110.365 -177.078 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.72 130.7 3.74 Favored Glycine 0 N--CA 1.441 -0.988 0 N-CA-C 108.943 -1.663 . . . . 0.59 108.943 -176.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -134.5 -79.44 0.45 Allowed 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 124.285 1.034 . . . . 0.29 108.471 177.175 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 19.5 m -91.61 4.28 53.04 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.208 1.003 . . . . 1.3 111.043 173.144 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -155.72 163.95 22.95 Favored Pre-proline 0 CA--C 1.536 0.407 0 C-N-CA 125.388 1.475 . . . . 0.22 107.884 -169.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -70.74 157.97 56.99 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.915 2.41 . . . . 0.24 110.582 -174.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.52 123.44 23.93 Favored 'General case' 0 C--N 1.331 -0.208 0 O-C-N 121.492 -0.755 . . . . 0.23 110.16 -175.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 44.0 pt -106.78 2.22 10.09 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.135 0 C-N-CA 124.22 1.008 . . . . 0.3 111.132 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.439 ' OD1' ' NZ ' ' A' ' 91' ' ' LYS . 24.4 t0 -42.01 -49.59 4.67 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 118.457 0.571 . . . . 2.9 112.149 177.643 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 5.3 pttt -101.28 26.32 7.28 Favored 'General case' 0 C--N 1.344 0.331 0 C-N-CA 125.743 1.617 . . . . 4.8 111.698 -178.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -53.74 -43.13 68.88 Favored 'General case' 0 N--CA 1.457 -0.122 0 O-C-N 121.483 -0.761 . . . . 0.3 110.302 -178.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -52.05 -23.82 12.92 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 114.682 0.633 . . . . 0.61 114.682 175.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -80.99 -35.69 31.67 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 118.061 0.931 . . . . 0.99 110.509 175.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 -74.2 -48.36 29.53 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 122.814 0.446 . . . . 2.03 109.997 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -140.4 153.67 46.42 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.356 1.062 . . . . 0.8 109.274 -170.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 20.0 m -83.83 166.92 17.53 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 118.485 0.584 . . . . 1.64 110.684 178.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.2 pm0 -47.07 -42.41 18.64 Favored 'General case' 0 C--O 1.223 -0.293 0 C-N-CA 124.793 1.237 . . . . 2.79 111.92 178.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -58.44 -45.83 87.73 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.378 0.609 . . . . 2.66 110.152 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -74.2 -46.68 40.38 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.599 0.76 . . . . 3.2 109.134 -176.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 62.6 mt -59.32 -44.28 91.95 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.132 0 O-C-N 121.475 -0.766 . . . . 0.38 109.018 179.263 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 52.8 tp -54.43 -51.17 65.79 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 109.14 -0.689 . . . . 0.44 109.14 176.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -52.48 -50.16 63.25 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 123.297 0.373 . . . . 1.5 110.253 174.147 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 76.7 mt -61.65 -24.09 32.88 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 O-C-N 121.323 -0.861 . . . . 1.01 112.621 179.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 75.1 mt -82.38 -46.66 19.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 O-C-N 120.059 -1.65 . . . . 0.36 109.621 176.129 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 68.7 mt -72.64 -30.29 64.19 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.395 1.078 . . . . 0.77 112.713 -176.146 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -127.39 17.31 7.06 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 119.207 0.912 . . . . 1.96 109.614 -169.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.585 ' N ' ' HA2' ' A' ' 73' ' ' GLY . . . 40.41 -143.87 0.55 Allowed Glycine 0 CA--C 1.539 1.539 0 C-N-CA 127.759 2.6 . . . . 0.71 111.814 -177.722 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 31.4 tt0 170.12 138.18 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 126.069 1.748 . . . . 1.2 109.731 -179.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 35.76 -116.62 0.28 Allowed Glycine 0 C--N 1.347 1.16 0 CA-C-N 120.46 1.482 . . . . 0.43 114.082 -175.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -67.32 -23.16 73.27 Favored Glycine 0 CA--C 1.531 1.091 0 CA-C-N 117.98 0.89 . . . . 0.53 112.555 -179.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 18.6 ttt -72.7 117.96 63.84 Favored Pre-proline 0 CA--C 1.535 0.398 0 C-N-CA 124.45 1.1 . . . . 0.51 112.053 179.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.417 ' HD2' HD11 ' A' ' 75' ' ' ILE . 37.2 Cg_endo -75.57 123.78 7.8 Favored 'Trans proline' 0 N--CA 1.446 -1.277 0 C-N-CA 122.848 2.366 . . . . 2.11 111.706 -179.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.585 ' HA2' ' N ' ' A' ' 67' ' ' GLY . . . -58.01 126.67 43.01 Favored Glycine 0 N--CA 1.443 -0.889 0 CA-C-N 115.012 -0.995 . . . . 0.7 115.246 179.191 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 86.66 48.01 4.63 Favored Glycine 0 C--N 1.337 0.636 0 N-CA-C 110.648 -0.981 . . . . 0.58 110.648 173.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.417 HD11 ' HD2' ' A' ' 72' ' ' PRO . 1.1 mt -69.11 -50.88 49.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 123.833 0.853 . . . . 1.18 109.497 175.168 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -102.92 153.63 20.02 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 126.002 1.721 . . . . 0.38 109.619 164.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 44.9 mttm -143.63 155.36 44.23 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 125.386 1.475 . . . . 2.79 108.861 178.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 72.63 -167.77 53.43 Favored Glycine 0 CA--C 1.53 0.981 0 N-CA-C 110.926 -0.869 . . . . 0.91 110.926 -175.183 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -52.04 -25.95 9.76 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.469 1.108 . . . . 1.06 112.728 -177.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.545 ' HG3' HG21 ' A' ' 27' ' ' VAL . 34.8 tt0 -42.19 -60.3 1.5 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.723 1.209 . . . . 2.21 110.939 168.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.27 -45.73 92.28 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 122.608 0.363 . . . . 0.34 110.638 -175.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -52.11 -57.12 10.55 Favored 'General case' 0 N--CA 1.461 0.096 0 C-N-CA 123.503 0.721 . . . . 3.04 111.196 174.129 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -53.95 -48.48 70.25 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 123.139 0.576 . . . . 0.3 109.812 -177.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.402 HG13 ' CG2' ' A' ' 28' ' ' VAL . 98.5 t -59.18 -53.32 49.71 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 N-CA-C 111.588 0.218 . . . . 0.32 111.588 177.32 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -51.29 -53.82 31.98 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 124.051 0.941 . . . . 0.29 111.455 178.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.89 -54.42 47.13 Favored 'General case' 0 C--O 1.224 -0.268 0 N-CA-C 109.299 -0.63 . . . . 0.6 109.299 179.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.551 ' CE3' HD23 ' A' ' 88' ' ' LEU . 50.2 t90 -49.38 -46.61 47.48 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 122.984 0.514 . . . . 0.51 111.134 177.066 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.551 HD23 ' CE3' ' A' ' 87' ' ' TRP . 0.1 OUTLIER -66.05 -31.82 72.93 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 124.585 1.154 . . . . 1.66 111.908 177.338 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -67.8 -44.85 76.35 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 118.739 0.7 . . . . 0.58 110.731 173.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -57.52 -39.76 77.27 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.286 0.634 . . . . 5.24 110.196 173.042 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.439 ' NZ ' ' OD1' ' A' ' 49' ' ' ASP . 1.6 mtmp? -73.45 136.22 44.2 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 118.852 0.751 . . . . 2.78 110.538 178.074 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 67.8 mttt . . . . . 0 C--O 1.249 1.044 0 CA-C-O 117.189 -1.386 . . . . 2.59 108.091 174.704 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 . . . . . 0 N--CA 1.452 -0.326 0 N-CA-C 108.664 -0.865 . . . . 2.58 108.664 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -51.84 -58.62 5.92 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.655 0.782 . . . . 0.38 110.906 -178.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -50.15 -45.14 52.94 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 118.936 -0.554 . . . . 2.85 111.362 176.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.99 -47.66 84.91 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 119.033 0.833 . . . . 0.39 110.829 179.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 89.3 t -56.32 -54.49 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.155 0 N-CA-C 108.934 -0.765 . . . . 0.4 108.934 176.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.614 HG13 ' HB2' ' A' ' 32' ' ' CYS . 96.4 t -56.02 -48.21 79.11 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 C-N-CA 122.55 0.34 . . . . 0.41 111.037 -177.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 36.4 mm-40 -53.67 -15.81 1.37 Allowed 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 126.912 2.085 . . . . 0.49 113.036 174.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -144.98 48.21 1.31 Allowed 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 119.286 0.948 . . . . 2.46 111.086 174.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 3.8 mttt -162.69 -49.28 0.04 OUTLIER 'General case' 0 C--O 1.227 -0.131 0 C-N-CA 124.483 1.113 . . . . 1.94 110.206 167.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.614 ' HB2' HG13 ' A' ' 28' ' ' VAL . 5.2 m -85.2 -50.11 7.66 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 121.443 0.64 . . . . 0.16 110.417 -172.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.4 pp -53.48 -28.63 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 CA-C-N 115.063 -0.971 . . . . 0.41 111.487 -178.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.9 m -41.61 -35.14 0.69 Allowed 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 125.574 1.549 . . . . 1.1 112.377 173.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 34.9 m -119.23 -41.53 2.73 Favored 'General case' 0 C--N 1.34 0.185 0 C-N-CA 123.546 0.739 . . . . 0.16 111.562 174.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 84.4 m-70 -74.18 -7.72 53.66 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.749 0.82 . . . . 0.35 112.791 -175.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 84.24 148.72 9.29 Favored Glycine 0 C--N 1.338 0.643 0 C-N-CA 125.511 1.529 . . . . 1.52 109.6 -179.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -44.49 -36.47 4.46 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 124.41 1.005 . . . . 0.46 112.317 174.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -88.61 -10.72 47.68 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 124.842 1.257 . . . . 2.06 111.454 -174.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.4 mt 71.78 10.59 6.31 Favored 'General case' 0 C--N 1.349 0.578 0 CA-C-N 120.197 1.362 . . . . 1.15 110.818 176.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.4 p -84.06 -0.27 51.13 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 128.415 2.686 . . . . 0.32 110.126 -175.456 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.4 138.88 5.84 Favored Glycine 0 N--CA 1.44 -1.071 0 N-CA-C 108.599 -1.801 . . . . 0.44 108.599 -176.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -145.35 -78.34 0.19 Allowed 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 123.789 0.836 . . . . 0.24 108.932 178.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.5 t -89.07 1.7 55.17 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.824 0.85 . . . . 1.25 110.355 174.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.457 ' HB1' ' HD2' ' A' ' 46' ' ' PRO . . . -162.43 165.13 15.98 Favored Pre-proline 0 CA--C 1.537 0.467 0 C-N-CA 125.12 1.368 . . . . 0.4 107.434 -167.372 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.457 ' HD2' ' HB1' ' A' ' 45' ' ' ALA . 33.3 Cg_endo -66.81 159.52 51.06 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 123.46 2.773 . . . . 0.32 111.54 -173.224 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.33 132.19 42.78 Favored 'General case' 0 C--N 1.332 -0.177 0 O-C-N 121.67 -0.643 . . . . 0.39 109.867 -178.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 35.3 pt -109.03 1.16 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 C-N-CA 123.242 0.617 . . . . 0.29 112.516 175.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -38.49 -47.4 1.27 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.459 1.104 . . . . 3.56 111.811 170.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 10.7 mttt -108.52 35.2 3.28 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 125.553 1.541 . . . . 5.64 111.683 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.81 -55.28 35.02 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 108.567 -0.901 . . . . 0.44 108.567 169.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -57.02 -21.28 37.58 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 124.726 1.155 . . . . 0.75 113.551 -179.246 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.01 -38.91 92.47 Favored 'General case' 0 N--CA 1.451 -0.394 0 O-C-N 121.799 -0.824 . . . . 1.4 110.994 177.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 72.0 m-80 -105.23 -53.66 2.62 Favored 'General case' 0 CA--C 1.523 -0.076 0 C-N-CA 123.411 0.684 . . . . 2.98 109.937 -174.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -94.66 142.34 27.57 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 124.848 1.259 . . . . 1.49 108.929 -171.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.5 167.06 17.76 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 118.748 0.704 . . . . 1.88 110.167 175.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -48.37 -47.43 37.32 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 124.009 0.924 . . . . 3.04 110.894 174.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -54.72 -34.95 63.14 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.39 0.676 . . . . 4.46 111.598 178.632 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -84.44 -47.05 11.04 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 121.533 0.682 . . . . 3.44 109.602 -175.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 87.1 mt -61.48 -41.93 91.93 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 N-CA-C 108.778 -0.823 . . . . 0.31 108.778 179.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.4 tp -54.95 -49.46 71.31 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 123.02 0.528 . . . . 0.35 109.714 175.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -52.1 -52.09 53.59 Favored 'General case' 0 CA--C 1.533 0.306 0 O-C-N 123.271 0.357 . . . . 1.51 110.152 176.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 75.7 mt -57.76 -50.69 76.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.288 0 O-C-N 121.572 -0.705 . . . . 0.54 110.311 178.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 46.3 mt -54.06 -44.39 62.62 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 O-C-N 120.383 -1.448 . . . . 0.3 110.411 179.163 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 84.8 mt -70.5 -32.78 70.42 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 118.33 -0.843 . . . . 0.4 112.892 -179.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -124.69 18.84 8.7 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 119.752 1.16 . . . . 1.69 110.387 -164.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.604 ' N ' ' HA2' ' A' ' 73' ' ' GLY . . . 30.81 -137.33 0.07 OUTLIER Glycine 0 CA--C 1.532 1.116 0 C-N-CA 128.819 3.104 . . . . 0.63 111.206 -167.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 11.6 tt0 165.7 129.74 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.518 1.527 . . . . 1.6 109.81 -178.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 41.04 -118.42 1.26 Allowed Glycine 0 C--N 1.346 1.089 0 CA-C-N 120.865 1.666 . . . . 0.73 113.846 -176.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -66.07 -17.36 65.55 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 123.711 0.672 . . . . 0.75 112.644 -179.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 19.4 ttt -81.39 117.74 69.41 Favored Pre-proline 0 N--CA 1.448 -0.531 0 C-N-CA 124.879 1.272 . . . . 0.39 111.525 179.063 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.563 ' HD2' HD11 ' A' ' 75' ' ' ILE . 37.5 Cg_endo -77.93 122.64 5.9 Favored 'Trans proline' 0 N--CA 1.447 -1.237 0 C-N-CA 122.992 2.461 . . . . 2.11 111.704 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.604 ' HA2' ' N ' ' A' ' 67' ' ' GLY . . . -57.84 132.93 52.8 Favored Glycine 0 N--CA 1.443 -0.853 0 N-CA-C 115.737 1.055 . . . . 0.65 115.737 -179.29 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 82.59 34.4 22.57 Favored Glycine 0 CA--C 1.527 0.803 0 CA-C-N 114.228 -0.986 . . . . 0.34 112.06 173.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.563 HD11 ' HD2' ' A' ' 72' ' ' PRO . 1.4 mt -53.9 -57.24 6.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 125.256 1.422 . . . . 1.13 110.038 174.389 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -101.73 150.06 23.51 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 124.292 1.037 . . . . 0.41 108.27 166.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 56.2 mttm -142.26 165.25 27.95 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 106.986 -1.487 . . . . 2.8 106.986 172.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 76.8 -170.29 55.04 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 110.022 -1.231 . . . . 1.26 110.022 -173.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -52.35 -30.19 27.52 Favored 'General case' 0 C--O 1.225 -0.222 0 C-N-CA 123.865 0.866 . . . . 0.75 111.15 -176.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.556 ' O ' HG23 ' A' ' 84' ' ' VAL . 11.5 mp0 -39.5 -62.98 0.61 Allowed 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.147 1.379 . . . . 4.54 111.063 170.03 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -58.46 -48.92 79.18 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.207 0.458 . . . . 0.37 111.125 -175.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -50.06 -57.63 7.23 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.362 1.065 . . . . 2.0 111.353 175.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.95 -43.63 98.44 Favored 'General case' 0 N--CA 1.449 -0.507 0 O-C-N 121.902 -0.499 . . . . 0.44 110.769 -177.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.556 HG23 ' O ' ' A' ' 80' ' ' GLU . 71.3 t -53.97 -53.95 23.89 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 C-N-CA 123.332 0.653 . . . . 0.53 109.737 176.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -52.73 -53.53 46.55 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 123.401 0.68 . . . . 0.21 112.082 175.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.61 -47.14 82.98 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 122.115 0.96 . . . . 0.27 110.976 -179.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.522 ' CE3' HD23 ' A' ' 88' ' ' LEU . 50.9 t90 -59.86 -42.48 93.78 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.315 1.046 . . . . 0.44 110.273 178.286 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.522 HD23 ' CE3' ' A' ' 87' ' ' TRP . 0.1 OUTLIER -64.25 -38.92 92.75 Favored 'General case' 0 C--N 1.333 -0.116 0 C-N-CA 123.996 0.918 . . . . 1.59 110.818 175.552 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -52.81 -45.5 67.28 Favored 'General case' 0 CA--C 1.528 0.12 0 N-CA-C 109.424 -0.584 . . . . 0.52 109.424 173.345 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -90.28 36.78 0.88 Allowed 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.216 0.606 . . . . 3.06 111.896 175.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 4.4 mttm -126.36 136.37 52.62 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.267 1.027 . . . . 2.96 108.702 164.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 30.8 mttt . . . . . 0 C--O 1.253 1.256 0 N-CA-C 105.162 -2.162 . . . . 3.47 105.162 172.916 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 . . . . . 0 N--CA 1.451 -0.415 0 N-CA-C 109.287 -0.634 . . . . 2.52 109.287 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -40.84 -51.91 3.09 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 125.012 1.325 . . . . 0.5 111.8 176.097 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -57.02 -46.09 82.59 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 110.146 -0.316 . . . . 2.93 110.146 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.1 -43.75 98.41 Favored 'General case' 0 CA--C 1.528 0.109 0 C-N-CA 123.386 0.674 . . . . 0.34 110.768 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 89.8 t -58.93 -58.76 5.44 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.261 0 N-CA-C 109.062 -0.718 . . . . 0.55 109.062 176.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.554 HG21 ' HZ3' ' A' ' 87' ' ' TRP . 44.1 t -53.02 -47.03 54.74 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 C-N-CA 123.224 0.609 . . . . 0.36 110.431 -177.114 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.448 ' HA ' HG12 ' A' ' 33' ' ' ILE . 24.7 mm-40 -48.9 -25.91 2.17 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 126.119 1.768 . . . . 0.68 113.427 173.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -141.01 56.73 1.56 Allowed 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 119.261 0.937 . . . . 3.26 111.624 174.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.47 -38.12 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 124.145 0.978 . . . . 1.27 110.033 170.442 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.525 ' SG ' HG22 ' A' ' 28' ' ' VAL . 3.4 m -101.18 -50.23 3.85 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 119.27 0.941 . . . . 0.23 110.86 -177.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.448 HG12 ' HA ' ' A' ' 29' ' ' GLN . 2.2 pp -56.88 -27.07 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 CA-C-N 116.107 -0.497 . . . . 0.4 112.027 -174.453 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.7 m -38.64 -35.76 0.21 Allowed 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.635 1.574 . . . . 1.06 112.473 170.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 20.9 m -121.02 -44.28 2.41 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.75 0.82 . . . . 0.19 111.371 174.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 86.5 m-70 -70.5 -9.55 56.9 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.753 0.821 . . . . 0.21 112.897 -176.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 88.37 148.08 15.54 Favored Glycine 0 C--N 1.338 0.643 0 N-CA-C 109.816 -1.314 . . . . 1.52 109.816 177.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -44.6 -36.29 4.51 Favored Glycine 0 C--N 1.341 0.807 0 C-N-CA 124.454 1.026 . . . . 0.47 111.852 175.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -93.7 -6.93 45.12 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 124.909 1.283 . . . . 2.55 111.758 -172.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 8.9 mt 70.91 11.12 7.07 Favored 'General case' 0 C--N 1.352 0.693 0 CA-C-N 120.237 1.381 . . . . 1.11 111.301 177.364 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 11.0 p -86.28 0.88 52.84 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 127.186 2.194 . . . . 0.35 109.832 -175.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.72 133.19 3.52 Favored Glycine 0 N--CA 1.443 -0.89 0 N-CA-C 108.881 -1.688 . . . . 0.45 108.881 -177.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -136.42 -75.82 0.43 Allowed 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 108.431 -0.951 . . . . 0.32 108.431 178.344 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 9.3 t -95.85 4.17 53.06 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.09 0.956 . . . . 1.53 110.753 173.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.508 ' HB1' ' HD2' ' A' ' 46' ' ' PRO . . . -157.92 167.39 14.58 Favored Pre-proline 0 CA--C 1.538 0.488 0 C-N-CA 125.207 1.403 . . . . 0.28 108.181 -169.583 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.508 ' HD2' ' HB1' ' A' ' 45' ' ' ALA . 49.3 Cg_endo -71.03 155.63 61.39 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 122.968 2.446 . . . . 0.23 110.801 -173.623 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.67 123.28 23.75 Favored 'General case' 0 C--N 1.332 -0.176 0 O-C-N 121.589 -0.695 . . . . 0.28 110.57 -176.119 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 45.4 pt -104.46 0.68 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 C-N-CA 123.526 0.73 . . . . 0.32 111.801 179.1 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -41.13 -39.29 1.24 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.971 0.908 . . . . 3.07 112.396 171.414 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 12.4 mtpt -117.73 34.08 5.32 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 125.187 1.395 . . . . 4.12 109.828 -177.339 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.18 -53.59 50.92 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 108.654 -0.869 . . . . 0.45 108.654 171.174 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -56.85 -21.76 38.4 Favored Glycine 0 C--N 1.34 0.765 0 C-N-CA 124.116 0.865 . . . . 0.59 114.247 -178.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -60.91 -38.86 87.22 Favored 'General case' 0 N--CA 1.449 -0.49 0 O-C-N 122.01 -0.7 . . . . 1.38 110.636 174.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 41.3 m-80 -107.55 -58.9 1.9 Allowed 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 124.356 1.062 . . . . 2.96 110.295 -174.271 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -78.37 149.49 33.37 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.391 1.077 . . . . 1.91 110.084 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 29.3 m -94.86 173.94 7.34 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.943 1.297 . . . . 1.64 110.13 176.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.481 ' HG3' ' HB2' ' A' ' 89' ' ' ALA . 3.5 mp0 -56.64 -53.09 61.65 Favored 'General case' 0 N--CA 1.457 -0.098 0 O-C-N 121.761 -0.587 . . . . 2.86 109.825 -176.31 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 35.3 mm-40 -55.38 -32.17 62.39 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.434 0.693 . . . . 4.45 111.816 177.334 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -75.97 -50.9 13.6 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 108.635 -0.876 . . . . 2.55 108.635 -177.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 66.4 mt -62.7 -43.47 98.66 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.133 0 O-C-N 121.431 -0.793 . . . . 0.37 108.89 -178.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 27.0 tp -55.9 -50.34 70.95 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 109.749 -0.463 . . . . 0.33 109.749 176.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -51.72 -51.91 52.46 Favored 'General case' 0 CA--C 1.53 0.21 0 O-C-N 123.057 0.223 . . . . 2.22 110.503 175.295 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 81.2 mt -57.33 -50.47 76.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 O-C-N 121.781 -0.575 . . . . 0.56 109.962 179.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 71.9 mt -53.35 -42.56 48.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 O-C-N 120.522 -1.361 . . . . 0.38 110.306 178.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 68.9 mt -72.23 -32.61 66.89 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 113.736 1.013 . . . . 0.58 113.736 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -122.75 20.06 10.19 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 120.176 1.353 . . . . 1.61 110.387 -167.255 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.591 ' N ' ' HA2' ' A' ' 73' ' ' GLY . . . 31.05 -133.61 0.11 Allowed Glycine 0 CA--C 1.532 1.107 0 C-N-CA 128.621 3.01 . . . . 0.72 111.462 -166.729 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 168.52 130.94 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 119.034 1.417 . . . . 1.54 109.465 -179.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 35.41 -111.97 0.1 OUTLIER Glycine 0 CA--C 1.532 1.147 0 CA-C-N 120.116 1.326 . . . . 0.49 113.815 -171.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -70.92 -20.91 78.07 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 123.367 0.508 . . . . 0.57 113.029 -178.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 19.0 ttt -74.39 120.24 80.48 Favored Pre-proline 0 N--CA 1.45 -0.466 0 C-N-CA 125.15 1.38 . . . . 0.37 110.353 -179.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.616 ' HD2' HD11 ' A' ' 75' ' ' ILE . 34.6 Cg_endo -79.73 121.41 4.6 Favored 'Trans proline' 0 N--CA 1.446 -1.319 0 C-N-CA 122.888 2.392 . . . . 2.03 111.534 -176.364 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.591 ' HA2' ' N ' ' A' ' 67' ' ' GLY . . . -57.06 134.05 52.44 Favored Glycine 0 N--CA 1.444 -0.792 0 N-CA-C 115.275 0.87 . . . . 0.69 115.275 -179.458 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 87.22 38.98 7.54 Favored Glycine 0 CA--C 1.527 0.792 0 CA-C-N 114.353 -0.924 . . . . 0.44 111.709 174.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.616 HD11 ' HD2' ' A' ' 72' ' ' PRO . 2.5 mt -63.79 -59.67 3.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 124.751 1.22 . . . . 1.31 110.22 176.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -104.18 161.36 14.09 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.632 1.173 . . . . 0.27 108.233 165.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 21.5 mttm -145.47 175.92 9.97 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.998 0.919 . . . . 3.51 109.659 173.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 57.94 -153.66 25.23 Favored Glycine 0 CA--C 1.531 1.093 0 CA-C-O 121.45 0.472 . . . . 0.64 112.537 177.167 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -53.39 -29.93 37.26 Favored 'General case' 0 C--N 1.339 0.13 0 C-N-CA 123.955 0.902 . . . . 0.64 111.681 174.079 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -52.42 -61.2 2.43 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 108.612 -0.885 . . . . 2.39 108.612 173.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -63.28 -51.09 67.54 Favored 'General case' 0 CA--C 1.53 0.209 0 O-C-N 122.187 -0.32 . . . . 0.27 111.668 179.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -51.34 -52.64 43.65 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 121.034 0.445 . . . . 2.73 111.67 -178.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -56.45 -48.79 76.29 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 109.788 -0.449 . . . . 0.27 109.788 -179.096 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.514 HG22 HG23 ' A' ' 28' ' ' VAL . 77.6 t -54.81 -49.97 65.06 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 CA-C-O 119.389 -0.339 . . . . 0.35 111.127 176.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -51.71 -54.22 30.64 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 122.757 0.423 . . . . 0.35 111.34 176.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.06 -44.85 95.8 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 121.269 0.557 . . . . 0.36 111.376 -177.4 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.586 ' CE3' HD23 ' A' ' 88' ' ' LEU . 47.9 t90 -60.29 -52.24 66.14 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 121.715 -0.615 . . . . 0.68 109.566 177.694 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.586 HD23 ' CE3' ' A' ' 87' ' ' TRP . 0.1 OUTLIER -55.59 -35.27 65.62 Favored 'General case' 0 C--O 1.222 -0.363 0 C-N-CA 124.068 0.947 . . . . 1.58 110.369 176.602 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.481 ' HB2' ' HG3' ' A' ' 57' ' ' GLU . . . -59.07 -44.69 91.9 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 118.559 0.618 . . . . 0.5 111.803 176.345 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -72.37 -27.88 62.67 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 110.248 -0.279 . . . . 4.27 110.248 173.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 12.3 tptp -69.51 116.4 9.88 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.788 0.835 . . . . 2.41 109.774 -175.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 23.9 mttt . . . . . 0 C--O 1.256 1.444 0 C-N-CA 128.649 2.779 . . . . 2.75 104.232 -178.128 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 . . . . . 0 N--CA 1.45 -0.428 0 N-CA-C 109.261 -0.644 . . . . 2.14 109.261 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -40.82 -55.07 2.54 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 124.096 0.958 . . . . 0.33 110.866 175.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -59.63 -40.37 87.38 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 119.514 -0.279 . . . . 3.09 110.814 -177.332 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.5 -44.78 93.35 Favored 'General case' 0 C--N 1.339 0.125 0 CA-C-N 118.532 0.606 . . . . 0.42 110.678 178.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 93.8 t -58.58 -53.34 48.23 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.219 0 N-CA-C 109.157 -0.683 . . . . 0.44 109.157 176.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 54.2 t -52.28 -48.92 43.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 N-CA-C 110.286 -0.264 . . . . 0.52 110.286 179.099 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 28.8 mm-40 -55.14 -18.45 5.72 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 126.05 1.74 . . . . 0.6 114.041 174.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -150.36 50.65 0.89 Allowed 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 120.046 1.294 . . . . 2.24 112.628 178.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.24 -37.34 0.02 OUTLIER 'General case' 0 C--O 1.225 -0.189 0 C-N-CA 126.056 1.742 . . . . 1.21 110.071 170.068 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 4.5 m -98.81 -52.79 3.48 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 119.431 1.014 . . . . 0.18 111.423 -176.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.5 pp -54.69 -27.4 18.15 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.077 0 CA-C-N 115.878 -0.601 . . . . 0.48 111.763 -177.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.8 m -40.07 -37.04 0.55 Allowed 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 126.392 1.877 . . . . 1.19 112.073 173.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 19.1 m -118.8 -40.08 2.9 Favored 'General case' 0 C--N 1.339 0.15 0 C-N-CA 123.115 0.566 . . . . 0.17 111.927 173.1 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 83.3 m-70 -72.65 -7.57 50.99 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 112.852 0.686 . . . . 0.3 112.852 -175.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 86.12 151.35 17.55 Favored Glycine 0 C--N 1.336 0.579 0 N-CA-C 109.324 -1.51 . . . . 1.51 109.324 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -42.41 -36.62 2.26 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 125.019 1.295 . . . . 0.43 112.928 178.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 44.5 m-20 -102.99 1.34 33.44 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.734 1.214 . . . . 2.18 112.342 -172.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.422 HD22 ' N ' ' A' ' 40' ' ' LEU . 1.9 mm? 64.12 21.67 12.64 Favored 'General case' 0 C--N 1.35 0.595 0 CA-C-N 120.482 1.492 . . . . 3.43 111.415 179.617 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.2 p -84.68 -5.13 59.3 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 127.661 2.384 . . . . 0.32 110.016 179.463 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.27 131.6 3.8 Favored Glycine 0 N--CA 1.439 -1.1 0 N-CA-C 108.954 -1.658 . . . . 0.55 108.954 -177.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -138.39 -79.97 0.34 Allowed 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.021 0.928 . . . . 0.25 109.44 177.183 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 70.9 m -89.12 4.02 49.88 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.638 0.775 . . . . 1.18 111.391 170.228 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -155.85 161.46 29.43 Favored Pre-proline 0 CA--C 1.535 0.373 0 C-N-CA 125.253 1.421 . . . . 0.21 107.823 -170.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -66.96 159.67 50.76 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 123.185 2.59 . . . . 0.23 111.164 -176.154 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.69 126.86 31.28 Favored 'General case' 0 C--N 1.331 -0.214 0 O-C-N 121.447 -0.783 . . . . 0.25 110.603 -175.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 25.4 pt -104.94 0.88 10.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 C-N-CA 123.27 0.628 . . . . 0.49 111.581 177.069 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -34.83 -48.03 0.37 Allowed 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.26 1.424 . . . . 2.46 113.595 172.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 29.5 pttt -106.92 22.76 15.46 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 124.143 0.977 . . . . 4.17 112.017 -176.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -54.94 -42.63 72.54 Favored 'General case' 0 N--CA 1.45 -0.43 0 O-C-N 121.548 -0.72 . . . . 0.38 110.261 -176.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -55.25 -25.77 41.24 Favored Glycine 0 CA--C 1.529 0.943 0 N-CA-C 114.603 0.601 . . . . 0.51 114.603 179.086 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.415 ' HB2' ' HB2' ' A' ' 92' ' ' LYS . . . -84.62 -45.28 12.67 Favored 'General case' 0 CA--C 1.522 -0.119 0 CA-C-N 118.287 1.043 . . . . 0.85 109.561 172.161 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -56.36 -46.75 79.85 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 119.555 -0.259 . . . . 2.24 111.037 -178.062 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -145.38 151.41 38.23 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.738 1.615 . . . . 0.67 108.71 -170.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 84.1 p -78.75 170.72 16.22 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 119.374 0.988 . . . . 2.45 111.422 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -49.69 -44.27 47.95 Favored 'General case' 0 C--O 1.224 -0.274 0 CA-C-O 118.619 -0.705 . . . . 3.05 111.491 174.03 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -56.91 -47.97 79.32 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 118.911 0.778 . . . . 2.4 110.461 178.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -69.51 -47.23 64.5 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 109.129 -0.693 . . . . 3.27 109.129 -174.613 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 52.3 mt -59.0 -48.28 87.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 109.249 -0.649 . . . . 0.33 109.249 179.587 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 41.3 tp -54.82 -50.32 68.86 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 123.668 0.787 . . . . 0.36 109.076 178.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -55.01 -47.86 74.12 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 110.305 -0.258 . . . . 2.28 110.305 175.838 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 46.7 mt -61.47 -33.82 58.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 O-C-N 121.018 -1.051 . . . . 0.61 111.812 178.427 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 75.8 mt -68.77 -48.17 72.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 O-C-N 120.157 -1.589 . . . . 0.23 108.986 175.082 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 92.9 mt -69.37 -31.24 69.51 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.43 1.092 . . . . 0.37 113.177 -176.053 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 22.3 m-20 -121.51 13.72 10.98 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 119.445 1.02 . . . . 1.77 109.735 -168.073 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.528 ' N ' ' HA2' ' A' ' 73' ' ' GLY . . . 40.14 -146.78 0.27 Allowed Glycine 0 CA--C 1.54 1.654 0 C-N-CA 127.604 2.526 . . . . 0.63 111.325 -169.164 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 10.6 tt0 178.29 135.65 0.08 Allowed 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 125.104 1.362 . . . . 1.13 108.596 -177.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 37.77 -114.6 0.3 Allowed Glycine 0 CA--C 1.533 1.198 0 CA-C-N 119.86 1.209 . . . . 0.4 113.361 -172.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -74.77 -20.53 79.46 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 123.289 0.471 . . . . 0.59 113.064 -179.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 21.3 ttt -67.42 119.19 63.53 Favored Pre-proline 0 N--CA 1.452 -0.373 0 C-N-CA 124.269 1.028 . . . . 0.42 110.662 179.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -76.22 123.93 7.52 Favored 'Trans proline' 0 N--CA 1.446 -1.321 0 C-N-CA 122.698 2.265 . . . . 2.15 110.795 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.528 ' HA2' ' N ' ' A' ' 67' ' ' GLY . . . -65.05 141.82 43.94 Favored Glycine 0 N--CA 1.442 -0.958 0 N-CA-C 115.349 0.9 . . . . 0.61 115.349 -176.333 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 78.34 33.42 39.62 Favored Glycine 0 CA--C 1.524 0.649 0 CA-C-N 114.047 -1.077 . . . . 0.35 110.84 175.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -56.53 -49.93 75.33 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 C-N-CA 124.407 1.083 . . . . 1.02 109.022 173.486 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -111.95 154.02 25.89 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.411 1.485 . . . . 0.39 110.409 165.218 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 4.7 mmmt -139.02 158.71 43.71 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.197 1.799 . . . . 3.05 109.896 179.609 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 56.13 -141.04 41.17 Favored Glycine 0 CA--C 1.528 0.892 0 N-CA-C 111.164 -0.775 . . . . 0.75 111.164 178.025 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -51.23 -36.65 42.78 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 117.496 0.648 . . . . 0.93 111.542 176.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -57.15 -37.0 71.41 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 122.892 0.477 . . . . 2.41 110.023 178.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -82.94 -56.6 3.71 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.212 0.605 . . . . 0.35 110.522 176.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -51.93 -52.21 51.68 Favored 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 124.543 1.137 . . . . 3.06 112.076 -176.331 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.04 -47.45 83.07 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 109.644 -0.502 . . . . 0.31 109.644 -177.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 78.9 t -59.01 -56.37 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 C-N-CA 122.895 0.478 . . . . 0.27 110.532 178.387 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -47.78 -56.12 8.11 Favored 'General case' 0 C--O 1.226 -0.146 0 C-N-CA 123.369 0.668 . . . . 0.18 111.296 177.151 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.77 -45.75 92.54 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.371 0.669 . . . . 0.36 110.887 -176.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 79.1 t90 -57.04 -52.41 65.39 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 121.713 -0.617 . . . . 0.6 109.722 177.295 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.74 -31.08 71.23 Favored 'General case' 0 C--O 1.223 -0.32 0 CA-C-O 118.603 -0.713 . . . . 1.89 112.654 175.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.08 -26.57 60.62 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 119.491 1.041 . . . . 0.75 111.534 172.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -90.81 -29.67 17.45 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 112.938 0.718 . . . . 4.93 112.938 171.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 19.7 mtpp -74.64 103.95 5.13 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 119.721 1.146 . . . . 3.04 110.633 174.227 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.415 ' HB2' ' HB2' ' A' ' 53' ' ' ALA . 20.2 pttt . . . . . 0 C--O 1.25 1.11 0 C-N-CA 126.298 1.839 . . . . 2.75 106.354 -175.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.9 t70 . . . . . 0 N--CA 1.451 -0.398 0 N-CA-C 109.307 -0.627 . . . . 3.83 109.307 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -52.9 -45.03 67.35 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 123.921 0.888 . . . . 0.42 111.608 -178.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -64.48 -48.91 73.43 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 108.195 -1.039 . . . . 3.33 108.195 -176.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.97 -47.61 74.33 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 123.44 0.696 . . . . 0.31 111.333 177.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 74.1 t -55.97 -55.64 17.05 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.12 0 N-CA-C 109.525 -0.546 . . . . 0.41 109.525 177.148 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.574 HG22 ' SG ' ' A' ' 32' ' ' CYS . 5.6 t -54.75 -49.4 68.91 Favored 'Isoleucine or valine' 0 C--O 1.239 0.525 0 CA-C-N 117.851 0.296 . . . . 0.38 111.265 -178.33 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.402 ' HA ' HG12 ' A' ' 33' ' ' ILE . 35.8 mm-40 -52.65 -14.86 0.58 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 126.732 2.013 . . . . 0.47 112.984 173.554 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.77 47.76 1.64 Allowed 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 119.469 1.031 . . . . 3.72 111.514 173.17 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.71 -42.7 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.16 0 O-C-N 121.915 -0.49 . . . . 1.18 110.485 169.205 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.574 ' SG ' HG22 ' A' ' 28' ' ' VAL . 3.6 m -93.36 -48.45 6.41 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 118.284 0.493 . . . . 0.16 110.026 -173.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.402 HG12 ' HA ' ' A' ' 29' ' ' GLN . 2.4 pp -51.65 -31.61 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 CA-C-N 115.977 -0.556 . . . . 0.54 111.962 -179.302 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 20.0 m -38.47 -37.31 0.3 Allowed 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 125.748 1.619 . . . . 1.06 112.73 173.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 21.5 m -121.3 -40.01 2.63 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 123.069 0.548 . . . . 0.19 112.009 173.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 82.2 m-70 -71.79 -7.66 49.57 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.616 0.766 . . . . 0.22 112.755 -177.197 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 84.44 148.29 9.16 Favored Glycine 0 C--N 1.337 0.602 0 N-CA-C 109.296 -1.522 . . . . 1.49 109.296 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -41.69 -35.11 1.35 Allowed Glycine 0 CA--C 1.527 0.843 0 C-N-CA 124.73 1.157 . . . . 0.49 112.496 174.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -95.39 -8.48 35.51 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 124.961 1.305 . . . . 2.38 111.264 -169.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.3 mt 72.33 6.89 5.6 Favored 'General case' 0 C--N 1.348 0.534 0 CA-C-N 120.136 1.334 . . . . 1.28 111.398 178.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 16.0 p -83.92 0.27 48.48 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 127.176 2.19 . . . . 0.39 110.102 -175.579 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.09 150.03 21.56 Favored Glycine 0 N--CA 1.436 -1.339 0 N-CA-C 108.855 -1.698 . . . . 0.53 108.855 -173.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -156.33 -78.03 0.09 Allowed 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 124.609 1.164 . . . . 0.26 108.863 177.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.0 m -97.37 2.63 50.77 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.448 1.099 . . . . 1.33 111.216 170.063 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -148.14 162.05 32.19 Favored Pre-proline 0 CA--C 1.535 0.372 0 C-N-CA 126.999 2.12 . . . . 0.43 107.159 -176.191 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -71.26 163.15 40.13 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 123.219 2.613 . . . . 0.25 111.203 -176.135 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -74.93 113.58 12.4 Favored 'General case' 0 C--N 1.332 -0.19 0 O-C-N 121.73 -0.607 . . . . 0.3 111.235 -174.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 48.1 pt -97.07 0.66 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 C-N-CA 123.307 0.643 . . . . 0.29 111.797 178.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -48.88 -34.9 13.54 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.154 0.581 . . . . 3.34 112.319 176.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.2 pttm -115.43 38.66 3.18 Favored 'General case' 0 C--N 1.343 0.311 0 C-N-CA 124.82 1.248 . . . . 3.43 111.216 175.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.73 -55.75 20.87 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 108.076 -1.083 . . . . 0.48 108.076 168.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -54.08 -27.0 36.91 Favored Glycine 0 C--N 1.339 0.717 0 C-N-CA 124.675 1.131 . . . . 0.64 113.695 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.95 -38.44 75.97 Favored 'General case' 0 N--CA 1.449 -0.488 0 O-C-N 121.957 -0.731 . . . . 1.45 111.446 175.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 47.3 m-80 -107.85 -57.73 2.06 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 124.318 1.047 . . . . 2.9 110.819 -174.166 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -89.51 149.47 22.89 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 125.086 1.354 . . . . 0.8 109.06 -174.297 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 60.7 m -94.29 164.11 13.16 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 122.961 0.505 . . . . 1.49 110.643 179.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.1 tm-20 -40.9 -64.39 0.54 Allowed 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.023 1.329 . . . . 5.66 111.002 178.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -41.12 -47.02 3.14 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.936 1.294 . . . . 4.11 112.905 174.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 61.1 mm-40 -69.55 -47.27 64.25 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 122.23 1.014 . . . . 3.33 108.573 -174.456 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 61.5 mt -61.46 -44.18 98.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-N 115.948 -0.569 . . . . 0.27 109.503 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 35.3 tp -55.31 -53.39 56.77 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 124.366 1.066 . . . . 0.38 109.163 175.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -49.72 -52.31 32.32 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 117.992 0.36 . . . . 1.53 110.389 175.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 87.4 mt -60.31 -37.65 74.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 119.744 -0.783 . . . . 0.48 111.557 179.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 60.5 mt -61.53 -46.81 95.78 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 O-C-N 120.041 -1.662 . . . . 0.32 109.851 173.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 85.6 mt -67.14 -32.17 73.1 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 117.179 -1.391 . . . . 0.48 114.479 -171.205 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -139.05 30.57 2.22 Favored 'General case' 0 C--N 1.344 0.362 0 CA-C-N 120.191 1.359 . . . . 3.22 110.112 -171.119 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 35.08 -141.28 0.13 Allowed Glycine 0 CA--C 1.542 1.754 0 C-N-CA 128.122 2.772 . . . . 0.65 112.81 -175.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 172.46 136.45 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.58 1.552 . . . . 1.82 108.022 -175.283 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 28.83 -106.7 0.01 OUTLIER Glycine 0 CA--C 1.534 1.222 0 C-N-CA 125.519 1.533 . . . . 0.44 114.785 -176.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -66.07 -27.27 72.75 Favored Glycine 0 CA--C 1.537 1.428 0 CA-C-N 117.769 0.784 . . . . 0.68 113.562 -178.479 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 15.8 ttt -76.47 123.04 87.69 Favored Pre-proline 0 CA--C 1.54 0.567 0 C-N-CA 125.888 1.675 . . . . 0.43 110.683 -178.126 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -62.32 -56.66 0.63 Allowed 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 124.462 3.441 . . . . 3.0 111.781 -168.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 118.24 144.92 7.72 Favored Glycine 0 N--CA 1.449 -0.482 0 CA-C-N 115.795 -0.639 . . . . 0.9 114.228 172.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 67.82 26.79 73.76 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.907 -0.877 . . . . 0.36 110.907 -174.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 2.0 mm -52.01 -51.88 26.92 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 124.561 1.144 . . . . 2.13 110.11 177.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -112.27 159.42 18.64 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.478 1.111 . . . . 0.42 108.974 161.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 21.3 mttp -146.01 158.09 43.87 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.35 1.06 . . . . 3.66 110.147 175.057 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 64.67 -153.35 49.66 Favored Glycine 0 CA--C 1.53 0.992 0 N-CA-C 111.343 -0.703 . . . . 0.84 111.343 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -45.61 -38.6 6.75 Favored 'General case' 0 C--N 1.34 0.186 0 C-N-CA 124.855 1.262 . . . . 0.63 112.154 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -50.51 -52.93 34.04 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.423 1.089 . . . . 2.15 110.396 175.006 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -71.32 -48.0 53.19 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.649 0.78 . . . . 0.25 110.853 179.261 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -53.97 -50.67 66.02 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.826 0.85 . . . . 2.67 110.708 -176.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -55.19 -49.54 71.64 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 123.071 0.548 . . . . 0.26 110.286 178.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.495 HG22 HG23 ' A' ' 28' ' ' VAL . 53.8 t -58.12 -52.9 52.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 CA-C-O 119.343 -0.36 . . . . 0.39 110.986 178.499 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -49.26 -52.49 27.01 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 123.341 0.656 . . . . 0.2 111.452 176.55 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.75 -51.88 67.45 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 121.46 0.648 . . . . 0.33 110.215 -177.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.535 ' CE3' HD23 ' A' ' 88' ' ' LEU . 48.9 t90 -54.84 -43.18 72.82 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 122.757 0.423 . . . . 0.52 110.69 177.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.535 HD23 ' CE3' ' A' ' 87' ' ' TRP . 0.1 OUTLIER -65.96 -37.73 86.76 Favored 'General case' 0 C--O 1.227 -0.118 0 C-N-CA 124.504 1.121 . . . . 1.64 110.712 178.271 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -52.96 -42.75 65.79 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 119.0 0.818 . . . . 0.48 109.55 171.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -85.79 21.6 1.85 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.439 1.095 . . . . 4.17 112.405 175.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 4.7 mtpm? -116.68 139.43 50.56 Favored 'General case' 0 C--N 1.342 0.253 0 CA-C-O 122.256 1.027 . . . . 2.41 109.956 167.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 53.2 mttm . . . . . 0 C--O 1.25 1.116 0 C-N-CA 129.206 3.002 . . . . 3.42 103.152 177.606 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 . . . . . 0 N--CA 1.449 -0.497 0 N-CA-C 108.475 -0.935 . . . . 2.38 108.475 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -41.15 -54.54 2.86 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 124.554 1.141 . . . . 0.31 110.708 175.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -58.39 -46.77 85.72 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 115.805 -0.634 . . . . 3.16 110.272 -178.128 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.2 -44.51 92.24 Favored 'General case' 0 C--N 1.34 0.159 0 C-N-CA 123.125 0.57 . . . . 0.31 111.147 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 77.8 t -57.81 -56.88 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 N-CA-C 109.279 -0.638 . . . . 0.33 109.279 175.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.724 HG11 HD21 ' A' ' 40' ' ' LEU . 71.7 t -54.0 -48.65 63.71 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 CA-C-N 117.933 0.333 . . . . 0.35 110.494 -176.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.404 ' HA ' HG12 ' A' ' 33' ' ' ILE . 28.0 mm-40 -47.94 -24.69 1.1 Allowed 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 126.261 1.824 . . . . 0.64 112.872 174.532 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -141.26 51.56 1.58 Allowed 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 119.144 0.884 . . . . 2.6 111.642 173.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.68 -36.63 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 124.319 1.048 . . . . 1.22 111.211 166.722 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.699 ' HB2' HG13 ' A' ' 28' ' ' VAL . 3.8 m -101.89 -50.87 3.55 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 119.159 0.89 . . . . 0.23 110.954 -174.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.404 HG12 ' HA ' ' A' ' 29' ' ' GLN . 2.2 pp -54.41 -29.37 19.92 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.082 0 CA-C-N 116.369 -0.378 . . . . 0.41 111.949 -176.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 10.0 m -35.26 -41.71 0.17 Allowed 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 125.507 1.523 . . . . 1.08 112.81 171.179 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 22.4 m -114.86 -35.63 4.73 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.294 0.638 . . . . 0.15 111.839 174.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 89.4 m-70 -80.66 2.09 27.28 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.226 1.01 . . . . 0.4 113.314 -175.314 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 107.78 -80.96 0.28 Allowed Glycine 0 CA--C 1.525 0.668 0 C-N-CA 125.747 1.641 . . . . 2.9 111.785 165.149 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -175.24 -52.51 0.06 OUTLIER Glycine 0 CA--C 1.519 0.304 0 N-CA-C 108.441 -1.864 . . . . 0.9 108.441 -171.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -97.71 4.6 49.94 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 124.452 1.101 . . . . 3.32 111.076 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.724 HD21 HG11 ' A' ' 28' ' ' VAL . 1.2 mt 76.15 14.33 2.51 Favored 'General case' 0 C--N 1.351 0.661 0 CA-C-N 119.85 1.205 . . . . 1.75 110.007 -179.618 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.0 p -76.27 -13.37 60.16 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 128.11 2.564 . . . . 0.61 109.822 -178.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.98 154.02 30.62 Favored Glycine 0 N--CA 1.442 -0.9 0 N-CA-C 108.449 -1.86 . . . . 0.68 108.449 -178.356 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -156.8 -76.89 0.09 Allowed 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.457 -0.572 . . . . 0.29 109.457 177.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 19.6 t -93.55 4.17 54.37 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 122.854 0.462 . . . . 1.54 110.483 172.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -157.53 163.01 26.25 Favored Pre-proline 0 N--CA 1.448 -0.56 0 C-N-CA 126.242 1.817 . . . . 0.3 107.195 -166.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -67.72 162.85 37.6 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 123.044 2.496 . . . . 0.27 111.193 -172.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -76.03 122.32 24.05 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 122.95 0.5 . . . . 0.27 109.693 -178.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 47.9 pt -107.95 2.79 9.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 123.739 0.816 . . . . 0.48 112.063 178.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.444 ' OD1' ' NZ ' ' A' ' 91' ' ' LYS . 28.4 t70 -45.25 -45.99 12.24 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 113.125 0.787 . . . . 2.79 113.125 175.475 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.5 mptp? -100.92 26.62 6.74 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.999 1.32 . . . . 6.21 109.837 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -52.9 -45.6 67.61 Favored 'General case' 0 N--CA 1.453 -0.277 0 O-C-N 121.345 -0.847 . . . . 0.28 109.318 177.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -54.84 -22.26 26.1 Favored Glycine 0 CA--C 1.528 0.883 0 N-CA-C 115.021 0.768 . . . . 0.61 115.021 177.047 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -81.54 -36.01 29.64 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 118.387 1.093 . . . . 0.97 110.513 174.021 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -76.55 -48.55 18.96 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 123.08 0.552 . . . . 1.95 111.003 -178.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -141.21 143.97 34.47 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.699 1.6 . . . . 0.76 107.756 -167.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 69.7 m -83.91 169.86 14.62 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 119.57 1.077 . . . . 1.74 111.096 178.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -51.03 -43.68 60.94 Favored 'General case' 0 C--O 1.222 -0.376 0 CA-C-O 118.602 -0.713 . . . . 2.73 112.681 -175.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -52.66 -45.69 66.84 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 119.057 0.844 . . . . 2.66 111.055 176.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -71.17 -51.01 27.3 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 108.96 -0.756 . . . . 3.48 108.96 -176.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 71.5 mt -58.11 -44.9 88.36 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 N-CA-C 108.765 -0.828 . . . . 0.21 108.765 -177.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 19.4 tp -56.27 -51.03 69.67 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 124.47 1.108 . . . . 0.67 109.401 177.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -53.92 -48.62 70.0 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 117.832 0.287 . . . . 1.46 111.345 175.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 93.0 mt -55.53 -54.88 20.8 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.211 0 O-C-N 121.526 -0.733 . . . . 0.7 109.443 177.262 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 52.2 mt -50.68 -46.54 28.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 O-C-N 120.807 -1.183 . . . . 0.2 110.154 178.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 61.3 mt -64.17 -31.72 73.02 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 117.685 -1.15 . . . . 0.6 113.541 178.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -131.63 20.09 4.69 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 120.278 1.399 . . . . 1.81 111.109 -163.308 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 29.41 -141.0 0.02 OUTLIER Glycine 0 CA--C 1.543 1.809 0 C-N-CA 127.295 2.379 . . . . 0.67 113.048 -160.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 37.4 tt0 174.63 141.72 0.05 OUTLIER 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 126.198 1.799 . . . . 1.85 106.977 -176.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 22.25 -100.39 0.01 OUTLIER Glycine 0 CA--C 1.535 1.328 0 C-N-CA 126.094 1.807 . . . . 0.61 114.822 -173.378 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -68.31 -34.08 79.31 Favored Glycine 0 CA--C 1.539 1.553 0 CA-C-N 118.802 1.301 . . . . 0.78 113.485 -178.167 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -55.55 130.99 71.13 Favored Pre-proline 0 CA--C 1.539 0.538 0 C-N-CA 124.044 0.938 . . . . 0.75 112.282 176.616 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -63.8 -57.23 0.38 Allowed 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 123.895 3.063 . . . . 3.03 110.857 178.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 116.74 146.68 8.52 Favored Glycine 0 C--N 1.335 0.497 0 C-N-CA 124.194 0.902 . . . . 0.83 113.761 173.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 69.45 24.56 76.07 Favored Glycine 0 CA--C 1.529 0.952 0 N-CA-C 111.558 -0.617 . . . . 0.46 111.558 -179.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.7 mt -52.61 -58.49 2.59 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 C-N-CA 126.212 1.805 . . . . 1.13 110.982 179.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -103.48 158.33 16.43 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.162 0.985 . . . . 0.39 108.967 162.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 4.9 mmtp -145.12 166.36 25.63 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.574 1.55 . . . . 2.96 108.783 179.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 56.94 -147.51 33.75 Favored Glycine 0 CA--C 1.532 1.135 0 O-C-N 121.741 -0.599 . . . . 0.67 112.491 176.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -50.23 -36.94 33.09 Favored 'General case' 0 C--N 1.34 0.186 0 C-N-CA 123.809 0.843 . . . . 0.74 111.255 175.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -52.78 -51.55 60.24 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.802 0.841 . . . . 2.02 109.599 176.16 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -69.51 -52.05 30.11 Favored 'General case' 0 CA--C 1.53 0.209 0 O-C-N 122.035 -0.416 . . . . 0.28 111.477 177.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -50.77 -56.23 13.04 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 123.117 0.567 . . . . 2.59 111.547 -177.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -55.38 -50.0 70.85 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 109.686 -0.487 . . . . 0.39 109.686 -175.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.582 HG22 HG23 ' A' ' 28' ' ' VAL . 54.4 t -55.26 -56.59 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 C-N-CA 123.006 0.522 . . . . 0.32 111.395 176.745 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -52.6 -50.88 62.18 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.343 0.657 . . . . 0.3 111.267 -178.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.79 -47.63 85.43 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.111 0.564 . . . . 0.39 110.365 -179.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.55 ' CE3' HD23 ' A' ' 88' ' ' LEU . 53.5 t90 -56.73 -50.44 72.21 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 121.991 -0.443 . . . . 0.51 110.164 177.31 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.55 HD23 ' CE3' ' A' ' 87' ' ' TRP . 0.1 OUTLIER -60.77 -34.93 75.21 Favored 'General case' 0 C--O 1.226 -0.184 0 C-N-CA 124.31 1.044 . . . . 1.65 110.802 177.548 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -67.09 -40.74 87.02 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 118.187 0.448 . . . . 0.73 110.978 176.011 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -61.39 -40.17 93.36 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 122.856 0.462 . . . . 4.11 110.643 171.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.444 ' NZ ' ' OD1' ' A' ' 49' ' ' ASP . 0.0 OUTLIER -73.31 105.66 4.8 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 121.527 -0.733 . . . . 2.1 110.169 178.983 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.163 0 CA-C-O 117.578 -1.201 . . . . 2.82 109.559 -177.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.446 -0.66 0 N-CA-C 108.153 -1.055 . . . . 2.24 108.153 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -41.07 -55.14 2.66 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.747 1.219 . . . . 0.28 111.519 177.197 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -51.87 -46.91 64.67 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 123.157 0.583 . . . . 2.98 111.785 176.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.67 -45.65 89.14 Favored 'General case' 0 N--CA 1.457 -0.104 0 CA-C-N 118.442 0.564 . . . . 0.26 110.442 -177.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 72.8 t -57.07 -57.71 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 N-CA-C 109.007 -0.738 . . . . 0.34 109.007 175.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.518 HG23 HG22 ' A' ' 84' ' ' VAL . 25.6 t -47.92 -50.83 9.58 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 C-N-CA 124.305 1.042 . . . . 0.42 110.64 -178.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.434 ' HA ' HG12 ' A' ' 33' ' ' ILE . 30.8 mm-40 -53.1 -25.21 12.21 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 125.811 1.645 . . . . 0.57 113.398 176.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 11.0 mt-30 -137.69 59.37 1.67 Allowed 'General case' 0 N--CA 1.456 -0.14 0 CA-C-N 119.309 0.959 . . . . 2.25 111.719 172.11 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 5.1 mttt -172.2 -36.46 0.01 OUTLIER 'General case' 0 C--O 1.224 -0.249 0 C-N-CA 124.204 1.002 . . . . 2.15 110.322 168.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 4.0 m -101.22 -52.62 3.21 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 119.426 1.012 . . . . 0.16 111.312 -177.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.434 HG12 ' HA ' ' A' ' 29' ' ' GLN . 2.2 pp -55.83 -26.66 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.095 0 CA-C-N 115.99 -0.55 . . . . 0.44 111.614 -177.376 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.1 t -40.17 -36.03 0.46 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.37 1.468 . . . . 1.88 111.83 173.563 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 32.9 m -118.78 -40.06 2.91 Favored 'General case' 0 C--N 1.342 0.259 0 C-N-CA 123.539 0.736 . . . . 0.17 111.908 174.425 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 87.1 m-70 -75.89 -7.11 53.75 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 113.171 0.804 . . . . 0.26 113.171 -174.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 86.26 150.26 15.46 Favored Glycine 0 C--N 1.337 0.625 0 N-CA-C 110.034 -1.227 . . . . 1.55 110.034 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -43.56 -39.19 4.41 Favored Glycine 0 C--N 1.34 0.801 0 C-N-CA 124.76 1.172 . . . . 0.42 112.338 178.259 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -97.65 -0.83 44.91 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 124.366 1.066 . . . . 2.21 110.959 -171.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.2 mp 67.41 15.8 9.93 Favored 'General case' 0 C--N 1.349 0.558 0 CA-C-N 120.11 1.323 . . . . 1.5 111.432 176.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 6.9 p -83.43 -1.73 54.18 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 128.132 2.573 . . . . 0.33 109.906 -178.008 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.98 144.71 9.72 Favored Glycine 0 N--CA 1.438 -1.174 0 N-CA-C 108.552 -1.819 . . . . 0.41 108.552 -175.076 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -150.15 -80.38 0.12 Allowed 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 124.406 1.083 . . . . 0.25 108.939 177.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 58.7 m -91.56 3.64 54.52 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.812 0.845 . . . . 1.16 111.422 170.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -154.38 163.41 24.27 Favored Pre-proline 0 N--CA 1.45 -0.469 0 C-N-CA 125.88 1.672 . . . . 0.25 107.197 -172.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -68.27 163.89 34.53 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.618 2.212 . . . . 0.4 110.877 -176.257 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -74.27 122.74 23.33 Favored 'General case' 0 N--CA 1.455 -0.193 0 O-C-N 121.931 -0.481 . . . . 0.24 110.306 -177.047 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 35.3 pt -105.78 0.88 10.16 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.181 0 C-N-CA 123.713 0.805 . . . . 0.32 110.917 177.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -39.32 -45.41 1.43 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.059 0.944 . . . . 2.4 112.409 169.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.59 15.97 21.81 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.129 0.972 . . . . 4.74 111.13 -175.18 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -56.39 -47.28 79.26 Favored 'General case' 0 N--CA 1.452 -0.326 0 O-C-N 121.198 -0.939 . . . . 0.33 110.069 -171.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -54.7 -26.62 40.21 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 114.447 0.539 . . . . 0.47 114.447 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -80.55 -42.05 23.06 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 117.815 0.808 . . . . 0.69 109.827 175.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 52.8 m-80 -63.5 -52.51 60.93 Favored 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 122.499 0.32 . . . . 1.53 110.906 179.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -138.1 145.88 42.21 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 125.956 1.702 . . . . 0.72 108.479 -167.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -79.96 170.82 15.94 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.543 0.737 . . . . 1.9 110.571 -178.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -49.94 -46.53 52.29 Favored 'General case' 0 C--O 1.225 -0.185 0 C-N-CA 124.079 0.952 . . . . 2.67 111.615 177.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -58.91 -29.72 67.28 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.237 0.615 . . . . 2.84 112.093 179.369 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -86.7 -48.0 8.65 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.0 -0.741 . . . . 3.41 109.0 -178.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 98.7 mt -61.36 -43.91 97.52 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 O-C-N 121.714 -0.616 . . . . 0.31 109.461 -179.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 60.0 tp -52.57 -51.06 61.58 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 109.197 -0.668 . . . . 0.47 109.197 175.195 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -58.51 -44.52 89.51 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 110.113 -0.329 . . . . 1.62 110.113 178.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 78.8 mt -60.2 -36.52 68.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 O-C-N 121.104 -0.997 . . . . 0.5 111.498 176.048 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 50.9 mt -67.41 -49.37 72.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 O-C-N 120.03 -1.669 . . . . 0.28 109.42 176.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 80.7 mt -66.74 -29.64 69.67 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 124.639 1.175 . . . . 0.37 113.154 -175.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 14.3 m-80 -124.1 11.57 8.87 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 119.789 1.177 . . . . 1.77 110.157 -170.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.597 ' N ' ' HA2' ' A' ' 73' ' ' GLY . . . 43.12 -147.4 0.81 Allowed Glycine 0 CA--C 1.539 1.571 0 C-N-CA 126.623 2.059 . . . . 0.63 110.833 -171.465 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 170.45 135.49 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 119.524 1.662 . . . . 1.18 110.82 -178.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 43.63 -122.14 3.83 Favored Glycine 0 CA--C 1.532 1.149 0 O-C-N 120.685 -1.259 . . . . 0.41 112.474 -173.088 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -69.08 -17.83 72.26 Favored Glycine 0 CA--C 1.531 1.046 0 O-C-N 122.483 -0.422 . . . . 0.5 112.886 179.34 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 20.8 ttt -73.95 119.73 77.68 Favored Pre-proline 0 N--CA 1.451 -0.42 0 C-N-CA 123.838 0.855 . . . . 0.4 111.486 -178.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.438 ' HD2' HD11 ' A' ' 75' ' ' ILE . 41.8 Cg_endo -78.08 120.88 5.14 Favored 'Trans proline' 0 N--CA 1.448 -1.172 0 C-N-CA 122.884 2.389 . . . . 2.13 112.031 -177.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.597 ' HA2' ' N ' ' A' ' 67' ' ' GLY . . . -57.84 135.5 51.7 Favored Glycine 0 N--CA 1.445 -0.711 0 N-CA-C 116.421 1.328 . . . . 0.6 116.421 -177.712 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 81.15 36.91 20.0 Favored Glycine 0 C--N 1.337 0.609 0 CA-C-N 114.124 -1.038 . . . . 0.34 111.454 173.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.438 HD11 ' HD2' ' A' ' 72' ' ' PRO . 1.3 mt -57.96 -57.0 12.39 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 124.876 1.27 . . . . 1.11 109.942 175.417 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -105.7 161.56 14.29 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.06 1.344 . . . . 0.31 109.508 167.16 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.0 mmtp -142.87 161.7 37.42 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.377 1.471 . . . . 2.45 110.466 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 55.55 -146.5 30.13 Favored Glycine 0 CA--C 1.531 1.04 0 O-C-N 121.596 -0.69 . . . . 0.72 111.437 179.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -54.55 -28.91 49.04 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 117.157 0.479 . . . . 0.72 111.814 175.006 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -56.54 -39.08 72.78 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 109.827 -0.434 . . . . 2.29 109.827 174.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -82.41 -52.43 6.9 Favored 'General case' 0 CA--C 1.53 0.208 0 O-C-N 121.738 -0.601 . . . . 0.24 110.963 174.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -58.44 -48.67 79.96 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 122.87 0.468 . . . . 2.32 112.077 -173.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.74 -48.15 80.43 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 109.363 -0.606 . . . . 0.22 109.363 179.31 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.518 HG22 HG23 ' A' ' 28' ' ' VAL . 49.6 t -55.38 -55.2 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 C-N-CA 123.065 0.546 . . . . 0.28 110.952 177.582 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -52.48 -53.48 45.14 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 123.313 0.645 . . . . 0.18 111.483 178.282 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.7 -48.61 81.0 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 121.772 0.796 . . . . 0.27 110.934 -178.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 83.6 t90 -57.22 -47.84 80.3 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 123.466 0.707 . . . . 0.59 110.084 178.427 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.02 -31.21 72.31 Favored 'General case' 0 C--O 1.221 -0.398 0 CA-C-O 118.167 -0.921 . . . . 1.9 112.649 173.359 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -56.39 -43.08 78.92 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 119.76 1.164 . . . . 0.34 109.898 171.068 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -68.0 -36.93 80.81 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 118.344 -0.836 . . . . 3.54 112.585 171.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 15.3 mtpp -72.11 113.43 9.13 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 120.35 1.432 . . . . 2.81 110.847 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 77.3 mttt . . . . . 0 C--O 1.254 1.337 0 N-CA-C 104.953 -2.24 . . . . 2.5 104.953 179.767 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 . . . . . 0 N--CA 1.45 -0.473 0 N-CA-C 108.312 -0.996 . . . . 2.17 108.312 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -39.02 -54.26 1.7 Allowed 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 125.387 1.475 . . . . 0.35 112.046 175.173 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -54.58 -48.86 71.59 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 116.108 -0.496 . . . . 2.69 111.26 177.058 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.1 -36.57 82.14 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 118.96 0.8 . . . . 0.51 111.932 -178.748 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 56.2 t -62.78 -58.46 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 N-CA-C 109.032 -0.729 . . . . 0.34 109.032 172.809 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.693 HG22 ' SG ' ' A' ' 32' ' ' CYS . 21.0 t -53.55 -48.71 58.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 C-N-CA 123.255 0.622 . . . . 0.37 110.757 -175.738 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.462 ' HA ' HG12 ' A' ' 33' ' ' ILE . 28.3 mm-40 -49.35 -21.92 0.99 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 126.495 1.918 . . . . 0.52 112.811 174.49 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -130.75 26.1 5.01 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.727 0.811 . . . . 4.96 111.59 -179.807 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.3 mppp? -148.96 -66.85 0.22 Allowed 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 109.151 -0.685 . . . . 1.76 109.151 171.718 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.693 ' SG ' HG22 ' A' ' 28' ' ' VAL . 2.0 m -71.76 -47.53 53.0 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.93 -0.396 . . . . 0.22 109.93 -168.926 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.462 HG12 ' HA ' ' A' ' 29' ' ' GLN . 2.0 pp -56.12 -26.37 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.075 0 N-CA-C 111.899 0.333 . . . . 0.37 111.899 -178.046 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.3 t -46.32 -36.0 5.89 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.376 1.071 . . . . 1.92 110.699 177.727 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 28.9 m -116.82 -44.13 2.84 Favored 'General case' 0 C--N 1.34 0.178 0 C-N-CA 123.286 0.635 . . . . 0.2 111.267 175.959 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 85.9 m-70 -71.09 -8.41 53.25 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.906 0.883 . . . . 0.22 112.564 -176.194 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 88.25 152.19 24.03 Favored Glycine 0 C--N 1.337 0.606 0 N-CA-C 109.707 -1.357 . . . . 1.51 109.707 178.235 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -39.39 -39.43 1.13 Allowed Glycine 0 CA--C 1.528 0.877 0 C-N-CA 125.366 1.46 . . . . 0.42 112.9 179.11 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -105.74 2.21 27.74 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.216 1.406 . . . . 2.23 112.241 -170.822 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.411 HD22 ' N ' ' A' ' 40' ' ' LEU . 1.8 mm? 64.88 23.04 12.59 Favored 'General case' 0 C--N 1.348 0.531 0 CA-C-N 120.493 1.497 . . . . 3.53 111.127 -179.731 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.7 p -85.55 -3.73 58.95 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 128.23 2.612 . . . . 0.39 109.992 179.277 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.52 139.75 5.68 Favored Glycine 0 N--CA 1.441 -0.969 0 N-CA-C 109.037 -1.625 . . . . 0.45 109.037 -174.387 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -145.4 -73.87 0.24 Allowed 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 107.813 -1.18 . . . . 0.39 107.813 176.355 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.1 t -100.16 4.62 44.56 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.307 1.443 . . . . 1.48 111.169 173.233 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -156.63 162.81 26.84 Favored Pre-proline 0 CA--C 1.537 0.451 0 C-N-CA 126.289 1.836 . . . . 0.31 108.004 -168.773 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.22 153.16 40.54 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 123.271 2.647 . . . . 0.39 111.414 -173.928 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -75.16 109.27 8.51 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.864 0.866 . . . . 0.6 113.097 -170.136 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 43.7 pt -91.45 1.06 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 C-N-CA 125.8 1.64 . . . . 0.34 111.793 -178.683 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -32.34 -48.59 0.18 Allowed 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 127.061 2.144 . . . . 2.79 113.044 164.226 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.51 36.83 3.25 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.955 0.902 . . . . 4.96 111.537 176.328 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.11 -52.54 58.66 Favored 'General case' 0 N--CA 1.454 -0.257 0 O-C-N 121.146 -0.971 . . . . 0.41 108.849 176.236 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -52.33 -27.1 23.62 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 124.187 0.899 . . . . 0.54 114.021 177.496 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.19 -38.24 88.37 Favored 'General case' 0 N--CA 1.452 -0.355 0 O-C-N 121.461 -1.023 . . . . 1.13 110.548 176.63 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 34.4 m-80 -103.83 -61.78 1.39 Allowed 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.798 1.239 . . . . 2.35 109.835 -171.5 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -91.93 136.13 33.4 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.007 1.323 . . . . 0.62 109.0 -174.896 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.7 t -80.69 166.91 20.6 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 118.102 0.41 . . . . 1.85 110.632 -179.928 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -43.72 -55.85 4.16 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 124.384 1.074 . . . . 4.9 109.856 177.352 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -57.01 -35.61 69.44 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.665 0.786 . . . . 3.34 111.359 -176.187 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -74.15 -49.05 25.38 Favored 'General case' 0 C--N 1.343 0.302 0 O-C-N 121.243 -0.911 . . . . 2.91 110.295 177.002 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 73.3 mt -58.56 -41.05 80.91 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.141 0 N-CA-C 108.375 -0.972 . . . . 0.29 108.375 -177.538 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 27.0 tp -55.22 -54.58 41.65 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 123.759 0.823 . . . . 0.33 110.171 174.115 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -50.98 -48.02 61.33 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 118.104 0.411 . . . . 1.72 111.498 176.521 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 93.1 mt -59.01 -55.77 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 O-C-N 121.54 -0.725 . . . . 0.72 109.767 177.197 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 56.5 mt -47.61 -46.08 10.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 O-C-N 121.276 -0.89 . . . . 0.22 110.192 178.976 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 69.5 mt -66.31 -36.4 82.84 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 113.503 0.927 . . . . 0.52 113.503 178.537 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -127.65 27.35 5.79 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 120.085 1.312 . . . . 1.84 110.418 -161.994 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 20.38 -130.47 0.01 OUTLIER Glycine 0 CA--C 1.539 1.585 0 C-N-CA 127.764 2.602 . . . . 0.65 112.749 -159.592 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 165.62 136.04 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 126.801 2.04 . . . . 1.17 107.707 -176.768 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 27.57 -108.42 0.01 OUTLIER Glycine 0 CA--C 1.535 1.286 0 C-N-CA 126.053 1.787 . . . . 0.39 114.714 -172.603 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -62.93 -28.22 71.59 Favored Glycine 0 CA--C 1.534 1.279 0 CA-C-N 117.694 0.747 . . . . 0.55 113.467 -178.443 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 6.5 ttt -70.86 126.0 92.08 Favored Pre-proline 0 CA--C 1.539 0.547 0 C-N-CA 124.887 1.275 . . . . 0.55 110.364 -178.751 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -62.8 -55.03 0.93 Allowed 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 123.686 2.924 . . . . 2.99 111.254 -172.71 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 116.94 147.23 8.59 Favored Glycine 0 C--N 1.334 0.457 0 C-N-CA 124.156 0.884 . . . . 0.88 113.19 175.028 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 69.73 24.4 76.32 Favored Glycine 0 CA--C 1.53 1.02 0 N-CA-C 111.524 -0.631 . . . . 0.46 111.524 179.76 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.0 mm -55.87 -44.96 79.53 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.843 0 C-N-CA 125.51 1.524 . . . . 2.19 111.597 -178.919 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -113.6 160.51 18.48 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.003 1.321 . . . . 0.3 108.843 161.021 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 5.0 ttmt -146.38 167.45 23.57 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 118.423 0.556 . . . . 2.69 110.768 170.53 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 55.91 -148.61 27.48 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 111.092 -0.803 . . . . 0.71 111.092 -179.595 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -49.53 -37.4 26.72 Favored 'General case' 0 C--N 1.341 0.204 0 C-N-CA 123.755 0.822 . . . . 0.68 111.314 -178.709 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -50.69 -49.48 57.3 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 124.994 1.318 . . . . 2.03 110.4 175.287 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -78.75 -48.6 14.56 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 123.233 0.613 . . . . 0.23 111.375 178.953 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -53.7 -50.75 65.19 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.252 1.021 . . . . 2.23 110.623 -176.319 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.01 -48.9 78.64 Favored 'General case' 0 N--CA 1.455 -0.214 0 O-C-N 122.022 -0.424 . . . . 0.21 110.144 177.893 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.436 HG22 HG23 ' A' ' 28' ' ' VAL . 56.0 t -55.54 -49.73 71.55 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 C-N-CA 122.783 0.433 . . . . 0.26 110.955 179.467 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -52.52 -53.17 49.66 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 123.331 0.652 . . . . 0.31 111.466 175.928 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.1 -48.26 82.25 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-O 121.417 0.627 . . . . 0.39 111.257 -179.736 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.533 ' CE3' HD23 ' A' ' 88' ' ' LEU . 47.8 t90 -56.05 -50.16 71.74 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.017 0.527 . . . . 0.48 109.733 177.848 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.533 HD23 ' CE3' ' A' ' 87' ' ' TRP . 0.1 OUTLIER -60.92 -34.61 74.96 Favored 'General case' 0 C--O 1.224 -0.279 0 C-N-CA 124.351 1.06 . . . . 1.55 111.449 176.897 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.28 -42.57 98.87 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 119.009 0.822 . . . . 0.38 110.095 173.332 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -59.66 -42.13 92.13 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.044 0.538 . . . . 3.01 111.093 172.244 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 9.5 mtpp -71.85 130.8 41.94 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 118.545 0.611 . . . . 2.93 110.357 -177.547 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 38.6 mttt . . . . . 0 C--O 1.25 1.102 0 N-CA-C 106.469 -1.678 . . . . 3.25 106.469 -178.274 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 28.8 t0 . . . . . 0 N--CA 1.451 -0.417 0 N-CA-C 108.306 -0.998 . . . . 3.72 108.306 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -47.69 -41.95 23.76 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.239 1.016 . . . . 0.35 111.739 176.097 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -66.99 -52.64 40.2 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 107.73 -1.211 . . . . 3.34 107.73 -176.75 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.99 -45.88 71.57 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.316 0.646 . . . . 0.47 111.484 178.483 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 64.0 t -56.57 -60.95 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 N-CA-C 109.181 -0.674 . . . . 0.52 109.181 176.148 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.682 HG11 HD21 ' A' ' 40' ' ' LEU . 46.2 t -55.81 -45.36 79.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 O-C-N 121.908 -0.495 . . . . 0.37 110.888 -175.969 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.447 ' HA ' HG12 ' A' ' 33' ' ' ILE . 23.2 mm-40 -49.78 -19.39 0.64 Allowed 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 126.968 2.107 . . . . 0.87 112.998 173.509 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 44.3 tt0 -139.69 35.06 2.0 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 119.012 0.823 . . . . 2.33 111.367 173.372 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 67.9 mmtt -145.96 -56.92 0.3 Allowed 'General case' 0 CA--C 1.516 -0.358 0 O-C-N 121.211 -0.931 . . . . 2.2 109.977 175.08 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.682 ' SG ' HG22 ' A' ' 28' ' ' VAL . 3.2 m -86.36 -49.71 7.45 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 109.213 -0.662 . . . . 0.28 109.213 -172.768 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.447 HG12 ' HA ' ' A' ' 29' ' ' GLN . 1.8 pp -56.23 -27.88 24.69 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.21 0 CA-C-N 115.739 -0.664 . . . . 0.55 110.569 -178.106 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -36.78 -40.46 0.27 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.199 1.399 . . . . 1.36 111.654 170.943 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 24.4 m -114.69 -35.72 4.76 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.792 0.837 . . . . 0.37 112.127 172.794 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 92.2 m-70 -80.59 3.56 21.43 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 125.065 1.346 . . . . 0.33 113.13 -175.115 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 112.46 -92.58 0.64 Allowed Glycine 0 CA--C 1.528 0.856 0 C-N-CA 126.396 1.951 . . . . 2.98 112.511 164.747 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -162.45 -47.82 0.02 OUTLIER Glycine 0 CA--C 1.522 0.519 0 N-CA-C 108.815 -1.714 . . . . 0.7 108.815 -173.306 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -102.21 7.24 40.89 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 126.099 1.759 . . . . 3.49 111.395 176.643 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.682 HD21 HG11 ' A' ' 28' ' ' VAL . 0.5 OUTLIER 76.28 13.34 2.56 Favored 'General case' 0 C--N 1.35 0.597 0 CA-C-N 120.006 1.276 . . . . 1.87 111.056 179.562 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 35.5 p -75.41 -10.79 59.77 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 126.953 2.101 . . . . 0.6 110.112 -175.777 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.84 147.11 22.14 Favored Glycine 0 N--CA 1.444 -0.817 0 N-CA-C 108.653 -1.779 . . . . 0.59 108.653 -177.396 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -154.23 -81.36 0.08 Allowed 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 123.181 0.593 . . . . 0.34 109.525 177.264 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 5.4 m -89.31 2.8 53.83 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.752 0.821 . . . . 1.02 110.862 171.451 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -152.71 162.73 25.65 Favored Pre-proline 0 N--CA 1.45 -0.459 0 C-N-CA 125.77 1.628 . . . . 0.29 107.256 -172.344 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -66.74 163.95 31.2 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 122.545 2.163 . . . . 0.27 110.905 -175.378 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.87 123.35 24.05 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 109.33 -0.618 . . . . 0.35 109.33 -178.89 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 49.8 pt -107.14 1.95 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 C-N-CA 123.544 0.737 . . . . 0.33 111.424 176.85 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 18.4 p-10 -34.08 -49.92 0.37 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.382 1.473 . . . . 3.76 112.21 167.739 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 18.1 pttt -109.9 34.7 3.71 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 125.086 1.354 . . . . 4.6 112.433 -179.924 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.13 -46.04 91.0 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 109.473 -0.566 . . . . 0.31 109.473 173.242 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -54.88 -32.58 55.73 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 123.154 0.407 . . . . 0.56 113.455 -176.829 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.32 -40.01 62.49 Favored 'General case' 0 CA--C 1.529 0.142 0 O-C-N 121.947 -0.737 . . . . 0.73 110.908 174.689 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 19.5 m-80 -65.71 -52.86 47.98 Favored 'General case' 0 C--O 1.227 -0.088 0 N-CA-C 110.384 -0.228 . . . . 1.69 110.384 -179.788 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -136.07 144.28 45.1 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.035 1.334 . . . . 0.66 108.401 -168.584 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 4.9 m -74.03 167.58 21.24 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 118.268 0.486 . . . . 1.58 110.38 177.626 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.8 pm0 -49.83 -41.68 45.54 Favored 'General case' 0 C--O 1.225 -0.232 0 C-N-CA 123.731 0.813 . . . . 2.65 111.354 -179.476 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -56.62 -44.3 81.06 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.775 0.83 . . . . 3.09 109.966 179.578 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -78.21 -43.65 27.88 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.07 0.948 . . . . 2.79 109.55 -174.481 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 76.2 mt -59.83 -48.34 88.04 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 O-C-N 121.094 -1.004 . . . . 0.39 108.749 176.606 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 33.5 tp -55.7 -45.33 77.88 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 109.193 -0.669 . . . . 0.54 109.193 178.425 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -47.22 -56.71 6.19 Favored 'General case' 0 N--CA 1.453 -0.302 0 O-C-N 124.108 0.88 . . . . 1.64 109.328 172.449 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 43.7 mt -61.78 -45.78 97.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 117.827 -1.549 . . . . 0.8 111.999 179.851 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 85.9 mt -52.6 -48.66 47.43 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 O-C-N 119.693 -1.879 . . . . 0.31 110.296 -179.023 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 88.3 mt -72.95 -31.94 64.91 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 123.416 0.687 . . . . 0.64 111.886 178.144 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 45.8 m-20 -129.18 46.91 2.55 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 107.699 -1.223 . . . . 1.8 107.699 -163.198 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -40.67 106.25 0.06 OUTLIER Glycine 0 CA--C 1.534 1.244 0 C-N-CA 125.838 1.685 . . . . 3.25 111.476 -171.256 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 -87.86 165.19 15.46 Favored 'General case' 0 N--CA 1.435 -1.212 0 C-N-CA 127.466 2.306 . . . . 3.44 109.382 -175.307 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 57.4 -127.81 45.86 Favored Glycine 0 CA--C 1.529 0.943 0 N-CA-C 111.521 -0.631 . . . . 0.83 111.521 174.385 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -73.79 -25.55 71.62 Favored Glycine 0 CA--C 1.53 0.979 0 CA-C-N 117.096 0.448 . . . . 0.92 112.131 179.799 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 5.5 ttt -63.44 137.22 97.02 Favored Pre-proline 0 CA--C 1.54 0.566 0 O-C-N 121.914 -0.757 . . . . 0.78 109.741 178.849 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -74.35 -54.19 0.1 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.844 2.362 . . . . 2.86 111.233 -177.234 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 113.73 149.81 10.31 Favored Glycine 0 C--N 1.335 0.515 0 C-N-CA 123.849 0.738 . . . . 0.96 112.785 177.321 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 67.25 24.4 73.46 Favored Glycine 0 CA--C 1.531 1.092 0 CA-C-N 114.906 -0.647 . . . . 0.39 112.146 176.727 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -55.5 -51.62 55.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 125.936 1.694 . . . . 1.05 110.877 177.784 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -104.99 149.08 26.06 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 125.171 1.389 . . . . 0.5 108.101 169.768 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 2.9 mtpm? -146.25 153.13 40.24 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.966 0.907 . . . . 4.35 111.441 -178.431 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 71.76 -162.64 54.38 Favored Glycine 0 CA--C 1.532 1.131 0 N-CA-C 110.638 -0.985 . . . . 0.99 110.638 -170.311 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -50.83 -26.72 6.09 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.823 1.249 . . . . 0.73 112.607 -178.702 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 51.7 tt0 -40.93 -62.34 0.83 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.081 1.352 . . . . 2.1 110.508 168.142 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -62.77 -46.85 86.13 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 122.816 0.446 . . . . 0.27 110.666 -174.688 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -51.12 -56.85 10.62 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 123.71 0.804 . . . . 1.94 111.06 175.705 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -56.34 -47.57 78.52 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 109.429 -0.582 . . . . 0.27 109.429 -177.682 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.486 HG22 HG23 ' A' ' 28' ' ' VAL . 53.3 t -57.93 -53.66 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 N-CA-C 111.774 0.287 . . . . 0.3 111.774 177.49 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -52.38 -52.69 52.23 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 123.214 0.605 . . . . 0.19 111.306 179.028 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.444 ' O ' ' HB3' ' A' ' 89' ' ' ALA . . . -58.76 -49.48 77.49 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 121.415 0.626 . . . . 0.35 110.134 179.189 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.564 ' CE3' HD23 ' A' ' 88' ' ' LEU . 46.3 t90 -53.63 -48.76 69.05 Favored 'General case' 0 N--CA 1.451 -0.413 0 O-C-N 121.69 -0.631 . . . . 0.5 110.378 177.473 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.564 HD23 ' CE3' ' A' ' 87' ' ' TRP . 0.1 OUTLIER -61.58 -34.68 76.02 Favored 'General case' 0 C--O 1.227 -0.123 0 C-N-CA 124.394 1.078 . . . . 1.65 111.004 177.206 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.444 ' HB3' ' O ' ' A' ' 86' ' ' ALA . . . -52.58 -47.11 67.07 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 118.889 0.768 . . . . 0.59 109.972 170.989 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -83.22 26.08 0.66 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.404 0.682 . . . . 5.06 112.597 173.686 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 8.1 mtpm? -125.69 120.99 32.17 Favored 'General case' 0 C--N 1.341 0.197 0 CA-C-N 119.775 1.171 . . . . 2.06 110.017 167.043 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.438 -1.043 0 C-N-CA 127.397 2.279 . . . . 2.36 105.1 173.933 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 N--CA 1.445 -0.697 0 N-CA-C 108.049 -1.093 . . . . 2.18 108.049 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -40.41 -55.66 2.2 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 125.087 1.355 . . . . 0.33 111.732 177.697 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -52.93 -47.0 68.35 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 123.012 0.525 . . . . 2.75 111.78 177.287 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.07 -46.44 87.46 Favored 'General case' 0 N--CA 1.458 -0.06 0 CA-C-N 118.494 0.588 . . . . 0.26 110.468 -178.233 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 69.8 t -55.33 -54.73 21.87 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.252 0 N-CA-C 109.221 -0.659 . . . . 0.34 109.221 175.274 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.473 HG22 ' SG ' ' A' ' 32' ' ' CYS . 34.1 t -56.66 -48.41 80.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 C-N-CA 123.375 0.67 . . . . 0.33 110.531 -175.14 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.416 ' HA ' HG12 ' A' ' 33' ' ' ILE . 36.4 mm-40 -51.42 -21.63 2.46 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.913 1.685 . . . . 0.49 112.78 172.373 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -136.81 49.42 2.06 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 119.151 0.887 . . . . 3.75 111.705 178.104 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -168.5 -59.18 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.183 0 N-CA-C 108.112 -1.07 . . . . 1.52 108.112 168.163 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.473 ' SG ' HG22 ' A' ' 28' ' ' VAL . 3.6 m -75.54 -51.55 12.67 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 120.862 0.363 . . . . 0.18 110.655 -170.231 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.416 HG12 ' HA ' ' A' ' 29' ' ' GLN . 2.2 pp -55.01 -26.58 17.88 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.165 0 CA-C-N 115.838 -0.619 . . . . 0.42 111.697 -179.225 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.7 t -43.61 -34.72 1.51 Allowed 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.034 0.933 . . . . 2.06 111.867 175.051 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 28.7 m -117.03 -37.34 3.59 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.482 0.713 . . . . 0.22 111.706 172.774 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -78.92 2.31 20.62 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.35 1.06 . . . . 0.27 113.0 -175.921 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 112.1 -85.63 0.4 Allowed Glycine 0 C--N 1.34 0.755 0 C-N-CA 125.676 1.607 . . . . 3.0 112.196 162.609 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -171.23 -50.23 0.04 OUTLIER Glycine 0 CA--C 1.518 0.242 0 N-CA-C 108.452 -1.859 . . . . 0.83 108.452 -171.906 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -102.0 4.91 40.38 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.711 1.204 . . . . 3.09 111.504 179.38 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 5.2 mt 80.16 15.29 0.8 Allowed 'General case' 0 C--N 1.354 0.761 0 CA-C-N 120.392 1.451 . . . . 1.53 110.206 -178.903 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.4 p -80.75 -9.4 59.81 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 128.34 2.656 . . . . 0.58 110.002 -175.906 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.56 161.27 36.95 Favored Glycine 0 N--CA 1.442 -0.908 0 N-CA-C 108.995 -1.642 . . . . 0.92 108.995 -174.691 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -164.8 -72.94 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 124.503 1.121 . . . . 0.31 108.187 174.066 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 30.3 m -101.73 3.14 39.31 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.398 1.079 . . . . 1.19 110.857 174.202 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -152.14 160.87 30.8 Favored Pre-proline 0 CA--C 1.536 0.417 0 C-N-CA 126.456 1.902 . . . . 0.24 107.092 -171.599 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.46 158.8 55.38 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 123.115 2.544 . . . . 0.22 110.942 -175.046 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -74.01 120.63 19.85 Favored 'General case' 0 N--CA 1.454 -0.229 0 O-C-N 121.887 -0.508 . . . . 0.27 109.871 -176.749 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 25.3 pt -100.32 2.64 10.6 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 C-N-CA 123.475 0.71 . . . . 0.31 111.679 177.728 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -36.28 -44.89 0.43 Allowed 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.215 1.406 . . . . 2.53 113.668 171.49 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 8.3 mtpt -111.36 26.23 10.88 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.371 1.068 . . . . 3.71 111.324 -177.542 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -58.31 -43.24 88.07 Favored 'General case' 0 N--CA 1.453 -0.317 0 O-C-N 121.631 -0.668 . . . . 0.31 110.205 179.923 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -54.13 -23.58 25.24 Favored Glycine 0 CA--C 1.53 0.98 0 CA-C-N 118.299 0.5 . . . . 0.5 114.344 179.172 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -88.03 -41.56 13.01 Favored 'General case' 0 N--CA 1.457 -0.123 0 CA-C-N 118.123 0.962 . . . . 0.75 109.818 175.849 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -56.85 -53.41 58.18 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 122.529 0.331 . . . . 2.02 110.801 176.504 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -139.15 154.61 48.11 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.677 1.191 . . . . 0.64 109.229 -170.576 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 2.1 p -80.07 167.37 20.5 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.793 0.837 . . . . 2.18 110.927 178.434 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -46.63 -46.22 19.66 Favored 'General case' 0 C--O 1.224 -0.258 0 C-N-CA 124.473 1.109 . . . . 2.74 111.319 176.703 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -58.72 -40.83 84.84 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.285 0.634 . . . . 2.81 110.638 -177.941 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -76.78 -47.93 20.16 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 108.877 -0.786 . . . . 3.01 108.877 -175.393 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 83.1 mt -59.58 -42.96 89.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 N-CA-C 109.087 -0.709 . . . . 0.22 109.087 178.666 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.8 tp -54.04 -52.91 59.36 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 109.383 -0.599 . . . . 0.3 109.383 175.954 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -50.51 -51.27 49.09 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 118.064 0.393 . . . . 1.65 110.824 175.004 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 60.9 mt -61.72 -30.57 48.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 O-C-N 121.574 -0.704 . . . . 0.73 112.307 -179.036 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 49.2 mt -69.99 -49.3 57.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 O-C-N 120.381 -1.449 . . . . 0.21 109.08 173.313 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 86.3 mt -67.39 -34.16 76.7 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 124.437 1.095 . . . . 0.49 113.354 -174.448 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -123.37 20.39 9.65 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 119.717 1.144 . . . . 1.83 110.224 -166.644 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 32.24 -141.23 0.05 OUTLIER Glycine 0 CA--C 1.543 1.827 0 C-N-CA 127.039 2.256 . . . . 0.64 112.207 -164.642 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 39.5 tt0 170.72 137.45 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 119.588 1.694 . . . . 1.67 109.243 -176.736 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 38.1 -114.85 0.34 Allowed Glycine 0 CA--C 1.531 1.067 0 CA-C-N 120.04 1.291 . . . . 0.39 113.291 -177.008 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -69.26 -25.04 75.79 Favored Glycine 0 CA--C 1.534 1.25 0 CA-C-N 117.263 0.532 . . . . 0.47 113.233 179.566 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 16.8 ttt -70.27 120.21 76.92 Favored Pre-proline 0 CA--C 1.539 0.532 0 C-N-CA 124.492 1.117 . . . . 0.37 110.058 -179.591 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -62.5 -55.89 0.8 Allowed 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 124.249 3.299 . . . . 2.91 111.578 -168.965 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 118.2 149.13 8.7 Favored Glycine 0 N--CA 1.449 -0.489 0 CA-C-N 115.857 -0.61 . . . . 0.91 114.124 172.429 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 67.41 21.65 72.52 Favored Glycine 0 CA--C 1.532 1.111 0 CA-C-N 114.782 -0.709 . . . . 0.52 111.686 -179.845 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 2.0 mt -52.53 -44.54 45.18 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 C-N-CA 126.872 2.069 . . . . 1.03 110.98 178.211 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -114.82 159.95 20.03 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.817 1.247 . . . . 0.27 110.311 161.775 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 19.3 mmtp -141.92 159.95 41.2 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.972 1.709 . . . . 2.27 110.28 -179.343 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 56.3 -142.94 38.8 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 111.426 -0.669 . . . . 0.78 111.426 176.027 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -50.07 -35.98 27.42 Favored 'General case' 0 C--N 1.341 0.22 0 C-N-CA 123.661 0.785 . . . . 0.71 111.592 174.753 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -57.9 -33.11 68.4 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.61 0.764 . . . . 2.1 110.795 178.782 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -91.97 -53.2 4.37 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.613 0.765 . . . . 0.23 110.882 175.415 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -50.15 -54.49 20.39 Favored 'General case' 0 N--CA 1.461 0.105 0 C-N-CA 124.563 1.145 . . . . 2.11 111.544 -179.533 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.25 -44.75 92.36 Favored 'General case' 0 C--O 1.225 -0.236 0 N-CA-C 109.588 -0.523 . . . . 0.31 109.588 -178.522 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 54.7 t -58.16 -53.75 41.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 C-N-CA 122.772 0.429 . . . . 0.32 111.1 179.451 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -53.17 -52.33 59.15 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 123.081 0.552 . . . . 0.23 111.533 174.921 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.2 -38.62 83.88 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.515 0.726 . . . . 0.59 111.155 -178.216 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 73.7 t90 -67.86 -51.08 52.4 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 123.82 0.848 . . . . 0.5 109.578 177.637 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.46 -30.33 69.6 Favored 'General case' 0 C--O 1.223 -0.318 0 O-C-N 121.363 -0.836 . . . . 1.99 112.143 175.91 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -55.31 -38.91 69.29 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 119.592 1.087 . . . . 0.41 110.836 170.9 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -68.54 -41.81 79.32 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 118.588 -0.72 . . . . 3.1 110.92 170.908 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.6 mtpm? -72.86 106.34 4.75 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 119.173 0.897 . . . . 1.98 110.384 -174.587 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 4.4 mtmp? . . . . . 0 C--O 1.25 1.084 0 C-N-CA 126.233 1.813 . . . . 2.06 106.51 179.374 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 . . . . . 0 N--CA 1.449 -0.514 0 N-CA-C 108.509 -0.923 . . . . 2.57 108.509 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -43.3 -52.07 5.95 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 124.335 1.054 . . . . 0.27 111.012 176.101 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -57.91 -47.14 83.7 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 116.287 -0.415 . . . . 2.68 110.401 179.938 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.07 -45.1 94.0 Favored 'General case' 0 N--CA 1.461 0.098 0 CA-C-N 118.472 0.578 . . . . 0.35 110.891 -178.874 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 79.5 t -57.49 -57.25 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 108.93 -0.767 . . . . 0.33 108.93 176.884 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.619 HG11 HD21 ' A' ' 40' ' ' LEU . 35.7 t -55.24 -46.04 77.79 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 C-N-CA 121.213 -0.195 . . . . 0.36 111.011 -176.762 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.429 ' HA ' HG12 ' A' ' 33' ' ' ILE . 26.3 mm-40 -49.98 -25.94 3.79 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 125.794 1.638 . . . . 0.5 112.808 173.769 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -140.66 67.23 1.36 Allowed 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 119.06 0.846 . . . . 2.7 112.001 171.4 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -178.22 -36.11 0.01 OUTLIER 'General case' 0 C--O 1.225 -0.221 0 C-N-CA 124.812 1.245 . . . . 1.2 109.202 169.627 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.492 ' SG ' HG22 ' A' ' 28' ' ' VAL . 2.7 m -103.95 -53.79 2.68 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 119.339 0.972 . . . . 0.25 111.13 -177.649 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.429 HG12 ' HA ' ' A' ' 29' ' ' GLN . 2.0 pp -55.26 -27.88 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 CA-C-N 115.9 -0.591 . . . . 0.54 111.386 -176.302 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.3 m -35.21 -42.12 0.18 Allowed 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 125.358 1.463 . . . . 1.18 112.633 170.244 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 18.2 m -112.66 -34.74 5.72 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.655 0.782 . . . . 0.23 111.706 174.14 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 92.5 m-70 -82.0 5.21 19.99 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.446 1.098 . . . . 0.35 113.409 -175.351 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 107.22 -91.05 0.68 Allowed Glycine 0 CA--C 1.525 0.667 0 C-N-CA 126.57 2.033 . . . . 2.87 111.961 166.312 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -167.63 -47.37 0.03 OUTLIER Glycine 0 CA--C 1.519 0.316 0 N-CA-C 108.792 -1.723 . . . . 0.84 108.792 -172.446 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -102.88 6.42 39.08 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.935 1.294 . . . . 4.1 111.158 178.675 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.619 HD21 HG11 ' A' ' 28' ' ' VAL . 2.5 mt 78.49 10.32 1.89 Allowed 'General case' 0 C--N 1.354 0.798 0 CA-C-N 120.075 1.307 . . . . 1.43 110.352 177.441 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.1 p -74.81 -10.26 59.34 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 128.62 2.768 . . . . 0.59 109.629 -179.69 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.64 159.11 34.3 Favored Glycine 0 N--CA 1.444 -0.822 0 N-CA-C 109.269 -1.532 . . . . 0.85 109.269 -177.017 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -160.67 -79.82 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 124.334 1.054 . . . . 0.35 108.653 175.692 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 58.5 m -91.55 2.24 56.58 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.474 0.709 . . . . 1.21 110.966 173.437 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.446 ' HB1' ' HD2' ' A' ' 46' ' ' PRO . . . -154.35 164.8 19.6 Favored Pre-proline 0 N--CA 1.448 -0.544 0 C-N-CA 125.245 1.418 . . . . 0.31 108.038 -169.672 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.446 ' HD2' ' HB1' ' A' ' 45' ' ' ALA . 27.9 Cg_endo -67.42 159.75 50.95 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 123.002 2.468 . . . . 0.27 111.243 -173.696 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -74.75 115.56 14.47 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.073 0.549 . . . . 0.38 109.999 -177.593 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 32.2 pt -102.55 2.5 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 C-N-CA 124.342 1.057 . . . . 0.55 111.528 179.549 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -34.3 -48.87 0.36 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.28 1.432 . . . . 2.26 112.427 167.49 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 10.0 pttt -109.19 26.26 10.83 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.58 0.752 . . . . 3.41 111.812 -176.458 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -51.55 -44.3 62.66 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 118.927 -0.559 . . . . 0.34 109.8 178.287 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -52.84 -25.72 23.82 Favored Glycine 0 CA--C 1.529 0.952 0 N-CA-C 114.566 0.586 . . . . 0.46 114.566 177.692 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -82.44 -42.36 18.66 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 118.076 0.938 . . . . 0.84 109.49 175.67 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 36.1 m120 -63.69 -48.41 77.22 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 122.574 0.35 . . . . 3.24 110.564 -179.471 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -144.2 145.62 32.18 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.547 1.539 . . . . 0.64 108.553 -169.925 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 19.6 m -75.33 169.17 18.57 Favored 'General case' 0 CA--C 1.532 0.284 0 O-C-N 121.542 -0.724 . . . . 1.52 111.198 179.132 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -44.17 -56.03 4.38 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 123.337 0.655 . . . . 4.77 110.735 174.182 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -53.13 -29.96 34.03 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 112.724 0.638 . . . . 2.96 112.724 -178.406 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 53.6 mm-40 -86.83 -48.85 7.86 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.709 0.804 . . . . 3.03 109.789 -178.315 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 84.0 mt -57.6 -46.5 86.33 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.097 0 O-C-N 121.114 -0.991 . . . . 0.26 108.73 178.143 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 46.6 tp -52.97 -47.55 68.08 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 123.618 0.767 . . . . 0.33 109.274 176.543 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -55.45 -46.99 76.72 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 118.244 0.474 . . . . 2.21 110.705 175.099 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 47.7 mt -60.51 -36.7 71.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 O-C-N 121.444 -0.785 . . . . 0.51 110.996 176.728 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 58.5 mt -69.21 -42.22 81.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 O-C-N 119.864 -1.773 . . . . 0.24 109.939 178.816 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 71.3 mt -76.65 -26.53 54.97 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.815 1.246 . . . . 0.44 112.891 -176.715 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 28.8 m-80 -124.85 14.43 8.59 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 119.584 1.084 . . . . 1.76 109.989 -172.044 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.586 ' N ' ' HA2' ' A' ' 73' ' ' GLY . . . 40.43 -139.99 1.13 Allowed Glycine 0 CA--C 1.537 1.451 0 C-N-CA 126.614 2.054 . . . . 0.64 110.994 -171.885 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 168.48 127.1 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.602 1.561 . . . . 1.39 110.41 179.152 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 42.13 -115.87 0.97 Allowed Glycine 0 C--N 1.346 1.092 0 CA-C-N 120.283 1.402 . . . . 0.66 113.294 -178.145 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -64.54 -22.06 67.45 Favored Glycine 0 CA--C 1.532 1.097 0 CA-C-N 117.349 0.574 . . . . 0.63 112.53 -179.54 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 21.5 ttt -80.32 118.93 74.79 Favored Pre-proline 0 N--CA 1.45 -0.442 0 C-N-CA 124.878 1.271 . . . . 0.37 111.433 -179.35 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.445 ' HD2' HD11 ' A' ' 75' ' ' ILE . 36.2 Cg_endo -77.83 122.77 6.0 Favored 'Trans proline' 0 N--CA 1.448 -1.193 0 C-N-CA 122.645 2.23 . . . . 2.05 112.066 -178.515 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.586 ' HA2' ' N ' ' A' ' 67' ' ' GLY . . . -57.26 131.28 51.97 Favored Glycine 0 N--CA 1.444 -0.817 0 N-CA-C 115.348 0.899 . . . . 0.72 115.348 179.376 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 87.55 40.63 6.74 Favored Glycine 0 C--N 1.338 0.678 0 CA-C-N 114.342 -0.929 . . . . 0.49 112.008 172.687 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.445 HD11 ' HD2' ' A' ' 72' ' ' PRO . 2.4 mt -66.92 -61.44 1.69 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 124.691 1.196 . . . . 1.08 109.925 176.616 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -98.36 161.35 13.73 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.632 1.173 . . . . 0.32 109.705 167.613 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.0 mttm -146.81 164.34 33.14 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 125.085 1.354 . . . . 2.49 110.71 176.828 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 52.7 -146.32 17.4 Favored Glycine 0 CA--C 1.529 0.92 0 N-CA-C 111.383 -0.687 . . . . 0.71 111.383 -178.527 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -53.12 -31.49 42.39 Favored 'General case' 0 C--O 1.225 -0.215 0 C-N-CA 122.942 0.497 . . . . 0.82 111.295 177.432 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -53.61 -46.1 70.3 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 123.299 0.64 . . . . 2.32 110.168 174.398 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -78.69 -52.25 8.68 Favored 'General case' 0 CA--C 1.53 0.191 0 O-C-N 121.552 -0.717 . . . . 0.22 111.098 176.496 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -57.17 -51.6 68.66 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.631 0.773 . . . . 2.6 111.331 -173.53 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.18 -45.62 90.56 Favored 'General case' 0 N--CA 1.457 -0.12 0 O-C-N 121.99 -0.444 . . . . 0.26 109.881 -179.265 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.588 HG22 HG23 ' A' ' 28' ' ' VAL . 37.9 t -56.25 -53.04 44.4 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 CA-C-O 119.515 -0.279 . . . . 0.3 110.94 176.263 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -52.43 -50.53 62.39 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 122.767 0.427 . . . . 0.17 111.048 177.831 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.04 -45.07 96.29 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-O 121.263 0.554 . . . . 0.3 110.964 -179.189 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.534 ' CE3' HD23 ' A' ' 88' ' ' LEU . 45.6 t90 -59.93 -48.11 83.05 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.863 0.84 . . . . 0.5 109.703 176.464 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.534 HD23 ' CE3' ' A' ' 87' ' ' TRP . 0.1 OUTLIER -62.11 -27.6 69.04 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 120.448 -1.407 . . . . 1.67 110.3 177.039 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -65.67 -43.75 88.39 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 123.319 0.648 . . . . 0.35 111.13 172.583 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -62.13 -42.09 98.9 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 118.537 -1.265 . . . . 3.76 109.944 171.807 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 7.8 mtpp -69.38 119.98 14.48 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 121.581 0.705 . . . . 2.18 111.501 -171.18 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 8.2 mttp . . . . . 0 C--O 1.25 1.083 0 C-N-CA 128.092 2.557 . . . . 2.38 105.456 -176.352 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 . . . . . 0 N--CA 1.448 -0.568 0 N-CA-C 109.228 -0.656 . . . . 2.63 109.228 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -38.25 -53.73 1.44 Allowed 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 125.669 1.587 . . . . 0.42 112.498 176.461 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -52.69 -49.79 64.6 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 122.844 0.458 . . . . 2.91 111.213 176.637 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.28 -43.92 95.82 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 118.429 0.559 . . . . 0.37 110.532 -179.777 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 89.4 t -58.6 -54.26 35.75 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 N-CA-C 109.702 -0.481 . . . . 0.46 109.702 176.649 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.447 HG23 HG22 ' A' ' 84' ' ' VAL . 32.7 t -53.4 -50.63 47.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 C-N-CA 122.709 0.404 . . . . 0.44 110.11 179.762 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 31.8 mm-40 -54.74 -14.47 1.39 Allowed 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 126.49 1.916 . . . . 0.67 113.953 174.518 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -141.48 34.06 1.65 Allowed 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 119.757 1.162 . . . . 2.94 112.583 176.668 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.3 mptt -152.0 -62.62 0.17 Allowed 'General case' 0 CA--C 1.521 -0.159 0 N-CA-C 108.401 -0.963 . . . . 2.61 108.401 166.056 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.438 ' SG ' HG22 ' A' ' 28' ' ' VAL . 3.7 m -69.65 -46.84 65.22 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 121.13 0.49 . . . . 0.19 110.144 -168.746 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.3 pp -56.15 -23.31 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 CA-C-N 115.462 -0.79 . . . . 0.51 112.882 -178.388 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.0 t -48.38 -35.45 12.61 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.981 0.913 . . . . 2.03 110.748 177.794 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 15.9 m -120.04 -40.49 2.72 Favored 'General case' 0 C--N 1.342 0.255 0 C-N-CA 123.564 0.746 . . . . 0.19 111.525 177.319 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 86.1 m-70 -72.16 -9.01 57.85 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.581 0.752 . . . . 0.23 112.219 -178.59 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 88.61 148.87 18.05 Favored Glycine 0 C--N 1.339 0.714 0 N-CA-C 109.742 -1.343 . . . . 1.44 109.742 177.595 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -42.34 -33.41 1.37 Allowed Glycine 0 CA--C 1.529 0.956 0 C-N-CA 125.202 1.382 . . . . 0.54 112.988 175.085 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -101.26 -5.29 25.7 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.076 1.351 . . . . 2.98 112.209 -171.687 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 73.37 8.63 5.18 Favored 'General case' 0 C--N 1.35 0.601 0 O-C-N 120.633 -1.292 . . . . 1.43 111.393 175.696 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 17.2 p -82.11 -1.99 50.52 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 127.491 2.316 . . . . 0.5 110.287 -174.523 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.57 145.27 9.84 Favored Glycine 0 N--CA 1.438 -1.19 0 N-CA-C 108.164 -1.975 . . . . 0.41 108.164 -171.475 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -150.88 -73.0 0.16 Allowed 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 124.181 0.992 . . . . 0.26 108.98 176.7 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.93 3.85 49.57 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.948 1.299 . . . . 1.13 110.441 173.33 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -158.05 163.68 23.79 Favored Pre-proline 0 CA--C 1.536 0.419 0 C-N-CA 125.994 1.718 . . . . 0.21 107.331 -167.523 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -70.16 158.01 57.8 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 123.144 2.563 . . . . 0.26 110.768 -174.823 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.39 126.96 31.36 Favored 'General case' 0 C--N 1.333 -0.148 0 O-C-N 121.636 -0.665 . . . . 0.31 110.075 -177.305 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 39.4 pt -106.9 -2.88 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 C-N-CA 123.07 0.548 . . . . 0.36 111.887 177.037 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 24.6 p-10 -33.66 -49.95 0.33 Allowed 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.29 1.436 . . . . 3.61 112.744 171.834 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.5 pttp -106.17 23.82 13.45 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.261 1.424 . . . . 3.95 112.579 -176.859 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.04 -50.02 75.67 Favored 'General case' 0 CA--C 1.527 0.072 0 O-C-N 121.228 -0.92 . . . . 0.51 109.963 179.168 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -60.18 -12.84 25.47 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 123.386 0.517 . . . . 0.94 114.157 178.804 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.98 -34.15 68.69 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 118.454 1.127 . . . . 1.53 110.664 173.539 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -107.24 -52.09 2.82 Favored 'General case' 0 C--N 1.34 0.174 0 C-N-CA 123.976 0.91 . . . . 3.05 111.878 -176.137 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -84.04 170.29 14.07 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.713 0.805 . . . . 1.32 110.184 175.763 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 54.1 m -119.53 169.1 10.35 Favored 'General case' 0 C--O 1.233 0.237 0 C-N-CA 125.647 1.579 . . . . 1.5 108.619 172.899 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.8 pm0 -46.25 -49.86 16.71 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 124.475 1.11 . . . . 2.74 112.355 -177.198 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -58.83 -41.71 87.51 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 118.298 0.499 . . . . 2.41 111.888 179.172 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.65 -49.07 51.34 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 122.114 0.959 . . . . 3.53 108.623 -176.253 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 31.2 mt -60.03 -44.48 94.91 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 O-C-N 121.631 -0.668 . . . . 0.31 109.253 178.545 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 61.7 tp -54.61 -52.45 62.19 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.289 -0.634 . . . . 0.72 109.289 177.119 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -48.28 -53.91 15.55 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.165 0.586 . . . . 1.89 109.77 179.264 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 81.4 mt -57.18 -47.87 83.22 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.283 0 O-C-N 121.707 -0.621 . . . . 0.48 111.409 177.37 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 79.5 mt -54.79 -43.0 65.24 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 O-C-N 120.464 -1.398 . . . . 0.3 110.216 176.665 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 94.3 mt -70.8 -40.41 72.55 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 113.957 1.095 . . . . 0.61 113.957 -176.171 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -123.3 27.51 7.49 Favored 'General case' 0 C--N 1.344 0.35 0 CA-C-N 120.956 1.707 . . . . 3.8 109.787 -171.515 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.532 ' N ' ' HA2' ' A' ' 73' ' ' GLY . . . 36.55 -136.97 0.52 Allowed Glycine 0 CA--C 1.532 1.151 0 C-N-CA 127.786 2.612 . . . . 0.64 110.613 -174.969 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 30.9 tt0 167.41 133.36 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 119.237 1.519 . . . . 1.76 109.197 -177.089 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 45.04 -122.5 5.15 Favored Glycine 0 CA--C 1.532 1.102 0 CA-C-N 119.872 1.215 . . . . 0.49 112.252 -175.396 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -70.8 -16.97 74.78 Favored Glycine 0 CA--C 1.532 1.131 0 CA-C-N 117.595 0.697 . . . . 0.7 113.017 178.448 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 20.5 ttt -71.29 119.03 71.27 Favored Pre-proline 0 N--CA 1.451 -0.385 0 CA-C-N 118.23 1.015 . . . . 0.43 110.434 -178.938 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -78.18 120.55 4.99 Favored 'Trans proline' 0 N--CA 1.446 -1.275 0 C-N-CA 122.847 2.365 . . . . 2.14 110.886 -179.431 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.532 ' HA2' ' N ' ' A' ' 67' ' ' GLY . . . -61.3 140.63 47.74 Favored Glycine 0 N--CA 1.443 -0.892 0 CA-C-N 115.047 -0.979 . . . . 0.61 115.499 -175.691 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 79.87 35.25 28.51 Favored Glycine 0 CA--C 1.524 0.644 0 CA-C-N 114.05 -1.075 . . . . 0.33 110.911 174.161 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -57.41 -52.04 61.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 125.094 1.358 . . . . 1.03 109.499 175.465 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -111.5 155.0 23.92 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 125.404 1.481 . . . . 0.33 108.339 163.147 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.2 mtpp -142.64 157.86 44.26 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.868 1.267 . . . . 2.38 109.408 175.959 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 62.32 -151.06 46.3 Favored Glycine 0 CA--C 1.529 0.94 0 N-CA-C 111.133 -0.787 . . . . 0.76 111.133 -177.38 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -50.79 -35.08 30.15 Favored 'General case' 0 C--N 1.34 0.192 0 C-N-CA 123.865 0.866 . . . . 0.56 111.736 -175.775 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -50.87 -50.96 55.89 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.006 0.922 . . . . 2.14 110.621 174.105 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -75.81 -49.59 17.6 Favored 'General case' 0 CA--C 1.528 0.1 0 C-N-CA 123.335 0.654 . . . . 0.24 111.043 179.36 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -55.11 -48.35 73.73 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.724 0.809 . . . . 2.49 110.696 -176.397 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.21 -50.67 72.73 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 109.909 -0.404 . . . . 0.26 109.909 177.638 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.447 HG22 HG23 ' A' ' 28' ' ' VAL . 57.4 t -53.57 -59.14 2.06 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.272 0 CA-C-O 119.508 -0.282 . . . . 0.35 110.465 178.591 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -42.87 -56.34 3.29 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 123.831 0.852 . . . . 0.2 112.144 174.299 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.67 -46.97 85.71 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 121.487 0.661 . . . . 0.31 111.923 -176.364 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.439 ' CZ3' HG21 ' A' ' 28' ' ' VAL . 74.9 t90 -58.99 -49.9 76.14 Favored 'General case' 0 C--N 1.328 -0.362 0 O-C-N 121.747 -0.596 . . . . 0.51 109.879 178.339 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.05 -32.89 74.37 Favored 'General case' 0 C--O 1.223 -0.329 0 CA-C-O 117.981 -1.009 . . . . 2.13 111.995 176.164 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -55.99 -36.16 67.59 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 119.621 1.1 . . . . 0.37 110.097 170.233 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -68.59 -36.06 78.19 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 118.459 -0.781 . . . . 3.31 111.51 172.589 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 4.2 mtpt -74.17 134.71 42.8 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 119.736 1.153 . . . . 2.15 110.801 -178.338 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 2.6 mptt . . . . . 0 C--O 1.25 1.12 0 N-CA-C 105.738 -1.949 . . . . 2.91 105.738 172.458 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 . . . . . 0 N--CA 1.452 -0.331 0 N-CA-C 103.587 -2.746 . . . . 2.73 103.587 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.62 -49.91 71.57 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-O 121.481 0.658 . . . . 0.36 109.905 -171.764 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -58.91 -48.25 82.12 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.116 -0.947 . . . . 3.17 109.929 -178.773 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.96 -47.07 87.3 Favored 'General case' 0 CA--C 1.527 0.096 0 C-N-CA 122.938 0.495 . . . . 0.32 111.066 -179.933 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 75.6 t -55.72 -55.54 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 N-CA-C 108.913 -0.773 . . . . 0.47 108.913 176.727 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.516 HG13 ' HB2' ' A' ' 32' ' ' CYS . 37.3 t -54.6 -47.55 72.13 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 C-N-CA 122.55 0.34 . . . . 0.37 111.188 -177.8 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 40.1 mm-40 -52.3 -19.46 2.09 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.098 1.359 . . . . 0.66 113.078 174.584 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -135.66 42.31 2.67 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 119.876 1.216 . . . . 2.67 111.939 174.903 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -163.5 -34.19 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 118.106 -0.949 . . . . 1.65 112.8 172.062 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.516 ' HB2' HG13 ' A' ' 28' ' ' VAL . 3.5 m -100.75 -50.66 3.79 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 119.668 1.122 . . . . 0.16 110.736 -178.619 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 8.6 pt -56.07 -27.19 22.82 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 CA-C-N 116.191 -0.459 . . . . 1.35 111.977 -175.627 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.7 m -40.1 -37.35 0.6 Allowed 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.51 1.524 . . . . 1.11 112.145 173.966 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 17.6 m -116.56 -36.65 3.89 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.398 0.679 . . . . 0.23 111.753 173.955 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 92.5 m-70 -80.63 3.31 22.39 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.018 0.927 . . . . 0.3 113.372 -175.628 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 108.43 -78.84 0.24 Allowed Glycine 0 CA--C 1.525 0.681 0 C-N-CA 125.778 1.656 . . . . 2.99 111.937 163.991 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -178.14 -53.4 0.07 OUTLIER Glycine 0 C--O 1.229 -0.219 0 N-CA-C 108.306 -1.918 . . . . 0.89 108.306 -171.355 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -97.07 3.93 51.58 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 117.948 -1.025 . . . . 2.52 110.919 -178.356 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.5 mt 77.76 13.23 1.8 Allowed 'General case' 0 C--N 1.352 0.702 0 CA-C-N 119.704 1.138 . . . . 1.46 110.054 -178.443 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.7 p -78.55 -11.92 59.99 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 128.462 2.705 . . . . 0.55 110.189 -176.166 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.42 156.72 32.41 Favored Glycine 0 N--CA 1.444 -0.829 0 N-CA-C 109.167 -1.573 . . . . 0.65 109.167 -178.758 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -163.21 -79.16 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 123.52 0.728 . . . . 0.28 109.719 179.222 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.5 m -93.1 2.49 56.71 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.187 0.995 . . . . 0.99 110.676 170.798 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -153.27 160.67 30.67 Favored Pre-proline 0 N--CA 1.447 -0.585 0 C-N-CA 126.219 1.808 . . . . 0.21 106.973 -171.455 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -67.15 164.5 29.99 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 123.282 2.655 . . . . 0.29 111.191 -174.86 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -74.38 123.87 25.45 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.858 -0.423 . . . . 0.27 109.858 -178.262 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 49.8 pt -109.85 1.35 9.34 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 C-N-CA 124.28 1.032 . . . . 0.46 112.486 177.784 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 22.0 p-10 -34.53 -48.46 0.36 Allowed 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.587 1.555 . . . . 3.53 112.574 167.516 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 4.6 tttt -113.68 38.97 2.78 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 126.606 1.962 . . . . 5.57 109.326 -177.595 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.36 -47.37 86.18 Favored 'General case' 0 N--CA 1.454 -0.245 0 O-C-N 121.119 -0.988 . . . . 0.32 109.896 170.559 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -51.26 -42.48 49.59 Favored Glycine 0 CA--C 1.526 0.761 0 C-N-CA 123.959 0.79 . . . . 0.77 114.448 -171.67 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.37 -21.06 58.6 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 121.684 -0.892 . . . . 0.92 112.107 179.285 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -82.55 -46.68 13.05 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 118.531 0.605 . . . . 1.97 109.516 176.027 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -138.05 137.78 38.14 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.858 1.263 . . . . 0.61 108.55 -171.777 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 35.1 t -75.64 167.2 22.34 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.898 0.879 . . . . 2.26 109.841 178.951 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -49.51 -43.19 45.32 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.864 0.865 . . . . 2.81 111.893 177.53 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -53.54 -37.54 62.94 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 118.991 0.814 . . . . 2.88 111.447 176.467 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -83.08 -49.07 9.91 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 123.615 0.766 . . . . 3.48 110.091 -178.352 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 65.2 mt -58.73 -44.93 91.15 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.052 0 O-C-N 121.283 -0.885 . . . . 0.25 108.758 -178.637 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 35.3 tp -54.41 -47.55 72.63 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 124.002 0.921 . . . . 0.32 109.846 176.182 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -56.0 -50.64 70.29 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 109.794 -0.447 . . . . 2.06 109.794 174.49 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 74.2 mt -60.22 -30.17 45.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 O-C-N 121.575 -0.703 . . . . 0.78 111.694 178.895 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 46.6 mt -71.64 -50.77 37.07 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 O-C-N 120.151 -1.593 . . . . 0.28 109.95 174.559 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 82.8 mt -70.74 -30.39 66.9 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.869 0.868 . . . . 0.54 112.91 -174.336 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -119.3 12.62 12.59 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 119.11 0.868 . . . . 1.68 109.974 -170.048 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.534 ' N ' ' HA2' ' A' ' 73' ' ' GLY . . . 39.38 -147.07 0.18 Allowed Glycine 0 CA--C 1.542 1.719 0 C-N-CA 127.722 2.582 . . . . 0.63 111.211 -172.449 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 38.8 tt0 175.34 131.1 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 119.344 1.572 . . . . 1.87 108.93 -177.144 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 40.72 -115.62 0.7 Allowed Glycine 0 CA--C 1.532 1.137 0 CA-C-N 119.957 1.253 . . . . 0.46 113.33 -175.95 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -69.98 -21.65 76.9 Favored Glycine 0 CA--C 1.532 1.142 0 O-C-N 122.335 -0.509 . . . . 0.53 112.992 -179.727 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 22.4 ttt -73.66 119.08 74.16 Favored Pre-proline 0 N--CA 1.452 -0.374 0 C-N-CA 124.363 1.065 . . . . 0.43 110.773 -179.817 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -78.85 128.1 8.25 Favored 'Trans proline' 0 N--CA 1.445 -1.376 0 C-N-CA 122.263 1.976 . . . . 2.16 110.525 -179.454 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.534 ' HA2' ' N ' ' A' ' 67' ' ' GLY . . . -61.31 134.17 48.28 Favored Glycine 0 N--CA 1.442 -0.921 0 CA-C-N 115.215 -0.902 . . . . 0.66 114.703 -179.486 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 84.23 38.56 9.93 Favored Glycine 0 CA--C 1.526 0.781 0 CA-C-N 114.543 -0.828 . . . . 0.32 111.676 171.261 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -61.2 -44.31 98.11 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.881 0 C-N-CA 125.43 1.492 . . . . 2.32 110.237 177.203 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -111.48 161.76 15.81 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.498 1.919 . . . . 0.52 109.565 164.659 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 68.6 mttt -133.12 157.64 44.8 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 124.798 1.239 . . . . 3.21 110.837 174.74 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 53.22 -141.74 29.64 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 110.712 -0.955 . . . . 0.71 110.712 176.854 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -52.44 -34.83 50.45 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 117.139 0.469 . . . . 0.72 111.835 179.254 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -53.77 -35.94 61.86 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.699 0.8 . . . . 2.47 109.48 178.39 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -82.18 -52.66 6.76 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.465 0.706 . . . . 0.3 110.805 170.967 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -57.4 -54.52 45.85 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 112.657 0.614 . . . . 1.96 112.657 -172.333 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -55.96 -42.79 76.78 Favored 'General case' 0 N--CA 1.454 -0.253 0 O-C-N 121.88 -0.513 . . . . 0.26 110.472 -179.832 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.481 HG22 HG23 ' A' ' 28' ' ' VAL . 50.8 t -61.12 -53.67 45.79 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 C-N-CA 122.66 0.384 . . . . 0.35 110.666 178.365 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -51.66 -50.46 60.32 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 123.12 0.568 . . . . 0.19 111.514 176.099 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.16 -48.41 81.7 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.452 0.701 . . . . 0.27 110.69 179.412 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.525 ' CE3' HD23 ' A' ' 88' ' ' LEU . 47.6 t90 -56.71 -47.53 79.74 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 121.915 -0.49 . . . . 0.44 109.769 177.086 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.525 HD23 ' CE3' ' A' ' 87' ' ' TRP . 0.1 OUTLIER -64.22 -36.32 83.69 Favored 'General case' 0 N--CA 1.462 0.139 0 C-N-CA 124.162 0.985 . . . . 1.64 111.476 179.305 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -54.55 -41.01 69.25 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 118.987 0.812 . . . . 0.42 110.096 170.988 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -88.4 27.39 1.26 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.722 0.809 . . . . 4.44 112.706 173.098 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.6 mtpm? -119.85 130.95 55.12 Favored 'General case' 0 C--N 1.341 0.21 0 O-C-N 120.858 -1.151 . . . . 2.11 109.245 165.14 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 9.5 mtmp? . . . . . 0 C--O 1.248 1.022 0 C-N-CA 127.924 2.49 . . . . 3.6 104.607 -177.243 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 . . . . . 0 N--CA 1.451 -0.418 0 N-CA-C 109.61 -0.515 . . . . 2.13 109.61 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -97.73 -61.94 1.32 Allowed 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 109.144 -0.687 . . . . 0.43 109.144 178.203 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -51.53 -43.74 62.4 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 116.173 -0.467 . . . . 3.13 111.116 178.164 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.55 -43.72 89.42 Favored 'General case' 0 CA--C 1.528 0.135 0 CA-C-N 118.579 0.627 . . . . 0.37 111.509 179.731 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 73.6 t -63.39 -53.18 48.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 N-CA-C 108.12 -1.067 . . . . 0.34 108.12 178.438 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.656 HG11 HD21 ' A' ' 40' ' ' LEU . 45.1 t -52.34 -48.44 44.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 110.437 -0.209 . . . . 0.32 110.437 -179.623 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.468 ' HA ' HG12 ' A' ' 33' ' ' ILE . 35.6 mm-40 -50.47 -24.5 3.16 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.448 1.899 . . . . 0.65 112.937 175.658 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -142.62 59.04 1.44 Allowed 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 119.184 0.902 . . . . 2.54 111.323 178.459 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -179.81 -36.28 0.01 OUTLIER 'General case' 0 C--O 1.225 -0.207 0 C-N-CA 124.648 1.179 . . . . 1.19 109.695 173.356 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.464 ' HB2' HG13 ' A' ' 28' ' ' VAL . 5.0 m -101.1 -53.66 2.98 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 119.28 0.945 . . . . 0.18 110.973 -178.632 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.468 HG12 ' HA ' ' A' ' 29' ' ' GLN . 2.1 pp -57.37 -25.92 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 CA-C-N 115.876 -0.602 . . . . 0.42 112.041 -175.735 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.1 m -38.17 -35.53 0.17 Allowed 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.001 1.72 . . . . 1.23 112.548 170.483 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 18.5 m -120.9 -44.02 2.44 Favored 'General case' 0 C--N 1.34 0.174 0 C-N-CA 123.326 0.651 . . . . 0.25 111.629 172.854 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 82.4 m-70 -70.13 -8.81 52.61 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.413 0.685 . . . . 0.34 112.817 -175.2 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 88.48 151.93 23.96 Favored Glycine 0 C--N 1.337 0.589 0 N-CA-C 109.757 -1.337 . . . . 1.51 109.757 177.488 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -44.51 -37.54 4.95 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 124.518 1.056 . . . . 0.44 112.31 178.514 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.482 ' C ' HD12 ' A' ' 40' ' ' LEU . 0.8 OUTLIER -98.37 0.24 45.03 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.707 1.203 . . . . 2.09 111.747 -174.061 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.656 HD21 HG11 ' A' ' 28' ' ' VAL . 2.4 mp 65.28 17.14 10.89 Favored 'General case' 0 C--N 1.347 0.458 0 CA-C-N 120.232 1.378 . . . . 1.84 111.543 178.582 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.3 p -84.9 -4.77 59.25 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 128.529 2.731 . . . . 0.4 110.03 -175.707 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.04 127.18 3.65 Favored Glycine 0 N--CA 1.442 -0.903 0 N-CA-C 109.009 -1.636 . . . . 0.55 109.009 179.437 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -134.31 -80.13 0.45 Allowed 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 124.229 1.012 . . . . 0.29 108.904 179.552 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 46.1 m -88.85 2.85 52.98 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.757 0.823 . . . . 1.42 111.047 172.695 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.445 ' HB1' ' HD2' ' A' ' 46' ' ' PRO . . . -158.99 164.86 19.78 Favored Pre-proline 0 CA--C 1.537 0.444 0 C-N-CA 124.529 1.132 . . . . 0.28 108.246 -169.188 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.445 ' HD2' ' HB1' ' A' ' 45' ' ' ALA . 55.2 Cg_endo -68.75 157.69 60.84 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 123.157 2.571 . . . . 0.27 110.951 -173.389 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.45 128.76 36.41 Favored 'General case' 0 CA--C 1.529 0.146 0 O-C-N 121.584 -0.697 . . . . 0.32 110.307 -175.653 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 48.6 pt -106.63 0.21 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 C-N-CA 123.328 0.651 . . . . 0.31 111.626 176.954 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -38.99 -38.29 0.43 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.789 0.836 . . . . 2.27 113.105 170.085 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 4.2 pttt -113.49 30.05 7.52 Favored 'General case' 0 C--N 1.343 0.316 0 C-N-CA 124.507 1.123 . . . . 4.08 111.642 -178.689 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -68.36 -41.97 79.86 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 118.652 -0.689 . . . . 0.35 109.624 176.766 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -53.38 -29.83 39.35 Favored Glycine 0 CA--C 1.526 0.735 0 CA-C-N 118.614 0.643 . . . . 0.72 114.646 -175.419 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -83.41 -47.49 11.36 Favored 'General case' 0 N--CA 1.455 -0.197 0 O-C-N 122.403 -0.469 . . . . 1.14 110.366 175.253 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 38.4 m-80 -55.63 -44.27 76.96 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 122.286 0.234 . . . . 1.54 111.158 179.43 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -139.75 134.15 31.46 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.022 1.729 . . . . 0.62 107.691 -167.309 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 49.2 m -74.98 170.73 15.4 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 118.348 0.522 . . . . 1.49 110.774 178.059 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 73.3 tt0 -45.54 -59.53 2.67 Favored 'General case' 0 C--N 1.342 0.267 0 C-N-CA 123.178 0.591 . . . . 5.26 110.75 177.148 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 31.5 mp0 -51.28 -31.86 22.71 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.656 0.782 . . . . 4.28 112.906 179.259 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -80.85 -48.46 12.38 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 119.23 0.923 . . . . 2.64 109.315 -179.191 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 84.6 mt -61.77 -47.1 94.85 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.222 0 O-C-N 121.565 -0.709 . . . . 0.26 109.256 -179.215 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 31.2 tp -52.2 -50.2 62.38 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 108.956 -0.757 . . . . 0.38 108.956 175.789 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -57.02 -43.23 81.65 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 120.72 -0.392 . . . . 1.67 110.997 178.157 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 31.6 mt -58.73 -54.0 39.63 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.262 0 O-C-N 120.861 -1.149 . . . . 0.67 110.494 173.257 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 58.2 mt -50.75 -41.97 22.04 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 O-C-N 120.655 -1.278 . . . . 0.19 110.513 -179.614 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 88.5 mt -69.18 -40.53 78.03 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 113.436 0.902 . . . . 0.58 113.436 176.951 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 -118.31 19.1 13.56 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 120.489 1.495 . . . . 1.77 110.202 -164.706 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.573 ' N ' ' HA2' ' A' ' 73' ' ' GLY . . . 29.47 -136.5 0.05 OUTLIER Glycine 0 CA--C 1.532 1.154 0 C-N-CA 128.511 2.958 . . . . 0.65 110.973 -162.458 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 171.66 133.01 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 119.085 1.443 . . . . 1.55 108.28 -176.736 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 40.76 -118.85 1.28 Allowed Glycine 0 CA--C 1.533 1.208 0 CA-C-N 120.405 1.457 . . . . 0.36 113.294 -178.199 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -68.49 -19.25 72.57 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 123.704 0.669 . . . . 0.51 113.23 179.204 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 19.9 ttt -74.41 119.12 74.95 Favored Pre-proline 0 N--CA 1.449 -0.485 0 C-N-CA 124.288 1.035 . . . . 0.38 110.677 179.174 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -74.86 127.34 10.7 Favored 'Trans proline' 0 N--CA 1.442 -1.551 0 C-N-CA 122.01 1.806 . . . . 2.1 109.812 177.631 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.573 ' HA2' ' N ' ' A' ' 67' ' ' GLY . . . -63.17 140.76 45.55 Favored Glycine 0 N--CA 1.442 -0.956 0 CA-C-N 115.487 -0.779 . . . . 0.65 114.655 176.953 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 84.27 38.0 10.47 Favored Glycine 0 CA--C 1.525 0.692 0 CA-C-N 113.757 -1.221 . . . . 0.56 111.507 173.605 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.5 mm -64.3 -58.03 8.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 C-N-CA 123.779 0.831 . . . . 1.99 110.002 176.559 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -104.94 152.58 22.5 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.893 1.277 . . . . 0.29 108.206 167.807 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 2.1 mmmt -142.28 154.99 45.19 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 124.732 1.213 . . . . 3.2 108.995 -178.721 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 63.67 -158.29 40.44 Favored Glycine 0 CA--C 1.531 1.043 0 N-CA-C 111.315 -0.714 . . . . 0.63 111.315 -173.814 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -53.14 -26.04 15.42 Favored 'General case' 0 C--N 1.34 0.173 0 C-N-CA 123.873 0.869 . . . . 0.62 112.415 -179.983 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -47.92 -48.81 31.61 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.493 1.117 . . . . 2.11 110.577 171.326 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -74.32 -47.68 33.07 Favored 'General case' 0 N--CA 1.455 -0.189 0 O-C-N 121.645 -0.659 . . . . 0.31 111.333 177.285 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -55.92 -51.95 65.82 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.24 0.616 . . . . 2.59 110.645 -174.979 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -54.0 -47.5 71.4 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.774 0.829 . . . . 0.27 110.308 178.644 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.516 HG22 HG23 ' A' ' 28' ' ' VAL . 44.4 t -58.84 -55.46 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 C-N-CA 122.607 0.363 . . . . 0.43 110.832 177.983 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -48.68 -51.9 26.1 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.183 0.593 . . . . 0.21 111.252 176.639 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.23 -48.91 79.74 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 121.449 0.642 . . . . 0.34 111.138 -179.768 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 75.2 t90 -58.75 -50.23 74.69 Favored 'General case' 0 CA--C 1.532 0.287 0 O-C-N 121.459 -0.776 . . . . 0.49 109.975 -179.987 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.71 -32.93 72.15 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 118.283 -0.865 . . . . 2.08 111.83 173.631 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -54.99 -31.49 60.95 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 119.85 1.204 . . . . 0.41 110.975 173.332 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -77.93 -38.34 45.7 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 118.342 -0.837 . . . . 3.28 112.448 169.534 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 42.6 mtpt -73.04 111.65 8.35 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 119.714 1.143 . . . . 2.49 111.162 -177.347 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 2.0 pttt . . . . . 0 C--O 1.251 1.149 0 C-N-CA 126.467 1.907 . . . . 2.33 107.175 177.514 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 . . . . . 0 N--CA 1.454 -0.273 0 N-CA-C 109.462 -0.569 . . . . 2.21 109.462 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -48.38 -52.72 20.52 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.94 0.896 . . . . 0.33 110.918 -179.325 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -58.78 -44.34 90.67 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 116.269 -0.423 . . . . 2.84 110.111 179.607 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.02 -43.27 99.14 Favored 'General case' 0 C--N 1.34 0.163 0 C-N-CA 122.719 0.408 . . . . 0.26 111.221 -179.675 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 77.7 t -58.4 -55.73 20.72 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.365 0 N-CA-C 108.923 -0.769 . . . . 0.38 108.923 175.432 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.553 HG13 ' HB2' ' A' ' 32' ' ' CYS . 50.9 t -54.6 -45.02 71.64 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 N-CA-C 110.331 -0.248 . . . . 0.27 110.331 -177.227 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.445 ' HA ' HG12 ' A' ' 33' ' ' ILE . 29.9 mm-40 -51.49 -26.28 8.02 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.927 1.691 . . . . 0.57 113.611 172.742 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -139.99 58.85 1.59 Allowed 'General case' 0 C--N 1.338 0.103 0 CA-C-N 119.851 1.205 . . . . 2.32 112.403 173.073 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -173.82 -36.74 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 123.866 0.867 . . . . 1.28 110.143 169.3 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.553 ' HB2' HG13 ' A' ' 28' ' ' VAL . 5.6 m -98.71 -51.67 3.84 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 118.958 0.799 . . . . 0.21 110.402 -177.923 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.445 HG12 ' HA ' ' A' ' 29' ' ' GLN . 2.2 pp -57.09 -26.67 25.57 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.08 0 CA-C-N 116.211 -0.449 . . . . 0.38 112.027 -176.414 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 50.3 m -37.82 -38.45 0.29 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.121 1.369 . . . . 1.06 112.194 170.989 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 22.5 m -120.23 -40.96 2.65 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.194 0.597 . . . . 0.18 111.549 174.625 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 84.1 m-70 -71.7 -8.93 57.2 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 112.766 0.654 . . . . 0.2 112.766 -176.15 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 86.09 150.15 14.8 Favored Glycine 0 C--N 1.338 0.66 0 N-CA-C 109.838 -1.305 . . . . 1.49 109.838 178.958 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -44.47 -36.91 4.63 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 124.558 1.075 . . . . 0.46 112.191 177.277 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -95.96 -3.82 44.43 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 124.691 1.196 . . . . 2.63 111.725 -172.831 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 8.7 mt 69.41 13.05 8.41 Favored 'General case' 0 C--N 1.35 0.607 0 CA-C-N 120.463 1.483 . . . . 1.1 111.316 176.126 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.4 p -86.03 -2.68 58.54 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 128.318 2.647 . . . . 0.3 109.9 -175.867 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.89 129.27 3.02 Favored Glycine 0 N--CA 1.441 -0.997 0 N-CA-C 108.827 -1.709 . . . . 0.53 108.827 -178.559 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -134.86 -78.42 0.45 Allowed 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 124.071 0.949 . . . . 0.29 108.773 178.662 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -90.72 3.58 53.89 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.148 0.979 . . . . 1.09 110.7 173.415 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.429 ' HB1' ' HD2' ' A' ' 46' ' ' PRO . . . -156.12 168.01 13.16 Favored Pre-proline 0 CA--C 1.537 0.45 0 C-N-CA 125.657 1.583 . . . . 0.23 108.078 -170.551 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.429 ' HD2' ' HB1' ' A' ' 45' ' ' ALA . 11.7 Cg_endo -67.11 168.79 16.54 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.698 2.266 . . . . 0.45 110.816 -178.793 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -85.19 124.46 31.87 Favored 'General case' 0 CA--C 1.53 0.199 0 O-C-N 121.234 -0.917 . . . . 0.26 110.883 -176.494 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 43.6 pt -100.41 0.09 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 C-N-CA 123.769 0.827 . . . . 0.48 111.312 178.942 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -36.87 -46.0 0.59 Allowed 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.807 1.243 . . . . 2.3 113.095 171.566 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.5 mttp -114.33 38.83 2.93 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.947 0.88 . . . . 3.56 110.573 -179.515 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.06 -50.08 74.76 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 118.641 -0.695 . . . . 0.31 109.432 175.106 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -54.3 -26.28 36.07 Favored Glycine 0 CA--C 1.528 0.878 0 CA-C-N 118.721 0.691 . . . . 0.56 113.695 -177.257 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -81.32 -44.23 17.95 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 117.507 0.653 . . . . 0.86 110.181 176.582 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 38.6 m-80 -62.08 -48.11 81.68 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 122.446 0.298 . . . . 1.7 110.934 178.12 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 -141.38 145.0 34.82 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.431 1.492 . . . . 0.65 108.731 -168.016 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 64.5 m -78.87 166.81 22.0 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.59 0.756 . . . . 1.59 111.118 179.659 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -43.96 -53.8 5.9 Favored 'General case' 0 C--N 1.342 0.266 0 C-N-CA 123.712 0.805 . . . . 4.55 110.927 177.52 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -51.1 -41.41 59.98 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 122.868 0.467 . . . . 4.08 111.387 -178.858 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -74.62 -48.48 26.19 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 123.32 0.648 . . . . 3.2 109.484 -177.484 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 67.0 mt -60.76 -46.73 95.56 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.078 0 N-CA-C 108.935 -0.765 . . . . 0.22 108.935 -177.915 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 24.6 tp -52.04 -53.72 38.68 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 124.223 1.009 . . . . 0.39 109.367 175.819 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -53.5 -48.47 68.95 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 120.879 0.371 . . . . 1.94 110.846 175.471 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 71.3 mt -62.2 -26.58 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 O-C-N 121.385 -0.822 . . . . 0.76 112.32 179.842 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 54.8 mt -75.12 -50.7 23.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 O-C-N 120.131 -1.606 . . . . 0.2 108.297 173.048 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 88.4 mt -62.62 -32.65 73.71 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.793 1.237 . . . . 0.42 113.193 -177.376 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -128.08 20.06 6.42 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 119.697 1.135 . . . . 1.85 110.213 -166.031 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.411 ' CA ' ' HA2' ' A' ' 73' ' ' GLY . . . 33.81 -137.97 0.17 Allowed Glycine 0 CA--C 1.544 1.852 0 C-N-CA 126.638 2.066 . . . . 0.68 112.023 -167.282 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 164.68 141.22 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 126.45 1.9 . . . . 1.27 109.191 -177.785 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 29.06 -111.71 0.03 OUTLIER Glycine 0 C--N 1.347 1.177 0 C-N-CA 125.68 1.609 . . . . 0.6 114.294 -172.471 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -62.35 -30.34 75.87 Favored Glycine 0 CA--C 1.535 1.344 0 CA-C-N 117.655 0.727 . . . . 0.78 113.087 -179.414 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 5.9 ttt -70.41 122.08 85.35 Favored Pre-proline 0 CA--C 1.542 0.652 0 C-N-CA 125.114 1.366 . . . . 0.54 111.224 -179.079 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -62.87 -58.27 0.34 Allowed 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 124.275 3.317 . . . . 3.07 111.333 -172.32 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.411 ' HA2' ' CA ' ' A' ' 67' ' ' GLY . . . 120.8 148.33 7.98 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-O 122.205 0.891 . . . . 0.79 114.448 172.82 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 70.91 21.94 78.26 Favored Glycine 0 CA--C 1.526 0.768 0 CA-C-O 118.484 -1.176 . . . . 0.51 112.126 177.518 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.5 mt -47.12 -52.4 4.56 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 C-N-CA 129.052 2.941 . . . . 1.14 111.158 175.001 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -109.98 156.87 19.92 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.609 1.564 . . . . 0.28 108.903 164.375 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 17.9 mtmm -146.28 159.75 42.92 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 124.559 1.144 . . . . 3.22 110.403 171.565 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 61.59 -151.22 43.91 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 110.05 -1.22 . . . . 0.69 110.05 -177.586 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -46.76 -37.3 8.35 Favored 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 123.901 0.88 . . . . 0.8 112.01 179.69 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -51.84 -45.68 64.09 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.73 0.812 . . . . 2.08 110.691 176.169 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -81.15 -50.22 9.87 Favored 'General case' 0 N--CA 1.455 -0.186 0 O-C-N 121.786 -0.572 . . . . 0.26 110.937 177.379 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -53.4 -51.06 63.78 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.461 0.704 . . . . 2.39 111.455 -175.781 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.26 -46.13 86.58 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 122.567 0.347 . . . . 0.26 110.309 179.791 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.483 HG22 HG23 ' A' ' 28' ' ' VAL . 67.2 t -58.25 -54.71 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 CA-C-O 119.385 -0.341 . . . . 0.28 110.629 178.12 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -49.99 -50.42 47.12 Favored 'General case' 0 C--O 1.224 -0.266 0 C-N-CA 122.855 0.462 . . . . 0.25 111.023 176.397 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.57 -48.12 83.17 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 121.822 0.82 . . . . 0.39 110.723 -177.616 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.565 ' CE3' HD23 ' A' ' 88' ' ' LEU . 50.8 t90 -60.92 -43.79 98.1 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 121.79 0.805 . . . . 0.54 110.768 178.197 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.565 HD23 ' CE3' ' A' ' 87' ' ' TRP . 0.1 OUTLIER -64.28 -33.85 76.78 Favored 'General case' 0 C--O 1.223 -0.291 0 O-C-N 121.189 -0.945 . . . . 1.61 109.698 175.527 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.8 -42.19 97.75 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 118.54 0.609 . . . . 0.5 109.553 174.292 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -52.45 -50.78 61.96 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 118.108 -0.949 . . . . 3.24 110.307 168.151 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 26.5 mttm -70.5 111.96 6.42 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 118.955 0.798 . . . . 3.06 111.973 -173.755 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 26.9 mttp . . . . . 0 C--O 1.254 1.303 0 CA-C-O 116.277 -1.821 . . . . 3.04 106.485 -178.505 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 . . . . . 0 N--CA 1.449 -0.5 0 N-CA-C 109.22 -0.659 . . . . 2.59 109.22 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -40.3 -56.0 2.07 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.896 1.278 . . . . 0.35 111.804 179.083 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -48.02 -48.38 32.93 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.451 0.701 . . . . 3.17 112.2 176.435 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.62 -42.27 98.2 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 123.025 0.53 . . . . 0.35 110.485 -179.043 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 61.5 t -61.83 -50.07 81.68 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 N-CA-C 109.768 -0.456 . . . . 0.44 109.768 176.1 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.453 HG21 ' CZ3' ' A' ' 87' ' ' TRP . 79.6 t -52.61 -49.9 43.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 C-N-CA 123.066 0.546 . . . . 0.53 109.593 178.379 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 30.3 mm-40 -54.29 -17.51 3.03 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.688 1.595 . . . . 0.58 114.298 173.517 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -149.15 58.14 1.02 Allowed 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 119.612 1.096 . . . . 3.89 111.853 -179.081 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.1 mttm 178.34 -35.34 0.01 OUTLIER 'General case' 0 C--O 1.225 -0.202 0 C-N-CA 126.233 1.813 . . . . 1.2 109.695 172.926 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 6.4 m -100.28 -53.07 3.21 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 118.949 0.795 . . . . 0.21 110.639 -177.115 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.471 HD12 ' N ' ' A' ' 34' ' ' SER . 2.0 pp -55.14 -26.96 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.111 0 CA-C-N 115.936 -0.574 . . . . 0.45 112.182 -177.94 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.471 ' N ' HD12 ' A' ' 33' ' ' ILE . 1.4 m -38.23 -37.15 0.26 Allowed 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 126.418 1.887 . . . . 1.24 112.434 171.313 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 39.5 m -120.52 -41.34 2.6 Favored 'General case' 0 C--N 1.341 0.201 0 C-N-CA 123.729 0.811 . . . . 0.18 111.741 173.519 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 85.1 m-70 -72.23 -6.78 45.37 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.33 0.652 . . . . 0.21 112.673 -175.735 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 87.1 148.16 12.85 Favored Glycine 0 C--N 1.337 0.633 0 N-CA-C 109.547 -1.421 . . . . 1.45 109.547 177.971 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -43.98 -33.11 2.56 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 124.71 1.148 . . . . 0.54 112.532 174.939 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -94.42 -9.88 34.23 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.582 1.553 . . . . 2.4 112.235 -172.839 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.434 ' CD2' HG22 ' A' ' 33' ' ' ILE . 1.5 mt 71.17 10.21 6.75 Favored 'General case' 0 C--N 1.348 0.516 0 CA-C-N 120.301 1.409 . . . . 1.46 111.395 179.563 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 11.9 p -86.43 0.28 54.46 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 127.206 2.202 . . . . 0.48 109.999 -175.753 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.87 132.42 2.95 Favored Glycine 0 N--CA 1.44 -1.083 0 N-CA-C 108.789 -1.724 . . . . 0.6 108.789 -177.024 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -136.73 -75.47 0.42 Allowed 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 124.122 0.969 . . . . 0.27 108.396 178.328 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -93.71 3.71 55.05 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.852 0.861 . . . . 1.35 110.859 174.615 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -160.53 163.89 20.58 Favored Pre-proline 0 CA--C 1.537 0.474 0 C-N-CA 125.799 1.64 . . . . 0.28 107.564 -166.093 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -69.37 158.87 55.89 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.952 2.435 . . . . 0.26 111.237 -174.124 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -74.5 125.17 28.01 Favored 'General case' 0 C--N 1.332 -0.164 0 O-C-N 121.675 -0.64 . . . . 0.29 111.045 -174.761 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 37.3 pt -103.98 -1.09 9.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-O 119.169 -0.443 . . . . 0.41 112.073 178.996 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -36.6 -40.32 0.25 Allowed 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.899 1.28 . . . . 2.74 113.721 171.548 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.6 mtpm? -119.47 36.62 4.43 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 124.548 1.139 . . . . 3.2 110.759 -178.085 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.53 -46.62 88.32 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 109.317 -0.623 . . . . 0.44 109.317 171.98 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -57.79 -14.94 17.39 Favored Glycine 0 CA--C 1.532 1.14 0 N-CA-C 114.76 0.664 . . . . 0.82 114.76 179.267 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -89.65 -45.41 9.36 Favored 'General case' 0 C--N 1.338 0.091 0 CA-C-N 119.048 1.424 . . . . 0.71 109.755 168.729 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -56.16 -54.33 46.47 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 122.608 0.363 . . . . 1.87 111.616 179.622 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -140.42 158.97 43.21 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.512 1.125 . . . . 0.64 109.563 -168.576 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 22.6 m -84.93 168.26 15.17 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.065 0.546 . . . . 1.53 110.825 178.217 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -50.72 -44.5 58.16 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 123.785 0.834 . . . . 3.0 111.908 -179.608 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -54.86 -46.26 74.68 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 119.116 0.871 . . . . 2.99 111.394 176.474 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 51.7 mm-40 -71.86 -47.17 54.81 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 121.751 0.786 . . . . 3.06 109.064 -173.511 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 64.3 mt -60.51 -46.31 95.63 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 N-CA-C 108.644 -0.873 . . . . 0.26 108.644 178.75 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 38.9 tp -53.95 -51.35 64.12 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 109.087 -0.709 . . . . 0.35 109.087 176.626 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -53.57 -47.06 70.43 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 117.969 0.35 . . . . 1.47 111.208 177.561 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 62.0 mt -58.71 -46.86 90.36 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.295 0 O-C-N 121.341 -0.849 . . . . 0.46 110.844 175.431 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 57.3 mt -58.6 -43.96 88.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 O-C-N 120.339 -1.476 . . . . 0.27 109.89 179.532 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 86.4 mt -71.45 -34.62 70.41 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.496 1.119 . . . . 0.41 113.321 -178.188 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 71.3 m-80 -119.43 16.8 13.0 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 120.069 1.304 . . . . 1.66 110.317 -168.532 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.519 ' N ' ' HA2' ' A' ' 73' ' ' GLY . . . 36.11 -142.46 0.15 Allowed Glycine 0 CA--C 1.536 1.404 0 C-N-CA 127.696 2.569 . . . . 0.62 111.106 -167.463 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 173.22 131.85 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 119.076 1.438 . . . . 1.29 109.216 -175.067 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 42.13 -119.14 1.81 Allowed Glycine 0 CA--C 1.534 1.224 0 CA-C-N 120.006 1.276 . . . . 0.49 112.687 -174.976 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -70.44 -19.35 76.11 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 123.561 0.6 . . . . 0.67 113.016 179.148 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 20.0 ttt -71.21 117.81 60.09 Favored Pre-proline 0 N--CA 1.452 -0.348 0 C-N-CA 124.404 1.081 . . . . 0.43 110.53 -179.584 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -78.26 122.09 5.53 Favored 'Trans proline' 0 N--CA 1.445 -1.349 0 C-N-CA 123.28 2.653 . . . . 2.17 110.732 179.986 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.519 ' HA2' ' N ' ' A' ' 67' ' ' GLY . . . -62.58 142.46 47.86 Favored Glycine 0 N--CA 1.442 -0.917 0 N-CA-C 115.503 0.961 . . . . 0.61 115.503 -175.285 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 77.95 33.49 41.18 Favored Glycine 0 CA--C 1.525 0.678 0 CA-C-N 114.01 -1.095 . . . . 0.37 111.135 174.889 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -56.49 -49.86 75.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.442 0 C-N-CA 124.899 1.28 . . . . 1.0 108.94 172.996 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -109.53 160.06 16.55 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.069 1.748 . . . . 0.35 109.879 164.314 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.1 mmtp -145.91 167.54 23.03 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 126.467 1.907 . . . . 2.37 108.922 177.21 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 50.31 -145.87 9.14 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 110.883 -0.887 . . . . 0.78 110.883 176.811 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -51.98 -34.9 44.46 Favored 'General case' 0 C--O 1.225 -0.199 0 CA-C-N 118.148 0.974 . . . . 0.77 112.045 176.517 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -57.52 -38.61 74.94 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 118.664 0.666 . . . . 2.18 110.118 177.598 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -83.18 -57.68 3.17 Favored 'General case' 0 N--CA 1.461 0.11 0 O-C-N 121.565 -0.71 . . . . 0.28 111.113 174.925 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -51.41 -49.37 61.76 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 124.887 1.275 . . . . 2.43 111.803 -176.123 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.22 -47.06 87.57 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 109.568 -0.53 . . . . 0.31 109.568 178.415 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 56.0 t -57.48 -52.74 53.24 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.312 0 CA-C-O 119.226 -0.416 . . . . 0.27 110.842 178.961 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -52.28 -57.79 8.65 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.548 0.739 . . . . 0.22 111.519 176.561 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.71 -40.76 89.06 Favored 'General case' 0 C--O 1.226 -0.144 0 C-N-CA 123.032 0.533 . . . . 0.61 110.934 -177.062 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.453 ' CZ3' HG21 ' A' ' 28' ' ' VAL . 83.6 t90 -63.79 -52.17 61.49 Favored 'General case' 0 N--CA 1.449 -0.513 0 O-C-N 121.721 -0.612 . . . . 0.74 109.724 176.34 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.36 -27.41 64.16 Favored 'General case' 0 C--N 1.33 -0.277 0 O-C-N 120.675 -1.266 . . . . 1.96 112.167 176.413 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -56.8 -31.79 65.04 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 118.935 0.789 . . . . 0.53 111.988 170.026 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -74.66 -36.36 62.82 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 118.844 0.747 . . . . 4.98 111.052 172.002 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 11.9 mmtm -73.85 102.92 4.2 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 121.428 0.633 . . . . 3.72 110.193 -178.484 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.25 1.088 0 C-N-CA 125.339 1.456 . . . . 2.85 107.711 173.57 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 N--CA 1.448 -0.549 0 N-CA-C 108.191 -1.04 . . . . 3.9 108.191 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -105.78 -62.39 1.37 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.053 -0.721 . . . . 0.4 109.053 173.22 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -55.04 -47.97 74.06 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 119.021 -0.514 . . . . 2.76 111.251 178.778 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.32 -41.58 93.82 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 118.95 0.796 . . . . 0.42 111.106 -176.731 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 73.6 t -59.93 -57.41 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 108.677 -0.86 . . . . 0.47 108.677 175.031 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.67 HG13 ' HB2' ' A' ' 32' ' ' CYS . 49.3 t -53.11 -48.37 53.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 CA-C-N 118.544 0.611 . . . . 0.33 110.885 -178.479 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 22.4 mm-40 -51.88 -16.21 0.67 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 127.032 2.133 . . . . 0.77 113.244 175.263 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -138.31 30.25 2.42 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 119.139 0.882 . . . . 2.62 111.812 173.431 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -146.59 -48.43 0.19 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 118.831 0.741 . . . . 2.17 111.103 176.481 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.67 ' HB2' HG13 ' A' ' 28' ' ' VAL . 3.5 m -93.45 -47.95 6.62 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 109.583 -0.525 . . . . 0.24 109.583 -174.6 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.3 pp -57.35 -25.74 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 CA-C-N 115.897 -0.592 . . . . 0.43 111.62 -178.451 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.1 m -41.89 -34.09 0.62 Allowed 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 126.157 1.783 . . . . 1.4 112.388 172.144 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 37.2 m -121.37 -42.43 2.46 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.454 0.702 . . . . 0.23 111.592 172.939 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 87.0 m-70 -72.93 -8.01 53.67 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.031 0.932 . . . . 0.24 113.161 -175.483 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 85.05 150.03 11.99 Favored Glycine 0 C--N 1.337 0.601 0 N-CA-C 110.028 -1.229 . . . . 1.58 110.028 178.699 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -43.83 -35.92 3.43 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 124.857 1.217 . . . . 0.48 112.558 178.227 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -93.12 -9.0 41.05 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.307 1.443 . . . . 2.07 112.41 -173.08 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.3 mt 71.41 9.49 6.49 Favored 'General case' 0 C--N 1.347 0.465 0 CA-C-N 120.254 1.388 . . . . 1.29 111.268 179.909 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.6 p -81.95 -2.47 51.53 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 127.764 2.425 . . . . 0.5 110.207 -177.205 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.54 150.31 25.18 Favored Glycine 0 N--CA 1.438 -1.169 0 N-CA-C 108.472 -1.851 . . . . 0.5 108.472 -174.597 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -156.77 -79.94 0.08 Allowed 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 124.477 1.111 . . . . 0.32 108.712 179.278 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.3 t -92.06 2.71 56.4 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.146 0.978 . . . . 1.26 110.379 172.963 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.437 ' HB1' ' HD2' ' A' ' 46' ' ' PRO . . . -158.62 163.89 22.86 Favored Pre-proline 0 N--CA 1.45 -0.47 0 C-N-CA 125.704 1.602 . . . . 0.27 107.494 -168.227 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.437 ' HD2' ' HB1' ' A' ' 45' ' ' ALA . 48.1 Cg_endo -69.01 162.47 41.57 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 123.63 2.887 . . . . 0.37 111.265 -174.207 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -74.76 122.49 23.37 Favored 'General case' 0 N--CA 1.455 -0.21 0 O-C-N 121.849 -0.532 . . . . 0.38 110.654 -176.072 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 33.8 pt -105.41 1.81 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.117 0 C-N-CA 123.717 0.807 . . . . 0.39 111.4 178.096 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -44.95 -45.45 10.48 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 112.982 0.734 . . . . 2.62 112.982 176.379 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.04 27.76 5.82 Favored 'General case' 0 C--N 1.343 0.303 0 C-N-CA 123.945 0.898 . . . . 4.04 111.582 178.63 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -56.17 -46.04 79.47 Favored 'General case' 0 N--CA 1.452 -0.352 0 O-C-N 121.62 -0.675 . . . . 0.27 109.502 177.07 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -53.47 -30.91 42.74 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 123.448 0.547 . . . . 0.49 113.313 -179.126 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -76.94 -42.32 39.77 Favored 'General case' 0 N--CA 1.455 -0.206 0 O-C-N 122.031 -0.687 . . . . 0.72 110.613 176.529 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 48.7 m-20 -66.05 -49.29 68.17 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 122.129 0.172 . . . . 1.53 111.034 -179.926 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -139.14 141.67 38.04 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 125.568 1.547 . . . . 0.68 107.837 -167.448 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 22.4 m -78.18 168.98 19.02 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 118.45 0.568 . . . . 1.59 110.363 179.65 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -50.82 -44.23 59.18 Favored 'General case' 0 C--O 1.224 -0.258 0 C-N-CA 123.346 0.658 . . . . 3.05 111.973 -179.593 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -54.92 -39.26 68.63 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 118.492 0.587 . . . . 2.9 111.67 176.98 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -78.67 -45.67 20.86 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 121.495 0.664 . . . . 3.49 109.47 -177.262 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 62.4 mt -59.11 -44.5 91.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 O-C-N 121.653 -0.654 . . . . 0.26 109.289 179.189 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 35.4 tp -55.33 -50.1 70.51 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 123.854 0.861 . . . . 0.32 109.453 176.174 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -50.98 -52.68 40.27 Favored 'General case' 0 N--CA 1.454 -0.235 0 O-C-N 123.312 0.382 . . . . 1.51 110.264 176.138 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 86.3 mt -56.8 -51.11 71.46 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.328 0 O-C-N 121.64 -0.663 . . . . 0.53 110.287 177.977 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 71.0 mt -52.65 -44.78 47.16 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 O-C-N 120.47 -1.394 . . . . 0.22 110.486 179.247 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 79.4 mt -73.06 -32.57 65.13 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 113.164 0.801 . . . . 0.39 113.164 -179.087 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -121.96 20.6 10.76 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 119.591 1.087 . . . . 1.64 110.161 -165.539 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.54 ' N ' ' HA2' ' A' ' 73' ' ' GLY . . . 28.75 -139.43 0.02 OUTLIER Glycine 0 CA--C 1.534 1.268 0 C-N-CA 129.127 3.251 . . . . 0.68 111.524 -165.401 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 174.58 133.95 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 118.994 1.397 . . . . 1.2 107.935 -178.394 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 31.43 -110.04 0.04 OUTLIER Glycine 0 CA--C 1.535 1.282 0 C-N-CA 124.971 1.272 . . . . 0.34 114.246 -172.515 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -69.61 -24.11 76.37 Favored Glycine 0 CA--C 1.533 1.206 0 CA-C-N 118.114 0.957 . . . . 0.42 113.166 -178.328 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 18.1 ttt -70.99 120.03 76.96 Favored Pre-proline 0 N--CA 1.452 -0.371 0 C-N-CA 125.004 1.321 . . . . 0.35 111.039 -178.605 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.431 ' HD2' HD11 ' A' ' 75' ' ' ILE . 37.4 Cg_endo -75.62 122.33 6.85 Favored 'Trans proline' 0 N--CA 1.446 -1.304 0 C-N-CA 123.297 2.665 . . . . 2.05 111.135 178.933 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.54 ' HA2' ' N ' ' A' ' 67' ' ' GLY . . . -61.06 137.39 48.16 Favored Glycine 0 N--CA 1.442 -0.934 0 CA-C-N 115.271 -0.877 . . . . 0.67 114.833 -179.272 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 82.16 42.71 8.53 Favored Glycine 0 CA--C 1.524 0.632 0 CA-C-N 114.225 -0.988 . . . . 0.54 110.636 175.829 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.431 HD11 ' HD2' ' A' ' 72' ' ' PRO . 0.9 OUTLIER -63.66 -57.42 11.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 C-N-CA 124.379 1.072 . . . . 1.23 109.283 174.172 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -98.12 155.94 16.9 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.952 1.301 . . . . 0.4 109.383 166.08 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -146.0 151.37 37.67 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 124.322 1.049 . . . . 2.75 110.959 178.424 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 72.51 -163.62 54.69 Favored Glycine 0 CA--C 1.53 1.016 0 N-CA-C 110.747 -0.941 . . . . 0.83 110.747 -174.437 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -52.02 -24.13 6.2 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.737 1.215 . . . . 0.95 112.718 -179.061 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 47.9 tt0 -43.99 -63.16 0.92 Allowed 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.736 1.215 . . . . 2.61 110.283 167.903 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.45 -45.09 94.93 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.189 0.596 . . . . 0.23 110.271 -176.275 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -53.81 -54.07 43.58 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.742 0.817 . . . . 1.99 110.979 178.001 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -56.41 -49.51 74.3 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 123.811 0.844 . . . . 0.31 109.764 -179.824 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.456 HG22 HG23 ' A' ' 28' ' ' VAL . 69.2 t -54.99 -52.77 40.58 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-N 116.939 -0.119 . . . . 0.3 111.26 176.802 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -54.63 -52.02 63.57 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.38 0.672 . . . . 0.18 111.919 -179.881 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.99 -48.06 79.33 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 121.553 0.692 . . . . 0.3 110.555 177.226 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.539 ' CE3' HD23 ' A' ' 88' ' ' LEU . 54.6 t90 -57.08 -44.97 83.64 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 121.71 -0.619 . . . . 0.5 110.548 177.778 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.539 HD23 ' CE3' ' A' ' 87' ' ' TRP . 0.1 OUTLIER -63.89 -37.38 87.17 Favored 'General case' 0 N--CA 1.461 0.088 0 C-N-CA 124.749 1.22 . . . . 1.6 111.599 177.203 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -54.69 -38.44 67.01 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 119.216 0.916 . . . . 0.55 110.432 169.552 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -88.76 26.2 1.58 Allowed 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 113.473 0.916 . . . . 3.31 113.473 171.795 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 2.1 mtpm? -122.05 117.88 27.41 Favored 'General case' 0 C--N 1.341 0.239 0 O-C-N 120.647 -1.283 . . . . 2.26 110.218 165.854 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.256 1.405 0 C-N-CA 129.535 3.134 . . . . 2.83 104.738 174.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.535 HG22 ' H ' ' A' ' 23' ' ' ASP 2.22 0.5 OUTLIER . . . . . 0 N--CA 1.471 0.623 0 CA-C-O 114.298 -2.763 . . . . 2.34 105.977 . . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.535 ' H ' HG22 ' A' ' 22' ' ' VAL . 0.1 OUTLIER -96.59 89.31 4.94 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 104.12 -2.548 . . . . 2.31 104.12 153.772 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.27 -52.49 33.22 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-O 122.428 1.109 . . . . 0.48 109.265 -166.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.434 ' HB3' ' CZ2' ' A' ' 87' ' ' TRP . 5.5 pt-20 -55.69 -48.06 75.72 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 114.15 -1.387 . . . . 2.73 111.839 175.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.462 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . . . -56.86 -46.06 82.05 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 119.617 1.099 . . . . 0.37 111.013 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.576 HG21 ' HG3' ' A' ' 80' ' ' GLU . 68.7 t -55.86 -56.76 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.225 0 N-CA-C 108.901 -0.777 . . . . 0.48 108.901 176.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.589 HG22 ' SG ' ' A' ' 32' ' ' CYS . 29.9 t -51.93 -49.14 38.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 O-C-N 122.343 -0.223 . . . . 0.29 111.274 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.414 ' HA ' HG12 ' A' ' 33' ' ' ILE . 18.1 mm-40 -57.34 -8.03 0.69 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 127.895 2.478 . . . . 1.22 113.671 176.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 19.6 tp60 -137.44 17.57 2.93 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 119.772 1.169 . . . . 2.94 111.522 172.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.476 ' O ' HMC3 ' A' ' 93' ' ' HEC . 50.3 mmtt -138.97 -59.44 0.6 Allowed 'General case' 0 CA--C 1.514 -0.434 0 O-C-N 121.111 -0.993 . . . . 2.54 110.435 -177.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.589 ' SG ' HG22 ' A' ' 28' ' ' VAL . 2.8 m -79.45 -47.68 15.24 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 108.698 -0.852 . . . . 0.34 108.698 -173.331 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.414 HG12 ' HA ' ' A' ' 29' ' ' GLN . 2.5 pp -52.85 -30.2 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 CA-C-N 115.384 -0.826 . . . . 0.39 111.95 -179.265 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.8 m -46.01 -30.81 1.97 Allowed 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.132 1.373 . . . . 1.23 112.738 176.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 30.1 m -121.93 -44.55 2.3 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.784 0.834 . . . . 0.17 111.386 173.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 87.1 m-70 -68.61 -10.13 54.07 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.724 1.21 . . . . 0.26 112.558 -177.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 87.99 148.31 15.19 Favored Glycine 0 C--N 1.339 0.702 0 C-N-CA 125.468 1.509 . . . . 1.48 109.64 179.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -41.83 -36.98 1.92 Allowed Glycine 0 C--N 1.341 0.84 0 C-N-CA 124.653 1.121 . . . . 0.47 112.214 173.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -89.94 -12.4 38.93 Favored 'General case' 0 N--CA 1.444 -0.76 0 C-N-CA 125.876 1.67 . . . . 3.08 111.429 -172.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.0 mt 71.24 11.61 6.79 Favored 'General case' 0 C--N 1.349 0.56 0 CA-C-N 119.983 1.265 . . . . 1.15 111.249 178.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.6 p -87.2 0.09 55.88 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 127.696 2.398 . . . . 0.5 110.018 -175.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.7 126.22 2.32 Favored Glycine 0 N--CA 1.441 -0.977 0 N-CA-C 109.052 -1.619 . . . . 0.81 109.052 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -131.27 -77.93 0.52 Allowed 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 124.311 1.044 . . . . 0.3 108.405 178.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 12.6 m -92.59 4.29 53.9 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.393 1.077 . . . . 1.35 110.984 173.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.468 ' HB1' ' HD2' ' A' ' 46' ' ' PRO . . . -157.82 166.63 16.16 Favored Pre-proline 0 CA--C 1.537 0.453 0 C-N-CA 125.013 1.325 . . . . 0.23 108.353 -168.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.468 ' HD2' ' HB1' ' A' ' 45' ' ' ALA . 69.7 Cg_endo -73.88 153.91 48.01 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 123.136 2.557 . . . . 0.39 110.552 -173.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -72.04 125.71 27.94 Favored 'General case' 0 C--N 1.332 -0.171 0 O-C-N 121.107 -0.996 . . . . 0.28 110.725 -174.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 18.1 pt -104.43 1.63 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.143 0 C-N-CA 123.351 0.66 . . . . 0.49 111.697 176.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -36.79 -44.9 0.51 Allowed 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.416 1.086 . . . . 2.38 112.986 170.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 8.4 pttp -113.2 31.89 6.13 Favored 'General case' 0 C--N 1.344 0.332 0 C-N-CA 123.94 0.896 . . . . 4.26 111.876 178.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.92 -44.32 96.41 Favored 'General case' 0 N--CA 1.454 -0.242 0 O-C-N 120.836 -1.165 . . . . 0.31 109.297 178.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -54.2 -26.65 36.62 Favored Glycine 0 C--N 1.339 0.746 0 CA-C-N 118.238 0.472 . . . . 0.59 113.915 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -83.59 -45.07 13.92 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 117.29 0.545 . . . . 0.77 110.031 175.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 35.3 m-80 -58.27 -51.77 68.37 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 122.728 0.411 . . . . 1.62 111.333 178.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -134.12 149.99 51.11 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.456 1.503 . . . . 0.87 108.485 -166.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.66 164.37 25.37 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 109.856 -0.424 . . . . 1.55 109.856 -179.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -49.39 -42.77 43.27 Favored 'General case' 0 C--O 1.223 -0.331 0 C-N-CA 123.301 0.64 . . . . 3.27 110.779 173.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 70.9 mt-10 -52.98 -44.86 67.5 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.207 0.603 . . . . 2.92 110.776 178.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 58.2 mm-40 -75.06 -47.96 26.28 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.172 0.589 . . . . 3.05 110.037 -177.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.532 HG23 HMA1 ' A' ' 93' ' ' HEC . 76.4 mt -62.77 -46.34 96.6 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.111 0 N-CA-C 108.941 -0.763 . . . . 0.31 108.941 -175.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 32.4 tp -53.48 -51.72 61.83 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 124.061 0.944 . . . . 0.56 109.281 176.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -53.09 -51.56 61.44 Favored 'General case' 0 N--CA 1.452 -0.368 0 O-C-N 123.374 0.421 . . . . 1.95 110.504 176.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 40.9 mt -56.02 -45.15 80.26 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.378 0 O-C-N 121.451 -0.781 . . . . 0.45 111.184 177.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.512 HD11 HMB2 ' A' ' 93' ' ' HEC . 43.3 mt -61.98 -45.41 98.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 O-C-N 119.951 -1.718 . . . . 0.34 109.482 179.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 87.5 mt -69.81 -29.04 66.23 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.118 0.967 . . . . 0.57 113.364 -178.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -128.87 19.54 6.05 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 119.683 1.128 . . . . 1.8 110.338 -166.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.525 ' N ' ' HA2' ' A' ' 73' ' ' GLY . . . 34.87 -146.52 0.04 OUTLIER Glycine 0 CA--C 1.538 1.516 0 C-N-CA 128.975 3.179 . . . . 0.64 112.397 -170.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 177.37 135.64 0.07 Allowed 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.173 1.389 . . . . 1.23 108.075 -176.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 32.0 -110.67 0.04 OUTLIER Glycine 0 CA--C 1.533 1.171 0 C-N-CA 125.038 1.304 . . . . 0.38 114.095 -174.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -71.03 -24.65 76.91 Favored Glycine 0 CA--C 1.534 1.243 0 CA-C-N 118.116 0.958 . . . . 0.53 113.053 -178.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.431 ' HB2' ' C1D' ' A' ' 93' ' ' HEC . 17.6 ttt -69.36 118.35 61.33 Favored Pre-proline 0 CA--C 1.535 0.388 0 C-N-CA 125.06 1.344 . . . . 0.4 111.3 -179.003 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -75.67 127.86 10.54 Favored 'Trans proline' 0 N--CA 1.446 -1.279 0 C-N-CA 122.877 2.385 . . . . 2.11 110.671 177.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.525 ' HA2' ' N ' ' A' ' 67' ' ' GLY . . . -66.48 140.35 38.86 Favored Glycine 0 N--CA 1.442 -0.909 0 N-CA-C 115.158 0.823 . . . . 0.7 115.158 -177.064 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 79.53 39.17 18.93 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 110.6 -1.0 . . . . 0.32 110.6 176.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -60.19 -48.95 86.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 124.645 1.178 . . . . 1.09 108.863 175.07 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -102.72 149.3 24.59 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 126.031 1.732 . . . . 0.32 108.87 162.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 65.6 mttt -141.42 160.04 40.97 Favored 'General case' 0 C--N 1.339 0.119 0 C-N-CA 124.097 0.959 . . . . 2.74 110.036 172.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 74.84 -165.16 54.73 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 109.999 -1.241 . . . . 0.97 109.999 -174.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -54.32 -24.47 19.38 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.451 0.701 . . . . 0.94 111.691 -178.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.576 ' HG3' HG21 ' A' ' 27' ' ' VAL . 30.8 tt0 -41.92 -60.14 1.49 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.198 1.399 . . . . 2.31 110.511 169.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.6 -45.66 93.16 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 122.537 0.335 . . . . 0.33 110.293 -174.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -51.73 -60.69 2.88 Favored 'General case' 0 C--N 1.339 0.111 0 C-N-CA 124.08 0.952 . . . . 2.73 110.739 174.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -52.77 -48.9 66.49 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-O 119.242 -0.408 . . . . 0.28 110.743 -179.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.461 HG13 ' CG2' ' A' ' 28' ' ' VAL . 78.6 t -53.69 -59.75 1.75 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 CA-C-N 117.787 0.267 . . . . 0.4 110.865 176.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -50.33 -51.47 45.28 Favored 'General case' 0 C--O 1.226 -0.138 0 C-N-CA 123.669 0.788 . . . . 0.22 112.159 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.2 -45.43 80.81 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.4 0.68 . . . . 0.38 110.683 -175.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.465 ' CZ3' HG21 ' A' ' 28' ' ' VAL . 77.3 t90 -55.23 -47.82 74.83 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 109.041 -0.726 . . . . 0.71 109.041 173.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.03 -37.79 80.83 Favored 'General case' 0 C--O 1.22 -0.474 0 CA-C-O 117.977 -1.011 . . . . 2.0 112.911 173.04 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -52.95 -40.89 64.02 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 120.381 1.446 . . . . 0.38 110.735 175.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -67.54 -38.08 83.66 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-O 118.944 -0.55 . . . . 3.74 112.329 170.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 24.2 mtpp -76.37 108.86 9.62 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 119.906 1.23 . . . . 2.79 111.092 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 88.9 mttt . . . . . 0 C--O 1.25 1.126 0 C-N-CA 126.013 1.725 . . . . 2.14 107.599 -176.356 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' HEC . . . . . 0.532 HMA1 HG23 ' A' ' 60' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.491 HG11 ' HA ' ' A' ' 80' ' ' GLU . 24.9 t . . . . . 0 N--CA 1.471 0.593 0 N-CA-C 106.994 -1.484 . . . . 1.17 106.994 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -83.04 106.36 14.79 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 108.137 -1.06 . . . . 2.2 108.137 -173.508 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -48.0 -54.14 13.91 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.834 0.854 . . . . 0.27 110.786 -179.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -53.34 -46.55 69.53 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 122.73 0.412 . . . . 3.29 111.621 176.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.3 -44.47 97.16 Favored 'General case' 0 CA--C 1.527 0.062 0 C-N-CA 122.877 0.471 . . . . 0.3 110.569 -179.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 77.7 t -57.94 -55.4 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 N-CA-C 109.232 -0.655 . . . . 0.44 109.232 175.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.423 ' HA ' ' SG ' ' A' ' 32' ' ' CYS . 79.0 t -50.99 -47.92 29.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 110.379 -0.23 . . . . 0.41 110.379 -179.288 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 28.6 mm-40 -54.22 -23.33 14.29 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 126.455 1.902 . . . . 0.64 114.72 174.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -142.6 59.23 1.44 Allowed 'General case' 0 N--CA 1.461 0.088 0 CA-C-N 120.54 1.518 . . . . 2.42 112.106 173.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.08 -36.39 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 124.435 1.094 . . . . 1.2 109.611 171.177 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.423 ' SG ' ' HA ' ' A' ' 28' ' ' VAL . 3.7 m -101.9 -50.4 3.69 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 118.813 0.733 . . . . 0.2 110.931 -177.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.536 HG22 HD23 ' A' ' 40' ' ' LEU . 2.0 pp -56.77 -25.77 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 N-CA-C 112.556 0.576 . . . . 0.5 112.556 -174.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.451 ' N ' HD12 ' A' ' 33' ' ' ILE . 8.3 m -41.8 -34.89 0.7 Allowed 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.576 1.55 . . . . 1.01 112.475 172.146 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 18.9 m -121.1 -42.97 2.46 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.369 0.668 . . . . 0.19 111.385 175.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 84.8 m-70 -71.34 -7.65 48.52 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.422 0.689 . . . . 0.17 112.741 -176.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 88.49 149.29 18.67 Favored Glycine 0 C--N 1.338 0.669 0 N-CA-C 109.776 -1.329 . . . . 1.44 109.776 178.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -43.17 -36.45 2.84 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 124.615 1.102 . . . . 0.52 112.233 174.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -97.58 -4.39 37.79 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 124.88 1.272 . . . . 2.9 111.793 -172.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.536 HD23 HG22 ' A' ' 33' ' ' ILE . 1.5 mt 71.43 12.83 6.58 Favored 'General case' 0 C--N 1.348 0.531 0 CA-C-N 120.238 1.381 . . . . 1.42 111.071 176.006 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.3 p -88.71 1.23 55.5 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 127.866 2.466 . . . . 0.31 110.038 -173.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.51 138.0 5.57 Favored Glycine 0 N--CA 1.444 -0.808 0 N-CA-C 109.049 -1.62 . . . . 0.42 109.049 -177.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -143.79 -71.56 0.29 Allowed 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.469 -0.567 . . . . 0.35 109.469 178.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -99.02 3.92 47.01 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.939 1.696 . . . . 0.98 110.315 172.393 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.428 ' HB1' ' HD2' ' A' ' 46' ' ' PRO . . . -158.28 165.43 18.6 Favored Pre-proline 0 CA--C 1.535 0.394 0 C-N-CA 124.907 1.283 . . . . 0.24 107.852 -168.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.428 ' HD2' ' HB1' ' A' ' 45' ' ' ALA . 46.3 Cg_endo -69.5 157.73 59.84 Favored 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 122.621 2.214 . . . . 0.2 110.53 -175.162 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.64 121.49 20.79 Favored 'General case' 0 N--CA 1.454 -0.246 0 O-C-N 121.724 -0.61 . . . . 0.24 109.934 -178.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 41.7 pt -100.99 1.88 10.56 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.161 0 C-N-CA 123.536 0.735 . . . . 0.26 111.039 178.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.434 ' OD1' ' NZ ' ' A' ' 91' ' ' LYS . 34.2 t70 -44.01 -41.23 5.28 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 113.506 0.928 . . . . 3.18 113.506 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 35.0 mttm -109.3 33.19 4.44 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 125.838 1.655 . . . . 6.12 111.403 179.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -58.26 -46.02 86.76 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 108.975 -0.75 . . . . 0.34 108.975 173.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -54.07 -28.55 41.62 Favored Glycine 0 CA--C 1.527 0.785 0 CA-C-N 118.243 0.474 . . . . 0.51 114.158 -179.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -78.62 -42.6 28.46 Favored 'General case' 0 N--CA 1.455 -0.223 0 O-C-N 122.227 -0.573 . . . . 0.72 110.049 175.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 15.8 m-80 -65.63 -48.53 71.91 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 122.784 0.434 . . . . 1.57 111.197 -178.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -138.79 147.74 42.93 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 125.423 1.489 . . . . 0.61 108.327 -170.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 89.6 p -74.62 168.28 20.11 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.033 0.533 . . . . 2.35 110.973 177.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -46.66 -47.21 20.3 Favored 'General case' 0 C--O 1.224 -0.278 0 C-N-CA 124.311 1.044 . . . . 2.76 111.582 174.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -57.7 -41.54 81.91 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.422 0.689 . . . . 4.03 110.531 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -76.23 -45.79 31.26 Favored 'General case' 0 N--CA 1.45 -0.428 0 O-C-N 121.437 -0.789 . . . . 3.44 109.391 -175.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.481 HG23 HMA1 ' A' ' 93' ' ' HEC . 80.9 mt -60.76 -44.43 97.37 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.125 0 N-CA-C 109.027 -0.731 . . . . 0.3 109.027 178.493 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 33.5 tp -54.66 -49.02 71.58 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 109.277 -0.638 . . . . 0.32 109.277 176.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -54.1 -46.19 72.04 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 117.891 0.314 . . . . 1.48 111.498 175.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 73.9 mt -59.63 -49.79 82.4 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.261 0 O-C-N 121.115 -0.991 . . . . 0.54 110.453 176.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.46 HD11 HMB2 ' A' ' 93' ' ' HEC . 58.8 mt -56.18 -44.64 79.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 O-C-N 120.386 -1.446 . . . . 0.22 110.002 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 69.5 mt -71.04 -28.64 64.52 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 124.309 1.043 . . . . 0.36 113.802 -178.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 51.3 m-80 -125.02 15.54 8.51 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 120.374 1.443 . . . . 1.73 110.629 -169.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.554 ' N ' ' HA2' ' A' ' 73' ' ' GLY . . . 35.84 -144.14 0.09 OUTLIER Glycine 0 CA--C 1.537 1.428 0 C-N-CA 128.082 2.753 . . . . 0.62 111.597 -166.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 173.83 133.56 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 119.465 1.632 . . . . 1.22 110.021 -177.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 40.26 -119.36 1.26 Allowed Glycine 0 CA--C 1.532 1.126 0 CA-C-N 119.574 1.079 . . . . 0.38 112.789 -173.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -66.14 -21.76 70.22 Favored Glycine 0 CA--C 1.534 1.233 0 CA-C-N 117.498 0.649 . . . . 0.48 113.245 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.42 ' HB2' ' C1D' ' A' ' 93' ' ' HEC . 18.2 ttt -74.04 121.07 84.33 Favored Pre-proline 0 CA--C 1.536 0.41 0 C-N-CA 124.406 1.082 . . . . 0.35 111.539 -176.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.455 ' HD2' HD11 ' A' ' 75' ' ' ILE . 53.3 Cg_endo -79.02 122.71 5.41 Favored 'Trans proline' 0 N--CA 1.449 -1.097 0 C-N-CA 123.262 2.641 . . . . 2.11 111.688 -178.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.554 ' HA2' ' N ' ' A' ' 67' ' ' GLY . . . -60.65 138.76 48.21 Favored Glycine 0 N--CA 1.443 -0.89 0 N-CA-C 115.5 0.96 . . . . 0.61 115.5 -177.212 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 81.94 35.63 21.03 Favored Glycine 0 CA--C 1.527 0.783 0 CA-C-N 114.379 -0.911 . . . . 0.33 111.612 174.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.455 HD11 ' HD2' ' A' ' 72' ' ' PRO . 1.2 mt -58.23 -52.16 62.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 124.924 1.29 . . . . 1.22 110.059 175.246 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -111.02 161.68 15.63 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.748 1.619 . . . . 0.26 109.036 165.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 18.0 mttm -144.32 164.3 31.18 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 124.931 1.292 . . . . 2.94 110.412 176.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 57.2 -144.5 39.51 Favored Glycine 0 CA--C 1.529 0.908 0 N-CA-C 111.185 -0.766 . . . . 0.71 111.185 179.083 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -52.23 -33.98 43.84 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.203 0.601 . . . . 0.8 111.526 174.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.491 ' HA ' HG11 ' A' ' 22' ' ' VAL . 7.2 tt0 -55.02 -36.64 65.69 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.443 0.697 . . . . 2.28 110.515 176.28 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -88.05 -52.69 5.12 Favored 'General case' 0 CA--C 1.534 0.336 0 O-C-N 121.662 -0.649 . . . . 0.21 111.086 175.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -54.73 -50.9 67.24 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.789 0.836 . . . . 2.48 111.568 -175.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.61 -45.37 92.14 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 109.644 -0.502 . . . . 0.24 109.644 -178.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 64.9 t -57.19 -55.12 22.43 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 C-N-CA 122.831 0.452 . . . . 0.29 110.363 176.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -50.28 -53.83 25.69 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 122.973 0.509 . . . . 0.2 111.497 177.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.33 -44.78 95.69 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 121.542 0.686 . . . . 0.33 111.278 -178.083 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 81.0 t90 -60.82 -50.08 74.91 Favored 'General case' 0 N--CA 1.452 -0.356 0 O-C-N 121.471 -0.768 . . . . 0.63 110.221 179.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.6 -30.64 70.82 Favored 'General case' 0 C--O 1.222 -0.367 0 O-C-N 121.3 -0.875 . . . . 1.97 111.927 172.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -58.92 -31.48 68.69 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 119.603 1.092 . . . . 0.53 111.21 171.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -76.02 -35.68 59.43 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 118.927 0.785 . . . . 3.49 111.784 169.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.517 ' HZ2' ' HB3' ' A' ' 91' ' ' LYS . 0.7 OUTLIER -73.34 110.18 7.44 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 119.522 1.055 . . . . 2.76 111.068 -179.64 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 19.7 mttt . . . . . 0 C--O 1.251 1.163 0 C-N-CA 125.507 1.523 . . . . 2.84 109.342 -170.817 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' HEC . . . . . 0.481 HMA1 HG23 ' A' ' 60' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.0 t . . . . . 0 N--CA 1.472 0.625 0 N-CA-C 106.566 -1.642 . . . . 1.33 106.566 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -74.1 103.83 4.7 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 108.383 -0.969 . . . . 2.68 108.383 -177.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -42.69 -56.09 3.3 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.677 1.191 . . . . 0.3 111.088 177.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -47.56 -47.04 28.45 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 123.524 0.73 . . . . 3.07 111.73 175.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.98 -46.06 90.91 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-N 118.682 0.674 . . . . 0.35 110.412 -179.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 94.5 t -58.51 -52.22 62.1 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.134 0 N-CA-C 109.691 -0.485 . . . . 0.42 109.691 177.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.406 ' HA ' ' SG ' ' A' ' 32' ' ' CYS . 72.4 t -52.47 -52.22 27.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 N-CA-C 109.756 -0.461 . . . . 0.4 109.756 179.033 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 35.3 mm-40 -58.12 -7.2 0.75 Allowed 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 127.547 2.339 . . . . 0.65 114.022 174.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -142.82 33.1 1.4 Allowed 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 119.81 1.187 . . . . 3.1 113.369 172.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.41 ' O ' HMC3 ' A' ' 93' ' ' HEC . 0.1 OUTLIER -153.92 -55.66 0.11 Allowed 'General case' 0 CA--C 1.517 -0.314 0 O-C-N 121.766 -0.584 . . . . 1.57 109.885 170.183 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.406 ' SG ' ' HA ' ' A' ' 28' ' ' VAL . 3.2 m -76.34 -48.29 20.5 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 109.824 -0.436 . . . . 0.2 109.824 -170.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.1 pt -49.93 -30.99 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-N 115.217 -0.901 . . . . 0.79 112.517 -179.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.9 m -46.06 -33.02 3.17 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 125.64 1.576 . . . . 1.02 112.077 177.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 14.6 m -121.95 -44.84 2.28 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.706 0.802 . . . . 0.18 111.228 175.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 82.0 m-70 -67.43 -11.11 57.0 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.189 0.996 . . . . 0.3 112.319 -178.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 87.82 148.04 14.25 Favored Glycine 0 C--N 1.339 0.712 0 N-CA-C 109.396 -1.481 . . . . 1.43 109.396 178.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -43.83 -31.92 2.04 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 124.655 1.121 . . . . 0.59 112.969 173.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -92.62 -12.44 31.63 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.596 1.559 . . . . 2.15 112.831 -175.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 73.0 9.71 5.37 Favored 'General case' 0 C--N 1.347 0.489 0 CA-C-N 120.326 1.421 . . . . 1.6 111.168 178.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.0 p -86.0 -1.66 57.55 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 127.947 2.499 . . . . 0.3 110.222 -174.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.64 132.25 4.64 Favored Glycine 0 N--CA 1.443 -0.86 0 N-CA-C 108.726 -1.75 . . . . 0.52 108.726 -179.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -137.45 -75.83 0.4 Allowed 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 108.869 -0.789 . . . . 0.25 108.869 179.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 15.7 m -95.47 4.3 53.4 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.658 1.183 . . . . 1.31 110.628 172.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.528 ' HB1' ' HD2' ' A' ' 46' ' ' PRO . . . -156.6 167.73 13.84 Favored Pre-proline 0 N--CA 1.45 -0.474 0 C-N-CA 124.842 1.257 . . . . 0.25 108.33 -171.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.528 ' HD2' ' HB1' ' A' ' 45' ' ' ALA . 36.7 Cg_endo -71.02 156.43 60.04 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 122.951 2.434 . . . . 0.29 110.508 -174.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.37 126.74 30.84 Favored 'General case' 0 N--CA 1.455 -0.199 0 O-C-N 121.513 -0.742 . . . . 0.29 110.083 -177.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 36.3 pt -103.2 0.62 10.32 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.191 0 C-N-CA 123.239 0.616 . . . . 0.48 111.196 174.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -33.23 -45.73 0.15 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.606 1.562 . . . . 2.29 113.071 168.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.62 39.95 3.2 Favored 'General case' 0 C--N 1.343 0.317 0 C-N-CA 124.184 0.993 . . . . 4.02 111.475 177.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.63 -42.99 85.88 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 121.324 -0.86 . . . . 0.29 109.601 174.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -52.4 -32.53 37.89 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-N 118.507 0.594 . . . . 0.66 114.387 -175.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -78.22 -49.13 14.33 Favored 'General case' 0 N--CA 1.455 -0.221 0 O-C-N 122.39 -0.477 . . . . 0.94 110.172 174.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 33.0 m-80 -56.6 -48.84 76.57 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 122.865 0.466 . . . . 1.53 111.533 -177.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -136.47 140.16 42.88 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.751 1.62 . . . . 1.07 107.373 -169.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 90.4 p -73.87 169.01 18.29 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 121.641 -0.662 . . . . 2.46 110.716 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -48.17 -52.59 20.1 Favored 'General case' 0 C--N 1.341 0.233 0 O-C-N 121.811 -0.555 . . . . 4.94 110.103 174.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -53.97 -27.22 29.94 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 118.69 -0.672 . . . . 2.75 112.51 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -87.87 -46.87 9.04 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 119.325 0.966 . . . . 3.28 110.248 177.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.606 HG23 HMA1 ' A' ' 93' ' ' HEC . 83.4 mt -62.62 -47.73 91.53 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.145 0 O-C-N 121.31 -0.868 . . . . 0.22 109.153 -177.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 25.3 tp -53.38 -50.07 65.87 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 109.036 -0.728 . . . . 0.42 109.036 176.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -49.43 -55.83 11.75 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 122.701 0.4 . . . . 2.77 110.054 173.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.412 HD13 HBA1 ' A' ' 93' ' ' HEC . 23.2 mt -56.16 -45.45 80.83 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.366 0 C-N-CA 120.329 -0.548 . . . . 0.47 110.69 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.554 HD11 HMB2 ' A' ' 93' ' ' HEC . 56.0 mt -58.46 -40.34 78.14 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 O-C-N 120.099 -1.626 . . . . 0.23 109.926 178.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 71.9 mt -70.73 -40.61 72.65 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.359 1.064 . . . . 0.54 113.439 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 14.8 p30 -124.29 27.16 7.14 Favored 'General case' 0 C--N 1.343 0.312 0 CA-C-N 120.899 1.681 . . . . 3.9 110.12 -168.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.538 ' N ' ' HA2' ' A' ' 73' ' ' GLY . . . 34.2 -140.33 0.12 Allowed Glycine 0 CA--C 1.534 1.268 0 C-N-CA 128.344 2.878 . . . . 0.64 110.999 -173.23 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 2.3 tp-100 176.87 140.58 0.07 Allowed 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 107.592 -1.262 . . . . 2.5 107.592 -179.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 40.97 -112.17 0.33 Allowed Glycine 0 CA--C 1.536 1.344 0 CA-C-N 119.953 1.251 . . . . 0.49 113.782 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -79.78 -20.92 67.2 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 123.87 0.748 . . . . 0.53 112.866 178.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.461 ' HB2' ' C1D' ' A' ' 93' ' ' HEC . 19.8 ttt -68.01 118.48 58.87 Favored Pre-proline 0 CA--C 1.534 0.338 0 C-N-CA 125.041 1.336 . . . . 0.35 110.734 179.18 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.403 ' HD2' HD11 ' A' ' 75' ' ' ILE . 37.4 Cg_endo -76.42 122.05 6.34 Favored 'Trans proline' 0 N--CA 1.446 -1.293 0 C-N-CA 122.698 2.265 . . . . 2.08 111.166 -179.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.538 ' HA2' ' N ' ' A' ' 67' ' ' GLY . . . -59.06 135.79 51.64 Favored Glycine 0 N--CA 1.442 -0.922 0 CA-C-N 115.364 -0.834 . . . . 0.63 114.869 -179.075 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 88.19 35.92 8.57 Favored Glycine 0 CA--C 1.53 0.97 0 CA-C-N 114.466 -0.867 . . . . 0.35 112.368 172.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.403 HD11 ' HD2' ' A' ' 72' ' ' PRO . 1.3 mt -64.94 -46.88 90.33 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.863 0 C-N-CA 125.76 1.624 . . . . 1.11 110.981 178.675 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -116.36 149.33 39.52 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 126.238 1.815 . . . . 0.47 107.561 163.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.3 mtpp -144.03 162.26 36.68 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 125.973 1.709 . . . . 2.31 108.293 178.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 63.68 -161.4 35.79 Favored Glycine 0 CA--C 1.529 0.966 0 N-CA-C 110.933 -0.867 . . . . 0.59 110.933 -174.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -51.6 -27.71 12.0 Favored 'General case' 0 C--O 1.225 -0.224 0 C-N-CA 123.949 0.9 . . . . 0.56 112.226 -177.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.498 ' O ' HG23 ' A' ' 84' ' ' VAL . 8.5 tt0 -44.63 -60.68 1.88 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.931 1.293 . . . . 2.08 109.766 168.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -69.47 -46.19 67.24 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.838 0.855 . . . . 0.28 110.821 -178.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -56.27 -49.58 73.83 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 121.231 0.539 . . . . 1.97 110.157 -176.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -55.52 -53.5 55.63 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 123.467 0.707 . . . . 0.3 109.678 176.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.571 HG11 HMB1 ' A' ' 93' ' ' HEC . 89.1 t -51.37 -56.24 5.84 Favored 'Isoleucine or valine' 0 C--N 1.339 0.138 0 CA-C-N 117.826 0.284 . . . . 0.35 110.738 178.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -50.66 -54.85 19.7 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 123.833 0.853 . . . . 0.2 111.763 179.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -63.04 -45.11 93.84 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 121.338 0.589 . . . . 0.33 110.995 -177.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 84.7 t90 -57.69 -52.74 64.2 Favored 'General case' 0 C--N 1.329 -0.286 0 O-C-N 121.701 -0.624 . . . . 0.63 109.485 177.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.77 -30.96 71.14 Favored 'General case' 0 C--O 1.222 -0.366 0 CA-C-O 118.028 -0.987 . . . . 1.97 112.714 174.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -55.88 -35.67 66.77 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 119.963 1.256 . . . . 0.41 109.985 172.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -74.18 -37.51 63.92 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.002 0.521 . . . . 2.82 111.392 173.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 3.5 mtpt -73.82 126.6 30.75 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 119.342 0.974 . . . . 2.18 110.988 -178.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 19.6 mtmt . . . . . 0 C--O 1.253 1.244 0 CA-C-O 115.897 -2.001 . . . . 2.21 106.187 -174.751 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' HEC . . . . . 0.606 HMA1 HG23 ' A' ' 60' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.1 t . . . . . 0 N--CA 1.472 0.67 0 N-CA-C 106.638 -1.616 . . . . 1.65 106.638 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -116.97 107.25 14.33 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 106.744 -1.576 . . . . 4.05 106.744 178.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -50.27 -44.97 53.98 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 123.682 0.793 . . . . 0.32 111.46 176.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -66.26 -46.94 75.34 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 107.94 -1.133 . . . . 2.75 107.94 -174.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.78 -46.64 77.9 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 122.886 0.474 . . . . 0.26 111.175 175.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 75.4 t -56.58 -57.49 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 N-CA-C 109.264 -0.643 . . . . 0.37 109.264 176.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.556 HG13 ' HB2' ' A' ' 32' ' ' CYS . 72.2 t -53.31 -47.8 56.81 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 CA-C-N 118.05 0.386 . . . . 0.31 110.865 -177.291 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -51.38 -23.92 4.26 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 126.326 1.85 . . . . 0.55 113.488 174.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -138.19 57.44 1.71 Allowed 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 119.354 0.979 . . . . 2.8 110.857 172.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -172.04 -38.58 0.02 OUTLIER 'General case' 0 C--O 1.225 -0.231 0 C-N-CA 123.736 0.815 . . . . 1.3 110.524 168.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.556 ' HB2' HG13 ' A' ' 28' ' ' VAL . 3.7 m -97.5 -50.85 4.35 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 119.042 0.837 . . . . 0.22 110.26 -178.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.495 HG22 HD23 ' A' ' 40' ' ' LEU . 1.6 pp -57.92 -26.05 27.44 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.156 0 CA-C-N 116.202 -0.454 . . . . 0.43 112.134 -173.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.422 ' N ' HD12 ' A' ' 33' ' ' ILE . 5.9 m -38.92 -36.75 0.3 Allowed 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 125.841 1.656 . . . . 1.09 112.224 170.451 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 15.0 m -120.27 -44.72 2.47 Favored 'General case' 0 C--N 1.34 0.187 0 C-N-CA 123.356 0.662 . . . . 0.23 111.317 174.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 85.7 m-70 -70.46 -7.79 46.06 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.899 0.879 . . . . 0.17 112.946 -175.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 87.92 149.3 17.16 Favored Glycine 0 C--N 1.337 0.622 0 N-CA-C 109.977 -1.249 . . . . 1.48 109.977 176.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -45.89 -38.7 8.17 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 124.197 0.903 . . . . 0.47 111.981 177.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -93.73 -1.13 55.52 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.417 1.087 . . . . 2.39 111.563 -174.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.495 HD23 HG22 ' A' ' 33' ' ' ILE . 4.5 mt 70.66 12.26 7.27 Favored 'General case' 0 C--N 1.349 0.58 0 CA-C-N 120.39 1.45 . . . . 1.3 110.828 174.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.5 p -87.81 0.26 56.02 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 128.185 2.594 . . . . 0.35 109.976 -172.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.56 136.25 4.42 Favored Glycine 0 N--CA 1.442 -0.916 0 N-CA-C 108.973 -1.651 . . . . 0.42 108.973 -177.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -143.52 -76.9 0.24 Allowed 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 123.967 0.907 . . . . 0.25 108.78 -179.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 24.4 t -95.91 4.97 52.32 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.902 1.281 . . . . 1.6 110.397 172.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.441 ' HB1' ' HD2' ' A' ' 46' ' ' PRO . . . -157.15 165.49 18.69 Favored Pre-proline 0 N--CA 1.451 -0.376 0 C-N-CA 125.339 1.456 . . . . 0.21 107.936 -170.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.441 ' HD2' ' HB1' ' A' ' 45' ' ' ALA . 45.5 Cg_endo -70.8 159.02 53.99 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.886 2.391 . . . . 0.23 110.71 -174.339 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.7 119.96 18.65 Favored 'General case' 0 C--N 1.332 -0.186 0 O-C-N 121.362 -0.836 . . . . 0.26 109.941 -178.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 46.5 pt -101.17 2.56 10.63 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.118 0 C-N-CA 124.46 1.104 . . . . 0.28 110.51 177.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.408 ' OD1' ' NZ ' ' A' ' 91' ' ' LYS . 24.6 t70 -43.51 -43.98 5.75 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 112.316 0.487 . . . . 3.07 112.316 178.214 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -109.31 40.87 1.76 Allowed 'General case' 0 C--N 1.344 0.345 0 C-N-CA 126.294 1.838 . . . . 4.04 110.517 179.3 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.21 -48.54 81.3 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 118.968 -0.539 . . . . 0.35 109.763 172.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -50.12 -39.28 34.03 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 123.578 0.609 . . . . 0.85 113.578 -177.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.468 ' HB2' ' HG2' ' A' ' 92' ' ' LYS . . . -63.57 -41.62 98.37 Favored 'General case' 0 CA--C 1.528 0.123 0 O-C-N 122.05 -0.677 . . . . 0.82 111.578 174.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 18.2 m-80 -72.21 -51.23 22.09 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 122.71 0.404 . . . . 1.7 110.196 -177.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -140.41 140.1 35.39 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.052 1.341 . . . . 0.71 107.832 -167.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.82 170.34 16.64 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 118.699 0.681 . . . . 2.02 109.748 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -50.31 -42.94 53.48 Favored 'General case' 0 C--O 1.224 -0.239 0 O-C-N 121.547 -0.721 . . . . 2.96 111.898 179.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -54.51 -40.63 68.76 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 120.981 0.419 . . . . 2.55 110.471 179.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -81.09 -45.58 16.26 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.241 1.016 . . . . 2.76 109.76 -175.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.467 HG23 HMA1 ' A' ' 93' ' ' HEC . 74.9 mt -61.63 -45.94 97.59 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.059 0 O-C-N 121.039 -1.038 . . . . 0.28 109.057 179.483 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 31.0 tp -54.2 -46.23 72.38 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 109.212 -0.662 . . . . 0.4 109.212 177.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -53.02 -53.24 53.01 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 123.148 0.28 . . . . 1.41 110.626 173.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 59.2 mt -56.24 -43.08 75.55 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 O-C-N 121.385 -0.822 . . . . 0.45 111.414 178.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.415 HD11 HMB2 ' A' ' 93' ' ' HEC . 45.4 mt -62.46 -45.29 99.14 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 O-C-N 120.07 -1.644 . . . . 0.29 109.677 179.072 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 76.5 mt -72.92 -28.9 62.73 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.425 1.09 . . . . 0.44 113.042 -177.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -127.19 17.44 7.16 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 119.614 1.097 . . . . 1.71 110.331 -166.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.56 ' N ' ' HA2' ' A' ' 73' ' ' GLY . . . 36.41 -146.99 0.06 OUTLIER Glycine 0 CA--C 1.539 1.536 0 C-N-CA 128.65 3.024 . . . . 0.66 112.216 -170.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 176.31 131.38 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 118.809 1.304 . . . . 1.21 108.907 -175.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 39.78 -117.13 0.77 Allowed Glycine 0 CA--C 1.532 1.152 0 CA-C-N 119.938 1.245 . . . . 0.37 113.16 -175.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -69.6 -20.64 75.81 Favored Glycine 0 CA--C 1.534 1.236 0 CA-C-N 117.481 0.641 . . . . 0.45 113.402 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.44 ' HB2' ' C1D' ' A' ' 93' ' ' HEC . 20.5 ttt -71.94 120.45 80.2 Favored Pre-proline 0 N--CA 1.452 -0.362 0 C-N-CA 124.536 1.134 . . . . 0.38 110.821 -178.443 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -76.54 128.25 10.17 Favored 'Trans proline' 0 N--CA 1.444 -1.43 0 C-N-CA 122.241 1.96 . . . . 2.07 110.434 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.56 ' HA2' ' N ' ' A' ' 67' ' ' GLY . . . -63.27 135.65 42.66 Favored Glycine 0 N--CA 1.443 -0.884 0 CA-C-N 115.627 -0.715 . . . . 0.72 114.691 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 82.78 41.36 8.88 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.648 -0.981 . . . . 0.44 110.648 176.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -60.34 -51.18 75.96 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 N-CA-C 108.765 -0.828 . . . . 2.02 108.765 174.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -105.74 156.82 17.92 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.746 1.618 . . . . 0.39 109.648 166.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.3 mmtm -144.86 157.68 44.07 Favored 'General case' 0 C--O 1.227 -0.104 0 C-N-CA 125.166 1.387 . . . . 3.33 108.038 178.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 67.37 -166.31 42.07 Favored Glycine 0 CA--C 1.531 1.046 0 N-CA-C 111.379 -0.688 . . . . 1.0 111.379 -173.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -51.32 -27.55 9.87 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.717 1.207 . . . . 0.57 112.27 -179.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -37.69 -59.82 0.77 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.678 1.591 . . . . 1.89 111.191 165.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.76 -49.12 69.52 Favored 'General case' 0 CA--C 1.531 0.215 0 O-C-N 121.937 -0.477 . . . . 0.22 111.128 -177.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -52.47 -54.62 30.01 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.568 1.147 . . . . 2.6 111.055 -178.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -54.72 -51.56 65.22 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.145 0.978 . . . . 0.24 109.82 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.518 HG22 HG23 ' A' ' 28' ' ' VAL . 54.7 t -54.12 -56.54 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 CA-C-N 116.933 -0.121 . . . . 0.29 111.165 177.478 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -51.71 -50.48 60.45 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 123.009 0.523 . . . . 0.2 111.831 179.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.437 ' O ' ' HB3' ' A' ' 89' ' ' ALA . . . -59.44 -48.71 80.59 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 121.689 0.756 . . . . 0.3 110.581 -179.45 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.495 ' HZ3' HG21 ' A' ' 28' ' ' VAL . 54.4 t90 -58.72 -44.26 90.36 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.08 0.552 . . . . 0.53 110.492 178.058 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.487 HD23 ' CE3' ' A' ' 87' ' ' TRP . 0.1 OUTLIER -63.11 -38.47 91.29 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.529 1.132 . . . . 1.68 110.476 177.26 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.437 ' HB3' ' O ' ' A' ' 86' ' ' ALA . . . -52.34 -49.77 63.63 Favored 'General case' 0 C--O 1.23 0.063 0 N-CA-C 109.468 -0.567 . . . . 0.44 109.468 171.073 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -84.7 35.65 0.57 Allowed 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 116.434 -0.348 . . . . 3.59 111.601 175.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.408 ' NZ ' ' OD1' ' A' ' 49' ' ' ASP . 0.5 OUTLIER -130.21 142.12 50.59 Favored 'General case' 0 C--N 1.343 0.311 0 O-C-N 121.171 -0.955 . . . . 2.93 110.651 165.09 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.468 ' HG2' ' HB2' ' A' ' 53' ' ' ALA . 16.9 mtmt . . . . . 0 C--O 1.252 1.219 0 C-N-CA 128.82 2.848 . . . . 2.71 105.413 -178.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' HEC . . . . . 0.467 HMA1 HG23 ' A' ' 60' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.5 t . . . . . 0 N--CA 1.471 0.593 0 N-CA-C 107.446 -1.316 . . . . 1.31 107.446 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -76.8 106.63 8.58 Favored 'General case' 0 N--CA 1.449 -0.511 0 O-C-N 124.053 0.845 . . . . 2.79 109.339 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -44.91 -52.26 8.85 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.124 0.969 . . . . 0.31 111.124 174.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -53.92 -44.83 70.92 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 116.632 -0.258 . . . . 3.44 111.456 177.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.89 -44.64 92.41 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 123.232 0.613 . . . . 0.31 110.44 -178.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 89.7 t -58.33 -54.66 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 N-CA-C 109.236 -0.653 . . . . 0.41 109.236 175.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.462 HG21 ' CZ3' ' A' ' 87' ' ' TRP . 53.9 t -52.54 -49.01 46.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 C-N-CA 122.53 0.332 . . . . 0.32 110.348 -178.445 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 24.4 mm-40 -52.52 -19.68 2.42 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 126.763 2.025 . . . . 0.63 114.248 174.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.43 48.6 1.18 Allowed 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 119.877 1.217 . . . . 3.2 111.994 176.249 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.407 ' NZ ' ' OE2' ' A' ' 80' ' ' GLU . 0.5 OUTLIER -162.46 -39.7 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 124.415 1.086 . . . . 1.5 110.314 169.154 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.433 ' SG ' ' HA ' ' A' ' 28' ' ' VAL . 3.4 m -97.21 -49.05 5.11 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 118.845 0.748 . . . . 0.2 110.383 -176.017 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.461 HD12 ' N ' ' A' ' 34' ' ' SER . 1.8 pp -58.01 -26.44 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 CA-C-N 115.819 -0.628 . . . . 0.5 112.148 -173.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.461 ' N ' HD12 ' A' ' 33' ' ' ILE . 68.0 m -37.38 -39.19 0.27 Allowed 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 125.234 1.414 . . . . 0.97 112.451 168.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 9.9 m -120.29 -41.16 2.63 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 122.818 0.447 . . . . 0.21 111.92 176.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 85.4 m-70 -71.63 -10.02 59.14 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.628 0.771 . . . . 0.24 112.6 -177.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 86.34 149.5 13.89 Favored Glycine 0 C--N 1.337 0.625 0 N-CA-C 109.783 -1.327 . . . . 1.52 109.783 179.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -44.42 -37.83 4.95 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 124.53 1.062 . . . . 0.43 112.103 175.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -93.22 -4.54 51.77 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.193 0.997 . . . . 2.37 111.788 -173.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.4 mt 70.3 10.84 7.39 Favored 'General case' 0 C--N 1.349 0.583 0 CA-C-N 120.513 1.506 . . . . 1.09 111.297 176.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.9 p -84.84 -0.66 54.72 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 127.801 2.44 . . . . 0.32 109.957 -175.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.86 137.66 5.09 Favored Glycine 0 N--CA 1.44 -1.057 0 N-CA-C 108.885 -1.686 . . . . 0.44 108.885 -175.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -143.6 -79.77 0.2 Allowed 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 124.332 1.053 . . . . 0.29 108.827 176.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -88.6 2.5 52.99 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.377 1.071 . . . . 0.96 110.756 171.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.583 ' HB1' ' HD2' ' A' ' 46' ' ' PRO . . . -157.14 169.52 10.48 Favored Pre-proline 0 N--CA 1.451 -0.378 0 C-N-CA 124.518 1.127 . . . . 0.23 108.629 -172.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.583 ' HD2' ' HB1' ' A' ' 45' ' ' ALA . 38.0 Cg_endo -70.08 158.69 55.71 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.973 2.448 . . . . 0.25 110.506 -174.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.68 124.41 25.93 Favored 'General case' 0 C--N 1.332 -0.177 0 O-C-N 121.512 -0.743 . . . . 0.31 110.181 -177.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 45.1 pt -102.02 0.36 10.29 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.158 0 CA-C-O 118.885 -0.579 . . . . 0.39 111.419 175.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.483 ' OD1' ' NZ ' ' A' ' 91' ' ' LYS . 37.9 t70 -44.35 -36.96 3.05 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 113.605 0.965 . . . . 3.28 113.605 178.005 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.4 ptpt -108.33 19.01 20.38 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.695 1.598 . . . . 3.76 112.015 -178.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -55.54 -45.26 77.22 Favored 'General case' 0 N--CA 1.455 -0.198 0 O-C-N 121.228 -0.92 . . . . 0.36 110.297 -172.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -51.16 -31.66 26.9 Favored Glycine 0 CA--C 1.523 0.582 0 C-N-CA 123.461 0.553 . . . . 0.6 114.26 179.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -77.08 -39.59 49.16 Favored 'General case' 0 N--CA 1.454 -0.273 0 O-C-N 122.036 -0.685 . . . . 0.73 110.046 176.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -66.24 -47.84 72.45 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.559 0.743 . . . . 2.22 111.22 -178.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -141.34 148.16 39.26 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.743 1.617 . . . . 0.96 107.971 -171.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 88.7 p -74.66 170.96 14.76 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 119.144 0.883 . . . . 2.49 110.692 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -49.13 -42.1 38.29 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 123.118 0.567 . . . . 2.7 111.187 173.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -62.49 -45.24 93.92 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 123.315 0.646 . . . . 2.77 109.55 -177.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -70.96 -47.15 60.59 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 108.362 -0.977 . . . . 2.79 108.362 -175.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.537 HG23 HMA1 ' A' ' 93' ' ' HEC . 91.2 mt -59.97 -46.21 94.36 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 O-C-N 121.672 -0.643 . . . . 0.29 109.403 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 58.4 tp -55.53 -50.1 70.89 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 109.127 -0.694 . . . . 0.44 109.127 176.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -52.7 -44.85 66.57 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 117.985 0.357 . . . . 1.95 111.341 178.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 79.6 mt -59.5 -56.7 15.44 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.288 0 C-N-CA 120.381 -0.528 . . . . 0.76 109.7 174.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.602 HD11 HMB2 ' A' ' 93' ' ' HEC . 69.9 mt -50.0 -41.65 18.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 O-C-N 120.655 -1.278 . . . . 0.24 110.87 -178.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 73.5 mt -70.98 -34.25 71.22 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.276 1.03 . . . . 0.44 113.619 178.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 48.1 m-80 -123.36 20.67 9.64 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 120.499 1.5 . . . . 1.78 110.59 -167.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.565 ' N ' ' HA2' ' A' ' 73' ' ' GLY . . . 29.27 -138.77 0.03 OUTLIER Glycine 0 CA--C 1.535 1.338 0 C-N-CA 128.961 3.172 . . . . 0.62 111.722 -164.031 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 173.98 130.18 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 119.119 1.46 . . . . 1.57 109.22 -178.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 43.23 -116.36 1.3 Allowed Glycine 0 CA--C 1.531 1.034 0 CA-C-N 119.719 1.145 . . . . 0.42 112.883 -177.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -70.65 -18.61 75.86 Favored Glycine 0 CA--C 1.531 1.079 0 O-C-N 122.374 -0.486 . . . . 0.48 113.16 -179.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.44 ' HB2' ' C1D' ' A' ' 93' ' ' HEC . 22.3 ttt -75.95 118.7 73.06 Favored Pre-proline 0 N--CA 1.45 -0.43 0 C-N-CA 124.52 1.128 . . . . 0.39 110.629 -178.234 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -75.65 119.41 5.45 Favored 'Trans proline' 0 N--CA 1.445 -1.369 0 C-N-CA 122.446 2.098 . . . . 2.1 111.286 -178.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.565 ' HA2' ' N ' ' A' ' 67' ' ' GLY . . . -58.66 138.13 49.59 Favored Glycine 0 N--CA 1.44 -1.083 0 CA-C-N 115.257 -0.883 . . . . 0.61 114.594 -179.299 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 76.06 50.13 7.97 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.19 -1.164 . . . . 0.84 110.19 177.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.418 HD13 HMC2 ' A' ' 93' ' ' HEC . 1.7 mt -72.61 -62.33 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 124.901 1.28 . . . . 1.02 108.889 168.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -103.45 158.44 16.35 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.919 1.288 . . . . 0.31 109.261 168.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.1 mttt -142.54 171.28 14.27 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 126.175 1.79 . . . . 4.32 109.702 177.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 54.55 -149.72 18.6 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 111.698 -0.561 . . . . 0.76 111.698 175.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -52.13 -32.21 34.54 Favored 'General case' 0 C--N 1.339 0.149 0 C-N-CA 122.983 0.513 . . . . 0.83 111.435 172.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.407 ' OE2' ' NZ ' ' A' ' 31' ' ' LYS . 6.8 tt0 -53.6 -43.39 68.57 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 110.032 -0.358 . . . . 1.91 110.032 176.009 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -84.57 -50.63 7.53 Favored 'General case' 0 CA--C 1.53 0.204 0 O-C-N 121.79 -0.569 . . . . 0.26 111.911 176.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -53.93 -50.9 65.4 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 118.591 0.632 . . . . 2.43 111.549 -177.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.63 -46.36 84.25 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 109.361 -0.607 . . . . 0.26 109.361 -179.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.407 HG22 HG23 ' A' ' 28' ' ' VAL . 53.8 t -57.19 -57.42 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 C-N-CA 122.913 0.485 . . . . 0.34 110.955 177.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -48.29 -53.13 18.36 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 123.516 0.727 . . . . 0.17 111.638 176.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -64.01 -44.31 93.0 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 121.329 0.585 . . . . 0.31 111.548 -178.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.462 ' CZ3' HG21 ' A' ' 28' ' ' VAL . 76.9 t90 -58.2 -49.43 77.08 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 121.493 -0.754 . . . . 0.52 109.425 177.286 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.6 -29.01 70.31 Favored 'General case' 0 C--O 1.222 -0.381 0 CA-C-O 118.374 -0.822 . . . . 1.85 112.977 173.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.58 -36.45 71.73 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 119.697 1.135 . . . . 0.36 110.299 170.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -73.74 -37.33 65.11 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 119.255 -0.402 . . . . 2.9 111.51 172.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.483 ' NZ ' ' OD1' ' A' ' 49' ' ' ASP . 8.5 mtpm? -72.81 114.18 10.67 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 119.039 0.836 . . . . 2.18 111.478 178.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 75.0 mttt . . . . . 0 C--O 1.252 1.197 0 CA-C-O 116.372 -1.775 . . . . 2.58 108.004 -174.924 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' HEC . . . . . 0.602 HMB2 HD11 ' A' ' 64' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.8 t . . . . . 0 N--CA 1.468 0.441 0 N-CA-C 106.762 -1.57 . . . . 1.15 106.762 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -74.71 97.25 3.18 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 123.937 0.895 . . . . 2.89 109.349 -169.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -45.68 -54.37 7.91 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 124.932 1.293 . . . . 0.38 111.664 -178.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -51.44 -51.58 53.69 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 122.998 0.519 . . . . 3.48 111.653 175.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.39 -45.59 93.0 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 118.586 0.63 . . . . 0.39 110.84 -177.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 72.1 t -58.14 -55.67 20.68 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 N-CA-C 109.178 -0.675 . . . . 0.61 109.178 177.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.607 HG13 ' HB2' ' A' ' 32' ' ' CYS . 39.4 t -53.21 -48.67 54.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 C-N-CA 124.149 0.979 . . . . 0.42 109.944 -179.051 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 26.7 mm-40 -50.86 -19.37 0.97 Allowed 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 125.706 1.602 . . . . 0.6 112.958 175.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -142.56 44.57 1.62 Allowed 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 119.126 0.875 . . . . 2.42 111.787 173.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -157.36 -39.98 0.07 Allowed 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 124.792 1.237 . . . . 1.23 111.428 168.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.607 ' HB2' HG13 ' A' ' 28' ' ' VAL . 4.5 m -96.6 -50.29 4.78 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 119.445 1.021 . . . . 0.2 110.657 -177.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.4 pp -59.14 -24.89 28.52 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 CA-C-N 116.067 -0.515 . . . . 0.48 111.889 -174.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 21.7 m -41.47 -35.79 0.76 Allowed 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 125.036 1.334 . . . . 1.04 112.455 172.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 24.3 m -119.2 -42.71 2.66 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 122.911 0.484 . . . . 0.25 111.328 175.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 84.2 m-70 -72.88 -9.54 58.81 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 113.074 0.768 . . . . 0.27 113.074 -175.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 87.1 149.75 16.25 Favored Glycine 0 C--N 1.337 0.611 0 N-CA-C 109.997 -1.241 . . . . 1.63 109.997 178.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -45.35 -39.21 7.21 Favored Glycine 0 C--N 1.34 0.767 0 C-N-CA 124.348 0.975 . . . . 0.47 111.936 178.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -94.67 -2.31 51.49 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.595 1.158 . . . . 3.21 111.452 -173.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.4 mt 72.31 11.09 5.86 Favored 'General case' 0 C--N 1.352 0.698 0 O-C-N 120.722 -1.236 . . . . 1.22 110.798 174.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 13.6 p -83.51 -0.37 49.93 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 127.865 2.466 . . . . 0.39 110.331 -174.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.5 147.84 17.25 Favored Glycine 0 N--CA 1.44 -1.067 0 N-CA-C 108.726 -1.75 . . . . 0.49 108.726 -173.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -151.79 -73.1 0.15 Allowed 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.15 0.98 . . . . 0.35 109.465 177.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.3 m -100.49 4.37 43.6 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.699 1.6 . . . . 1.0 110.756 171.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.426 ' HB1' ' HD2' ' A' ' 46' ' ' PRO . . . -155.59 164.88 19.75 Favored Pre-proline 0 N--CA 1.451 -0.405 0 C-N-CA 125.369 1.467 . . . . 0.22 107.636 -170.53 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.426 ' HD2' ' HB1' ' A' ' 45' ' ' ALA . 51.7 Cg_endo -68.88 159.72 52.71 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.837 2.358 . . . . 0.22 110.385 -176.063 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.11 127.15 31.75 Favored 'General case' 0 C--N 1.332 -0.189 0 O-C-N 121.937 -0.477 . . . . 0.32 109.808 -177.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 45.8 pt -107.85 2.02 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 C-N-CA 123.971 0.909 . . . . 0.3 111.488 176.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -35.22 -45.43 0.3 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.597 1.559 . . . . 3.99 112.623 168.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -113.16 28.24 8.95 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 125.552 1.541 . . . . 3.56 111.721 -178.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.7 -44.58 85.97 Favored 'General case' 0 N--CA 1.451 -0.389 0 O-C-N 121.57 -0.706 . . . . 0.26 109.236 175.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -54.5 -29.61 48.05 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 123.755 0.693 . . . . 0.49 114.472 -176.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -76.57 -43.68 37.89 Favored 'General case' 0 N--CA 1.457 -0.102 0 O-C-N 121.786 -0.832 . . . . 0.79 110.544 174.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 40.5 m-80 -66.81 -47.63 71.46 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 122.662 0.385 . . . . 1.54 110.665 -177.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -136.84 133.71 36.15 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 126.022 1.729 . . . . 0.7 107.089 -168.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.5 p -74.78 171.87 13.18 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 119.179 0.899 . . . . 1.8 110.268 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -48.9 -45.24 41.04 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 123.476 0.71 . . . . 2.83 111.764 178.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -59.24 -32.32 69.88 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.352 0.661 . . . . 3.02 111.795 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -86.89 -44.33 11.76 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 121.808 -0.557 . . . . 2.88 110.266 -178.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 45.3 mt -56.96 -46.49 83.95 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 N-CA-C 109.251 -0.648 . . . . 0.31 109.251 176.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 57.9 tp -54.41 -49.69 69.33 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 109.166 -0.679 . . . . 0.41 109.166 178.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -52.44 -49.26 64.93 Favored 'General case' 0 N--CA 1.451 -0.401 0 O-C-N 123.195 0.309 . . . . 1.46 110.652 178.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 31.5 mt -57.77 -53.1 49.4 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.267 0 O-C-N 121.529 -0.732 . . . . 0.55 110.677 175.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.642 HD11 HMB2 ' A' ' 93' ' ' HEC . 96.8 mt -51.62 -42.64 30.78 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 O-C-N 120.645 -1.284 . . . . 0.28 110.706 179.398 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 82.8 mt -72.77 -36.13 67.59 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.065 0.946 . . . . 0.4 113.141 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -116.63 15.59 15.5 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 119.82 1.191 . . . . 1.6 110.165 -165.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.553 ' N ' ' HA2' ' A' ' 73' ' ' GLY . . . 31.31 -141.74 0.03 OUTLIER Glycine 0 CA--C 1.533 1.187 0 C-N-CA 128.21 2.814 . . . . 0.62 111.389 -162.506 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 1.7 tp60 176.51 136.28 0.06 Allowed 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 118.621 1.21 . . . . 1.58 107.933 -175.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 42.38 -118.19 1.62 Allowed Glycine 0 CA--C 1.536 1.357 0 CA-C-N 120.584 1.538 . . . . 0.42 113.384 -179.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -74.51 -18.23 79.93 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 124.038 0.828 . . . . 0.61 113.007 178.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.455 ' HB2' ' C1D' ' A' ' 93' ' ' HEC . 19.3 ttt -71.86 118.19 64.54 Favored Pre-proline 0 N--CA 1.452 -0.374 0 C-N-CA 124.859 1.264 . . . . 0.41 110.414 179.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.46 ' HD2' HD11 ' A' ' 75' ' ' ILE . 43.9 Cg_endo -78.18 122.57 5.76 Favored 'Trans proline' 0 N--CA 1.444 -1.388 0 C-N-CA 122.782 2.322 . . . . 2.12 110.925 -178.187 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.553 ' HA2' ' N ' ' A' ' 67' ' ' GLY . . . -58.84 138.17 49.72 Favored Glycine 0 N--CA 1.442 -0.907 0 CA-C-N 115.27 -0.877 . . . . 0.63 114.999 -178.48 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 83.4 35.44 17.31 Favored Glycine 0 CA--C 1.528 0.856 0 CA-C-N 114.072 -1.064 . . . . 0.32 111.758 174.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.46 HD11 ' HD2' ' A' ' 72' ' ' PRO . 1.2 mt -57.61 -52.96 50.79 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 125.196 1.398 . . . . 1.25 109.859 174.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -101.08 151.32 21.96 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.317 1.447 . . . . 0.36 108.991 164.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.4 mtpm? -143.43 155.75 44.47 Favored 'General case' 0 C--N 1.34 0.157 0 C-N-CA 124.323 1.049 . . . . 3.51 109.317 173.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.29 -170.28 54.79 Favored Glycine 0 CA--C 1.528 0.845 0 N-CA-C 110.108 -1.197 . . . . 0.89 110.108 -175.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -51.38 -25.97 7.01 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.243 1.017 . . . . 1.24 112.232 179.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -39.86 -58.85 1.29 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.92 1.288 . . . . 2.1 110.634 166.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.23 -47.76 84.6 Favored 'General case' 0 CA--C 1.531 0.247 0 O-C-N 122.071 -0.393 . . . . 0.47 110.893 -174.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -50.68 -56.49 11.66 Favored 'General case' 0 C--N 1.338 0.094 0 C-N-CA 123.829 0.852 . . . . 3.05 110.852 174.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -54.4 -49.51 69.73 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 123.139 0.575 . . . . 0.31 110.132 -178.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.442 HG13 ' CG2' ' A' ' 28' ' ' VAL . 85.6 t -56.94 -54.92 23.74 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-N 117.523 0.147 . . . . 0.4 111.176 177.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -51.69 -51.49 55.62 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 123.676 0.79 . . . . 0.25 111.733 178.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.4 -46.56 89.53 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 124.175 0.99 . . . . 0.32 110.546 -179.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.531 ' CE3' HD23 ' A' ' 88' ' ' LEU . 46.6 t90 -57.25 -48.31 79.17 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 109.588 -0.523 . . . . 0.46 109.588 175.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.531 HD23 ' CE3' ' A' ' 87' ' ' TRP . 0.1 OUTLIER -60.49 -33.94 73.33 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.179 0.992 . . . . 1.62 111.59 176.905 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -54.62 -37.44 65.62 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 118.551 0.614 . . . . 0.48 110.936 172.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -94.76 22.04 6.8 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.798 0.839 . . . . 2.95 111.958 175.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 2.7 mtpm? -113.38 119.62 38.28 Favored 'General case' 0 C--N 1.342 0.24 0 O-C-N 121.122 -0.986 . . . . 2.16 109.094 169.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 89.1 mttt . . . . . 0 C--O 1.257 1.462 0 C-N-CA 129.451 3.1 . . . . 2.78 104.116 -178.274 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' HEC . . . . . 0.642 HMB2 HD11 ' A' ' 64' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.1 t . . . . . 0 N--CA 1.469 0.524 0 N-CA-C 106.473 -1.677 . . . . 1.39 106.473 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -107.95 100.03 9.42 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 106.968 -1.493 . . . . 2.15 106.968 -168.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -41.38 -54.22 3.11 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 124.682 1.193 . . . . 0.32 110.9 179.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -58.2 -47.21 84.16 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 115.239 -0.891 . . . . 2.6 110.258 -179.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.26 -45.8 92.02 Favored 'General case' 0 C--N 1.339 0.111 0 C-N-CA 122.935 0.494 . . . . 0.26 111.135 -179.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 81.9 t -56.58 -54.25 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 N-CA-C 108.766 -0.828 . . . . 0.34 108.766 177.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.627 HG22 ' SG ' ' A' ' 32' ' ' CYS . 22.8 t -53.78 -49.69 56.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 CA-C-N 117.742 0.246 . . . . 0.36 111.237 178.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 27.6 mm-40 -54.87 -14.85 1.59 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.1 1.76 . . . . 0.59 113.285 174.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 14.1 mt-30 -136.36 44.05 2.44 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 119.795 1.179 . . . . 3.48 112.617 169.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.28 -58.61 0.05 Allowed 'General case' 0 CA--C 1.519 -0.244 0 O-C-N 121.782 -0.574 . . . . 1.57 109.799 168.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.627 ' SG ' HG22 ' A' ' 28' ' ' VAL . 2.8 m -75.63 -48.14 23.48 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 109.938 -0.393 . . . . 0.17 109.938 -171.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.0 pp -50.01 -32.77 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.14 0 C-N-CA 123.449 0.7 . . . . 0.67 112.435 -178.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.4 m -44.08 -35.34 2.1 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 125.076 1.35 . . . . 1.05 112.033 178.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.4 ' SG ' HMC1 ' A' ' 93' ' ' HEC . 13.1 m -119.36 -41.76 2.7 Favored 'General case' 0 CA--C 1.53 0.207 0 O-C-N 123.522 0.514 . . . . 0.18 111.922 175.319 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 79.6 m-70 -70.35 -9.01 55.0 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.028 0.931 . . . . 0.22 112.481 -178.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 85.56 148.64 10.99 Favored Glycine 0 C--N 1.337 0.621 0 N-CA-C 109.224 -1.55 . . . . 1.45 109.224 -179.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -43.02 -33.25 1.7 Allowed Glycine 0 CA--C 1.53 0.989 0 C-N-CA 124.496 1.046 . . . . 0.52 112.687 173.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -94.98 -10.01 32.25 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.986 1.315 . . . . 2.33 111.613 -172.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 70.63 11.75 7.27 Favored 'General case' 0 C--N 1.347 0.467 0 CA-C-N 120.263 1.392 . . . . 1.44 111.255 178.357 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 10.4 p -85.43 -2.29 57.95 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 127.808 2.443 . . . . 0.33 109.986 -177.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.93 145.3 12.66 Favored Glycine 0 N--CA 1.437 -1.261 0 N-CA-C 108.648 -1.781 . . . . 0.43 108.648 -174.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -152.52 -80.34 0.1 Allowed 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 124.758 1.223 . . . . 0.25 109.043 177.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 17.0 m -91.46 4.02 53.54 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.457 1.103 . . . . 1.14 111.14 170.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -153.4 163.68 22.93 Favored Pre-proline 0 N--CA 1.45 -0.439 0 C-N-CA 126.065 1.746 . . . . 0.31 107.554 -172.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -70.51 161.52 45.75 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 123.128 2.552 . . . . 0.27 110.59 -176.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -74.06 124.01 25.45 Favored 'General case' 0 N--CA 1.454 -0.268 0 O-C-N 121.577 -0.702 . . . . 0.26 110.235 -176.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 44.6 pt -104.44 2.45 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 CA-C-O 119.055 -0.498 . . . . 0.28 111.564 176.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -40.33 -52.64 2.68 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 112.985 0.735 . . . . 2.68 112.985 176.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.26 21.49 11.87 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 126.3 1.84 . . . . 5.35 110.653 -175.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -54.19 -39.5 66.71 Favored 'General case' 0 N--CA 1.453 -0.307 0 O-C-N 121.506 -0.746 . . . . 0.27 110.146 -178.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -54.8 -24.95 35.15 Favored Glycine 0 CA--C 1.53 1.022 0 N-CA-C 114.603 0.601 . . . . 0.52 114.603 176.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -78.95 -36.95 40.84 Favored 'General case' 0 C--N 1.338 0.097 0 CA-C-N 118.616 1.208 . . . . 0.84 110.278 174.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -73.91 -47.85 34.89 Favored 'General case' 0 N--CA 1.457 -0.078 0 C-N-CA 122.515 0.326 . . . . 1.92 110.326 -177.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -139.96 149.04 42.8 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.47 1.108 . . . . 0.68 108.689 -168.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.92 168.32 18.03 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 109.614 -0.514 . . . . 1.93 109.614 178.446 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -48.2 -43.52 32.02 Favored 'General case' 0 C--O 1.226 -0.179 0 C-N-CA 124.43 1.092 . . . . 2.8 111.553 178.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -53.2 -47.69 68.69 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.654 0.782 . . . . 2.75 110.481 178.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -74.56 -45.69 43.83 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.78 0.832 . . . . 3.25 109.575 -175.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 58.6 mt -59.55 -44.16 92.5 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 N-CA-C 109.194 -0.669 . . . . 0.28 109.194 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 31.3 tp -54.77 -54.38 42.82 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 123.468 0.707 . . . . 0.37 109.38 175.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -52.07 -49.48 63.45 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 123.107 0.254 . . . . 1.48 111.2 178.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 57.6 mt -55.16 -55.49 16.16 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.155 0 O-C-N 121.564 -0.71 . . . . 0.65 110.558 176.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 57.8 mt -49.15 -46.75 17.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 O-C-N 121.191 -0.943 . . . . 0.26 110.199 178.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 91.7 mt -66.11 -33.3 75.46 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 113.932 1.086 . . . . 0.39 113.932 179.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -128.97 24.13 5.65 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 120.37 1.441 . . . . 1.82 110.641 -163.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 23.75 -136.97 0.01 OUTLIER Glycine 0 CA--C 1.543 1.791 0 C-N-CA 127.702 2.572 . . . . 0.67 112.808 -159.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 170.46 139.13 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 126.483 1.913 . . . . 1.3 107.603 -175.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 23.78 -106.2 0.01 OUTLIER Glycine 0 CA--C 1.535 1.316 0 C-N-CA 126.386 1.945 . . . . 0.57 115.029 -170.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.26 -29.05 74.33 Favored Glycine 0 CA--C 1.533 1.187 0 CA-C-N 118.271 1.036 . . . . 0.71 113.169 -177.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 4.6 ttt -67.32 126.19 92.18 Favored Pre-proline 0 CA--C 1.542 0.635 0 C-N-CA 125.053 1.341 . . . . 0.58 110.688 -179.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -62.66 -57.2 0.47 Allowed 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 123.893 3.062 . . . . 3.03 111.144 -174.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 118.14 149.92 8.87 Favored Glycine 0 C--N 1.334 0.471 0 C-N-CA 123.925 0.774 . . . . 0.87 113.536 174.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 69.06 23.21 76.14 Favored Glycine 0 CA--C 1.531 1.06 0 CA-C-N 115.156 -0.522 . . . . 0.4 111.852 178.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.6 mt -56.32 -49.29 77.41 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.919 0 C-N-CA 126.12 1.768 . . . . 1.07 111.267 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -109.71 161.22 15.62 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.133 0.973 . . . . 0.38 108.589 160.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -146.42 172.72 13.1 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.082 0.953 . . . . 3.46 109.198 173.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 54.18 -147.06 22.78 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 123.336 0.494 . . . . 0.76 112.015 176.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -47.47 -41.03 19.77 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.19 0.996 . . . . 0.74 111.23 175.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -53.07 -44.43 67.49 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.889 1.276 . . . . 2.74 110.799 177.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -79.18 -49.97 11.71 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 121.759 -0.588 . . . . 0.21 111.487 176.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -51.4 -54.39 27.16 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 124.027 0.931 . . . . 2.19 111.691 -178.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.24 -47.59 83.06 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.824 -0.435 . . . . 0.25 109.824 -177.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.412 HG22 HG23 ' A' ' 28' ' ' VAL . 53.8 t -56.72 -53.96 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 C-N-CA 123.442 0.697 . . . . 0.29 110.748 177.538 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -52.19 -51.86 55.58 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 123.896 0.878 . . . . 0.18 111.915 176.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.26 -50.59 73.04 Favored 'General case' 0 C--N 1.333 -0.116 0 C-N-CA 123.192 0.597 . . . . 0.32 110.204 -179.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.506 ' CE3' HD23 ' A' ' 88' ' ' LEU . 50.0 t90 -56.59 -46.43 80.83 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.622 0.769 . . . . 0.53 110.49 177.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.506 HD23 ' CE3' ' A' ' 87' ' ' TRP . 0.1 OUTLIER -63.15 -38.8 92.6 Favored 'General case' 0 C--O 1.224 -0.282 0 O-C-N 121.416 -0.803 . . . . 1.65 109.88 178.269 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -62.26 -42.31 99.22 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 118.723 0.692 . . . . 0.5 110.683 174.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -55.74 -45.46 78.02 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 121.843 -0.535 . . . . 3.6 110.61 169.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 4.1 mtmp? -74.93 100.29 4.07 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 118.921 0.782 . . . . 2.89 111.553 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 9.7 ptpp? . . . . . 0 C--O 1.25 1.095 0 N-CA-C 106.869 -1.53 . . . . 2.78 106.869 174.311 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' HEC . . . . . 0.434 HMB1 ' SG ' ' A' ' 32' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 10.5 t . . . . . 0 N--CA 1.469 0.514 0 N-CA-C 105.873 -1.899 . . . . 1.63 105.873 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -125.04 97.38 5.23 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 105.787 -1.931 . . . . 2.75 105.787 -166.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -41.38 -52.84 3.46 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 124.655 1.182 . . . . 0.33 110.857 -177.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -57.13 -47.79 80.27 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 115.9 -0.591 . . . . 3.17 110.677 -179.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.07 -44.83 94.46 Favored 'General case' 0 C--N 1.339 0.11 0 C-N-CA 122.926 0.49 . . . . 0.32 110.691 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 97.7 t -58.5 -57.4 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 N-CA-C 108.934 -0.765 . . . . 0.43 108.934 177.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.681 HG13 ' HB2' ' A' ' 32' ' ' CYS . 52.9 t -52.21 -48.34 43.34 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 C-N-CA 122.741 0.416 . . . . 0.32 110.875 -179.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -51.03 -24.44 3.79 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 125.503 1.521 . . . . 0.63 113.115 175.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 11.6 mt-30 -137.4 55.75 1.8 Allowed 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 119.514 1.052 . . . . 2.66 112.179 170.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.96 -38.97 0.02 OUTLIER 'General case' 0 C--O 1.226 -0.138 0 C-N-CA 123.566 0.746 . . . . 1.25 110.214 168.24 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.681 ' HB2' HG13 ' A' ' 28' ' ' VAL . 4.0 m -98.21 -50.01 4.51 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 119.004 0.82 . . . . 0.18 110.971 -177.322 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.9 pp -58.08 -25.86 27.53 Favored 'Isoleucine or valine' 0 C--N 1.338 0.071 0 N-CA-C 112.127 0.417 . . . . 0.4 112.127 -174.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 59.7 m -37.92 -38.55 0.31 Allowed 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 125.491 1.516 . . . . 0.99 112.646 170.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 18.9 m -120.7 -40.15 2.68 Favored 'General case' 0 C--N 1.34 0.189 0 C-N-CA 122.892 0.477 . . . . 0.16 111.901 175.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 81.6 m-70 -73.31 -7.92 53.66 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 112.65 0.611 . . . . 0.19 112.65 -176.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 85.59 149.78 12.83 Favored Glycine 0 C--N 1.337 0.627 0 N-CA-C 109.497 -1.441 . . . . 1.51 109.497 179.064 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -42.35 -34.95 1.73 Allowed Glycine 0 CA--C 1.527 0.826 0 C-N-CA 124.855 1.216 . . . . 0.46 112.176 175.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -99.03 -5.9 29.52 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 124.937 1.295 . . . . 2.36 111.402 -168.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 8.8 mt 69.34 13.04 8.47 Favored 'General case' 0 C--N 1.352 0.682 0 CA-C-N 120.712 1.596 . . . . 1.11 111.326 178.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.2 p -89.39 -1.37 58.03 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 127.802 2.441 . . . . 0.34 109.815 -176.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.62 130.44 2.81 Favored Glycine 0 N--CA 1.44 -1.085 0 N-CA-C 109.502 -1.439 . . . . 0.54 109.502 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -135.39 -78.1 0.44 Allowed 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 124.387 1.075 . . . . 0.28 108.641 178.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 50.1 m -93.45 4.01 54.65 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.176 0.991 . . . . 1.36 111.102 171.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -153.6 161.74 28.41 Favored Pre-proline 0 CA--C 1.533 0.314 0 C-N-CA 125.808 1.643 . . . . 0.31 107.488 -171.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -71.78 159.58 50.32 Favored 'Trans proline' 0 N--CA 1.459 -0.541 0 C-N-CA 122.977 2.451 . . . . 0.28 111.172 -175.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -74.68 117.36 16.43 Favored 'General case' 0 CA--C 1.53 0.211 0 O-C-N 121.727 -0.608 . . . . 0.45 111.768 -172.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 42.2 pt -95.94 0.54 10.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 C-N-CA 123.642 0.777 . . . . 0.3 112.031 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -45.34 -35.74 3.73 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.526 0.936 . . . . 2.64 113.526 172.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -112.98 27.94 9.21 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 124.11 0.964 . . . . 4.94 110.687 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -58.63 -43.83 89.82 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 108.998 -0.742 . . . . 0.33 108.998 176.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -53.77 -29.55 41.85 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 123.349 0.499 . . . . 0.63 113.692 179.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.13 -32.95 65.23 Favored 'General case' 0 N--CA 1.454 -0.229 0 O-C-N 122.078 -0.66 . . . . 0.83 110.356 178.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 -85.31 -44.94 12.4 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.962 0.905 . . . . 1.67 109.954 -174.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -138.38 133.28 32.7 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 125.273 1.429 . . . . 1.0 108.025 -167.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 13.9 m -73.63 169.97 16.18 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 118.409 0.55 . . . . 1.51 110.095 175.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -47.24 -48.13 24.46 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.277 1.031 . . . . 2.92 112.44 -176.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -58.1 -41.77 84.25 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.835 -0.541 . . . . 2.98 111.618 177.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -72.39 -41.96 65.74 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 109.053 -0.721 . . . . 2.99 109.053 -176.14 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 41.3 mt -61.86 -46.71 95.91 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.131 0 O-C-N 121.286 -0.884 . . . . 0.3 109.386 175.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 66.8 tp -53.95 -48.41 70.3 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.441 -0.577 . . . . 0.47 109.441 178.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -48.54 -56.02 9.48 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 117.993 0.36 . . . . 2.37 110.996 174.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 95.4 mt -55.78 -46.25 79.77 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.298 0 O-C-N 121.6 -0.688 . . . . 0.48 110.778 178.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.468 HD11 HMB2 ' A' ' 93' ' ' HEC . 73.3 mt -55.8 -44.77 78.64 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 O-C-N 120.45 -1.406 . . . . 0.28 110.164 176.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 90.9 mt -67.81 -36.81 81.06 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 113.903 1.075 . . . . 0.67 113.903 -176.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -128.82 26.32 5.56 Favored 'General case' 0 C--N 1.344 0.338 0 CA-C-N 120.85 1.659 . . . . 3.78 110.205 -170.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.511 ' N ' ' HA2' ' A' ' 73' ' ' GLY . . . 37.41 -142.78 0.23 Allowed Glycine 0 CA--C 1.534 1.258 0 C-N-CA 128.247 2.832 . . . . 0.65 111.009 -176.226 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 44.9 tt0 174.3 132.87 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 119.246 1.523 . . . . 1.46 109.658 -178.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 45.14 -118.94 3.04 Favored Glycine 0 CA--C 1.532 1.138 0 O-C-N 121.22 -0.925 . . . . 0.4 112.18 -175.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -70.93 -19.63 77.13 Favored Glycine 0 CA--C 1.531 1.082 0 O-C-N 122.495 -0.415 . . . . 0.48 113.016 179.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.417 ' HB2' ' C1D' ' A' ' 93' ' ' HEC . 20.0 ttt -73.4 119.27 74.95 Favored Pre-proline 0 N--CA 1.451 -0.424 0 C-N-CA 124.163 0.985 . . . . 0.34 110.604 -178.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.448 ' HD2' HD11 ' A' ' 75' ' ' ILE . 58.0 Cg_endo -80.22 124.74 5.52 Favored 'Trans proline' 0 N--CA 1.447 -1.221 0 C-N-CA 123.208 2.605 . . . . 2.07 111.054 -179.075 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.511 ' HA2' ' N ' ' A' ' 67' ' ' GLY . . . -63.38 142.6 47.35 Favored Glycine 0 N--CA 1.444 -0.8 0 N-CA-C 115.902 1.121 . . . . 0.64 115.902 -174.317 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 78.2 32.41 43.7 Favored Glycine 0 CA--C 1.526 0.779 0 CA-C-N 114.142 -1.029 . . . . 0.34 111.442 174.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.448 HD11 ' HD2' ' A' ' 72' ' ' PRO . 0.8 OUTLIER -51.37 -53.02 17.28 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 125.692 1.597 . . . . 1.18 109.878 174.45 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -105.48 160.05 15.46 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 124.961 1.304 . . . . 0.34 108.652 162.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 81.7 mttt -144.1 168.7 19.4 Favored 'General case' 0 CA--C 1.527 0.086 0 N-CA-C 107.461 -1.311 . . . . 2.56 107.461 170.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 65.7 -164.04 39.28 Favored Glycine 0 CA--C 1.528 0.902 0 N-CA-C 111.517 -0.633 . . . . 0.66 111.517 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -54.32 -29.6 48.28 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.457 0.703 . . . . 0.59 112.283 -174.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -40.32 -67.63 0.22 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.79 1.236 . . . . 2.95 110.457 164.068 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -59.07 -43.91 91.8 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.25 0.62 . . . . 0.28 110.977 -175.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -59.13 -53.48 57.86 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.411 1.084 . . . . 2.69 110.597 -178.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.18 -49.12 78.12 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.008 0.923 . . . . 0.27 109.797 179.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.557 HG22 HG23 ' A' ' 28' ' ' VAL . 54.1 t -52.5 -56.49 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 C-N-CA 122.292 0.237 . . . . 0.27 110.598 176.223 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -49.56 -51.38 37.28 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 123.738 0.815 . . . . 0.2 111.764 177.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.38 -50.33 74.38 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 121.673 0.749 . . . . 0.43 111.163 -178.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.552 ' CE3' HD23 ' A' ' 88' ' ' LEU . 51.0 t90 -58.23 -45.34 87.87 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 121.228 0.537 . . . . 0.63 110.047 178.543 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.552 HD23 ' CE3' ' A' ' 87' ' ' TRP . 0.1 OUTLIER -62.73 -36.41 82.91 Favored 'General case' 0 CA--C 1.531 0.213 0 O-C-N 121.493 -0.754 . . . . 1.61 110.814 176.571 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -59.74 -39.19 83.92 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 118.758 0.708 . . . . 0.44 110.848 173.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -59.74 -41.06 90.11 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 122.28 0.232 . . . . 3.21 110.535 173.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.1 mtpm? -74.04 104.12 4.76 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.806 0.813 . . . . 2.3 111.21 179.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 15.5 pttp . . . . . 0 C--O 1.25 1.089 0 C-N-CA 126.619 1.967 . . . . 3.13 106.048 176.364 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' HEC . . . . . 0.468 HMB2 HD11 ' A' ' 64' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.4 t . . . . . 0 N--CA 1.471 0.624 0 N-CA-C 105.831 -1.915 . . . . 1.26 105.831 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -83.81 108.56 16.91 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.726 -0.842 . . . . 2.86 108.726 -173.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -46.39 -55.15 7.78 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 123.25 0.62 . . . . 0.31 110.024 176.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -57.36 -46.71 83.07 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 110.233 -0.284 . . . . 2.69 110.233 -177.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.24 -48.69 79.63 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 118.262 0.483 . . . . 0.29 111.399 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 55.6 t -56.46 -56.18 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 N-CA-C 109.233 -0.654 . . . . 0.41 109.233 177.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.562 HG23 HG22 ' A' ' 84' ' ' VAL . 61.1 t -53.5 -49.92 52.11 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 C-N-CA 122.888 0.475 . . . . 0.4 110.305 -177.201 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.458 ' HA ' HG12 ' A' ' 33' ' ' ILE . 33.6 mm-40 -51.55 -17.44 0.83 Allowed 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 126.454 1.902 . . . . 0.5 112.964 175.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 16.6 tp60 -141.71 43.67 1.72 Allowed 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 119.519 1.054 . . . . 3.67 112.204 171.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.18 -39.73 0.1 Allowed 'General case' 0 C--O 1.227 -0.083 0 C-N-CA 123.659 0.784 . . . . 1.18 111.425 166.377 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.485 ' HB2' HG13 ' A' ' 28' ' ' VAL . 3.6 m -98.12 -49.51 4.71 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 119.124 0.874 . . . . 0.17 110.539 -174.106 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.458 HG12 ' HA ' ' A' ' 29' ' ' GLN . 2.2 pp -55.51 -29.13 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 CA-C-N 115.766 -0.652 . . . . 0.4 111.564 -177.127 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.1 m -37.75 -37.01 0.21 Allowed 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 125.61 1.564 . . . . 1.14 112.713 171.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 28.2 m -119.59 -40.45 2.77 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.298 0.639 . . . . 0.17 112.009 174.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 84.7 m-70 -73.37 -8.71 57.03 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.474 0.71 . . . . 0.22 112.711 -175.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 85.55 151.14 15.28 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 109.628 -1.389 . . . . 1.52 109.628 -178.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -40.46 -42.27 2.54 Favored Glycine 0 C--N 1.34 0.802 0 C-N-CA 124.996 1.284 . . . . 0.49 112.21 178.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -95.89 -6.34 39.47 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 125.556 1.542 . . . . 2.57 110.939 -169.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.537 HD21 ' CG1' ' A' ' 28' ' ' VAL . 0.6 OUTLIER 69.56 19.1 7.55 Favored 'General case' 0 C--N 1.347 0.469 0 CA-C-N 119.648 1.113 . . . . 1.48 111.026 177.456 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 11.2 p -82.18 -4.84 57.83 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 128.462 2.705 . . . . 0.35 109.898 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.14 148.26 21.19 Favored Glycine 0 N--CA 1.44 -1.035 0 N-CA-C 108.32 -1.912 . . . . 0.6 108.32 -173.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -155.08 -72.98 0.12 Allowed 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 123.91 0.884 . . . . 0.49 109.552 176.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.3 t -98.35 1.17 46.73 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.627 1.171 . . . . 1.34 110.252 172.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.495 ' HB1' ' HD2' ' A' ' 46' ' ' PRO . . . -155.62 167.07 14.94 Favored Pre-proline 0 CA--C 1.536 0.432 0 C-N-CA 125.551 1.541 . . . . 0.26 107.913 -171.503 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.495 ' HD2' ' HB1' ' A' ' 45' ' ' ALA . 54.9 Cg_endo -70.43 160.98 47.67 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 123.098 2.532 . . . . 0.3 111.195 -173.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -74.87 119.99 19.8 Favored 'General case' 0 CA--C 1.531 0.214 0 O-C-N 121.748 -0.595 . . . . 0.31 110.638 -177.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 47.4 pt -105.05 0.83 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 C-N-CA 124.157 0.983 . . . . 0.4 111.551 179.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -34.17 -46.39 0.24 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.572 1.549 . . . . 2.42 112.856 167.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 5.3 pttt -111.44 35.32 3.67 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.798 1.239 . . . . 3.93 111.166 -178.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.01 -46.4 87.83 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-O 118.868 -0.587 . . . . 0.3 109.51 174.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -51.73 -32.73 33.34 Favored Glycine 0 CA--C 1.527 0.795 0 CA-C-N 118.566 0.621 . . . . 0.65 114.329 -177.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.21 -37.08 66.57 Favored 'General case' 0 N--CA 1.455 -0.196 0 O-C-N 121.898 -0.766 . . . . 0.79 110.797 176.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 20.5 m-80 -73.51 -50.77 19.77 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 122.929 0.492 . . . . 1.68 110.15 -178.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -137.6 138.07 39.16 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.211 1.404 . . . . 0.72 107.382 -169.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 67.3 m -76.19 172.0 13.57 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 119.03 0.832 . . . . 1.6 110.389 179.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.0 pm0 -50.5 -43.29 55.61 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 123.78 0.832 . . . . 2.87 111.834 -178.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -56.15 -41.37 75.3 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 121.336 0.588 . . . . 2.81 110.136 179.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -80.01 -47.38 15.01 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 123.81 0.844 . . . . 3.54 108.995 -173.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 63.9 mt -56.33 -44.99 81.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 N-CA-C 109.113 -0.699 . . . . 0.24 109.113 176.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 33.8 tp -54.77 -49.47 70.8 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 109.375 -0.602 . . . . 0.46 109.375 177.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -55.11 -46.44 75.56 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 118.576 0.625 . . . . 1.48 111.604 175.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 86.7 mt -61.92 -30.34 48.34 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 O-C-N 121.351 -0.843 . . . . 0.66 111.521 178.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.565 HD11 HMB2 ' A' ' 93' ' ' HEC . 46.4 mt -73.19 -50.24 32.87 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 O-C-N 120.278 -1.514 . . . . 0.34 109.128 174.253 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 77.3 mt -61.88 -28.43 69.5 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 125.232 1.413 . . . . 0.38 113.474 -175.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 11.0 m-80 -130.62 15.37 5.41 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 120.02 1.282 . . . . 1.75 110.386 -169.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 40.01 -141.97 0.69 Allowed Glycine 0 CA--C 1.545 1.906 0 C-N-CA 125.679 1.609 . . . . 0.66 111.707 -167.05 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 167.08 139.63 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 126.386 1.874 . . . . 1.54 108.447 -174.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 31.77 -111.45 0.05 OUTLIER Glycine 0 C--N 1.347 1.18 0 C-N-CA 125.465 1.507 . . . . 0.52 114.153 -174.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.58 -30.1 76.67 Favored Glycine 0 CA--C 1.534 1.23 0 CA-C-N 117.299 0.549 . . . . 0.7 112.834 -179.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 2.3 ttt -65.42 123.74 85.2 Favored Pre-proline 0 CA--C 1.541 0.615 0 C-N-CA 124.576 1.15 . . . . 0.51 111.393 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -63.64 -55.38 0.7 Allowed 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 124.223 3.282 . . . . 2.96 111.224 -173.117 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 115.28 149.08 9.53 Favored Glycine 0 N--CA 1.448 -0.514 0 CA-C-N 115.732 -0.667 . . . . 0.9 114.185 171.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 67.45 22.38 73.06 Favored Glycine 0 CA--C 1.531 1.036 0 CA-C-N 114.712 -0.744 . . . . 0.49 111.854 -178.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -51.69 -53.01 18.63 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 C-N-CA 126.611 1.964 . . . . 1.08 111.127 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -107.76 159.99 16.07 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.164 1.386 . . . . 0.34 108.335 162.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 36.6 mttt -145.84 174.77 10.94 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.554 1.141 . . . . 3.31 109.57 171.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 53.11 -149.55 11.66 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 123.826 0.727 . . . . 0.7 112.045 178.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -49.63 -36.61 25.01 Favored 'General case' 0 C--N 1.34 0.163 0 C-N-CA 123.877 0.871 . . . . 0.69 111.278 179.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.531 ' O ' HG23 ' A' ' 84' ' ' VAL . 3.9 tt0 -47.76 -66.41 0.41 Allowed 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.992 1.317 . . . . 1.91 109.216 173.047 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -62.97 -45.48 92.23 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 122.829 0.452 . . . . 0.26 112.011 -178.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -54.79 -52.9 61.19 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 122.931 0.492 . . . . 2.15 110.488 -178.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.42 -50.17 73.87 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 122.915 0.486 . . . . 0.39 110.233 178.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.571 HG11 HMB1 ' A' ' 93' ' ' HEC . 70.1 t -50.63 -58.51 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-O 120.613 0.244 . . . . 0.56 110.919 177.293 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -55.26 -49.98 70.67 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.206 1.003 . . . . 0.29 111.684 -179.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.69 -46.01 88.18 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 121.67 0.748 . . . . 0.35 110.584 -179.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.532 ' CE3' HD23 ' A' ' 88' ' ' LEU . 48.6 t90 -60.71 -50.48 73.3 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.667 -0.494 . . . . 0.56 109.667 176.538 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.532 HD23 ' CE3' ' A' ' 87' ' ' TRP . 0.1 OUTLIER -59.92 -32.01 70.38 Favored 'General case' 0 CA--C 1.531 0.247 0 O-C-N 121.487 -0.758 . . . . 1.6 111.193 179.152 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.9 -42.85 97.33 Favored 'General case' 0 N--CA 1.457 -0.097 0 CA-C-N 118.671 0.669 . . . . 0.41 111.146 171.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -58.59 -40.73 84.02 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 110.347 -0.242 . . . . 3.29 110.347 173.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 21.4 mtpp -73.38 133.98 43.94 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 121.916 -0.49 . . . . 2.42 110.984 -178.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 49.8 mtmt . . . . . 0 C--O 1.25 1.084 0 N-CA-C 105.887 -1.894 . . . . 2.55 105.887 179.36 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' HEC . . . . . 0.571 HMB1 HG11 ' A' ' 84' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.47 0.554 0 N-CA-C 106.542 -1.651 . . . . 1.42 106.542 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -74.21 144.83 44.56 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.311 1.044 . . . . 2.92 108.639 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -89.29 -65.38 1.02 Allowed 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 109.327 -0.619 . . . . 0.5 109.327 177.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -47.35 -47.01 26.13 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.578 0.751 . . . . 3.09 111.702 -178.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.69 -42.82 79.75 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.057 0.543 . . . . 0.33 111.676 178.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 53.4 t -64.45 -54.13 34.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 N-CA-C 108.23 -1.026 . . . . 0.35 108.23 178.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.606 HG11 HD21 ' A' ' 40' ' ' LEU . 65.9 t -48.33 -51.49 10.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 C-N-CA 122.486 0.314 . . . . 0.58 110.376 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.414 ' HA ' HG12 ' A' ' 33' ' ' ILE . 35.7 mm-40 -50.55 -26.82 5.7 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 126.313 1.845 . . . . 0.62 113.416 177.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 -136.6 53.48 1.91 Allowed 'General case' 0 C--N 1.339 0.125 0 CA-C-N 119.756 1.162 . . . . 2.4 112.121 173.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -166.43 -38.9 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 123.459 0.704 . . . . 1.26 110.504 167.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.484 ' HB2' HG13 ' A' ' 28' ' ' VAL . 6.5 m -97.69 -51.31 4.15 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 118.913 0.779 . . . . 0.23 110.843 -175.463 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.414 HG12 ' HA ' ' A' ' 29' ' ' GLN . 2.4 pp -56.41 -27.94 25.56 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.095 0 CA-C-N 116.128 -0.487 . . . . 0.39 111.925 -175.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.9 m -36.92 -39.31 0.22 Allowed 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 125.605 1.562 . . . . 1.05 112.683 171.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 38.1 m -117.88 -38.86 3.18 Favored 'General case' 0 C--N 1.339 0.122 0 C-N-CA 123.127 0.571 . . . . 0.21 111.652 174.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 83.8 m-70 -77.03 -6.49 52.89 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 113.167 0.803 . . . . 0.24 113.167 -174.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 84.54 151.83 14.5 Favored Glycine 0 C--N 1.338 0.645 0 N-CA-C 109.865 -1.294 . . . . 1.57 109.865 -179.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -41.87 -39.53 2.8 Favored Glycine 0 C--N 1.341 0.84 0 C-N-CA 125.015 1.293 . . . . 0.45 112.274 178.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -99.84 -0.44 39.72 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 125.249 1.42 . . . . 2.42 111.058 -169.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.606 HD21 HG11 ' A' ' 28' ' ' VAL . 1.3 mp 66.12 18.34 10.96 Favored 'General case' 0 C--N 1.347 0.476 0 CA-C-N 119.779 1.172 . . . . 1.85 111.351 -179.395 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.0 p -82.14 -5.24 58.3 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 127.413 2.285 . . . . 0.36 110.277 -177.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.58 148.21 18.35 Favored Glycine 0 N--CA 1.437 -1.277 0 N-CA-C 108.129 -1.988 . . . . 0.51 108.129 -172.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -156.24 -76.77 0.09 Allowed 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 124.035 0.934 . . . . 0.26 109.09 178.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -95.38 2.37 54.59 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.683 1.193 . . . . 1.15 110.552 172.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -157.58 161.75 28.56 Favored Pre-proline 0 N--CA 1.452 -0.374 0 C-N-CA 126.834 2.054 . . . . 0.21 106.577 -170.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -68.1 164.65 31.26 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 123.178 2.585 . . . . 0.34 111.807 -175.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -75.52 116.39 16.18 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 123.265 0.626 . . . . 0.26 110.841 -176.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 40.4 pt -98.11 1.0 10.54 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.174 0 C-N-CA 123.162 0.585 . . . . 0.32 110.886 176.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -43.13 -37.31 1.99 Allowed 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 114.037 1.125 . . . . 2.42 114.037 174.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.13 23.7 13.97 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 124.899 1.28 . . . . 4.21 111.681 179.565 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -58.09 -43.4 87.03 Favored 'General case' 0 N--CA 1.45 -0.449 0 O-C-N 121.607 -0.683 . . . . 0.34 109.573 178.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -51.38 -30.16 25.03 Favored Glycine 0 CA--C 1.529 0.913 0 N-CA-C 114.643 0.617 . . . . 0.61 114.643 -178.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -87.28 -40.59 14.36 Favored 'General case' 0 C--O 1.227 -0.092 0 CA-C-N 117.965 0.882 . . . . 0.87 110.45 176.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 15.3 m-80 -62.48 -41.82 99.05 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 122.135 0.174 . . . . 1.57 111.322 -179.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -140.35 142.74 35.55 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 125.722 1.609 . . . . 0.67 107.649 -170.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 57.9 m -83.06 176.67 9.06 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 121.491 0.663 . . . . 1.72 110.504 177.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.468 ' HG3' ' HB2' ' A' ' 89' ' ' ALA . 2.8 mp0 -58.07 -45.75 86.59 Favored 'General case' 0 N--CA 1.454 -0.228 0 O-C-N 121.505 -0.747 . . . . 2.81 110.705 -166.138 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -61.73 -38.78 89.19 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.228 0.611 . . . . 2.97 110.199 -177.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.1 mp0 -70.33 -46.14 64.78 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 124.186 0.994 . . . . 4.21 108.489 -178.015 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.594 HG23 HMA1 ' A' ' 93' ' ' HEC . 62.2 mt -62.96 -46.19 96.95 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.109 0 N-CA-C 108.834 -0.802 . . . . 0.24 108.834 178.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 46.4 tp -51.8 -54.06 32.97 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 123.132 0.573 . . . . 0.36 109.682 176.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -50.61 -52.48 38.98 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.338 0.655 . . . . 1.6 110.586 175.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 76.2 mt -62.6 -25.76 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 O-C-N 121.652 -0.655 . . . . 0.73 112.196 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.521 HD11 HMB2 ' A' ' 93' ' ' HEC . 51.9 mt -73.26 -49.37 38.16 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 O-C-N 120.213 -1.554 . . . . 0.28 108.993 170.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 86.7 mt -62.89 -34.28 77.08 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 125.006 1.322 . . . . 0.42 114.238 -173.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -134.49 29.95 3.55 Favored 'General case' 0 C--N 1.342 0.257 0 CA-C-N 120.572 1.533 . . . . 3.24 109.68 -172.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 37.95 -140.26 0.47 Allowed Glycine 0 CA--C 1.542 1.72 0 C-N-CA 127.05 2.262 . . . . 0.65 111.837 -176.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 167.03 140.72 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 126.052 1.741 . . . . 1.27 109.516 -178.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 44.62 -120.67 3.74 Favored Glycine 0 CA--C 1.531 1.067 0 CA-C-N 119.684 1.129 . . . . 0.46 112.551 -177.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -71.36 -19.46 77.58 Favored Glycine 0 CA--C 1.534 1.222 0 O-C-N 122.379 -0.483 . . . . 0.48 112.972 178.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 17.1 ttt -72.25 119.94 77.57 Favored Pre-proline 0 CA--C 1.537 0.464 0 C-N-CA 123.762 0.825 . . . . 0.37 109.968 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -63.41 -53.25 1.51 Allowed 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 124.178 3.252 . . . . 2.89 111.467 -169.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 114.39 152.07 10.47 Favored Glycine 0 N--CA 1.447 -0.596 0 CA-C-O 121.98 0.767 . . . . 0.95 114.555 172.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 66.18 19.47 68.21 Favored Glycine 0 CA--C 1.531 1.04 0 CA-C-N 114.247 -0.976 . . . . 0.57 111.74 -177.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 2.5 mt -50.21 -49.85 21.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 126.382 1.873 . . . . 1.05 110.793 177.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -111.44 155.36 23.31 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.467 1.107 . . . . 0.51 108.909 159.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.5 mttm -146.13 157.87 43.86 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.276 1.43 . . . . 2.44 109.859 178.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 56.49 -149.28 28.56 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 110.414 -1.074 . . . . 1.02 110.414 -176.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -51.18 -32.85 24.91 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 117.548 0.674 . . . . 0.59 112.483 -178.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -51.79 -47.4 64.26 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.268 0.627 . . . . 2.36 109.619 174.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -75.92 -49.23 18.42 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.175 0.59 . . . . 0.35 111.304 175.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -57.34 -47.82 80.58 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 118.138 0.427 . . . . 2.0 111.503 -172.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.24 -49.07 77.19 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 109.625 -0.509 . . . . 0.28 109.625 178.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.46 HG22 HG23 ' A' ' 28' ' ' VAL . 45.9 t -57.62 -52.62 55.09 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 C-N-CA 122.898 0.479 . . . . 0.38 111.035 178.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -52.04 -55.8 18.32 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 123.467 0.707 . . . . 0.36 111.366 176.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.453 ' O ' ' HB3' ' A' ' 89' ' ' ALA . . . -59.69 -40.49 88.06 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.085 0.554 . . . . 0.47 111.084 -178.16 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.406 ' CZ3' HG21 ' A' ' 28' ' ' VAL . 70.6 t90 -64.36 -52.44 58.32 Favored 'General case' 0 N--CA 1.453 -0.315 0 O-C-N 121.709 -0.619 . . . . 0.61 109.727 177.032 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.52 -28.09 66.77 Favored 'General case' 0 C--O 1.224 -0.246 0 O-C-N 120.374 -1.454 . . . . 2.04 112.436 176.067 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.468 ' HB2' ' HG3' ' A' ' 57' ' ' GLU . . . -54.56 -35.34 63.16 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 119.036 0.834 . . . . 0.64 111.387 169.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -70.64 -41.21 72.45 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 109.287 -0.634 . . . . 4.86 109.287 174.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 4.1 mtpm? -74.33 105.85 5.69 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 120.988 0.423 . . . . 2.64 111.459 -174.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.093 0 C-N-CA 126.341 1.856 . . . . 2.28 106.736 170.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' HEC . . . . . 0.594 HMA1 HG23 ' A' ' 60' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.596 HG22 ' H ' ' A' ' 23' ' ' ASP 2.303 1.1 t . . . . . 0 N--CA 1.47 0.554 0 CA-C-O 116.56 -1.686 . . . . 2.46 106.586 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.596 ' H ' HG22 ' A' ' 22' ' ' VAL . 9.2 t0 -101.81 153.68 19.6 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 103.487 -2.783 . . . . 3.61 103.487 133.18 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -111.65 -62.07 1.61 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.447 -0.946 . . . . 0.38 108.447 173.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -58.05 -44.54 87.5 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.749 -0.66 . . . . 3.36 110.417 -176.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.35 -36.7 83.05 Favored 'General case' 0 C--N 1.339 0.144 0 CA-C-N 118.707 0.685 . . . . 0.3 111.21 -179.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 92.8 t -62.87 -55.98 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 N-CA-C 107.891 -1.152 . . . . 0.46 107.891 176.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.548 HG13 ' HB2' ' A' ' 32' ' ' CYS . 74.0 t -52.76 -48.33 49.75 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 CA-C-N 117.547 0.158 . . . . 0.33 110.868 -179.598 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.434 ' HA ' HG12 ' A' ' 33' ' ' ILE . 25.3 mm-40 -50.06 -21.03 1.11 Allowed 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 126.565 1.946 . . . . 0.56 113.496 174.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 17.4 tp60 -144.67 55.1 1.25 Allowed 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 119.481 1.037 . . . . 3.97 111.528 172.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -167.25 -38.29 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 124.005 0.922 . . . . 1.35 110.025 170.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.548 ' HB2' HG13 ' A' ' 28' ' ' VAL . 3.7 m -99.58 -50.52 4.04 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 119.0 0.818 . . . . 0.21 110.772 -178.662 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.434 HG12 ' HA ' ' A' ' 29' ' ' GLN . 2.2 pp -56.91 -26.26 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.153 0 CA-C-N 116.151 -0.477 . . . . 0.39 111.89 -175.021 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.6 t -42.23 -32.33 0.48 Allowed 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.041 1.336 . . . . 2.11 111.848 172.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 12.5 m -123.08 -43.71 2.21 Favored 'General case' 0 C--N 1.341 0.212 0 C-N-CA 123.413 0.685 . . . . 0.17 111.593 173.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 84.3 m-70 -70.09 -10.18 57.9 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.745 0.818 . . . . 0.18 112.768 -176.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 88.67 149.09 18.75 Favored Glycine 0 C--N 1.337 0.635 0 N-CA-C 109.747 -1.341 . . . . 1.52 109.747 178.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -43.28 -39.49 4.17 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 124.512 1.053 . . . . 0.44 111.485 176.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -94.03 -7.16 43.51 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 125.574 1.549 . . . . 3.17 111.027 -170.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.9 mt 71.16 11.54 6.87 Favored 'General case' 0 C--N 1.35 0.589 0 CA-C-N 119.524 1.057 . . . . 1.07 111.627 177.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 12.5 p -83.49 0.1 47.86 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 127.128 2.171 . . . . 0.37 109.742 -176.049 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.85 129.92 2.78 Favored Glycine 0 N--CA 1.442 -0.917 0 N-CA-C 108.978 -1.649 . . . . 0.56 108.978 -178.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -135.95 -79.55 0.42 Allowed 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 124.195 0.998 . . . . 0.23 108.825 178.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.6 t -90.28 4.62 50.16 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.948 0.899 . . . . 1.59 110.705 172.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.566 ' HB1' ' HD2' ' A' ' 46' ' ' PRO . . . -158.08 168.89 11.55 Favored Pre-proline 0 CA--C 1.535 0.374 0 C-N-CA 124.688 1.195 . . . . 0.24 108.387 -172.315 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.566 ' HD2' ' HB1' ' A' ' 45' ' ' ALA . 38.1 Cg_endo -70.01 158.72 55.73 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.927 2.418 . . . . 0.19 110.528 -174.44 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.53 126.74 30.92 Favored 'General case' 0 C--N 1.332 -0.162 0 O-C-N 121.516 -0.74 . . . . 0.26 109.927 -178.098 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 50.6 pt -107.34 1.36 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 C-N-CA 123.716 0.806 . . . . 0.27 111.331 176.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 18.5 p-10 -35.75 -49.56 0.6 Allowed 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 124.894 1.278 . . . . 3.53 111.744 171.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.68 32.32 4.62 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 127.232 2.213 . . . . 3.59 113.103 -179.56 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.12 -49.24 78.61 Favored 'General case' 0 CA--C 1.535 0.371 0 O-C-N 120.746 -1.221 . . . . 0.44 110.147 177.462 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -54.11 -17.26 7.33 Favored Glycine 0 C--N 1.343 0.926 0 C-N-CA 124.64 1.114 . . . . 0.67 114.886 178.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.7 -40.7 88.58 Favored 'General case' 0 N--CA 1.453 -0.32 0 O-C-N 121.373 -1.075 . . . . 1.03 110.978 176.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 -105.5 -52.05 2.9 Favored 'General case' 0 CA--C 1.52 -0.198 0 N-CA-C 109.563 -0.532 . . . . 2.76 109.563 -172.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -92.7 147.86 22.53 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.725 -1.213 . . . . 0.81 107.725 -176.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -96.29 167.29 11.28 Favored 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 108.383 -0.969 . . . . 1.96 108.383 174.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -45.27 -43.51 10.6 Favored 'General case' 0 C--O 1.225 -0.216 0 C-N-CA 124.797 1.239 . . . . 2.8 111.484 177.014 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -55.82 -49.29 73.65 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.842 0.857 . . . . 3.04 110.72 178.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -74.55 -43.25 56.62 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 123.228 0.611 . . . . 3.17 109.423 -175.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 61.4 mt -60.57 -45.22 97.54 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 109.173 -0.677 . . . . 0.32 109.173 179.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 55.2 tp -55.44 -50.44 69.81 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.274 -0.639 . . . . 0.35 109.274 176.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -53.79 -48.75 69.5 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 121.197 -0.201 . . . . 1.5 110.562 175.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 49.7 mt -63.88 -21.09 27.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 O-C-N 121.421 -0.799 . . . . 0.95 112.48 179.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.573 HD11 HMB2 ' A' ' 93' ' ' HEC . 66.1 mt -78.63 -44.99 25.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 O-C-N 120.264 -1.522 . . . . 0.26 109.207 173.641 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 80.7 mt -75.64 -31.28 59.76 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 113.43 0.9 . . . . 0.75 113.43 -176.132 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -120.06 19.47 12.28 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 119.641 1.109 . . . . 1.75 109.592 -171.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.536 ' N ' ' HA2' ' A' ' 73' ' ' GLY . . . 36.42 -136.99 0.5 Allowed Glycine 0 CA--C 1.532 1.148 0 C-N-CA 127.689 2.566 . . . . 0.69 111.169 -173.12 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 31.1 tt0 166.73 138.38 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 125.718 1.607 . . . . 1.13 109.988 177.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 41.3 -119.95 1.74 Allowed Glycine 0 CA--C 1.531 1.072 0 O-C-N 120.436 -1.415 . . . . 0.36 113.157 -173.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -71.66 -18.44 77.27 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 123.374 0.512 . . . . 0.48 112.976 179.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.457 ' HB2' ' C1D' ' A' ' 93' ' ' HEC . 23.3 ttt -71.55 118.69 68.57 Favored Pre-proline 0 N--CA 1.45 -0.426 0 C-N-CA 123.734 0.813 . . . . 0.39 110.52 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -75.25 125.03 8.89 Favored 'Trans proline' 0 N--CA 1.442 -1.53 0 C-N-CA 121.845 1.697 . . . . 2.16 109.923 179.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.536 ' HA2' ' N ' ' A' ' 67' ' ' GLY . . . -63.56 140.44 44.56 Favored Glycine 0 N--CA 1.44 -1.077 0 CA-C-N 115.077 -0.965 . . . . 0.58 114.558 178.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 84.74 33.72 17.98 Favored Glycine 0 CA--C 1.525 0.668 0 CA-C-N 113.95 -1.125 . . . . 0.32 111.329 173.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -61.47 -50.76 79.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 124.606 1.162 . . . . 2.28 109.247 179.007 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -104.18 154.39 19.81 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.668 1.587 . . . . 0.37 109.476 164.197 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.3 mtmp? -143.74 150.97 39.41 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 124.781 1.232 . . . . 5.06 109.556 179.003 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 68.82 -163.21 50.39 Favored Glycine 0 CA--C 1.528 0.886 0 N-CA-C 110.379 -1.088 . . . . 0.71 110.379 -173.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -48.6 -31.05 6.03 Favored 'General case' 0 C--O 1.226 -0.166 0 C-N-CA 123.967 0.907 . . . . 0.79 112.053 -179.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -41.73 -54.85 3.18 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.778 1.231 . . . . 1.96 109.904 174.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.17 -45.25 77.56 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 122.822 0.449 . . . . 0.22 110.93 -179.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 57.4 mt-10 -55.98 -51.62 67.05 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.162 0.985 . . . . 1.92 110.643 -176.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -53.34 -52.01 60.58 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.027 0.931 . . . . 0.28 110.451 176.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.544 HG11 HMB1 ' A' ' 93' ' ' HEC . 77.0 t -55.02 -52.04 48.0 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 C-N-CA 120.997 -0.281 . . . . 0.35 110.395 178.226 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -53.79 -51.51 63.23 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 123.172 0.589 . . . . 0.18 111.972 179.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.77 -48.43 77.87 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 123.611 0.764 . . . . 0.31 110.701 178.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.565 ' CE3' HD23 ' A' ' 88' ' ' LEU . 48.9 t90 -61.61 -45.6 93.41 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 121.916 -0.49 . . . . 0.7 110.386 179.065 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.565 HD23 ' CE3' ' A' ' 87' ' ' TRP . 0.1 OUTLIER -64.17 -32.68 74.35 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 124.427 1.091 . . . . 1.54 111.184 178.337 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -65.66 -44.63 85.72 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 123.377 0.671 . . . . 0.42 110.279 171.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -59.83 -39.45 85.16 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 109.924 -0.398 . . . . 3.65 109.924 174.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -73.62 149.88 41.75 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 121.526 0.679 . . . . 2.7 110.878 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 18.6 mttt . . . . . 0 C--O 1.251 1.144 0 N-CA-C 105.274 -2.121 . . . . 2.72 105.274 177.345 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' HEC . . . . . 0.573 HMB2 HD11 ' A' ' 64' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.473 0.694 0 N-CA-C 106.505 -1.665 . . . . 2.15 106.505 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.444 ' HB3' ' HB3' ' A' ' 26' ' ' ALA . 0.7 OUTLIER -113.78 158.76 20.56 Favored 'General case' 0 N--CA 1.446 -0.645 0 O-C-N 124.597 1.186 . . . . 3.11 109.088 173.547 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -105.18 -64.12 1.16 Allowed 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 107.975 -1.12 . . . . 0.37 107.975 174.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -48.92 -48.95 42.19 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 115.65 -0.704 . . . . 2.86 111.166 178.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.444 ' HB3' ' HB3' ' A' ' 23' ' ' ASP . . . -59.56 -44.96 93.11 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 118.878 0.763 . . . . 0.28 111.426 -177.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 71.9 t -59.8 -54.19 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 N-CA-C 108.495 -0.928 . . . . 0.44 108.495 177.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.538 HG13 ' HB2' ' A' ' 32' ' ' CYS . 85.5 t -54.39 -50.74 55.12 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-N 117.979 0.354 . . . . 0.32 110.595 -178.391 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 34.8 mm-40 -53.48 -15.68 1.18 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 126.696 1.998 . . . . 0.62 112.931 174.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -135.94 32.75 2.93 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 119.416 1.007 . . . . 2.85 113.129 173.26 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 8.3 mtmt -152.37 -56.67 0.14 Allowed 'General case' 0 CA--C 1.521 -0.145 0 CA-C-N 118.694 0.679 . . . . 1.76 109.633 172.272 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.538 ' HB2' HG13 ' A' ' 28' ' ' VAL . 4.0 m -75.08 -49.78 18.57 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 121.071 0.462 . . . . 0.2 110.406 -171.415 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.4 pp -53.38 -27.16 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.142 0 CA-C-N 115.487 -0.779 . . . . 0.41 111.963 179.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.5 t -46.86 -29.19 1.86 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.27 1.028 . . . . 2.1 111.92 176.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.421 ' SG ' HMC1 ' A' ' 93' ' ' HEC . 15.9 m -122.45 -42.1 2.36 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.433 0.693 . . . . 0.3 111.662 170.368 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 89.0 m-70 -70.5 -4.44 22.84 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.226 1.01 . . . . 0.32 112.722 -177.16 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 116.44 -76.25 0.27 Allowed Glycine 0 C--N 1.339 0.746 0 C-N-CA 125.269 1.414 . . . . 3.19 111.927 161.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -178.91 -51.24 0.08 OUTLIER Glycine 0 CA--C 1.519 0.318 0 N-CA-C 108.597 -1.801 . . . . 0.81 108.597 -170.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -101.36 3.79 40.9 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 124.086 0.955 . . . . 2.2 110.777 -174.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.495 HD21 ' CG1' ' A' ' 28' ' ' VAL . 15.3 mt 75.4 11.61 3.35 Favored 'General case' 0 C--N 1.351 0.661 0 CA-C-N 119.764 1.165 . . . . 1.31 110.384 -178.609 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.6 p -81.24 -9.3 59.8 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 127.941 2.496 . . . . 0.49 109.913 -175.248 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.41 143.68 9.26 Favored Glycine 0 N--CA 1.441 -0.994 0 N-CA-C 109.142 -1.583 . . . . 0.47 109.142 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -152.92 -81.92 0.09 Allowed 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 124.137 0.975 . . . . 0.58 108.978 -178.406 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -88.93 3.44 51.44 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.544 1.137 . . . . 0.99 110.828 171.142 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -156.05 160.9 30.46 Favored Pre-proline 0 N--CA 1.449 -0.499 0 C-N-CA 125.988 1.715 . . . . 0.33 107.266 -169.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -68.17 160.03 50.6 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 123.466 2.778 . . . . 0.4 111.069 -174.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.45 125.65 28.39 Favored 'General case' 0 N--CA 1.455 -0.224 0 O-C-N 121.513 -0.742 . . . . 0.29 109.762 -177.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 46.1 pt -105.29 2.54 10.39 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 C-N-CA 123.555 0.742 . . . . 0.39 111.482 175.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -33.39 -47.9 0.23 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.528 1.931 . . . . 2.48 112.869 166.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.7 33.68 5.22 Favored 'General case' 0 C--N 1.344 0.35 0 C-N-CA 124.389 1.075 . . . . 4.66 110.281 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.22 -46.91 88.14 Favored 'General case' 0 N--CA 1.45 -0.435 0 O-C-N 121.15 -0.969 . . . . 0.37 108.923 176.081 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -56.87 -23.02 43.66 Favored Glycine 0 C--N 1.341 0.813 0 CA-C-N 118.65 0.659 . . . . 0.6 114.588 178.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -83.92 -47.38 11.09 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 117.81 0.805 . . . . 0.71 109.558 173.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 13.2 m-80 -59.5 -49.91 75.96 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.016 0.526 . . . . 1.65 111.535 -178.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -137.06 154.81 50.25 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.472 1.509 . . . . 0.87 108.578 -169.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.6 p -84.57 165.87 17.65 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 123.925 0.89 . . . . 2.35 110.226 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -50.53 -39.39 48.88 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 123.723 0.809 . . . . 3.24 111.407 178.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -57.29 -50.46 72.84 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 118.457 0.571 . . . . 4.52 110.83 177.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 27.5 mm-40 -68.09 -46.2 71.63 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 121.733 0.777 . . . . 3.09 108.917 -175.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 48.7 mt -60.19 -47.31 92.6 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 N-CA-C 109.44 -0.578 . . . . 0.39 109.44 -179.431 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.9 tp -58.45 -49.58 76.8 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 109.117 -0.697 . . . . 0.36 109.117 178.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -50.42 -51.05 49.96 Favored 'General case' 0 N--CA 1.452 -0.355 0 O-C-N 123.409 0.443 . . . . 1.82 109.961 176.27 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 55.0 mt -57.62 -52.32 58.92 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 O-C-N 121.868 -0.52 . . . . 0.51 110.957 178.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 60.7 mt -53.4 -44.9 56.45 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 O-C-N 120.561 -1.337 . . . . 0.26 110.404 179.383 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 75.1 mt -72.91 -32.67 65.49 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 113.361 0.874 . . . . 0.55 113.361 -178.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -123.04 19.77 9.98 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 119.655 1.116 . . . . 1.74 109.981 -165.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.562 ' N ' ' HA2' ' A' ' 73' ' ' GLY . . . 31.0 -142.98 0.02 OUTLIER Glycine 0 CA--C 1.533 1.207 0 C-N-CA 129.107 3.242 . . . . 0.62 111.492 -167.477 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 173.27 133.41 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 119.005 1.403 . . . . 1.38 109.057 -175.147 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 35.39 -113.64 0.14 Allowed Glycine 0 CA--C 1.534 1.224 0 CA-C-N 120.019 1.282 . . . . 0.47 113.925 -171.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -71.76 -21.42 78.91 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 123.47 0.557 . . . . 0.61 112.936 -178.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.441 ' HB2' ' C1D' ' A' ' 93' ' ' HEC . 19.6 ttt -71.13 117.98 61.54 Favored Pre-proline 0 N--CA 1.451 -0.409 0 C-N-CA 124.994 1.318 . . . . 0.43 110.793 179.507 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.548 ' HD2' HD11 ' A' ' 75' ' ' ILE . 41.3 Cg_endo -77.95 123.76 6.42 Favored 'Trans proline' 0 N--CA 1.447 -1.262 0 C-N-CA 122.938 2.425 . . . . 2.1 111.015 -178.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.562 ' HA2' ' N ' ' A' ' 67' ' ' GLY . . . -59.48 137.06 50.21 Favored Glycine 0 N--CA 1.444 -0.815 0 N-CA-C 115.688 1.035 . . . . 0.68 115.688 -177.262 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 80.49 38.64 16.84 Favored Glycine 0 CA--C 1.525 0.688 0 CA-C-N 114.071 -1.064 . . . . 0.32 111.005 174.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.548 HD11 ' HD2' ' A' ' 72' ' ' PRO . 1.2 mt -58.35 -58.04 8.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 124.892 1.277 . . . . 1.13 109.255 174.4 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -93.97 151.5 19.5 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 108.31 -0.996 . . . . 0.39 108.31 163.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -143.0 164.81 29.08 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 105.985 -1.857 . . . . 3.4 105.985 172.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 75.17 -173.19 53.02 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 110.306 -1.117 . . . . 1.31 110.306 -173.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -51.46 -27.96 11.83 Favored 'General case' 0 C--O 1.225 -0.23 0 C-N-CA 123.877 0.871 . . . . 0.83 111.628 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 6.2 mp0 -42.23 -57.85 2.38 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 124.097 0.959 . . . . 4.59 111.39 170.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -58.24 -47.98 81.82 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 118.519 0.599 . . . . 0.41 110.782 -175.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -52.37 -60.92 2.65 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 124.507 1.123 . . . . 2.04 111.348 174.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -55.16 -47.34 75.28 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 124.233 1.013 . . . . 0.35 109.922 -177.418 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 62.4 t -55.91 -55.58 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 C-N-CA 123.669 0.788 . . . . 0.36 110.339 176.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -51.4 -53.75 33.46 Favored 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 123.178 0.591 . . . . 0.24 111.614 176.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -63.34 -42.13 98.92 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.872 0.869 . . . . 0.36 110.784 -175.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.495 ' CZ3' HG21 ' A' ' 28' ' ' VAL . 62.0 t90 -58.69 -50.8 72.56 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 108.626 -0.879 . . . . 0.48 108.626 174.507 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.39 -32.1 69.85 Favored 'General case' 0 C--O 1.222 -0.357 0 O-C-N 120.512 -1.367 . . . . 1.98 112.585 173.381 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -60.64 -32.02 71.21 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 119.556 1.071 . . . . 0.67 111.925 172.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -77.59 -34.64 53.49 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 119.668 1.122 . . . . 3.9 111.643 168.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 21.6 mtpp -73.96 116.32 14.44 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 119.806 1.185 . . . . 2.95 111.029 -175.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 12.3 mttt . . . . . 0 C--O 1.254 1.299 0 C-N-CA 127.787 2.435 . . . . 2.65 105.569 -176.747 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' HEC . . . . . 0.446 HMB1 ' SG ' ' A' ' 32' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 91.2 t . . . . . 0 N--CA 1.472 0.652 0 N-CA-C 106.697 -1.594 . . . . 1.55 106.697 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -74.47 99.44 3.56 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 108.45 -0.945 . . . . 2.23 108.45 -174.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -41.64 -57.38 2.3 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 124.951 1.3 . . . . 0.35 111.371 177.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -55.67 -48.21 75.43 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 116.314 -0.403 . . . . 2.33 111.502 179.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.16 -44.7 83.72 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 118.266 0.485 . . . . 0.38 110.921 178.256 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.439 HG21 ' HG3' ' A' ' 80' ' ' GLU . 54.6 t -57.53 -55.67 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 N-CA-C 109.332 -0.618 . . . . 0.33 109.332 175.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.666 HG13 ' HB2' ' A' ' 32' ' ' CYS . 78.9 t -54.08 -49.61 60.13 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 N-CA-C 110.292 -0.262 . . . . 0.39 110.292 -177.316 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.421 ' HA ' HG12 ' A' ' 33' ' ' ILE . 30.6 mm-40 -51.83 -15.97 0.61 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.624 1.969 . . . . 0.87 113.588 174.266 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.43 30.96 2.61 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 119.313 0.961 . . . . 2.39 112.314 178.496 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 5.0 mtmt -157.08 -47.31 0.07 Allowed 'General case' 0 CA--C 1.519 -0.214 0 O-C-N 121.85 -0.531 . . . . 1.49 111.384 173.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.666 ' HB2' HG13 ' A' ' 28' ' ' VAL . 4.3 m -86.26 -48.13 8.8 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.65 -0.5 . . . . 0.2 109.65 -174.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.421 HG12 ' HA ' ' A' ' 29' ' ' GLN . 2.5 pp -55.22 -27.8 20.51 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 CA-C-N 115.854 -0.612 . . . . 0.38 112.332 -177.314 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.7 m -42.53 -34.42 0.85 Allowed 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.692 1.197 . . . . 1.08 112.702 172.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 26.2 m -120.05 -41.37 2.65 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.134 0.574 . . . . 0.18 111.763 174.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 84.5 m-70 -73.49 -7.85 53.49 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.712 0.805 . . . . 0.24 112.688 -176.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 87.94 149.14 16.85 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 109.825 -1.31 . . . . 1.48 109.825 178.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -42.92 -34.89 2.08 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 124.78 1.181 . . . . 0.45 112.237 173.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -97.84 -6.99 31.35 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 125.737 1.615 . . . . 2.29 111.537 -171.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.2 mt 71.89 10.73 6.22 Favored 'General case' 0 C--N 1.351 0.665 0 CA-C-N 120.604 1.547 . . . . 1.16 111.232 176.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.7 p -88.79 0.43 56.53 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 128.603 2.761 . . . . 0.36 109.992 -173.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.84 124.21 1.73 Allowed Glycine 0 N--CA 1.439 -1.106 0 N-CA-C 109.271 -1.532 . . . . 0.75 109.271 178.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -128.5 -78.74 0.57 Allowed 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 124.368 1.067 . . . . 0.29 108.873 177.237 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 21.4 m -93.67 4.55 53.77 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.387 1.075 . . . . 1.28 111.104 172.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -152.16 163.28 24.09 Favored Pre-proline 0 CA--C 1.534 0.358 0 C-N-CA 126.096 1.758 . . . . 0.31 107.164 -171.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -70.52 160.59 48.98 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 122.683 2.255 . . . . 0.26 110.423 -176.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.52 128.23 34.91 Favored 'General case' 0 C--N 1.332 -0.187 0 O-C-N 121.461 -0.774 . . . . 0.31 110.255 -176.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.425 HD12 HD11 ' A' ' 88' ' ' LEU . 26.7 pt -108.21 0.84 9.74 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 C-N-CA 123.904 0.882 . . . . 0.35 111.931 177.309 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 22.8 p-10 -33.08 -50.67 0.29 Allowed 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.812 1.645 . . . . 3.87 113.243 169.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 12.6 pttp -111.96 22.46 14.85 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 125.796 1.638 . . . . 4.86 112.054 -178.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -54.72 -38.34 66.97 Favored 'General case' 0 C--O 1.224 -0.285 0 O-C-N 121.632 -0.667 . . . . 0.36 109.576 177.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -57.96 -17.58 29.91 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 123.862 0.744 . . . . 0.58 114.927 176.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -90.0 -39.58 12.87 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 118.295 1.048 . . . . 0.7 109.733 172.247 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -63.17 -48.86 76.63 Favored 'General case' 0 CA--C 1.527 0.084 0 C-N-CA 123.129 0.572 . . . . 2.58 111.504 178.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -141.05 148.88 40.91 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 125.695 1.598 . . . . 0.65 107.969 -166.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 16.6 m -81.89 167.57 18.83 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 118.39 0.541 . . . . 1.54 110.573 179.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -46.9 -43.12 18.57 Favored 'General case' 0 C--O 1.225 -0.225 0 C-N-CA 124.191 0.996 . . . . 3.1 111.424 175.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -55.13 -45.62 75.61 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.039 0.936 . . . . 2.69 110.568 179.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -73.42 -49.42 27.11 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 123.766 0.826 . . . . 3.12 109.75 -178.007 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.503 HG23 HMA1 ' A' ' 93' ' ' HEC . 72.8 mt -60.05 -42.76 90.9 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 N-CA-C 108.618 -0.882 . . . . 0.22 108.618 -176.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 23.4 tp -55.01 -52.11 64.15 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 123.473 0.709 . . . . 0.4 109.739 175.199 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -52.04 -48.31 64.62 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 118.118 0.417 . . . . 1.5 111.136 176.168 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 95.6 mt -57.81 -54.22 34.56 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 O-C-N 121.348 -0.845 . . . . 0.67 110.446 177.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 38.3 mt -50.0 -46.02 23.22 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 O-C-N 121.163 -0.961 . . . . 0.34 109.909 178.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 96.5 mt -62.96 -40.02 96.41 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 118.044 -0.979 . . . . 0.61 113.395 177.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -127.85 25.45 5.96 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 120.369 1.44 . . . . 1.84 110.442 -159.59 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 23.57 -134.98 0.01 OUTLIER Glycine 0 CA--C 1.542 1.758 0 C-N-CA 127.615 2.531 . . . . 0.65 112.694 -159.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 21.6 tt0 169.25 138.62 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.148 0 CA-C-N 119.799 1.8 . . . . 1.22 108.933 -177.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 30.06 -111.15 0.03 OUTLIER Glycine 0 CA--C 1.534 1.247 0 C-N-CA 125.212 1.387 . . . . 0.44 114.154 -171.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -66.97 -25.85 73.25 Favored Glycine 0 CA--C 1.534 1.226 0 CA-C-N 118.069 0.935 . . . . 0.55 113.415 -178.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 16.7 ttt -70.9 120.67 80.72 Favored Pre-proline 0 CA--C 1.536 0.441 0 C-N-CA 124.747 1.219 . . . . 0.39 110.033 -179.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -61.89 -56.0 0.9 Allowed 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 124.358 3.372 . . . . 2.96 111.237 -169.139 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 118.25 151.56 9.16 Favored Glycine 0 N--CA 1.447 -0.63 0 CA-C-N 115.58 -0.736 . . . . 0.91 113.874 173.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 65.73 22.47 70.05 Favored Glycine 0 CA--C 1.528 0.849 0 CA-C-N 114.313 -0.943 . . . . 0.42 111.522 -179.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 2.6 mt -50.13 -57.51 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 C-N-CA 125.282 1.433 . . . . 1.06 109.462 176.107 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -102.62 152.74 20.84 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.36 0.664 . . . . 0.37 109.794 163.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 3.2 mmmp? -145.03 151.82 39.16 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.594 1.158 . . . . 3.79 109.598 177.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 71.99 -156.67 52.61 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 123.518 0.58 . . . . 0.71 111.749 177.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -48.22 -35.59 12.18 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 124.941 1.296 . . . . 0.82 112.09 -177.007 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.439 ' HG3' HG21 ' A' ' 27' ' ' VAL . 43.5 tt0 -47.45 -63.53 1.03 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.897 1.279 . . . . 2.18 110.715 169.406 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.03 -44.34 94.69 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.979 0.912 . . . . 0.29 110.794 -179.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -54.59 -52.31 62.55 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 121.219 0.533 . . . . 2.53 110.047 179.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.13 -51.67 68.76 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.57 0.748 . . . . 0.21 109.971 179.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 55.7 t -49.55 -56.71 2.67 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 123.027 0.531 . . . . 0.45 111.012 176.312 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -53.44 -51.9 61.16 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 124.059 0.944 . . . . 0.19 111.855 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.95 -48.61 80.99 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 121.599 0.714 . . . . 0.29 110.434 -179.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.529 ' CE3' HD23 ' A' ' 88' ' ' LEU . 49.9 t90 -56.5 -43.35 79.65 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.165 0.586 . . . . 0.4 110.303 177.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.529 HD23 ' CE3' ' A' ' 87' ' ' TRP . 0.1 OUTLIER -63.43 -42.31 98.71 Favored 'General case' 0 C--O 1.227 -0.117 0 C-N-CA 123.646 0.778 . . . . 1.58 110.862 175.568 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -55.36 -38.15 68.42 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 119.236 0.925 . . . . 0.41 110.716 171.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -84.15 13.09 5.49 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.655 1.182 . . . . 3.53 113.655 174.063 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.46 122.7 43.37 Favored 'General case' 0 C--N 1.34 0.189 0 CA-C-N 119.954 1.252 . . . . 2.28 109.733 173.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.255 1.378 0 C-N-CA 127.541 2.336 . . . . 2.81 104.959 178.097 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' HEC . . . . . 0.503 HMA1 HG23 ' A' ' 60' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 84.8 t . . . . . 0 N--CA 1.472 0.63 0 N-CA-C 106.853 -1.536 . . . . 1.51 106.853 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -74.87 95.91 3.03 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 107.786 -1.19 . . . . 2.59 107.786 -175.14 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -49.69 -50.22 44.51 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.204 1.002 . . . . 0.59 109.805 179.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -60.61 -51.59 68.77 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 116.002 -0.544 . . . . 3.2 110.414 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.99 -45.28 79.06 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 118.916 0.78 . . . . 0.59 110.99 -178.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.545 HG21 ' HG3' ' A' ' 80' ' ' GLU . 24.5 t -56.64 -56.43 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 CA-C-N 116.12 -0.491 . . . . 0.81 109.713 175.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.639 HG22 ' SG ' ' A' ' 32' ' ' CYS . 52.2 t -55.68 -45.72 79.22 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 N-CA-C 110.005 -0.369 . . . . 0.4 110.005 -178.384 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.439 ' HA ' HG12 ' A' ' 33' ' ' ILE . 26.0 mm-40 -55.72 -11.31 0.91 Allowed 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 127.355 2.262 . . . . 0.84 113.859 173.699 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -139.05 16.62 2.63 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 119.63 1.104 . . . . 2.92 113.514 173.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.431 ' O ' HMC3 ' A' ' 93' ' ' HEC . 23.6 mttm -135.86 -62.79 0.67 Allowed 'General case' 0 CA--C 1.518 -0.257 0 C-N-CA 123.919 0.888 . . . . 2.28 109.457 176.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.639 ' SG ' HG22 ' A' ' 28' ' ' VAL . 3.2 m -72.71 -47.93 42.99 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.096 0.474 . . . . 0.27 110.43 -173.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.439 HG12 ' HA ' ' A' ' 29' ' ' GLN . 2.2 pp -58.72 -25.13 27.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 CA-C-N 115.533 -0.758 . . . . 0.38 111.688 -174.483 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.6 m -46.16 -32.93 3.23 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.829 1.251 . . . . 1.11 111.768 175.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 21.6 m -120.31 -42.57 2.56 Favored 'General case' 0 C--N 1.341 0.21 0 C-N-CA 123.523 0.729 . . . . 0.19 111.516 175.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -72.56 -8.63 56.15 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.577 0.751 . . . . 0.21 112.667 -177.321 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 86.46 148.81 12.71 Favored Glycine 0 C--N 1.336 0.567 0 N-CA-C 109.442 -1.463 . . . . 1.47 109.442 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -42.05 -33.43 1.23 Allowed Glycine 0 CA--C 1.527 0.821 0 C-N-CA 125.241 1.401 . . . . 0.48 112.914 175.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -100.66 -4.8 27.62 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 125.408 1.483 . . . . 3.11 112.089 -170.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 13.0 mt 68.94 12.94 8.77 Favored 'General case' 0 C--N 1.352 0.699 0 CA-C-N 120.212 1.369 . . . . 1.09 112.002 177.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 11.0 p -84.32 -3.63 58.37 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 127.329 2.252 . . . . 0.42 110.365 -177.078 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.72 130.7 3.74 Favored Glycine 0 N--CA 1.441 -0.988 0 N-CA-C 108.943 -1.663 . . . . 0.59 108.943 -176.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -134.5 -79.44 0.45 Allowed 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 124.285 1.034 . . . . 0.29 108.471 177.175 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 19.5 m -91.61 4.28 53.04 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.208 1.003 . . . . 1.3 111.043 173.144 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -155.72 163.95 22.95 Favored Pre-proline 0 CA--C 1.536 0.407 0 C-N-CA 125.388 1.475 . . . . 0.22 107.884 -169.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -70.74 157.97 56.99 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.915 2.41 . . . . 0.24 110.582 -174.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.52 123.44 23.93 Favored 'General case' 0 C--N 1.331 -0.208 0 O-C-N 121.492 -0.755 . . . . 0.23 110.16 -175.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 44.0 pt -106.78 2.22 10.09 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.135 0 C-N-CA 124.22 1.008 . . . . 0.3 111.132 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.439 ' OD1' ' NZ ' ' A' ' 91' ' ' LYS . 24.4 t0 -42.01 -49.59 4.67 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 118.457 0.571 . . . . 2.9 112.149 177.643 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 5.3 pttt -101.28 26.32 7.28 Favored 'General case' 0 C--N 1.344 0.331 0 C-N-CA 125.743 1.617 . . . . 4.8 111.698 -178.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -53.74 -43.13 68.88 Favored 'General case' 0 N--CA 1.457 -0.122 0 O-C-N 121.483 -0.761 . . . . 0.3 110.302 -178.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -52.05 -23.82 12.92 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 114.682 0.633 . . . . 0.61 114.682 175.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -80.99 -35.69 31.67 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 118.061 0.931 . . . . 0.99 110.509 175.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 -74.2 -48.36 29.53 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 122.814 0.446 . . . . 2.03 109.997 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -140.4 153.67 46.42 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.356 1.062 . . . . 0.8 109.274 -170.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 20.0 m -83.83 166.92 17.53 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 118.485 0.584 . . . . 1.64 110.684 178.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.2 pm0 -47.07 -42.41 18.64 Favored 'General case' 0 C--O 1.223 -0.293 0 C-N-CA 124.793 1.237 . . . . 2.79 111.92 178.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -58.44 -45.83 87.73 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.378 0.609 . . . . 2.66 110.152 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -74.2 -46.68 40.38 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.599 0.76 . . . . 3.2 109.134 -176.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 62.6 mt -59.32 -44.28 91.95 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.132 0 O-C-N 121.475 -0.766 . . . . 0.38 109.018 179.263 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 52.8 tp -54.43 -51.17 65.79 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 109.14 -0.689 . . . . 0.44 109.14 176.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -52.48 -50.16 63.25 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 123.297 0.373 . . . . 1.5 110.253 174.147 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 76.7 mt -61.65 -24.09 32.88 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 O-C-N 121.323 -0.861 . . . . 1.01 112.621 179.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.572 HD11 HMB2 ' A' ' 93' ' ' HEC . 75.1 mt -82.38 -46.66 19.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 O-C-N 120.059 -1.65 . . . . 0.36 109.621 176.129 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 68.7 mt -72.64 -30.29 64.19 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.395 1.078 . . . . 0.77 112.713 -176.146 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -127.39 17.31 7.06 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 119.207 0.912 . . . . 1.96 109.614 -169.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.585 ' N ' ' HA2' ' A' ' 73' ' ' GLY . . . 40.41 -143.87 0.55 Allowed Glycine 0 CA--C 1.539 1.539 0 C-N-CA 127.759 2.6 . . . . 0.71 111.814 -177.722 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 31.4 tt0 170.12 138.18 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 126.069 1.748 . . . . 1.2 109.731 -179.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 35.76 -116.62 0.28 Allowed Glycine 0 C--N 1.347 1.16 0 CA-C-N 120.46 1.482 . . . . 0.43 114.082 -175.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -67.32 -23.16 73.27 Favored Glycine 0 CA--C 1.531 1.091 0 CA-C-N 117.98 0.89 . . . . 0.53 112.555 -179.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 18.6 ttt -72.7 117.96 63.84 Favored Pre-proline 0 CA--C 1.535 0.398 0 C-N-CA 124.45 1.1 . . . . 0.51 112.053 179.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.417 ' HD2' HD11 ' A' ' 75' ' ' ILE . 37.2 Cg_endo -75.57 123.78 7.8 Favored 'Trans proline' 0 N--CA 1.446 -1.277 0 C-N-CA 122.848 2.366 . . . . 2.11 111.706 -179.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.585 ' HA2' ' N ' ' A' ' 67' ' ' GLY . . . -58.01 126.67 43.01 Favored Glycine 0 N--CA 1.443 -0.889 0 CA-C-N 115.012 -0.995 . . . . 0.7 115.246 179.191 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 86.66 48.01 4.63 Favored Glycine 0 C--N 1.337 0.636 0 N-CA-C 110.648 -0.981 . . . . 0.58 110.648 173.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.417 HD11 ' HD2' ' A' ' 72' ' ' PRO . 1.1 mt -69.11 -50.88 49.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 123.833 0.853 . . . . 1.18 109.497 175.168 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -102.92 153.63 20.02 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 126.002 1.721 . . . . 0.38 109.619 164.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 44.9 mttm -143.63 155.36 44.23 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 125.386 1.475 . . . . 2.79 108.861 178.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 72.63 -167.77 53.43 Favored Glycine 0 CA--C 1.53 0.981 0 N-CA-C 110.926 -0.869 . . . . 0.91 110.926 -175.183 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -52.04 -25.95 9.76 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.469 1.108 . . . . 1.06 112.728 -177.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.545 ' HG3' HG21 ' A' ' 27' ' ' VAL . 34.8 tt0 -42.19 -60.3 1.5 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.723 1.209 . . . . 2.21 110.939 168.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.27 -45.73 92.28 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 122.608 0.363 . . . . 0.34 110.638 -175.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -52.11 -57.12 10.55 Favored 'General case' 0 N--CA 1.461 0.096 0 C-N-CA 123.503 0.721 . . . . 3.04 111.196 174.129 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -53.95 -48.48 70.25 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 123.139 0.576 . . . . 0.3 109.812 -177.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.402 HG13 ' CG2' ' A' ' 28' ' ' VAL . 98.5 t -59.18 -53.32 49.71 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 N-CA-C 111.588 0.218 . . . . 0.32 111.588 177.32 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -51.29 -53.82 31.98 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 124.051 0.941 . . . . 0.29 111.455 178.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.89 -54.42 47.13 Favored 'General case' 0 C--O 1.224 -0.268 0 N-CA-C 109.299 -0.63 . . . . 0.6 109.299 179.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.551 ' CE3' HD23 ' A' ' 88' ' ' LEU . 50.2 t90 -49.38 -46.61 47.48 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 122.984 0.514 . . . . 0.51 111.134 177.066 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.551 HD23 ' CE3' ' A' ' 87' ' ' TRP . 0.1 OUTLIER -66.05 -31.82 72.93 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 124.585 1.154 . . . . 1.66 111.908 177.338 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -67.8 -44.85 76.35 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 118.739 0.7 . . . . 0.58 110.731 173.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -57.52 -39.76 77.27 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.286 0.634 . . . . 5.24 110.196 173.042 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.439 ' NZ ' ' OD1' ' A' ' 49' ' ' ASP . 1.6 mtmp? -73.45 136.22 44.2 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 118.852 0.751 . . . . 2.78 110.538 178.074 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 67.8 mttt . . . . . 0 C--O 1.249 1.044 0 CA-C-O 117.189 -1.386 . . . . 2.59 108.091 174.704 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' HEC . . . . . 0.572 HMB2 HD11 ' A' ' 64' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.518 HG11 ' HA ' ' A' ' 80' ' ' GLU . 4.1 p . . . . . 0 N--CA 1.475 0.794 0 N-CA-C 105.384 -2.08 . . . . 2.18 105.384 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -91.88 95.29 9.75 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 119.439 1.018 . . . . 2.58 108.664 -173.21 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -51.84 -58.62 5.92 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.655 0.782 . . . . 0.38 110.906 -178.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -50.15 -45.14 52.94 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 118.936 -0.554 . . . . 2.85 111.362 176.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.99 -47.66 84.91 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 119.033 0.833 . . . . 0.39 110.829 179.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 89.3 t -56.32 -54.49 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.155 0 N-CA-C 108.934 -0.765 . . . . 0.4 108.934 176.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.614 HG13 ' HB2' ' A' ' 32' ' ' CYS . 96.4 t -56.02 -48.21 79.11 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 C-N-CA 122.55 0.34 . . . . 0.41 111.037 -177.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 36.4 mm-40 -53.67 -15.81 1.37 Allowed 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 126.912 2.085 . . . . 0.49 113.036 174.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -144.98 48.21 1.31 Allowed 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 119.286 0.948 . . . . 2.46 111.086 174.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 3.8 mttt -162.69 -49.28 0.04 OUTLIER 'General case' 0 C--O 1.227 -0.131 0 C-N-CA 124.483 1.113 . . . . 1.94 110.206 167.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.614 ' HB2' HG13 ' A' ' 28' ' ' VAL . 5.2 m -85.2 -50.11 7.66 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 121.443 0.64 . . . . 0.16 110.417 -172.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.4 pp -53.48 -28.63 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 CA-C-N 115.063 -0.971 . . . . 0.41 111.487 -178.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.9 m -41.61 -35.14 0.69 Allowed 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 125.574 1.549 . . . . 1.1 112.377 173.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 34.9 m -119.23 -41.53 2.73 Favored 'General case' 0 C--N 1.34 0.185 0 C-N-CA 123.546 0.739 . . . . 0.16 111.562 174.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 84.4 m-70 -74.18 -7.72 53.66 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.749 0.82 . . . . 0.35 112.791 -175.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 84.24 148.72 9.29 Favored Glycine 0 C--N 1.338 0.643 0 C-N-CA 125.511 1.529 . . . . 1.52 109.6 -179.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -44.49 -36.47 4.46 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 124.41 1.005 . . . . 0.46 112.317 174.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -88.61 -10.72 47.68 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 124.842 1.257 . . . . 2.06 111.454 -174.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.4 mt 71.78 10.59 6.31 Favored 'General case' 0 C--N 1.349 0.578 0 CA-C-N 120.197 1.362 . . . . 1.15 110.818 176.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.4 p -84.06 -0.27 51.13 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 128.415 2.686 . . . . 0.32 110.126 -175.456 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.4 138.88 5.84 Favored Glycine 0 N--CA 1.44 -1.071 0 N-CA-C 108.599 -1.801 . . . . 0.44 108.599 -176.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -145.35 -78.34 0.19 Allowed 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 123.789 0.836 . . . . 0.24 108.932 178.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.5 t -89.07 1.7 55.17 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.824 0.85 . . . . 1.25 110.355 174.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.457 ' HB1' ' HD2' ' A' ' 46' ' ' PRO . . . -162.43 165.13 15.98 Favored Pre-proline 0 CA--C 1.537 0.467 0 C-N-CA 125.12 1.368 . . . . 0.4 107.434 -167.372 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.457 ' HD2' ' HB1' ' A' ' 45' ' ' ALA . 33.3 Cg_endo -66.81 159.52 51.06 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 123.46 2.773 . . . . 0.32 111.54 -173.224 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.33 132.19 42.78 Favored 'General case' 0 C--N 1.332 -0.177 0 O-C-N 121.67 -0.643 . . . . 0.39 109.867 -178.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 35.3 pt -109.03 1.16 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 C-N-CA 123.242 0.617 . . . . 0.29 112.516 175.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -38.49 -47.4 1.27 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.459 1.104 . . . . 3.56 111.811 170.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 10.7 mttt -108.52 35.2 3.28 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 125.553 1.541 . . . . 5.64 111.683 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.81 -55.28 35.02 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 108.567 -0.901 . . . . 0.44 108.567 169.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -57.02 -21.28 37.58 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 124.726 1.155 . . . . 0.75 113.551 -179.246 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.01 -38.91 92.47 Favored 'General case' 0 N--CA 1.451 -0.394 0 O-C-N 121.799 -0.824 . . . . 1.4 110.994 177.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 72.0 m-80 -105.23 -53.66 2.62 Favored 'General case' 0 CA--C 1.523 -0.076 0 C-N-CA 123.411 0.684 . . . . 2.98 109.937 -174.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -94.66 142.34 27.57 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 124.848 1.259 . . . . 1.49 108.929 -171.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.5 167.06 17.76 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 118.748 0.704 . . . . 1.88 110.167 175.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -48.37 -47.43 37.32 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 124.009 0.924 . . . . 3.04 110.894 174.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -54.72 -34.95 63.14 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.39 0.676 . . . . 4.46 111.598 178.632 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -84.44 -47.05 11.04 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 121.533 0.682 . . . . 3.44 109.602 -175.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.592 HG23 HMA1 ' A' ' 93' ' ' HEC . 87.1 mt -61.48 -41.93 91.93 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 N-CA-C 108.778 -0.823 . . . . 0.31 108.778 179.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.4 tp -54.95 -49.46 71.31 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 123.02 0.528 . . . . 0.35 109.714 175.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -52.1 -52.09 53.59 Favored 'General case' 0 CA--C 1.533 0.306 0 O-C-N 123.271 0.357 . . . . 1.51 110.152 176.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 75.7 mt -57.76 -50.69 76.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.288 0 O-C-N 121.572 -0.705 . . . . 0.54 110.311 178.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 46.3 mt -54.06 -44.39 62.62 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 O-C-N 120.383 -1.448 . . . . 0.3 110.411 179.163 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 84.8 mt -70.5 -32.78 70.42 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 118.33 -0.843 . . . . 0.4 112.892 -179.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -124.69 18.84 8.7 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 119.752 1.16 . . . . 1.69 110.387 -164.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.604 ' N ' ' HA2' ' A' ' 73' ' ' GLY . . . 30.81 -137.33 0.07 OUTLIER Glycine 0 CA--C 1.532 1.116 0 C-N-CA 128.819 3.104 . . . . 0.63 111.206 -167.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 11.6 tt0 165.7 129.74 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.518 1.527 . . . . 1.6 109.81 -178.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 41.04 -118.42 1.26 Allowed Glycine 0 C--N 1.346 1.089 0 CA-C-N 120.865 1.666 . . . . 0.73 113.846 -176.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -66.07 -17.36 65.55 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 123.711 0.672 . . . . 0.75 112.644 -179.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.427 ' HB2' ' C1D' ' A' ' 93' ' ' HEC . 19.4 ttt -81.39 117.74 69.41 Favored Pre-proline 0 N--CA 1.448 -0.531 0 C-N-CA 124.879 1.272 . . . . 0.39 111.525 179.063 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.563 ' HD2' HD11 ' A' ' 75' ' ' ILE . 37.5 Cg_endo -77.93 122.64 5.9 Favored 'Trans proline' 0 N--CA 1.447 -1.237 0 C-N-CA 122.992 2.461 . . . . 2.11 111.704 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.604 ' HA2' ' N ' ' A' ' 67' ' ' GLY . . . -57.84 132.93 52.8 Favored Glycine 0 N--CA 1.443 -0.853 0 N-CA-C 115.737 1.055 . . . . 0.65 115.737 -179.29 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 82.59 34.4 22.57 Favored Glycine 0 CA--C 1.527 0.803 0 CA-C-N 114.228 -0.986 . . . . 0.34 112.06 173.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.563 HD11 ' HD2' ' A' ' 72' ' ' PRO . 1.4 mt -53.9 -57.24 6.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 125.256 1.422 . . . . 1.13 110.038 174.389 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -101.73 150.06 23.51 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 124.292 1.037 . . . . 0.41 108.27 166.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 56.2 mttm -142.26 165.25 27.95 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 106.986 -1.487 . . . . 2.8 106.986 172.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 76.8 -170.29 55.04 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 110.022 -1.231 . . . . 1.26 110.022 -173.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -52.35 -30.19 27.52 Favored 'General case' 0 C--O 1.225 -0.222 0 C-N-CA 123.865 0.866 . . . . 0.75 111.15 -176.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.556 ' O ' HG23 ' A' ' 84' ' ' VAL . 11.5 mp0 -39.5 -62.98 0.61 Allowed 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.147 1.379 . . . . 4.54 111.063 170.03 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -58.46 -48.92 79.18 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.207 0.458 . . . . 0.37 111.125 -175.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -50.06 -57.63 7.23 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.362 1.065 . . . . 2.0 111.353 175.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.95 -43.63 98.44 Favored 'General case' 0 N--CA 1.449 -0.507 0 O-C-N 121.902 -0.499 . . . . 0.44 110.769 -177.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.556 HG23 ' O ' ' A' ' 80' ' ' GLU . 71.3 t -53.97 -53.95 23.89 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 C-N-CA 123.332 0.653 . . . . 0.53 109.737 176.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -52.73 -53.53 46.55 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 123.401 0.68 . . . . 0.21 112.082 175.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.61 -47.14 82.98 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 122.115 0.96 . . . . 0.27 110.976 -179.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.522 ' CE3' HD23 ' A' ' 88' ' ' LEU . 50.9 t90 -59.86 -42.48 93.78 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.315 1.046 . . . . 0.44 110.273 178.286 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.522 HD23 ' CE3' ' A' ' 87' ' ' TRP . 0.1 OUTLIER -64.25 -38.92 92.75 Favored 'General case' 0 C--N 1.333 -0.116 0 C-N-CA 123.996 0.918 . . . . 1.59 110.818 175.552 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -52.81 -45.5 67.28 Favored 'General case' 0 CA--C 1.528 0.12 0 N-CA-C 109.424 -0.584 . . . . 0.52 109.424 173.345 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -90.28 36.78 0.88 Allowed 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.216 0.606 . . . . 3.06 111.896 175.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 4.4 mttm -126.36 136.37 52.62 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.267 1.027 . . . . 2.96 108.702 164.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 30.8 mttt . . . . . 0 C--O 1.253 1.256 0 N-CA-C 105.162 -2.162 . . . . 3.47 105.162 172.916 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' HEC . . . . . 0.592 HMA1 HG23 ' A' ' 60' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 53.7 t . . . . . 0 N--CA 1.473 0.712 0 N-CA-C 106.965 -1.494 . . . . 1.48 106.965 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -73.8 97.73 2.8 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 118.655 0.661 . . . . 2.52 109.287 -175.022 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -40.84 -51.91 3.09 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 125.012 1.325 . . . . 0.5 111.8 176.097 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -57.02 -46.09 82.59 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 110.146 -0.316 . . . . 2.93 110.146 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.1 -43.75 98.41 Favored 'General case' 0 CA--C 1.528 0.109 0 C-N-CA 123.386 0.674 . . . . 0.34 110.768 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 89.8 t -58.93 -58.76 5.44 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.261 0 N-CA-C 109.062 -0.718 . . . . 0.55 109.062 176.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.554 HG21 ' HZ3' ' A' ' 87' ' ' TRP . 44.1 t -53.02 -47.03 54.74 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 C-N-CA 123.224 0.609 . . . . 0.36 110.431 -177.114 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.448 ' HA ' HG12 ' A' ' 33' ' ' ILE . 24.7 mm-40 -48.9 -25.91 2.17 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 126.119 1.768 . . . . 0.68 113.427 173.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -141.01 56.73 1.56 Allowed 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 119.261 0.937 . . . . 3.26 111.624 174.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.47 -38.12 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 124.145 0.978 . . . . 1.27 110.033 170.442 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.525 ' SG ' HG22 ' A' ' 28' ' ' VAL . 3.4 m -101.18 -50.23 3.85 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 119.27 0.941 . . . . 0.23 110.86 -177.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.448 HG12 ' HA ' ' A' ' 29' ' ' GLN . 2.2 pp -56.88 -27.07 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 CA-C-N 116.107 -0.497 . . . . 0.4 112.027 -174.453 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.7 m -38.64 -35.76 0.21 Allowed 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.635 1.574 . . . . 1.06 112.473 170.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 20.9 m -121.02 -44.28 2.41 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.75 0.82 . . . . 0.19 111.371 174.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 86.5 m-70 -70.5 -9.55 56.9 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.753 0.821 . . . . 0.21 112.897 -176.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 88.37 148.08 15.54 Favored Glycine 0 C--N 1.338 0.643 0 N-CA-C 109.816 -1.314 . . . . 1.52 109.816 177.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -44.6 -36.29 4.51 Favored Glycine 0 C--N 1.341 0.807 0 C-N-CA 124.454 1.026 . . . . 0.47 111.852 175.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -93.7 -6.93 45.12 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 124.909 1.283 . . . . 2.55 111.758 -172.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 8.9 mt 70.91 11.12 7.07 Favored 'General case' 0 C--N 1.352 0.693 0 CA-C-N 120.237 1.381 . . . . 1.11 111.301 177.364 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 11.0 p -86.28 0.88 52.84 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 127.186 2.194 . . . . 0.35 109.832 -175.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.72 133.19 3.52 Favored Glycine 0 N--CA 1.443 -0.89 0 N-CA-C 108.881 -1.688 . . . . 0.45 108.881 -177.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -136.42 -75.82 0.43 Allowed 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 108.431 -0.951 . . . . 0.32 108.431 178.344 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 9.3 t -95.85 4.17 53.06 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.09 0.956 . . . . 1.53 110.753 173.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.508 ' HB1' ' HD2' ' A' ' 46' ' ' PRO . . . -157.92 167.39 14.58 Favored Pre-proline 0 CA--C 1.538 0.488 0 C-N-CA 125.207 1.403 . . . . 0.28 108.181 -169.583 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.508 ' HD2' ' HB1' ' A' ' 45' ' ' ALA . 49.3 Cg_endo -71.03 155.63 61.39 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 122.968 2.446 . . . . 0.23 110.801 -173.623 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.67 123.28 23.75 Favored 'General case' 0 C--N 1.332 -0.176 0 O-C-N 121.589 -0.695 . . . . 0.28 110.57 -176.119 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 45.4 pt -104.46 0.68 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 C-N-CA 123.526 0.73 . . . . 0.32 111.801 179.1 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -41.13 -39.29 1.24 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.971 0.908 . . . . 3.07 112.396 171.414 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 12.4 mtpt -117.73 34.08 5.32 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 125.187 1.395 . . . . 4.12 109.828 -177.339 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.18 -53.59 50.92 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 108.654 -0.869 . . . . 0.45 108.654 171.174 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -56.85 -21.76 38.4 Favored Glycine 0 C--N 1.34 0.765 0 C-N-CA 124.116 0.865 . . . . 0.59 114.247 -178.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -60.91 -38.86 87.22 Favored 'General case' 0 N--CA 1.449 -0.49 0 O-C-N 122.01 -0.7 . . . . 1.38 110.636 174.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 41.3 m-80 -107.55 -58.9 1.9 Allowed 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 124.356 1.062 . . . . 2.96 110.295 -174.271 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -78.37 149.49 33.37 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.391 1.077 . . . . 1.91 110.084 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 29.3 m -94.86 173.94 7.34 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.943 1.297 . . . . 1.64 110.13 176.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.481 ' HG3' ' HB2' ' A' ' 89' ' ' ALA . 3.5 mp0 -56.64 -53.09 61.65 Favored 'General case' 0 N--CA 1.457 -0.098 0 O-C-N 121.761 -0.587 . . . . 2.86 109.825 -176.31 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 35.3 mm-40 -55.38 -32.17 62.39 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.434 0.693 . . . . 4.45 111.816 177.334 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -75.97 -50.9 13.6 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 108.635 -0.876 . . . . 2.55 108.635 -177.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.495 HG23 HMA1 ' A' ' 93' ' ' HEC . 66.4 mt -62.7 -43.47 98.66 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.133 0 O-C-N 121.431 -0.793 . . . . 0.37 108.89 -178.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 27.0 tp -55.9 -50.34 70.95 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 109.749 -0.463 . . . . 0.33 109.749 176.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -51.72 -51.91 52.46 Favored 'General case' 0 CA--C 1.53 0.21 0 O-C-N 123.057 0.223 . . . . 2.22 110.503 175.295 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 81.2 mt -57.33 -50.47 76.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 O-C-N 121.781 -0.575 . . . . 0.56 109.962 179.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.487 HD11 HMB2 ' A' ' 93' ' ' HEC . 71.9 mt -53.35 -42.56 48.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 O-C-N 120.522 -1.361 . . . . 0.38 110.306 178.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 68.9 mt -72.23 -32.61 66.89 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 113.736 1.013 . . . . 0.58 113.736 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -122.75 20.06 10.19 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 120.176 1.353 . . . . 1.61 110.387 -167.255 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.591 ' N ' ' HA2' ' A' ' 73' ' ' GLY . . . 31.05 -133.61 0.11 Allowed Glycine 0 CA--C 1.532 1.107 0 C-N-CA 128.621 3.01 . . . . 0.72 111.462 -166.729 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 168.52 130.94 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 119.034 1.417 . . . . 1.54 109.465 -179.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 35.41 -111.97 0.1 OUTLIER Glycine 0 CA--C 1.532 1.147 0 CA-C-N 120.116 1.326 . . . . 0.49 113.815 -171.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -70.92 -20.91 78.07 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 123.367 0.508 . . . . 0.57 113.029 -178.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.444 ' HB2' ' C1D' ' A' ' 93' ' ' HEC . 19.0 ttt -74.39 120.24 80.48 Favored Pre-proline 0 N--CA 1.45 -0.466 0 C-N-CA 125.15 1.38 . . . . 0.37 110.353 -179.403 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.616 ' HD2' HD11 ' A' ' 75' ' ' ILE . 34.6 Cg_endo -79.73 121.41 4.6 Favored 'Trans proline' 0 N--CA 1.446 -1.319 0 C-N-CA 122.888 2.392 . . . . 2.03 111.534 -176.364 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.591 ' HA2' ' N ' ' A' ' 67' ' ' GLY . . . -57.06 134.05 52.44 Favored Glycine 0 N--CA 1.444 -0.792 0 N-CA-C 115.275 0.87 . . . . 0.69 115.275 -179.458 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 87.22 38.98 7.54 Favored Glycine 0 CA--C 1.527 0.792 0 CA-C-N 114.353 -0.924 . . . . 0.44 111.709 174.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.616 HD11 ' HD2' ' A' ' 72' ' ' PRO . 2.5 mt -63.79 -59.67 3.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 124.751 1.22 . . . . 1.31 110.22 176.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -104.18 161.36 14.09 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.632 1.173 . . . . 0.27 108.233 165.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 21.5 mttm -145.47 175.92 9.97 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.998 0.919 . . . . 3.51 109.659 173.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 57.94 -153.66 25.23 Favored Glycine 0 CA--C 1.531 1.093 0 CA-C-O 121.45 0.472 . . . . 0.64 112.537 177.167 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -53.39 -29.93 37.26 Favored 'General case' 0 C--N 1.339 0.13 0 C-N-CA 123.955 0.902 . . . . 0.64 111.681 174.079 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -52.42 -61.2 2.43 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 108.612 -0.885 . . . . 2.39 108.612 173.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -63.28 -51.09 67.54 Favored 'General case' 0 CA--C 1.53 0.209 0 O-C-N 122.187 -0.32 . . . . 0.27 111.668 179.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -51.34 -52.64 43.65 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 121.034 0.445 . . . . 2.73 111.67 -178.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -56.45 -48.79 76.29 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 109.788 -0.449 . . . . 0.27 109.788 -179.096 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.514 HG22 HG23 ' A' ' 28' ' ' VAL . 77.6 t -54.81 -49.97 65.06 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 CA-C-O 119.389 -0.339 . . . . 0.35 111.127 176.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -51.71 -54.22 30.64 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 122.757 0.423 . . . . 0.35 111.34 176.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.06 -44.85 95.8 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 121.269 0.557 . . . . 0.36 111.376 -177.4 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.586 ' CE3' HD23 ' A' ' 88' ' ' LEU . 47.9 t90 -60.29 -52.24 66.14 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 121.715 -0.615 . . . . 0.68 109.566 177.694 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.586 HD23 ' CE3' ' A' ' 87' ' ' TRP . 0.1 OUTLIER -55.59 -35.27 65.62 Favored 'General case' 0 C--O 1.222 -0.363 0 C-N-CA 124.068 0.947 . . . . 1.58 110.369 176.602 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.481 ' HB2' ' HG3' ' A' ' 57' ' ' GLU . . . -59.07 -44.69 91.9 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 118.559 0.618 . . . . 0.5 111.803 176.345 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -72.37 -27.88 62.67 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 110.248 -0.279 . . . . 4.27 110.248 173.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 12.3 tptp -69.51 116.4 9.88 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.788 0.835 . . . . 2.41 109.774 -175.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 23.9 mttt . . . . . 0 C--O 1.256 1.444 0 C-N-CA 128.649 2.779 . . . . 2.75 104.232 -178.128 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' HEC . . . . . 0.495 HMA1 HG23 ' A' ' 60' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 39.5 t . . . . . 0 N--CA 1.471 0.606 0 N-CA-C 107.322 -1.362 . . . . 1.57 107.322 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -74.47 104.29 5.14 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 123.585 0.754 . . . . 2.14 109.261 -178.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -40.82 -55.07 2.54 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 124.096 0.958 . . . . 0.33 110.866 175.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -59.63 -40.37 87.38 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 119.514 -0.279 . . . . 3.09 110.814 -177.332 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.5 -44.78 93.35 Favored 'General case' 0 C--N 1.339 0.125 0 CA-C-N 118.532 0.606 . . . . 0.42 110.678 178.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 93.8 t -58.58 -53.34 48.23 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.219 0 N-CA-C 109.157 -0.683 . . . . 0.44 109.157 176.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 54.2 t -52.28 -48.92 43.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 N-CA-C 110.286 -0.264 . . . . 0.52 110.286 179.099 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 28.8 mm-40 -55.14 -18.45 5.72 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 126.05 1.74 . . . . 0.6 114.041 174.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -150.36 50.65 0.89 Allowed 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 120.046 1.294 . . . . 2.24 112.628 178.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.24 -37.34 0.02 OUTLIER 'General case' 0 C--O 1.225 -0.189 0 C-N-CA 126.056 1.742 . . . . 1.21 110.071 170.068 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 4.5 m -98.81 -52.79 3.48 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 119.431 1.014 . . . . 0.18 111.423 -176.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.5 pp -54.69 -27.4 18.15 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.077 0 CA-C-N 115.878 -0.601 . . . . 0.48 111.763 -177.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.8 m -40.07 -37.04 0.55 Allowed 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 126.392 1.877 . . . . 1.19 112.073 173.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 19.1 m -118.8 -40.08 2.9 Favored 'General case' 0 C--N 1.339 0.15 0 C-N-CA 123.115 0.566 . . . . 0.17 111.927 173.1 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 83.3 m-70 -72.65 -7.57 50.99 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 112.852 0.686 . . . . 0.3 112.852 -175.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 86.12 151.35 17.55 Favored Glycine 0 C--N 1.336 0.579 0 N-CA-C 109.324 -1.51 . . . . 1.51 109.324 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -42.41 -36.62 2.26 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 125.019 1.295 . . . . 0.43 112.928 178.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 44.5 m-20 -102.99 1.34 33.44 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.734 1.214 . . . . 2.18 112.342 -172.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.422 HD22 ' N ' ' A' ' 40' ' ' LEU . 1.9 mm? 64.12 21.67 12.64 Favored 'General case' 0 C--N 1.35 0.595 0 CA-C-N 120.482 1.492 . . . . 3.43 111.415 179.617 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.2 p -84.68 -5.13 59.3 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 127.661 2.384 . . . . 0.32 110.016 179.463 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.27 131.6 3.8 Favored Glycine 0 N--CA 1.439 -1.1 0 N-CA-C 108.954 -1.658 . . . . 0.55 108.954 -177.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -138.39 -79.97 0.34 Allowed 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.021 0.928 . . . . 0.25 109.44 177.183 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 70.9 m -89.12 4.02 49.88 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.638 0.775 . . . . 1.18 111.391 170.228 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -155.85 161.46 29.43 Favored Pre-proline 0 CA--C 1.535 0.373 0 C-N-CA 125.253 1.421 . . . . 0.21 107.823 -170.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -66.96 159.67 50.76 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 123.185 2.59 . . . . 0.23 111.164 -176.154 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.69 126.86 31.28 Favored 'General case' 0 C--N 1.331 -0.214 0 O-C-N 121.447 -0.783 . . . . 0.25 110.603 -175.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 25.4 pt -104.94 0.88 10.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 C-N-CA 123.27 0.628 . . . . 0.49 111.581 177.069 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -34.83 -48.03 0.37 Allowed 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.26 1.424 . . . . 2.46 113.595 172.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 29.5 pttt -106.92 22.76 15.46 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 124.143 0.977 . . . . 4.17 112.017 -176.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -54.94 -42.63 72.54 Favored 'General case' 0 N--CA 1.45 -0.43 0 O-C-N 121.548 -0.72 . . . . 0.38 110.261 -176.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -55.25 -25.77 41.24 Favored Glycine 0 CA--C 1.529 0.943 0 N-CA-C 114.603 0.601 . . . . 0.51 114.603 179.086 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.415 ' HB2' ' HB2' ' A' ' 92' ' ' LYS . . . -84.62 -45.28 12.67 Favored 'General case' 0 CA--C 1.522 -0.119 0 CA-C-N 118.287 1.043 . . . . 0.85 109.561 172.161 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -56.36 -46.75 79.85 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 119.555 -0.259 . . . . 2.24 111.037 -178.062 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -145.38 151.41 38.23 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.738 1.615 . . . . 0.67 108.71 -170.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 84.1 p -78.75 170.72 16.22 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 119.374 0.988 . . . . 2.45 111.422 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -49.69 -44.27 47.95 Favored 'General case' 0 C--O 1.224 -0.274 0 CA-C-O 118.619 -0.705 . . . . 3.05 111.491 174.03 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -56.91 -47.97 79.32 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 118.911 0.778 . . . . 2.4 110.461 178.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -69.51 -47.23 64.5 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 109.129 -0.693 . . . . 3.27 109.129 -174.613 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 52.3 mt -59.0 -48.28 87.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 109.249 -0.649 . . . . 0.33 109.249 179.587 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 41.3 tp -54.82 -50.32 68.86 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 123.668 0.787 . . . . 0.36 109.076 178.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -55.01 -47.86 74.12 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 110.305 -0.258 . . . . 2.28 110.305 175.838 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 46.7 mt -61.47 -33.82 58.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 O-C-N 121.018 -1.051 . . . . 0.61 111.812 178.427 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.501 HD11 HMB2 ' A' ' 93' ' ' HEC . 75.8 mt -68.77 -48.17 72.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 O-C-N 120.157 -1.589 . . . . 0.23 108.986 175.082 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 92.9 mt -69.37 -31.24 69.51 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.43 1.092 . . . . 0.37 113.177 -176.053 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 22.3 m-20 -121.51 13.72 10.98 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 119.445 1.02 . . . . 1.77 109.735 -168.073 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.528 ' N ' ' HA2' ' A' ' 73' ' ' GLY . . . 40.14 -146.78 0.27 Allowed Glycine 0 CA--C 1.54 1.654 0 C-N-CA 127.604 2.526 . . . . 0.63 111.325 -169.164 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 10.6 tt0 178.29 135.65 0.08 Allowed 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 125.104 1.362 . . . . 1.13 108.596 -177.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 37.77 -114.6 0.3 Allowed Glycine 0 CA--C 1.533 1.198 0 CA-C-N 119.86 1.209 . . . . 0.4 113.361 -172.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -74.77 -20.53 79.46 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 123.289 0.471 . . . . 0.59 113.064 -179.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.447 ' HB2' ' C1D' ' A' ' 93' ' ' HEC . 21.3 ttt -67.42 119.19 63.53 Favored Pre-proline 0 N--CA 1.452 -0.373 0 C-N-CA 124.269 1.028 . . . . 0.42 110.662 179.509 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -76.22 123.93 7.52 Favored 'Trans proline' 0 N--CA 1.446 -1.321 0 C-N-CA 122.698 2.265 . . . . 2.15 110.795 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.528 ' HA2' ' N ' ' A' ' 67' ' ' GLY . . . -65.05 141.82 43.94 Favored Glycine 0 N--CA 1.442 -0.958 0 N-CA-C 115.349 0.9 . . . . 0.61 115.349 -176.333 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 78.34 33.42 39.62 Favored Glycine 0 CA--C 1.524 0.649 0 CA-C-N 114.047 -1.077 . . . . 0.35 110.84 175.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -56.53 -49.93 75.33 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 C-N-CA 124.407 1.083 . . . . 1.02 109.022 173.486 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -111.95 154.02 25.89 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.411 1.485 . . . . 0.39 110.409 165.218 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 4.7 mmmt -139.02 158.71 43.71 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.197 1.799 . . . . 3.05 109.896 179.609 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 56.13 -141.04 41.17 Favored Glycine 0 CA--C 1.528 0.892 0 N-CA-C 111.164 -0.775 . . . . 0.75 111.164 178.025 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -51.23 -36.65 42.78 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 117.496 0.648 . . . . 0.93 111.542 176.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -57.15 -37.0 71.41 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 122.892 0.477 . . . . 2.41 110.023 178.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -82.94 -56.6 3.71 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.212 0.605 . . . . 0.35 110.522 176.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -51.93 -52.21 51.68 Favored 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 124.543 1.137 . . . . 3.06 112.076 -176.331 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.04 -47.45 83.07 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 109.644 -0.502 . . . . 0.31 109.644 -177.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.446 HG11 HMB1 ' A' ' 93' ' ' HEC . 78.9 t -59.01 -56.37 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 C-N-CA 122.895 0.478 . . . . 0.27 110.532 178.387 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -47.78 -56.12 8.11 Favored 'General case' 0 C--O 1.226 -0.146 0 C-N-CA 123.369 0.668 . . . . 0.18 111.296 177.151 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.77 -45.75 92.54 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.371 0.669 . . . . 0.36 110.887 -176.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 79.1 t90 -57.04 -52.41 65.39 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 121.713 -0.617 . . . . 0.6 109.722 177.295 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.74 -31.08 71.23 Favored 'General case' 0 C--O 1.223 -0.32 0 CA-C-O 118.603 -0.713 . . . . 1.89 112.654 175.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.08 -26.57 60.62 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 119.491 1.041 . . . . 0.75 111.534 172.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -90.81 -29.67 17.45 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 112.938 0.718 . . . . 4.93 112.938 171.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 19.7 mtpp -74.64 103.95 5.13 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 119.721 1.146 . . . . 3.04 110.633 174.227 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.415 ' HB2' ' HB2' ' A' ' 53' ' ' ALA . 20.2 pttt . . . . . 0 C--O 1.25 1.11 0 C-N-CA 126.298 1.839 . . . . 2.75 106.354 -175.351 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' HEC . . . . . 0.501 HMB2 HD11 ' A' ' 64' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 25.1 t . . . . . 0 N--CA 1.471 0.587 0 N-CA-C 106.456 -1.683 . . . . 1.25 106.456 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -78.5 111.4 14.5 Favored 'General case' 0 N--CA 1.451 -0.398 0 O-C-N 123.79 0.681 . . . . 3.83 109.307 -176.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -52.9 -45.03 67.35 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 123.921 0.888 . . . . 0.42 111.608 -178.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -64.48 -48.91 73.43 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 108.195 -1.039 . . . . 3.33 108.195 -176.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.97 -47.61 74.33 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 123.44 0.696 . . . . 0.31 111.333 177.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 74.1 t -55.97 -55.64 17.05 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.12 0 N-CA-C 109.525 -0.546 . . . . 0.41 109.525 177.148 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.574 HG22 ' SG ' ' A' ' 32' ' ' CYS . 5.6 t -54.75 -49.4 68.91 Favored 'Isoleucine or valine' 0 C--O 1.239 0.525 0 CA-C-N 117.851 0.296 . . . . 0.38 111.265 -178.33 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.402 ' HA ' HG12 ' A' ' 33' ' ' ILE . 35.8 mm-40 -52.65 -14.86 0.58 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 126.732 2.013 . . . . 0.47 112.984 173.554 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.77 47.76 1.64 Allowed 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 119.469 1.031 . . . . 3.72 111.514 173.17 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.71 -42.7 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.16 0 O-C-N 121.915 -0.49 . . . . 1.18 110.485 169.205 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.574 ' SG ' HG22 ' A' ' 28' ' ' VAL . 3.6 m -93.36 -48.45 6.41 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 118.284 0.493 . . . . 0.16 110.026 -173.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.402 HG12 ' HA ' ' A' ' 29' ' ' GLN . 2.4 pp -51.65 -31.61 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 CA-C-N 115.977 -0.556 . . . . 0.54 111.962 -179.302 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 20.0 m -38.47 -37.31 0.3 Allowed 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 125.748 1.619 . . . . 1.06 112.73 173.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 21.5 m -121.3 -40.01 2.63 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 123.069 0.548 . . . . 0.19 112.009 173.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 82.2 m-70 -71.79 -7.66 49.57 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.616 0.766 . . . . 0.22 112.755 -177.197 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 84.44 148.29 9.16 Favored Glycine 0 C--N 1.337 0.602 0 N-CA-C 109.296 -1.522 . . . . 1.49 109.296 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -41.69 -35.11 1.35 Allowed Glycine 0 CA--C 1.527 0.843 0 C-N-CA 124.73 1.157 . . . . 0.49 112.496 174.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -95.39 -8.48 35.51 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 124.961 1.305 . . . . 2.38 111.264 -169.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.3 mt 72.33 6.89 5.6 Favored 'General case' 0 C--N 1.348 0.534 0 CA-C-N 120.136 1.334 . . . . 1.28 111.398 178.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 16.0 p -83.92 0.27 48.48 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 127.176 2.19 . . . . 0.39 110.102 -175.579 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.09 150.03 21.56 Favored Glycine 0 N--CA 1.436 -1.339 0 N-CA-C 108.855 -1.698 . . . . 0.53 108.855 -173.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -156.33 -78.03 0.09 Allowed 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 124.609 1.164 . . . . 0.26 108.863 177.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.0 m -97.37 2.63 50.77 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.448 1.099 . . . . 1.33 111.216 170.063 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -148.14 162.05 32.19 Favored Pre-proline 0 CA--C 1.535 0.372 0 C-N-CA 126.999 2.12 . . . . 0.43 107.159 -176.191 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -71.26 163.15 40.13 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 123.219 2.613 . . . . 0.25 111.203 -176.135 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -74.93 113.58 12.4 Favored 'General case' 0 C--N 1.332 -0.19 0 O-C-N 121.73 -0.607 . . . . 0.3 111.235 -174.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 48.1 pt -97.07 0.66 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 C-N-CA 123.307 0.643 . . . . 0.29 111.797 178.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -48.88 -34.9 13.54 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.154 0.581 . . . . 3.34 112.319 176.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.2 pttm -115.43 38.66 3.18 Favored 'General case' 0 C--N 1.343 0.311 0 C-N-CA 124.82 1.248 . . . . 3.43 111.216 175.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.73 -55.75 20.87 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 108.076 -1.083 . . . . 0.48 108.076 168.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -54.08 -27.0 36.91 Favored Glycine 0 C--N 1.339 0.717 0 C-N-CA 124.675 1.131 . . . . 0.64 113.695 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.95 -38.44 75.97 Favored 'General case' 0 N--CA 1.449 -0.488 0 O-C-N 121.957 -0.731 . . . . 1.45 111.446 175.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 47.3 m-80 -107.85 -57.73 2.06 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 124.318 1.047 . . . . 2.9 110.819 -174.166 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -89.51 149.47 22.89 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 125.086 1.354 . . . . 0.8 109.06 -174.297 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 60.7 m -94.29 164.11 13.16 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 122.961 0.505 . . . . 1.49 110.643 179.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.1 tm-20 -40.9 -64.39 0.54 Allowed 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.023 1.329 . . . . 5.66 111.002 178.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -41.12 -47.02 3.14 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.936 1.294 . . . . 4.11 112.905 174.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 61.1 mm-40 -69.55 -47.27 64.25 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 122.23 1.014 . . . . 3.33 108.573 -174.456 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 61.5 mt -61.46 -44.18 98.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-N 115.948 -0.569 . . . . 0.27 109.503 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 35.3 tp -55.31 -53.39 56.77 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 124.366 1.066 . . . . 0.38 109.163 175.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -49.72 -52.31 32.32 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 117.992 0.36 . . . . 1.53 110.389 175.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 87.4 mt -60.31 -37.65 74.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 119.744 -0.783 . . . . 0.48 111.557 179.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.545 HD11 HMB2 ' A' ' 93' ' ' HEC . 60.5 mt -61.53 -46.81 95.78 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 O-C-N 120.041 -1.662 . . . . 0.32 109.851 173.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 85.6 mt -67.14 -32.17 73.1 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 117.179 -1.391 . . . . 0.48 114.479 -171.205 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -139.05 30.57 2.22 Favored 'General case' 0 C--N 1.344 0.362 0 CA-C-N 120.191 1.359 . . . . 3.22 110.112 -171.119 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 35.08 -141.28 0.13 Allowed Glycine 0 CA--C 1.542 1.754 0 C-N-CA 128.122 2.772 . . . . 0.65 112.81 -175.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 172.46 136.45 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.58 1.552 . . . . 1.82 108.022 -175.283 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 28.83 -106.7 0.01 OUTLIER Glycine 0 CA--C 1.534 1.222 0 C-N-CA 125.519 1.533 . . . . 0.44 114.785 -176.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -66.07 -27.27 72.75 Favored Glycine 0 CA--C 1.537 1.428 0 CA-C-N 117.769 0.784 . . . . 0.68 113.562 -178.479 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 15.8 ttt -76.47 123.04 87.69 Favored Pre-proline 0 CA--C 1.54 0.567 0 C-N-CA 125.888 1.675 . . . . 0.43 110.683 -178.126 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -62.32 -56.66 0.63 Allowed 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 124.462 3.441 . . . . 3.0 111.781 -168.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 118.24 144.92 7.72 Favored Glycine 0 N--CA 1.449 -0.482 0 CA-C-N 115.795 -0.639 . . . . 0.9 114.228 172.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 67.82 26.79 73.76 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.907 -0.877 . . . . 0.36 110.907 -174.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 2.0 mm -52.01 -51.88 26.92 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 124.561 1.144 . . . . 2.13 110.11 177.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -112.27 159.42 18.64 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.478 1.111 . . . . 0.42 108.974 161.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 21.3 mttp -146.01 158.09 43.87 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.35 1.06 . . . . 3.66 110.147 175.057 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 64.67 -153.35 49.66 Favored Glycine 0 CA--C 1.53 0.992 0 N-CA-C 111.343 -0.703 . . . . 0.84 111.343 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -45.61 -38.6 6.75 Favored 'General case' 0 C--N 1.34 0.186 0 C-N-CA 124.855 1.262 . . . . 0.63 112.154 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -50.51 -52.93 34.04 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.423 1.089 . . . . 2.15 110.396 175.006 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -71.32 -48.0 53.19 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.649 0.78 . . . . 0.25 110.853 179.261 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -53.97 -50.67 66.02 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.826 0.85 . . . . 2.67 110.708 -176.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -55.19 -49.54 71.64 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 123.071 0.548 . . . . 0.26 110.286 178.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.495 HG22 HG23 ' A' ' 28' ' ' VAL . 53.8 t -58.12 -52.9 52.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 CA-C-O 119.343 -0.36 . . . . 0.39 110.986 178.499 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -49.26 -52.49 27.01 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 123.341 0.656 . . . . 0.2 111.452 176.55 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.75 -51.88 67.45 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 121.46 0.648 . . . . 0.33 110.215 -177.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.535 ' CE3' HD23 ' A' ' 88' ' ' LEU . 48.9 t90 -54.84 -43.18 72.82 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 122.757 0.423 . . . . 0.52 110.69 177.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.535 HD23 ' CE3' ' A' ' 87' ' ' TRP . 0.1 OUTLIER -65.96 -37.73 86.76 Favored 'General case' 0 C--O 1.227 -0.118 0 C-N-CA 124.504 1.121 . . . . 1.64 110.712 178.271 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -52.96 -42.75 65.79 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 119.0 0.818 . . . . 0.48 109.55 171.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -85.79 21.6 1.85 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.439 1.095 . . . . 4.17 112.405 175.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 4.7 mtpm? -116.68 139.43 50.56 Favored 'General case' 0 C--N 1.342 0.253 0 CA-C-O 122.256 1.027 . . . . 2.41 109.956 167.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 53.2 mttm . . . . . 0 C--O 1.25 1.116 0 C-N-CA 129.206 3.002 . . . . 3.42 103.152 177.606 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' HEC . . . . . 0.545 HMB2 HD11 ' A' ' 64' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.5 t . . . . . 0 N--CA 1.471 0.588 0 N-CA-C 106.882 -1.525 . . . . 1.19 106.882 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -75.94 104.43 6.47 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 108.475 -0.935 . . . . 2.38 108.475 -176.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -41.15 -54.54 2.86 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 124.554 1.141 . . . . 0.31 110.708 175.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -58.39 -46.77 85.72 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 115.805 -0.634 . . . . 3.16 110.272 -178.128 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.2 -44.51 92.24 Favored 'General case' 0 C--N 1.34 0.159 0 C-N-CA 123.125 0.57 . . . . 0.31 111.147 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 77.8 t -57.81 -56.88 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 N-CA-C 109.279 -0.638 . . . . 0.33 109.279 175.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.724 HG11 HD21 ' A' ' 40' ' ' LEU . 71.7 t -54.0 -48.65 63.71 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 CA-C-N 117.933 0.333 . . . . 0.35 110.494 -176.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.404 ' HA ' HG12 ' A' ' 33' ' ' ILE . 28.0 mm-40 -47.94 -24.69 1.1 Allowed 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 126.261 1.824 . . . . 0.64 112.872 174.532 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -141.26 51.56 1.58 Allowed 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 119.144 0.884 . . . . 2.6 111.642 173.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.68 -36.63 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 124.319 1.048 . . . . 1.22 111.211 166.722 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.699 ' HB2' HG13 ' A' ' 28' ' ' VAL . 3.8 m -101.89 -50.87 3.55 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 119.159 0.89 . . . . 0.23 110.954 -174.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.404 HG12 ' HA ' ' A' ' 29' ' ' GLN . 2.2 pp -54.41 -29.37 19.92 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.082 0 CA-C-N 116.369 -0.378 . . . . 0.41 111.949 -176.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 10.0 m -35.26 -41.71 0.17 Allowed 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 125.507 1.523 . . . . 1.08 112.81 171.179 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 22.4 m -114.86 -35.63 4.73 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.294 0.638 . . . . 0.15 111.839 174.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 89.4 m-70 -80.66 2.09 27.28 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.226 1.01 . . . . 0.4 113.314 -175.314 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 107.78 -80.96 0.28 Allowed Glycine 0 CA--C 1.525 0.668 0 C-N-CA 125.747 1.641 . . . . 2.9 111.785 165.149 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -175.24 -52.51 0.06 OUTLIER Glycine 0 CA--C 1.519 0.304 0 N-CA-C 108.441 -1.864 . . . . 0.9 108.441 -171.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -97.71 4.6 49.94 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 124.452 1.101 . . . . 3.32 111.076 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.724 HD21 HG11 ' A' ' 28' ' ' VAL . 1.2 mt 76.15 14.33 2.51 Favored 'General case' 0 C--N 1.351 0.661 0 CA-C-N 119.85 1.205 . . . . 1.75 110.007 -179.618 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.0 p -76.27 -13.37 60.16 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 128.11 2.564 . . . . 0.61 109.822 -178.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.98 154.02 30.62 Favored Glycine 0 N--CA 1.442 -0.9 0 N-CA-C 108.449 -1.86 . . . . 0.68 108.449 -178.356 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -156.8 -76.89 0.09 Allowed 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.457 -0.572 . . . . 0.29 109.457 177.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 19.6 t -93.55 4.17 54.37 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 122.854 0.462 . . . . 1.54 110.483 172.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -157.53 163.01 26.25 Favored Pre-proline 0 N--CA 1.448 -0.56 0 C-N-CA 126.242 1.817 . . . . 0.3 107.195 -166.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -67.72 162.85 37.6 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 123.044 2.496 . . . . 0.27 111.193 -172.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -76.03 122.32 24.05 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 122.95 0.5 . . . . 0.27 109.693 -178.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 47.9 pt -107.95 2.79 9.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 123.739 0.816 . . . . 0.48 112.063 178.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.444 ' OD1' ' NZ ' ' A' ' 91' ' ' LYS . 28.4 t70 -45.25 -45.99 12.24 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 113.125 0.787 . . . . 2.79 113.125 175.475 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.5 mptp? -100.92 26.62 6.74 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.999 1.32 . . . . 6.21 109.837 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -52.9 -45.6 67.61 Favored 'General case' 0 N--CA 1.453 -0.277 0 O-C-N 121.345 -0.847 . . . . 0.28 109.318 177.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -54.84 -22.26 26.1 Favored Glycine 0 CA--C 1.528 0.883 0 N-CA-C 115.021 0.768 . . . . 0.61 115.021 177.047 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -81.54 -36.01 29.64 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 118.387 1.093 . . . . 0.97 110.513 174.021 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -76.55 -48.55 18.96 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 123.08 0.552 . . . . 1.95 111.003 -178.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -141.21 143.97 34.47 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.699 1.6 . . . . 0.76 107.756 -167.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 69.7 m -83.91 169.86 14.62 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 119.57 1.077 . . . . 1.74 111.096 178.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -51.03 -43.68 60.94 Favored 'General case' 0 C--O 1.222 -0.376 0 CA-C-O 118.602 -0.713 . . . . 2.73 112.681 -175.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -52.66 -45.69 66.84 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 119.057 0.844 . . . . 2.66 111.055 176.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -71.17 -51.01 27.3 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 108.96 -0.756 . . . . 3.48 108.96 -176.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.586 HG23 HMA1 ' A' ' 93' ' ' HEC . 71.5 mt -58.11 -44.9 88.36 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 N-CA-C 108.765 -0.828 . . . . 0.21 108.765 -177.724 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 19.4 tp -56.27 -51.03 69.67 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 124.47 1.108 . . . . 0.67 109.401 177.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -53.92 -48.62 70.0 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 117.832 0.287 . . . . 1.46 111.345 175.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 93.0 mt -55.53 -54.88 20.8 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.211 0 O-C-N 121.526 -0.733 . . . . 0.7 109.443 177.262 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.527 HD11 HMB2 ' A' ' 93' ' ' HEC . 52.2 mt -50.68 -46.54 28.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 O-C-N 120.807 -1.183 . . . . 0.2 110.154 178.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 61.3 mt -64.17 -31.72 73.02 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 117.685 -1.15 . . . . 0.6 113.541 178.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -131.63 20.09 4.69 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 120.278 1.399 . . . . 1.81 111.109 -163.308 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 29.41 -141.0 0.02 OUTLIER Glycine 0 CA--C 1.543 1.809 0 C-N-CA 127.295 2.379 . . . . 0.67 113.048 -160.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 37.4 tt0 174.63 141.72 0.05 OUTLIER 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 126.198 1.799 . . . . 1.85 106.977 -176.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 22.25 -100.39 0.01 OUTLIER Glycine 0 CA--C 1.535 1.328 0 C-N-CA 126.094 1.807 . . . . 0.61 114.822 -173.378 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -68.31 -34.08 79.31 Favored Glycine 0 CA--C 1.539 1.553 0 CA-C-N 118.802 1.301 . . . . 0.78 113.485 -178.167 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.453 ' HG3' ' C4C' ' A' ' 93' ' ' HEC . 0.1 OUTLIER -55.55 130.99 71.13 Favored Pre-proline 0 CA--C 1.539 0.538 0 C-N-CA 124.044 0.938 . . . . 0.75 112.282 176.616 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -63.8 -57.23 0.38 Allowed 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 123.895 3.063 . . . . 3.03 110.857 178.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 116.74 146.68 8.52 Favored Glycine 0 C--N 1.335 0.497 0 C-N-CA 124.194 0.902 . . . . 0.83 113.761 173.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 69.45 24.56 76.07 Favored Glycine 0 CA--C 1.529 0.952 0 N-CA-C 111.558 -0.617 . . . . 0.46 111.558 -179.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.7 mt -52.61 -58.49 2.59 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 C-N-CA 126.212 1.805 . . . . 1.13 110.982 179.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -103.48 158.33 16.43 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.162 0.985 . . . . 0.39 108.967 162.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 4.9 mmtp -145.12 166.36 25.63 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.574 1.55 . . . . 2.96 108.783 179.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 56.94 -147.51 33.75 Favored Glycine 0 CA--C 1.532 1.135 0 O-C-N 121.741 -0.599 . . . . 0.67 112.491 176.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -50.23 -36.94 33.09 Favored 'General case' 0 C--N 1.34 0.186 0 C-N-CA 123.809 0.843 . . . . 0.74 111.255 175.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -52.78 -51.55 60.24 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.802 0.841 . . . . 2.02 109.599 176.16 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -69.51 -52.05 30.11 Favored 'General case' 0 CA--C 1.53 0.209 0 O-C-N 122.035 -0.416 . . . . 0.28 111.477 177.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -50.77 -56.23 13.04 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 123.117 0.567 . . . . 2.59 111.547 -177.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -55.38 -50.0 70.85 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 109.686 -0.487 . . . . 0.39 109.686 -175.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.582 HG22 HG23 ' A' ' 28' ' ' VAL . 54.4 t -55.26 -56.59 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 C-N-CA 123.006 0.522 . . . . 0.32 111.395 176.745 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -52.6 -50.88 62.18 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.343 0.657 . . . . 0.3 111.267 -178.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.79 -47.63 85.43 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.111 0.564 . . . . 0.39 110.365 -179.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.55 ' CE3' HD23 ' A' ' 88' ' ' LEU . 53.5 t90 -56.73 -50.44 72.21 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 121.991 -0.443 . . . . 0.51 110.164 177.31 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.55 HD23 ' CE3' ' A' ' 87' ' ' TRP . 0.1 OUTLIER -60.77 -34.93 75.21 Favored 'General case' 0 C--O 1.226 -0.184 0 C-N-CA 124.31 1.044 . . . . 1.65 110.802 177.548 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -67.09 -40.74 87.02 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 118.187 0.448 . . . . 0.73 110.978 176.011 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -61.39 -40.17 93.36 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 122.856 0.462 . . . . 4.11 110.643 171.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.444 ' NZ ' ' OD1' ' A' ' 49' ' ' ASP . 0.0 OUTLIER -73.31 105.66 4.8 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 121.527 -0.733 . . . . 2.1 110.169 178.983 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.163 0 CA-C-O 117.578 -1.201 . . . . 2.82 109.559 -177.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' HEC . . . . . 0.586 HMA1 HG23 ' A' ' 60' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 18.7 t . . . . . 0 N--CA 1.469 0.486 0 N-CA-C 107.284 -1.376 . . . . 1.19 107.284 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -78.38 101.26 7.15 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 108.153 -1.055 . . . . 2.24 108.153 -173.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -41.07 -55.14 2.66 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.747 1.219 . . . . 0.28 111.519 177.197 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -51.87 -46.91 64.67 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 123.157 0.583 . . . . 2.98 111.785 176.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.67 -45.65 89.14 Favored 'General case' 0 N--CA 1.457 -0.104 0 CA-C-N 118.442 0.564 . . . . 0.26 110.442 -177.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 72.8 t -57.07 -57.71 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 N-CA-C 109.007 -0.738 . . . . 0.34 109.007 175.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.518 HG23 HG22 ' A' ' 84' ' ' VAL . 25.6 t -47.92 -50.83 9.58 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 C-N-CA 124.305 1.042 . . . . 0.42 110.64 -178.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.434 ' HA ' HG12 ' A' ' 33' ' ' ILE . 30.8 mm-40 -53.1 -25.21 12.21 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 125.811 1.645 . . . . 0.57 113.398 176.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 11.0 mt-30 -137.69 59.37 1.67 Allowed 'General case' 0 N--CA 1.456 -0.14 0 CA-C-N 119.309 0.959 . . . . 2.25 111.719 172.11 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 5.1 mttt -172.2 -36.46 0.01 OUTLIER 'General case' 0 C--O 1.224 -0.249 0 C-N-CA 124.204 1.002 . . . . 2.15 110.322 168.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.427 ' SG ' HMB1 ' A' ' 93' ' ' HEC . 4.0 m -101.22 -52.62 3.21 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 119.426 1.012 . . . . 0.16 111.312 -177.502 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.434 HG12 ' HA ' ' A' ' 29' ' ' GLN . 2.2 pp -55.83 -26.66 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.095 0 CA-C-N 115.99 -0.55 . . . . 0.44 111.614 -177.376 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.1 t -40.17 -36.03 0.46 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.37 1.468 . . . . 1.88 111.83 173.563 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 32.9 m -118.78 -40.06 2.91 Favored 'General case' 0 C--N 1.342 0.259 0 C-N-CA 123.539 0.736 . . . . 0.17 111.908 174.425 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 87.1 m-70 -75.89 -7.11 53.75 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 113.171 0.804 . . . . 0.26 113.171 -174.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 86.26 150.26 15.46 Favored Glycine 0 C--N 1.337 0.625 0 N-CA-C 110.034 -1.227 . . . . 1.55 110.034 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -43.56 -39.19 4.41 Favored Glycine 0 C--N 1.34 0.801 0 C-N-CA 124.76 1.172 . . . . 0.42 112.338 178.259 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -97.65 -0.83 44.91 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 124.366 1.066 . . . . 2.21 110.959 -171.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.2 mp 67.41 15.8 9.93 Favored 'General case' 0 C--N 1.349 0.558 0 CA-C-N 120.11 1.323 . . . . 1.5 111.432 176.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 6.9 p -83.43 -1.73 54.18 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 128.132 2.573 . . . . 0.33 109.906 -178.008 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.98 144.71 9.72 Favored Glycine 0 N--CA 1.438 -1.174 0 N-CA-C 108.552 -1.819 . . . . 0.41 108.552 -175.076 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -150.15 -80.38 0.12 Allowed 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 124.406 1.083 . . . . 0.25 108.939 177.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 58.7 m -91.56 3.64 54.52 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.812 0.845 . . . . 1.16 111.422 170.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -154.38 163.41 24.27 Favored Pre-proline 0 N--CA 1.45 -0.469 0 C-N-CA 125.88 1.672 . . . . 0.25 107.197 -172.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -68.27 163.89 34.53 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.618 2.212 . . . . 0.4 110.877 -176.257 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -74.27 122.74 23.33 Favored 'General case' 0 N--CA 1.455 -0.193 0 O-C-N 121.931 -0.481 . . . . 0.24 110.306 -177.047 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 35.3 pt -105.78 0.88 10.16 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.181 0 C-N-CA 123.713 0.805 . . . . 0.32 110.917 177.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -39.32 -45.41 1.43 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.059 0.944 . . . . 2.4 112.409 169.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.59 15.97 21.81 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.129 0.972 . . . . 4.74 111.13 -175.18 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -56.39 -47.28 79.26 Favored 'General case' 0 N--CA 1.452 -0.326 0 O-C-N 121.198 -0.939 . . . . 0.33 110.069 -171.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -54.7 -26.62 40.21 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 114.447 0.539 . . . . 0.47 114.447 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -80.55 -42.05 23.06 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 117.815 0.808 . . . . 0.69 109.827 175.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 52.8 m-80 -63.5 -52.51 60.93 Favored 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 122.499 0.32 . . . . 1.53 110.906 179.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -138.1 145.88 42.21 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 125.956 1.702 . . . . 0.72 108.479 -167.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -79.96 170.82 15.94 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.543 0.737 . . . . 1.9 110.571 -178.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -49.94 -46.53 52.29 Favored 'General case' 0 C--O 1.225 -0.185 0 C-N-CA 124.079 0.952 . . . . 2.67 111.615 177.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -58.91 -29.72 67.28 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.237 0.615 . . . . 2.84 112.093 179.369 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -86.7 -48.0 8.65 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.0 -0.741 . . . . 3.41 109.0 -178.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.441 HG23 HMA1 ' A' ' 93' ' ' HEC . 98.7 mt -61.36 -43.91 97.52 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 O-C-N 121.714 -0.616 . . . . 0.31 109.461 -179.632 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 60.0 tp -52.57 -51.06 61.58 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 109.197 -0.668 . . . . 0.47 109.197 175.195 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -58.51 -44.52 89.51 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 110.113 -0.329 . . . . 1.62 110.113 178.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 78.8 mt -60.2 -36.52 68.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 O-C-N 121.104 -0.997 . . . . 0.5 111.498 176.048 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.503 HD11 HMB2 ' A' ' 93' ' ' HEC . 50.9 mt -67.41 -49.37 72.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 O-C-N 120.03 -1.669 . . . . 0.28 109.42 176.738 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 80.7 mt -66.74 -29.64 69.67 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 124.639 1.175 . . . . 0.37 113.154 -175.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 14.3 m-80 -124.1 11.57 8.87 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 119.789 1.177 . . . . 1.77 110.157 -170.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.597 ' N ' ' HA2' ' A' ' 73' ' ' GLY . . . 43.12 -147.4 0.81 Allowed Glycine 0 CA--C 1.539 1.571 0 C-N-CA 126.623 2.059 . . . . 0.63 110.833 -171.465 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 170.45 135.49 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 119.524 1.662 . . . . 1.18 110.82 -178.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 43.63 -122.14 3.83 Favored Glycine 0 CA--C 1.532 1.149 0 O-C-N 120.685 -1.259 . . . . 0.41 112.474 -173.088 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -69.08 -17.83 72.26 Favored Glycine 0 CA--C 1.531 1.046 0 O-C-N 122.483 -0.422 . . . . 0.5 112.886 179.34 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.4 ' HB2' ' C1D' ' A' ' 93' ' ' HEC . 20.8 ttt -73.95 119.73 77.68 Favored Pre-proline 0 N--CA 1.451 -0.42 0 C-N-CA 123.838 0.855 . . . . 0.4 111.486 -178.771 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.438 ' HD2' HD11 ' A' ' 75' ' ' ILE . 41.8 Cg_endo -78.08 120.88 5.14 Favored 'Trans proline' 0 N--CA 1.448 -1.172 0 C-N-CA 122.884 2.389 . . . . 2.13 112.031 -177.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.597 ' HA2' ' N ' ' A' ' 67' ' ' GLY . . . -57.84 135.5 51.7 Favored Glycine 0 N--CA 1.445 -0.711 0 N-CA-C 116.421 1.328 . . . . 0.6 116.421 -177.712 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 81.15 36.91 20.0 Favored Glycine 0 C--N 1.337 0.609 0 CA-C-N 114.124 -1.038 . . . . 0.34 111.454 173.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.438 HD11 ' HD2' ' A' ' 72' ' ' PRO . 1.3 mt -57.96 -57.0 12.39 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 124.876 1.27 . . . . 1.11 109.942 175.417 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -105.7 161.56 14.29 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.06 1.344 . . . . 0.31 109.508 167.16 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.0 mmtp -142.87 161.7 37.42 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.377 1.471 . . . . 2.45 110.466 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 55.55 -146.5 30.13 Favored Glycine 0 CA--C 1.531 1.04 0 O-C-N 121.596 -0.69 . . . . 0.72 111.437 179.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -54.55 -28.91 49.04 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 117.157 0.479 . . . . 0.72 111.814 175.006 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -56.54 -39.08 72.78 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 109.827 -0.434 . . . . 2.29 109.827 174.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -82.41 -52.43 6.9 Favored 'General case' 0 CA--C 1.53 0.208 0 O-C-N 121.738 -0.601 . . . . 0.24 110.963 174.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -58.44 -48.67 79.96 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 122.87 0.468 . . . . 2.32 112.077 -173.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.74 -48.15 80.43 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 109.363 -0.606 . . . . 0.22 109.363 179.31 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.518 HG22 HG23 ' A' ' 28' ' ' VAL . 49.6 t -55.38 -55.2 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 C-N-CA 123.065 0.546 . . . . 0.28 110.952 177.582 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -52.48 -53.48 45.14 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 123.313 0.645 . . . . 0.18 111.483 178.282 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.7 -48.61 81.0 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 121.772 0.796 . . . . 0.27 110.934 -178.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 83.6 t90 -57.22 -47.84 80.3 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 123.466 0.707 . . . . 0.59 110.084 178.427 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.02 -31.21 72.31 Favored 'General case' 0 C--O 1.221 -0.398 0 CA-C-O 118.167 -0.921 . . . . 1.9 112.649 173.359 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -56.39 -43.08 78.92 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 119.76 1.164 . . . . 0.34 109.898 171.068 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -68.0 -36.93 80.81 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 118.344 -0.836 . . . . 3.54 112.585 171.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 15.3 mtpp -72.11 113.43 9.13 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 120.35 1.432 . . . . 2.81 110.847 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 77.3 mttt . . . . . 0 C--O 1.254 1.337 0 N-CA-C 104.953 -2.24 . . . . 2.5 104.953 179.767 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' HEC . . . . . 0.503 HMB2 HD11 ' A' ' 64' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 29.5 t . . . . . 0 N--CA 1.471 0.608 0 N-CA-C 106.899 -1.519 . . . . 1.35 106.899 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 -76.1 100.38 4.95 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 108.312 -0.996 . . . . 2.17 108.312 -177.104 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -39.02 -54.26 1.7 Allowed 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 125.387 1.475 . . . . 0.35 112.046 175.173 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -54.58 -48.86 71.59 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 116.108 -0.496 . . . . 2.69 111.26 177.058 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.1 -36.57 82.14 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 118.96 0.8 . . . . 0.51 111.932 -178.748 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 56.2 t -62.78 -58.46 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 N-CA-C 109.032 -0.729 . . . . 0.34 109.032 172.809 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.693 HG22 ' SG ' ' A' ' 32' ' ' CYS . 21.0 t -53.55 -48.71 58.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 C-N-CA 123.255 0.622 . . . . 0.37 110.757 -175.738 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.462 ' HA ' HG12 ' A' ' 33' ' ' ILE . 28.3 mm-40 -49.35 -21.92 0.99 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 126.495 1.918 . . . . 0.52 112.811 174.49 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -130.75 26.1 5.01 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.727 0.811 . . . . 4.96 111.59 -179.807 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.3 mppp? -148.96 -66.85 0.22 Allowed 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 109.151 -0.685 . . . . 1.76 109.151 171.718 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.693 ' SG ' HG22 ' A' ' 28' ' ' VAL . 2.0 m -71.76 -47.53 53.0 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.93 -0.396 . . . . 0.22 109.93 -168.926 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.462 HG12 ' HA ' ' A' ' 29' ' ' GLN . 2.0 pp -56.12 -26.37 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.075 0 N-CA-C 111.899 0.333 . . . . 0.37 111.899 -178.046 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.3 t -46.32 -36.0 5.89 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.376 1.071 . . . . 1.92 110.699 177.727 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 28.9 m -116.82 -44.13 2.84 Favored 'General case' 0 C--N 1.34 0.178 0 C-N-CA 123.286 0.635 . . . . 0.2 111.267 175.959 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 85.9 m-70 -71.09 -8.41 53.25 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.906 0.883 . . . . 0.22 112.564 -176.194 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 88.25 152.19 24.03 Favored Glycine 0 C--N 1.337 0.606 0 N-CA-C 109.707 -1.357 . . . . 1.51 109.707 178.235 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -39.39 -39.43 1.13 Allowed Glycine 0 CA--C 1.528 0.877 0 C-N-CA 125.366 1.46 . . . . 0.42 112.9 179.11 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -105.74 2.21 27.74 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.216 1.406 . . . . 2.23 112.241 -170.822 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.411 HD22 ' N ' ' A' ' 40' ' ' LEU . 1.8 mm? 64.88 23.04 12.59 Favored 'General case' 0 C--N 1.348 0.531 0 CA-C-N 120.493 1.497 . . . . 3.53 111.127 -179.731 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.7 p -85.55 -3.73 58.95 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 128.23 2.612 . . . . 0.39 109.992 179.277 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.52 139.75 5.68 Favored Glycine 0 N--CA 1.441 -0.969 0 N-CA-C 109.037 -1.625 . . . . 0.45 109.037 -174.387 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -145.4 -73.87 0.24 Allowed 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 107.813 -1.18 . . . . 0.39 107.813 176.355 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.1 t -100.16 4.62 44.56 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.307 1.443 . . . . 1.48 111.169 173.233 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -156.63 162.81 26.84 Favored Pre-proline 0 CA--C 1.537 0.451 0 C-N-CA 126.289 1.836 . . . . 0.31 108.004 -168.773 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.22 153.16 40.54 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 123.271 2.647 . . . . 0.39 111.414 -173.928 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -75.16 109.27 8.51 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.864 0.866 . . . . 0.6 113.097 -170.136 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 43.7 pt -91.45 1.06 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 C-N-CA 125.8 1.64 . . . . 0.34 111.793 -178.683 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -32.34 -48.59 0.18 Allowed 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 127.061 2.144 . . . . 2.79 113.044 164.226 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.51 36.83 3.25 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.955 0.902 . . . . 4.96 111.537 176.328 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.11 -52.54 58.66 Favored 'General case' 0 N--CA 1.454 -0.257 0 O-C-N 121.146 -0.971 . . . . 0.41 108.849 176.236 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -52.33 -27.1 23.62 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 124.187 0.899 . . . . 0.54 114.021 177.496 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.19 -38.24 88.37 Favored 'General case' 0 N--CA 1.452 -0.355 0 O-C-N 121.461 -1.023 . . . . 1.13 110.548 176.63 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 34.4 m-80 -103.83 -61.78 1.39 Allowed 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.798 1.239 . . . . 2.35 109.835 -171.5 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -91.93 136.13 33.4 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.007 1.323 . . . . 0.62 109.0 -174.896 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.7 t -80.69 166.91 20.6 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 118.102 0.41 . . . . 1.85 110.632 -179.928 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -43.72 -55.85 4.16 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 124.384 1.074 . . . . 4.9 109.856 177.352 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -57.01 -35.61 69.44 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.665 0.786 . . . . 3.34 111.359 -176.187 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -74.15 -49.05 25.38 Favored 'General case' 0 C--N 1.343 0.302 0 O-C-N 121.243 -0.911 . . . . 2.91 110.295 177.002 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.553 HG23 HMA1 ' A' ' 93' ' ' HEC . 73.3 mt -58.56 -41.05 80.91 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.141 0 N-CA-C 108.375 -0.972 . . . . 0.29 108.375 -177.538 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 27.0 tp -55.22 -54.58 41.65 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 123.759 0.823 . . . . 0.33 110.171 174.115 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -50.98 -48.02 61.33 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 118.104 0.411 . . . . 1.72 111.498 176.521 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 93.1 mt -59.01 -55.77 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 O-C-N 121.54 -0.725 . . . . 0.72 109.767 177.197 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.476 HD11 HMB2 ' A' ' 93' ' ' HEC . 56.5 mt -47.61 -46.08 10.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 O-C-N 121.276 -0.89 . . . . 0.22 110.192 178.976 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 69.5 mt -66.31 -36.4 82.84 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 113.503 0.927 . . . . 0.52 113.503 178.537 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -127.65 27.35 5.79 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 120.085 1.312 . . . . 1.84 110.418 -161.994 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 20.38 -130.47 0.01 OUTLIER Glycine 0 CA--C 1.539 1.585 0 C-N-CA 127.764 2.602 . . . . 0.65 112.749 -159.592 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 165.62 136.04 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 126.801 2.04 . . . . 1.17 107.707 -176.768 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 27.57 -108.42 0.01 OUTLIER Glycine 0 CA--C 1.535 1.286 0 C-N-CA 126.053 1.787 . . . . 0.39 114.714 -172.603 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -62.93 -28.22 71.59 Favored Glycine 0 CA--C 1.534 1.279 0 CA-C-N 117.694 0.747 . . . . 0.55 113.467 -178.443 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 6.5 ttt -70.86 126.0 92.08 Favored Pre-proline 0 CA--C 1.539 0.547 0 C-N-CA 124.887 1.275 . . . . 0.55 110.364 -178.751 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -62.8 -55.03 0.93 Allowed 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 123.686 2.924 . . . . 2.99 111.254 -172.71 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 116.94 147.23 8.59 Favored Glycine 0 C--N 1.334 0.457 0 C-N-CA 124.156 0.884 . . . . 0.88 113.19 175.028 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 69.73 24.4 76.32 Favored Glycine 0 CA--C 1.53 1.02 0 N-CA-C 111.524 -0.631 . . . . 0.46 111.524 179.76 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.0 mm -55.87 -44.96 79.53 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.843 0 C-N-CA 125.51 1.524 . . . . 2.19 111.597 -178.919 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -113.6 160.51 18.48 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.003 1.321 . . . . 0.3 108.843 161.021 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 5.0 ttmt -146.38 167.45 23.57 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 118.423 0.556 . . . . 2.69 110.768 170.53 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 55.91 -148.61 27.48 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 111.092 -0.803 . . . . 0.71 111.092 -179.595 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -49.53 -37.4 26.72 Favored 'General case' 0 C--N 1.341 0.204 0 C-N-CA 123.755 0.822 . . . . 0.68 111.314 -178.709 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -50.69 -49.48 57.3 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 124.994 1.318 . . . . 2.03 110.4 175.287 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -78.75 -48.6 14.56 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 123.233 0.613 . . . . 0.23 111.375 178.953 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -53.7 -50.75 65.19 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.252 1.021 . . . . 2.23 110.623 -176.319 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.01 -48.9 78.64 Favored 'General case' 0 N--CA 1.455 -0.214 0 O-C-N 122.022 -0.424 . . . . 0.21 110.144 177.893 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.436 HG22 HG23 ' A' ' 28' ' ' VAL . 56.0 t -55.54 -49.73 71.55 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 C-N-CA 122.783 0.433 . . . . 0.26 110.955 179.467 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -52.52 -53.17 49.66 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 123.331 0.652 . . . . 0.31 111.466 175.928 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.1 -48.26 82.25 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-O 121.417 0.627 . . . . 0.39 111.257 -179.736 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.533 ' CE3' HD23 ' A' ' 88' ' ' LEU . 47.8 t90 -56.05 -50.16 71.74 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.017 0.527 . . . . 0.48 109.733 177.848 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.533 HD23 ' CE3' ' A' ' 87' ' ' TRP . 0.1 OUTLIER -60.92 -34.61 74.96 Favored 'General case' 0 C--O 1.224 -0.279 0 C-N-CA 124.351 1.06 . . . . 1.55 111.449 176.897 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.28 -42.57 98.87 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 119.009 0.822 . . . . 0.38 110.095 173.332 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -59.66 -42.13 92.13 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.044 0.538 . . . . 3.01 111.093 172.244 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 9.5 mtpp -71.85 130.8 41.94 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 118.545 0.611 . . . . 2.93 110.357 -177.547 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 38.6 mttt . . . . . 0 C--O 1.25 1.102 0 N-CA-C 106.469 -1.678 . . . . 3.25 106.469 -178.274 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' HEC . . . . . 0.553 HMA1 HG23 ' A' ' 60' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.4 t . . . . . 0 N--CA 1.471 0.619 0 N-CA-C 106.178 -1.786 . . . . 1.2 106.178 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -74.35 99.27 3.45 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 108.306 -0.998 . . . . 3.72 108.306 -175.971 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -47.69 -41.95 23.76 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.239 1.016 . . . . 0.35 111.739 176.097 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -66.99 -52.64 40.2 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 107.73 -1.211 . . . . 3.34 107.73 -176.75 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.99 -45.88 71.57 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.316 0.646 . . . . 0.47 111.484 178.483 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 64.0 t -56.57 -60.95 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 N-CA-C 109.181 -0.674 . . . . 0.52 109.181 176.148 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.682 HG11 HD21 ' A' ' 40' ' ' LEU . 46.2 t -55.81 -45.36 79.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 O-C-N 121.908 -0.495 . . . . 0.37 110.888 -175.969 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.447 ' HA ' HG12 ' A' ' 33' ' ' ILE . 23.2 mm-40 -49.78 -19.39 0.64 Allowed 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 126.968 2.107 . . . . 0.87 112.998 173.509 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 44.3 tt0 -139.69 35.06 2.0 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 119.012 0.823 . . . . 2.33 111.367 173.372 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.417 ' O ' HMC3 ' A' ' 93' ' ' HEC . 67.9 mmtt -145.96 -56.92 0.3 Allowed 'General case' 0 CA--C 1.516 -0.358 0 O-C-N 121.211 -0.931 . . . . 2.2 109.977 175.08 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.682 ' SG ' HG22 ' A' ' 28' ' ' VAL . 3.2 m -86.36 -49.71 7.45 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 109.213 -0.662 . . . . 0.28 109.213 -172.768 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.447 HG12 ' HA ' ' A' ' 29' ' ' GLN . 1.8 pp -56.23 -27.88 24.69 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.21 0 CA-C-N 115.739 -0.664 . . . . 0.55 110.569 -178.106 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -36.78 -40.46 0.27 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.199 1.399 . . . . 1.36 111.654 170.943 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 24.4 m -114.69 -35.72 4.76 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.792 0.837 . . . . 0.37 112.127 172.794 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 92.2 m-70 -80.59 3.56 21.43 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 125.065 1.346 . . . . 0.33 113.13 -175.115 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 112.46 -92.58 0.64 Allowed Glycine 0 CA--C 1.528 0.856 0 C-N-CA 126.396 1.951 . . . . 2.98 112.511 164.747 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -162.45 -47.82 0.02 OUTLIER Glycine 0 CA--C 1.522 0.519 0 N-CA-C 108.815 -1.714 . . . . 0.7 108.815 -173.306 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -102.21 7.24 40.89 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 126.099 1.759 . . . . 3.49 111.395 176.643 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.682 HD21 HG11 ' A' ' 28' ' ' VAL . 0.5 OUTLIER 76.28 13.34 2.56 Favored 'General case' 0 C--N 1.35 0.597 0 CA-C-N 120.006 1.276 . . . . 1.87 111.056 179.562 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 35.5 p -75.41 -10.79 59.77 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 126.953 2.101 . . . . 0.6 110.112 -175.777 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.84 147.11 22.14 Favored Glycine 0 N--CA 1.444 -0.817 0 N-CA-C 108.653 -1.779 . . . . 0.59 108.653 -177.396 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -154.23 -81.36 0.08 Allowed 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 123.181 0.593 . . . . 0.34 109.525 177.264 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 5.4 m -89.31 2.8 53.83 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.752 0.821 . . . . 1.02 110.862 171.451 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -152.71 162.73 25.65 Favored Pre-proline 0 N--CA 1.45 -0.459 0 C-N-CA 125.77 1.628 . . . . 0.29 107.256 -172.344 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -66.74 163.95 31.2 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 122.545 2.163 . . . . 0.27 110.905 -175.378 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.87 123.35 24.05 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 109.33 -0.618 . . . . 0.35 109.33 -178.89 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 49.8 pt -107.14 1.95 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 C-N-CA 123.544 0.737 . . . . 0.33 111.424 176.85 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 18.4 p-10 -34.08 -49.92 0.37 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.382 1.473 . . . . 3.76 112.21 167.739 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 18.1 pttt -109.9 34.7 3.71 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 125.086 1.354 . . . . 4.6 112.433 -179.924 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.13 -46.04 91.0 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 109.473 -0.566 . . . . 0.31 109.473 173.242 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -54.88 -32.58 55.73 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 123.154 0.407 . . . . 0.56 113.455 -176.829 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.32 -40.01 62.49 Favored 'General case' 0 CA--C 1.529 0.142 0 O-C-N 121.947 -0.737 . . . . 0.73 110.908 174.689 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 19.5 m-80 -65.71 -52.86 47.98 Favored 'General case' 0 C--O 1.227 -0.088 0 N-CA-C 110.384 -0.228 . . . . 1.69 110.384 -179.788 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -136.07 144.28 45.1 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.035 1.334 . . . . 0.66 108.401 -168.584 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 4.9 m -74.03 167.58 21.24 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 118.268 0.486 . . . . 1.58 110.38 177.626 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.8 pm0 -49.83 -41.68 45.54 Favored 'General case' 0 C--O 1.225 -0.232 0 C-N-CA 123.731 0.813 . . . . 2.65 111.354 -179.476 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -56.62 -44.3 81.06 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.775 0.83 . . . . 3.09 109.966 179.578 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -78.21 -43.65 27.88 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.07 0.948 . . . . 2.79 109.55 -174.481 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.558 HG23 HMA1 ' A' ' 93' ' ' HEC . 76.2 mt -59.83 -48.34 88.04 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 O-C-N 121.094 -1.004 . . . . 0.39 108.749 176.606 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 33.5 tp -55.7 -45.33 77.88 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 109.193 -0.669 . . . . 0.54 109.193 178.425 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -47.22 -56.71 6.19 Favored 'General case' 0 N--CA 1.453 -0.302 0 O-C-N 124.108 0.88 . . . . 1.64 109.328 172.449 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 43.7 mt -61.78 -45.78 97.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 117.827 -1.549 . . . . 0.8 111.999 179.851 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.565 HD11 HMB2 ' A' ' 93' ' ' HEC . 85.9 mt -52.6 -48.66 47.43 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 O-C-N 119.693 -1.879 . . . . 0.31 110.296 -179.023 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 88.3 mt -72.95 -31.94 64.91 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 123.416 0.687 . . . . 0.64 111.886 178.144 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 45.8 m-20 -129.18 46.91 2.55 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 107.699 -1.223 . . . . 1.8 107.699 -163.198 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -40.67 106.25 0.06 OUTLIER Glycine 0 CA--C 1.534 1.244 0 C-N-CA 125.838 1.685 . . . . 3.25 111.476 -171.256 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 -87.86 165.19 15.46 Favored 'General case' 0 N--CA 1.435 -1.212 0 C-N-CA 127.466 2.306 . . . . 3.44 109.382 -175.307 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 57.4 -127.81 45.86 Favored Glycine 0 CA--C 1.529 0.943 0 N-CA-C 111.521 -0.631 . . . . 0.83 111.521 174.385 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -73.79 -25.55 71.62 Favored Glycine 0 CA--C 1.53 0.979 0 CA-C-N 117.096 0.448 . . . . 0.92 112.131 179.799 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 5.5 ttt -63.44 137.22 97.02 Favored Pre-proline 0 CA--C 1.54 0.566 0 O-C-N 121.914 -0.757 . . . . 0.78 109.741 178.849 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -74.35 -54.19 0.1 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.844 2.362 . . . . 2.86 111.233 -177.234 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 113.73 149.81 10.31 Favored Glycine 0 C--N 1.335 0.515 0 C-N-CA 123.849 0.738 . . . . 0.96 112.785 177.321 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 67.25 24.4 73.46 Favored Glycine 0 CA--C 1.531 1.092 0 CA-C-N 114.906 -0.647 . . . . 0.39 112.146 176.727 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -55.5 -51.62 55.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 125.936 1.694 . . . . 1.05 110.877 177.784 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -104.99 149.08 26.06 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 125.171 1.389 . . . . 0.5 108.101 169.768 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 2.9 mtpm? -146.25 153.13 40.24 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.966 0.907 . . . . 4.35 111.441 -178.431 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 71.76 -162.64 54.38 Favored Glycine 0 CA--C 1.532 1.131 0 N-CA-C 110.638 -0.985 . . . . 0.99 110.638 -170.311 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -50.83 -26.72 6.09 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.823 1.249 . . . . 0.73 112.607 -178.702 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 51.7 tt0 -40.93 -62.34 0.83 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.081 1.352 . . . . 2.1 110.508 168.142 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -62.77 -46.85 86.13 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 122.816 0.446 . . . . 0.27 110.666 -174.688 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -51.12 -56.85 10.62 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 123.71 0.804 . . . . 1.94 111.06 175.705 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -56.34 -47.57 78.52 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 109.429 -0.582 . . . . 0.27 109.429 -177.682 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.486 HG22 HG23 ' A' ' 28' ' ' VAL . 53.3 t -57.93 -53.66 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 N-CA-C 111.774 0.287 . . . . 0.3 111.774 177.49 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -52.38 -52.69 52.23 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 123.214 0.605 . . . . 0.19 111.306 179.028 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.444 ' O ' ' HB3' ' A' ' 89' ' ' ALA . . . -58.76 -49.48 77.49 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 121.415 0.626 . . . . 0.35 110.134 179.189 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.564 ' CE3' HD23 ' A' ' 88' ' ' LEU . 46.3 t90 -53.63 -48.76 69.05 Favored 'General case' 0 N--CA 1.451 -0.413 0 O-C-N 121.69 -0.631 . . . . 0.5 110.378 177.473 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.564 HD23 ' CE3' ' A' ' 87' ' ' TRP . 0.1 OUTLIER -61.58 -34.68 76.02 Favored 'General case' 0 C--O 1.227 -0.123 0 C-N-CA 124.394 1.078 . . . . 1.65 111.004 177.206 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.444 ' HB3' ' O ' ' A' ' 86' ' ' ALA . . . -52.58 -47.11 67.07 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 118.889 0.768 . . . . 0.59 109.972 170.989 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -83.22 26.08 0.66 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.404 0.682 . . . . 5.06 112.597 173.686 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 8.1 mtpm? -125.69 120.99 32.17 Favored 'General case' 0 C--N 1.341 0.197 0 CA-C-N 119.775 1.171 . . . . 2.06 110.017 167.043 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.438 -1.043 0 C-N-CA 127.397 2.279 . . . . 2.36 105.1 173.933 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 93' ' ' HEC . . . . . 0.565 HMB2 HD11 ' A' ' 64' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 23.3 t . . . . . 0 N--CA 1.469 0.495 0 N-CA-C 107.204 -1.406 . . . . 1.19 107.204 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -78.28 99.35 6.26 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 108.049 -1.093 . . . . 2.18 108.049 -173.496 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -40.41 -55.66 2.2 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 125.087 1.355 . . . . 0.33 111.732 177.697 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -52.93 -47.0 68.35 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 123.012 0.525 . . . . 2.75 111.78 177.287 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.07 -46.44 87.46 Favored 'General case' 0 N--CA 1.458 -0.06 0 CA-C-N 118.494 0.588 . . . . 0.26 110.468 -178.233 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 69.8 t -55.33 -54.73 21.87 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.252 0 N-CA-C 109.221 -0.659 . . . . 0.34 109.221 175.274 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.473 HG22 ' SG ' ' A' ' 32' ' ' CYS . 34.1 t -56.66 -48.41 80.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 C-N-CA 123.375 0.67 . . . . 0.33 110.531 -175.14 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.416 ' HA ' HG12 ' A' ' 33' ' ' ILE . 36.4 mm-40 -51.42 -21.63 2.46 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.913 1.685 . . . . 0.49 112.78 172.373 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -136.81 49.42 2.06 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 119.151 0.887 . . . . 3.75 111.705 178.104 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -168.5 -59.18 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.183 0 N-CA-C 108.112 -1.07 . . . . 1.52 108.112 168.163 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.473 ' SG ' HG22 ' A' ' 28' ' ' VAL . 3.6 m -75.54 -51.55 12.67 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 120.862 0.363 . . . . 0.18 110.655 -170.231 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.416 HG12 ' HA ' ' A' ' 29' ' ' GLN . 2.2 pp -55.01 -26.58 17.88 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.165 0 CA-C-N 115.838 -0.619 . . . . 0.42 111.697 -179.225 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.7 t -43.61 -34.72 1.51 Allowed 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.034 0.933 . . . . 2.06 111.867 175.051 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 28.7 m -117.03 -37.34 3.59 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.482 0.713 . . . . 0.22 111.706 172.774 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -78.92 2.31 20.62 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.35 1.06 . . . . 0.27 113.0 -175.921 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 112.1 -85.63 0.4 Allowed Glycine 0 C--N 1.34 0.755 0 C-N-CA 125.676 1.607 . . . . 3.0 112.196 162.609 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -171.23 -50.23 0.04 OUTLIER Glycine 0 CA--C 1.518 0.242 0 N-CA-C 108.452 -1.859 . . . . 0.83 108.452 -171.906 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -102.0 4.91 40.38 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.711 1.204 . . . . 3.09 111.504 179.38 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 5.2 mt 80.16 15.29 0.8 Allowed 'General case' 0 C--N 1.354 0.761 0 CA-C-N 120.392 1.451 . . . . 1.53 110.206 -178.903 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.4 p -80.75 -9.4 59.81 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 128.34 2.656 . . . . 0.58 110.002 -175.906 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.56 161.27 36.95 Favored Glycine 0 N--CA 1.442 -0.908 0 N-CA-C 108.995 -1.642 . . . . 0.92 108.995 -174.691 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -164.8 -72.94 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 124.503 1.121 . . . . 0.31 108.187 174.066 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 30.3 m -101.73 3.14 39.31 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.398 1.079 . . . . 1.19 110.857 174.202 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -152.14 160.87 30.8 Favored Pre-proline 0 CA--C 1.536 0.417 0 C-N-CA 126.456 1.902 . . . . 0.24 107.092 -171.599 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.46 158.8 55.38 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 123.115 2.544 . . . . 0.22 110.942 -175.046 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -74.01 120.63 19.85 Favored 'General case' 0 N--CA 1.454 -0.229 0 O-C-N 121.887 -0.508 . . . . 0.27 109.871 -176.749 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 25.3 pt -100.32 2.64 10.6 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 C-N-CA 123.475 0.71 . . . . 0.31 111.679 177.728 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -36.28 -44.89 0.43 Allowed 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.215 1.406 . . . . 2.53 113.668 171.49 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 8.3 mtpt -111.36 26.23 10.88 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.371 1.068 . . . . 3.71 111.324 -177.542 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -58.31 -43.24 88.07 Favored 'General case' 0 N--CA 1.453 -0.317 0 O-C-N 121.631 -0.668 . . . . 0.31 110.205 179.923 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -54.13 -23.58 25.24 Favored Glycine 0 CA--C 1.53 0.98 0 CA-C-N 118.299 0.5 . . . . 0.5 114.344 179.172 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -88.03 -41.56 13.01 Favored 'General case' 0 N--CA 1.457 -0.123 0 CA-C-N 118.123 0.962 . . . . 0.75 109.818 175.849 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -56.85 -53.41 58.18 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 122.529 0.331 . . . . 2.02 110.801 176.504 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -139.15 154.61 48.11 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.677 1.191 . . . . 0.64 109.229 -170.576 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 2.1 p -80.07 167.37 20.5 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.793 0.837 . . . . 2.18 110.927 178.434 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -46.63 -46.22 19.66 Favored 'General case' 0 C--O 1.224 -0.258 0 C-N-CA 124.473 1.109 . . . . 2.74 111.319 176.703 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -58.72 -40.83 84.84 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.285 0.634 . . . . 2.81 110.638 -177.941 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -76.78 -47.93 20.16 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 108.877 -0.786 . . . . 3.01 108.877 -175.393 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.527 HG23 HMA1 ' A' ' 93' ' ' HEC . 83.1 mt -59.58 -42.96 89.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 N-CA-C 109.087 -0.709 . . . . 0.22 109.087 178.666 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.8 tp -54.04 -52.91 59.36 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 109.383 -0.599 . . . . 0.3 109.383 175.954 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -50.51 -51.27 49.09 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 118.064 0.393 . . . . 1.65 110.824 175.004 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 60.9 mt -61.72 -30.57 48.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 O-C-N 121.574 -0.704 . . . . 0.73 112.307 -179.036 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 49.2 mt -69.99 -49.3 57.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 O-C-N 120.381 -1.449 . . . . 0.21 109.08 173.313 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 86.3 mt -67.39 -34.16 76.7 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 124.437 1.095 . . . . 0.49 113.354 -174.448 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -123.37 20.39 9.65 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 119.717 1.144 . . . . 1.83 110.224 -166.644 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 32.24 -141.23 0.05 OUTLIER Glycine 0 CA--C 1.543 1.827 0 C-N-CA 127.039 2.256 . . . . 0.64 112.207 -164.642 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 39.5 tt0 170.72 137.45 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 119.588 1.694 . . . . 1.67 109.243 -176.736 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 38.1 -114.85 0.34 Allowed Glycine 0 CA--C 1.531 1.067 0 CA-C-N 120.04 1.291 . . . . 0.39 113.291 -177.008 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -69.26 -25.04 75.79 Favored Glycine 0 CA--C 1.534 1.25 0 CA-C-N 117.263 0.532 . . . . 0.47 113.233 179.566 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 16.8 ttt -70.27 120.21 76.92 Favored Pre-proline 0 CA--C 1.539 0.532 0 C-N-CA 124.492 1.117 . . . . 0.37 110.058 -179.591 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -62.5 -55.89 0.8 Allowed 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 124.249 3.299 . . . . 2.91 111.578 -168.965 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 118.2 149.13 8.7 Favored Glycine 0 N--CA 1.449 -0.489 0 CA-C-N 115.857 -0.61 . . . . 0.91 114.124 172.429 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 67.41 21.65 72.52 Favored Glycine 0 CA--C 1.532 1.111 0 CA-C-N 114.782 -0.709 . . . . 0.52 111.686 -179.845 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 2.0 mt -52.53 -44.54 45.18 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 C-N-CA 126.872 2.069 . . . . 1.03 110.98 178.211 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -114.82 159.95 20.03 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.817 1.247 . . . . 0.27 110.311 161.775 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 19.3 mmtp -141.92 159.95 41.2 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.972 1.709 . . . . 2.27 110.28 -179.343 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 56.3 -142.94 38.8 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 111.426 -0.669 . . . . 0.78 111.426 176.027 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -50.07 -35.98 27.42 Favored 'General case' 0 C--N 1.341 0.22 0 C-N-CA 123.661 0.785 . . . . 0.71 111.592 174.753 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -57.9 -33.11 68.4 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.61 0.764 . . . . 2.1 110.795 178.782 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -91.97 -53.2 4.37 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.613 0.765 . . . . 0.23 110.882 175.415 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -50.15 -54.49 20.39 Favored 'General case' 0 N--CA 1.461 0.105 0 C-N-CA 124.563 1.145 . . . . 2.11 111.544 -179.533 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.25 -44.75 92.36 Favored 'General case' 0 C--O 1.225 -0.236 0 N-CA-C 109.588 -0.523 . . . . 0.31 109.588 -178.522 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 54.7 t -58.16 -53.75 41.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 C-N-CA 122.772 0.429 . . . . 0.32 111.1 179.451 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -53.17 -52.33 59.15 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 123.081 0.552 . . . . 0.23 111.533 174.921 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.2 -38.62 83.88 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.515 0.726 . . . . 0.59 111.155 -178.216 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 73.7 t90 -67.86 -51.08 52.4 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 123.82 0.848 . . . . 0.5 109.578 177.637 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.46 -30.33 69.6 Favored 'General case' 0 C--O 1.223 -0.318 0 O-C-N 121.363 -0.836 . . . . 1.99 112.143 175.91 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -55.31 -38.91 69.29 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 119.592 1.087 . . . . 0.41 110.836 170.9 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -68.54 -41.81 79.32 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 118.588 -0.72 . . . . 3.1 110.92 170.908 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.6 mtpm? -72.86 106.34 4.75 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 119.173 0.897 . . . . 1.98 110.384 -174.587 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 4.4 mtmp? . . . . . 0 C--O 1.25 1.084 0 C-N-CA 126.233 1.813 . . . . 2.06 106.51 179.374 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 93' ' ' HEC . . . . . 0.527 HMA1 HG23 ' A' ' 60' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 12.4 t . . . . . 0 N--CA 1.471 0.587 0 N-CA-C 107.687 -1.227 . . . . 1.18 107.687 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -75.0 97.8 3.46 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 108.509 -0.923 . . . . 2.57 108.509 -178.305 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -43.3 -52.07 5.95 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 124.335 1.054 . . . . 0.27 111.012 176.101 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -57.91 -47.14 83.7 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 116.287 -0.415 . . . . 2.68 110.401 179.938 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.07 -45.1 94.0 Favored 'General case' 0 N--CA 1.461 0.098 0 CA-C-N 118.472 0.578 . . . . 0.35 110.891 -178.874 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 79.5 t -57.49 -57.25 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 108.93 -0.767 . . . . 0.33 108.93 176.884 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.619 HG11 HD21 ' A' ' 40' ' ' LEU . 35.7 t -55.24 -46.04 77.79 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 C-N-CA 121.213 -0.195 . . . . 0.36 111.011 -176.762 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.429 ' HA ' HG12 ' A' ' 33' ' ' ILE . 26.3 mm-40 -49.98 -25.94 3.79 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 125.794 1.638 . . . . 0.5 112.808 173.769 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -140.66 67.23 1.36 Allowed 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 119.06 0.846 . . . . 2.7 112.001 171.4 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -178.22 -36.11 0.01 OUTLIER 'General case' 0 C--O 1.225 -0.221 0 C-N-CA 124.812 1.245 . . . . 1.2 109.202 169.627 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.492 ' SG ' HG22 ' A' ' 28' ' ' VAL . 2.7 m -103.95 -53.79 2.68 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 119.339 0.972 . . . . 0.25 111.13 -177.649 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.429 HG12 ' HA ' ' A' ' 29' ' ' GLN . 2.0 pp -55.26 -27.88 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 CA-C-N 115.9 -0.591 . . . . 0.54 111.386 -176.302 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.3 m -35.21 -42.12 0.18 Allowed 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 125.358 1.463 . . . . 1.18 112.633 170.244 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 18.2 m -112.66 -34.74 5.72 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.655 0.782 . . . . 0.23 111.706 174.14 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 92.5 m-70 -82.0 5.21 19.99 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.446 1.098 . . . . 0.35 113.409 -175.351 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 107.22 -91.05 0.68 Allowed Glycine 0 CA--C 1.525 0.667 0 C-N-CA 126.57 2.033 . . . . 2.87 111.961 166.312 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -167.63 -47.37 0.03 OUTLIER Glycine 0 CA--C 1.519 0.316 0 N-CA-C 108.792 -1.723 . . . . 0.84 108.792 -172.446 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -102.88 6.42 39.08 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.935 1.294 . . . . 4.1 111.158 178.675 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.619 HD21 HG11 ' A' ' 28' ' ' VAL . 2.5 mt 78.49 10.32 1.89 Allowed 'General case' 0 C--N 1.354 0.798 0 CA-C-N 120.075 1.307 . . . . 1.43 110.352 177.441 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.1 p -74.81 -10.26 59.34 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 128.62 2.768 . . . . 0.59 109.629 -179.69 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.64 159.11 34.3 Favored Glycine 0 N--CA 1.444 -0.822 0 N-CA-C 109.269 -1.532 . . . . 0.85 109.269 -177.017 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -160.67 -79.82 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 124.334 1.054 . . . . 0.35 108.653 175.692 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 58.5 m -91.55 2.24 56.58 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.474 0.709 . . . . 1.21 110.966 173.437 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.446 ' HB1' ' HD2' ' A' ' 46' ' ' PRO . . . -154.35 164.8 19.6 Favored Pre-proline 0 N--CA 1.448 -0.544 0 C-N-CA 125.245 1.418 . . . . 0.31 108.038 -169.672 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.446 ' HD2' ' HB1' ' A' ' 45' ' ' ALA . 27.9 Cg_endo -67.42 159.75 50.95 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 123.002 2.468 . . . . 0.27 111.243 -173.696 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -74.75 115.56 14.47 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.073 0.549 . . . . 0.38 109.999 -177.593 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 32.2 pt -102.55 2.5 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 C-N-CA 124.342 1.057 . . . . 0.55 111.528 179.549 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -34.3 -48.87 0.36 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.28 1.432 . . . . 2.26 112.427 167.49 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 10.0 pttt -109.19 26.26 10.83 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.58 0.752 . . . . 3.41 111.812 -176.458 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -51.55 -44.3 62.66 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 118.927 -0.559 . . . . 0.34 109.8 178.287 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -52.84 -25.72 23.82 Favored Glycine 0 CA--C 1.529 0.952 0 N-CA-C 114.566 0.586 . . . . 0.46 114.566 177.692 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -82.44 -42.36 18.66 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 118.076 0.938 . . . . 0.84 109.49 175.67 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 36.1 m120 -63.69 -48.41 77.22 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 122.574 0.35 . . . . 3.24 110.564 -179.471 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -144.2 145.62 32.18 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.547 1.539 . . . . 0.64 108.553 -169.925 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 19.6 m -75.33 169.17 18.57 Favored 'General case' 0 CA--C 1.532 0.284 0 O-C-N 121.542 -0.724 . . . . 1.52 111.198 179.132 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -44.17 -56.03 4.38 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 123.337 0.655 . . . . 4.77 110.735 174.182 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -53.13 -29.96 34.03 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 112.724 0.638 . . . . 2.96 112.724 -178.406 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 53.6 mm-40 -86.83 -48.85 7.86 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.709 0.804 . . . . 3.03 109.789 -178.315 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.553 HG23 HMA1 ' A' ' 93' ' ' HEC . 84.0 mt -57.6 -46.5 86.33 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.097 0 O-C-N 121.114 -0.991 . . . . 0.26 108.73 178.143 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 46.6 tp -52.97 -47.55 68.08 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 123.618 0.767 . . . . 0.33 109.274 176.543 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -55.45 -46.99 76.72 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 118.244 0.474 . . . . 2.21 110.705 175.099 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 47.7 mt -60.51 -36.7 71.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 O-C-N 121.444 -0.785 . . . . 0.51 110.996 176.728 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.527 HD11 HMB2 ' A' ' 93' ' ' HEC . 58.5 mt -69.21 -42.22 81.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 O-C-N 119.864 -1.773 . . . . 0.24 109.939 178.816 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 71.3 mt -76.65 -26.53 54.97 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.815 1.246 . . . . 0.44 112.891 -176.715 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 28.8 m-80 -124.85 14.43 8.59 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 119.584 1.084 . . . . 1.76 109.989 -172.044 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.586 ' N ' ' HA2' ' A' ' 73' ' ' GLY . . . 40.43 -139.99 1.13 Allowed Glycine 0 CA--C 1.537 1.451 0 C-N-CA 126.614 2.054 . . . . 0.64 110.994 -171.885 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 168.48 127.1 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.602 1.561 . . . . 1.39 110.41 179.152 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 42.13 -115.87 0.97 Allowed Glycine 0 C--N 1.346 1.092 0 CA-C-N 120.283 1.402 . . . . 0.66 113.294 -178.145 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -64.54 -22.06 67.45 Favored Glycine 0 CA--C 1.532 1.097 0 CA-C-N 117.349 0.574 . . . . 0.63 112.53 -179.54 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.421 ' HB2' ' C1D' ' A' ' 93' ' ' HEC . 21.5 ttt -80.32 118.93 74.79 Favored Pre-proline 0 N--CA 1.45 -0.442 0 C-N-CA 124.878 1.271 . . . . 0.37 111.433 -179.35 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.445 ' HD2' HD11 ' A' ' 75' ' ' ILE . 36.2 Cg_endo -77.83 122.77 6.0 Favored 'Trans proline' 0 N--CA 1.448 -1.193 0 C-N-CA 122.645 2.23 . . . . 2.05 112.066 -178.515 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.586 ' HA2' ' N ' ' A' ' 67' ' ' GLY . . . -57.26 131.28 51.97 Favored Glycine 0 N--CA 1.444 -0.817 0 N-CA-C 115.348 0.899 . . . . 0.72 115.348 179.376 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 87.55 40.63 6.74 Favored Glycine 0 C--N 1.338 0.678 0 CA-C-N 114.342 -0.929 . . . . 0.49 112.008 172.687 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.445 HD11 ' HD2' ' A' ' 72' ' ' PRO . 2.4 mt -66.92 -61.44 1.69 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 124.691 1.196 . . . . 1.08 109.925 176.616 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -98.36 161.35 13.73 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.632 1.173 . . . . 0.32 109.705 167.613 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.0 mttm -146.81 164.34 33.14 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 125.085 1.354 . . . . 2.49 110.71 176.828 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 52.7 -146.32 17.4 Favored Glycine 0 CA--C 1.529 0.92 0 N-CA-C 111.383 -0.687 . . . . 0.71 111.383 -178.527 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -53.12 -31.49 42.39 Favored 'General case' 0 C--O 1.225 -0.215 0 C-N-CA 122.942 0.497 . . . . 0.82 111.295 177.432 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -53.61 -46.1 70.3 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 123.299 0.64 . . . . 2.32 110.168 174.398 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -78.69 -52.25 8.68 Favored 'General case' 0 CA--C 1.53 0.191 0 O-C-N 121.552 -0.717 . . . . 0.22 111.098 176.496 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -57.17 -51.6 68.66 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.631 0.773 . . . . 2.6 111.331 -173.53 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.18 -45.62 90.56 Favored 'General case' 0 N--CA 1.457 -0.12 0 O-C-N 121.99 -0.444 . . . . 0.26 109.881 -179.265 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.588 HG22 HG23 ' A' ' 28' ' ' VAL . 37.9 t -56.25 -53.04 44.4 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 CA-C-O 119.515 -0.279 . . . . 0.3 110.94 176.263 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -52.43 -50.53 62.39 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 122.767 0.427 . . . . 0.17 111.048 177.831 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.04 -45.07 96.29 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-O 121.263 0.554 . . . . 0.3 110.964 -179.189 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.534 ' CE3' HD23 ' A' ' 88' ' ' LEU . 45.6 t90 -59.93 -48.11 83.05 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.863 0.84 . . . . 0.5 109.703 176.464 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.534 HD23 ' CE3' ' A' ' 87' ' ' TRP . 0.1 OUTLIER -62.11 -27.6 69.04 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 120.448 -1.407 . . . . 1.67 110.3 177.039 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -65.67 -43.75 88.39 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 123.319 0.648 . . . . 0.35 111.13 172.583 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -62.13 -42.09 98.9 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 118.537 -1.265 . . . . 3.76 109.944 171.807 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 7.8 mtpp -69.38 119.98 14.48 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 121.581 0.705 . . . . 2.18 111.501 -171.18 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 8.2 mttp . . . . . 0 C--O 1.25 1.083 0 C-N-CA 128.092 2.557 . . . . 2.38 105.456 -176.352 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 93' ' ' HEC . . . . . 0.553 HMA1 HG23 ' A' ' 60' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 29.6 t . . . . . 0 N--CA 1.47 0.538 0 N-CA-C 106.696 -1.594 . . . . 1.32 106.696 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -73.64 99.8 3.19 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 123.907 0.883 . . . . 2.63 109.228 -171.932 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -38.25 -53.73 1.44 Allowed 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 125.669 1.587 . . . . 0.42 112.498 176.461 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -52.69 -49.79 64.6 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 122.844 0.458 . . . . 2.91 111.213 176.637 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.28 -43.92 95.82 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 118.429 0.559 . . . . 0.37 110.532 -179.777 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 89.4 t -58.6 -54.26 35.75 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 N-CA-C 109.702 -0.481 . . . . 0.46 109.702 176.649 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.447 HG23 HG22 ' A' ' 84' ' ' VAL . 32.7 t -53.4 -50.63 47.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 C-N-CA 122.709 0.404 . . . . 0.44 110.11 179.762 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 31.8 mm-40 -54.74 -14.47 1.39 Allowed 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 126.49 1.916 . . . . 0.67 113.953 174.518 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -141.48 34.06 1.65 Allowed 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 119.757 1.162 . . . . 2.94 112.583 176.668 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.3 mptt -152.0 -62.62 0.17 Allowed 'General case' 0 CA--C 1.521 -0.159 0 N-CA-C 108.401 -0.963 . . . . 2.61 108.401 166.056 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.438 ' SG ' HG22 ' A' ' 28' ' ' VAL . 3.7 m -69.65 -46.84 65.22 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 121.13 0.49 . . . . 0.19 110.144 -168.746 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.3 pp -56.15 -23.31 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 CA-C-N 115.462 -0.79 . . . . 0.51 112.882 -178.388 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.0 t -48.38 -35.45 12.61 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.981 0.913 . . . . 2.03 110.748 177.794 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 15.9 m -120.04 -40.49 2.72 Favored 'General case' 0 C--N 1.342 0.255 0 C-N-CA 123.564 0.746 . . . . 0.19 111.525 177.319 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 86.1 m-70 -72.16 -9.01 57.85 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.581 0.752 . . . . 0.23 112.219 -178.59 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 88.61 148.87 18.05 Favored Glycine 0 C--N 1.339 0.714 0 N-CA-C 109.742 -1.343 . . . . 1.44 109.742 177.595 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -42.34 -33.41 1.37 Allowed Glycine 0 CA--C 1.529 0.956 0 C-N-CA 125.202 1.382 . . . . 0.54 112.988 175.085 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -101.26 -5.29 25.7 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.076 1.351 . . . . 2.98 112.209 -171.687 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 73.37 8.63 5.18 Favored 'General case' 0 C--N 1.35 0.601 0 O-C-N 120.633 -1.292 . . . . 1.43 111.393 175.696 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 17.2 p -82.11 -1.99 50.52 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 127.491 2.316 . . . . 0.5 110.287 -174.523 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.57 145.27 9.84 Favored Glycine 0 N--CA 1.438 -1.19 0 N-CA-C 108.164 -1.975 . . . . 0.41 108.164 -171.475 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -150.88 -73.0 0.16 Allowed 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 124.181 0.992 . . . . 0.26 108.98 176.7 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.93 3.85 49.57 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.948 1.299 . . . . 1.13 110.441 173.33 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -158.05 163.68 23.79 Favored Pre-proline 0 CA--C 1.536 0.419 0 C-N-CA 125.994 1.718 . . . . 0.21 107.331 -167.523 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -70.16 158.01 57.8 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 123.144 2.563 . . . . 0.26 110.768 -174.823 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.39 126.96 31.36 Favored 'General case' 0 C--N 1.333 -0.148 0 O-C-N 121.636 -0.665 . . . . 0.31 110.075 -177.305 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 39.4 pt -106.9 -2.88 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 C-N-CA 123.07 0.548 . . . . 0.36 111.887 177.037 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 24.6 p-10 -33.66 -49.95 0.33 Allowed 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.29 1.436 . . . . 3.61 112.744 171.834 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.5 pttp -106.17 23.82 13.45 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.261 1.424 . . . . 3.95 112.579 -176.859 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.04 -50.02 75.67 Favored 'General case' 0 CA--C 1.527 0.072 0 O-C-N 121.228 -0.92 . . . . 0.51 109.963 179.168 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -60.18 -12.84 25.47 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 123.386 0.517 . . . . 0.94 114.157 178.804 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.98 -34.15 68.69 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 118.454 1.127 . . . . 1.53 110.664 173.539 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -107.24 -52.09 2.82 Favored 'General case' 0 C--N 1.34 0.174 0 C-N-CA 123.976 0.91 . . . . 3.05 111.878 -176.137 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -84.04 170.29 14.07 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.713 0.805 . . . . 1.32 110.184 175.763 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 54.1 m -119.53 169.1 10.35 Favored 'General case' 0 C--O 1.233 0.237 0 C-N-CA 125.647 1.579 . . . . 1.5 108.619 172.899 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.8 pm0 -46.25 -49.86 16.71 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 124.475 1.11 . . . . 2.74 112.355 -177.198 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -58.83 -41.71 87.51 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 118.298 0.499 . . . . 2.41 111.888 179.172 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.65 -49.07 51.34 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 122.114 0.959 . . . . 3.53 108.623 -176.253 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 31.2 mt -60.03 -44.48 94.91 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 O-C-N 121.631 -0.668 . . . . 0.31 109.253 178.545 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 61.7 tp -54.61 -52.45 62.19 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.289 -0.634 . . . . 0.72 109.289 177.119 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -48.28 -53.91 15.55 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.165 0.586 . . . . 1.89 109.77 179.264 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 81.4 mt -57.18 -47.87 83.22 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.283 0 O-C-N 121.707 -0.621 . . . . 0.48 111.409 177.37 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.48 HD11 HMB2 ' A' ' 93' ' ' HEC . 79.5 mt -54.79 -43.0 65.24 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 O-C-N 120.464 -1.398 . . . . 0.3 110.216 176.665 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 94.3 mt -70.8 -40.41 72.55 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 113.957 1.095 . . . . 0.61 113.957 -176.171 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -123.3 27.51 7.49 Favored 'General case' 0 C--N 1.344 0.35 0 CA-C-N 120.956 1.707 . . . . 3.8 109.787 -171.515 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.532 ' N ' ' HA2' ' A' ' 73' ' ' GLY . . . 36.55 -136.97 0.52 Allowed Glycine 0 CA--C 1.532 1.151 0 C-N-CA 127.786 2.612 . . . . 0.64 110.613 -174.969 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 30.9 tt0 167.41 133.36 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 119.237 1.519 . . . . 1.76 109.197 -177.089 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 45.04 -122.5 5.15 Favored Glycine 0 CA--C 1.532 1.102 0 CA-C-N 119.872 1.215 . . . . 0.49 112.252 -175.396 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -70.8 -16.97 74.78 Favored Glycine 0 CA--C 1.532 1.131 0 CA-C-N 117.595 0.697 . . . . 0.7 113.017 178.448 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.421 ' HB2' ' C1D' ' A' ' 93' ' ' HEC . 20.5 ttt -71.29 119.03 71.27 Favored Pre-proline 0 N--CA 1.451 -0.385 0 CA-C-N 118.23 1.015 . . . . 0.43 110.434 -178.938 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -78.18 120.55 4.99 Favored 'Trans proline' 0 N--CA 1.446 -1.275 0 C-N-CA 122.847 2.365 . . . . 2.14 110.886 -179.431 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.532 ' HA2' ' N ' ' A' ' 67' ' ' GLY . . . -61.3 140.63 47.74 Favored Glycine 0 N--CA 1.443 -0.892 0 CA-C-N 115.047 -0.979 . . . . 0.61 115.499 -175.691 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 79.87 35.25 28.51 Favored Glycine 0 CA--C 1.524 0.644 0 CA-C-N 114.05 -1.075 . . . . 0.33 110.911 174.161 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -57.41 -52.04 61.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 125.094 1.358 . . . . 1.03 109.499 175.465 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -111.5 155.0 23.92 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 125.404 1.481 . . . . 0.33 108.339 163.147 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.2 mtpp -142.64 157.86 44.26 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.868 1.267 . . . . 2.38 109.408 175.959 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 62.32 -151.06 46.3 Favored Glycine 0 CA--C 1.529 0.94 0 N-CA-C 111.133 -0.787 . . . . 0.76 111.133 -177.38 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -50.79 -35.08 30.15 Favored 'General case' 0 C--N 1.34 0.192 0 C-N-CA 123.865 0.866 . . . . 0.56 111.736 -175.775 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -50.87 -50.96 55.89 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.006 0.922 . . . . 2.14 110.621 174.105 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -75.81 -49.59 17.6 Favored 'General case' 0 CA--C 1.528 0.1 0 C-N-CA 123.335 0.654 . . . . 0.24 111.043 179.36 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -55.11 -48.35 73.73 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.724 0.809 . . . . 2.49 110.696 -176.397 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.21 -50.67 72.73 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 109.909 -0.404 . . . . 0.26 109.909 177.638 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.492 HG11 HMB1 ' A' ' 93' ' ' HEC . 57.4 t -53.57 -59.14 2.06 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.272 0 CA-C-O 119.508 -0.282 . . . . 0.35 110.465 178.591 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -42.87 -56.34 3.29 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 123.831 0.852 . . . . 0.2 112.144 174.299 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.67 -46.97 85.71 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 121.487 0.661 . . . . 0.31 111.923 -176.364 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.439 ' CZ3' HG21 ' A' ' 28' ' ' VAL . 74.9 t90 -58.99 -49.9 76.14 Favored 'General case' 0 C--N 1.328 -0.362 0 O-C-N 121.747 -0.596 . . . . 0.51 109.879 178.339 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.05 -32.89 74.37 Favored 'General case' 0 C--O 1.223 -0.329 0 CA-C-O 117.981 -1.009 . . . . 2.13 111.995 176.164 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -55.99 -36.16 67.59 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 119.621 1.1 . . . . 0.37 110.097 170.233 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -68.59 -36.06 78.19 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 118.459 -0.781 . . . . 3.31 111.51 172.589 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 4.2 mtpt -74.17 134.71 42.8 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 119.736 1.153 . . . . 2.15 110.801 -178.338 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 2.6 mptt . . . . . 0 C--O 1.25 1.12 0 N-CA-C 105.738 -1.949 . . . . 2.91 105.738 172.458 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 93' ' ' HEC . . . . . 0.492 HMB1 HG11 ' A' ' 84' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.47 HG22 ' H ' ' A' ' 23' ' ' ASP 2.191 0.7 OUTLIER . . . . . 0 N--CA 1.469 0.507 0 CA-C-O 113.97 -2.919 . . . . 1.72 106.474 . . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.47 ' H ' HG22 ' A' ' 22' ' ' VAL . 83.9 m-20 -91.11 91.78 8.41 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 103.587 -2.746 . . . . 2.73 103.587 156.534 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.62 -49.91 71.57 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-O 121.481 0.658 . . . . 0.36 109.905 -171.764 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -58.91 -48.25 82.12 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.116 -0.947 . . . . 3.17 109.929 -178.773 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.96 -47.07 87.3 Favored 'General case' 0 CA--C 1.527 0.096 0 C-N-CA 122.938 0.495 . . . . 0.32 111.066 -179.933 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 75.6 t -55.72 -55.54 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 N-CA-C 108.913 -0.773 . . . . 0.47 108.913 176.727 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.516 HG13 ' HB2' ' A' ' 32' ' ' CYS . 37.3 t -54.6 -47.55 72.13 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 C-N-CA 122.55 0.34 . . . . 0.37 111.188 -177.8 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 40.1 mm-40 -52.3 -19.46 2.09 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.098 1.359 . . . . 0.66 113.078 174.584 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -135.66 42.31 2.67 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 119.876 1.216 . . . . 2.67 111.939 174.903 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -163.5 -34.19 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 118.106 -0.949 . . . . 1.65 112.8 172.062 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.516 ' HB2' HG13 ' A' ' 28' ' ' VAL . 3.5 m -100.75 -50.66 3.79 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 119.668 1.122 . . . . 0.16 110.736 -178.619 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 8.6 pt -56.07 -27.19 22.82 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 CA-C-N 116.191 -0.459 . . . . 1.35 111.977 -175.627 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.7 m -40.1 -37.35 0.6 Allowed 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.51 1.524 . . . . 1.11 112.145 173.966 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 17.6 m -116.56 -36.65 3.89 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.398 0.679 . . . . 0.23 111.753 173.955 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 92.5 m-70 -80.63 3.31 22.39 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.018 0.927 . . . . 0.3 113.372 -175.628 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 108.43 -78.84 0.24 Allowed Glycine 0 CA--C 1.525 0.681 0 C-N-CA 125.778 1.656 . . . . 2.99 111.937 163.991 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -178.14 -53.4 0.07 OUTLIER Glycine 0 C--O 1.229 -0.219 0 N-CA-C 108.306 -1.918 . . . . 0.89 108.306 -171.355 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -97.07 3.93 51.58 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 117.948 -1.025 . . . . 2.52 110.919 -178.356 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.5 mt 77.76 13.23 1.8 Allowed 'General case' 0 C--N 1.352 0.702 0 CA-C-N 119.704 1.138 . . . . 1.46 110.054 -178.443 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.7 p -78.55 -11.92 59.99 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 128.462 2.705 . . . . 0.55 110.189 -176.166 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.42 156.72 32.41 Favored Glycine 0 N--CA 1.444 -0.829 0 N-CA-C 109.167 -1.573 . . . . 0.65 109.167 -178.758 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -163.21 -79.16 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 123.52 0.728 . . . . 0.28 109.719 179.222 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.5 m -93.1 2.49 56.71 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.187 0.995 . . . . 0.99 110.676 170.798 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -153.27 160.67 30.67 Favored Pre-proline 0 N--CA 1.447 -0.585 0 C-N-CA 126.219 1.808 . . . . 0.21 106.973 -171.455 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -67.15 164.5 29.99 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 123.282 2.655 . . . . 0.29 111.191 -174.86 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -74.38 123.87 25.45 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.858 -0.423 . . . . 0.27 109.858 -178.262 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 49.8 pt -109.85 1.35 9.34 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 C-N-CA 124.28 1.032 . . . . 0.46 112.486 177.784 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 22.0 p-10 -34.53 -48.46 0.36 Allowed 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.587 1.555 . . . . 3.53 112.574 167.516 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 4.6 tttt -113.68 38.97 2.78 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 126.606 1.962 . . . . 5.57 109.326 -177.595 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.36 -47.37 86.18 Favored 'General case' 0 N--CA 1.454 -0.245 0 O-C-N 121.119 -0.988 . . . . 0.32 109.896 170.559 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -51.26 -42.48 49.59 Favored Glycine 0 CA--C 1.526 0.761 0 C-N-CA 123.959 0.79 . . . . 0.77 114.448 -171.67 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.37 -21.06 58.6 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 121.684 -0.892 . . . . 0.92 112.107 179.285 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -82.55 -46.68 13.05 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 118.531 0.605 . . . . 1.97 109.516 176.027 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -138.05 137.78 38.14 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.858 1.263 . . . . 0.61 108.55 -171.777 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 35.1 t -75.64 167.2 22.34 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.898 0.879 . . . . 2.26 109.841 178.951 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -49.51 -43.19 45.32 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.864 0.865 . . . . 2.81 111.893 177.53 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -53.54 -37.54 62.94 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 118.991 0.814 . . . . 2.88 111.447 176.467 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -83.08 -49.07 9.91 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 123.615 0.766 . . . . 3.48 110.091 -178.352 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.445 HG23 HMA1 ' A' ' 93' ' ' HEC . 65.2 mt -58.73 -44.93 91.15 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.052 0 O-C-N 121.283 -0.885 . . . . 0.25 108.758 -178.637 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 35.3 tp -54.41 -47.55 72.63 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 124.002 0.921 . . . . 0.32 109.846 176.182 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -56.0 -50.64 70.29 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 109.794 -0.447 . . . . 2.06 109.794 174.49 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 74.2 mt -60.22 -30.17 45.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 O-C-N 121.575 -0.703 . . . . 0.78 111.694 178.895 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.511 HD11 HMB2 ' A' ' 93' ' ' HEC . 46.6 mt -71.64 -50.77 37.07 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 O-C-N 120.151 -1.593 . . . . 0.28 109.95 174.559 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 82.8 mt -70.74 -30.39 66.9 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.869 0.868 . . . . 0.54 112.91 -174.336 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -119.3 12.62 12.59 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 119.11 0.868 . . . . 1.68 109.974 -170.048 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.534 ' N ' ' HA2' ' A' ' 73' ' ' GLY . . . 39.38 -147.07 0.18 Allowed Glycine 0 CA--C 1.542 1.719 0 C-N-CA 127.722 2.582 . . . . 0.63 111.211 -172.449 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 38.8 tt0 175.34 131.1 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 119.344 1.572 . . . . 1.87 108.93 -177.144 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 40.72 -115.62 0.7 Allowed Glycine 0 CA--C 1.532 1.137 0 CA-C-N 119.957 1.253 . . . . 0.46 113.33 -175.95 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -69.98 -21.65 76.9 Favored Glycine 0 CA--C 1.532 1.142 0 O-C-N 122.335 -0.509 . . . . 0.53 112.992 -179.727 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.444 ' HB2' ' C1D' ' A' ' 93' ' ' HEC . 22.4 ttt -73.66 119.08 74.16 Favored Pre-proline 0 N--CA 1.452 -0.374 0 C-N-CA 124.363 1.065 . . . . 0.43 110.773 -179.817 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -78.85 128.1 8.25 Favored 'Trans proline' 0 N--CA 1.445 -1.376 0 C-N-CA 122.263 1.976 . . . . 2.16 110.525 -179.454 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.534 ' HA2' ' N ' ' A' ' 67' ' ' GLY . . . -61.31 134.17 48.28 Favored Glycine 0 N--CA 1.442 -0.921 0 CA-C-N 115.215 -0.902 . . . . 0.66 114.703 -179.486 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 84.23 38.56 9.93 Favored Glycine 0 CA--C 1.526 0.781 0 CA-C-N 114.543 -0.828 . . . . 0.32 111.676 171.261 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -61.2 -44.31 98.11 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.881 0 C-N-CA 125.43 1.492 . . . . 2.32 110.237 177.203 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -111.48 161.76 15.81 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.498 1.919 . . . . 0.52 109.565 164.659 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 68.6 mttt -133.12 157.64 44.8 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 124.798 1.239 . . . . 3.21 110.837 174.74 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 53.22 -141.74 29.64 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 110.712 -0.955 . . . . 0.71 110.712 176.854 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -52.44 -34.83 50.45 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 117.139 0.469 . . . . 0.72 111.835 179.254 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -53.77 -35.94 61.86 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.699 0.8 . . . . 2.47 109.48 178.39 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -82.18 -52.66 6.76 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.465 0.706 . . . . 0.3 110.805 170.967 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -57.4 -54.52 45.85 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 112.657 0.614 . . . . 1.96 112.657 -172.333 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -55.96 -42.79 76.78 Favored 'General case' 0 N--CA 1.454 -0.253 0 O-C-N 121.88 -0.513 . . . . 0.26 110.472 -179.832 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.481 HG22 HG23 ' A' ' 28' ' ' VAL . 50.8 t -61.12 -53.67 45.79 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 C-N-CA 122.66 0.384 . . . . 0.35 110.666 178.365 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -51.66 -50.46 60.32 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 123.12 0.568 . . . . 0.19 111.514 176.099 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.16 -48.41 81.7 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.452 0.701 . . . . 0.27 110.69 179.412 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.525 ' CE3' HD23 ' A' ' 88' ' ' LEU . 47.6 t90 -56.71 -47.53 79.74 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 121.915 -0.49 . . . . 0.44 109.769 177.086 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.525 HD23 ' CE3' ' A' ' 87' ' ' TRP . 0.1 OUTLIER -64.22 -36.32 83.69 Favored 'General case' 0 N--CA 1.462 0.139 0 C-N-CA 124.162 0.985 . . . . 1.64 111.476 179.305 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -54.55 -41.01 69.25 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 118.987 0.812 . . . . 0.42 110.096 170.988 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -88.4 27.39 1.26 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.722 0.809 . . . . 4.44 112.706 173.098 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.6 mtpm? -119.85 130.95 55.12 Favored 'General case' 0 C--N 1.341 0.21 0 O-C-N 120.858 -1.151 . . . . 2.11 109.245 165.14 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 9.5 mtmp? . . . . . 0 C--O 1.248 1.022 0 C-N-CA 127.924 2.49 . . . . 3.6 104.607 -177.243 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 93' ' ' HEC . . . . . 0.511 HMB2 HD11 ' A' ' 64' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.467 HG11 ' HA ' ' A' ' 80' ' ' GLU . 43.0 t . . . . . 0 N--CA 1.47 0.551 0 N-CA-C 107.289 -1.375 . . . . 1.14 107.289 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -74.08 156.92 36.92 Favored 'General case' 0 N--CA 1.451 -0.418 0 O-C-N 124.049 0.843 . . . . 2.13 109.61 178.266 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -97.73 -61.94 1.32 Allowed 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 109.144 -0.687 . . . . 0.43 109.144 178.203 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -51.53 -43.74 62.4 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 116.173 -0.467 . . . . 3.13 111.116 178.164 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.55 -43.72 89.42 Favored 'General case' 0 CA--C 1.528 0.135 0 CA-C-N 118.579 0.627 . . . . 0.37 111.509 179.731 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 73.6 t -63.39 -53.18 48.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 N-CA-C 108.12 -1.067 . . . . 0.34 108.12 178.438 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.656 HG11 HD21 ' A' ' 40' ' ' LEU . 45.1 t -52.34 -48.44 44.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 110.437 -0.209 . . . . 0.32 110.437 -179.623 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.468 ' HA ' HG12 ' A' ' 33' ' ' ILE . 35.6 mm-40 -50.47 -24.5 3.16 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.448 1.899 . . . . 0.65 112.937 175.658 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -142.62 59.04 1.44 Allowed 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 119.184 0.902 . . . . 2.54 111.323 178.459 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -179.81 -36.28 0.01 OUTLIER 'General case' 0 C--O 1.225 -0.207 0 C-N-CA 124.648 1.179 . . . . 1.19 109.695 173.356 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.464 ' HB2' HG13 ' A' ' 28' ' ' VAL . 5.0 m -101.1 -53.66 2.98 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 119.28 0.945 . . . . 0.18 110.973 -178.632 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.468 HG12 ' HA ' ' A' ' 29' ' ' GLN . 2.1 pp -57.37 -25.92 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 CA-C-N 115.876 -0.602 . . . . 0.42 112.041 -175.735 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.1 m -38.17 -35.53 0.17 Allowed 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.001 1.72 . . . . 1.23 112.548 170.483 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 18.5 m -120.9 -44.02 2.44 Favored 'General case' 0 C--N 1.34 0.174 0 C-N-CA 123.326 0.651 . . . . 0.25 111.629 172.854 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 82.4 m-70 -70.13 -8.81 52.61 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.413 0.685 . . . . 0.34 112.817 -175.2 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 88.48 151.93 23.96 Favored Glycine 0 C--N 1.337 0.589 0 N-CA-C 109.757 -1.337 . . . . 1.51 109.757 177.488 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -44.51 -37.54 4.95 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 124.518 1.056 . . . . 0.44 112.31 178.514 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.482 ' C ' HD12 ' A' ' 40' ' ' LEU . 0.8 OUTLIER -98.37 0.24 45.03 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.707 1.203 . . . . 2.09 111.747 -174.061 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.656 HD21 HG11 ' A' ' 28' ' ' VAL . 2.4 mp 65.28 17.14 10.89 Favored 'General case' 0 C--N 1.347 0.458 0 CA-C-N 120.232 1.378 . . . . 1.84 111.543 178.582 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.3 p -84.9 -4.77 59.25 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 128.529 2.731 . . . . 0.4 110.03 -175.707 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.04 127.18 3.65 Favored Glycine 0 N--CA 1.442 -0.903 0 N-CA-C 109.009 -1.636 . . . . 0.55 109.009 179.437 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -134.31 -80.13 0.45 Allowed 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 124.229 1.012 . . . . 0.29 108.904 179.552 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 46.1 m -88.85 2.85 52.98 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.757 0.823 . . . . 1.42 111.047 172.695 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.445 ' HB1' ' HD2' ' A' ' 46' ' ' PRO . . . -158.99 164.86 19.78 Favored Pre-proline 0 CA--C 1.537 0.444 0 C-N-CA 124.529 1.132 . . . . 0.28 108.246 -169.188 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.445 ' HD2' ' HB1' ' A' ' 45' ' ' ALA . 55.2 Cg_endo -68.75 157.69 60.84 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 123.157 2.571 . . . . 0.27 110.951 -173.389 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.45 128.76 36.41 Favored 'General case' 0 CA--C 1.529 0.146 0 O-C-N 121.584 -0.697 . . . . 0.32 110.307 -175.653 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 48.6 pt -106.63 0.21 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 C-N-CA 123.328 0.651 . . . . 0.31 111.626 176.954 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -38.99 -38.29 0.43 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.789 0.836 . . . . 2.27 113.105 170.085 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 4.2 pttt -113.49 30.05 7.52 Favored 'General case' 0 C--N 1.343 0.316 0 C-N-CA 124.507 1.123 . . . . 4.08 111.642 -178.689 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -68.36 -41.97 79.86 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 118.652 -0.689 . . . . 0.35 109.624 176.766 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -53.38 -29.83 39.35 Favored Glycine 0 CA--C 1.526 0.735 0 CA-C-N 118.614 0.643 . . . . 0.72 114.646 -175.419 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -83.41 -47.49 11.36 Favored 'General case' 0 N--CA 1.455 -0.197 0 O-C-N 122.403 -0.469 . . . . 1.14 110.366 175.253 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 38.4 m-80 -55.63 -44.27 76.96 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 122.286 0.234 . . . . 1.54 111.158 179.43 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -139.75 134.15 31.46 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.022 1.729 . . . . 0.62 107.691 -167.309 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 49.2 m -74.98 170.73 15.4 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 118.348 0.522 . . . . 1.49 110.774 178.059 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 73.3 tt0 -45.54 -59.53 2.67 Favored 'General case' 0 C--N 1.342 0.267 0 C-N-CA 123.178 0.591 . . . . 5.26 110.75 177.148 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 31.5 mp0 -51.28 -31.86 22.71 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.656 0.782 . . . . 4.28 112.906 179.259 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -80.85 -48.46 12.38 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 119.23 0.923 . . . . 2.64 109.315 -179.191 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.569 HG23 HMA1 ' A' ' 93' ' ' HEC . 84.6 mt -61.77 -47.1 94.85 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.222 0 O-C-N 121.565 -0.709 . . . . 0.26 109.256 -179.215 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 31.2 tp -52.2 -50.2 62.38 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 108.956 -0.757 . . . . 0.38 108.956 175.789 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -57.02 -43.23 81.65 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 120.72 -0.392 . . . . 1.67 110.997 178.157 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 31.6 mt -58.73 -54.0 39.63 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.262 0 O-C-N 120.861 -1.149 . . . . 0.67 110.494 173.257 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.536 HD11 HMB2 ' A' ' 93' ' ' HEC . 58.2 mt -50.75 -41.97 22.04 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 O-C-N 120.655 -1.278 . . . . 0.19 110.513 -179.614 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 88.5 mt -69.18 -40.53 78.03 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 113.436 0.902 . . . . 0.58 113.436 176.951 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 -118.31 19.1 13.56 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 120.489 1.495 . . . . 1.77 110.202 -164.706 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.573 ' N ' ' HA2' ' A' ' 73' ' ' GLY . . . 29.47 -136.5 0.05 OUTLIER Glycine 0 CA--C 1.532 1.154 0 C-N-CA 128.511 2.958 . . . . 0.65 110.973 -162.458 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 171.66 133.01 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 119.085 1.443 . . . . 1.55 108.28 -176.736 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 40.76 -118.85 1.28 Allowed Glycine 0 CA--C 1.533 1.208 0 CA-C-N 120.405 1.457 . . . . 0.36 113.294 -178.199 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -68.49 -19.25 72.57 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 123.704 0.669 . . . . 0.51 113.23 179.204 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.429 ' HB2' ' C1D' ' A' ' 93' ' ' HEC . 19.9 ttt -74.41 119.12 74.95 Favored Pre-proline 0 N--CA 1.449 -0.485 0 C-N-CA 124.288 1.035 . . . . 0.38 110.677 179.174 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -74.86 127.34 10.7 Favored 'Trans proline' 0 N--CA 1.442 -1.551 0 C-N-CA 122.01 1.806 . . . . 2.1 109.812 177.631 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.573 ' HA2' ' N ' ' A' ' 67' ' ' GLY . . . -63.17 140.76 45.55 Favored Glycine 0 N--CA 1.442 -0.956 0 CA-C-N 115.487 -0.779 . . . . 0.65 114.655 176.953 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 84.27 38.0 10.47 Favored Glycine 0 CA--C 1.525 0.692 0 CA-C-N 113.757 -1.221 . . . . 0.56 111.507 173.605 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.5 mm -64.3 -58.03 8.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 C-N-CA 123.779 0.831 . . . . 1.99 110.002 176.559 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -104.94 152.58 22.5 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.893 1.277 . . . . 0.29 108.206 167.807 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 2.1 mmmt -142.28 154.99 45.19 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 124.732 1.213 . . . . 3.2 108.995 -178.721 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 63.67 -158.29 40.44 Favored Glycine 0 CA--C 1.531 1.043 0 N-CA-C 111.315 -0.714 . . . . 0.63 111.315 -173.814 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -53.14 -26.04 15.42 Favored 'General case' 0 C--N 1.34 0.173 0 C-N-CA 123.873 0.869 . . . . 0.62 112.415 -179.983 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.467 ' HA ' HG11 ' A' ' 22' ' ' VAL . 6.1 tt0 -47.92 -48.81 31.61 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.493 1.117 . . . . 2.11 110.577 171.326 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -74.32 -47.68 33.07 Favored 'General case' 0 N--CA 1.455 -0.189 0 O-C-N 121.645 -0.659 . . . . 0.31 111.333 177.285 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -55.92 -51.95 65.82 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.24 0.616 . . . . 2.59 110.645 -174.979 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -54.0 -47.5 71.4 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.774 0.829 . . . . 0.27 110.308 178.644 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.516 HG22 HG23 ' A' ' 28' ' ' VAL . 44.4 t -58.84 -55.46 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 C-N-CA 122.607 0.363 . . . . 0.43 110.832 177.983 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -48.68 -51.9 26.1 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.183 0.593 . . . . 0.21 111.252 176.639 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.23 -48.91 79.74 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 121.449 0.642 . . . . 0.34 111.138 -179.768 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 75.2 t90 -58.75 -50.23 74.69 Favored 'General case' 0 CA--C 1.532 0.287 0 O-C-N 121.459 -0.776 . . . . 0.49 109.975 -179.987 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.71 -32.93 72.15 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 118.283 -0.865 . . . . 2.08 111.83 173.631 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -54.99 -31.49 60.95 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 119.85 1.204 . . . . 0.41 110.975 173.332 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -77.93 -38.34 45.7 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 118.342 -0.837 . . . . 3.28 112.448 169.534 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 42.6 mtpt -73.04 111.65 8.35 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 119.714 1.143 . . . . 2.49 111.162 -177.347 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 2.0 pttt . . . . . 0 C--O 1.251 1.149 0 C-N-CA 126.467 1.907 . . . . 2.33 107.175 177.514 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 93' ' ' HEC . . . . . 0.569 HMA1 HG23 ' A' ' 60' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 42.1 t . . . . . 0 N--CA 1.469 0.507 0 N-CA-C 106.986 -1.487 . . . . 1.51 106.986 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -74.54 110.9 9.2 Favored 'General case' 0 N--CA 1.454 -0.273 0 O-C-N 123.755 0.66 . . . . 2.21 109.462 -176.073 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -48.38 -52.72 20.52 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.94 0.896 . . . . 0.33 110.918 -179.325 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -58.78 -44.34 90.67 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 116.269 -0.423 . . . . 2.84 110.111 179.607 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.02 -43.27 99.14 Favored 'General case' 0 C--N 1.34 0.163 0 C-N-CA 122.719 0.408 . . . . 0.26 111.221 -179.675 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 77.7 t -58.4 -55.73 20.72 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.365 0 N-CA-C 108.923 -0.769 . . . . 0.38 108.923 175.432 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.553 HG13 ' HB2' ' A' ' 32' ' ' CYS . 50.9 t -54.6 -45.02 71.64 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 N-CA-C 110.331 -0.248 . . . . 0.27 110.331 -177.227 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.445 ' HA ' HG12 ' A' ' 33' ' ' ILE . 29.9 mm-40 -51.49 -26.28 8.02 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.927 1.691 . . . . 0.57 113.611 172.742 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -139.99 58.85 1.59 Allowed 'General case' 0 C--N 1.338 0.103 0 CA-C-N 119.851 1.205 . . . . 2.32 112.403 173.073 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -173.82 -36.74 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 123.866 0.867 . . . . 1.28 110.143 169.3 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.553 ' HB2' HG13 ' A' ' 28' ' ' VAL . 5.6 m -98.71 -51.67 3.84 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 118.958 0.799 . . . . 0.21 110.402 -177.923 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.445 HG12 ' HA ' ' A' ' 29' ' ' GLN . 2.2 pp -57.09 -26.67 25.57 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.08 0 CA-C-N 116.211 -0.449 . . . . 0.38 112.027 -176.414 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 50.3 m -37.82 -38.45 0.29 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.121 1.369 . . . . 1.06 112.194 170.989 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 22.5 m -120.23 -40.96 2.65 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.194 0.597 . . . . 0.18 111.549 174.625 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 84.1 m-70 -71.7 -8.93 57.2 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 112.766 0.654 . . . . 0.2 112.766 -176.15 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 86.09 150.15 14.8 Favored Glycine 0 C--N 1.338 0.66 0 N-CA-C 109.838 -1.305 . . . . 1.49 109.838 178.958 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -44.47 -36.91 4.63 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 124.558 1.075 . . . . 0.46 112.191 177.277 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -95.96 -3.82 44.43 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 124.691 1.196 . . . . 2.63 111.725 -172.831 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 8.7 mt 69.41 13.05 8.41 Favored 'General case' 0 C--N 1.35 0.607 0 CA-C-N 120.463 1.483 . . . . 1.1 111.316 176.126 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.4 p -86.03 -2.68 58.54 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 128.318 2.647 . . . . 0.3 109.9 -175.867 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.89 129.27 3.02 Favored Glycine 0 N--CA 1.441 -0.997 0 N-CA-C 108.827 -1.709 . . . . 0.53 108.827 -178.559 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -134.86 -78.42 0.45 Allowed 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 124.071 0.949 . . . . 0.29 108.773 178.662 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -90.72 3.58 53.89 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.148 0.979 . . . . 1.09 110.7 173.415 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.429 ' HB1' ' HD2' ' A' ' 46' ' ' PRO . . . -156.12 168.01 13.16 Favored Pre-proline 0 CA--C 1.537 0.45 0 C-N-CA 125.657 1.583 . . . . 0.23 108.078 -170.551 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.429 ' HD2' ' HB1' ' A' ' 45' ' ' ALA . 11.7 Cg_endo -67.11 168.79 16.54 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.698 2.266 . . . . 0.45 110.816 -178.793 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -85.19 124.46 31.87 Favored 'General case' 0 CA--C 1.53 0.199 0 O-C-N 121.234 -0.917 . . . . 0.26 110.883 -176.494 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 43.6 pt -100.41 0.09 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 C-N-CA 123.769 0.827 . . . . 0.48 111.312 178.942 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -36.87 -46.0 0.59 Allowed 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.807 1.243 . . . . 2.3 113.095 171.566 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.5 mttp -114.33 38.83 2.93 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.947 0.88 . . . . 3.56 110.573 -179.515 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.06 -50.08 74.76 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 118.641 -0.695 . . . . 0.31 109.432 175.106 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -54.3 -26.28 36.07 Favored Glycine 0 CA--C 1.528 0.878 0 CA-C-N 118.721 0.691 . . . . 0.56 113.695 -177.257 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -81.32 -44.23 17.95 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 117.507 0.653 . . . . 0.86 110.181 176.582 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 38.6 m-80 -62.08 -48.11 81.68 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 122.446 0.298 . . . . 1.7 110.934 178.12 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 -141.38 145.0 34.82 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.431 1.492 . . . . 0.65 108.731 -168.016 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 64.5 m -78.87 166.81 22.0 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.59 0.756 . . . . 1.59 111.118 179.659 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -43.96 -53.8 5.9 Favored 'General case' 0 C--N 1.342 0.266 0 C-N-CA 123.712 0.805 . . . . 4.55 110.927 177.52 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -51.1 -41.41 59.98 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 122.868 0.467 . . . . 4.08 111.387 -178.858 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -74.62 -48.48 26.19 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 123.32 0.648 . . . . 3.2 109.484 -177.484 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.483 HG23 HMA1 ' A' ' 93' ' ' HEC . 67.0 mt -60.76 -46.73 95.56 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.078 0 N-CA-C 108.935 -0.765 . . . . 0.22 108.935 -177.915 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 24.6 tp -52.04 -53.72 38.68 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 124.223 1.009 . . . . 0.39 109.367 175.819 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -53.5 -48.47 68.95 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 120.879 0.371 . . . . 1.94 110.846 175.471 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 71.3 mt -62.2 -26.58 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 O-C-N 121.385 -0.822 . . . . 0.76 112.32 179.842 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.493 HD11 HMB2 ' A' ' 93' ' ' HEC . 54.8 mt -75.12 -50.7 23.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 O-C-N 120.131 -1.606 . . . . 0.2 108.297 173.048 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 88.4 mt -62.62 -32.65 73.71 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.793 1.237 . . . . 0.42 113.193 -177.376 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -128.08 20.06 6.42 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 119.697 1.135 . . . . 1.85 110.213 -166.031 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.411 ' CA ' ' HA2' ' A' ' 73' ' ' GLY . . . 33.81 -137.97 0.17 Allowed Glycine 0 CA--C 1.544 1.852 0 C-N-CA 126.638 2.066 . . . . 0.68 112.023 -167.282 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 164.68 141.22 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 126.45 1.9 . . . . 1.27 109.191 -177.785 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 29.06 -111.71 0.03 OUTLIER Glycine 0 C--N 1.347 1.177 0 C-N-CA 125.68 1.609 . . . . 0.6 114.294 -172.471 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -62.35 -30.34 75.87 Favored Glycine 0 CA--C 1.535 1.344 0 CA-C-N 117.655 0.727 . . . . 0.78 113.087 -179.414 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 5.9 ttt -70.41 122.08 85.35 Favored Pre-proline 0 CA--C 1.542 0.652 0 C-N-CA 125.114 1.366 . . . . 0.54 111.224 -179.079 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -62.87 -58.27 0.34 Allowed 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 124.275 3.317 . . . . 3.07 111.333 -172.32 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.411 ' HA2' ' CA ' ' A' ' 67' ' ' GLY . . . 120.8 148.33 7.98 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-O 122.205 0.891 . . . . 0.79 114.448 172.82 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 70.91 21.94 78.26 Favored Glycine 0 CA--C 1.526 0.768 0 CA-C-O 118.484 -1.176 . . . . 0.51 112.126 177.518 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.5 mt -47.12 -52.4 4.56 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 C-N-CA 129.052 2.941 . . . . 1.14 111.158 175.001 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -109.98 156.87 19.92 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.609 1.564 . . . . 0.28 108.903 164.375 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 17.9 mtmm -146.28 159.75 42.92 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 124.559 1.144 . . . . 3.22 110.403 171.565 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 61.59 -151.22 43.91 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 110.05 -1.22 . . . . 0.69 110.05 -177.586 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -46.76 -37.3 8.35 Favored 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 123.901 0.88 . . . . 0.8 112.01 179.69 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -51.84 -45.68 64.09 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.73 0.812 . . . . 2.08 110.691 176.169 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -81.15 -50.22 9.87 Favored 'General case' 0 N--CA 1.455 -0.186 0 O-C-N 121.786 -0.572 . . . . 0.26 110.937 177.379 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -53.4 -51.06 63.78 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.461 0.704 . . . . 2.39 111.455 -175.781 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.26 -46.13 86.58 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 122.567 0.347 . . . . 0.26 110.309 179.791 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.483 HG22 HG23 ' A' ' 28' ' ' VAL . 67.2 t -58.25 -54.71 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 CA-C-O 119.385 -0.341 . . . . 0.28 110.629 178.12 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -49.99 -50.42 47.12 Favored 'General case' 0 C--O 1.224 -0.266 0 C-N-CA 122.855 0.462 . . . . 0.25 111.023 176.397 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.57 -48.12 83.17 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 121.822 0.82 . . . . 0.39 110.723 -177.616 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.565 ' CE3' HD23 ' A' ' 88' ' ' LEU . 50.8 t90 -60.92 -43.79 98.1 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 121.79 0.805 . . . . 0.54 110.768 178.197 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.565 HD23 ' CE3' ' A' ' 87' ' ' TRP . 0.1 OUTLIER -64.28 -33.85 76.78 Favored 'General case' 0 C--O 1.223 -0.291 0 O-C-N 121.189 -0.945 . . . . 1.61 109.698 175.527 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.8 -42.19 97.75 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 118.54 0.609 . . . . 0.5 109.553 174.292 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -52.45 -50.78 61.96 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 118.108 -0.949 . . . . 3.24 110.307 168.151 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 26.5 mttm -70.5 111.96 6.42 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 118.955 0.798 . . . . 3.06 111.973 -173.755 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 26.9 mttp . . . . . 0 C--O 1.254 1.303 0 CA-C-O 116.277 -1.821 . . . . 3.04 106.485 -178.505 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 93' ' ' HEC . . . . . 0.493 HMB2 HD11 ' A' ' 64' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 5.4 t . . . . . 0 N--CA 1.469 0.51 0 N-CA-C 106.605 -1.628 . . . . 1.33 106.605 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -75.68 98.06 3.97 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 123.794 0.684 . . . . 2.59 109.22 -173.204 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -40.3 -56.0 2.07 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.896 1.278 . . . . 0.35 111.804 179.083 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -48.02 -48.38 32.93 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.451 0.701 . . . . 3.17 112.2 176.435 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.62 -42.27 98.2 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 123.025 0.53 . . . . 0.35 110.485 -179.043 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 61.5 t -61.83 -50.07 81.68 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 N-CA-C 109.768 -0.456 . . . . 0.44 109.768 176.1 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.453 HG21 ' CZ3' ' A' ' 87' ' ' TRP . 79.6 t -52.61 -49.9 43.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 C-N-CA 123.066 0.546 . . . . 0.53 109.593 178.379 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 30.3 mm-40 -54.29 -17.51 3.03 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.688 1.595 . . . . 0.58 114.298 173.517 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -149.15 58.14 1.02 Allowed 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 119.612 1.096 . . . . 3.89 111.853 -179.081 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.1 mttm 178.34 -35.34 0.01 OUTLIER 'General case' 0 C--O 1.225 -0.202 0 C-N-CA 126.233 1.813 . . . . 1.2 109.695 172.926 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 6.4 m -100.28 -53.07 3.21 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 118.949 0.795 . . . . 0.21 110.639 -177.115 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.471 HD12 ' N ' ' A' ' 34' ' ' SER . 2.0 pp -55.14 -26.96 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.111 0 CA-C-N 115.936 -0.574 . . . . 0.45 112.182 -177.94 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.471 ' N ' HD12 ' A' ' 33' ' ' ILE . 1.4 m -38.23 -37.15 0.26 Allowed 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 126.418 1.887 . . . . 1.24 112.434 171.313 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 39.5 m -120.52 -41.34 2.6 Favored 'General case' 0 C--N 1.341 0.201 0 C-N-CA 123.729 0.811 . . . . 0.18 111.741 173.519 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 85.1 m-70 -72.23 -6.78 45.37 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.33 0.652 . . . . 0.21 112.673 -175.735 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 87.1 148.16 12.85 Favored Glycine 0 C--N 1.337 0.633 0 N-CA-C 109.547 -1.421 . . . . 1.45 109.547 177.971 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -43.98 -33.11 2.56 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 124.71 1.148 . . . . 0.54 112.532 174.939 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -94.42 -9.88 34.23 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.582 1.553 . . . . 2.4 112.235 -172.839 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.434 ' CD2' HG22 ' A' ' 33' ' ' ILE . 1.5 mt 71.17 10.21 6.75 Favored 'General case' 0 C--N 1.348 0.516 0 CA-C-N 120.301 1.409 . . . . 1.46 111.395 179.563 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 11.9 p -86.43 0.28 54.46 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 127.206 2.202 . . . . 0.48 109.999 -175.753 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.87 132.42 2.95 Favored Glycine 0 N--CA 1.44 -1.083 0 N-CA-C 108.789 -1.724 . . . . 0.6 108.789 -177.024 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -136.73 -75.47 0.42 Allowed 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 124.122 0.969 . . . . 0.27 108.396 178.328 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -93.71 3.71 55.05 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.852 0.861 . . . . 1.35 110.859 174.615 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -160.53 163.89 20.58 Favored Pre-proline 0 CA--C 1.537 0.474 0 C-N-CA 125.799 1.64 . . . . 0.28 107.564 -166.093 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -69.37 158.87 55.89 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.952 2.435 . . . . 0.26 111.237 -174.124 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -74.5 125.17 28.01 Favored 'General case' 0 C--N 1.332 -0.164 0 O-C-N 121.675 -0.64 . . . . 0.29 111.045 -174.761 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 37.3 pt -103.98 -1.09 9.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-O 119.169 -0.443 . . . . 0.41 112.073 178.996 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -36.6 -40.32 0.25 Allowed 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.899 1.28 . . . . 2.74 113.721 171.548 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.6 mtpm? -119.47 36.62 4.43 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 124.548 1.139 . . . . 3.2 110.759 -178.085 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.53 -46.62 88.32 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 109.317 -0.623 . . . . 0.44 109.317 171.98 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -57.79 -14.94 17.39 Favored Glycine 0 CA--C 1.532 1.14 0 N-CA-C 114.76 0.664 . . . . 0.82 114.76 179.267 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -89.65 -45.41 9.36 Favored 'General case' 0 C--N 1.338 0.091 0 CA-C-N 119.048 1.424 . . . . 0.71 109.755 168.729 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -56.16 -54.33 46.47 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 122.608 0.363 . . . . 1.87 111.616 179.622 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -140.42 158.97 43.21 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.512 1.125 . . . . 0.64 109.563 -168.576 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 22.6 m -84.93 168.26 15.17 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.065 0.546 . . . . 1.53 110.825 178.217 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -50.72 -44.5 58.16 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 123.785 0.834 . . . . 3.0 111.908 -179.608 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -54.86 -46.26 74.68 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 119.116 0.871 . . . . 2.99 111.394 176.474 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 51.7 mm-40 -71.86 -47.17 54.81 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 121.751 0.786 . . . . 3.06 109.064 -173.511 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.502 HG23 HMA1 ' A' ' 93' ' ' HEC . 64.3 mt -60.51 -46.31 95.63 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 N-CA-C 108.644 -0.873 . . . . 0.26 108.644 178.75 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 38.9 tp -53.95 -51.35 64.12 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 109.087 -0.709 . . . . 0.35 109.087 176.626 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -53.57 -47.06 70.43 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 117.969 0.35 . . . . 1.47 111.208 177.561 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 62.0 mt -58.71 -46.86 90.36 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.295 0 O-C-N 121.341 -0.849 . . . . 0.46 110.844 175.431 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.429 HD11 HMB2 ' A' ' 93' ' ' HEC . 57.3 mt -58.6 -43.96 88.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 O-C-N 120.339 -1.476 . . . . 0.27 109.89 179.532 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 86.4 mt -71.45 -34.62 70.41 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.496 1.119 . . . . 0.41 113.321 -178.188 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 71.3 m-80 -119.43 16.8 13.0 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 120.069 1.304 . . . . 1.66 110.317 -168.532 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.519 ' N ' ' HA2' ' A' ' 73' ' ' GLY . . . 36.11 -142.46 0.15 Allowed Glycine 0 CA--C 1.536 1.404 0 C-N-CA 127.696 2.569 . . . . 0.62 111.106 -167.463 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 173.22 131.85 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 119.076 1.438 . . . . 1.29 109.216 -175.067 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 42.13 -119.14 1.81 Allowed Glycine 0 CA--C 1.534 1.224 0 CA-C-N 120.006 1.276 . . . . 0.49 112.687 -174.976 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -70.44 -19.35 76.11 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 123.561 0.6 . . . . 0.67 113.016 179.148 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.449 ' HB2' ' C1D' ' A' ' 93' ' ' HEC . 20.0 ttt -71.21 117.81 60.09 Favored Pre-proline 0 N--CA 1.452 -0.348 0 C-N-CA 124.404 1.081 . . . . 0.43 110.53 -179.584 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -78.26 122.09 5.53 Favored 'Trans proline' 0 N--CA 1.445 -1.349 0 C-N-CA 123.28 2.653 . . . . 2.17 110.732 179.986 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.519 ' HA2' ' N ' ' A' ' 67' ' ' GLY . . . -62.58 142.46 47.86 Favored Glycine 0 N--CA 1.442 -0.917 0 N-CA-C 115.503 0.961 . . . . 0.61 115.503 -175.285 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 77.95 33.49 41.18 Favored Glycine 0 CA--C 1.525 0.678 0 CA-C-N 114.01 -1.095 . . . . 0.37 111.135 174.889 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -56.49 -49.86 75.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.442 0 C-N-CA 124.899 1.28 . . . . 1.0 108.94 172.996 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -109.53 160.06 16.55 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.069 1.748 . . . . 0.35 109.879 164.314 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.1 mmtp -145.91 167.54 23.03 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 126.467 1.907 . . . . 2.37 108.922 177.21 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 50.31 -145.87 9.14 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 110.883 -0.887 . . . . 0.78 110.883 176.811 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -51.98 -34.9 44.46 Favored 'General case' 0 C--O 1.225 -0.199 0 CA-C-N 118.148 0.974 . . . . 0.77 112.045 176.517 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -57.52 -38.61 74.94 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 118.664 0.666 . . . . 2.18 110.118 177.598 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -83.18 -57.68 3.17 Favored 'General case' 0 N--CA 1.461 0.11 0 O-C-N 121.565 -0.71 . . . . 0.28 111.113 174.925 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -51.41 -49.37 61.76 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 124.887 1.275 . . . . 2.43 111.803 -176.123 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.22 -47.06 87.57 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 109.568 -0.53 . . . . 0.31 109.568 178.415 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.435 HG11 HMB1 ' A' ' 93' ' ' HEC . 56.0 t -57.48 -52.74 53.24 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.312 0 CA-C-O 119.226 -0.416 . . . . 0.27 110.842 178.961 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -52.28 -57.79 8.65 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.548 0.739 . . . . 0.22 111.519 176.561 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.71 -40.76 89.06 Favored 'General case' 0 C--O 1.226 -0.144 0 C-N-CA 123.032 0.533 . . . . 0.61 110.934 -177.062 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.453 ' CZ3' HG21 ' A' ' 28' ' ' VAL . 83.6 t90 -63.79 -52.17 61.49 Favored 'General case' 0 N--CA 1.449 -0.513 0 O-C-N 121.721 -0.612 . . . . 0.74 109.724 176.34 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.36 -27.41 64.16 Favored 'General case' 0 C--N 1.33 -0.277 0 O-C-N 120.675 -1.266 . . . . 1.96 112.167 176.413 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -56.8 -31.79 65.04 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 118.935 0.789 . . . . 0.53 111.988 170.026 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -74.66 -36.36 62.82 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 118.844 0.747 . . . . 4.98 111.052 172.002 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 11.9 mmtm -73.85 102.92 4.2 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 121.428 0.633 . . . . 3.72 110.193 -178.484 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.25 1.088 0 C-N-CA 125.339 1.456 . . . . 2.85 107.711 173.57 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 93' ' ' HEC . . . . . 0.502 HMA1 HG23 ' A' ' 60' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 69.1 t . . . . . 0 N--CA 1.471 0.607 0 N-CA-C 106.924 -1.51 . . . . 1.45 106.924 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -71.42 161.66 30.69 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 124.466 1.106 . . . . 3.9 108.191 -177.746 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -105.78 -62.39 1.37 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.053 -0.721 . . . . 0.4 109.053 173.22 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -55.04 -47.97 74.06 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 119.021 -0.514 . . . . 2.76 111.251 178.778 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.32 -41.58 93.82 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 118.95 0.796 . . . . 0.42 111.106 -176.731 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 73.6 t -59.93 -57.41 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 108.677 -0.86 . . . . 0.47 108.677 175.031 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.67 HG13 ' HB2' ' A' ' 32' ' ' CYS . 49.3 t -53.11 -48.37 53.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 CA-C-N 118.544 0.611 . . . . 0.33 110.885 -178.479 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 22.4 mm-40 -51.88 -16.21 0.67 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 127.032 2.133 . . . . 0.77 113.244 175.263 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -138.31 30.25 2.42 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 119.139 0.882 . . . . 2.62 111.812 173.431 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -146.59 -48.43 0.19 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 118.831 0.741 . . . . 2.17 111.103 176.481 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.67 ' HB2' HG13 ' A' ' 28' ' ' VAL . 3.5 m -93.45 -47.95 6.62 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 109.583 -0.525 . . . . 0.24 109.583 -174.6 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.3 pp -57.35 -25.74 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 CA-C-N 115.897 -0.592 . . . . 0.43 111.62 -178.451 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.1 m -41.89 -34.09 0.62 Allowed 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 126.157 1.783 . . . . 1.4 112.388 172.144 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 37.2 m -121.37 -42.43 2.46 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.454 0.702 . . . . 0.23 111.592 172.939 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 87.0 m-70 -72.93 -8.01 53.67 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.031 0.932 . . . . 0.24 113.161 -175.483 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 85.05 150.03 11.99 Favored Glycine 0 C--N 1.337 0.601 0 N-CA-C 110.028 -1.229 . . . . 1.58 110.028 178.699 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -43.83 -35.92 3.43 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 124.857 1.217 . . . . 0.48 112.558 178.227 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -93.12 -9.0 41.05 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.307 1.443 . . . . 2.07 112.41 -173.08 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.3 mt 71.41 9.49 6.49 Favored 'General case' 0 C--N 1.347 0.465 0 CA-C-N 120.254 1.388 . . . . 1.29 111.268 179.909 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.6 p -81.95 -2.47 51.53 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 127.764 2.425 . . . . 0.5 110.207 -177.205 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.54 150.31 25.18 Favored Glycine 0 N--CA 1.438 -1.169 0 N-CA-C 108.472 -1.851 . . . . 0.5 108.472 -174.597 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -156.77 -79.94 0.08 Allowed 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 124.477 1.111 . . . . 0.32 108.712 179.278 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.3 t -92.06 2.71 56.4 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.146 0.978 . . . . 1.26 110.379 172.963 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.437 ' HB1' ' HD2' ' A' ' 46' ' ' PRO . . . -158.62 163.89 22.86 Favored Pre-proline 0 N--CA 1.45 -0.47 0 C-N-CA 125.704 1.602 . . . . 0.27 107.494 -168.227 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.437 ' HD2' ' HB1' ' A' ' 45' ' ' ALA . 48.1 Cg_endo -69.01 162.47 41.57 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 123.63 2.887 . . . . 0.37 111.265 -174.207 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -74.76 122.49 23.37 Favored 'General case' 0 N--CA 1.455 -0.21 0 O-C-N 121.849 -0.532 . . . . 0.38 110.654 -176.072 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 33.8 pt -105.41 1.81 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.117 0 C-N-CA 123.717 0.807 . . . . 0.39 111.4 178.096 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -44.95 -45.45 10.48 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 112.982 0.734 . . . . 2.62 112.982 176.379 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.04 27.76 5.82 Favored 'General case' 0 C--N 1.343 0.303 0 C-N-CA 123.945 0.898 . . . . 4.04 111.582 178.63 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -56.17 -46.04 79.47 Favored 'General case' 0 N--CA 1.452 -0.352 0 O-C-N 121.62 -0.675 . . . . 0.27 109.502 177.07 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -53.47 -30.91 42.74 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 123.448 0.547 . . . . 0.49 113.313 -179.126 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -76.94 -42.32 39.77 Favored 'General case' 0 N--CA 1.455 -0.206 0 O-C-N 122.031 -0.687 . . . . 0.72 110.613 176.529 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 48.7 m-20 -66.05 -49.29 68.17 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 122.129 0.172 . . . . 1.53 111.034 -179.926 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -139.14 141.67 38.04 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 125.568 1.547 . . . . 0.68 107.837 -167.448 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 22.4 m -78.18 168.98 19.02 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 118.45 0.568 . . . . 1.59 110.363 179.65 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -50.82 -44.23 59.18 Favored 'General case' 0 C--O 1.224 -0.258 0 C-N-CA 123.346 0.658 . . . . 3.05 111.973 -179.593 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -54.92 -39.26 68.63 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 118.492 0.587 . . . . 2.9 111.67 176.98 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -78.67 -45.67 20.86 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 121.495 0.664 . . . . 3.49 109.47 -177.262 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 62.4 mt -59.11 -44.5 91.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 O-C-N 121.653 -0.654 . . . . 0.26 109.289 179.189 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 35.4 tp -55.33 -50.1 70.51 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 123.854 0.861 . . . . 0.32 109.453 176.174 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -50.98 -52.68 40.27 Favored 'General case' 0 N--CA 1.454 -0.235 0 O-C-N 123.312 0.382 . . . . 1.51 110.264 176.138 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 86.3 mt -56.8 -51.11 71.46 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.328 0 O-C-N 121.64 -0.663 . . . . 0.53 110.287 177.977 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.526 HD11 HMB2 ' A' ' 93' ' ' HEC . 71.0 mt -52.65 -44.78 47.16 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 O-C-N 120.47 -1.394 . . . . 0.22 110.486 179.247 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 79.4 mt -73.06 -32.57 65.13 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 113.164 0.801 . . . . 0.39 113.164 -179.087 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -121.96 20.6 10.76 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 119.591 1.087 . . . . 1.64 110.161 -165.539 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.54 ' N ' ' HA2' ' A' ' 73' ' ' GLY . . . 28.75 -139.43 0.02 OUTLIER Glycine 0 CA--C 1.534 1.268 0 C-N-CA 129.127 3.251 . . . . 0.68 111.524 -165.401 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 174.58 133.95 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 118.994 1.397 . . . . 1.2 107.935 -178.394 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 31.43 -110.04 0.04 OUTLIER Glycine 0 CA--C 1.535 1.282 0 C-N-CA 124.971 1.272 . . . . 0.34 114.246 -172.515 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -69.61 -24.11 76.37 Favored Glycine 0 CA--C 1.533 1.206 0 CA-C-N 118.114 0.957 . . . . 0.42 113.166 -178.328 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.405 ' HB2' ' C1D' ' A' ' 93' ' ' HEC . 18.1 ttt -70.99 120.03 76.96 Favored Pre-proline 0 N--CA 1.452 -0.371 0 C-N-CA 125.004 1.321 . . . . 0.35 111.039 -178.605 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.431 ' HD2' HD11 ' A' ' 75' ' ' ILE . 37.4 Cg_endo -75.62 122.33 6.85 Favored 'Trans proline' 0 N--CA 1.446 -1.304 0 C-N-CA 123.297 2.665 . . . . 2.05 111.135 178.933 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.54 ' HA2' ' N ' ' A' ' 67' ' ' GLY . . . -61.06 137.39 48.16 Favored Glycine 0 N--CA 1.442 -0.934 0 CA-C-N 115.271 -0.877 . . . . 0.67 114.833 -179.272 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 82.16 42.71 8.53 Favored Glycine 0 CA--C 1.524 0.632 0 CA-C-N 114.225 -0.988 . . . . 0.54 110.636 175.829 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.431 HD11 ' HD2' ' A' ' 72' ' ' PRO . 0.9 OUTLIER -63.66 -57.42 11.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 C-N-CA 124.379 1.072 . . . . 1.23 109.283 174.172 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -98.12 155.94 16.9 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.952 1.301 . . . . 0.4 109.383 166.08 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -146.0 151.37 37.67 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 124.322 1.049 . . . . 2.75 110.959 178.424 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 72.51 -163.62 54.69 Favored Glycine 0 CA--C 1.53 1.016 0 N-CA-C 110.747 -0.941 . . . . 0.83 110.747 -174.437 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -52.02 -24.13 6.2 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.737 1.215 . . . . 0.95 112.718 -179.061 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 47.9 tt0 -43.99 -63.16 0.92 Allowed 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.736 1.215 . . . . 2.61 110.283 167.903 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.45 -45.09 94.93 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.189 0.596 . . . . 0.23 110.271 -176.275 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -53.81 -54.07 43.58 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.742 0.817 . . . . 1.99 110.979 178.001 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -56.41 -49.51 74.3 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 123.811 0.844 . . . . 0.31 109.764 -179.824 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.456 HG22 HG23 ' A' ' 28' ' ' VAL . 69.2 t -54.99 -52.77 40.58 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-N 116.939 -0.119 . . . . 0.3 111.26 176.802 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -54.63 -52.02 63.57 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.38 0.672 . . . . 0.18 111.919 -179.881 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -56.99 -48.06 79.33 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 121.553 0.692 . . . . 0.3 110.555 177.226 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.539 ' CE3' HD23 ' A' ' 88' ' ' LEU . 54.6 t90 -57.08 -44.97 83.64 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 121.71 -0.619 . . . . 0.5 110.548 177.778 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.539 HD23 ' CE3' ' A' ' 87' ' ' TRP . 0.1 OUTLIER -63.89 -37.38 87.17 Favored 'General case' 0 N--CA 1.461 0.088 0 C-N-CA 124.749 1.22 . . . . 1.6 111.599 177.203 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -54.69 -38.44 67.01 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 119.216 0.916 . . . . 0.55 110.432 169.552 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -88.76 26.2 1.58 Allowed 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 113.473 0.916 . . . . 3.31 113.473 171.795 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 2.1 mtpm? -122.05 117.88 27.41 Favored 'General case' 0 C--N 1.341 0.239 0 O-C-N 120.647 -1.283 . . . . 2.26 110.218 165.854 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.256 1.405 0 C-N-CA 129.535 3.134 . . . . 2.83 104.738 174.483 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 93' ' ' HEC . . . . . 0.526 HMB2 HD11 ' A' ' 64' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 stop_ save_